#Chr	Start	End	Ref	Alt	Ref.Gene	Func.refGene	ExonicFunc.refGene	Gene.ensGene	avsnp150	AAChange.ensGene	AAChange.refGene	clinvar: Clinvar 	 CancerVar: CancerVar and Evidence 	Freq_ExAC_ALL	Freq_esp6500siv2_all	Freq_1000g2015aug_all	Freq_gnomAD_genome_ALL	CADD_raw	CADD_phred	SIFT_score	GERP++_RS	phastCons20way_mammalian	dbscSNV_ADA_SCORE	dbscSNV_RF_SCORE	Interpro_domain	AAChange.knownGene	MetaSVM_score	Freq_gnomAD_genome_POPs	OMIM	Phenotype_MIM	OrphaNumber	Orpha	Pathway	Therap_list	Diag_list	Prog_list	Polyphen2_HDIV_score	FATHMM_score	MetaLR_score	MutationAssessor_score	cosmic91	icgc28	Otherinfo
1	2488153	2488153	A	G	TNFRSF14	exonic	nonsynonymous SNV	ENSG00000157873	rs4870	ENSG00000157873:ENST00000355716:exon1:c.A50G:p.K17R,ENSG00000157873:ENST00000409119:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000426449:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000434817:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000435221:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000451778:exon2:c.A50G:p.K17R	TNFRSF14:NM_001297605:exon1:c.A50G:p.K17R,TNFRSF14:NM_003820:exon1:c.A50G:p.K17R	clinvar: not_provided 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5443	0.5580	0.614816	MU4560918	-0.182	1.198	0.471	-1.09	0.000	.	.	.	TNFRSF14:uc001ajr.3:exon1:c.A50G:p.K17R,TNFRSF14:uc009vlf.1:exon1:c.A50G:p.K17R,TNFRSF14:uc010nzc.1:exon1:c.A50G:p.K17R	-0.931	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,AMR:0.5446,EAS:0.5143,FIN:0.4467,NFE:0.4609,OTH:0.4842,ASJ:0.7156	602746	.	.	.	.	.	.	.	0.61	-2.37	0.000	1.175	1	1(pancreas)	0.4735
1	2490898	2490898	C	A	TNFRSF14	intronic	.	ENSG00000157873	rs2257763	.	.	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5899	.	0.640775	0.5671	.	.	.	.	.	.	.	.	TNFRSF14:uc001ajt.1:exon3:c.C450A:p.C150X	.	AFR:0.7517,AMR:0.5358,EAS:0.5143,FIN:0.5020,NFE:0.4867,OTH:0.5307,ASJ:0.4603	602746	.	.	.	.	.	.	.	.	.	.	.	1	MU15519966	hom
1	2490942	2490942	C	A	TNFRSF14	intronic	.	ENSG00000157873	rs2281852	.	.	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5713	.	0.597843	ESAD-UK|2|409|0.00488998,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	TNFRSF14:uc001ajt.1:exon3:c.C494A:p.A165E	.	AFR:0.5331,AMR:0.6520,EAS:0.4570,FIN:0.4611,NFE:0.4991,OTH:0.4821,ASJ:0.5251	602746	.	.	.	.	.	.	.	.	.	.	.	1	1(lung)	0.5256
1	2491205	2491205	C	T	TNFRSF14	intronic	.	ENSG00000157873	rs2234161	.	.	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6596	.	0.64397	12(central_nervous_system)	.	.	.	.	.	.	.	.	TNFRSF14:uc001ajt.1:exon3:c.C757T:p.R253C	.	AFR:MU15520040,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.7639,FIN:0.5358,NFE:0.4603,OTH:0.5130,ASJ:0.5704	602746	.	.	.	.	.	.	.	.	.	.	.	1	1(lung)	0.5006
1	2494645	2494645	C	T	TNFRSF14	exonic	nonsynonymous SNV	ENSG00000157873	rs371087831	ENSG00000157873:ENST00000355716:exon8:c.C785T:p.P262L	TNFRSF14:NM_003820:exon8:c.C785T:p.P262L	clinvar: not_provided 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 1, 1, 0] 	0.0014	7.7e-05	0.00159744	3.233e-05	2.806	21.4	0.0	1.96	0.011	.	.	.	TNFRSF14:uc001ajr.3:exon8:c.C785T:p.P262L	-0.374	AFR:0,AMR:0.0012,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	602746	.	.	.	.	.	.	.	0.997	-2.17	0.559	1.845	1	MU124751	het
1	3301721	3301721	C	T	PRDM16	exonic	synonymous SNV	ENSG00000142611	rs2282198	ENSG00000142611:ENST00000463591:exon2:c.C12T:p.S4S,ENSG00000142611:ENST00000270722:exon4:c.C444T:p.S148S,ENSG00000142611:ENST00000378391:exon4:c.C444T:p.S148S,ENSG00000142611:ENST00000378398:exon4:c.C444T:p.S148S,ENSG00000142611:ENST00000441472:exon4:c.C444T:p.S148S,ENSG00000142611:ENST00000442529:exon4:c.C444T:p.S148S,ENSG00000142611:ENST00000511072:exon4:c.C447T:p.S149S,ENSG00000142611:ENST00000514189:exon4:c.C447T:p.S149S	PRDM16:NM_022114:exon4:c.C444T:p.S148S,PRDM16:NM_199454:exon4:c.C444T:p.S148S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3295	0.2049	0.340455	1(lung)	.	.	.	.	.	.	.	.	PRDM16:uc001akc.3:exon4:c.C444T:p.S148S,PRDM16:uc001ake.3:exon4:c.C444T:p.S148S,PRDM16:uc001akf.3:exon4:c.C444T:p.S148S	.	AFR:1(thyroid),AMR:MU4547297,EAS:0.2446,FIN:0.0786,NFE:0.3816,OTH:0.2649,ASJ:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BTCA-JP|1|239|0.0041841	605557	615373;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	1	1(liver)	0.6075
1	3328358	3328358	T	C	PRDM16	exonic	nonsynonymous SNV	ENSG00000142611	rs870124	ENSG00000142611:ENST00000509860:exon5:c.T1024C:p.S342P,ENSG00000142611:ENST00000270722:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000378391:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000441472:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000442529:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000511072:exon9:c.T1600C:p.S534P,ENSG00000142611:ENST00000514189:exon9:c.T1600C:p.S534P,ENSG00000142611:ENST00000378398:exon10:c.T1600C:p.S534P	PRDM16:NM_022114:exon9:c.T1597C:p.S533P,PRDM16:NM_199454:exon9:c.T1597C:p.S533P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8897	0.8777	0.945088	0.9008	-0.543	0.172	0.651	5.33	0.826	.	.	.	PRDM16:uc001akc.3:exon9:c.T1597C:p.S533P,PRDM16:uc001ake.3:exon9:c.T1597C:p.S533P,PRDM16:uc001akf.3:exon9:c.T1597C:p.S533P,PRDM16:uc009vlh.3:exon9:c.T700C:p.S234P	-0.955	AFR:0.9696,AMR:0.9332,EAS:0.9994,FIN:0.9196,NFE:0.8459,OTH:0.8794,ASJ:0.86	605557	615373;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	0.0	3.38	0.000	-1.7	1	MU113190	hom
1	6529188	6529188	C	T	PLEKHG5	exonic	synonymous SNV	ENSG00000171680	rs62639695	ENSG00000171680:ENST00000340850:exon19:c.G2163A:p.E721E,ENSG00000171680:ENST00000377725:exon19:c.G2163A:p.E721E,ENSG00000171680:ENST00000377728:exon19:c.G2163A:p.E721E,ENSG00000171680:ENST00000377732:exon19:c.G2274A:p.E758E,ENSG00000171680:ENST00000400913:exon19:c.G2163A:p.E721E,ENSG00000171680:ENST00000535355:exon19:c.G2370A:p.E790E,ENSG00000171680:ENST00000377737:exon20:c.G2163A:p.E721E,ENSG00000171680:ENST00000377740:exon20:c.G2394A:p.E798E,ENSG00000171680:ENST00000377748:exon20:c.G2394A:p.E798E,ENSG00000171680:ENST00000400915:exon20:c.G2331A:p.E777E,ENSG00000171680:ENST00000537245:exon20:c.G2400A:p.E800E,ENSG00000171680:ENST00000544978:exon20:c.G2163A:p.E721E	PLEKHG5:NM_001042664:exon19:c.G2163A:p.E721E,PLEKHG5:NM_001042665:exon19:c.G2163A:p.E721E,PLEKHG5:NM_001265593:exon19:c.G2370A:p.E790E,PLEKHG5:NM_001265594:exon19:c.G2163A:p.E721E,PLEKHG5:NM_020631:exon19:c.G2163A:p.E721E,PLEKHG5:NM_001042663:exon20:c.G2331A:p.E777E,PLEKHG5:NM_001265592:exon20:c.G2400A:p.E800E,PLEKHG5:NM_198681:exon20:c.G2394A:p.E798E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0794	0.1253	0.120008	0.0970	.	.	.	.	.	.	.	.	PLEKHG5:uc001anj.1:exon7:c.G846A:p.E282E,PLEKHG5:uc009vma.1:exon17:c.G1683A:p.E561E,PLEKHG5:uc001ank.1:exon19:c.G2163A:p.E721E,PLEKHG5:uc001anl.2:exon19:c.G2163A:p.E721E,PLEKHG5:uc001anm.2:exon19:c.G2163A:p.E721E,PLEKHG5:uc001ann.1:exon19:c.G2274A:p.E758E,PLEKHG5:uc009vmb.2:exon19:c.G2163A:p.E721E,PLEKHG5:uc010nzr.1:exon19:c.G2370A:p.E790E,PLEKHG5:uc001ano.1:exon20:c.G2331A:p.E777E,PLEKHG5:uc001anp.2:exon20:c.G2394A:p.E798E,PLEKHG5:uc001anq.2:exon20:c.G2394A:p.E798E,PLEKHG5:uc031plb.1:exon20:c.G2400A:p.E800E	.	AFR:0.1626,AMR:0.0467,EAS:0,FIN:0.0798,NFE:0.0814,OTH:0.0742,ASJ:0.0530	611101	611067;615376;	369867;206580;	369867|RI-CMT type C|<1 / 1 000 000|Autosomal recessive|All ages<br>Childhood<br>Adult|615376 ~206580|Autosomal recessive distal spinal muscular atrophy type 4<br>Distal spinal muscular atrophy type 4<br>dSMA4|<1 / 1 000 000|Autosomal recessive|Childhood|611067 ~	~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	1	.	het
1	6529443	6529443	A	G	PLEKHG5	exonic	synonymous SNV	ENSG00000171680	rs730600	ENSG00000171680:ENST00000340850:exon18:c.T2001C:p.S667S,ENSG00000171680:ENST00000377725:exon18:c.T2001C:p.S667S,ENSG00000171680:ENST00000377728:exon18:c.T2001C:p.S667S,ENSG00000171680:ENST00000377732:exon18:c.T2112C:p.S704S,ENSG00000171680:ENST00000400913:exon18:c.T2001C:p.S667S,ENSG00000171680:ENST00000535355:exon18:c.T2208C:p.S736S,ENSG00000171680:ENST00000377737:exon19:c.T2001C:p.S667S,ENSG00000171680:ENST00000377740:exon19:c.T2232C:p.S744S,ENSG00000171680:ENST00000377748:exon19:c.T2232C:p.S744S,ENSG00000171680:ENST00000400915:exon19:c.T2169C:p.S723S,ENSG00000171680:ENST00000537245:exon19:c.T2238C:p.S746S,ENSG00000171680:ENST00000544978:exon19:c.T2001C:p.S667S	PLEKHG5:NM_001042664:exon18:c.T2001C:p.S667S,PLEKHG5:NM_001042665:exon18:c.T2001C:p.S667S,PLEKHG5:NM_001265593:exon18:c.T2208C:p.S736S,PLEKHG5:NM_001265594:exon18:c.T2001C:p.S667S,PLEKHG5:NM_020631:exon18:c.T2001C:p.S667S,PLEKHG5:NM_001042663:exon19:c.T2169C:p.S723S,PLEKHG5:NM_001265592:exon19:c.T2238C:p.S746S,PLEKHG5:NM_198681:exon19:c.T2232C:p.S744S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1723	0.2872	0.269569	0.2653	.	.	.	.	.	.	.	.	PLEKHG5:uc001anj.1:exon6:c.T684C:p.S228S,PLEKHG5:uc009vma.1:exon16:c.T1521C:p.S507S,PLEKHG5:uc001ank.1:exon18:c.T2001C:p.S667S,PLEKHG5:uc001anl.2:exon18:c.T2001C:p.S667S,PLEKHG5:uc001anm.2:exon18:c.T2001C:p.S667S,PLEKHG5:uc001ann.1:exon18:c.T2112C:p.S704S,PLEKHG5:uc009vmb.2:exon18:c.T2001C:p.S667S,PLEKHG5:uc010nzr.1:exon18:c.T2208C:p.S736S,PLEKHG5:uc001ano.1:exon19:c.T2169C:p.S723S,PLEKHG5:uc001anp.2:exon19:c.T2232C:p.S744S,PLEKHG5:uc001anq.2:exon19:c.T2232C:p.S744S,PLEKHG5:uc031plb.1:exon19:c.T2238C:p.S746S	.	AFR:0.5904,AMR:0.1169,EAS:0,FIN:0.1584,NFE:0.1460,OTH:0.1833,ASJ:0.1424	611101	611067;615376;	369867;206580;	369867|RI-CMT type C|<1 / 1 000 000|Autosomal recessive|All ages<br>Childhood<br>Adult|615376 ~206580|Autosomal recessive distal spinal muscular atrophy type 4<br>Distal spinal muscular atrophy type 4<br>dSMA4|<1 / 1 000 000|Autosomal recessive|Childhood|611067 ~	~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	1	.	het
1	6529748	6529748	G	T	PLEKHG5	intronic	.	ENSG00000171680	rs943584	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0776	0.1131	0.0990415	0.1098	.	.	.	.	.	0.0003	0.064	.	.	.	AFR:0.2139,AMR:0.0443,EAS:0,FIN:0.0770,NFE:0.0764,OTH:0.0716,ASJ:0.0364	611101	611067;615376;	369867;206580;	369867|RI-CMT type C|<1 / 1 000 000|Autosomal recessive|All ages<br>Childhood<br>Adult|615376 ~206580|Autosomal recessive distal spinal muscular atrophy type 4<br>Distal spinal muscular atrophy type 4<br>dSMA4|<1 / 1 000 000|Autosomal recessive|Childhood|611067 ~	~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	1	.	het
1	6530435	6530435	A	G	PLEKHG5	intronic	.	ENSG00000171680	rs2986753	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1355	0.1971	0.171725	0.1807	.	.	.	.	.	.	.	.	.	.	AFR:0.3435,AMR:0.1026,EAS:0,FIN:0.0997,NFE:0.1327,OTH:0.1418,ASJ:0.1233	611101	611067;615376;	369867;206580;	369867|RI-CMT type C|<1 / 1 000 000|Autosomal recessive|All ages<br>Childhood<br>Adult|615376 ~206580|Autosomal recessive distal spinal muscular atrophy type 4<br>Distal spinal muscular atrophy type 4<br>dSMA4|<1 / 1 000 000|Autosomal recessive|Childhood|611067 ~	~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	1	.	het
1	6531124	6531124	T	C	PLEKHG5	exonic	nonsynonymous SNV	ENSG00000171680	rs61740145	ENSG00000171680:ENST00000340850:exon13:c.A1318G:p.M440V,ENSG00000171680:ENST00000377725:exon13:c.A1318G:p.M440V,ENSG00000171680:ENST00000377728:exon13:c.A1318G:p.M440V,ENSG00000171680:ENST00000377732:exon13:c.A1429G:p.M477V,ENSG00000171680:ENST00000400913:exon13:c.A1318G:p.M440V,ENSG00000171680:ENST00000535355:exon13:c.A1525G:p.M509V,ENSG00000171680:ENST00000377737:exon14:c.A1318G:p.M440V,ENSG00000171680:ENST00000377740:exon14:c.A1549G:p.M517V,ENSG00000171680:ENST00000377748:exon14:c.A1549G:p.M517V,ENSG00000171680:ENST00000400915:exon14:c.A1486G:p.M496V,ENSG00000171680:ENST00000537245:exon14:c.A1555G:p.M519V,ENSG00000171680:ENST00000544978:exon14:c.A1318G:p.M440V	PLEKHG5:NM_001042664:exon13:c.A1318G:p.M440V,PLEKHG5:NM_001042665:exon13:c.A1318G:p.M440V,PLEKHG5:NM_001265593:exon13:c.A1525G:p.M509V,PLEKHG5:NM_001265594:exon13:c.A1318G:p.M440V,PLEKHG5:NM_020631:exon13:c.A1318G:p.M440V,PLEKHG5:NM_001042663:exon14:c.A1486G:p.M496V,PLEKHG5:NM_001265592:exon14:c.A1555G:p.M519V,PLEKHG5:NM_198681:exon14:c.A1549G:p.M517V	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 1, 0] 	0.0875	0.0608	0.048123	0.0615	3.276	22.8	0.084	5.11	1.000	.	.	Dbl homology (DH) domain	PLEKHG5:uc001anj.1:exon1:c.A1G:p.M1V,PLEKHG5:uc009vma.1:exon11:c.A838G:p.M280V,PLEKHG5:uc001ank.1:exon13:c.A1318G:p.M440V,PLEKHG5:uc001anl.2:exon13:c.A1318G:p.M440V,PLEKHG5:uc001anm.2:exon13:c.A1318G:p.M440V,PLEKHG5:uc001ann.1:exon13:c.A1429G:p.M477V,PLEKHG5:uc009vmb.2:exon13:c.A1318G:p.M440V,PLEKHG5:uc010nzr.1:exon13:c.A1525G:p.M509V,PLEKHG5:uc001ano.1:exon14:c.A1486G:p.M496V,PLEKHG5:uc001anp.2:exon14:c.A1549G:p.M517V,PLEKHG5:uc001anq.2:exon14:c.A1549G:p.M517V,PLEKHG5:uc031plb.1:exon14:c.A1555G:p.M519V	-0.957	AFR:0.0438,AMR:0.0384,EAS:0,FIN:0.0769,NFE:0.0764,OTH:0.0648,ASJ:0.0364	611101	611067;615376;	369867;206580;	369867|RI-CMT type C|<1 / 1 000 000|Autosomal recessive|All ages<br>Childhood<br>Adult|615376 ~206580|Autosomal recessive distal spinal muscular atrophy type 4<br>Distal spinal muscular atrophy type 4<br>dSMA4|<1 / 1 000 000|Autosomal recessive|Childhood|611067 ~	~ko05200 Pathways in cancer ~	.	.	.	0.009	0.01	0.034	1.76	1	.	het
1	6533393	6533393	G	C	PLEKHG5	exonic	nonsynonymous SNV	ENSG00000171680	rs61741379	ENSG00000171680:ENST00000340850:exon8:c.C713G:p.T238S,ENSG00000171680:ENST00000377725:exon8:c.C713G:p.T238S,ENSG00000171680:ENST00000377728:exon8:c.C713G:p.T238S,ENSG00000171680:ENST00000377732:exon8:c.C824G:p.T275S,ENSG00000171680:ENST00000400913:exon8:c.C713G:p.T238S,ENSG00000171680:ENST00000535355:exon8:c.C920G:p.T307S,ENSG00000171680:ENST00000377737:exon9:c.C713G:p.T238S,ENSG00000171680:ENST00000377740:exon9:c.C944G:p.T315S,ENSG00000171680:ENST00000377748:exon9:c.C944G:p.T315S,ENSG00000171680:ENST00000400915:exon9:c.C881G:p.T294S,ENSG00000171680:ENST00000537245:exon9:c.C950G:p.T317S,ENSG00000171680:ENST00000544978:exon9:c.C713G:p.T238S	PLEKHG5:NM_001042664:exon8:c.C713G:p.T238S,PLEKHG5:NM_001042665:exon8:c.C713G:p.T238S,PLEKHG5:NM_001265593:exon8:c.C920G:p.T307S,PLEKHG5:NM_001265594:exon8:c.C713G:p.T238S,PLEKHG5:NM_020631:exon8:c.C713G:p.T238S,PLEKHG5:NM_001042663:exon9:c.C881G:p.T294S,PLEKHG5:NM_001265592:exon9:c.C950G:p.T317S,PLEKHG5:NM_198681:exon9:c.C944G:p.T315S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2212	0.2727	0.285743	.	-1.995	0.001	1.0	0.976	0.000	.	.	.	PLEKHG5:uc009vma.1:exon6:c.C233G:p.T78S,PLEKHG5:uc001ank.1:exon8:c.C713G:p.T238S,PLEKHG5:uc001anl.2:exon8:c.C713G:p.T238S,PLEKHG5:uc001anm.2:exon8:c.C713G:p.T238S,PLEKHG5:uc001ann.1:exon8:c.C824G:p.T275S,PLEKHG5:uc009vmb.2:exon8:c.C713G:p.T238S,PLEKHG5:uc010nzr.1:exon8:c.C920G:p.T307S,PLEKHG5:uc001ano.1:exon9:c.C881G:p.T294S,PLEKHG5:uc001anp.2:exon9:c.C944G:p.T315S,PLEKHG5:uc001anq.2:exon9:c.C944G:p.T315S,PLEKHG5:uc031plb.1:exon9:c.C950G:p.T317S	-0.968	AFR:0.2792,AMR:0.6409,EAS:0.1391,FIN:0.0019,NFE:0.1577,OTH:0.1454,ASJ:0.1205	611101	611067;615376;	369867;206580;	369867|RI-CMT type C|<1 / 1 000 000|Autosomal recessive|All ages<br>Childhood<br>Adult|615376 ~206580|Autosomal recessive distal spinal muscular atrophy type 4<br>Distal spinal muscular atrophy type 4<br>dSMA4|<1 / 1 000 000|Autosomal recessive|Childhood|611067 ~	~ko05200 Pathways in cancer ~	.	.	.	0.0	-0.09	0.000	0	1	2(thyroid)	0.1816
1	6704635	6704635	A	G	DNAJC11	exonic	synonymous SNV	ENSG00000007923	rs200458	ENSG00000007923:ENST00000377573:exon9:c.T810C:p.G270G,ENSG00000007923:ENST00000294401:exon10:c.T1080C:p.G360G,ENSG00000007923:ENST00000377577:exon10:c.T1080C:p.G360G,ENSG00000007923:ENST00000542246:exon10:c.T966C:p.G322G	DNAJC11:NM_018198:exon10:c.T1080C:p.G360G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8836	0.9000	0.833067	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	DNAJC11:uc010nzu.1:exon9:c.T810C:p.G270G,DNAJC11:uc001aof.2:exon10:c.T1080C:p.G360G,DNAJC11:uc001aog.2:exon10:c.T1080C:p.G360G	.	AFR:0.8748,AMR:0.8724,EAS:0.8841,FIN:0.5730,NFE:0.8712,OTH:0.9033,ASJ:0.9499	614827	.	.	.	.	.	.	.	.	.	.	.	1	1(lung)	0.9041
1	6947717	6947717	C	T	CAMTA1	exonic	nonsynonymous SNV	ENSG00000171735	rs3810982	ENSG00000171735:ENST00000557126:exon4:c.C238T:p.L80F	CAMTA1:NM_001242701:exon4:c.C238T:p.L80F	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1909	.	0.208267	0.1898	2.631	20.4	0.005	3.21	1.000	.	.	CG-1 DNA-binding domain	CAMTA1:uc021ofq.1:exon4:c.C238T:p.L80F	-0.952	AFR:0.1976,AMR:0.1029,EAS:0.2621,FIN:0.2021,NFE:0.1813,OTH:0.1527,ASJ:0.2185	611501	614756;	314647;	314647|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614756 ~	.	.	.	.	.	.	0.000	.	1	MU4566693	het
1	7430266	7430266	C	T	CAMTA1	intronic	.	ENSG00000237402	rs3752542	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.29393	0.1749	.	.	.	.	.	.	.	.	.	.	AFR:0.1209,AMR:0.3186,EAS:0.5284,FIN:0.1766,NFE:0.1603,OTH:0.1772,ASJ:0.1424	611501	614756;	314647;	314647|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614756 ~	.	.	.	.	.	.	.	.	1	MU15700596	het
1	7723407	7723407	C	-	CAMTA1	intronic	.	ENSG00000171735	rs200318010	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0088	0.0071	0.0071885	0.0067	.	.	.	.	.	.	.	.	.	.	AFR:0.0010,AMR:0.0095,EAS:0,FIN:0.0054,NFE:0.0106,OTH:0.0112,ASJ:0.0033	611501	614756;	314647;	314647|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614756 ~	.	.	.	.	.	.	.	.	1	.	het
1	7723957	7723957	G	A	CAMTA1	exonic	synonymous SNV	ENSG00000171735	rs12128526	ENSG00000171735:ENST00000303635:exon9:c.G1350A:p.S450S,ENSG00000171735:ENST00000439411:exon9:c.G1350A:p.S450S	CAMTA1:NM_001349608:exon8:c.G1260A:p.S420S,CAMTA1:NM_001349612:exon8:c.G1260A:p.S420S,CAMTA1:NM_001349609:exon9:c.G1350A:p.S450S,CAMTA1:NM_001349610:exon9:c.G1350A:p.S450S,CAMTA1:NM_015215:exon9:c.G1350A:p.S450S	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4450	0.4300	0.40016	1(large_intestine)	.	.	.	.	.	.	.	.	CAMTA1:uc001aoi.3:exon9:c.G1350A:p.S450S	.	AFR:MU110401,AMR:LAML-KR|4|205|0.0195122,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,EAS:0.3886,FIN:0.4964,NFE:0.4333,OTH:0.3456,ASJ:0.4396	611501	614756;	314647;	314647|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614756 ~	.	.	.	.	.	.	.	.	1	2(lung)	0.4891
1	7737799	7737799	A	G	CAMTA1	intronic	.	ENSG00000171735	rs3011926	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5498	0.5563	0.591653	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.5458,AMR:0.5805,EAS:0.6093,FIN:0.6447,NFE:0.4857,OTH:0.5329,ASJ:0.4773	611501	614756;	314647;	314647|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614756 ~	.	.	.	.	.	.	.	.	1	1(biliary_tract)	0.5236
1	9784423	9784423	C	T	PIK3CD	exonic	synonymous SNV	ENSG00000171608	rs11121484	ENSG00000171608:ENST00000361110:exon21:c.C2880T:p.Y960Y,ENSG00000171608:ENST00000377346:exon22:c.C2808T:p.Y936Y,ENSG00000171608:ENST00000536656:exon22:c.C2880T:p.Y960Y	PIK3CD:NM_001350235:exon21:c.C2721T:p.Y907Y,PIK3CD:NM_001350234:exon22:c.C2805T:p.Y935Y,PIK3CD:NM_005026:exon22:c.C2808T:p.Y936Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1730	0.2305	0.305911	2(large_intestine)	.	.	.	.	.	.	.	.	PIK3CD:uc001aqe.4:exon21:c.C2880T:p.Y960Y,PIK3CD:uc010oaf.2:exon21:c.C2805T:p.Y935Y,PIK3CD:uc021ogb.1:exon21:c.C2160T:p.Y720Y,PIK3CD:uc001aqb.4:exon22:c.C2808T:p.Y936Y	.	AFR:MU130633,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,EAS:0.5410,FIN:0.1993,NFE:0.0861,OTH:0.1187,ASJ:0.2123	602839	615513;	397596;	397596|APDS<br>Senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adult|615513 616005 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04361 Axon regeneration~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	1	1(lung)	0.0613
1	10318652	10318652	C	G	KIF1B	exonic	synonymous SNV	ENSG00000054523	rs12402052	ENSG00000054523:ENST00000377081:exon3:c.C285G:p.A95A,ENSG00000054523:ENST00000263934:exon4:c.C285G:p.A95A,ENSG00000054523:ENST00000377083:exon4:c.C285G:p.A95A,ENSG00000054523:ENST00000377086:exon4:c.C285G:p.A95A,ENSG00000054523:ENST00000377093:exon4:c.C285G:p.A95A	KIF1B:NM_001365951:exon4:c.C285G:p.A95A,KIF1B:NM_001365952:exon4:c.C285G:p.A95A,KIF1B:NM_001365953:exon4:c.C285G:p.A95A,KIF1B:NM_015074:exon4:c.C285G:p.A95A,KIF1B:NM_183416:exon4:c.C285G:p.A95A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2689	0.2273	0.230032	MU102638	.	.	.	.	.	.	.	.	KIF1B:uc001aqy.3:exon3:c.C285G:p.A95A,KIF1B:uc001aqz.3:exon3:c.C285G:p.A95A,KIF1B:uc001ara.3:exon3:c.C285G:p.A95A,KIF1B:uc001arb.3:exon3:c.C285G:p.A95A,KIF1B:uc001aqv.4:exon4:c.C285G:p.A95A,KIF1B:uc001aqw.4:exon4:c.C285G:p.A95A,KIF1B:uc001aqx.4:exon4:c.C285G:p.A95A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,AMR:0.2391,EAS:0.3198,FIN:0.2947,NFE:0.2910,OTH:0.3039,ASJ:0.0905	605995	118210;171300;256700;	635;29072;99946;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~99946|CMT2A1|<1 / 1 000 000|Autosomal dominant|Childhood|118210 ~	.	.	.	.	.	.	.	.	1	2(stomach)	0.2973
1	10328338	10328338	C	T	KIF1B	intronic	.	ENSG00000054523	rs1339458	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2847	0.2482	0.253994	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:MU579964,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,EAS:0.1529,FIN:0.3242,NFE:0.2947,OTH:0.2944,ASJ:0.2570	605995	118210;171300;256700;	635;29072;99946;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~99946|CMT2A1|<1 / 1 000 000|Autosomal dominant|Childhood|118210 ~	.	.	.	.	.	.	.	.	1	1(stomach)	0.3036
1	10339210	10339211	AT	-	KIF1B	intronic	.	ENSG00000054523	rs35347635	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2526	.	0.234625	0.2407	.	.	.	.	.	.	.	.	.	.	AFR:0.0998,AMR:0.3213,EAS:0.2922,FIN:0.3034,NFE:0.2953,OTH:0.2729,ASJ:0.29	605995	118210;171300;256700;	635;29072;99946;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~99946|CMT2A1|<1 / 1 000 000|Autosomal dominant|Childhood|118210 ~	.	.	.	.	.	.	.	.	1	.	het
1	10355834	10355834	C	T	KIF1B	intronic	.	ENSG00000054523	rs3753037	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2787	0.2594	0.263978	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	.	.	AFR:0.2667,AMR:0.1847,EAS:0.2980,FIN:0.2969,NFE:0.3040,OTH:0.2975,ASJ:0.3289	605995	118210;171300;256700;	635;29072;99946;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~99946|CMT2A1|<1 / 1 000 000|Autosomal dominant|Childhood|118210 ~	.	.	.	.	.	.	.	.	1	1(stomach)	0.2796
1	10421878	10421878	A	G	KIF1B	exonic	synonymous SNV	ENSG00000054523	rs12125492	ENSG00000054523:ENST00000263934:exon38:c.A4161G:p.P1387P,ENSG00000054523:ENST00000377081:exon39:c.A4299G:p.P1433P,ENSG00000054523:ENST00000377086:exon40:c.A4299G:p.P1433P	KIF1B:NM_015074:exon38:c.A4161G:p.P1387P,KIF1B:NM_001365951:exon40:c.A4299G:p.P1433P,KIF1B:NM_001365952:exon40:c.A4299G:p.P1433P	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1128	0.0903	0.0802716	0.0854	.	.	.	.	.	.	.	.	KIF1B:uc001aqw.4:exon38:c.A4161G:p.P1387P,KIF1B:uc001ara.3:exon38:c.A4179G:p.P1393P,KIF1B:uc001arb.3:exon38:c.A4257G:p.P1419P,KIF1B:uc001aqy.3:exon39:c.A4221G:p.P1407P,KIF1B:uc001aqz.3:exon39:c.A4299G:p.P1433P,KIF1B:uc001aqx.4:exon40:c.A4299G:p.P1433P	.	AFR:0.0218,AMR:0.0680,EAS:0.0031,FIN:0.1042,NFE:0.1237,OTH:0.1255,ASJ:0.1623	605995	118210;171300;256700;	635;29072;99946;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~99946|CMT2A1|<1 / 1 000 000|Autosomal dominant|Childhood|118210 ~	.	.	.	.	.	.	.	.	1	.	het
1	10435324	10435324	C	A	KIF1B	exonic	synonymous SNV	ENSG00000054523	rs11121552	ENSG00000054523:ENST00000263934:exon46:c.C5163A:p.T1721T,ENSG00000054523:ENST00000377081:exon47:c.C5301A:p.T1767T,ENSG00000054523:ENST00000377086:exon48:c.C5301A:p.T1767T	KIF1B:NM_015074:exon46:c.C5163A:p.T1721T,KIF1B:NM_001365951:exon48:c.C5301A:p.T1767T,KIF1B:NM_001365952:exon48:c.C5301A:p.T1767T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2717	0.2305	0.231629	MU102673	.	.	.	.	.	.	.	.	KIF1B:uc001aqw.4:exon46:c.C5163A:p.T1721T,KIF1B:uc001ara.3:exon46:c.C5181A:p.T1727T,KIF1B:uc001arb.3:exon46:c.C5259A:p.T1753T,KIF1B:uc001aqy.3:exon47:c.C5223A:p.T1741T,KIF1B:uc001aqz.3:exon47:c.C5301A:p.T1767T,KIF1B:uc001aqx.4:exon48:c.C5301A:p.T1767T	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,AMR:0.2409,EAS:0.3206,FIN:0.2947,NFE:0.2836,OTH:0.3075,ASJ:0.0914	605995	118210;171300;256700;	635;29072;99946;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~99946|CMT2A1|<1 / 1 000 000|Autosomal dominant|Childhood|118210 ~	.	.	.	.	.	.	.	.	1	2(stomach)	0.3002
1	11187674	11187674	C	T	MTOR	intronic	.	ENSG00000198793	rs770282056	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	2.56e-05	.	.	.	.	.	.	.	.	0	0.002	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	1	.	het
1	11205058	11205058	C	T	MTOR	exonic	synonymous SNV	ENSG00000198793	rs1057079	ENSG00000198793:ENST00000361445:exon33:c.G4731A:p.A1577A	MTOR:NM_004958:exon33:c.G4731A:p.A1577A	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6779	0.5459	0.547524	COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	MTOR:uc001asd.3:exon33:c.G4731A:p.A1577A	.	AFR:0.5689,AMR:0.1535,EAS:0.5530,FIN:0.8004,NFE:0.7093,OTH:0.7379,ASJ:0.7124	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	7625,,7629	.	,7626	.	.	.	.	1	2(breast)	0.6735
1	11288758	11288758	G	A	MTOR	exonic	synonymous SNV	ENSG00000198793	rs1064261	ENSG00000198793:ENST00000361445:exon19:c.C2997T:p.N999N	MTOR:NM_004958:exon19:c.C2997T:p.N999N	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.7429	0.6176	0.700479	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MTOR:uc001asd.3:exon19:c.C2997T:p.N999N	.	AFR:0.6449,AMR:0.3858,EAS:0.6126,FIN:0.9283,NFE:0.7467,OTH:0.7263,ASJ:0.8365	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	7625,,7629	.	,7626	.	.	.	.	1	1(breast)	0.7157
1	11301714	11301714	A	G	MTOR	exonic	synonymous SNV	ENSG00000198793	rs1135172	ENSG00000198793:ENST00000361445:exon10:c.T1437C:p.D479D	MTOR:NM_004958:exon10:c.T1437C:p.D479D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7170	0.5853	0.639577	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MTOR:uc001asd.3:exon10:c.T1437C:p.D479D	.	AFR:0.6129,AMR:0.2871,EAS:0.6126,FIN:0.8837,NFE:0.7487,OTH:0.7263,ASJ:0.7751	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	7625,,7629	.	,7626	.	.	.	.	1	1(breast)	0.7070
1	11303153	11303153	C	A	MTOR	intronic	.	ENSG00000198793	rs12141961	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0565	0.0512	0.0970447	3(soft_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:0.1074,FIN:0.0752,NFE:0.0662,OTH:0.0928,ASJ:0.0580	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	1	1(stomach)	0.0612
1	11735245	11735245	A	C	MAD2L2	intronic	.	ENSG00000116670	rs878778	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1009	0.0338	0.149561	0.0652	.	.	.	.	.	.	.	.	.	.	AFR:0.0106,AMR:0.1110,EAS:0.4963,FIN:0.0542,NFE:0.0511,OTH:0.0726,ASJ:0.0232	604094	.	.	.	.	.	.	.	.	.	.	.	1	MU580078	het
1	11850927	11850927	C	T	MTHFR	exonic	nonsynonymous SNV	ENSG00000177000	rs2274976	ENSG00000177000:ENST00000376592:exon11:c.G1781A:p.R594Q,ENSG00000177000:ENST00000376583:exon12:c.G1904A:p.R635Q,ENSG00000177000:ENST00000376590:exon12:c.G1781A:p.R594Q,ENSG00000177000:ENST00000376585:exon13:c.G1904A:p.R635Q	MTHFR:NM_001330358:exon12:c.G1904A:p.R635Q,MTHFR:NM_005957:exon12:c.G1781A:p.R594Q	clinvar: Benign/Likely_benign,_other 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0563	0.0406	0.0744808	MU113406935	2.264	17.93	1.0	2.99	0.978	.	.	.	MTHFR:uc031plg.1:exon8:c.G1046A:p.R349Q,MTHFR:uc001atb.1:exon11:c.G1850A:p.R617Q,MTHFR:uc001atc.2:exon12:c.G1781A:p.R594Q	-1.011	AFR:LAML-KR|2|205|0.0097561,AMR:0.0408,EAS:0.0382,FIN:0.0166,NFE:0.1205,OTH:0.0157,ASJ:0.0319	607093	181500;188050;236250;601634;	268357;823;395;	268357|-|Unknown|-|-|182940 301410 601634 ~823|-|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182940 301410 601634 ~395|MTHFR deficiency<br>Methylene tetrahydrofolate reductase deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|236250 ~	.	.	.	.	0.0	-1.43	0.005	-1.82	1	6(soft_tissue)	0.0444
1	11854457	11854457	G	A	MTHFR	exonic	synonymous SNV	ENSG00000177000	rs4846051	ENSG00000177000:ENST00000376592:exon7:c.C1305T:p.F435F,ENSG00000177000:ENST00000376583:exon8:c.C1428T:p.F476F,ENSG00000177000:ENST00000376590:exon8:c.C1305T:p.F435F,ENSG00000177000:ENST00000376585:exon9:c.C1428T:p.F476F	MTHFR:NM_001330358:exon8:c.C1428T:p.F476F,MTHFR:NM_005957:exon8:c.C1305T:p.F435F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9697	0.8905	0.902955	0.9091	.	.	.	.	.	.	.	.	MTHFR:uc031plg.1:exon4:c.C570T:p.F190F,MTHFR:uc001atb.1:exon7:c.C1374T:p.F458F,MTHFR:uc001atc.2:exon8:c.C1305T:p.F435F	.	AFR:0.6825,AMR:0.9809,EAS:0.9988,FIN:1,NFE:0.9992,OTH:0.9867,ASJ:0.9768	607093	181500;188050;236250;601634;	268357;823;395;	268357|-|Unknown|-|-|182940 301410 601634 ~823|-|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182940 301410 601634 ~395|MTHFR deficiency<br>Methylene tetrahydrofolate reductase deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|236250 ~	.	.	.	.	.	.	.	.	1	MU81691184	unknown
1	11854476	11854476	T	G	MTHFR	exonic	nonsynonymous SNV	ENSG00000177000	rs1801131	ENSG00000177000:ENST00000376592:exon7:c.A1286C:p.E429A,ENSG00000177000:ENST00000376583:exon8:c.A1409C:p.E470A,ENSG00000177000:ENST00000376590:exon8:c.A1286C:p.E429A,ENSG00000177000:ENST00000376585:exon9:c.A1409C:p.E470A	MTHFR:NM_001330358:exon8:c.A1409C:p.E470A,MTHFR:NM_005957:exon8:c.A1286C:p.E429A	clinvar: Conflicting_interpretations_of_pathogenicity,_other,_risk_factor 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 1, 2, -1, 0, 0] 	0.2950	0.2596	0.249401	4(haematopoietic_and_lymphoid_tissue)	2.566	19.89	0.1	4.74	0.914	.	.	.	MTHFR:uc031plg.1:exon4:c.A551C:p.E184A,MTHFR:uc001atb.1:exon7:c.A1355C:p.E452A,MTHFR:uc001atc.2:exon8:c.A1286C:p.E429A	-1.076	AFR:1(skin),AMR:1(large_intestine),EAS:1(liver),FIN:MU119948,NFE:LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,OTH:0.2590,ASJ:1(pancreas)	607093	181500;188050;236250;601634;	268357;823;395;	268357|-|Unknown|-|-|182940 301410 601634 ~823|-|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182940 301410 601634 ~395|MTHFR deficiency<br>Methylene tetrahydrofolate reductase deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|236250 ~	.	.	.	.	0.021	-0.78	0.000	1.45	1	10(soft_tissue)	0.1663
1	11854896	11854896	G	A	MTHFR	exonic	synonymous SNV	ENSG00000177000	rs2066462	ENSG00000177000:ENST00000376592:exon6:c.C1056T:p.S352S,ENSG00000177000:ENST00000376583:exon7:c.C1179T:p.S393S,ENSG00000177000:ENST00000376590:exon7:c.C1056T:p.S352S,ENSG00000177000:ENST00000376585:exon8:c.C1179T:p.S393S	MTHFR:NM_001330358:exon7:c.C1179T:p.S393S,MTHFR:NM_005957:exon7:c.C1056T:p.S352S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1002	0.0940	0.103435	MU30671838	.	.	.	.	.	.	.	.	MTHFR:uc031plg.1:exon3:c.C321T:p.S107S,MTHFR:uc001atb.1:exon6:c.C1125T:p.S375S,MTHFR:uc001atc.2:exon7:c.C1056T:p.S352S	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.0999,EAS:0.0740,FIN:0.03,NFE:0.1199,OTH:0.1134,ASJ:0.0906	607093	181500;188050;236250;601634;	268357;823;395;	268357|-|Unknown|-|-|182940 301410 601634 ~823|-|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182940 301410 601634 ~395|MTHFR deficiency<br>Methylene tetrahydrofolate reductase deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|236250 ~	.	.	.	.	.	.	.	.	1	1(lung)	0.1029
1	11863057	11863057	G	A	MTHFR	exonic	synonymous SNV	ENSG00000177000	rs2066470	ENSG00000177000:ENST00000376592:exon1:c.C117T:p.P39P,ENSG00000177000:ENST00000376583:exon2:c.C240T:p.P80P,ENSG00000177000:ENST00000376590:exon2:c.C117T:p.P39P,ENSG00000177000:ENST00000418034:exon2:c.C117T:p.P39P,ENSG00000177000:ENST00000376585:exon3:c.C240T:p.P80P	MTHFR:NM_001330358:exon2:c.C240T:p.P80P,MTHFR:NM_005957:exon2:c.C117T:p.P39P	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0998	0.0897	0.101637	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	MTHFR:uc001atb.1:exon1:c.C186T:p.P62P,MTHFR:uc001atc.2:exon2:c.C117T:p.P39P	.	AFR:0.0937,AMR:0.0775,EAS:0.0265,FIN:0.1238,NFE:0.1104,OTH:0.0981,ASJ:0.0752	607093	181500;188050;236250;601634;	268357;823;395;	268357|-|Unknown|-|-|182940 301410 601634 ~823|-|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182940 301410 601634 ~395|MTHFR deficiency<br>Methylene tetrahydrofolate reductase deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|236250 ~	.	.	.	.	.	.	.	.	1	5(soft_tissue)	0.0982
1	14105139	14105139	T	A	PRDM2	exonic	nonsynonymous SNV	ENSG00000116731	rs2076324	ENSG00000116731:ENST00000413440:exon3:c.T246A:p.D82E,ENSG00000116731:ENST00000343137:exon4:c.T246A:p.D82E,ENSG00000116731:ENST00000235372:exon8:c.T849A:p.D283E,ENSG00000116731:ENST00000311066:exon8:c.T849A:p.D283E	PRDM2:NM_001007257:exon3:c.T246A:p.D82E,PRDM2:NM_012231:exon8:c.T849A:p.D283E,PRDM2:NM_015866:exon8:c.T849A:p.D283E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3563	0.3206	0.371206	0.3255	-1.966	0.001	1.0	-3.62	0.313	.	.	SET domain	PRDM2:uc001avk.3:exon4:c.T246A:p.D82E,PRDM2:uc021ogk.1:exon4:c.T138A:p.D46E,PRDM2:uc001avh.3:exon8:c.T849A:p.D283E,PRDM2:uc001avi.3:exon8:c.T849A:p.D283E	-1.058	AFR:0.2430,AMR:0.5269,EAS:0.3429,FIN:0.3495,NFE:0.3530,OTH:0.3623,ASJ:0.3067	601196	.	.	.	.	.	.	.	0.003	4.98	0.000	0	1	MU19318037	hom
1	14105298	14105298	G	A	PRDM2	exonic	synonymous SNV	ENSG00000116731	rs1203678	ENSG00000116731:ENST00000413440:exon3:c.G405A:p.E135E,ENSG00000116731:ENST00000343137:exon4:c.G405A:p.E135E,ENSG00000116731:ENST00000235372:exon8:c.G1008A:p.E336E,ENSG00000116731:ENST00000311066:exon8:c.G1008A:p.E336E	PRDM2:NM_001007257:exon3:c.G405A:p.E135E,PRDM2:NM_012231:exon8:c.G1008A:p.E336E,PRDM2:NM_015866:exon8:c.G1008A:p.E336E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3560	0.3104	0.316294	0.3200	.	.	.	.	.	.	.	.	PRDM2:uc001avk.3:exon4:c.G405A:p.E135E,PRDM2:uc021ogk.1:exon4:c.G297A:p.E99E,PRDM2:uc001avh.3:exon8:c.G1008A:p.E336E,PRDM2:uc001avi.3:exon8:c.G1008A:p.E336E	.	AFR:0.2357,AMR:0.5490,EAS:0.3284,FIN:0.3496,NFE:0.3463,OTH:0.3620,ASJ:0.2881	601196	.	.	.	.	.	.	.	.	.	.	.	1	MU147772	het
1	14106394	14106394	-	CTC	PRDM2	exonic	nonframeshift insertion	ENSG00000116731	rs2308040	ENSG00000116731:ENST00000413440:exon3:c.1501_1502insCTC:p.T501delinsTP,ENSG00000116731:ENST00000343137:exon4:c.1501_1502insCTC:p.T501delinsTP,ENSG00000116731:ENST00000235372:exon8:c.2104_2105insCTC:p.T702delinsTP,ENSG00000116731:ENST00000311066:exon8:c.2104_2105insCTC:p.T702delinsTP	PRDM2:NM_001007257:exon3:c.1501_1502insCTC:p.T501delinsTP,PRDM2:NM_012231:exon8:c.2104_2105insCTC:p.T702delinsTP,PRDM2:NM_015866:exon8:c.2104_2105insCTC:p.T702delinsTP	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4687	0.4698	.	0.4693	.	.	.	.	.	.	.	.	PRDM2:uc001avk.3:exon4:c.1501_1502insCTC:p.T501delinsTP,PRDM2:uc021ogk.1:exon4:c.1393_1394insCTC:p.T465delinsTP,PRDM2:uc001avh.3:exon8:c.2104_2105insCTC:p.T702delinsTP,PRDM2:uc001avi.3:exon8:c.2104_2105insCTC:p.T702delinsTP	.	AFR:0.5742,AMR:0.6065,EAS:0.5768,FIN:0.4068,NFE:0.4075,OTH:0.4427,ASJ:0.3758	601196	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	14109114	14109114	A	G	PRDM2	exonic	synonymous SNV	ENSG00000116731	rs1203651	ENSG00000116731:ENST00000413440:exon3:c.A4221G:p.S1407S,ENSG00000116731:ENST00000343137:exon4:c.A4221G:p.S1407S,ENSG00000116731:ENST00000235372:exon8:c.A4824G:p.S1608S,ENSG00000116731:ENST00000311066:exon8:c.A4824G:p.S1608S	PRDM2:NM_001007257:exon3:c.A4221G:p.S1407S,PRDM2:NM_012231:exon8:c.A4824G:p.S1608S,PRDM2:NM_015866:exon8:c.A4824G:p.S1608S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3881	0.3308	0.365016	0.3377	.	.	.	.	.	.	.	.	PRDM2:uc001avk.3:exon4:c.A4221G:p.S1407S,PRDM2:uc001avh.3:exon8:c.A4824G:p.S1608S,PRDM2:uc001avi.3:exon8:c.A4824G:p.S1608S	.	AFR:0.2576,AMR:0.5513,EAS:0.3469,FIN:0.3631,NFE:0.3631,OTH:0.3776,ASJ:0.3212	601196	.	.	.	.	.	.	.	.	.	.	.	1	MU147799	het
1	14143003	14143003	A	G	PRDM2	exonic	nonsynonymous SNV	ENSG00000116731	rs1046331	ENSG00000116731:ENST00000505823:exon3:c.A101G:p.Q34R,ENSG00000116731:ENST00000503842:exon4:c.A101G:p.Q34R,ENSG00000116731:ENST00000376048:exon7:c.A593G:p.Q198R	PRDM2:NM_001135610:exon7:c.A593G:p.Q198R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8256	0.8744	0.821286	0.8594	0.129	3.917	0.0	-4.33	0.332	.	.	.	PRDM2:uc001avg.3:exon7:c.A593G:p.Q198R	-1.038	AFR:0.9377,AMR:0.8067,EAS:0.6968,FIN:0.8144,NFE:0.8477,OTH:0.8388,ASJ:0.7748	601196	.	.	.	.	.	.	.	0.0	0.56	0.000	.	1	MU20384874	hom
1	16256007	16256007	T	C	SPEN	exonic	nonsynonymous SNV	ENSG00000065526	rs848209	ENSG00000065526:ENST00000375759:exon11:c.T3272C:p.L1091P	SPEN:NM_015001:exon11:c.T3272C:p.L1091P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6154	0.6878	0.648962	1(lung)	-0.797	0.043	0.846	3.51	0.197	.	.	.	SPEN:uc010obp.1:exon10:c.T3149C:p.L1050P,SPEN:uc001axk.1:exon11:c.T3272C:p.L1091P	-1.030	AFR:1(urinary_tract),AMR:MU4550099,EAS:0.6713,FIN:0.9243,NFE:0.7584,OTH:0.61,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|4|205|0.0195122,COCA-CN|3|321|0.00934579	613484	.	.	.	.	.	.	.	0.0	3.2	0.000	-0.895	1	1(thyroid)	0.2983
1	16259813	16259813	A	G	SPEN	exonic	nonsynonymous SNV	ENSG00000065526	rs848210	ENSG00000065526:ENST00000375759:exon11:c.A7078G:p.N2360D	SPEN:NM_015001:exon11:c.A7078G:p.N2360D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6146	0.6896	0.648962	MU4549778	-1.105	0.010	0.853	3.1	0.006	.	.	.	SPEN:uc010obp.1:exon10:c.A6955G:p.N2319D,SPEN:uc001axk.1:exon11:c.A7078G:p.N2360D	-1.042	AFR:LAML-KR|4|205|0.0195122,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.6706,EAS:0.7590,FIN:0.6033,NFE:0.2976,OTH:0.6101,ASJ:0.9239	613484	.	.	.	.	.	.	.	0.0	3.13	0.000	-0.625	1	3(haematopoietic_and_lymphoid_tissue)	0.5793
1	16451767	16451767	G	A	EPHA2	exonic	synonymous SNV	ENSG00000142627	rs3754334	ENSG00000142627:ENST00000358432:exon17:c.C2874T:p.I958I	EPHA2:NM_001329090:exon16:c.C2712T:p.I904I,EPHA2:NM_004431:exon17:c.C2874T:p.I958I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2751	0.2279	0.236621	0.2237	.	.	.	.	.	.	.	.	EPHA2:uc001aya.2:exon17:c.C2874T:p.I958I	.	AFR:0.1269,AMR:0.3337,EAS:0.1429,FIN:0.2669,NFE:0.2687,OTH:0.2649,ASJ:0.2848	176946	116600;	91492;	91492|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|115650 115660 115665 115700 115800 115900 116100 116200 116300 116400 116600 116700 116800 212500 302200 600881 601202 601547 601885 604219 604307 605387 605728 605749 607304 609376 609741 610019 610202 610425 610623 611391 611544 611597 612968 613763 614422 614691 615188 615274 615277 616279 616509 616851 ~	.	.	.	.	.	.	.	.	1	MU699553	het
1	17380497	17380497	G	T	SDHB	exonic	synonymous SNV	ENSG00000117118	rs2746462	ENSG00000117118:ENST00000375499:exon1:c.C18A:p.A6A	SDHB:NM_003000:exon1:c.C18A:p.A6A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9721	0.9515	0.957069	0.9577	.	.	.	.	.	.	.	.	SDHB:uc001bae.3:exon1:c.C18A:p.A6A	.	AFR:0.9069,AMR:0.9690,EAS:0.9994,FIN:0.9823,NFE:0.9755,OTH:0.9785,ASJ:0.9371	185470	115310;171300;606764;606864;612359;	201;97286;44890;29072;29072;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~97286|Carney dyad<br>Carney-Stratakis dyad<br>GIST-paraganglioma dyad<br>Paraganglioma and gastric stromal sarcoma|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|606864 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~	.	.	.	.	.	.	.	.	1	MU81693539	hom
1	19027239	19027239	A	G	PAX7	exonic	synonymous SNV	ENSG00000009709	rs2743201	ENSG00000009709:ENST00000375375:exon6:c.A879G:p.P293P,ENSG00000009709:ENST00000400661:exon6:c.A873G:p.P291P,ENSG00000009709:ENST00000420770:exon6:c.A879G:p.P293P	PAX7:NM_001135254:exon6:c.A879G:p.P293P,PAX7:NM_002584:exon6:c.A879G:p.P293P,PAX7:NM_013945:exon6:c.A873G:p.P291P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3747	0.3721	0.488618	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	PAX7:uc001bay.3:exon6:c.A879G:p.P293P,PAX7:uc001baz.3:exon6:c.A873G:p.P291P,PAX7:uc010oct.2:exon6:c.A879G:p.P293P	.	AFR:MU760649,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.5991,FIN:0.4414,NFE:0.3767,OTH:0.5857,ASJ:0.3923	167410	268220;	780;99756;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~	 ~	.	.	.	.	.	.	.	1	2(liver)	0.3289
1	20980880	20980880	G	A	DDOST	intronic	.	ENSG00000244038	rs607254	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3878	0.3863	0.357228	ESAD-UK|2|409|0.00488998,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.3787,AMR:0.3687,EAS:0.4338,FIN:0.2736,NFE:0.3759,OTH:0.3940,ASJ:0.4007	602202	614507;	300536;	300536|CDG syndrome type Ir<br>CDG-Ir<br>CDG1R<br>Carbohydrate deficient glycoprotein syndrome type Ir<br>Congenital disorder of glycosylation type 1r<br>Congenital disorder of glycosylation type Ir|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614507 ~	.	.	.	.	.	.	.	.	1	1(lung)	0.3814
1	20982151	20982151	G	A	DDOST	intronic	.	ENSG00000244038	rs3738140	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1818	0.1971	0.153754	0.1984	.	.	.	.	.	.	.	.	.	.	AFR:0.1965,AMR:0.1364,EAS:0.0909,FIN:0.2418,NFE:0.2056,OTH:0.2004,ASJ:0.1424	602202	614507;	300536;	300536|CDG syndrome type Ir<br>CDG-Ir<br>CDG1R<br>Carbohydrate deficient glycoprotein syndrome type Ir<br>Congenital disorder of glycosylation type 1r<br>Congenital disorder of glycosylation type Ir|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614507 ~	.	.	.	.	.	.	.	.	1	MU44431950	het
1	20982631	20982631	G	A	DDOST	exonic	synonymous SNV	ENSG00000244038	rs4704	ENSG00000244038:ENST00000415136:exon2:c.C255T:p.G85G,ENSG00000244038:ENST00000375048:exon3:c.C366T:p.G122G,ENSG00000244038:ENST00000602624:exon3:c.C315T:p.G105G	DDOST:NM_005216:exon3:c.C366T:p.G122G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5844	0.6502	0.58726	1(oesophagus)	.	.	.	.	.	.	.	.	DDOST:uc010ode.1:exon2:c.C255T:p.G85G,DDOST:uc001bdo.1:exon3:c.C366T:p.G122G	.	AFR:MU4553462,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,ESCA-CN|1|332|0.00301205,EAS:0.7344,FIN:0.5573,NFE:0.59,OTH:0.3861,ASJ:0.6286	602202	614507;	300536;	300536|CDG syndrome type Ir<br>CDG-Ir<br>CDG1R<br>Carbohydrate deficient glycoprotein syndrome type Ir<br>Congenital disorder of glycosylation type 1r<br>Congenital disorder of glycosylation type Ir|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614507 ~	.	.	.	.	.	.	.	.	1	1(lung)	0.6179
1	23885498	23885498	T	C	ID3	exonic	nonsynonymous SNV	ENSG00000117318	rs11574	ENSG00000117318:ENST00000374561:exon2:c.A313G:p.T105A	ID3:NM_002167:exon2:c.A313G:p.T105A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8037	0.8219	0.890375	0.8086	-2.559	0.001	0.865	-2.76	0.145	.	.	.	ID3:uc001bhh.4:exon2:c.A313G:p.T105A	-0.986	AFR:0.9543,AMR:0.7303,EAS:0.9746,FIN:0.6847,NFE:0.7405,OTH:0.7541,ASJ:0.9040	600277	.	.	.	.	.	.	.	0.0	-0.56	0.000	-0.205	1	MU81695702	hom
1	23885599	23885599	T	C	ID3	intronic	.	ENSG00000117318	rs2067053	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3787	0.4114	0.463658	1(breast)	.	.	.	.	.	.	.	.	.	.	AFR:4(large_intestine),AMR:MU762893,EAS:0.4032,FIN:0.5970,NFE:0.3161,OTH:0.3633,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	600277	.	.	.	.	.	.	.	.	.	.	.	1	2(lung)	0.3548
1	36937059	36937059	A	G	CSF3R	exonic	synonymous SNV	ENSG00000119535	rs3917981	ENSG00000119535:ENST00000331941:exon8:c.T1260C:p.T420T,ENSG00000119535:ENST00000338937:exon8:c.T1260C:p.T420T,ENSG00000119535:ENST00000418048:exon8:c.T1260C:p.T420T,ENSG00000119535:ENST00000440588:exon8:c.T1260C:p.T420T,ENSG00000119535:ENST00000361632:exon9:c.T1260C:p.T420T,ENSG00000119535:ENST00000373103:exon10:c.T1260C:p.T420T,ENSG00000119535:ENST00000373104:exon10:c.T1260C:p.T420T,ENSG00000119535:ENST00000373106:exon10:c.T1260C:p.T420T	CSF3R:NM_000760:exon10:c.T1260C:p.T420T,CSF3R:NM_156039:exon10:c.T1260C:p.T420T,CSF3R:NM_172313:exon10:c.T1260C:p.T420T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5648	0.6086	0.592452	2(lung)	.	.	.	.	.	.	.	.	CSF3R:uc001cav.2:exon10:c.T1260C:p.T420T,CSF3R:uc001caw.2:exon10:c.T1260C:p.T420T,CSF3R:uc001cax.2:exon10:c.T1260C:p.T420T	.	AFR:MU767632,AMR:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,EAS:0.7304,FIN:0.4165,NFE:0.5397,OTH:0.4061,ASJ:0.5927	138971	617014;	420702;	420702|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|617014 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer ~	.	,2078,2077	.	.	.	.	.	1	1(urinary_tract)	0.6111
1	36937065	36937065	A	G	CSF3R	exonic	synonymous SNV	ENSG00000119535	rs3917980	ENSG00000119535:ENST00000331941:exon8:c.T1254C:p.R418R,ENSG00000119535:ENST00000338937:exon8:c.T1254C:p.R418R,ENSG00000119535:ENST00000418048:exon8:c.T1254C:p.R418R,ENSG00000119535:ENST00000440588:exon8:c.T1254C:p.R418R,ENSG00000119535:ENST00000361632:exon9:c.T1254C:p.R418R,ENSG00000119535:ENST00000373103:exon10:c.T1254C:p.R418R,ENSG00000119535:ENST00000373104:exon10:c.T1254C:p.R418R,ENSG00000119535:ENST00000373106:exon10:c.T1254C:p.R418R	CSF3R:NM_000760:exon10:c.T1254C:p.R418R,CSF3R:NM_156039:exon10:c.T1254C:p.R418R,CSF3R:NM_172313:exon10:c.T1254C:p.R418R	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3156	0.2997	0.246406	0.2815	.	.	.	.	.	.	.	.	CSF3R:uc001cav.2:exon10:c.T1254C:p.R418R,CSF3R:uc001caw.2:exon10:c.T1254C:p.R418R,CSF3R:uc001cax.2:exon10:c.T1254C:p.R418R	.	AFR:0.2036,AMR:0.2404,EAS:0.1168,FIN:0.3480,NFE:0.3277,OTH:0.3190,ASJ:0.3543	138971	617014;	420702;	420702|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|617014 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer ~	.	,2078,2077	.	.	.	.	.	1	MU4568824	unknown
1	40363054	40363054	G	C	MYCL	exonic	nonsynonymous SNV	ENSG00000116990	rs3134614	ENSG00000116990:ENST00000372816:exon2:c.C1085G:p.T362S,ENSG00000116990:ENST00000397332:exon3:c.C1175G:p.T392S	MYCL:NM_001033081:exon2:c.C1085G:p.T362S,MYCL:NM_001033082:exon3:c.C1175G:p.T392S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8865	0.9037	0.935703	0.9116	0.145	4.091	1.0	4.53	0.999	.	.	.	MYCL1:uc001ces.2:exon2:c.C1085G:p.T362S,MYCL1:uc001cer.2:exon3:c.C1175G:p.T392S	-0.955	AFR:0.9750,AMR:0.8568,EAS:0.9975,FIN:0.8808,NFE:0.8796,OTH:0.8707,ASJ:0.8477	164850	.	.	.	.	.	.	.	0.0	-0.9	0.000	-0.77	1	MU3888723	hom
1	40980559	40980559	G	A	EXO5	exonic	nonsynonymous SNV	ENSG00000164002	rs1134586	ENSG00000164002:ENST00000372703:exon2:c.G343A:p.D115N,ENSG00000164002:ENST00000418186:exon2:c.G343A:p.D115N,ENSG00000164002:ENST00000419161:exon2:c.G343A:p.D115N,ENSG00000164002:ENST00000420209:exon2:c.G343A:p.D115N,ENSG00000164002:ENST00000296380:exon3:c.G343A:p.D115N,ENSG00000164002:ENST00000443729:exon3:c.G343A:p.D115N,ENSG00000164002:ENST00000358527:exon4:c.G343A:p.D115N,ENSG00000164002:ENST00000415550:exon4:c.G343A:p.D115N	EXO5:NM_001346948:exon2:c.G343A:p.D115N,EXO5:NM_001346954:exon2:c.G343A:p.D115N,EXO5:NM_001346956:exon2:c.G343A:p.D115N,EXO5:NM_001346946:exon3:c.G343A:p.D115N,EXO5:NM_001346951:exon3:c.G343A:p.D115N,EXO5:NM_001346952:exon3:c.G343A:p.D115N,EXO5:NM_001346955:exon3:c.G343A:p.D115N,EXO5:NM_022774:exon3:c.G343A:p.D115N,EXO5:NM_001346947:exon4:c.G343A:p.D115N,EXO5:NM_001346949:exon4:c.G343A:p.D115N,EXO5:NM_001346950:exon4:c.G343A:p.D115N,EXO5:NM_001346953:exon4:c.G343A:p.D115N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1535	0.1562	0.106629	0.1412	1.649	14.12	0.182	3.65	0.987	.	.	.	EXO5:uc021omb.1:exon1:c.G343A:p.D115N,EXO5:uc001cfr.3:exon2:c.G343A:p.D115N,EXO5:uc001cfp.3:exon3:c.G343A:p.D115N,EXO5:uc001cfq.3:exon4:c.G343A:p.D115N	-1.056	AFR:0.1011,AMR:0.1122,EAS:0.0272,FIN:0.1532,NFE:0.1740,OTH:0.1469,ASJ:0.2119	.	.	.	.	.	.	.	.	0.446	1.56	0.000	2.48	1	MU67330825	het
1	40980731	40980731	G	T	EXO5	exonic	nonsynonymous SNV	ENSG00000164002	rs11208299	ENSG00000164002:ENST00000372703:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000418186:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000419161:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000420209:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000296380:exon3:c.G515T:p.G172V,ENSG00000164002:ENST00000443729:exon3:c.G515T:p.G172V,ENSG00000164002:ENST00000358527:exon4:c.G515T:p.G172V	EXO5:NM_001346948:exon2:c.G515T:p.G172V,EXO5:NM_001346954:exon2:c.G515T:p.G172V,EXO5:NM_001346956:exon2:c.G515T:p.G172V,EXO5:NM_001346946:exon3:c.G515T:p.G172V,EXO5:NM_001346951:exon3:c.G515T:p.G172V,EXO5:NM_001346952:exon3:c.G515T:p.G172V,EXO5:NM_001346955:exon3:c.G515T:p.G172V,EXO5:NM_022774:exon3:c.G515T:p.G172V,EXO5:NM_001346947:exon4:c.G515T:p.G172V,EXO5:NM_001346949:exon4:c.G515T:p.G172V,EXO5:NM_001346950:exon4:c.G515T:p.G172V,EXO5:NM_001346953:exon4:c.G515T:p.G172V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4444	0.4619	0.542133	LAML-KR|2|205|0.0097561,COCA-CN|6|321|0.0186916	1.360	12.58	1.0	3.96	0.998	.	.	.	EXO5:uc021omb.1:exon1:c.G515T:p.G172V,EXO5:uc001cfr.3:exon2:c.G515T:p.G172V,EXO5:uc001cfp.3:exon3:c.G515T:p.G172V,EXO5:uc001cfq.3:exon4:c.G515T:p.G172V	-0.951	AFR:0.4570,AMR:0.6495,EAS:0.4967,FIN:0.4858,NFE:0.3426,OTH:0.3644,ASJ:0.5550	.	.	.	.	.	.	.	.	0.0	1.83	0.000	-3.005	1	1(large_intestine)	0.4286
1	41466806	41466811	GCCTTG	-	CTPS1	intronic	.	ENSG00000171793	rs780399530	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	8.634e-06	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	123860	615897;	420573;	420573|SCID due to CTPS1 deficiency|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|615897 ~	.	.	.	.	.	.	.	.	1	.	het
1	43805240	43805240	A	G	MPL	exonic	synonymous SNV	ENSG00000117400	rs16830693	ENSG00000117400:ENST00000372470:exon4:c.A690G:p.E230E,ENSG00000117400:ENST00000413998:exon4:c.A690G:p.E230E	MPL:NM_005373:exon4:c.A690G:p.E230E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0375	0.0544	0.0591054	MU113465428	.	.	.	.	.	0.0005	0.072	.	MPL:uc001civ.3:exon4:c.A690G:p.E230E,MPL:uc001ciw.3:exon4:c.A690G:p.E230E,MPL:uc009vwr.3:exon4:c.A669G:p.E223E	.	AFR:LAML-KR|1|205|0.00487805,AMR:0.0475,EAS:0.0204,FIN:0.0099,NFE:0.0234,OTH:0.0392,ASJ:0.0943	159530	254450;601977;604498;	3319;3318;71493;824;	3319|CAMT<br>Congenital amegakaryocytic thrombocytopenic purpura|Unknown|Autosomal recessive|Neonatal|604498 ~3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.0272
1	46521517	46521517	G	A	LOC110117498-PIK3R3;PIK3R3	exonic	synonymous SNV	ENSG00000117461	rs785468	ENSG00000117461:ENST00000262741:exon7:c.C891T:p.S297S,ENSG00000117461:ENST00000540385:exon7:c.C1029T:p.S343S,ENSG00000117461:ENST00000372006:exon8:c.C891T:p.S297S,ENSG00000117461:ENST00000420542:exon8:c.C891T:p.S297S	PIK3R3:NM_001328654:exon5:c.C423T:p.S141S,PIK3R3:NM_001328653:exon6:c.C648T:p.S216S,LOC110117498-PIK3R3:NM_001303427:exon7:c.C1029T:p.S343S,PIK3R3:NM_001328648:exon7:c.C759T:p.S253S,PIK3R3:NM_001328649:exon7:c.C759T:p.S253S,PIK3R3:NM_001328650:exon7:c.C759T:p.S253S,PIK3R3:NM_001328651:exon7:c.C759T:p.S253S,PIK3R3:NM_001328652:exon7:c.C891T:p.S297S,PIK3R3:NM_003629:exon7:c.C891T:p.S297S,PIK3R3:NM_001114172:exon8:c.C891T:p.S297S,PIK3R3:NM_001303428:exon8:c.C942T:p.S314S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6810	0.6715	0.637979	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	PIK3R3:uc010olv.2:exon2:c.C261T:p.S87S,PIK3R3:uc001cpb.4:exon7:c.C891T:p.S297S,PIK3R3:uc010olw.2:exon7:c.C1029T:p.S343S,PIK3R3:uc001cpc.4:exon8:c.C891T:p.S297S,PIK3R3:uc009vyc.3:exon8:c.C942T:p.S314S	.	AFR:0.6766,AMR:0.5981,EAS:0.7086,FIN:0.645,NFE:0.7415,OTH:0.7094,ASJ:0.6487	.	.	.	.	.	.	.	.	.	.	.	.	1	1(large_intestine)	0.7047
1	46521559	46521559	A	T	LOC110117498-PIK3R3;PIK3R3	exonic	nonsynonymous SNV	ENSG00000117461	rs785467	ENSG00000117461:ENST00000262741:exon7:c.T849A:p.N283K,ENSG00000117461:ENST00000540385:exon7:c.T987A:p.N329K,ENSG00000117461:ENST00000372006:exon8:c.T849A:p.N283K,ENSG00000117461:ENST00000420542:exon8:c.T849A:p.N283K	PIK3R3:NM_001328654:exon5:c.T381A:p.N127K,PIK3R3:NM_001328653:exon6:c.T606A:p.N202K,LOC110117498-PIK3R3:NM_001303427:exon7:c.T987A:p.N329K,PIK3R3:NM_001328648:exon7:c.T717A:p.N239K,PIK3R3:NM_001328649:exon7:c.T717A:p.N239K,PIK3R3:NM_001328650:exon7:c.T717A:p.N239K,PIK3R3:NM_001328651:exon7:c.T717A:p.N239K,PIK3R3:NM_001328652:exon7:c.T849A:p.N283K,PIK3R3:NM_003629:exon7:c.T849A:p.N283K,PIK3R3:NM_001114172:exon8:c.T849A:p.N283K,PIK3R3:NM_001303428:exon8:c.T900A:p.N300K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6940	0.7183	0.682109	MU81700272	0.729	9.016	1.0	3.95	0.999	.	.	PI3K p85 subunit, inter-SH2 domain	PIK3R3:uc010olv.2:exon2:c.T219A:p.N73K,PIK3R3:uc001cpb.4:exon7:c.T849A:p.N283K,PIK3R3:uc010olw.2:exon7:c.T987A:p.N329K,PIK3R3:uc001cpc.4:exon8:c.T849A:p.N283K,PIK3R3:uc009vyc.3:exon8:c.T900A:p.N300K	-0.960	AFR:COCA-CN|5|321|0.0155763,AMR:0.7188,EAS:0.6599,FIN:0.7086,NFE:0.6461,OTH:0.7414,ASJ:0.7464	.	.	.	.	.	.	.	.	0.0	1.75	0.000	-1.725	1	1(skin)	0.7095
1	46743900	46743900	C	T	RAD54L	exonic	synonymous SNV	ENSG00000085999	rs1048771	ENSG00000085999:ENST00000371975:exon18:c.C2190T:p.A730A,ENSG00000085999:ENST00000442598:exon19:c.C2190T:p.A730A	RAD54L:NM_001370766:exon18:c.C1650T:p.A550A,RAD54L:NM_003579:exon18:c.C2190T:p.A730A,RAD54L:NM_001142548:exon19:c.C2190T:p.A730A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1595	0.0950	0.185703	0.1053	.	.	.	.	.	.	.	.	RAD54L:uc001cpl.2:exon18:c.C2190T:p.A730A,RAD54L:uc009vye.2:exon19:c.C2190T:p.A730A	.	AFR:0.0443,AMR:0.0959,EAS:0.3158,FIN:0.1022,NFE:0.1163,OTH:0.1445,ASJ:0.1391	603615	114480;605027;	547;227535;	547|NHL|1-5 / 10 000|-|Adult|605027 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	1	MU770413	hom
1	47685455	47685455	T	C	TAL1	exonic	synonymous SNV	ENSG00000162367	rs927462	ENSG00000162367:ENST00000294339:exon4:c.A933G:p.K311K,ENSG00000162367:ENST00000371883:exon4:c.A939G:p.K313K,ENSG00000162367:ENST00000371884:exon5:c.A933G:p.K311K	TAL1:NM_001290406:exon3:c.A456G:p.K152K,TAL1:NM_001287347:exon5:c.A933G:p.K311K,TAL1:NM_001290403:exon5:c.A933G:p.K311K,TAL1:NM_001290405:exon5:c.A933G:p.K311K,TAL1:NM_001290404:exon6:c.A933G:p.K311K,TAL1:NM_003189:exon6:c.A933G:p.K311K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	1.0000	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	TAL1:uc009vyq.2:exon3:c.A203G:p.N68S	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	187040	613065;	513;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~	.	.	.	.	.	.	.	.	1	2(large_intestine)	1
1	47717189	47717189	A	G	STIL	exonic	synonymous SNV	ENSG00000123473	rs2758735	ENSG00000123473:ENST00000243182:exon17:c.T3483C:p.P1161P,ENSG00000123473:ENST00000337817:exon17:c.T3483C:p.P1161P,ENSG00000123473:ENST00000371877:exon17:c.T3486C:p.P1162P,ENSG00000123473:ENST00000396221:exon17:c.T3432C:p.P1144P,ENSG00000123473:ENST00000360380:exon18:c.T3483C:p.P1161P	STIL:NM_001048166:exon17:c.T3486C:p.P1162P,STIL:NM_003035:exon17:c.T3483C:p.P1161P,STIL:NM_001282936:exon18:c.T3483C:p.P1161P,STIL:NM_001282937:exon18:c.T3432C:p.P1144P,STIL:NM_001282938:exon19:c.T3345C:p.P1115P,STIL:NM_001282939:exon19:c.T3291C:p.P1097P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4979	0.4085	0.393371	0.4384	.	.	.	.	.	.	.	.	STIL:uc001crc.1:exon17:c.T3483C:p.P1161P,STIL:uc001crd.1:exon17:c.T3486C:p.P1162P,STIL:uc010omo.1:exon17:c.T3432C:p.P1144P,STIL:uc001cre.1:exon18:c.T3483C:p.P1161P,STIL:uc010omn.1:exon18:c.T3345C:p.P1115P	.	AFR:0.1619,AMR:0.4426,EAS:0.4621,FIN:0.6309,NFE:0.5404,OTH:0.5510,ASJ:0.6358	181590	612703;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU15861869	het
1	47746678	47746678	G	C	STIL	exonic	synonymous SNV	ENSG00000123473	rs10789505	ENSG00000123473:ENST00000243182:exon12:c.C1452G:p.S484S,ENSG00000123473:ENST00000337817:exon12:c.C1452G:p.S484S,ENSG00000123473:ENST00000371877:exon12:c.C1452G:p.S484S,ENSG00000123473:ENST00000396221:exon12:c.C1452G:p.S484S,ENSG00000123473:ENST00000360380:exon13:c.C1452G:p.S484S,ENSG00000123473:ENST00000447475:exon14:c.C1311G:p.S437S	STIL:NM_001048166:exon12:c.C1452G:p.S484S,STIL:NM_003035:exon12:c.C1452G:p.S484S,STIL:NM_001282936:exon13:c.C1452G:p.S484S,STIL:NM_001282937:exon13:c.C1452G:p.S484S,STIL:NM_001282938:exon14:c.C1311G:p.S437S,STIL:NM_001282939:exon14:c.C1311G:p.S437S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1269	0.1650	0.232029	4(soft_tissue)	.	.	.	.	.	.	.	.	STIL:uc001crf.1:exon2:c.C291G:p.S97S,STIL:uc001crc.1:exon12:c.C1452G:p.S484S,STIL:uc001crd.1:exon12:c.C1452G:p.S484S,STIL:uc010omo.1:exon12:c.C1452G:p.S484S,STIL:uc001cre.1:exon13:c.C1452G:p.S484S,STIL:uc010omn.1:exon13:c.C1311G:p.S437S,STIL:uc001crg.1:exon14:c.C1311G:p.S437S	.	AFR:1(large_intestine),AMR:MU29706754,EAS:0.1618,FIN:0.3569,NFE:0.0585,OTH:0.0861,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763	181590	612703;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	1(stomach)	0.2993
1	47767914	47767914	G	A	STIL	exonic	nonsynonymous SNV	ENSG00000123473	rs3125630	ENSG00000123473:ENST00000413565:exon2:c.C269T:p.A90V,ENSG00000123473:ENST00000243182:exon4:c.C257T:p.A86V,ENSG00000123473:ENST00000337817:exon4:c.C257T:p.A86V,ENSG00000123473:ENST00000371877:exon4:c.C257T:p.A86V,ENSG00000123473:ENST00000396221:exon4:c.C257T:p.A86V,ENSG00000123473:ENST00000360380:exon5:c.C257T:p.A86V,ENSG00000123473:ENST00000447475:exon5:c.C257T:p.A86V	STIL:NM_001048166:exon4:c.C257T:p.A86V,STIL:NM_003035:exon4:c.C257T:p.A86V,STIL:NM_001282936:exon5:c.C257T:p.A86V,STIL:NM_001282937:exon5:c.C257T:p.A86V,STIL:NM_001282938:exon5:c.C257T:p.A86V,STIL:NM_001282939:exon5:c.C257T:p.A86V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.5034	0.5931	0.60643	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	0.778	9.328	1.0	5.42	0.994	.	.	.	STIL:uc001crc.1:exon4:c.C257T:p.A86V,STIL:uc001crd.1:exon4:c.C257T:p.A86V,STIL:uc010omn.1:exon4:c.C257T:p.A86V,STIL:uc010omo.1:exon4:c.C257T:p.A86V,STIL:uc001cre.1:exon5:c.C257T:p.A86V,STIL:uc001crg.1:exon5:c.C257T:p.A86V	-0.967	AFR:0.5630,AMR:0.8405,EAS:0.3609,FIN:0.5386,NFE:0.3710,OTH:0.4608,ASJ:0.5561	181590	612703;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.0	1.87	0.000	-2.85	1	1(breast)	0.4497
1	51873951	51873951	G	A	EPS15	exonic	synonymous SNV	ENSG00000085832	rs1065754	ENSG00000085832:ENST00000396122:exon4:c.C360T:p.Y120Y,ENSG00000085832:ENST00000371733:exon15:c.C1329T:p.Y443Y	EPS15:NM_001159969:exon3:c.C387T:p.Y129Y,EPS15:NM_001981:exon15:c.C1329T:p.Y443Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7347	0.7293	0.822684	0.7522	.	.	.	.	.	.	.	.	EPS15:uc001csp.3:exon3:c.C387T:p.Y129Y,EPS15:uc001csq.1:exon15:c.C1329T:p.Y443Y	.	AFR:0.8763,AMR:0.7840,EAS:0.9975,FIN:0.7030,NFE:0.6682,OTH:0.7290,ASJ:0.5728	600051	.	.	.	.	.	.	.	.	.	.	.	1	MU81700903	hom
1	55505732	55505732	A	G	PCSK9	intronic	.	ENSG00000169174	rs2495482	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9370	0.9116	0.908546	0.9128	.	.	.	.	.	.	.	.	.	.	AFR:0.8318,AMR:0.8389,EAS:0.9353,FIN:0.9691,NFE:0.9459,OTH:0.9440,ASJ:0.9437	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU81701675	hom
1	55517940	55517940	G	A	PCSK9	intronic	.	ENSG00000169174	rs11800231	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0549	0.0879	0.0828674	0.0777	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.1766,AMR:0.0382,EAS:0.0309,FIN:0.0203,NFE:0.0424,OTH:0.0450,ASJ:0.1159	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	.	het
1	55518093	55518093	G	A	PCSK9	intronic	.	ENSG00000169174	rs11800243	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0] 	0.0424	0.0457	0.0391374	0.0389	.	.	.	.	.	.	.	.	.	.	AFR:0.0420,AMR:0.0263,EAS:0.0316,FIN:0.0203,NFE:0.0418,OTH:0.0369,ASJ:0.0993	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU33177249	het
1	55518467	55518467	A	G	PCSK9	intronic	.	ENSG00000169174	rs2495477	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4311	0.5042	0.466254	0.4935	.	.	.	.	.	0.0012	0.014	.	.	.	AFR:0.7191,AMR:0.3218,EAS:0.2649,FIN:0.4432,NFE:0.4139,OTH:0.4216,ASJ:0.4396	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU17742898	het
1	55523033	55523033	A	G	PCSK9	exonic	synonymous SNV	ENSG00000169174	rs509504	ENSG00000169174:ENST00000543384:exon5:c.A426G:p.Q142Q,ENSG00000169174:ENST00000302118:exon7:c.A1026G:p.Q342Q	PCSK9:NM_174936:exon7:c.A1026G:p.Q342Q	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0] 	0.9945	0.9797	0.981829	0.9829	.	.	.	.	.	.	.	.	PCSK9:uc001cyf.2:exon7:c.A1026G:p.Q342Q	.	AFR:0.9397,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU81701677	hom
1	55524197	55524197	A	G	PCSK9	exonic	synonymous SNV	ENSG00000169174	rs540796	ENSG00000169174:ENST00000543384:exon7:c.A728G:p.Y243C	PCSK9:NM_174936:exon9:c.A1380G:p.V460V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8544	0.8178	0.869209	0.8316	.	.	.	.	.	.	.	.	PCSK9:uc001cyf.2:exon9:c.A1380G:p.V460V	.	AFR:0.7927,AMR:0.9069,EAS:0.9988,FIN:0.8171,NFE:0.8337,OTH:0.8582,ASJ:0.8245	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU9830779	hom
1	55524237	55524237	G	A	PCSK9	exonic	nonsynonymous SNV	ENSG00000169174	rs562556	ENSG00000169174:ENST00000302118:exon9:c.G1420A:p.V474I	PCSK9:NM_174936:exon9:c.G1420A:p.V474I	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8544	0.8178	0.86901	COCA-CN|5|321|0.0155763	-1.303	0.004	0.412	-8.95	0.000	.	.	.	PCSK9:uc001cyf.2:exon9:c.G1420A:p.V474I	-0.970	AFR:0.8315,AMR:0.7928,EAS:0.8245,FIN:0.9988,NFE:0.8170,OTH:0.8334,ASJ:0.9069	607786	603776;	.	.	.	.	.	.	0.013	-0.52	0.000	1.555	1	1(thyroid)	0.8571
1	55524340	55524353	GTGTGTGTGTGTGT	-	PCSK9	intronic	.	ENSG00000169174	rs368103912	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1478	.	0.911542	0.6520	.	.	.	.	.	.	.	.	.	.	AFR:0.5516,AMR:0.6592,EAS:0.8207,FIN:0.5988,NFE:0.6917,OTH:0.7062,ASJ:0.7344	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU113565531	hom
1	55529187	55529187	G	A	PCSK9	exonic	nonsynonymous SNV	ENSG00000169174	rs505151	ENSG00000169174:ENST00000302118:exon12:c.G2009A:p.G670E	PCSK9:NM_174936:exon12:c.G2009A:p.G670E	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9433	0.8894	0.898962	0.8930	-1.402	0.003	1.0	0.348	0.001	.	.	.	PCSK9:uc001cyf.2:exon12:c.G2009A:p.G670E	-0.976	AFR:0.7349,AMR:0.9761,EAS:0.9427,FIN:0.9485,NFE:0.9569,OTH:0.9532,ASJ:0.9437	607786	603776;	.	.	.	.	.	.	0.0	-0.35	0.000	-2.34	1	MU26731505	hom
1	65310489	65310489	T	C	JAK1	exonic	synonymous SNV	ENSG00000162434	rs2230588	ENSG00000162434:ENST00000342505:exon16:c.A2199G:p.P733P	JAK1:NM_001321852:exon16:c.A2199G:p.P733P,JAK1:NM_001321856:exon16:c.A2199G:p.P733P,JAK1:NM_001321857:exon16:c.A2196G:p.P732P,JAK1:NM_002227:exon16:c.A2199G:p.P733P,JAK1:NM_001320923:exon17:c.A2199G:p.P733P,JAK1:NM_001321854:exon17:c.A2199G:p.P733P,JAK1:NM_001321855:exon17:c.A2199G:p.P733P,JAK1:NM_001321853:exon18:c.A2199G:p.P733P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.2935	0.3492	0.372604	0.3717	.	.	.	.	.	.	.	.	JAK1:uc001dbu.1:exon16:c.A2199G:p.P733P,JAK1:uc009wam.1:exon17:c.A2199G:p.P733P	.	AFR:0.6204,AMR:0.3349,EAS:0.3046,FIN:0.2774,NFE:0.2630,OTH:0.2969,ASJ:0.3675	147795	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04621 NOD-like receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05212 Pancreatic cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,6193,6191,6192	.	.	.	.	.	.	1	MU110244	het
1	65311262	65311262	G	A	JAK1	exonic	synonymous SNV	ENSG00000162434	rs2230587	ENSG00000162434:ENST00000342505:exon15:c.C2049T:p.S683S	JAK1:NM_001321852:exon15:c.C2049T:p.S683S,JAK1:NM_001321856:exon15:c.C2049T:p.S683S,JAK1:NM_001321857:exon15:c.C2046T:p.S682S,JAK1:NM_002227:exon15:c.C2049T:p.S683S,JAK1:NM_001320923:exon16:c.C2049T:p.S683S,JAK1:NM_001321854:exon16:c.C2049T:p.S683S,JAK1:NM_001321855:exon16:c.C2049T:p.S683S,JAK1:NM_001321853:exon17:c.C2049T:p.S683S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.1507	0.1356	0.198283	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	JAK1:uc001dbu.1:exon15:c.C2049T:p.S683S,JAK1:uc009wam.1:exon16:c.C2049T:p.S683S	.	AFR:0.1514,AMR:0.1953,EAS:0.1225,FIN:0.3181,NFE:0.1246,OTH:0.1155,ASJ:0.1599	147795	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04621 NOD-like receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05212 Pancreatic cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,6193,6191,6192	.	.	.	.	.	.	1	2(soft_tissue)	0.1316
1	65321388	65321388	G	A	JAK1	intronic	.	ENSG00000162434	rs310229	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3574	0.3801	0.402556	MU17839990	.	.	.	.	.	0	0	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.4079,EAS:0.4665,FIN:0.3974,NFE:0.3180,OTH:0.3254,ASJ:0.5930	147795	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04621 NOD-like receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05212 Pancreatic cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	1	1(lung)	0.3296
1	66036501	66036501	G	T	LEPR	intronic	.	ENSG00000116678	rs2186248	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9999	0.9995	1	0.9996	.	.	.	.	.	.	.	.	.	.	AFR:0.9987,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	601007	614963;	179494;	179494|-|-|Autosomal recessive|-|614963 ~	.	.	.	.	.	.	.	.	1	MU81702628	hom
1	76269460	76269460	G	A	MSH4	exonic	nonsynonymous SNV	ENSG00000057468	rs5745325	ENSG00000057468:ENST00000263187:exon2:c.G289A:p.A97T	MSH4:NM_002440:exon2:c.G289A:p.A97T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2634	0.2996	0.212859	0.2752	-0.333	0.558	0.177	0.632	0.013	.	.	.	MSH4:uc001dhd.2:exon2:c.G289A:p.A97T	-1.046	AFR:0.2945,AMR:0.1854,EAS:0.0191,FIN:0.3246,NFE:0.2811,OTH:0.2791,ASJ:0.4669	602105	.	.	.	.	.	.	.	0.001	-2.23	0.186	1.1	1	MU30770069	het
1	76272837	76272837	A	G	MSH4	intronic	.	ENSG00000057468	rs3737574	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3315	0.2249	0.330272	0.2571	.	.	.	.	.	.	.	.	.	.	AFR:0.0743,AMR:0.2572,EAS:0.7135,FIN:0.2787,NFE:0.3070,OTH:0.2908,ASJ:0.2583	602105	.	.	.	.	.	.	.	.	.	.	.	1	MU13888352	het
1	76344011	76344011	C	A	MSH4	intronic	.	ENSG00000057468	rs1493367	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7967	0.7411	0.792732	0.7763	.	.	.	.	.	0	0.006	.	.	.	AFR:0.7152,AMR:0.8218,EAS:0.9845,FIN:0.8051,NFE:0.7779,OTH:0.7912,ASJ:0.8377	602105	.	.	.	.	.	.	.	.	.	.	.	1	MU81703300	hom
1	76344705	76344705	T	C	MSH4	exonic	synonymous SNV	ENSG00000057468	rs5745448	ENSG00000057468:ENST00000263187:exon12:c.T1569C:p.Y523Y	MSH4:NM_002440:exon12:c.T1569C:p.Y523Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3450	0.2433	0.33746	0.2719	.	.	.	.	.	.	.	.	MSH4:uc001dhd.2:exon12:c.T1569C:p.Y523Y	.	AFR:0.0799,AMR:0.2667,EAS:0.7197,FIN:0.2944,NFE:0.3281,OTH:0.3112,ASJ:0.2649	602105	.	.	.	.	.	.	.	.	.	.	.	1	MU9965201	unknown
1	76344711	76344711	A	T	MSH4	exonic	synonymous SNV	ENSG00000057468	rs5745449	ENSG00000057468:ENST00000263187:exon12:c.A1575T:p.L525L	MSH4:NM_002440:exon12:c.A1575T:p.L525L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7963	0.7415	0.792732	0.7759	.	.	.	.	.	.	.	.	MSH4:uc001dhd.2:exon12:c.A1575T:p.L525L	.	AFR:0.7147,AMR:0.8234,EAS:0.9833,FIN:0.8055,NFE:0.7774,OTH:0.7898,ASJ:0.8377	602105	.	.	.	.	.	.	.	.	.	.	.	1	MU81703331	unknown
1	76346920	76346920	-	AT	MSH4	intronic	.	ENSG00000057468	rs5745466	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9880	0.9555	0.956669	0.9644	.	.	.	.	.	.	.	.	.	.	AFR:0.8755,AMR:0.9952,EAS:1,FIN:1,NFE:0.9995,OTH:0.9959,ASJ:1	602105	.	.	.	.	.	.	.	.	.	.	.	1	.	hom
1	76378361	76378361	T	A	MSH4	intronic	.	ENSG00000057468	rs5020911	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4851	.	0.392173	0.4691	.	.	.	.	.	.	.	.	.	.	AFR:0.2766,AMR:0.4447,EAS:0.7278,FIN:0.4959,NFE:0.5372,OTH:0.5113,ASJ:0.4890	602105	.	.	.	.	.	.	.	.	.	.	.	1	MU21151650	het
1	76378363	76378363	T	A	MSH4	intronic	.	ENSG00000057468	rs28693610	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2635	0.0568	0.30631	0.3104	.	.	.	.	.	.	.	.	.	.	AFR:0.1093,AMR:0.3,EAS:0.5897,FIN:0.3172,NFE:0.3737,OTH:0.3443,ASJ:0.2901	602105	.	.	.	.	.	.	.	.	.	.	.	1	MU32992349	het
1	85741684	85741684	T	C	BCL10	intronic	.	ENSG00000142867	rs4949928	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.229034	0.2841	.	.	.	.	.	.	.	.	.	.	AFR:0.2487,AMR:0.2053,EAS:0.0758,FIN:0.3263,NFE:0.3203,OTH:0.2882,ASJ:0.35	603517	137245;156240;605027;616098;	547;50251;52417;	547|NHL|1-5 / 10 000|-|Adult|605027 ~50251|-|1-9 / 100 000|Not applicable|All ages|156240 ~52417|Extranodal marginal zone B-cell lymphoma<br>MALToma<br>Mucosa-associated lymphatic tissue lymphoma<br>Mucosa-associated lymphoid tissue lymphoma|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|137245 ~	.	.	.	.	.	.	.	.	1	MU18406014	hom
1	85742012	85742012	G	C	BCL10	exonic	synonymous SNV	ENSG00000142867	rs11576939	ENSG00000142867:ENST00000370580:exon1:c.C24G:p.L8L	BCL10:NM_001320715:exon1:c.C24G:p.L8L,BCL10:NM_003921:exon1:c.C24G:p.L8L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2755	0.2868	0.228235	0.2826	.	.	.	.	.	.	.	.	BCL10:uc021opd.1:exon1:c.C24G:p.L8L	.	AFR:0.2455,AMR:0.2045,EAS:0.0759,FIN:0.3263,NFE:0.3191,OTH:0.2888,ASJ:0.3477	603517	137245;156240;605027;616098;	547;50251;52417;	547|NHL|1-5 / 10 000|-|Adult|605027 ~50251|-|1-9 / 100 000|Not applicable|All ages|156240 ~52417|Extranodal marginal zone B-cell lymphoma<br>MALToma<br>Mucosa-associated lymphatic tissue lymphoma<br>Mucosa-associated lymphoid tissue lymphoma|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|137245 ~	.	.	.	.	.	.	.	.	1	MU4549472	hom
1	91728053	91728053	G	A	HFM1	exonic	synonymous SNV	ENSG00000162669	rs585898	ENSG00000162669:ENST00000370424:exon33:c.C3108T:p.A1036A,ENSG00000162669:ENST00000370425:exon37:c.C4071T:p.A1357A	HFM1:NM_001017975:exon37:c.C4071T:p.A1357A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9997	0.9990	0.999201	0.9987	.	.	.	.	.	.	.	.	HFM1:uc001dob.4:exon18:c.C1635T:p.A545A,HFM1:uc010osu.2:exon33:c.C3108T:p.A1036A,HFM1:uc001doa.4:exon37:c.C4071T:p.A1357A	.	AFR:0.9954,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	MU81704389	hom
1	91781413	91781413	T	G	HFM1	exonic	synonymous SNV	ENSG00000162669	rs281992	ENSG00000162669:ENST00000370424:exon24:c.A2136C:p.I712I,ENSG00000162669:ENST00000294696:exon28:c.A795C:p.I265I,ENSG00000162669:ENST00000370425:exon28:c.A3099C:p.I1033I	HFM1:NM_001017975:exon28:c.A3099C:p.I1033I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7059	0.6881	0.762979	0.6920	.	.	.	.	.	.	.	.	HFM1:uc001dob.4:exon9:c.A663C:p.I221I,HFM1:uc010osv.1:exon22:c.A2151C:p.I717I,HFM1:uc010osu.2:exon24:c.A2136C:p.I712I,HFM1:uc001doa.4:exon28:c.A3099C:p.I1033I	.	AFR:0.7378,AMR:0.7105,EAS:0.8246,FIN:0.6821,NFE:0.6500,OTH:0.6875,ASJ:0.8212	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	MU19378877	hom
1	91841301	91841301	T	C	HFM1	intronic	.	ENSG00000162669	rs282036	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9997	0.9991	0.999201	0.9987	.	.	.	.	.	.	.	.	.	.	AFR:0.9953,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	MU81704472	hom
1	91851253	91851253	T	C	HFM1	exonic	synonymous SNV	ENSG00000162669	rs282026	ENSG00000162669:ENST00000448819:exon3:c.A210G:p.Q70Q,ENSG00000162669:ENST00000427444:exon4:c.A507G:p.Q169Q,ENSG00000162669:ENST00000370425:exon5:c.A633G:p.Q211Q	HFM1:NM_001017975:exon5:c.A633G:p.Q211Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9997	0.9990	0.999201	0.9987	.	.	.	.	.	.	.	.	HFM1:uc001doc.1:exon4:c.A633G:p.Q211Q,HFM1:uc001doa.4:exon5:c.A633G:p.Q211Q	.	AFR:0.9955,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	MU81704499	hom
1	91859795	91859795	T	C	HFM1	exonic	nonsynonymous SNV	ENSG00000162669	rs282009	ENSG00000162669:ENST00000427444:exon3:c.A223G:p.I75V,ENSG00000162669:ENST00000370425:exon4:c.A349G:p.I117V,ENSG00000162669:ENST00000455133:exon4:c.A349G:p.I117V	HFM1:NM_001017975:exon4:c.A349G:p.I117V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9997	0.9991	0.999201	0.9987	-2.189	0.001	1.0	1.52	0.304	.	.	.	HFM1:uc001doc.1:exon3:c.A349G:p.I117V,HFM1:uc001doa.4:exon4:c.A349G:p.I117V	-0.972	AFR:0.9954,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	615684	615724;	.	.	.	.	.	.	0.0	0.49	0.015	-2.24	1	MU81704512	hom
1	92174260	92174260	A	G	TGFBR3	exonic	synonymous SNV	ENSG00000069702	rs284878	ENSG00000069702:ENST00000525962:exon13:c.T2247C:p.T749T,ENSG00000069702:ENST00000212355:exon14:c.T2247C:p.T749T,ENSG00000069702:ENST00000465892:exon14:c.T2244C:p.T748T,ENSG00000069702:ENST00000370399:exon15:c.T2244C:p.T748T	TGFBR3:NM_001195683:exon14:c.T2244C:p.T748T,TGFBR3:NM_003243:exon14:c.T2247C:p.T749T,TGFBR3:NM_001195684:exon15:c.T2244C:p.T748T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9337	0.9394	0.906749	0.9356	.	.	.	.	.	.	.	.	TGFBR3:uc001doh.3:exon14:c.T2247C:p.T749T,TGFBR3:uc001doi.3:exon14:c.T2244C:p.T748T,TGFBR3:uc001doj.3:exon15:c.T2244C:p.T748T,TGFBR3:uc010osy.2:exon15:c.T2121C:p.T707T,TGFBR3:uc009wde.3:exon17:c.T1332C:p.T444T	.	AFR:0.9334,AMR:0.9582,EAS:0.7531,FIN:0.9699,NFE:0.9472,OTH:0.9491,ASJ:0.9007	600742	.	.	.	.	.	.	.	.	.	.	.	1	MU81704562	hom
1	92185657	92185657	C	T	TGFBR3	exonic	synonymous SNV	ENSG00000069702	rs1805112	ENSG00000069702:ENST00000525962:exon8:c.G1206A:p.P402P,ENSG00000069702:ENST00000212355:exon9:c.G1206A:p.P402P,ENSG00000069702:ENST00000465892:exon9:c.G1203A:p.P401P,ENSG00000069702:ENST00000370399:exon10:c.G1203A:p.P401P	TGFBR3:NM_001195683:exon9:c.G1203A:p.P401P,TGFBR3:NM_003243:exon9:c.G1206A:p.P402P,TGFBR3:NM_001195684:exon10:c.G1203A:p.P401P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4177	0.3817	0.40615	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	TGFBR3:uc001doh.3:exon9:c.G1206A:p.P402P,TGFBR3:uc001doi.3:exon9:c.G1203A:p.P401P,TGFBR3:uc001doj.3:exon10:c.G1203A:p.P401P,TGFBR3:uc010osy.2:exon10:c.G1080A:p.P360P,TGFBR3:uc009wde.3:exon12:c.G537A:p.P179P	.	AFR:0.4029,AMR:0.3062,EAS:0.4272,FIN:0.5458,NFE:0.4860,OTH:0.4281,ASJ:0.3062	600742	.	.	.	.	.	.	.	.	.	.	.	1	1(lung)	0.4192
1	92262874	92262874	T	C	TGFBR3	exonic	synonymous SNV	ENSG00000069702	rs2810904	ENSG00000069702:ENST00000525962:exon2:c.A216G:p.A72A,ENSG00000069702:ENST00000533089:exon2:c.A216G:p.A72A,ENSG00000069702:ENST00000212355:exon3:c.A216G:p.A72A,ENSG00000069702:ENST00000465892:exon3:c.A216G:p.A72A,ENSG00000069702:ENST00000370399:exon4:c.A216G:p.A72A	TGFBR3:NM_001195683:exon3:c.A216G:p.A72A,TGFBR3:NM_003243:exon3:c.A216G:p.A72A,TGFBR3:NM_001195684:exon4:c.A216G:p.A72A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6631	0.6786	0.715256	0.6616	.	.	.	.	.	.	.	.	TGFBR3:uc001doh.3:exon3:c.A216G:p.A72A,TGFBR3:uc001doi.3:exon3:c.A216G:p.A72A,TGFBR3:uc001doj.3:exon4:c.A216G:p.A72A,TGFBR3:uc010osy.2:exon4:c.A90G:p.A30A	.	AFR:0.7388,AMR:0.6730,EAS:0.7667,FIN:0.5975,NFE:0.6226,OTH:0.6375,ASJ:0.5867	600742	.	.	.	.	.	.	.	.	.	.	.	1	MU143026	het
1	92944314	92944314	-	AGAGAGAG	GFI1	intronic	.	ENSG00000162676	rs371078453	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0] 	0.0327	.	.	0.0723	.	.	.	.	.	.	.	.	.	.	AFR:0.1008,AMR:0.0772,EAS:0.1319,FIN:0.0643,NFE:0.0555,OTH:0.0695,ASJ:0.0893	600871	607847;613107;	486;2688;	486|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|202700 257100 613107 ~2688|-|-|-|-|607847 ~	.	.	.	.	.	.	.	.	1	.	hom
1	92946479	92946479	G	A	GFI1	exonic	synonymous SNV	ENSG00000162676	rs11164605	ENSG00000162676:ENST00000294702:exon4:c.C465T:p.C155C,ENSG00000162676:ENST00000370332:exon4:c.C465T:p.C155C,ENSG00000162676:ENST00000427103:exon4:c.C465T:p.C155C	GFI1:NM_001127215:exon4:c.C465T:p.C155C,GFI1:NM_001127216:exon4:c.C465T:p.C155C,GFI1:NM_005263:exon4:c.C465T:p.C155C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8883	0.8519	0.91893	0.8503	.	.	.	.	.	.	.	.	GFI1:uc001dou.4:exon4:c.C465T:p.C155C,GFI1:uc001dov.4:exon4:c.C465T:p.C155C,GFI1:uc001dow.4:exon4:c.C465T:p.C155C	.	AFR:0.9214,AMR:0.9076,EAS:0.9667,FIN:0.7807,NFE:0.8087,OTH:0.8330,ASJ:0.9139	600871	607847;613107;	486;2688;	486|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|202700 257100 613107 ~2688|-|-|-|-|607847 ~	.	.	.	.	.	.	.	.	1	MU81704682	hom
1	97770920	97770920	C	T	DPYD	exonic	nonsynonymous SNV	ENSG00000188641	rs1801160	ENSG00000188641:ENST00000370192:exon18:c.G2194A:p.V732I	DPYD:NM_000110:exon18:c.G2194A:p.V732I	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0465	0.0414	0.0439297	ESAD-UK|1|409|0.00244499	5.369	25.9	0.057	5.55	0.806	.	.	Aldolase-type TIM barrel|Dihydroorotate dehydrogenase domain	DPYD:uc001drv.3:exon18:c.G2194A:p.V732I	-0.076	AFR:0.0324,AMR:0.0213,EAS:0.1060,FIN:0.0128,NFE:0.0200,OTH:0.0412,ASJ:0.0359	612779	274270;	1675;	1675|Familial pyrimidinemia|Unknown|-|All ages|274270 ~	.	.	.	.	0.998	-0.75	0.473	1.71	1	1(large_intestine)	0.0468
1	97981395	97981395	T	C	DPYD	exonic	nonsynonymous SNV	ENSG00000188641	rs1801159	ENSG00000188641:ENST00000370192:exon13:c.A1627G:p.I543V	DPYD:NM_000110:exon13:c.A1627G:p.I543V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1930	0.1836	0.184904	1(liver)	0.829	9.639	0.111	-3.13	0.975	.	.	Aldolase-type TIM barrel|Dihydroorotate dehydrogenase domain	DPYD:uc001drv.3:exon13:c.A1627G:p.I543V	-1.011	AFR:MU10081619,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611,AML-US|1|166|0.0060241,EAS:0.1552,FIN:0.2608,NFE:0.21,OTH:0.2427,ASJ:0.1754	612779	274270;	1675;	1675|Familial pyrimidinemia|Unknown|-|All ages|274270 ~	.	.	.	.	0.0	-0.8	0.053	0.49	1	1(stomach)	0.1556
1	98039541	98039541	A	G	DPYD	intronic	.	ENSG00000188641	rs56293913	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1046	0.0948	0.0636981	0.1070	.	.	.	.	.	.	.	.	.	.	AFR:0.0585,AMR:0.0622,EAS:0.0087,FIN:0.1890,NFE:0.1273,OTH:0.1354,ASJ:0.1060	612779	274270;	1675;	1675|Familial pyrimidinemia|Unknown|-|All ages|274270 ~	.	.	.	.	.	.	.	.	1	MU580780	het
1	98348885	98348885	G	A	DPYD	exonic	nonsynonymous SNV	ENSG00000188641	rs1801265	ENSG00000188641:ENST00000306031:exon2:c.C85T:p.R29C,ENSG00000188641:ENST00000370192:exon2:c.C85T:p.R29C	DPYD:NM_000110:exon2:c.C85T:p.R29C,DPYD:NM_001160301:exon2:c.C85T:p.R29C	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7652	0.7159	0.739816	0.7199	.	.	.	.	.	.	.	.	DPYD:uc001drv.3:exon2:c.C85T:p.R29C,DPYD:uc001drw.3:exon2:c.C85T:p.R29C	.	AFR:0.5991,AMR:0.7769,EAS:0.9284,FIN:0.7140,NFE:0.7626,OTH:0.7352,ASJ:0.8642	612779	274270;	1675;	1675|Familial pyrimidinemia|Unknown|-|All ages|274270 ~	.	.	.	.	.	.	.	.	1	MU4134499	hom
1	110233138	110233138	G	C	GSTM1	exonic	nonsynonymous SNV	ENSG00000134184	rs1065411	ENSG00000134184:ENST00000309851:exon7:c.G519C:p.K173N,ENSG00000134184:ENST00000369823:exon7:c.G576C:p.K192N	GSTM1:NM_000561:exon7:c.G519C:p.K173N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3680	0.2895	0.461661	1(liver)	-0.360	0.482	0.152	-1.09	0.000	.	.	Glutathione S-transferase, C-terminal|Glutathione S-transferase, C-terminal-like	GSTM1:uc001dyk.3:exon7:c.G519C:p.K173N	-0.951	AFR:MU608636,AMR:LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,EAS:0.0927,FIN:0.4450,NFE:0.3429,OTH:0.6227,ASJ:0.2720	138350	.	.	.	~ko00480 Glutathione metabolism~ko00980 Metabolism of xenobiotics by cytochrome P450~ko00982 Drug metabolism - cytochrome P450~ko00983 Drug metabolism - other enzymes~ko01100 Metabolic pathways~ko01524 Platinum drug resistance~ko04212 Longevity regulating pathway - worm~ko05200 Pathways in cancer~ko05204 Chemical carcinogenesis~ko05225 Hepatocellular carcinoma~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	0.028	4.55	0.003	2.74	1	1(haematopoietic_and_lymphoid_tissue)	0.4462
1	110882444	110882444	A	G	RBM15	exonic	synonymous SNV	ENSG00000162775	rs814771	ENSG00000162775:ENST00000369784:exon1:c.A417G:p.E139E,ENSG00000162775:ENST00000487146:exon1:c.A417G:p.E139E,ENSG00000162775:ENST00000602849:exon1:c.A417G:p.E139E	RBM15:NM_001201545:exon1:c.A417G:p.E139E,RBM15:NM_022768:exon1:c.A417G:p.E139E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7613	0.7918	0.822883	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	RBM15:uc001dzl.1:exon1:c.A417G:p.E139E,RBM15:uc001dzm.1:exon1:c.A417G:p.E139E,RBM15:uc021orn.1:exon1:c.A417G:p.E139E	.	AFR:0.7926,AMR:0.9240,EAS:0.6954,FIN:0.7301,NFE:0.6873,OTH:0.7495,ASJ:0.8385	606077	.	.	.	.	.	.	.	.	.	.	.	1	1(biliary_tract)	0.7510
1	110883569	110883569	A	T	RBM15	exonic	synonymous SNV	ENSG00000162775	rs3738752	ENSG00000162775:ENST00000369784:exon1:c.A1542T:p.P514P,ENSG00000162775:ENST00000487146:exon1:c.A1542T:p.P514P,ENSG00000162775:ENST00000602849:exon1:c.A1542T:p.P514P	RBM15:NM_001201545:exon1:c.A1542T:p.P514P,RBM15:NM_022768:exon1:c.A1542T:p.P514P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1960	0.1416	0.176118	1(lung)	.	.	.	.	.	.	.	.	RBM15:uc001dzl.1:exon1:c.A1542T:p.P514P,RBM15:uc001dzm.1:exon1:c.A1542T:p.P514P,RBM15:uc021orn.1:exon1:c.A1542T:p.P514P	.	AFR:1(breast),AMR:1(large_intestine),EAS:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,FIN:0.1518,NFE:0.0524,OTH:0.1882,ASJ:MU580808	606077	.	.	.	.	.	.	.	.	.	.	.	1	1(stomach)	0.2583
1	114646258	114646258	C	T	SYT6	exonic	nonsynonymous SNV	ENSG00000134207	rs745931024	ENSG00000134207:ENST00000369547:exon4:c.G902A:p.R301Q,ENSG00000134207:ENST00000393296:exon4:c.G1157A:p.R386Q,ENSG00000134207:ENST00000607941:exon4:c.G902A:p.R301Q,ENSG00000134207:ENST00000609117:exon4:c.G902A:p.R301Q,ENSG00000134207:ENST00000610222:exon4:c.G1157A:p.R386Q	SYT6:NM_001253772:exon4:c.G1157A:p.R386Q,SYT6:NM_001270805:exon4:c.G902A:p.R301Q,SYT6:NM_001366223:exon4:c.G902A:p.R301Q,SYT6:NM_001366224:exon4:c.G1157A:p.R386Q,SYT6:NM_001366225:exon4:c.G1157A:p.R386Q,SYT6:NM_001366226:exon4:c.G902A:p.R301Q,SYT6:NM_205848:exon4:c.G902A:p.R301Q	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 1, 0, 0] 	4.121e-05	.	.	COCA-CN|1|321|0.00311526	6.982	33	0.009	5.85	0.997	.	.	C2 domain	SYT6:uc001eev.3:exon4:c.G902A:p.R301Q,SYT6:uc021orz.1:exon4:c.G902A:p.R301Q	-0.463	AFR:3.229e-05,AMR:0,EAS:0,FIN:0.0006,NFE:0,OTH:0,ASJ:0	607718	.	.	.	.	.	.	.	0.976	-0.43	0.311	1.72	1	1(skin)	0
1	114682632	114682632	G	T	SYT6	intronic	.	ENSG00000134207	rs72690087	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1112	.	0.0690895	0.0961	.	.	.	.	.	.	.	.	.	.	AFR:0.0813,AMR:0.0766,EAS:0.0006,FIN:0.0816,NFE:0.1204,OTH:0.0900,ASJ:0.0662	607718	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	114940633	114940633	A	-	TRIM33	intronic	.	ENSG00000197323	rs397981357	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5981	.	0.696685	0.8236	.	.	.	.	.	.	.	.	.	.	AFR:0.8736,AMR:0.8254,EAS:0.9741,FIN:0.7737,NFE:0.7888,OTH:0.7803,ASJ:0.7243	605769	.	.	.	.	.	.	.	.	.	.	.	1	.	hom
1	114948281	114948281	A	G	TRIM33	exonic	nonsynonymous SNV	ENSG00000197323	rs6537825	ENSG00000197323:ENST00000450349:exon14:c.T1415C:p.I472T,ENSG00000197323:ENST00000358465:exon15:c.T2519C:p.I840T,ENSG00000197323:ENST00000369543:exon15:c.T2519C:p.I840T	TRIM33:NM_015906:exon15:c.T2519C:p.I840T,TRIM33:NM_033020:exon15:c.T2519C:p.I840T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8921	0.9423	0.85643	MU807108	0.726	8.995	1.0	4.35	0.993	.	.	.	TRIM33:uc001eey.1:exon2:c.T104C:p.I35T,TRIM33:uc010owr.2:exon10:c.T1361C:p.I454T,TRIM33:uc010ows.2:exon14:c.T1415C:p.I472T,TRIM33:uc001eew.3:exon15:c.T2519C:p.I840T,TRIM33:uc001eex.3:exon15:c.T2519C:p.I840T	-1.066	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,AMR:0.9250,EAS:0.8266,FIN:0.87,NFE:0.5813,OTH:0.9674,ASJ:0.9707	605769	.	.	.	.	.	.	.	0.0	-0.55	0.039	-1.955	1	86(lung)	0.9320
1	120054208	120054208	C	T	HSD3B1	exonic	synonymous SNV	ENSG00000203857	rs6200	ENSG00000203857:ENST00000528909:exon2:c.C228T:p.V76V,ENSG00000203857:ENST00000235547:exon3:c.C234T:p.V78V,ENSG00000203857:ENST00000369413:exon3:c.C228T:p.V76V,ENSG00000203857:ENST00000531340:exon3:c.C228T:p.V76V	HSD3B1:NM_000862:exon3:c.C228T:p.V76V,HSD3B1:NM_001328615:exon3:c.C228T:p.V76V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0456	0.1009	0.128794	0.0897	.	.	.	.	.	.	.	.	HSD3B1:uc031pnt.1:exon2:c.C228T:p.V76V,HSD3B1:uc001ehv.1:exon3:c.C228T:p.V76V	.	AFR:0.2994,AMR:0.0573,EAS:0.0446,FIN:0,NFE:0.0018,OTH:0.0234,ASJ:0.0033	109715	.	.	.	.	.	.	.	.	.	.	.	1	MU85093349	unknown
1	120054215	120054215	A	G	HSD3B1	exonic	nonsynonymous SNV	ENSG00000203857	rs6201	ENSG00000203857:ENST00000528909:exon2:c.A235G:p.I79V,ENSG00000203857:ENST00000235547:exon3:c.A241G:p.I81V,ENSG00000203857:ENST00000369413:exon3:c.A235G:p.I79V,ENSG00000203857:ENST00000531340:exon3:c.A235G:p.I79V	HSD3B1:NM_000862:exon3:c.A235G:p.I79V,HSD3B1:NM_001328615:exon3:c.A235G:p.I79V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0482	0.1092	0.136581	0.0974	-2.148	0.001	1.0	0.153	0.047	.	.	3-beta hydroxysteroid dehydrogenase/isomerase|NAD(P)-binding domain	HSD3B1:uc031pnt.1:exon2:c.A235G:p.I79V,HSD3B1:uc001ehv.1:exon3:c.A235G:p.I79V	-0.998	AFR:0.3269,AMR:0.0585,EAS:0.0446,FIN:0,NFE:0.0019,OTH:0.0244,ASJ:0.0033	109715	.	.	.	.	.	.	.	0.0	-1.46	0.045	-1.625	1	MU85093350	unknown
1	120054250	120054250	T	A	HSD3B1	exonic	synonymous SNV	ENSG00000203857	rs6202	ENSG00000203857:ENST00000528909:exon2:c.T270A:p.G90G,ENSG00000203857:ENST00000235547:exon3:c.T276A:p.G92G,ENSG00000203857:ENST00000369413:exon3:c.T270A:p.G90G	HSD3B1:NM_000862:exon3:c.T270A:p.G90G,HSD3B1:NM_001328615:exon3:c.T270A:p.G90G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0460	0.1023	0.128794	0.0899	.	.	.	.	.	.	.	.	HSD3B1:uc031pnt.1:exon2:c.T270A:p.G90G,HSD3B1:uc001ehv.1:exon3:c.T270A:p.G90G	.	AFR:0.3018,AMR:0.0591,EAS:0.0456,FIN:0,NFE:0.0018,OTH:0.0239,ASJ:0.0034	109715	.	.	.	.	.	.	.	.	.	.	.	1	MU85093361	het
1	120057002	120057002	T	C	HSD3B1	exonic	nonsynonymous SNV	ENSG00000203857	rs6205	ENSG00000203857:ENST00000528909:exon3:c.T856C:p.F286L,ENSG00000203857:ENST00000235547:exon4:c.T862C:p.F288L,ENSG00000203857:ENST00000369413:exon4:c.T856C:p.F286L	HSD3B1:NM_000862:exon4:c.T856C:p.F286L,HSD3B1:NM_001328615:exon4:c.T856C:p.F286L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0543	0.1318	0.157748	0.1136	-1.838	0.002	1.0	-0.227	0.105	.	.	3-beta hydroxysteroid dehydrogenase/isomerase|NAD(P)-binding domain	HSD3B1:uc031pnt.1:exon3:c.T856C:p.F286L,HSD3B1:uc001ehv.1:exon4:c.T856C:p.F286L	-0.986	AFR:0.3826,AMR:0.0644,EAS:0.0465,FIN:0.0003,NFE:0.0020,OTH:0.0265,ASJ:0.0033	109715	.	.	.	.	.	.	.	0.0	0.31	0.007	-2.765	1	MU85093362	het
1	120057246	120057246	C	A	HSD3B1	exonic	nonsynonymous SNV	ENSG00000203857	rs1047303	ENSG00000203857:ENST00000528909:exon3:c.C1100A:p.T367N,ENSG00000203857:ENST00000235547:exon4:c.C1106A:p.T369N,ENSG00000203857:ENST00000369413:exon4:c.C1100A:p.T367N	HSD3B1:NM_000862:exon4:c.C1100A:p.T367N,HSD3B1:NM_001328615:exon4:c.C1100A:p.T367N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7554	0.7492	0.833466	COCA-CN|5|321|0.0155763	-1.422	0.003	0.303	-0.043	0.000	.	.	.	HSD3B1:uc031pnt.1:exon3:c.C1100A:p.T367N,HSD3B1:uc001ehv.1:exon4:c.C1100A:p.T367N	-1.061	AFR:0.7697,AMR:0.8843,EAS:0.6887,FIN:0.9312,NFE:0.7460,OTH:0.6915,ASJ:0.8141	109715	.	.	.	.	.	.	.	0.01	-0.58	0.151	2.52	1	1(large_intestine)	0.7485
1	120458004	120458004	A	T	NOTCH2	exonic	synonymous SNV	ENSG00000134250	rs6685892	ENSG00000134250:ENST00000256646:exon34:c.T7341A:p.G2447G	NOTCH2:NM_024408:exon34:c.T7341A:p.G2447G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.1293	0.1785	0.192492	0.1687	.	.	.	.	.	.	.	.	NOTCH2:uc001eik.3:exon34:c.T7341A:p.G2447G	.	AFR:0.3249,AMR:0.0993,EAS:0.0284,FIN:0.1294,NFE:0.1107,OTH:0.1214,ASJ:0.0960	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7845	.	.	.	.	.	.	1	.	het
1	120458924	120458924	G	A	NOTCH2	exonic	synonymous SNV	ENSG00000134250	rs3795666	ENSG00000134250:ENST00000256646:exon34:c.C6421T:p.L2141L	NOTCH2:NM_024408:exon34:c.C6421T:p.L2141L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0415	0.0179	0.0483227	0.0251	.	.	.	.	.	.	.	.	NOTCH2:uc001eik.3:exon34:c.C6421T:p.L2141L	.	AFR:0.0140,AMR:0.0716,EAS:0.0728,FIN:0.0355,NFE:0.0207,OTH:0.0387,ASJ:0.0199	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7845	.	.	.	.	.	.	1	MU11268904	het
1	120479920	120479920	A	G	NOTCH2	exonic	synonymous SNV	ENSG00000134250	rs587758205	ENSG00000134250:ENST00000256646:exon21:c.T3507C:p.G1169G	NOTCH2:NM_001200001:exon21:c.T3507C:p.G1169G,NOTCH2:NM_024408:exon21:c.T3507C:p.G1169G	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1] 	0.0001	.	0.000199681	.	.	.	.	.	.	.	.	.	NOTCH2:uc001eik.3:exon21:c.T3507C:p.G1169G,NOTCH2:uc001eil.3:exon21:c.T3507C:p.G1169G	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7845	.	.	.	.	.	.	1	.	het
1	120548152	120548152	C	T	NOTCH2	exonic	nonsynonymous SNV	ENSG00000134250	rs201838650	ENSG00000134250:ENST00000256646:exon3:c.G215A:p.R72H,ENSG00000134250:ENST00000602566:exon4:c.G98A:p.R33H	NOTCH2:NM_001200001:exon3:c.G215A:p.R72H,NOTCH2:NM_024408:exon3:c.G215A:p.R72H	clinvar: Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.0035	0.0002	0.00519169	STAD-US|1|439|0.0022779	3.955	23.6	0.55	3.51	0.999	.	.	EGF-like calcium-binding domain|EGF-like domain	NOTCH2:uc001eik.3:exon3:c.G215A:p.R72H,NOTCH2:uc001eil.3:exon3:c.G215A:p.R72H,NOTCH2:uc021osy.1:exon3:c.G98A:p.R33H	-1.108	AFR:9.806e-05,AMR:0.0001,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7845	.	.	0.157	0.42	0.042	0.425	1	2(prostate)	0.0021
1	120572547	120572547	T	C	NOTCH2	exonic	nonsynonymous SNV	ENSG00000134250	rs61788900	ENSG00000134250:ENST00000256646:exon2:c.A137G:p.N46S,ENSG00000134250:ENST00000602566:exon3:c.A20G:p.N7S	NOTCH2:NM_001200001:exon2:c.A137G:p.N46S,NOTCH2:NM_024408:exon2:c.A137G:p.N46S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.4736	.	.	4(penis)	2.196	17.48	0.129	5.05	1.000	.	.	EGF-like domain	NOTCH2:uc001eik.3:exon2:c.A137G:p.N46S,NOTCH2:uc001eil.3:exon2:c.A137G:p.N46S,NOTCH2:uc021osy.1:exon2:c.A20G:p.N7S	-0.943	AFR:4(thyroid),AMR:2(large_intestine),EAS:1(biliary_tract),FIN:MU617194,NFE:LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,THCA-CN|1|50|0.02,OTH:0.3958,ASJ:1(kidney)	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7845	.	.	0.01	-0.03	0.124	0.885	1	4(haematopoietic_and_lymphoid_tissue)	0.2468
1	120572572	120572572	C	T	NOTCH2	exonic	nonsynonymous SNV	ENSG00000134250	rs61788901	ENSG00000134250:ENST00000256646:exon2:c.G112A:p.E38K	NOTCH2:NM_001200001:exon2:c.G112A:p.E38K,NOTCH2:NM_024408:exon2:c.G112A:p.E38K	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.4699	.	.	2(haematopoietic_and_lymphoid_tissue)	2.535	19.69	0.058	2.14	0.988	.	.	EGF-like domain	NOTCH2:uc001eik.3:exon2:c.G112A:p.E38K,NOTCH2:uc001eil.3:exon2:c.G112A:p.E38K	-1.097	AFR:1(central_nervous_system),AMR:18(upper_aerodigestive_tract),EAS:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,FIN:0.3980,NFE:0.2513,OTH:0.4313,ASJ:MU4547029	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7845	.	.	0.044	0.13	0.049	0.02	1	1(thyroid)	0.4424
1	120611964	120611964	G	C	NOTCH2	exonic	nonsynonymous SNV	ENSG00000134250	rs11810554	ENSG00000134250:ENST00000256646:exon1:c.C57G:p.C19W	NOTCH2:NM_001200001:exon1:c.C57G:p.C19W,NOTCH2:NM_024408:exon1:c.C57G:p.C19W	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.4493	.	.	0.3877	2.208	17.56	0.185	2.04	0.868	.	.	.	NOTCH2:uc001eik.3:exon1:c.C57G:p.C19W,NOTCH2:uc001eil.3:exon1:c.C57G:p.C19W	-1.048	AFR:0.2278,AMR:0.4293,EAS:0.4526,FIN:0.4558,NFE:0.4469,OTH:0.4300,ASJ:0.4312	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7845	.	.	0.001	0.4	0.036	1.04	1	MU815514	het
1	120612006	120612006	G	A	NOTCH2	exonic	synonymous SNV	ENSG00000134250	rs4021006	ENSG00000134250:ENST00000256646:exon1:c.C15T:p.R5R	NOTCH2:NM_001200001:exon1:c.C15T:p.R5R,NOTCH2:NM_024408:exon1:c.C15T:p.R5R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4638	.	0.39397	0.3802	.	.	.	.	.	.	.	.	NOTCH2:uc001eik.3:exon1:c.C15T:p.R5R,NOTCH2:uc001eil.3:exon1:c.C15T:p.R5R	.	AFR:0.2426,AMR:0.4346,EAS:0.4369,FIN:0.4496,NFE:0.4286,OTH:0.4243,ASJ:0.4070	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7845	.	.	.	.	.	.	1	MU657255	het
1	120612040	120612040	-	CCTCCTCCG	NOTCH2NLR	ncRNA_exonic	.	ENSG00000134250	rs782658834	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0167	0.0669	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	.	.	.	.	.	.	.	.	1	.	het
1	147096112	147096112	G	A	BCL9	exonic	nonsynonymous SNV	ENSG00000116128	rs61751618	ENSG00000116128:ENST00000234739:exon10:c.G3633A:p.M1211I	BCL9:NM_004326:exon10:c.G3633A:p.M1211I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0108	0.0122	0.00519169	0.0084	2.251	17.84	0.037	4.01	1.000	.	.	.	BCL9:uc010ozr.1:exon7:c.G3375A:p.M1125I,BCL9:uc001epq.3:exon10:c.G3633A:p.M1211I	-1.052	AFR:0.0018,AMR:0.0084,EAS:0,FIN:0.0072,NFE:0.0137,OTH:0.0061,ASJ:0	602597	.	.	.	.	.	.	.	0.0	0.46	0.065	1.87	1	.	het
1	150239745	150239745	G	A	APH1A	intronic	.	ENSG00000117362	rs199893609	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0029	8.1e-05	0.00479233	6.459e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0020,ASJ:0	607629	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	153923772	153923772	C	T	CRTC2	exonic	synonymous SNV	ENSG00000160741	rs563056498	ENSG00000160741:ENST00000368630:exon2:c.G408A:p.S136S,ENSG00000160741:ENST00000461638:exon9:c.G1128A:p.S376S,ENSG00000160741:ENST00000368633:exon11:c.G1368A:p.S456S	CRTC2:NM_181715:exon11:c.G1368A:p.S456S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 0, 0, 0] 	3.423e-05	.	.	.	.	.	.	.	.	.	.	.	CRTC2:uc021pab.1:exon11:c.G1368A:p.S456S	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608972	.	.	.	.	.	.	.	.	.	.	.	1	1(large_intestine)	.
1	154557685	154557685	C	T	ADAR	intronic	.	ENSG00000160710	rs9427094	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4630	0.4032	0.388778	0.4128	.	.	.	.	.	0.0004	0.01	.	.	.	AFR:0.2448,AMR:0.4797,EAS:0.5392,FIN:0.4581,NFE:0.4804,OTH:0.4324,ASJ:0.4636	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	.	.	.	.	1	MU20489329	het
1	154573967	154573967	T	C	ADAR	exonic	nonsynonymous SNV	ENSG00000160710	rs2229857	ENSG00000160710:ENST00000529168:exon1:c.A1136G:p.K379R,ENSG00000160710:ENST00000292205:exon2:c.A1280G:p.K427R,ENSG00000160710:ENST00000368471:exon2:c.A266G:p.K89R,ENSG00000160710:ENST00000368474:exon2:c.A1151G:p.K384R	ADAR:NM_001025107:exon2:c.A266G:p.K89R,ADAR:NM_001111:exon2:c.A1151G:p.K384R,ADAR:NM_001193495:exon2:c.A266G:p.K89R,ADAR:NM_001365045:exon2:c.A1178G:p.K393R,ADAR:NM_001365048:exon2:c.A266G:p.K89R,ADAR:NM_015840:exon2:c.A1151G:p.K384R,ADAR:NM_015841:exon2:c.A1151G:p.K384R,ADAR:NM_001365046:exon3:c.A266G:p.K89R,ADAR:NM_001365047:exon3:c.A266G:p.K89R,ADAR:NM_001365049:exon3:c.A266G:p.K89R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6956	0.6079	0.622604	0.6279	-1.245	0.005	0.381	-0.812	0.003	.	.	.	ADAR:uc001ffh.3:exon2:c.A1151G:p.K384R,ADAR:uc001ffi.3:exon2:c.A1151G:p.K384R,ADAR:uc001ffj.3:exon2:c.A1151G:p.K384R,ADAR:uc001ffk.3:exon2:c.A266G:p.K89R,ADAR:uc001ffl.1:exon2:c.A266G:p.K89R,ADAR:uc021pag.1:exon2:c.A266G:p.K89R	-0.976	AFR:0.4283,AMR:0.7673,EAS:0.7093,FIN:0.6791,NFE:0.7098,OTH:0.6994,ASJ:0.6689	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	0.0	2.73	0.009	2.015	1	MU20489500	hom
1	154574820	154574820	T	C	ADAR	exonic	nonsynonymous SNV	ENSG00000160710	rs1466731	ENSG00000160710:ENST00000529168:exon1:c.A283G:p.R95G,ENSG00000160710:ENST00000292205:exon2:c.A427G:p.R143G,ENSG00000160710:ENST00000368474:exon2:c.A298G:p.R100G	ADAR:NM_001111:exon2:c.A298G:p.R100G,ADAR:NM_001365045:exon2:c.A325G:p.R109G,ADAR:NM_015840:exon2:c.A298G:p.R100G,ADAR:NM_015841:exon2:c.A298G:p.R100G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9988	0.9957	0.996206	0.9969	-1.562	0.002	0.807	-2.82	0.000	.	.	.	ADAR:uc001ffh.3:exon2:c.A298G:p.R100G,ADAR:uc001ffi.3:exon2:c.A298G:p.R100G,ADAR:uc001ffj.3:exon2:c.A298G:p.R100G	-1.015	AFR:0.9892,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:0.9980,ASJ:1	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	0.0	2.45	0.009	-0.205	1	MU81711582	hom
1	154575040	154575040	C	T	ADAR	exonic	synonymous SNV	ENSG00000160710	rs1802645	ENSG00000160710:ENST00000529168:exon1:c.G63A:p.R21R,ENSG00000160710:ENST00000292205:exon2:c.G207A:p.R69R,ENSG00000160710:ENST00000368474:exon2:c.G78A:p.R26R	ADAR:NM_001111:exon2:c.G78A:p.R26R,ADAR:NM_001365045:exon2:c.G105A:p.R35R,ADAR:NM_015840:exon2:c.G78A:p.R26R,ADAR:NM_015841:exon2:c.G78A:p.R26R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9992	0.9972	0.997005	0.9978	.	.	.	.	.	.	.	.	ADAR:uc001ffh.3:exon2:c.G78A:p.R26R,ADAR:uc001ffi.3:exon2:c.G78A:p.R26R,ADAR:uc001ffj.3:exon2:c.G78A:p.R26R,ADAR:uc001ffn.2:exon2:c.G78A:p.R26R	.	AFR:0.9924,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	.	.	.	.	1	MU81711590	hom
1	154580458	154580458	C	A	ADAR	intronic	.	ENSG00000160710	rs58655370	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2584	0.2792	0.304712	0.2782	.	.	.	.	.	.	.	.	.	.	AFR:0.4208,AMR:0.2950,EAS:0.1395,FIN:0.2209,NFE:0.2255,OTH:0.2679,ASJ:0.1854	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	.	.	.	.	1	MU26073242	het
1	155870416	155870416	G	A	RIT1	intronic	.	ENSG00000143622	rs1749409	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8772	0.7934	0.779752	0.8171	.	.	.	.	.	0	0	.	.	.	AFR:0.5463,AMR:0.9356,EAS:0.9377,FIN:0.9035,NFE:0.9284,OTH:0.8921,ASJ:0.8676	609591	615355;	648;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	.	.	.	.	.	.	.	.	1	MU26075081	hom
1	155880573	155880573	C	G	RIT1	exonic	nonsynonymous SNV	ENSG00000143622	rs493446	ENSG00000143622:ENST00000368322:exon2:c.G31C:p.E11Q	RIT1:NM_001256821:exon2:c.G31C:p.E11Q	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 1] 	0.8775	0.7952	0.779952	0.8174	-0.532	0.183	0.43	-0.379	0.012	.	.	.	RIT1:uc031pqc.1:exon2:c.G31C:p.E11Q	-1.065	AFR:0.5470,AMR:0.9356,EAS:0.9382,FIN:0.9038,NFE:0.9286,OTH:0.8918,ASJ:0.8676	609591	615355;	648;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	.	9551,,9550	.	.	.	-0.21	0.078	.	1	MU26075246	hom
1	156107534	156107534	C	T	LMNA	exonic	synonymous SNV	ENSG00000160789	rs4641	ENSG00000160789:ENST00000361308:exon10:c.C1698T:p.H566H,ENSG00000160789:ENST00000368299:exon10:c.C1698T:p.H566H,ENSG00000160789:ENST00000368300:exon10:c.C1698T:p.H566H,ENSG00000160789:ENST00000392353:exon10:c.C1455T:p.H485H,ENSG00000160789:ENST00000448611:exon10:c.C1362T:p.H454H,ENSG00000160789:ENST00000368297:exon11:c.C1455T:p.H485H,ENSG00000160789:ENST00000473598:exon11:c.C1401T:p.H467H,ENSG00000160789:ENST00000368301:exon13:c.C1698T:p.H566H	LMNA:NM_001257374:exon10:c.C1362T:p.H454H,LMNA:NM_001282626:exon10:c.C1698T:p.H566H,LMNA:NM_005572:exon10:c.C1698T:p.H566H,LMNA:NM_170707:exon10:c.C1698T:p.H566H,LMNA:NM_001282624:exon11:c.C1455T:p.H485H,LMNA:NM_001282625:exon13:c.C1698T:p.H566H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2655	0.1970	0.220248	1(stomach)	.	.	.	.	.	.	.	.	LMNA:uc010pha.1:exon5:c.C666T:p.H222H,LMNA:uc001fng.2:exon10:c.C1698T:p.H566H,LMNA:uc001fni.3:exon10:c.C1698T:p.H566H,LMNA:uc009wro.2:exon10:c.C1698T:p.H566H,LMNA:uc010pgz.2:exon10:c.C1362T:p.H454H,LMNA:uc001fnj.3:exon11:c.C1455T:p.H485H,LMNA:uc001fnk.3:exon11:c.C1401T:p.H467H,LMNA:uc001fnf.1:exon13:c.C1698T:p.H566H	.	AFR:2(breast),AMR:MU107165,EAS:0.1960,FIN:0.0919,NFE:0.2912,OTH:0.23,ASJ:LUSC-KR|6|170|0.0352941,COCA-CN|4|321|0.0124611	150330	115200;151660;159001;176670;181350;212112;248370;275210;605588;610140;613205;616516;	261;98855;157973;168796;98856;1662;2457;90153;2229;261;98853;740;264;2348;300751;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98855|EDMD3|-|Autosomal recessive|-|616516 ~157973|L-CMD<br>LMNA-related congenital muscular dystrophy|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|613205 ~168796|Atriodigital dysplasia, Slovenian type<br>Cardiac conduction disease-dilated cardiomyopathy-brachydactyly syndrome|<1 / 1 000 000|Autosomal dominant|Adult|610140 ~98856|AR-CMT2B1<br>Autosomal recessive Charcot-Marie-Tooth disease type 2B1<br>Autosomal recessive axonal CMT4C1|Unknown|Autosomal recessive|Childhood|605588 ~1662|Hyperkeratosis-contracture syndrome<br>Lethal restrictive dermopathy<br>Tight skin contracture syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal|275210 ~2457|MAD|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|248370 608612 ~90153|-|-|Autosomal recessive|-|248370 ~2229|Cardiogenital syndrome<br>Malouf syndrome<br>Najjar syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|212112 ~261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~740|HGPS<br>Progeria|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|176670 ~264|LGMD1B<br>Limb-girdle muscular dystrophy due to lamin A/C deficiency|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Childhood|159001 ~2348|Dunnigan syndrome<br>FPLD2<br>Familial partial lipodystrophy type 2|Unknown|Autosomal dominant|Adolescent<br>Adult|151660 ~300751|-|Unknown|Autosomal dominant|-|115200 ~	.	.	.	.	.	.	.	.	1	1(thyroid)	0.2466
1	156785617	156785617	G	A	NTRK1	UTR5	.	ENSG00000198400	rs1800601	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6674	0.6177	0.636981	0.6243	.	.	.	.	.	.	.	.	.	.	AFR:0.5074,AMR:0.6926,EAS:0.8288,FIN:0.6437,NFE:0.6591,OTH:0.6449,ASJ:0.6887	191315	155240;256800;	642;653;99361;	642|HSAN4<br>Insensitivity to pain-anhidrosis syndrome|-|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|256800 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	1	MU718802	hom
1	156848995	156848995	C	T	NTRK1	exonic	synonymous SNV	ENSG00000198400	rs6337	ENSG00000198400:ENST00000358660:exon14:c.C1878T:p.A626A,ENSG00000198400:ENST00000368196:exon14:c.C1869T:p.A623A,ENSG00000198400:ENST00000392302:exon15:c.C1779T:p.A593A,ENSG00000198400:ENST00000524377:exon15:c.C1887T:p.A629A	NTRK1:NM_001012331:exon14:c.C1869T:p.A623A,NTRK1:NM_001007792:exon15:c.C1779T:p.A593A,NTRK1:NM_002529:exon15:c.C1887T:p.A629A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5724	0.5568	0.334065	MU687507	.	.	.	.	.	.	.	.	NTRK1:uc001fqi.1:exon14:c.C1869T:p.A623A,NTRK1:uc009wsi.1:exon14:c.C984T:p.A328A,NTRK1:uc009wsk.1:exon14:c.C1878T:p.A626A,NTRK1:uc001fqf.1:exon15:c.C1779T:p.A593A,NTRK1:uc001fqh.1:exon15:c.C1887T:p.A629A	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,BRCA-KR|1|50|0.02,AMR:0.5379,EAS:0.5919,FIN:0.7351,NFE:0.0433,OTH:0.7278,ASJ:0.2079	191315	155240;256800;	642;653;99361;	642|HSAN4<br>Insensitivity to pain-anhidrosis syndrome|-|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|256800 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	1	2(thyroid)	0.7271
1	161284224	161284224	-	GT	SDHC	intronic	.	ENSG00000143252	rs35215598	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1053	0.1122	0.169728	0.1217	.	.	.	.	.	.	.	.	.	.	AFR:0.2141,AMR:0.0668,EAS:0.1867,FIN:0.1002,NFE:0.0724,OTH:0.0998,ASJ:0.03	602413	605373;606764;606864;	97286;44890;29072;	97286|Carney dyad<br>Carney-Stratakis dyad<br>GIST-paraganglioma dyad<br>Paraganglioma and gastric stromal sarcoma|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|606864 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~	.	.	.	.	.	.	.	.	1	.	het
1	161332346	161332346	C	G	SDHC	UTR3	.	ENSG00000143252	rs3813632	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1029	0.0694	0.128794	0.0873	.	.	.	.	.	.	.	.	.	.	AFR:0.0978,AMR:0.0656,EAS:0.1768,FIN:0.0986,NFE:0.0710,OTH:0.0937,ASJ:0.0298	602413	605373;606764;606864;	97286;44890;29072;	97286|Carney dyad<br>Carney-Stratakis dyad<br>GIST-paraganglioma dyad<br>Paraganglioma and gastric stromal sarcoma|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|606864 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~	.	.	.	.	.	.	.	.	1	MU652984	het
1	161642752	161642752	T	C	FCGR2B	intronic	.	ENSG00000234211	rs4657089	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0002	.	.	0.0007	.	.	.	.	.	.	.	.	.	.	AFR:0.0014,AMR:0.0012,EAS:0,FIN:0,NFE:0.0007,OTH:0,ASJ:0	604590	152700;611162;	673;	673|-|1-9 / 100 000|Not applicable|All ages|611162 ~	.	.	.	.	.	.	.	.	1	.	het
1	161645259	161645259	T	G	FCGR2B	intronic	.	ENSG00000072694	rs1674759	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.792532	0.8326	.	.	.	.	.	.	.	.	.	.	AFR:0.7640,AMR:0.8604,EAS:0.8306,FIN:0.8873,NFE:0.8578,OTH:0.8535,ASJ:0.7919	604590	152700;611162;	673;	673|-|1-9 / 100 000|Not applicable|All ages|611162 ~	.	.	.	.	.	.	.	.	1	MU113392205	hom
1	162740327	162740327	T	C	DDR2	intronic	.	ENSG00000162733	rs1780003	ENSG00000162733:ENST00000458105:exon2:c.T359C:p.V120A	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9855	0.9476	0.945487	0.9541	-0.266	0.793	0.0	-10.1	0.000	.	.	.	.	-1.062	AFR:0.8402,AMR:0.9928,EAS:1,FIN:1,NFE:0.9993,OTH:0.9867,ASJ:1	191311	271665;	93358;	93358|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|271665 ~	.	.	.	.	.	1.39	0.010	.	1	MU81714571	hom
1	164529120	164529120	G	A	PBX1	exonic	nonsynonymous SNV	ENSG00000185630	rs2275558	ENSG00000185630:ENST00000367897:exon1:c.G61A:p.G21S,ENSG00000185630:ENST00000401534:exon1:c.G61A:p.G21S,ENSG00000185630:ENST00000420696:exon1:c.G61A:p.G21S,ENSG00000185630:ENST00000540236:exon1:c.G61A:p.G21S,ENSG00000185630:ENST00000559240:exon1:c.G61A:p.G21S,ENSG00000185630:ENST00000340699:exon2:c.G61A:p.G21S,ENSG00000185630:ENST00000485769:exon2:c.G61A:p.G21S	PBX1:NM_001204961:exon1:c.G61A:p.G21S,PBX1:NM_001204963:exon1:c.G61A:p.G21S,PBX1:NM_001353131:exon1:c.G61A:p.G21S,PBX1:NM_002585:exon1:c.G61A:p.G21S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.2977	0.1381	0.307308	MU21780744	2.102	16.87	0.118	5.18	1.000	.	.	.	PBX1:uc001gcs.3:exon1:c.G61A:p.G21S,PBX1:uc001gct.3:exon1:c.G61A:p.G21S,PBX1:uc010pku.2:exon1:c.G61A:p.G21S	-0.502	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|2|50|0.04,AMR:0.2004,EAS:0.4354,FIN:0.2649,NFE:0.6461,OTH:0.2045,ASJ:0.0390	176310	.	.	.	~ko04927 Cortisol synthesis and secretion~ko04934 Cushing syndrome~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.054	0.79	0.329	1.04	1	2(lung)	0.2274
1	170501385	170501385	A	C	GORAB	exonic	synonymous SNV	ENSG00000120370	rs7531125	ENSG00000120370:ENST00000367762:exon1:c.A96C:p.G32G,ENSG00000120370:ENST00000367763:exon1:c.A96C:p.G32G	GORAB:NM_001146039:exon1:c.A96C:p.G32G,GORAB:NM_152281:exon1:c.A96C:p.G32G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9797	0.9355	0.927516	0.9418	.	.	.	.	.	.	.	.	GORAB:uc001ggz.4:exon1:c.A96C:p.G32G,GORAB:uc001gha.2:exon1:c.A96C:p.G32G,GORAB:uc009wvw.2:exon1:c.A96C:p.G32G	.	AFR:0.7985,AMR:0.9821,EAS:0.9994,FIN:1,NFE:0.9987,OTH:0.9919,ASJ:0.9834	607983	231070;	2078;	2078|-|<1 / 1 000 000|Autosomal recessive|Neonatal|231070 ~	.	.	.	.	.	.	.	.	1	MU4568428	hom
1	170521376	170521376	G	A	GORAB	exonic	nonsynonymous SNV	ENSG00000120370	rs913257	ENSG00000120370:ENST00000367763:exon5:c.G958A:p.E320K	GORAB:NM_152281:exon5:c.G958A:p.E320K,GORAB:NM_001320252:exon7:c.G418A:p.E140K	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.5394	0.4859	0.592652	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	5.381	25.9	0.059	2.65	0.171	.	.	.	GORAB:uc001ghd.2:exon2:c.G337A:p.E113K,GORAB:uc001ghc.2:exon4:c.G418A:p.E140K,GORAB:uc001gha.2:exon5:c.G958A:p.E320K,GORAB:uc009wvx.2:exon5:c.G418A:p.E140K,GORAB:uc001ghb.2:exon7:c.G418A:p.E140K	-1.034	AFR:0.5294,AMR:0.5227,EAS:0.4139,FIN:0.9022,NFE:0.5713,OTH:0.4809,ASJ:0.6193	607983	231070;	2078;	2078|-|<1 / 1 000 000|Autosomal recessive|Neonatal|231070 ~	.	.	.	.	0.777	-0.01	0.085	2.16	1	1(large_intestine)	0.5245
1	173878832	173878832	T	C	SERPINC1	exonic	synonymous SNV	ENSG00000117601	rs5878	ENSG00000117601:ENST00000367698:exon5:c.A1011G:p.Q337Q	SERPINC1:NM_000488:exon5:c.A1011G:p.Q337Q,SERPINC1:NM_001365052:exon6:c.A867G:p.Q289Q	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4029	0.4882	0.535743	0.4717	.	.	.	.	.	.	.	.	SERPINC1:uc001gjt.3:exon5:c.A1011G:p.Q337Q	.	AFR:0.7680,AMR:0.2632,EAS:0.6539,FIN:0.2885,NFE:0.3395,OTH:0.3706,ASJ:0.53	107300	613118;	82;	82|Hereditary thrombophilia due to congenital antithrombin 3 deficiency|-|-|-|613118 ~	.	.	.	.	.	.	.	.	1	MU158486	het
1	173878862	173878862	T	C	SERPINC1	exonic	synonymous SNV	ENSG00000117601	rs5877	ENSG00000117601:ENST00000367698:exon5:c.A981G:p.V327V	SERPINC1:NM_000488:exon5:c.A981G:p.V327V,SERPINC1:NM_001365052:exon6:c.A837G:p.V279V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4079	0.4836	0.545327	0.4688	.	.	.	.	.	.	.	.	SERPINC1:uc001gjt.3:exon5:c.A981G:p.V327V	.	AFR:0.7612,AMR:0.3353,EAS:0.6751,FIN:0.2736,NFE:0.3346,OTH:0.3673,ASJ:0.5265	107300	613118;	82;	82|Hereditary thrombophilia due to congenital antithrombin 3 deficiency|-|-|-|613118 ~	.	.	.	.	.	.	.	.	1	MU158492	het
1	173885536	173885536	G	T	SERPINC1	intronic	.	ENSG00000117601	rs2227593	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.23762	0.1994	.	.	.	.	.	.	.	.	.	.	AFR:0.3825,AMR:0.0955,EAS:0.2562,FIN:0.0944,NFE:0.1217,OTH:0.1324,ASJ:0.2020	107300	613118;	82;	82|Hereditary thrombophilia due to congenital antithrombin 3 deficiency|-|-|-|613118 ~	.	.	.	.	.	.	.	.	1	MU20014487	het
1	179112110	179112110	G	T	ABL2	exonic	nonsynonymous SNV	ENSG00000143322	rs202125612	ENSG00000143322:ENST00000344730:exon1:c.C70A:p.L24M,ENSG00000143322:ENST00000408940:exon1:c.C70A:p.L24M,ENSG00000143322:ENST00000504405:exon1:c.C70A:p.L24M,ENSG00000143322:ENST00000512653:exon1:c.C70A:p.L24M	ABL2:NM_001136000:exon1:c.C70A:p.L24M,ABL2:NM_001168239:exon1:c.C70A:p.L24M,ABL2:NM_005158:exon1:c.C70A:p.L24M	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, -1, 1, 0] 	0.0067	.	0.0109824	9.687e-05	0.495	7.390	0.05	4.41	0.106	.	.	.	ABL2:uc001gmg.4:exon1:c.C70A:p.L24M,ABL2:uc001gmi.4:exon1:c.C70A:p.L24M,ABL2:uc001gmk.3:exon1:c.C70A:p.L24M,ABL2:uc009wxf.2:exon1:c.C70A:p.L24M,ABL2:uc010pne.2:exon1:c.C70A:p.L24M	-0.493	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0020,ASJ:0	164690	.	.	.	.	.	.	.	0.005	-0.94	0.443	.	1	MU85325260	het
1	179176398	179176398	G	A	ABL2	intronic	.	ENSG00000143322	rs2171958	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.4998	0.5052	.	.	.	.	.	.	.	.	.	.	AFR:0.5225,AMR:0.5744,EAS:0.4956,FIN:0.4744,NFE:0.5020,OTH:0.5032,ASJ:0.3833	164690	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	180240510	180240510	T	C	LHX4-AS1	ncRNA_exonic	.	ENSG00000230124	rs2764449	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0665	0.0590	0.0413339	0.0652	.	.	.	.	.	.	.	.	.	.	AFR:0.0140,AMR:0.0501,EAS:0.0154,FIN:0.1274,NFE:0.0868,OTH:0.0682,ASJ:0.0497	616352	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	183177218	183177218	A	G	LAMC2	intronic	.	ENSG00000058085	rs647347	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4739	0.4475	0.496206	0.4515	.	.	.	.	.	.	.	.	.	.	AFR:0.4648,AMR:0.5120,EAS:0.5694,FIN:0.4966,NFE:0.4171,OTH:0.4662,ASJ:0.4073	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU11323905	hom
1	183184616	183184616	C	T	LAMC2	exonic	synonymous SNV	ENSG00000058085	rs2274980	ENSG00000058085:ENST00000264144:exon3:c.C297T:p.S99S,ENSG00000058085:ENST00000493293:exon3:c.C297T:p.S99S	LAMC2:NM_005562:exon3:c.C297T:p.S99S,LAMC2:NM_018891:exon3:c.C297T:p.S99S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2460	0.2461	0.313698	0.2528	.	.	.	.	.	.	.	.	LAMC2:uc001gpz.4:exon3:c.C297T:p.S99S,LAMC2:uc001gqa.2:exon3:c.C297T:p.S99S	.	AFR:0.3893,AMR:0.3556,EAS:0.3401,FIN:0.1934,NFE:0.1766,OTH:0.2189,ASJ:0.1490	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU59731	hom
1	183187603	183187603	C	T	LAMC2	exonic	synonymous SNV	ENSG00000058085	rs1129723	ENSG00000058085:ENST00000264144:exon4:c.C483T:p.V161V,ENSG00000058085:ENST00000493293:exon4:c.C483T:p.V161V	LAMC2:NM_005562:exon4:c.C483T:p.V161V,LAMC2:NM_018891:exon4:c.C483T:p.V161V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2566	0.2461	0.313898	0.2528	.	.	.	.	.	.	.	.	LAMC2:uc001gpz.4:exon4:c.C483T:p.V161V,LAMC2:uc001gqa.2:exon4:c.C483T:p.V161V	.	AFR:0.3887,AMR:0.3529,EAS:0.3375,FIN:0.1935,NFE:0.1772,OTH:0.2189,ASJ:0.1490	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU81716861	hom
1	183191324	183191324	C	A	LAMC2	exonic	nonsynonymous SNV	ENSG00000058085	rs2296306	ENSG00000058085:ENST00000264144:exon6:c.C741A:p.D247E,ENSG00000058085:ENST00000493293:exon6:c.C741A:p.D247E	LAMC2:NM_005562:exon6:c.C741A:p.D247E,LAMC2:NM_018891:exon6:c.C741A:p.D247E	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0559	0.0336	0.0642971	0.0336	1.344	12.50	1.0	1.82	0.942	.	.	Laminin IV	LAMC2:uc001gpz.4:exon6:c.C741A:p.D247E,LAMC2:uc001gqa.2:exon6:c.C741A:p.D247E	-1.037	AFR:0.0225,AMR:0.0907,EAS:0.0679,FIN:0.0260,NFE:0.0341,OTH:0.0429,ASJ:0.0397	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.282	2.56	0.001	0.425	1	MU81716879	hom
1	183192304	183192304	T	G	LAMC2	exonic	synonymous SNV	ENSG00000058085	rs1047980	ENSG00000058085:ENST00000264144:exon7:c.T798G:p.G266G,ENSG00000058085:ENST00000493293:exon7:c.T798G:p.G266G	LAMC2:NM_005562:exon7:c.T798G:p.G266G,LAMC2:NM_018891:exon7:c.T798G:p.G266G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2589	0.2871	0.355032	0.2881	.	.	.	.	.	.	.	.	LAMC2:uc001gpz.4:exon7:c.T798G:p.G266G,LAMC2:uc001gqa.2:exon7:c.T798G:p.G266G	.	AFR:0.5103,AMR:0.3687,EAS:0.3410,FIN:0.1934,NFE:0.1782,OTH:0.2223,ASJ:0.1433	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU581268	hom
1	183206573	183206573	G	A	LAMC2	exonic	synonymous SNV	ENSG00000058085	rs1047981	ENSG00000058085:ENST00000264144:exon18:c.G2688A:p.Q896Q,ENSG00000058085:ENST00000493293:exon18:c.G2688A:p.Q896Q	LAMC2:NM_005562:exon18:c.G2688A:p.Q896Q,LAMC2:NM_018891:exon18:c.G2688A:p.Q896Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2579	0.2864	0.352436	0.2871	.	.	.	.	.	.	.	.	LAMC2:uc001gpz.4:exon18:c.G2688A:p.Q896Q,LAMC2:uc001gqa.2:exon18:c.G2688A:p.Q896Q,LAMC2:uc010poa.2:exon18:c.G1788A:p.Q596Q	.	AFR:0.5071,AMR:0.3648,EAS:0.3428,FIN:0.1929,NFE:0.1780,OTH:0.2254,ASJ:0.1433	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU21003025	hom
1	183212548	183212548	T	G	LAMC2	UTR3	.	ENSG00000058085	rs3768593	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2372	0.2296	0.310903	0.2352	.	.	.	.	.	.	.	.	.	.	AFR:0.3540,AMR:0.3484,EAS:0.3623,FIN:0.1626,NFE:0.1668,OTH:0.2067,ASJ:0.1490	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU21936644	hom
1	183542387	183542387	T	C	NCF2	exonic	nonsynonymous SNV	ENSG00000116701	rs2274064	ENSG00000116701:ENST00000413720:exon4:c.A407G:p.K136R,ENSG00000116701:ENST00000367535:exon5:c.A542G:p.K181R,ENSG00000116701:ENST00000367536:exon6:c.A542G:p.K181R	NCF2:NM_001190794:exon4:c.A407G:p.K136R,NCF2:NM_000433:exon5:c.A542G:p.K181R,NCF2:NM_001127651:exon6:c.A542G:p.K181R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4895	0.4300	0.491613	1(breast)	0.553	7.827	0.909	1.27	0.983	.	.	Tetratricopeptide-like helical domain	NCF2:uc010pod.2:exon4:c.A407G:p.K136R,NCF2:uc001gqj.4:exon5:c.A542G:p.K181R,NCF2:uc001gqk.4:exon6:c.A542G:p.K181R	-0.933	AFR:1(lung),AMR:3(urinary_tract),EAS:SKCA-BR|1|100|0.01,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,FIN:0.4535,NFE:0.3690,OTH:0.6005,ASJ:MU117998	608515	233710;	379;	379|CGD<br>Chronic septic granulomatosis|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Childhood<br>Adolescent<br>Adult|233670 233690 233700 233710 306400 613960 ~	.	.	.	.	0.0	-0.17	0.000	0	1	2(thyroid)	0.4238
1	186292803	186292803	C	T	TPR	intronic	.	ENSG00000047410	rs3818293	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1242	0.0733	0.121805	LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.0934,AMR:0.0248,EAS:0.0733,FIN:0.2668,NFE:0.1009,OTH:0.1073,ASJ:0.1643	189940	.	.	.	~ko03013 RNA transport~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.1245
1	186313197	186313197	C	T	TPR	exonic	nonsynonymous SNV	ENSG00000047410	rs201004855	ENSG00000047410:ENST00000367478:exon26:c.G3443A:p.R1148H	TPR:NM_003292:exon26:c.G3443A:p.R1148H	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 1, 1, 0] 	0.0043	0.0011	0.00259585	0.0012	6.059	28.1	0.001	4.83	0.996	.	.	Nucleoprotein TPR/MLP1	TPR:uc001grv.3:exon26:c.G3443A:p.R1148H	-0.561	AFR:0.0005,AMR:0.0012,EAS:0,FIN:0,NFE:0.0020,OTH:0.0010,ASJ:0.0033	189940	.	.	.	~ko03013 RNA transport~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	1.0	0.9	0.257	2.63	1	.	het
1	196642233	196642233	G	A	CFH	exonic	nonsynonymous SNV	ENSG00000000971	rs800292	ENSG00000000971:ENST00000359637:exon2:c.G184A:p.V62I,ENSG00000000971:ENST00000367429:exon2:c.G184A:p.V62I,ENSG00000000971:ENST00000439155:exon2:c.G184A:p.V62I	CFH:NM_000186:exon2:c.G184A:p.V62I,CFH:NM_001014975:exon2:c.G184A:p.V62I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3210	0.3866	0.468051	MU581298	-0.812	0.040	1.0	5.12	0.028	.	.	Sushi/SCR/CCP domain	CFH:uc001gti.4:exon2:c.G184A:p.V62I,CFH:uc001gtj.4:exon2:c.G184A:p.V62I,CFH:uc009wyw.3:exon2:c.G184A:p.V62I,CFH:uc009wyx.3:exon2:c.G184A:p.V62I	-0.942	AFR:LAML-KR|4|205|0.0195122,COCA-CN|1|321|0.00311526,AMR:0.3934,EAS:0.3640,FIN:0.2318,NFE:0.4191,OTH:0.2930,ASJ:0.7150	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	0.0	-0.09	0.000	-2.885	1	2(stomach)	0.2372
1	196642969	196642969	-	TT	CFH	intronic	.	ENSG00000000971	rs35507625	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2568	.	0.305711	0.2361	.	.	.	.	.	.	.	.	.	.	AFR:0.1806,AMR:0.2958,EAS:0.5019,FIN:0.2693,NFE:0.2270,OTH:0.2716,ASJ:0.2252	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	.	hom
1	196654324	196654324	A	C	CFH	exonic	synonymous SNV	ENSG00000000971	rs1061147	ENSG00000000971:ENST00000359637:exon6:c.A729C:p.A243A,ENSG00000000971:ENST00000367429:exon7:c.A921C:p.A307A,ENSG00000000971:ENST00000439155:exon7:c.A921C:p.A307A	CFH:NM_000186:exon7:c.A921C:p.A307A,CFH:NM_001014975:exon7:c.A921C:p.A307A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6666	0.6081	0.713059	0.6188	.	.	.	.	.	.	.	.	CFH:uc009wyx.3:exon6:c.A729C:p.A243A,CFH:uc001gti.4:exon7:c.A921C:p.A307A,CFH:uc001gtj.4:exon7:c.A921C:p.A307A,CFH:uc009wyw.3:exon7:c.A921C:p.A307A	.	AFR:0.5773,AMR:0.7830,EAS:0.9559,FIN:0.5500,NFE:0.6138,OTH:0.6071,ASJ:0.6689	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	MU155913	hom
1	196659237	196659237	C	T	CFH	exonic	nonsynonymous SNV	ENSG00000000971	rs1061170	ENSG00000000971:ENST00000359637:exon8:c.C1012T:p.H338Y,ENSG00000000971:ENST00000367429:exon9:c.C1204T:p.H402Y,ENSG00000000971:ENST00000439155:exon9:c.C1204T:p.H402Y	CFH:NM_000186:exon9:c.C1204T:p.H402Y,CFH:NM_001014975:exon9:c.C1204T:p.H402Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6721	0.6243	0.733427	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	-3.918	0.001	1.0	-9.09	0.000	.	.	Sushi/SCR/CCP domain	CFH:uc009wyx.3:exon8:c.C1012T:p.H338Y,CFH:uc001gti.4:exon9:c.C1204T:p.H402Y,CFH:uc001gtj.4:exon9:c.C1204T:p.H402Y,CFH:uc009wyw.3:exon9:c.C1129T:p.H377Y	-1.007	AFR:0.6336,AMR:0.6282,EAS:0.6689,FIN:0.9557,NFE:0.55,OTH:0.6144,ASJ:0.7885	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	0.0	-0.03	0.000	.	1	1(large_intestine)	0.6104
1	196661505	196661505	G	C	CFH	intronic	.	ENSG00000000971	rs10922094	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.733227	0.6325	.	.	.	.	.	.	.	.	.	.	AFR:0.6290,AMR:0.7862,EAS:0.9554,FIN:0.5514,NFE:0.6109,OTH:0.6076,ASJ:0.6689	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	MU115452194	hom
1	196682947	196682947	G	A	CFH	exonic	synonymous SNV	ENSG00000000971	rs2274700	ENSG00000000971:ENST00000367429:exon10:c.G1419A:p.A473A	CFH:NM_000186:exon10:c.G1419A:p.A473A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4431	0.4262	0.479034	LAML-KR|4|205|0.0195122,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	CFH:uc001gtj.4:exon10:c.G1419A:p.A473A	.	AFR:0.4239,AMR:0.4696,EAS:0.51,FIN:0.4261,NFE:0.3805,OTH:0.4042,ASJ:0.4412	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	5(haematopoietic_and_lymphoid_tissue)	0.4274
1	196712577	196712577	T	C	CFH	intronic	.	ENSG00000000971	rs513699	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2585	.	.	1(pancreas)	.	.	.	.	.	0	0.028	.	.	.	AFR:MU11352223,AMR:SKCA-BR|1|100|0.01,PACA-CA|1|268|0.00373134,LICA-CN|1|402|0.00248756,LAML-KR|7|205|0.0341463,COCA-CN|4|321|0.0124611,NKTL-SG|1|50|0.02,ESCA-CN|1|332|0.00301205,EAS:0.0245,FIN:0.0230,NFE:0.0144,OTH:0.0716,ASJ:0.0246	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	8(haematopoietic_and_lymphoid_tissue)	0.0147
1	196712586	196712586	C	T	CFH	exonic	synonymous SNV	ENSG00000000971	rs61822181	ENSG00000000971:ENST00000367429:exon20:c.C3138T:p.T1046T	CFH:NM_000186:exon20:c.C3138T:p.T1046T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2657	.	.	2(thyroid)	.	.	.	.	.	.	.	.	CFH:uc001gtj.4:exon20:c.C3138T:p.T1046T	.	AFR:1(pancreas),AMR:MU4550049,EAS:0.0505,FIN:0.0457,NFE:0.0428,OTH:0.0510,ASJ:SKCA-BR|1|100|0.01,PACA-CA|1|268|0.00373134,LICA-CN|1|402|0.00248756,LAML-KR|6|205|0.0292683,COCA-CN|3|321|0.00934579,NKTL-SG|1|50|0.02	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	6(lung)	0.1337
1	197053561	197053561	-	A	ASPM	intronic	.	ENSG00000066279	rs200839523	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2816	.	.	0.3436	.	.	.	.	.	.	.	.	.	.	AFR:0.1751,AMR:0.2805,EAS:0.1960,FIN:0.4242,NFE:0.4495,OTH:0.4074,ASJ:0.4405	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU9408466	het
1	197055925	197055925	T	C	ASPM	intronic	.	ENSG00000066279	rs10754213	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8786	0.7551	0.782748	0.7908	.	.	.	.	.	0	0	.	.	.	AFR:0.4511,AMR:0.9079,EAS:1,FIN:0.9407,NFE:0.9131,OTH:0.9192,ASJ:0.9238	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU81717435	hom
1	197070442	197070442	G	T	ASPM	exonic	nonsynonymous SNV	ENSG00000066279	rs3762271	ENSG00000066279:ENST00000367409:exon18:c.C7939A:p.L2647I	ASPM:NM_018136:exon18:c.C7939A:p.L2647I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3399	0.3229	0.214257	2(large_intestine)	0.354	6.204	0.203	-1.27	0.115	.	.	IQ motif, EF-hand binding site;IQ motif, EF-hand binding site|P-loop containing nucleoside triphosphate hydrolase	ASPM:uc001gtw.4:exon4:c.C1483A:p.L495I,ASPM:uc001gtu.3:exon18:c.C7939A:p.L2647I	-0.998	AFR:MU152290,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.0920,FIN:0.2236,NFE:0.4106,OTH:0.1720,ASJ:0.3159	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.989	-0.83	0.000	2.215	1	1(lung)	0.3893
1	197070697	197070697	T	C	ASPM	exonic	nonsynonymous SNV	ENSG00000066279	rs41310927	ENSG00000066279:ENST00000367409:exon18:c.A7684G:p.S2562G	ASPM:NM_018136:exon18:c.A7684G:p.S2562G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.3409	0.3211	0.214257	3(haematopoietic_and_lymphoid_tissue)	5.206	25.5	0.021	5.15	1.000	.	.	IQ motif, EF-hand binding site|P-loop containing nucleoside triphosphate hydrolase	ASPM:uc001gtw.4:exon4:c.A1228G:p.S410G,ASPM:uc001gtu.3:exon18:c.A7684G:p.S2562G	-1.045	AFR:MU152297,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.0912,FIN:0.2224,NFE:0.4106,OTH:0.1714,ASJ:0.3140	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.978	-0.75	0.000	3.175	1	1(liver)	0.3896
1	197070707	197070707	G	A	ASPM	exonic	synonymous SNV	ENSG00000066279	rs41308365	ENSG00000066279:ENST00000367409:exon18:c.C7674T:p.I2558I	ASPM:NM_018136:exon18:c.C7674T:p.I2558I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3403	0.3217	0.214257	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ASPM:uc001gtw.4:exon4:c.C1218T:p.I406I,ASPM:uc001gtu.3:exon18:c.C7674T:p.I2558I	.	AFR:MU152305,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.0908,FIN:0.2212,NFE:0.4106,OTH:0.1712,ASJ:0.3133	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	1(breast)	0.3894
1	197070776	197070776	C	T	ASPM	exonic	synonymous SNV	ENSG00000066279	rs10922162	ENSG00000066279:ENST00000367409:exon18:c.G7605A:p.V2535V	ASPM:NM_018136:exon18:c.G7605A:p.V2535V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2396	0.1149	0.294928	0.1742	.	.	.	.	.	.	.	.	ASPM:uc001gtw.4:exon4:c.G1149A:p.V383V,ASPM:uc001gtu.3:exon18:c.G7605A:p.V2535V	.	AFR:0.0399,AMR:0.4067,EAS:0.7106,FIN:0.2460,NFE:0.1641,OTH:0.2255,ASJ:0.1656	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU698269	het
1	197070815	197070815	T	C	ASPM	exonic	synonymous SNV	ENSG00000066279	rs1412640	ENSG00000066279:ENST00000367409:exon18:c.A7566G:p.L2522L	ASPM:NM_018136:exon18:c.A7566G:p.L2522L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8876	0.7869	0.815895	0.8174	.	.	.	.	.	.	.	.	ASPM:uc001gtw.4:exon4:c.A1110G:p.L370L,ASPM:uc001gtu.3:exon18:c.A7566G:p.L2522L	.	AFR:0.5454,AMR:0.9163,EAS:1,FIN:0.9410,NFE:0.9131,OTH:0.9254,ASJ:0.9272	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU81717480	hom
1	197070901	197070901	A	G	ASPM	exonic	nonsynonymous SNV	ENSG00000066279	rs964201	ENSG00000066279:ENST00000367409:exon18:c.T7480C:p.Y2494H	ASPM:NM_018136:exon18:c.T7480C:p.Y2494H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9956	0.9957	0.997404	0.9962	0.626	8.336	1.0	4.83	0.900	.	.	IQ motif, EF-hand binding site|P-loop containing nucleoside triphosphate hydrolase	ASPM:uc001gtw.4:exon4:c.T1024C:p.Y342H,ASPM:uc001gtu.3:exon18:c.T7480C:p.Y2494H	-0.934	AFR:0.9994,AMR:0.9988,EAS:1,FIN:1,NFE:0.9927,OTH:0.9980,ASJ:1	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.001	-0.74	0.000	-2.065	1	MU81717489	hom
1	197072420	197072420	T	C	ASPM	exonic	synonymous SNV	ENSG00000066279	rs41310925	ENSG00000066279:ENST00000367409:exon18:c.A5961G:p.Q1987Q	ASPM:NM_018136:exon18:c.A5961G:p.Q1987Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3408	0.3213	0.213059	1(large_intestine)	.	.	.	.	.	.	.	.	ASPM:uc001gtu.3:exon18:c.A5961G:p.Q1987Q	.	AFR:4(lung),AMR:2(urinary_tract),EAS:LAML-KR|2|205|0.0097561,LUSC-KR|5|170|0.0294118,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,FIN:0.3144,NFE:0.0855,OTH:0.2248,ASJ:MU152312	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	5(haematopoietic_and_lymphoid_tissue)	0.4106
1	197073932	197073932	T	C	ASPM	exonic	synonymous SNV	ENSG00000066279	rs2878749	ENSG00000066279:ENST00000367409:exon18:c.A4449G:p.K1483K	ASPM:NM_018136:exon18:c.A4449G:p.K1483K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3439	0.3224	0.214457	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ASPM:uc001gtu.3:exon18:c.A4449G:p.K1483K	.	AFR:MU9408519,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.0921,FIN:0.2242,NFE:0.4106,OTH:0.1715,ASJ:0.3162	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	1(breast)	0.3895
1	197091537	197091537	A	T	ASPM	exonic	synonymous SNV	ENSG00000066279	rs4915337	ENSG00000066279:ENST00000367408:exon10:c.T1329A:p.S443S,ENSG00000066279:ENST00000294732:exon14:c.T3579A:p.S1193S,ENSG00000066279:ENST00000367409:exon14:c.T3579A:p.S1193S	ASPM:NM_001206846:exon14:c.T3579A:p.S1193S,ASPM:NM_018136:exon14:c.T3579A:p.S1193S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8779	0.7547	0.782548	0.7906	.	.	.	.	.	.	.	.	ASPM:uc001gtu.3:exon14:c.T3579A:p.S1193S,ASPM:uc001gtv.3:exon14:c.T3579A:p.S1193S	.	AFR:0.4511,AMR:0.9079,EAS:0.9988,FIN:0.9408,NFE:0.9126,OTH:0.9194,ASJ:0.92	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU81717511	hom
1	197102745	197102745	A	G	ASPM	intronic	.	ENSG00000066279	rs4915344	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2416	0.1140	0.29972	MU795121	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,AMR:0.1757,EAS:0.4029,FIN:0.1656,NFE:0.7078,OTH:0.2457,ASJ:0.0428	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	1(lung)	0.1640
1	197112533	197112533	G	A	ASPM	exonic	synonymous SNV	ENSG00000066279	rs6677082	ENSG00000066279:ENST00000294732:exon3:c.C849T:p.S283S,ENSG00000066279:ENST00000367409:exon3:c.C849T:p.S283S	ASPM:NM_001206846:exon3:c.C849T:p.S283S,ASPM:NM_018136:exon3:c.C849T:p.S283S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8698	0.7308	0.755591	0.7690	.	.	.	.	.	.	.	.	ASPM:uc001gtu.3:exon3:c.C849T:p.S283S,ASPM:uc001gtv.3:exon3:c.C849T:p.S283S	.	AFR:0.3794,AMR:0.9043,EAS:0.9808,FIN:0.9408,NFE:0.9125,OTH:0.9129,ASJ:0.9205	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU17987338	hom
1	197113073	197113073	G	A	ASPM	intronic	.	ENSG00000066279	rs1571964	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8704	0.7302	0.755591	0.7694	.	.	.	.	.	.	.	.	.	.	AFR:0.3798,AMR:0.9043,EAS:0.9802,FIN:0.9408,NFE:0.9125,OTH:0.9131,ASJ:0.9205	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU17987498	hom
1	198703306	198703306	C	T	PTPRC	intronic	.	ENSG00000081237	rs6683595	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1938	0.2212	0.278754	0.2181	.	.	.	.	.	.	.	.	.	.	AFR:0.3838,AMR:0.3165,EAS:0.2680,FIN:0.1180,NFE:0.1410,OTH:0.1373,ASJ:0.1325	151460	608971;609532;	284102;169154;169157;169160;	284102|Response to PEG/IFN-ribavirin in HCV|-|-|-|609532 ~169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	.	.	.	.	.	.	.	.	1	MU11357414	hom
1	198704294	198704294	C	T	PTPRC	exonic	synonymous SNV	ENSG00000081237	rs7540378	ENSG00000081237:ENST00000348564:exon20:c.C1833T:p.G611G,ENSG00000081237:ENST00000594404:exon20:c.C1827T:p.G609G,ENSG00000081237:ENST00000352140:exon22:c.C2166T:p.G722G,ENSG00000081237:ENST00000367367:exon22:c.C2118T:p.G706G,ENSG00000081237:ENST00000529828:exon22:c.C2172T:p.G724G,ENSG00000081237:ENST00000367376:exon23:c.C2310T:p.G770G,ENSG00000081237:ENST00000442510:exon23:c.C2316T:p.G772G	PTPRC:NM_080921:exon20:c.C1833T:p.G611G,PTPRC:NM_002838:exon23:c.C2316T:p.G772G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1683	0.1639	0.226238	LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PTPRC:uc001gut.2:exon20:c.C1833T:p.G611G,PTPRC:uc010ppg.2:exon22:c.C2118T:p.G706G,PTPRC:uc021pgy.2:exon22:c.C2172T:p.G724G,PTPRC:uc001gur.2:exon23:c.C2316T:p.G772G	.	AFR:0.1624,AMR:0.2423,EAS:0.1291,FIN:0.2645,NFE:0.0688,OTH:0.1234,ASJ:0.2940	151460	608971;609532;	284102;169154;169157;169160;	284102|Response to PEG/IFN-ribavirin in HCV|-|-|-|609532 ~169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	.	.	.	.	.	.	.	.	1	2(large_intestine)	0.1150
1	198717219	198717220	TT	-	PTPRC	intronic	.	ENSG00000081237	rs546749152	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.2059	.	0.279553	0.1991	.	.	.	.	.	.	.	.	.	.	AFR:0.3068,AMR:0.3094,EAS:0.2757,FIN:0.0693,NFE:0.1311,OTH:0.1295,ASJ:0.1445	151460	608971;609532;	284102;169154;169157;169160;	284102|Response to PEG/IFN-ribavirin in HCV|-|-|-|609532 ~169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	.	.	.	.	.	.	.	.	1	.	hom
1	200522566	200522566	G	C	KIF14	exonic	nonsynonymous SNV	ENSG00000118193	rs12120084	ENSG00000118193:ENST00000367350:exon30:c.C4897G:p.P1633A	KIF14:NM_001305792:exon28:c.C3424G:p.P1142A,KIF14:NM_014875:exon30:c.C4897G:p.P1633A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3203	0.3058	0.219649	0.2696	-0.976	0.018	0.091	0.605	0.017	.	.	.	KIF14:uc010ppj.1:exon28:c.C3424G:p.P1142A,KIF14:uc010ppk.1:exon30:c.C4897G:p.P1633A	-1.020	AFR:0.0894,AMR:0.2093,EAS:0.2261,FIN:0.2695,NFE:0.3773,OTH:0.3020,ASJ:0.4272	611279	616258;	439897;	439897|-|<1 / 1 000 000|Autosomal recessive|Antenatal|616258 ~	.	.	.	.	0.307	-0.77	0.000	1.195	1	MU102596	het
1	200534248	200534248	C	T	KIF14	exonic	synonymous SNV	ENSG00000118193	rs7543730	ENSG00000118193:ENST00000367350:exon25:c.G4020A:p.E1340E	KIF14:NM_001305792:exon23:c.G2547A:p.E849E,KIF14:NM_014875:exon25:c.G4020A:p.E1340E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5717	0.5359	0.563498	0.5250	.	.	.	.	.	.	.	.	KIF14:uc010ppj.1:exon23:c.G2547A:p.E849E,KIF14:uc010ppk.1:exon25:c.G4020A:p.E1340E	.	AFR:0.4177,AMR:0.4868,EAS:0.6865,FIN:0.5287,NFE:0.5686,OTH:0.5400,ASJ:0.6093	611279	616258;	439897;	439897|-|<1 / 1 000 000|Autosomal recessive|Antenatal|616258 ~	.	.	.	.	.	.	.	.	1	MU708297	het
1	200558363	200558363	T	C	KIF14	exonic	synonymous SNV	ENSG00000118193	rs6665951	ENSG00000118193:ENST00000367350:exon18:c.A3096G:p.E1032E	KIF14:NM_001305792:exon16:c.A1623G:p.E541E,KIF14:NM_014875:exon18:c.A3096G:p.E1032E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7515	0.8067	0.766573	0.7926	.	.	.	.	.	.	.	.	KIF14:uc010ppj.1:exon16:c.A1623G:p.E541E,KIF14:uc010ppk.1:exon18:c.A3096G:p.E1032E	.	AFR:0.8873,AMR:0.6100,EAS:0.6856,FIN:0.7478,NFE:0.7711,OTH:0.7556,ASJ:0.8411	611279	616258;	439897;	439897|-|<1 / 1 000 000|Autosomal recessive|Antenatal|616258 ~	.	.	.	.	.	.	.	.	1	MU9422538	het
1	201016296	201016296	G	A	CACNA1S	exonic	nonsynonymous SNV	ENSG00000081248	rs3850625	ENSG00000081248:ENST00000367338:exon37:c.C4558T:p.R1520C,ENSG00000081248:ENST00000362061:exon38:c.C4615T:p.R1539C	CACNA1S:NM_000069:exon38:c.C4615T:p.R1539C	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.1172	0.0893	0.0840655	1(skin)	7.420	34	0.008	5.17	1.000	.	.	Voltage-dependent calcium channel, alpha-1 subunit, IQ domain	CACNA1S:uc001gvv.3:exon38:c.C4615T:p.R1539C	-0.915	AFR:MU154669,AMR:COCA-CN|1|321|0.00311526,EOPC-DE|1|202|0.0049505,GACA-JP|1|585|0.0017094,EAS:0.0235,FIN:0.1086,NFE:0.1026,OTH:0.0304,ASJ:0.0947	114208	170400;188580;601887;	423;79102;681;	423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~79102|Thyrotoxic hypokalemic periodic paralysis|<1 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|188580 613239 614834 ~681|Westphall disease|1-9 / 100 000|Autosomal dominant|Childhood|170400 613345 ~	.	.	.	.	0.736	-0.47	0.006	2.02	1	1(urinary_tract)	0.1557
1	201020105	201020105	A	G	CACNA1S	intronic	.	ENSG00000081248	rs6702590	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7705	0.7548	0.880391	0.7864	.	.	.	.	.	0	0	.	.	.	AFR:0.9291,AMR:0.8532,EAS:0.9975,FIN:0.7546,NFE:0.6883,OTH:0.7332,ASJ:0.7450	114208	170400;188580;601887;	423;79102;681;	423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~79102|Thyrotoxic hypokalemic periodic paralysis|<1 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|188580 613239 614834 ~681|Westphall disease|1-9 / 100 000|Autosomal dominant|Childhood|170400 613345 ~	.	.	.	.	.	.	.	.	1	MU32834473	hom
1	201044748	201044748	A	G	CACNA1S	intronic	.	ENSG00000081248	rs1998721	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7814	0.7033	0.759585	0.7224	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.5560,AMR:0.7148,EAS:0.9470,FIN:0.7916,NFE:0.7745,OTH:0.7827,ASJ:0.7583	114208	170400;188580;601887;	423;79102;681;	423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~79102|Thyrotoxic hypokalemic periodic paralysis|<1 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|188580 613239 614834 ~681|Westphall disease|1-9 / 100 000|Autosomal dominant|Childhood|170400 613345 ~	.	.	.	.	.	.	.	.	1	MU81717919	hom
1	201334382	201334382	G	A	TNNT2	exonic	synonymous SNV	ENSG00000118194	rs3729547	ENSG00000118194:ENST00000360372:exon7:c.C303T:p.I101I,ENSG00000118194:ENST00000236918:exon8:c.C333T:p.I111I,ENSG00000118194:ENST00000367315:exon8:c.C318T:p.I106I,ENSG00000118194:ENST00000367317:exon8:c.C318T:p.I106I,ENSG00000118194:ENST00000438742:exon8:c.C303T:p.I101I,ENSG00000118194:ENST00000367318:exon9:c.C318T:p.I106I,ENSG00000118194:ENST00000367322:exon9:c.C318T:p.I106I,ENSG00000118194:ENST00000421663:exon9:c.C324T:p.I108I,ENSG00000118194:ENST00000422165:exon9:c.C333T:p.I111I,ENSG00000118194:ENST00000509001:exon9:c.C318T:p.I106I,ENSG00000118194:ENST00000455702:exon10:c.C348T:p.I116I,ENSG00000118194:ENST00000458432:exon10:c.C354T:p.I118I	TNNT2:NM_001001432:exon8:c.C303T:p.I101I,TNNT2:NM_001001430:exon9:c.C318T:p.I106I,TNNT2:NM_001001431:exon9:c.C318T:p.I106I,TNNT2:NM_001276347:exon9:c.C318T:p.I106I,TNNT2:NM_000364:exon10:c.C348T:p.I116I,TNNT2:NM_001276345:exon10:c.C348T:p.I116I	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7194	0.6828	0.695088	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	TNNT2:uc009wzs.1:exon3:c.C243T:p.I81I,TNNT2:uc001gwk.1:exon7:c.C141T:p.I47I,TNNT2:uc009wzr.4:exon7:c.C141T:p.I47I,TNNT2:uc001gwh.4:exon8:c.C291T:p.I97I,TNNT2:uc021phc.2:exon8:c.C318T:p.I106I,TNNT2:uc001gwg.4:exon9:c.C318T:p.I106I,TNNT2:uc009wzt.2:exon9:c.C318T:p.I106I,TNNT2:uc001gwf.4:exon10:c.C348T:p.I116I	.	AFR:MU109570,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.6157,FIN:0.7685,NFE:0.7682,OTH:0.5336,ASJ:0.6921	191045	115195;601494;612422;	75249;154;54260;	75249|Familial or idiopathic restrictive cardiomyopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|115210 609578 612422 615248 617047 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	1	1(thyroid)	0.7944
1	201341176	201341180	AGAAG	-	TNNT2	intronic	.	ENSG00000118194	rs45533739	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.5919	.	0.520367	0.5292	.	.	.	.	.	.	.	.	.	.	AFR:0.3040,AMR:0.6776,EAS:0.4630,FIN:0.6784,NFE:0.6170,OTH:0.6173,ASJ:0.6333	191045	115195;601494;612422;	75249;154;54260;	75249|Familial or idiopathic restrictive cardiomyopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|115210 609578 612422 615248 617047 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	1	.	het
1	201981218	201981218	C	G	ELF3	exonic	synonymous SNV	ENSG00000163435	rs11543979	ENSG00000163435:ENST00000359651:exon2:c.C297G:p.G99G,ENSG00000163435:ENST00000367283:exon3:c.C297G:p.G99G,ENSG00000163435:ENST00000367284:exon3:c.C297G:p.G99G,ENSG00000163435:ENST00000446188:exon3:c.C291G:p.G97G	ELF3:NM_001114309:exon3:c.C297G:p.G99G,ELF3:NM_004433:exon3:c.C297G:p.G99G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2550	0.2956	0.338259	13(soft_tissue)	.	.	.	.	.	.	.	.	ELF3:uc001gxg.4:exon2:c.C297G:p.G99G,ELF3:uc001gxh.4:exon3:c.C297G:p.G99G,ELF3:uc001gxi.4:exon3:c.C297G:p.G99G	.	AFR:MU581346,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.4636,FIN:0.2067,NFE:0.2616,OTH:0.3694,ASJ:0.2957	602191	.	.	.	.	.	.	.	.	.	.	.	1	1(stomach)	0.1785
1	201981774	201981774	G	A	ELF3	exonic	nonsynonymous SNV	ENSG00000163435	rs55729978	ENSG00000163435:ENST00000359651:exon4:c.G485A:p.G162D,ENSG00000163435:ENST00000367283:exon5:c.G485A:p.G162D,ENSG00000163435:ENST00000367284:exon5:c.G485A:p.G162D,ENSG00000163435:ENST00000446188:exon5:c.G479A:p.G160D	ELF3:NM_001114309:exon5:c.G485A:p.G162D,ELF3:NM_004433:exon5:c.G485A:p.G162D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0300	0.0644	0.0726837	0.0602	1.815	15.08	0.202	3.29	0.845	.	.	.	ELF3:uc001gxg.4:exon4:c.G485A:p.G162D,ELF3:uc001gxh.4:exon5:c.G485A:p.G162D,ELF3:uc001gxi.4:exon5:c.G485A:p.G162D	-1.066	AFR:0.1683,AMR:0.0215,EAS:0,FIN:0.0241,NFE:0.0170,OTH:0.0214,ASJ:0.0464	602191	.	.	.	.	.	.	.	0.003	2.47	0.000	1.975	1	MU85098775	het
1	201981862	201981862	T	C	ELF3	exonic	synonymous SNV	ENSG00000163435	rs2819362	ENSG00000163435:ENST00000359651:exon4:c.T573C:p.P191P,ENSG00000163435:ENST00000367283:exon5:c.T573C:p.P191P,ENSG00000163435:ENST00000367284:exon5:c.T573C:p.P191P,ENSG00000163435:ENST00000446188:exon5:c.T567C:p.P189P	ELF3:NM_001114309:exon5:c.T573C:p.P191P,ELF3:NM_004433:exon5:c.T573C:p.P191P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6047	0.6059	0.704273	0.6257	.	.	.	.	.	.	.	.	ELF3:uc001gxg.4:exon4:c.T573C:p.P191P,ELF3:uc001gxh.4:exon5:c.T573C:p.P191P,ELF3:uc001gxi.4:exon5:c.T573C:p.P191P	.	AFR:0.7838,AMR:0.6002,EAS:0.7574,FIN:0.5828,NFE:0.5337,OTH:0.5939,ASJ:0.5933	602191	.	.	.	.	.	.	.	.	.	.	.	1	MU4555319	hom
1	204400783	204400783	A	G	PIK3C2B	intronic	.	ENSG00000226330	rs2271421	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1404	0.0741	0.191294	1(lung)	.	.	.	.	.	.	.	.	.	.	AFR:4(soft_tissue),AMR:MU11367805,EAS:0.1021,FIN:0.0370,NFE:0.0990,OTH:0.0795,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	602838	.	.	.	.	.	.	.	.	.	.	.	1	18(meninges)	0.4553
1	204403659	204403659	A	G	PIK3C2B	exonic	synonymous SNV	ENSG00000133056	rs3747636	ENSG00000133056:ENST00000367187:exon25:c.T3594C:p.N1198N,ENSG00000133056:ENST00000424712:exon26:c.T3510C:p.N1170N	PIK3C2B:NM_002646:exon25:c.T3594C:p.N1198N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3009	0.3060	0.404952	1(breast)	.	.	.	.	.	.	.	.	PIK3C2B:uc001haw.3:exon25:c.T3594C:p.N1198N,PIK3C2B:uc010pqv.2:exon26:c.T3510C:p.N1170N	.	AFR:MU145541,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.4997,FIN:0.2685,NFE:0.1854,OTH:0.5248,ASJ:0.3431	602838	.	.	.	.	.	.	.	.	.	.	.	1	1(large_intestine)	0.3210
1	204413297	204413297	C	T	PIK3C2B	intronic	.	ENSG00000133056	rs2292459	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7286	0.7105	0.610823	MU813473	.	.	.	.	.	0.0004	0.054	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.6782,EAS:0.7578,FIN:0.8433,NFE:0.4751,OTH:0.7230,ASJ:0.4977	602838	.	.	.	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.7839
1	204413299	204413299	G	A	PIK3C2B	intronic	.	ENSG00000133056	rs2292460	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7081	0.6927	0.561502	MU731753	.	.	.	.	.	0	0.006	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.6541,EAS:0.7458,FIN:0.8267,NFE:0.3269,OTH:0.7226,ASJ:0.4457	602838	.	.	.	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.7821
1	204416111	204416111	A	G	PIK3C2B	intronic	.	ENSG00000133056	rs3106365	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.865815	0.9020	.	.	.	.	.	.	.	.	.	.	AFR:0.6910,AMR:0.9618,EAS:0.8517,FIN:0.9997,NFE:0.9969,OTH:0.9816,ASJ:0.9801	602838	.	.	.	.	.	.	.	.	.	.	.	1	.	hom
1	204425028	204425028	G	A	PIK3C2B	exonic	synonymous SNV	ENSG00000133056	rs3765156	ENSG00000133056:ENST00000367187:exon12:c.C1899T:p.F633F,ENSG00000133056:ENST00000424712:exon12:c.C1899T:p.F633F	PIK3C2B:NM_002646:exon12:c.C1899T:p.F633F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1914	0.1389	0.203275	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	PIK3C2B:uc001hax.1:exon11:c.C1899T:p.F633F,PIK3C2B:uc001haw.3:exon12:c.C1899T:p.F633F,PIK3C2B:uc010pqv.2:exon12:c.C1899T:p.F633F	.	AFR:1(large_intestine),AMR:1(breast),EAS:MU145551,FIN:ESAD-UK|2|409|0.00488998,LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,NFE:0.1695,OTH:0.0746,ASJ:1(liver)	602838	.	.	.	.	.	.	.	.	.	.	.	1	1(lung)	0.0668
1	204438334	204438334	C	T	PIK3C2B	exonic	synonymous SNV	ENSG00000133056	rs1124777	ENSG00000133056:ENST00000367187:exon3:c.G597A:p.P199P,ENSG00000133056:ENST00000424712:exon3:c.G597A:p.P199P	PIK3C2B:NM_002646:exon3:c.G597A:p.P199P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8916	0.7767	0.728035	0.7878	.	.	.	.	.	.	.	.	PIK3C2B:uc001hax.1:exon2:c.G597A:p.P199P,PIK3C2B:uc001haw.3:exon3:c.G597A:p.P199P,PIK3C2B:uc010pqv.2:exon3:c.G597A:p.P199P	.	AFR:0.3585,AMR:0.8413,EAS:0.7540,FIN:0.9648,NFE:0.9841,OTH:0.9265,ASJ:0.9636	602838	.	.	.	.	.	.	.	.	.	.	.	1	MU17996773	het
1	204438643	204438643	G	T	PIK3C2B	exonic	synonymous SNV	ENSG00000133056	rs1553921	ENSG00000133056:ENST00000415899:exon2:c.C288A:p.L96L,ENSG00000133056:ENST00000367187:exon3:c.C288A:p.L96L,ENSG00000133056:ENST00000424712:exon3:c.C288A:p.L96L	PIK3C2B:NM_002646:exon3:c.C288A:p.L96L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8903	0.7763	0.727236	0.7869	.	.	.	.	.	.	.	.	PIK3C2B:uc001hax.1:exon2:c.C288A:p.L96L,PIK3C2B:uc001haw.3:exon3:c.C288A:p.L96L,PIK3C2B:uc010pqv.2:exon3:c.C288A:p.L96L	.	AFR:0.3551,AMR:0.8405,EAS:0.7531,FIN:0.9645,NFE:0.9840,OTH:0.9264,ASJ:0.9636	602838	.	.	.	.	.	.	.	.	.	.	.	1	MU17996820	het
1	204501383	204501383	C	T	MDM4	intronic	.	ENSG00000198625	rs4252697	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1897	0.1557	0.198083	1(breast)	.	.	.	.	.	.	.	.	.	.	AFR:MU11368138,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.0792,FIN:0.0859,NFE:0.1987,OTH:0.3660,ASJ:0.1771	602704	.	.	.	.	.	.	.	.	.	.	.	1	8(meninges)	0.2064
1	204516025	204516025	A	G	MDM4	intronic	.	ENSG00000198625	rs2290854	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6451	0.5536	0.539337	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.6003,AMR:0.2930,EAS:0.6324,FIN:0.6473,NFE:0.7944,OTH:0.7221,ASJ:0.5993	602704	.	.	.	.	.	.	.	.	.	.	.	1	4(soft_tissue)	0.6908
1	206647742	206647742	A	G	IKBKE	exonic	synonymous SNV	ENSG00000143466	rs1539242	ENSG00000143466:ENST00000367120:exon4:c.A156G:p.Q52Q	IKBKE:NM_001193322:exon4:c.A156G:p.Q52Q,IKBKE:NM_014002:exon4:c.A156G:p.Q52Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9986	0.9984	0.999401	0.9985	.	.	.	.	.	.	.	.	IKBKE:uc001hdz.2:exon4:c.A156G:p.Q52Q,IKBKE:uc009xbu.2:exon4:c.A156G:p.Q52Q,IKBKE:uc009xbv.2:exon4:c.A156G:p.Q52Q	.	AFR:0.9998,AMR:0.9988,EAS:1,FIN:0.9991,NFE:0.9974,OTH:0.9980,ASJ:1	605048	.	.	.	.	.	.	.	.	.	.	.	1	MU4564045	hom
1	206647787	206647787	T	C	IKBKE	exonic	synonymous SNV	ENSG00000143466	rs1539243	ENSG00000143466:ENST00000367120:exon4:c.T201C:p.I67I	IKBKE:NM_001193322:exon4:c.T201C:p.I67I,IKBKE:NM_014002:exon4:c.T201C:p.I67I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8591	0.8459	0.899161	0.8525	.	.	.	.	.	.	.	.	IKBKE:uc001hdz.2:exon4:c.T201C:p.I67I,IKBKE:uc009xbu.2:exon4:c.T201C:p.I67I,IKBKE:uc009xbv.2:exon4:c.T201C:p.I67I	.	AFR:0.8711,AMR:0.9129,EAS:0.9846,FIN:0.8333,NFE:0.8311,OTH:0.8299,ASJ:0.7947	605048	.	.	.	.	.	.	.	.	.	.	.	1	MU81719582	hom
1	206651107	206651107	G	A	IKBKE	exonic	synonymous SNV	ENSG00000143466	rs2297545	ENSG00000143466:ENST00000537984:exon7:c.G462A:p.T154T,ENSG00000143466:ENST00000367120:exon8:c.G717A:p.T239T	IKBKE:NM_001193321:exon7:c.G462A:p.T154T,IKBKE:NM_001193322:exon8:c.G717A:p.T239T,IKBKE:NM_014002:exon8:c.G717A:p.T239T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3248	0.1942	0.315495	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	IKBKE:uc001hea.2:exon7:c.G462A:p.T154T,IKBKE:uc001hdz.2:exon8:c.G717A:p.T239T,IKBKE:uc009xbu.2:exon8:c.G717A:p.T239T,IKBKE:uc009xbv.2:exon8:c.G717A:p.T239T	.	AFR:0.2324,AMR:0.1714,EAS:0.2252,FIN:0.6378,NFE:0.2370,OTH:0.2155,ASJ:0.3493	605048	.	.	.	.	.	.	.	.	.	.	.	1	1(thyroid)	0.2480
1	206651595	206651595	C	G	IKBKE	exonic	nonsynonymous SNV	ENSG00000143466	rs578108079	ENSG00000143466:ENST00000537984:exon8:c.C650G:p.T217S,ENSG00000143466:ENST00000367120:exon9:c.C905G:p.T302S	IKBKE:NM_001193321:exon8:c.C650G:p.T217S,IKBKE:NM_001193322:exon9:c.C905G:p.T302S,IKBKE:NM_014002:exon9:c.C905G:p.T302S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0004	.	0.00119808	0.0001	4.886	24.9	.	5.31	1.000	.	.	Protein kinase domain;Protein kinase domain|Protein kinase-like domain	IKBKE:uc001hea.2:exon8:c.C650G:p.T217S,IKBKE:uc001hdz.2:exon9:c.C905G:p.T302S,IKBKE:uc009xbv.2:exon9:c.C905G:p.T302S	-0.654	AFR:0,AMR:0.0012,EAS:0,FIN:0,NFE:0.0002,OTH:0,ASJ:0	605048	.	.	.	.	.	.	.	0.489	-0.1	0.251	1.245	1	.	het
1	206658344	206658344	G	A	IKBKE	exonic	nonsynonymous SNV	ENSG00000143466	rs139758641	ENSG00000143466:ENST00000537984:exon13:c.G1183A:p.V395M,ENSG00000143466:ENST00000367120:exon14:c.G1438A:p.V480M	IKBKE:NM_001193321:exon13:c.G1183A:p.V395M,IKBKE:NM_001193322:exon14:c.G1438A:p.V480M,IKBKE:NM_014002:exon14:c.G1438A:p.V480M	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	8.242e-05	7.7e-05	0.000798722	3.228e-05	0.171	4.373	.	-3.41	0.173	.	.	.	IKBKE:uc001hea.2:exon13:c.G1183A:p.V395M,IKBKE:uc001hdz.2:exon14:c.G1438A:p.V480M,IKBKE:uc009xbv.2:exon14:c.G1438A:p.V480M	-1.027	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	605048	.	.	.	.	.	.	.	0.021	-0.08	0.123	-0.755	1	.	het
1	206665052	206665052	C	T	IKBKE	exonic	nonsynonymous SNV	ENSG00000143466	rs12059562	ENSG00000143466:ENST00000537984:exon17:c.C1550T:p.A517V,ENSG00000143466:ENST00000367120:exon18:c.C1805T:p.A602V	IKBKE:NM_001193321:exon17:c.C1550T:p.A517V,IKBKE:NM_001193322:exon18:c.C1805T:p.A602V,IKBKE:NM_014002:exon18:c.C1805T:p.A602V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0965	0.0816	0.23143	MU796147	0.420	6.789	.	1.36	0.125	.	.	.	IKBKE:uc001hea.2:exon17:c.C1550T:p.A517V,IKBKE:uc001hdz.2:exon18:c.C1805T:p.A602V,IKBKE:uc009xbv.2:exon18:c.C1805T:p.A602V	-0.903	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.0999,EAS:0.1897,FIN:0.0033,NFE:0.4508,OTH:0.0097,ASJ:0.2376	605048	.	.	.	.	.	.	.	0.008	2.36	0.000	1.1	1	3(soft_tissue)	0.0027
1	206669465	206669465	C	T	IKBKE	exonic	nonsynonymous SNV	ENSG00000143466	rs3748022	ENSG00000143466:ENST00000537984:exon21:c.C1883T:p.P628L,ENSG00000143466:ENST00000367120:exon22:c.C2138T:p.P713L	IKBKE:NM_001193321:exon21:c.C1883T:p.P628L,IKBKE:NM_014002:exon22:c.C2138T:p.P713L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1930	0.1592	0.148163	1(haematopoietic_and_lymphoid_tissue)	2.072	16.67	.	3.45	0.437	.	.	.	IKBKE:uc001hea.2:exon21:c.C1883T:p.P628L,IKBKE:uc001hdz.2:exon22:c.C2138T:p.P713L	-1.059	AFR:1(large_intestine),AMR:MU91278,EAS:0.1675,FIN:0.0406,NFE:0.2602,OTH:0.1821,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579	605048	.	.	.	.	.	.	.	0.03	0.16	0.000	1.1	1	7(soft_tissue)	0.2042
1	226019633	226019633	T	C	EPHX1	exonic	nonsynonymous SNV	ENSG00000143819	rs1051740	ENSG00000143819:ENST00000272167:exon3:c.T337C:p.Y113H,ENSG00000143819:ENST00000366837:exon3:c.T337C:p.Y113H,ENSG00000143819:ENST00000445856:exon3:c.T337C:p.Y113H,ENSG00000143819:ENST00000448202:exon3:c.T337C:p.Y113H	EPHX1:NM_000120:exon3:c.T337C:p.Y113H,EPHX1:NM_001136018:exon3:c.T337C:p.Y113H,EPHX1:NM_001291163:exon3:c.T337C:p.Y113H	clinvar: drug_response 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 1, 0] 	0.3134	0.2578	0.313299	LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053	6.403	29.6	0.012	5.58	0.997	.	.	Alpha/Beta hydrolase fold|Epoxide hydrolase, N-terminal	EPHX1:uc001hpk.3:exon3:c.T337C:p.Y113H,EPHX1:uc001hpl.3:exon3:c.T337C:p.Y113H,EPHX1:uc031psj.1:exon3:c.T337C:p.Y113H	-0.886	AFR:0.2784,AMR:0.1876,EAS:0.2748,FIN:0.4615,NFE:0.3038,OTH:0.2992,ASJ:0.3544	132810	189800;607748;	238475;275555;	238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~275555|-|1-5 / 10 000|-|Adult|189800 609402 609403 609404 614595 ~	~ko00980 Metabolism of xenobiotics by cytochrome P450~ko04976 Bile secretion~ko05204 Chemical carcinogenesis ~	.	.	.	0.998	3.7	0.000	1.92	1	4(haematopoietic_and_lymphoid_tissue)	0.3129
1	226027067	226027067	-	GTGT	EPHX1	intronic	.	ENSG00000143819	rs35708670	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	.	0.2034	.	.	.	.	.	.	.	.	.	.	AFR:0.2088,AMR:0.1931,EAS:0.2942,FIN:0.1322,NFE:0.2099,OTH:0.1761,ASJ:0.1641	132810	189800;607748;	238475;275555;	238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~275555|-|1-5 / 10 000|-|Adult|189800 609402 609403 609404 614595 ~	~ko00980 Metabolism of xenobiotics by cytochrome P450~ko04976 Bile secretion~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	1	MU111684001	unknown
1	226555302	226555302	A	G	PARP1	exonic	nonsynonymous SNV	ENSG00000143799	rs1136410	ENSG00000143799:ENST00000366794:exon17:c.T2285C:p.V762A	PARP1:NM_001618:exon17:c.T2285C:p.V762A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.2018	0.1233	0.196885	1(liver)	6.781	32	0.176	5.56	0.998	.	.	Poly(ADP-ribose) polymerase, regulatory domain	PARP1:uc001hqd.4:exon17:c.T2285C:p.V762A	-0.836	AFR:1(breast),AMR:1(thyroid),EAS:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,FIN:0.1620,NFE:0.0490,OTH:0.3600,ASJ:MU4559871	173870	.	.	.	.	.	.	.	0.728	2.69	0.000	2.22	1	5(haematopoietic_and_lymphoid_tissue)	0.1589
1	226570840	226570840	T	C	PARP1	exonic	synonymous SNV	ENSG00000143799	rs1805415	ENSG00000143799:ENST00000366794:exon8:c.A1056G:p.K352K	PARP1:NM_001618:exon8:c.A1056G:p.K352K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7939	0.8601	0.789337	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	PARP1:uc001hqd.4:exon8:c.A1056G:p.K352K	.	AFR:MU4559844,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,EAS:0.8962,FIN:0.6388,NFE:0.8411,OTH:0.5603,ASJ:0.8228	173870	.	.	.	.	.	.	.	.	.	.	.	1	1(liver)	0.7643
1	226573364	226573364	A	G	PARP1	exonic	synonymous SNV	ENSG00000143799	rs1805414	ENSG00000143799:ENST00000366794:exon7:c.T852C:p.A284A	PARP1:NM_001618:exon7:c.T852C:p.A284A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4228	0.4077	0.516573	MU4559841	.	.	.	.	.	.	.	.	PARP1:uc001hqd.4:exon7:c.T852C:p.A284A	.	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763,AMR:0.4306,EAS:0.5060,FIN:0.33,NFE:0.8154,OTH:0.3971,ASJ:0.5477	173870	.	.	.	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.3312
1	226578099	226578099	T	C	PARP1	intronic	.	ENSG00000143799	rs1805403	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8059	0.8233	0.857628	0.8477	.	.	.	.	.	.	.	.	.	.	AFR:0.9384,AMR:0.8246,EAS:0.9481,FIN:0.8815,NFE:0.7819,OTH:0.8255,ASJ:0.6933	173870	.	.	.	.	.	.	.	.	.	.	.	1	MU18520760	hom
1	226589958	226589958	G	A	PARP1	exonic	synonymous SNV	ENSG00000143799	rs1805404	ENSG00000143799:ENST00000366790:exon2:c.C243T:p.D81D,ENSG00000143799:ENST00000366791:exon2:c.C243T:p.D81D,ENSG00000143799:ENST00000366792:exon2:c.C243T:p.D81D,ENSG00000143799:ENST00000366794:exon2:c.C243T:p.D81D	PARP1:NM_001618:exon2:c.C243T:p.D81D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2085	0.1477	0.218251	ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	PARP1:uc001hqd.4:exon2:c.C243T:p.D81D	.	AFR:0.1842,AMR:0.1274,EAS:0.1533,FIN:0.4411,NFE:0.2358,OTH:0.1661,ASJ:0.3652	173870	.	.	.	.	.	.	.	.	.	.	.	1	5(haematopoietic_and_lymphoid_tissue)	0.2138
1	226595647	226595647	C	G	PARP1	UTR5	.	ENSG00000143799	rs907187	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2035	0.1191	0.199081	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:1(liver),AMR:1(breast),EAS:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,PBCA-DE|1|499|0.00200401,BRCA-KR|1|50|0.02,BLCA-CN|1|103|0.00970874,FIN:0.1680,NFE:0.0486,OTH:0.3592,ASJ:MU1698315	173870	.	.	.	.	.	.	.	.	.	.	.	1	1(lung)	0.1656
1	231488524	231488524	C	T	SPRTN	exonic	nonsynonymous SNV	ENSG00000010072	rs2437150	ENSG00000010072:ENST00000295050:exon5:c.C887T:p.P296L	SPRTN:NM_032018:exon5:c.C887T:p.P296L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5988	0.5793	0.532947	0.5920	0.053	3.111	0.293	1.26	0.001	.	.	.	SPRTN:uc001hur.4:exon5:c.C887T:p.P296L	-0.903	AFR:0.4543,AMR:0.5227,EAS:0.5725,FIN:0.6947,NFE:0.6493,OTH:0.6478,ASJ:0.6490	616086	616200;	435953;	435953|Ruijs-Aalfs syndrome|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent|616200 ~	.	.	.	.	0.0	0.99	0.000	0.73	1	MU21239736	het
1	231557255	231557255	C	G	EGLN1	exonic	nonsynonymous SNV	ENSG00000135766	rs12097901	ENSG00000135766:ENST00000366641:exon1:c.G380C:p.C127S	EGLN1:NM_022051:exon1:c.G380C:p.C127S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.2963	.	0.260383	0.1584	-0.760	0.053	0.734	3.26	0.001	.	.	.	EGLN1:uc001huv.2:exon1:c.G380C:p.C127S	-1.059	AFR:0.3097,AMR:0.1115,EAS:0.4338,FIN:0.0822,NFE:0.0652,OTH:0.1130,ASJ:0.0733	606425	609070;609820;	247511;	247511|Autosomal dominant secondary erythrocytosis|Unknown|Autosomal dominant|Infancy<br>Neonatal|609820 611783 ~	~ko04066 HIF-1 signaling pathway~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	0.0	-1.95	0.000	-0.345	1	MU4555774	het
1	237551376	237551376	T	A	RYR2	intronic	.	ENSG00000198626	rs10754602	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5751	0.5273	0.55651	0.5325	.	.	.	.	.	0.0001	0.008	.	.	.	AFR:0.4675,AMR:0.7446,EAS:0.6148,FIN:0.5416,NFE:0.5458,OTH:0.5662,ASJ:0.5033	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU24513954	het
1	237586384	237586384	T	C	RYR2	intronic	.	ENSG00000198626	rs16835237	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1403	0.0879	0.170128	0.0985	.	.	.	.	.	0.0001	0.006	.	.	.	AFR:0.0651,AMR:0.2673,EAS:0.2964,FIN:0.0885,NFE:0.0891,OTH:0.1090,ASJ:0.0795	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU11418175	het
1	237617757	237617757	C	T	RYR2	exonic	synonymous SNV	ENSG00000198626	rs3765097	ENSG00000198626:ENST00000542537:exon14:c.C1311T:p.S437S,ENSG00000198626:ENST00000366574:exon15:c.C1359T:p.S453S,ENSG00000198626:ENST00000360064:exon16:c.C1353T:p.S451S	RYR2:NM_001035:exon15:c.C1359T:p.S453S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5755	0.5119	0.535743	0.5238	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon15:c.C1359T:p.S453S	.	AFR:0.3184,AMR:0.5897,EAS:0.7073,FIN:0.5894,NFE:0.5988,OTH:0.5867,ASJ:0.6033	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU18032197	het
1	237620049	237620049	T	C	RYR2	intronic	.	ENSG00000198626	rs2045955	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5514	0.4634	0.53115	0.4984	.	.	.	.	.	.	.	.	.	.	AFR:0.3107,AMR:0.5624,EAS:0.7823,FIN:0.5657,NFE:0.5521,OTH:0.5643,ASJ:0.57	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU786721	het
1	237666583	237666583	C	T	RYR2	intronic	.	ENSG00000198626	rs78165942	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0093	0.0113	0.0131789	0.0092	.	.	.	.	.	0	0.008	.	.	.	AFR:0.0320,AMR:0.0012,EAS:0,FIN:0,NFE:6.661e-05,OTH:0.0031,ASJ:0	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	.	het
1	237711797	237711797	A	G	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2253273	ENSG00000198626:ENST00000542537:exon25:c.A2925G:p.S975S,ENSG00000198626:ENST00000366574:exon26:c.A2973G:p.S991S,ENSG00000198626:ENST00000360064:exon27:c.A2967G:p.S989S	RYR2:NM_001035:exon26:c.A2973G:p.S991S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9262	0.8511	0.830272	0.8540	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon26:c.A2973G:p.S991S	.	AFR:0.6002,AMR:0.9414,EAS:0.8838,FIN:0.9762,NFE:0.9567,OTH:0.9450,ASJ:0.9603	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU4558519	hom
1	237753075	237753075	T	-	RYR2	intronic	.	ENSG00000198626	rs11331089	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.4622	0.3469	0.285144	0.3537	.	.	.	.	.	.	.	.	.	.	AFR:0.1250,AMR:0.5570,EAS:0.2506,FIN:0.4796,NFE:0.4511,OTH:0.4165,ASJ:0.4467	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	.	het
1	237774051	237774051	C	T	RYR2	intronic	.	ENSG00000198626	rs7546045	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0465	0.0557	0.0638978	0.0514	.	.	.	.	.	0	0	.	.	.	AFR:0.1779,AMR:0.0060,EAS:0.0043,FIN:0,NFE:0.0008,OTH:0.0153,ASJ:0.0033	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	.	het
1	237801770	237801770	T	C	RYR2	exonic	synonymous SNV	ENSG00000198626	rs707189	ENSG00000198626:ENST00000542537:exon44:c.T6858C:p.L2286L,ENSG00000198626:ENST00000366574:exon45:c.T6906C:p.L2302L,ENSG00000198626:ENST00000360064:exon46:c.T6900C:p.L2300L	RYR2:NM_001035:exon45:c.T6906C:p.L2302L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9884	0.9592	0.954872	0.9641	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon45:c.T6906C:p.L2302L	.	AFR:0.8753,AMR:0.9881,EAS:1,FIN:0.9994,NFE:0.9999,OTH:0.9898,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724737	hom
1	237814783	237814783	C	T	RYR2	exonic	synonymous SNV	ENSG00000198626	rs684923	ENSG00000198626:ENST00000542537:exon50:c.C7758T:p.H2586H,ENSG00000198626:ENST00000366574:exon51:c.C7806T:p.H2602H,ENSG00000198626:ENST00000360064:exon52:c.C7800T:p.H2600H	RYR2:NM_001035:exon51:c.C7806T:p.H2602H	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5198	0.4507	0.554912	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon51:c.C7806T:p.H2602H	.	AFR:0.4881,AMR:0.5021,EAS:0.2947,FIN:0.8125,NFE:0.4991,OTH:0.4477,ASJ:0.4940	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.4603
1	237863718	237863718	T	G	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2797436	ENSG00000198626:ENST00000542537:exon64:c.T9270G:p.S3090S,ENSG00000198626:ENST00000366574:exon65:c.T9318G:p.S3106S,ENSG00000198626:ENST00000360064:exon66:c.T9312G:p.S3104S	RYR2:NM_001035:exon65:c.T9318G:p.S3106S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9917	0.9718	0.969249	0.9715	.	.	.	.	.	.	.	.	RYR2:uc010pxz.1:exon4:c.T183G:p.S61S,RYR2:uc001hyl.1:exon65:c.T9318G:p.S3106S	.	AFR:0.9005,AMR:0.9964,EAS:1,FIN:1,NFE:0.9993,OTH:0.9969,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724751	hom
1	237881770	237881770	C	T	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2797441	ENSG00000198626:ENST00000542537:exon72:c.C10455T:p.T3485T,ENSG00000198626:ENST00000366574:exon73:c.C10503T:p.T3501T,ENSG00000198626:ENST00000360064:exon74:c.C10497T:p.T3499T	RYR2:NM_001035:exon73:c.C10503T:p.T3501T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9886	0.9616	0.960463	0.9623	.	.	.	.	.	.	.	.	RYR2:uc010pxz.1:exon12:c.C1368T:p.T456T,RYR2:uc001hyl.1:exon73:c.C10503T:p.T3501T	.	AFR:0.8678,AMR:0.9964,EAS:1,FIN:1,NFE:0.9995,OTH:0.9949,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724767	hom
1	237890437	237890437	C	T	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2685301	ENSG00000198626:ENST00000542537:exon75:c.C10728T:p.S3576S,ENSG00000198626:ENST00000366574:exon76:c.C10776T:p.S3592S,ENSG00000198626:ENST00000360064:exon77:c.C10770T:p.S3590S	RYR2:NM_001035:exon76:c.C10776T:p.S3592S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9885	0.9608	0.960264	0.9625	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon76:c.C10776T:p.S3592S	.	AFR:0.8687,AMR:0.9964,EAS:1,FIN:1,NFE:0.9995,OTH:0.9949,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724775	hom
1	237893674	237893674	C	T	RYR2	intronic	.	ENSG00000198626	rs2797445	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9954	0.9854	0.985224	0.9853	.	.	.	.	.	.	.	.	.	.	AFR:0.9485,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724780	hom
1	237957161	237957161	A	G	RYR2	intronic	.	ENSG00000198626	rs790901	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7399	0.6514	0.757588	0.6830	.	.	.	.	.	0	0	.	.	.	AFR:0.5929,AMR:0.8091,EAS:0.9580,FIN:0.6922,NFE:0.6941,OTH:0.7182,ASJ:0.6821	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU13920819	hom
1	237957309	237957309	A	C	RYR2	intronic	.	ENSG00000198626	rs790900	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7273	0.6478	0.750799	0.6803	.	.	.	.	.	.	.	.	.	.	AFR:0.6020,AMR:0.7995,EAS:0.9579,FIN:0.6896,NFE:0.6851,OTH:0.7122,ASJ:0.6755	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU13920863	hom
1	241663902	241663902	-	GAGAGAGAGA	FH	intronic	.	ENSG00000091483	rs144131869	.	.	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	.	0.0424	.	.	.	.	.	.	.	.	.	.	AFR:0.0672,AMR:0.0240,EAS:0.0355,FIN:0.0404,NFE:0.0330,OTH:0.0353,ASJ:0.0042	136850	150800;606812;	24;523;	24|Fumarase deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|606812 ~523|Familial leiomyomatosis and renal cell cancer<br>Familial leiomyomatosis cutis et uteri<br>Familial leiomyomatosis with renal carcinoma<br>Familial multiple cutaneous leiomyomas<br>HLRCC<br>Hereditary leiomyomatosis<br>Hereditary leiomyomatosis with renal carcinoma<br>Hereditary multiple cutaneous leiomyomas<br>MCUL<br>Multiple cutaneous and uterine leiomyomas<br>Reed syndrome|Unknown|Autosomal dominant|Adolescent<br>Adult<br>Elderly|150800 ~	~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko00720 Carbon fixation pathways in prokaryotes~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04934 Cushing syndrome~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma~~M00009 Citrate cycle (TCA cycle, Krebs cycle)~M00011 Citrate cycle, second carbon oxidation, 2-oxoglutarate =>~~M00173 Reductive citrate cycle (Arnon-Buchanan cycle)~M00376 3-Hydroxypropionate bi-cycle ~	.	.	.	.	.	.	.	1	.	unknown
1	242030151	242030151	A	G	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs735943	ENSG00000174371:ENST00000348581:exon9:c.A1061G:p.H354R,ENSG00000174371:ENST00000518483:exon9:c.A1061G:p.H354R,ENSG00000174371:ENST00000366548:exon11:c.A1061G:p.H354R	EXO1:NM_003686:exon9:c.A1061G:p.H354R,EXO1:NM_006027:exon9:c.A1061G:p.H354R,EXO1:NM_001319224:exon10:c.A1061G:p.H354R,EXO1:NM_130398:exon11:c.A1061G:p.H354R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5930	0.5674	0.636981	0.6067	-0.879	0.029	0.997	-0.821	0.933	.	.	.	EXO1:uc021plj.1:exon9:c.A1061G:p.H354R,EXO1:uc021plk.1:exon9:c.A1061G:p.H354R,EXO1:uc009xgq.3:exon10:c.A1061G:p.H354R,EXO1:uc001hzh.3:exon11:c.A1061G:p.H354R	-0.990	AFR:0.6181,AMR:0.6770,EAS:0.7866,FIN:0.6154,NFE:0.5774,OTH:0.5922,ASJ:0.5232	606063	.	.	.	.	.	.	.	0.0	1.41	0.000	1.025	1	MU16150612	het
1	242042301	242042301	G	A	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs1047840	ENSG00000174371:ENST00000348581:exon11:c.G1765A:p.E589K,ENSG00000174371:ENST00000518483:exon11:c.G1765A:p.E589K,ENSG00000174371:ENST00000366548:exon13:c.G1765A:p.E589K	EXO1:NM_003686:exon11:c.G1765A:p.E589K,EXO1:NM_006027:exon11:c.G1765A:p.E589K,EXO1:NM_001319224:exon12:c.G1762A:p.E588K,EXO1:NM_130398:exon13:c.G1765A:p.E589K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3610	0.4087	0.351637	1(haematopoietic_and_lymphoid_tissue)	-0.283	0.727	1.0	-3.34	0.000	.	.	.	EXO1:uc021plj.1:exon11:c.G1765A:p.E589K,EXO1:uc021plk.1:exon11:c.G1765A:p.E589K,EXO1:uc009xgq.3:exon12:c.G1762A:p.E588K,EXO1:uc001hzh.3:exon13:c.G1765A:p.E589K	-0.938	AFR:1(skin),AMR:MU581675,EAS:0.4007,FIN:0.4647,NFE:0.3720,OTH:0.3808,ASJ:ESAD-UK|1|409|0.00244499,LAML-KR|4|205|0.0195122,COCA-CN|2|321|0.00623053	606063	.	.	.	.	.	.	.	0.0	1.24	0.000	-0.6	1	1(prostate)	0.1951
1	242042545	242042545	A	G	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs1776148	ENSG00000174371:ENST00000348581:exon11:c.A2009G:p.E670G,ENSG00000174371:ENST00000518483:exon11:c.A2009G:p.E670G,ENSG00000174371:ENST00000366548:exon13:c.A2009G:p.E670G	EXO1:NM_003686:exon11:c.A2009G:p.E670G,EXO1:NM_006027:exon11:c.A2009G:p.E670G,EXO1:NM_001319224:exon12:c.A2006G:p.E669G,EXO1:NM_130398:exon13:c.A2009G:p.E670G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6573	0.6550	0.681909	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	-0.519	0.197	0.382	-5.51	0.000	.	.	.	EXO1:uc021plj.1:exon11:c.A2009G:p.E670G,EXO1:uc021plk.1:exon11:c.A2009G:p.E670G,EXO1:uc009xgq.3:exon12:c.A2006G:p.E669G,EXO1:uc001hzh.3:exon13:c.A2009G:p.E670G	-1.000	AFR:0.6669,AMR:0.6913,EAS:0.6722,FIN:0.8226,NFE:0.6128,OTH:0.6491,ASJ:0.6885	606063	.	.	.	.	.	.	.	0.0	1.44	0.000	0.41	1	1(thyroid)	0.6373
1	242045275	242045275	C	T	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs1635498	ENSG00000174371:ENST00000348581:exon12:c.C2167T:p.R723C,ENSG00000174371:ENST00000518483:exon12:c.C2167T:p.R723C,ENSG00000174371:ENST00000366548:exon14:c.C2167T:p.R723C	EXO1:NM_003686:exon12:c.C2167T:p.R723C,EXO1:NM_006027:exon12:c.C2167T:p.R723C,EXO1:NM_001319224:exon13:c.C2164T:p.R722C,EXO1:NM_130398:exon14:c.C2167T:p.R723C	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9564	0.9452	0.915335	0.9462	3.117	22.6	0.188	1.84	0.565	.	.	.	EXO1:uc021plj.1:exon12:c.C2167T:p.R723C,EXO1:uc021plk.1:exon12:c.C2167T:p.R723C,EXO1:uc009xgq.3:exon13:c.C2164T:p.R722C,EXO1:uc001hzh.3:exon14:c.C2167T:p.R723C	-0.976	AFR:0.8801,AMR:0.9712,EAS:0.8691,FIN:0.9954,NFE:0.9780,OTH:0.9744,ASJ:0.9669	606063	.	.	.	.	.	.	.	0.85	1.35	0.000	0.345	1	MU18036633	hom
1	247587477	247587477	G	A	NLRP3	exonic	synonymous SNV	ENSG00000162711	rs3806268	ENSG00000162711:ENST00000336119:exon3:c.G732A:p.A244A,ENSG00000162711:ENST00000348069:exon3:c.G732A:p.A244A,ENSG00000162711:ENST00000366496:exon3:c.G732A:p.A244A,ENSG00000162711:ENST00000391827:exon3:c.G732A:p.A244A,ENSG00000162711:ENST00000366497:exon4:c.G732A:p.A244A,ENSG00000162711:ENST00000391828:exon5:c.G732A:p.A244A	NLRP3:NM_001127462:exon3:c.G732A:p.A244A,NLRP3:NM_001243133:exon3:c.G726A:p.A242A,NLRP3:NM_004895:exon3:c.G732A:p.A244A,NLRP3:NM_183395:exon3:c.G732A:p.A244A,NLRP3:NM_001127461:exon4:c.G732A:p.A244A,NLRP3:NM_001079821:exon5:c.G732A:p.A244A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4996	0.4060	0.38738	2(stomach)	.	.	.	.	.	.	.	.	NLRP3:uc001ict.1:exon3:c.G726A:p.A242A,NLRP3:uc001icu.3:exon3:c.G732A:p.A244A,NLRP3:uc001icv.3:exon3:c.G732A:p.A244A,NLRP3:uc001icw.3:exon3:c.G732A:p.A244A,NLRP3:uc010pyw.2:exon3:c.G726A:p.A242A,NLRP3:uc001ics.3:exon4:c.G732A:p.A244A,NLRP3:uc001icr.3:exon5:c.G732A:p.A244A	.	AFR:MU581687,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|5|321|0.0155763,EAS:0.1151,FIN:0.4177,NFE:0.5333,OTH:0.5286,ASJ:0.4313	606416	120100;191900;607115;	1451;575;47045;	1451|Chronic infantile neurological cutaneous articular syndrome<br>IOMID syndrome<br>Infantile-onset multisystem inflammatory disease<br>NOMID syndrome<br>Neonatal-onset multisystem inflammatory disease<br>Prieur-Griscelli syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|607115 ~575|Neutrophilic urticaria|Unknown|Autosomal dominant|Childhood<br>Neonatal<br>Infancy|191900 ~47045|FCAS<br>FCU<br>Familial cold autoinflammatory syndrome|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|120100 616115 ~	.	.	.	.	.	.	.	.	1	2(haematopoietic_and_lymphoid_tissue)	0.5387
1	247587531	247587531	A	G	NLRP3	exonic	synonymous SNV	ENSG00000162711	rs4925543	ENSG00000162711:ENST00000336119:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000348069:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000366496:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000391827:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000366497:exon4:c.A786G:p.R262R,ENSG00000162711:ENST00000391828:exon5:c.A786G:p.R262R	NLRP3:NM_001127462:exon3:c.A786G:p.R262R,NLRP3:NM_001243133:exon3:c.A780G:p.R260R,NLRP3:NM_004895:exon3:c.A786G:p.R262R,NLRP3:NM_183395:exon3:c.A786G:p.R262R,NLRP3:NM_001127461:exon4:c.A786G:p.R262R,NLRP3:NM_001079821:exon5:c.A786G:p.R262R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9426	0.9188	0.919928	0.9332	.	.	.	.	.	.	.	.	NLRP3:uc001ict.1:exon3:c.A780G:p.R260R,NLRP3:uc001icu.3:exon3:c.A786G:p.R262R,NLRP3:uc001icv.3:exon3:c.A786G:p.R262R,NLRP3:uc001icw.3:exon3:c.A786G:p.R262R,NLRP3:uc010pyw.2:exon3:c.A780G:p.R260R,NLRP3:uc001ics.3:exon4:c.A786G:p.R262R,NLRP3:uc001icr.3:exon5:c.A786G:p.R262R	.	AFR:0.8519,AMR:0.9737,EAS:0.9975,FIN:0.9522,NFE:0.9645,OTH:0.9562,ASJ:0.9735	606416	120100;191900;607115;	1451;575;47045;	1451|Chronic infantile neurological cutaneous articular syndrome<br>IOMID syndrome<br>Infantile-onset multisystem inflammatory disease<br>NOMID syndrome<br>Neonatal-onset multisystem inflammatory disease<br>Prieur-Griscelli syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|607115 ~575|Neutrophilic urticaria|Unknown|Autosomal dominant|Childhood<br>Neonatal<br>Infancy|191900 ~47045|FCAS<br>FCU<br>Familial cold autoinflammatory syndrome|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|120100 616115 ~	.	.	.	.	.	.	.	.	1	MU81725544	hom
1	247587795	247587795	G	A	NLRP3	exonic	synonymous SNV	ENSG00000162711	rs143140947	ENSG00000162711:ENST00000336119:exon3:c.G1050A:p.T350T,ENSG00000162711:ENST00000348069:exon3:c.G1050A:p.T350T,ENSG00000162711:ENST00000366496:exon3:c.G1050A:p.T350T,ENSG00000162711:ENST00000391827:exon3:c.G1050A:p.T350T,ENSG00000162711:ENST00000366497:exon4:c.G1050A:p.T350T,ENSG00000162711:ENST00000391828:exon5:c.G1050A:p.T350T	NLRP3:NM_001127462:exon3:c.G1050A:p.T350T,NLRP3:NM_001243133:exon3:c.G1044A:p.T348T,NLRP3:NM_004895:exon3:c.G1050A:p.T350T,NLRP3:NM_183395:exon3:c.G1050A:p.T350T,NLRP3:NM_001127461:exon4:c.G1050A:p.T350T,NLRP3:NM_001079821:exon5:c.G1050A:p.T350T	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 2, 0, 0, 0] 	0.0061	7.7e-05	0.0115815	0.0001	.	.	.	.	.	.	.	.	NLRP3:uc001ict.1:exon3:c.G1044A:p.T348T,NLRP3:uc001icu.3:exon3:c.G1050A:p.T350T,NLRP3:uc001icv.3:exon3:c.G1050A:p.T350T,NLRP3:uc001icw.3:exon3:c.G1050A:p.T350T,NLRP3:uc010pyw.2:exon3:c.G1044A:p.T348T,NLRP3:uc001ics.3:exon4:c.G1050A:p.T350T,NLRP3:uc001icr.3:exon5:c.G1050A:p.T350T	.	AFR:0.0001,AMR:0,EAS:0.0006,FIN:0,NFE:0,OTH:0.0020,ASJ:0	606416	120100;191900;607115;	1451;575;47045;	1451|Chronic infantile neurological cutaneous articular syndrome<br>IOMID syndrome<br>Infantile-onset multisystem inflammatory disease<br>NOMID syndrome<br>Neonatal-onset multisystem inflammatory disease<br>Prieur-Griscelli syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|607115 ~575|Neutrophilic urticaria|Unknown|Autosomal dominant|Childhood<br>Neonatal<br>Infancy|191900 ~47045|FCAS<br>FCU<br>Familial cold autoinflammatory syndrome|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|120100 616115 ~	.	.	.	.	.	.	.	.	1	MU82388961	het
2	17942775	17942775	T	A	GEN1	exonic	nonsynonymous SNV	ENSG00000178295	rs1812152	ENSG00000178295:ENST00000317402:exon3:c.T274A:p.S92T,ENSG00000178295:ENST00000381254:exon3:c.T274A:p.S92T,ENSG00000178295:ENST00000524465:exon3:c.T274A:p.S92T,ENSG00000178295:ENST00000532257:exon3:c.T274A:p.S92T	GEN1:NM_001130009:exon3:c.T274A:p.S92T,GEN1:NM_182625:exon3:c.T274A:p.S92T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7138	0.6712	0.813698	0.6849	0.082	3.418	1.0	0.326	0.953	.	.	PIN domain-like|XPG N-terminal	GEN1:uc002rct.2:exon3:c.T274A:p.S92T,GEN1:uc002rcu.2:exon3:c.T274A:p.S92T,GEN1:uc010yjs.1:exon3:c.T274A:p.S92T	-1.005	AFR:0.7717,AMR:0.7912,EAS:0.9790,FIN:0.5835,NFE:0.6234,OTH:0.6493,ASJ:0.6376	612449	.	.	.	.	.	.	.	0.0	-0.01	0.000	-0.86	2	MU31230816	hom
2	17954027	17954027	G	A	GEN1	exonic	nonsynonymous SNV	ENSG00000178295	rs300175	ENSG00000178295:ENST00000528873:exon3:c.G242A:p.S81N,ENSG00000178295:ENST00000317402:exon8:c.G929A:p.S310N,ENSG00000178295:ENST00000381254:exon8:c.G929A:p.S310N	GEN1:NM_001130009:exon8:c.G929A:p.S310N,GEN1:NM_182625:exon8:c.G929A:p.S310N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9932	0.9835	0.977037	0.9882	-3.164	0.001	0.706	-11.3	0.001	.	.	.	GEN1:uc002rct.2:exon8:c.G929A:p.S310N,GEN1:uc002rcu.2:exon8:c.G929A:p.S310N,GEN1:uc010yjs.1:exon8:c.G929A:p.S310N	-0.973	AFR:0.9588,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:0.9949,ASJ:1	612449	.	.	.	.	.	.	.	0.001	0.81	0.000	-0.66	2	MU81728351	hom
2	17962450	17962450	A	G	GEN1	exonic	synonymous SNV	ENSG00000178295	rs300168	ENSG00000178295:ENST00000317402:exon14:c.A1971G:p.E657E,ENSG00000178295:ENST00000381254:exon14:c.A1971G:p.E657E	GEN1:NM_001130009:exon14:c.A1971G:p.E657E,GEN1:NM_182625:exon14:c.A1971G:p.E657E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5758	0.4261	0.573882	0.4552	.	.	.	.	.	.	.	.	GEN1:uc002rct.2:exon14:c.A1971G:p.E657E,GEN1:uc002rcu.2:exon14:c.A1971G:p.E657E,GEN1:uc010yjs.1:exon14:c.A1971G:p.E657E	.	AFR:0.2301,AMR:0.6746,EAS:0.9261,FIN:0.5026,NFE:0.5059,OTH:0.5378,ASJ:0.5033	612449	.	.	.	.	.	.	.	.	.	.	.	2	MU17872203	hom
2	17962518	17962518	C	T	GEN1	exonic	nonsynonymous SNV	ENSG00000178295	rs300169	ENSG00000178295:ENST00000317402:exon14:c.C2039T:p.T680I,ENSG00000178295:ENST00000381254:exon14:c.C2039T:p.T680I	GEN1:NM_001130009:exon14:c.C2039T:p.T680I,GEN1:NM_182625:exon14:c.C2039T:p.T680I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6981	0.6187	0.757987	0.6392	-0.073	1.943	1.0	1.16	0.862	.	.	.	GEN1:uc002rct.2:exon14:c.C2039T:p.T680I,GEN1:uc002rcu.2:exon14:c.C2039T:p.T680I,GEN1:uc010yjs.1:exon14:c.C2039T:p.T680I	-0.997	AFR:0.6127,AMR:0.7721,EAS:0.9783,FIN:0.5833,NFE:0.6234,OTH:0.6442,ASJ:0.63	612449	.	.	.	.	.	.	.	0.0	2.01	0.000	-1.845	2	MU31230939	hom
2	21228386	21228386	G	A	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs143710616	ENSG00000084674:ENST00000233242:exon26:c.C11354T:p.T3785I	APOB:NM_000384:exon26:c.C11354T:p.T3785I	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 1, 1, -1, 0, 0] 	0.0006	0.0004	0.000199681	6.457e-05	-0.383	0.425	0.194	-3.7	0.708	.	.	.	APOB:uc002red.3:exon26:c.C11354T:p.T3785I	-0.947	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0001,OTH:0,ASJ:0	107730	144010;615558;	.	.	.	.	.	.	0.374	5.79	0.003	0.86	2	.	het
2	21231524	21231524	G	A	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs676210	ENSG00000084674:ENST00000233242:exon26:c.C8216T:p.P2739L	APOB:NM_000384:exon26:c.C8216T:p.P2739L	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.2928	0.1965	0.366214	MU156045	5.787	27.1	0.0	5.22	1.000	.	.	.	APOB:uc002red.3:exon26:c.C8216T:p.P2739L	-1.071	AFR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.2347,EAS:0.2153,FIN:0.1424,NFE:0.7298,OTH:0.2563,ASJ:0.1459	107730	144010;615558;	.	.	.	.	.	.	1.0	5.21	0.000	2.785	2	1(large_intestine)	0.2276
2	21232803	21232803	T	C	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs584542	ENSG00000084674:ENST00000233242:exon26:c.A6937G:p.I2313V	APOB:NM_000384:exon26:c.A6937G:p.I2313V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9950	0.9816	0.986222	0.9842	-4.107	0.001	0.626	-3.8	0.005	.	.	.	APOB:uc002red.3:exon26:c.A6937G:p.I2313V	-0.985	AFR:0.9457,AMR:0.9976,EAS:0.9981,FIN:1,NFE:0.9996,OTH:0.9969,ASJ:1	107730	144010;615558;	.	.	.	.	.	.	0.002	5.78	0.000	1.465	2	MU81728574	hom
2	21235475	21235475	T	C	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs568413	ENSG00000084674:ENST00000233242:exon26:c.A4265G:p.Y1422C	APOB:NM_000384:exon26:c.A4265G:p.Y1422C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9999	0.9997	1	0.9997	.	.	.	.	.	.	.	.	APOB:uc002red.3:exon26:c.A4265G:p.Y1422C	.	AFR:0.9997,AMR:1,EAS:1,FIN:1,NFE:0.9997,OTH:0.9990,ASJ:1	107730	144010;615558;	.	.	.	.	.	.	.	.	.	.	2	MU81728579	hom
2	21250914	21250914	G	A	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs679899	ENSG00000084674:ENST00000233242:exon14:c.C1853T:p.A618V,ENSG00000084674:ENST00000399256:exon14:c.C1853T:p.A618V	APOB:NM_000384:exon14:c.C1853T:p.A618V	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.4857	0.3655	0.485024	0.4190	5.620	26.6	0.005	5.73	0.712	.	.	Lipid transport protein, N-terminal|Vitellinogen, superhelical	APOB:uc002red.3:exon14:c.C1853T:p.A618V	-0.928	AFR:0.1710,AMR:0.3926,EAS:0.8424,FIN:0.5479,NFE:0.4846,OTH:0.5061,ASJ:0.3576	107730	144010;615558;	.	.	.	.	.	.	1.0	-0.62	0.000	2.695	2	MU4129271	hom
2	24905927	24905927	G	C	NCOA1	exonic	synonymous SNV	ENSG00000084676	rs11125744	ENSG00000084676:ENST00000288599:exon6:c.G462C:p.T154T,ENSG00000084676:ENST00000348332:exon6:c.G462C:p.T154T,ENSG00000084676:ENST00000395856:exon6:c.G462C:p.T154T,ENSG00000084676:ENST00000407230:exon6:c.G9C:p.T3T,ENSG00000084676:ENST00000538539:exon7:c.G462C:p.T154T,ENSG00000084676:ENST00000406961:exon8:c.G462C:p.T154T,ENSG00000084676:ENST00000405141:exon9:c.G462C:p.T154T	NCOA1:NM_147233:exon6:c.G462C:p.T154T,NCOA1:NM_147223:exon7:c.G462C:p.T154T,NCOA1:NM_001362950:exon8:c.G462C:p.T154T,NCOA1:NM_001362952:exon8:c.G462C:p.T154T,NCOA1:NM_001362954:exon8:c.G462C:p.T154T,NCOA1:NM_001362955:exon8:c.G462C:p.T154T,NCOA1:NM_003743:exon8:c.G462C:p.T154T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8689	0.7864	0.80651	0.8160	.	.	.	.	.	.	.	.	NCOA1:uc002rfi.3:exon6:c.G9C:p.T3T,NCOA1:uc002rfj.3:exon6:c.G462C:p.T154T,NCOA1:uc002rfk.3:exon6:c.G462C:p.T154T,NCOA1:uc002rfl.3:exon6:c.G462C:p.T154T,NCOA1:uc010eye.3:exon7:c.G462C:p.T154T	.	AFR:0.5729,AMR:0.9306,EAS:0.9957,FIN:0.9123,NFE:0.9034,OTH:0.8724,ASJ:0.9040	602691	.	.	.	~ko04915 Estrogen signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	2	MU4558267	het
2	24929851	24929851	A	T	NCOA1	exonic	synonymous SNV	ENSG00000084676	rs3731628	ENSG00000084676:ENST00000288599:exon11:c.A1512T:p.P504P,ENSG00000084676:ENST00000348332:exon11:c.A1512T:p.P504P,ENSG00000084676:ENST00000395856:exon11:c.A1512T:p.P504P,ENSG00000084676:ENST00000407230:exon11:c.A1059T:p.P353P,ENSG00000084676:ENST00000538539:exon12:c.A1512T:p.P504P,ENSG00000084676:ENST00000406961:exon13:c.A1512T:p.P504P,ENSG00000084676:ENST00000405141:exon14:c.A1512T:p.P504P	NCOA1:NM_147233:exon11:c.A1512T:p.P504P,NCOA1:NM_147223:exon12:c.A1512T:p.P504P,NCOA1:NM_001362950:exon13:c.A1512T:p.P504P,NCOA1:NM_001362952:exon13:c.A1512T:p.P504P,NCOA1:NM_001362954:exon13:c.A1512T:p.P504P,NCOA1:NM_001362955:exon13:c.A1512T:p.P504P,NCOA1:NM_003743:exon13:c.A1512T:p.P504P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0794	0.0817	0.107827	MU13465127	.	.	.	.	.	.	.	.	NCOA1:uc002rfi.3:exon11:c.A1059T:p.P353P,NCOA1:uc002rfj.3:exon11:c.A1512T:p.P504P,NCOA1:uc002rfk.3:exon11:c.A1512T:p.P504P,NCOA1:uc002rfl.3:exon11:c.A1512T:p.P504P,NCOA1:uc010eye.3:exon12:c.A1512T:p.P504P	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.0813,EAS:0.0919,FIN:0.0464,NFE:0.1194,OTH:0.0722,ASJ:0.1194	602691	.	.	.	~ko04915 Estrogen signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.0584
2	24974945	24974945	T	G	NCOA1	exonic	synonymous SNV	ENSG00000084676	rs11125763	ENSG00000084676:ENST00000288599:exon18:c.T3801G:p.L1267L,ENSG00000084676:ENST00000348332:exon18:c.T3801G:p.L1267L,ENSG00000084676:ENST00000395856:exon18:c.T3801G:p.L1267L,ENSG00000084676:ENST00000407230:exon18:c.T3348G:p.L1116L,ENSG00000084676:ENST00000538539:exon19:c.T3801G:p.L1267L,ENSG00000084676:ENST00000406961:exon20:c.T3801G:p.L1267L,ENSG00000084676:ENST00000405141:exon21:c.T3801G:p.L1267L	NCOA1:NM_147233:exon18:c.T3801G:p.L1267L,NCOA1:NM_147223:exon19:c.T3801G:p.L1267L,NCOA1:NM_001362950:exon20:c.T3801G:p.L1267L,NCOA1:NM_001362952:exon20:c.T3801G:p.L1267L,NCOA1:NM_001362954:exon20:c.T3801G:p.L1267L,NCOA1:NM_001362955:exon20:c.T3801G:p.L1267L,NCOA1:NM_003743:exon20:c.T3801G:p.L1267L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8784	0.8189	0.836062	0.8444	.	.	.	.	.	.	.	.	NCOA1:uc010eyf.3:exon2:c.T480G:p.L160L,NCOA1:uc002rfi.3:exon18:c.T3348G:p.L1116L,NCOA1:uc002rfj.3:exon18:c.T3801G:p.L1267L,NCOA1:uc002rfk.3:exon18:c.T3801G:p.L1267L,NCOA1:uc002rfl.3:exon18:c.T3801G:p.L1267L,NCOA1:uc010eye.3:exon19:c.T3801G:p.L1267L	.	AFR:0.6732,AMR:0.9368,EAS:0.9957,FIN:0.9118,NFE:0.9033,OTH:0.8763,ASJ:0.9040	602691	.	.	.	~ko04915 Estrogen signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	2	MU81728834	het
2	25469913	25469913	C	T	DNMT3A	intronic	.	ENSG00000119772	rs2276599	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7167	0.6863	0.614018	ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|6|321|0.0186916	.	.	.	.	.	0	0	.	.	.	AFR:0.7006,AMR:0.5654,EAS:0.6656,FIN:0.6001,NFE:0.8238,OTH:0.7565,ASJ:0.7363	602769	615879;	404443;	404443|DNMT3A-related overgrowth syndrome|<1 / 1 000 000|Unknown|Neonatal|615879 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.7525
2	25536827	25536827	G	A	DNMT3A	exonic	synonymous SNV	ENSG00000119772	rs41284843	ENSG00000119772:ENST00000264709:exon2:c.C27T:p.P9P,ENSG00000119772:ENST00000321117:exon2:c.C27T:p.P9P,ENSG00000119772:ENST00000380756:exon2:c.C27T:p.P9P,ENSG00000119772:ENST00000406659:exon2:c.C27T:p.P9P	DNMT3A:NM_001320892:exon2:c.C27T:p.P9P,DNMT3A:NM_022552:exon2:c.C27T:p.P9P,DNMT3A:NM_175629:exon2:c.C27T:p.P9P,DNMT3A:NM_175630:exon2:c.C27T:p.P9P	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.1550	0.0766	0.0948482	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,LIAD-FR|1|32|0.03125	.	.	.	.	.	.	.	.	DNMT3A:uc002rgc.4:exon2:c.C27T:p.P9P,DNMT3A:uc002rgd.4:exon2:c.C27T:p.P9P,DNMT3A:uc002rgf.3:exon2:c.C27T:p.P9P	.	AFR:0.0809,AMR:0.0589,EAS:0.0894,FIN:0.0871,NFE:0.0619,OTH:0.0972,ASJ:0.0610	602769	615879;	404443;	404443|DNMT3A-related overgrowth syndrome|<1 / 1 000 000|Unknown|Neonatal|615879 ~	.	,2226,2236,2228,2233,2229,2225	.	,2227,2234,2235,2231,2232,2230	.	.	.	.	2	1(liver)	0.0990
2	27440785	27440785	C	T	CAD	exonic	synonymous SNV	ENSG00000084774	rs1275536	ENSG00000084774:ENST00000264705:exon2:c.C123T:p.T41T,ENSG00000084774:ENST00000403525:exon2:c.C123T:p.T41T	CAD:NM_001306079:exon2:c.C123T:p.T41T,CAD:NM_004341:exon2:c.C123T:p.T41T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9986	0.9958	0.995807	0.9947	.	.	.	.	.	.	.	.	CAD:uc002rji.3:exon2:c.C123T:p.T41T,CAD:uc010eyw.3:exon2:c.C123T:p.T41T	.	AFR:0.9815,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	114010	616457;	448010;	448010|CDG syndrome type IZ<br>CDG-IZ<br>CDG1Z<br>Carbohydrate deficient glycoprotein syndrome type IZ<br>Congenital disorder of glycosylation type 1Z|<1 / 1 000 000|Autosomal recessive|Infancy|616457 ~	.	.	.	.	.	.	.	.	2	MU81729819	hom
2	27460968	27460968	A	G	CAD	exonic	synonymous SNV	ENSG00000084774	rs1141313	ENSG00000084774:ENST00000403525:exon29:c.A4584G:p.A1528A,ENSG00000084774:ENST00000264705:exon30:c.A4773G:p.A1591A	CAD:NM_001306079:exon29:c.A4584G:p.A1528A,CAD:NM_004341:exon30:c.A4773G:p.A1591A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3653	0.4499	0.454673	0.4209	.	.	.	.	.	.	.	.	CAD:uc010eyw.3:exon29:c.A4584G:p.A1528A,CAD:uc002rji.3:exon30:c.A4773G:p.A1591A	.	AFR:0.7635,AMR:0.5552,EAS:0.1469,FIN:0.2536,NFE:0.2903,OTH:0.3265,ASJ:0.3411	114010	616457;	448010;	448010|CDG syndrome type IZ<br>CDG-IZ<br>CDG1Z<br>Carbohydrate deficient glycoprotein syndrome type IZ<br>Congenital disorder of glycosylation type 1Z|<1 / 1 000 000|Autosomal recessive|Infancy|616457 ~	.	.	.	.	.	.	.	.	2	MU67341713	het
2	27462076	27462076	C	T	CAD	exonic	synonymous SNV	ENSG00000084774	rs3739092	ENSG00000084774:ENST00000403525:exon31:c.C5040T:p.P1680P,ENSG00000084774:ENST00000264705:exon32:c.C5229T:p.P1743P	CAD:NM_001306079:exon31:c.C5040T:p.P1680P,CAD:NM_004341:exon32:c.C5229T:p.P1743P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2681	0.2340	0.265575	MU72482	.	.	.	.	.	.	.	.	CAD:uc010eyw.3:exon31:c.C5040T:p.P1680P,CAD:uc002rji.3:exon32:c.C5229T:p.P1743P	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,BTCA-JP|1|239|0.0041841,AMR:0.2303,EAS:0.4773,FIN:0.2914,NFE:0.1465,OTH:0.2115,ASJ:0.2366	114010	616457;	448010;	448010|CDG syndrome type IZ<br>CDG-IZ<br>CDG1Z<br>Carbohydrate deficient glycoprotein syndrome type IZ<br>Congenital disorder of glycosylation type 1Z|<1 / 1 000 000|Autosomal recessive|Infancy|616457 ~	.	.	.	.	.	.	.	.	2	1(large_intestine)	0.2242
2	29001691	29001691	A	G	PPP1CB	exonic	synonymous SNV	ENSG00000213639	rs1128416	ENSG00000213639:ENST00000395366:exon3:c.A201G:p.Q67Q,ENSG00000213639:ENST00000455580:exon3:c.A117G:p.Q39Q,ENSG00000213639:ENST00000296122:exon4:c.A201G:p.Q67Q,ENSG00000213639:ENST00000358506:exon4:c.A201G:p.Q67Q,ENSG00000213639:ENST00000420282:exon4:c.A201G:p.Q67Q,ENSG00000213639:ENST00000441461:exon4:c.A201G:p.Q67Q	PPP1CB:NM_002709:exon3:c.A201G:p.Q67Q,PPP1CB:NM_206876:exon4:c.A201G:p.Q67Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5447	0.5951	0.495407	0.5690	.	.	.	.	.	.	.	.	PPP1CB:uc002rmh.3:exon3:c.A201G:p.Q67Q,PPP1CB:uc010ymj.2:exon3:c.A117G:p.Q39Q,PPP1CB:uc010ymk.2:exon3:c.A117G:p.Q39Q,PPP1CB:uc010yml.2:exon3:c.A117G:p.Q39Q,PPP1CB:uc002rmg.3:exon4:c.A201G:p.Q67Q	.	AFR:0.5769,AMR:0.3864,EAS:0.2261,FIN:0.5867,NFE:0.6068,OTH:0.5625,ASJ:0.6192	600590	.	.	.	~ko03015 mRNA surveillance pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04113 Meiosis - yeast~ko04114 Oocyte meiosis~ko04218 Cellular senescence~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04390 Hippo signaling pathway~ko04510 Focal adhesion~ko04611 Platelet activation~ko04720 Long-term potentiation~ko04728 Dopaminergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04921 Oxytocin signaling pathway~ko04931 Insulin resistance~ko05031 Amphetamine addiction~ko05034 Alcoholism~ko05168 Herpes simplex virus 1 infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	2	MU14440316	hom
2	29416572	29416572	T	C	ALK	exonic	nonsynonymous SNV	ENSG00000171094	rs1670283	ENSG00000171094:ENST00000431873:exon4:c.A871G:p.I291V,ENSG00000171094:ENST00000389048:exon29:c.A4381G:p.I1461V	ALK:NM_001353765:exon10:c.A1177G:p.I393V,ALK:NM_004304:exon29:c.A4381G:p.I1461V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.9972	0.9903	0.992212	COCA-CN|5|321|0.0155763	-2.014	0.001	1.0	-0.134	0.001	.	.	.	ALK:uc010ymo.3:exon10:c.A1177G:p.I393V,ALK:uc031rnw.1:exon11:c.A1177G:p.I393V,ALK:uc002rmy.3:exon29:c.A4381G:p.I1461V	-0.987	AFR:0.9907,AMR:0.9680,EAS:0.9934,FIN:1,NFE:1,OTH:0.9999,ASJ:0.9940	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,619,617,620,623,624,616,618,622,621	.	.	0.0	-0.89	0.000	-1.1	2	30(lung)	0.9990
2	29444095	29444095	C	T	ALK	intronic	.	ENSG00000171094	rs1569156	ENSG00000171094:ENST00000453137:exon4:c.G218A:p.W73X	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9757	.	0.914736	0.9329	0.034	2.916	.	-1.17	0.003	.	.	.	.	.	AFR:0.7762,AMR:0.9833,EAS:0.9414,FIN:1,NFE:0.9995,OTH:0.9898,ASJ:0.9934	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	MU23036355	hom
2	29445798	29445798	T	C	ALK	intronic	.	ENSG00000171094	rs4666182	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.922923	0.9371	.	.	.	.	.	.	.	.	.	.	AFR:0.7909,AMR:0.9868,EAS:0.9426,FIN:1,NFE:0.9995,OTH:0.9898,ASJ:0.9934	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	unknown
2	29445809	29445809	T	C	ALK	intronic	.	ENSG00000171094	rs11685441	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.130591	0.2166	.	.	.	.	.	.	.	.	.	.	AFR:0.0494,AMR:0.1519,EAS:0.0068,FIN:0.3335,NFE:0.3075,OTH:0.2689,ASJ:0.3233	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	unknown
2	29445982	29445982	G	C	ALK	intronic	.	ENSG00000171094	rs11689436	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.25599	0.3873	.	.	.	.	.	.	.	.	.	.	AFR:0.2100,AMR:0.2410,EAS:0.0327,FIN:0.5147,NFE:0.5011,OTH:0.4600,ASJ:0.4834	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29446202	29446202	G	A	ALK	intronic	.	ENSG00000171094	rs4622670	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2896	0.2663	0.176518	MU742525	.	.	.	.	.	0.0001	0.012	.	.	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.2520,EAS:0.1818,FIN:0.3543,NFE:0.0327,OTH:0.3506,ASJ:0.0629	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	1(lung)	0.3609
2	29446701	29446701	T	C	ALK	UTR5	.	ENSG00000171094	rs12619049	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.305711	0.3932	.	.	.	.	.	.	.	.	.	.	AFR:0.4174,AMR:0.2649,EAS:0.1656,FIN:0.3302,NFE:0.4251,OTH:0.3939,ASJ:0.4205	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	MU22244114	unknown
2	29446721	29446721	A	G	ALK	UTR5	.	ENSG00000171094	rs4665447	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.854633	0.8794	.	.	.	.	.	.	.	.	.	.	AFR:0.6369,AMR:0.9617,EAS:0.9340,FIN:0.9759,NFE:0.9801,OTH:0.9622,ASJ:0.9669	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	unknown
2	29447108	29447108	G	A	ALK	intronic	.	ENSG00000171094	rs4387740	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.727436	0.7086	.	.	.	.	.	.	.	.	.	.	AFR:0.6098,AMR:0.7947,EAS:0.7670,FIN:0.8268,NFE:0.7242,OTH:0.7495,ASJ:0.7152	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	MU114075717	het
2	29447253	29447253	A	G	ALK	intronic	.	ENSG00000171094	rs6723311	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.629393	0.5322	.	.	.	.	.	.	.	.	.	.	AFR:0.4892,AMR:0.7375,EAS:0.8872,FIN:0.5295,NFE:0.5070,OTH:0.5439,ASJ:0.5364	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29447585	29447585	C	T	ALK	intronic	.	ENSG00000171094	rs537833916	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	0.00139776	6.46e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0020,ASJ:0	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29448760	29448760	C	T	ALK	intronic	.	ENSG00000171094	rs34935102	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.177915	0.2081	.	.	.	.	.	.	.	.	.	.	AFR:0.2094,AMR:0.1691,EAS:0.1400,FIN:0.1163,NFE:0.2386,OTH:0.1939,ASJ:0.2384	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29448846	29448846	C	G	ALK	intronic	.	ENSG00000171094	rs11683248	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.256789	0.3521	.	.	.	.	.	.	.	.	.	.	AFR:0.3117,AMR:0.1814,EAS:0.0358,FIN:0.4512,NFE:0.3948,OTH:0.3650,ASJ:0.3907	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29449005	29449005	G	T	ALK	intronic	.	ENSG00000171094	rs1317902	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.129593	0.1288	.	.	.	.	.	.	.	.	.	.	AFR:0.1719,AMR:0.0621,EAS:0.1359,FIN:0.0960,NFE:0.1143,OTH:0.1245,ASJ:0.1457	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	MU22244224	het
2	29449345	29449348	AAAA	-	ALK	intronic	.	ENSG00000171094	rs147512176	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	.	0.4651	.	.	.	.	.	.	.	.	.	.	AFR:0.3345,AMR:0.4043,EAS:0.2934,FIN:0.3602,NFE:0.5546,OTH:0.4664,ASJ:0.4805	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	unknown
2	29449423	29449423	G	A	ALK	intronic	.	ENSG00000171094	rs6744522	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.305112	0.4403	.	.	.	.	.	.	.	.	.	.	AFR:0.2829,AMR:0.3270,EAS:0.0315,FIN:0.5762,NFE:0.5481,OTH:0.4856,ASJ:0.4597	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29449819	29449819	C	T	ALK	exonic	synonymous SNV	ENSG00000171094	rs2293563	ENSG00000171094:ENST00000389048:exon18:c.G3036A:p.T1012T	ALK:NM_004304:exon18:c.G3036A:p.T1012T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1591	0.1896	0.169928	1(stomach)	.	.	.	.	.	.	.	.	ALK:uc002rmy.3:exon18:c.G3036A:p.T1012T	.	AFR:5(soft_tissue),AMR:2(lung),EAS:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,FIN:0.1686,NFE:0.2114,OTH:0.1122,ASJ:MU584959	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,619,617,620,623,624,616,618,622,621	.	.	.	.	.	.	2	2(haematopoietic_and_lymphoid_tissue)	0.2550
2	29455267	29455267	A	G	ALK	exonic	synonymous SNV	ENSG00000171094	rs2256740	ENSG00000171094:ENST00000389048:exon15:c.T2535C:p.G845G	ALK:NM_004304:exon15:c.T2535C:p.G845G	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6121	0.6614	0.5	1(stomach)	.	.	.	.	.	.	.	.	ALK:uc002rmy.3:exon15:c.T2535C:p.G845G	.	AFR:19(soft_tissue),AMR:16(meninges),EAS:MU584960,FIN:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,NFE:0.6208,OTH:0.5538,ASJ:1(haematopoietic_and_lymphoid_tissue)	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,619,617,620,623,624,616,618,622,621	.	.	.	.	.	.	2	1(liver)	0.4880
2	29474048	29474048	G	T	ALK	exonic	nonsynonymous SNV	ENSG00000171094	rs376175333	ENSG00000171094:ENST00000389048:exon12:c.C2127A:p.N709K	ALK:NM_004304:exon12:c.C2127A:p.N709K	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 1, -1, 1, -1, 1, 1] 	0.0011	.	0.00399361	3.231e-05	2.830	21.5	0.059	4.32	0.999	.	.	.	ALK:uc002rmy.3:exon12:c.C2127A:p.N709K	-0.505	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,619,617,620,623,624,616,618,622,621	.	.	0.382	-1.19	0.364	1.975	2	.	het
2	29543663	29543663	T	C	ALK	exonic	synonymous SNV	ENSG00000171094	rs2293564	ENSG00000171094:ENST00000389048:exon7:c.A1500G:p.Q500Q	ALK:NM_004304:exon7:c.A1500G:p.Q500Q	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8716	0.7909	0.776558	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ALK:uc002rmy.3:exon7:c.A1500G:p.Q500Q	.	AFR:0.8023,AMR:0.5071,EAS:0.8808,FIN:0.9086,NFE:0.9241,OTH:0.9216,ASJ:0.8771	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,619,617,620,623,624,616,618,622,621	.	.	.	.	.	.	2	18(meninges)	0.8939
2	29543736	29543736	A	G	ALK	exonic	nonsynonymous SNV	ENSG00000171094	rs35093491	ENSG00000171094:ENST00000389048:exon7:c.T1427C:p.V476A	ALK:NM_004304:exon7:c.T1427C:p.V476A	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.0293	0.0274	0.0159744	1(breast)	-0.045	2.178	0.539	2.96	0.336	.	.	Concanavalin A-like lectin/glucanase domain	ALK:uc002rmy.3:exon7:c.T1427C:p.V476A	-0.779	AFR:1(large_intestine),AMR:.,EAS:0.0213,FIN:0.0062,NFE:0.0191,OTH:0.0662,ASJ:.	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,619,617,620,623,624,616,618,622,621	.	.	0.0	4.55	0.001	-0.69	2	27(prostate)	0.0006
2	29940529	29940529	A	T	ALK	exonic	synonymous SNV	ENSG00000171094	rs2246745	ENSG00000171094:ENST00000389048:exon2:c.T702A:p.P234P,ENSG00000171094:ENST00000431873:exon2:c.T702A:p.P234P	ALK:NM_004304:exon2:c.T702A:p.P234P	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7335	0.6270	0.589257	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ALK:uc002rmy.3:exon2:c.T702A:p.P234P	.	AFR:0.6361,AMR:0.2397,EAS:0.7881,FIN:0.7342,NFE:0.7362,OTH:0.8163,ASJ:0.7224	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,619,617,620,623,624,616,618,622,621	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.7633
2	30143499	30143499	G	C	ALK	exonic	synonymous SNV	ENSG00000171094	rs4358080	ENSG00000171094:ENST00000389048:exon1:c.C27G:p.L9L,ENSG00000171094:ENST00000431873:exon1:c.C27G:p.L9L	ALK:NM_004304:exon1:c.C27G:p.L9L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8949	0.9093	0.89377	0.8892	.	.	.	.	.	.	.	.	ALK:uc002rmy.3:exon1:c.C27G:p.L9L	.	AFR:0.8349,AMR:0.9459,EAS:1,FIN:0.8627,NFE:0.9123,OTH:0.9002,ASJ:0.8245	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,619,617,620,623,624,616,618,622,621	.	.	.	.	.	.	2	MU84195	hom
2	31133939	31133939	G	C	GALNT14	intronic	.	ENSG00000158089	rs2278079	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2249	0.2108	0.191893	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.2175,AMR:0.1433,EAS:0.1987,FIN:0.2509,NFE:0.2802,OTH:0.2443,ASJ:0.1811	608225	.	.	.	.	.	.	.	.	.	.	.	2	1(lung)	0.2260
2	31135184	31135184	G	T	GALNT14	exonic	nonsynonymous SNV	ENSG00000158089	rs2288101	ENSG00000158089:ENST00000356174:exon13:c.C1306A:p.Q436K,ENSG00000158089:ENST00000349752:exon14:c.C1405A:p.Q469K,ENSG00000158089:ENST00000324589:exon15:c.C1420A:p.Q474K,ENSG00000158089:ENST00000420311:exon15:c.C1300A:p.Q434K,ENSG00000158089:ENST00000406653:exon16:c.C1345A:p.Q449K	GALNT14:NM_001329097:exon12:c.C1176A:p.S392R,GALNT14:NM_024572:exon14:c.C1405A:p.Q469K,GALNT14:NM_001253826:exon15:c.C1420A:p.Q474K,GALNT14:NM_001329095:exon15:c.C1300A:p.Q434K,GALNT14:NM_001253827:exon16:c.C1345A:p.Q449K,GALNT14:NM_001329096:exon16:c.C1345A:p.Q449K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2262	0.2155	0.198283	MU17896558	4.520	24.3	0.398	5.04	0.999	.	.	Ricin B, lectin domain	GALNT14:uc002rnr.3:exon14:c.C1405A:p.Q469K,GALNT14:uc002rns.3:exon15:c.C1420A:p.Q474K,GALNT14:uc010ymr.2:exon15:c.C1300A:p.Q434K,GALNT14:uc002rnq.3:exon16:c.C1345A:p.Q449K	-1.122	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526,AMR:0.2228,EAS:0.1838,FIN:0.2185,NFE:0.2463,OTH:0.2845,ASJ:0.1629	608225	.	.	.	.	.	.	.	0.336	1.65	0.000	2.56	2	1(skin)	0.2430
2	31178818	31178818	C	T	GALNT14	exonic	synonymous SNV	ENSG00000158089	rs2288100	ENSG00000158089:ENST00000356174:exon4:c.G393A:p.K131K,ENSG00000158089:ENST00000430167:exon4:c.G393A:p.K131K,ENSG00000158089:ENST00000349752:exon5:c.G492A:p.K164K,ENSG00000158089:ENST00000324589:exon6:c.G507A:p.K169K,ENSG00000158089:ENST00000420311:exon6:c.G387A:p.K129K,ENSG00000158089:ENST00000406653:exon7:c.G432A:p.K144K	GALNT14:NM_001329097:exon5:c.G492A:p.K164K,GALNT14:NM_024572:exon5:c.G492A:p.K164K,GALNT14:NM_001253826:exon6:c.G507A:p.K169K,GALNT14:NM_001329095:exon6:c.G387A:p.K129K,GALNT14:NM_001253827:exon7:c.G432A:p.K144K,GALNT14:NM_001329096:exon7:c.G432A:p.K144K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1541	0.1322	0.127995	MU82738	.	.	.	.	.	.	.	.	GALNT14:uc010ezo.2:exon4:c.G393A:p.K131K,GALNT14:uc002rnr.3:exon5:c.G492A:p.K164K,GALNT14:uc002rns.3:exon6:c.G507A:p.K169K,GALNT14:uc010ymr.2:exon6:c.G387A:p.K129K,GALNT14:uc002rnq.3:exon7:c.G432A:p.K144K,GALNT14:uc010ezp.1:exon7:c.G405A:p.K135K	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.1358,EAS:0.0800,FIN:0.3013,NFE:0.1837,OTH:0.1787,ASJ:0.0640	608225	.	.	.	.	.	.	.	.	.	.	.	2	1(lung)	0.1599
2	31215799	31215799	G	A	GALNT14	exonic	synonymous SNV	ENSG00000158089	rs41280619	ENSG00000158089:ENST00000349752:exon2:c.C204T:p.R68R,ENSG00000158089:ENST00000356174:exon2:c.C204T:p.R68R,ENSG00000158089:ENST00000430167:exon2:c.C204T:p.R68R,ENSG00000158089:ENST00000420311:exon3:c.C99T:p.R33R,ENSG00000158089:ENST00000406653:exon4:c.C144T:p.R48R	GALNT14:NM_001329097:exon2:c.C204T:p.R68R,GALNT14:NM_024572:exon2:c.C204T:p.R68R,GALNT14:NM_001329095:exon3:c.C99T:p.R33R,GALNT14:NM_001253827:exon4:c.C144T:p.R48R,GALNT14:NM_001329096:exon4:c.C144T:p.R48R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0156	0.0099	0.00738818	0.0168	.	.	.	.	.	.	.	.	GALNT14:uc002rnr.3:exon2:c.C204T:p.R68R,GALNT14:uc010ezo.2:exon2:c.C204T:p.R68R,GALNT14:uc010ymr.2:exon3:c.C99T:p.R33R,GALNT14:uc002rnq.3:exon4:c.C144T:p.R48R,GALNT14:uc010ezp.1:exon4:c.C117T:p.R39R	.	AFR:0.0032,AMR:0.0072,EAS:0,FIN:0.0538,NFE:0.0182,OTH:0.0194,ASJ:0.0232	608225	.	.	.	.	.	.	.	.	.	.	.	2	MU116797342	het
2	44123759	44123759	G	A	LRPPRC	intronic	.	ENSG00000138095	rs3795859	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1599	0.0823	0.205072	LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.1099,AMR:0.0266,EAS:0.1325,FIN:0.4553,NFE:0.1376,OTH:0.1069,ASJ:0.2029	607544	220111;	70472;	70472|COX deficiency, French-Canadian type<br>Cytochrome C oxidase deficiency, French-Canadian type<br>Cytochrome oxidase deficiency, Saguenay-Lac-Saint-Jean type<br>Leigh syndrome, French-Canadian type<br>Leigh syndrome, Saguenay-Lac-Saint-Jean type<br>SLSJ-COX deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|220111 ~	.	.	.	.	.	.	.	.	2	3(haematopoietic_and_lymphoid_tissue)	0.1469
2	44175552	44175552	A	G	LRPPRC	exonic	nonsynonymous SNV	ENSG00000138095	rs374400665	ENSG00000138095:ENST00000260665:exon17:c.T1841C:p.M614T	LRPPRC:NM_133259:exon17:c.T1841C:p.M614T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 1, 0, 0] 	0.0005	.	0.00219649	.	3.451	23.0	0.085	5.6	1.000	0.0338	0.232	Tetratricopeptide-like helical domain	LRPPRC:uc010yob.1:exon16:c.T1541C:p.M514T,LRPPRC:uc002rtr.2:exon17:c.T1841C:p.M614T	-0.748	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607544	220111;	70472;	70472|COX deficiency, French-Canadian type<br>Cytochrome C oxidase deficiency, French-Canadian type<br>Cytochrome oxidase deficiency, Saguenay-Lac-Saint-Jean type<br>Leigh syndrome, French-Canadian type<br>Leigh syndrome, Saguenay-Lac-Saint-Jean type<br>SLSJ-COX deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|220111 ~	.	.	.	.	0.865	0.45	0.219	2.955	2	.	het
2	44201376	44201376	T	C	LRPPRC	exonic	synonymous SNV	ENSG00000138095	rs4953042	ENSG00000138095:ENST00000260665:exon9:c.A1068G:p.Q356Q,ENSG00000138095:ENST00000409659:exon9:c.A1068G:p.Q356Q,ENSG00000138095:ENST00000409946:exon9:c.A1068G:p.Q356Q,ENSG00000138095:ENST00000447246:exon9:c.A990G:p.Q330Q	LRPPRC:NM_133259:exon9:c.A1068G:p.Q356Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2099	0.1152	0.255791	MU733051	.	.	.	.	.	.	.	.	LRPPRC:uc010yob.1:exon8:c.A768G:p.Q256Q,LRPPRC:uc002rtr.2:exon9:c.A1068G:p.Q356Q,LRPPRC:uc010faw.1:exon9:c.A990G:p.Q330Q	.	AFR:SKCA-BR|1|100|0.01,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.1504,EAS:0.2847,FIN:0.1689,NFE:0.5044,OTH:0.1844,ASJ:0.0500	607544	220111;	70472;	70472|COX deficiency, French-Canadian type<br>Cytochrome C oxidase deficiency, French-Canadian type<br>Cytochrome oxidase deficiency, Saguenay-Lac-Saint-Jean type<br>Leigh syndrome, French-Canadian type<br>Leigh syndrome, Saguenay-Lac-Saint-Jean type<br>SLSJ-COX deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|220111 ~	.	.	.	.	.	.	.	.	2	2(haematopoietic_and_lymphoid_tissue)	0.1521
2	44209477	44209477	C	T	LRPPRC	exonic	synonymous SNV	ENSG00000138095	rs6741066	ENSG00000138095:ENST00000260665:exon2:c.G246A:p.Q82Q,ENSG00000138095:ENST00000409659:exon2:c.G246A:p.Q82Q,ENSG00000138095:ENST00000409946:exon2:c.G246A:p.Q82Q,ENSG00000138095:ENST00000447246:exon2:c.G168A:p.Q56Q	LRPPRC:NM_133259:exon2:c.G246A:p.Q82Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6240	0.7243	0.503994	2(large_intestine)	.	.	.	.	.	.	.	.	LRPPRC:uc002rtr.2:exon2:c.G246A:p.Q82Q,LRPPRC:uc010faw.1:exon2:c.G168A:p.Q56Q	.	AFR:MU108002,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,EAS:0.7029,FIN:0.5347,NFE:0.7550,OTH:0.0222,ASJ:0.6781	607544	220111;	70472;	70472|COX deficiency, French-Canadian type<br>Cytochrome C oxidase deficiency, French-Canadian type<br>Cytochrome oxidase deficiency, Saguenay-Lac-Saint-Jean type<br>Leigh syndrome, French-Canadian type<br>Leigh syndrome, Saguenay-Lac-Saint-Jean type<br>SLSJ-COX deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|220111 ~	.	.	.	.	.	.	.	.	2	1(stomach)	0.7353
2	44223008	44223008	G	C	LRPPRC	exonic	nonsynonymous SNV	ENSG00000138095	rs116727742	ENSG00000138095:ENST00000260665:exon1:c.C79G:p.L27V,ENSG00000138095:ENST00000409659:exon1:c.C79G:p.L27V,ENSG00000138095:ENST00000409946:exon1:c.C79G:p.L27V	LRPPRC:NM_133259:exon1:c.C79G:p.L27V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 1, 0, 0] 	0.0006	.	0.00139776	.	0.421	6.795	0.131	3.38	0.834	.	.	.	LRPPRC:uc002rtr.2:exon1:c.C79G:p.L27V	-1.023	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607544	220111;	70472;	70472|COX deficiency, French-Canadian type<br>Cytochrome C oxidase deficiency, French-Canadian type<br>Cytochrome oxidase deficiency, Saguenay-Lac-Saint-Jean type<br>Leigh syndrome, French-Canadian type<br>Leigh syndrome, Saguenay-Lac-Saint-Jean type<br>SLSJ-COX deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|220111 ~	.	.	.	.	0.734	0.4	0.132	2.52	2	.	het
2	46583278	46583278	-	G	EPAS1	intronic	.	ENSG00000116016	rs61586942	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3480	.	.	0.4475	.	.	.	.	.	.	.	.	.	.	AFR:0.4979,AMR:0.4742,EAS:0.7933,FIN:0.3989,NFE:0.3877,OTH:0.4149,ASJ:0.3803	603349	611783;	247511;	247511|Autosomal dominant secondary erythrocytosis|Unknown|Autosomal dominant|Infancy<br>Neonatal|609820 611783 ~	~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	2	MU113958442	unknown
2	46583279	46583279	-	T	EPAS1	intronic	.	ENSG00000116016	rs142684263	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3680	.	.	0.4466	.	.	.	.	.	.	.	.	.	.	AFR:0.4990,AMR:0.4729,EAS:0.7943,FIN:0.3948,NFE:0.3871,OTH:0.4122,ASJ:0.3761	603349	611783;	247511;	247511|Autosomal dominant secondary erythrocytosis|Unknown|Autosomal dominant|Infancy<br>Neonatal|609820 611783 ~	~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	2	.	unknown
2	46583281	46583281	-	T	EPAS1	intronic	.	ENSG00000116016	rs35508970	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.2007	.	0.707468	0.1773	.	.	.	.	.	.	.	.	.	.	AFR:0.2228,AMR:0.2924,EAS:0.0907,FIN:0.1698,NFE:0.1551,OTH:0.1682,ASJ:0.2008	603349	611783;	247511;	247511|Autosomal dominant secondary erythrocytosis|Unknown|Autosomal dominant|Infancy<br>Neonatal|609820 611783 ~	~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	2	.	unknown
2	46603671	46603671	C	G	EPAS1	intronic	.	ENSG00000116016	rs7557402	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4104	0.4291	0.3125	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	0.0217	0.11	.	.	.	AFR:0.3909,AMR:0.2780,EAS:0.47,FIN:0.1968,NFE:0.4450,OTH:0.4659,ASJ:0.2703	603349	611783;	247511;	247511|Autosomal dominant secondary erythrocytosis|Unknown|Autosomal dominant|Infancy<br>Neonatal|609820 611783 ~	~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.4539
2	47601106	47601106	T	C	EPCAM	exonic	nonsynonymous SNV	ENSG00000119888	rs1126497	ENSG00000119888:ENST00000263735:exon3:c.T344C:p.M115T,ENSG00000119888:ENST00000419334:exon3:c.T572C:p.M191T,ENSG00000119888:ENST00000405271:exon4:c.T428C:p.M143T,ENSG00000119888:ENST00000456133:exon4:c.T428C:p.M143T	EPCAM:NM_002354:exon3:c.T344C:p.M115T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5198	0.5667	0.666134	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	-0.486	0.238	1.0	1.71	0.815	.	.	Thyroglobulin type-1	EPCAM:uc002rvx.3:exon3:c.T344C:p.M115T	-0.934	AFR:0.6033,AMR:0.8316,EAS:0.3775,FIN:0.8403,NFE:0.6001,OTH:0.4616,ASJ:0.4557	185535	613217;613244;	144;92050;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~92050|Congenital familial intractable diarrhea with epithelial or epithelium abnormalities<br>IED<br>Tufting enteropathy|Unknown|Autosomal recessive|All ages|613217 ~	.	.	.	.	0.0	0.05	0.000	-1.4	2	2(prostate)	0.5545
2	47630550	47630550	C	G	MSH2	intronic	.	ENSG00000095002	rs2303426	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5047	0.4759	0.628395	0.5569	.	.	.	.	.	.	.	.	.	.	AFR:0.7546,AMR:0.4376,EAS:0.8292,FIN:0.5805,NFE:0.4201,OTH:0.5295,ASJ:0.3477	609309	120435;158320;276300;	252202;587;144;	252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~587|Multiple keratoacanthoma, Muir-Torre type|Unknown|Autosomal dominant|Adult|158320 ~144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	2	MU16913554	hom
2	47641561	47641562	AA	-	MSH2	intronic	.	ENSG00000095002	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	609309	120435;158320;276300;	252202;587;144;	252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~587|Multiple keratoacanthoma, Muir-Torre type|Unknown|Autosomal dominant|Adult|158320 ~144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	2	.	unknown
2	47693959	47693959	G	A	MSH2	intronic	.	ENSG00000095002	rs3732183	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3501	0.3787	0.483427	0.4185	.	.	.	.	.	.	.	.	.	.	AFR:0.6166,AMR:0.2950,EAS:0.6795,FIN:0.3975,NFE:0.2923,OTH:0.3961,ASJ:0.2285	609309	120435;158320;276300;	252202;587;144;	252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~587|Multiple keratoacanthoma, Muir-Torre type|Unknown|Autosomal dominant|Adult|158320 ~144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	2	MU13928740	het
2	47703500	47703500	T	C	MSH2	intronic	.	ENSG00000095002	rs2303428	.	.	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1155	0.0726	0.131989	1(stomach)	.	.	.	.	.	0.9081	0.724	.	.	.	AFR:1(lung),AMR:15(prostate),EAS:MU585006,FIN:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,NFE:0.0978,OTH:0.0271,ASJ:3(soft_tissue)	609309	120435;158320;276300;	252202;587;144;	252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~587|Multiple keratoacanthoma, Muir-Torre type|Unknown|Autosomal dominant|Adult|158320 ~144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	2	1(breast)	0.0919
2	47739551	47739551	A	G	MSH2;KCNK12	intergenic	.	ENSG00000095002	rs2303424	ENSG00000095002:ENST00000406134:exon16:c.A2744G:p.Q915R	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4579	0.4292	0.527955	0.4826	-0.939	0.021	0.0	-3.02	0.000	.	.	.	MSH2:uc002rvz.4:exon16:c.A2744G:p.Q915R	-0.971	AFR:0.6099,AMR:0.3341,EAS:0.6993,FIN:0.4986,NFE:0.3940,OTH:0.4714,ASJ:0.3154	609309	120435;158320;276300;	252202;587;144;	252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~587|Multiple keratoacanthoma, Muir-Torre type|Unknown|Autosomal dominant|Adult|158320 ~144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	.	.	.	.	0.0	-2.79	0.000	.	2	MU13928820	het
2	48030838	48030838	A	T	MSH6	intronic	.	ENSG00000116062;ENSG00000138081	rs2020911	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4043	0.3146	0.400958	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.3215,AMR:0.1746,EAS:0.37,FIN:0.6412,NFE:0.3298,OTH:0.3606,ASJ:0.4761	600678	276300;608089;614350;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	2	22(large_intestine)	0.3313
2	48033551	48033551	C	G	MSH6	intronic	.	ENSG00000116062;ENSG00000138081	rs3136367	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7426	0.7872	0.809105	MU18078954	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,AMR:0.7725,EAS:0.6214,FIN:0.7351,NFE:0.8835,OTH:0.6606,ASJ:0.9177	600678	276300;608089;614350;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	2	1(liver)	0.7160
2	58388696	58388696	A	G	FANCL	exonic	synonymous SNV	ENSG00000115392	rs848291	ENSG00000115392:ENST00000403676:exon8:c.T630C:p.S210S,ENSG00000115392:ENST00000449070:exon9:c.T804C:p.S268S,ENSG00000115392:ENST00000403295:exon11:c.T897C:p.S299S,ENSG00000115392:ENST00000233741:exon12:c.T981C:p.S327S,ENSG00000115392:ENST00000402135:exon12:c.T996C:p.S332S	FANCL:NM_001114636:exon12:c.T996C:p.S332S,FANCL:NM_018062:exon12:c.T981C:p.S327S	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.6487	0.7041	0.70647	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FANCL:uc010fcf.1:exon9:c.T804C:p.S268S,FANCL:uc010fce.3:exon11:c.T897C:p.S299S,FANCL:uc002rzw.4:exon12:c.T981C:p.S327S,FANCL:uc002rzx.4:exon12:c.T996C:p.S332S	.	AFR:0.6976,AMR:0.8947,EAS:0.5430,FIN:0.5789,NFE:0.6272,OTH:0.6195,ASJ:0.6751	608111	614083;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	,4922	.	.	.	.	.	.	2	2(haematopoietic_and_lymphoid_tissue)	0.6442
2	58453843	58453843	-	A	FANCL	intronic	.	ENSG00000115392	rs372101290	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3679	0.2509	0.259585	0.2920	.	.	.	.	.	.	.	.	.	.	AFR:0.0835,AMR:0.4194,EAS:0.3209,FIN:0.4288,NFE:0.3730,OTH:0.3878,ASJ:0.3333	608111	614083;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	2	MU112120040	het
2	60687959	60687959	A	G	BCL11A	exonic	synonymous SNV	ENSG00000119866	rs7569946	ENSG00000119866:ENST00000358510:exon3:c.T1986C:p.S662S,ENSG00000119866:ENST00000538214:exon3:c.T1986C:p.S662S,ENSG00000119866:ENST00000335712:exon4:c.T2088C:p.S696S,ENSG00000119866:ENST00000356842:exon4:c.T2088C:p.S696S,ENSG00000119866:ENST00000537768:exon6:c.T1095C:p.S365S	BCL11A:NM_001363864:exon3:c.T1986C:p.S662S,BCL11A:NM_001365609:exon3:c.T1986C:p.S662S,BCL11A:NM_018014:exon4:c.T2088C:p.S696S,BCL11A:NM_022893:exon4:c.T2088C:p.S696S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6977	0.7125	0.830072	0.7089	.	.	.	.	.	.	.	.	BCL11A:uc002sad.1:exon3:c.T1632C:p.S544S,BCL11A:uc002saf.1:exon3:c.T1986C:p.S662S,BCL11A:uc010ypj.2:exon3:c.T1986C:p.S662S,BCL11A:uc002sab.3:exon4:c.T2088C:p.S696S,BCL11A:uc002sae.1:exon4:c.T2088C:p.S696S,BCL11A:uc010ypi.2:exon6:c.T1095C:p.S365S	.	AFR:0.9088,AMR:0.8118,EAS:0.9994,FIN:0.5992,NFE:0.5886,OTH:0.6311,ASJ:0.5530	606557	617101;	.	.	.	.	.	.	.	.	.	.	2	MU68453	hom
2	74080159	74080159	T	C	STAMBP	intronic	.	ENSG00000124356	rs6722659	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.466254	0.4312	.	.	.	.	.	.	.	.	.	.	AFR:0.7235,AMR:0.3409,EAS:0.3953,FIN:0.2668,NFE:0.3157,OTH:0.3327,ASJ:0.4007	606247	614261;	294016;	294016|MIC-CAP syndrome<br>MIC-CM syndrome<br>Microcephaly-cutaneous capillary malformation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614261 ~	.	.	.	.	.	.	.	.	2	MU116790481	het
2	74087298	74087298	A	G	STAMBP	intronic	.	ENSG00000124356	rs2303987	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0884	0.0833	0.159545	0.0871	.	.	.	.	.	.	.	.	.	.	AFR:0.1737,AMR:0.0346,EAS:0.3043,FIN:0.0280,NFE:0.0322,OTH:0.0550,ASJ:0.0861	606247	614261;	294016;	294016|MIC-CAP syndrome<br>MIC-CM syndrome<br>Microcephaly-cutaneous capillary malformation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614261 ~	.	.	.	.	.	.	.	.	2	MU81734246	het
2	74128433	74128433	C	T	ACTG2	UTR5	.	ENSG00000163017	rs1050146	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7697	0.7628	0.707867	0.7708	.	.	.	.	.	.	.	.	.	.	AFR:0.7010,AMR:0.8795,EAS:0.5767,FIN:0.8539,NFE:0.8053,OTH:0.8014,ASJ:0.7517	102545	155310;	2604;	2604|Familial hollow visceral myopathy<br>Hereditary hollow visceral myopathy<br>Megaduodenum and/or megacystis|Unknown|Autosomal dominant|All ages|155310 ~	.	.	.	.	.	.	.	.	2	MU753936	het
2	74605119	74605119	G	A	DCTN1	intronic	.	ENSG00000204843	rs376401397	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, 0, 1, 0] 	0.0002	7.7e-05	.	0.0013	.	.	.	.	.	0	0	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0.0017,NFE:0.0021,OTH:0.0031,ASJ:0	601143	105400;168605;607641;	139589;178509;803;	139589|Distal spinal muscular atrophy with vocal cord paralysis<br>dHMN7|-|Autosomal dominant|Childhood<br>Adolescent<br>Adult|158580 607641 ~178509|Parkinsonism with alveolar hypoventilation and mental depression|<1 / 1 000 000|Autosomal dominant|Adult|168605 ~803|ALS<br>Charcot disease<br>Lou Gehrig disease|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Adult|105400 205250 300857 606070 606640 608030 608031 608627 611895 612069 612577 613435 613954 614696 614808 615426 615515 616208 616437 ~	.	.	.	.	.	.	.	.	2	.	het
2	85622059	85622059	T	C	CAPG	exonic	nonsynonymous SNV	ENSG00000042493	rs6886	ENSG00000042493:ENST00000453973:exon4:c.A269G:p.H90R,ENSG00000042493:ENST00000263867:exon10:c.A1004G:p.H335R,ENSG00000042493:ENST00000409670:exon10:c.A1004G:p.H335R,ENSG00000042493:ENST00000409724:exon10:c.A1004G:p.H335R,ENSG00000042493:ENST00000409921:exon10:c.A959G:p.H320R	CAPG:NM_001320734:exon9:c.A911G:p.H304R,CAPG:NM_001256139:exon10:c.A1004G:p.H335R,CAPG:NM_001256140:exon10:c.A959G:p.H320R,CAPG:NM_001320732:exon10:c.A1004G:p.H335R,CAPG:NM_001320733:exon10:c.A1004G:p.H335R,CAPG:NM_001747:exon10:c.A1004G:p.H335R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5882	0.6744	0.585064	0.6479	1.450	13.05	0.477	3.9	0.995	.	.	ADF-H/Gelsolin-like domain|Gelsolin-like domain	CAPG:uc002spl.2:exon10:c.A1004G:p.H335R,CAPG:uc002spm.2:exon10:c.A959G:p.H320R,CAPG:uc010fgi.2:exon10:c.A1004G:p.H335R	-1.007	AFR:0.7341,AMR:0.4057,EAS:0.4653,FIN:0.6216,NFE:0.6419,OTH:0.6076,ASJ:0.5397	153615	.	.	.	.	.	.	.	0.0	0.64	0.000	-0.045	2	MU805017	het
2	88913273	88913273	G	C	EIF2AK3	exonic	nonsynonymous SNV	ENSG00000172071	rs867529	ENSG00000172071:ENST00000303236:exon2:c.C407G:p.S136C	EIF2AK3:NM_004836:exon2:c.C407G:p.S136C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2983	0.1984	0.280551	LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	2.316	18.27	0.134	5.38	0.950	.	.	Quinoprotein alcohol dehydrogenase-like superfamily	EIF2AK3:uc002stc.4:exon2:c.C407G:p.S136C	-0.898	AFR:0.2313,AMR:0.0559,EAS:0.2167,FIN:0.4832,NFE:0.3419,OTH:0.2732,ASJ:0.2950	604032	226980;	1667;	1667|Early-onset diabetes mellitus with multiple epiphyseal dysplasia<br>WRS|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226980 ~	.	.	.	.	0.002	1.51	0.000	1.295	2	4(lung)	0.2949
2	88926730	88926732	CAG	-	EIF2AK3	exonic	nonframeshift deletion	ENSG00000172071	rs72416210	ENSG00000172071:ENST00000303236:exon1:c.61_63del:p.21_21del	EIF2AK3:NM_004836:exon1:c.61_63del:p.21_21del	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.6612	.	0.796526	0.7771	.	.	.	.	.	.	.	.	EIF2AK3:uc002stc.4:exon1:c.61_63del:p.21_21del	.	AFR:0.8697,AMR:0.8137,EAS:0.8371,FIN:0.7781,NFE:0.7198,OTH:0.7446,ASJ:0.6162	604032	226980;	1667;	1667|Early-onset diabetes mellitus with multiple epiphyseal dysplasia<br>WRS|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226980 ~	.	.	.	.	.	.	.	.	2	.	hom
2	100019496	100019496	A	G	REV1	exonic	synonymous SNV	ENSG00000135945	rs2305354	ENSG00000135945:ENST00000258428:exon20:c.T3240C:p.I1080I,ENSG00000135945:ENST00000393445:exon20:c.T3237C:p.I1079I	REV1:NM_001037872:exon20:c.T3237C:p.I1079I,REV1:NM_016316:exon20:c.T3240C:p.I1080I,REV1:NM_001321454:exon21:c.T3348C:p.I1116I,REV1:NM_001321455:exon21:c.T3027C:p.I1009I,REV1:NM_001321458:exon21:c.T1770C:p.I590I,REV1:NM_001321459:exon21:c.T1671C:p.I557I,REV1:NM_001321460:exon21:c.T1671C:p.I557I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5797	0.6132	0.588658	1(breast)	.	.	.	.	.	.	.	.	REV1:uc002tac.3:exon20:c.T3237C:p.I1079I,REV1:uc002tad.3:exon20:c.T3240C:p.I1080I	.	AFR:MU13237564,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,EAS:0.7456,FIN:0.6885,NFE:0.5066,OTH:0.3393,ASJ:0.6129	606134	.	.	.	.	.	.	.	.	.	.	.	2	1(stomach)	0.6567
2	100022772	100022772	T	C	REV1	intronic	.	ENSG00000135945	rs717454	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4276	0.4140	0.396366	MU13237569	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.4061,EAS:0.6196,FIN:0.4437,NFE:0.3045,OTH:0.4470,ASJ:0.4033	606134	.	.	.	.	.	.	.	.	.	.	.	2	1(lung)	0.3961
2	100035298	100035298	T	C	REV1	exonic	nonsynonymous SNV	ENSG00000135945	rs753197177	ENSG00000135945:ENST00000258428:exon12:c.A1943G:p.N648S,ENSG00000135945:ENST00000393445:exon12:c.A1940G:p.N647S	REV1:NM_001037872:exon12:c.A1940G:p.N647S,REV1:NM_016316:exon12:c.A1943G:p.N648S,REV1:NM_001321454:exon13:c.A2051G:p.N684S,REV1:NM_001321455:exon13:c.A1730G:p.N577S,REV1:NM_001321458:exon13:c.A473G:p.N158S,REV1:NM_001321459:exon13:c.A374G:p.N125S,REV1:NM_001321460:exon13:c.A374G:p.N125S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	2.476e-05	.	.	.	0.449	7.025	0.501	3.33	0.984	.	.	UmuC domain	REV1:uc002tac.3:exon12:c.A1940G:p.N647S,REV1:uc002tad.3:exon12:c.A1943G:p.N648S	-1.034	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606134	.	.	.	.	.	.	.	0.008	-0.42	0.113	-0.455	2	.	het
2	100055158	100055158	T	C	REV1	exonic	nonsynonymous SNV	ENSG00000135945	rs3087399	ENSG00000135945:ENST00000450415:exon1:c.A32G:p.N11S,ENSG00000135945:ENST00000258428:exon6:c.A1118G:p.N373S,ENSG00000135945:ENST00000393445:exon6:c.A1118G:p.N373S	REV1:NM_001037872:exon6:c.A1118G:p.N373S,REV1:NM_001321454:exon6:c.A1118G:p.N373S,REV1:NM_016316:exon6:c.A1118G:p.N373S,REV1:NM_001321455:exon7:c.A908G:p.N303S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1384	0.1655	0.167931	0.1742	0.043	3.016	0.194	-0.648	0.997	.	.	.	REV1:uc002tae.1:exon4:c.A1055G:p.N352S,REV1:uc002tac.3:exon6:c.A1118G:p.N373S,REV1:uc002tad.3:exon6:c.A1118G:p.N373S	-0.984	AFR:0.2740,AMR:0.0525,EAS:0.0314,FIN:0.1968,NFE:0.1352,OTH:0.1796,ASJ:0.0530	606134	.	.	.	.	.	.	.	0.069	1.55	0.000	2.395	2	MU135349	het
2	100055506	100055506	A	G	REV1	exonic	nonsynonymous SNV	ENSG00000135945	rs3087386	ENSG00000135945:ENST00000258428:exon6:c.T770C:p.F257S,ENSG00000135945:ENST00000393445:exon6:c.T770C:p.F257S	REV1:NM_001037872:exon6:c.T770C:p.F257S,REV1:NM_001321454:exon6:c.T770C:p.F257S,REV1:NM_016316:exon6:c.T770C:p.F257S,REV1:NM_001321455:exon7:c.T560C:p.F187S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5755	0.6015	0.580272	1(stomach)	-1.561	0.002	0.465	-0.027	0.333	.	.	.	REV1:uc002tae.1:exon4:c.T707C:p.F236S,REV1:uc002tac.3:exon6:c.T770C:p.F257S,REV1:uc002tad.3:exon6:c.T770C:p.F257S	-0.979	AFR:1(breast),AMR:3(haematopoietic_and_lymphoid_tissue),EAS:MU754754,FIN:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02,NFE:0.6019,OTH:0.7121,ASJ:1(oesophagus)	606134	.	.	.	.	.	.	.	0.0	1.8	0.000	-2.045	2	1(thyroid)	0.6874
2	100096371	100096371	T	C	REV1	intronic	.	ENSG00000135945	rs13430962	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.167133	0.1756	.	.	.	.	.	.	.	.	.	.	AFR:0.2769,AMR:0.0526,EAS:0.0335,FIN:0.1976,NFE:0.1358,OTH:0.1816,ASJ:0.0533	606134	.	.	.	.	.	.	.	.	.	.	.	2	.	het
2	100210074	100210074	G	C	AFF3	exonic	synonymous SNV	ENSG00000144218	rs1047281	ENSG00000144218:ENST00000409236:exon13:c.C2049G:p.S683S,ENSG00000144218:ENST00000317233:exon14:c.C2049G:p.S683S,ENSG00000144218:ENST00000356421:exon14:c.C2124G:p.S708S,ENSG00000144218:ENST00000409579:exon15:c.C2124G:p.S708S	AFF3:NM_001025108:exon14:c.C2124G:p.S708S,AFF3:NM_002285:exon14:c.C2049G:p.S683S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1851	0.1708	0.146765	1(thyroid)	.	.	.	.	.	.	.	.	AFF3:uc010fiq.1:exon13:c.C2049G:p.S683S,AFF3:uc002taf.3:exon14:c.C2124G:p.S708S,AFF3:uc002tag.3:exon14:c.C2049G:p.S683S,AFF3:uc002tah.1:exon15:c.C2124G:p.S708S,AFF3:uc010yvr.1:exon15:c.C2508G:p.S836S	.	AFR:MU4549462,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.1105,FIN:0.1184,NFE:0.2318,OTH:0.0996,ASJ:0.1689	601464	.	.	.	.	.	.	.	.	.	.	.	2	2(lung)	0.1883
2	100210642	100210642	T	C	AFF3	exonic	nonsynonymous SNV	ENSG00000144218	rs1047265	ENSG00000144218:ENST00000409236:exon13:c.A1481G:p.N494S,ENSG00000144218:ENST00000317233:exon14:c.A1481G:p.N494S,ENSG00000144218:ENST00000356421:exon14:c.A1556G:p.N519S,ENSG00000144218:ENST00000409579:exon15:c.A1556G:p.N519S	AFF3:NM_001025108:exon14:c.A1556G:p.N519S,AFF3:NM_002285:exon14:c.A1481G:p.N494S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1833	0.1734	0.147764	MU156907	-2.861	0.001	0.469	-11.7	0.989	.	.	.	AFF3:uc010fiq.1:exon13:c.A1481G:p.N494S,AFF3:uc002taf.3:exon14:c.A1556G:p.N519S,AFF3:uc002tag.3:exon14:c.A1481G:p.N494S,AFF3:uc002tah.1:exon15:c.A1556G:p.N519S,AFF3:uc010yvr.1:exon15:c.A1940G:p.N647S	-1.143	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.1688,EAS:0.1175,FIN:0.2318,NFE:0.0999,OTH:0.1876,ASJ:0.1106	601464	.	.	.	.	.	.	.	0.001	-0.01	0.000	-1.23	2	9(soft_tissue)	0.2059
2	100218080	100218080	G	A	AFF3	exonic	synonymous SNV	ENSG00000144218	rs4851214	ENSG00000144218:ENST00000409236:exon12:c.C1188T:p.A396A,ENSG00000144218:ENST00000317233:exon13:c.C1188T:p.A396A,ENSG00000144218:ENST00000356421:exon13:c.C1263T:p.A421A,ENSG00000144218:ENST00000409579:exon14:c.C1263T:p.A421A	AFF3:NM_001025108:exon13:c.C1263T:p.A421A,AFF3:NM_002285:exon13:c.C1188T:p.A396A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3073	0.1981	0.239816	1(urinary_tract)	.	.	.	.	.	.	.	.	AFF3:uc010fiq.1:exon12:c.C1188T:p.A396A,AFF3:uc002taf.3:exon13:c.C1263T:p.A421A,AFF3:uc002tag.3:exon13:c.C1188T:p.A396A,AFF3:uc002tah.1:exon14:c.C1263T:p.A421A,AFF3:uc010yvr.1:exon14:c.C1647T:p.A549A	.	AFR:4(lung),AMR:MU71617,EAS:0.2102,FIN:0.0550,NFE:0.2440,OTH:0.2252,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|5|170|0.0294118,COCA-CN|3|321|0.00934579	601464	.	.	.	.	.	.	.	.	.	.	.	2	2(large_intestine)	0.3587
2	100343557	100343557	C	T	AFF3	exonic	nonsynonymous SNV	ENSG00000144218	rs4851223	ENSG00000144218:ENST00000409236:exon9:c.G1073A:p.S358N,ENSG00000144218:ENST00000317233:exon10:c.G1073A:p.S358N,ENSG00000144218:ENST00000356421:exon10:c.G1148A:p.S383N,ENSG00000144218:ENST00000409579:exon11:c.G1148A:p.S383N	AFF3:NM_001025108:exon10:c.G1148A:p.S383N,AFF3:NM_002285:exon10:c.G1073A:p.S358N	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	AFF3:uc010fiq.1:exon9:c.G1073A:p.S358N,AFF3:uc002taf.3:exon10:c.G1148A:p.S383N,AFF3:uc002tag.3:exon10:c.G1073A:p.S358N,AFF3:uc002tah.1:exon11:c.G1148A:p.S383N,AFF3:uc010fir.1:exon11:c.G1304A:p.S435N,AFF3:uc010yvr.1:exon11:c.G1535A:p.S512N	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	601464	.	.	.	.	.	.	.	.	.	.	.	2	MU81737770	hom
2	109347947	109347947	T	G	RANBP2	intronic	.	ENSG00000153201	rs826526	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2698	0.3914	0.382987	LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	.	.	AFR:0.3568,AMR:0.7089,EAS:0.2947,FIN:0.0532,NFE:0.1984,OTH:0.2391,ASJ:0.1683	601181	608033;	88619;	88619|ADANE<br>Recurrent acute necrotizing encephalopathy|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|608033 ~	.	.	.	.	.	.	.	.	2	1(lung)	0.2730
2	109356978	109356978	G	C	RANBP2	exonic	nonsynonymous SNV	ENSG00000153201	rs76352345	ENSG00000153201:ENST00000283195:exon7:c.G816C:p.L272F	RANBP2:NM_006267:exon7:c.G816C:p.L272F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 1, 0] 	0.0220	0.0079	0.0319489	0.0144	2.081	16.73	0.169	0.924	0.887	.	.	Tetratricopeptide-like helical domain	RANBP2:uc002tem.4:exon7:c.G816C:p.L272F	-1.041	AFR:0.0024,AMR:0.0107,EAS:0.0253,FIN:0.0432,NFE:0.0127,OTH:0.0316,ASJ:0.0066	601181	608033;	88619;	88619|ADANE<br>Recurrent acute necrotizing encephalopathy|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|608033 ~	.	.	.	.	0.026	1.36	0.015	0.69	2	.	het
2	109367977	109367977	A	G	RANBP2	intronic	.	ENSG00000153201	rs144029181	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1587	.	0.146366	LUSC-KR|2|170|0.0117647,GACA-CN|1|123|0.00813008	.	.	.	.	.	0.0001	0.024	.	.	.	AFR:0.1600,AMR:0.1523,EAS:0.2114,FIN:0.0272,NFE:0.1744,OTH:0.1763,ASJ:0.1029	601181	608033;	88619;	88619|ADANE<br>Recurrent acute necrotizing encephalopathy|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|608033 ~	.	.	.	.	.	.	.	.	2	1(skin)	0.1825
2	109374952	109374952	A	G	RANBP2	exonic	synonymous SNV	ENSG00000153201	rs826549	ENSG00000153201:ENST00000283195:exon18:c.A2550G:p.S850S	RANBP2:NM_006267:exon18:c.A2550G:p.S850S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2604	0.3083	.	MU585172	.	.	.	.	.	.	.	.	RANBP2:uc002tem.4:exon18:c.A2550G:p.S850S	.	AFR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,AMR:0.3427,EAS:0.1541,FIN:0.2857,NFE:0.0354,OTH:0.1939,ASJ:0.6873	601181	608033;	88619;	88619|ADANE<br>Recurrent acute necrotizing encephalopathy|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|608033 ~	.	.	.	.	.	.	.	.	2	1(lung)	0.2293
2	109389463	109389463	G	A	RANBP2	exonic	synonymous SNV	ENSG00000153201	rs826580	ENSG00000153201:ENST00000283195:exon23:c.G8253A:p.E2751E	RANBP2:NM_006267:exon23:c.G8253A:p.E2751E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9959	0.9842	0.98722	0.9884	.	.	.	.	.	.	.	.	RANBP2:uc002tem.4:exon23:c.G8253A:p.E2751E	.	AFR:0.9595,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:1	601181	608033;	88619;	88619|ADANE<br>Recurrent acute necrotizing encephalopathy|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|608033 ~	.	.	.	.	.	.	.	.	2	MU81738486	hom
2	112686988	112686988	G	A	MERTK	exonic	nonsynonymous SNV	ENSG00000153208	rs13027171	ENSG00000153208:ENST00000295408:exon2:c.G353A:p.S118N,ENSG00000153208:ENST00000421804:exon2:c.G353A:p.S118N	MERTK:NM_006343:exon2:c.G353A:p.S118N	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2313	0.2219	0.168131	MU13261932	-1.221	0.006	0.714	-3.98	0.569	.	.	Immunoglobulin|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	MERTK:uc002thk.1:exon2:c.G353A:p.S118N	-1.025	AFR:COCA-CN|1|321|0.00311526,AMR:0.1977,EAS:0.1791,FIN:0.3212,NFE:0.1420,OTH:0.2009,ASJ:0.0645	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	0.001	-0.34	0.000	0.495	2	1(urinary_tract)	0.2780
2	112702647	112702647	C	T	MERTK	intronic	.	ENSG00000153208	rs11683694	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2395	0.2487	0.190695	0.2196	.	.	.	.	.	.	.	.	.	.	AFR:0.1381,AMR:0.1885,EAS:0.1418,FIN:0.2022,NFE:0.2795,OTH:0.2133,ASJ:0.3278	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	2	MU755137	hom
2	112705157	112705157	T	C	MERTK	intronic	.	ENSG00000153208	rs3761701	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5845	0.5847	0.514776	1(bone)	.	.	.	.	.	.	.	.	.	.	AFR:MU13261954,AMR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,GACA-CN|1|123|0.00813008,COCA-CN|2|321|0.00623053,EAS:0.5057,FIN:0.6244,NFE:0.6887,OTH:0.2478,ASJ:0.5774	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	2	1(stomach)	0.6613
2	112751928	112751928	G	A	MERTK	exonic	nonsynonymous SNV	ENSG00000153208	rs7604639	ENSG00000153208:ENST00000409780:exon8:c.G869A:p.R290K,ENSG00000153208:ENST00000295408:exon9:c.G1397A:p.R466K,ENSG00000153208:ENST00000421804:exon9:c.G1397A:p.R466K	MERTK:NM_006343:exon9:c.G1397A:p.R466K	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5972	0.6340	0.561502	73(lung)	-1.256	0.005	1.0	-3.17	0.328	.	.	Fibronectin type III|Immunoglobulin-like fold	MERTK:uc002thk.1:exon9:c.G1397A:p.R466K,MERTK:uc002thl.1:exon9:c.G869A:p.R290K	-0.967	AFR:MU755143,AMR:LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.6596,FIN:0.6340,NFE:0.6887,OTH:0.2466,ASJ:0.6217	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	0.0	0.65	0.000	-1.685	2	5(haematopoietic_and_lymphoid_tissue)	0.6623
2	112754880	112754880	G	A	MERTK	intronic	.	ENSG00000153208	rs3811633	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2384	0.2495	0.190096	MU755152	.	.	.	.	.	.	.	.	.	.	AFR:COCA-CN|2|321|0.00623053,AMR:0.2197,EAS:0.1874,FIN:0.3278,NFE:0.1409,OTH:0.2021,ASJ:0.1392	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.2791
2	112754943	112754943	C	T	MERTK	exonic	synonymous SNV	ENSG00000153208	rs3811634	ENSG00000153208:ENST00000409780:exon9:c.C966T:p.N322N,ENSG00000153208:ENST00000295408:exon10:c.C1494T:p.N498N,ENSG00000153208:ENST00000421804:exon10:c.C1494T:p.N498N	MERTK:NM_006343:exon10:c.C1494T:p.N498N	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2385	0.2497	0.190495	0.2198	1.865	15.37	.	1.35	0.913	.	.	.	MERTK:uc002thk.1:exon10:c.C1494T:p.N498N,MERTK:uc002thl.1:exon10:c.C966T:p.N322N	-1.042	AFR:0.1394,AMR:0.1878,EAS:0.1413,FIN:0.2022,NFE:0.2791,OTH:0.2153,ASJ:0.3278	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	0.000	.	2	MU755155	hom
2	112755001	112755001	A	G	MERTK	exonic	nonsynonymous SNV	ENSG00000153208	rs2230515	ENSG00000153208:ENST00000409780:exon9:c.A1024G:p.I342V,ENSG00000153208:ENST00000295408:exon10:c.A1552G:p.I518V,ENSG00000153208:ENST00000421804:exon10:c.A1552G:p.I518V	MERTK:NM_006343:exon10:c.A1552G:p.I518V	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5973	0.6339	0.561502	73(lung)	-1.806	0.002	0.795	-2.03	0.431	.	.	.	MERTK:uc002thk.1:exon10:c.A1552G:p.I518V,MERTK:uc002thl.1:exon10:c.A1024G:p.I342V	-0.960	AFR:1(large_intestine),AMR:MU755158,EAS:0.6218,FIN:0.6603,NFE:0.6340,OTH:0.6887,ASJ:LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	0.001	-0.81	0.000	-0.085	2	4(haematopoietic_and_lymphoid_tissue)	0.2469
2	112765973	112765973	A	G	MERTK	exonic	synonymous SNV	ENSG00000153208	rs1131244	ENSG00000153208:ENST00000409780:exon13:c.A1353G:p.S451S,ENSG00000153208:ENST00000295408:exon14:c.A1881G:p.S627S,ENSG00000153208:ENST00000421804:exon14:c.A1881G:p.S627S	MERTK:NM_006343:exon14:c.A1881G:p.S627S	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5825	0.5878	0.515176	LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	MERTK:uc002thk.1:exon14:c.A1881G:p.S627S,MERTK:uc002thl.1:exon14:c.A1353G:p.S451S	.	AFR:0.5805,AMR:0.5181,EAS:0.6887,FIN:0.2469,NFE:0.6615,OTH:0.6273,ASJ:0.6223	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	2	2(lung)	0.6090
2	121554896	121554896	G	C	GLI2	UTR5	.	ENSG00000074047	rs369138377	.	.	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, 0, 1, 0] 	0.0046	7.7e-05	0.0081869	9.697e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0031,ASJ:0	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	2	.	het
2	121713022	121713022	C	G	GLI2	intronic	.	ENSG00000074047	rs6718382	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9999	.	1	1.0000	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	2	MU81739801	hom
2	121726447	121726447	G	A	GLI2	exonic	synonymous SNV	ENSG00000074047	rs2592595	ENSG00000074047:ENST00000360874:exon3:c.G388A:p.G130S	GLI2:NM_001371271:exon6:c.G801A:p.S267S,GLI2:NM_005270:exon6:c.G801A:p.S267S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9401	0.8092	0.827276	0.8415	0.628	8.346	0.994	-9.82	0.535	.	.	.	GLI2:uc002tmv.1:exon3:c.G412A:p.G138S	-0.987	AFR:0.4716,AMR:0.9582,EAS:0.9988,FIN:0.9954,NFE:0.9864,OTH:0.9633,ASJ:0.9570	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	0.006	.	0.000	.	2	MU81739854	hom
2	121746508	121746508	C	T	GLI2	exonic	synonymous SNV	ENSG00000074047	rs373880077	ENSG00000074047:ENST00000314490:exon13:c.C2034T:p.G678G,ENSG00000074047:ENST00000361492:exon13:c.C3018T:p.G1006G,ENSG00000074047:ENST00000452319:exon14:c.C3018T:p.G1006G	GLI2:NM_001371271:exon14:c.C3018T:p.G1006G,GLI2:NM_005270:exon14:c.C3018T:p.G1006G	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0098	0.0004	0.00379393	0.0018	.	.	.	.	.	.	.	.	GLI2:uc002tmq.1:exon10:c.C2034T:p.G678G,GLI2:uc002tmr.1:exon10:c.C1983T:p.G661G,GLI2:uc002tmt.4:exon10:c.C2034T:p.G678G,GLI2:uc002tmu.4:exon10:c.C1983T:p.G661G,GLI2:uc010flp.3:exon13:c.C3018T:p.G1006G	.	AFR:0.0007,AMR:0.0065,EAS:0,FIN:0,NFE:0.0028,OTH:0.0021,ASJ:0	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	2	.	het
2	121746956	121746956	G	T	GLI2	exonic	nonsynonymous SNV	ENSG00000074047	rs3738880	ENSG00000074047:ENST00000361492:exon13:c.G3466T:p.A1156S,ENSG00000074047:ENST00000452319:exon14:c.G3466T:p.A1156S	GLI2:NM_001371271:exon14:c.G3466T:p.A1156S,GLI2:NM_005270:exon14:c.G3466T:p.A1156S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6296	0.6234	0.508986	0.6086	-0.059	2.058	0.515	0.039	0.049	.	.	.	GLI2:uc002tmt.4:exon10:c.G2482T:p.A828S,GLI2:uc002tmu.4:exon10:c.G2431T:p.A811S,GLI2:uc010flp.3:exon13:c.G3466T:p.A1156S	-1.041	AFR:0.4041,AMR:0.5730,EAS:0.4901,FIN:0.6738,NFE:0.7230,OTH:0.6582,ASJ:0.6589	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	0.156	2.53	0.000	1.65	2	MU22958533	het
2	121747406	121747406	G	A	GLI2	exonic	nonsynonymous SNV	ENSG00000074047	rs12711538	ENSG00000074047:ENST00000361492:exon13:c.G3916A:p.D1306N,ENSG00000074047:ENST00000452319:exon14:c.G3916A:p.D1306N	GLI2:NM_001371271:exon14:c.G3916A:p.D1306N,GLI2:NM_005270:exon14:c.G3916A:p.D1306N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6464	0.6769	0.567093	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	-0.401	0.385	1.0	2.13	0.005	.	.	.	GLI2:uc002tmt.4:exon10:c.G2932A:p.D978N,GLI2:uc002tmu.4:exon10:c.G2881A:p.D961N,GLI2:uc010flp.3:exon13:c.G3916A:p.D1306N	-1.028	AFR:0.6592,AMR:0.5805,EAS:0.6623,FIN:0.4870,NFE:0.6745,OTH:0.7234,ASJ:0.5883	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	0.0	2.6	0.000	-1.545	2	1(large_intestine)	0.6701
2	121747429	121747429	A	G	GLI2	exonic	synonymous SNV	ENSG00000074047	rs10167980	ENSG00000074047:ENST00000361492:exon13:c.A3939G:p.P1313P,ENSG00000074047:ENST00000452319:exon14:c.A3939G:p.P1313P	GLI2:NM_001371271:exon14:c.A3939G:p.P1313P,GLI2:NM_005270:exon14:c.A3939G:p.P1313P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6344	0.6241	0.51238	0.6130	.	.	.	.	.	.	.	.	GLI2:uc002tmt.4:exon10:c.A2955G:p.P985P,GLI2:uc002tmu.4:exon10:c.A2904G:p.P968P,GLI2:uc010flp.3:exon13:c.A3939G:p.P1313P	.	AFR:0.4068,AMR:0.5728,EAS:0.4981,FIN:0.6808,NFE:0.7277,OTH:0.6615,ASJ:0.6623	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	2	MU634692	het
2	127815193	127815193	G	A	BIN1	intronic	.	ENSG00000136717	rs547659375	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, 0, 0, 0] 	0.0047	.	0.00319489	6.48e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0.0006,FIN:0,NFE:6.687e-05,OTH:0,ASJ:0	601248	255200;	169186;	169186|AR-CNM|Unknown|Autosomal recessive|Childhood|255200 615959 ~	.	.	.	.	.	.	.	.	2	.	het
2	127816743	127816743	G	T	BIN1	intronic	.	ENSG00000136717	rs6720741	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2230	0.1979	0.1873	0.2054	.	.	.	.	.	0.0014	0.098	.	.	.	AFR:0.2486,AMR:0.1112,EAS:0.1252,FIN:0.2131,NFE:0.1931,OTH:0.2124,ASJ:0.1477	601248	255200;	169186;	169186|AR-CNM|Unknown|Autosomal recessive|Childhood|255200 615959 ~	.	.	.	.	.	.	.	.	2	MU114042904	het
2	136874237	136874237	C	T	CXCR4	exonic	nonsynonymous SNV	ENSG00000121966	rs117273229	.	CXCR4:NM_001348056:exon2:c.G37A:p.V13I,CXCR4:NM_001348059:exon2:c.G37A:p.V13I	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	.	.	0.0329473	0.0062	.	.	.	.	.	.	.	.	.	.	AFR:0.0018,AMR:0.1002,EAS:0.0309,FIN:0,NFE:0.0021,OTH:0.0112,ASJ:0	162643	193670;	51636;	51636|WILM<br>Warts-hypogammaglobulinemia-infections-myelokathexis syndrome<br>Warts-infections-leukopenia-myelokatexis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|193670 ~	~ko04020 Calcium signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04061 Viral protein interaction with cytokine and cytokine~~ko04062 Chemokine signaling pathway~ko04144 Endocytosis~ko04360 Axon guidance~ko04670 Leukocyte transendothelial migration~ko04672 Intestinal immune network for IgA production~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer ~	,2168	.	.	.	.	.	.	2	MU114036139	hom
2	140992337	140992337	C	A	LRP1B	intronic	.	ENSG00000168702	rs13387241	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5495	0.5303	0.467452	0.5345	.	.	.	.	.	.	.	.	.	.	AFR:0.3965,AMR:0.4940,EAS:0.5443,FIN:0.6355,NFE:0.5916,OTH:0.5849,ASJ:0.4106	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU735230	het
2	141032088	141032088	C	T	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs1386356	ENSG00000168702:ENST00000389484:exon85:c.G13047A:p.T4349T	LRP1B:NM_018557:exon85:c.G13047A:p.T4349T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6037	0.5320	0.486222	0.5412	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon85:c.G13047A:p.T4349T	.	AFR:0.2389,AMR:0.5469,EAS:0.7081,FIN:0.6794,NFE:0.6628,OTH:0.6222,ASJ:0.4967	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU26066624	hom
2	141259283	141259283	G	A	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs35296183	ENSG00000168702:ENST00000389484:exon55:c.C8823T:p.D2941D	LRP1B:NM_018557:exon55:c.C8823T:p.D2941D	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.1741	0.1715	0.104433	0.1568	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon55:c.C8823T:p.D2941D	.	AFR:0.0628,AMR:0.1358,EAS:0.0130,FIN:0.1996,NFE:0.2148,OTH:0.2049,ASJ:0.1788	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU115423	het
2	141259376	141259376	G	A	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs35164907	ENSG00000168702:ENST00000389484:exon55:c.C8730T:p.C2910C	LRP1B:NM_018557:exon55:c.C8730T:p.C2910C	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.2154	0.2067	0.126198	0.2063	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon55:c.C8730T:p.C2910C	.	AFR:0.0852,AMR:0.1583,EAS:0.0136,FIN:0.2952,NFE:0.2750,OTH:0.2740,ASJ:0.2252	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU115441	het
2	141260668	141260668	A	G	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs4444457	ENSG00000168702:ENST00000389484:exon54:c.T8526C:p.Y2842Y	LRP1B:NM_018557:exon54:c.T8526C:p.Y2842Y	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.5490	0.5328	0.543131	0.5463	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon54:c.T8526C:p.Y2842Y	.	AFR:0.4917,AMR:0.4580,EAS:0.7593,FIN:0.5842,NFE:0.5528,OTH:0.5647,ASJ:0.4040	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU115465	hom
2	141274576	141274576	T	C	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs4954672	ENSG00000168702:ENST00000389484:exon50:c.A8031G:p.Q2677Q	LRP1B:NM_018557:exon50:c.A8031G:p.Q2677Q	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.7150	0.7467	0.642372	0.7137	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon50:c.A8031G:p.Q2677Q	.	AFR:0.6961,AMR:0.7542,EAS:0.3999,FIN:0.6857,NFE:0.7578,OTH:0.7296,ASJ:0.8543	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU800510	het
2	141298674	141298674	T	C	LRP1B	intronic	.	ENSG00000168702	rs13013854	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3911	0.3490	0.329473	0.3494	.	.	.	.	.	0	0	.	.	.	AFR:0.1858,AMR:0.3621,EAS:0.3510,FIN:0.4485,NFE:0.4165,OTH:0.4083,ASJ:0.3742	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU585211	unknown
2	141298682	141298682	G	C	LRP1B	intronic	.	ENSG00000168702	rs11694934	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5084	0.4952	0.504792	0.4973	.	.	.	.	.	.	.	.	.	.	AFR:0.4414,AMR:0.4233,EAS:0.5985,FIN:0.5407,NFE:0.5137,OTH:0.5092,ASJ:0.4338	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU13320946	unknown
2	141474402	141474402	-	A	LRP1B	intronic	.	ENSG00000168702	rs398104769	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5608	0.5631	0.46246	0.5477	.	.	.	.	.	.	.	.	.	.	AFR:0.3869,AMR:0.4498,EAS:0.3916,FIN:0.5835,NFE:0.6495,OTH:0.5813,ASJ:0.7318	608766	.	.	.	.	.	.	.	.	.	.	.	2	.	het
2	141528592	141528592	T	C	LRP1B	intronic	.	ENSG00000168702	rs7599219	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8727	0.8384	.	0.8586	.	.	.	.	.	.	.	.	.	.	AFR:0.7653,AMR:0.9111,EAS:1,FIN:0.8989,NFE:0.8841,OTH:0.8755,ASJ:0.8676	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU81741507	hom
2	141533662	141533662	T	C	LRP1B	intronic	.	ENSG00000168702	rs996361	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8732	0.8384	0.855232	0.8591	.	.	.	.	.	0.0002	0.01	.	.	.	AFR:0.7660,AMR:0.9117,EAS:1,FIN:0.8985,NFE:0.8846,OTH:0.8758,ASJ:0.8676	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU81741515	hom
2	141571329	141571329	T	C	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs3749010	ENSG00000168702:ENST00000389484:exon32:c.A5256G:p.S1752S	LRP1B:NM_018557:exon32:c.A5256G:p.S1752S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.8708	0.8370	0.845248	0.8491	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon32:c.A5256G:p.S1752S	.	AFR:0.7260,AMR:0.8098,EAS:0.9932,FIN:0.8967,NFE:0.8937,OTH:0.8809,ASJ:0.8642	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU4547566	hom
2	141598473	141598473	-	T	LRP1B	intronic	.	ENSG00000168702	rs35745624	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9923	8e-05	0.977636	0.9811	.	.	.	.	.	.	.	.	.	.	AFR:0.9375,AMR:0.9880,EAS:1,FIN:1,NFE:0.9987,OTH:0.9888,ASJ:1	608766	.	.	.	.	.	.	.	.	.	.	.	2	.	hom
2	141709419	141709419	T	G	LRP1B	intronic	.	ENSG00000168702	rs1429348	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6465	0.5681	0.536542	0.5993	.	.	.	.	.	.	.	.	.	.	AFR:0.3409,AMR:0.6400,EAS:0.6889,FIN:0.7539,NFE:0.6946,OTH:0.6929,ASJ:0.6358	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU755724	hom
2	141751592	141751592	G	A	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs13007735	ENSG00000168702:ENST00000389484:exon16:c.C2616T:p.D872D	LRP1B:NM_018557:exon16:c.C2616T:p.D872D	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.3880	0.3987	0.509585	0.3874	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon16:c.C2616T:p.D872D	.	AFR:0.5551,AMR:0.3553,EAS:0.5853,FIN:0.2413,NFE:0.3080,OTH:0.3145,ASJ:0.4834	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU26807821	het
2	141816621	141816621	A	G	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs1525579	ENSG00000168702:ENST00000389484:exon9:c.T1239C:p.V413V	LRP1B:NM_018557:exon9:c.T1239C:p.V413V	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9843	0.9405	0.945288	0.9499	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon9:c.T1239C:p.V413V	.	AFR:0.8252,AMR:0.9916,EAS:1,FIN:1,NFE:0.9996,OTH:0.9918,ASJ:1	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU81741570	hom
2	142567910	142567910	T	C	LRP1B	exonic	nonsynonymous SNV	ENSG00000168702	rs12990449	ENSG00000168702:ENST00000389484:exon2:c.A143G:p.Q48R,ENSG00000168702:ENST00000434794:exon2:c.A143G:p.Q48R	LRP1B:NM_018557:exon2:c.A143G:p.Q48R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.2338	0.1752	0.217452	0.1856	1.379	12.68	0.329	4.45	1.000	.	.	EGF-like domain;Low-density lipoprotein (LDL) receptor class A, conserved site	LRP1B:uc002tvj.1:exon2:c.A143G:p.Q48R,LRP1B:uc010fnl.1:exon2:c.A254G:p.Q85R	-1.072	AFR:0.0954,AMR:0.1986,EAS:0.4038,FIN:0.1832,NFE:0.2105,OTH:0.2010,ASJ:0.3477	608766	.	.	.	.	,7092	.	.	0.001	-3.68	0.000	-0.31	2	MU760781	hom
2	152349026	152349026	G	A	NEB	intronic	.	ENSG00000080345;ENSG00000183091	rs2288195	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6624	0.6419	0.638379	0.6572	.	.	.	.	.	.	.	.	.	.	AFR:0.5802,AMR:0.7644,EAS:0.7720,FIN:0.6878,NFE:0.6762,OTH:0.6616,ASJ:0.6490	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	MU47002120	het
2	152352843	152352843	C	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs7575451	ENSG00000183091:ENST00000509223:exon5:c.G265C:p.A89P,ENSG00000183091:ENST00000397336:exon6:c.G358C:p.A120P,ENSG00000183091:ENST00000424585:exon9:c.G742C:p.A248P,ENSG00000183091:ENST00000413693:exon67:c.G8065C:p.A2689P,ENSG00000183091:ENST00000172853:exon140:c.G18865C:p.A6289P,ENSG00000183091:ENST00000409198:exon141:c.G18865C:p.A6289P,ENSG00000183091:ENST00000603639:exon171:c.G24433C:p.A8145P,ENSG00000183091:ENST00000604864:exon171:c.G24433C:p.A8145P,ENSG00000183091:ENST00000397345:exon173:c.G24433C:p.A8145P,ENSG00000183091:ENST00000427231:exon173:c.G24433C:p.A8145P	NEB:NM_004543:exon141:c.G18865C:p.A6289P,NEB:NM_001164507:exon173:c.G24433C:p.A8145P,NEB:NM_001164508:exon173:c.G24433C:p.A8145P,NEB:NM_001271208:exon174:c.G24538C:p.A8180P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6499	0.6288	0.627796	0.6500	3.599	23.2	0.936	4.11	0.995	.	.	.	NEB:uc010zbz.2:exon4:c.G265C:p.A89P,NEB:uc010zca.2:exon5:c.G358C:p.A120P,NEB:uc010zcb.2:exon5:c.G265C:p.A89P,NEB:uc002txq.3:exon6:c.G502C:p.A168P,NEB:uc002txr.3:exon67:c.G8170C:p.A2724P,NEB:uc021vrb.1:exon139:c.G18865C:p.A6289P,NEB:uc010fnx.3:exon140:c.G18829C:p.A6277P,NEB:uc021vrd.1:exon141:c.G18865C:p.A6289P,NEB:uc002txu.3:exon173:c.G24433C:p.A8145P,NEB:uc021vrc.1:exon173:c.G24433C:p.A8145P,NEB:uc031rpp.1:exon174:c.G24538C:p.A8180P	-1.033	AFR:0.5877,AMR:0.7530,EAS:0.7717,FIN:0.6821,NFE:0.6613,OTH:0.6477,ASJ:0.5795	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.0	3.44	0.000	-1.405	2	MU4139573	het
2	152370904	152370904	C	T	NEB	exonic	synonymous SNV	ENSG00000183091	rs563896790	ENSG00000183091:ENST00000413693:exon59:c.G7245A:p.G2415G,ENSG00000183091:ENST00000172853:exon131:c.G17952A:p.G5984G,ENSG00000183091:ENST00000409198:exon132:c.G17952A:p.G5984G,ENSG00000183091:ENST00000603639:exon157:c.G23055A:p.G7685G,ENSG00000183091:ENST00000604864:exon157:c.G23055A:p.G7685G,ENSG00000183091:ENST00000397345:exon159:c.G23055A:p.G7685G,ENSG00000183091:ENST00000427231:exon159:c.G23055A:p.G7685G	NEB:NM_004543:exon132:c.G17952A:p.G5984G,NEB:NM_001164507:exon159:c.G23055A:p.G7685G,NEB:NM_001164508:exon159:c.G23055A:p.G7685G,NEB:NM_001271208:exon160:c.G23160A:p.G7720G	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 1, 2, 0, 0, 0] 	0.0047	.	0.00459265	9.687e-05	.	.	.	.	.	.	.	.	NEB:uc002txt.4:exon16:c.G1467A:p.G489G,NEB:uc002txr.3:exon59:c.G7350A:p.G2450G,NEB:uc021vrb.1:exon130:c.G17952A:p.G5984G,NEB:uc010fnx.3:exon131:c.G17916A:p.G5972G,NEB:uc021vrd.1:exon132:c.G17952A:p.G5984G,NEB:uc002txu.3:exon159:c.G23055A:p.G7685G,NEB:uc021vrc.1:exon159:c.G23055A:p.G7685G,NEB:uc031rpp.1:exon160:c.G23160A:p.G7720G	.	AFR:0.0002,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	MU129337943	het
2	152398045	152398045	G	C	NEB	exonic	synonymous SNV	ENSG00000183091	rs16830192	ENSG00000183091:ENST00000413693:exon36:c.C4788G:p.G1596G,ENSG00000183091:ENST00000172853:exon108:c.C15495G:p.G5165G,ENSG00000183091:ENST00000409198:exon109:c.C15495G:p.G5165G,ENSG00000183091:ENST00000603639:exon134:c.C20598G:p.G6866G,ENSG00000183091:ENST00000604864:exon134:c.C20598G:p.G6866G,ENSG00000183091:ENST00000397345:exon136:c.C20598G:p.G6866G,ENSG00000183091:ENST00000427231:exon136:c.C20598G:p.G6866G	NEB:NM_004543:exon109:c.C15495G:p.G5165G,NEB:NM_001164507:exon136:c.C20598G:p.G6866G,NEB:NM_001164508:exon136:c.C20598G:p.G6866G,NEB:NM_001271208:exon136:c.C20598G:p.G6866G	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0322	0.0365	0.0840655	COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	NEB:uc002txr.3:exon36:c.C4893G:p.G1631G,NEB:uc021vrb.1:exon107:c.C15495G:p.G5165G,NEB:uc010fnx.3:exon108:c.C15459G:p.G5153G,NEB:uc021vrd.1:exon109:c.C15495G:p.G5165G,NEB:uc002txu.3:exon136:c.C20598G:p.G6866G,NEB:uc021vrc.1:exon136:c.C20598G:p.G6866G,NEB:uc031rpp.1:exon136:c.C20598G:p.G6866G	.	AFR:0.0427,AMR:0.1158,EAS:0.0364,FIN:0.1487,NFE:0,OTH:0.0022,ASJ:0.0107	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	2(haematopoietic_and_lymphoid_tissue)	0.0184
2	152404218	152404218	T	A	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs2288200	ENSG00000183091:ENST00000413693:exon32:c.A4382T:p.D1461V,ENSG00000183091:ENST00000172853:exon104:c.A15089T:p.D5030V,ENSG00000183091:ENST00000409198:exon105:c.A15089T:p.D5030V,ENSG00000183091:ENST00000603639:exon130:c.A20192T:p.D6731V,ENSG00000183091:ENST00000604864:exon130:c.A20192T:p.D6731V,ENSG00000183091:ENST00000397345:exon132:c.A20192T:p.D6731V,ENSG00000183091:ENST00000427231:exon132:c.A20192T:p.D6731V	NEB:NM_004543:exon105:c.A15089T:p.D5030V,NEB:NM_001164507:exon132:c.A20192T:p.D6731V,NEB:NM_001164508:exon132:c.A20192T:p.D6731V,NEB:NM_001271208:exon132:c.A20192T:p.D6731V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0345	0.0391	0.0882588	COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	6.828	33	0.063	5.86	1.000	.	.	.	NEB:uc002txr.3:exon32:c.A4487T:p.D1496V,NEB:uc021vrb.1:exon103:c.A15089T:p.D5030V,NEB:uc010fnx.3:exon104:c.A15053T:p.D5018V,NEB:uc021vrd.1:exon105:c.A15089T:p.D5030V,NEB:uc002txu.3:exon132:c.A20192T:p.D6731V,NEB:uc021vrc.1:exon132:c.A20192T:p.D6731V,NEB:uc031rpp.1:exon132:c.A20192T:p.D6731V	-1.115	AFR:0.0454,AMR:0.1255,EAS:0.0364,FIN:0.1484,NFE:0,OTH:0.0021,ASJ:0.0107	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	1.0	2.51	0.000	1.75	2	1(breast)	0.0214
2	152422076	152422076	C	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs2288210	ENSG00000183091:ENST00000413693:exon16:c.G2495C:p.R832T,ENSG00000183091:ENST00000172853:exon88:c.G13202C:p.R4401T,ENSG00000183091:ENST00000409198:exon89:c.G13202C:p.R4401T,ENSG00000183091:ENST00000603639:exon114:c.G18305C:p.R6102T,ENSG00000183091:ENST00000604864:exon114:c.G18305C:p.R6102T,ENSG00000183091:ENST00000397345:exon116:c.G18305C:p.R6102T,ENSG00000183091:ENST00000427231:exon116:c.G18305C:p.R6102T	NEB:NM_004543:exon89:c.G13202C:p.R4401T,NEB:NM_001164507:exon116:c.G18305C:p.R6102T,NEB:NM_001164508:exon116:c.G18305C:p.R6102T,NEB:NM_001271208:exon116:c.G18305C:p.R6102T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6707	0.6498	0.653155	MU4139526	1.906	15.63	1.0	5.28	0.999	.	.	.	NEB:uc002txr.3:exon16:c.G2600C:p.R867T,NEB:uc021vrb.1:exon87:c.G13202C:p.R4401T,NEB:uc010fnx.3:exon88:c.G13166C:p.R4389T,NEB:uc021vrd.1:exon89:c.G13202C:p.R4401T,NEB:uc002txu.3:exon116:c.G18305C:p.R6102T,NEB:uc021vrc.1:exon116:c.G18305C:p.R6102T,NEB:uc031rpp.1:exon116:c.G18305C:p.R6102T	-0.998	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.6716,EAS:0.7601,FIN:0.5728,NFE:0.7938,OTH:0.6926,ASJ:0.6153	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.0	3.89	0.000	-2.6	2	1(lung)	0.6829
2	152424933	152424933	-	A	NEB	splicing	.	ENSG00000183091	rs3214503	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, 0, 0, 0] 	0.4669	0.5018	0.506589	0.6575	.	.	.	.	.	.	.	.	.	.	AFR:0.6146,AMR:0.6713,EAS:0.7938,FIN:0.5860,NFE:0.6813,OTH:0.6525,ASJ:0.5725	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	.	het
2	152432811	152432811	A	T	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs35227368	ENSG00000183091:ENST00000413693:exon6:c.T952A:p.S318T,ENSG00000183091:ENST00000172853:exon78:c.T11659A:p.S3887T,ENSG00000183091:ENST00000409198:exon79:c.T11659A:p.S3887T,ENSG00000183091:ENST00000603639:exon104:c.T16762A:p.S5588T,ENSG00000183091:ENST00000604864:exon104:c.T16762A:p.S5588T,ENSG00000183091:ENST00000397345:exon106:c.T16762A:p.S5588T,ENSG00000183091:ENST00000427231:exon106:c.T16762A:p.S5588T	NEB:NM_004543:exon79:c.T11659A:p.S3887T,NEB:NM_001164507:exon106:c.T16762A:p.S5588T,NEB:NM_001164508:exon106:c.T16762A:p.S5588T,NEB:NM_001271208:exon106:c.T16762A:p.S5588T	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0307	0.0317	0.0778754	0.0396	3.612	23.2	0.011	5.9	0.991	.	.	.	NEB:uc002txr.3:exon6:c.T1057A:p.S353T,NEB:uc021vrb.1:exon77:c.T11659A:p.S3887T,NEB:uc010fnx.3:exon78:c.T11623A:p.S3875T,NEB:uc021vrd.1:exon79:c.T11659A:p.S3887T,NEB:uc002txu.3:exon106:c.T16762A:p.S5588T,NEB:uc021vrc.1:exon106:c.T16762A:p.S5588T,NEB:uc031rpp.1:exon106:c.T16762A:p.S5588T	-1.137	AFR:0.1042,AMR:0.0064,EAS:0.1501,FIN:0,NFE:0.0019,OTH:0.0159,ASJ:0.0372	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.985	2.88	0.001	2.93	2	MU81742053	het
2	152436014	152436014	G	C	NEB	exonic	synonymous SNV	ENSG00000183091	rs200602229	ENSG00000183091:ENST00000413693:exon5:c.C732G:p.A244A,ENSG00000183091:ENST00000603639:exon103:c.C16542G:p.A5514A,ENSG00000183091:ENST00000604864:exon103:c.C16542G:p.A5514A,ENSG00000183091:ENST00000397345:exon105:c.C16542G:p.A5514A,ENSG00000183091:ENST00000427231:exon105:c.C16542G:p.A5514A	NEB:NM_001164507:exon105:c.C16542G:p.A5514A,NEB:NM_001164508:exon105:c.C16542G:p.A5514A,NEB:NM_001271208:exon105:c.C16542G:p.A5514A	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0882	.	0.0501198	0.0223	.	.	.	.	.	.	.	.	NEB:uc002txr.3:exon5:c.C837G:p.A279A,NEB:uc002txu.3:exon105:c.C16542G:p.A5514A,NEB:uc021vrc.1:exon105:c.C16542G:p.A5514A,NEB:uc031rpp.1:exon105:c.C16542G:p.A5514A	.	AFR:0.0348,AMR:0.0064,EAS:0.1727,FIN:0,NFE:0.0022,OTH:0.0144,ASJ:0.0446	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	.	het
2	152476130	152476130	C	T	NEB	exonic	synonymous SNV	ENSG00000183091	rs6717213	ENSG00000183091:ENST00000172853:exon69:c.G9978A:p.K3326K,ENSG00000183091:ENST00000409198:exon70:c.G9978A:p.K3326K,ENSG00000183091:ENST00000603639:exon71:c.G10707A:p.K3569K,ENSG00000183091:ENST00000604864:exon71:c.G10707A:p.K3569K,ENSG00000183091:ENST00000397345:exon73:c.G10707A:p.K3569K,ENSG00000183091:ENST00000427231:exon73:c.G10707A:p.K3569K	NEB:NM_004543:exon70:c.G9978A:p.K3326K,NEB:NM_001164507:exon73:c.G10707A:p.K3569K,NEB:NM_001164508:exon73:c.G10707A:p.K3569K,NEB:NM_001271208:exon73:c.G10707A:p.K3569K	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0598	0.0777	0.140575	COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	NEB:uc021vrb.1:exon68:c.G9978A:p.K3326K,NEB:uc010fnx.3:exon69:c.G9942A:p.K3314K,NEB:uc021vrd.1:exon70:c.G9978A:p.K3326K,NEB:uc002txu.3:exon73:c.G10707A:p.K3569K,NEB:uc021vrc.1:exon73:c.G10707A:p.K3569K,NEB:uc031rpp.1:exon73:c.G10707A:p.K3569K	.	AFR:0.0802,AMR:0.2040,EAS:0.0596,FIN:0.1669,NFE:0.0149,OTH:0.0197,ASJ:0.0203	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.0519
2	152490219	152490219	A	G	NEB	exonic	synonymous SNV	ENSG00000183091	rs6709886	ENSG00000183091:ENST00000603639:exon63:c.T9363C:p.P3121P,ENSG00000183091:ENST00000604864:exon63:c.T9363C:p.P3121P,ENSG00000183091:ENST00000397345:exon65:c.T9363C:p.P3121P,ENSG00000183091:ENST00000427231:exon65:c.T9363C:p.P3121P	NEB:NM_001164507:exon65:c.T9363C:p.P3121P,NEB:NM_001164508:exon65:c.T9363C:p.P3121P,NEB:NM_001271208:exon65:c.T9363C:p.P3121P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6362	0.5988	0.625998	0.6229	.	.	.	.	.	.	.	.	NEB:uc002txu.3:exon65:c.T9363C:p.P3121P,NEB:uc021vrc.1:exon65:c.T9363C:p.P3121P,NEB:uc031rpp.1:exon65:c.T9363C:p.P3121P	.	AFR:0.5127,AMR:0.7387,EAS:0.7948,FIN:0.6513,NFE:0.6551,OTH:0.6526,ASJ:0.5331	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	MU24599370	het
2	152490458	152490458	A	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs6710212	ENSG00000183091:ENST00000603639:exon63:c.T9124C:p.C3042R,ENSG00000183091:ENST00000604864:exon63:c.T9124C:p.C3042R,ENSG00000183091:ENST00000397345:exon65:c.T9124C:p.C3042R,ENSG00000183091:ENST00000427231:exon65:c.T9124C:p.C3042R	NEB:NM_001164507:exon65:c.T9124C:p.C3042R,NEB:NM_001164508:exon65:c.T9124C:p.C3042R,NEB:NM_001271208:exon65:c.T9124C:p.C3042R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9928	0.9757	0.972045	0.9771	0.806	9.498	0.971	6.02	0.994	.	.	.	NEB:uc002txu.3:exon65:c.T9124C:p.C3042R,NEB:uc021vrc.1:exon65:c.T9124C:p.C3042R,NEB:uc031rpp.1:exon65:c.T9124C:p.C3042R	-0.915	AFR:0.9192,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:0.9990,ASJ:1	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	3.85	0.000	.	2	MU81742117	hom
2	152496526	152496526	A	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs6713162	ENSG00000183091:ENST00000603639:exon60:c.T8734C:p.S2912P,ENSG00000183091:ENST00000604864:exon60:c.T8734C:p.S2912P,ENSG00000183091:ENST00000172853:exon62:c.T8734C:p.S2912P,ENSG00000183091:ENST00000397345:exon62:c.T8734C:p.S2912P,ENSG00000183091:ENST00000409198:exon62:c.T8734C:p.S2912P,ENSG00000183091:ENST00000427231:exon62:c.T8734C:p.S2912P	NEB:NM_001164507:exon62:c.T8734C:p.S2912P,NEB:NM_001164508:exon62:c.T8734C:p.S2912P,NEB:NM_001271208:exon62:c.T8734C:p.S2912P,NEB:NM_004543:exon62:c.T8734C:p.S2912P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2540	0.3010	0.445288	MU119575	2.013	16.29	1.0	5.46	0.985	.	.	.	NEB:uc021vrb.1:exon60:c.T8734C:p.S2912P,NEB:uc002txu.3:exon62:c.T8734C:p.S2912P,NEB:uc010fnx.3:exon62:c.T8734C:p.S2912P,NEB:uc021vrc.1:exon62:c.T8734C:p.S2912P,NEB:uc021vrd.1:exon62:c.T8734C:p.S2912P,NEB:uc031rpp.1:exon62:c.T8734C:p.S2912P	-0.974	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.3143,EAS:0.1376,FIN:0.2417,NFE:0.5910,OTH:0.1398,ASJ:0.6350	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.0	3.73	0.000	-2.8	2	1(large_intestine)	0.1572
2	152511778	152511778	A	C	NEB	intronic	.	ENSG00000183091	rs10930723	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3411	0.2905	0.430911	0.3008	.	.	.	.	.	0.0001	0.064	.	.	.	AFR:0.5887,AMR:0.1316,EAS:0.5946,FIN:0.1401,NFE:0.1569,OTH:0.1980,ASJ:0.2483	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	MU17371938	hom
2	152515634	152515634	A	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs199862790	ENSG00000183091:ENST00000603639:exon45:c.T6020C:p.M2007T,ENSG00000183091:ENST00000604864:exon45:c.T6020C:p.M2007T,ENSG00000183091:ENST00000172853:exon47:c.T6020C:p.M2007T,ENSG00000183091:ENST00000397345:exon47:c.T6020C:p.M2007T,ENSG00000183091:ENST00000409198:exon47:c.T6020C:p.M2007T,ENSG00000183091:ENST00000427231:exon47:c.T6020C:p.M2007T	NEB:NM_001164507:exon47:c.T6020C:p.M2007T,NEB:NM_001164508:exon47:c.T6020C:p.M2007T,NEB:NM_001271208:exon47:c.T6020C:p.M2007T,NEB:NM_004543:exon47:c.T6020C:p.M2007T	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 1, 1, -1, 0, 0] 	0.0005	.	0.000599042	.	1.138	11.42	0.33	2.48	0.999	.	.	.	NEB:uc021vrb.1:exon45:c.T6020C:p.M2007T,NEB:uc002txu.3:exon47:c.T6020C:p.M2007T,NEB:uc010fnx.3:exon47:c.T6020C:p.M2007T,NEB:uc021vrc.1:exon47:c.T6020C:p.M2007T,NEB:uc021vrd.1:exon47:c.T6020C:p.M2007T,NEB:uc031rpp.1:exon47:c.T6020C:p.M2007T	-0.997	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.002	3.38	0.017	0.045	2	.	het
2	152515683	152515683	G	A	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs75807392	ENSG00000183091:ENST00000603639:exon45:c.C5971T:p.H1991Y,ENSG00000183091:ENST00000604864:exon45:c.C5971T:p.H1991Y,ENSG00000183091:ENST00000172853:exon47:c.C5971T:p.H1991Y,ENSG00000183091:ENST00000397345:exon47:c.C5971T:p.H1991Y,ENSG00000183091:ENST00000409198:exon47:c.C5971T:p.H1991Y,ENSG00000183091:ENST00000427231:exon47:c.C5971T:p.H1991Y	NEB:NM_001164507:exon47:c.C5971T:p.H1991Y,NEB:NM_001164508:exon47:c.C5971T:p.H1991Y,NEB:NM_001271208:exon47:c.C5971T:p.H1991Y,NEB:NM_004543:exon47:c.C5971T:p.H1991Y	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0774	0.0422	0.0920527	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	-0.057	2.073	1.0	4.38	0.474	0.0002	0.046	.	NEB:uc021vrb.1:exon45:c.C5971T:p.H1991Y,NEB:uc002txu.3:exon47:c.C5971T:p.H1991Y,NEB:uc010fnx.3:exon47:c.C5971T:p.H1991Y,NEB:uc021vrc.1:exon47:c.C5971T:p.H1991Y,NEB:uc021vrd.1:exon47:c.C5971T:p.H1991Y,NEB:uc031rpp.1:exon47:c.C5971T:p.H1991Y	-1.006	AFR:0.0621,AMR:0.0224,EAS:0.0298,FIN:0.2491,NFE:0.0930,OTH:0.0587,ASJ:0.0489	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.677	0.92	0.000	1.59	2	1(lung)	0.0723
2	152521096	152521096	C	T	NEB	exonic	synonymous SNV	ENSG00000183091	rs10170273	ENSG00000183091:ENST00000603639:exon42:c.G5370A:p.E1790E,ENSG00000183091:ENST00000604864:exon42:c.G5370A:p.E1790E,ENSG00000183091:ENST00000172853:exon44:c.G5370A:p.E1790E,ENSG00000183091:ENST00000397345:exon44:c.G5370A:p.E1790E,ENSG00000183091:ENST00000409198:exon44:c.G5370A:p.E1790E,ENSG00000183091:ENST00000427231:exon44:c.G5370A:p.E1790E	NEB:NM_001164507:exon44:c.G5370A:p.E1790E,NEB:NM_001164508:exon44:c.G5370A:p.E1790E,NEB:NM_001271208:exon44:c.G5370A:p.E1790E,NEB:NM_004543:exon44:c.G5370A:p.E1790E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3018	0.2951	0.434904	MU119622	.	.	.	.	.	.	.	.	NEB:uc021vrb.1:exon42:c.G5370A:p.E1790E,NEB:uc002txu.3:exon44:c.G5370A:p.E1790E,NEB:uc010fnx.3:exon44:c.G5370A:p.E1790E,NEB:uc021vrc.1:exon44:c.G5370A:p.E1790E,NEB:uc021vrd.1:exon44:c.G5370A:p.E1790E,NEB:uc031rpp.1:exon44:c.G5370A:p.E1790E	.	AFR:MELA-AU|1|183|0.00546448,COCA-CN|5|321|0.0155763,AMR:0.3056,EAS:0.1325,FIN:0.2533,NFE:0.5882,OTH:0.1394,ASJ:0.6058	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	1(skin)	0.1569
2	152527608	152527608	C	T	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs34577613	ENSG00000183091:ENST00000603639:exon36:c.G4435A:p.V1479I,ENSG00000183091:ENST00000604864:exon36:c.G4435A:p.V1479I,ENSG00000183091:ENST00000172853:exon38:c.G4435A:p.V1479I,ENSG00000183091:ENST00000397345:exon38:c.G4435A:p.V1479I,ENSG00000183091:ENST00000409198:exon38:c.G4435A:p.V1479I,ENSG00000183091:ENST00000427231:exon38:c.G4435A:p.V1479I	NEB:NM_001164507:exon38:c.G4435A:p.V1479I,NEB:NM_001164508:exon38:c.G4435A:p.V1479I,NEB:NM_001271208:exon38:c.G4435A:p.V1479I,NEB:NM_004543:exon38:c.G4435A:p.V1479I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1899	0.1914	0.335264	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	1.430	12.95	0.597	4.25	0.998	.	.	.	NEB:uc021vrb.1:exon36:c.G4435A:p.V1479I,NEB:uc002txu.3:exon38:c.G4435A:p.V1479I,NEB:uc010fnx.3:exon38:c.G4435A:p.V1479I,NEB:uc021vrc.1:exon38:c.G4435A:p.V1479I,NEB:uc021vrd.1:exon38:c.G4435A:p.V1479I,NEB:uc031rpp.1:exon38:c.G4435A:p.V1479I	-1.009	AFR:0.2132,AMR:0.3921,EAS:0.1490,FIN:0.5405,NFE:0.1216,OTH:0.1069,ASJ:0.1017	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.0	3.5	0.000	-1.78	2	1(large_intestine)	0.1544
2	152531781	152531781	C	A	NEB	intronic	.	ENSG00000183091	rs12618063	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2548	0.1643	0.28774	0.1840	.	.	.	.	.	.	.	.	.	.	AFR:0.3115,AMR:0.0897,EAS:0.4639,FIN:0.1117,NFE:0.1057,OTH:0.1393,ASJ:0.1490	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	MU761022	hom
2	169789016	169789016	T	C	ABCB11	exonic	synonymous SNV	ENSG00000073734	rs497692	ENSG00000073734:ENST00000263817:exon24:c.A3084G:p.A1028A	ABCB11:NM_003742:exon24:c.A3084G:p.A1028A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5557	0.4546	0.496805	0.4676	.	.	.	.	.	.	.	.	ABCB11:uc010zda.1:exon11:c.A1410G:p.A470A,ABCB11:uc010zdb.1:exon11:c.A1512G:p.A504A,ABCB11:uc002ueo.1:exon24:c.A3084G:p.A1028A	.	AFR:0.2680,AMR:0.5859,EAS:0.6359,FIN:0.5378,NFE:0.5353,OTH:0.5337,ASJ:0.6126	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	.	.	.	.	2	MU585262	hom
2	169801488	169801488	A	G	ABCB11	intronic	.	ENSG00000073734	rs853789	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7663	0.7523	0.855232	0.7491	.	.	.	.	.	.	.	.	.	.	AFR:0.9016,AMR:0.8433,EAS:0.9806,FIN:0.6540,NFE:0.6558,OTH:0.7090,ASJ:0.7517	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	.	.	.	.	2	MU81743974	hom
2	169814655	169814655	G	T	ABCB11	intronic	.	ENSG00000073734	rs853772	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5399	0.4506	0.497604	0.4537	.	.	.	.	.	.	.	.	.	.	AFR:0.2681,AMR:0.5815,EAS:0.6344,FIN:0.5161,NFE:0.5150,OTH:0.5163,ASJ:0.5828	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	.	.	.	.	2	MU18167943	hom
2	169830328	169830328	A	G	ABCB11	exonic	nonsynonymous SNV	ENSG00000073734	rs2287622	ENSG00000073734:ENST00000263817:exon13:c.T1331C:p.V444A	ABCB11:NM_003742:exon13:c.T1331C:p.V444A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5794	0.5958	0.588658	MU13370497	1.830	15.16	0.25	4.62	0.998	.	.	ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	ABCB11:uc002ueo.1:exon13:c.T1331C:p.V444A	-0.896	AFR:COCA-CN|5|321|0.0155763,AMR:0.5706,EAS:0.4185,FIN:0.5497,NFE:0.7126,OTH:0.5115,ASJ:0.5576	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	0.001	-3.2	0.000	0.145	2	1(haematopoietic_and_lymphoid_tissue)	0.5895
2	169842809	169842809	T	C	ABCB11	intronic	.	ENSG00000073734	rs2287618	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7053	0.7396	0.774161	0.7312	.	.	.	.	.	.	.	.	.	.	AFR:0.8273,AMR:0.5203,EAS:0.7994,FIN:0.6964,NFE:0.6929,OTH:0.6701,ASJ:0.6887	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	.	.	.	.	2	MU23484908	hom
2	173292709	173292709	A	G	ITGA6	intronic	.	ENSG00000226963	rs6744873	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3560	0.3208	0.500599	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,EOPC-DE|1|202|0.0049505	.	.	.	.	.	.	.	.	.	.	AFR:0.3607,AMR:0.4865,EAS:0.2416,FIN:0.8855,NFE:0.3204,OTH:0.2360,ASJ:0.4988	147556	226730;	79403;	79403|Carmi syndrome<br>JEB-PA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226730 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko05145 Toxoplasmosis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.3509
2	173292713	173292713	C	T	ITGA6	intronic	.	ENSG00000226963	rs6716540	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3463	0.3175	0.489018	0.3521	.	.	.	.	.	.	.	.	.	.	AFR:0.4824,AMR:0.4730,EAS:0.8664,FIN:0.2892,NFE:0.2327,OTH:0.3306,ASJ:0.2384	147556	226730;	79403;	79403|Carmi syndrome<br>JEB-PA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226730 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko05145 Toxoplasmosis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	2	MU16475346	unknown
2	173337618	173337618	G	A	ITGA6	exonic	nonsynonymous SNV	ENSG00000091409	rs74728869	ENSG00000091409:ENST00000343713:exon5:c.G760A:p.G254S,ENSG00000091409:ENST00000409532:exon5:c.G418A:p.G140S,ENSG00000091409:ENST00000458358:exon5:c.G760A:p.G254S,ENSG00000091409:ENST00000264106:exon6:c.G892A:p.G298S,ENSG00000091409:ENST00000375221:exon6:c.G892A:p.G298S,ENSG00000091409:ENST00000442250:exon6:c.G892A:p.G298S	ITGA6:NM_001316306:exon5:c.G418A:p.G140S	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 1, 0] 	0.0105	0.0024	0.013778	0.0047	2.836	21.6	0.002	5.67	1.000	0.9830	0.826	.	ITGA6:uc010zdy.1:exon5:c.G418A:p.G140S	-0.539	AFR:0.0078,AMR:0.0060,EAS:0.0401,FIN:0,NFE:0.0001,OTH:0.0051,ASJ:0	147556	226730;	79403;	79403|Carmi syndrome<br>JEB-PA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226730 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko05145 Toxoplasmosis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	1.0	0.61	0.159	.	2	MU13376725	het
2	173339808	173339808	G	A	ITGA6	exonic	nonsynonymous SNV	ENSG00000091409	rs11895564	ENSG00000091409:ENST00000264107:exon7:c.G1138A:p.A380T,ENSG00000091409:ENST00000343713:exon7:c.G1123A:p.A375T,ENSG00000091409:ENST00000409080:exon7:c.G1138A:p.A380T,ENSG00000091409:ENST00000409532:exon7:c.G781A:p.A261T,ENSG00000091409:ENST00000458358:exon7:c.G1123A:p.A375T,ENSG00000091409:ENST00000264106:exon8:c.G1255A:p.A419T,ENSG00000091409:ENST00000375221:exon8:c.G1255A:p.A419T,ENSG00000091409:ENST00000442250:exon8:c.G1255A:p.A419T	ITGA6:NM_000210:exon7:c.G1138A:p.A380T,ITGA6:NM_001079818:exon7:c.G1138A:p.A380T,ITGA6:NM_001316306:exon7:c.G781A:p.A261T,ITGA6:NM_001365529:exon7:c.G1138A:p.A380T,ITGA6:NM_001365530:exon7:c.G1138A:p.A380T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2810	0.3125	0.251597	0.2847	3.009	22.3	0.145	4.46	0.921	.	.	.	ITGA6:uc010fqm.1:exon1:c.G76A:p.A26T,ITGA6:uc002uho.1:exon7:c.G1138A:p.A380T,ITGA6:uc002uhp.1:exon7:c.G1138A:p.A380T,ITGA6:uc010fqk.1:exon7:c.G796A:p.A266T,ITGA6:uc010zdy.1:exon7:c.G781A:p.A261T	-1.136	AFR:0.3284,AMR:0.2812,EAS:0.0852,FIN:0.2676,NFE:0.2834,OTH:0.2955,ASJ:0.3311	147556	226730;	79403;	79403|Carmi syndrome<br>JEB-PA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226730 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko05145 Toxoplasmosis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	0.571	-0.7	0.000	1.89	2	MU109800	het
2	173344474	173344474	A	G	ITGA6	intronic	.	ENSG00000091409	rs1920979	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3710	0.4081	0.407149	LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	0.0002	0	.	.	.	AFR:0.3839,AMR:0.5102,EAS:0.3433,FIN:0.3661,NFE:0.3025,OTH:0.3347,ASJ:0.3663	147556	226730;	79403;	79403|Carmi syndrome<br>JEB-PA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226730 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko05145 Toxoplasmosis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	2	1(lung)	0.3624
2	175436940	175436940	G	A	WIPF1	exonic	nonsynonymous SNV	ENSG00000115935	rs4972450	ENSG00000115935:ENST00000272746:exon5:c.C593T:p.P198L,ENSG00000115935:ENST00000359761:exon5:c.C593T:p.P198L,ENSG00000115935:ENST00000392547:exon5:c.C593T:p.P198L,ENSG00000115935:ENST00000409415:exon5:c.C593T:p.P198L,ENSG00000115935:ENST00000409891:exon5:c.C593T:p.P198L,ENSG00000115935:ENST00000392546:exon6:c.C593T:p.P198L	WIPF1:NM_001077269:exon5:c.C593T:p.P198L,WIPF1:NM_003387:exon5:c.C593T:p.P198L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9411	0.923	0.907947	0.9292	0.950	10.37	1.0	5.02	0.942	.	.	.	WIPF1:uc002uiz.3:exon5:c.C593T:p.P198L,WIPF1:uc002uja.3:exon5:c.C593T:p.P198L,WIPF1:uc002ujb.2:exon5:c.C593T:p.P198L,WIPF1:uc002ujc.1:exon5:c.C593T:p.P198L,WIPF1:uc010fqt.1:exon5:c.C593T:p.P198L,WIPF1:uc010zep.1:exon5:c.C593T:p.P198L	-0.966	AFR:0.8450,AMR:0.9558,EAS:0.9926,FIN:0.9774,NFE:0.9571,OTH:0.9612,ASJ:0.8940	602357	614493;	906;	906|Eczema-thrombocytopenia-immunodeficiency syndrome<br>WAS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|277970 301000 600903 614493 ~	.	.	.	.	0.0	1.68	0.000	-2.28	2	MU26801477	hom
2	176952792	176952792	G	A	EVX2;HOXD13	intergenic	.	ENSG00000174279;ENSG00000128714	rs73974635	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.438299	0.3480	.	.	.	.	.	.	.	.	.	.	AFR:0.6538,AMR:0.2986,EAS:0.3222,FIN:0.1477,NFE:0.2311,OTH:0.2684,ASJ:0.2384	.	.	.	.	.	.	.	.	.	.	.	.	2	MU87912363	unknown
2	176952798	176952798	G	T	EVX2;HOXD13	intergenic	.	ENSG00000174279;ENSG00000128714	rs73974637	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.438299	0.3482	.	.	.	.	.	.	.	.	.	.	AFR:0.6539,AMR:0.2990,EAS:0.3214,FIN:0.1477,NFE:0.2314,OTH:0.2695,ASJ:0.2384	.	.	.	.	.	.	.	.	.	.	.	.	2	MU87912364	unknown
2	176952926	176952926	C	T	EVX2;HOXD13	intergenic	.	ENSG00000174279;ENSG00000128714	rs66508389	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.421925	0.3506	.	.	.	.	.	.	.	.	.	.	AFR:0.6577,AMR:0.3026,EAS:0.3241,FIN:0.1474,NFE:0.2328,OTH:0.2648,ASJ:0.2384	.	.	.	.	.	.	.	.	.	.	.	.	2	MU116798863	hom
2	176953061	176953061	A	T	EVX2;HOXD13	intergenic	.	ENSG00000174279;ENSG00000128714	rs6732069	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.422524	0.3513	.	.	.	.	.	.	.	.	.	.	AFR:0.6578,AMR:0.3034,EAS:0.3265,FIN:0.1476,NFE:0.2333,OTH:0.2639,ASJ:0.2384	.	.	.	.	.	.	.	.	.	.	.	.	2	MU87912365	hom
2	176953287	176953287	-	C	EVX2;HOXD13	intergenic	.	ENSG00000174279;ENSG00000128714	rs397943469	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.420927	0.3503	.	.	.	.	.	.	.	.	.	.	AFR:0.6570,AMR:0.3026,EAS:0.3232,FIN:0.1481,NFE:0.2329,OTH:0.2643,ASJ:0.2367	.	.	.	.	.	.	.	.	.	.	.	.	2	.	hom
2	176957822	176957822	G	A	HOXD13	exonic	synonymous SNV	ENSG00000128714	rs2518053	ENSG00000128714:ENST00000392539:exon1:c.G204A:p.A68A	HOXD13:NM_000523:exon1:c.G204A:p.A68A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3683	.	0.447883	LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	HOXD13:uc002ukf.1:exon1:c.G204A:p.A68A	.	AFR:0.4274,AMR:0.7508,EAS:0.3192,FIN:0.3236,NFE:0.2284,OTH:0.3080,ASJ:0.2533	142989	113200;113300;186000;186300;610713;	93409;93406;295195;93403;93387;	93409|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|610713 ~93406|Postaxial syndactyly with metacarpal synostosis<br>SD5|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|186300 ~295195|SD2, Vordingborg type<br>SD2a<br>SPD, Vordingborg type<br>SPD1<br>Synpolydactyly, Vordingborg type|-|Autosomal dominant|-|186000 ~93403|Synpolydactyly|Unknown|Autosomal dominant|Infancy<br>Neonatal|186000 608180 610234 ~93387|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|113300 613382 ~	.	.	.	.	.	.	.	.	2	8(large_intestine)	0.3191
2	187487160	187487160	G	A	ITGAV	intronic	.	ENSG00000138448	rs9333288	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7458	0.7575	0.76258	0.7530	.	.	.	.	.	0	0.004	.	.	.	AFR:0.7741,AMR:0.7291,EAS:0.8623,FIN:0.7467,NFE:0.7342,OTH:0.7295,ASJ:0.7119	193210	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	2	MU26816650	het
2	187498107	187498107	T	C	ITGAV	intronic	.	ENSG00000138448	rs9333289	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2493	0.2051	0.179513	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647	.	.	.	.	.	0.3053	0.424	.	.	.	AFR:0.2113,AMR:0.0525,EAS:0.31,FIN:0.1346,NFE:0.2320,OTH:0.2992,ASJ:0.2863	193210	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	2	2(haematopoietic_and_lymphoid_tissue)	0.2495
2	187532417	187532417	G	A	ITGAV	exonic	nonsynonymous SNV	ENSG00000138448	rs2230616	ENSG00000138448:ENST00000374907:exon22:c.G2239A:p.V747I,ENSG00000138448:ENST00000261023:exon24:c.G2347A:p.V783I,ENSG00000138448:ENST00000433736:exon24:c.G2209A:p.V737I	ITGAV:NM_001145000:exon22:c.G2239A:p.V747I,ITGAV:NM_001144999:exon24:c.G2209A:p.V737I,ITGAV:NM_002210:exon24:c.G2347A:p.V783I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9978	0.9909	0.992212	0.9923	2.394	18.78	0.694	3.39	1.000	.	.	Integrin alpha-2|Integrin domain	ITGAV:uc010frs.4:exon22:c.G2239A:p.V747I,ITGAV:uc002upq.4:exon24:c.G2347A:p.V783I,ITGAV:uc010zfv.3:exon24:c.G2209A:p.V737I	-0.948	AFR:0.9732,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:1,ASJ:1	193210	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	0.002	0.62	0.000	0.39	2	MU81747102	hom
2	189862048	189862048	G	C	COL3A1	intronic	.	ENSG00000168542	rs7579815	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1263	0.1667	0.128994	0.1453	.	.	.	.	.	.	.	.	.	.	AFR:0.2106,AMR:0.0981,EAS:0.0019,FIN:0.0954,NFE:0.1375,OTH:0.1408,ASJ:0.1457	120180	130050;	286;	286|EDS IV<br>EDS type 4<br>Ehlers-Danlos syndrome type 4<br>Ehlers-Danlos syndrome type IV<br>Sack-Barabas syndrome|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|130050 ~	.	.	.	.	.	.	.	.	2	.	het
2	189862097	189862097	G	A	COL3A1	exonic	synonymous SNV	ENSG00000168542	rs7579903	ENSG00000168542:ENST00000304636:exon26:c.G1851A:p.Q617Q,ENSG00000168542:ENST00000317840:exon26:c.G1851A:p.Q617Q	COL3A1:NM_000090:exon26:c.G1851A:p.Q617Q	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1260	0.1645	0.128994	0.1452	.	.	.	.	.	.	.	.	COL3A1:uc002uqj.1:exon26:c.G1851A:p.Q617Q	.	AFR:0.2112,AMR:0.0981,EAS:0.0018,FIN:0.0954,NFE:0.1371,OTH:0.1395,ASJ:0.1457	120180	130050;	286;	286|EDS IV<br>EDS type 4<br>Ehlers-Danlos syndrome type 4<br>Ehlers-Danlos syndrome type IV<br>Sack-Barabas syndrome|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|130050 ~	.	.	.	.	.	.	.	.	2	.	het
2	189864582	189864582	T	C	COL3A1	exonic	synonymous SNV	ENSG00000168542	rs1801184	ENSG00000168542:ENST00000304636:exon32:c.T2244C:p.G748G,ENSG00000168542:ENST00000317840:exon32:c.T2244C:p.G748G	COL3A1:NM_000090:exon32:c.T2244C:p.G748G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3138	0.2850	0.212061	0.2518	.	.	.	.	.	.	.	.	COL3A1:uc002uqj.1:exon32:c.T2244C:p.G748G	.	AFR:0.2929,AMR:0.2026,EAS:0.0637,FIN:0.1812,NFE:0.2668,OTH:0.2439,ASJ:0.3079	120180	130050;	286;	286|EDS IV<br>EDS type 4<br>Ehlers-Danlos syndrome type 4<br>Ehlers-Danlos syndrome type IV<br>Sack-Barabas syndrome|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|130050 ~	.	.	.	.	.	.	.	.	2	MU4568253	het
2	189875421	189875421	T	G	COL3A1	exonic	nonsynonymous SNV	ENSG00000168542	rs1516446	ENSG00000168542:ENST00000317840:exon41:c.T3150G:p.H1050Q,ENSG00000168542:ENST00000304636:exon50:c.T4059G:p.H1353Q	COL3A1:NM_000090:exon50:c.T4059G:p.H1353Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9985	0.9949	0.996605	0.9958	0.421	6.799	1.0	1.42	0.979	.	.	Fibrillar collagen, C-terminal|Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1	COL3A1:uc002uqj.1:exon50:c.T4059G:p.H1353Q	-0.950	AFR:0.9852,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:0.9967	120180	130050;	286;	286|EDS IV<br>EDS type 4<br>Ehlers-Danlos syndrome type 4<br>Ehlers-Danlos syndrome type IV<br>Sack-Barabas syndrome|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|130050 ~	.	.	.	.	0.0	0.36	0.000	-3.715	2	MU81747200	hom
2	190718999	190718999	C	T	PMS1	exonic	nonsynonymous SNV	ENSG00000064933	rs147084726	ENSG00000064933:ENST00000409593:exon4:c.C356T:p.T119M,ENSG00000064933:ENST00000424307:exon7:c.C818T:p.T273M,ENSG00000064933:ENST00000432292:exon7:c.C473T:p.T158M,ENSG00000064933:ENST00000409823:exon8:c.C884T:p.T295M,ENSG00000064933:ENST00000418224:exon8:c.C473T:p.T158M,ENSG00000064933:ENST00000441310:exon9:c.C1001T:p.T334M,ENSG00000064933:ENST00000447232:exon9:c.C1001T:p.T334M,ENSG00000064933:ENST00000450931:exon9:c.C884T:p.T295M	PMS1:NM_001289409:exon7:c.C473T:p.T158M,PMS1:NM_001128143:exon8:c.C884T:p.T295M,PMS1:NM_001289408:exon8:c.C473T:p.T158M,PMS1:NM_001321044:exon8:c.C884T:p.T295M,PMS1:NM_001321046:exon8:c.C818T:p.T273M,PMS1:NM_000534:exon9:c.C1001T:p.T334M,PMS1:NM_001128144:exon9:c.C1001T:p.T334M,PMS1:NM_001321047:exon9:c.C1001T:p.T334M,PMS1:NM_001321045:exon10:c.C1001T:p.T334M,PMS1:NM_001321048:exon10:c.C1001T:p.T334M	clinvar: Uncertain_significance 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0010	0.0002	0.000798722	.	1.827	15.14	0.182	0.895	0.991	.	.	DNA mismatch repair protein, C-terminal|Ribosomal protein S5 domain 2-type fold|Ribosomal protein S5 domain 2-type fold, subgroup;Histidine kinase-like ATPase, C-terminal domain	PMS1:uc002urn.1:exon2:c.C5T:p.T2M,PMS1:uc002url.3:exon4:c.C356T:p.T119M,PMS1:uc010fry.1:exon7:c.C884T:p.T295M,PMS1:uc010zgd.2:exon7:c.C473T:p.T158M,PMS1:uc002urk.4:exon8:c.C884T:p.T295M,PMS1:uc010zga.1:exon8:c.C884T:p.T295M,PMS1:uc010zgb.1:exon8:c.C818T:p.T273M,PMS1:uc010zgc.2:exon8:c.C473T:p.T158M,PMS1:uc002urh.4:exon9:c.C1001T:p.T334M,PMS1:uc002uri.4:exon9:c.C1001T:p.T334M	-0.756	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0002,ASJ:0.0012	600258	.	.	.	.	.	.	.	0.46	-1.84	0.240	0.755	2	1(kidney)	0
2	191841759	191841759	G	A	STAT1	intronic	.	ENSG00000115415	rs2066804	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2260	0.2174	0.226637	LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	0	0.004	.	.	.	AFR:0.2288,AMR:0.1717,EAS:0.2550,FIN:0.4347,NFE:0.2619,OTH:0.2342,ASJ:0.1471	600555	613796;614162;614892;	319595;391487;391311;	319595|MSMD due to partial STAT1 deficiency<br>MSMD due to partial signal transducer and activator of transcription 1 deficiency<br>Mendelian susceptibility to mycobacterial diseases due to partial signal transducer and activator of transcription 1 deficiency|<1 / 1 000 000|Autosomal dominant|Childhood|614892 ~391487|-|<1 / 1 000 000|Autosomal dominant|Infancy|614162 ~391311|STAT1 deficiency|-|Autosomal recessive|-|613796 ~	~ko04062 Chemokine signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	2	1(lung)	0.2587
2	191922841	191922841	G	A	STAT4	intronic	.	ENSG00000138378	rs3024866	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6415	0.5701	0.496406	0.5778	.	.	.	.	.	0.0006	0.06	.	.	.	AFR:0.2175,AMR:0.5168,EAS:0.5229,FIN:0.7042,NFE:0.7574,OTH:0.6857,ASJ:0.7185	600558	612253;	.	.	~ko04217 Necroptosis~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko05161 Hepatitis B~ko05200 Pathways in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	2	MU13402894	het
2	198257795	198257795	T	C	SF3B1	exonic	synonymous SNV	ENSG00000115524	rs4685	ENSG00000115524:ENST00000335508:exon24:c.A3657G:p.V1219V	SF3B1:NM_012433:exon24:c.A3657G:p.V1219V	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6717	0.7360	0.71845	0.6804	.	.	.	.	.	.	.	.	SF3B1:uc002uue.3:exon24:c.A3657G:p.V1219V	.	AFR:0.8292,AMR:0.5299,EAS:0.5310,FIN:0.5539,NFE:0.6499,OTH:0.6245,ASJ:0.7517	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	9685,,9683,9684	.	,9676,9680,9677,9675,9679,9681,9678	.	.	.	.	2	MU137937	het
2	198265173	198265173	T	A	SF3B1	intronic	.	ENSG00000115524	rs788017	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6669	.	0.717851	0.6813	.	.	.	.	.	.	.	.	.	.	AFR:0.8299,AMR:0.5255,EAS:0.5281,FIN:0.5566,NFE:0.6509,OTH:0.6255,ASJ:0.7433	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	.	.	.	.	.	.	.	2	MU13407940	het
2	198265526	198265526	A	G	SF3B1	exonic	synonymous SNV	ENSG00000115524	rs788018	ENSG00000115524:ENST00000335508:exon18:c.T2631C:p.G877G	SF3B1:NM_012433:exon18:c.T2631C:p.G877G	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6708	0.7351	0.716653	0.6806	.	.	.	.	.	.	.	.	SF3B1:uc002uue.3:exon18:c.T2631C:p.G877G	.	AFR:0.8284,AMR:0.5310,EAS:0.5255,FIN:0.5545,NFE:0.6510,OTH:0.6301,ASJ:0.7450	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	9685,,9683,9684	.	,9676,9680,9677,9675,9679,9681,9678	.	.	.	.	2	MU137951	het
2	198267770	198267770	-	AA	SF3B1	intronic	.	ENSG00000115524	rs3217350	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.6743	0.7355	0.717452	0.6793	.	.	.	.	.	.	.	.	.	.	AFR:0.8259,AMR:0.5323,EAS:0.5323,FIN:0.5537,NFE:0.6492,OTH:0.6268,ASJ:0.7450	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	.	.	.	.	.	.	.	2	.	het
2	198283305	198283305	T	C	SF3B1	exonic	synonymous SNV	ENSG00000115524	rs788023	ENSG00000115524:ENST00000335508:exon5:c.A423G:p.K141K	SF3B1:NM_012433:exon5:c.A423G:p.K141K	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6725	0.7394	0.720647	0.6838	.	.	.	.	.	.	.	.	SF3B1:uc002uue.3:exon5:c.A423G:p.K141K	.	AFR:0.8395,AMR:0.5311,EAS:0.5273,FIN:0.5554,NFE:0.6508,OTH:0.6281,ASJ:0.7450	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	9685,,9683,9684	.	,9676,9680,9677,9675,9679,9681,9678	.	.	.	.	2	MU137962	het
2	202122995	202122995	A	G	CASP8	exonic	nonsynonymous SNV	ENSG00000064012	rs3769823	ENSG00000064012:ENST00000358485:exon1:c.A41G:p.K14R,ENSG00000064012:ENST00000437283:exon1:c.A41G:p.K14R	CASP8:NM_001080125:exon1:c.A41G:p.K14R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6673	0.6695	0.646366	LAML-KR|1|205|0.00487805,COCA-CN|6|321|0.0186916	-0.732	0.061	1.0	2.78	0.001	.	.	Death effector domain|Death-like domain	CASP8:uc002uxt.1:exon1:c.A41G:p.K14R	-0.995	AFR:0.6618,AMR:0.5774,EAS:0.6167,FIN:0.7326,NFE:0.6444,OTH:0.7127,ASJ:0.5658	601763	114480;114550;211980;607271;	275517;449;88673;227535;	275517|ALPS with recurrent viral infections<br>CEDS<br>Caspase 8 deficiency syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|607271 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04668 TNF signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05130 Pathogenic Escherichia coli infection~ko05134 Legionellosis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05416 Viral myocarditis ~	.	.	.	0.008	4.26	0.000	.	2	1(thyroid)	0.6714
2	202137664	202137664	T	C	CASP8	exonic	synonymous SNV	ENSG00000064012	rs571991898	ENSG00000064012:ENST00000358485:exon5:c.T771C:p.N257N,ENSG00000064012:ENST00000413726:exon5:c.T594C:p.N198N,ENSG00000064012:ENST00000392258:exon6:c.T594C:p.N198N,ENSG00000064012:ENST00000392259:exon6:c.T594C:p.N198N,ENSG00000064012:ENST00000432109:exon6:c.T594C:p.N198N	CASP8:NM_001080125:exon5:c.T771C:p.N257N,CASP8:NM_033355:exon6:c.T594C:p.N198N,CASP8:NM_033358:exon6:c.T594C:p.N198N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	0.0023	.	0.00379393	9.687e-05	.	.	.	.	.	0	0.004	.	CASP8:uc021vuz.1:exon4:c.T594C:p.N198N,CASP8:uc002uxt.1:exon5:c.T771C:p.N257N,CASP8:uc002uxo.1:exon6:c.T594C:p.N198N,CASP8:uc002uxr.1:exon6:c.T594C:p.N198N	.	AFR:0,AMR:0,EAS:0.0006,FIN:0,NFE:0,OTH:0.0020,ASJ:0	601763	114480;114550;211980;607271;	275517;449;88673;227535;	275517|ALPS with recurrent viral infections<br>CEDS<br>Caspase 8 deficiency syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|607271 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04668 TNF signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05130 Pathogenic Escherichia coli infection~ko05134 Legionellosis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	2	.	het
2	202149696	202149696	G	A	CASP8	exonic	synonymous SNV	ENSG00000064012	rs1045487	ENSG00000064012:ENST00000444430:exon2:c.G297A:p.K99K,ENSG00000064012:ENST00000264274:exon6:c.G708A:p.K236K,ENSG00000064012:ENST00000323492:exon7:c.G915A:p.K305K,ENSG00000064012:ENST00000358485:exon8:c.G1137A:p.K379K,ENSG00000064012:ENST00000392263:exon8:c.G915A:p.K305K,ENSG00000064012:ENST00000264275:exon9:c.G1011A:p.K337K,ENSG00000064012:ENST00000432109:exon9:c.G960A:p.K320K	CASP8:NM_033356:exon7:c.G915A:p.K305K,CASP8:NM_001080124:exon8:c.G915A:p.K305K,CASP8:NM_001080125:exon8:c.G1137A:p.K379K,CASP8:NM_001228:exon9:c.G1011A:p.K337K,CASP8:NM_033355:exon9:c.G960A:p.K320K	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1020	0.1062	0.175319	LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	CASP8:uc010ftf.2:exon4:c.G708A:p.K236K,CASP8:uc002uxw.1:exon7:c.G915A:p.K305K,CASP8:uc002uxq.1:exon8:c.G915A:p.K305K,CASP8:uc002uxt.1:exon8:c.G1137A:p.K379K,CASP8:uc002uxp.1:exon9:c.G1011A:p.K337K,CASP8:uc002uxr.1:exon9:c.G960A:p.K320K	.	AFR:0.0977,AMR:0.2068,EAS:0.0828,FIN:0.1938,NFE:0.0475,OTH:0.0418,ASJ:0.0358	601763	114480;114550;211980;607271;	275517;449;88673;227535;	275517|ALPS with recurrent viral infections<br>CEDS<br>Caspase 8 deficiency syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|607271 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04668 TNF signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05130 Pathogenic Escherichia coli infection~ko05134 Legionellosis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	2	2(lung)	0.0644
2	202151163	202151163	A	G	CASP8	intronic	.	ENSG00000064012	rs3769818	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7151	0.7429	0.745208	MU18189875	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,AMR:0.7305,EAS:0.5670,FIN:0.6424,NFE:0.7249,OTH:0.6720,ASJ:0.7850	601763	114480;114550;211980;607271;	275517;449;88673;227535;	275517|ALPS with recurrent viral infections<br>CEDS<br>Caspase 8 deficiency syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|607271 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04668 TNF signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05130 Pathogenic Escherichia coli infection~ko05134 Legionellosis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	2	2(upper_aerodigestive_tract)	0.7251
2	209101906	209101906	A	-	IDH1	intronic	.	ENSG00000138413	rs57383668	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9898	.	0.982628	0.9861	.	.	.	.	.	.	.	.	.	.	AFR:0.9526,AMR:0.9964,EAS:1,FIN:1,NFE:0.9994,OTH:0.9938,ASJ:1	147700	137800;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	~ko00020 Citrate cycle (TCA cycle)~ko00480 Glutathione metabolism~ko00720 Carbon fixation pathways in prokaryotes~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko01210 2-Oxocarboxylic acid metabolism~ko01230 Biosynthesis of amino acids~ko04146 Peroxisome~~M00009 Citrate cycle (TCA cycle, Krebs cycle)~M00010 Citrate cycle, first carbon oxidation, oxaloacetate =>~~M00173 Reductive citrate cycle (Arnon-Buchanan cycle)~M00740 Methylaspartate cycle ~	.	.	.	.	.	.	.	2	.	hom
2	211421452	211421452	-	TCT	CPS1	exonic	nonframeshift insertion	ENSG00000021826	rs61509952	ENSG00000021826:ENST00000430249:exon2:c.13_14insTCT:p.I5delinsIF,ENSG00000021826:ENST00000523702:exon2:c.13_14insTCT:p.I5delinsIF	CPS1:NM_001369256:exon2:c.28_29insTCT:p.I10delinsIF	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4350	0.4615	0.477037	0.4418	.	.	.	.	.	.	.	.	CPS1:uc010fur.3:exon2:c.13_14insTCT:p.I5delinsIF	.	AFR:0.5763,AMR:0.5251,EAS:0.3760,FIN:0.4139,NFE:0.3741,OTH:0.4302,ASJ:0.3940	608307	237300;615371;	147;	147|CPS1 deficiency<br>CPS1D<br>Carbamoyl-phosphate synthetase I deficiency<br>Carbamoyl-phosphate synthetase deficiency|1-9 / 1 000 000|Autosomal recessive|Neonatal<br>All ages|237300 ~	.	.	.	.	.	.	.	.	2	MU2185764	hom
2	211456637	211456637	A	G	CPS1	exonic	nonsynonymous SNV	ENSG00000021826	rs1047883	ENSG00000021826:ENST00000233072:exon10:c.A1030G:p.T344A,ENSG00000021826:ENST00000430249:exon11:c.A1048G:p.T350A	CPS1:NM_001875:exon10:c.A1030G:p.T344A,CPS1:NM_001122633:exon11:c.A1030G:p.T344A,CPS1:NM_001369256:exon11:c.A1063G:p.T355A,CPS1:NM_001369257:exon12:c.A1030G:p.T344A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5697	0.5917	.	0.5769	0.154	4.189	0.067	-0.92	0.417	.	.	Carbamoyl-phosphate synthase small subunit, GATase1 domain|Class I glutamine amidotransferase-like|Glutamine amidotransferase	CPS1:uc002vee.4:exon10:c.A1030G:p.T344A,CPS1:uc010fur.3:exon11:c.A1048G:p.T350A	-0.903	AFR:0.6195,AMR:0.4952,EAS:0.5581,FIN:0.6195,NFE:0.5478,OTH:0.5938,ASJ:0.5638	608307	237300;615371;	147;	147|CPS1 deficiency<br>CPS1D<br>Carbamoyl-phosphate synthetase I deficiency<br>Carbamoyl-phosphate synthetase deficiency|1-9 / 1 000 000|Autosomal recessive|Neonatal<br>All ages|237300 ~	.	.	.	.	0.001	-2.59	0.000	1.495	2	MU4566590	unknown
2	211456639	211456639	C	T	CPS1	exonic	synonymous SNV	ENSG00000021826	rs2229589	ENSG00000021826:ENST00000233072:exon10:c.C1032T:p.T344T,ENSG00000021826:ENST00000430249:exon11:c.C1050T:p.T350T	CPS1:NM_001875:exon10:c.C1032T:p.T344T,CPS1:NM_001122633:exon11:c.C1032T:p.T344T,CPS1:NM_001369256:exon11:c.C1065T:p.T355T,CPS1:NM_001369257:exon12:c.C1032T:p.T344T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5736	0.5976	0.591254	0.5896	.	.	.	.	.	.	.	.	CPS1:uc002vee.4:exon10:c.C1032T:p.T344T,CPS1:uc010fur.3:exon11:c.C1050T:p.T350T	.	AFR:0.6634,AMR:0.5024,EAS:0.5581,FIN:0.6195,NFE:0.5481,OTH:0.5938,ASJ:0.5638	608307	237300;615371;	147;	147|CPS1 deficiency<br>CPS1D<br>Carbamoyl-phosphate synthetase I deficiency<br>Carbamoyl-phosphate synthetase deficiency|1-9 / 1 000 000|Autosomal recessive|Neonatal<br>All ages|237300 ~	.	.	.	.	.	.	.	.	2	MU13944213	unknown
2	211481257	211481257	C	G	CPS1	exonic	synonymous SNV	ENSG00000021826	rs2287599	ENSG00000021826:ENST00000451903:exon11:c.C1326G:p.G442G,ENSG00000021826:ENST00000233072:exon21:c.C2679G:p.G893G,ENSG00000021826:ENST00000430249:exon22:c.C2697G:p.G899G	CPS1:NM_001875:exon21:c.C2679G:p.G893G,CPS1:NM_001122633:exon22:c.C2679G:p.G893G,CPS1:NM_001369256:exon22:c.C2712G:p.G904G,CPS1:NM_001369257:exon23:c.C2679G:p.G893G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5861	0.6622	0.649161	0.6316	.	.	.	.	.	.	.	.	CPS1:uc010fus.3:exon11:c.C1326G:p.G442G,CPS1:uc002vee.4:exon21:c.C2679G:p.G893G,CPS1:uc010fur.3:exon22:c.C2697G:p.G899G	.	AFR:0.8648,AMR:0.5155,EAS:0.5,FIN:0.5673,NFE:0.5358,OTH:0.5680,ASJ:0.5767	608307	237300;615371;	147;	147|CPS1 deficiency<br>CPS1D<br>Carbamoyl-phosphate synthetase I deficiency<br>Carbamoyl-phosphate synthetase deficiency|1-9 / 1 000 000|Autosomal recessive|Neonatal<br>All ages|237300 ~	.	.	.	.	.	.	.	.	2	MU13944242	hom
2	211527828	211527828	T	-	CPS1	intronic	.	ENSG00000021826	rs397703682	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.7547	.	0.77476	0.8552	.	.	.	.	.	.	.	.	.	.	AFR:0.7533,AMR:0.8290,EAS:0.9375,FIN:0.9002,NFE:0.8987,OTH:0.9048,ASJ:0.9190	608307	237300;615371;	147;	147|CPS1 deficiency<br>CPS1D<br>Carbamoyl-phosphate synthetase I deficiency<br>Carbamoyl-phosphate synthetase deficiency|1-9 / 1 000 000|Autosomal recessive|Neonatal<br>All ages|237300 ~	.	.	.	.	.	.	.	.	2	.	hom
2	212251864	212251864	T	C	ERBB4	exonic	synonymous SNV	ENSG00000178568	rs3748962	ENSG00000178568:ENST00000436443:exon26:c.A3147G:p.V1049V,ENSG00000178568:ENST00000342788:exon27:c.A3195G:p.V1065V,ENSG00000178568:ENST00000402597:exon27:c.A3165G:p.V1055V	ERBB4:NM_001042599:exon26:c.A3147G:p.V1049V,ERBB4:NM_005235:exon27:c.A3195G:p.V1065V	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.2954	0.2527	0.223043	1(breast)	.	.	.	.	.	.	.	.	ERBB4:uc002veh.1:exon26:c.A3147G:p.V1049V,ERBB4:uc010zjj.1:exon26:c.A3117G:p.V1039V,ERBB4:uc002veg.1:exon27:c.A3195G:p.V1065V,ERBB4:uc010zji.1:exon27:c.A3165G:p.V1055V	.	AFR:1(urinary_tract),AMR:1(lung),EAS:MU159309,FIN:LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,NFE:0.2698,OTH:0.0988,ASJ:1(haematopoietic_and_lymphoid_tissue)	600543	615515;	803;	803|ALS<br>Charcot disease<br>Lou Gehrig disease|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Adult|105400 205250 300857 606070 606640 608030 608031 608627 611895 612069 612577 613435 613954 614696 614808 615426 615515 616208 616437 ~	~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04151 PI3K-Akt signaling pathway~ko05205 Proteoglycans in cancer ~	,4763,4764	.	.	.	.	.	.	2	5(large_intestine)	0.2530
2	212578380	212578380	A	-	ERBB4	intronic	.	ENSG00000178568	rs397987661	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.4628	.	0.442891	0.3497	.	.	.	.	.	.	.	.	.	.	AFR:0.3398,AMR:0.3713,EAS:0.2683,FIN:0.4472,NFE:0.3540,OTH:0.3663,ASJ:0.236	600543	615515;	803;	803|ALS<br>Charcot disease<br>Lou Gehrig disease|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Adult|105400 205250 300857 606070 606640 608030 608031 608627 611895 612069 612577 613435 613954 614696 614808 615426 615515 616208 616437 ~	~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04151 PI3K-Akt signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	2	.	hom
2	215603804	215603804	T	A	BARD1	intronic	.	ENSG00000138376	rs2034250	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.297724	0.2956	.	.	.	.	.	.	.	.	.	.	AFR:0.2751,AMR:0.2721,EAS:0.3973,FIN:0.3766,NFE:0.2762,OTH:0.3258,ASJ:0.3377	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	2	.	het
2	215632192	215632192	G	A	BARD1	intronic	.	ENSG00000138376	rs5031011	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3614	0.3353	0.352236	0.3655	.	.	.	.	.	.	.	.	.	.	AFR:0.3481,AMR:0.2938,EAS:0.3850,FIN:0.4501,NFE:0.3537,OTH:0.4131,ASJ:0.4073	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	2	MU757044	het
2	215632255	215632255	C	T	BARD1	exonic	nonsynonymous SNV	ENSG00000138376	rs2070094	ENSG00000138376:ENST00000449967:exon5:c.G1087A:p.V363M,ENSG00000138376:ENST00000260947:exon6:c.G1519A:p.V507M	BARD1:NM_001282543:exon5:c.G1462A:p.V488M,BARD1:NM_000465:exon6:c.G1519A:p.V507M	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3783	0.2806	0.366214	0.3845	0.209	4.771	0.269	-11.3	0.313	.	.	Ankyrin repeat-containing domain	BARD1:uc021vwf.1:exon4:c.G1228A:p.V410M,BARD1:uc010zjm.1:exon5:c.G1087A:p.V363M,BARD1:uc021vwd.1:exon5:c.G217A:p.V73M,BARD1:uc021vwe.1:exon5:c.G1462A:p.V488M,BARD1:uc002veu.2:exon6:c.G1519A:p.V507M,BARD1:uc021vwj.1:exon6:c.G1111A:p.V371M	-1.097	AFR:0.3705,AMR:0.3103,EAS:0.3806,FIN:0.4676,NFE:0.3741,OTH:0.4286,ASJ:0.4238	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.001	-0.17	0.000	1.23	2	MU152802	unknown
2	215632256	215632256	A	G	BARD1	exonic	synonymous SNV	ENSG00000138376	rs2070093	ENSG00000138376:ENST00000449967:exon5:c.T1086C:p.H362H,ENSG00000138376:ENST00000260947:exon6:c.T1518C:p.H506H	BARD1:NM_001282543:exon5:c.T1461C:p.H487H,BARD1:NM_000465:exon6:c.T1518C:p.H506H	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8134	0.7138	0.770567	0.7658	.	.	.	.	.	.	.	.	BARD1:uc021vwf.1:exon4:c.T1227C:p.H409H,BARD1:uc010zjm.1:exon5:c.T1086C:p.H362H,BARD1:uc021vwd.1:exon5:c.T216C:p.H72H,BARD1:uc021vwe.1:exon5:c.T1461C:p.H487H,BARD1:uc002veu.2:exon6:c.T1518C:p.H506H,BARD1:uc021vwj.1:exon6:c.T1110C:p.H370H	.	AFR:0.6055,AMR:0.7883,EAS:0.9543,FIN:0.8947,NFE:0.8028,OTH:0.8286,ASJ:0.7848	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	2	MU31491380	unknown
2	215634055	215634055	C	T	BARD1	intronic	.	ENSG00000138376	rs6704780	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3818	0.3595	0.365216	0.3855	.	.	.	.	.	.	.	.	.	.	AFR:0.3717,AMR:0.3110,EAS:0.3835,FIN:0.4670,NFE:0.3754,OTH:0.4284,ASJ:0.4267	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	2	MU757049	het
2	215645464	215645464	C	G	BARD1	exonic	nonsynonymous SNV	ENSG00000138376	rs2229571	ENSG00000138376:ENST00000449967:exon3:c.G702C:p.R234S,ENSG00000138376:ENST00000260947:exon4:c.G1134C:p.R378S	BARD1:NM_001282543:exon3:c.G1077C:p.R359S,BARD1:NM_000465:exon4:c.G1134C:p.R378S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.5487	0.5318	0.459265	0.5519	0.673	8.652	0.174	-1.03	0.050	.	.	.	BARD1:uc021vwf.1:exon2:c.G843C:p.R281S,BARD1:uc010zjm.1:exon3:c.G702C:p.R234S,BARD1:uc021vwe.1:exon3:c.G1077C:p.R359S,BARD1:uc002veu.2:exon4:c.G1134C:p.R378S	-0.921	AFR:0.4006,AMR:0.4376,EAS:0.3851,FIN:0.6827,NFE:0.6283,OTH:0.6214,ASJ:0.5894	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.024	-0.67	0.000	1.67	2	MU152809	hom
2	215674224	215674224	G	A	BARD1	exonic	nonsynonymous SNV	ENSG00000138376	rs1048108	ENSG00000138376:ENST00000260947:exon1:c.C70T:p.P24S,ENSG00000138376:ENST00000421162:exon1:c.C70T:p.P24S,ENSG00000138376:ENST00000455743:exon1:c.C70T:p.P24S	BARD1:NM_000465:exon1:c.C70T:p.P24S,BARD1:NM_001282543:exon1:c.C70T:p.P24S,BARD1:NM_001282545:exon1:c.C70T:p.P24S,BARD1:NM_001282548:exon1:c.C70T:p.P24S,BARD1:NM_001282549:exon1:c.C70T:p.P24S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4377	0.3031	0.33127	0.3408	1.242	11.97	0.184	3.1	0.116	.	.	.	BARD1:uc002veu.2:exon1:c.C70T:p.P24S,BARD1:uc021vwe.1:exon1:c.C70T:p.P24S,BARD1:uc021vwg.1:exon1:c.C70T:p.P24S,BARD1:uc021vwh.1:exon1:c.C70T:p.P24S,BARD1:uc021vwi.1:exon1:c.C70T:p.P24S,BARD1:uc021vwj.1:exon1:c.C70T:p.P24S	-1.043	AFR:0.2121,AMR:0.4141,EAS:0.3779,FIN:0.4177,NFE:0.3819,OTH:0.4378,ASJ:0.41	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.002	-0.72	0.000	1.195	2	MU152818	het
2	216229692	216229692	A	G	FN1	exonic	synonymous SNV	ENSG00000115414	rs11651	ENSG00000115414:ENST00000456923:exon19:c.T3039C:p.Y1013Y,ENSG00000115414:ENST00000345488:exon41:c.T6282C:p.Y2094Y,ENSG00000115414:ENST00000346544:exon42:c.T6363C:p.Y2121Y,ENSG00000115414:ENST00000356005:exon42:c.T6618C:p.Y2206Y,ENSG00000115414:ENST00000357867:exon42:c.T6258C:p.Y2086Y,ENSG00000115414:ENST00000359671:exon43:c.T6888C:p.Y2296Y,ENSG00000115414:ENST00000421182:exon43:c.T6450C:p.Y2150Y,ENSG00000115414:ENST00000432072:exon43:c.T6531C:p.Y2177Y,ENSG00000115414:ENST00000443816:exon43:c.T6525C:p.Y2175Y,ENSG00000115414:ENST00000336916:exon44:c.T6795C:p.Y2265Y,ENSG00000115414:ENST00000354785:exon44:c.T7161C:p.Y2387Y,ENSG00000115414:ENST00000446046:exon44:c.T6720C:p.Y2240Y,ENSG00000115414:ENST00000323926:exon45:c.T7068C:p.Y2356Y	FN1:NM_001365523:exon42:c.T6543C:p.Y2181Y,FN1:NM_212474:exon42:c.T6258C:p.Y2086Y,FN1:NM_212476:exon42:c.T6618C:p.Y2206Y,FN1:NM_001306130:exon43:c.T6531C:p.Y2177Y,FN1:NM_001306131:exon43:c.T6525C:p.Y2175Y,FN1:NM_001306132:exon43:c.T6450C:p.Y2150Y,FN1:NM_001365517:exon43:c.T6891C:p.Y2297Y,FN1:NM_001365518:exon43:c.T6888C:p.Y2296Y,FN1:NM_001365519:exon43:c.T6816C:p.Y2272Y,FN1:NM_001365520:exon43:c.T6813C:p.Y2271Y,FN1:NM_001365524:exon43:c.T6528C:p.Y2176Y,FN1:NM_001365521:exon44:c.T6798C:p.Y2266Y,FN1:NM_001365522:exon44:c.T6723C:p.Y2241Y,FN1:NM_002026:exon44:c.T6795C:p.Y2265Y,FN1:NM_212478:exon44:c.T6720C:p.Y2240Y,FN1:NM_212482:exon44:c.T7161C:p.Y2387Y,FN1:NM_001306129:exon45:c.T7068C:p.Y2356Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4079	0.2481	0.282748	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	FN1:uc002vez.3:exon17:c.T1650C:p.Y550Y,FN1:uc010zjp.2:exon19:c.T2772C:p.Y924Y,FN1:uc002vfg.3:exon42:c.T6618C:p.Y2206Y,FN1:uc002vfh.3:exon42:c.T6258C:p.Y2086Y,FN1:uc002vfb.3:exon43:c.T6525C:p.Y2175Y,FN1:uc002vfc.3:exon43:c.T6450C:p.Y2150Y,FN1:uc002vfj.3:exon43:c.T6531C:p.Y2177Y,FN1:uc002vfa.3:exon44:c.T7161C:p.Y2387Y,FN1:uc002vfe.3:exon44:c.T6795C:p.Y2265Y,FN1:uc002vff.3:exon44:c.T6720C:p.Y2240Y,FN1:uc002vfi.3:exon45:c.T7068C:p.Y2356Y	.	AFR:0.2534,AMR:0.0982,EAS:0.3940,FIN:0.2816,NFE:0.2758,OTH:0.3266,ASJ:0.3369	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	1(large_intestine)	0.2751
2	216235089	216235089	C	T	FN1	exonic	nonsynonymous SNV	ENSG00000115414	rs1250209	ENSG00000115414:ENST00000456923:exon16:c.G2659A:p.V887I,ENSG00000115414:ENST00000356005:exon39:c.G6238A:p.V2080I,ENSG00000115414:ENST00000357867:exon39:c.G5878A:p.V1960I,ENSG00000115414:ENST00000346544:exon40:c.G6148A:p.V2050I,ENSG00000115414:ENST00000359671:exon40:c.G6508A:p.V2170I,ENSG00000115414:ENST00000421182:exon40:c.G6070A:p.V2024I,ENSG00000115414:ENST00000432072:exon40:c.G6151A:p.V2051I,ENSG00000115414:ENST00000443816:exon40:c.G6145A:p.V2049I,ENSG00000115414:ENST00000336916:exon41:c.G6415A:p.V2139I,ENSG00000115414:ENST00000354785:exon41:c.G6781A:p.V2261I,ENSG00000115414:ENST00000446046:exon41:c.G6340A:p.V2114I,ENSG00000115414:ENST00000323926:exon42:c.G6688A:p.V2230I	FN1:NM_001365523:exon39:c.G6163A:p.V2055I,FN1:NM_212474:exon39:c.G5878A:p.V1960I,FN1:NM_212476:exon39:c.G6238A:p.V2080I,FN1:NM_001306130:exon40:c.G6151A:p.V2051I,FN1:NM_001306131:exon40:c.G6145A:p.V2049I,FN1:NM_001306132:exon40:c.G6070A:p.V2024I,FN1:NM_001365517:exon40:c.G6511A:p.V2171I,FN1:NM_001365518:exon40:c.G6508A:p.V2170I,FN1:NM_001365519:exon40:c.G6436A:p.V2146I,FN1:NM_001365520:exon40:c.G6433A:p.V2145I,FN1:NM_001365524:exon40:c.G6148A:p.V2050I,FN1:NM_001365521:exon41:c.G6418A:p.V2140I,FN1:NM_001365522:exon41:c.G6343A:p.V2115I,FN1:NM_002026:exon41:c.G6415A:p.V2139I,FN1:NM_212478:exon41:c.G6340A:p.V2114I,FN1:NM_212482:exon41:c.G6781A:p.V2261I,FN1:NM_001306129:exon42:c.G6688A:p.V2230I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	1.0000	0.9998	0.9998	0.9998	3.072	22.4	1.0	5.6	0.999	.	.	Fibronectin type III|Immunoglobulin-like fold;Fibronectin, type I	FN1:uc010fvd.1:exon7:c.G961A:p.V321I,FN1:uc010fvc.1:exon11:c.G1507A:p.V503I,FN1:uc002vez.3:exon14:c.G1270A:p.V424I,FN1:uc010zjp.2:exon16:c.G2392A:p.V798I,FN1:uc002vfg.3:exon39:c.G6238A:p.V2080I,FN1:uc002vfh.3:exon39:c.G5878A:p.V1960I,FN1:uc002vfb.3:exon40:c.G6145A:p.V2049I,FN1:uc002vfc.3:exon40:c.G6070A:p.V2024I,FN1:uc002vfj.3:exon40:c.G6151A:p.V2051I,FN1:uc002vfa.3:exon41:c.G6781A:p.V2261I,FN1:uc002vfe.3:exon41:c.G6415A:p.V2139I,FN1:uc002vff.3:exon41:c.G6340A:p.V2114I,FN1:uc002vfi.3:exon42:c.G6688A:p.V2230I	-0.928	AFR:0.9994,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.0	0.29	0.000	-0.455	2	MU81750207	hom
2	216249587	216249587	C	T	FN1	exonic	synonymous SNV	ENSG00000115414	rs13652	ENSG00000115414:ENST00000456923:exon5:c.G873A:p.E291E,ENSG00000115414:ENST00000336916:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000345488:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000346544:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000356005:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000357009:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000357867:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000359671:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000421182:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000443816:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000446046:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000323926:exon29:c.G4725A:p.E1575E,ENSG00000115414:ENST00000354785:exon29:c.G4725A:p.E1575E,ENSG00000115414:ENST00000432072:exon29:c.G4725A:p.E1575E	FN1:NM_001306131:exon28:c.G4452A:p.E1484E,FN1:NM_001306132:exon28:c.G4452A:p.E1484E,FN1:NM_001365518:exon28:c.G4452A:p.E1484E,FN1:NM_001365520:exon28:c.G4452A:p.E1484E,FN1:NM_001365523:exon28:c.G4452A:p.E1484E,FN1:NM_001365524:exon28:c.G4452A:p.E1484E,FN1:NM_002026:exon28:c.G4452A:p.E1484E,FN1:NM_212474:exon28:c.G4452A:p.E1484E,FN1:NM_212476:exon28:c.G4452A:p.E1484E,FN1:NM_212478:exon28:c.G4452A:p.E1484E,FN1:NM_001306129:exon29:c.G4725A:p.E1575E,FN1:NM_001306130:exon29:c.G4725A:p.E1575E,FN1:NM_001365517:exon29:c.G4725A:p.E1575E,FN1:NM_001365519:exon29:c.G4725A:p.E1575E,FN1:NM_001365521:exon29:c.G4725A:p.E1575E,FN1:NM_001365522:exon29:c.G4725A:p.E1575E,FN1:NM_212482:exon29:c.G4725A:p.E1575E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8752	0.8493	0.86861	0.8734	.	.	.	.	.	.	.	.	FN1:uc010zjp.2:exon5:c.G606A:p.E202E,FN1:uc002vfb.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfc.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfe.3:exon28:c.G4452A:p.E1484E,FN1:uc002vff.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfg.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfh.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfa.3:exon29:c.G4725A:p.E1575E,FN1:uc002vfi.3:exon29:c.G4725A:p.E1575E,FN1:uc002vfj.3:exon29:c.G4725A:p.E1575E	.	AFR:0.8131,AMR:0.8890,EAS:1,FIN:0.9270,NFE:0.8818,OTH:0.8890,ASJ:0.8046	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU81750265	hom
2	216253039	216253039	G	C	FN1	intronic	.	ENSG00000115414	rs1250215	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5491	0.5241	0.411741	0.5267	.	.	.	.	.	.	.	.	.	.	AFR:0.3086,AMR:0.4880,EAS:0.2151,FIN:0.6778,NFE:0.6522,OTH:0.5939,ASJ:0.4073	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU25472968	hom
2	216269095	216269095	C	T	FN1	intronic	.	ENSG00000115414	rs13306359	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3648	0.3458	0.286941	0.3347	.	.	.	.	.	.	.	.	.	.	AFR:0.2350,AMR:0.3041,EAS:0.0686,FIN:0.3869,NFE:0.4101,OTH:0.3727,ASJ:0.3245	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU82177168	hom
2	216269209	216269209	T	G	FN1	exonic	synonymous SNV	ENSG00000115414	rs1053238	ENSG00000115414:ENST00000323926:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000336916:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000345488:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000346544:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000354785:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000356005:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000357009:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000357867:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000359671:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000421182:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000432072:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000443816:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000446046:exon20:c.A3156C:p.P1052P	FN1:NM_001306129:exon20:c.A3156C:p.P1052P,FN1:NM_001306130:exon20:c.A3156C:p.P1052P,FN1:NM_001306131:exon20:c.A3156C:p.P1052P,FN1:NM_001306132:exon20:c.A3156C:p.P1052P,FN1:NM_001365517:exon20:c.A3156C:p.P1052P,FN1:NM_001365518:exon20:c.A3156C:p.P1052P,FN1:NM_001365519:exon20:c.A3156C:p.P1052P,FN1:NM_001365520:exon20:c.A3156C:p.P1052P,FN1:NM_001365521:exon20:c.A3156C:p.P1052P,FN1:NM_001365522:exon20:c.A3156C:p.P1052P,FN1:NM_001365523:exon20:c.A3156C:p.P1052P,FN1:NM_001365524:exon20:c.A3156C:p.P1052P,FN1:NM_002026:exon20:c.A3156C:p.P1052P,FN1:NM_212474:exon20:c.A3156C:p.P1052P,FN1:NM_212476:exon20:c.A3156C:p.P1052P,FN1:NM_212478:exon20:c.A3156C:p.P1052P,FN1:NM_212482:exon20:c.A3156C:p.P1052P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3643	0.3462	0.286741	0.3376	.	.	.	.	.	.	.	.	FN1:uc002vfa.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfb.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfc.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfe.3:exon20:c.A3156C:p.P1052P,FN1:uc002vff.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfg.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfh.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfi.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfj.3:exon20:c.A3156C:p.P1052P	.	AFR:0.2361,AMR:0.3062,EAS:0.0698,FIN:0.3954,NFE:0.4123,OTH:0.3724,ASJ:0.3245	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU82177191	hom
2	216269254	216269254	T	G	FN1	exonic	synonymous SNV	ENSG00000115414	rs7589580	ENSG00000115414:ENST00000323926:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000336916:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000345488:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000346544:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000354785:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000356005:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000357009:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000357867:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000359671:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000421182:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000432072:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000443816:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000446046:exon20:c.A3111C:p.G1037G	FN1:NM_001306129:exon20:c.A3111C:p.G1037G,FN1:NM_001306130:exon20:c.A3111C:p.G1037G,FN1:NM_001306131:exon20:c.A3111C:p.G1037G,FN1:NM_001306132:exon20:c.A3111C:p.G1037G,FN1:NM_001365517:exon20:c.A3111C:p.G1037G,FN1:NM_001365518:exon20:c.A3111C:p.G1037G,FN1:NM_001365519:exon20:c.A3111C:p.G1037G,FN1:NM_001365520:exon20:c.A3111C:p.G1037G,FN1:NM_001365521:exon20:c.A3111C:p.G1037G,FN1:NM_001365522:exon20:c.A3111C:p.G1037G,FN1:NM_001365523:exon20:c.A3111C:p.G1037G,FN1:NM_001365524:exon20:c.A3111C:p.G1037G,FN1:NM_002026:exon20:c.A3111C:p.G1037G,FN1:NM_212474:exon20:c.A3111C:p.G1037G,FN1:NM_212476:exon20:c.A3111C:p.G1037G,FN1:NM_212478:exon20:c.A3111C:p.G1037G,FN1:NM_212482:exon20:c.A3111C:p.G1037G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3644	0.3462	0.286941	0.3384	.	.	.	.	.	.	.	.	FN1:uc002vfa.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfb.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfc.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfe.3:exon20:c.A3111C:p.G1037G,FN1:uc002vff.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfg.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfh.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfi.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfj.3:exon20:c.A3111C:p.G1037G	.	AFR:0.237,AMR:0.3079,EAS:0.0699,FIN:0.3945,NFE:0.4131,OTH:0.3760,ASJ:0.3245	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU82177210	hom
2	216272900	216272900	T	G	FN1	exonic	nonsynonymous SNV	ENSG00000115414	rs2577301	ENSG00000115414:ENST00000323926:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000336916:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000345488:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000346544:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000354785:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000356005:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000357009:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000357867:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000359671:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000421182:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000432072:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000443816:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000446046:exon17:c.A2449C:p.T817P	FN1:NM_001306129:exon17:c.A2449C:p.T817P,FN1:NM_001306130:exon17:c.A2449C:p.T817P,FN1:NM_001306131:exon17:c.A2449C:p.T817P,FN1:NM_001306132:exon17:c.A2449C:p.T817P,FN1:NM_001365517:exon17:c.A2449C:p.T817P,FN1:NM_001365518:exon17:c.A2449C:p.T817P,FN1:NM_001365519:exon17:c.A2449C:p.T817P,FN1:NM_001365520:exon17:c.A2449C:p.T817P,FN1:NM_001365521:exon17:c.A2449C:p.T817P,FN1:NM_001365522:exon17:c.A2449C:p.T817P,FN1:NM_001365523:exon17:c.A2449C:p.T817P,FN1:NM_001365524:exon17:c.A2449C:p.T817P,FN1:NM_002026:exon17:c.A2449C:p.T817P,FN1:NM_212474:exon17:c.A2449C:p.T817P,FN1:NM_212476:exon17:c.A2449C:p.T817P,FN1:NM_212478:exon17:c.A2449C:p.T817P,FN1:NM_212482:exon17:c.A2449C:p.T817P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	1.0000	0.9999	0.9998	0.9998	1.626	14.00	0.314	5.93	0.070	.	.	Fibronectin type III|Immunoglobulin-like fold	FN1:uc002vfa.3:exon17:c.A2449C:p.T817P,FN1:uc002vfb.3:exon17:c.A2449C:p.T817P,FN1:uc002vfc.3:exon17:c.A2449C:p.T817P,FN1:uc002vfe.3:exon17:c.A2449C:p.T817P,FN1:uc002vff.3:exon17:c.A2449C:p.T817P,FN1:uc002vfg.3:exon17:c.A2449C:p.T817P,FN1:uc002vfh.3:exon17:c.A2449C:p.T817P,FN1:uc002vfi.3:exon17:c.A2449C:p.T817P,FN1:uc002vfj.3:exon17:c.A2449C:p.T817P	-0.957	AFR:0.9995,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.0	0.51	0.000	-0.69	2	MU81750388	hom
2	216274853	216274853	-	AC	FN1	intronic	.	ENSG00000115414	rs567632293	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2816	.	0.23742	0.3057	.	.	.	.	.	.	.	.	.	.	AFR:0.2012,AMR:0.2896,EAS:0.0704,FIN:0.3596,NFE:0.3779,OTH:0.3387,ASJ:0.3438	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	.	hom
2	217012901	217012901	A	G	XRCC5	exonic	synonymous SNV	ENSG00000079246	rs207906	ENSG00000079246:ENST00000392132:exon14:c.A1572G:p.T524T,ENSG00000079246:ENST00000392133:exon16:c.A1572G:p.T524T	XRCC5:NM_021141:exon14:c.A1572G:p.T524T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8710	0.8732	0.882788	0.8815	.	.	.	.	.	.	.	.	XRCC5:uc002vfz.3:exon11:c.A1230G:p.T410T,XRCC5:uc002vfy.3:exon14:c.A1572G:p.T524T	.	AFR:0.8683,AMR:0.9093,EAS:0.9220,FIN:0.9187,NFE:0.8729,OTH:0.9083,ASJ:0.8742	194364	.	.	.	.	.	.	.	.	.	.	.	2	MU26214825	het
2	220022176	220022176	C	T	NHEJ1	intronic	.	ENSG00000187736;ENSG00000213901	rs6436120	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9646	0.9163	0.902356	0.9324	.	.	.	.	.	.	.	.	.	.	AFR:0.7672,AMR:0.9785,EAS:1,FIN:1,NFE:0.9984,OTH:0.9827,ASJ:0.9868	611290	611291;	169079;	169079|Cernunnos XLFD<br>Cernunnos deficiency<br>Combined immunodeficiency-microcephaly-growth retardation-sensitivity to ionizing radiation syndrome<br>NHEJ1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|611291 ~	.	.	.	.	.	.	.	.	2	MU81751416	hom
2	220466344	220466344	-	T	STK11IP	intronic	.	ENSG00000144589	rs397735129	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.5384	.	0.591653	0.8052	.	.	.	.	.	.	.	.	.	.	AFR:0.5218,AMR:0.8675,EAS:0.9961,FIN:0.7952,NFE:0.9438,OTH:0.9109,ASJ:0.8881	607172	.	.	.	.	.	.	.	.	.	.	.	2	.	hom
2	220473355	220473355	G	A	STK11IP	exonic	nonsynonymous SNV	ENSG00000144589	rs673951	ENSG00000144589:ENST00000295641:exon15:c.G1687A:p.V563I,ENSG00000144589:ENST00000456909:exon15:c.G1654A:p.V552I	STK11IP:NM_052902:exon15:c.G1654A:p.V552I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3671	0.2519	0.350439	0.3047	0.176	4.425	0.253	0.456	0.001	.	.	.	STK11IP:uc002vmm.1:exon14:c.G1654A:p.V552I,STK11IP:uc010zll.2:exon14:c.G1558A:p.V520I,STK11IP:uc002vml.3:exon15:c.G1687A:p.V563I	-1.030	AFR:0.0784,AMR:0.3652,EAS:0.6822,FIN:0.4357,NFE:0.3574,OTH:0.3640,ASJ:0.3344	607172	.	.	.	.	.	.	.	0.035	3.5	0.000	1.32	2	MU738070	het
2	220476443	220476443	C	T	STK11IP	exonic	nonsynonymous SNV	ENSG00000144589	rs627530	ENSG00000144589:ENST00000295641:exon18:c.C2255T:p.S752F,ENSG00000144589:ENST00000456909:exon18:c.C2222T:p.S741F	STK11IP:NM_052902:exon18:c.C2222T:p.S741F	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9376	0.8398	0.839058	0.8456	1.670	14.24	0.054	1.31	0.000	.	.	.	STK11IP:uc002vml.3:exon18:c.C2255T:p.S752F	-1.018	AFR:0.5283,AMR:0.9642,EAS:0.9975,FIN:0.9547,NFE:0.9720,OTH:0.9517,ASJ:0.9570	607172	.	.	.	.	.	.	.	0.004	3.48	0.000	1.6	2	MU81752072	hom
2	223161889	223161889	A	G	PAX3	exonic	synonymous SNV	ENSG00000135903	rs12623857	ENSG00000135903:ENST00000258387:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000336840:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000344493:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000350526:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000392069:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000392070:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000409551:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000409828:exon2:c.T129C:p.G43G	PAX3:NM_000438:exon2:c.T129C:p.G43G,PAX3:NM_001127366:exon2:c.T129C:p.G43G,PAX3:NM_013942:exon2:c.T129C:p.G43G,PAX3:NM_181457:exon2:c.T129C:p.G43G,PAX3:NM_181458:exon2:c.T129C:p.G43G,PAX3:NM_181459:exon2:c.T129C:p.G43G,PAX3:NM_181460:exon2:c.T129C:p.G43G,PAX3:NM_181461:exon2:c.T129C:p.G43G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8872	0.8465	0.904353	0.8514	.	.	.	.	.	.	.	.	PAX3:uc002vmt.2:exon2:c.T129C:p.G43G,PAX3:uc002vmv.2:exon2:c.T129C:p.G43G,PAX3:uc002vmw.2:exon2:c.T129C:p.G43G,PAX3:uc002vmx.2:exon2:c.T129C:p.G43G,PAX3:uc002vmy.2:exon2:c.T129C:p.G43G,PAX3:uc002vmz.2:exon2:c.T129C:p.G43G,PAX3:uc002vna.2:exon2:c.T129C:p.G43G,PAX3:uc010fwo.3:exon2:c.T129C:p.G43G	.	AFR:0.8433,AMR:0.9165,EAS:1,FIN:0.8283,NFE:0.8402,OTH:0.8523,ASJ:0.9305	606597	122880;148820;193500;268220;	780;99756;3440;894;3440;896;1529;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~894|WS1<br>Waardenburg syndrome type I|1-9 / 100 000|Autosomal dominant|Neonatal|193500 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~896|Klein-Waardenburg syndrome<br>WS3<br>Waardenburg syndrome type III<br>Waardenburg syndrome with limb anomalies|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|148820 ~1529|CDHS<br>Sommer-Young-Wee-Frye syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|122880 ~	 ~	.	.	.	.	.	.	.	2	MU81752201	hom
2	225346646	225346646	T	C	CUL3	exonic	synonymous SNV	ENSG00000036257	rs2070127	ENSG00000036257:ENST00000344951:exon13:c.A1794G:p.Q598Q,ENSG00000036257:ENST00000264414:exon14:c.A1992G:p.Q664Q,ENSG00000036257:ENST00000409096:exon14:c.A1920G:p.Q640Q,ENSG00000036257:ENST00000409777:exon14:c.A1920G:p.Q640Q	CUL3:NM_001257197:exon13:c.A1794G:p.Q598Q,CUL3:NM_001257198:exon14:c.A2010G:p.Q670Q,CUL3:NM_003590:exon14:c.A1992G:p.Q664Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1845	0.1744	0.232628	0.1837	.	.	.	.	.	.	.	.	CUL3:uc010zls.2:exon13:c.A1794G:p.Q598Q,CUL3:uc002vny.3:exon14:c.A1992G:p.Q664Q,CUL3:uc010fwy.2:exon14:c.A2010G:p.Q670Q	.	AFR:0.2716,AMR:0.2285,EAS:0.2708,FIN:0.1473,NFE:0.1309,OTH:0.1721,ASJ:0.1358	603136	614496;	300530;757;	300530|PHA2E|<1 / 1 000 000|Autosomal dominant|-|614496 ~757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~	.	.	.	.	.	.	.	.	2	MU25439382	het
2	225367669	225367669	C	T	CUL3	intronic	.	ENSG00000036257	rs3754629	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1857	0.1752	0.232628	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.1857,AMR:0.2727,EAS:0.1358,FIN:0.2711,NFE:0.1564,OTH:0.1322,ASJ:0.2277	603136	614496;	300530;757;	300530|PHA2E|<1 / 1 000 000|Autosomal dominant|-|614496 ~757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~	.	.	.	.	.	.	.	.	2	1(breast)	0.1728
2	225434445	225434445	A	G	CUL3	exonic	synonymous SNV	ENSG00000036257	rs10498163	.	CUL3:NM_001257198:exon1:c.T45C:p.H15H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2999	.	0.28095	0.2821	.	.	.	.	.	.	.	.	CUL3:uc010fwy.2:exon1:c.T45C:p.H15H	.	AFR:0.1706,AMR:0.3594,EAS:0.3046,FIN:0.2849,NFE:0.3338,OTH:0.3476,ASJ:0.3709	603136	614496;	300530;757;	300530|PHA2E|<1 / 1 000 000|Autosomal dominant|-|614496 ~757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~	.	.	.	.	.	.	.	.	2	MU24815200	het
2	228111435	228111435	T	C	COL4A3	exonic	nonsynonymous SNV	ENSG00000169031	rs10178458	ENSG00000169031:ENST00000396578:exon7:c.T422C:p.L141P	COL4A3:NM_000091:exon7:c.T422C:p.L141P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8302	0.7704	0.796725	0.7805	-0.830	0.037	1.0	3.62	0.029	.	.	.	COL4A3:uc002vom.2:exon7:c.T422C:p.L141P	-0.919	AFR:0.6284,AMR:0.8720,EAS:0.9280,FIN:0.8270,NFE:0.8347,OTH:0.8180,ASJ:0.7781	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.004	-3.4	0.000	-1.39	2	MU18207837	hom
2	228113175	228113175	A	G	COL4A3	exonic	nonsynonymous SNV	ENSG00000169031	rs6436669	ENSG00000169031:ENST00000396578:exon9:c.A485G:p.E162G	COL4A3:NM_000091:exon9:c.A485G:p.E162G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8304	0.7701	0.796326	0.7808	0.832	9.659	0.828	1.24	0.181	.	.	.	COL4A3:uc002vom.2:exon9:c.A485G:p.E162G	-0.962	AFR:0.6290,AMR:0.8723,EAS:0.9284,FIN:0.8286,NFE:0.8343,OTH:0.8184,ASJ:0.7781	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.001	-3.17	0.000	1.355	2	MU18208095	hom
2	228128540	228128540	C	T	COL4A3	exonic	synonymous SNV	ENSG00000169031	rs10205042	ENSG00000169031:ENST00000396578:exon21:c.C1195T:p.L399L	COL4A3:NM_000091:exon21:c.C1195T:p.L399L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7667	0.7180	0.767572	0.7419	.	.	.	.	.	.	.	.	COL4A3:uc002vom.2:exon21:c.C1195T:p.L399L	.	AFR:0.6775,AMR:0.8242,EAS:0.8912,FIN:0.8013,NFE:0.7453,OTH:0.7597,ASJ:0.6589	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU18208390	hom
2	228135631	228135631	C	T	COL4A3	exonic	nonsynonymous SNV	ENSG00000169031	rs28381984	ENSG00000169031:ENST00000396578:exon25:c.C1721T:p.P574L	COL4A3:NM_000091:exon25:c.C1721T:p.P574L	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 2, 1, 0] 	0.4694	0.3890	0.39996	0.3967	5.446	26.1	0.005	5.8	0.226	.	.	.	COL4A3:uc002vom.2:exon25:c.C1721T:p.P574L	-1.332	AFR:0.1974,AMR:0.4474,EAS:0.4578,FIN:0.4653,NFE:0.4817,OTH:0.4559,ASJ:0.4702	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.999	-3.16	0.000	3.25	2	MU121370	hom
2	228159661	228159661	T	-	LOC654841	ncRNA_intronic	.	ENSG00000236432	rs35803812	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4894	.	0.536941	0.6519	.	.	.	.	.	.	.	.	.	.	AFR:0.5499,AMR:0.6095,EAS:0.596,FIN:0.6067,NFE:0.7267,OTH:0.6856,ASJ:0.6944	.	.	.	.	.	.	.	.	.	.	.	.	2	.	hom
2	232952286	232952286	A	G	DIS3L2	exonic	synonymous SNV	ENSG00000144535	rs11887184	ENSG00000144535:ENST00000409307:exon5:c.A456G:p.Q152Q,ENSG00000144535:ENST00000433430:exon5:c.A456G:p.Q152Q,ENSG00000144535:ENST00000273009:exon6:c.A456G:p.Q152Q,ENSG00000144535:ENST00000325385:exon6:c.A456G:p.Q152Q,ENSG00000144535:ENST00000360410:exon6:c.A456G:p.Q152Q,ENSG00000144535:ENST00000390005:exon6:c.A456G:p.Q152Q,ENSG00000144535:ENST00000409401:exon6:c.A456G:p.Q152Q,ENSG00000144535:ENST00000445090:exon6:c.A456G:p.Q152Q	DIS3L2:NM_001257281:exon6:c.A456G:p.Q152Q,DIS3L2:NM_001257282:exon6:c.A456G:p.Q152Q,DIS3L2:NM_152383:exon6:c.A456G:p.Q152Q	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0961	0.1047	0.11242	0.1046	.	.	.	.	.	.	.	.	DIS3L2:uc010fxz.3:exon6:c.A456G:p.Q152Q,DIS3L2:uc031rrt.1:exon6:c.A456G:p.Q152Q	.	AFR:0.1882,AMR:0.1471,EAS:0.0389,FIN:0.0685,NFE:0.0699,OTH:0.0988,ASJ:0.0894	614184	267000;	2849;	2849|Nephroblastomatosis-fetal ascites-macrosomia-Wilms tumor syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267000 ~	.	.	.	.	.	.	.	.	2	.	het
2	240003870	240003870	G	A	HDAC4	exonic	synonymous SNV	ENSG00000068024	rs1063639	ENSG00000068024:ENST00000543185:exon15:c.C1317T:p.P439P,ENSG00000068024:ENST00000345617:exon21:c.C2565T:p.P855P	HDAC4:NM_006037:exon21:c.C2565T:p.P855P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5333	0.5061	0.595248	0.5092	.	.	.	.	.	.	.	.	HDAC4:uc010fyy.3:exon18:c.C2436T:p.P812P,HDAC4:uc002vyk.4:exon21:c.C2565T:p.P855P	.	AFR:0.5783,AMR:0.6277,EAS:0.7295,FIN:0.4685,NFE:0.4490,OTH:0.5092,ASJ:0.4667	605314	.	.	.	~ko04371 Apelin signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	2	MU792285	het
2	240029736	240029736	T	C	HDAC4	intronic	.	ENSG00000068024	rs7585225	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8336	0.7889	0.838658	0.8060	.	.	.	.	.	.	.	.	.	.	AFR:0.7561,AMR:0.9045,EAS:0.8403,FIN:0.8229,NFE:0.8207,OTH:0.8347,ASJ:0.7767	605314	.	.	.	~ko04371 Apelin signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	2	MU26830207	hom
2	240066417	240066417	A	G	HDAC4	intronic	.	ENSG00000068024	rs2290087	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8616	0.8947	0.88778	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	.	.	.	.	.	0.0001	0.048	.	.	.	AFR:0.8949,AMR:0.9678,EAS:0.7980,FIN:0.8407,NFE:0.9032,OTH:0.8698,ASJ:0.6914	605314	.	.	.	~ko04371 Apelin signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.8931
2	240111757	240111757	C	T	HDAC4	exonic	synonymous SNV	ENSG00000068024	rs540431173	ENSG00000068024:ENST00000454542:exon2:c.G18A:p.A6A,ENSG00000068024:ENST00000541256:exon2:c.G18A:p.A6A,ENSG00000068024:ENST00000446876:exon3:c.G30A:p.A10A,ENSG00000068024:ENST00000345617:exon4:c.G111A:p.A37A	HDAC4:NM_006037:exon4:c.G111A:p.A37A	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 0, 1, 0] 	0.0014	.	0.00179712	6.489e-05	.	.	.	.	.	.	.	.	HDAC4:uc010fyz.1:exon3:c.G96A:p.A32A,HDAC4:uc010zoa.1:exon3:c.G96A:p.A32A,HDAC4:uc002vyk.4:exon4:c.G111A:p.A37A,HDAC4:uc010fza.2:exon4:c.G111A:p.A37A	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0020,ASJ:0	605314	.	.	.	~ko04371 Apelin signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	2	MU49310319	het
2	242793273	242793273	A	G	PDCD1	exonic	synonymous SNV	ENSG00000188389	rs2227981	ENSG00000188389:ENST00000334409:exon5:c.T804C:p.A268A	PDCD1:NM_005018:exon5:c.T804C:p.A268A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6284	0.5864	0.647963	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	PDCD1:uc010fzs.3:exon3:c.T441C:p.A147A,PDCD1:uc002wcq.4:exon5:c.T804C:p.A268A	.	AFR:0.6047,AMR:0.5763,EAS:0.5894,FIN:0.7311,NFE:0.7071,OTH:0.5808,ASJ:0.6124	600244	126200;605218;	.	.	.	.	.	.	.	.	.	.	2	1(large_intestine)	0.6462
3	3197918	3197918	A	G	CRBN	exonic	synonymous SNV	ENSG00000113851	rs17027638	ENSG00000113851:ENST00000231948:exon6:c.T735C:p.Y245Y,ENSG00000113851:ENST00000432408:exon6:c.T732C:p.Y244Y	CRBN:NM_001173482:exon6:c.T732C:p.Y244Y,CRBN:NM_016302:exon6:c.T735C:p.Y245Y	clinvar: Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.1349	0.0154	0.248403	0.0734	.	.	.	.	.	.	.	.	CRBN:uc011aso.2:exon5:c.T546C:p.Y182Y,CRBN:uc003bpq.3:exon6:c.T735C:p.Y245Y,CRBN:uc003bpr.3:exon6:c.T732C:p.Y244Y	.	AFR:0.0103,AMR:0.2422,EAS:0.6993,FIN:0.1083,NFE:0.0252,OTH:0.0908,ASJ:0.0099	609262	607417;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	2055,2057,2056,	.	.	.	.	.	.	3	MU18013455	het
3	3215954	3215954	A	G	CRBN	intronic	.	ENSG00000113851	rs1669321	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9673	0.8820	0.883786	0.9009	.	.	.	.	.	0.0001	0.07	.	.	.	AFR:0.6555,AMR:0.9713,EAS:1,FIN:1,NFE:0.9985,OTH:0.9786,ASJ:0.9934	609262	607417;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	.	.	.	.	3	MU81756919	hom
3	8955389	8955389	C	T	RAD18	exonic	nonsynonymous SNV	ENSG00000070950	rs373572	ENSG00000070950:ENST00000264926:exon8:c.G905A:p.R302Q	RAD18:NM_020165:exon8:c.G905A:p.R302Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6951	0.7043	0.647564	0.6904	3.782	23.4	0.617	4.47	0.998	.	.	SAP domain	RAD18:uc003brd.3:exon8:c.G905A:p.R302Q	-0.988	AFR:0.6630,AMR:0.6631,EAS:0.3531,FIN:0.7584,NFE:0.7244,OTH:0.7270,ASJ:0.7550	605256	.	.	.	.	.	.	.	0.001	1.85	0.000	-1.61	3	MU17638060	hom
3	9005078	9005078	C	T	RAD18	UTR5	.	ENSG00000070950	rs615967	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7529	0.6622	0.597644	LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.6503,AMR:0.3926,EAS:0.8046,FIN:0.3831,NFE:0.7921,OTH:0.7830,ASJ:0.6914	605256	.	.	.	.	.	.	.	.	.	.	.	3	1(lung)	0.7561
3	9824651	9824651	C	T	TADA3	intronic	.	ENSG00000114026;ENSG00000171148	rs6443265	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.65016	0.6563	.	.	.	.	.	.	.	.	.	.	AFR:0.5406,AMR:0.6340,EAS:0.7360,FIN:0.6966,NFE:0.7027,OTH:0.6708,ASJ:0.8146	602945	.	.	.	.	.	.	.	.	.	.	.	3	.	hom
3	10076843	10076844	TT	-	FANCD2	intronic	.	ENSG00000144554	rs55973240	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.2080	0.2553	0.211462	0.2354	.	.	.	.	.	.	.	.	.	.	AFR:0.4218,AMR:0.2269,EAS:0.0676,FIN:0.1558,NFE:0.1652,OTH:0.175,ASJ:0.1812	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	.	het
3	10077955	10077955	A	G	FANCD2	intronic	.	ENSG00000144554	rs17032278	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1662	0.2185	0.182109	0.1945	.	.	.	.	.	.	.	.	.	.	AFR:0.3130,AMR:0.1964,EAS:0.0665,FIN:0.1287,NFE:0.1584,OTH:0.1543,ASJ:0.1667	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	MU749573	het
3	10081545	10081545	G	C	FANCD2	intronic	.	ENSG00000144554	rs17032283	ENSG00000144554:ENST00000431693:exon8:c.G711C:p.L237L	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1659	0.2170	0.182109	0.1966	.	.	.	.	.	.	.	.	FANCD2:uc003buv.3:exon9:c.G711C:p.L237L	.	AFR:0.3153,AMR:0.1969,EAS:0.0674,FIN:0.1311,NFE:0.1603,OTH:0.1561,ASJ:0.1656	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	MU764298	het
3	10084224	10084224	C	T	FANCD2	intronic	.	ENSG00000144554	rs9879080	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1743	0.2527	0.210663	0.2261	.	.	.	.	.	.	.	.	.	.	AFR:0.4177,AMR:0.2045,EAS:0.0673,FIN:0.1320,NFE:0.1605,OTH:0.1640,ASJ:0.1656	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	MU117059691	het
3	10085536	10085536	A	G	FANCD2	exonic	synonymous SNV	ENSG00000144554	rs34046352	ENSG00000144554:ENST00000287647:exon14:c.A1122G:p.V374V,ENSG00000144554:ENST00000383806:exon14:c.A1122G:p.V374V,ENSG00000144554:ENST00000383807:exon14:c.A1122G:p.V374V,ENSG00000144554:ENST00000419585:exon14:c.A1122G:p.V374V	FANCD2:NM_001018115:exon14:c.A1122G:p.V374V,FANCD2:NM_001319984:exon14:c.A1122G:p.V374V,FANCD2:NM_033084:exon14:c.A1122G:p.V374V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1239	.	.	ESAD-UK|1|409|0.00244499	.	.	.	.	.	.	.	.	FANCD2:uc003buw.3:exon14:c.A1122G:p.V374V,FANCD2:uc003bux.1:exon14:c.A1122G:p.V374V,FANCD2:uc003buy.1:exon14:c.A1122G:p.V374V	.	AFR:0.1939,AMR:0.3364,EAS:0.15,FIN:0.0598,NFE:0.1226,OTH:0.1466,ASJ:0.1874	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	1(large_intestine)	0.1493
3	10088266	10088266	G	T	FANCD2	exonic	synonymous SNV	ENSG00000144554	rs72492997	ENSG00000144554:ENST00000287647:exon15:c.G1137T:p.V379V,ENSG00000144554:ENST00000383806:exon15:c.G1137T:p.V379V,ENSG00000144554:ENST00000383807:exon15:c.G1137T:p.V379V,ENSG00000144554:ENST00000419585:exon15:c.G1137T:p.V379V	FANCD2:NM_001018115:exon15:c.G1137T:p.V379V,FANCD2:NM_001319984:exon15:c.G1137T:p.V379V,FANCD2:NM_033084:exon15:c.G1137T:p.V379V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3745	.	.	1(large_intestine)	.	.	.	.	.	.	.	.	FANCD2:uc003buw.3:exon15:c.G1137T:p.V379V,FANCD2:uc003bux.1:exon15:c.G1137T:p.V379V,FANCD2:uc003buy.1:exon15:c.G1137T:p.V379V	.	AFR:1(thyroid),AMR:MU4554264,EAS:0.4393,FIN:0.4755,NFE:0.3902,OTH:0.3111,ASJ:LAML-KR|1|205|0.00487805,COCA-CN|6|321|0.0186916	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	2(skin)	0.4121
3	10088299	10088299	C	T	FANCD2	exonic	synonymous SNV	ENSG00000144554	rs112887807	ENSG00000144554:ENST00000287647:exon15:c.C1170T:p.S390S,ENSG00000144554:ENST00000383806:exon15:c.C1170T:p.S390S,ENSG00000144554:ENST00000383807:exon15:c.C1170T:p.S390S,ENSG00000144554:ENST00000419585:exon15:c.C1170T:p.S390S	FANCD2:NM_001018115:exon15:c.C1170T:p.S390S,FANCD2:NM_001319984:exon15:c.C1170T:p.S390S,FANCD2:NM_033084:exon15:c.C1170T:p.S390S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4304	.	.	MU23560209	.	.	.	.	.	.	.	.	FANCD2:uc003buw.3:exon15:c.C1170T:p.S390S,FANCD2:uc003bux.1:exon15:c.C1170T:p.S390S,FANCD2:uc003buy.1:exon15:c.C1170T:p.S390S	.	AFR:LUSC-KR|6|170|0.0352941,COCA-CN|8|321|0.0249221,RECA-EU|1|422|0.00236967,AMR:0.4501,EAS:0.4059,FIN:0.3421,NFE:0.4245,OTH:0.4638,ASJ:0.4796	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	3(large_intestine)	0.4337
3	10088308	10088308	T	C	FANCD2	exonic	synonymous SNV	ENSG00000144554	rs72492998	ENSG00000144554:ENST00000287647:exon15:c.T1179C:p.T393T,ENSG00000144554:ENST00000383806:exon15:c.T1179C:p.T393T,ENSG00000144554:ENST00000383807:exon15:c.T1179C:p.T393T,ENSG00000144554:ENST00000419585:exon15:c.T1179C:p.T393T	FANCD2:NM_001018115:exon15:c.T1179C:p.T393T,FANCD2:NM_001319984:exon15:c.T1179C:p.T393T,FANCD2:NM_033084:exon15:c.T1179C:p.T393T	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4331	.	.	MU4081966	.	.	.	.	.	.	.	.	FANCD2:uc003buw.3:exon15:c.T1179C:p.T393T,FANCD2:uc003bux.1:exon15:c.T1179C:p.T393T,FANCD2:uc003buy.1:exon15:c.T1179C:p.T393T	.	AFR:LUSC-KR|7|170|0.0411765,COCA-CN|9|321|0.0280374,RECA-EU|1|422|0.00236967,AMR:0.4504,EAS:0.4082,FIN:0.3480,NFE:0.4244,OTH:0.4642,ASJ:0.4799	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	4(large_intestine)	0.4338
3	10088343	10088343	A	G	FANCD2	exonic	nonsynonymous SNV	ENSG00000144554	rs73126218	ENSG00000144554:ENST00000287647:exon15:c.A1214G:p.N405S,ENSG00000144554:ENST00000383806:exon15:c.A1214G:p.N405S,ENSG00000144554:ENST00000383807:exon15:c.A1214G:p.N405S,ENSG00000144554:ENST00000419585:exon15:c.A1214G:p.N405S	FANCD2:NM_001018115:exon15:c.A1214G:p.N405S,FANCD2:NM_001319984:exon15:c.A1214G:p.N405S,FANCD2:NM_033084:exon15:c.A1214G:p.N405S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4201	.	.	3(thyroid)	0.077	3.368	0.314	0.307	0.999	.	.	.	FANCD2:uc003buw.3:exon15:c.A1214G:p.N405S,FANCD2:uc003bux.1:exon15:c.A1214G:p.N405S,FANCD2:uc003buy.1:exon15:c.A1214G:p.N405S	-0.975	AFR:1(soft_tissue),AMR:5(large_intestine),EAS:LAML-KR|1|205|0.00487805,LUSC-KR|5|170|0.0294118,COCA-CN|9|321|0.0280374,THCA-CN|1|50|0.02,FIN:0.4320,NFE:0.4779,OTH:0.4005,ASJ:MU4081957	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.022	0.89	0.000	1.465	3	1(kidney)	0.2822
3	10106532	10106532	C	T	FANCD2	exonic	nonsynonymous SNV	ENSG00000144554	rs3864017	ENSG00000144554:ENST00000287647:exon23:c.C2141T:p.P714L,ENSG00000144554:ENST00000383806:exon23:c.C2141T:p.P714L,ENSG00000144554:ENST00000383807:exon23:c.C2141T:p.P714L,ENSG00000144554:ENST00000419585:exon23:c.C2141T:p.P714L	FANCD2:NM_001018115:exon23:c.C2141T:p.P714L,FANCD2:NM_001319984:exon23:c.C2141T:p.P714L,FANCD2:NM_033084:exon23:c.C2141T:p.P714L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.1545	.	.	2(pleura)	-0.097	1.749	0.251	-3.09	0.000	.	.	Armadillo-like helical	FANCD2:uc003buw.3:exon23:c.C2141T:p.P714L,FANCD2:uc003bux.1:exon23:c.C2141T:p.P714L,FANCD2:uc003buy.1:exon23:c.C2141T:p.P714L	-0.974	AFR:.,AMR:.,EAS:0.2802,FIN:0.1883,NFE:0.1552,OTH:0.0638,ASJ:0.1870	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.001	0.88	0.000	0	3	9(upper_aerodigestive_tract)	0.1325
3	10128966	10128966	T	-	FANCD2;FANCD2OS	intronic	.	ENSG00000144554;ENSG00000163705	rs535944248	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2140	.	0.368011	0.0127	.	.	.	.	.	.	.	.	.	.	AFR:0.0065,AMR:0.0621,EAS:0.0045,FIN:0.0761,NFE:0.0131,OTH:0.0206,ASJ:0.0202	.	.	.	.	.	.	.	.	.	.	.	.	3	.	unknown
3	10133949	10133949	A	G	FANCD2;FANCD2OS	intronic	.	ENSG00000144554;ENSG00000163705	rs9811771	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1918	0.2754	0.254193	0.2462	.	.	.	.	.	.	.	.	.	.	AFR:0.4832,AMR:0.2249,EAS:0.0897,FIN:0.1311,NFE:0.1603,OTH:0.1711,ASJ:0.1667	.	.	.	.	.	.	.	.	.	.	.	.	3	MU117109838	het
3	10138069	10138069	T	G	FANCD2	exonic	synonymous SNV	ENSG00000144554	rs2272125	ENSG00000144554:ENST00000287647:exon42:c.T4098G:p.L1366L,ENSG00000144554:ENST00000383807:exon42:c.T4098G:p.L1366L,ENSG00000144554:ENST00000419585:exon42:c.T4098G:p.L1366L	FANCD2:NM_001018115:exon42:c.T4098G:p.L1366L,FANCD2:NM_001319984:exon42:c.T4098G:p.L1366L,FANCD2:NM_033084:exon42:c.T4098G:p.L1366L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1868	0.2686	0.242212	MU152343	.	.	.	.	.	.	.	.	FANCD2:uc003buw.3:exon42:c.T4098G:p.L1366L,FANCD2:uc003bux.1:exon42:c.T4098G:p.L1366L,FANCD2:uc003buy.1:exon42:c.T4098G:p.L1366L	.	AFR:ESAD-UK|1|409|0.00244499,AMR:0.2404,EAS:0.2243,FIN:0.1656,NFE:0.0902,OTH:0.1307,ASJ:0.4626	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	1(urinary_tract)	0.1601
3	10142949	10142949	C	T	FANCD2	UTR3	.	ENSG00000144554	rs3172417	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3281	0.3072	0.214657	.	.	.	.	.	.	.	.	.	.	.	AFR:0.3122,AMR:0.0833,EAS:0.4834,FIN:0.1103,NFE:0.4501,OTH:0.4301,ASJ:0.2512	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	17(soft_tissue)	0.3905
3	14174427	14174427	A	T	TMEM43	exonic	nonsynonymous SNV	ENSG00000170876	rs4685076	ENSG00000170876:ENST00000306077:exon6:c.A504T:p.K168N	TMEM43:NM_024334:exon6:c.A504T:p.K168N	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3209	0.2876	0.352636	0.2969	2.489	19.40	0.219	1.56	1.000	.	.	.	TMEM43:uc003byl.1:exon4:c.A144T:p.K48N,TMEM43:uc003byk.2:exon6:c.A504T:p.K168N	-0.896	AFR:0.2786,AMR:0.4212,EAS:0.4300,FIN:0.2923,NFE:0.2893,OTH:0.2740,ASJ:0.2682	612048	604400;614302;	261;98853;217656;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	0.203	1.3	0.000	2.015	3	MU124093	het
3	14175262	14175262	T	C	TMEM43	exonic	nonsynonymous SNV	ENSG00000170876	rs2340917	ENSG00000170876:ENST00000306077:exon7:c.T536C:p.M179T	TMEM43:NM_024334:exon7:c.T536C:p.M179T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3724	0.3328	0.463259	0.3565	0.428	6.855	1.0	5.32	0.297	.	.	.	TMEM43:uc003byl.1:exon5:c.T176C:p.M59T,TMEM43:uc003byk.2:exon7:c.T536C:p.M179T	-0.943	AFR:0.4188,AMR:0.5095,EAS:0.6592,FIN:0.3033,NFE:0.2967,OTH:0.3037,ASJ:0.2682	612048	604400;614302;	261;98853;217656;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	0.0	1.6	0.000	-2.25	3	MU124112	het
3	14187449	14187449	G	T	XPC	exonic	nonsynonymous SNV	ENSG00000154767	rs2228001	ENSG00000154767:ENST00000285021:exon16:c.C2815A:p.Q939K,ENSG00000154767:ENST00000449060:exon16:c.C2704A:p.Q902K	XPC:NM_001354726:exon15:c.C2236A:p.Q746K,XPC:NM_001354727:exon16:c.C2809A:p.Q937K,XPC:NM_001354729:exon16:c.C2797A:p.Q933K,XPC:NM_001354730:exon16:c.C2569A:p.Q857K,XPC:NM_004628:exon16:c.C2815A:p.Q939K	clinvar: drug_response 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6325	0.6421	0.684704	0.6556	1.250	12.01	1.0	4.24	0.998	.	.	.	XPC:uc011avf.2:exon15:c.C2236A:p.Q746K,XPC:uc011ave.2:exon16:c.C2815A:p.Q939K,XPC:uc011avg.2:exon16:c.C2704A:p.Q902K	-0.955	AFR:0.7228,AMR:0.7057,EAS:0.6382,FIN:0.6985,NFE:0.6087,OTH:0.6337,ASJ:0.5629	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	0.0	1.93	0.000	-2.455	3	MU11483739	het
3	14190237	14190237	T	G	XPC	intronic	.	ENSG00000154767	rs2279017	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6302	0.6353	0.679712	0.6502	.	.	.	.	.	0	0.046	.	.	.	AFR:0.7024,AMR:0.7041,EAS:0.6413,FIN:0.6985,NFE:0.6094,OTH:0.6319,ASJ:0.5667	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	3	MU705240	het
3	14193889	14193889	C	T	XPC	exonic	synonymous SNV	ENSG00000154767	rs2227998	ENSG00000154767:ENST00000285021:exon11:c.G2061A:p.R687R,ENSG00000154767:ENST00000449060:exon11:c.G1950A:p.R650R	XPC:NM_001354726:exon10:c.G1482A:p.R494R,XPC:NM_001354727:exon11:c.G2055A:p.R685R,XPC:NM_001354729:exon11:c.G2043A:p.R681R,XPC:NM_001354730:exon11:c.G1815A:p.R605R,XPC:NM_004628:exon11:c.G2061A:p.R687R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2734	0.2658	0.235423	1(lung)	.	.	.	.	.	.	.	.	XPC:uc021wtm.1:exon2:c.G364A:p.G122R	.	AFR:MU131806,AMR:LUSC-KR|1|170|0.00588235,EAS:0.2989,FIN:0.3022,NFE:0.2649,OTH:0.0358,ASJ:0.2561	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	3	1(thyroid)	0.2282
3	14197987	14197987	A	T	XPC	exonic	synonymous SNV	ENSG00000154767	rs2958057	ENSG00000154767:ENST00000285021:exon10:c.T1881A:p.A627A,ENSG00000154767:ENST00000449060:exon10:c.T1770A:p.A590A	XPC:NM_001354726:exon9:c.T1302A:p.A434A,XPC:NM_001354729:exon10:c.T1863A:p.A621A,XPC:NM_001354730:exon10:c.T1635A:p.A545A,XPC:NM_004628:exon10:c.T1881A:p.A627A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	1	.	1	1	.	.	.	.	.	.	.	.	XPC:uc021wtl.1:exon2:c.T99A:p.A33A,XPC:uc011avf.2:exon9:c.T1302A:p.A434A,XPC:uc011ave.2:exon10:c.T1881A:p.A627A,XPC:uc011avg.2:exon10:c.T1770A:p.A590A	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	3	MU81758228	hom
3	24164510	24164510	A	G	THRB	exonic	synonymous SNV	ENSG00000151090	rs13081063	ENSG00000151090:ENST00000280696:exon7:c.T1296C:p.F432F,ENSG00000151090:ENST00000356447:exon10:c.T1251C:p.F417F,ENSG00000151090:ENST00000396671:exon11:c.T1251C:p.F417F,ENSG00000151090:ENST00000416420:exon12:c.T1251C:p.F417F	THRB:NM_001354714:exon9:c.T1158C:p.F386F,THRB:NM_001354715:exon9:c.T1158C:p.F386F,THRB:NM_000461:exon10:c.T1251C:p.F417F,THRB:NM_001354708:exon10:c.T1251C:p.F417F,THRB:NM_001354711:exon10:c.T1251C:p.F417F,THRB:NM_001354713:exon10:c.T1251C:p.F417F,THRB:NM_001128176:exon11:c.T1251C:p.F417F,THRB:NM_001128177:exon11:c.T1251C:p.F417F,THRB:NM_001354709:exon11:c.T1251C:p.F417F,THRB:NM_001354710:exon11:c.T1251C:p.F417F,THRB:NM_001354712:exon11:c.T1251C:p.F417F,THRB:NM_001252634:exon12:c.T1251C:p.F417F	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0265	0.0243	0.0113818	0.0277	.	.	.	.	.	.	.	.	THRB:uc003ccy.4:exon10:c.T1251C:p.F417F,THRB:uc003ccx.4:exon11:c.T1251C:p.F417F,THRB:uc010hfe.3:exon11:c.T1251C:p.F417F,THRB:uc003ccz.4:exon12:c.T1251C:p.F417F	.	AFR:0.0070,AMR:0.0095,EAS:0.0012,FIN:0.0590,NFE:0.0362,OTH:0.0326,ASJ:0.0166	190160	145650;188570;274300;	3221;3221;165994;	3221|Deafness-thyroid hormone resistance syndrome<br>Refetoff syndrome|-|-|-|188570 274300 ~3221|Deafness-thyroid hormone resistance syndrome<br>Refetoff syndrome|-|-|-|188570 274300 ~165994|-|-|Autosomal dominant|-|145650 ~	.	.	.	.	.	.	.	.	3	.	het
3	24168981	24168981	C	T	THRB	intronic	.	ENSG00000151090	rs13063628	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1103	0.1217	0.0628994	0.1175	.	.	.	.	.	.	.	.	.	.	AFR:0.0721,AMR:0.0609,EAS:0.0018,FIN:0.1637,NFE:0.1476,OTH:0.1378,ASJ:0.1067	190160	145650;188570;274300;	3221;3221;165994;	3221|Deafness-thyroid hormone resistance syndrome<br>Refetoff syndrome|-|-|-|188570 274300 ~3221|Deafness-thyroid hormone resistance syndrome<br>Refetoff syndrome|-|-|-|188570 274300 ~165994|-|-|Autosomal dominant|-|145650 ~	.	.	.	.	.	.	.	.	3	.	het
3	30656168	30656168	G	A	TGFBR2	intronic	.	ENSG00000163513	rs6791557	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.502995	0.4614	.	.	.	.	.	.	.	.	.	.	AFR:0.3984,AMR:0.4117,EAS:0.7776,FIN:0.5140,NFE:0.4560,OTH:0.4826,ASJ:0.3154	190182	133239;610168;614331;	144;284973;558;60030;91387;99977;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~284973|MFS2|-|Autosomal dominant|All ages|610168 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~60030|Aortic aneurysm syndrome due to TGF-beta receptors anomalies|Unknown|Autosomal dominant|Infancy<br>Neonatal|609192 610168 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04380 Osteoclast differentiation~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04659 Th17 cell differentiation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05142 Chagas disease (American trypanosomiasis)~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	3	MU86952688	het
3	30686414	30686414	A	G	TGFBR2	intronic	.	ENSG00000163513	rs1155705	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3725	0.3215	0.412939	0.3733	.	.	.	.	.	0	0.004	.	.	.	AFR:0.3381,AMR:0.3005,EAS:0.6901,FIN:0.3946,NFE:0.3618,OTH:0.3615,ASJ:0.2616	190182	133239;610168;614331;	144;284973;558;60030;91387;99977;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~284973|MFS2|-|Autosomal dominant|All ages|610168 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~60030|Aortic aneurysm syndrome due to TGF-beta receptors anomalies|Unknown|Autosomal dominant|Infancy<br>Neonatal|609192 610168 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04380 Osteoclast differentiation~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04659 Th17 cell differentiation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05142 Chagas disease (American trypanosomiasis)~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	3	MU15034252	het
3	30713126	30713126	T	A	TGFBR2	intronic	.	ENSG00000163513	rs11466512	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2928	0.2555	0.271965	0.2595	.	.	.	.	.	0.0003	0.022	.	.	.	AFR:0.1511,AMR:0.4243,EAS:0.2998,FIN:0.2978,NFE:0.3006,OTH:0.2658,ASJ:0.2167	190182	133239;610168;614331;	144;284973;558;60030;91387;99977;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~284973|MFS2|-|Autosomal dominant|All ages|610168 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~60030|Aortic aneurysm syndrome due to TGF-beta receptors anomalies|Unknown|Autosomal dominant|Infancy<br>Neonatal|609192 610168 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04380 Osteoclast differentiation~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04659 Th17 cell differentiation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05142 Chagas disease (American trypanosomiasis)~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	3	MU585873	het
3	38592406	38592406	A	G	SCN5A	exonic	synonymous SNV	ENSG00000183873	rs1805126	ENSG00000183873:ENST00000414099:exon26:c.T5403C:p.D1801D,ENSG00000183873:ENST00000449557:exon26:c.T5295C:p.D1765D,ENSG00000183873:ENST00000450102:exon26:c.T5295C:p.D1765D,ENSG00000183873:ENST00000423572:exon27:c.T5454C:p.D1818D,ENSG00000183873:ENST00000425664:exon27:c.T5403C:p.D1801D,ENSG00000183873:ENST00000451551:exon27:c.T5295C:p.D1765D,ENSG00000183873:ENST00000455624:exon27:c.T5358C:p.D1786D,ENSG00000183873:ENST00000333535:exon28:c.T5457C:p.D1819D,ENSG00000183873:ENST00000413689:exon28:c.T5457C:p.D1819D,ENSG00000183873:ENST00000443581:exon28:c.T5454C:p.D1818D	SCN5A:NM_001099405:exon27:c.T5403C:p.D1801D,SCN5A:NM_001160161:exon27:c.T5295C:p.D1765D,SCN5A:NM_001354701:exon27:c.T5400C:p.D1800D,SCN5A:NM_000335:exon28:c.T5454C:p.D1818D,SCN5A:NM_001099404:exon28:c.T5457C:p.D1819D,SCN5A:NM_001160160:exon28:c.T5358C:p.D1786D,SCN5A:NM_198056:exon28:c.T5457C:p.D1819D	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3878	0.4314	0.492412	0.4472	.	.	.	.	.	.	.	.	SCN5A:uc021wvj.1:exon24:c.T4893C:p.D1631D,SCN5A:uc021wvi.1:exon25:c.T5055C:p.D1685D,SCN5A:uc021wvl.1:exon26:c.T5295C:p.D1765D,SCN5A:uc021wvm.1:exon26:c.T5403C:p.D1801D,SCN5A:uc021wvk.1:exon27:c.T5358C:p.D1786D,SCN5A:uc021wvn.1:exon27:c.T5454C:p.D1818D,SCN5A:uc021wvo.1:exon27:c.T5457C:p.D1819D,SCN5A:uc021wvp.1:exon27:c.T5457C:p.D1819D	.	AFR:0.6625,AMR:0.3765,EAS:0.5580,FIN:0.4376,NFE:0.3240,OTH:0.3633,ASJ:0.3367	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	.	.	.	.	3	MU4554855	het
3	38622467	38622467	T	C	SCN5A	exonic	synonymous SNV	ENSG00000183873	rs7430407	ENSG00000183873:ENST00000414099:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000423572:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000449557:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000450102:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000455624:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000333535:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000413689:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000425664:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000443581:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000451551:exon17:c.A3183G:p.E1061E	SCN5A:NM_000335:exon17:c.A3183G:p.E1061E,SCN5A:NM_001099404:exon17:c.A3183G:p.E1061E,SCN5A:NM_001099405:exon17:c.A3183G:p.E1061E,SCN5A:NM_001160160:exon17:c.A3183G:p.E1061E,SCN5A:NM_001160161:exon17:c.A3183G:p.E1061E,SCN5A:NM_001354701:exon17:c.A3183G:p.E1061E,SCN5A:NM_198056:exon17:c.A3183G:p.E1061E	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9128	0.8850	0.923123	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SCN5A:uc021wvw.1:exon8:c.A2016G:p.E672E,SCN5A:uc021wvi.1:exon14:c.A2781G:p.E927E,SCN5A:uc021wvj.1:exon14:c.A2781G:p.E927E,SCN5A:uc021wvk.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvl.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvm.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvn.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvo.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvp.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvq.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvr.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvs.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvt.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvu.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvv.1:exon17:c.A3183G:p.E1061E	.	AFR:0.9032,AMR:0.8836,EAS:0.8742,FIN:0.9994,NFE:0.9242,OTH:0.8978,ASJ:0.9284	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	.	.	.	.	3	1(thyroid)	0.9155
3	38645420	38645420	T	C	SCN5A	exonic	nonsynonymous SNV	ENSG00000183873	rs1805124	ENSG00000183873:ENST00000414099:exon11:c.A1673G:p.H558R,ENSG00000183873:ENST00000423572:exon11:c.A1673G:p.H558R,ENSG00000183873:ENST00000449557:exon11:c.A1673G:p.H558R,ENSG00000183873:ENST00000450102:exon11:c.A1673G:p.H558R,ENSG00000183873:ENST00000455624:exon11:c.A1673G:p.H558R,ENSG00000183873:ENST00000333535:exon12:c.A1673G:p.H558R,ENSG00000183873:ENST00000413689:exon12:c.A1673G:p.H558R,ENSG00000183873:ENST00000425664:exon12:c.A1673G:p.H558R,ENSG00000183873:ENST00000443581:exon12:c.A1673G:p.H558R,ENSG00000183873:ENST00000451551:exon12:c.A1673G:p.H558R	SCN5A:NM_000335:exon12:c.A1673G:p.H558R,SCN5A:NM_001099404:exon12:c.A1673G:p.H558R,SCN5A:NM_001099405:exon12:c.A1673G:p.H558R,SCN5A:NM_001160160:exon12:c.A1673G:p.H558R,SCN5A:NM_001160161:exon12:c.A1673G:p.H558R,SCN5A:NM_001354701:exon12:c.A1673G:p.H558R,SCN5A:NM_198056:exon12:c.A1673G:p.H558R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2217	0.2463	0.230431	MU23011183	-1.102	0.010	1.0	2.44	0.751	.	.	Voltage-gated Na+ ion channel, cytoplasmic domain	SCN5A:uc021wvw.1:exon3:c.A506G:p.H169R,SCN5A:uc021wvi.1:exon9:c.A1271G:p.H424R,SCN5A:uc021wvj.1:exon9:c.A1271G:p.H424R,SCN5A:uc021wvk.1:exon11:c.A1673G:p.H558R,SCN5A:uc021wvl.1:exon11:c.A1673G:p.H558R,SCN5A:uc021wvm.1:exon11:c.A1673G:p.H558R,SCN5A:uc021wvn.1:exon11:c.A1673G:p.H558R,SCN5A:uc021wvo.1:exon11:c.A1673G:p.H558R,SCN5A:uc021wvp.1:exon11:c.A1673G:p.H558R,SCN5A:uc021wvq.1:exon12:c.A1673G:p.H558R,SCN5A:uc021wvr.1:exon12:c.A1673G:p.H558R,SCN5A:uc021wvs.1:exon12:c.A1673G:p.H558R,SCN5A:uc021wvt.1:exon12:c.A1673G:p.H558R,SCN5A:uc021wvu.1:exon12:c.A1673G:p.H558R,SCN5A:uc021wvv.1:exon12:c.A1673G:p.H558R	-0.924	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.2453,EAS:0.2315,FIN:0.2152,NFE:0.1072,OTH:0.2009,ASJ:0.2934	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	0.0	-3.39	0.000	-2.58	3	1(salivary_gland)	0.2467
3	38647642	38647642	G	T	SCN5A	intronic	.	ENSG00000183873	rs41312433	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1722	0.1664	0.151158	0.1745	.	.	.	.	.	0.9992	0.79	.	.	.	AFR:0.1281,AMR:0.1866,EAS:0.1038,FIN:0.1742,NFE:0.2089,OTH:0.1701,ASJ:0.1722	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	.	.	.	.	3	MU776375	het
3	38674712	38674712	T	C	SCN5A	exonic	synonymous SNV	ENSG00000183873	rs6599230	ENSG00000183873:ENST00000414099:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000423572:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000449557:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000450102:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000455624:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000327956:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000333535:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000413689:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000425664:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000443581:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000451551:exon2:c.A87G:p.A29A	SCN5A:NM_000335:exon2:c.A87G:p.A29A,SCN5A:NM_001099404:exon2:c.A87G:p.A29A,SCN5A:NM_001099405:exon2:c.A87G:p.A29A,SCN5A:NM_001160160:exon2:c.A87G:p.A29A,SCN5A:NM_001160161:exon2:c.A87G:p.A29A,SCN5A:NM_001354701:exon2:c.A87G:p.A29A,SCN5A:NM_198056:exon2:c.A87G:p.A29A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7737	0.8360	0.781749	0.7947	.	.	.	.	.	.	.	.	SCN5A:uc021wvx.1:exon2:c.A95G:p.Q32R	.	AFR:0.8943,AMR:0.7255,EAS:0.7012,FIN:0.6997,NFE:0.7774,OTH:0.7398,ASJ:0.7417	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	.	.	.	.	3	MU24669512	hom
3	47125385	47125385	G	A	SETD2	exonic	nonsynonymous SNV	ENSG00000181555	rs4082155	ENSG00000181555:ENST00000409792:exon12:c.C5885T:p.P1962L	SETD2:NM_001349370:exon11:c.C5753T:p.P1918L,SETD2:NM_014159:exon12:c.C5885T:p.P1962L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.5342	0.4713	0.469848	0.4931	1.276	12.14	0.311	2.94	0.998	.	.	.	SETD2:uc003cqs.3:exon12:c.C5885T:p.P1962L,SETD2:uc003cqv.3:exon13:c.C6086T:p.P2029L	-0.947	AFR:0.2820,AMR:0.4771,EAS:0.5424,FIN:0.6158,NFE:0.5774,OTH:0.5767,ASJ:0.4933	612778	616831;	.	.	.	9653,,9651,9650	.	.	0.001	1.98	0.000	0.895	3	MU585924	het
3	47162661	47162661	A	G	SETD2	exonic	synonymous SNV	ENSG00000181555	rs6767907	ENSG00000181555:ENST00000409792:exon3:c.T3465C:p.N1155N,ENSG00000181555:ENST00000412450:exon3:c.T3333C:p.N1111N	SETD2:NM_001349370:exon2:c.T3333C:p.N1111N,SETD2:NM_014159:exon3:c.T3465C:p.N1155N	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6343	0.6448	0.678315	0.6568	.	.	.	.	.	.	.	.	SETD2:uc003cqs.3:exon3:c.T3465C:p.N1155N,SETD2:uc003cqv.3:exon3:c.T3432C:p.N1144N	.	AFR:0.7570,AMR:0.6945,EAS:0.6937,FIN:0.6316,NFE:0.6017,OTH:0.6337,ASJ:0.5667	612778	616831;	.	.	.	9653,,9651	.	.	.	.	.	.	3	MU18259588	het
3	47449058	47449058	T	C	PTPN23	exonic	synonymous SNV	ENSG00000076201	rs900688	ENSG00000076201:ENST00000431726:exon11:c.T609C:p.T203T,ENSG00000076201:ENST00000265562:exon12:c.T987C:p.T329T	PTPN23:NM_001304482:exon11:c.T609C:p.T203T,PTPN23:NM_015466:exon12:c.T987C:p.T329T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9863	0.9493	0.953874	0.9584	.	.	.	.	.	.	.	.	PTPN23:uc011baw.1:exon11:c.T882C:p.T294T,PTPN23:uc011bay.1:exon11:c.T597C:p.T199T,PTPN23:uc003crf.1:exon12:c.T987C:p.T329T	.	AFR:0.8548,AMR:0.9928,EAS:1,FIN:1,NFE:0.9993,OTH:0.9959,ASJ:0.9901	606584	.	.	.	.	.	.	.	.	.	.	.	3	MU81761996	hom
3	47451411	47451411	C	T	PTPN23	intronic	.	ENSG00000076201	rs3736177	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4389	0.3590	0.400559	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.3680,AMR:0.2721,EAS:0.4967,FIN:0.5317,NFE:0.3682,OTH:0.3949,ASJ:0.5	606584	.	.	.	.	.	.	.	.	.	.	.	3	1(lung)	0.3868
3	47452087	47452087	G	A	PTPN23	exonic	synonymous SNV	ENSG00000076201	rs900689	ENSG00000076201:ENST00000431726:exon19:c.G2421A:p.P807P,ENSG00000076201:ENST00000265562:exon20:c.G2799A:p.P933P	PTPN23:NM_001304482:exon19:c.G2421A:p.P807P,PTPN23:NM_015466:exon20:c.G2799A:p.P933P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9867	0.9511	0.954872	0.9600	.	.	.	.	.	.	.	.	PTPN23:uc011baw.1:exon19:c.G2694A:p.P898P,PTPN23:uc011bay.1:exon19:c.G2409A:p.P803P,PTPN23:uc003crf.1:exon20:c.G2799A:p.P933P	.	AFR:0.8595,AMR:0.9928,EAS:1,FIN:1,NFE:0.9994,OTH:0.9959,ASJ:0.99	606584	.	.	.	.	.	.	.	.	.	.	.	3	MU4555978	hom
3	47452118	47452118	G	A	PTPN23	exonic	nonsynonymous SNV	ENSG00000076201	rs6780013	ENSG00000076201:ENST00000431726:exon19:c.G2452A:p.A818T,ENSG00000076201:ENST00000265562:exon20:c.G2830A:p.A944T	PTPN23:NM_001304482:exon19:c.G2452A:p.A818T,PTPN23:NM_015466:exon20:c.G2830A:p.A944T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3708	0.3481	0.345248	1(salivary_gland)	-0.951	0.020	1.0	-5.83	0.018	.	.	.	PTPN23:uc011baw.1:exon19:c.G2725A:p.A909T,PTPN23:uc011bay.1:exon19:c.G2440A:p.A814T,PTPN23:uc003crf.1:exon20:c.G2830A:p.A944T	-0.972	AFR:MU133991,AMR:COCA-CN|2|321|0.00623053,PBCA-DE|1|499|0.00200401,EAS:0.2631,FIN:0.3005,NFE:0.42,OTH:0.3756,ASJ:0.3439	606584	.	.	.	.	.	.	.	0.0	4.31	0.000	-0.77	3	1(thyroid)	0.3590
3	47452786	47452786	G	A	PTPN23	exonic	synonymous SNV	ENSG00000076201	rs1531875	ENSG00000076201:ENST00000431726:exon19:c.G3120A:p.E1040E,ENSG00000076201:ENST00000265562:exon20:c.G3498A:p.E1166E	PTPN23:NM_001304482:exon19:c.G3120A:p.E1040E,PTPN23:NM_015466:exon20:c.G3498A:p.E1166E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5413	0.4852	0.458866	LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	PTPN23:uc011baw.1:exon19:c.G3393A:p.E1131E,PTPN23:uc011bay.1:exon19:c.G3108A:p.E1036E,PTPN23:uc003crf.1:exon20:c.G3498A:p.E1166E	.	AFR:0.5033,AMR:0.2811,EAS:0.4934,FIN:0.4622,NFE:0.6315,OTH:0.6030,ASJ:0.4819	606584	.	.	.	.	.	.	.	.	.	.	.	3	2(haematopoietic_and_lymphoid_tissue)	0.5888
3	47454399	47454399	G	A	PTPN23	exonic	synonymous SNV	ENSG00000076201	rs6789730	ENSG00000076201:ENST00000431726:exon24:c.G4257A:p.P1419P,ENSG00000076201:ENST00000265562:exon25:c.G4635A:p.P1545P	PTPN23:NM_001304482:exon24:c.G4257A:p.P1419P,PTPN23:NM_015466:exon25:c.G4635A:p.P1545P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9872	0.9547	0.954673	0.9077	.	.	.	.	.	.	.	.	PTPN23:uc011bay.1:exon24:c.G4245A:p.P1415P,PTPN23:uc003crf.1:exon25:c.G4635A:p.P1545P	.	AFR:0.8071,AMR:0.9365,EAS:0.9812,FIN:0.9173,NFE:0.9510,OTH:0.9412,ASJ:0.9458	606584	.	.	.	.	.	.	.	.	.	.	.	3	MU4564936	hom
3	48505964	48505964	C	A	ATRIP-TREX1	ncRNA_intronic	.	ENSG00000164053	rs2242150	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3998	0.4692	0.383586	MU759385	.	.	.	.	.	.	.	.	.	.	AFR:SKCA-BR|1|100|0.01,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,AMR:0.4324,EAS:0.2667,FIN:0.4503,NFE:0.2766,OTH:0.4023,ASJ:0.4629	606605	.	.	.	.	.	.	.	.	.	.	.	3	1(skin)	0.4487
3	48508585	48508585	C	T	TREX1	exonic	synonymous SNV	ENSG00000213689	rs11797	ENSG00000213689:ENST00000422277:exon1:c.C696T:p.Y232Y,ENSG00000213689:ENST00000436480:exon2:c.C531T:p.Y177Y,ENSG00000213689:ENST00000444177:exon2:c.C501T:p.Y167Y,ENSG00000213689:ENST00000456089:exon2:c.C114T:p.Y38Y,ENSG00000213689:ENST00000296443:exon3:c.C531T:p.Y177Y,ENSG00000213689:ENST00000433541:exon4:c.C114T:p.Y38Y	TREX1:NM_007248:exon2:c.C501T:p.Y167Y,TREX1:NM_033629:exon2:c.C531T:p.Y177Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3706	0.3931	0.313299	MU759387	.	.	.	.	.	.	.	.	TREX1:uc010hka.4:exon1:c.C696T:p.Y232Y,ATRIP:uc003ctj.3:exon2:c.C696T:p.Y232Y,TREX1:uc010hjz.3:exon2:c.C531T:p.Y177Y,TREX1:uc031rzp.1:exon2:c.C501T:p.Y167Y,TREX1:uc003ctk.3:exon4:c.C114T:p.Y38Y,TREX1:uc010hjy.3:exon10:c.C531T:p.Y177Y	.	AFR:LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.3693,EAS:0.2410,FIN:0.4305,NFE:0.2732,OTH:0.3910,ASJ:0.2720	606609	152700;192315;225750;610448;	90280;51;247691;3421;63261;71291;	90280|-|-|-|-|610448 614415 ~51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~247691|RVCL|Unknown|Autosomal dominant|-|192315 ~3421|CRV<br>Grand-Kaine-Fulling syndrome|<1 / 1 000 000|Autosomal dominant|Adult|192315 ~63261|Hereditary endotheliopathy-retinopathy-nephropathy-stroke syndrome|<1 / 1 000 000|Autosomal dominant|No data available|192315 ~71291|HVR<br>Hereditary vascular retinopathy-Raynaud phenomenon-migraine syndrome|<1 / 1 000 000|Autosomal dominant|Adult|192315 ~	.	.	.	.	.	.	.	.	3	1(thyroid)	0.4361
3	48602523	48602523	-	GGC	COL7A1	intronic	.	ENSG00000114270	rs138595277	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.9999	0.9998	0.999401	1	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	120120	131705;131750;131850;132000;226600;604129;607523;	89843;79408;79409;79410;231568;79411;	89843|DEB, pruriginosa<br>DEB-Pr<br>Pruriginous dystrophic epidermolysis bullosa|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604129 ~79408|Autosomal recessive dystrophic epidermolysis bullosa generalisata gravis<br>Autosomal recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens type<br>RDEB generalisata gravis<br>RDEB, Hallopeau-Siemens type<br>RDEB-sev gen<br>Severe generalized RDEB|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226600 ~79409|Dystrophic epidermolysis bullosa inversa<br>Inverse RDEB<br>Inverse recessive dystrophic epidermolysis bullosa<br>RDEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226600 ~79410|DEB-Pt<br>Pretibial DEB|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|131850 ~231568|Autosomal dominant dystrophic epidermolysis bullosa, Pasini and Cockayne-Touraine types<br>DDEB, Pasini and Cockayne-Touraine types<br>DDEB, generalized<br>DDEB-gen|Unknown|Autosomal dominant|Infancy<br>Neonatal|131750 ~79411|DEB, bullous dermolysis of the newborn<br>DEB-BDN|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|131705 ~	.	.	.	.	.	.	.	.	3	.	hom
3	48625266	48625266	T	C	COL7A1	exonic	synonymous SNV	ENSG00000114270	rs1264194	ENSG00000114270:ENST00000328333:exon21:c.A2817G:p.P939P,ENSG00000114270:ENST00000454817:exon21:c.A2817G:p.P939P	COL7A1:NM_000094:exon21:c.A2817G:p.P939P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6799	0.7736	0.68111	MU703853	.	.	.	.	.	.	.	.	COL7A1:uc003ctz.2:exon21:c.A2817G:p.P939P	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,AMR:0.7408,EAS:0.6086,FIN:0.7947,NFE:0.3558,OTH:0.7227,ASJ:0.9026	120120	131705;131750;131850;132000;226600;604129;607523;	89843;79408;79409;79410;231568;79411;	89843|DEB, pruriginosa<br>DEB-Pr<br>Pruriginous dystrophic epidermolysis bullosa|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604129 ~79408|Autosomal recessive dystrophic epidermolysis bullosa generalisata gravis<br>Autosomal recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens type<br>RDEB generalisata gravis<br>RDEB, Hallopeau-Siemens type<br>RDEB-sev gen<br>Severe generalized RDEB|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226600 ~79409|Dystrophic epidermolysis bullosa inversa<br>Inverse RDEB<br>Inverse recessive dystrophic epidermolysis bullosa<br>RDEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226600 ~79410|DEB-Pt<br>Pretibial DEB|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|131850 ~231568|Autosomal dominant dystrophic epidermolysis bullosa, Pasini and Cockayne-Touraine types<br>DDEB, Pasini and Cockayne-Touraine types<br>DDEB, generalized<br>DDEB-gen|Unknown|Autosomal dominant|Infancy<br>Neonatal|131750 ~79411|DEB, bullous dermolysis of the newborn<br>DEB-BDN|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|131705 ~	.	.	.	.	.	.	.	.	3	2(haematopoietic_and_lymphoid_tissue)	0.7018
3	49398514	49398514	C	A	RHOA	intronic	.	ENSG00000067560	rs892974	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.8667	.	0.886182	0.8014	.	.	.	.	.	.	.	.	.	.	AFR:0.8630,AMR:0.8333,EAS:0.9944,FIN:0.7823,NFE:0.7436,OTH:0.7887,ASJ:0.7727	165390	.	.	.	~ko04011 MAPK signaling pathway - yeast~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04150 mTOR signaling pathway~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04350 TGF-beta signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04660 T cell receptor signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04921 Oxytocin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04972 Pancreatic secretion~ko05100 Bacterial invasion of epithelial cells~ko05130 Pathogenic Escherichia coli infection~ko05133 Pertussis~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	3	.	hom
3	49721532	49721532	G	A	MST1	exonic	nonsynonymous SNV	ENSG00000173531	rs3197999	ENSG00000173531:ENST00000449682:exon18:c.C2107T:p.R703C	MST1:NM_020998:exon18:c.C2107T:p.R703C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.2557	0.2738	0.191893	1(upper_aerodigestive_tract)	5.174	25.5	0.02	-2.82	0.942	.	.	Peptidase S1, PA clan|Serine proteases, trypsin domain	MST1:uc003cxg.3:exon18:c.C2107T:p.R703C	-1.025	AFR:MU585952,AMR:LUSC-KR|1|170|0.00588235,EAS:0.2266,FIN:0.1579,NFE:0.3775,OTH:0.0414,ASJ:0.2622	142408	.	.	.	.	.	.	.	0.727	-2.48	0.000	2.26	3	2(soft_tissue)	0.4019
3	49721653	49721653	G	A	MST1	intronic	.	ENSG00000173531	rs201428113	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0004	.	.	0.0005	.	.	.	.	.	.	.	.	.	.	AFR:0.0003,AMR:0,EAS:0,FIN:0,NFE:0.0008,OTH:0,ASJ:0	142408	.	.	.	.	.	.	.	.	.	.	.	3	MU112998720	het
3	49721798	49721798	C	A	MST1	exonic	synonymous SNV	ENSG00000173531	rs13085791	ENSG00000173531:ENST00000449682:exon17:c.G1965T:p.R655R	MST1:NM_020998:exon17:c.G1965T:p.R655R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2663	0.2891	0.208866	0.2799	.	.	.	.	.	.	.	.	MST1:uc003cxg.3:exon17:c.G1965T:p.R655R	.	AFR:0.2672,AMR:0.1683,EAS:0.0408,FIN:0.4231,NFE:0.2824,OTH:0.3075,ASJ:0.3725	142408	.	.	.	.	.	.	.	.	.	.	.	3	MU29787735	het
3	49723727	49723727	C	-	MST1	intronic	.	ENSG00000173531	rs762013151	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0044	.	.	0.1617	.	.	.	.	.	.	.	.	MST1:uc011bcs.1:exon8:c.1031delG:p.G344fs	.	AFR:0.2859,AMR:0.1439,EAS:0.2840,FIN:0.1129,NFE:0.0759,OTH:0.08,ASJ:0.0417	142408	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	49723735	49723735	C	G	MST1	intronic	.	ENSG00000173531	rs184629099	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3671	.	.	0.0093	.	.	.	.	.	.	.	.	MST1:uc011bcs.1:exon8:c.G1023C:p.G341G	.	AFR:0.0017,AMR:0.0135,EAS:0,FIN:0.0003,NFE:0.0164,OTH:0.0180,ASJ:0.0327	142408	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	49723784	49723784	C	A	MST1	exonic	synonymous SNV	ENSG00000173531	rs9713651	ENSG00000173531:ENST00000383728:exon7:c.G753T:p.P251P,ENSG00000173531:ENST00000449682:exon8:c.G978T:p.P326P	MST1:NM_020998:exon8:c.G978T:p.P326P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4369	0.3782	.	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MST1:uc011bcs.1:exon8:c.G974T:p.R325L	.	AFR:0.4461,AMR:0.3271,EAS:0.3973,FIN:0.9428,NFE:0.4230,OTH:0.4640,ASJ:0.5537	142408	.	.	.	.	.	.	.	.	.	.	.	3	1(large_intestine)	0.4705
3	49723823	49723823	A	G	MST1	exonic	synonymous SNV	ENSG00000173531	rs7431215	ENSG00000173531:ENST00000383728:exon7:c.T714C:p.T238T,ENSG00000173531:ENST00000449682:exon8:c.T939C:p.T313T	MST1:NM_020998:exon8:c.T939C:p.T313T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3743	.	.	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	MST1:uc011bcs.1:exon8:c.T935C:p.L312P	.	AFR:MU4552991,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,BRCA-KR|1|50|0.02,EAS:0.0761,FIN:0.2579,NFE:0.1089,OTH:0.0021,ASJ:0.1358	142408	.	.	.	.	.	.	.	.	.	.	.	3	2(breast)	0.1803
3	49724808	49724808	T	C	MST1	exonic	synonymous SNV	ENSG00000173531	rs3020779	ENSG00000173531:ENST00000383728:exon3:c.A234G:p.P78P,ENSG00000173531:ENST00000449682:exon4:c.A459G:p.P153P	MST1:NM_020998:exon4:c.A459G:p.P153P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8574	0.7876	0.860224	0.8201	.	.	.	.	.	.	.	.	MST1:uc003cxg.3:exon4:c.A459G:p.P153P,MST1:uc010hkx.2:exon4:c.A222G:p.P74P,MST1:uc011bcs.1:exon4:c.A459G:p.P153P,MST1:uc011bct.1:exon4:c.A459G:p.P153P	.	AFR:0.7258,AMR:0.8819,EAS:0.9963,FIN:0.8986,NFE:0.8320,OTH:0.8599,ASJ:0.8079	142408	.	.	.	.	.	.	.	.	.	.	.	3	MU81762505	hom
3	49726028	49726028	T	C	MST1	intronic	.	ENSG00000173531	rs62262685	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4498	.	.	0.2800	.	.	.	.	.	0.0005	0.002	.	.	.	AFR:0.3296,AMR:0.3122,EAS:0.3076,FIN:0.3306,NFE:0.2354,OTH:0.2416,ASJ:0.2722	142408	.	.	.	.	.	.	.	.	.	.	.	3	MU665637	het
3	49726070	49726070	G	A	MST1	exonic	nonsynonymous SNV	ENSG00000173531	rs62262686	ENSG00000173531:ENST00000449682:exon1:c.C55T:p.P19S,ENSG00000173531:ENST00000545762:exon1:c.C13T:p.P5S	MST1:NM_020998:exon1:c.C55T:p.P19S	clinvar: not_provided 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3968	.	.	3(pancreas)	0.054	3.124	0.251	-0.229	0.997	.	.	.	MST1:uc003cxg.3:exon1:c.C55T:p.P19S,MST1:uc011bcs.1:exon1:c.C55T:p.P19S,MST1:uc011bct.1:exon1:c.C55T:p.P19S	-0.390	AFR:1(thyroid),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:18(upper_aerodigestive_tract),FIN:3(central_nervous_system),NFE:MU684592,OTH:SKCA-BR|1|100|0.01,LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,ASJ:1(oesophagus)	142408	.	.	.	.	.	.	.	0.982	-2.17	0.542	1.69	3	1(liver)	0.1420
3	49760039	49760039	T	C	GMPPB	exonic	nonsynonymous SNV	ENSG00000173540	rs1466685	ENSG00000173540:ENST00000308375:exon5:c.A551G:p.Q184R,ENSG00000173540:ENST00000308388:exon5:c.A551G:p.Q184R,ENSG00000173540:ENST00000480687:exon6:c.A551G:p.Q184R	GMPPB:NM_013334:exon5:c.A551G:p.Q184R,GMPPB:NM_021971:exon5:c.A551G:p.Q184R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9967	0.9892	0.989018	0.9889	0.422	6.799	0.071	-2.63	0.913	.	.	Nucleotide-diphospho-sugar transferases|Nucleotidyl transferase domain	GMPPB:uc003cxk.1:exon5:c.A551G:p.Q184R,GMPPB:uc003cxl.1:exon5:c.A551G:p.Q184R	-0.902	AFR:0.9620,AMR:0.9952,EAS:1,FIN:1,NFE:0.9997,OTH:0.9949,ASJ:1	615320	615350;615351;615352;	363623;370959;370968;588;	363623|LGMD2T|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615352 ~370959|CMD with cerebellar involvement<br>CMD-CRB|-|-|-|606612 613151 613155 613156 615351 ~370968|CMD with intellectual disability<br>CMD-MR|-|-|-|606612 608840 613155 613156 615351 ~588|MEB syndrome<br>Muscle-eye-brain syndrome<br>Santavuori congenital muscular dystrophy|Unknown|Autosomal recessive|Infancy<br>Neonatal|236670 253280 253800 613150 613153 613154 615181 615350 ~	.	.	.	.	0.0	-3.29	0.000	-0.49	3	MU81762601	hom
3	49924940	49924940	T	C	MST1R	exonic	nonsynonymous SNV	ENSG00000164078	rs1062633	ENSG00000164078:ENST00000344206:exon19:c.A3856G:p.R1286G,ENSG00000164078:ENST00000296474:exon20:c.A4003G:p.R1335G	MST1R:NM_001318913:exon18:c.A3685G:p.R1229G,MST1R:NM_001244937:exon19:c.A3856G:p.R1286G,MST1R:NM_002447:exon20:c.A4003G:p.R1335G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4180	0.5629	0.419129	3(haematopoietic_and_lymphoid_tissue)	-1.266	0.005	0.51	-4.24	0.000	.	.	Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase, catalytic domain|Tyrosine-protein kinase, catalytic domain;Protein kinase domain|Tyrosine-protein kinase, catalytic domain	MST1R:uc031rzv.1:exon7:c.A337G:p.R113G,MST1R:uc031rzw.1:exon18:c.A3685G:p.R1229G,MST1R:uc011bdc.2:exon19:c.A3856G:p.R1286G,MST1R:uc003cxy.4:exon20:c.A4003G:p.R1335G	-0.969	AFR:MU14496730,AMR:LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,EAS:0.6804,FIN:0.3282,NFE:0.4603,OTH:0.1433,ASJ:0.5150	600168	617075;	150;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~	.	.	.	.	0.0	-1.68	0.000	0.895	3	57(lung)	0.3751
3	49927503	49927503	G	T	MST1R	intronic	.	ENSG00000164078	rs12489386	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0648	0.0820	0.0573083	0.0774	.	.	.	.	.	0.0036	0.114	.	.	.	AFR:0.0884,AMR:0.0418,EAS:0.0290,FIN:0.0647,NFE:0.0816,OTH:0.0743,ASJ:0.0667	600168	617075;	150;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~	.	.	.	.	.	.	.	.	3	.	het
3	49928691	49928691	T	C	MST1R	exonic	nonsynonymous SNV	ENSG00000164078	rs7433231	ENSG00000164078:ENST00000344206:exon16:c.A3436G:p.S1146G,ENSG00000164078:ENST00000296474:exon17:c.A3583G:p.S1195G	MST1R:NM_001318913:exon15:c.A3265G:p.S1089G,MST1R:NM_001244937:exon16:c.A3436G:p.S1146G,MST1R:NM_002447:exon17:c.A3583G:p.S1195G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MST1R:uc031rzv.1:exon6:c.A220G:p.S74G,MST1R:uc031rzw.1:exon15:c.A3265G:p.S1089G,MST1R:uc011bdc.2:exon16:c.A3436G:p.S1146G,MST1R:uc003cxy.4:exon17:c.A3583G:p.S1195G	.	AFR:1.0000,AMR:0.9999,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600168	617075;	150;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~	.	.	.	.	.	.	.	.	3	23(upper_aerodigestive_tract)	1
3	49929025	49929025	C	A	MST1R	intronic	.	ENSG00000164078	rs55643042	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0624	0.0775	0.0543131	0.0739	.	.	.	.	.	0	0.002	.	.	.	AFR:0.0759,AMR:0.0406,EAS:0.0285,FIN:0.0647,NFE:0.0816,OTH:0.0746,ASJ:0.0728	600168	617075;	150;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~	.	.	.	.	.	.	.	.	3	.	het
3	49936102	49936102	T	C	MST1R	exonic	nonsynonymous SNV	ENSG00000164078	rs2230590	ENSG00000164078:ENST00000296474:exon4:c.A1568G:p.Q523R,ENSG00000164078:ENST00000344206:exon4:c.A1568G:p.Q523R,ENSG00000164078:ENST00000411578:exon4:c.A1568G:p.Q523R	MST1R:NM_001318913:exon2:c.A1250G:p.Q417R,MST1R:NM_001244937:exon4:c.A1568G:p.Q523R,MST1R:NM_002447:exon4:c.A1568G:p.Q523R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4172	0.5606	0.416534	1(haematopoietic_and_lymphoid_tissue)	-3.309	0.001	1.0	-6.78	0.078	.	.	Sema domain|WD40/YVTN repeat-like-containing domain	MST1R:uc011bdf.1:exon2:c.A1250G:p.Q417R,MST1R:uc031rzw.1:exon2:c.A1250G:p.Q417R,MST1R:uc003cxy.4:exon4:c.A1568G:p.Q523R,MST1R:uc011bdc.2:exon4:c.A1568G:p.Q523R,MST1R:uc011bdd.2:exon4:c.A1568G:p.Q523R,MST1R:uc011bde.1:exon4:c.A1568G:p.Q523R	-0.975	AFR:61(lung),AMR:MU14496755,EAS:0.5134,FIN:0.6738,NFE:0.3282,OTH:0.4603,ASJ:PACA-CA|1|268|0.00373134,LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647	600168	617075;	150;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~	.	.	.	.	0.0	1.05	0.000	0.125	3	1(pancreas)	0.1436
3	49936715	49936715	G	A	MST1R	intronic	.	ENSG00000164078	rs41291716	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0625	0.0735	0.0541134	0.0739	.	.	.	.	.	.	.	.	.	.	AFR:0.0759,AMR:0.0406,EAS:0.0290,FIN:0.0648,NFE:0.0817,OTH:0.0746,ASJ:0.0728	600168	617075;	150;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~	.	.	.	.	.	.	.	.	3	.	het
3	51978220	51978220	A	G	PARP3	exonic	nonsynonymous SNV	ENSG00000041880	rs28547534	ENSG00000041880:ENST00000498510:exon2:c.A299G:p.H100R,ENSG00000041880:ENST00000398755:exon3:c.A320G:p.H107R,ENSG00000041880:ENST00000431474:exon3:c.A299G:p.H100R,ENSG00000041880:ENST00000417220:exon4:c.A299G:p.H100R	PARP3:NM_001003931:exon3:c.A320G:p.H107R,PARP3:NM_001370240:exon3:c.A299G:p.H100R,PARP3:NM_005485:exon3:c.A299G:p.H100R,PARP3:NM_001370239:exon4:c.A299G:p.H100R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9927	0.9920	0.997604	0.9937	.	.	.	.	.	.	.	.	PARP3:uc003dby.3:exon3:c.A299G:p.H100R,PARP3:uc003dbz.3:exon3:c.A320G:p.H107R	.	AFR:0.9977,AMR:0.9928,EAS:1,FIN:0.9946,NFE:0.9907,OTH:0.9908,ASJ:1	607726	.	.	.	.	.	.	.	.	.	.	.	3	MU4565297	hom
3	53213657	53213657	T	C	PRKCD	exonic	synonymous SNV	ENSG00000163932	rs2230493	ENSG00000163932:ENST00000394729:exon3:c.T180C:p.D60D,ENSG00000163932:ENST00000464818:exon3:c.T180C:p.D60D,ENSG00000163932:ENST00000330452:exon4:c.T180C:p.D60D,ENSG00000163932:ENST00000478843:exon4:c.T180C:p.D60D,ENSG00000163932:ENST00000487897:exon4:c.T180C:p.D60D	PRKCD:NM_001354676:exon3:c.T237C:p.D79D,PRKCD:NM_001354678:exon3:c.T228C:p.D76D,PRKCD:NM_212539:exon3:c.T180C:p.D60D,PRKCD:NM_001316327:exon4:c.T180C:p.D60D,PRKCD:NM_001354679:exon4:c.T180C:p.D60D,PRKCD:NM_006254:exon4:c.T180C:p.D60D,PRKCD:NM_001354680:exon5:c.T180C:p.D60D	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1281	0.1296	0.081869	0.1279	.	.	.	.	.	.	.	.	PRKCD:uc003dgn.2:exon2:c.T180C:p.D60D,PRKCD:uc003dgm.3:exon3:c.T180C:p.D60D,PRKCD:uc003dgl.3:exon4:c.T180C:p.D60D	.	AFR:0.0635,AMR:0.0776,EAS:0.0123,FIN:0.1350,NFE:0.1765,OTH:0.1551,ASJ:0.1722	176977	615559;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	.	.	.	.	.	.	.	.	3	.	het
3	53222761	53222761	C	T	PRKCD	exonic	synonymous SNV	ENSG00000163932	rs2306574	ENSG00000163932:ENST00000394729:exon15:c.C1441T:p.L481L,ENSG00000163932:ENST00000330452:exon16:c.C1441T:p.L481L	PRKCD:NM_001354676:exon15:c.C1498T:p.L500L,PRKCD:NM_001354678:exon15:c.C1489T:p.L497L,PRKCD:NM_212539:exon15:c.C1441T:p.L481L,PRKCD:NM_001316327:exon16:c.C1441T:p.L481L,PRKCD:NM_001354679:exon16:c.C1441T:p.L481L,PRKCD:NM_006254:exon16:c.C1441T:p.L481L,PRKCD:NM_001354680:exon17:c.C1441T:p.L481L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7480	0.7583	0.713458	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PRKCD:uc003dgm.3:exon15:c.C1441T:p.L481L,PRKCD:uc003dgl.3:exon16:c.C1441T:p.L481L	.	AFR:0.7580,AMR:0.7198,EAS:0.7667,FIN:0.7833,NFE:0.7338,OTH:0.7843,ASJ:0.7356	176977	615559;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	.	.	.	.	.	.	.	.	3	1(urinary_tract)	0.7556
3	53223927	53223927	C	G	PRKCD	exonic	synonymous SNV	ENSG00000163932	rs1075865	ENSG00000163932:ENST00000394729:exon17:c.C1782G:p.T594T,ENSG00000163932:ENST00000330452:exon18:c.C1782G:p.T594T	PRKCD:NM_001354676:exon17:c.C1839G:p.T613T,PRKCD:NM_001354678:exon17:c.C1830G:p.T610T,PRKCD:NM_212539:exon17:c.C1782G:p.T594T,PRKCD:NM_001316327:exon18:c.C1782G:p.T594T,PRKCD:NM_001354679:exon18:c.C1782G:p.T594T,PRKCD:NM_006254:exon18:c.C1782G:p.T594T,PRKCD:NM_001354680:exon19:c.C1782G:p.T594T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9655	0.9335	0.901957	0.9428	.	.	.	.	.	.	.	.	PRKCD:uc003dgm.3:exon17:c.C1782G:p.T594T,PRKCD:uc003dgl.3:exon18:c.C1782G:p.T594T	.	AFR:0.8065,AMR:0.9905,EAS:0.9728,FIN:1,NFE:0.9993,OTH:0.9806,ASJ:0.9967	176977	615559;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	.	.	.	.	.	.	.	.	3	MU81763707	hom
3	53224002	53224002	T	C	PRKCD	exonic	synonymous SNV	ENSG00000163932	rs900495	ENSG00000163932:ENST00000394729:exon17:c.T1857C:p.P619P,ENSG00000163932:ENST00000330452:exon18:c.T1857C:p.P619P	PRKCD:NM_001354676:exon17:c.T1914C:p.P638P,PRKCD:NM_001354678:exon17:c.T1905C:p.P635P,PRKCD:NM_212539:exon17:c.T1857C:p.P619P,PRKCD:NM_001316327:exon18:c.T1857C:p.P619P,PRKCD:NM_001354679:exon18:c.T1857C:p.P619P,PRKCD:NM_006254:exon18:c.T1857C:p.P619P,PRKCD:NM_001354680:exon19:c.T1857C:p.P619P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9835	0.9393	0.940495	0.9481	.	.	.	.	.	.	.	.	PRKCD:uc003dgm.3:exon17:c.T1857C:p.P619P,PRKCD:uc003dgl.3:exon18:c.T1857C:p.P619P	.	AFR:0.8192,AMR:0.9905,EAS:1,FIN:1,NFE:0.9993,OTH:0.9888,ASJ:0.9967	176977	615559;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	.	.	.	.	.	.	.	.	3	MU81763716	hom
3	53700550	53700550	T	C	CACNA1D	exonic	synonymous SNV	ENSG00000157388	rs2250736	ENSG00000157388:ENST00000481478:exon1:c.T123C:p.D41D,ENSG00000157388:ENST00000288139:exon7:c.T1104C:p.D368D,ENSG00000157388:ENST00000350061:exon7:c.T1104C:p.D368D,ENSG00000157388:ENST00000422281:exon7:c.T1104C:p.D368D	CACNA1D:NM_000720:exon7:c.T1104C:p.D368D,CACNA1D:NM_001128839:exon7:c.T1104C:p.D368D,CACNA1D:NM_001128840:exon7:c.T1104C:p.D368D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5945	0.6475	0.70647	0.6466	.	.	.	.	.	.	.	.	CACNA1D:uc003dgw.4:exon1:c.T45C:p.D15D,CACNA1D:uc003dgu.5:exon7:c.T1104C:p.D368D,CACNA1D:uc003dgv.5:exon7:c.T1104C:p.D368D,CACNA1D:uc003dgy.5:exon7:c.T1104C:p.D368D	.	AFR:0.8772,AMR:0.6026,EAS:0.6200,FIN:0.5856,NFE:0.5390,OTH:0.5833,ASJ:0.4967	114206	614896;615474;	369929;324321;	369929|APA with seizures and neurological abnormalities<br>Aldosterone-secreting adenoma with seizures and neurological abnormalities<br>Conn adenoma with seizures and neurological abnormalities|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|615474 ~324321|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614896 ~	.	.	.	.	.	.	.	.	3	MU19620305	hom
3	53766026	53766026	T	C	CACNA1D	intronic	.	ENSG00000157388	rs2612033	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8887	0.8671	0.910942	0.8868	.	.	.	.	.	.	.	.	.	.	AFR:0.8822,AMR:0.9115,EAS:1,FIN:0.9115,NFE:0.8702,OTH:0.9012,ASJ:0.8344	114206	614896;615474;	369929;324321;	369929|APA with seizures and neurological abnormalities<br>Aldosterone-secreting adenoma with seizures and neurological abnormalities<br>Conn adenoma with seizures and neurological abnormalities|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|615474 ~324321|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614896 ~	.	.	.	.	.	.	.	.	3	MU81763800	hom
3	53769479	53769479	C	T	CACNA1D	exonic	synonymous SNV	ENSG00000157388	rs1045958	ENSG00000157388:ENST00000481478:exon15:c.C1779T:p.S593S,ENSG00000157388:ENST00000350061:exon20:c.C2700T:p.S900S,ENSG00000157388:ENST00000422281:exon20:c.C2700T:p.S900S,ENSG00000157388:ENST00000288139:exon21:c.C2760T:p.S920S	CACNA1D:NM_001128839:exon20:c.C2700T:p.S900S,CACNA1D:NM_001128840:exon20:c.C2700T:p.S900S,CACNA1D:NM_000720:exon21:c.C2760T:p.S920S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2994	0.2545	0.192292	0.2681	.	.	.	.	.	.	.	.	CACNA1D:uc003dgx.1:exon4:c.C144T:p.S48S,CACNA1D:uc003dgw.4:exon15:c.C1701T:p.S567S,CACNA1D:uc003dgv.5:exon20:c.C2700T:p.S900S,CACNA1D:uc003dgy.5:exon20:c.C2700T:p.S900S,CACNA1D:uc003dgu.5:exon21:c.C2760T:p.S920S	.	AFR:0.0693,AMR:0.3313,EAS:0.2042,FIN:0.3673,NFE:0.3585,OTH:0.3374,ASJ:0.3377	114206	614896;615474;	369929;324321;	369929|APA with seizures and neurological abnormalities<br>Aldosterone-secreting adenoma with seizures and neurological abnormalities<br>Conn adenoma with seizures and neurological abnormalities|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|615474 ~324321|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614896 ~	.	.	.	.	.	.	.	.	3	MU4565454	het
3	57132200	57132200	A	G	IL17RD	exonic	synonymous SNV	ENSG00000144730	rs2291462	ENSG00000144730:ENST00000296318:exon12:c.T1531C:p.L511L,ENSG00000144730:ENST00000427856:exon12:c.T1459C:p.L487L,ENSG00000144730:ENST00000463523:exon12:c.T1099C:p.L367L,ENSG00000144730:ENST00000320057:exon13:c.T1099C:p.L367L	IL17RD:NM_017563:exon12:c.T1531C:p.L511L,IL17RD:NM_001318864:exon13:c.T1099C:p.L367L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8239	0.7910	0.736222	0.7820	.	.	.	.	.	.	.	.	IL17RD:uc003dik.3:exon12:c.T1459C:p.L487L,IL17RD:uc003dil.3:exon12:c.T1531C:p.L511L,IL17RD:uc011bex.1:exon12:c.T1099C:p.L367L,IL17RD:uc010hna.3:exon13:c.T1099C:p.L367L	.	AFR:0.6457,AMR:0.8377,EAS:0.4777,FIN:0.8980,NFE:0.8579,OTH:0.8405,ASJ:0.8841	606807	615267;	478;	478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	.	.	.	.	.	.	.	.	3	MU21327509	hom
3	57138419	57138419	G	A	IL17RD	exonic	nonsynonymous SNV	ENSG00000144730	rs6780995	ENSG00000144730:ENST00000296318:exon8:c.C764T:p.T255M,ENSG00000144730:ENST00000427856:exon8:c.C692T:p.T231M,ENSG00000144730:ENST00000463523:exon8:c.C332T:p.T111M,ENSG00000144730:ENST00000320057:exon9:c.C332T:p.T111M	IL17RD:NM_017563:exon8:c.C764T:p.T255M,IL17RD:NM_001318864:exon9:c.C332T:p.T111M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6490	0.6661	0.530152	ESAD-UK|1|409|0.00244499,LUSC-KR|4|170|0.0235294,COCA-CN|2|321|0.00623053	2.678	20.7	0.094	-0.521	0.999	.	.	Interleukin 17 receptor D, N-terminal	IL17RD:uc003dik.3:exon8:c.C692T:p.T231M,IL17RD:uc003dil.3:exon8:c.C764T:p.T255M,IL17RD:uc011bex.1:exon8:c.C332T:p.T111M,IL17RD:uc010hna.3:exon9:c.C332T:p.T111M	-1.079	AFR:0.6306,AMR:0.5815,EAS:0.6921,FIN:0.1156,NFE:0.7376,OTH:0.6926,ASJ:0.5180	606807	615267;	478;	478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	.	.	.	.	0.943	2.89	0.000	1.245	3	1(bone)	0.6633
3	57139972	57139972	A	G	IL17RD	exonic	synonymous SNV	ENSG00000144730	rs1545981	ENSG00000144730:ENST00000296318:exon7:c.T660C:p.H220H,ENSG00000144730:ENST00000427856:exon7:c.T588C:p.H196H,ENSG00000144730:ENST00000463523:exon7:c.T228C:p.H76H,ENSG00000144730:ENST00000320057:exon8:c.T228C:p.H76H	IL17RD:NM_017563:exon7:c.T660C:p.H220H,IL17RD:NM_001318864:exon8:c.T228C:p.H76H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8697	0.8589	0.79373	0.8421	.	.	.	.	.	.	.	.	IL17RD:uc003dik.3:exon7:c.T588C:p.H196H,IL17RD:uc003dil.3:exon7:c.T660C:p.H220H,IL17RD:uc011bex.1:exon7:c.T228C:p.H76H,IL17RD:uc010hna.3:exon8:c.T228C:p.H76H	.	AFR:0.7636,AMR:0.8926,EAS:0.4838,FIN:0.9342,NFE:0.8975,OTH:0.8929,ASJ:0.8974	606807	615267;	478;	478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	.	.	.	.	.	.	.	.	3	MU21327553	hom
3	59738064	59738064	A	T	FHIT	intronic	.	ENSG00000189283	rs1683356	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1893	0.1940	0.246406	0.1853	.	.	.	.	.	.	.	.	.	.	AFR:0.2974,AMR:0.1492,EAS:0.2114,FIN:0.1232,NFE:0.1376,OTH:0.1426,ASJ:0.1424	601153	.	.	.	.	.	.	.	.	.	.	.	3	MU759718	het
3	59908126	59908126	A	G	FHIT	exonic	synonymous SNV	ENSG00000189283	rs1385816	ENSG00000189283:ENST00000341848:exon4:c.T294C:p.H98H,ENSG00000189283:ENST00000468189:exon8:c.T294C:p.H98H,ENSG00000189283:ENST00000476844:exon8:c.T294C:p.H98H,ENSG00000189283:ENST00000492590:exon8:c.T294C:p.H98H	FHIT:NM_001320901:exon6:c.T126C:p.H42H,FHIT:NM_001166243:exon8:c.T294C:p.H98H,FHIT:NM_001320899:exon8:c.T294C:p.H98H,FHIT:NM_002012:exon8:c.T294C:p.H98H,FHIT:NM_001320900:exon9:c.T294C:p.H98H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2453	0.1671	0.22484	MU585983	.	.	.	.	.	.	.	.	FHIT:uc003dkx.4:exon8:c.T294C:p.H98H,FHIT:uc003dky.3:exon8:c.T294C:p.H98H,FHIT:uc010hnn.1:exon8:c.T294C:p.H98H	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.2171,EAS:0.3792,FIN:0.0861,NFE:0.3110,OTH:0.3657,ASJ:0.0926	601153	.	.	.	.	.	.	.	.	.	.	.	3	7(soft_tissue)	0.2349
3	70014335	70014335	G	A	MITF	exonic	nonsynonymous SNV	ENSG00000187098	rs548265796	ENSG00000187098:ENST00000314557:exon9:c.G1178A:p.G393E,ENSG00000187098:ENST00000394351:exon9:c.G1196A:p.G399E,ENSG00000187098:ENST00000394355:exon9:c.G1424A:p.G475E,ENSG00000187098:ENST00000531774:exon9:c.G1010A:p.G337E,ENSG00000187098:ENST00000314589:exon10:c.G1451A:p.G484E,ENSG00000187098:ENST00000328528:exon10:c.G1496A:p.G499E,ENSG00000187098:ENST00000352241:exon10:c.G1499A:p.G500E,ENSG00000187098:ENST00000448226:exon10:c.G1517A:p.G506E,ENSG00000187098:ENST00000472437:exon10:c.G1343A:p.G448E	MITF:NM_000248:exon9:c.G1196A:p.G399E,MITF:NM_198158:exon9:c.G1178A:p.G393E,MITF:NM_198178:exon9:c.G1010A:p.G337E,MITF:NM_001184967:exon10:c.G1343A:p.G448E,MITF:NM_001354604:exon10:c.G1517A:p.G506E,MITF:NM_001354605:exon10:c.G1514A:p.G505E,MITF:NM_001354606:exon10:c.G1496A:p.G499E,MITF:NM_006722:exon10:c.G1496A:p.G499E,MITF:NM_198159:exon10:c.G1499A:p.G500E,MITF:NM_198177:exon10:c.G1451A:p.G484E,MITF:NM_001354607:exon11:c.G1448A:p.G483E,MITF:NM_001354608:exon11:c.G1343A:p.G448E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0004	.	0.000599042	.	3.569	23.1	0.222	6.04	0.934	.	.	MiT/TFE transcription factors, C-terminal;Myc-type, basic helix-loop-helix (bHLH) domain	MITF:uc003doe.3:exon9:c.G1178A:p.G393E,MITF:uc003dof.3:exon9:c.G1196A:p.G399E,MITF:uc021xam.1:exon9:c.G1010A:p.G337E,MITF:uc003dnz.3:exon10:c.G1499A:p.G500E,MITF:uc003doa.3:exon10:c.G1496A:p.G499E,MITF:uc003dob.3:exon10:c.G1451A:p.G484E,MITF:uc011bgb.2:exon10:c.G1343A:p.G448E	-0.814	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	156845	103470;103500;193510;614456;	293822;3440;895;42665;352740;	293822|-|<1 / 1 000 000|-|-|614456 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~895|WS2<br>Waardenburg syndrome type II|Unknown|Autosomal dominant|Neonatal|193510 600193 606662 608890 611584 ~42665|Hypopigmentation-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|103500 ~352740|Waardenburg syndrome type 2 with ocular albinism|<1 / 1 000 000|-|Infancy<br>Neonatal|103470 ~	~ko04137 Mitophagy - animal~ko04380 Osteoclast differentiation~ko04916 Melanogenesis~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05218 Melanoma ~	.	.	.	0.952	0.16	0.238	1.015	3	.	het
3	71015021	71015021	G	T	FOXP1	intronic	.	ENSG00000114861	rs7638391	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9452	0.9413	0.974641	0.9489	.	.	.	.	.	.	.	.	.	.	AFR:0.9831,AMR:0.9535,EAS:1,FIN:0.9476,NFE:0.9238,OTH:0.9559,ASJ:0.9139	605515	613670;	391372;	391372|-|<1 / 1 000 000|-|Infancy<br>Neonatal|613670 ~	.	.	.	.	.	.	.	.	3	MU81765255	hom
3	78663956	78663956	G	A	ROBO1	intronic	.	ENSG00000169855	rs1027832	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4516	0.3502	0.353435	0.3768	.	.	.	.	.	0	0.012	.	.	.	AFR:0.2184,AMR:0.5679,EAS:0.3237,FIN:0.5078,NFE:0.4363,OTH:0.4279,ASJ:0.4759	602430	.	.	.	.	.	.	.	.	.	.	.	3	MU759938	het
3	78666765	78666765	T	C	ROBO1	intronic	.	ENSG00000169855	rs9839790	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6225	0.6195	0.575479	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.5908,AMR:0.4635,EAS:0.7053,FIN:0.5208,NFE:0.6726,OTH:0.6460,ASJ:0.6483	602430	.	.	.	.	.	.	.	.	.	.	.	3	1(haematopoietic_and_lymphoid_tissue)	0.6148
3	78676467	78676467	A	G	ROBO1	intronic	.	ENSG00000169855	rs7636043	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9648	0.9735	0.969848	0.9692	.	.	.	.	.	0	0	.	.	.	AFR:0.9787,AMR:0.9881,EAS:0.9926,FIN:0.9648,NFE:0.9616,OTH:0.9541,ASJ:0.9901	602430	.	.	.	.	.	.	.	.	.	.	.	3	MU18278522	hom
3	78700901	78700901	G	T	ROBO1	exonic	synonymous SNV	ENSG00000169855	rs6795556	ENSG00000169855:ENST00000436010:exon17:c.C2676A:p.T892T,ENSG00000169855:ENST00000467549:exon18:c.C2685A:p.T895T,ENSG00000169855:ENST00000495273:exon18:c.C2685A:p.T895T,ENSG00000169855:ENST00000464233:exon19:c.C2793A:p.T931T	ROBO1:NM_001145845:exon18:c.C2685A:p.T895T,ROBO1:NM_133631:exon18:c.C2685A:p.T895T,ROBO1:NM_002941:exon19:c.C2793A:p.T931T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2246	0.2191	0.216653	MU135913	.	.	.	.	.	.	.	.	ROBO1:uc011bgl.1:exon9:c.C1509A:p.T503T,ROBO1:uc010hoh.2:exon11:c.C369A:p.T123T,ROBO1:uc003dqb.2:exon17:c.C2676A:p.T892T,ROBO1:uc003dqc.2:exon18:c.C2685A:p.T895T,ROBO1:uc003dqd.2:exon18:c.C2685A:p.T895T,ROBO1:uc003dqe.2:exon19:c.C2793A:p.T931T	.	AFR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.2105,EAS:0.1885,FIN:0.2682,NFE:0.1900,OTH:0.2504,ASJ:0.1721	602430	.	.	.	.	.	.	.	.	.	.	.	3	1(large_intestine)	0.2258
3	78717343	78717343	C	T	ROBO1	exonic	synonymous SNV	ENSG00000169855	rs2271151	ENSG00000169855:ENST00000495961:exon3:c.G351A:p.S117S,ENSG00000169855:ENST00000436010:exon11:c.G1623A:p.S541S,ENSG00000169855:ENST00000467549:exon12:c.G1632A:p.S544S,ENSG00000169855:ENST00000495273:exon12:c.G1632A:p.S544S,ENSG00000169855:ENST00000464233:exon13:c.G1740A:p.S580S	ROBO1:NM_001145845:exon12:c.G1632A:p.S544S,ROBO1:NM_133631:exon12:c.G1632A:p.S544S,ROBO1:NM_002941:exon13:c.G1740A:p.S580S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2342	0.2794	0.282548	1(breast)	.	.	.	.	.	.	.	.	ROBO1:uc011bgl.1:exon3:c.G456A:p.S152S,ROBO1:uc003dqf.1:exon7:c.G777A:p.S259S,ROBO1:uc003dqb.2:exon11:c.G1623A:p.S541S,ROBO1:uc003dqc.2:exon12:c.G1632A:p.S544S,ROBO1:uc003dqd.2:exon12:c.G1632A:p.S544S,ROBO1:uc003dqe.2:exon13:c.G1740A:p.S580S	.	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:MU135923,EAS:0.2710,FIN:0.3941,NFE:0.1957,OTH:0.2152,ASJ:LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	602430	.	.	.	.	.	.	.	.	.	.	.	3	7(soft_tissue)	0.1836
3	100467018	100467018	T	C	TFG	exonic	synonymous SNV	ENSG00000114354	rs11353	ENSG00000114354:ENST00000240851:exon8:c.T846C:p.P282P,ENSG00000114354:ENST00000418917:exon8:c.T834C:p.P278P,ENSG00000114354:ENST00000476228:exon8:c.T834C:p.P278P,ENSG00000114354:ENST00000490574:exon8:c.T846C:p.P282P	TFG:NM_001007565:exon8:c.T846C:p.P282P,TFG:NM_001195478:exon8:c.T846C:p.P282P,TFG:NM_001195479:exon8:c.T834C:p.P278P,TFG:NM_006070:exon8:c.T846C:p.P282P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6993	0.6551	0.713059	MU760146	-0.585	0.136	.	4.77	0.997	.	.	.	TFG:uc003due.3:exon8:c.T846C:p.P282P,TFG:uc003duf.3:exon8:c.T846C:p.P282P,TFG:uc003dug.3:exon8:c.T834C:p.P278P,TFG:uc003dui.3:exon8:c.T846C:p.P282P	-1.026	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.6676,EAS:0.7792,FIN:0.6192,NFE:0.5946,OTH:0.6703,ASJ:0.6560	602498	604484;615658;	431329;90117;	431329|SPG57<br>Spastic paraplegia due to partial TFG deficiency|<1 / 1 000 000|Autosomal recessive|Infancy|615658 ~90117|HMSNP<br>Hereditary motor and sensory neuropathy, proximal type|Unknown|Autosomal dominant|-|604484 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	.	.	0.000	.	3	2(haematopoietic_and_lymphoid_tissue)	0.6739
3	121154974	121154974	T	C	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	rs1381057	ENSG00000051341:ENST00000264233:exon28:c.A7538G:p.Q2513R	POLQ:NM_199420:exon28:c.A7538G:p.Q2513R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7217	0.6696	0.745208	0.6799	-1.556	0.002	1.0	-0.307	0.086	.	.	DNA-directed DNA polymerase, family A, palm domain	POLQ:uc003eed.3:exon13:c.A5054G:p.Q1685R,POLQ:uc003eee.4:exon28:c.A7538G:p.Q2513R	-0.965	AFR:0.6569,AMR:0.6957,EAS:0.9017,FIN:0.7032,NFE:0.6616,OTH:0.7031,ASJ:0.6767	604419	.	.	.	.	.	.	.	0.0	0.85	0.000	-1.14	3	MU13963964	hom
3	121208176	121208176	T	C	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	rs3218651	ENSG00000051341:ENST00000264233:exon16:c.A3602G:p.H1201R	POLQ:NM_199420:exon16:c.A3602G:p.H1201R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.2325	0.1325	0.289736	0.1807	-1.287	0.005	0.275	4.24	0.020	.	.	.	POLQ:uc003eed.3:exon1:c.A1118G:p.H373R,POLQ:uc003eee.4:exon16:c.A3602G:p.H1201R	-0.947	AFR:0.1205,AMR:0.3091,EAS:0.5717,FIN:0.2207,NFE:0.1576,OTH:0.1935,ASJ:0.1159	604419	.	.	.	.	.	.	.	0.048	0.9	0.000	0	3	MU13964063	het
3	121208833	121208833	G	C	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	rs3218649	ENSG00000051341:ENST00000264233:exon16:c.C2945G:p.T982R	POLQ:NM_199420:exon16:c.C2945G:p.T982R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6741	0.6028	0.696486	0.6272	-1.568	0.002	0.567	-3.86	0.006	.	.	.	POLQ:uc003eed.3:exon1:c.C461G:p.T154R,POLQ:uc003eee.4:exon16:c.C2945G:p.T982R	-1.009	AFR:0.5635,AMR:0.6376,EAS:0.9020,FIN:0.6802,NFE:0.6208,OTH:0.6663,ASJ:0.5430	604419	.	.	.	.	.	.	.	0.0	0.82	0.000	-0.84	3	MU132061	hom
3	121238721	121238721	C	G	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	rs544117810	ENSG00000051341:ENST00000264233:exon9:c.G1465C:p.V489L	POLQ:NM_199420:exon9:c.G1465C:p.V489L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0037	.	0.00778754	.	1.869	15.40	0.56	0.058	0.906	.	.	Helicase, C-terminal|P-loop containing nucleoside triphosphate hydrolase	POLQ:uc003eee.4:exon9:c.G1465C:p.V489L	-1.015	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	604419	.	.	.	.	.	.	.	0.0	-0.51	0.132	0.97	3	.	het
3	121238749	121238749	G	A	POLQ	exonic	synonymous SNV	ENSG00000051341	rs702018	ENSG00000051341:ENST00000264233:exon9:c.C1437T:p.G479G	POLQ:NM_199420:exon9:c.C1437T:p.G479G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9995	0.9985	0.997404	0.9983	.	.	.	.	.	.	.	.	POLQ:uc003eee.4:exon9:c.C1437T:p.G479G	.	AFR:0.9940,AMR:1,EAS:1,FIN:1,NFE:1,OTH:0.9990,ASJ:1	604419	.	.	.	.	.	.	.	.	.	.	.	3	MU81768041	hom
3	121263720	121263720	C	A	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	rs702017	ENSG00000051341:ENST00000264233:exon2:c.G197T:p.R66I	POLQ:NM_199420:exon2:c.G197T:p.R66I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9964	0.9886	0.988618	0.9896	0.494	7.389	0.525	-2.11	0.374	.	.	.	POLQ:uc003eee.4:exon2:c.G197T:p.R66I	-0.988	AFR:0.9637,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	604419	.	.	.	.	.	.	.	0.0	0.86	0.000	-1.67	3	MU81768070	hom
3	121976253	121976253	G	A	CASR	intronic	.	ENSG00000036828	rs9869985	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9437	0.9123	0.921925	0.9106	.	.	.	.	.	.	.	.	.	.	AFR:0.8122,AMR:0.9773,EAS:0.9808,FIN:0.9189,NFE:0.9519,OTH:0.9257,ASJ:0.9934	601199	145980;239200;601198;612899;	112;2238;263417;428;417;405;93372;	112|Renal tubular normotensive hypokalemic alkalosis with hypercalciuria<br>Salt-losing tubular disorder, Henle's loop type<br>Salt-wasting tubulopathy, Henle's loop type|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|241200 300971 601198 601678 602522 607364 613090 ~2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~263417|Bartter syndrome type 5<br>Bartter syndrome type V|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|601198 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~417|NSHPT|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|Neonatal|239200 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~93372|FHH type 1|1-9 / 100 000|Autosomal dominant|All ages|145980 ~	.	.	.	.	.	.	.	.	3	MU81768493	hom
3	122003045	122003045	G	C	CASR	exonic	synonymous SNV	ENSG00000036828	rs2036400	ENSG00000036828:ENST00000296154:exon6:c.G2244C:p.P748P,ENSG00000036828:ENST00000490131:exon7:c.G2244C:p.P748P,ENSG00000036828:ENST00000498619:exon7:c.G2274C:p.P758P	CASR:NM_000388:exon7:c.G2244C:p.P748P,CASR:NM_001178065:exon7:c.G2274C:p.P758P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9916	0.9720	0.972843	0.9740	.	.	.	.	.	.	.	.	CASR:uc003eev.4:exon7:c.G2244C:p.P748P,CASR:uc003eew.4:exon7:c.G2274C:p.P758P	.	AFR:0.9092,AMR:0.9952,EAS:1,FIN:1,NFE:0.9997,OTH:0.9949,ASJ:1	601199	145980;239200;601198;612899;	112;2238;263417;428;417;405;93372;	112|Renal tubular normotensive hypokalemic alkalosis with hypercalciuria<br>Salt-losing tubular disorder, Henle's loop type<br>Salt-wasting tubulopathy, Henle's loop type|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|241200 300971 601198 601678 602522 607364 613090 ~2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~263417|Bartter syndrome type 5<br>Bartter syndrome type V|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|601198 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~417|NSHPT|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|Neonatal|239200 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~93372|FHH type 1|1-9 / 100 000|Autosomal dominant|All ages|145980 ~	.	.	.	.	.	.	.	.	3	MU81768516	hom
3	122003769	122003769	A	G	CASR	exonic	nonsynonymous SNV	ENSG00000036828	rs1042636	ENSG00000036828:ENST00000296154:exon6:c.A2968G:p.R990G,ENSG00000036828:ENST00000490131:exon7:c.A2968G:p.R990G,ENSG00000036828:ENST00000498619:exon7:c.A2998G:p.R1000G	CASR:NM_000388:exon7:c.A2968G:p.R990G,CASR:NM_001178065:exon7:c.A2998G:p.R1000G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.1451	0.0629	0.20647	LIRI-JP|1|258|0.00387597,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	2.338	18.42	0.002	3.26	0.340	.	.	.	CASR:uc003eev.4:exon7:c.A2968G:p.R990G,CASR:uc003eew.4:exon7:c.A2998G:p.R1000G	-0.936	AFR:0.1041,AMR:0.0461,EAS:0.0596,FIN:0.5093,NFE:0.1093,OTH:0.0851,ASJ:0.2339	601199	145980;239200;601198;612899;	112;2238;263417;428;417;405;93372;	112|Renal tubular normotensive hypokalemic alkalosis with hypercalciuria<br>Salt-losing tubular disorder, Henle's loop type<br>Salt-wasting tubulopathy, Henle's loop type|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|241200 300971 601198 601678 602522 607364 613090 ~2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~263417|Bartter syndrome type 5<br>Bartter syndrome type V|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|601198 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~417|NSHPT|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|Neonatal|239200 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~93372|FHH type 1|1-9 / 100 000|Autosomal dominant|All ages|145980 ~	.	.	.	.	0.319	-2.56	0.000	1.735	3	1(liver)	0.1255
3	122003832	122003832	G	C	CASR	exonic	nonsynonymous SNV	ENSG00000036828	rs1801726	ENSG00000036828:ENST00000296154:exon6:c.G3031C:p.E1011Q,ENSG00000036828:ENST00000490131:exon7:c.G3031C:p.E1011Q,ENSG00000036828:ENST00000498619:exon7:c.G3061C:p.E1021Q	CASR:NM_000388:exon7:c.G3031C:p.E1011Q,CASR:NM_001178065:exon7:c.G3061C:p.E1021Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9446	0.9178	0.924121	0.9148	-0.624	0.109	1.0	5.79	0.342	.	.	.	CASR:uc003eev.4:exon7:c.G3031C:p.E1011Q,CASR:uc003eew.4:exon7:c.G3061C:p.E1021Q	-0.937	AFR:0.8274,AMR:0.9785,EAS:0.9809,FIN:0.9190,NFE:0.9516,OTH:0.9264,ASJ:0.9934	601199	145980;239200;601198;612899;	112;2238;263417;428;417;405;93372;	112|Renal tubular normotensive hypokalemic alkalosis with hypercalciuria<br>Salt-losing tubular disorder, Henle's loop type<br>Salt-wasting tubulopathy, Henle's loop type|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|241200 300971 601198 601678 602522 607364 613090 ~2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~263417|Bartter syndrome type 5<br>Bartter syndrome type V|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|601198 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~417|NSHPT|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|Neonatal|239200 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~93372|FHH type 1|1-9 / 100 000|Autosomal dominant|All ages|145980 ~	.	.	.	.	0.0	-2.35	0.000	.	3	MU81768527	hom
3	124482495	124482503	TTGTTGAAC	-	ITGB5	exonic	nonframeshift deletion	ENSG00000082781	rs150512726	ENSG00000082781:ENST00000296181:exon15:c.2367_2375del:p.789_792del	ITGB5:NM_001354766:exon14:c.1908_1916del:p.636_639del,ITGB5:NM_001354764:exon15:c.2043_2051del:p.681_684del,ITGB5:NM_001354765:exon15:c.2043_2051del:p.681_684del,ITGB5:NM_002213:exon15:c.2367_2375del:p.789_792del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1111	0.1083	0.0872604	0.0837	.	.	.	.	.	.	.	.	ITGB5:uc003eho.3:exon15:c.2367_2375del:p.789_792del	.	AFR:0.0243,AMR:0.0778,EAS:0.0611,FIN:0.0971,NFE:0.1170,OTH:0.0978,ASJ:0.0861	147561	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	3	.	het
3	124487849	124487849	A	G	ITGB5	intronic	.	ENSG00000082781	rs2291082	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2695	0.2910	0.36242	0.2918	.	.	.	.	.	.	.	.	.	.	AFR:0.4786,AMR:0.3864,EAS:0.2948,FIN:0.2540,NFE:0.1932,OTH:0.2520,ASJ:0.0960	147561	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	3	MU11452336	het
3	124515308	124515308	A	G	ITGB5	exonic	synonymous SNV	ENSG00000082781	rs1803825	ENSG00000082781:ENST00000488466:exon4:c.T804C:p.F268F,ENSG00000082781:ENST00000296181:exon10:c.T1620C:p.F540F	ITGB5:NM_001354766:exon9:c.T1161C:p.F387F,ITGB5:NM_001354764:exon10:c.T1296C:p.F432F,ITGB5:NM_001354765:exon10:c.T1296C:p.F432F,ITGB5:NM_002213:exon10:c.T1620C:p.F540F	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2601	0.2742	0.336661	0.2766	.	.	.	.	.	.	.	.	ITGB5:uc003eho.3:exon10:c.T1620C:p.F540F	.	AFR:0.4273,AMR:0.3337,EAS:0.3062,FIN:0.2564,NFE:0.1930,OTH:0.2449,ASJ:0.0960	147561	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	3	MU109941	het
3	124515498	124515498	T	C	ITGB5	exonic	nonsynonymous SNV	ENSG00000082781	rs2291087	ENSG00000082781:ENST00000488466:exon4:c.A614G:p.N205S,ENSG00000082781:ENST00000296181:exon10:c.A1430G:p.N477S	ITGB5:NM_001354766:exon9:c.A971G:p.N324S,ITGB5:NM_001354764:exon10:c.A1106G:p.N369S,ITGB5:NM_001354765:exon10:c.A1106G:p.N369S,ITGB5:NM_002213:exon10:c.A1430G:p.N477S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.0457	0.0497	0.0611022	0.0454	-1.680	0.002	0.768	3.49	0.050	.	.	.	ITGB5:uc003eho.3:exon10:c.A1430G:p.N477S	-1.040	AFR:0.0879,AMR:0.0334,EAS:0.0377,FIN:0.0249,NFE:0.0282,OTH:0.0307,ASJ:0.0265	147561	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	0.0	-2.57	0.002	-1.05	3	MU113473949	het
3	124515646	124515646	A	C	ITGB5	exonic	nonsynonymous SNV	ENSG00000082781	rs2291090	ENSG00000082781:ENST00000488466:exon4:c.T466G:p.L156V,ENSG00000082781:ENST00000296181:exon10:c.T1282G:p.L428V	ITGB5:NM_001354766:exon9:c.T823G:p.L275V,ITGB5:NM_001354764:exon10:c.T958G:p.L320V,ITGB5:NM_001354765:exon10:c.T958G:p.L320V,ITGB5:NM_002213:exon10:c.T1282G:p.L428V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.0465	0.0499	0.0605032	0.0457	1.223	11.87	1.0	5.11	0.520	.	.	Integrin beta subunit, VWA domain|Integrin domain	ITGB5:uc003eho.3:exon10:c.T1282G:p.L428V	-0.737	AFR:0.0888,AMR:0.0334,EAS:0.0376,FIN:0.0249,NFE:0.0283,OTH:0.0316,ASJ:0.0265	147561	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	0.0	-2.65	0.021	-1.84	3	MU113337569	het
3	128204951	128204951	C	T	GATA2	exonic	nonsynonymous SNV	ENSG00000179348	rs2335052	ENSG00000179348:ENST00000341105:exon3:c.G490A:p.A164T,ENSG00000179348:ENST00000430265:exon3:c.G490A:p.A164T,ENSG00000179348:ENST00000487848:exon4:c.G490A:p.A164T	GATA2:NM_001145662:exon3:c.G490A:p.A164T,GATA2:NM_032638:exon3:c.G490A:p.A164T,GATA2:NM_001145661:exon4:c.G490A:p.A164T	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.2056	0.1638	0.232827	1(breast)	1.482	13.22	0.403	1.83	0.999	.	.	.	GATA2:uc003ekn.3:exon3:c.G490A:p.A164T,GATA2:uc003eko.2:exon3:c.G490A:p.A164T,GATA2:uc003ekm.3:exon4:c.G490A:p.A164T	-1.065	AFR:MU83133,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.1769,FIN:0.2524,NFE:0.2185,OTH:0.3781,ASJ:0.1800	137295	601626;614038;614172;614286;	52688;228423;3226;519;	52688|-|1-9 / 100 000|-|All ages|614286 ~228423|Combined immunodeficiency with susceptibility to mycobacterial, viral and fungal infections<br>Dendritic cell, monocyte, B and NK lymphoid deficiency<br>MonoMAC<br>Monocyte-B-natural killer-dendritic cell deficiency syndrome<br>Monocytopenia and mycobacterial infection syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|614172 ~3226|Emberger syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614038 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	,5843	.	,5844	0.013	-4.32	0.000	0	3	1(large_intestine)	0.1862
3	128205860	128205860	G	C	GATA2	exonic	synonymous SNV	ENSG00000179348	rs1573858	ENSG00000179348:ENST00000341105:exon2:c.C15G:p.P5P,ENSG00000179348:ENST00000430265:exon2:c.C15G:p.P5P,ENSG00000179348:ENST00000492608:exon2:c.C15G:p.P5P,ENSG00000179348:ENST00000487848:exon3:c.C15G:p.P5P,ENSG00000179348:ENST00000498200:exon3:c.C15G:p.P5P	GATA2:NM_001145662:exon2:c.C15G:p.P5P,GATA2:NM_032638:exon2:c.C15G:p.P5P,GATA2:NM_001145661:exon3:c.C15G:p.P5P	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6943	0.6934	0.709864	1(prostate)	.	.	.	.	.	.	.	.	GATA2:uc003ekn.3:exon2:c.C15G:p.P5P,GATA2:uc003eko.2:exon2:c.C15G:p.P5P,GATA2:uc003ekm.3:exon3:c.C15G:p.P5P	.	AFR:MU77941,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.7816,FIN:0.7236,NFE:0.7318,OTH:0.7293,ASJ:0.6532	137295	601626;614038;614172;614286;	52688;228423;3226;519;	52688|-|1-9 / 100 000|-|All ages|614286 ~228423|Combined immunodeficiency with susceptibility to mycobacterial, viral and fungal infections<br>Dendritic cell, monocyte, B and NK lymphoid deficiency<br>MonoMAC<br>Monocyte-B-natural killer-dendritic cell deficiency syndrome<br>Monocytopenia and mycobacterial infection syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|614172 ~3226|Emberger syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614038 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	,5843	.	,5844	.	.	.	.	3	4(large_intestine)	0.5255
3	129020778	129020778	A	G	HMCES	intronic	.	ENSG00000183624	rs6765930	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7957	0.8211	0.809704	0.8190	.	.	.	.	.	.	.	.	.	.	AFR:0.9009,AMR:0.7524,EAS:0.7009,FIN:0.8328,NFE:0.7859,OTH:0.7984,ASJ:0.8278	.	.	.	.	.	.	.	.	.	.	.	.	3	MU18309036	hom
3	133329943	133329943	G	A	TOPBP1	exonic	synonymous SNV	ENSG00000163781	rs1444601	ENSG00000163781:ENST00000260810:exon25:c.C4078T:p.L1360L	TOPBP1:NM_001363889:exon25:c.C4063T:p.L1355L,TOPBP1:NM_007027:exon25:c.C4078T:p.L1360L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6905	0.7468	0.682109	0.7131	.	.	.	.	.	.	.	.	TOPBP1:uc003eps.3:exon25:c.C4078T:p.L1360L	.	AFR:0.7736,AMR:0.6842,EAS:0.5854,FIN:0.6523,NFE:0.7102,OTH:0.6811,ASJ:0.6788	607760	.	.	.	.	.	.	.	.	.	.	.	3	MU4134346	hom
3	133335787	133335787	C	T	TOPBP1	intronic	.	ENSG00000163781	rs3732574	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6891	0.6987	0.632188	0.6683	.	.	.	.	.	.	.	.	.	.	AFR:0.6156,AMR:0.6706,EAS:0.5899,FIN:0.6531,NFE:0.7103,OTH:0.6725,ASJ:0.6755	607760	.	.	.	.	.	.	.	.	.	.	.	3	MU23050173	hom
3	133341988	133341988	T	C	TOPBP1	exonic	nonsynonymous SNV	ENSG00000163781	rs10935070	ENSG00000163781:ENST00000260810:exon19:c.A3125G:p.N1042S	TOPBP1:NM_001363889:exon19:c.A3110G:p.N1037S,TOPBP1:NM_007027:exon19:c.A3125G:p.N1042S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.2898	0.2447	0.187899	0.2219	-2.603	0.001	0.313	-9.36	0.001	.	.	BRCT domain	TOPBP1:uc003ept.1:exon4:c.A137G:p.N46S,TOPBP1:uc003eps.3:exon19:c.A3125G:p.N1042S	-0.918	AFR:0.0614,AMR:0.3628,EAS:0.0198,FIN:0.2466,NFE:0.3187,OTH:0.2714,ASJ:0.3079	607760	.	.	.	.	.	.	.	0.0	2.78	0.000	-0.77	3	.	hom
3	133368362	133368362	T	G	TOPBP1	exonic	nonsynonymous SNV	ENSG00000163781	rs3192149	ENSG00000163781:ENST00000260810:exon10:c.A1369C:p.K457Q	TOPBP1:NM_001363889:exon10:c.A1354C:p.K452Q,TOPBP1:NM_007027:exon10:c.A1369C:p.K457Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7159	0.7728	0.695887	0.7347	1.150	11.48	1.0	4.84	0.873	.	.	.	TOPBP1:uc003eps.3:exon10:c.A1369C:p.K457Q	-1.029	AFR:0.7850,AMR:0.6957,EAS:0.5878,FIN:0.6737,NFE:0.7405,OTH:0.6976,ASJ:0.7119	607760	.	.	.	.	.	.	.	0.0	2.75	0.000	-1.265	3	MU14391089	hom
3	134670524	134670524	C	T	EPHB1	exonic	synonymous SNV	ENSG00000154928	rs7644369	ENSG00000154928:ENST00000398015:exon3:c.C435T:p.S145S,ENSG00000154928:ENST00000474732:exon3:c.C369T:p.S123S,ENSG00000154928:ENST00000482618:exon3:c.C435T:p.S145S	EPHB1:NM_004441:exon3:c.C435T:p.S145S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4628	0.4879	0.48143	2(lung)	.	.	.	.	.	.	.	.	EPHB1:uc003eqt.3:exon3:c.C435T:p.S145S,EPHB1:uc011bly.2:exon3:c.C435T:p.S145S	.	AFR:MU150981,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.6072,FIN:0.5359,NFE:0.5430,OTH:0.1963,ASJ:0.4687	600600	.	.	.	.	.	.	.	.	.	.	.	3	1(large_intestine)	0.3564
3	134898742	134898742	C	T	EPHB1	exonic	synonymous SNV	ENSG00000154928	rs1042787	ENSG00000154928:ENST00000493838:exon8:c.C483T:p.Y161Y,ENSG00000154928:ENST00000398015:exon10:c.C1800T:p.Y600Y	EPHB1:NM_004441:exon10:c.C1800T:p.Y600Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4494	0.4166	0.537939	0.4358	.	.	.	.	.	.	.	.	EPHB1:uc003equ.3:exon8:c.C483T:p.Y161Y,EPHB1:uc003eqt.3:exon10:c.C1800T:p.Y600Y	.	AFR:0.5083,AMR:0.4653,EAS:0.7172,FIN:0.3184,NFE:0.3933,OTH:0.4206,ASJ:0.2748	600600	.	.	.	.	.	.	.	.	.	.	.	3	MU4133192	hom
3	134967368	134967368	G	A	EPHB1	intronic	.	ENSG00000154928	rs11717042	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3120	0.2276	0.280751	MU28582199	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.2490,EAS:0.2386,FIN:0.2914,NFE:0.2867,OTH:0.2944,ASJ:0.2552	600600	.	.	.	.	.	.	.	.	.	.	.	3	1(lung)	0.2304
3	138433568	138433568	C	T	PIK3CB	intronic	.	ENSG00000051382	rs497900	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6224	0.5603	0.701877	0.6127	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.6083,AMR:0.7291,EAS:0.9907,FIN:0.6583,NFE:0.5586,OTH:0.6339,ASJ:0.4735	602925	.	.	.	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04361 Axon regeneration~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	3	MU4126273	hom
3	141327474	141327474	G	A	RASA2	exonic	synonymous SNV	ENSG00000155903	rs295323	ENSG00000155903:ENST00000286364:exon21:c.G2160A:p.L720L,ENSG00000155903:ENST00000452898:exon21:c.G2163A:p.L721L	RASA2:NM_001303245:exon21:c.G2163A:p.L721L,RASA2:NM_006506:exon21:c.G2160A:p.L720L,RASA2:NM_001303246:exon22:c.G2172A:p.L724L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3965	0.4843	0.450479	MU586107	.	.	.	.	.	.	.	.	RASA2:uc003etz.1:exon21:c.G2160A:p.L720L,RASA2:uc003eua.1:exon21:c.G2163A:p.L721L,RASA2:uc010huq.1:exon22:c.G2172A:p.L724L	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,AMR:0.4531,EAS:0.4414,FIN:0.3742,NFE:0.3292,OTH:0.3624,ASJ:0.6718	601589	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	3	2(lung)	0.3695
3	142168331	142168331	C	T	ATR	exonic	synonymous SNV	ENSG00000175054	rs1802904	ENSG00000175054:ENST00000383101:exon46:c.G7683A:p.Q2561Q,ENSG00000175054:ENST00000350721:exon47:c.G7875A:p.Q2625Q	ATR:NM_001354579:exon46:c.G7683A:p.Q2561Q,ATR:NM_001184:exon47:c.G7875A:p.Q2625Q	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8646	0.8978	0.916334	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ATR:uc003eux.4:exon47:c.G7875A:p.Q2625Q	.	AFR:0.8880,AMR:0.9702,EAS:0.8079,FIN:0.9420,NFE:0.7995,OTH:0.8651,ASJ:0.7775	601215	210600;614564;	313846;808;	313846|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614564 ~808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	,925,926	.	.	.	.	.	.	3	17(meninges)	0.8510
3	148756825	148756825	G	A	HLTF	intronic	.	ENSG00000071794	rs6764352	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9754	0.9796	0.980232	0.9847	.	.	.	.	.	.	.	.	.	.	AFR:0.9954,AMR:0.9857,EAS:1,FIN:0.9903,NFE:0.9752,OTH:0.9878,ASJ:0.9834	603257	.	.	.	.	.	.	.	.	.	.	.	3	MU81772047	hom
3	148759325	148759325	T	C	HLTF	exonic	synonymous SNV	ENSG00000071794	rs2290725	ENSG00000071794:ENST00000467858:exon6:c.A732G:p.A244A,ENSG00000071794:ENST00000310053:exon20:c.A2328G:p.A776A,ENSG00000071794:ENST00000392912:exon20:c.A2328G:p.A776A,ENSG00000071794:ENST00000465259:exon20:c.A2325G:p.A775A,ENSG00000071794:ENST00000494055:exon20:c.A2328G:p.A776A	HLTF:NM_001318934:exon20:c.A2325G:p.A775A,HLTF:NM_001318935:exon20:c.A2328G:p.A776A,HLTF:NM_003071:exon20:c.A2328G:p.A776A,HLTF:NM_139048:exon20:c.A2328G:p.A776A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3187	0.3052	0.315695	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	HLTF:uc003ewq.1:exon20:c.A2328G:p.A776A,HLTF:uc003ewr.1:exon20:c.A2328G:p.A776A,HLTF:uc003ews.1:exon20:c.A2325G:p.A775A,HLTF:uc010hve.1:exon20:c.A2325G:p.A775A	.	AFR:1(large_intestine),AMR:1(breast),EAS:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,FIN:0.3153,NFE:0.3025,OTH:0.3565,ASJ:MU106674	603257	.	.	.	.	.	.	.	.	.	.	.	3	1(stomach)	0.2980
3	148786108	148786108	C	T	HLTF	exonic	synonymous SNV	ENSG00000071794	rs812249	ENSG00000071794:ENST00000310053:exon8:c.G909A:p.T303T,ENSG00000071794:ENST00000392912:exon8:c.G909A:p.T303T,ENSG00000071794:ENST00000465259:exon8:c.G909A:p.T303T,ENSG00000071794:ENST00000494055:exon8:c.G909A:p.T303T	HLTF:NM_001318934:exon8:c.G909A:p.T303T,HLTF:NM_001318935:exon8:c.G909A:p.T303T,HLTF:NM_003071:exon8:c.G909A:p.T303T,HLTF:NM_139048:exon8:c.G909A:p.T303T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7161	0.7527	0.742412	MU16602666	.	.	.	.	.	.	.	.	HLTF:uc003ewq.1:exon8:c.G909A:p.T303T,HLTF:uc003ewr.1:exon8:c.G909A:p.T303T,HLTF:uc003ews.1:exon8:c.G909A:p.T303T,HLTF:uc010hve.1:exon8:c.G909A:p.T303T	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,AMR:0.7369,EAS:0.8289,FIN:0.7980,NFE:0.7213,OTH:0.7109,ASJ:0.8307	603257	.	.	.	.	.	.	.	.	.	.	.	3	1(prostate)	0.6853
3	149245675	149245675	T	A	WWTR1	exonic	nonsynonymous SNV	ENSG00000018408	rs28763914	ENSG00000018408:ENST00000472417:exon4:c.A427T:p.T143S,ENSG00000018408:ENST00000360632:exon5:c.A853T:p.T285S,ENSG00000018408:ENST00000467467:exon5:c.A853T:p.T285S,ENSG00000018408:ENST00000465804:exon6:c.A853T:p.T285S	WWTR1:NM_001168280:exon5:c.A853T:p.T285S,WWTR1:NM_015472:exon5:c.A853T:p.T285S,WWTR1:NM_001168278:exon6:c.A853T:p.T285S,WWTR1:NM_001348362:exon8:c.A853T:p.T285S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0145	0.0048	0.0195687	0.0059	1.176	11.62	1.0	3.92	0.995	.	.	.	WWTR1:uc003exe.3:exon4:c.A853T:p.T285S,WWTR1:uc003exf.3:exon5:c.A853T:p.T285S,WWTR1:uc021xfm.1:exon5:c.A853T:p.T285S,WWTR1:uc003exh.3:exon6:c.A853T:p.T285S	-1.021	AFR:0.0047,AMR:0.0036,EAS:0.0006,FIN:0.0006,NFE:0.0074,OTH:0.0112,ASJ:0.0430	607392	.	.	.	.	.	.	.	0.0	1.05	0.025	0.405	3	.	het
3	158306627	158306627	A	G	MLF1	intronic	.	ENSG00000178053	rs1075551	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5630	.	0.571286	0.5541	.	.	.	.	.	.	.	.	.	.	AFR:0.7255,AMR:0.5407,EAS:0.3040,FIN:0.4707,NFE:0.5063,OTH:0.4856,ASJ:0.5430	601402	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	3	MU14910846	hom
3	158320597	158320597	T	C	MLF1	exonic	synonymous SNV	ENSG00000178053	rs4875	ENSG00000178053:ENST00000491767:exon5:c.T348C:p.S116S,ENSG00000178053:ENST00000498592:exon5:c.T435C:p.S145S,ENSG00000178053:ENST00000355893:exon6:c.T570C:p.S190S,ENSG00000178053:ENST00000359117:exon6:c.T495C:p.S165S,ENSG00000178053:ENST00000469452:exon6:c.T366C:p.S122S,ENSG00000178053:ENST00000482628:exon7:c.T495C:p.S165S,ENSG00000178053:ENST00000484955:exon7:c.T495C:p.S165S,ENSG00000178053:ENST00000392822:exon8:c.T663C:p.S221S,ENSG00000178053:ENST00000471745:exon8:c.T540C:p.S180S,ENSG00000178053:ENST00000478894:exon8:c.T540C:p.S180S	MLF1:NM_001369781:exon5:c.T435C:p.S145S,MLF1:NM_001369782:exon5:c.T348C:p.S116S,MLF1:NM_001130156:exon6:c.T495C:p.S165S,MLF1:NM_001195433:exon6:c.T366C:p.S122S,MLF1:NM_022443:exon6:c.T570C:p.S190S,MLF1:NM_001130157:exon7:c.T495C:p.S165S,MLF1:NM_001369783:exon7:c.T615C:p.S205S,MLF1:NM_001369784:exon7:c.T495C:p.S165S,MLF1:NM_001369785:exon7:c.T540C:p.S180S,MLF1:NM_001195432:exon8:c.T663C:p.S221S,MLF1:NM_001195434:exon8:c.T540C:p.S180S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5453	0.5966	0.576478	LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579	.	.	.	.	.	0.0043	0.14	.	MLF1:uc003fca.3:exon6:c.T495C:p.S165S,MLF1:uc003fcb.3:exon6:c.T570C:p.S190S,MLF1:uc010hvx.3:exon6:c.T366C:p.S122S,MLF1:uc003fby.3:exon7:c.T348C:p.S116S,MLF1:uc003fbz.3:exon7:c.T495C:p.S165S,MLF1:uc003fbx.3:exon8:c.T540C:p.S180S,MLF1:uc003fcc.3:exon8:c.T663C:p.S221S	.	AFR:0.5732,AMR:0.7265,EAS:0.5464,FIN:0.3068,NFE:0.5278,OTH:0.5294,ASJ:0.5442	601402	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	3	1(stomach)	0.5133
3	158320703	158320703	C	A	MLF1	exonic	nonsynonymous SNV	ENSG00000178053	rs15967	ENSG00000178053:ENST00000491767:exon5:c.C454A:p.P152T,ENSG00000178053:ENST00000498592:exon5:c.C541A:p.P181T,ENSG00000178053:ENST00000355893:exon6:c.C676A:p.P226T,ENSG00000178053:ENST00000359117:exon6:c.C601A:p.P201T,ENSG00000178053:ENST00000469452:exon6:c.C472A:p.P158T,ENSG00000178053:ENST00000482628:exon7:c.C601A:p.P201T,ENSG00000178053:ENST00000484955:exon7:c.C601A:p.P201T,ENSG00000178053:ENST00000392822:exon8:c.C769A:p.P257T,ENSG00000178053:ENST00000471745:exon8:c.C646A:p.P216T,ENSG00000178053:ENST00000478894:exon8:c.C646A:p.P216T	MLF1:NM_001369781:exon5:c.C541A:p.P181T,MLF1:NM_001369782:exon5:c.C454A:p.P152T,MLF1:NM_001130156:exon6:c.C601A:p.P201T,MLF1:NM_001195433:exon6:c.C472A:p.P158T,MLF1:NM_022443:exon6:c.C676A:p.P226T,MLF1:NM_001130157:exon7:c.C601A:p.P201T,MLF1:NM_001369783:exon7:c.C721A:p.P241T,MLF1:NM_001369784:exon7:c.C601A:p.P201T,MLF1:NM_001369785:exon7:c.C646A:p.P216T,MLF1:NM_001195432:exon8:c.C769A:p.P257T,MLF1:NM_001195434:exon8:c.C646A:p.P216T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3674	0.3470	0.328275	0.3537	-0.045	2.178	0.04	-1.14	0.088	.	.	.	MLF1:uc003fca.3:exon6:c.C601A:p.P201T,MLF1:uc003fcb.3:exon6:c.C676A:p.P226T,MLF1:uc010hvx.3:exon6:c.C472A:p.P158T,MLF1:uc003fby.3:exon7:c.C454A:p.P152T,MLF1:uc003fbz.3:exon7:c.C601A:p.P201T,MLF1:uc003fbx.3:exon8:c.C646A:p.P216T,MLF1:uc003fcc.3:exon8:c.C769A:p.P257T	-0.995	AFR:0.2776,AMR:0.3854,EAS:0.2807,FIN:0.4098,NFE:0.3902,OTH:0.3605,ASJ:0.3642	601402	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.085	0.94	0.000	1.1	3	MU51157802	hom
3	178922274	178922274	C	A	PIK3CA	intronic	.	ENSG00000121879	rs2699896	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5614	0.6697	0.584665	LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.6189,AMR:0.8533,EAS:0.6689,FIN:0.2710,NFE:0.4851,OTH:0.5604,ASJ:0.5203	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04361 Axon regeneration~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	3	3(soft_tissue)	0.5509
3	178952020	178952020	C	T	PIK3CA	exonic	synonymous SNV	ENSG00000121879	rs17849079	ENSG00000121879:ENST00000263967:exon21:c.C3075T:p.T1025T	PIK3CA:NM_006218:exon21:c.C3075T:p.T1025T	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0233	0.0117	0.0407348	.	.	.	.	.	.	.	.	.	PIK3CA:uc003fjk.3:exon21:c.C3075T:p.T1025T	.	AFR:0.0126,AMR:0.0339,EAS:0,FIN:0.0012,NFE:0.0003,OTH:0.0044,ASJ:0.0060	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04361 Axon regeneration~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	,8644,8941,8939,8978,8988,8643,9026,9004,9006,8920,8953,8914,8980,8938,8969,9034,8963,8974,8997,8966,9032,8645,9013,9007,8952,8919,9003,8991,8949,8766,8999,9027,8975,8915,8943,8945,9005,8767,8922,9011,9002,9035,8989,8967,8942,9012,8931,8957,8976,9029,8964,8990,8935,8981,8971,8968,8983,8996,9031,8977,8958,8933,9028,8928,8944,8979,8982,8929,8984,8947,9025,8916,8951,8994,8985,8956,8954,8934,8972,9008,8911,8917,8940,8960,8769,8965,8913,8955,8908,8992,9014,8962,8936,8925,8768,8918,8961,8986,8973,8923,9030,8959,9015,8970,8932,8909,8924,8950,8948,8998,9009,9000,8921,9001,8930,9010,8912,8987,8926,8946,8927,9033,8937,8995,8910,8770	.	,8993	.	.	.	.	3	1(upper_aerodigestive_tract)	0.0194
3	182681740	182681740	C	T	DCUN1D1	exonic	synonymous SNV	ENSG00000043093	rs4859146	ENSG00000043093:ENST00000292782:exon3:c.G318A:p.A106A,ENSG00000043093:ENST00000469954:exon3:c.G273A:p.A91A,ENSG00000043093:ENST00000497606:exon3:c.G273A:p.A91A,ENSG00000043093:ENST00000460412:exon4:c.G273A:p.A91A,ENSG00000043093:ENST00000487822:exon4:c.G273A:p.A91A	DCUN1D1:NM_001308101:exon3:c.G273A:p.A91A,DCUN1D1:NM_020640:exon3:c.G318A:p.A106A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6885	0.7567	0.613019	0.7363	.	.	.	.	.	.	.	.	DCUN1D1:uc003fld.1:exon3:c.G318A:p.A106A	.	AFR:0.7379,AMR:0.6966,EAS:0.2701,FIN:0.7646,NFE:0.7835,OTH:0.7352,ASJ:0.6291	605905	.	.	.	.	.	.	.	.	.	.	.	3	MU11206066	het
3	182681853	182681853	T	C	DCUN1D1	intronic	.	ENSG00000043093	rs4859147	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5527	0.4870	0.377796	0.4947	.	.	.	.	.	.	.	.	.	.	AFR:0.1233,AMR:0.5668,EAS:0.2506,FIN:0.6638,NFE:0.6864,OTH:0.6130,ASJ:0.4768	605905	.	.	.	.	.	.	.	.	.	.	.	3	MU26132409	het
3	183211906	183211906	A	G	KLHL6	exonic	synonymous SNV	ENSG00000172578	rs1520101	ENSG00000172578:ENST00000341319:exon5:c.T1311C:p.N437N,ENSG00000172578:ENST00000468734:exon5:c.T1278C:p.N426N	KLHL6:NM_130446:exon5:c.T1311C:p.N437N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5610	0.5813	0.697883	0.5713	.	.	.	.	.	.	.	.	KLHL6:uc003flr.3:exon5:c.T1311C:p.N437N	.	AFR:0.8114,AMR:0.6065,EAS:0.7741,FIN:0.3972,NFE:0.4564,OTH:0.4501,ASJ:0.5667	614214	.	.	.	.	.	.	.	.	.	.	.	3	MU103694	hom
3	183226072	183226072	G	A	KLHL6	exonic	synonymous SNV	ENSG00000172578	rs16857707	ENSG00000172578:ENST00000341319:exon3:c.C684T:p.Y228Y,ENSG00000172578:ENST00000468734:exon3:c.C651T:p.Y217Y	KLHL6:NM_130446:exon3:c.C684T:p.Y228Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0486	0.0772	0.122005	0.0767	.	.	.	.	.	.	.	.	KLHL6:uc003flr.3:exon3:c.C684T:p.Y228Y,KLHL6:uc003flt.1:exon3:c.C678T:p.Y226Y	.	AFR:0.2244,AMR:0.0477,EAS:0.1790,FIN:0.0083,NFE:0.0019,OTH:0.0286,ASJ:0.0033	614214	.	.	.	.	.	.	.	.	.	.	.	3	MU794080	het
3	183226186	183226186	C	T	KLHL6	exonic	synonymous SNV	ENSG00000172578	rs61447052	ENSG00000172578:ENST00000341319:exon3:c.G570A:p.K190K,ENSG00000172578:ENST00000468734:exon3:c.G537A:p.K179K	KLHL6:NM_130446:exon3:c.G570A:p.K190K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0346	0.0254	0.0804712	0.0335	.	.	.	.	.	.	.	.	KLHL6:uc003flr.3:exon3:c.G570A:p.K190K,KLHL6:uc003flt.1:exon3:c.G564A:p.K188K	.	AFR:0.0728,AMR:0.0394,EAS:0.1796,FIN:0.0083,NFE:0.0017,OTH:0.0234,ASJ:0.0033	614214	.	.	.	.	.	.	.	.	.	.	.	3	MU586201	het
3	183226213	183226213	A	G	KLHL6	exonic	synonymous SNV	ENSG00000172578	rs16857710	ENSG00000172578:ENST00000341319:exon3:c.T543C:p.A181A,ENSG00000172578:ENST00000468734:exon3:c.T510C:p.A170A	KLHL6:NM_130446:exon3:c.T543C:p.A181A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0565	0.1069	0.146166	0.0994	.	.	.	.	.	.	.	.	KLHL6:uc003flr.3:exon3:c.T543C:p.A181A,KLHL6:uc003flt.1:exon3:c.T537C:p.A179A	.	AFR:0.3031,AMR:0.0513,EAS:0.1794,FIN:0.0083,NFE:0.0025,OTH:0.0346,ASJ:0.0033	614214	.	.	.	.	.	.	.	.	.	.	.	3	MU586202	het
3	184094183	184094183	A	G	THPO	exonic	synonymous SNV	ENSG00000090534	rs956732	.	THPO:NM_001290003:exon3:c.T285C:p.S95S	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	.	.	0.506789	0.5124	.	.	.	.	.	.	.	.	.	.	AFR:0.6077,AMR:0.5979,EAS:0.4200,FIN:0.3705,NFE:0.4993,OTH:0.4469,ASJ:0.5298	600044	187950;	3318;71493;	3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~	.	.	.	.	.	.	.	.	3	.	het
3	185046766	185046766	T	A	MAP3K13	intronic	.	ENSG00000073803	rs9859234	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.730831	0.7726	.	.	.	.	.	.	.	.	.	.	AFR:0.6109,AMR:0.7998,EAS:0.7895,FIN:0.8489,NFE:0.8412,OTH:0.8202,ASJ:0.8167	604915	.	.	.	.	.	.	.	.	.	.	.	3	.	hom
3	185155430	185155430	-	T	MAP3K13	intronic	.	ENSG00000073803	rs5855064	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5905	.	0.616214	0.7684	.	.	.	.	.	.	.	.	.	.	AFR:0.6852,AMR:0.7870,EAS:0.7418,FIN:0.7263,NFE:0.8259,OTH:0.7861,ASJ:0.8433	604915	.	.	.	.	.	.	.	.	.	.	.	3	.	hom
3	186507922	186507922	C	T	RFC4	intronic	.	ENSG00000163918	rs2066500	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2827	0.1991	0.279952	0.2482	.	.	.	.	.	.	.	.	.	.	AFR:0.1106,AMR:0.3902,EAS:0.3939,FIN:0.3918,NFE:0.2685,OTH:0.2908,ASJ:0.2417	102577	.	.	.	.	.	.	.	.	.	.	.	3	MU11567550	het
3	186509517	186509517	G	A	RFC4	exonic	synonymous SNV	ENSG00000163918	rs187868	ENSG00000163918:ENST00000417876:exon1:c.C123T:p.A41A,ENSG00000163918:ENST00000433496:exon7:c.C798T:p.A266A,ENSG00000163918:ENST00000296273:exon8:c.C798T:p.A266A,ENSG00000163918:ENST00000392481:exon8:c.C798T:p.A266A	RFC4:NM_002916:exon8:c.C798T:p.A266A,RFC4:NM_181573:exon8:c.C798T:p.A266A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4918	0.4748	0.483826	MU18338543	.	.	.	.	.	.	.	.	RFC4:uc003fqz.3:exon8:c.C798T:p.A266A,RFC4:uc011bsc.2:exon8:c.C798T:p.A266A,RFC4:uc011bsd.2:exon8:c.C798T:p.A266A	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.5062,EAS:0.5215,FIN:0.4172,NFE:0.4684,OTH:0.6110,ASJ:0.4608	102577	.	.	.	.	.	.	.	.	.	.	.	3	1(stomach)	0.5122
3	187447032	187447032	G	A	BCL6	exonic	synonymous SNV	ENSG00000113916	rs1056932	ENSG00000113916:ENST00000450123:exon4:c.C1161T:p.N387N,ENSG00000113916:ENST00000232014:exon5:c.C1161T:p.N387N,ENSG00000113916:ENST00000406870:exon5:c.C1161T:p.N387N	BCL6:NM_001134738:exon4:c.C1161T:p.N387N,BCL6:NM_001130845:exon5:c.C1161T:p.N387N,BCL6:NM_001706:exon5:c.C1161T:p.N387N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6435	0.4974	0.565296	MU794210	.	.	.	.	.	.	.	.	BCL6:uc011bsf.1:exon4:c.C1161T:p.N387N,BCL6:uc003frp.3:exon5:c.C1161T:p.N387N,BCL6:uc003frq.2:exon5:c.C1161T:p.N387N,BCL6:uc010hza.2:exon5:c.C855T:p.N285N	.	AFR:COCA-CN|6|321|0.0186916,AMR:0.5310,EAS:0.7482,FIN:0.7086,NFE:0.7937,OTH:0.6955,ASJ:0.1832	109565	.	.	.	~ko04068 FoxO signaling pathway~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	3	1(breast)	0.6432
3	191888454	191888454	A	-	FGF12	intronic	.	ENSG00000114279	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601513	.	.	.	.	.	.	.	.	.	.	.	3	.	unknown
3	195782160	195782160	G	A	TFRC	exonic	nonsynonymous SNV	ENSG00000072274	rs571673598	ENSG00000072274:ENST00000535031:exon15:c.C844T:p.P282S,ENSG00000072274:ENST00000420415:exon16:c.C1447T:p.P483S,ENSG00000072274:ENST00000360110:exon17:c.C1690T:p.P564S,ENSG00000072274:ENST00000392396:exon17:c.C1690T:p.P564S	TFRC:NM_001313966:exon15:c.C844T:p.P282S,TFRC:NM_001313965:exon16:c.C1447T:p.P483S,TFRC:NM_001128148:exon17:c.C1690T:p.P564S,TFRC:NM_003234:exon17:c.C1690T:p.P564S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0] 	0.0002	.	0.00119808	.	1.623	13.98	0.015	4.43	0.976	.	.	Peptidase M28	TFRC:uc011btr.2:exon15:c.C844T:p.P282S,TFRC:uc010hzy.3:exon16:c.C1447T:p.P483S,TFRC:uc003fvz.4:exon17:c.C1690T:p.P564S,TFRC:uc003fwa.4:exon17:c.C1690T:p.P564S	-0.324	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	190010	616740;	.	.	.	.	.	.	0.896	0.93	0.464	3.705	3	.	hom
3	195782176	195782176	C	T	TFRC	intronic	.	ENSG00000072274	rs419068	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3201	0.1909	0.298123	0.3158	.	.	.	.	.	0	0.002	.	.	.	AFR:0.3054,AMR:0.2614,EAS:0.1800,FIN:0.3665,NFE:0.3264,OTH:0.3296,ASJ:0.3467	190010	616740;	.	.	.	.	.	.	.	.	.	.	3	MU28881240	unknown
3	195782177	195782177	A	G	TFRC	intronic	.	ENSG00000072274	rs366268	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3203	0.1933	0.298323	0.3163	.	.	.	.	.	0.0008	0.026	.	.	.	AFR:0.3066,AMR:0.2614,EAS:0.1807,FIN:0.3666,NFE:0.3265,OTH:0.3296,ASJ:0.3467	190010	616740;	.	.	.	.	.	.	.	.	.	.	3	MU81776678	unknown
3	195782184	195782184	C	T	TFRC	intronic	.	ENSG00000072274	rs419059	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3204	0.3201	0.298123	0.3160	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.3056,AMR:0.2614,EAS:0.1802,FIN:0.3667,NFE:0.3265,OTH:0.3296,ASJ:0.3467	190010	616740;	.	.	.	.	.	.	.	.	.	.	3	MU81776694	unknown
3	195798258	195798258	T	C	TFRC	intronic	.	ENSG00000072274	rs480760	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9497	0.8857	0.894169	0.9015	.	.	.	.	.	.	.	.	.	.	AFR:0.7292,AMR:0.9606,EAS:1,FIN:0.9657,NFE:0.9670,OTH:0.9654,ASJ:0.9768	190010	616740;	.	.	.	.	.	.	.	.	.	.	3	MU81776721	hom
3	196199204	196199204	G	T	RNF168	exonic	nonsynonymous SNV	ENSG00000163961	rs3796129	ENSG00000163961:ENST00000318037:exon6:c.C1202A:p.P401Q	RNF168:NM_152617:exon6:c.C1202A:p.P401Q	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.5405	0.5172	0.402356	0.5038	2.051	16.54	0.058	4.29	0.713	.	.	.	RNF168:uc010iah.3:exon5:c.C701A:p.P234Q,RNF168:uc003fwq.3:exon6:c.C1202A:p.P401Q	-1.041	AFR:0.2989,AMR:0.4306,EAS:0.1776,FIN:0.6676,NFE:0.6172,OTH:0.5706,ASJ:0.6225	612688	611943;	420741;	420741|RNF168 deficiency<br>Radiosensitivity-immunodeficiency-dysmorphic features-learning difficulties syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Adolescent|611943 ~	.	.	.	.	0.8	3.18	0.000	2.38	3	MU27951640	het
4	1206058	1206058	C	T	CTBP1	exonic	synonymous SNV	ENSG00000159692	rs532821312	ENSG00000159692:ENST00000290921:exon9:c.G1293A:p.A431A,ENSG00000159692:ENST00000382952:exon10:c.G1260A:p.A420A	CTBP1:NM_001328:exon9:c.G1293A:p.A431A,CTBP1:NM_001012614:exon10:c.G1260A:p.A420A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	0.0025	.	0.00179712	9.719e-05	.	.	.	.	.	.	.	.	CTBP1:uc003gcv.1:exon9:c.G1293A:p.A431A,CTBP1:uc003gcw.3:exon9:c.G1296A:p.A432A,CTBP1:uc003gcu.1:exon10:c.G1260A:p.A420A	.	AFR:0.0001,AMR:0.0012,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	602618	.	.	.	~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	4	.	het
4	1340353	1340353	C	T	UVSSA	upstream	.	ENSG00000163945	rs13141169	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.19369	0.3032	.	.	.	.	.	.	.	.	.	.	AFR:0.1202,AMR:0.3654,EAS:0.0476,FIN:0.4234,NFE:0.4017,OTH:0.3672,ASJ:0.3245	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	.	het
4	1343405	1343405	T	C	UVSSA	exonic	synonymous SNV	ENSG00000163945	rs2276903	ENSG00000163945:ENST00000389851:exon3:c.T192C:p.I64I,ENSG00000163945:ENST00000507531:exon3:c.T192C:p.I64I,ENSG00000163945:ENST00000511216:exon3:c.T192C:p.I64I	UVSSA:NM_001317934:exon3:c.T192C:p.I64I,UVSSA:NM_001317935:exon3:c.T192C:p.I64I,UVSSA:NM_020894:exon3:c.T192C:p.I64I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5806	0.6383	0.632987	0.6343	.	.	.	.	.	.	.	.	UVSSA:uc003gde.4:exon3:c.T192C:p.I64I	.	AFR:0.8063,AMR:0.7710,EAS:0.4907,FIN:0.5806,NFE:0.5635,OTH:0.5543,ASJ:0.4396	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	MU641948	het
4	1346190	1346190	G	A	UVSSA	intronic	.	ENSG00000163945	rs17164680	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.0830671	0.0379	.	.	.	.	.	.	.	.	.	.	AFR:0.0582,AMR:0.0298,EAS:0.2147,FIN:0.0198,NFE:0.0122,OTH:0.0286,ASJ:0.0397	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	.	het
4	1350322	1350322	C	T	UVSSA	intronic	.	ENSG00000163945	rs2336081	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.779952	0.7631	.	.	.	.	.	.	.	.	.	.	AFR:0.9337,AMR:0.8457,EAS:0.7097,FIN:0.7048,NFE:0.6859,OTH:0.6980,ASJ:0.6060	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	.	hom
4	1360238	1360238	G	-	UVSSA	intronic	.	ENSG00000163945	rs3216721	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0445	0.0359	0.0870607	0.0422	.	.	.	.	.	.	.	.	.	.	AFR:0.0723,AMR:0.0314,EAS:0.2179,FIN:0.0201,NFE:0.0123,OTH:0.0298,ASJ:0.0403	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	MU77736493	het
4	1369885	1369885	G	A	UVSSA	exonic	synonymous SNV	ENSG00000163945	rs11724369	ENSG00000163945:ENST00000511563:exon3:c.G150A:p.A50A,ENSG00000163945:ENST00000512728:exon3:c.G150A:p.A50A,ENSG00000163945:ENST00000389851:exon10:c.G1497A:p.A499A,ENSG00000163945:ENST00000507531:exon10:c.G1497A:p.A499A,ENSG00000163945:ENST00000511216:exon10:c.G1497A:p.A499A	UVSSA:NM_001317934:exon10:c.G1497A:p.A499A,UVSSA:NM_001317935:exon10:c.G1497A:p.A499A,UVSSA:NM_020894:exon10:c.G1497A:p.A499A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3676	0.2825	0.182308	0.3021	.	.	.	.	.	.	.	.	UVSSA:uc010ibv.3:exon3:c.G150A:p.A50A,UVSSA:uc003gde.4:exon10:c.G1497A:p.A499A	.	AFR:0.0940,AMR:0.3657,EAS:0.0488,FIN:0.4264,NFE:0.4140,OTH:0.3673,ASJ:0.3179	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	MU41949956	het
4	1374695	1374695	C	A	UVSSA	exonic	synonymous SNV	ENSG00000163945	rs28614045	ENSG00000163945:ENST00000511563:exon5:c.C433A:p.R145R,ENSG00000163945:ENST00000512728:exon5:c.C433A:p.R145R,ENSG00000163945:ENST00000389851:exon12:c.C1780A:p.R594R,ENSG00000163945:ENST00000507531:exon12:c.C1780A:p.R594R,ENSG00000163945:ENST00000511216:exon12:c.C1780A:p.R594R	UVSSA:NM_001317934:exon12:c.C1780A:p.R594R,UVSSA:NM_001317935:exon12:c.C1780A:p.R594R,UVSSA:NM_020894:exon12:c.C1780A:p.R594R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6940	0.6910	0.70028	0.6956	.	.	.	.	.	.	.	.	UVSSA:uc010ibv.3:exon5:c.C433A:p.R145R,UVSSA:uc003gde.4:exon12:c.C1780A:p.R594R	.	AFR:0.7032,AMR:0.8313,EAS:0.6937,FIN:0.7049,NFE:0.6846,OTH:0.6837,ASJ:0.5833	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	MU10012471	hom
4	1374774	1374774	C	T	UVSSA	exonic	nonsynonymous SNV	ENSG00000163945	rs28522910	ENSG00000163945:ENST00000511563:exon5:c.C512T:p.P171L,ENSG00000163945:ENST00000512728:exon5:c.C512T:p.P171L,ENSG00000163945:ENST00000389851:exon12:c.C1859T:p.P620L,ENSG00000163945:ENST00000507531:exon12:c.C1859T:p.P620L,ENSG00000163945:ENST00000511216:exon12:c.C1859T:p.P620L	UVSSA:NM_001317934:exon12:c.C1859T:p.P620L,UVSSA:NM_001317935:exon12:c.C1859T:p.P620L,UVSSA:NM_020894:exon12:c.C1859T:p.P620L	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 0, 0] 	0.6946	0.6907	0.696486	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	4.114	23.8	0.017	4.56	0.008	0.8986	0.64	.	UVSSA:uc010ibv.3:exon5:c.C512T:p.P171L,UVSSA:uc003gde.4:exon12:c.C1859T:p.P620L	-1.015	AFR:0.6950,AMR:0.7013,EAS:0.5833,FIN:0.6923,NFE:0.7053,OTH:0.6846,ASJ:0.8317	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	0.67	1.35	0.000	2.125	4	1(haematopoietic_and_lymphoid_tissue)	0.6830
4	1374789	1374789	A	G	UVSSA	intronic	.	ENSG00000163945	rs28733902	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7161	0.7530	0.763578	0.7527	.	.	.	.	.	.	.	.	.	.	AFR:0.9011,AMR:0.8425,EAS:0.6951,FIN:0.7057,NFE:0.6853,OTH:0.6939,ASJ:0.59	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	MU24274429	hom
4	1377615	1377615	A	G	UVSSA	exonic	synonymous SNV	ENSG00000163945	rs9996817	ENSG00000163945:ENST00000511563:exon6:c.A576G:p.S192S,ENSG00000163945:ENST00000512728:exon6:c.A576G:p.S192S,ENSG00000163945:ENST00000389851:exon13:c.A1923G:p.S641S,ENSG00000163945:ENST00000507531:exon13:c.A1923G:p.S641S,ENSG00000163945:ENST00000511216:exon13:c.A1923G:p.S641S	UVSSA:NM_001317934:exon13:c.A1923G:p.S641S,UVSSA:NM_001317935:exon13:c.A1923G:p.S641S,UVSSA:NM_020894:exon13:c.A1923G:p.S641S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7195	0.7205	0.717252	0.7205	.	.	.	.	.	.	.	.	UVSSA:uc010ibv.3:exon6:c.A576G:p.S192S,UVSSA:uc003gde.4:exon13:c.A1923G:p.S641S	.	AFR:0.7138,AMR:0.8481,EAS:0.7077,FIN:0.7226,NFE:0.7205,OTH:0.7156,ASJ:0.6225	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	MU4566462	hom
4	1803704	1803704	T	C	FGFR3	exonic	synonymous SNV	ENSG00000068078	rs2234909	ENSG00000068078:ENST00000260795:exon6:c.T882C:p.N294N,ENSG00000068078:ENST00000352904:exon6:c.T882C:p.N294N,ENSG00000068078:ENST00000340107:exon7:c.T882C:p.N294N,ENSG00000068078:ENST00000412135:exon7:c.T882C:p.N294N,ENSG00000068078:ENST00000440486:exon7:c.T882C:p.N294N,ENSG00000068078:ENST00000481110:exon7:c.T882C:p.N294N	FGFR3:NM_000142:exon7:c.T882C:p.N294N,FGFR3:NM_001163213:exon7:c.T882C:p.N294N,FGFR3:NM_001354809:exon7:c.T882C:p.N294N,FGFR3:NM_001354810:exon7:c.T882C:p.N294N,FGFR3:NM_022965:exon7:c.T882C:p.N294N	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1692	0.2139	0.207468	5(meninges)	.	.	.	.	.	.	.	.	FGFR3:uc003gdt.1:exon3:c.T408C:p.N136N,FGFR3:uc003gdq.3:exon7:c.T882C:p.N294N,FGFR3:uc003gdr.3:exon7:c.T882C:p.N294N,FGFR3:uc003gds.3:exon7:c.T882C:p.N294N,FGFR3:uc003gdu.2:exon7:c.T882C:p.N294N	.	AFR:2(skin),AMR:1(large_intestine),EAS:1(breast),FIN:MU153774,NFE:LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,OTH:0.1948,ASJ:1(thyroid)	134934	100800;109800;114500;146000;149730;162900;187600;187601;273300;602849;603956;610474;612247;616482;	85165;93262;85164;53271;363483;363494;363504;842;876;99865;2655;93274;1860;2655;79414;2363;429;15;	85165|SADDAN|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|616482 ~93262|Crouzon-dermoskeletal syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal|612247 ~85164|CATSHL syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610474 ~53271|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|602849 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~93274|Cloverleaf skull-micromelic bone dysplasia syndrome<br>TD2<br>Thanatophoric dwarfism type 2<br>Thanatophoric dwarfism-cloverleaf skull syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|156830 187601 ~1860|TD1<br>Thanatophoric dwarfism type 1|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal|187600 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~429|-|1-9 / 100 000|Autosomal dominant|Childhood|146000 ~15|-|1-9 / 100 000|Autosomal dominant|Neonatal|100800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05219 Bladder cancer~ko05230 Central carbon metabolism in cancer ~	,5479,5475,5470,5486,5480,5472,5471,5498,5481,5487,5473,5477,5488,5497,5483,5485,5469,5478,5476,5482,5484,5474	.	.	.	.	.	.	4	1(urinary_tract)	0.3538
4	1807894	1807894	G	A	FGFR3	exonic	synonymous SNV	ENSG00000068078	rs7688609	ENSG00000068078:ENST00000352904:exon11:c.G1617A:p.T539T,ENSG00000068078:ENST00000412135:exon12:c.G1617A:p.T539T,ENSG00000068078:ENST00000260795:exon13:c.G1953A:p.T651T,ENSG00000068078:ENST00000340107:exon14:c.G1959A:p.T653T,ENSG00000068078:ENST00000440486:exon14:c.G1953A:p.T651T,ENSG00000068078:ENST00000481110:exon14:c.G1956A:p.T652T	FGFR3:NM_022965:exon12:c.G1617A:p.T539T,FGFR3:NM_000142:exon14:c.G1953A:p.T651T,FGFR3:NM_001163213:exon14:c.G1959A:p.T653T,FGFR3:NM_001354809:exon14:c.G1956A:p.T652T,FGFR3:NM_001354810:exon14:c.G1956A:p.T652T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9873	0.9551	0.95607	MU81778057	.	.	.	.	.	.	.	.	FGFR3:uc003gds.3:exon12:c.G1617A:p.T539T,FGFR3:uc003gdq.3:exon14:c.G1956A:p.T652T,FGFR3:uc003gdr.3:exon14:c.G1953A:p.T651T,FGFR3:uc003gdu.2:exon14:c.G1959A:p.T653T	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.9604,EAS:0.9988,FIN:1,NFE:1,OTH:1,ASJ:0.8608	134934	100800;109800;114500;146000;149730;162900;187600;187601;273300;602849;603956;610474;612247;616482;	85165;93262;85164;53271;363483;363494;363504;842;876;99865;2655;93274;1860;2655;79414;2363;429;15;	85165|SADDAN|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|616482 ~93262|Crouzon-dermoskeletal syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal|612247 ~85164|CATSHL syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610474 ~53271|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|602849 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~93274|Cloverleaf skull-micromelic bone dysplasia syndrome<br>TD2<br>Thanatophoric dwarfism type 2<br>Thanatophoric dwarfism-cloverleaf skull syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|156830 187601 ~1860|TD1<br>Thanatophoric dwarfism type 1|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal|187600 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~429|-|1-9 / 100 000|Autosomal dominant|Childhood|146000 ~15|-|1-9 / 100 000|Autosomal dominant|Neonatal|100800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05219 Bladder cancer~ko05230 Central carbon metabolism in cancer ~	,5479,5475,5470,5486,5480,5472,5471,5498,5481,5487,5473,5477,5488,5497,5483,5485,5469,5478,5476,5482,5484,5474	.	.	.	.	.	.	4	18(meninges)	0.9997
4	2160894	2160894	C	T	POLN	exonic	synonymous SNV	ENSG00000130997	rs10488836	ENSG00000130997:ENST00000382865:exon12:c.G1599A:p.L533L,ENSG00000130997:ENST00000511885:exon14:c.G1599A:p.L533L	POLN:NM_181808:exon14:c.G1599A:p.L533L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1132	0.1179	0.201478	0.1202	.	.	.	.	.	.	.	.	POLN:uc003ger.2:exon12:c.G1599A:p.L533L,POLN:uc011bvi.1:exon14:c.G1599A:p.L533L	.	AFR:0.2293,AMR:0.1647,EAS:0.3679,FIN:0.0338,NFE:0.0519,OTH:0.0754,ASJ:0.0695	610887	.	.	.	.	.	.	.	.	.	.	.	4	MU762430	het
4	2175733	2175733	A	G	POLN	exonic	synonymous SNV	ENSG00000130997	rs2022302	ENSG00000130997:ENST00000382865:exon9:c.T1323C:p.H441H,ENSG00000130997:ENST00000511885:exon11:c.T1323C:p.H441H	POLN:NM_181808:exon11:c.T1323C:p.H441H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1898	0.2473	0.321885	0.2399	.	.	.	.	.	.	.	.	POLN:uc010ich.1:exon5:c.T96C:p.H32H,POLN:uc003ger.2:exon9:c.T1323C:p.H441H,POLN:uc011bvi.1:exon11:c.T1323C:p.H441H	.	AFR:0.5182,AMR:0.2470,EAS:0.3956,FIN:0.0859,NFE:0.1042,OTH:0.1589,ASJ:0.1391	610887	.	.	.	.	.	.	.	.	.	.	.	4	MU24274680	het
4	2176454	2176454	G	A	POLN	exonic	nonsynonymous SNV	ENSG00000130997	rs9328764	ENSG00000130997:ENST00000382865:exon8:c.C1273T:p.R425C,ENSG00000130997:ENST00000511885:exon10:c.C1273T:p.R425C	POLN:NM_181808:exon10:c.C1273T:p.R425C	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1905	0.2472	0.321885	0.2401	3.482	23.1	0.258	4.48	0.992	.	.	.	POLN:uc010ich.1:exon4:c.C46T:p.R16C,POLN:uc003ger.2:exon8:c.C1273T:p.R425C,POLN:uc011bvi.1:exon10:c.C1273T:p.R425C	-0.974	AFR:0.5190,AMR:0.2476,EAS:0.3965,FIN:0.0860,NFE:0.1043,OTH:0.1571,ASJ:0.1391	610887	.	.	.	.	.	.	.	0.0	3.0	0.000	-2.4	4	MU11968384	het
4	2181016	2181016	T	C	POLN	intronic	.	ENSG00000130997	rs35787308	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1899	0.2460	0.321885	0.2399	.	.	.	.	.	.	.	.	.	.	AFR:0.5187,AMR:0.2482,EAS:0.3974,FIN:0.0857,NFE:0.1041,OTH:0.1589,ASJ:0.1391	610887	.	.	.	.	.	.	.	.	.	.	.	4	MU18358960	het
4	2181080	2181080	T	C	POLN	exonic	synonymous SNV	ENSG00000130997	rs6830513	ENSG00000130997:ENST00000382865:exon6:c.A1134G:p.T378T,ENSG00000130997:ENST00000511885:exon8:c.A1134G:p.T378T	POLN:NM_181808:exon8:c.A1134G:p.T378T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1896	0.2470	0.321885	0.2400	.	.	.	.	.	.	.	.	POLN:uc003ger.2:exon6:c.A1134G:p.T378T,POLN:uc011bvi.1:exon8:c.A1134G:p.T378T	.	AFR:0.5191,AMR:0.2470,EAS:0.3964,FIN:0.0859,NFE:0.1041,OTH:0.1571,ASJ:0.1391	610887	.	.	.	.	.	.	.	.	.	.	.	4	MU11968459	het
4	2194946	2194946	C	T	POLN	exonic	nonsynonymous SNV	ENSG00000130997	rs10011549	ENSG00000130997:ENST00000382865:exon5:c.G1006A:p.G336S,ENSG00000130997:ENST00000511885:exon7:c.G1006A:p.G336S	POLN:NM_181808:exon7:c.G1006A:p.G336S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1906	0.2575	0.330671	0.2457	-0.253	0.844	0.214	0.379	0.225	.	.	.	POLN:uc010ich.1:exon3:c.G6A:p.M2I,POLN:uc003ger.2:exon5:c.G1006A:p.G336S,POLN:uc011bvi.1:exon7:c.G1006A:p.G336S	-0.974	AFR:0.5431,AMR:0.2464,EAS:0.3944,FIN:0.0854,NFE:0.1039,OTH:0.1588,ASJ:0.1333	610887	.	.	.	.	.	.	.	0.014	3.54	0.000	.	4	MU18359031	unknown
4	2194953	2194953	G	A	POLN	exonic	synonymous SNV	ENSG00000130997	rs10002583	ENSG00000130997:ENST00000382865:exon5:c.C999T:p.G333G,ENSG00000130997:ENST00000511885:exon7:c.C999T:p.G333G	POLN:NM_181808:exon7:c.C999T:p.G333G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1905	0.2578	0.330671	0.2460	.	.	.	.	.	.	.	.	POLN:uc003ger.2:exon5:c.C999T:p.G333G,POLN:uc011bvi.1:exon7:c.C999T:p.G333G	.	AFR:0.5437,AMR:0.2464,EAS:0.3949,FIN:0.0855,NFE:0.1039,OTH:0.1588,ASJ:0.1333	610887	.	.	.	.	.	.	.	.	.	.	.	4	MU18359053	unknown
4	2195024	2195024	T	G	POLN	exonic	nonsynonymous SNV	ENSG00000130997	rs10018786	ENSG00000130997:ENST00000382865:exon5:c.A928C:p.M310L,ENSG00000130997:ENST00000511885:exon7:c.A928C:p.M310L	POLN:NM_181808:exon7:c.A928C:p.M310L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1940	0.2574	0.330671	0.2479	-0.932	0.022	1.0	4.64	0.109	.	.	.	POLN:uc003ger.2:exon5:c.A928C:p.M310L,POLN:uc011bvi.1:exon7:c.A928C:p.M310L	-0.944	AFR:0.5470,AMR:0.2452,EAS:0.3980,FIN:0.0859,NFE:0.1037,OTH:0.1619,ASJ:0.1333	610887	.	.	.	.	.	.	.	0.0	2.61	0.000	-2.445	4	MU762445	het
4	25678199	25678199	A	G	SLC34A2	exonic	nonsynonymous SNV	ENSG00000157765	rs6448389	ENSG00000157765:ENST00000382051:exon13:c.A1901G:p.D634G,ENSG00000157765:ENST00000503434:exon13:c.A1898G:p.D633G,ENSG00000157765:ENST00000504570:exon13:c.A1898G:p.D633G	SLC34A2:NM_001177998:exon13:c.A1898G:p.D633G,SLC34A2:NM_001177999:exon13:c.A1898G:p.D633G,SLC34A2:NM_006424:exon13:c.A1901G:p.D634G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8643	0.8760	0.910743	0.8992	0.576	7.988	1.0	4.99	0.264	.	.	.	SLC34A2:uc003grr.3:exon13:c.A1901G:p.D634G,SLC34A2:uc003grs.3:exon13:c.A1898G:p.D633G,SLC34A2:uc010iev.3:exon13:c.A1898G:p.D633G	-0.970	AFR:0.9638,AMR:0.8612,EAS:0.9994,FIN:0.9121,NFE:0.8528,OTH:0.8824,ASJ:0.8113	604217	265100;	60025;	60025|-|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|All ages|265100 ~	.	.	.	.	0.0	2.17	0.000	-2.62	4	MU81781878	hom
4	39302029	39302029	T	C	RFC1	exonic	synonymous SNV	ENSG00000035928	rs2066786	ENSG00000035928:ENST00000349703:exon20:c.A2541G:p.P847P,ENSG00000035928:ENST00000381897:exon20:c.A2544G:p.P848P	RFC1:NM_001363495:exon19:c.A2463G:p.P821P,RFC1:NM_001363496:exon19:c.A2466G:p.P822P,RFC1:NM_001204747:exon20:c.A2544G:p.P848P,RFC1:NM_002913:exon20:c.A2541G:p.P847P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5511	0.4247	0.465256	LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	RFC1:uc003gtx.2:exon20:c.A2541G:p.P847P,RFC1:uc003gty.2:exon20:c.A2544G:p.P848P	.	AFR:0.4539,AMR:0.1328,EAS:0.56,FIN:0.6638,NFE:0.5629,OTH:0.5747,ASJ:0.6139	102579	.	.	.	.	.	.	.	.	.	.	.	4	1(urinary_tract)	0.5541
4	41259633	41259633	C	A	UCHL1	exonic	nonsynonymous SNV	ENSG00000154277	rs5030732	ENSG00000154277:ENST00000512419:exon2:c.C52A:p.P18T,ENSG00000154277:ENST00000284440:exon3:c.C53A:p.S18Y,ENSG00000154277:ENST00000505232:exon3:c.C53A:p.S18Y,ENSG00000154277:ENST00000508768:exon3:c.C53A:p.S18Y,ENSG00000154277:ENST00000512788:exon3:c.C53A:p.S18Y,ENSG00000154277:ENST00000503431:exon4:c.C53A:p.S18Y,ENSG00000154277:ENST00000514924:exon5:c.C53A:p.S18Y	UCHL1:NM_004181:exon3:c.C53A:p.S18Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3502	0.0986	0.253994	1(liver)	2.700	20.8	0.072	2.84	0.971	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase	UCHL1:uc003gvo.3:exon3:c.C53A:p.S18Y	-0.933	AFR:4(thyroid),AMR:1(large_intestine),EAS:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,FIN:0.1632,NFE:0.0390,OTH:0.3242,ASJ:MU4555612	191342	613643;615491;	352654;2828;	352654|-|<1 / 1 000 000|Autosomal recessive|Childhood|615491 ~2828|Early-onset Parkinson disease<br>YOPD|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|300557 600116 602404 605909 606324 606852 610297 613643 615528 616840 ~	.	.	.	.	0.626	0.47	0.000	1.32	4	3(soft_tissue)	0.2433
4	41263718	41263718	-	T	UCHL1	intronic	.	ENSG00000154277	rs3214812	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2981	0.2143	0.307308	0.2392	.	.	.	.	.	.	.	.	.	.	AFR:0.1493,AMR:0.3841,EAS:0.5320,FIN:0.2205,NFE:0.2539,OTH:0.2393,ASJ:0.3592	191342	613643;615491;	352654;2828;	352654|-|<1 / 1 000 000|Autosomal recessive|Childhood|615491 ~2828|Early-onset Parkinson disease<br>YOPD|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|300557 600116 602404 605909 606324 606852 610297 613643 615528 616840 ~	.	.	.	.	.	.	.	.	4	.	hom
4	55130078	55130078	T	C	PDGFRA	exonic	synonymous SNV	ENSG00000134853	rs2229307	ENSG00000134853:ENST00000257290:exon4:c.T612C:p.N204N,ENSG00000134853:ENST00000508170:exon4:c.T612C:p.N204N,ENSG00000134853:ENST00000509490:exon4:c.T612C:p.N204N	PDGFRA:NM_001347827:exon4:c.T612C:p.N204N,PDGFRA:NM_001347829:exon4:c.T612C:p.N204N,PDGFRA:NM_001347830:exon4:c.T651C:p.N217N,PDGFRA:NM_006206:exon4:c.T612C:p.N204N,PDGFRA:NM_001347828:exon5:c.T687C:p.N229N	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1796	0.1650	0.236222	0.1677	.	.	.	.	.	.	.	.	PDGFRA:uc010igq.1:exon3:c.T294C:p.N98N,PDGFRA:uc003hal.3:exon4:c.T612C:p.N204N,PDGFRA:uc003han.4:exon4:c.T612C:p.N204N	.	AFR:0.2562,AMR:0.3759,EAS:0.1780,FIN:0.1216,NFE:0.1175,OTH:0.1487,ASJ:0.07	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	,8564,8557	,8558	.	.	.	.	.	4	MU12032527	het
4	55133726	55133726	T	G	PDGFRA	exonic	synonymous SNV	ENSG00000134853	rs4358459	ENSG00000134853:ENST00000257290:exon7:c.T939G:p.G313G,ENSG00000134853:ENST00000509490:exon7:c.T939G:p.G313G	PDGFRA:NM_001347827:exon7:c.T939G:p.G313G,PDGFRA:NM_001347829:exon7:c.T939G:p.G313G,PDGFRA:NM_001347830:exon7:c.T978G:p.G326G,PDGFRA:NM_006206:exon7:c.T939G:p.G313G,PDGFRA:NM_001347828:exon8:c.T1014G:p.G338G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1775	0.1632	0.234225	0.1669	.	.	.	.	.	.	.	.	PDGFRA:uc010igq.1:exon6:c.T621G:p.G207G,PDGFRA:uc003han.4:exon7:c.T939G:p.G313G	.	AFR:0.2557,AMR:0.3747,EAS:0.1782,FIN:0.1219,NFE:0.1162,OTH:0.1472,ASJ:0.0662	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	,8564,8557	,8558	.	.	.	.	.	4	MU12032533	het
4	55141055	55141055	A	G	PDGFRA	exonic	synonymous SNV	ENSG00000134853	rs1873778	ENSG00000134853:ENST00000257290:exon12:c.A1701G:p.P567P,ENSG00000134853:ENST00000509490:exon12:c.A1701G:p.P567P	PDGFRA:NM_001347827:exon12:c.A1701G:p.P567P,PDGFRA:NM_001347829:exon12:c.A1701G:p.P567P,PDGFRA:NM_001347830:exon12:c.A1740G:p.P580P,PDGFRA:NM_006206:exon12:c.A1701G:p.P567P,PDGFRA:NM_001347828:exon13:c.A1776G:p.P592P	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9880	0.9589	0.957668	0.9677	.	.	.	.	.	.	.	.	PDGFRA:uc010igq.1:exon11:c.A1383G:p.P461P,PDGFRA:uc003han.4:exon12:c.A1701G:p.P567P	.	AFR:0.8906,AMR:0.9881,EAS:0.9994,FIN:1,NFE:0.9986,OTH:0.9908,ASJ:0.9834	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	,8564,8557	,8558	.	.	.	.	.	4	MU81783993	hom
4	55161391	55161391	T	C	PDGFRA	exonic	synonymous SNV	ENSG00000134853;ENSG00000145216	rs7685117	ENSG00000134853:ENST00000257290:exon23:c.T3222C:p.D1074D,ENSG00000145216:ENST00000507166:exon24:c.T2502C:p.D834D	PDGFRA:NM_001347829:exon23:c.T3222C:p.D1074D,PDGFRA:NM_001347830:exon23:c.T3261C:p.D1087D,PDGFRA:NM_006206:exon23:c.T3222C:p.D1074D,PDGFRA:NM_001347828:exon24:c.T3297C:p.D1099D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9990	0.9968	0.997204	0.9980	.	.	.	.	.	.	.	.	PDGFRA:uc003han.4:exon23:c.T3222C:p.D1074D,PDGFRA:uc003haa.3:exon24:c.T2502C:p.D834D	.	AFR:0.9929,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	,8564,8557	,8558	.	.	.	.	.	4	MU81784009	hom
4	55948108	55948108	A	G	KDR	intronic	.	ENSG00000250646	rs2412617	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9986	0.9976	0.996805	0.9975	.	.	.	.	.	.	.	.	.	.	AFR:0.9923,AMR:1,EAS:1,FIN:1,NFE:0.9995,OTH:0.9980,ASJ:0.9967	191306	602089;	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04370 VEGF signaling pathway~ko04510 Focal adhesion~ko05205 Proteoglycans in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	MU81784046	hom
4	57797414	57797414	C	T	REST	exonic	nonsynonymous SNV	ENSG00000084093	rs3796529	ENSG00000084093:ENST00000309042:exon4:c.C2390T:p.P797L	REST:NM_001193508:exon4:c.C2390T:p.P797L,REST:NM_001363453:exon4:c.C2390T:p.P797L,REST:NM_005612:exon4:c.C2390T:p.P797L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2250	0.2120	0.260783	8(prostate)	0.310	5.794	0.194	0.384	0.004	.	.	.	REST:uc031sey.1:exon2:c.C1133T:p.P378L,REST:uc031sex.1:exon3:c.C2306T:p.P769L,REST:uc031sfc.1:exon3:c.C1424T:p.P475L,REST:uc031sfj.1:exon3:c.C1424T:p.P475L,REST:uc031sfo.1:exon3:c.C1424T:p.P475L,REST:uc003hch.3:exon4:c.C2390T:p.P797L,REST:uc003hci.3:exon4:c.C2390T:p.P797L,REST:uc031sez.1:exon4:c.C1412T:p.P471L,REST:uc031sfa.1:exon4:c.C1424T:p.P475L,REST:uc031sfb.1:exon4:c.C1424T:p.P475L,REST:uc031sfp.1:exon4:c.C1943T:p.P648L,REST:uc010ihf.4:exon5:c.C1412T:p.P471L,REST:uc031sfi.1:exon5:c.C1424T:p.P475L,REST:uc031sfk.1:exon5:c.C1412T:p.P471L	-0.907	AFR:MU3888701,AMR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.2576,FIN:0.2064,NFE:0.1887,OTH:0.4154,ASJ:0.2359	600571	616806;	654;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~	.	.	.	.	0.004	3.33	0.000	0	4	2(haematopoietic_and_lymphoid_tissue)	0.2335
4	57798189	57798189	G	A	REST	exonic	synonymous SNV	ENSG00000084093	rs2227901	ENSG00000084093:ENST00000309042:exon4:c.G3165A:p.A1055A	REST:NM_001193508:exon4:c.G3165A:p.A1055A,REST:NM_001363453:exon4:c.G3165A:p.A1055A,REST:NM_005612:exon4:c.G3165A:p.A1055A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2227	0.2062	0.253594	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	REST:uc031sey.1:exon2:c.G1908A:p.A636A,REST:uc031sex.1:exon3:c.G3081A:p.A1027A,REST:uc031sfc.1:exon3:c.G2199A:p.A733A,REST:uc031sfj.1:exon3:c.G2199A:p.A733A,REST:uc031sfo.1:exon3:c.G2199A:p.A733A,REST:uc003hch.3:exon4:c.G3165A:p.A1055A,REST:uc003hci.3:exon4:c.G3165A:p.A1055A,REST:uc031sez.1:exon4:c.G2187A:p.A729A,REST:uc031sfa.1:exon4:c.G2199A:p.A733A,REST:uc031sfb.1:exon4:c.G2199A:p.A733A,REST:uc031sfp.1:exon4:c.G2718A:p.A906A,REST:uc010ihf.4:exon5:c.G2187A:p.A729A,REST:uc031ses.1:exon5:c.G816A:p.A272A,REST:uc031sfi.1:exon5:c.G2199A:p.A733A,REST:uc031sfk.1:exon5:c.G2187A:p.A729A	.	AFR:0.2300,AMR:0.2390,EAS:0.1887,FIN:0.4022,NFE:0.2341,OTH:0.2076,ASJ:0.2064	600571	616806;	654;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~	.	.	.	.	.	.	.	.	4	2(haematopoietic_and_lymphoid_tissue)	0.2260
4	66197804	66197804	C	T	EPHA5	exonic	synonymous SNV	ENSG00000145242	rs7349683	ENSG00000145242:ENST00000432638:exon15:c.G2406A:p.G802G,ENSG00000145242:ENST00000354839:exon16:c.G2829A:p.G943G,ENSG00000145242:ENST00000273854:exon17:c.G2895A:p.G965G,ENSG00000145242:ENST00000511294:exon17:c.G2898A:p.G966G	EPHA5:NM_001281766:exon16:c.G2832A:p.G944G,EPHA5:NM_182472:exon16:c.G2829A:p.G943G,EPHA5:NM_001281765:exon17:c.G2898A:p.G966G,EPHA5:NM_001281767:exon17:c.G2898A:p.G966G,EPHA5:NM_001318761:exon17:c.G2691A:p.G897G,EPHA5:NM_004439:exon17:c.G2895A:p.G965G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3465	0.2829	0.326677	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	EPHA5:uc003hcz.3:exon16:c.G2829A:p.G943G,EPHA5:uc011cai.2:exon16:c.G2832A:p.G944G,EPHA5:uc003hcx.3:exon17:c.G2691A:p.G897G,EPHA5:uc003hcy.3:exon17:c.G2895A:p.G965G,EPHA5:uc003hda.2:exon17:c.G2898A:p.G966G,EPHA5:uc011cah.2:exon17:c.G2898A:p.G966G	.	AFR:0.2977,AMR:0.1274,EAS:0.3411,FIN:0.4289,NFE:0.3329,OTH:0.3694,ASJ:0.2888	600004	.	.	.	.	.	.	.	.	.	.	.	4	1(breast)	0.3796
4	66280171	66280171	C	T	EPHA5	intronic	.	ENSG00000145242	rs2305351	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1895	0.1131	0.180911	MU586371	.	.	.	.	.	0.0003	0.016	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,AMR:0.1540,EAS:0.3149,FIN:0.1589,NFE:0.2989,OTH:0.2119,ASJ:0.0408	600004	.	.	.	.	.	.	.	.	.	.	.	4	1(stomach)	0.1791
4	74285239	74285239	C	T	ALB	exonic	synonymous SNV	ENSG00000163631	rs962004	ENSG00000163631:ENST00000415165:exon9:c.C1092T:p.L364L,ENSG00000163631:ENST00000401494:exon11:c.C1323T:p.L441L,ENSG00000163631:ENST00000503124:exon11:c.C1218T:p.L406L,ENSG00000163631:ENST00000295897:exon13:c.C1668T:p.L556L,ENSG00000163631:ENST00000509063:exon13:c.C1668T:p.L556L	ALB:NM_000477:exon13:c.C1668T:p.L556L	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5354	0.5183	0.483427	MU14553863	.	.	.	.	.	.	.	.	ALB:uc003hgw.4:exon9:c.C1092T:p.L364L,ALB:uc011cbf.2:exon12:c.C1338T:p.L446L,ALB:uc003hgs.4:exon13:c.C1668T:p.L556L,ALB:uc011cbe.2:exon13:c.C705T:p.L235L	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.5268,EAS:0.4401,FIN:0.47,NFE:0.5680,OTH:0.5490,ASJ:0.4163	103600	615999;616000;	86816;	86816|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|616000 ~	.	.	.	.	.	.	.	.	4	1(lung)	0.5874
4	75248434	75248434	A	G	EREG	exonic	synonymous SNV	ENSG00000124882	rs2367707	ENSG00000124882:ENST00000244869:exon4:c.A351G:p.E117E	EREG:NM_001432:exon4:c.A351G:p.E117E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7927	0.7781	0.767772	0.7915	.	.	.	.	.	.	.	.	EREG:uc003hie.1:exon4:c.A351G:p.E117E	.	AFR:0.7749,AMR:0.8747,EAS:0.6850,FIN:0.8136,NFE:0.7999,OTH:0.8241,ASJ:0.8377	602061	.	.	.	.	.	.	.	.	.	.	.	4	MU796131	het
4	83778839	83778839	T	C	SEC31A	intronic	.	ENSG00000138674	rs7658703	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2412	0.2843	0.351637	1(breast)	.	.	.	.	.	0.0303	0.15	.	.	.	AFR:MU586415,AMR:ESAD-UK|2|409|0.00488998,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.4382,FIN:0.1571,NFE:0.2053,OTH:0.5118,ASJ:0.2720	610257	.	.	.	.	.	.	.	.	.	.	.	4	1(stomach)	0.1630
4	83783714	83783714	G	A	SEC31A	exonic	synonymous SNV	ENSG00000138674	rs537113231	ENSG00000138674:ENST00000443462:exon12:c.C1506T:p.A502A,ENSG00000138674:ENST00000505472:exon12:c.C1521T:p.A507A,ENSG00000138674:ENST00000311785:exon13:c.C1521T:p.A507A,ENSG00000138674:ENST00000395310:exon13:c.C1521T:p.A507A,ENSG00000138674:ENST00000432794:exon13:c.C1521T:p.A507A,ENSG00000138674:ENST00000448323:exon13:c.C1521T:p.A507A,ENSG00000138674:ENST00000508479:exon13:c.C1521T:p.A507A,ENSG00000138674:ENST00000508502:exon13:c.C1521T:p.A507A,ENSG00000138674:ENST00000509142:exon13:c.C1521T:p.A507A,ENSG00000138674:ENST00000355196:exon15:c.C1521T:p.A507A	SEC31A:NM_001191049:exon12:c.C1506T:p.A502A,SEC31A:NM_001077206:exon13:c.C1521T:p.A507A,SEC31A:NM_001077207:exon13:c.C1521T:p.A507A,SEC31A:NM_001077208:exon13:c.C1521T:p.A507A,SEC31A:NM_001318119:exon13:c.C1521T:p.A507A,SEC31A:NM_001318120:exon15:c.C1521T:p.A507A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	3.302e-05	.	0.000798722	.	.	.	.	.	.	.	.	.	SEC31A:uc011ccm.2:exon12:c.C1506T:p.A502A,SEC31A:uc003hnf.3:exon13:c.C1521T:p.A507A,SEC31A:uc003hng.3:exon13:c.C1521T:p.A507A,SEC31A:uc003hnh.3:exon13:c.C1521T:p.A507A,SEC31A:uc003hni.3:exon13:c.C1521T:p.A507A,SEC31A:uc003hnn.2:exon13:c.C1521T:p.A507A,SEC31A:uc011ccn.2:exon13:c.C1521T:p.A507A,SEC31A:uc003hnm.3:exon15:c.C1521T:p.A507A	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	610257	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	83784466	83784466	T	C	SEC31A	intronic	.	ENSG00000138674	rs529522056	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0019	.	0.00399361	9.699e-05	.	.	.	.	.	0.0030	0.208	.	SEC31A:uc003hno.3:exon12:c.A1514G:p.N505S	.	AFR:0,AMR:0.0012,EAS:0,FIN:0,NFE:0,OTH:0.0020,ASJ:0	610257	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	83788344	83788344	A	T	SEC31A	exonic	synonymous SNV	ENSG00000138674	rs2045478	ENSG00000138674:ENST00000264405:exon3:c.T324A:p.G108G,ENSG00000138674:ENST00000443462:exon8:c.T993A:p.G331G,ENSG00000138674:ENST00000500777:exon8:c.T1008A:p.G336G,ENSG00000138674:ENST00000505472:exon8:c.T1008A:p.G336G,ENSG00000138674:ENST00000311785:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000326950:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000348405:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000395310:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000432794:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000448323:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000505984:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000508479:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000508502:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000509142:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000513858:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000355196:exon11:c.T1008A:p.G336G	SEC31A:NM_001191049:exon8:c.T993A:p.G331G,SEC31A:NM_001077206:exon9:c.T1008A:p.G336G,SEC31A:NM_001077207:exon9:c.T1008A:p.G336G,SEC31A:NM_001077208:exon9:c.T1008A:p.G336G,SEC31A:NM_001300744:exon9:c.T1008A:p.G336G,SEC31A:NM_001300745:exon9:c.T1008A:p.G336G,SEC31A:NM_001318119:exon9:c.T1008A:p.G336G,SEC31A:NM_016211:exon9:c.T1008A:p.G336G,SEC31A:NM_001318120:exon11:c.T1008A:p.G336G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9990	0.9967	0.996805	0.9971	.	.	.	.	.	.	.	.	SEC31A:uc003hne.3:exon3:c.T324A:p.G108G,SEC31A:uc011ccm.2:exon8:c.T993A:p.G331G,SEC31A:uc003hnf.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hng.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hnh.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hni.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hnk.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hnl.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hnn.2:exon9:c.T1008A:p.G336G,SEC31A:uc003hno.3:exon9:c.T1008A:p.G336G,SEC31A:uc011ccl.2:exon9:c.T1008A:p.G336G,SEC31A:uc011ccn.2:exon9:c.T1008A:p.G336G,SEC31A:uc003hnm.3:exon11:c.T1008A:p.G336G	.	AFR:0.9896,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	610257	.	.	.	.	.	.	.	.	.	.	.	4	MU81786544	hom
4	83793243	83793243	A	C	SEC31A	intronic	.	ENSG00000138674	rs4693525	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7608	0.7377	0.712859	0.7453	.	.	.	.	.	0.0004	0.302	.	.	.	AFR:0.6426,AMR:0.8019,EAS:0.7389,FIN:0.8280,NFE:0.7823,OTH:0.7739,ASJ:0.6987	610257	.	.	.	.	.	.	.	.	.	.	.	4	MU16678361	hom
4	83795806	83795806	T	C	SEC31A	exonic	synonymous SNV	ENSG00000138674	rs10025654	ENSG00000138674:ENST00000443462:exon5:c.A582G:p.R194R,ENSG00000138674:ENST00000500777:exon5:c.A597G:p.R199R,ENSG00000138674:ENST00000503058:exon5:c.A510G:p.R170R,ENSG00000138674:ENST00000505472:exon5:c.A597G:p.R199R,ENSG00000138674:ENST00000311785:exon6:c.A597G:p.R199R,ENSG00000138674:ENST00000326950:exon6:c.A597G:p.R199R,ENSG00000138674:ENST00000348405:exon6:c.A597G:p.R199R,ENSG00000138674:ENST00000395310:exon6:c.A597G:p.R199R,ENSG00000138674:ENST00000432794:exon6:c.A597G:p.R199R,ENSG00000138674:ENST00000448323:exon6:c.A597G:p.R199R,ENSG00000138674:ENST00000505984:exon6:c.A597G:p.R199R,ENSG00000138674:ENST00000508479:exon6:c.A597G:p.R199R,ENSG00000138674:ENST00000508502:exon6:c.A597G:p.R199R,ENSG00000138674:ENST00000509142:exon6:c.A597G:p.R199R,ENSG00000138674:ENST00000513858:exon6:c.A597G:p.R199R,ENSG00000138674:ENST00000355196:exon8:c.A597G:p.R199R	SEC31A:NM_001191049:exon5:c.A582G:p.R194R,SEC31A:NM_001077206:exon6:c.A597G:p.R199R,SEC31A:NM_001077207:exon6:c.A597G:p.R199R,SEC31A:NM_001077208:exon6:c.A597G:p.R199R,SEC31A:NM_001300744:exon6:c.A597G:p.R199R,SEC31A:NM_001300745:exon6:c.A597G:p.R199R,SEC31A:NM_001318119:exon6:c.A597G:p.R199R,SEC31A:NM_016211:exon6:c.A597G:p.R199R,SEC31A:NM_001318120:exon8:c.A597G:p.R199R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5133	0.4444	0.352636	1(stomach)	.	.	.	.	.	.	.	.	SEC31A:uc011ccm.2:exon5:c.A582G:p.R194R,SEC31A:uc003hnf.3:exon6:c.A597G:p.R199R,SEC31A:uc003hng.3:exon6:c.A597G:p.R199R,SEC31A:uc003hnh.3:exon6:c.A597G:p.R199R,SEC31A:uc003hni.3:exon6:c.A597G:p.R199R,SEC31A:uc003hnk.3:exon6:c.A597G:p.R199R,SEC31A:uc003hnl.3:exon6:c.A597G:p.R199R,SEC31A:uc003hnn.2:exon6:c.A597G:p.R199R,SEC31A:uc003hno.3:exon6:c.A597G:p.R199R,SEC31A:uc011ccl.2:exon6:c.A597G:p.R199R,SEC31A:uc011ccn.2:exon6:c.A597G:p.R199R,SEC31A:uc003hnm.3:exon8:c.A597G:p.R199R	.	AFR:3(lung),AMR:MU23603113,EAS:0.4585,FIN:0.1837,NFE:0.6647,OTH:0.4868,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053	610257	.	.	.	.	.	.	.	.	.	.	.	4	1(liver)	0.2491
4	84362443	84362443	T	C	HELQ	intronic	.	ENSG00000163312	rs4693088	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1177	.	0.182508	0.1670	.	.	.	.	.	.	.	.	.	.	AFR:0.3923,AMR:0.0764,EAS:0.0012,FIN:0.0531,NFE:0.0898,OTH:0.1010,ASJ:0.1755	606769	.	.	.	.	.	.	.	.	.	.	.	4	MU117531820	het
4	84370125	84370125	A	-	HELQ	intronic	.	ENSG00000163312	rs10718573	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.6132	.	0.676518	0.6258	.	.	.	.	.	.	.	.	.	.	AFR:0.7816,AMR:0.6349,EAS:0.6820,FIN:0.5842,NFE:0.5366,OTH:0.6048,ASJ:0.4781	606769	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	84374480	84374480	C	T	HELQ	exonic	nonsynonymous SNV	ENSG00000163312	rs1494961	ENSG00000163312:ENST00000295488:exon2:c.G916A:p.V306I,ENSG00000163312:ENST00000508591:exon2:c.G916A:p.V306I,ENSG00000163312:ENST00000510985:exon2:c.G916A:p.V306I	HELQ:NM_001297755:exon2:c.G916A:p.V306I,HELQ:NM_001297758:exon2:c.G805A:p.V269I,HELQ:NM_001297759:exon2:c.G916A:p.V306I,HELQ:NM_133636:exon2:c.G916A:p.V306I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5623	0.5944	0.664537	1(haematopoietic_and_lymphoid_tissue)	0.595	8.121	1.0	2.29	0.990	.	.	P-loop containing nucleoside triphosphate hydrolase	HELQ:uc003hom.3:exon2:c.G916A:p.V306I,HELQ:uc003hon.1:exon2:c.G598A:p.V200I,HELQ:uc003hoo.1:exon2:c.G805A:p.V269I,HELQ:uc003hop.1:exon2:c.G598A:p.V200I,HELQ:uc003hoq.1:exon2:c.G916A:p.V306I,HELQ:uc010ikb.3:exon2:c.G916A:p.V306I	-1.011	AFR:MU18419015,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611,THCA-CN|1|50|0.02,EAS:0.7809,FIN:0.6244,NFE:0.4470,OTH:0.6774,ASJ:0.6032	606769	.	.	.	.	.	.	.	0.0	0.39	0.000	-2.42	4	19(soft_tissue)	0.5052
4	84376743	84376743	A	T	HELQ	exonic	nonsynonymous SNV	ENSG00000163312	rs6831595	ENSG00000163312:ENST00000295488:exon1:c.T104A:p.V35E,ENSG00000163312:ENST00000508591:exon1:c.T104A:p.V35E,ENSG00000163312:ENST00000510985:exon1:c.T104A:p.V35E	HELQ:NM_001297755:exon1:c.T104A:p.V35E,HELQ:NM_001297758:exon1:c.T104A:p.V35E,HELQ:NM_001297759:exon1:c.T104A:p.V35E,HELQ:NM_133636:exon1:c.T104A:p.V35E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	1.0000	0.9999	1	1.0000	-1.530	0.002	1.0	-3.44	0.000	.	.	.	HELQ:uc003hom.3:exon1:c.T104A:p.V35E,HELQ:uc003hoo.1:exon1:c.T104A:p.V35E,HELQ:uc003hoq.1:exon1:c.T104A:p.V35E,HELQ:uc010ikb.3:exon1:c.T104A:p.V35E	-0.964	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	606769	.	.	.	.	.	.	.	0.0	0.53	0.000	-1.24	4	MU81786772	hom
4	88048163	88048163	-	T	AFF1	intronic	.	ENSG00000172493	rs11448202	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2324	0.1770	0.213059	0.1729	.	.	.	.	.	.	.	.	.	.	AFR:0.1048,AMR:0.3033,EAS:0.2317,FIN:0.1355,NFE:0.2035,OTH:0.1964,ASJ:0.2986	159557	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	4	.	hom
4	88052219	88052219	T	C	AFF1	intronic	.	ENSG00000172493	rs342467	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5937	0.5927	0.567292	0.5752	.	.	.	.	.	.	.	.	.	.	AFR:0.5581,AMR:0.7005,EAS:0.5726,FIN:0.5315,NFE:0.5867,OTH:0.5615,ASJ:0.7086	159557	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	4	MU23102211	hom
4	88056720	88056720	T	-	AFF1	intronic	.	ENSG00000172493	rs398083273	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.6550	.	0.570288	0.5778	.	.	.	.	.	.	.	.	.	.	AFR:0.5653,AMR:0.7017,EAS:0.5720,FIN:0.5331,NFE:0.5873,OTH:0.5634,ASJ:0.7133	159557	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	4	.	hom
4	99850126	99850126	A	G	EIF4E	UTR5	.	ENSG00000263923	rs11723037	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5189	0.5489	0.614217	LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.5561,AMR:0.8307,EAS:0.48,FIN:0.6716,NFE:0.4572,OTH:0.4207,ASJ:0.4748	133440	615091;	.	.	.	.	.	.	.	.	.	.	4	1(haematopoietic_and_lymphoid_tissue)	0.4370
4	103514658	103514658	T	C	NFKB1	exonic	synonymous SNV	ENSG00000109320	rs1609993	ENSG00000109320:ENST00000600343:exon5:c.T600C:p.A200A,ENSG00000109320:ENST00000508584:exon6:c.T522C:p.A174A,ENSG00000109320:ENST00000226574:exon12:c.T1143C:p.A381A,ENSG00000109320:ENST00000394820:exon12:c.T1140C:p.A380A,ENSG00000109320:ENST00000505458:exon12:c.T1140C:p.A380A	NFKB1:NM_001165412:exon12:c.T1140C:p.A380A,NFKB1:NM_001319226:exon12:c.T1140C:p.A380A,NFKB1:NM_003998:exon12:c.T1143C:p.A381A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9401	0.9420	0.969848	0.9425	.	.	.	.	.	.	.	.	NFKB1:uc011cer.2:exon5:c.T600C:p.A200A,NFKB1:uc011cep.2:exon12:c.T1143C:p.A381A,NFKB1:uc011ceq.2:exon12:c.T1140C:p.A380A	.	AFR:0.9856,AMR:0.9402,EAS:1,FIN:0.9250,NFE:0.9179,OTH:0.9173,ASJ:0.9040	164011	616576;	1572;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~	~ko01523 Antifolate resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04071 Sphingolipid signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04218 Cellular senescence~ko04380 Osteoclast differentiation~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04623 Cytosolic DNA-sensing pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04926 Relaxin signaling pathway~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05030 Cocaine addiction~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05132 Salmonella infection~ko05133 Pertussis~ko05134 Legionellosis~ko05135 Yersinia infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	MU81788168	hom
4	103534740	103534740	-	A	NFKB1	splicing	.	ENSG00000109320	rs148268461	.	.	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0706	0.0835	0.0842652	0.0790	.	.	.	.	.	.	.	.	.	.	AFR:0.1183,AMR:0.0411,EAS:0.0884,FIN:0.0791,NFE:0.0593,OTH:0.0661,ASJ:0.0102	164011	616576;	1572;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~	~ko01523 Antifolate resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04071 Sphingolipid signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04218 Cellular senescence~ko04380 Osteoclast differentiation~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04623 Cytosolic DNA-sensing pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04926 Relaxin signaling pathway~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05030 Cocaine addiction~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05132 Salmonella infection~ko05133 Pertussis~ko05134 Legionellosis~ko05135 Yersinia infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	MU29134980	het
4	104061993	104061993	C	G	CENPE	exonic	nonsynonymous SNV	ENSG00000138778	rs1381657	ENSG00000138778:ENST00000380026:exon35:c.G5657C:p.S1886T,ENSG00000138778:ENST00000265148:exon36:c.G5732C:p.S1911T	CENPE:NM_001286734:exon35:c.G5657C:p.S1886T,CENPE:NM_001813:exon36:c.G5732C:p.S1911T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1932	0.1815	0.210863	2(haematopoietic_and_lymphoid_tissue)	-1.564	0.002	0.501	-1.34	0.001	.	.	.	CENPE:uc003hxc.1:exon35:c.G5657C:p.S1886T,CENPE:uc003hxb.1:exon36:c.G5732C:p.S1911T	-1.099	AFR:MU77894,AMR:BRCA-KR|1|50|0.02,EAS:0.1713,FIN:0.1874,NFE:0.2185,OTH:0.1307,ASJ:0.1679	117143	616051;	808;	808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	.	.	.	0.247	-0.65	0.000	0.11	4	1(thyroid)	0.1195
4	104062223	104062223	C	T	CENPE	exonic	synonymous SNV	ENSG00000138778	rs1381658	ENSG00000138778:ENST00000380026:exon35:c.G5427A:p.T1809T,ENSG00000138778:ENST00000265148:exon36:c.G5502A:p.T1834T	CENPE:NM_001286734:exon35:c.G5427A:p.T1809T,CENPE:NM_001813:exon36:c.G5502A:p.T1834T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1909	0.1397	0.169129	MU4566242	.	.	.	.	.	.	.	.	CENPE:uc003hxc.1:exon35:c.G5427A:p.T1809T,CENPE:uc003hxb.1:exon36:c.G5502A:p.T1834T	.	AFR:COCA-CN|1|321|0.00311526,AMR:0.1342,EAS:0.1766,FIN:0.2185,NFE:0.1311,OTH:0.1205,ASJ:0.0570	117143	616051;	808;	808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	.	.	.	.	.	.	.	4	1(thyroid)	0.1757
4	104063071	104063071	C	T	CENPE	intronic	.	ENSG00000138778	rs2711898	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4066	0.4567	0.449681	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	0.0001	0.012	.	.	.	AFR:0.4467,AMR:0.5847,EAS:0.4305,FIN:0.2948,NFE:0.4197,OTH:0.3950,ASJ:0.3807	117143	616051;	808;	808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	.	.	.	.	.	.	.	4	1(haematopoietic_and_lymphoid_tissue)	0.4170
4	104082349	104082349	C	T	CENPE	exonic	synonymous SNV	ENSG00000138778	rs2251634	ENSG00000138778:ENST00000380026:exon19:c.G1950A:p.Q650Q,ENSG00000138778:ENST00000265148:exon20:c.G2025A:p.Q675Q,ENSG00000138778:ENST00000503705:exon20:c.G2025A:p.Q675Q	CENPE:NM_001286734:exon19:c.G1950A:p.Q650Q,CENPE:NM_001813:exon20:c.G2025A:p.Q675Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4063	0.4585	0.45008	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	CENPE:uc003hxc.1:exon19:c.G1950A:p.Q650Q,CENPE:uc003hxb.1:exon20:c.G2025A:p.Q675Q	.	AFR:0.4486,AMR:0.5911,EAS:0.4305,FIN:0.2931,NFE:0.4200,OTH:0.3953,ASJ:0.3807	117143	616051;	808;	808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	.	.	.	.	.	.	.	4	3(lung)	0.4175
4	106196829	106196829	T	G	TET2	exonic	nonsynonymous SNV	ENSG00000168769	rs34402524	ENSG00000168769:ENST00000380013:exon11:c.T5162G:p.L1721W,ENSG00000168769:ENST00000513237:exon11:c.T5225G:p.L1742W,ENSG00000168769:ENST00000540549:exon11:c.T5162G:p.L1721W	TET2:NM_001127208:exon11:c.T5162G:p.L1721W	clinvar: not_provided 	 CancerVar: 8#Tier_II_potential EVS=[1, 0, 1, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.1291	0.1233	0.0916534	COCA-CN|1|321|0.00311526	2.834	21.5	0.003	5.16	0.124	.	.	2OGFeDO, oxygenase domain|WD40/YVTN repeat-like-containing domain	TET2:uc003hxk.3:exon11:c.T5162G:p.L1721W,TET2:uc011cez.2:exon11:c.T5225G:p.L1742W	-0.626	AFR:0.1149,AMR:0.0881,EAS:0.1424,FIN:0.0358,NFE:0.1756,OTH:0.1248,ASJ:0.0871	612839	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	9974,9975,	.	,9978,9977,9980,9981,9976,9979	0.794	4.35	0.000	0.895	4	2(haematopoietic_and_lymphoid_tissue)	0.1316
4	119654028	119654028	T	C	SEC24D	exonic	nonsynonymous SNV	ENSG00000150961	rs34510328	ENSG00000150961:ENST00000511481:exon13:c.A1429G:p.M477V,ENSG00000150961:ENST00000280551:exon20:c.A2536G:p.M846V,ENSG00000150961:ENST00000379735:exon20:c.A2539G:p.M847V	SEC24D:NM_001318066:exon20:c.A2539G:p.M847V,SEC24D:NM_014822:exon20:c.A2536G:p.M846V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0013	0.0039	0.00299521	0.0045	0.520	7.580	0.81	5.62	1.000	.	.	Sec23/Sec24, helical domain	SEC24D:uc003ick.2:exon1:c.A22G:p.M8V,SEC24D:uc003ici.4:exon20:c.A2536G:p.M846V,SEC24D:uc003icj.4:exon20:c.A2539G:p.M847V	-0.588	AFR:0.0156,AMR:0.0024,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	607186	616294;	2050;	2050|Bone fragility-craniosynostosis-proptosis-hydrocephalus syndrome|<1 / 1 000 000|Not applicable<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|112240 616294 ~	.	.	.	.	0.017	-2.46	0.324	0.83	4	.	het
4	119674051	119674051	-	A	SEC24D	intronic	.	ENSG00000150961	rs71595318	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3198	0.2827	0.208466	0.3138	.	.	.	.	.	.	.	.	.	.	AFR:0.1786,AMR:0.2793,EAS:0.1624,FIN:0.4409,NFE:0.3853,OTH:0.3627,ASJ:0.2882	607186	616294;	2050;	2050|Bone fragility-craniosynostosis-proptosis-hydrocephalus syndrome|<1 / 1 000 000|Not applicable<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|112240 616294 ~	.	.	.	.	.	.	.	.	4	.	het
4	119736598	119736598	C	T	SEC24D	intronic	.	ENSG00000150961	rs6843524	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8717	0.8982	0.854832	0.8819	.	.	.	.	.	0	0	.	.	.	AFR:0.9290,AMR:0.8878,EAS:0.7006,FIN:0.8623,NFE:0.8791,OTH:0.8643,ASJ:0.9007	607186	616294;	2050;	2050|Bone fragility-craniosynostosis-proptosis-hydrocephalus syndrome|<1 / 1 000 000|Not applicable<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|112240 616294 ~	.	.	.	.	.	.	.	.	4	MU797145	hom
4	119736796	119736796	A	C	SEC24D	exonic	synonymous SNV	ENSG00000150961	rs2389688	ENSG00000150961:ENST00000509818:exon4:c.T334G:p.F112V,ENSG00000150961:ENST00000506622:exon6:c.T590G:p.L197R	SEC24D:NM_001318066:exon5:c.T483G:p.P161P,SEC24D:NM_014822:exon5:c.T483G:p.P161P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4624	0.3966	0.436901	0.4121	.	.	.	.	.	.	.	.	SEC24D:uc003ici.4:exon5:c.T483G:p.P161P,SEC24D:uc003icj.4:exon5:c.T483G:p.P161P	.	AFR:0.2911,AMR:0.5372,EAS:0.5509,FIN:0.4851,NFE:0.4376,OTH:0.4764,ASJ:0.5033	607186	616294;	2050;	2050|Bone fragility-craniosynostosis-proptosis-hydrocephalus syndrome|<1 / 1 000 000|Not applicable<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|112240 616294 ~	.	.	.	.	.	.	.	.	4	MU158328	het
4	122739183	122739183	C	G	CCNA2	intronic	.	ENSG00000145386	rs3217772	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3623	0.2780	0.276757	0.2988	.	.	.	.	.	.	.	.	.	.	AFR:0.0769,AMR:0.4545,EAS:0.4112,FIN:0.4229,NFE:0.3729,OTH:0.3765,ASJ:0.32	123835	.	.	.	~ko04110 Cell cycle~ko04152 AMPK signaling pathway~ko04218 Cellular senescence~ko04914 Progesterone-mediated oocyte maturation~ko05161 Hepatitis B~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	4	MU11832855	hom
4	122742217	122742217	T	C	CCNA2	exonic	nonsynonymous SNV	ENSG00000145386	rs769242	ENSG00000145386:ENST00000274026:exon3:c.A487G:p.I163V	CCNA2:NM_001237:exon3:c.A487G:p.I163V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9629	0.9691	0.96865	0.9672	0.665	8.596	1.0	4.14	0.999	.	.	Cyclin-A, N-terminal	CCNA2:uc003iec.4:exon3:c.A487G:p.I163V	-0.995	AFR:0.9913,AMR:0.9760,EAS:0.9382,FIN:0.9453,NFE:0.9605,OTH:0.9664,ASJ:0.9901	123835	.	.	.	~ko04110 Cell cycle~ko04152 AMPK signaling pathway~ko04218 Cellular senescence~ko04914 Progesterone-mediated oocyte maturation~ko05161 Hepatitis B~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	0.0	2.65	0.000	-2.175	4	MU27950768	hom
4	126329789	126329789	T	C	FAT4	exonic	synonymous SNV	ENSG00000196159	rs958415	ENSG00000196159:ENST00000335110:exon4:c.T654C:p.D218D,ENSG00000196159:ENST00000394329:exon4:c.T5760C:p.D1920D	FAT4:NM_001291285:exon4:c.T5760C:p.D1920D,FAT4:NM_001291303:exon4:c.T5760C:p.D1920D,FAT4:NM_024582:exon4:c.T5760C:p.D1920D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9966	0.9905	0.988419	0.9917	.	.	.	.	.	.	.	.	FAT4:uc003ifj.4:exon4:c.T5760C:p.D1920D,FAT4:uc011cgp.2:exon4:c.T654C:p.D218D	.	AFR:0.9728,AMR:0.9952,EAS:1,FIN:1,NFE:0.9991,OTH:0.9959,ASJ:1	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU81789789	hom
4	126369872	126369872	G	C	FAT4	exonic	synonymous SNV	ENSG00000196159	rs988863	ENSG00000196159:ENST00000335110:exon9:c.G2595C:p.V865V,ENSG00000196159:ENST00000394329:exon9:c.G7701C:p.V2567V	FAT4:NM_001291285:exon9:c.G7707C:p.V2569V,FAT4:NM_001291303:exon9:c.G7707C:p.V2569V,FAT4:NM_024582:exon9:c.G7701C:p.V2567V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9978	0.9924	0.990815	0.9932	.	.	.	.	.	.	.	.	FAT4:uc003ifi.1:exon1:c.G135C:p.V45V,FAT4:uc003ifj.4:exon9:c.G7701C:p.V2567V,FAT4:uc011cgp.2:exon9:c.G2595C:p.V865V	.	AFR:0.9763,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:0.9980,ASJ:1	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU81789833	hom
4	126373789	126373789	G	A	FAT4	exonic	nonsynonymous SNV	ENSG00000196159	rs12650153	ENSG00000196159:ENST00000335110:exon9:c.G6512A:p.S2171N,ENSG00000196159:ENST00000394329:exon9:c.G11618A:p.S3873N	FAT4:NM_001291285:exon9:c.G11624A:p.S3875N,FAT4:NM_001291303:exon9:c.G11624A:p.S3875N,FAT4:NM_024582:exon9:c.G11618A:p.S3873N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9978	0.9925	0.991014	0.9931	1.631	14.02	0.671	5.27	0.994	.	.	Cadherin|Cadherin-like;EGF-like calcium-binding domain|EGF-like domain|Growth factor receptor cysteine-rich domain	FAT4:uc003ifi.1:exon1:c.G4052A:p.S1351N,FAT4:uc003ifj.4:exon9:c.G11618A:p.S3873N,FAT4:uc011cgp.2:exon9:c.G6512A:p.S2171N	-0.924	AFR:0.9760,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:0.9980,ASJ:1	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	0.0	-2.26	0.000	-2.215	4	MU81789855	hom
4	126397321	126397321	C	T	FAT4	intronic	.	ENSG00000196159	rs17009761	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3745	0.3960	0.337859	0.3952	.	.	.	.	.	0	0.004	.	.	.	AFR:0.3859,AMR:0.2751,EAS:0.2744,FIN:0.4394,NFE:0.4083,OTH:0.4252,ASJ:0.3907	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU11839003	het
4	126402890	126402890	G	A	FAT4	exonic	synonymous SNV	ENSG00000196159	rs6824160	ENSG00000196159:ENST00000335110:exon13:c.G7536A:p.V2512V,ENSG00000196159:ENST00000394329:exon15:c.G12813A:p.V4271V	FAT4:NM_001291285:exon15:c.G12819A:p.V4273V,FAT4:NM_001291303:exon15:c.G12819A:p.V4273V,FAT4:NM_024582:exon15:c.G12813A:p.V4271V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1354	0.0894	0.134385	0.1052	.	.	.	.	.	.	.	.	FAT4:uc003ifi.1:exon7:c.G5247A:p.V1749V,FAT4:uc011cgp.2:exon13:c.G7536A:p.V2512V,FAT4:uc003ifj.4:exon15:c.G12813A:p.V4271V	.	AFR:0.0263,AMR:0.1158,EAS:0.2618,FIN:0.1274,NFE:0.1276,OTH:0.1303,ASJ:0.0629	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU11839012	het
4	126411594	126411594	G	A	FAT4	exonic	synonymous SNV	ENSG00000196159	rs62312781	ENSG00000196159:ENST00000335110:exon15:c.G8340A:p.E2780E,ENSG00000196159:ENST00000394329:exon17:c.G13617A:p.E4539E	FAT4:NM_001291285:exon17:c.G13620A:p.E4540E,FAT4:NM_001291303:exon17:c.G13623A:p.E4541E,FAT4:NM_024582:exon17:c.G13617A:p.E4539E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1726	0.1924	0.156949	0.1782	.	.	.	.	.	.	.	.	FAT4:uc003ifi.1:exon9:c.G6048A:p.E2016E,FAT4:uc011cgp.2:exon15:c.G8340A:p.E2780E,FAT4:uc003ifj.4:exon17:c.G13617A:p.E4539E	.	AFR:0.2108,AMR:0.2064,EAS:0.0012,FIN:0.1672,NFE:0.1792,OTH:0.1629,ASJ:0.2333	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU113459994	het
4	126412575	126412575	A	G	FAT4	exonic	synonymous SNV	ENSG00000196159	rs1014866	ENSG00000196159:ENST00000335110:exon15:c.A9321G:p.R3107R,ENSG00000196159:ENST00000394329:exon17:c.A14598G:p.R4866R	FAT4:NM_001291285:exon17:c.A14601G:p.R4867R,FAT4:NM_001291303:exon17:c.A14604G:p.R4868R,FAT4:NM_024582:exon17:c.A14598G:p.R4866R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7569	0.7442	0.740615	0.7566	.	.	.	.	.	.	.	.	FAT4:uc003ifi.1:exon9:c.A7029G:p.R2343R,FAT4:uc011cgp.2:exon15:c.A9321G:p.R3107R,FAT4:uc003ifj.4:exon17:c.A14598G:p.R4866R	.	AFR:0.7063,AMR:0.7321,EAS:0.8694,FIN:0.7915,NFE:0.7663,OTH:0.7673,ASJ:0.7567	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU21902856	het
4	143007419	143007419	A	G	INPP4B	intronic	.	ENSG00000109452	rs336324	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7139	0.5949	0.604832	0.6499	.	.	.	.	.	0	0.002	.	.	.	AFR:0.3903,AMR:0.7464,EAS:0.6491,FIN:0.7729,NFE:0.7603,OTH:0.7290,ASJ:0.7086	607494	.	.	.	.	.	.	.	.	.	.	.	4	MU779897	hom
4	143130034	143130034	A	T	INPP4B	intronic	.	ENSG00000109452	rs1907123	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9301	0.9015	0.903355	0.9142	.	.	.	.	.	.	.	.	.	.	AFR:0.8248,AMR:0.9318,EAS:0.9469,FIN:0.9570,NFE:0.9520,OTH:0.9402,ASJ:0.8212	607494	.	.	.	.	.	.	.	.	.	.	.	4	MU27779519	hom
4	143324094	143324094	G	A	INPP4B	exonic	synonymous SNV	ENSG00000109452	rs1982966	ENSG00000109452:ENST00000506297:exon1:c.C69T:p.D23D,ENSG00000109452:ENST00000308502:exon4:c.C369T:p.D123D,ENSG00000109452:ENST00000506217:exon4:c.C369T:p.D123D,ENSG00000109452:ENST00000262992:exon5:c.C369T:p.D123D,ENSG00000109452:ENST00000508116:exon6:c.C369T:p.D123D,ENSG00000109452:ENST00000510812:exon6:c.C369T:p.D123D,ENSG00000109452:ENST00000512630:exon6:c.C369T:p.D123D,ENSG00000109452:ENST00000509777:exon7:c.C369T:p.D123D,ENSG00000109452:ENST00000513000:exon8:c.C369T:p.D123D	INPP4B:NM_001101669:exon7:c.C369T:p.D123D,INPP4B:NM_001331040:exon7:c.C369T:p.D123D,INPP4B:NM_003866:exon8:c.C369T:p.D123D	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.3155	0.2579	0.252596	13(soft_tissue)	.	.	.	.	.	.	.	.	INPP4B:uc003iiw.4:exon7:c.C369T:p.D123D,INPP4B:uc003iix.4:exon8:c.C369T:p.D123D	.	AFR:1(large_intestine),AMR:MU586505,EAS:0.2785,FIN:0.0757,NFE:0.2470,OTH:0.3477,ASJ:LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	607494	.	.	.	.	,6189	.	.	.	.	.	.	4	1(thyroid)	0.2472
4	169428733	169428733	T	C	PALLD	intronic	.	ENSG00000129116	rs1962362	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.402356	0.4093	.	.	.	.	.	.	.	.	.	.	AFR:0.2371,AMR:0.4260,EAS:0.6077,FIN:0.4851,NFE:0.4693,OTH:0.4376,ASJ:0.3344	608092	606856;	1333;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~	.	.	.	.	.	.	.	.	4	MU18750111	het
4	178274565	178274565	A	G	NEIL3	exonic	synonymous SNV	ENSG00000109674	rs2048074	ENSG00000109674:ENST00000264596:exon8:c.A1143G:p.R381R	NEIL3:NM_018248:exon8:c.A1143G:p.R381R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6907	0.7412	0.609026	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	NEIL3:uc003iut.2:exon8:c.A1143G:p.R381R	.	AFR:MU122629,AMR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.6957,FIN:0.7026,NFE:0.7682,OTH:0.3804,ASJ:0.7119	608934	.	.	.	.	.	.	.	.	.	.	.	4	1(breast)	0.7453
4	178274694	178274694	T	G	NEIL3	exonic	synonymous SNV	ENSG00000109674	rs10007075	ENSG00000109674:ENST00000264596:exon8:c.T1272G:p.V424V	NEIL3:NM_018248:exon8:c.T1272G:p.V424V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6661	0.6685	0.542532	MU122640	.	.	.	.	.	.	.	.	NEIL3:uc003iut.2:exon8:c.T1272G:p.V424V	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.6496,EAS:0.6851,FIN:0.77,NFE:0.3833,OTH:0.7401,ASJ:0.4904	608934	.	.	.	.	.	.	.	.	.	.	.	4	1(breast)	0.7430
4	178274750	178274750	C	T	NEIL3	exonic	nonsynonymous SNV	ENSG00000109674	rs13112358	ENSG00000109674:ENST00000264596:exon8:c.C1328T:p.P443L	NEIL3:NM_018248:exon8:c.C1328T:p.P443L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6899	0.7407	0.608826	1(haematopoietic_and_lymphoid_tissue)	-0.693	0.075	0.686	-4.99	0.715	.	.	.	NEIL3:uc003iut.2:exon8:c.C1328T:p.P443L	-1.000	AFR:MU122663,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.6950,FIN:0.7050,NFE:0.7682,OTH:0.3794,ASJ:0.7119	608934	.	.	.	.	.	.	.	0.0	3.84	0.000	0.485	4	1(lung)	0.7447
4	178274835	178274835	A	C	NEIL3	exonic	nonsynonymous SNV	ENSG00000109674	rs13112390	ENSG00000109674:ENST00000264596:exon8:c.A1413C:p.Q471H	NEIL3:NM_018248:exon8:c.A1413C:p.Q471H	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7337	0.7711	0.66254	1(liver)	-0.597	0.127	0.642	-1.15	0.022	.	.	.	NEIL3:uc003iut.2:exon8:c.A1413C:p.Q471H	-1.063	AFR:1(large_intestine),AMR:MU122675,EAS:0.7413,FIN:0.7233,NFE:0.7691,OTH:0.8013,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	608934	.	.	.	.	.	.	.	0.0	3.81	0.000	-2.515	4	1(prostate)	0.4387
4	178281754	178281754	G	A	NEIL3	exonic	nonsynonymous SNV	ENSG00000109674	rs1876268	ENSG00000109674:ENST00000264596:exon9:c.G1558A:p.G520R	NEIL3:NM_018248:exon9:c.G1558A:p.G520R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9539	0.9492	0.931909	0.9510	0.752	9.165	1.0	4.74	0.398	.	.	Zinc finger, GRF-type	NEIL3:uc003iut.2:exon9:c.G1558A:p.G520R	-0.977	AFR:0.9044,AMR:0.9605,EAS:0.9833,FIN:0.9791,NFE:0.9657,OTH:0.9664,ASJ:0.9901	608934	.	.	.	.	.	.	.	0.0	2.24	0.000	-2.8	4	MU81792852	hom
4	185310218	185310218	C	T	IRF2	exonic	synonymous SNV	ENSG00000168310	rs1131553	ENSG00000168310:ENST00000502750:exon4:c.G315A:p.G105G,ENSG00000168310:ENST00000393593:exon9:c.G744A:p.G248G	IRF2:NM_002199:exon9:c.G744A:p.G248G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4220	0.3768	0.423123	0.3864	.	.	.	.	.	.	.	.	IRF2:uc003iwf.4:exon9:c.G744A:p.G248G	.	AFR:0.3492,AMR:0.5312,EAS:0.4330,FIN:0.3788,NFE:0.3945,OTH:0.4158,ASJ:0.4007	147576	.	.	.	.	.	.	.	.	.	.	.	4	MU586547	het
4	185340725	185340725	-	AA	IRF2	intronic	.	ENSG00000168310	rs72397805	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0668	.	.	0.2124	.	.	.	.	.	.	.	.	.	.	AFR:0.1978,AMR:0.1938,EAS:0.0470,FIN:0.0935,NFE:0.2470,OTH:0.2177,ASJ:0.2079	147576	.	.	.	.	.	.	.	.	.	.	.	4	.	unknown
4	185578485	185578485	C	T	PRIMPOL	intronic	.	ENSG00000164306	rs56194967	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1006	0.0869	0.0541134	0.0837	.	.	.	.	.	.	.	.	.	.	AFR:0.0307,AMR:0.1067,EAS:0.0012,FIN:0.1274,NFE:0.1098,OTH:0.0992,ASJ:0.1433	615421	615420;	.	.	.	.	.	.	.	.	.	.	4	.	het
4	185587165	185587165	A	G	PRIMPOL	exonic	nonsynonymous SNV	ENSG00000164306	rs2463447	ENSG00000164306:ENST00000515774:exon5:c.A116G:p.Q39R,ENSG00000164306:ENST00000314970:exon6:c.A503G:p.Q168R,ENSG00000164306:ENST00000503752:exon6:c.A503G:p.Q168R,ENSG00000164306:ENST00000512834:exon6:c.A503G:p.Q168R	PRIMPOL:NM_001300767:exon5:c.A116G:p.Q39R,PRIMPOL:NM_001300768:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345891:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345892:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345893:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345895:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345896:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345899:exon6:c.A503G:p.Q168R,PRIMPOL:NM_152683:exon6:c.A503G:p.Q168R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9873	0.9592	0.966853	0.9642	.	.	.	.	.	.	.	.	CCDC111:uc003iwm.2:exon5:c.A116G:p.Q39R,CCDC111:uc003iwj.2:exon6:c.A503G:p.Q168R,CCDC111:uc003iwk.2:exon6:c.A503G:p.Q168R	.	AFR:0.8792,AMR:0.9893,EAS:1,FIN:0.9977,NFE:0.9981,OTH:0.9919,ASJ:1	615421	615420;	.	.	.	.	.	.	.	.	.	.	4	MU81793151	hom
4	185599489	185599489	G	A	PRIMPOL	exonic	synonymous SNV	ENSG00000164306	rs34985821	ENSG00000164306:ENST00000508001:exon1:c.G59A:p.S20N	PRIMPOL:NM_001345900:exon6:c.G423A:p.Q141Q,PRIMPOL:NM_001345901:exon6:c.G252A:p.Q84Q,PRIMPOL:NM_001300767:exon7:c.G561A:p.Q187Q,PRIMPOL:NM_001345894:exon7:c.G252A:p.Q84Q,PRIMPOL:NM_001345897:exon7:c.G252A:p.Q84Q,PRIMPOL:NM_001345898:exon7:c.G252A:p.Q84Q,PRIMPOL:NM_001300768:exon8:c.G948A:p.Q316Q,PRIMPOL:NM_001345891:exon8:c.G948A:p.Q316Q,PRIMPOL:NM_001345892:exon8:c.G948A:p.Q316Q,PRIMPOL:NM_001345893:exon8:c.G948A:p.Q316Q,PRIMPOL:NM_001345895:exon8:c.G948A:p.Q316Q,PRIMPOL:NM_001345896:exon8:c.G948A:p.Q316Q,PRIMPOL:NM_152683:exon8:c.G948A:p.Q316Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1117	0.1048	0.0613019	0.0979	-0.929	0.022	0.311	-1.91	0.003	.	.	.	CCDC111:uc003iwm.2:exon7:c.G561A:p.Q187Q,CCDC111:uc003iwj.2:exon8:c.G948A:p.Q316Q,CCDC111:uc003iwk.2:exon8:c.G948A:p.Q316Q	-1.005	AFR:0.0386,AMR:0.1332,EAS:0.0006,FIN:0.1412,NFE:0.1284,OTH:0.1135,ASJ:0.1767	615421	615420;	.	.	.	.	.	.	.	.	0.001	.	4	.	het
4	185615764	185615764	C	A	PRIMPOL	exonic	nonsynonymous SNV	ENSG00000164306	rs14969	ENSG00000164306:ENST00000515774:exon13:c.C1127A:p.T376K,ENSG00000164306:ENST00000314970:exon14:c.C1514A:p.T505K,ENSG00000164306:ENST00000503752:exon14:c.C1514A:p.T505K,ENSG00000164306:ENST00000512834:exon14:c.C1511A:p.T504K	PRIMPOL:NM_001345899:exon12:c.C1262A:p.T421K,PRIMPOL:NM_001345900:exon12:c.C989A:p.T330K,PRIMPOL:NM_001345901:exon12:c.C818A:p.T273K,PRIMPOL:NM_001300767:exon13:c.C1127A:p.T376K,PRIMPOL:NM_001345897:exon13:c.C818A:p.T273K,PRIMPOL:NM_001345898:exon13:c.C815A:p.T272K,PRIMPOL:NM_001300768:exon14:c.C1511A:p.T504K,PRIMPOL:NM_001345894:exon14:c.C857A:p.T286K,PRIMPOL:NM_001345895:exon14:c.C1514A:p.T505K,PRIMPOL:NM_001345896:exon14:c.C1511A:p.T504K,PRIMPOL:NM_152683:exon14:c.C1514A:p.T505K,PRIMPOL:NM_001345891:exon15:c.C1553A:p.T518K,PRIMPOL:NM_001345892:exon15:c.C1550A:p.T517K,PRIMPOL:NM_001345893:exon15:c.C1550A:p.T517K	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.1473	0.2020	0.146366	0.1759	-0.914	0.024	0.936	-0.002	0.001	.	.	.	CCDC111:uc003iwn.2:exon10:c.C734A:p.T245K,CCDC111:uc003iwm.2:exon13:c.C1127A:p.T376K,CCDC111:uc003iwj.2:exon14:c.C1511A:p.T504K,CCDC111:uc003iwk.2:exon14:c.C1514A:p.T505K	-0.977	AFR:0.2696,AMR:0.1607,EAS:0.0006,FIN:0.1525,NFE:0.1495,OTH:0.1329,ASJ:0.1921	615421	615420;	.	.	.	.	.	.	0.0	1.63	0.000	-1.39	4	.	unknown
4	185615768	185615768	T	G	PRIMPOL	exonic	synonymous SNV	ENSG00000164306	rs3184982	ENSG00000164306:ENST00000515774:exon13:c.T1131G:p.G377G,ENSG00000164306:ENST00000314970:exon14:c.T1518G:p.G506G,ENSG00000164306:ENST00000503752:exon14:c.T1518G:p.G506G,ENSG00000164306:ENST00000512834:exon14:c.T1515G:p.G505G	PRIMPOL:NM_001345899:exon12:c.T1266G:p.G422G,PRIMPOL:NM_001345900:exon12:c.T993G:p.G331G,PRIMPOL:NM_001345901:exon12:c.T822G:p.G274G,PRIMPOL:NM_001300767:exon13:c.T1131G:p.G377G,PRIMPOL:NM_001345897:exon13:c.T822G:p.G274G,PRIMPOL:NM_001345898:exon13:c.T819G:p.G273G,PRIMPOL:NM_001300768:exon14:c.T1515G:p.G505G,PRIMPOL:NM_001345894:exon14:c.T861G:p.G287G,PRIMPOL:NM_001345895:exon14:c.T1518G:p.G506G,PRIMPOL:NM_001345896:exon14:c.T1515G:p.G505G,PRIMPOL:NM_152683:exon14:c.T1518G:p.G506G,PRIMPOL:NM_001345891:exon15:c.T1557G:p.G519G,PRIMPOL:NM_001345892:exon15:c.T1554G:p.G518G,PRIMPOL:NM_001345893:exon15:c.T1554G:p.G518G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1473	0.2019	0.146366	0.1758	.	.	.	.	.	.	.	.	CCDC111:uc003iwn.2:exon10:c.T738G:p.G246G,CCDC111:uc003iwm.2:exon13:c.T1131G:p.G377G,CCDC111:uc003iwj.2:exon14:c.T1515G:p.G505G,CCDC111:uc003iwk.2:exon14:c.T1518G:p.G506G	.	AFR:0.2696,AMR:0.1607,EAS:0.0006,FIN:0.1525,NFE:0.1492,OTH:0.1329,ASJ:0.1921	615421	615420;	.	.	.	.	.	.	.	.	.	.	4	.	unknown
4	187516880	187516880	A	G	FAT1	exonic	synonymous SNV	ENSG00000083857	rs1298865	ENSG00000083857:ENST00000509927:exon1:c.T75C:p.S25S,ENSG00000083857:ENST00000441802:exon26:c.T13101C:p.S4367S	FAT1:NM_005245:exon26:c.T13101C:p.S4367S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4212	0.4541	0.491813	1(thyroid)	.	.	.	.	.	.	.	.	FAT1:uc003izf.3:exon26:c.T13101C:p.S4367S	.	AFR:MU4567056,AMR:ESAD-UK|2|409|0.00488998,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.6638,FIN:0.5299,NFE:0.4172,OTH:0.6185,ASJ:0.4742	600976	.	.	.	.	,4923	.	.	.	.	.	.	4	1(lung)	0.3804
4	187519206	187519206	C	G	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs1280097	ENSG00000083857:ENST00000441802:exon23:c.G12177C:p.K4059N	FAT1:NM_005245:exon23:c.G12177C:p.K4059N	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.9953	0.9952	0.997404	0.9958	0.199	4.672	1.0	-0.147	0.797	.	.	EGF-like calcium-binding domain|EGF-like domain	FAT1:uc003izf.3:exon23:c.G12177C:p.K4059N	-0.950	AFR:0.9987,AMR:0.9976,EAS:1,FIN:0.9969,NFE:0.9933,OTH:0.9949,ASJ:1	600976	.	.	.	.	,4923	.	.	0.0	-2.25	0.000	-1.635	4	MU81793643	hom
4	187521037	187521037	C	A	FAT1	intronic	.	ENSG00000083857	rs10009030	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3225	0.2838	0.284744	ESAD-UK|2|409|0.00488998,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.2971,AMR:0.2302,EAS:0.3967,FIN:0.4142,NFE:0.2841,OTH:0.3191,ASJ:0.3592	600976	.	.	.	.	.	.	.	.	.	.	.	4	1(upper_aerodigestive_tract)	0.3269
4	187525020	187525020	A	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs2637777	ENSG00000083857:ENST00000441802:exon19:c.T10660G:p.S3554A	FAT1:NM_005245:exon19:c.T10660G:p.S3554A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.4276	0.4716	0.51278	1(breast)	-0.348	0.515	0.43	2.19	0.761	.	.	Cadherin-like	FAT1:uc003izf.3:exon19:c.T10660G:p.S3554A	-1.002	AFR:MU14006115,AMR:ESAD-UK|1|409|0.00244499,PACA-CA|1|268|0.00373134,COCA-CN|4|321|0.0124611,EAS:0.7324,FIN:0.5371,NFE:0.4172,OTH:0.6255,ASJ:0.4939	600976	.	.	.	.	,4923	.	.	0.0	1.2	0.000	0.425	4	1(haematopoietic_and_lymphoid_tissue)	0.3789
4	187531022	187531022	A	G	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs28647489	ENSG00000083857:ENST00000441802:exon15:c.T10001C:p.V3334A	FAT1:NM_005245:exon15:c.T10001C:p.V3334A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.1497	0.1284	0.192492	MU3888713	0.149	4.138	0.732	2.77	0.856	.	.	Cadherin-like	FAT1:uc003izf.3:exon15:c.T10001C:p.V3334A	-0.930	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.1602,EAS:0.1563,FIN:0.1225,NFE:0.4094,OTH:0.1389,ASJ:0.1609	600976	.	.	.	.	,4923	.	.	0.001	4.04	0.000	1.395	4	5(prostate)	0.1387
4	187534363	187534363	G	A	FAT1	exonic	synonymous SNV	ENSG00000083857	rs2249916	ENSG00000083857:ENST00000441802:exon13:c.C9363T:p.N3121N	FAT1:NM_005245:exon13:c.C9363T:p.N3121N	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.5913	0.6222	0.611422	0.6188	.	.	.	.	.	.	.	.	FAT1:uc003izf.3:exon13:c.C9363T:p.N3121N	.	AFR:0.6946,AMR:0.6430,EAS:0.6702,FIN:0.5823,NFE:0.5777,OTH:0.6091,ASJ:0.5861	600976	.	.	.	.	,4923	.	.	.	.	.	.	4	MU14006196	het
4	187538942	187538942	T	G	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs1280098	ENSG00000083857:ENST00000441802:exon10:c.A8798C:p.Q2933P	FAT1:NM_005245:exon10:c.A8798C:p.Q2933P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.5554	0.6234	0.592053	LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BLCA-CN|1|103|0.00970874	-1.112	0.009	1.0	4.04	0.044	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon10:c.A8798C:p.Q2933P	-0.940	AFR:0.5898,AMR:0.7045,EAS:0.5298,FIN:0.6355,NFE:0.5183,OTH:0.5375,ASJ:0.5871	600976	.	.	.	.	,4923	.	.	0.0	0.79	0.000	-2.575	4	1(haematopoietic_and_lymphoid_tissue)	0.5682
4	187542755	187542755	T	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs28489116	ENSG00000083857:ENST00000441802:exon10:c.A4985G:p.N1662S	FAT1:NM_005245:exon10:c.A4985G:p.N1662S	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.1517	0.1314	0.200479	7(prostate)	2.935	22.0	0.335	5.19	0.675	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon10:c.A4985G:p.N1662S	-1.037	AFR:1(large_intestine),AMR:MU159933,EAS:0.1646,FIN:0.1775,NFE:0.1627,OTH:0.1225,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	600976	.	.	.	.	,4923	.	.	0.998	0.17	0.000	2.195	4	1(haematopoietic_and_lymphoid_tissue)	0.4214
4	187557893	187557893	T	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs328418	ENSG00000083857:ENST00000441802:exon5:c.A3818G:p.H1273R	FAT1:NM_005245:exon5:c.A3818G:p.H1273R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.5876	0.6338	0.645767	1(kidney)	-1.030	0.014	1.0	4.99	0.003	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon5:c.A3818G:p.H1273R	-0.954	AFR:MU14006434,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,RECA-EU|1|422|0.00236967,EAS:0.8076,FIN:0.6471,NFE:0.6060,OTH:0.6689,ASJ:0.6358	600976	.	.	.	.	,4923	.	.	0.0	0.84	0.000	-2.11	4	1(urinary_tract)	0.5607
4	187584771	187584771	C	G	FAT1	intronic	.	ENSG00000083857	rs172903	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9673	0.9625	0.983427	0.9714	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.9888,AMR:0.9666,EAS:1,FIN:0.9720,NFE:0.9585,OTH:0.9705,ASJ:0.9702	600976	.	.	.	.	.	.	.	.	.	.	.	4	MU81793736	hom
4	187627792	187627792	T	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs11939575	ENSG00000083857:ENST00000441802:exon2:c.A3190G:p.R1064G	FAT1:NM_005245:exon2:c.A3190G:p.R1064G	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.7609	0.8272	0.745807	LAML-KR|5|205|0.0243902,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	0.930	10.26	1.0	4.6	0.007	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.A3190G:p.R1064G,FAT1:uc010iso.1:exon2:c.A3190G:p.R1064G	-0.947	AFR:0.7963,AMR:0.8886,EAS:0.7517,FIN:0.5136,NFE:0.7496,OTH:0.7913,ASJ:0.6790	600976	.	.	.	.	,4923	.	.	0.0	0.54	0.000	-3.06	4	1(breast)	0.7959
4	187628398	187628398	C	G	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs1877731	ENSG00000083857:ENST00000441802:exon2:c.G2584C:p.V862L	FAT1:NM_005245:exon2:c.G2584C:p.V862L	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.7460	0.7755	0.689097	LAML-KR|5|205|0.0243902,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	-1.358	0.004	1.0	3.06	0.035	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.G2584C:p.V862L,FAT1:uc010iso.1:exon2:c.G2584C:p.V862L	-0.935	AFR:0.7483,AMR:0.7208,EAS:0.7533,FIN:0.5149,NFE:0.7503,OTH:0.7906,ASJ:0.6663	600976	.	.	.	.	,4923	.	.	0.0	0.95	0.000	-0.735	4	5(haematopoietic_and_lymphoid_tissue)	0.7908
4	187629140	187629140	G	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs367863	ENSG00000083857:ENST00000441802:exon2:c.C1842G:p.F614L	FAT1:NM_005245:exon2:c.C1842G:p.F614L	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.7476	0.7801	0.690495	MU11955600	-0.701	0.071	1.0	3.53	0.206	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.C1842G:p.F614L,FAT1:uc010iso.1:exon2:c.C1842G:p.F614L	-0.980	AFR:LAML-KR|5|205|0.0243902,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.7519,EAS:0.6659,FIN:0.7517,NFE:0.5111,OTH:0.7499,ASJ:0.7350	600976	.	.	.	.	,4923	.	.	0.0	1.35	0.000	-1.85	4	3(lung)	0.7907
4	187629497	187629497	G	A	FAT1	exonic	synonymous SNV	ENSG00000083857	rs458021	ENSG00000083857:ENST00000441802:exon2:c.C1485T:p.N495N	FAT1:NM_005245:exon2:c.C1485T:p.N495N	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.5644	0.5618	0.421925	LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	FAT1:uc003izf.3:exon2:c.C1485T:p.N495N,FAT1:uc010iso.1:exon2:c.C1485T:p.N495N	.	AFR:0.5399,AMR:0.3539,EAS:0.5927,FIN:0.2295,NFE:0.6330,OTH:0.6530,ASJ:0.5465	600976	.	.	.	.	,4923	.	.	.	.	.	.	4	1(lung)	0.6196
4	187629538	187629538	C	T	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs3733413	ENSG00000083857:ENST00000441802:exon2:c.G1444A:p.V482I,ENSG00000083857:ENST00000509647:exon2:c.G1444A:p.V482I	FAT1:NM_005245:exon2:c.G1444A:p.V482I	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.4865	0.4607	0.338858	MU21520090	0.580	8.014	0.144	2.77	0.069	.	.	Cadherin-like;Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.G1444A:p.V482I,FAT1:uc010iso.1:exon2:c.G1444A:p.V482I	-0.917	AFR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.4354,EAS:0.4594,FIN:0.5596,NFE:0.1415,OTH:0.4957,ASJ:0.2282	600976	.	.	.	.	,4923	.	.	0.059	0.44	0.000	1.075	4	1(urinary_tract)	0.5652
4	187629770	187629770	A	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs3733414	ENSG00000083857:ENST00000441802:exon2:c.T1212G:p.S404R,ENSG00000083857:ENST00000509647:exon2:c.T1212G:p.S404R	FAT1:NM_005245:exon2:c.T1212G:p.S404R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.5576	0.5432	0.398962	LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	0.506	7.479	0.531	1.45	0.626	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.T1212G:p.S404R,FAT1:uc010iso.1:exon2:c.T1212G:p.S404R	-0.899	AFR:0.5191,AMR:0.2812,EAS:0.6,FIN:0.2302,NFE:0.6335,OTH:0.6523,ASJ:0.5453	600976	.	.	.	.	,4923	.	.	0.134	-1.75	0.000	1.32	4	5(haematopoietic_and_lymphoid_tissue)	0.6186
5	223646	223646	A	T	SDHA	exonic	nonsynonymous SNV	ENSG00000073578	rs34635677	ENSG00000073578:ENST00000264932:exon2:c.A113T:p.D38V,ENSG00000073578:ENST00000504309:exon2:c.A113T:p.D38V,ENSG00000073578:ENST00000510361:exon2:c.A113T:p.D38V,ENSG00000073578:ENST00000509632:exon3:c.A211T:p.M71L	SDHA:NM_001294332:exon2:c.A113T:p.D38V,SDHA:NM_001330758:exon2:c.A113T:p.D38V,SDHA:NM_004168:exon2:c.A113T:p.D38V	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0353	0.0328	0.0185703	.	0.820	9.589	0.614	1.56	0.832	.	.	.	SDHA:uc003jao.4:exon2:c.A113T:p.D38V,SDHA:uc011clv.1:exon2:c.A113T:p.D38V,SDHA:uc011clw.2:exon2:c.A113T:p.D38V	-1.079	AFR:0.0291,AMR:0.0080,EAS:0.0364,FIN:0,NFE:0.0260,OTH:0.0444,ASJ:0.0227	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	0.001	-0.6	0.039	0.46	5	2(ovary)	0.0448
5	224633	224633	A	G	SDHA	exonic	synonymous SNV	ENSG00000073578	rs1139424	ENSG00000073578:ENST00000264932:exon3:c.A309G:p.A103A,ENSG00000073578:ENST00000504309:exon3:c.A309G:p.A103A,ENSG00000073578:ENST00000510361:exon3:c.A309G:p.A103A	SDHA:NM_001294332:exon3:c.A309G:p.A103A,SDHA:NM_001330758:exon3:c.A309G:p.A103A,SDHA:NM_004168:exon3:c.A309G:p.A103A	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1529	0.2578	0.240016	MU158205	.	.	.	.	.	.	.	.	SDHA:uc003jao.4:exon3:c.A309G:p.A103A,SDHA:uc011clv.1:exon3:c.A309G:p.A103A,SDHA:uc011clw.2:exon3:c.A309G:p.A103A	.	AFR:ESAD-UK|2|409|0.00488998,AMR:0.2257,EAS:0.1885,FIN:0.1589,NFE:0.0501,OTH:0.0816,ASJ:0.5261	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	6(soft_tissue)	0.1134
5	226160	226160	A	C	SDHA	exonic	synonymous SNV	ENSG00000073578	rs6555055	ENSG00000073578:ENST00000510361:exon4:c.A475C:p.R159R,ENSG00000073578:ENST00000264932:exon5:c.A619C:p.R207R,ENSG00000073578:ENST00000504309:exon5:c.A619C:p.R207R	SDHA:NM_001294332:exon4:c.A475C:p.R159R,SDHA:NM_001330758:exon5:c.A619C:p.R207R,SDHA:NM_004168:exon5:c.A619C:p.R207R	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1568	0.2710	0.247404	ESAD-UK|1|409|0.00244499	.	.	.	.	.	0.0001	0	.	SDHA:uc011clw.2:exon4:c.A475C:p.R159R,SDHA:uc003jao.4:exon5:c.A619C:p.R207R,SDHA:uc011clv.1:exon5:c.A619C:p.R207R	.	AFR:0.2255,AMR:0.5258,EAS:0.1589,FIN:0.05,NFE:0.0816,OTH:0.1135,ASJ:0.1885	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	1(haematopoietic_and_lymphoid_tissue)	0.1327
5	228362	228362	T	C	SDHA	exonic	synonymous SNV	ENSG00000073578	rs2115272	ENSG00000073578:ENST00000510361:exon5:c.T540C:p.N180N,ENSG00000073578:ENST00000264932:exon6:c.T684C:p.N228N,ENSG00000073578:ENST00000504309:exon6:c.T684C:p.N228N	SDHA:NM_001294332:exon5:c.T540C:p.N180N,SDHA:NM_001330758:exon6:c.T684C:p.N228N,SDHA:NM_004168:exon6:c.T684C:p.N228N	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1565	0.2716	0.247404	.	.	.	.	.	.	.	.	.	SDHA:uc003jaq.4:exon1:c.T9C:p.N3N,SDHA:uc021xvu.1:exon1:c.T9C:p.N3N,SDHA:uc011clw.2:exon5:c.T540C:p.N180N,SDHA:uc003jao.4:exon6:c.T684C:p.N228N,SDHA:uc011clv.1:exon6:c.T684C:p.N228N	.	AFR:.,AMR:0.2259,EAS:0.1885,FIN:0.1589,NFE:0.05,OTH:0.0816,ASJ:0.5255	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	6(soft_tissue)	0.1140
5	230980	230980	A	G	SDHA	intronic	.	ENSG00000073578	rs2288461	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8810	0.9126	0.858427	0.9009	.	.	.	.	.	0	0	.	.	.	AFR:0.9713,AMR:0.8923,EAS:0.6590,FIN:0.9201,NFE:0.8853,OTH:0.8867,ASJ:0.7848	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	MU16880685	hom
5	231111	231111	T	C	SDHA	exonic	synonymous SNV	ENSG00000073578	rs1126417	ENSG00000073578:ENST00000510361:exon6:c.T747C:p.P249P,ENSG00000073578:ENST00000264932:exon7:c.T891C:p.P297P,ENSG00000073578:ENST00000504309:exon7:c.T891C:p.P297P	SDHA:NM_001294332:exon6:c.T747C:p.P249P,SDHA:NM_001330758:exon7:c.T891C:p.P297P,SDHA:NM_004168:exon7:c.T891C:p.P297P	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7078	0.7687	0.653355	MU4562957	.	.	.	.	.	.	.	.	SDHA:uc003jaq.4:exon2:c.T216C:p.P72P,SDHA:uc021xvu.1:exon2:c.T216C:p.P72P,SDHA:uc011clw.2:exon6:c.T747C:p.P249P,SDHA:uc003jao.4:exon7:c.T891C:p.P297P,SDHA:uc011clv.1:exon7:c.T891C:p.P297P	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.7402,EAS:0.6516,FIN:0.7067,NFE:0.3323,OTH:0.7666,ASJ:0.7825	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	1(thyroid)	0.7589
5	233572	233572	A	G	SDHA	intronic	.	ENSG00000073578	rs7710005	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1566	0.2709	0.247204	0.2255	.	.	.	.	.	.	.	.	.	.	AFR:0.5241,AMR:0.1885,EAS:0.05,FIN:0.0819,NFE:0.1138,OTH:0.1324,ASJ:0.1589	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	MU117586435	het
5	233734	233734	C	G	SDHA	exonic	synonymous SNV	ENSG00000073578	rs1041949	ENSG00000073578:ENST00000510361:exon7:c.C894G:p.S298S,ENSG00000073578:ENST00000264932:exon8:c.C1038G:p.S346S,ENSG00000073578:ENST00000504309:exon8:c.C1038G:p.S346S	SDHA:NM_001294332:exon7:c.C894G:p.S298S,SDHA:NM_001330758:exon8:c.C1038G:p.S346S,SDHA:NM_004168:exon8:c.C1038G:p.S346S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1597	0.2824	0.257788	MU158216	.	.	.	.	.	.	.	.	SDHA:uc003jaq.4:exon3:c.C363G:p.S121S,SDHA:uc021xvu.1:exon3:c.C363G:p.S121S,SDHA:uc011clw.2:exon7:c.C894G:p.S298S,SDHA:uc003jao.4:exon8:c.C1038G:p.S346S,SDHA:uc011clv.1:exon8:c.C1038G:p.S346S	.	AFR:ESAD-UK|1|409|0.00244499,AMR:0.2339,EAS:0.1897,FIN:0.17,NFE:0.0506,OTH:0.0816,ASJ:0.5549	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	1(haematopoietic_and_lymphoid_tissue)	0.1132
5	251469	251469	G	A	SDHA	exonic	synonymous SNV	ENSG00000073578	rs1139449	ENSG00000073578:ENST00000509564:exon1:c.G18A:p.T6T,ENSG00000073578:ENST00000510361:exon12:c.G1536A:p.T512T,ENSG00000073578:ENST00000264932:exon13:c.G1680A:p.T560T	SDHA:NM_001294332:exon12:c.G1536A:p.T512T,SDHA:NM_004168:exon13:c.G1680A:p.T560T	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1527	.	0.248403	MU46396662	.	.	.	.	.	.	.	.	SDHA:uc003jaq.4:exon8:c.G1005A:p.T335T,SDHA:uc011clw.2:exon12:c.G1536A:p.T512T,SDHA:uc003jao.4:exon13:c.G1680A:p.T560T,SDHA:uc011clv.1:exon13:c.G1680A:p.T560T	.	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|1|321|0.00311526,AMR:0.2252,EAS:0.1854,FIN:0.1589,NFE:0.0501,OTH:0.0816,ASJ:0.5265	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	1(upper_aerodigestive_tract)	0.1131
5	251541	251541	A	G	SDHA	exonic	synonymous SNV	ENSG00000073578	rs13070	ENSG00000073578:ENST00000509564:exon1:c.A90G:p.A30A,ENSG00000073578:ENST00000510361:exon12:c.A1608G:p.A536A,ENSG00000073578:ENST00000264932:exon13:c.A1752G:p.A584A	SDHA:NM_001294332:exon12:c.A1608G:p.A536A,SDHA:NM_004168:exon13:c.A1752G:p.A584A	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1559	0.2696	0.248403	MU117616463	.	.	.	.	.	.	.	.	SDHA:uc003jaq.4:exon8:c.A1077G:p.A359A,SDHA:uc011clw.2:exon12:c.A1608G:p.A536A,SDHA:uc003jao.4:exon13:c.A1752G:p.A584A,SDHA:uc011clv.1:exon13:c.A1752G:p.A584A	.	AFR:ESAD-UK|1|409|0.00244499,AMR:0.2261,EAS:0.1902,FIN:0.16,NFE:0.0501,OTH:0.0816,ASJ:0.5269	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	6(soft_tissue)	0.1137
5	254599	254599	A	T	SDHA	exonic	nonsynonymous SNV	ENSG00000073578	rs6960	ENSG00000073578:ENST00000509564:exon2:c.A259T:p.M87L,ENSG00000073578:ENST00000504309:exon12:c.A1643T:p.Y548F,ENSG00000073578:ENST00000510361:exon13:c.A1742T:p.Y581F,ENSG00000073578:ENST00000264932:exon14:c.A1886T:p.Y629F	SDHA:NM_001330758:exon12:c.A1643T:p.Y548F,SDHA:NM_001294332:exon13:c.A1742T:p.Y581F,SDHA:NM_004168:exon14:c.A1886T:p.Y629F	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.1515	0.0927	.	1(adrenal_gland)	0.503	7.453	0.444	2.85	0.006	.	.	Fumarate reductase/succinate dehydrogenase flavoprotein-like, C-terminal	SDHA:uc021xvu.1:exon7:c.A968T:p.Y323F,SDHA:uc003jaq.4:exon9:c.A1211T:p.Y404F,SDHA:uc011clw.2:exon13:c.A1742T:p.Y581F,SDHA:uc003jao.4:exon14:c.A1886T:p.Y629F	-1.068	AFR:MU113467702,AMR:LUSC-KR|1|170|0.00588235,EAS:0.5146,FIN:0.1878,NFE:0.16,OTH:0.0491,ASJ:0.2188	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	0.005	-1.36	0.001	1.355	5	5(soft_tissue)	0.0809
5	254706	254706	G	A	SDHA	intronic	.	ENSG00000073578	rs6864807	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	.	0.2188	.	.	.	.	.	.	.	.	.	.	AFR:0.5318,AMR:0.1880,EAS:0.0455,FIN:0.0804,NFE:0.1072,OTH:0.1276,ASJ:0.1473	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	.	unknown
5	254711	254711	A	G	SDHA	intronic	.	ENSG00000073578	rs6888536	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	.	0.2201	.	.	.	.	.	.	.	.	.	.	AFR:0.5343,AMR:0.1892,EAS:0.0472,FIN:0.0802,NFE:0.1078,OTH:0.1281,ASJ:0.1497	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	MU30243764	unknown
5	254861	254861	C	G	SDHA	intronic	.	ENSG00000073578	rs2241600	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.652756	0.7383	.	.	.	.	.	.	.	.	.	.	AFR:0.7851,AMR:0.6516,EAS:0.3348,FIN:0.7478,NFE:0.7577,OTH:0.7418,ASJ:0.6987	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	MU1256647	hom
5	254996	254996	T	C	SDHA	intronic	.	ENSG00000073578	rs10078265	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.2498	0.2272	.	.	.	.	.	.	.	.	.	.	AFR:0.5308,AMR:0.1918,EAS:0.0508,FIN:0.0817,NFE:0.1138,OTH:0.1340,ASJ:0.1589	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	MU117575018	het
5	256472	256472	G	A	SDHA	exonic	synonymous SNV	ENSG00000073578	rs6961	ENSG00000073578:ENST00000509564:exon3:c.G305A:p.X102X,ENSG00000073578:ENST00000504309:exon13:c.G1689A:p.V563V,ENSG00000073578:ENST00000510361:exon14:c.G1788A:p.V596V,ENSG00000073578:ENST00000264932:exon15:c.G1932A:p.V644V	SDHA:NM_001330758:exon13:c.G1689A:p.V563V,SDHA:NM_001294332:exon14:c.G1788A:p.V596V,SDHA:NM_004168:exon15:c.G1932A:p.V644V	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1716	0.2783	0.335264	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	SDHA:uc021xvu.1:exon8:c.G1014A:p.V338V,SDHA:uc003jaq.4:exon10:c.G1257A:p.V419V,SDHA:uc011clw.2:exon14:c.G1788A:p.V596V,SDHA:uc003jao.4:exon15:c.G1932A:p.V644V	.	AFR:MU29931335,AMR:ESAD-UK|1|409|0.00244499,PACA-CA|1|268|0.00373134,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,EAS:0.5394,FIN:0.2049,NFE:0.1727,OTH:0.0572,ASJ:0.2417	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	1(thyroid)	0.0907
5	256509	256509	G	A	SDHA	exonic	nonsynonymous SNV	ENSG00000073578	rs6962	ENSG00000073578:ENST00000504309:exon13:c.G1726A:p.V576I,ENSG00000073578:ENST00000510361:exon14:c.G1825A:p.V609I,ENSG00000073578:ENST00000264932:exon15:c.G1969A:p.V657I	SDHA:NM_001330758:exon13:c.G1726A:p.V576I,SDHA:NM_001294332:exon14:c.G1825A:p.V609I,SDHA:NM_004168:exon15:c.G1969A:p.V657I	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.1298	0.1964	0.175319	1(adrenal_gland)	0.913	10.15	0.328	4.12	0.257	.	.	Fumarate reductase/succinate dehydrogenase flavoprotein-like, C-terminal	SDHA:uc021xvu.1:exon8:c.G1051A:p.V351I,SDHA:uc003jaq.4:exon10:c.G1294A:p.V432I,SDHA:uc011clw.2:exon14:c.G1825A:p.V609I,SDHA:uc003jao.4:exon15:c.G1969A:p.V657I	-1.065	AFR:.,AMR:.,EAS:0.3120,FIN:0.1615,NFE:0.1556,OTH:0.0489,ASJ:0.1616	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	0.391	-1.32	0.000	1.13	5	6(soft_tissue)	0.0810
5	263513	263513	T	C	SDHA;HRAT5	intergenic	.	ENSG00000073578;ENSG00000248925	rs7714335	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.224641	0.2069	.	.	.	.	.	.	.	.	.	.	AFR:0.4577,AMR:0.1862,EAS:0.0507,FIN:0.0814,NFE:0.1144,OTH:0.1309,ASJ:0.1623	.	.	.	.	.	.	.	.	.	.	.	.	5	MU117484125	het
5	1294086	1294086	C	T	TERT	exonic	synonymous SNV	ENSG00000164362	rs2736098	ENSG00000164362:ENST00000296820:exon2:c.G915A:p.A305A,ENSG00000164362:ENST00000310581:exon2:c.G915A:p.A305A,ENSG00000164362:ENST00000334602:exon2:c.G915A:p.A305A,ENSG00000164362:ENST00000460137:exon2:c.G915A:p.A305A,ENSG00000164362:ENST00000508104:exon2:c.G915A:p.A305A	TERT:NM_001193376:exon2:c.G915A:p.A305A,TERT:NM_198253:exon2:c.G915A:p.A305A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4045	0.2075	0.265575	1(stomach)	.	.	.	.	.	.	.	.	TERT:uc003jca.1:exon2:c.G915A:p.A305A,TERT:uc003jcb.1:exon2:c.G915A:p.A305A,TERT:uc003jcc.1:exon2:c.G915A:p.A305A	.	AFR:5(meninges),AMR:MU88724,EAS:0.2150,FIN:0.1015,NFE:0.2243,OTH:0.2450,ASJ:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	187270	601626;613989;614742;615134;	618;88;1775;3322;519;	618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~1775|DC<br>DKC<br>Zinsser-Engman-Cole syndrome|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|127550 224230 305000 613987 613988 613989 613990 615190 616353 ~3322|Progressive pancytopenia-immunodeficiency-cerebellar hypoplasia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|305000 613989 613990 615190 616353 616553 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	5	1(breast)	0.3790
5	1295349	1295349	A	G	TERT	upstream	.	ENSG00000164362	rs2853669	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	.	.	0.297923	0.2395	.	.	.	.	.	.	.	.	.	.	AFR:0.1181,AMR:0.2482,EAS:0.3893,FIN:0.2318,NFE:0.2906,OTH:0.2887,ASJ:0.3212	187270	601626;613989;614742;615134;	618;88;1775;3322;519;	618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~1775|DC<br>DKC<br>Zinsser-Engman-Cole syndrome|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|127550 224230 305000 613987 613988 613989 613990 615190 616353 ~3322|Progressive pancytopenia-immunodeficiency-cerebellar hypoplasia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|305000 613989 613990 615190 616353 616553 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	5	.	het
5	6600150	6600150	G	A	NSUN2	exonic	synonymous SNV	ENSG00000037474	rs3822434	ENSG00000037474:ENST00000506139:exon18:c.C2088T:p.D696D,ENSG00000037474:ENST00000539938:exon18:c.C1485T:p.D495D,ENSG00000037474:ENST00000264670:exon19:c.C2193T:p.D731D	NSUN2:NM_001193455:exon18:c.C2088T:p.D696D,NSUN2:NM_017755:exon19:c.C2193T:p.D731D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1743	0.1299	0.173522	MU122540	.	.	.	.	.	.	.	.	NSUN2:uc003jdt.3:exon13:c.C1485T:p.D495D,NSUN2:uc003jdv.3:exon18:c.C1485T:p.D495D,NSUN2:uc011cmk.2:exon18:c.C2088T:p.D696D,NSUN2:uc003jdu.3:exon19:c.C2193T:p.D731D	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.1567,EAS:0.2208,FIN:0.1093,NFE:0.2189,OTH:0.2471,ASJ:0.0906	610916	611091;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	.	.	.	.	5	2(large_intestine)	0.1621
5	6605532	6605532	C	A	NSUN2	intronic	.	ENSG00000037474	rs2303707	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6609	.	0.675319	0.6733	.	.	.	.	.	0	0	.	.	.	AFR:0.7452,AMR:0.6205,EAS:0.6636,FIN:0.5731,NFE:0.6623,OTH:0.6120,ASJ:0.6987	610916	611091;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	.	.	.	.	5	MU16722209	het
5	10250443	10250443	T	C	CCT5	UTR5	.	ENSG00000150753	rs2578618	ENSG00000150753:ENST00000511700:exon1:c.T89C:p.V30A	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7892	0.7181	0.685304	0.7414	.	.	.	.	.	.	.	.	.	.	AFR:0.4588,AMR:0.7983,EAS:0.8346,FIN:0.8600,NFE:0.8573,OTH:0.8173,ASJ:0.8609	610150	256840;	139578;	139578|HSAN with spastic paraplegia|<1 / 1 000 000|Autosomal recessive|Childhood|256840 ~	.	.	.	.	.	.	.	.	5	MU81795367	het
5	10254817	10254817	A	G	CCT5	exonic	synonymous SNV	ENSG00000150753	rs2578617	ENSG00000150753:ENST00000280326:exon3:c.A198G:p.G66G,ENSG00000150753:ENST00000503026:exon3:c.A135G:p.G45G,ENSG00000150753:ENST00000515676:exon3:c.A84G:p.G28G	CCT5:NM_001306153:exon3:c.A135G:p.G45G,CCT5:NM_001306156:exon3:c.A84G:p.G28G,CCT5:NM_012073:exon3:c.A198G:p.G66G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7895	0.7187	0.685903	0.7418	.	.	.	.	.	.	.	.	CCT5:uc003jeq.3:exon3:c.A198G:p.G66G,CCT5:uc011cms.2:exon3:c.A84G:p.G28G	.	AFR:0.4596,AMR:0.7962,EAS:0.8331,FIN:0.8603,NFE:0.8578,OTH:0.8166,ASJ:0.8576	610150	256840;	139578;	139578|HSAN with spastic paraplegia|<1 / 1 000 000|Autosomal recessive|Childhood|256840 ~	.	.	.	.	.	.	.	.	5	MU81795384	het
5	10256161	10256161	T	C	CCT5	exonic	synonymous SNV	ENSG00000150753	rs1042392	ENSG00000150753:ENST00000506600:exon3:c.T147C:p.R49R,ENSG00000150753:ENST00000515390:exon3:c.T261C:p.R87R,ENSG00000150753:ENST00000280326:exon4:c.T426C:p.R142R,ENSG00000150753:ENST00000503026:exon4:c.T363C:p.R121R,ENSG00000150753:ENST00000515676:exon4:c.T312C:p.R104R	CCT5:NM_001306154:exon3:c.T261C:p.R87R,CCT5:NM_001306155:exon3:c.T147C:p.R49R,CCT5:NM_001306153:exon4:c.T363C:p.R121R,CCT5:NM_001306156:exon4:c.T312C:p.R104R,CCT5:NM_012073:exon4:c.T426C:p.R142R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7948	0.7274	0.692492	0.7493	.	.	.	.	.	.	.	.	CCT5:uc011cmr.2:exon3:c.T261C:p.R87R,CCT5:uc011cmt.2:exon3:c.T147C:p.R49R,CCT5:uc003jeq.3:exon4:c.T426C:p.R142R,CCT5:uc011cms.2:exon4:c.T312C:p.R104R	.	AFR:0.4732,AMR:0.7983,EAS:0.8465,FIN:0.8612,NFE:0.8637,OTH:0.8177,ASJ:0.8576	610150	256840;	139578;	139578|HSAN with spastic paraplegia|<1 / 1 000 000|Autosomal recessive|Childhood|256840 ~	.	.	.	.	.	.	.	.	5	MU44187827	het
5	10262740	10262740	C	A	CCT5	intronic	.	ENSG00000150753	rs2578642	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7894	0.7187	0.685903	0.7416	.	.	.	.	.	.	.	.	.	.	AFR:0.4589,AMR:0.7971,EAS:0.8337,FIN:0.8603,NFE:0.8580,OTH:0.8153,ASJ:0.8576	610150	256840;	139578;	139578|HSAN with spastic paraplegia|<1 / 1 000 000|Autosomal recessive|Childhood|256840 ~	.	.	.	.	.	.	.	.	5	MU81795401	het
5	14184079	14184079	G	A	TRIO	intronic	.	ENSG00000038382	rs354300	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8173	.	0.8127	0.8239	.	.	.	.	.	.	.	.	.	.	AFR:0.6845,AMR:0.7278,EAS:0.9926,FIN:0.9139,NFE:0.8693,OTH:0.8517,ASJ:0.8179	601893	617061;	.	.	.	.	.	.	.	.	.	.	5	MU81795659	hom
5	35857177	35857177	G	C	IL7R	intronic	.	ENSG00000168685	rs1353252	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6395	0.7428	0.647364	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:MU586611,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,EAS:0.8686,FIN:0.5442,NFE:0.6567,OTH:0.4019,ASJ:0.7189	146661	608971;	169154;169157;169160;	169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05340 Primary immunodeficiency ~	.	.	.	.	.	.	.	5	2(lung)	0.7384
5	35861068	35861068	T	C	IL7R	exonic	nonsynonymous SNV	ENSG00000168685	rs1494558	ENSG00000168685:ENST00000303115:exon2:c.T197C:p.I66T,ENSG00000168685:ENST00000343305:exon2:c.T197C:p.I66T,ENSG00000168685:ENST00000506850:exon2:c.T197C:p.I66T,ENSG00000168685:ENST00000511982:exon2:c.T197C:p.I66T,ENSG00000168685:ENST00000514217:exon2:c.T197C:p.I66T	IL7R:NM_002185:exon2:c.T197C:p.I66T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.6279	0.7009	0.59984	3(urinary_tract)	-0.950	0.020	0.881	2.16	0.292	.	.	.	IL7R:uc003jjs.4:exon2:c.T197C:p.I66T,IL7R:uc011coo.3:exon2:c.T197C:p.I66T	-0.953	AFR:2(stomach),AMR:2(large_intestine),EAS:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,FIN:0.6843,NFE:0.7474,OTH:0.5358,ASJ:MU586612	146661	608971;	169154;169157;169160;	169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05340 Primary immunodeficiency ~	,6187	.	.	0.0	-0.76	0.000	.	5	18(soft_tissue)	0.6556
5	35871190	35871190	G	A	IL7R	exonic	nonsynonymous SNV	ENSG00000168685	rs1494555	ENSG00000168685:ENST00000303115:exon4:c.G412A:p.V138I,ENSG00000168685:ENST00000343305:exon4:c.G412A:p.V138I,ENSG00000168685:ENST00000506850:exon4:c.G412A:p.V138I,ENSG00000168685:ENST00000514217:exon4:c.G412A:p.V138I	IL7R:NM_002185:exon4:c.G412A:p.V138I	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.6519	0.7458	0.666933	18(soft_tissue)	-0.630	0.106	0.664	-1.61	0.008	.	.	Fibronectin type III|Immunoglobulin-like fold	IL7R:uc003jjs.4:exon4:c.G412A:p.V138I,IL7R:uc011coo.3:exon4:c.G412A:p.V138I	-0.974	AFR:2(stomach),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:MU586614,FIN:MELA-AU|1|183|0.00546448,ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611,NFE:0.7252,OTH:0.8671,ASJ:1(skin)	146661	608971;	169154;169157;169160;	169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05340 Primary immunodeficiency ~	,6187	.	.	0.0	-1.12	0.000	.	5	2(large_intestine)	0.5530
5	35871273	35871273	C	T	IL7R	exonic	synonymous SNV	ENSG00000168685	rs2228141	ENSG00000168685:ENST00000303115:exon4:c.C495T:p.H165H,ENSG00000168685:ENST00000343305:exon4:c.C495T:p.H165H,ENSG00000168685:ENST00000506850:exon4:c.C495T:p.H165H,ENSG00000168685:ENST00000514217:exon4:c.C495T:p.H165H	IL7R:NM_002185:exon4:c.C495T:p.H165H	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1268	0.1351	0.128594	MU108834	.	.	.	.	.	.	.	.	IL7R:uc003jjs.4:exon4:c.C495T:p.H165H,IL7R:uc011coo.3:exon4:c.C495T:p.H165H	.	AFR:ESAD-UK|2|409|0.00488998,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.1268,EAS:0.1531,FIN:0.1490,NFE:0.1518,OTH:0.1143,ASJ:0.1249	146661	608971;	169154;169157;169160;	169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05340 Primary immunodeficiency ~	,6187	.	.	.	.	.	.	5	1(haematopoietic_and_lymphoid_tissue)	0.1270
5	35874575	35874575	C	T	IL7R	exonic	nonsynonymous SNV	ENSG00000168685	rs6897932	ENSG00000168685:ENST00000303115:exon6:c.C731T:p.T244I	IL7R:NM_002185:exon6:c.C731T:p.T244I	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.2327	0.2141	0.172524	2(haematopoietic_and_lymphoid_tissue)	-0.235	0.925	0.522	-2.49	0.543	.	.	.	IL7R:uc003jjs.4:exon6:c.C731T:p.T244I	-0.806	AFR:4(large_intestine),AMR:1(pancreas),EAS:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,FIN:0.2188,NFE:0.0963,OTH:0.1802,ASJ:MU98017	146661	608971;	169154;169157;169160;	169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05340 Primary immunodeficiency ~	,6187	.	.	0.0	-3.91	0.000	0.46	5	1(lung)	0.2781
5	38528952	38528953	AC	-	LIFR	intronic	.	ENSG00000113594	rs34759137	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0] 	0.3454	.	.	0.3139	.	.	.	.	.	.	.	.	.	.	AFR:0.1280,AMR:0.2796,EAS:0.2913,FIN:0.3561,NFE:0.4149,OTH:0.3691,ASJ:0.5404	151443	601559;	3206;	3206|Neonatal Schwartz-Jampel syndrome<br>SJS2<br>Schwartz-Jampel syndrome type 2<br>Stve-Wiedemann dysplasia<br>Stve-Wiedemann/Schwartz-Jampel type 2 syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|601559 ~	.	.	.	.	.	.	.	.	5	.	hom
5	38942449	38942449	G	A	RICTOR	exonic	nonsynonymous SNV	ENSG00000164327	rs61748204	ENSG00000164327:ENST00000357387:exon38:c.C5084T:p.T1695I,ENSG00000164327:ENST00000296782:exon39:c.C5156T:p.T1719I	RICTOR:NM_001285440:exon38:c.C4115T:p.T1372I,RICTOR:NM_152756:exon38:c.C5084T:p.T1695I,RICTOR:NM_001285439:exon39:c.C5156T:p.T1719I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0292	0.0270	0.0351438	0.0224	-0.019	2.411	0.734	-3.13	0.985	.	.	.	RICTOR:uc003jlp.2:exon38:c.C5084T:p.T1695I,RICTOR:uc010ivf.2:exon38:c.C4115T:p.T1372I,RICTOR:uc003jlo.2:exon39:c.C5156T:p.T1719I	-1.065	AFR:0.0345,AMR:0.0299,EAS:0.0074,FIN:0.0086,NFE:0.0198,OTH:0.0235,ASJ:0.0166	609022	.	.	.	.	.	.	.	0.0	0.94	0.015	0.55	5	.	het
5	38950776	38950776	G	A	RICTOR	exonic	synonymous SNV	ENSG00000164327	rs2115949	ENSG00000164327:ENST00000296782:exon31:c.C3174T:p.S1058S,ENSG00000164327:ENST00000357387:exon31:c.C3174T:p.S1058S	RICTOR:NM_001285439:exon31:c.C3174T:p.S1058S,RICTOR:NM_001285440:exon31:c.C2319T:p.S773S,RICTOR:NM_152756:exon31:c.C3174T:p.S1058S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9658	0.9521	0.949481	0.9624	.	.	.	.	.	.	.	.	RICTOR:uc003jlo.2:exon31:c.C3174T:p.S1058S,RICTOR:uc003jlp.2:exon31:c.C3174T:p.S1058S,RICTOR:uc010ivf.2:exon31:c.C2319T:p.S773S	.	AFR:0.9120,AMR:0.9665,EAS:0.9926,FIN:0.9914,NFE:0.9802,OTH:0.9755,ASJ:0.9834	609022	.	.	.	.	.	.	.	.	.	.	.	5	MU81796672	het
5	38953665	38953665	-	A	RICTOR	intronic	.	ENSG00000164327	rs33912683	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9376	0.8929	0.934105	0.9387	.	.	.	.	.	.	.	.	.	.	AFR:0.8858,AMR:0.9494,EAS:0.9913,FIN:0.9582,NFE:0.9581,OTH:0.9537,ASJ:0.9733	609022	.	.	.	.	.	.	.	.	.	.	.	5	.	het
5	38958750	38958750	A	G	RICTOR	intronic	.	ENSG00000164327	rs6868087	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4063	0.3804	0.382987	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.3617,AMR:0.3386,EAS:0.3133,FIN:0.3488,NFE:0.3637,OTH:0.3701,ASJ:0.4867	609022	.	.	.	.	.	.	.	.	.	.	.	5	14(soft_tissue)	0.3609
5	55243420	55243420	-	A	IL6ST	intronic	.	ENSG00000134352	rs71602925	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0136	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600694	.	.	.	~ko04060 Cytokine-cytokine receptor interaction~ko04061 Viral protein interaction with cytokine and cytokine~~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	5	.	het
5	55248135	55248135	C	T	IL6ST	exonic	nonsynonymous SNV	ENSG00000134352	rs34417936	ENSG00000134352:ENST00000381294:exon9:c.G1312A:p.V438I,ENSG00000134352:ENST00000336909:exon10:c.G1495A:p.V499I,ENSG00000134352:ENST00000502326:exon11:c.G1495A:p.V499I,ENSG00000134352:ENST00000381298:exon12:c.G1495A:p.V499I	IL6ST:NM_001364279:exon10:c.G499A:p.V167I,IL6ST:NM_001190981:exon11:c.G1312A:p.V438I,IL6ST:NM_001364278:exon11:c.G592A:p.V198I,IL6ST:NM_001364276:exon12:c.G1285A:p.V429I,IL6ST:NM_001364277:exon12:c.G628A:p.V210I,IL6ST:NM_002184:exon12:c.G1495A:p.V499I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0193	0.0218	0.0107827	0.0154	2.982	22.2	0.551	5.93	0.901	.	.	Fibronectin type III|Immunoglobulin-like fold;Fibronectin type III|Immunoglobulin-like fold|Long hematopoietin receptor, Gp130 family 2, conserved site	IL6ST:uc010iwb.3:exon11:c.G1312A:p.V438I,IL6ST:uc003jqq.3:exon12:c.G1495A:p.V499I,IL6ST:uc011cqk.2:exon12:c.G628A:p.V210I	-1.077	AFR:0.0054,AMR:0.0167,EAS:0,FIN:0.0118,NFE:0.0231,OTH:0.0173,ASJ:0.0364	600694	.	.	.	~ko04060 Cytokine-cytokine receptor interaction~ko04061 Viral protein interaction with cytokine and cytokine~~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis ~	.	.	.	0.0	0.53	0.028	1.94	5	.	het
5	56111751	56111751	G	C	MAP3K1	exonic	synonymous SNV	ENSG00000095015	rs28710284	ENSG00000095015:ENST00000399503:exon1:c.G351C:p.A117A	MAP3K1:NM_005921:exon1:c.G351C:p.A117A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7955	.	0.685703	COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	MAP3K1:uc003jqw.4:exon1:c.G351C:p.A117A	.	AFR:0.7508,AMR:0.6573,EAS:0.8404,FIN:0.5916,NFE:0.8094,OTH:0.8129,ASJ:0.6225	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	1(thyroid)	0.7950
5	56152416	56152416	C	A	MAP3K1	intronic	.	ENSG00000237705	rs832567	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6132	0.6989	0.526158	0.6521	.	.	.	.	.	0.0006	0.018	.	.	.	AFR:0.6500,AMR:0.4618,EAS:0.2040,FIN:0.7156,NFE:0.6929,OTH:0.6793,ASJ:0.7748	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	MU767397	het
5	56161787	56161787	G	A	MAP3K1	exonic	synonymous SNV	ENSG00000095015	rs832575	ENSG00000095015:ENST00000399503:exon6:c.G1284A:p.T428T	MAP3K1:NM_005921:exon6:c.G1284A:p.T428T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8479	0.8530	0.804313	0.8481	.	.	.	.	.	.	.	.	MAP3K1:uc003jqw.4:exon6:c.G1284A:p.T428T	.	AFR:0.7975,AMR:0.7005,EAS:0.7163,FIN:0.9001,NFE:0.8844,OTH:0.8890,ASJ:0.8907	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	MU18483702	hom
5	56177443	56177443	G	A	MAP3K1	exonic	nonsynonymous SNV	ENSG00000095015	rs702689	ENSG00000095015:ENST00000399503:exon14:c.G2416A:p.D806N	MAP3K1:NM_005921:exon14:c.G2416A:p.D806N	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.5984	0.6501	0.476438	MU12351955	2.329	18.36	0.195	5.56	1.000	.	.	.	MAP3K1:uc003jqw.4:exon14:c.G2416A:p.D806N	-0.975	AFR:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579,AMR:0.6061,EAS:0.4555,FIN:0.7748,NFE:0.2011,OTH:0.7146,ASJ:0.4892	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	0.999	0.82	0.000	2.085	5	76(lung)	0.6930
5	56177743	56177743	G	A	MAP3K1	exonic	nonsynonymous SNV	ENSG00000095015	rs832582	ENSG00000095015:ENST00000399503:exon14:c.G2716A:p.V906I	MAP3K1:NM_005921:exon14:c.G2716A:p.V906I	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7648	0.7985	0.708267	75(lung)	-2.273	0.001	0.847	3.58	0.036	.	.	.	MAP3K1:uc003jqw.4:exon14:c.G2716A:p.V906I	-1.009	AFR:MU12351967,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02,EAS:0.7459,FIN:0.6089,NFE:0.8477,OTH:0.5902,ASJ:0.7760	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	0.0	1.56	0.000	0.11	5	1(large_intestine)	0.8130
5	56177849	56177851	CAA	-	MAP3K1	exonic	nonframeshift deletion	ENSG00000095015	rs10552703	ENSG00000095015:ENST00000399503:exon14:c.2822_2824del:p.941_942del	MAP3K1:NM_005921:exon14:c.2822_2824del:p.941_942del	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.7393	.	.	0.7706	.	.	.	.	.	.	.	.	MAP3K1:uc003jqw.4:exon14:c.2822_2824del:p.941_942del	.	AFR:0.7403,AMR:0.5958,EAS:0.5813,FIN:0.8033,NFE:0.8077,OTH:0.7961,ASJ:0.8425	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	.	hom
5	56178217	56178217	A	C	MAP3K1	exonic	synonymous SNV	ENSG00000095015	rs832583	ENSG00000095015:ENST00000399503:exon14:c.A3190C:p.R1064R	MAP3K1:NM_005921:exon14:c.A3190C:p.R1064R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7653	0.7995	0.708267	1(thyroid)	.	.	.	.	.	.	.	.	MAP3K1:uc003jqw.4:exon14:c.A3190C:p.R1064R	.	AFR:2(breast),AMR:MU4558542,EAS:0.7764,FIN:0.7465,NFE:0.6089,OTH:0.8477,ASJ:LICA-CN|2|402|0.00497512,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	1(haematopoietic_and_lymphoid_tissue)	0.5897
5	56179341	56179341	G	A	MAP3K1	intronic	.	ENSG00000095015	rs16886463	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1462	0.0768	0.163538	2(breast)	.	.	.	.	.	.	.	.	.	.	AFR:MU12351990,AMR:LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.0213,FIN:0.1451,NFE:0.07,OTH:0.3877,ASJ:0.1027	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	5(soft_tissue)	0.0979
5	56180480	56180480	A	G	MAP3K1	intronic	.	ENSG00000095015	rs3736430	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1552	0.0995	0.182708	1(breast)	.	.	.	.	.	0	0	.	.	.	AFR:1(liver),AMR:1(biliary_tract),EAS:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,FIN:0.1246,NFE:0.0962,OTH:0.1587,ASJ:MU678558	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	5(soft_tissue)	0.0728
5	57754004	57754004	C	T	PLK2	intronic	.	ENSG00000145632	rs697135	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4229	0.5076	0.422324	0.5019	.	.	.	.	.	0.0001	0.162	.	.	.	AFR:0.6283,AMR:0.4317,EAS:0.2460,FIN:0.4819,NFE:0.4702,OTH:0.4561,ASJ:0.3691	607023	.	.	.	.	.	.	.	.	.	.	.	5	MU27120297	het
5	67522722	67522722	C	T	PIK3R1	exonic	synonymous SNV	ENSG00000145675	rs706713	ENSG00000145675:ENST00000274335:exon1:c.C219T:p.Y73Y,ENSG00000145675:ENST00000396611:exon1:c.C219T:p.Y73Y,ENSG00000145675:ENST00000521381:exon2:c.C219T:p.Y73Y,ENSG00000145675:ENST00000521657:exon2:c.C219T:p.Y73Y	PIK3R1:NM_181523:exon2:c.C219T:p.Y73Y	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3129	0.2933	0.419329	1(liver)	.	.	.	.	.	.	.	.	PIK3R1:uc003jva.3:exon2:c.C219T:p.Y73Y	.	AFR:MU10857398,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.4091,FIN:0.3690,NFE:0.2351,OTH:0.6857,ASJ:0.3176	171833	269880;615214;616005;	397596;229717;33110;3163;	397596|APDS<br>Senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adult|615513 616005 ~229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~3163|Aarskog-Ose-Pande syndrome<br>Lipodystrophy-Rieger anomaly-diabetes syndrome<br>Rieger anomaly-partial lipodystrophy syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|269880 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	,9068,9069,9067	.	.	.	.	.	.	5	1(breast)	0.2703
5	67522851	67522851	A	C	PIK3R1	intronic	.	ENSG00000145675	rs706714	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3317	0.2939	0.42492	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.3193,AMR:0.3820,EAS:0.2450,FIN:0.7184,NFE:0.2758,OTH:0.2513,ASJ:0.3711	171833	269880;615214;616005;	397596;229717;33110;3163;	397596|APDS<br>Senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adult|615513 616005 ~229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~3163|Aarskog-Ose-Pande syndrome<br>Lipodystrophy-Rieger anomaly-diabetes syndrome<br>Rieger anomaly-partial lipodystrophy syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|269880 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	5	1(liver)	0.2781
5	67575498	67575498	C	T	PIK3R1	exonic	synonymous SNV	ENSG00000145675	rs533077843	ENSG00000145675:ENST00000274335:exon4:c.C571T:p.L191L,ENSG00000145675:ENST00000396611:exon4:c.C571T:p.L191L,ENSG00000145675:ENST00000520675:exon4:c.C277T:p.L93L,ENSG00000145675:ENST00000521381:exon5:c.C571T:p.L191L,ENSG00000145675:ENST00000521657:exon5:c.C571T:p.L191L	PIK3R1:NM_181523:exon5:c.C571T:p.L191L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 1, -1, 1, 0, 1, 1] 	0.0012	.	0.00179712	3.229e-05	.	.	.	.	.	.	.	.	PIK3R1:uc003jva.3:exon5:c.C571T:p.L191L	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	171833	269880;615214;616005;	397596;229717;33110;3163;	397596|APDS<br>Senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adult|615513 616005 ~229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~3163|Aarskog-Ose-Pande syndrome<br>Lipodystrophy-Rieger anomaly-diabetes syndrome<br>Rieger anomaly-partial lipodystrophy syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|269880 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	,9068,9069,9067	.	.	.	.	.	.	5	.	het
5	67576748	67576748	C	T	PIK3R1	intronic	.	ENSG00000145675	rs571365105	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, 0, 1, 0] 	0.0013	.	0.00179712	3.229e-05	.	.	.	.	.	0	0	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	171833	269880;615214;616005;	397596;229717;33110;3163;	397596|APDS<br>Senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adult|615513 616005 ~229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~3163|Aarskog-Ose-Pande syndrome<br>Lipodystrophy-Rieger anomaly-diabetes syndrome<br>Rieger anomaly-partial lipodystrophy syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|269880 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	5	.	het
5	68531253	68531253	C	T	CDK7	exonic	nonsynonymous SNV	ENSG00000134058	rs2972388	ENSG00000134058:ENST00000256443:exon2:c.C99T:p.N33N,ENSG00000134058:ENST00000504147:exon2:c.C99T:p.N33N,ENSG00000134058:ENST00000506789:exon2:c.C99T:p.N33N,ENSG00000134058:ENST00000508726:exon2:c.C99T:p.N33N,ENSG00000134058:ENST00000510106:exon2:c.C99T:p.N33N,ENSG00000134058:ENST00000514676:exon2:c.C99T:p.N33N,ENSG00000134058:ENST00000515180:exon2:c.C99T:p.N33N,ENSG00000134058:ENST00000515391:exon2:c.C99T:p.N33N	CDK7:NM_001324071:exon2:c.C65T:p.T22I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5842	0.5963	0.629792	0.5993	.	.	.	.	.	.	.	.	CDK7:uc003jvs.4:exon2:c.C99T:p.N33N,CDK7:uc010ixd.1:exon2:c.C99T:p.N33N,CDK7:uc021xzo.1:exon2:c.C99T:p.N33N	.	AFR:0.7158,AMR:0.6295,EAS:0.4963,FIN:0.5807,NFE:0.5476,OTH:0.5840,ASJ:0.5298	601955	.	.	.	.	.	.	.	.	.	.	.	5	MU18490713	hom
5	68692375	68692375	-	A	RAD17	splicing	.	ENSG00000152942	rs34097088	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4291	.	.	0.7119	.	.	.	.	.	.	.	.	.	.	AFR:0.8725,AMR:0.6617,EAS:0.5665,FIN:0.5864,NFE:0.6473,OTH:0.6717,ASJ:0.7159	603139	.	.	.	.	.	.	.	.	.	.	.	5	.	hom
5	68695940	68695940	T	G	RAD17	exonic	nonsynonymous SNV	ENSG00000152942	rs1045051	ENSG00000152942:ENST00000513214:exon5:c.T494G:p.L165R,ENSG00000152942:ENST00000282891:exon14:c.T1379G:p.L460R,ENSG00000152942:ENST00000358030:exon14:c.T1142G:p.L381R,ENSG00000152942:ENST00000380774:exon14:c.T1670G:p.L557R,ENSG00000152942:ENST00000305138:exon15:c.T1637G:p.L546R,ENSG00000152942:ENST00000345306:exon15:c.T1637G:p.L546R,ENSG00000152942:ENST00000521422:exon15:c.T1142G:p.L381R,ENSG00000152942:ENST00000354312:exon16:c.T1637G:p.L546R,ENSG00000152942:ENST00000361732:exon16:c.T1637G:p.L546R,ENSG00000152942:ENST00000509734:exon16:c.T1670G:p.L557R,ENSG00000152942:ENST00000354868:exon17:c.T1637G:p.L546R	RAD17:NM_133339:exon14:c.T1670G:p.L557R,RAD17:NM_133340:exon14:c.T1142G:p.L381R,RAD17:NM_133341:exon14:c.T1379G:p.L460R,RAD17:NM_002873:exon15:c.T1637G:p.L546R,RAD17:NM_133344:exon15:c.T1637G:p.L546R,RAD17:NM_001278622:exon16:c.T1637G:p.L546R,RAD17:NM_133342:exon16:c.T1637G:p.L546R,RAD17:NM_133343:exon16:c.T1637G:p.L546R,RAD17:NM_133338:exon17:c.T1637G:p.L546R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.2992	0.2412	0.254792	MU134717	6.449	29.8	0.0	5.73	0.997	.	.	.	RAD17:uc003jwm.3:exon14:c.T1142G:p.L381R,RAD17:uc003jwn.3:exon14:c.T1379G:p.L460R,RAD17:uc003jwo.3:exon14:c.T1670G:p.L557R,RAD17:uc003jwj.3:exon15:c.T1637G:p.L546R,RAD17:uc003jwl.3:exon15:c.T1637G:p.L546R,RAD17:uc003jwg.3:exon16:c.T1637G:p.L546R,RAD17:uc003jwh.3:exon16:c.T1637G:p.L546R,RAD17:uc003jwk.3:exon16:c.T1637G:p.L546R,RAD17:uc003jwi.3:exon17:c.T1637G:p.L546R	-1.039	AFR:ESAD-UK|2|409|0.00488998,COCA-CN|4|321|0.0124611,AML-US|1|166|0.0060241,AMR:0.2485,EAS:0.2386,FIN:0.2919,NFE:0.3064,OTH:0.3063,ASJ:0.0798	603139	.	.	.	.	.	.	.	1.0	1.79	0.000	2.56	5	1(liver)	0.3247
5	79950781	79950781	A	G	MSH3	exonic	nonsynonymous SNV	ENSG00000113318	rs1650697	ENSG00000113318:ENST00000265081:exon1:c.A235G:p.I79V	MSH3:NM_002439:exon1:c.A235G:p.I79V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.9029	.	0.76857	MU4555167	-2.211	0.001	1.0	-4.46	0.000	0.0025	0.082	.	MSH3:uc003kgz.4:exon1:c.A235G:p.I79V,DHFR:uc011ctl.2:exon1:c.T2C:p.M1T	-1.021	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.7888,EAS:0.7488,FIN:0.7417,NFE:0.6673,OTH:0.7326,ASJ:0.9090	600887	608089;617100;	.	.	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	,7597	.	.	0.0	-2.04	0.000	-1.1	5	1(thyroid)	0.7527
5	80149981	80149981	A	G	MSH3	exonic	nonsynonymous SNV	ENSG00000113318	rs184967	ENSG00000113318:ENST00000265081:exon21:c.A2846G:p.Q949R	MSH3:NM_002439:exon21:c.A2846G:p.Q949R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.8731	0.8552	0.902157	MU4549212	0.224	4.933	1.0	0.287	0.991	.	.	DNA mismatch repair protein MutS, C-terminal|P-loop containing nucleoside triphosphate hydrolase	MSH3:uc003kgz.4:exon21:c.A2846G:p.Q949R	-0.948	AFR:LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,AMR:0.8711,EAS:0.9189,FIN:0.8067,NFE:1,OTH:0.8713,ASJ:0.8881	600887	608089;617100;	.	.	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	,7597	.	.	0.0	-1.93	0.000	-0.32	5	42(large_intestine)	0.8461
5	80168937	80168937	G	A	MSH3	exonic	nonsynonymous SNV	ENSG00000113318	rs26279	ENSG00000113318:ENST00000265081:exon23:c.G3133A:p.A1045T	MSH3:NM_002439:exon23:c.G3133A:p.A1045T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.7305	0.6947	0.720248	LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	0.480	7.280	0.551	-2.54	0.009	.	.	DNA mismatch repair protein MutS, C-terminal|P-loop containing nucleoside triphosphate hydrolase	MSH3:uc003kgz.4:exon23:c.G3133A:p.A1045T	-0.949	AFR:0.7083,AMR:0.6658,EAS:0.6987,FIN:0.7423,NFE:0.7239,OTH:0.7223,ASJ:0.7524	600887	608089;617100;	.	.	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	,7597	.	.	0.075	-2.14	0.000	-0.245	5	1(haematopoietic_and_lymphoid_tissue)	0.7249
5	98193867	98193867	G	T	CHD1	intronic	.	ENSG00000153922	rs77597932	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0735	0.0606	0.0700879	0.0554	.	.	.	.	.	.	.	.	.	.	AFR:0.0400,AMR:0.0694,EAS:0.0760,FIN:0.0421,NFE:0.0653,OTH:0.0449,ASJ:0.0430	602118	.	.	.	.	.	.	.	.	.	.	.	5	MU11025025	het
5	98224802	98224802	T	C	CHD1	exonic	nonsynonymous SNV	ENSG00000153922	rs144567251	ENSG00000153922:ENST00000284049:exon15:c.A2321G:p.Y774C	CHD1:NM_001270:exon15:c.A2321G:p.Y774C,CHD1:NM_001364113:exon16:c.A2321G:p.Y774C	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 1] 	8.334e-06	.	.	.	3.877	23.5	0.183	5.82	1.000	.	.	P-loop containing nucleoside triphosphate hydrolase	CHD1:uc003knf.3:exon15:c.A2321G:p.Y774C	-0.245	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602118	.	.	.	.	,2048	.	.	0.887	-0.92	0.425	1.445	5	.	het
5	112162854	112162854	T	C	APC	exonic	synonymous SNV	ENSG00000134982	rs2229992	ENSG00000134982:ENST00000504915:exon3:c.T147C:p.Y49Y,ENSG00000134982:ENST00000507379:exon10:c.T1404C:p.Y468Y,ENSG00000134982:ENST00000257430:exon12:c.T1458C:p.Y486Y,ENSG00000134982:ENST00000457016:exon12:c.T1458C:p.Y486Y,ENSG00000134982:ENST00000512211:exon12:c.T1458C:p.Y486Y,ENSG00000134982:ENST00000508376:exon13:c.T1458C:p.Y486Y	APC:NM_001127511:exon10:c.T1404C:p.Y468Y,APC:NM_001354897:exon11:c.T1488C:p.Y496Y,APC:NM_001354899:exon11:c.T1374C:p.Y458Y,APC:NM_001354901:exon11:c.T1281C:p.Y427Y,APC:NM_001354902:exon11:c.T1185C:p.Y395Y,APC:NM_001354905:exon11:c.T978C:p.Y326Y,APC:NM_000038:exon12:c.T1458C:p.Y486Y,APC:NM_001354895:exon12:c.T1458C:p.Y486Y,APC:NM_001354898:exon12:c.T1383C:p.Y461Y,APC:NM_001354900:exon12:c.T1335C:p.Y445Y,APC:NM_001354903:exon12:c.T1155C:p.Y385Y,APC:NM_001354904:exon12:c.T1080C:p.Y360Y,APC:NM_001127510:exon13:c.T1458C:p.Y486Y,APC:NM_001354896:exon13:c.T1512C:p.Y504Y,APC:NM_001354906:exon13:c.T609C:p.Y203Y	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5780	0.4622	0.509984	0.4692	.	.	.	.	.	.	.	.	APC:uc011cvt.2:exon10:c.T1404C:p.Y468Y,APC:uc003kpy.4:exon12:c.T1458C:p.Y486Y,APC:uc003kpz.4:exon13:c.T1458C:p.Y486Y,APC:uc010jbz.3:exon13:c.T609C:p.Y203Y	.	AFR:0.2085,AMR:0.6579,EAS:0.6538,FIN:0.5003,NFE:0.5762,OTH:0.5430,ASJ:0.5894	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,740,743,742,739,738,737,745	.	,741	.	.	.	.	5	MU151723	hom
5	112164561	112164561	G	A	APC	exonic	synonymous SNV	ENSG00000134982;ENSG00000258864	rs351771	ENSG00000134982:ENST00000504915:exon5:c.G324A:p.A108A,ENSG00000134982:ENST00000507379:exon12:c.G1581A:p.A527A,ENSG00000134982:ENST00000257430:exon14:c.G1635A:p.A545A,ENSG00000134982:ENST00000457016:exon14:c.G1635A:p.A545A,ENSG00000134982:ENST00000512211:exon14:c.G1635A:p.A545A,ENSG00000134982:ENST00000508376:exon15:c.G1635A:p.A545A	APC:NM_001127511:exon12:c.G1581A:p.A527A,APC:NM_001354897:exon13:c.G1665A:p.A555A,APC:NM_001354899:exon13:c.G1551A:p.A517A,APC:NM_001354901:exon13:c.G1458A:p.A486A,APC:NM_001354902:exon13:c.G1362A:p.A454A,APC:NM_001354905:exon13:c.G1155A:p.A385A,APC:NM_000038:exon14:c.G1635A:p.A545A,APC:NM_001354895:exon14:c.G1635A:p.A545A,APC:NM_001354898:exon14:c.G1560A:p.A520A,APC:NM_001354900:exon14:c.G1512A:p.A504A,APC:NM_001354903:exon14:c.G1332A:p.A444A,APC:NM_001354904:exon14:c.G1257A:p.A419A,APC:NM_001127510:exon15:c.G1635A:p.A545A,APC:NM_001354896:exon15:c.G1689A:p.A563A,APC:NM_001354906:exon15:c.G786A:p.A262A	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6481	0.5864	0.666134	0.5927	.	.	.	.	.	.	.	.	APC:uc011cvt.2:exon12:c.G1581A:p.A527A,APC:uc003kpy.4:exon14:c.G1635A:p.A545A,APC:uc003kpz.4:exon15:c.G1635A:p.A545A,APC:uc010jbz.3:exon15:c.G786A:p.A262A	.	AFR:0.5342,AMR:0.6926,EAS:0.8064,FIN:0.5564,NFE:0.6048,OTH:0.6212,ASJ:0.5894	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,740,743,742,739,738,737,745	.	,741	.	.	.	.	5	MU151734	hom
5	112175770	112175770	G	A	APC	exonic	synonymous SNV	ENSG00000134982	rs41115	ENSG00000134982:ENST00000257430:exon16:c.G4479A:p.T1493T,ENSG00000134982:ENST00000457016:exon16:c.G4479A:p.T1493T,ENSG00000134982:ENST00000508376:exon17:c.G4479A:p.T1493T	APC:NM_001127511:exon14:c.G4425A:p.T1475T,APC:NM_001354897:exon15:c.G4509A:p.T1503T,APC:NM_001354899:exon15:c.G4395A:p.T1465T,APC:NM_001354901:exon15:c.G4302A:p.T1434T,APC:NM_001354902:exon15:c.G4206A:p.T1402T,APC:NM_001354905:exon15:c.G3999A:p.T1333T,APC:NM_000038:exon16:c.G4479A:p.T1493T,APC:NM_001354895:exon16:c.G4479A:p.T1493T,APC:NM_001354898:exon16:c.G4404A:p.T1468T,APC:NM_001354900:exon16:c.G4356A:p.T1452T,APC:NM_001354903:exon16:c.G4176A:p.T1392T,APC:NM_001354904:exon16:c.G4101A:p.T1367T,APC:NM_001127510:exon17:c.G4479A:p.T1493T,APC:NM_001354896:exon17:c.G4533A:p.T1511T,APC:NM_001354906:exon17:c.G3630A:p.T1210T	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6486	0.5862	0.665535	0.5933	.	.	.	.	.	.	.	.	APC:uc010jca.3:exon3:c.G2379A:p.T793T,APC:uc011cvt.2:exon14:c.G4425A:p.T1475T,APC:uc003kpy.4:exon16:c.G4479A:p.T1493T,APC:uc003kpz.4:exon17:c.G4479A:p.T1493T,APC:uc010jbz.3:exon17:c.G3630A:p.T1210T	.	AFR:0.5356,AMR:0.6918,EAS:0.8082,FIN:0.5563,NFE:0.6050,OTH:0.6209,ASJ:0.5927	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,740,743,742,739,738,737,745	.	,741	.	.	.	.	5	MU62815	hom
5	112176325	112176325	G	A	APC	exonic	synonymous SNV	ENSG00000134982	rs42427	ENSG00000134982:ENST00000257430:exon16:c.G5034A:p.G1678G,ENSG00000134982:ENST00000457016:exon16:c.G5034A:p.G1678G,ENSG00000134982:ENST00000508376:exon17:c.G5034A:p.G1678G	APC:NM_001127511:exon14:c.G4980A:p.G1660G,APC:NM_001354897:exon15:c.G5064A:p.G1688G,APC:NM_001354899:exon15:c.G4950A:p.G1650G,APC:NM_001354901:exon15:c.G4857A:p.G1619G,APC:NM_001354902:exon15:c.G4761A:p.G1587G,APC:NM_001354905:exon15:c.G4554A:p.G1518G,APC:NM_000038:exon16:c.G5034A:p.G1678G,APC:NM_001354895:exon16:c.G5034A:p.G1678G,APC:NM_001354898:exon16:c.G4959A:p.G1653G,APC:NM_001354900:exon16:c.G4911A:p.G1637G,APC:NM_001354903:exon16:c.G4731A:p.G1577G,APC:NM_001354904:exon16:c.G4656A:p.G1552G,APC:NM_001127510:exon17:c.G5034A:p.G1678G,APC:NM_001354896:exon17:c.G5088A:p.G1696G,APC:NM_001354906:exon17:c.G4185A:p.G1395G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6514	0.5901	0.666733	0.5956	.	.	.	.	.	.	.	.	APC:uc010jca.3:exon3:c.G2934A:p.G978G,APC:uc011cvt.2:exon14:c.G4980A:p.G1660G,APC:uc003kpy.4:exon16:c.G5034A:p.G1678G,APC:uc003kpz.4:exon17:c.G5034A:p.G1678G,APC:uc010jbz.3:exon17:c.G4185A:p.G1395G	.	AFR:0.5373,AMR:0.6950,EAS:0.8068,FIN:0.5573,NFE:0.6082,OTH:0.6255,ASJ:0.5927	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,740,743,742,739,738,737,745	.	,741	.	.	.	.	5	MU62789	hom
5	112176559	112176559	T	G	APC	exonic	synonymous SNV	ENSG00000134982	rs866006	ENSG00000134982:ENST00000257430:exon16:c.T5268G:p.S1756S,ENSG00000134982:ENST00000457016:exon16:c.T5268G:p.S1756S,ENSG00000134982:ENST00000508376:exon17:c.T5268G:p.S1756S	APC:NM_001127511:exon14:c.T5214G:p.S1738S,APC:NM_001354897:exon15:c.T5298G:p.S1766S,APC:NM_001354899:exon15:c.T5184G:p.S1728S,APC:NM_001354901:exon15:c.T5091G:p.S1697S,APC:NM_001354902:exon15:c.T4995G:p.S1665S,APC:NM_001354905:exon15:c.T4788G:p.S1596S,APC:NM_000038:exon16:c.T5268G:p.S1756S,APC:NM_001354895:exon16:c.T5268G:p.S1756S,APC:NM_001354898:exon16:c.T5193G:p.S1731S,APC:NM_001354900:exon16:c.T5145G:p.S1715S,APC:NM_001354903:exon16:c.T4965G:p.S1655S,APC:NM_001354904:exon16:c.T4890G:p.S1630S,APC:NM_001127510:exon17:c.T5268G:p.S1756S,APC:NM_001354896:exon17:c.T5322G:p.S1774S,APC:NM_001354906:exon17:c.T4419G:p.S1473S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6508	0.5880	0.666933	0.5942	.	.	.	.	.	.	.	.	APC:uc010jca.3:exon3:c.T3168G:p.S1056S,APC:uc011cvt.2:exon14:c.T5214G:p.S1738S,APC:uc003kpy.4:exon16:c.T5268G:p.S1756S,APC:uc003kpz.4:exon17:c.T5268G:p.S1756S,APC:uc010jbz.3:exon17:c.T4419G:p.S1473S	.	AFR:0.5361,AMR:0.6933,EAS:0.8055,FIN:0.5574,NFE:0.6065,OTH:0.6214,ASJ:0.5993	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,740,743,742,739,738,737,745	.	,741	.	.	.	.	5	MU18515471	hom
5	112176756	112176756	T	A	APC	exonic	nonsynonymous SNV	ENSG00000134982	rs459552	ENSG00000134982:ENST00000257430:exon16:c.T5465A:p.V1822D,ENSG00000134982:ENST00000457016:exon16:c.T5465A:p.V1822D,ENSG00000134982:ENST00000508376:exon17:c.T5465A:p.V1822D	APC:NM_001127511:exon14:c.T5411A:p.V1804D,APC:NM_001354897:exon15:c.T5495A:p.V1832D,APC:NM_001354899:exon15:c.T5381A:p.V1794D,APC:NM_001354901:exon15:c.T5288A:p.V1763D,APC:NM_001354902:exon15:c.T5192A:p.V1731D,APC:NM_001354905:exon15:c.T4985A:p.V1662D,APC:NM_000038:exon16:c.T5465A:p.V1822D,APC:NM_001354895:exon16:c.T5465A:p.V1822D,APC:NM_001354898:exon16:c.T5390A:p.V1797D,APC:NM_001354900:exon16:c.T5342A:p.V1781D,APC:NM_001354903:exon16:c.T5162A:p.V1721D,APC:NM_001354904:exon16:c.T5087A:p.V1696D,APC:NM_001127510:exon17:c.T5465A:p.V1822D,APC:NM_001354896:exon17:c.T5519A:p.V1840D,APC:NM_001354906:exon17:c.T4616A:p.V1539D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.7981	0.8263	0.865415	0.8113	1.486	13.24	0.672	3.59	0.991	.	.	.	APC:uc010jca.3:exon3:c.T3365A:p.V1122D,APC:uc011cvt.2:exon14:c.T5411A:p.V1804D,APC:uc003kpy.4:exon16:c.T5465A:p.V1822D,APC:uc003kpz.4:exon17:c.T5465A:p.V1822D,APC:uc010jbz.3:exon17:c.T4616A:p.V1539D	-0.947	AFR:0.9616,AMR:0.8062,EAS:0.8937,FIN:0.6910,NFE:0.7465,OTH:0.7719,ASJ:0.7767	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,740,743,698,742,739,738,737,745	.	,741	0.0	-2.3	0.000	-0.895	5	MU151742	hom
5	112177171	112177171	G	A	APC	exonic	synonymous SNV	ENSG00000134982	rs465899	ENSG00000134982:ENST00000257430:exon16:c.G5880A:p.P1960P,ENSG00000134982:ENST00000457016:exon16:c.G5880A:p.P1960P,ENSG00000134982:ENST00000508376:exon17:c.G5880A:p.P1960P	APC:NM_001127511:exon14:c.G5826A:p.P1942P,APC:NM_001354897:exon15:c.G5910A:p.P1970P,APC:NM_001354899:exon15:c.G5796A:p.P1932P,APC:NM_001354901:exon15:c.G5703A:p.P1901P,APC:NM_001354902:exon15:c.G5607A:p.P1869P,APC:NM_001354905:exon15:c.G5400A:p.P1800P,APC:NM_000038:exon16:c.G5880A:p.P1960P,APC:NM_001354895:exon16:c.G5880A:p.P1960P,APC:NM_001354898:exon16:c.G5805A:p.P1935P,APC:NM_001354900:exon16:c.G5757A:p.P1919P,APC:NM_001354903:exon16:c.G5577A:p.P1859P,APC:NM_001354904:exon16:c.G5502A:p.P1834P,APC:NM_001127510:exon17:c.G5880A:p.P1960P,APC:NM_001354896:exon17:c.G5934A:p.P1978P,APC:NM_001354906:exon17:c.G5031A:p.P1677P	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6488	0.5869	0.666534	0.5952	.	.	.	.	.	.	.	.	APC:uc010jca.3:exon3:c.G3780A:p.P1260P,APC:uc011cvt.2:exon14:c.G5826A:p.P1942P,APC:uc003kpy.4:exon16:c.G5880A:p.P1960P,APC:uc003kpz.4:exon17:c.G5880A:p.P1960P,APC:uc010jbz.3:exon17:c.G5031A:p.P1677P	.	AFR:0.5409,AMR:0.6938,EAS:0.8097,FIN:0.5564,NFE:0.6055,OTH:0.6224,ASJ:0.5927	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,740,743,742,739,738,737,745	.	,741	.	.	.	.	5	MU62778	hom
5	121780245	121780245	C	G	MGC32805	ncRNA_intronic	.	ENSG00000250328	rs777790846	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	1.647e-05	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	.	.	.	.	.	.	.	.	.	.	.	.	5	.	het
5	127614472	127614472	A	G	FBN2	exonic	synonymous SNV	ENSG00000138829	rs190450	ENSG00000138829:ENST00000262464:exon57:c.T7200C:p.S2400S,ENSG00000138829:ENST00000508053:exon63:c.T7200C:p.S2400S	FBN2:NM_001999:exon57:c.T7200C:p.S2400S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7281	0.6779	0.726637	0.7155	.	.	.	.	.	.	.	.	FBN2:uc003kuu.3:exon57:c.T7200C:p.S2400S	.	AFR:0.6347,AMR:0.6766,EAS:0.8793,FIN:0.7811,NFE:0.7281,OTH:0.7694,ASJ:0.7119	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	.	.	.	.	5	MU801110	hom
5	127622983	127622983	C	T	FBN2	intronic	.	ENSG00000138829	rs2042327	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5184	0.4436	0.357628	0.4745	.	.	.	.	.	.	.	.	.	.	AFR:0.1661,AMR:0.5453,EAS:0.1747,FIN:0.6929,NFE:0.6211,OTH:0.6061,ASJ:0.5430	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	.	.	.	.	5	MU798954	hom
5	127640783	127640783	G	A	FBN2	intronic	.	ENSG00000138829	rs27713	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7258	.	0.734425	0.6851	.	.	.	.	.	0	0.034	.	.	.	AFR:0.5368,AMR:0.6599,EAS:0.8618,FIN:0.7728,NFE:0.7275,OTH:0.7669,ASJ:0.7	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	.	.	.	.	5	MU681300	hom
5	127685135	127685135	C	T	FBN2	exonic	nonsynonymous SNV	ENSG00000138829	rs154001	ENSG00000138829:ENST00000508989:exon22:c.G2794A:p.V932I,ENSG00000138829:ENST00000262464:exon23:c.G2893A:p.V965I,ENSG00000138829:ENST00000508053:exon29:c.G2893A:p.V965I	FBN2:NM_001999:exon23:c.G2893A:p.V965I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7234	0.6622	0.73103	COCA-CN|5|321|0.0155763	3.009	22.3	0.331	3.32	1.000	.	.	EGF-like calcium-binding domain|EGF-like calcium-binding, conserved site|EGF-like domain|TB domain	FBN2:uc003kuv.2:exon22:c.G2794A:p.V932I,FBN2:uc003kuu.3:exon23:c.G2893A:p.V965I	-0.947	AFR:0.6947,AMR:0.6250,EAS:0.7682,FIN:0.9442,NFE:0.7234,OTH:0.6936,ASJ:0.7655	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	0.118	-3.01	0.000	-0.39	5	1(haematopoietic_and_lymphoid_tissue)	0.7357
5	131705949	131705949	T	C	SLC22A5	exonic	synonymous SNV	ENSG00000197375	rs2631365	ENSG00000197375:ENST00000245407:exon1:c.T285C:p.L95L,ENSG00000197375:ENST00000435065:exon1:c.T285C:p.L95L,ENSG00000197375:ENST00000437841:exon1:c.T285C:p.L95L	SLC22A5:NM_001308122:exon1:c.T285C:p.L95L,SLC22A5:NM_003060:exon1:c.T285C:p.L95L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4968	0.3497	0.486222	0.4225	.	.	.	.	.	.	.	.	SLC22A5:uc003kww.4:exon1:c.T285C:p.L95L,SLC22A5:uc003kwx.4:exon1:c.T285C:p.L95L	.	AFR:0.3594,AMR:0.3258,EAS:0.6584,FIN:0.5161,NFE:0.4164,OTH:0.4498,ASJ:0.3733	603377	212140;	158;	158|CDSP<br>CUD<br>Carnitine transporter defect<br>Carnitine uptake deficiency<br>Deficiency of plasma-membrane carnitine transporter<br>SPCD|-|Autosomal recessive|Infancy<br>Neonatal|212140 ~	~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	5	MU4553927	het
5	131719999	131719999	A	G	SLC22A5	intronic	.	ENSG00000197375	rs4551059	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	1	.	1	1	.	.	.	.	.	0.0001	0.008	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	603377	212140;	158;	158|CDSP<br>CUD<br>Carnitine transporter defect<br>Carnitine uptake deficiency<br>Deficiency of plasma-membrane carnitine transporter<br>SPCD|-|Autosomal recessive|Infancy<br>Neonatal|212140 ~	~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	5	MU81802464	hom
5	131721174	131721174	A	G	SLC22A5	exonic	synonymous SNV	ENSG00000197375	rs274558	ENSG00000197375:ENST00000245407:exon4:c.A807G:p.L269L,ENSG00000197375:ENST00000415928:exon5:c.A576G:p.L192L,ENSG00000197375:ENST00000435065:exon5:c.A879G:p.L293L	SLC22A5:NM_003060:exon4:c.A807G:p.L269L,SLC22A5:NM_001308122:exon5:c.A879G:p.L293L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4393	0.3783	0.486222	0.4229	.	.	.	.	.	.	.	.	SLC22A5:uc003kww.4:exon4:c.A807G:p.L269L,SLC22A5:uc003kwx.4:exon5:c.A879G:p.L293L	.	AFR:0.3601,AMR:0.3225,EAS:0.6601,FIN:0.5161,NFE:0.4168,OTH:0.4509,ASJ:0.3775	603377	212140;	158;	158|CDSP<br>CUD<br>Carnitine transporter defect<br>Carnitine uptake deficiency<br>Deficiency of plasma-membrane carnitine transporter<br>SPCD|-|Autosomal recessive|Infancy<br>Neonatal|212140 ~	~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	5	MU159204	het
5	131721204	131721204	T	C	SLC22A5	intronic	.	ENSG00000197375	rs274557	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4399	0.3739	0.486022	0.4228	.	.	.	.	.	.	.	.	.	.	AFR:0.3599,AMR:0.3233,EAS:0.6611,FIN:0.5157,NFE:0.4168,OTH:0.4477,ASJ:0.3775	603377	212140;	158;	158|CDSP<br>CUD<br>Carnitine transporter defect<br>Carnitine uptake deficiency<br>Deficiency of plasma-membrane carnitine transporter<br>SPCD|-|Autosomal recessive|Infancy<br>Neonatal|212140 ~	~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	5	MU18216091	het
5	131915213	131915213	G	A	RAD50	intronic	.	ENSG00000113522	rs17166050	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1988	0.1759	0.167732	0.1988	.	.	.	.	.	.	.	.	.	.	AFR:0.1184,AMR:0.1408,EAS:0.1656,FIN:0.2596,NFE:0.2351,OTH:0.2280,ASJ:0.2583	604040	613078;	240760;	240760|Microcephaly and chromosomal instability without immunodeficiency<br>NBS-like disorder<br>NBSLD<br>RAD50 deficiency|-|-|-|613078 ~	.	.	.	.	.	.	.	.	5	MU23155169	het
5	135390546	135390546	G	A	TGFBI	exonic	nonsynonymous SNV	ENSG00000120708	rs376761086	ENSG00000120708:ENST00000604555:exon5:c.G638A:p.R213H,ENSG00000120708:ENST00000305126:exon10:c.G1406A:p.R469H,ENSG00000120708:ENST00000442011:exon10:c.G1406A:p.R469H	TGFBI:NM_000358:exon10:c.G1406A:p.R469H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.0005	0.0002	0.00179712	UCEC-US|1|531|0.00188324,CESC-US|1|289|0.00346021	7.735	35	0.001	5.83	0.997	.	.	FAS1 domain	TGFBI:uc011cyb.2:exon6:c.G884A:p.R295H,TGFBI:uc003lbf.4:exon10:c.G1406A:p.R469H,TGFBI:uc003lbg.4:exon10:c.G605A:p.R202H,TGFBI:uc003lbh.4:exon10:c.G884A:p.R295H	0.123	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601692	121820;121900;122200;602082;607541;608470;608471;	98964;98961;98963;98960;98964;98962;98956;	98964|Biber-Haab-Dimmer dystrophy<br>Classic lattice corneal dystrophy<br>LCD1<br>LCDI<br>Lattice corneal dystrophy type 1|Unknown|Autosomal dominant|All ages|122200 608471 ~98961|Anterior limiting membrane dystrophy type I<br>Atypical granular corneal dystrophy<br>Corneal dystrophy of Bowman layer type I<br>Geographic corneal dystrophy<br>Granular corneal dystrophy type 3<br>Granular corneal dystrophy type III<br>RBCD<br>Superficial granular corneal dystrophy|<1 / 1 000 000|Autosomal dominant|Childhood|608470 ~98963|Avellino corneal dystrophy<br>GCD2<br>GCDII<br>Granular corneal dystrophy type 2<br>Granular-lattice corneal dystrophy|Unknown|Autosomal dominant|Childhood|607541 ~98960|Anterior limiting membrane dystrophy type II<br>Corneal dystrophy of Bowman layer type II<br>Curly fiber corneal dystrophy<br>Honeycomb corneal dystrophy<br>TBCD<br>Waardenburg-Jonker corneal dystrophy|Unknown|Autosomal dominant|Adolescent<br>Childhood<br>Adult|602082 ~98964|Biber-Haab-Dimmer dystrophy<br>Classic lattice corneal dystrophy<br>LCD1<br>LCDI<br>Lattice corneal dystrophy type 1|Unknown|Autosomal dominant|All ages|122200 608471 ~98962|Classic GCD<br>Classic granular corneal dystrophy<br>Corneal dystrophy Groenouw type I<br>GCD1<br>GCDI<br>Granular corneal dystrophy type 1|Unknown|Autosomal dominant|Childhood|121900 ~98956|-|-|Autosomal dominant|-|121820 ~	.	.	.	.	1.0	-0.68	0.586	2.755	5	1(cervix)	.
5	137708434	137708434	C	T	KDM3B	exonic	synonymous SNV	ENSG00000120733	rs4835678	ENSG00000120733:ENST00000510866:exon1:c.C72T:p.I24I,ENSG00000120733:ENST00000314358:exon2:c.C264T:p.I88I	KDM3B:NM_016604:exon2:c.C264T:p.I88I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6376	0.5804	0.67492	0.5873	.	.	.	.	.	.	.	.	KDM3B:uc003lcy.1:exon2:c.C264T:p.I88I	.	AFR:0.5556,AMR:0.7237,EAS:0.8572,FIN:0.5458,NFE:0.5802,OTH:0.55,ASJ:0.6225	609373	.	.	.	.	.	.	.	.	.	.	.	5	MU16771788	het
5	137717265	137717265	G	A	KDM3B	exonic	nonsynonymous SNV	ENSG00000120733	rs6865472	ENSG00000120733:ENST00000510866:exon5:c.G574A:p.A192T,ENSG00000120733:ENST00000314358:exon6:c.G766A:p.A256T	KDM3B:NM_016604:exon6:c.G766A:p.A256T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9951	0.9823	0.978435	0.9828	-0.332	0.561	0.773	-2.75	0.029	.	.	.	KDM3B:uc003lcy.1:exon6:c.G766A:p.A256T	-1.016	AFR:0.9396,AMR:0.9988,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	609373	.	.	.	.	.	.	.	0.0	0.15	0.000	0.69	5	MU81803283	hom
5	137733891	137733891	A	G	KDM3B	exonic	synonymous SNV	ENSG00000120733	rs17294563	ENSG00000120733:ENST00000394866:exon5:c.A1824G:p.V608V,ENSG00000120733:ENST00000314358:exon10:c.A2856G:p.V952V	KDM3B:NM_016604:exon10:c.A2856G:p.V952V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1563	0.1338	0.111621	LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	KDM3B:uc003lcy.1:exon10:c.A2856G:p.V952V,KDM3B:uc010jew.1:exon10:c.A1824G:p.V608V	.	AFR:0.1287,AMR:0.0348,EAS:0.1424,FIN:0.0123,NFE:0.1719,OTH:0.1851,ASJ:0.0931	609373	.	.	.	.	.	.	.	.	.	.	.	5	1(urinary_tract)	0.1673
5	137754695	137754695	T	C	KDM3B	exonic	synonymous SNV	ENSG00000120733	rs7726234	ENSG00000120733:ENST00000542866:exon7:c.T585C:p.G195G,ENSG00000120733:ENST00000394866:exon9:c.T2457C:p.G819G,ENSG00000120733:ENST00000314358:exon14:c.T3489C:p.G1163G	KDM3B:NM_016604:exon14:c.T3489C:p.G1163G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6389	0.5840	0.678115	0.5891	.	.	.	.	.	.	.	.	KDM3B:uc011cys.1:exon7:c.T585C:p.G195G,KDM3B:uc003lcy.1:exon14:c.T3489C:p.G1163G,KDM3B:uc010jew.1:exon14:c.T2457C:p.G819G	.	AFR:0.5631,AMR:0.7237,EAS:0.8617,FIN:0.5458,NFE:0.5795,OTH:0.5482,ASJ:0.6225	609373	.	.	.	.	.	.	.	.	.	.	.	5	MU801381	het
5	137754808	137754808	G	A	KDM3B	exonic	nonsynonymous SNV	ENSG00000120733	rs7706614	ENSG00000120733:ENST00000542866:exon7:c.G698A:p.S233N,ENSG00000120733:ENST00000394866:exon9:c.G2570A:p.S857N,ENSG00000120733:ENST00000314358:exon14:c.G3602A:p.S1201N	KDM3B:NM_016604:exon14:c.G3602A:p.S1201N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0434	0.0401	0.0597045	0.0363	1.942	15.85	0.144	5.63	1.000	.	.	.	KDM3B:uc011cys.1:exon7:c.G698A:p.S233N,KDM3B:uc003lcy.1:exon14:c.G3602A:p.S1201N,KDM3B:uc010jew.1:exon14:c.G2570A:p.S857N	-1.050	AFR:0.0556,AMR:0.0322,EAS:0.0105,FIN:0.0289,NFE:0.0301,OTH:0.0346,ASJ:0.0331	609373	.	.	.	.	.	.	.	0.001	0.03	0.016	0.6	5	.	het
5	137760048	137760048	G	A	KDM3B	intronic	.	ENSG00000120733	rs41300795	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0440	0.0405	0.0595048	0.0366	.	.	.	.	.	.	.	.	.	.	AFR:0.0565,AMR:0.0322,EAS:0.0111,FIN:0.0289,NFE:0.0299,OTH:0.0348,ASJ:0.0331	609373	.	.	.	.	.	.	.	.	.	.	.	5	.	het
5	137766066	137766066	G	A	KDM3B	exonic	synonymous SNV	ENSG00000120733	rs61749634	ENSG00000120733:ENST00000542866:exon15:c.G2118A:p.V706V,ENSG00000120733:ENST00000394866:exon17:c.G3990A:p.V1330V,ENSG00000120733:ENST00000314358:exon22:c.G5022A:p.V1674V	KDM3B:NM_016604:exon22:c.G5022A:p.V1674V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0434	0.0401	.	0.0362	.	.	.	.	.	.	.	.	KDM3B:uc011cys.1:exon15:c.G2118A:p.V706V,KDM3B:uc003lcy.1:exon22:c.G5022A:p.V1674V,KDM3B:uc010jew.1:exon22:c.G3990A:p.V1330V	.	AFR:0.0554,AMR:0.0322,EAS:0.0111,FIN:0.0289,NFE:0.0299,OTH:0.0348,ASJ:0.0331	609373	.	.	.	.	.	.	.	.	.	.	.	5	.	het
5	141014494	141014494	T	C	HDAC3	exonic	synonymous SNV	ENSG00000171720	rs2530223	ENSG00000171720:ENST00000305264:exon3:c.A165G:p.Q55Q	HDAC3:NM_001355039:exon3:c.A165G:p.Q55Q,HDAC3:NM_003883:exon3:c.A165G:p.Q55Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6253	0.6832	0.639776	0.6716	.	.	.	.	.	.	.	.	HDAC3:uc003llf.2:exon3:c.A165G:p.Q55Q	.	AFR:0.8538,AMR:0.7303,EAS:0.3067,FIN:0.6067,NFE:0.6193,OTH:0.6582,ASJ:0.5927	605166	.	.	.	~ko04919 Thyroid hormone signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	5	MU105200	het
5	141016288	141016288	T	G	HDAC3	intronic	.	ENSG00000171720	rs1421896	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6339	0.6985	0.65635	0.6829	.	.	.	.	.	.	.	.	.	.	AFR:0.8823,AMR:0.7506,EAS:0.3059,FIN:0.6066,NFE:0.6247,OTH:0.6609,ASJ:0.6026	605166	.	.	.	~ko04919 Thyroid hormone signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	5	MU19773804	unknown
5	142150942	142150942	T	C	ARHGAP26	splicing	.	ENSG00000145819	rs10042074	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.39996	0.3053	.	.	.	.	.	.	.	.	.	.	AFR:0.7692,AMR:0.2625,EAS:0.3792,FIN:0.1354,NFE:0.0816,OTH:0.1612,ASJ:0.13	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	.	het
5	142254679	142254679	A	G	ARHGAP26	exonic	synonymous SNV	ENSG00000145819	rs185200	ENSG00000145819:ENST00000274498:exon3:c.A255G:p.R85R,ENSG00000145819:ENST00000378004:exon3:c.A255G:p.R85R,ENSG00000145819:ENST00000378013:exon3:c.A171G:p.R57R	ARHGAP26:NM_001135608:exon3:c.A255G:p.R85R,ARHGAP26:NM_001349547:exon3:c.A147G:p.R49R,ARHGAP26:NM_015071:exon3:c.A255G:p.R85R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4468	0.4620	0.673722	0.4728	.	.	.	.	.	.	.	.	ARHGAP26:uc003lmt.3:exon3:c.A255G:p.R85R,ARHGAP26:uc003lmw.3:exon3:c.A255G:p.R85R,ARHGAP26:uc011dbj.2:exon3:c.A255G:p.R85R	.	AFR:0.8006,AMR:0.5084,EAS:0.8806,FIN:0.2917,NFE:0.2887,OTH:0.3640,ASJ:0.3079	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	MU24874862	hom
5	142416741	142416741	T	C	ARHGAP26	intronic	.	ENSG00000145819	rs192194	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7071	0.7795	0.644768	0.7523	.	.	.	.	.	.	.	.	.	.	AFR:0.7955,AMR:0.5621,EAS:0.3362,FIN:0.7196,NFE:0.7903,OTH:0.7474,ASJ:0.7649	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	MU15244426	hom
5	142421415	142421415	T	G	ARHGAP26	exonic	synonymous SNV	ENSG00000145819	rs2270068	ENSG00000145819:ENST00000274498:exon14:c.T1245G:p.G415G,ENSG00000145819:ENST00000378004:exon14:c.T1245G:p.G415G	ARHGAP26:NM_001135608:exon14:c.T1245G:p.G415G,ARHGAP26:NM_001349547:exon14:c.T1137G:p.G379G,ARHGAP26:NM_015071:exon14:c.T1245G:p.G415G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9619	0.9983	0.888179	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ARHGAP26:uc003lmt.3:exon14:c.T1245G:p.G415G,ARHGAP26:uc003lmw.3:exon14:c.T1245G:p.G415G,ARHGAP26:uc011dbj.2:exon14:c.T1245G:p.G415G	.	AFR:0.9698,AMR:0.9969,EAS:1,FIN:0.5162,NFE:0.9885,OTH:0.9983,ASJ:0.9414	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	1(breast)	0.9827
5	142513686	142513686	A	G	ARHGAP26	intronic	.	ENSG00000145819	rs246607	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5453	0.5822	0.502796	MU15247376	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|5|170|0.0294118,COCA-CN|4|321|0.0124611,AMR:0.5567,EAS:0.3669,FIN:0.6987,NFE:0.3232,OTH:0.5825,ASJ:0.5057	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	15(soft_tissue)	0.6123
5	142593652	142593652	C	T	ARHGAP26	exonic	synonymous SNV	ENSG00000145819	rs258819	ENSG00000145819:ENST00000425417:exon2:c.C200T:p.T67M	ARHGAP26:NM_001349547:exon21:c.C1971T:p.N657N,ARHGAP26:NM_001135608:exon22:c.C2190T:p.N730N,ARHGAP26:NM_015071:exon22:c.C2355T:p.N785N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9938	0.9962	0.996406	0.9931	.	.	.	.	.	0.0002	0.11	.	ARHGAP26:uc003lmw.3:exon21:c.C2079T:p.N693N,ARHGAP26:uc003lmt.3:exon22:c.C2190T:p.N730N,ARHGAP26:uc011dbj.2:exon22:c.C2355T:p.N785N	.	AFR:0.9993,AMR:0.9964,EAS:1,FIN:0.9675,NFE:0.9949,OTH:0.9876,ASJ:1	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	MU81804076	hom
5	149457678	149457678	G	A	CSF1R	exonic	synonymous SNV	ENSG00000182578	rs2228422	ENSG00000182578:ENST00000504875:exon4:c.C726T:p.T242T,ENSG00000182578:ENST00000543093:exon4:c.C726T:p.T242T,ENSG00000182578:ENST00000286301:exon5:c.C726T:p.T242T	CSF1R:NM_001288705:exon4:c.C726T:p.T242T,CSF1R:NM_005211:exon5:c.C726T:p.T242T,CSF1R:NM_001349736:exon6:c.C726T:p.T242T	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5153	0.4807	0.38738	4(lung)	.	.	.	.	.	.	.	.	CSF1R:uc011dcd.2:exon3:c.C282T:p.T94T,CSF1R:uc003lrl.3:exon4:c.C726T:p.T242T,CSF1R:uc011dce.1:exon4:c.C726T:p.T242T,CSF1R:uc011dcf.2:exon4:c.C726T:p.T242T,CSF1R:uc003lrm.3:exon5:c.C726T:p.T242T	.	AFR:1(stomach),AMR:1(breast),EAS:1(thyroid),FIN:MU586881,NFE:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,OTH:0.4998,ASJ:1(liver)	164770	221820;	313808;	313808|ALSP<br>Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia<br>Autosomal dominant leukoencephalopathy with neuroaxonal spheroids<br>FPSG<br>Familial dementia, Neumann type<br>Familial progressive subcortical gliosis<br>GPSC<br>HDLS<br>Hereditary diffuse leukoencephalopathy with spheroids<br>POLD<br>Pigmentary orthochromatic leukodystrophy<br>Subcortical gliosis of Neumann|<1 / 1 000 000|Autosomal dominant|Adult|221820 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04061 Viral protein interaction with cytokine and cytokine~~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	,2067,2070,2068	.	,2069	.	.	.	.	5	14(meninges)	0.3213
5	149460553	149460553	A	G	CSF1R	exonic	synonymous SNV	ENSG00000182578	rs216123	ENSG00000182578:ENST00000504875:exon2:c.T84C:p.P28P,ENSG00000182578:ENST00000543093:exon2:c.T84C:p.P28P,ENSG00000182578:ENST00000286301:exon3:c.T84C:p.P28P	CSF1R:NM_001288705:exon2:c.T84C:p.P28P,CSF1R:NM_005211:exon3:c.T84C:p.P28P,CSF1R:NM_001349736:exon4:c.T84C:p.P28P	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4872	0.4737	0.335264	1(liver)	.	.	.	.	.	.	.	.	CSF1R:uc003lrl.3:exon2:c.T84C:p.P28P,CSF1R:uc011dce.1:exon2:c.T84C:p.P28P,CSF1R:uc011dcf.2:exon2:c.T84C:p.P28P,CSF1R:uc003lrm.3:exon3:c.T84C:p.P28P	.	AFR:1(breast),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,FIN:0.4814,NFE:0.2924,OTH:0.3696,ASJ:MU10482767	164770	221820;	313808;	313808|ALSP<br>Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia<br>Autosomal dominant leukoencephalopathy with neuroaxonal spheroids<br>FPSG<br>Familial dementia, Neumann type<br>Familial progressive subcortical gliosis<br>GPSC<br>HDLS<br>Hereditary diffuse leukoencephalopathy with spheroids<br>POLD<br>Pigmentary orthochromatic leukodystrophy<br>Subcortical gliosis of Neumann|<1 / 1 000 000|Autosomal dominant|Adult|221820 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04061 Viral protein interaction with cytokine and cytokine~~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	,2067,2070,2068	.	,2069	.	.	.	.	5	2(lung)	0.4161
5	151054165	151054165	C	A	SPARC	intronic	.	ENSG00000113140	rs199756185	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0039	0.0002	0.0115815	0.0007	.	.	.	.	.	0	0.002	.	.	.	AFR:0.0003,AMR:0,EAS:0.0086,FIN:0.0006,NFE:6.66e-05,OTH:0.0020,ASJ:0	182120	616507;	216820;666;	216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~	.	.	.	.	.	.	.	.	5	.	het
5	161113004	161113004	G	A	GABRA6	exonic	synonymous SNV	ENSG00000145863	rs13188991	ENSG00000145863:ENST00000274545:exon1:c.G9A:p.S3S,ENSG00000145863:ENST00000523217:exon1:c.G9A:p.S3S	GABRA6:NM_000811:exon1:c.G9A:p.S3S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1893	0.1877	0.0992412	1(thyroid)	.	.	.	.	.	.	.	.	GABRA6:uc003lyu.2:exon1:c.G9A:p.S3S	.	AFR:1(liver),AMR:MU4567513,EAS:0.1857,FIN:0.0473,NFE:0.1235,OTH:0.2848,ASJ:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647	137143	.	.	.	.	.	.	.	.	.	.	.	5	1(central_nervous_system)	0.0895
5	161119071	161119071	G	T	GABRA6	exonic	synonymous SNV	ENSG00000145863	rs12522663	ENSG00000145863:ENST00000274545:exon8:c.G951T:p.A317A,ENSG00000145863:ENST00000523217:exon8:c.G921T:p.A307A	GABRA6:NM_000811:exon8:c.G951T:p.A317A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9902	0.9655	0.968251	0.9699	.	.	.	.	.	.	.	.	GABRA6:uc003lyv.2:exon2:c.G264T:p.A88A,GABRA6:uc003lyu.2:exon8:c.G951T:p.A317A	.	AFR:0.8962,AMR:0.9881,EAS:1,FIN:1,NFE:0.9997,OTH:0.9878,ASJ:1	137143	.	.	.	.	.	.	.	.	.	.	.	5	MU81806764	hom
5	161119125	161119125	C	G	GABRA6	exonic	synonymous SNV	ENSG00000145863	rs13184586	ENSG00000145863:ENST00000274545:exon8:c.C1005G:p.A335A,ENSG00000145863:ENST00000523217:exon8:c.C975G:p.A325A	GABRA6:NM_000811:exon8:c.C1005G:p.A335A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4854	0.4881	0.401158	MU12248552	.	.	.	.	.	.	.	.	GABRA6:uc003lyv.2:exon2:c.C318G:p.A106A,GABRA6:uc003lyu.2:exon8:c.C1005G:p.A335A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.4862,EAS:0.3801,FIN:0.5695,NFE:0.3021,OTH:0.5499,ASJ:0.3513	137143	.	.	.	.	.	.	.	.	.	.	.	5	2(haematopoietic_and_lymphoid_tissue)	0.5715
5	161128761	161128761	C	G	GABRA6	exonic	synonymous SNV	ENSG00000145863	rs4277944	ENSG00000145863:ENST00000274545:exon9:c.C1344G:p.V448V,ENSG00000145863:ENST00000523217:exon9:c.C1314G:p.V438V	GABRA6:NM_000811:exon9:c.C1344G:p.V448V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9893	0.9620	.	0.9680	.	.	.	.	.	.	.	.	GABRA6:uc003lyv.2:exon3:c.C657G:p.V219V,GABRA6:uc003lyu.2:exon9:c.C1344G:p.V448V	.	AFR:0.8895,AMR:0.9869,EAS:1,FIN:1,NFE:0.9996,OTH:0.9888,ASJ:1	137143	.	.	.	.	.	.	.	.	.	.	.	5	MU81806783	hom
5	162890953	162890953	G	A	HMMR	exonic	synonymous SNV	ENSG00000072571	rs380101	ENSG00000072571:ENST00000353866:exon2:c.G138A:p.Q46Q,ENSG00000072571:ENST00000358715:exon2:c.G138A:p.Q46Q,ENSG00000072571:ENST00000393915:exon2:c.G138A:p.Q46Q	HMMR:NM_001142556:exon2:c.G138A:p.Q46Q,HMMR:NM_012484:exon2:c.G138A:p.Q46Q,HMMR:NM_012485:exon2:c.G138A:p.Q46Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	.	1	1.0000	.	.	.	.	.	.	.	.	HMMR:uc003lzf.3:exon2:c.G138A:p.Q46Q,HMMR:uc003lzg.3:exon2:c.G138A:p.Q46Q,HMMR:uc003lzh.3:exon2:c.G138A:p.Q46Q	.	AFR:0.9999,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600936	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	5	MU81806833	hom
5	169145648	169145648	A	T	DOCK2	intronic	.	ENSG00000134516	rs80250373	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0614	0.0580	0.0557109	0.0541	.	.	.	.	.	.	.	.	.	.	AFR:0.0492,AMR:0.0335,EAS:0.0006,FIN:0.0710,NFE:0.0591,OTH:0.0580,ASJ:0.0861	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	.	hom
5	169361660	169361660	C	G	DOCK2;INSYN2B	intronic	.	ENSG00000134516	rs259898	ENSG00000134516:ENST00000519628:exon5:c.C416G:p.A139G	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0815	.	0.161342	0.1503	0.317	5.854	0.171	-0.014	0.033	.	.	.	.	-0.959	AFR:0.3095,AMR:0.0574,EAS:0.0815,FIN:0.0885,NFE:0.0902,OTH:0.0845,ASJ:0.0960	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	0.000	.	5	MU114154854	het
5	169361685	169361685	T	G	DOCK2;INSYN2B	intronic	.	ENSG00000134516	rs259899	ENSG00000134516:ENST00000519628:exon5:c.T441G:p.I147M	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0812	.	0.15635	0.1438	-0.258	0.826	0.05	-5.51	0.000	.	.	.	.	-0.979	AFR:0.2859,AMR:0.0573,EAS:0.0815,FIN:0.0888,NFE:0.0904,OTH:0.0847,ASJ:0.0960	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	0.000	.	5	MU32165554	het
5	169435713	169435713	A	C	DOCK2	exonic	synonymous SNV	ENSG00000134516	rs2287727	ENSG00000134516:ENST00000520908:exon18:c.A1671C:p.L557L,ENSG00000134516:ENST00000540750:exon18:c.A378C:p.L126L,ENSG00000134516:ENST00000256935:exon32:c.A3195C:p.L1065L	DOCK2:NM_004946:exon32:c.A3195C:p.L1065L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2919	0.2207	0.243011	0.2467	.	.	.	.	.	.	.	.	DOCK2:uc010jjm.3:exon18:c.A1671C:p.L557L,DOCK2:uc003maf.3:exon32:c.A3195C:p.L1065L	.	AFR:0.0696,AMR:0.3517,EAS:0.4252,FIN:0.3768,NFE:0.2895,OTH:0.3129,ASJ:0.2781	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU137499	het
5	169454941	169454941	C	G	DOCK2	exonic	synonymous SNV	ENSG00000134516	rs9791113	ENSG00000134516:ENST00000520908:exon20:c.C1932G:p.L644L,ENSG00000134516:ENST00000540750:exon20:c.C639G:p.L213L,ENSG00000134516:ENST00000256935:exon34:c.C3456G:p.L1152L	DOCK2:NM_004946:exon34:c.C3456G:p.L1152L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3923	0.4059	0.486222	0.4008	.	.	.	.	.	.	.	.	DOCK2:uc010jjm.3:exon20:c.C1932G:p.L644L,DOCK2:uc003maf.3:exon34:c.C3456G:p.L1152L	.	AFR:0.5439,AMR:0.3995,EAS:0.5767,FIN:0.3441,NFE:0.3172,OTH:0.3361,ASJ:0.3543	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU21948493	hom
5	169461399	169461399	G	A	DOCK2	intronic	.	ENSG00000134516	rs3763047	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3921	0.4232	0.499201	0.4113	.	.	.	.	.	0	0.002	.	.	.	AFR:0.6033,AMR:0.4031,EAS:0.5722,FIN:0.3246,NFE:0.3099,OTH:0.3282,ASJ:0.3510	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU799485	hom
5	169461547	169461547	C	T	DOCK2	exonic	synonymous SNV	ENSG00000134516	rs3763048	ENSG00000134516:ENST00000520908:exon21:c.C2088T:p.T696T,ENSG00000134516:ENST00000540750:exon21:c.C795T:p.T265T,ENSG00000134516:ENST00000256935:exon35:c.C3612T:p.T1204T	DOCK2:NM_004946:exon35:c.C3612T:p.T1204T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3995	0.4343	0.506789	0.4184	.	.	.	.	.	.	.	.	DOCK2:uc010jjm.3:exon21:c.C2088T:p.T696T,DOCK2:uc003maf.3:exon35:c.C3612T:p.T1204T	.	AFR:0.6093,AMR:0.4069,EAS:0.5732,FIN:0.3263,NFE:0.3194,OTH:0.3306,ASJ:0.37	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU586927	hom
5	176517461	176517461	T	G	FGFR4	exonic	synonymous SNV	ENSG00000160867	rs446382	ENSG00000160867:ENST00000393637:exon2:c.T162G:p.R54R,ENSG00000160867:ENST00000292408:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000292410:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000393648:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000502906:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000503708:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000513166:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000514472:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000510911:exon4:c.T162G:p.R54R	FGFR4:NM_022963:exon2:c.T162G:p.R54R,FGFR4:NM_001291980:exon3:c.T162G:p.R54R,FGFR4:NM_001354984:exon3:c.T162G:p.R54R,FGFR4:NM_002011:exon3:c.T162G:p.R54R,FGFR4:NM_213647:exon3:c.T162G:p.R54R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7647	0.6832	0.775958	MU71026	.	.	.	.	.	.	.	.	FGFR4:uc003mfn.1:exon2:c.T162G:p.R54R,FGFR4:uc003mfo.3:exon2:c.T162G:p.R54R,FGFR4:uc011dfw.1:exon2:c.T162G:p.R54R,FGFR4:uc003mfl.3:exon3:c.T162G:p.R54R,FGFR4:uc003mfm.3:exon3:c.T162G:p.R54R,FGFR4:uc011dfu.2:exon3:c.T162G:p.R54R	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.7118,EAS:0.8103,FIN:0.7119,NFE:0.9729,OTH:0.7490,ASJ:0.5979	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	5	17(meninges)	0.7323
5	176517797	176517797	C	T	FGFR4	exonic	nonsynonymous SNV	ENSG00000160867	rs376618	ENSG00000160867:ENST00000393637:exon3:c.C407T:p.P136L,ENSG00000160867:ENST00000292408:exon4:c.C407T:p.P136L,ENSG00000160867:ENST00000292410:exon4:c.C407T:p.P136L,ENSG00000160867:ENST00000393648:exon4:c.C407T:p.P136L,ENSG00000160867:ENST00000502906:exon4:c.C407T:p.P136L,ENSG00000160867:ENST00000503708:exon4:c.C407T:p.P136L	FGFR4:NM_022963:exon3:c.C407T:p.P136L,FGFR4:NM_001291980:exon4:c.C407T:p.P136L,FGFR4:NM_001354984:exon4:c.C407T:p.P136L,FGFR4:NM_002011:exon4:c.C407T:p.P136L,FGFR4:NM_213647:exon4:c.C407T:p.P136L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7950	0.7211	0.807308	COCA-CN|5|321|0.0155763	0.399	6.606	0.332	2.85	0.010	.	.	.	FGFR4:uc003mfn.1:exon3:c.C407T:p.P136L,FGFR4:uc003mfo.3:exon3:c.C407T:p.P136L,FGFR4:uc011dfw.1:exon3:c.C407T:p.P136L,FGFR4:uc003mfl.3:exon4:c.C407T:p.P136L,FGFR4:uc003mfm.3:exon4:c.C407T:p.P136L,FGFR4:uc011dfu.2:exon4:c.C407T:p.P136L	-0.960	AFR:0.7468,AMR:0.6533,EAS:0.7550,FIN:1,NFE:0.8038,OTH:0.7525,ASJ:0.8337	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	0.0	-1.26	0.000	0	5	17(meninges)	0.7873
5	176518784	176518784	C	T	FGFR4	exonic	synonymous SNV	ENSG00000160867	rs452885	ENSG00000160867:ENST00000393637:exon5:c.C702T:p.R234R,ENSG00000160867:ENST00000292408:exon6:c.C702T:p.R234R,ENSG00000160867:ENST00000292410:exon6:c.C702T:p.R234R,ENSG00000160867:ENST00000393648:exon6:c.C702T:p.R234R,ENSG00000160867:ENST00000502906:exon6:c.C702T:p.R234R	FGFR4:NM_022963:exon5:c.C702T:p.R234R,FGFR4:NM_001291980:exon6:c.C702T:p.R234R,FGFR4:NM_001354984:exon6:c.C702T:p.R234R,FGFR4:NM_002011:exon6:c.C702T:p.R234R,FGFR4:NM_213647:exon6:c.C702T:p.R234R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7949	0.7211	0.807109	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FGFR4:uc003mfo.3:exon5:c.C702T:p.R234R,FGFR4:uc011dfw.1:exon5:c.C702T:p.R234R,FGFR4:uc003mfl.3:exon6:c.C702T:p.R234R,FGFR4:uc003mfm.3:exon6:c.C702T:p.R234R,FGFR4:uc011dfu.2:exon6:c.C702T:p.R234R	.	AFR:0.7460,AMR:0.6523,EAS:0.7550,FIN:1,NFE:0.8033,OTH:0.7520,ASJ:0.8329	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	5	17(meninges)	0.7883
5	176522728	176522728	C	T	FGFR4	intronic	.	ENSG00000160867	rs42409	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7280	0.5984	0.701877	0.6355	.	.	.	.	.	0.0001	0.018	.	.	.	AFR:0.4138,AMR:0.7770,EAS:0.9715,FIN:0.7158,NFE:0.6962,OTH:0.7080,ASJ:0.6623	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	5	MU81808028	het
5	176523597	176523597	A	G	FGFR4	intronic	.	ENSG00000160867	rs31776	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7643	0.6889	0.785343	0.7157	.	.	.	.	.	0	0.004	.	.	.	AFR:0.6139,AMR:0.8079,EAS:0.9727,FIN:0.7489,NFE:0.7318,OTH:0.7592,ASJ:0.6887	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	5	MU10675511	het
5	176721198	176721198	T	C	NSD1	exonic	synonymous SNV	ENSG00000165671	rs28580074	ENSG00000165671:ENST00000361032:exon20:c.T6520C:p.L2174L,ENSG00000165671:ENST00000439151:exon23:c.T6829C:p.L2277L,ENSG00000165671:ENST00000347982:exon24:c.T6022C:p.L2008L,ENSG00000165671:ENST00000354179:exon24:c.T6022C:p.L2008L	NSD1:NM_022455:exon23:c.T6829C:p.L2277L,NSD1:NM_001365684:exon24:c.T6022C:p.L2008L,NSD1:NM_172349:exon24:c.T6022C:p.L2008L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8242	0.8990	0.771366	1(stomach)	.	.	.	.	.	.	.	.	NSD1:uc021yip.1:exon3:c.T301C:p.L101L,NSD1:uc003mfr.4:exon23:c.T6829C:p.L2277L,NSD1:uc003mft.4:exon24:c.T6022C:p.L2008L,NSD1:uc011dfx.2:exon24:c.T5773C:p.L1925L	.	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:MU586936,EAS:0.8480,FIN:0.9257,NFE:0.7888,OTH:0.8907,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579	606681	117550;130650;601626;	519;116;821;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~821|Cerebral gigantism|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown<br>or&nbsp;Autosomal recessive|Neonatal|117550 617169 ~	.	.	.	.	.	.	.	.	5	22(soft_tissue)	0.4776
5	176940384	176940384	G	A	DDX41	exonic	synonymous SNV	ENSG00000183258	rs335438	ENSG00000183258:ENST00000330503:exon10:c.C1254T:p.R418R,ENSG00000183258:ENST00000507955:exon11:c.C1200T:p.R400R	DDX41:NM_001321732:exon10:c.C822T:p.R274R,DDX41:NM_001321830:exon11:c.C822T:p.R274R,DDX41:NM_016222:exon11:c.C1200T:p.R400R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4198	0.4609	0.386382	0.4396	.	.	.	.	.	.	.	.	DDX41:uc003mhq.1:exon9:c.C540T:p.R180R,DDX41:uc003mhn.3:exon10:c.C807T:p.R269R,DDX41:uc003mhp.3:exon10:c.C807T:p.R269R,DDX41:uc003mho.3:exon11:c.C1200T:p.R400R	.	AFR:0.4548,AMR:0.3266,EAS:0.1702,FIN:0.4526,NFE:0.4664,OTH:0.4061,ASJ:0.4040	608170	616871;	.	.	.	.	.	.	.	.	.	.	5	MU157920	het
5	180036239	180036239	G	A	FLT4	intronic	.	ENSG00000037280	rs11750658	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.14377	0.1783	.	.	.	.	.	.	.	.	.	.	AFR:0.1055,AMR:0.1420,EAS:0.0722,FIN:0.1847,NFE:0.2314,OTH:0.1840,ASJ:0.2252	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	5	MU113446607	hom
5	180043388	180043388	G	A	FLT4	exonic	synonymous SNV	ENSG00000037280	rs1130378	ENSG00000037280:ENST00000512795:exon4:c.C312T:p.P104P,ENSG00000037280:ENST00000261937:exon23:c.C3198T:p.P1066P,ENSG00000037280:ENST00000393347:exon23:c.C3198T:p.P1066P,ENSG00000037280:ENST00000502649:exon23:c.C3198T:p.P1066P	FLT4:NM_001354989:exon23:c.C3198T:p.P1066P,FLT4:NM_002020:exon23:c.C3198T:p.P1066P,FLT4:NM_182925:exon23:c.C3198T:p.P1066P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2700	0.2526	0.240415	14(soft_tissue)	.	.	.	.	.	.	.	.	FLT4:uc003mlz.4:exon23:c.C3198T:p.P1066P,FLT4:uc003mma.4:exon23:c.C3198T:p.P1066P	.	AFR:1(stomach),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,FIN:0.2371,NFE:0.1658,OTH:0.1727,ASJ:MU160401	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	5	2(lung)	0.3477
5	180047863	180047863	C	G	FLT4	intronic	.	ENSG00000037280	rs423086	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9876	0.9531	0.960064	0.9627	.	.	.	.	.	.	.	.	.	.	AFR:0.8699,AMR:0.9940,EAS:1,FIN:1,NFE:0.9993,OTH:0.9929,ASJ:1	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	5	MU81809230	hom
6	325126	325126	A	G	DUSP22	intronic	.	ENSG00000112679	rs2757553	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.996805	0.9836	.	.	.	.	.	.	.	.	.	.	AFR:0.9701,AMR:0.9817,EAS:0.9950,FIN:0.9786,NFE:0.9909,OTH:0.9896,ASJ:0.9966	616778	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	325403	325403	G	A	DUSP22	intronic	.	ENSG00000112679	rs28517601	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.448882	SKCA-BR|1|100|0.01	.	.	.	.	.	.	.	.	.	.	AFR:0.4451,AMR:0.4021,EAS:0.4362,FIN:0.4699,NFE:0.4720,OTH:0.4602,ASJ:0.4648	616778	.	.	.	.	.	.	.	.	.	.	.	6	1(skin)	0.448
6	325544	325544	A	G	DUSP22	intronic	.	ENSG00000112679	rs28733103	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	SKCA-BR|1|100|0.01,PRAD-CA|1|306|0.00326797	.	.	.	.	.	.	.	.	.	.	AFR:0.4135,AMR:0.4588,EAS:0.2794,FIN:0.4791,NFE:0.3795,OTH:0.3840,ASJ:0.4074	616778	.	.	.	.	.	.	.	.	.	.	.	6	1(prostate)	0.3932
6	325549	325549	G	A	DUSP22	intronic	.	ENSG00000112679	rs2488422	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	0.1463	.	.	.	.	.	.	.	.	.	.	AFR:0.2011,AMR:0.1741,EAS:0.2748,FIN:0.1402,NFE:0.1075,OTH:0.1175,ASJ:0.0481	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU43698069	unknown
6	325557	325557	G	T	DUSP22	intronic	.	ENSG00000112679	rs2797328	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	0.1947	.	.	.	.	.	.	.	.	.	.	AFR:0.2682,AMR:0.2135,EAS:0.3047,FIN:0.2377,NFE:0.1407,OTH:0.1202,ASJ:0.0612	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU43698139	unknown
6	325873	325873	T	C	DUSP22	intronic	.	ENSG00000112679	rs2797329	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.997804	0.9956	.	.	.	.	.	.	.	.	.	.	AFR:0.9902,AMR:0.9986,EAS:0.9992,FIN:0.9932,NFE:0.9986,OTH:0.9974,ASJ:1	616778	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	325900	325900	C	T	DUSP22	intronic	.	ENSG00000112679	rs866305319	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	SKCA-BR|1|100|0.01,PAEN-AU|1|52|0.0192308	.	.	.	.	.	.	.	.	.	.	AFR:0.0010,AMR:0.0019,EAS:0,FIN:0.0007,NFE:0.0011,OTH:0.0003,ASJ:0.0042	616778	.	.	.	.	.	.	.	.	.	.	.	6	1(skin)	0.0035
6	325961	325961	T	C	DUSP22	intronic	.	ENSG00000112679	rs2797330	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.971046	0.9765	.	.	.	.	.	.	.	.	.	.	AFR:0.9660,AMR:0.9744,EAS:0.9888,FIN:0.9693,NFE:0.9835,OTH:0.9676,ASJ:0.9795	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU80942806	hom
6	326134	326134	G	A	DUSP22	intronic	.	ENSG00000112679	rs2757557	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.996805	0.9956	.	.	.	.	.	.	.	.	.	.	AFR:0.9887,AMR:0.9913,EAS:1,FIN:0.9949,NFE:0.9992,OTH:0.9978,ASJ:1	616778	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	326819	326819	C	A	DUSP22	intronic	.	ENSG00000112679	rs2757558	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	0.2842	.	.	.	.	.	.	.	.	.	.	AFR:0.3320,AMR:0.2538,EAS:0.3289,FIN:0.2667,NFE:0.2583,OTH:0.2819,ASJ:0.2797	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU25012989	het
6	335175	335175	A	T	DUSP22	intronic	.	ENSG00000112679	rs2671431	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9993	0.9980	0.997804	0.9980	.	.	.	.	.	.	.	.	.	.	AFR:0.9932,AMR:0.9988,EAS:1,FIN:0.9997,NFE:1,OTH:1,ASJ:1	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU81809497	hom
6	348906	348906	G	A	DUSP22	exonic	synonymous SNV	ENSG00000112679	rs11242812	ENSG00000112679:ENST00000604971:exon4:c.G264A:p.P88P,ENSG00000112679:ENST00000605315:exon4:c.G264A:p.P88P,ENSG00000112679:ENST00000603453:exon6:c.G264A:p.P88P,ENSG00000112679:ENST00000419235:exon7:c.G573A:p.P191P	DUSP22:NM_001286555:exon7:c.G573A:p.P191P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4882	.	.	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	DUSP22:uc003msy.1:exon6:c.G444A:p.P148P,DUSP22:uc011dhn.1:exon7:c.G573A:p.P191P	.	AFR:MU4553881,AMR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,EAS:0.4929,FIN:0.4795,NFE:0.4567,OTH:0.4781,ASJ:0.4800	616778	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.4698
6	350829	350829	G	A	DUSP22	exonic	synonymous SNV	ENSG00000112679	rs1129085	ENSG00000112679:ENST00000344450:exon8:c.G516A:p.P172P	DUSP22:NM_020185:exon8:c.G516A:p.P172P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3887	0.3573	.	0.3837	.	.	.	.	.	.	.	.	DUSP22:uc003msx.3:exon8:c.G516A:p.P172P	.	AFR:0.4602,AMR:0.3674,EAS:0.4923,FIN:0.3651,NFE:0.3336,OTH:0.3775,ASJ:0.3423	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU34371818	het
6	1611802	1611802	-	GGC	FOXC1	exonic	nonframeshift insertion	ENSG00000054598	rs545470261	ENSG00000054598:ENST00000380874:exon1:c.1122_1123insGGC:p.S374delinsSG	FOXC1:NM_001453:exon1:c.1122_1123insGGC:p.S374delinsSG	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0614	0.1601	0.152157	0.2124	.	.	.	.	.	.	.	.	FOXC1:uc003mtp.3:exon1:c.1122_1123insGGC:p.S374delinsSG	.	AFR:0.1174,AMR:0.2957,EAS:0.6654,FIN:0.1875,NFE:0.2132,OTH:0.2433,ASJ:0.3243	601090	601631;602482;	782;91483;98978;91483;98978;	782|Axenfeld syndrome<br>Rieger syndrome|1-9 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|180500 601499 602482 ~91483|-|-|Autosomal dominant|Neonatal|137600 601631 602482 ~98978|-|-|Autosomal dominant|-|601631 602482 ~91483|-|-|Autosomal dominant|Neonatal|137600 601631 602482 ~98978|-|-|Autosomal dominant|-|601631 602482 ~	.	.	.	.	.	.	.	.	6	MU5018396	het
6	7563983	7563983	T	G	DSP	exonic	synonymous SNV	ENSG00000096696	rs2806234	ENSG00000096696:ENST00000379802:exon6:c.T741G:p.A247A,ENSG00000096696:ENST00000418664:exon6:c.T741G:p.A247A	DSP:NM_001008844:exon6:c.T741G:p.A247A,DSP:NM_001319034:exon6:c.T741G:p.A247A,DSP:NM_004415:exon6:c.T741G:p.A247A	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9991	0.9985	1	0.9995	.	.	.	.	.	.	.	.	DSP:uc003mxp.1:exon6:c.T741G:p.A247A,DSP:uc003mxq.1:exon6:c.T741G:p.A247A,DSP:uc021yle.1:exon6:c.T741G:p.A247A	.	AFR:0.9999,AMR:1,EAS:1,FIN:0.9991,NFE:0.9992,OTH:0.9990,ASJ:1	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	.	.	.	.	6	MU81810273	hom
6	7572262	7572262	A	G	DSP	exonic	synonymous SNV	ENSG00000096696	rs2076304	ENSG00000096696:ENST00000379802:exon15:c.A2091G:p.G697G,ENSG00000096696:ENST00000418664:exon15:c.A2091G:p.G697G	DSP:NM_001008844:exon15:c.A2091G:p.G697G,DSP:NM_001319034:exon15:c.A2091G:p.G697G,DSP:NM_004415:exon15:c.A2091G:p.G697G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7614	0.7859	0.774361	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	DSP:uc003mxp.1:exon15:c.A2091G:p.G697G,DSP:uc003mxq.1:exon15:c.A2091G:p.G697G,DSP:uc021yle.1:exon15:c.A2091G:p.G697G	.	AFR:0.7676,AMR:0.7984,EAS:0.8543,FIN:0.8169,NFE:0.7120,OTH:0.7585,ASJ:0.7506	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	.	.	.	.	6	1(lung)	0.7357
6	7576527	7576527	G	A	DSP	exonic	synonymous SNV	ENSG00000096696	rs1016835	ENSG00000096696:ENST00000379802:exon19:c.G2631A:p.R877R,ENSG00000096696:ENST00000418664:exon19:c.G2631A:p.R877R	DSP:NM_001008844:exon19:c.G2631A:p.R877R,DSP:NM_001319034:exon19:c.G2631A:p.R877R,DSP:NM_004415:exon19:c.G2631A:p.R877R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7718	0.7481	0.735423	0.7345	.	.	.	.	.	0.0001	0.03	.	DSP:uc003mxp.1:exon19:c.G2631A:p.R877R,DSP:uc003mxq.1:exon19:c.G2631A:p.R877R,DSP:uc021yle.1:exon19:c.G2631A:p.R877R	.	AFR:0.6387,AMR:0.7661,EAS:0.7970,FIN:0.7140,NFE:0.7824,OTH:0.7628,ASJ:0.8444	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	.	.	.	.	6	MU14034205	hom
6	7585967	7585967	G	C	DSP	exonic	synonymous SNV	ENSG00000096696	rs2744380	ENSG00000096696:ENST00000379802:exon24:c.G8472C:p.G2824G,ENSG00000096696:ENST00000418664:exon24:c.G6675C:p.G2225G	DSP:NM_001008844:exon24:c.G6675C:p.G2225G,DSP:NM_001319034:exon24:c.G7143C:p.G2381G,DSP:NM_004415:exon24:c.G8472C:p.G2824G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7117	0.6881	0.709465	0.6718	.	.	.	.	.	.	.	.	DSP:uc003mxp.1:exon24:c.G8472C:p.G2824G,DSP:uc003mxq.1:exon24:c.G6675C:p.G2225G,DSP:uc021yle.1:exon24:c.G7143C:p.G2381G	.	AFR:0.6315,AMR:0.7398,EAS:0.7978,FIN:0.6403,NFE:0.6820,OTH:0.6875,ASJ:0.7781	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	.	.	.	.	6	MU14034520	hom
6	10420098	10420098	C	T	TFAP2A	UTR5	.	ENSG00000137203	rs1621700	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.147364	0.1736	.	.	.	.	.	.	.	.	.	.	AFR:0.0385,AMR:0.3580,EAS:0.0470,FIN:0.2999,NFE:0.2238,OTH:0.2168,ASJ:0.1523	107580	113620;	1297;	1297|BOFS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;No data available|Neonatal|113620 ~	.	.	.	.	.	.	.	.	6	MU118048284	het
6	18134021	18134021	C	A	TPMT	intronic	.	ENSG00000137364	rs2842949	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6115	0.4515	0.585064	0.6325	.	.	.	.	.	.	.	.	TPMT:uc010jpm.1:exon7:c.G594T:p.G198G	.	AFR:0.3941,AMR:0.6850,EAS:0.7730,FIN:0.7322,NFE:0.7267,OTH:0.6854,ASJ:0.6803	187680	610460;	413687;	413687|-|-|-|-|610460 616903 ~	.	.	.	.	.	.	.	.	6	MU799869	het
6	18139214	18139214	G	A	TPMT	exonic	synonymous SNV	ENSG00000137364	rs2842934	ENSG00000137364:ENST00000309983:exon6:c.C474T:p.I158I	TPMT:NM_000367:exon6:c.C474T:p.I158I,TPMT:NM_001346818:exon6:c.C474T:p.I158I,TPMT:NM_001346817:exon7:c.C474T:p.I158I	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7633	0.7943	0.752995	LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	TPMT:uc003ncm.3:exon6:c.C474T:p.I158I,TPMT:uc010jpm.1:exon6:c.C474T:p.I158I	.	AFR:0.7849,AMR:0.8096,EAS:0.7053,FIN:0.7670,NFE:0.7666,OTH:0.7819,ASJ:0.7596	187680	610460;	413687;	413687|-|-|-|-|610460 616903 ~	.	.	.	.	.	.	.	.	6	1(stomach)	0.7515
6	18139965	18139965	A	-	TPMT	intronic	.	ENSG00000137364	rs375276814	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.6526	0.6125	.	0.6203	.	.	.	.	.	.	.	.	.	.	AFR:0.3704,AMR:0.6591,EAS:0.7996,FIN:0.6882,NFE:0.7238,OTH:0.6868,ASJ:0.6690	187680	610460;	413687;	413687|-|-|-|-|610460 616903 ~	.	.	.	.	.	.	.	.	6	.	het
6	24653376	24653376	G	A	TDP2	exonic	synonymous SNV	ENSG00000111802	rs1129644	ENSG00000111802:ENST00000341060:exon5:c.C468T:p.N156N,ENSG00000111802:ENST00000378198:exon6:c.C642T:p.N214N,ENSG00000111802:ENST00000545995:exon6:c.C732T:p.N244N	TDP2:NM_016614:exon6:c.C642T:p.N214N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7393	0.7642	0.805112	1(urinary_tract)	.	.	.	.	.	.	.	.	TDP2:uc003nej.3:exon6:c.C642T:p.N214N,TDP2:uc010jpu.1:exon6:c.C642T:p.N214N	.	AFR:1(oesophagus),AMR:MU4132850,EAS:0.7576,FIN:0.9091,NFE:0.8469,OTH:0.6755,ASJ:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205	605764	616949;	404493;	404493|SCAR23<br>Spinocerebellar ataxia autosomal recessive type 23|<1 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|616949 ~	.	.	.	.	.	.	.	.	6	1(kidney)	0.8453
6	24658149	24658149	T	C	TDP2	intronic	.	ENSG00000111802	rs559444246	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0026	.	0.00399361	3.231e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.67e-05,OTH:0,ASJ:0	605764	616949;	404493;	404493|SCAR23<br>Spinocerebellar ataxia autosomal recessive type 23|<1 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|616949 ~	.	.	.	.	.	.	.	.	6	.	het
6	26045737	26045737	C	G	HIST1H3C	exonic	synonymous SNV	ENSG00000196532	rs3752418	ENSG00000196532:ENST00000540144:exon1:c.C99G:p.T33T	HIST1H3C:NM_003531:exon1:c.C99G:p.T33T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1456	0.0752	0.216853	0.1068	.	.	.	.	.	.	.	.	HIST1H3C:uc003nfv.3:exon1:c.C99G:p.T33T	.	AFR:0.0960,AMR:0.2625,EAS:0.5179,FIN:0.0825,NFE:0.0660,OTH:0.1018,ASJ:0.1126	602812	.	.	.	~ko05034 Alcoholism~ko05202 Transcriptional misregulation in cancer~ko05322 Systemic lupus erythematosus ~	.	.	.	.	.	.	.	6	MU105929	het
6	26045929	26045929	T	C	HIST1H3C	exonic	synonymous SNV	ENSG00000196532	rs3752416	ENSG00000196532:ENST00000540144:exon1:c.T291C:p.C97C	HIST1H3C:NM_003531:exon1:c.T291C:p.C97C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6713	0.6891	0.705272	0.6989	.	.	.	.	.	.	.	.	HIST1H3C:uc003nfv.3:exon1:c.T291C:p.C97C	.	AFR:0.7176,AMR:0.6591,EAS:0.8665,FIN:0.6825,NFE:0.6759,OTH:0.7071,ASJ:0.6733	602812	.	.	.	~ko05034 Alcoholism~ko05202 Transcriptional misregulation in cancer~ko05322 Systemic lupus erythematosus ~	.	.	.	.	.	.	.	6	MU4557974	het
6	28872446	28872446	T	C	TRIM27	intronic	.	ENSG00000204713	rs209126	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5675	0.6261	0.680911	0.6037	.	.	.	.	.	0.0011	0.018	.	.	.	AFR:0.8643,AMR:0.5683,EAS:0.6902,FIN:0.4335,NFE:0.4924,OTH:0.4990,ASJ:0.5464	602165	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	28891423	28891423	G	A	TRIM27	UTR5	.	ENSG00000204713	rs11545588	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1813	0.0986	0.107827	0.1101	.	.	.	.	.	.	.	.	.	.	AFR:0.1440,AMR:0.1495,EAS:0.1078,FIN:0.1081,NFE:0.0907,OTH:0.0900,ASJ:0.0927	602165	.	.	.	.	.	.	.	.	.	.	.	6	MU63423109	het
6	30680916	30680916	C	T	MDC1	exonic	nonsynonymous SNV	ENSG00000137337	rs9262152	ENSG00000137337:ENST00000376405:exon5:c.G803A:p.R268K,ENSG00000137337:ENST00000376406:exon5:c.G803A:p.R268K	MDC1:NM_014641:exon5:c.G803A:p.R268K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1479	0.1129	0.106629	0.1152	0.500	7.435	0.448	-2.14	0.000	.	.	.	MDC1:uc003nrg.4:exon5:c.G803A:p.R268K,MDC1:uc003nri.2:exon5:c.G803A:p.R268K,MDC1:uc003nrh.1:exon6:c.G419A:p.R140K,MDC1:uc011dmp.1:exon6:c.G419A:p.R140K	-0.935	AFR:0.0286,AMR:0.1531,EAS:0.0684,FIN:0.1628,NFE:0.1555,OTH:0.1564,ASJ:0.08	607593	.	.	.	.	.	.	.	0.046	4.36	0.001	1.14	6	MU113352448	het
6	30857072	30857072	G	C	DDR1	exonic	synonymous SNV	ENSG00000204580	rs2229933	ENSG00000204580:ENST00000376567:exon3:c.G282C:p.L94L,ENSG00000204580:ENST00000513240:exon3:c.G282C:p.L94L,ENSG00000204580:ENST00000376568:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000396342:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000418800:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000421124:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000460944:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000482873:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000503495:exon4:c.G360C:p.L120L,ENSG00000204580:ENST00000504679:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000504927:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000505066:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000508312:exon4:c.G336C:p.L112L,ENSG00000204580:ENST00000511510:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000512694:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000512725:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000515233:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000376569:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000428153:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000437124:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000452441:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000505534:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000508317:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000509639:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000512336:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000324771:exon6:c.G282C:p.L94L,ENSG00000204580:ENST00000376570:exon6:c.G282C:p.L94L,ENSG00000204580:ENST00000376575:exon6:c.G282C:p.L94L,ENSG00000204580:ENST00000446312:exon6:c.G282C:p.L94L,ENSG00000204580:ENST00000454612:exon8:c.G282C:p.L94L	DDR1:NM_001202521:exon3:c.G282C:p.L94L,DDR1:NM_001202522:exon3:c.G282C:p.L94L,DDR1:NM_013994:exon3:c.G282C:p.L94L,DDR1:NM_001202523:exon4:c.G336C:p.L112L,DDR1:NM_001297652:exon4:c.G282C:p.L94L,DDR1:NM_001297653:exon4:c.G282C:p.L94L,DDR1:NM_001297654:exon4:c.G282C:p.L94L,DDR1:NM_013993:exon5:c.G282C:p.L94L,DDR1:NM_001954:exon6:c.G282C:p.L94L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3051	0.2076	0.415335	0.2548	.	.	.	.	.	.	.	.	DDR1:uc003nru.3:exon3:c.G282C:p.L94L,DDR1:uc003nrv.3:exon3:c.G282C:p.L94L,DDR1:uc003nrx.2:exon3:c.G282C:p.L94L,DDR1:uc003nry.2:exon3:c.G282C:p.L94L,DDR1:uc011dmu.1:exon3:c.G282C:p.L94L,DDR1:uc003nrs.3:exon4:c.G282C:p.L94L,DDR1:uc003nrt.3:exon4:c.G282C:p.L94L,DDR1:uc010jse.3:exon4:c.G282C:p.L94L,DDR1:uc011dms.2:exon4:c.G336C:p.L112L,DDR1:uc011dmt.2:exon4:c.G360C:p.L120L,DDR1:uc003nrr.3:exon5:c.G282C:p.L94L,DDR1:uc003nrq.3:exon6:c.G282C:p.L94L	.	AFR:0.2781,AMR:0.4594,EAS:0.5861,FIN:0.2629,NFE:0.1910,OTH:0.2776,ASJ:0.2384	600408	.	.	.	.	.	.	.	.	.	.	.	6	MU640884	hom
6	30858857	30858857	C	T	DDR1	exonic	synonymous SNV	ENSG00000204580	rs1049622	ENSG00000204580:ENST00000515219:exon3:c.C51T:p.S17S,ENSG00000204580:ENST00000376567:exon4:c.C525T:p.S175S,ENSG00000204580:ENST00000513240:exon4:c.C525T:p.S175S,ENSG00000204580:ENST00000376568:exon5:c.C525T:p.S175S,ENSG00000204580:ENST00000418800:exon5:c.C525T:p.S175S,ENSG00000204580:ENST00000421124:exon5:c.C525T:p.S175S,ENSG00000204580:ENST00000460944:exon5:c.C525T:p.S175S,ENSG00000204580:ENST00000482873:exon5:c.C525T:p.S175S,ENSG00000204580:ENST00000508312:exon5:c.C579T:p.S193S,ENSG00000204580:ENST00000376569:exon6:c.C525T:p.S175S,ENSG00000204580:ENST00000428153:exon6:c.C525T:p.S175S,ENSG00000204580:ENST00000452441:exon6:c.C525T:p.S175S,ENSG00000204580:ENST00000324771:exon7:c.C525T:p.S175S,ENSG00000204580:ENST00000376570:exon7:c.C525T:p.S175S,ENSG00000204580:ENST00000376575:exon7:c.C525T:p.S175S,ENSG00000204580:ENST00000446312:exon7:c.C525T:p.S175S,ENSG00000204580:ENST00000454612:exon9:c.C525T:p.S175S	DDR1:NM_001202521:exon4:c.C525T:p.S175S,DDR1:NM_001202522:exon4:c.C525T:p.S175S,DDR1:NM_013994:exon4:c.C525T:p.S175S,DDR1:NM_001202523:exon5:c.C579T:p.S193S,DDR1:NM_001297652:exon5:c.C525T:p.S175S,DDR1:NM_001297653:exon5:c.C525T:p.S175S,DDR1:NM_001297654:exon5:c.C525T:p.S175S,DDR1:NM_013993:exon6:c.C525T:p.S175S,DDR1:NM_001954:exon7:c.C525T:p.S175S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3051	0.2080	0.415535	LAML-KR|1|205|0.00487805	.	.	.	.	.	.	.	.	DDR1:uc003nru.3:exon4:c.C525T:p.S175S,DDR1:uc003nrv.3:exon4:c.C525T:p.S175S,DDR1:uc003nrx.2:exon4:c.C525T:p.S175S,DDR1:uc003nry.2:exon4:c.C525T:p.S175S,DDR1:uc011dmu.1:exon4:c.C525T:p.S175S,DDR1:uc003nrs.3:exon5:c.C525T:p.S175S,DDR1:uc003nrt.3:exon5:c.C525T:p.S175S,DDR1:uc010jse.3:exon5:c.C525T:p.S175S,DDR1:uc011dms.2:exon5:c.C579T:p.S193S,DDR1:uc011dmt.2:exon5:c.C603T:p.S201S,DDR1:uc003nrr.3:exon6:c.C525T:p.S175S,DDR1:uc003nrq.3:exon7:c.C525T:p.S175S	.	AFR:0.2552,AMR:0.2786,EAS:0.2384,FIN:0.5855,NFE:0.2630,OTH:0.1914,ASJ:0.4594	600408	.	.	.	.	.	.	.	.	.	.	.	6	52(meninges)	0.2770
6	30862423	30862423	C	T	DDR1	exonic	nonsynonymous SNV	ENSG00000204580	rs1264319	ENSG00000204580:ENST00000361741:exon6:c.C599T:p.P200L,ENSG00000204580:ENST00000417521:exon6:c.C794T:p.P265L	DDR1:NM_001202522:exon10:c.C1406T:p.P469L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1676	0.1966	0.128195	3(soft_tissue)	2.508	19.52	0.308	2.73	0.970	.	.	.	DDR1:uc003nrw.1:exon6:c.C803T:p.P268L,DDR1:uc003nrx.2:exon10:c.C1406T:p.P469L	-1.073	AFR:29(lung),AMR:.,EAS:0.1792,FIN:0.1869,NFE:0.1098,OTH:0.1433,ASJ:.	600408	.	.	.	.	.	.	.	0.0	-1.19	0.064	.	6	3(breast)	0.0900
6	30864829	30864829	T	C	DDR1	exonic	synonymous SNV	ENSG00000204580	rs1049623	ENSG00000204580:ENST00000361741:exon9:c.T909C:p.V303V,ENSG00000204580:ENST00000417521:exon9:c.T1104C:p.V368V,ENSG00000204580:ENST00000376567:exon12:c.T1797C:p.V599V,ENSG00000204580:ENST00000418800:exon13:c.T1797C:p.V599V,ENSG00000204580:ENST00000508312:exon13:c.T1851C:p.V617V,ENSG00000204580:ENST00000513240:exon13:c.T1908C:p.V636V,ENSG00000204580:ENST00000376568:exon14:c.T1908C:p.V636V,ENSG00000204580:ENST00000376569:exon14:c.T1797C:p.V599V,ENSG00000204580:ENST00000376570:exon15:c.T1797C:p.V599V,ENSG00000204580:ENST00000452441:exon15:c.T1908C:p.V636V,ENSG00000204580:ENST00000324771:exon16:c.T1908C:p.V636V,ENSG00000204580:ENST00000376575:exon16:c.T1908C:p.V636V,ENSG00000204580:ENST00000454612:exon17:c.T1797C:p.V599V	DDR1:NM_001202522:exon11:c.T1470C:p.V490V,DDR1:NM_001202523:exon13:c.T1851C:p.V617V,DDR1:NM_001297652:exon13:c.T1797C:p.V599V,DDR1:NM_001297653:exon13:c.T1797C:p.V599V,DDR1:NM_013994:exon13:c.T1908C:p.V636V,DDR1:NM_001297654:exon14:c.T1908C:p.V636V,DDR1:NM_001954:exon15:c.T1797C:p.V599V,DDR1:NM_013993:exon15:c.T1908C:p.V636V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4631	0.4071	0.535743	1(large_intestine)	.	.	.	.	.	.	.	.	DDR1:uc003nrw.1:exon9:c.T1113C:p.V371V,DDR1:uc003nrx.2:exon11:c.T1470C:p.V490V,DDR1:uc003nru.3:exon12:c.T1797C:p.V599V,DDR1:uc003nrt.3:exon13:c.T1797C:p.V599V,DDR1:uc003nrv.3:exon13:c.T1908C:p.V636V,DDR1:uc010jse.3:exon13:c.T1797C:p.V599V,DDR1:uc011dms.2:exon13:c.T1851C:p.V617V,DDR1:uc003nrs.3:exon14:c.T1908C:p.V636V,DDR1:uc003nrq.3:exon15:c.T1797C:p.V599V,DDR1:uc003nrr.3:exon15:c.T1908C:p.V636V	.	AFR:MU157872,AMR:LAML-KR|1|205|0.00487805,EAS:0.4650,FIN:0.5692,NFE:0.3808,OTH:0.6677,ASJ:0.4341	600408	.	.	.	.	.	.	.	.	.	.	.	6	1(prostate)	0.4067
6	30865204	30865204	A	C	DDR1	exonic	synonymous SNV	ENSG00000204580	rs2267641	ENSG00000204580:ENST00000361741:exon10:c.A1047C:p.P349P,ENSG00000204580:ENST00000417521:exon10:c.A1242C:p.P414P,ENSG00000204580:ENST00000376567:exon13:c.A1935C:p.P645P,ENSG00000204580:ENST00000418800:exon14:c.A1935C:p.P645P,ENSG00000204580:ENST00000508312:exon14:c.A1989C:p.P663P,ENSG00000204580:ENST00000513240:exon14:c.A2064C:p.P688P,ENSG00000204580:ENST00000376568:exon15:c.A2046C:p.P682P,ENSG00000204580:ENST00000376569:exon15:c.A1935C:p.P645P,ENSG00000204580:ENST00000376570:exon16:c.A1935C:p.P645P,ENSG00000204580:ENST00000452441:exon16:c.A2046C:p.P682P,ENSG00000204580:ENST00000324771:exon17:c.A2046C:p.P682P,ENSG00000204580:ENST00000376575:exon17:c.A2064C:p.P688P,ENSG00000204580:ENST00000454612:exon18:c.A1935C:p.P645P	DDR1:NM_001202522:exon12:c.A1608C:p.P536P,DDR1:NM_001202523:exon14:c.A1989C:p.P663P,DDR1:NM_001297652:exon14:c.A1935C:p.P645P,DDR1:NM_001297653:exon14:c.A1935C:p.P645P,DDR1:NM_013994:exon14:c.A2064C:p.P688P,DDR1:NM_001297654:exon15:c.A2046C:p.P682P,DDR1:NM_001954:exon16:c.A1935C:p.P645P,DDR1:NM_013993:exon16:c.A2046C:p.P682P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2300	0.1472	0.282348	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	DDR1:uc003nrw.1:exon10:c.A1251C:p.P417P,DDR1:uc003nrx.2:exon12:c.A1608C:p.P536P,DDR1:uc003nru.3:exon13:c.A1935C:p.P645P,DDR1:uc003nrt.3:exon14:c.A1935C:p.P645P,DDR1:uc003nrv.3:exon14:c.A2064C:p.P688P,DDR1:uc010jse.3:exon14:c.A1935C:p.P645P,DDR1:uc011dms.2:exon14:c.A1989C:p.P663P,DDR1:uc003nrs.3:exon15:c.A2046C:p.P682P,DDR1:uc003nrq.3:exon16:c.A1935C:p.P645P,DDR1:uc003nrr.3:exon16:c.A2046C:p.P682P	.	AFR:MU4548109,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,EAS:0.1392,FIN:0.3699,NFE:0.1788,OTH:0.3280,ASJ:0.1777	600408	.	.	.	.	.	.	.	.	.	.	.	6	1(thyroid)	0.2270
6	30877202	30877202	T	C	GTF2H4	intronic	.	ENSG00000213780	rs916920	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3007	0.2074	0.407748	0.2543	.	.	.	.	.	0	0	.	.	.	AFR:0.2780,AMR:0.4581,EAS:0.5821,FIN:0.2637,NFE:0.1909,OTH:0.2751,ASJ:0.2285	601760	.	.	.	~ko03022 Basal transcription factors~ko03420 Nucleotide excision repair~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	6	.	het
6	30877760	30877760	A	C	GTF2H4	exonic	synonymous SNV	ENSG00000213780	rs1419693	ENSG00000213780:ENST00000539324:exon3:c.A126C:p.T42T,ENSG00000213780:ENST00000259895:exon4:c.A294C:p.T98T,ENSG00000213780:ENST00000376316:exon4:c.A294C:p.T98T,ENSG00000213780:ENST00000453897:exon4:c.A294C:p.T98T	GTF2H4:NM_001517:exon4:c.A294C:p.T98T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3002	0.2076	0.407748	0.2544	.	.	.	.	.	.	.	.	GTF2H4:uc011dmv.1:exon3:c.A126C:p.T42T,GTF2H4:uc003nsa.1:exon4:c.A294C:p.T98T,GTF2H4:uc010jsf.2:exon4:c.A294C:p.T98T	.	AFR:0.2780,AMR:0.4581,EAS:0.5797,FIN:0.2629,NFE:0.1915,OTH:0.2765,ASJ:0.2285	601760	.	.	.	~ko03022 Basal transcription factors~ko03420 Nucleotide excision repair~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	6	MU16197142	het
6	30878919	30878919	T	C	GTF2H4	intronic	.	ENSG00000213780	rs2074512	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2979	0.2101	0.407348	0.2541	.	.	.	.	.	.	.	.	.	.	AFR:0.2776,AMR:0.4605,EAS:0.5781,FIN:0.2635,NFE:0.1908,OTH:0.2761,ASJ:0.2285	601760	.	.	.	~ko03022 Basal transcription factors~ko03420 Nucleotide excision repair~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	6	.	het
6	32172065	32172065	T	G	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs1044506	ENSG00000204301:ENST00000375023:exon19:c.A2967C:p.G989G	NOTCH4:NM_004557:exon19:c.A2967C:p.G989G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9165	0.9034	0.963259	0.9054	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon19:c.A2967C:p.G989G	.	AFR:0.9704,AMR:0.9427,EAS:0.9957,FIN:0.8716,NFE:0.8629,OTH:0.8988,ASJ:0.9603	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	.	hom
6	32180241	32180241	C	T	NOTCH4	intronic	.	ENSG00000204301	rs206019	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1293	0.1463	0.182508	0.1358	.	.	.	.	.	.	.	.	.	.	AFR:0.2251,AMR:0.1241,EAS:0.3007,FIN:0.0521,NFE:0.0895,OTH:0.0847,ASJ:0.1391	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	MU29867583	hom
6	32184705	32184705	G	A	NOTCH4	intronic	.	ENSG00000204301	rs3134798	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.7723	0.7697	0.824481	0.7647	.	.	.	.	.	.	.	.	NOTCH4:uc003obc.3:exon11:c.C1878T:p.H626H	.	AFR:0.8603,AMR:0.6782,EAS:0.8995,FIN:0.6301,NFE:0.7298,OTH:0.7311,ASJ:0.9133	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	.	hom
6	32190390	32190390	T	G	NOTCH4	exonic	nonsynonymous SNV	ENSG00000204301	rs915894	ENSG00000204301:ENST00000375023:exon3:c.A349C:p.K117Q	NOTCH4:NM_004557:exon3:c.A349C:p.K117Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3584	0.3722	0.398762	1(lung)	-0.306	0.643	0.399	2.36	0.002	.	.	.	NOTCH4:uc003obb.3:exon3:c.A349C:p.K117Q,NOTCH4:uc003obc.3:exon3:c.A349C:p.K117Q	-0.758	AFR:1(urinary_tract),AMR:MU12600545,EAS:0.3603,FIN:0.3721,NFE:0.2542,OTH:0.3609,ASJ:LUSC-KR|2|170|0.0117647,BRCA-KR|1|50|0.02	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	0.0	-2.92	0.370	0.04	6	1(haematopoietic_and_lymphoid_tissue)	0.4819
6	32190406	32190406	A	G	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs443198	ENSG00000204301:ENST00000375023:exon3:c.T333C:p.G111G	NOTCH4:NM_004557:exon3:c.T333C:p.G111G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3804	0.4040	0.460663	2(lung)	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon3:c.T333C:p.G111G,NOTCH4:uc003obc.3:exon3:c.T333C:p.G111G	.	AFR:2(breast),AMR:MU713734,EAS:0.3795,FIN:0.4611,NFE:0.3225,OTH:0.4338,ASJ:LUSC-KR|2|170|0.0117647,BRCA-KR|1|50|0.02	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	1(urinary_tract)	0.5261
6	35423662	35423662	A	C	FANCE	exonic	synonymous SNV	ENSG00000112039	rs4713867	ENSG00000112039:ENST00000229769:exon2:c.A387C:p.P129P	FANCE:NM_021922:exon2:c.A387C:p.P129P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7211	0.7357	0.777955	0.7433	.	.	.	.	.	.	.	.	FANCE:uc003oko.1:exon2:c.A387C:p.P129P,FANCE:uc010jvw.1:exon2:c.A387C:p.P129P	.	AFR:0.8741,AMR:0.7995,EAS:0.6605,FIN:0.6994,NFE:0.6843,OTH:0.7255,ASJ:0.7417	613976	600901;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	6	MU18657626	hom
6	36645696	36645696	A	G	CDKN1A	exonic	nonsynonymous SNV	ENSG00000124762	rs2395655	ENSG00000124762:ENST00000448526:exon1:c.A83G:p.D28G	CDKN1A:NM_001291549:exon2:c.A83G:p.D28G	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4641	.	0.527556	MU46305489	.	.	.	.	.	.	.	.	CDKN1A:uc011dtq.2:exon1:c.A83G:p.D28G	.	AFR:COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.4816,EAS:0.3425,FIN:0.5596,NFE:0.4895,OTH:0.3667,ASJ:0.6871	116899	.	.	.	~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04630 JAK-STAT signaling pathway~ko04921 Oxytocin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	1969,	.	.	.	.	.	.	6	1(large_intestine)	0.3996
6	36652339	36652339	C	G	CDKN1A	intronic	.	ENSG00000124762	rs3176352	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3667	0.3878	0.503594	MU29871221	.	.	.	.	.	.	.	.	.	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.3870,EAS:0.4702,FIN:0.3146,NFE:0.5938,OTH:0.2368,ASJ:0.6302	116899	.	.	.	~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04630 JAK-STAT signaling pathway~ko04921 Oxytocin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	6	1(lung)	0.2599
6	41903782	41903782	A	C	CCND3	exonic	nonsynonymous SNV	ENSG00000112576	rs1051130	ENSG00000112576:ENST00000414200:exon4:c.T559G:p.S187A,ENSG00000112576:ENST00000415497:exon4:c.T187G:p.S63A,ENSG00000112576:ENST00000510503:exon4:c.T395G:p.L132R,ENSG00000112576:ENST00000372987:exon5:c.T625G:p.S209A,ENSG00000112576:ENST00000372988:exon5:c.T532G:p.S178A,ENSG00000112576:ENST00000372991:exon5:c.T775G:p.S259A,ENSG00000112576:ENST00000511642:exon5:c.T532G:p.S178A	CCND3:NM_001136125:exon4:c.T559G:p.S187A,CCND3:NM_001136126:exon4:c.T187G:p.S63A,CCND3:NM_001136017:exon5:c.T532G:p.S178A,CCND3:NM_001287427:exon5:c.T625G:p.S209A,CCND3:NM_001287434:exon5:c.T187G:p.S63A,CCND3:NM_001760:exon5:c.T775G:p.S259A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5443	0.6243	0.592452	1(biliary_tract)	-1.116	0.009	0.561	0.192	0.074	.	.	Cyclin, C-terminal domain;Cyclin, C-terminal domain|Cyclin-like;Cyclin, N-terminal|Cyclin-like	CCND3:uc003oro.3:exon4:c.T559G:p.S187A,CCND3:uc011duk.2:exon4:c.T187G:p.S63A,CCND3:uc003orm.3:exon5:c.T625G:p.S209A,CCND3:uc003orn.3:exon5:c.T775G:p.S259A,CCND3:uc003orp.3:exon5:c.T532G:p.S178A	-0.932	AFR:1(breast),AMR:1(thyroid),EAS:MU4550745,FIN:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,BLCA-CN|1|103|0.00970874,NFE:0.6191,OTH:0.8028,ASJ:1(pancreas)	123834	.	.	.	~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04510 Focal adhesion~ko04630 JAK-STAT signaling pathway~ko05162 Measles~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis ~	.	.	.	0.0	1.93	0.010	0.205	6	62(lung)	0.5263
6	42931261	42931261	C	G	CNPY3-GNMT;GNMT	intronic	.	ENSG00000124713	rs2296804	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5897	0.6896	0.647364	0.6479	.	.	.	.	.	0.0014	0.014	.	.	.	AFR:0.9126,AMR:0.5574,EAS:0.3269,FIN:0.5114,NFE:0.5733,OTH:0.5758,ASJ:0.48	606628	606664;	289891;	289891|Glycine N-methyltransferase deficiency<br>Hypermethioninemia due to GNMT deficiency|-|-|-|606664 ~	.	.	.	.	.	.	.	.	6	MU20718783	hom
6	43581935	43581935	A	G	POLH	exonic	nonsynonymous SNV	ENSG00000170734	rs9333555	ENSG00000170734:ENST00000535400:exon10:c.A1597G:p.M533V,ENSG00000170734:ENST00000372236:exon11:c.A1783G:p.M595V	POLH:NM_001291969:exon9:c.A1411G:p.M471V,POLH:NM_006502:exon11:c.A1783G:p.M595V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0225	0.0233	0.0189696	0.0172	-1.937	0.001	0.367	-6.76	0.007	.	.	.	POLH:uc003ovr.4:exon8:c.A1531G:p.M511V,POLH:uc010jyu.2:exon9:c.A1411G:p.M471V,POLH:uc003ovq.4:exon11:c.A1783G:p.M595V	-1.088	AFR:0.0057,AMR:0.0131,EAS:0.0019,FIN:0.0046,NFE:0.0284,OTH:0.0224,ASJ:0.0132	603968	278750;	90342;	90342|XPV|<1 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|278750 ~	.	.	.	.	0.0	0.52	0.025	0.69	6	MU114230898	het
6	44268371	44268371	T	C	AARS2	exonic	synonymous SNV	ENSG00000124608	rs325008	ENSG00000124608:ENST00000244571:exon22:c.A2871G:p.S957S	AARS2:NM_020745:exon22:c.A2871G:p.S957S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9426	0.8711	0.869409	0.8912	.	.	.	.	.	.	.	.	AARS2:uc010jza.1:exon22:c.A2871G:p.S957S	.	AFR:0.6787,AMR:0.9606,EAS:0.9975,FIN:0.9954,NFE:0.9709,OTH:0.9469,ASJ:0.9139	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	.	.	.	.	6	MU4546910	hom
6	44269023	44269023	T	C	AARS2	intronic	.	ENSG00000124608;ENSG00000178233;ENSG00000272442	rs325007	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9421	0.8683	0.867812	0.8895	.	.	.	.	.	.	.	.	.	.	AFR:0.6724,AMR:0.9593,EAS:0.9969,FIN:0.9954,NFE:0.9709,OTH:0.9467,ASJ:0.9139	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	.	.	.	.	6	MU81815181	hom
6	44269193	44269193	C	T	AARS2	exonic	synonymous SNV	ENSG00000124608	rs498512	ENSG00000124608:ENST00000244571:exon20:c.G2607A:p.K869K	AARS2:NM_020745:exon20:c.G2607A:p.K869K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7015	0.6790	0.582668	0.6673	.	.	.	.	.	.	.	.	AARS2:uc010jza.1:exon20:c.G2607A:p.K869K	.	AFR:0.5090,AMR:0.7823,EAS:0.4097,FIN:0.7069,NFE:0.7661,OTH:0.7284,ASJ:0.7351	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	.	.	.	.	6	MU4552846	hom
6	44275011	44275011	T	C	AARS2	exonic	nonsynonymous SNV	ENSG00000124608	rs324136	ENSG00000124608:ENST00000244571:exon6:c.A1015G:p.I339V	AARS2:NM_020745:exon6:c.A1015G:p.I339V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9469	0.8866	0.888978	0.9059	-0.555	0.161	0.378	2.88	0.879	.	.	Alanine-tRNA ligase, class IIc, anti-codon-binding domain|Alanyl-tRNA synthetase, class IIc, N-terminal|Alanyl-tRNA synthetase, class IIc, core domain	AARS2:uc010jza.1:exon6:c.A1015G:p.I339V	-1.086	AFR:0.7292,AMR:0.9618,EAS:0.9975,FIN:0.9954,NFE:0.9716,OTH:0.9497,ASJ:0.9139	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	0.0	-0.43	0.033	-1.04	6	MU81815212	hom
6	44280812	44280812	C	T	AARS2	intronic	.	ENSG00000124608;ENSG00000272442	rs167772	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5333	0.4974	0.453275	0.4873	.	.	.	.	.	0.0006	0.04	.	.	.	AFR:0.3649,AMR:0.6158,EAS:0.3812,FIN:0.5097,NFE:0.5520,OTH:0.5297,ASJ:0.6324	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	.	.	.	.	6	MU707496	hom
6	91266349	91266349	-	A	MAP3K7	intronic	.	ENSG00000135341	rs3215663	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3310	0.0544	0.38139	0.3347	.	.	.	.	.	.	.	.	.	.	AFR:0.4363,AMR:0.2770,EAS:0.3025,FIN:0.2483,NFE:0.3033,OTH:0.2660,ASJ:0.4503	602614	157800;617137;	1826;3238;	1826|-|<1 / 1 000 000|X-linked dominant<br>or&nbsp;Autosomal dominant|Neonatal|305620 617137 ~3238|Forney syndrome<br>Forney-Robinson-Pascoe syndrome<br>Mitral regurgitation-deafness-skeletal anomalies syndrome|<1 / 1 000 000|Autosomal dominant|All ages|157800 ~	.	.	.	.	.	.	.	.	6	.	het
6	93967851	93967851	C	T	EPHA7	exonic	synonymous SNV	ENSG00000135333	rs345730	ENSG00000135333:ENST00000369303:exon11:c.G2076A:p.P692P	EPHA7:NM_001288629:exon11:c.G2061A:p.P687P,EPHA7:NM_004440:exon11:c.G2076A:p.P692P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7226	0.6783	0.73123	0.6823	.	.	.	.	.	.	.	.	EPHA7:uc003poe.3:exon11:c.G2076A:p.P692P,EPHA7:uc003pof.3:exon11:c.G2061A:p.P687P,EPHA7:uc011eac.2:exon11:c.G2064A:p.P688P	.	AFR:0.6010,AMR:0.6930,EAS:0.7868,FIN:0.7228,NFE:0.7056,OTH:0.7035,ASJ:0.7550	602190	.	.	.	.	.	.	.	.	.	.	.	6	MU20730318	hom
6	93982124	93982124	A	G	EPHA7	exonic	synonymous SNV	ENSG00000135333	rs345713	ENSG00000135333:ENST00000369303:exon6:c.T1341C:p.S447S	EPHA7:NM_001288629:exon6:c.T1341C:p.S447S,EPHA7:NM_004440:exon6:c.T1341C:p.S447S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8735	0.9151	0.900359	0.8912	.	.	.	.	.	.	.	.	EPHA7:uc003poe.3:exon6:c.T1341C:p.S447S,EPHA7:uc003pof.3:exon6:c.T1341C:p.S447S,EPHA7:uc011eac.2:exon6:c.T1341C:p.S447S	.	AFR:0.9733,AMR:0.8070,EAS:0.7869,FIN:0.8502,NFE:0.8689,OTH:0.8686,ASJ:0.9437	602190	.	.	.	.	.	.	.	.	.	.	.	6	MU721640	hom
6	94067981	94067981	C	T	EPHA7	exonic	synonymous SNV	ENSG00000135333	rs164544	ENSG00000135333:ENST00000369303:exon4:c.G981A:p.A327A	EPHA7:NM_001288629:exon4:c.G981A:p.A327A,EPHA7:NM_004440:exon4:c.G981A:p.A327A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6284	0.6362	0.730431	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	EPHA7:uc003poe.3:exon4:c.G981A:p.A327A,EPHA7:uc003pof.3:exon4:c.G981A:p.A327A,EPHA7:uc011eac.2:exon4:c.G981A:p.A327A	.	AFR:0.6591,AMR:0.8392,EAS:0.4899,FIN:0.8439,NFE:0.6164,OTH:0.5493,ASJ:0.6906	602190	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.6063
6	96999725	96999725	C	T	UFL1	exonic	synonymous SNV	ENSG00000014123	rs1127175	ENSG00000014123:ENST00000369278:exon17:c.C1911T:p.D637D	UFL1:NM_015323:exon17:c.C1911T:p.D637D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3383	0.3435	0.326677	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	UFL1:uc003por.3:exon17:c.C1911T:p.D637D	.	AFR:MU9863497,AMR:LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579,PBCA-DE|1|499|0.00200401,BTCA-JP|1|239|0.0041841,EAS:0.3366,FIN:0.2566,NFE:0.4007,OTH:0.2797,ASJ:0.3404	613372	.	.	.	.	.	.	.	.	.	.	.	6	1(liver)	0.3366
6	105300262	105300262	-	AG	HACE1	intronic	.	ENSG00000085382	rs10635352	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.6682	0.6597	0.620008	0.6452	.	.	.	.	.	.	.	.	.	.	AFR:0.5858,AMR:0.6190,EAS:0.5638,FIN:0.6368,NFE:0.6865,OTH:0.6902,ASJ:0.7633	610876	616756;	464282;	464282|SPPRS syndrome<br>Spastic paraplegia-psychomotor retardation-seizures syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616756 ~	.	.	.	.	.	.	.	.	6	.	hom
6	105307435	105307435	G	A	HACE1	intronic	.	ENSG00000085382	rs2499655	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5276	0.3781	0.438099	0.4390	.	.	.	.	.	0.0013	0.092	.	.	.	AFR:0.2035,AMR:0.4353,EAS:0.5557,FIN:0.5210,NFE:0.5351,OTH:0.5277,ASJ:0.6060	610876	616756;	464282;	464282|SPPRS syndrome<br>Spastic paraplegia-psychomotor retardation-seizures syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616756 ~	.	.	.	.	.	.	.	.	6	MU81819230	hom
6	106547372	106547372	C	G	PRDM1	exonic	nonsynonymous SNV	ENSG00000057657	rs811925	ENSG00000057657:ENST00000369089:exon2:c.C207G:p.D69E,ENSG00000057657:ENST00000450060:exon2:c.C246G:p.D82E,ENSG00000057657:ENST00000369091:exon4:c.C501G:p.D167E,ENSG00000057657:ENST00000369096:exon4:c.C609G:p.D203E	PRDM1:NM_182907:exon2:c.C207G:p.D69E,PRDM1:NM_001198:exon4:c.C609G:p.D203E	clinvar: not_provided 	 CancerVar: 7#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.1651	0.1672	0.15016	3(soft_tissue)	0.884	9.973	0.712	5.94	1.000	.	.	SET domain	PRDM1:uc003pre.3:exon2:c.C207G:p.D69E,PRDM1:uc003prd.2:exon4:c.C609G:p.D203E	-0.381	AFR:.,AMR:.,EAS:0.1580,FIN:0.1551,NFE:0.1225,OTH:0.0179,ASJ:0.1657	603423	.	.	.	.	.	.	9097,	0.66	-2.5	0.262	2.42	6	1(pleura)	0.2450
6	107019880	107019880	A	G	RTN4IP1	exonic	synonymous SNV	ENSG00000130347	rs9486410	ENSG00000130347:ENST00000369063:exon9:c.T1182C:p.N394N	RTN4IP1:NM_001318746:exon9:c.T882C:p.N294N,RTN4IP1:NM_032730:exon9:c.T1182C:p.N394N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1319	0.1698	0.185503	MU136492	.	.	.	.	.	.	.	.	RTN4IP1:uc003prj.3:exon9:c.T1182C:p.N394N,RTN4IP1:uc003prk.3:exon9:c.T882C:p.N294N	.	AFR:LAML-KR|2|205|0.0097561,COCA-CN|1|321|0.00311526,AMR:0.1544,EAS:0.1134,FIN:0.1026,NFE:0.1178,OTH:0.1156,ASJ:0.2767	610502	616732;	.	.	.	.	.	.	.	.	.	.	6	1(stomach)	0.1023
6	107019994	107019994	G	T	RTN4IP1	intronic	.	ENSG00000130347	rs9486411	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1316	0.1697	0.185104	0.1540	.	.	.	.	.	.	.	.	.	.	AFR:0.2763,AMR:0.1122,EAS:0.1179,FIN:0.1139,NFE:0.1024,OTH:0.1122,ASJ:0.1007	610502	616732;	.	.	.	.	.	.	.	.	.	.	6	MU12428712	het
6	107076783	107076783	A	T	RTN4IP1	exonic	synonymous SNV	ENSG00000130347	rs1987623	ENSG00000130347:ENST00000369063:exon1:c.T114A:p.P38P,ENSG00000130347:ENST00000539449:exon1:c.T114A:p.P38P	RTN4IP1:NM_032730:exon1:c.T114A:p.P38P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3516	0.3766	0.467252	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	RTN4IP1:uc003prj.3:exon1:c.T114A:p.P38P,RTN4IP1:uc010kdd.3:exon1:c.T114A:p.P38P	.	AFR:0.3914,AMR:0.5712,EAS:0.2119,FIN:0.6532,NFE:0.3526,OTH:0.2706,ASJ:0.4820	610502	616732;	.	.	.	.	.	.	.	.	.	.	6	1(lung)	0.3255
6	108984782	108984782	G	A	FOXO3	exonic	nonsynonymous SNV	ENSG00000118689	.	ENSG00000118689:ENST00000406360:exon2:c.G746A:p.R249Q,ENSG00000118689:ENST00000540898:exon2:c.G86A:p.R29Q,ENSG00000118689:ENST00000343882:exon3:c.G746A:p.R249Q	FOXO3:NM_001455:exon2:c.G746A:p.R249Q,FOXO3:NM_201559:exon3:c.G746A:p.R249Q	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 2, 1, 0] 	.	.	.	.	6.221	28.8	0.0	5.74	0.999	.	.	Fork head domain	FOXO3:uc003psm.2:exon2:c.G746A:p.R249Q,FOXO3:uc010kdj.1:exon2:c.G86A:p.R29Q,FOXO3:uc011ean.1:exon2:c.G86A:p.R29Q,FOXO3:uc003psk.2:exon3:c.G746A:p.R249Q	0.965	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602681	.	.	.	.	.	.	.	1.0	-3.4	0.903	3.04	6	.	het
6	111695073	111695073	C	T	REV3L	exonic	synonymous SNV	ENSG00000009413	rs455645	ENSG00000009413:ENST00000368802:exon13:c.G4485A:p.S1495S,ENSG00000009413:ENST00000358835:exon14:c.G4485A:p.S1495S,ENSG00000009413:ENST00000368805:exon14:c.G4485A:p.S1495S,ENSG00000009413:ENST00000435970:exon15:c.G4251A:p.S1417S	REV3L:NM_002912:exon14:c.G4485A:p.S1495S,REV3L:NM_001286432:exon15:c.G4251A:p.S1417S,REV3L:NM_001286431:exon16:c.G4251A:p.S1417S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7159	0.6862	0.586462	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	REV3L:uc003puy.4:exon13:c.G4485A:p.S1495S,REV3L:uc003pux.4:exon15:c.G4251A:p.S1417S,REV3L:uc003puz.4:exon15:c.G4251A:p.S1417S	.	AFR:0.6670,AMR:0.4393,EAS:0.7682,FIN:0.4651,NFE:0.6989,OTH:0.8072,ASJ:0.6826	602776	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.7169
6	111695268	111695268	C	T	REV3L	exonic	synonymous SNV	ENSG00000009413	rs455732	ENSG00000009413:ENST00000368802:exon13:c.G4290A:p.V1430V,ENSG00000009413:ENST00000358835:exon14:c.G4290A:p.V1430V,ENSG00000009413:ENST00000368805:exon14:c.G4290A:p.V1430V,ENSG00000009413:ENST00000435970:exon15:c.G4056A:p.V1352V	REV3L:NM_002912:exon14:c.G4290A:p.V1430V,REV3L:NM_001286432:exon15:c.G4056A:p.V1352V,REV3L:NM_001286431:exon16:c.G4056A:p.V1352V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4703	0.3946	0.354034	1(liver)	.	.	.	.	.	.	.	.	REV3L:uc003puy.4:exon13:c.G4290A:p.V1430V,REV3L:uc003pux.4:exon15:c.G4056A:p.V1352V,REV3L:uc003puz.4:exon15:c.G4056A:p.V1352V	.	AFR:MU721734,AMR:LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579,EAS:0.1064,FIN:0.4246,NFE:0.4702,OTH:0.4310,ASJ:0.3983	602776	.	.	.	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.4971
6	111695887	111695887	G	A	REV3L	exonic	nonsynonymous SNV	ENSG00000009413	rs462779	ENSG00000009413:ENST00000368802:exon13:c.C3671T:p.T1224I,ENSG00000009413:ENST00000358835:exon14:c.C3671T:p.T1224I,ENSG00000009413:ENST00000368805:exon14:c.C3671T:p.T1224I,ENSG00000009413:ENST00000435970:exon15:c.C3437T:p.T1146I	REV3L:NM_002912:exon14:c.C3671T:p.T1224I,REV3L:NM_001286432:exon15:c.C3437T:p.T1146I,REV3L:NM_001286431:exon16:c.C3437T:p.T1146I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7165	0.6866	0.586462	0.6672	0.396	6.577	1.0	1.45	0.417	.	.	.	REV3L:uc003puy.4:exon13:c.C3671T:p.T1224I,REV3L:uc003pux.4:exon15:c.C3437T:p.T1146I,REV3L:uc003puz.4:exon15:c.C3437T:p.T1146I	-0.991	AFR:0.4399,AMR:0.6818,EAS:0.4652,FIN:0.6987,NFE:0.8075,OTH:0.7172,ASJ:0.7667	602776	.	.	.	.	.	.	.	0.0	5.02	0.001	-1.355	6	MU4714890	het
6	111696257	111696257	G	A	REV3L	exonic	synonymous SNV	ENSG00000009413	rs461646	ENSG00000009413:ENST00000368802:exon13:c.C3301T:p.L1101L,ENSG00000009413:ENST00000358835:exon14:c.C3301T:p.L1101L,ENSG00000009413:ENST00000368805:exon14:c.C3301T:p.L1101L,ENSG00000009413:ENST00000435970:exon15:c.C3067T:p.L1023L	REV3L:NM_002912:exon14:c.C3301T:p.L1101L,REV3L:NM_001286432:exon15:c.C3067T:p.L1023L,REV3L:NM_001286431:exon16:c.C3067T:p.L1023L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7161	0.6859	0.586661	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	REV3L:uc003puy.4:exon13:c.C3301T:p.L1101L,REV3L:uc003pux.4:exon15:c.C3067T:p.L1023L,REV3L:uc003puz.4:exon15:c.C3067T:p.L1023L	.	AFR:MU4714901,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.4403,FIN:0.6859,NFE:0.7682,OTH:0.4633,ASJ:0.6671	602776	.	.	.	.	.	.	.	.	.	.	.	6	1(liver)	0.6988
6	111696852	111696852	T	C	REV3L	exonic	synonymous SNV	ENSG00000009413	rs458486	ENSG00000009413:ENST00000368802:exon13:c.A2706G:p.G902G,ENSG00000009413:ENST00000358835:exon14:c.A2706G:p.G902G,ENSG00000009413:ENST00000368805:exon14:c.A2706G:p.G902G,ENSG00000009413:ENST00000435970:exon15:c.A2472G:p.G824G	REV3L:NM_002912:exon14:c.A2706G:p.G902G,REV3L:NM_001286432:exon15:c.A2472G:p.G824G,REV3L:NM_001286431:exon16:c.A2472G:p.G824G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4710	0.3945	0.354233	MU12436274	.	.	.	.	.	.	.	.	REV3L:uc003puy.4:exon13:c.A2706G:p.G902G,REV3L:uc003pux.4:exon15:c.A2472G:p.G824G,REV3L:uc003puz.4:exon15:c.A2472G:p.G824G	.	AFR:LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,AMR:0.3978,EAS:0.4221,FIN:0.4702,NFE:0.4268,OTH:0.4974,ASJ:0.1059	602776	.	.	.	.	.	.	.	.	.	.	.	6	1(breast)	0.5350
6	117642992	117642992	-	T	ROS1	intronic	.	ENSG00000047936	rs11451804	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.438299	0.4604	.	.	.	.	.	.	.	.	.	.	AFR:0.5757,AMR:0.5584,EAS:0.4341,FIN:0.1336,NFE:0.4016,OTH:0.4516,ASJ:0.4433	165020	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	117654711	117654711	T	C	ROS1	intronic	.	ENSG00000047936	rs2095283	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	1	0.9990	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:0.9988,FIN:0.9991,NFE:0.9983,OTH:0.9980,ASJ:1	165020	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	117656555	117656555	T	G	ROS1	intronic	.	ENSG00000047936	rs9385006	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.757987	0.7751	.	.	.	.	.	.	.	.	.	.	AFR:0.8458,AMR:0.7422,EAS:0.6043,FIN:0.6943,NFE:0.7745,OTH:0.7525,ASJ:0.7767	165020	.	.	.	.	.	.	.	.	.	.	.	6	MU114372260	hom
6	117678083	117678083	A	G	ROS1	intronic	.	ENSG00000047936	rs2243384	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4657	0.4254	0.394569	MU687081	.	.	.	.	.	0	0	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.4054,EAS:0.4093,FIN:0.5033,NFE:0.4882,OTH:0.4413,ASJ:0.2292	165020	.	.	.	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.4875
6	117725448	117725448	T	G	ROS1	exonic	nonsynonymous SNV	ENSG00000047936	rs1998206	ENSG00000047936:ENST00000368508:exon5:c.A433C:p.T145P,ENSG00000047936:ENST00000368507:exon6:c.A460C:p.T154P	ROS1:NM_002944:exon5:c.A433C:p.T145P	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.1618	0.1469	0.167732	1(haematopoietic_and_lymphoid_tissue)	3.089	22.5	0.128	5.41	0.113	.	.	Fibronectin type III|Immunoglobulin-like fold	ROS1:uc003pxp.1:exon5:c.A433C:p.T145P	-0.724	AFR:31(meninges),AMR:1(breast),EAS:MU9240538,FIN:LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,NFE:0.1710,OTH:0.1571,ASJ:1(liver)	165020	.	.	.	.	,9578,9580,9579	.	.	1.0	0.35	0.210	2.045	6	13(lung)	0.1602
6	117725578	117725578	T	A	ROS1	exonic	synonymous SNV	ENSG00000047936	rs2243378	ENSG00000047936:ENST00000368508:exon5:c.A303T:p.L101L,ENSG00000047936:ENST00000368507:exon6:c.A330T:p.L110L	ROS1:NM_002944:exon5:c.A303T:p.L101L	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.5497	0.5992	0.67512	MU136033	.	.	.	.	.	.	.	.	ROS1:uc003pxp.1:exon5:c.A303T:p.L101L	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,AMR:0.6261,EAS:0.4785,FIN:0.3775,NFE:0.5655,OTH:0.6040,ASJ:0.8677	165020	.	.	.	.	,9578,9580,9579	.	.	.	.	.	.	6	2(large_intestine)	0.5096
6	128383562	128383562	-	A	LOC101928140	ncRNA_intronic	.	ENSG00000227945	rs11422080	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.957668	0.9075	.	.	.	.	.	.	.	.	.	.	AFR:0.9730,AMR:0.9342,EAS:1,FIN:0.9064,NFE:0.8568,OTH:0.9090,ASJ:0.9536	.	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	128403745	128403745	A	G	PTPRK	exonic	synonymous SNV	ENSG00000152894	rs17828130	ENSG00000152894:ENST00000368207:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000368210:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000368213:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000368215:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000368226:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000368227:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000532331:exon10:c.T1614C:p.V538V	PTPRK:NM_001291983:exon9:c.T1227C:p.V409V,PTPRK:NM_001135648:exon10:c.T1614C:p.V538V,PTPRK:NM_001291981:exon10:c.T1614C:p.V538V,PTPRK:NM_001291982:exon10:c.T1614C:p.V538V,PTPRK:NM_001291984:exon10:c.T1614C:p.V538V,PTPRK:NM_002844:exon10:c.T1614C:p.V538V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5892	0.4865	0.481829	0.4893	.	.	.	.	.	.	.	.	PTPRK:uc003qbl.1:exon8:c.T1224C:p.V408V,PTPRK:uc003qbj.3:exon10:c.T1614C:p.V538V,PTPRK:uc003qbk.3:exon10:c.T1614C:p.V538V,PTPRK:uc010kfc.3:exon10:c.T1614C:p.V538V,PTPRK:uc011ebu.2:exon10:c.T1614C:p.V538V,PTPRK:uc011ebv.1:exon10:c.T1614C:p.V538V	.	AFR:0.1828,AMR:0.6918,EAS:0.5370,FIN:0.5369,NFE:0.6335,OTH:0.5806,ASJ:0.5232	602545	.	.	.	.	.	.	.	.	.	.	.	6	MU14046683	hom
6	129381026	129381026	C	A	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs4404787	ENSG00000196569:ENST00000421865:exon3:c.C381A:p.T127T	LAMA2:NM_000426:exon3:c.C381A:p.T127T,LAMA2:NM_001079823:exon3:c.C381A:p.T127T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9578	0.9473	0.936701	0.9540	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon3:c.C381A:p.T127T,LAMA2:uc003qbo.3:exon3:c.C381A:p.T127T,LAMA2:uc021zfb.1:exon3:c.C381A:p.T127T	.	AFR:0.9027,AMR:0.9773,EAS:0.9759,FIN:0.9840,NFE:0.9723,OTH:0.9644,ASJ:0.9636	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU81821229	hom
6	129511373	129511373	T	C	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs2306220	ENSG00000196569:ENST00000421865:exon11:c.T1491C:p.C497C	LAMA2:NM_000426:exon11:c.T1491C:p.C497C,LAMA2:NM_001079823:exon11:c.T1491C:p.C497C	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0323	0.0120	0.0565096	0.0207	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon11:c.T1491C:p.C497C,LAMA2:uc003qbo.3:exon11:c.T1491C:p.C497C,LAMA2:uc021zfb.1:exon11:c.T1491C:p.C497C	.	AFR:0.0141,AMR:0.0167,EAS:0.1650,FIN:0.0226,NFE:0.0087,OTH:0.0214,ASJ:0.0232	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU80602964	het
6	129511468	129511468	G	A	LAMA2	exonic	nonsynonymous SNV	ENSG00000196569	rs370691060	ENSG00000196569:ENST00000421865:exon11:c.G1586A:p.S529N	LAMA2:NM_000426:exon11:c.G1586A:p.S529N,LAMA2:NM_001079823:exon11:c.G1586A:p.S529N	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, -1, 1, 1, 1, 0] 	0.0033	.	0.0081869	6.459e-05	4.036	23.7	0.018	4.77	0.998	.	.	Growth factor receptor cysteine-rich domain	LAMA2:uc003qbn.3:exon11:c.G1586A:p.S529N,LAMA2:uc003qbo.3:exon11:c.G1586A:p.S529N,LAMA2:uc021zfb.1:exon11:c.G1586A:p.S529N	-1.033	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	0.651	1.15	0.047	3.235	6	.	het
6	129612808	129612808	A	G	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs1027199	ENSG00000196569:ENST00000421865:exon20:c.A2799G:p.Q933Q	LAMA2:NM_000426:exon20:c.A2799G:p.Q933Q,LAMA2:NM_001079823:exon20:c.A2799G:p.Q933Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2683	0.2584	0.313898	0.2719	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon20:c.A2799G:p.Q933Q,LAMA2:uc003qbo.3:exon20:c.A2799G:p.Q933Q,LAMA2:uc021zfb.1:exon20:c.A2799G:p.Q933Q	.	AFR:0.3228,AMR:0.2524,EAS:0.4294,FIN:0.2984,NFE:0.2232,OTH:0.2459,ASJ:0.2067	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU105678	het
6	129634213	129634213	A	G	LAMA2	exonic	nonsynonymous SNV	ENSG00000196569	rs529055249	ENSG00000196569:ENST00000421865:exon23:c.A3382G:p.S1128G	LAMA2:NM_000426:exon23:c.A3382G:p.S1128G,LAMA2:NM_001079823:exon23:c.A3382G:p.S1128G	clinvar: Uncertain_significance 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 0] 	0.0003	.	0.000998403	6.457e-05	-0.955	0.020	0.146	-4.57	0.181	.	.	Laminin EGF domain	LAMA2:uc003qbn.3:exon23:c.A3382G:p.S1128G,LAMA2:uc003qbo.3:exon23:c.A3382G:p.S1128G,LAMA2:uc021zfb.1:exon23:c.A3382G:p.S1128G	-1.029	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0020,ASJ:0	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	0.032	0.56	0.024	0.18	6	.	het
6	129634255	129634255	G	A	LAMA2	intronic	.	ENSG00000196569	rs3798663	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2190	0.2277	0.355232	0.2465	.	.	.	.	.	.	.	.	.	.	AFR:0.4602,AMR:0.3146,EAS:0.5412,FIN:0.1478,NFE:0.1187,OTH:0.1561,ASJ:0.1126	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU18714958	het
6	129635800	129635800	G	A	LAMA2	exonic	nonsynonymous SNV	ENSG00000196569	rs2306942	ENSG00000196569:ENST00000421865:exon24:c.G3412A:p.V1138M	LAMA2:NM_000426:exon24:c.G3412A:p.V1138M,LAMA2:NM_001079823:exon24:c.G3412A:p.V1138M	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0687	0.0911	0.120008	0.0849	2.722	20.9	0.07	4.72	0.980	0.0857	0.288	Laminin EGF domain	LAMA2:uc003qbn.3:exon24:c.G3412A:p.V1138M,LAMA2:uc003qbo.3:exon24:c.G3412A:p.V1138M,LAMA2:uc021zfb.1:exon24:c.G3412A:p.V1138M	-1.053	AFR:0.1852,AMR:0.0632,EAS:0.1432,FIN:0.0223,NFE:0.0398,OTH:0.0429,ASJ:0.0364	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	0.018	0.55	0.069	1.685	6	MU12472046	het
6	129637177	129637177	T	A	LAMA2	intronic	.	ENSG00000196569	rs372612467	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, 0, 1, 0] 	0.0011	.	0.00239617	3.229e-05	.	.	.	.	.	0.0156	0.248	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	.	het
6	129722389	129722389	A	G	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs3749877	ENSG00000196569:ENST00000421865:exon38:c.A5466G:p.E1822E	LAMA2:NM_000426:exon38:c.A5466G:p.E1822E,LAMA2:NM_001079823:exon38:c.A5466G:p.E1822E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4978	0.5161	0.544529	0.5112	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon38:c.A5466G:p.E1822E,LAMA2:uc003qbo.3:exon38:c.A5466G:p.E1822E,LAMA2:uc021zfb.1:exon38:c.A5466G:p.E1822E	.	AFR:0.6206,AMR:0.4845,EAS:0.5824,FIN:0.4613,NFE:0.4523,OTH:0.5051,ASJ:0.5705	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU12472152	hom
6	129722425	129722425	G	A	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs3749878	ENSG00000196569:ENST00000421865:exon38:c.G5502A:p.E1834E	LAMA2:NM_000426:exon38:c.G5502A:p.E1834E,LAMA2:NM_001079823:exon38:c.G5502A:p.E1834E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4963	0.5150	0.543331	0.5089	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon38:c.G5502A:p.E1834E,LAMA2:uc003qbo.3:exon38:c.G5502A:p.E1834E,LAMA2:uc021zfb.1:exon38:c.G5502A:p.E1834E	.	AFR:0.6208,AMR:0.4784,EAS:0.5815,FIN:0.4559,NFE:0.4496,OTH:0.5020,ASJ:0.5667	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU4554300	hom
6	129807629	129807629	C	T	LAMA2	exonic	nonsynonymous SNV	ENSG00000196569	rs2229848	ENSG00000196569:ENST00000421865:exon56:c.C7760T:p.A2587V	LAMA2:NM_001079823:exon55:c.C7748T:p.A2583V,LAMA2:NM_000426:exon56:c.C7760T:p.A2587V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.6678	0.6386	0.583866	0.6270	7.378	34	0.056	5.6	0.894	.	.	Concanavalin A-like lectin/glucanase domain|Laminin G domain	LAMA2:uc003qbo.3:exon54:c.C7742T:p.A2581V,LAMA2:uc003qbn.3:exon55:c.C7754T:p.A2585V,LAMA2:uc021zfb.1:exon56:c.C7760T:p.A2587V	0.056	AFR:0.4529,AMR:0.6878,EAS:0.6160,FIN:0.6464,NFE:0.7152,OTH:0.6851,ASJ:0.7384	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	0.998	-1.2	0.584	2.395	6	MU687237	hom
6	129807699	129807699	G	C	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs2229849	ENSG00000196569:ENST00000421865:exon56:c.G7830C:p.V2610V	LAMA2:NM_001079823:exon55:c.G7818C:p.V2606V,LAMA2:NM_000426:exon56:c.G7830C:p.V2610V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6682	0.6400	0.584265	0.6279	.	.	.	.	.	.	.	.	LAMA2:uc003qbo.3:exon54:c.G7812C:p.V2604V,LAMA2:uc003qbn.3:exon55:c.G7824C:p.V2608V,LAMA2:uc021zfb.1:exon56:c.G7830C:p.V2610V	.	AFR:0.4568,AMR:0.6894,EAS:0.6113,FIN:0.6461,NFE:0.7153,OTH:0.6857,ASJ:0.7384	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU20737955	hom
6	137519588	137519588	A	C	IFNGR1	exonic	synonymous SNV	ENSG00000027697	rs11914	ENSG00000027697:ENST00000367739:exon7:c.T1050G:p.S350S,ENSG00000027697:ENST00000543628:exon7:c.T966G:p.S322S	IFNGR1:NM_000416:exon7:c.T1050G:p.S350S,IFNGR1:NM_001363527:exon7:c.T927G:p.S309S,IFNGR1:NM_001363526:exon8:c.T1020G:p.S340S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1317	0.1286	0.0940495	.	.	.	.	.	.	.	.	.	IFNGR1:uc003qho.2:exon7:c.T1050G:p.S350S,IFNGR1:uc011edm.1:exon7:c.T966G:p.S322S	.	AFR:0.1234,AMR:0.0624,EAS:0.2086,FIN:0.1399,NFE:0.0967,OTH:0.1618,ASJ:0.1077	107470	209950;600263;607948;610424;615978;	319581;3389;319569;99898;	319581|Autosomal dominant MSMD due to partial IFNgammaR1 deficiency<br>Autosomal dominant MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal dominant|Adolescent|615978 ~3389|-|1-5 / 10 000|Not applicable|All ages|607948 ~319569|Autosomal recessive MSMD due to partial IFNgammaR1 deficiency<br>Autosomal recessive MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal recessive|-|209950 ~99898|MSMD due to complete IFNgammaR1 deficiency<br>MSMD due to complete interferon gamma receptor 1 deficiency<br>Mendelian susceptibility to mycobacterial diseases due to complete interferon gamma receptor 1 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|209950 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04066 HIF-1 signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05132 Salmonella infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	6	1(large_intestine)	0.1337
6	137536455	137536455	G	A	IFNGR1	exonic	nonsynonymous SNV	ENSG00000027697	rs1327475	ENSG00000027697:ENST00000367735:exon2:c.C4T:p.L2F,ENSG00000027697:ENST00000414770:exon2:c.C4T:p.L2F	IFNGR1:NM_001363526:exon2:c.C4T:p.L2F	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1222	.	0.0924521	0.1205	0.554	7.832	0.0	1.42	0.001	.	.	.	IFNGR1:uc011edn.1:exon2:c.C4T:p.L2F	-0.764	AFR:0.0548,AMR:0.1041,EAS:0.1403,FIN:0.0965,NFE:0.1606,OTH:0.1316,ASJ:0.2086	107470	209950;600263;607948;610424;615978;	319581;3389;319569;99898;	319581|Autosomal dominant MSMD due to partial IFNgammaR1 deficiency<br>Autosomal dominant MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal dominant|Adolescent|615978 ~3389|-|1-5 / 10 000|Not applicable|All ages|607948 ~319569|Autosomal recessive MSMD due to partial IFNgammaR1 deficiency<br>Autosomal recessive MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal recessive|-|209950 ~99898|MSMD due to complete IFNgammaR1 deficiency<br>MSMD due to complete interferon gamma receptor 1 deficiency<br>Mendelian susceptibility to mycobacterial diseases due to complete interferon gamma receptor 1 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|209950 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04066 HIF-1 signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05132 Salmonella infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	0.137	-2.3	0.317	.	6	.	het
6	137540370	137540370	A	G	IFNGR1	intronic	.	ENSG00000027697	rs7749390	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4834	0.4282	0.502396	0.4295	.	.	.	.	.	.	.	.	.	.	AFR:0.5046,AMR:0.3696,EAS:0.5894,FIN:0.3465,NFE:0.3881,OTH:0.45,ASJ:0.5232	107470	209950;600263;607948;610424;615978;	319581;3389;319569;99898;	319581|Autosomal dominant MSMD due to partial IFNgammaR1 deficiency<br>Autosomal dominant MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal dominant|Adolescent|615978 ~3389|-|1-5 / 10 000|Not applicable|All ages|607948 ~319569|Autosomal recessive MSMD due to partial IFNgammaR1 deficiency<br>Autosomal recessive MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal recessive|-|209950 ~99898|MSMD due to complete IFNgammaR1 deficiency<br>MSMD due to complete interferon gamma receptor 1 deficiency<br>Mendelian susceptibility to mycobacterial diseases due to complete interferon gamma receptor 1 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|209950 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04066 HIF-1 signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05132 Salmonella infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	6	MU20697206	het
6	138195962	138195964	CTC	-	TNFAIP3	intronic	.	ENSG00000118503	rs2307859	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.6105	0.4825	0.533946	0.5196	.	.	.	.	.	.	.	.	.	.	AFR:0.1745,AMR:0.5396,EAS:0.8602,FIN:0.6460,NFE:0.6471,OTH:0.6118,ASJ:0.5728	191163	616744;	.	.	.	.	.	.	.	.	.	.	6	.	het
6	146207563	146207563	A	G	LOC100507557	ncRNA_exonic	.	ENSG00000235652	rs1062067	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4445	0.3704	0.349641	0.3706	.	.	.	.	.	.	.	.	.	.	AFR:0.2724,AMR:0.2148,EAS:0.3506,FIN:0.4762,NFE:0.4118,OTH:0.3937,ASJ:0.3974	.	.	.	.	.	.	.	.	.	.	.	.	6	MU12506364	het
6	146234644	146234644	G	A	SHPRH	exonic	synonymous SNV	ENSG00000146414	rs9497426	ENSG00000146414:ENST00000275233:exon24:c.C4296T:p.C1432C,ENSG00000146414:ENST00000367503:exon24:c.C4308T:p.C1436C,ENSG00000146414:ENST00000367505:exon24:c.C4296T:p.C1432C,ENSG00000146414:ENST00000438092:exon24:c.C4308T:p.C1436C	SHPRH:NM_001042683:exon24:c.C4296T:p.C1432C,SHPRH:NM_001370327:exon24:c.C4296T:p.C1432C,SHPRH:NM_173082:exon24:c.C4308T:p.C1436C,SHPRH:NM_001370328:exon26:c.C2853T:p.C951C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7804	0.8120	0.836262	0.8023	.	.	.	.	.	.	.	.	SHPRH:uc003qlg.1:exon23:c.C2964T:p.C988C,SHPRH:uc003qle.3:exon24:c.C4308T:p.C1436C,SHPRH:uc003qlf.3:exon24:c.C4296T:p.C1432C	.	AFR:0.9376,AMR:0.8950,EAS:0.8269,FIN:0.6485,NFE:0.7536,OTH:0.7688,ASJ:0.7980	608048	.	.	.	.	.	.	.	.	.	.	.	6	MU800391	het
6	146268623	146268623	T	A	SHPRH	intronic	.	ENSG00000146414	rs9386141	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5704	0.5484	0.562899	0.5517	.	.	.	.	.	0.0004	0.006	.	.	.	AFR:0.4600,AMR:0.7512,EAS:0.6516,FIN:0.5235,NFE:0.5864,OTH:0.5888,ASJ:0.6026	608048	.	.	.	.	.	.	.	.	.	.	.	6	MU807192	het
6	149983216	149983216	G	A	LATS1	exonic	synonymous SNV	ENSG00000131023	rs3924871	ENSG00000131023:ENST00000253339:exon7:c.C3042T:p.D1014D,ENSG00000131023:ENST00000543571:exon8:c.C3042T:p.D1014D	LATS1:NM_001350392:exon7:c.C2202T:p.D734D,LATS1:NM_004690:exon8:c.C3042T:p.D1014D,LATS1:NM_001350340:exon9:c.C2727T:p.D909D,LATS1:NM_001350339:exon10:c.C2826T:p.D942D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4492	0.4227	0.550719	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LATS1:uc003qmu.2:exon8:c.C3042T:p.D1014D,LATS1:uc010kif.2:exon9:c.C2727T:p.D909D	.	AFR:0.4418,AMR:0.5405,EAS:0.3742,FIN:0.8296,NFE:0.3674,OTH:0.3535,ASJ:0.6346	603473	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.3998
6	150004779	150004779	A	G	LATS1	exonic	synonymous SNV	ENSG00000131023	rs3798761	ENSG00000131023:ENST00000253339:exon3:c.T1446C:p.S482S,ENSG00000131023:ENST00000392273:exon4:c.T1446C:p.S482S,ENSG00000131023:ENST00000543571:exon4:c.T1446C:p.S482S	LATS1:NM_001350392:exon3:c.T606C:p.S202S,LATS1:NM_001270519:exon4:c.T1446C:p.S482S,LATS1:NM_004690:exon4:c.T1446C:p.S482S,LATS1:NM_001350339:exon5:c.T1131C:p.S377S,LATS1:NM_001350340:exon5:c.T1131C:p.S377S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4493	0.4243	0.552316	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LATS1:uc003qmv.2:exon3:c.T1446C:p.S482S,LATS1:uc003qmu.2:exon4:c.T1446C:p.S482S,LATS1:uc003qmw.3:exon4:c.T1446C:p.S482S,LATS1:uc010kif.2:exon5:c.T1131C:p.S377S,LATS1:uc010kig.1:exon5:c.T1131C:p.S377S	.	AFR:0.4425,AMR:0.5429,EAS:0.3742,FIN:0.8317,NFE:0.3673,OTH:0.3535,ASJ:0.6376	603473	.	.	.	.	.	.	.	.	.	.	.	6	1(urinary_tract)	0.3949
6	152129077	152129077	T	C	ESR1	exonic	synonymous SNV	ENSG00000091831	rs2077647	ENSG00000091831:ENST00000206249:exon1:c.T30C:p.S10S,ENSG00000091831:ENST00000406599:exon1:c.T30C:p.S10S,ENSG00000091831:ENST00000338799:exon2:c.T30C:p.S10S,ENSG00000091831:ENST00000443427:exon2:c.T30C:p.S10S,ENSG00000091831:ENST00000446550:exon2:c.T30C:p.S10S,ENSG00000091831:ENST00000456483:exon2:c.T30C:p.S10S,ENSG00000091831:ENST00000404742:exon3:c.T30C:p.S10S,ENSG00000091831:ENST00000440973:exon3:c.T30C:p.S10S	ESR1:NM_000125:exon1:c.T30C:p.S10S,ESR1:NM_001122740:exon2:c.T30C:p.S10S,ESR1:NM_001122741:exon2:c.T30C:p.S10S,ESR1:NM_001291230:exon2:c.T30C:p.S10S,ESR1:NM_001291241:exon2:c.T30C:p.S10S,ESR1:NM_001122742:exon3:c.T30C:p.S10S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4654	0.4789	0.466454	MU159353	.	.	.	.	.	.	.	.	ESR1:uc003qoo.4:exon1:c.T30C:p.S10S,ESR1:uc010kir.3:exon1:c.T30C:p.S10S,ESR1:uc003qon.4:exon2:c.T30C:p.S10S,ESR1:uc010kin.3:exon2:c.T30C:p.S10S,ESR1:uc010kio.3:exon2:c.T30C:p.S10S,ESR1:uc010kip.3:exon2:c.T30C:p.S10S,ESR1:uc031sqc.1:exon2:c.T30C:p.S10S,ESR1:uc003qom.4:exon3:c.T30C:p.S10S,ESR1:uc031sqb.1:exon3:c.T30C:p.S10S,ESR1:uc021zgx.1:exon4:c.T30C:p.S10S,ESR1:uc031spz.1:exon4:c.T30C:p.S10S,ESR1:uc031sqa.1:exon4:c.T30C:p.S10S	.	AFR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|1|321|0.00311526,AMR:0.4776,EAS:0.4294,FIN:0.5,NFE:0.3759,OTH:0.4365,ASJ:0.4960	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05224 Breast cancer ~	,4804,4805,4803	.	.	.	.	.	.	6	3(haematopoietic_and_lymphoid_tissue)	0.4893
6	152201875	152201875	T	C	ESR1	exonic	synonymous SNV	ENSG00000091831	rs4986934	ENSG00000091831:ENST00000415488:exon1:c.T84C:p.R28R,ENSG00000091831:ENST00000206249:exon3:c.T729C:p.R243R,ENSG00000091831:ENST00000427531:exon3:c.T210C:p.R70R,ENSG00000091831:ENST00000338799:exon4:c.T729C:p.R243R,ENSG00000091831:ENST00000443427:exon4:c.T729C:p.R243R,ENSG00000091831:ENST00000456483:exon4:c.T729C:p.R243R,ENSG00000091831:ENST00000440973:exon5:c.T729C:p.R243R	ESR1:NM_000125:exon3:c.T729C:p.R243R,ESR1:NM_001328100:exon3:c.T210C:p.R70R,ESR1:NM_001122740:exon4:c.T729C:p.R243R,ESR1:NM_001122741:exon4:c.T729C:p.R243R,ESR1:NM_001291230:exon4:c.T735C:p.R245R,ESR1:NM_001291241:exon4:c.T729C:p.R243R,ESR1:NM_001122742:exon5:c.T729C:p.R243R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9707	0.9708	0.985623	0.9679	.	.	.	.	.	.	.	.	ESR1:uc011eex.2:exon1:c.T72C:p.R24R,ESR1:uc010kis.3:exon2:c.T210C:p.R70R,ESR1:uc003qoo.4:exon3:c.T729C:p.R243R,ESR1:uc003qon.4:exon4:c.T729C:p.R243R,ESR1:uc010kin.3:exon4:c.T729C:p.R243R,ESR1:uc010kio.3:exon4:c.T735C:p.R245R,ESR1:uc010kip.3:exon4:c.T729C:p.R243R,ESR1:uc003qom.4:exon5:c.T729C:p.R243R	.	AFR:0.9929,AMR:0.9845,EAS:1,FIN:0.9562,NFE:0.9525,OTH:0.9633,ASJ:0.9437	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05224 Breast cancer ~	,4804,4805,4803	.	.	.	.	.	.	6	MU81823068	hom
6	152265522	152265522	G	C	ESR1	exonic	synonymous SNV	ENSG00000091831	rs1801132	ENSG00000091831:ENST00000206249:exon4:c.G975C:p.P325P,ENSG00000091831:ENST00000427531:exon4:c.G456C:p.P152P,ENSG00000091831:ENST00000338799:exon5:c.G975C:p.P325P,ENSG00000091831:ENST00000443427:exon5:c.G975C:p.P325P,ENSG00000091831:ENST00000440973:exon6:c.G975C:p.P325P	ESR1:NM_000125:exon4:c.G975C:p.P325P,ESR1:NM_001328100:exon4:c.G456C:p.P152P,ESR1:NM_001122740:exon5:c.G975C:p.P325P,ESR1:NM_001122741:exon5:c.G975C:p.P325P,ESR1:NM_001291230:exon5:c.G981C:p.P327P,ESR1:NM_001291241:exon5:c.G972C:p.P324P,ESR1:NM_001122742:exon6:c.G975C:p.P325P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.7362	0.8144	0.717652	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	ESR1:uc010kit.1:exon1:c.G186C:p.P62P,ESR1:uc011eey.2:exon1:c.G186C:p.P62P,ESR1:uc011eex.2:exon2:c.G318C:p.P106P,ESR1:uc003qoo.4:exon4:c.G975C:p.P325P,ESR1:uc003qon.4:exon5:c.G975C:p.P325P,ESR1:uc010kin.3:exon5:c.G975C:p.P325P,ESR1:uc010kio.3:exon5:c.G981C:p.P327P,ESR1:uc010kip.3:exon5:c.G972C:p.P324P,ESR1:uc003qom.4:exon6:c.G975C:p.P325P	.	AFR:0.7877,AMR:0.8925,EAS:0.7781,FIN:0.4950,NFE:0.7264,OTH:0.7793,ASJ:0.7124	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05224 Breast cancer ~	,4804,4805,4803	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.7505
6	152464839	152464839	A	G	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs2256135	ENSG00000131018:ENST00000539504:exon9:c.T1503C:p.R501R,ENSG00000131018:ENST00000354674:exon10:c.T1572C:p.R524R,ENSG00000131018:ENST00000367257:exon18:c.T2976C:p.R992R,ENSG00000131018:ENST00000367251:exon24:c.T3873C:p.R1291R,ENSG00000131018:ENST00000356820:exon53:c.T8610C:p.R2870R,ENSG00000131018:ENST00000265368:exon138:c.T25038C:p.R8346R,ENSG00000131018:ENST00000367255:exon138:c.T25038C:p.R8346R,ENSG00000131018:ENST00000423061:exon138:c.T24894C:p.R8298R,ENSG00000131018:ENST00000341594:exon139:c.T23874C:p.R7958R,ENSG00000131018:ENST00000448038:exon139:c.T24894C:p.R8298R	SYNE1:NM_001347702:exon10:c.T1572C:p.R524R,SYNE1:NM_001347701:exon11:c.T1644C:p.R548R,SYNE1:NM_033071:exon138:c.T24894C:p.R8298R,SYNE1:NM_182961:exon138:c.T25038C:p.R8346R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6109	0.6235	0.689696	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SYNE1:uc003qoq.4:exon11:c.T1644C:p.R548R,SYNE1:uc011eez.2:exon11:c.T1644C:p.R548R,SYNE1:uc003qor.4:exon24:c.T3807C:p.R1269R,SYNE1:uc003qos.4:exon53:c.T8610C:p.R2870R,SYNE1:uc003qot.4:exon138:c.T24894C:p.R8298R,SYNE1:uc003qou.4:exon138:c.T25038C:p.R8346R	.	AFR:0.6144,AMR:0.7548,EAS:0.5927,FIN:0.6994,NFE:0.4963,OTH:0.5468,ASJ:0.7069	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.6071
6	152466674	152466674	T	C	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs2747662	ENSG00000131018:ENST00000354674:exon9:c.A1458G:p.E486E,ENSG00000131018:ENST00000367251:exon23:c.A3759G:p.E1253E,ENSG00000131018:ENST00000423061:exon137:c.A24780G:p.E8260E,ENSG00000131018:ENST00000448038:exon138:c.A24780G:p.E8260E	SYNE1:NM_001347702:exon9:c.A1458G:p.E486E,SYNE1:NM_033071:exon137:c.A24780G:p.E8260E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3452	0.3359	0.366214	1(urinary_tract)	.	.	.	.	.	.	.	.	SYNE1:uc003qor.4:exon23:c.A3693G:p.E1231E,SYNE1:uc003qot.4:exon137:c.A24780G:p.E8260E	.	AFR:MU93147,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611,EAS:0.3364,FIN:0.4928,NFE:0.4139,OTH:0.2984,ASJ:0.3146	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	5(large_intestine)	0.2218
6	152469188	152469188	C	G	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs2252755	ENSG00000131018:ENST00000354674:exon8:c.G1433C:p.G478A,ENSG00000131018:ENST00000539504:exon8:c.G1433C:p.G478A,ENSG00000131018:ENST00000367257:exon17:c.G2906C:p.G969A,ENSG00000131018:ENST00000367251:exon22:c.G3734C:p.G1245A,ENSG00000131018:ENST00000356820:exon52:c.G8540C:p.G2847A,ENSG00000131018:ENST00000423061:exon136:c.G24755C:p.G8252A,ENSG00000131018:ENST00000265368:exon137:c.G24968C:p.G8323A,ENSG00000131018:ENST00000367255:exon137:c.G24968C:p.G8323A,ENSG00000131018:ENST00000448038:exon137:c.G24755C:p.G8252A,ENSG00000131018:ENST00000341594:exon138:c.G23804C:p.G7935A	SYNE1:NM_001347702:exon8:c.G1433C:p.G478A,SYNE1:NM_001347701:exon10:c.G1574C:p.G525A,SYNE1:NM_033071:exon136:c.G24755C:p.G8252A,SYNE1:NM_182961:exon137:c.G24968C:p.G8323A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3592	0.3736	0.399361	5(large_intestine)	0.755	9.179	1.0	5.34	1.000	.	.	.	SYNE1:uc003qoq.4:exon10:c.G1574C:p.G525A,SYNE1:uc011eez.2:exon10:c.G1574C:p.G525A,SYNE1:uc003qor.4:exon22:c.G3668C:p.G1223A,SYNE1:uc003qos.4:exon52:c.G8540C:p.G2847A,SYNE1:uc003qot.4:exon136:c.G24755C:p.G8252A,SYNE1:uc003qou.4:exon137:c.G24968C:p.G8323A	-1.079	AFR:MU9449237,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,EAS:0.4444,FIN:0.5036,NFE:0.4272,OTH:0.3043,ASJ:0.3490	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.696	0.85	0.051	0.58	6	2(lung)	0.2255
6	152469331	152469331	C	T	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs2252748	ENSG00000131018:ENST00000354674:exon8:c.G1290A:p.P430P,ENSG00000131018:ENST00000539504:exon8:c.G1290A:p.P430P,ENSG00000131018:ENST00000367257:exon17:c.G2763A:p.P921P,ENSG00000131018:ENST00000367251:exon22:c.G3591A:p.P1197P,ENSG00000131018:ENST00000356820:exon52:c.G8397A:p.P2799P,ENSG00000131018:ENST00000423061:exon136:c.G24612A:p.P8204P,ENSG00000131018:ENST00000265368:exon137:c.G24825A:p.P8275P,ENSG00000131018:ENST00000367255:exon137:c.G24825A:p.P8275P,ENSG00000131018:ENST00000448038:exon137:c.G24612A:p.P8204P,ENSG00000131018:ENST00000341594:exon138:c.G23661A:p.P7887P	SYNE1:NM_001347702:exon8:c.G1290A:p.P430P,SYNE1:NM_001347701:exon10:c.G1431A:p.P477P,SYNE1:NM_033071:exon136:c.G24612A:p.P8204P,SYNE1:NM_182961:exon137:c.G24825A:p.P8275P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3130	0.3009	0.339457	5(large_intestine)	.	.	.	.	.	.	.	.	SYNE1:uc003qoq.4:exon10:c.G1431A:p.P477P,SYNE1:uc011eez.2:exon10:c.G1431A:p.P477P,SYNE1:uc003qor.4:exon22:c.G3525A:p.P1175P,SYNE1:uc003qos.4:exon52:c.G8397A:p.P2799P,SYNE1:uc003qot.4:exon136:c.G24612A:p.P8204P,SYNE1:uc003qou.4:exon137:c.G24825A:p.P8275P	.	AFR:MU93160,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,BTCA-JP|1|239|0.0041841,EAS:0.3034,FIN:0.4450,NFE:0.3533,OTH:0.3041,ASJ:0.2826	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(liver)	0.1874
6	152470752	152470752	C	A	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs17082236	ENSG00000131018:ENST00000354674:exon7:c.G967T:p.A323S,ENSG00000131018:ENST00000539504:exon7:c.G967T:p.A323S,ENSG00000131018:ENST00000367257:exon16:c.G2440T:p.A814S,ENSG00000131018:ENST00000367251:exon21:c.G3268T:p.A1090S,ENSG00000131018:ENST00000356820:exon51:c.G8074T:p.A2692S,ENSG00000131018:ENST00000423061:exon135:c.G24289T:p.A8097S,ENSG00000131018:ENST00000265368:exon136:c.G24502T:p.A8168S,ENSG00000131018:ENST00000367255:exon136:c.G24502T:p.A8168S,ENSG00000131018:ENST00000448038:exon136:c.G24289T:p.A8097S,ENSG00000131018:ENST00000341594:exon137:c.G23338T:p.A7780S	SYNE1:NM_001347702:exon7:c.G967T:p.A323S,SYNE1:NM_001347701:exon9:c.G1108T:p.A370S,SYNE1:NM_033071:exon135:c.G24289T:p.A8097S,SYNE1:NM_182961:exon136:c.G24502T:p.A8168S	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0677	0.1330	0.115615	0.1135	2.796	21.3	0.433	3.96	1.000	.	.	.	SYNE1:uc003qoq.4:exon9:c.G1108T:p.A370S,SYNE1:uc011eez.2:exon9:c.G1108T:p.A370S,SYNE1:uc003qor.4:exon21:c.G3202T:p.A1068S,SYNE1:uc003qos.4:exon51:c.G8074T:p.A2692S,SYNE1:uc003qot.4:exon135:c.G24289T:p.A8097S,SYNE1:uc003qou.4:exon136:c.G24502T:p.A8168S	-1.055	AFR:0.2937,AMR:0.0835,EAS:0.0006,FIN:0.0381,NFE:0.0441,OTH:0.0541,ASJ:0.1225	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.001	0.63	0.027	0	6	.	het
6	152473181	152473181	T	C	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs910415	ENSG00000131018:ENST00000354674:exon5:c.A690G:p.A230A,ENSG00000131018:ENST00000539504:exon5:c.A690G:p.A230A,ENSG00000131018:ENST00000367257:exon14:c.A2163G:p.A721A,ENSG00000131018:ENST00000367251:exon19:c.A2991G:p.A997A,ENSG00000131018:ENST00000356820:exon49:c.A7797G:p.A2599A,ENSG00000131018:ENST00000423061:exon133:c.A24012G:p.A8004A,ENSG00000131018:ENST00000265368:exon134:c.A24225G:p.A8075A,ENSG00000131018:ENST00000367255:exon134:c.A24225G:p.A8075A,ENSG00000131018:ENST00000448038:exon134:c.A24012G:p.A8004A,ENSG00000131018:ENST00000341594:exon135:c.A23061G:p.A7687A	SYNE1:NM_001347702:exon5:c.A690G:p.A230A,SYNE1:NM_001347701:exon7:c.A831G:p.A277A,SYNE1:NM_033071:exon133:c.A24012G:p.A8004A,SYNE1:NM_182961:exon134:c.A24225G:p.A8075A	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0397	0.0495	0.0365415	0.0440	.	.	.	.	.	.	.	.	SYNE1:uc003qoq.4:exon7:c.A831G:p.A277A,SYNE1:uc011eez.2:exon7:c.A831G:p.A277A,SYNE1:uc003qor.4:exon19:c.A2925G:p.A975A,SYNE1:uc003qos.4:exon49:c.A7797G:p.A2599A,SYNE1:uc003qot.4:exon133:c.A24012G:p.A8004A,SYNE1:uc003qou.4:exon134:c.A24225G:p.A8075A	.	AFR:0.0620,AMR:0.0525,EAS:0,FIN:0.0384,NFE:0.0386,OTH:0.0397,ASJ:0.0828	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	.	het
6	152489294	152489294	T	C	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs998147	ENSG00000131018:ENST00000354674:exon1:c.A46G:p.S16G,ENSG00000131018:ENST00000539504:exon1:c.A46G:p.S16G	SYNE1:NM_001347702:exon1:c.A46G:p.S16G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8278	0.8572	0.867013	0.8364	2.090	16.79	0.75	2.24	0.979	.	.	.	.	-0.952	AFR:0.9369,AMR:0.8361,EAS:0.8813,FIN:0.7483,NFE:0.7964,OTH:0.8101,ASJ:0.7833	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	4.66	0.001	.	6	MU81823126	hom
6	152540278	152540278	A	C	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs2147377	ENSG00000131018:ENST00000367251:exon5:c.T670G:p.F224V,ENSG00000131018:ENST00000356820:exon35:c.T5476G:p.F1826V,ENSG00000131018:ENST00000423061:exon119:c.T21691G:p.F7231V,ENSG00000131018:ENST00000265368:exon120:c.T21904G:p.F7302V,ENSG00000131018:ENST00000367255:exon120:c.T21904G:p.F7302V,ENSG00000131018:ENST00000448038:exon120:c.T21691G:p.F7231V,ENSG00000131018:ENST00000341594:exon121:c.T20740G:p.F6914V	SYNE1:NM_033071:exon119:c.T21691G:p.F7231V,SYNE1:NM_182961:exon120:c.T21904G:p.F7302V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9923	0.9931	0.995607	0.9922	-0.224	0.977	1.0	3.99	0.127	.	.	.	SYNE1:uc003qor.4:exon5:c.T604G:p.F202V,SYNE1:uc003qos.4:exon35:c.T5476G:p.F1826V,SYNE1:uc003qot.4:exon119:c.T21691G:p.F7231V,SYNE1:uc003qou.4:exon120:c.T21904G:p.F7302V	-0.974	AFR:0.9984,AMR:0.9905,EAS:1,FIN:0.9877,NFE:0.9892,OTH:0.9878,ASJ:0.9868	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.0	0.82	0.009	-2.32	6	MU81823155	hom
6	152629617	152629617	C	T	SYNE1	intronic	.	ENSG00000131018	rs9383985	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3236	0.2455	0.304313	0.2809	.	.	.	.	.	0	0	.	.	.	AFR:0.0884,AMR:0.3046,EAS:0.6065,FIN:0.3625,NFE:0.3338,OTH:0.3060,ASJ:0.4027	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	MU14055157	het
6	152629773	152629773	A	-	SYNE1	intronic	.	ENSG00000131018	rs55633181	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.4174	.	0.426518	0.4328	.	.	.	.	.	.	.	.	.	.	AFR:0.3111,AMR:0.5885,EAS:0.7624,FIN:0.4817,NFE:0.4450,OTH:0.4729,ASJ:0.5775	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	.	hom
6	152647681	152647681	A	T	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs2306916	ENSG00000131018:ENST00000423061:exon78:c.T14830A:p.L4944M,ENSG00000131018:ENST00000265368:exon79:c.T15043A:p.L5015M,ENSG00000131018:ENST00000367255:exon79:c.T15043A:p.L5015M,ENSG00000131018:ENST00000448038:exon79:c.T14830A:p.L4944M,ENSG00000131018:ENST00000341594:exon82:c.T14284A:p.L4762M	SYNE1:NM_033071:exon78:c.T14830A:p.L4944M,SYNE1:NM_182961:exon79:c.T15043A:p.L5015M	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7797	0.8105	0.814696	0.8331	1.978	16.07	0.607	3.2	0.996	.	.	.	SYNE1:uc010kiz.4:exon3:c.T2308A:p.L770M,SYNE1:uc003qot.4:exon78:c.T14830A:p.L4944M,SYNE1:uc003qou.4:exon79:c.T15043A:p.L5015M	-0.977	AFR:0.9341,AMR:0.8592,EAS:0.8358,FIN:0.8481,NFE:0.7754,OTH:0.7802,ASJ:0.6887	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.009	1.24	0.012	-0.165	6	MU641312	het
6	152652034	152652034	A	T	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs6911096	ENSG00000131018:ENST00000423061:exon77:c.T13573A:p.S4525T,ENSG00000131018:ENST00000265368:exon78:c.T13786A:p.S4596T,ENSG00000131018:ENST00000367255:exon78:c.T13786A:p.S4596T,ENSG00000131018:ENST00000448038:exon78:c.T13573A:p.S4525T,ENSG00000131018:ENST00000341594:exon81:c.T13027A:p.S4343T	SYNE1:NM_033071:exon77:c.T13573A:p.S4525T,SYNE1:NM_182961:exon78:c.T13786A:p.S4596T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7760	0.7959	0.803315	COCA-CN|4|321|0.0124611	-5.477	0.001	0.568	-11.9	0.002	.	.	.	SYNE1:uc010kiz.4:exon2:c.T1051A:p.S351T,SYNE1:uc003qot.4:exon77:c.T13573A:p.S4525T,SYNE1:uc003qou.4:exon78:c.T13786A:p.S4596T	-1.024	AFR:0.8219,AMR:0.8947,EAS:0.6887,FIN:0.8465,NFE:0.8479,OTH:0.7745,ASJ:0.8568	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.0	1.35	0.008	0.025	6	1(urinary_tract)	0.7760
6	152653037	152653037	T	C	SYNE1	intronic	.	ENSG00000131018	rs9478314	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4608	0.4863	0.413139	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.4793,AMR:0.5492,EAS:0.5265,FIN:0.1273,NFE:0.4653,OTH:0.4722,ASJ:0.6480	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.4398
6	152658142	152658142	T	C	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs9479297	ENSG00000131018:ENST00000423061:exon75:c.A12149G:p.K4050R,ENSG00000131018:ENST00000265368:exon76:c.A12362G:p.K4121R,ENSG00000131018:ENST00000367255:exon76:c.A12362G:p.K4121R,ENSG00000131018:ENST00000448038:exon76:c.A12149G:p.K4050R,ENSG00000131018:ENST00000341594:exon78:c.A11957G:p.K3986R	SYNE1:NM_033071:exon75:c.A12149G:p.K4050R,SYNE1:NM_182961:exon76:c.A12362G:p.K4121R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7547	0.7882	0.793131	0.8208	0.371	6.360	1.0	4.48	0.964	.	.	.	SYNE1:uc010kja.2:exon19:c.A2477G:p.K826R,SYNE1:uc003qot.4:exon75:c.A12149G:p.K4050R,SYNE1:uc003qou.4:exon76:c.A12362G:p.K4121R	-0.969	AFR:0.9307,AMR:0.7081,EAS:0.8488,FIN:0.8345,NFE:0.7642,OTH:0.7515,ASJ:0.6788	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.0	1.37	0.009	-1.81	6	MU21289282	het
6	152665261	152665261	C	A	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs4645434	ENSG00000131018:ENST00000423061:exon73:c.G11967T:p.E3989D,ENSG00000131018:ENST00000265368:exon74:c.G12180T:p.E4060D,ENSG00000131018:ENST00000367255:exon74:c.G12180T:p.E4060D,ENSG00000131018:ENST00000448038:exon74:c.G11967T:p.E3989D,ENSG00000131018:ENST00000341594:exon76:c.G11775T:p.E3925D	SYNE1:NM_033071:exon73:c.G11967T:p.E3989D,SYNE1:NM_182961:exon74:c.G12180T:p.E4060D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5761	0.5673	0.545527	1(central_nervous_system)	0.235	5.046	0.071	-1.25	0.019	.	.	.	SYNE1:uc010kja.2:exon17:c.G2295T:p.E765D,SYNE1:uc003qot.4:exon73:c.G11967T:p.E3989D,SYNE1:uc003qou.4:exon74:c.G12180T:p.E4060D	-0.976	AFR:2(large_intestine),AMR:MU588841,EAS:0.5601,FIN:0.4517,NFE:0.6160,OTH:0.66,ASJ:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.203	1.33	0.015	0.345	6	1(skin)	0.6582
6	152671475	152671475	A	C	SYNE1	intronic	.	ENSG00000131018	rs9478320	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5846	0.5962	0.58746	0.5913	.	.	.	.	.	0.7992	0.178	.	.	.	AFR:0.5714,AMR:0.6184,EAS:0.6219,FIN:0.5573,NFE:0.6074,OTH:0.5490,ASJ:0.6589	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	MU27526564	het
6	152671919	152671919	-	A	SYNE1	intronic	.	ENSG00000131018	rs5880967	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.5746	.	0.56889	0.5828	.	.	.	.	.	.	.	.	.	.	AFR:0.5302,AMR:0.6158,EAS:0.6216,FIN:0.5655,NFE:0.6112,OTH:0.5601,ASJ:0.6567	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	.	het
6	152673147	152673147	G	A	SYNE1	intronic	.	ENSG00000131018	rs6908392	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5790	0.5783	0.565895	MU26896544	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.5750,EAS:0.6169,FIN:0.6589,NFE:0.6222,OTH:0.5570,ASJ:0.5128	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.6083
6	152675854	152675854	A	G	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs9397102	ENSG00000131018:ENST00000265368:exon67:c.T10866C:p.S3622S,ENSG00000131018:ENST00000367255:exon67:c.T10866C:p.S3622S,ENSG00000131018:ENST00000341594:exon70:c.T10779C:p.S3593S	SYNE1:NM_182961:exon67:c.T10866C:p.S3622S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5799	0.5812	0.568291	MU26896631	.	.	.	.	.	.	.	.	SYNE1:uc010kja.2:exon10:c.T981C:p.S327S,SYNE1:uc003qou.4:exon67:c.T10866C:p.S3622S	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.5777,EAS:0.6169,FIN:0.6567,NFE:0.6256,OTH:0.5568,ASJ:0.5229	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.6074
6	152683413	152683413	G	T	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs4407724	ENSG00000131018:ENST00000265368:exon64:c.C10191A:p.G3397G,ENSG00000131018:ENST00000367255:exon64:c.C10191A:p.G3397G,ENSG00000131018:ENST00000423061:exon64:c.C10212A:p.G3404G,ENSG00000131018:ENST00000448038:exon65:c.C10212A:p.G3404G	SYNE1:NM_033071:exon64:c.C10212A:p.G3404G,SYNE1:NM_182961:exon64:c.C10191A:p.G3397G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6541	0.6481	0.659145	SKCA-BR|1|100|0.01,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	SYNE1:uc010kja.2:exon7:c.C306A:p.G102G,SYNE1:uc003qot.4:exon64:c.C10212A:p.G3404G,SYNE1:uc003qou.4:exon64:c.C10191A:p.G3397G	.	AFR:0.6496,AMR:0.5876,EAS:0.7384,FIN:0.7752,NFE:0.6216,OTH:0.6773,ASJ:0.6746	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	2(large_intestine)	0.6214
6	152694184	152694184	T	C	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs6913579	ENSG00000131018:ENST00000265368:exon59:c.A9495G:p.E3165E,ENSG00000131018:ENST00000367255:exon59:c.A9495G:p.E3165E,ENSG00000131018:ENST00000423061:exon59:c.A9516G:p.E3172E,ENSG00000131018:ENST00000448038:exon60:c.A9516G:p.E3172E,ENSG00000131018:ENST00000341594:exon62:c.A9612G:p.E3204E	SYNE1:NM_033071:exon59:c.A9516G:p.E3172E,SYNE1:NM_182961:exon59:c.A9495G:p.E3165E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4993	0.5288	0.468251	3(lung)	.	.	.	.	.	.	.	.	SYNE1:uc003qov.3:exon4:c.A729G:p.E243E,SYNE1:uc003qot.4:exon59:c.A9516G:p.E3172E,SYNE1:uc003qou.4:exon59:c.A9495G:p.E3165E	.	AFR:MU29885722,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|4|170|0.0235294,COCA-CN|1|321|0.00311526,EAS:0.4821,FIN:0.5276,NFE:0.5298,OTH:0.4532,ASJ:0.5133	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	2(large_intestine)	0.5040
6	152697706	152697706	C	T	SYNE1	intronic	.	ENSG00000131018	rs214955	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5101	0.4883	0.529153	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.4989,AMR:0.5436,EAS:0.4801,FIN:0.5446,NFE:0.4974,OTH:0.4662,ASJ:0.4880	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(liver)	0.5460
6	152708310	152708310	G	A	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs214950	ENSG00000131018:ENST00000265368:exon54:c.C8384T:p.A2795V,ENSG00000131018:ENST00000367255:exon54:c.C8384T:p.A2795V,ENSG00000131018:ENST00000423061:exon54:c.C8405T:p.A2802V,ENSG00000131018:ENST00000448038:exon55:c.C8405T:p.A2802V,ENSG00000131018:ENST00000341594:exon57:c.C8501T:p.A2834V	SYNE1:NM_033071:exon54:c.C8405T:p.A2802V,SYNE1:NM_182961:exon54:c.C8384T:p.A2795V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2373	0.1984	0.249002	1(breast)	0.486	7.324	0.028	1.51	0.000	.	.	.	SYNE1:uc010kjb.1:exon52:c.C8333T:p.A2778V,SYNE1:uc003qot.4:exon54:c.C8405T:p.A2802V,SYNE1:uc003qou.4:exon54:c.C8384T:p.A2795V	-1.029	AFR:MU93209,AMR:LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.1555,FIN:0.1866,NFE:0.2533,OTH:0.4410,ASJ:0.2061	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.007	1.27	0.017	1.95	6	1(haematopoietic_and_lymphoid_tissue)	0.1855
6	152711395	152711395	T	A	SYNE1	intronic	.	ENSG00000131018	rs214943	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4440	0.4833	0.561901	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.4900,AMR:0.6936,EAS:0.4305,FIN:0.7853,NFE:0.3829,OTH:0.3795,ASJ:0.3209	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(upper_aerodigestive_tract)	0.4223
6	152712715	152712715	-	AAAAAA	SYNE1	intronic	.	ENSG00000131018	rs768125041	.	.	clinvar: Uncertain_significance 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0692	.	.	0.1766	.	.	.	.	.	.	.	.	.	.	AFR:0.1673,AMR:0.0825,EAS:0.3713,FIN:0.1391,NFE:0.1628,OTH:0.1585,ASJ:0.1992	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	.	het
6	152746593	152746593	A	T	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs111250109	ENSG00000131018:ENST00000265368:exon39:c.T5190A:p.D1730E,ENSG00000131018:ENST00000367255:exon39:c.T5190A:p.D1730E,ENSG00000131018:ENST00000423061:exon39:c.T5211A:p.D1737E,ENSG00000131018:ENST00000448038:exon40:c.T5211A:p.D1737E,ENSG00000131018:ENST00000341594:exon42:c.T5301A:p.D1767E	SYNE1:NM_033071:exon39:c.T5211A:p.D1737E,SYNE1:NM_182961:exon39:c.T5190A:p.D1730E	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0442	0.0482	0.0327476	.	-0.505	0.213	0.737	-6.32	0.997	.	.	.	SYNE1:uc010kjb.1:exon37:c.T5139A:p.D1713E,SYNE1:uc003qot.4:exon39:c.T5211A:p.D1737E,SYNE1:uc003qou.4:exon39:c.T5190A:p.D1730E	-0.974	AFR:0.0481,AMR:0.0337,EAS:0.0762,FIN:0.0019,NFE:0.0475,OTH:0.0622,ASJ:0.0274	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.001	1.52	0.007	0.245	6	1(liver)	0.0468
6	152763258	152763258	T	C	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs138705766	ENSG00000131018:ENST00000367253:exon29:c.A3960G:p.T1320T,ENSG00000131018:ENST00000413186:exon29:c.A3960G:p.T1320T,ENSG00000131018:ENST00000367248:exon30:c.A3930G:p.T1310T,ENSG00000131018:ENST00000265368:exon31:c.A3960G:p.T1320T,ENSG00000131018:ENST00000367255:exon31:c.A3960G:p.T1320T,ENSG00000131018:ENST00000423061:exon31:c.A3981G:p.T1327T,ENSG00000131018:ENST00000448038:exon32:c.A3981G:p.T1327T,ENSG00000131018:ENST00000341594:exon34:c.A4158G:p.T1386T	SYNE1:NM_033071:exon31:c.A3981G:p.T1327T,SYNE1:NM_182961:exon31:c.A3960G:p.T1320T	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0193	0.0161	0.0127796	0.0212	.	.	.	.	.	.	.	.	SYNE1:uc003qow.3:exon12:c.A1845G:p.T615T,SYNE1:uc003qox.1:exon18:c.A2508G:p.T836T,SYNE1:uc010kjb.1:exon29:c.A3909G:p.T1303T,SYNE1:uc003qot.4:exon31:c.A3981G:p.T1327T,SYNE1:uc003qou.4:exon31:c.A3960G:p.T1320T	.	AFR:0.0097,AMR:0.0107,EAS:0,FIN:0.0312,NFE:0.0275,OTH:0.0266,ASJ:0.05	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	.	het
6	152771849	152771849	G	A	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs17082701	ENSG00000131018:ENST00000367253:exon25:c.C3306T:p.H1102H,ENSG00000131018:ENST00000413186:exon25:c.C3306T:p.H1102H,ENSG00000131018:ENST00000367248:exon26:c.C3276T:p.H1092H,ENSG00000131018:ENST00000265368:exon27:c.C3306T:p.H1102H,ENSG00000131018:ENST00000367255:exon27:c.C3306T:p.H1102H,ENSG00000131018:ENST00000423061:exon27:c.C3327T:p.H1109H,ENSG00000131018:ENST00000448038:exon28:c.C3327T:p.H1109H,ENSG00000131018:ENST00000341594:exon30:c.C3504T:p.H1168H	SYNE1:NM_033071:exon27:c.C3327T:p.H1109H,SYNE1:NM_182961:exon27:c.C3306T:p.H1102H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0576	0.0715	0.048722	1(thyroid)	.	.	.	.	.	.	.	.	SYNE1:uc003qow.3:exon8:c.C1191T:p.H397H,SYNE1:uc003qox.1:exon14:c.C1854T:p.H618H,SYNE1:uc010kjb.1:exon25:c.C3255T:p.H1085H,SYNE1:uc003qot.4:exon27:c.C3327T:p.H1109H,SYNE1:uc003qou.4:exon27:c.C3306T:p.H1102H	.	AFR:.,AMR:.,EAS:0.0709,FIN:0.0394,NFE:0.1126,OTH:0.0019,ASJ:0.0657	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(liver)	0.0558
6	152772264	152772264	A	G	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs214976	ENSG00000131018:ENST00000367253:exon24:c.T3104C:p.V1035A,ENSG00000131018:ENST00000413186:exon24:c.T3104C:p.V1035A,ENSG00000131018:ENST00000367248:exon25:c.T3074C:p.V1025A,ENSG00000131018:ENST00000265368:exon26:c.T3104C:p.V1035A,ENSG00000131018:ENST00000367255:exon26:c.T3104C:p.V1035A,ENSG00000131018:ENST00000423061:exon26:c.T3125C:p.V1042A,ENSG00000131018:ENST00000448038:exon27:c.T3125C:p.V1042A,ENSG00000131018:ENST00000341594:exon29:c.T3302C:p.V1101A	SYNE1:NM_033071:exon26:c.T3125C:p.V1042A,SYNE1:NM_182961:exon26:c.T3104C:p.V1035A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4811	0.5325	0.607228	MU18833080	3.767	23.4	0.006	5.84	0.998	.	.	.	SYNE1:uc003qow.3:exon7:c.T989C:p.V330A,SYNE1:uc003qox.1:exon13:c.T1652C:p.V551A,SYNE1:uc010kjb.1:exon24:c.T3053C:p.V1018A,SYNE1:uc003qot.4:exon26:c.T3125C:p.V1042A,SYNE1:uc003qou.4:exon26:c.T3104C:p.V1035A	0.108	AFR:COCA-CN|5|321|0.0155763,AMR:0.5270,EAS:0.3565,FIN:0.5302,NFE:0.7779,OTH:0.3912,ASJ:0.7437	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.033	0.55	0.536	1.905	6	1(pancreas)	0.4198
6	152777095	152777095	A	C	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs17082709	ENSG00000131018:ENST00000495090:exon10:c.T1354G:p.L452V,ENSG00000131018:ENST00000367253:exon21:c.T2653G:p.L885V,ENSG00000131018:ENST00000413186:exon21:c.T2653G:p.L885V,ENSG00000131018:ENST00000367248:exon22:c.T2623G:p.L875V,ENSG00000131018:ENST00000265368:exon23:c.T2653G:p.L885V,ENSG00000131018:ENST00000367255:exon23:c.T2653G:p.L885V,ENSG00000131018:ENST00000423061:exon23:c.T2674G:p.L892V,ENSG00000131018:ENST00000448038:exon24:c.T2674G:p.L892V,ENSG00000131018:ENST00000341594:exon25:c.T2809G:p.L937V	SYNE1:NM_033071:exon23:c.T2674G:p.L892V,SYNE1:NM_182961:exon23:c.T2653G:p.L885V	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0556	0.0634	0.0433307	0.0607	0.696	8.803	0.244	1.49	0.766	.	.	.	SYNE1:uc003qow.3:exon4:c.T538G:p.L180V,SYNE1:uc003qox.1:exon10:c.T1201G:p.L401V,SYNE1:uc003qoy.2:exon10:c.T1354G:p.L452V,SYNE1:uc003qoz.2:exon10:c.T949G:p.L317V,SYNE1:uc010kjb.1:exon21:c.T2602G:p.L868V,SYNE1:uc003qot.4:exon23:c.T2674G:p.L892V,SYNE1:uc003qou.4:exon23:c.T2653G:p.L885V	-1.086	AFR:0.0522,AMR:0.0382,EAS:0.0019,FIN:0.0556,NFE:0.0734,OTH:0.0591,ASJ:0.1126	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.055	1.23	0.037	1.61	6	.	het
6	152809527	152809527	A	T	SYNE1	intronic	.	ENSG00000131018	rs9397106	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4810	0.5072	0.589257	0.5097	.	.	.	.	.	0	0.028	.	.	.	AFR:0.6693,AMR:0.3537,EAS:0.7736,FIN:0.4046,NFE:0.4250,OTH:0.4551,ASJ:0.5232	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	MU18839010	hom
6	157405930	157405930	G	A	ARID1B	exonic	synonymous SNV	ENSG00000049618	rs3734441	ENSG00000049618:ENST00000319584:exon3:c.G399A:p.A133A,ENSG00000049618:ENST00000275248:exon5:c.G1959A:p.A653A,ENSG00000049618:ENST00000350026:exon5:c.G2133A:p.A711A,ENSG00000049618:ENST00000367148:exon5:c.G2133A:p.A711A,ENSG00000049618:ENST00000414678:exon5:c.G630A:p.A210A,ENSG00000049618:ENST00000346085:exon6:c.G2172A:p.A724A	ARID1B:NM_001346813:exon5:c.G2133A:p.A711A,ARID1B:NM_017519:exon5:c.G2133A:p.A711A,ARID1B:NM_020732:exon6:c.G2172A:p.A724A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5190	0.4726	0.495208	1(breast)	.	.	.	.	.	.	.	.	ARID1B:uc003qqq.1:exon3:c.G285A:p.A95A,ARID1B:uc003qqn.3:exon5:c.G2133A:p.A711A,ARID1B:uc003qqp.3:exon5:c.G2133A:p.A711A,ARID1B:uc003qqo.3:exon6:c.G2172A:p.A724A	.	AFR:MU155753,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.3460,FIN:0.5730,NFE:0.6026,OTH:0.5256,ASJ:0.4492	614556	135900;	1465;	1465|CSS|<1 / 1 000 000|Autosomal dominant|Neonatal|135900 614607 614608 614609 615866 616938 ~	.	.	.	.	.	.	.	.	6	14(meninges)	0.3897
6	157527493	157527495	GAC	-	ARID1B	exonic	nonframeshift deletion	ENSG00000049618	rs113820273	ENSG00000049618:ENST00000350026:exon19:c.5179_5181del:p.1727_1727del,ENSG00000049618:ENST00000414678:exon19:c.3745_3747del:p.1249_1249del,ENSG00000049618:ENST00000275248:exon20:c.5164_5166del:p.1722_1722del,ENSG00000049618:ENST00000346085:exon20:c.5218_5220del:p.1740_1740del,ENSG00000049618:ENST00000367148:exon20:c.5338_5340del:p.1780_1780del	ARID1B:NM_001363725:exon18:c.3088_3090del:p.1030_1030del,ARID1B:NM_017519:exon19:c.5179_5181del:p.1727_1727del,ARID1B:NM_001346813:exon20:c.5338_5340del:p.1780_1780del,ARID1B:NM_020732:exon20:c.5218_5220del:p.1740_1740del	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0067	0.0005	0.0109824	0.0004	.	.	.	.	.	.	.	.	ARID1B:uc003qqp.3:exon19:c.5179_5181del:p.1727_1727del,ARID1B:uc003qqn.3:exon20:c.5338_5340del:p.1780_1780del,ARID1B:uc003qqo.3:exon20:c.5218_5220del:p.1740_1740del	.	AFR:0.0001,AMR:0,EAS:0,FIN:0.0003,NFE:0.0004,OTH:0.0031,ASJ:0.0066	614556	135900;	1465;	1465|CSS|<1 / 1 000 000|Autosomal dominant|Neonatal|135900 614607 614608 614609 615866 616938 ~	.	.	.	.	.	.	.	.	6	.	het
6	159188128	159188128	A	G	EZR	intronic	.	ENSG00000092820	rs2242318	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6369	0.6978	0.522963	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.6788,AMR:0.6095,EAS:0.5993,FIN:0.1592,NFE:0.8257,OTH:0.7540,ASJ:0.4149	123900	.	.	.	~ko04530 Tight junction~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko04971 Gastric acid secretion~ko05130 Pathogenic Escherichia coli infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	6	2(lung)	0.7296
6	159188282	159188282	T	G	EZR	intronic	.	ENSG00000092820	rs9364994	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1778	0.1448	0.127995	0.1478	.	.	.	.	.	.	.	.	.	.	AFR:0.0413,AMR:0.1062,EAS:0.0611,FIN:0.2310,NFE:0.1986,OTH:0.2051,ASJ:0.1457	123900	.	.	.	~ko04530 Tight junction~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko04971 Gastric acid secretion~ko05130 Pathogenic Escherichia coli infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	6	MU25189207	het
6	159191788	159191788	C	T	EZR	intronic	.	ENSG00000092820	rs3212308	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4051	0.4257	0.33127	0.4118	.	.	.	.	.	0.0003	0.004	.	.	.	AFR:0.3299,AMR:0.2811,EAS:0.1406,FIN:0.5043,NFE:0.4736,OTH:0.4458,ASJ:0.34	123900	.	.	.	~ko04530 Tight junction~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko04971 Gastric acid secretion~ko05130 Pathogenic Escherichia coli infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	6	MU800661	het
6	159205668	159205668	G	A	EZR	intronic	.	ENSG00000092820	rs3103003	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5112	0.5553	0.419129	0.5414	.	.	.	.	.	0	0.002	.	.	.	AFR:0.4613,AMR:0.3365,EAS:0.1527,FIN:0.6371,NFE:0.6173,OTH:0.5799,ASJ:0.5033	123900	.	.	.	~ko04530 Tight junction~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko04971 Gastric acid secretion~ko05130 Pathogenic Escherichia coli infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	6	MU23689302	het
6	160113872	160113872	A	G	SOD2	exonic	nonsynonymous SNV	ENSG00000112096	rs4880	ENSG00000112096:ENST00000337404:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000367054:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000367055:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000444946:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000452684:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000535561:exon2:c.T116C:p.V39A,ENSG00000112096:ENST00000538183:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000545162:exon2:c.T116C:p.V39A,ENSG00000112096:ENST00000546260:exon2:c.T47C:p.V16A	SOD2:NM_000636:exon2:c.T47C:p.V16A,SOD2:NM_001024465:exon2:c.T47C:p.V16A,SOD2:NM_001024466:exon2:c.T47C:p.V16A,SOD2:NM_001322814:exon2:c.T47C:p.V16A,SOD2:NM_001322815:exon2:c.T47C:p.V16A,SOD2:NM_001322816:exon2:c.T47C:p.V16A	clinvar: drug_response 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5024	0.4731	0.410743	MU140155	-0.079	1.894	0.926	3.08	0.004	.	.	.	SOD2:uc003qsg.3:exon2:c.T47C:p.V16A,SOD2:uc003qsh.3:exon2:c.T47C:p.V16A,SOD2:uc003qsi.1:exon2:c.T47C:p.V16A,SOD2:uc003qsj.3:exon2:c.T47C:p.V16A,SOD2:uc011efu.1:exon2:c.T47C:p.V16A,SOD2:uc011efv.1:exon2:c.T47C:p.V16A	-0.931	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526,AMR:0.4676,EAS:0.6062,FIN:0.5397,NFE:0.1510,OTH:0.4716,ASJ:0.4235	147460	612634;	.	.	.	.	.	.	0.0	2.8	0.008	.	6	3(lung)	0.5131
6	160468278	160468278	A	G	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs998075	ENSG00000197081:ENST00000356956:exon16:c.A2139G:p.T713T	IGF2R:NM_000876:exon16:c.A2139G:p.T713T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5299	0.5167	0.577476	0.5485	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon16:c.A2139G:p.T713T	.	AFR:0.6179,AMR:0.5217,EAS:0.6582,FIN:0.5868,NFE:0.4919,OTH:0.5205,ASJ:0.4834	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	MU23691521	het
6	160468383	160468383	T	C	IGF2R	intronic	.	ENSG00000197081	rs998074	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5357	0.5080	0.573083	1(liver)	.	.	.	.	.	.	.	.	.	.	AFR:MU9524334,AMR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.6046,FIN:0.5179,NFE:0.4735,OTH:0.6611,ASJ:0.5441	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.5873
6	160494409	160494409	A	G	IGF2R	exonic	nonsynonymous SNV	ENSG00000197081	rs629849	ENSG00000197081:ENST00000356956:exon34:c.A4855G:p.R1619G	IGF2R:NM_000876:exon34:c.A4855G:p.R1619G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8963	0.9107	0.903155	0.9115	-0.274	0.760	1.0	4.43	0.492	.	.	Mannose-6-phosphate receptor binding domain	IGF2R:uc003qta.3:exon34:c.A4855G:p.R1619G	-0.945	AFR:0.9723,AMR:0.9391,EAS:0.8269,FIN:0.9097,NFE:0.8832,OTH:0.9114,ASJ:0.9570	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	0.0	4.55	0.001	.	6	MU23691754	hom
6	160505199	160505199	C	G	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs614754	ENSG00000197081:ENST00000356956:exon40:c.C6051G:p.L2017L	IGF2R:NM_000876:exon40:c.C6051G:p.L2017L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9918	0.9897	0.996006	0.9896	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon40:c.C6051G:p.L2017L	.	AFR:0.9954,AMR:0.9916,EAS:0.9994,FIN:0.9906,NFE:0.9845,OTH:0.9919,ASJ:1	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	MU81824095	hom
6	160524773	160524773	T	A	IGF2R	intronic	.	ENSG00000197081	rs2297370	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2408	0.1781	0.222444	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579	.	.	.	.	.	0	0.016	.	.	.	AFR:0.2029,AMR:0.1047,EAS:0.1523,FIN:0.4019,NFE:0.2385,OTH:0.2235,ASJ:0.3357	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	9(soft_tissue)	0.2150
6	161771116	161771116	G	T	PRKN	UTR3	.	ENSG00000185345	rs35125035	.	.	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0029	.	0.0061901	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.0018,AMR:0,EAS:0,FIN:0.0345,NFE:0,OTH:0,ASJ:0	602544	167000;211980;600116;607572;	548;2828;	548|-|Unknown|Multigenic/multifactorial|All ages|246300 607572 609888 610988 613223 613407 ~2828|Early-onset Parkinson disease<br>YOPD|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|300557 600116 602404 605909 606324 606852 610297 613643 615528 616840 ~	.	.	.	.	.	.	.	.	6	1(liver)	0
6	162622304	162622304	A	G	PRKN	intronic	.	ENSG00000185345	rs4709583	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9329	0.9403	0.950479	0.9475	.	.	.	.	.	.	.	.	.	.	AFR:0.9849,AMR:0.9642,EAS:0.9920,FIN:0.9473,NFE:0.9217,OTH:0.9206,ASJ:0.9536	602544	167000;211980;600116;607572;	548;2828;	548|-|Unknown|Multigenic/multifactorial|All ages|246300 607572 609888 610988 613223 613407 ~2828|Early-onset Parkinson disease<br>YOPD|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|300557 600116 602404 605909 606324 606852 610297 613643 615528 616840 ~	.	.	.	.	.	.	.	.	6	MU81824308	hom
6	162683815	162683815	A	-	PRKN	intronic	.	ENSG00000185345	rs756249386	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0782	.	.	0.0489	.	.	.	.	.	.	.	.	.	.	AFR:0.0192,AMR:0.1099,EAS:0.1132,FIN:0.1765,NFE:0.0478,OTH:0.0992,ASJ:0.09	602544	167000;211980;600116;607572;	548;2828;	548|-|Unknown|Multigenic/multifactorial|All ages|246300 607572 609888 610988 613223 613407 ~2828|Early-onset Parkinson disease<br>YOPD|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|300557 600116 602404 605909 606324 606852 610297 613643 615528 616840 ~	.	.	.	.	.	.	.	.	6	.	het
6	166826255	166826255	G	A	RPS6KA2	exonic	synonymous SNV	ENSG00000071242	rs909631	ENSG00000071242:ENST00000265678:exon21:c.C2197T:p.L733L,ENSG00000071242:ENST00000405189:exon21:c.C1930T:p.L644L,ENSG00000071242:ENST00000481261:exon21:c.C1930T:p.L644L,ENSG00000071242:ENST00000503859:exon22:c.C2221T:p.L741L,ENSG00000071242:ENST00000510118:exon23:c.C2272T:p.L758L	RPS6KA2:NM_001318937:exon19:c.C1903T:p.L635L,RPS6KA2:NM_001318938:exon21:c.C1930T:p.L644L,RPS6KA2:NM_021135:exon21:c.C2197T:p.L733L,RPS6KA2:NM_001006932:exon22:c.C2221T:p.L741L,RPS6KA2:NM_001318936:exon23:c.C2272T:p.L758L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6917	0.5785	0.620208	0.5670	.	.	.	.	.	.	.	.	RPS6KA2:uc010kkk.1:exon6:c.C493T:p.L165L,RPS6KA2:uc003qvb.1:exon21:c.C2197T:p.L733L,RPS6KA2:uc010kkl.1:exon21:c.C1930T:p.L644L,RPS6KA2:uc011ego.1:exon21:c.C1930T:p.L644L,RPS6KA2:uc003qvc.1:exon22:c.C2221T:p.L741L,RPS6KA2:uc003qvd.1:exon23:c.C2272T:p.L758L	.	AFR:0.3648,AMR:0.5837,EAS:0.7602,FIN:0.5688,NFE:0.6530,OTH:0.6577,ASJ:0.7285	601685	.	.	.	.	.	.	.	.	.	.	.	6	MU73172	hom
6	166826304	166826304	T	C	RPS6KA2	exonic	synonymous SNV	ENSG00000071242	rs760670	ENSG00000071242:ENST00000265678:exon21:c.A2148G:p.S716S,ENSG00000071242:ENST00000405189:exon21:c.A1881G:p.S627S,ENSG00000071242:ENST00000481261:exon21:c.A1881G:p.S627S,ENSG00000071242:ENST00000503859:exon22:c.A2172G:p.S724S,ENSG00000071242:ENST00000510118:exon23:c.A2223G:p.S741S	RPS6KA2:NM_001318937:exon19:c.A1854G:p.S618S,RPS6KA2:NM_001318938:exon21:c.A1881G:p.S627S,RPS6KA2:NM_021135:exon21:c.A2148G:p.S716S,RPS6KA2:NM_001006932:exon22:c.A2172G:p.S724S,RPS6KA2:NM_001318936:exon23:c.A2223G:p.S741S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7481	0.7414	0.795527	LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	RPS6KA2:uc010kkk.1:exon6:c.A444G:p.S148S,RPS6KA2:uc003qvb.1:exon21:c.A2148G:p.S716S,RPS6KA2:uc010kkl.1:exon21:c.A1881G:p.S627S,RPS6KA2:uc011ego.1:exon21:c.A1881G:p.S627S,RPS6KA2:uc003qvc.1:exon22:c.A2172G:p.S724S,RPS6KA2:uc003qvd.1:exon23:c.A2223G:p.S741S	.	AFR:0.7166,AMR:0.8338,EAS:0.7417,FIN:0.8130,NFE:0.5989,OTH:0.6677,ASJ:0.6854	601685	.	.	.	.	.	.	.	.	.	.	.	6	3(large_intestine)	0.7043
6	166827436	166827436	T	C	RPS6KA2	intronic	.	ENSG00000071242	rs2235295	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6984	0.6625	0.726637	0.6510	.	.	.	.	.	.	.	.	.	.	AFR:0.6304,AMR:0.6706,EAS:0.7953,FIN:0.5956,NFE:0.6555,OTH:0.6828,ASJ:0.7351	601685	.	.	.	.	.	.	.	.	.	.	.	6	MU12549640	hom
6	166831694	166831694	C	T	RPS6KA2	intronic	.	ENSG00000071242	rs10946164	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3599	0.3324	0.253594	LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.3043,AMR:0.0806,EAS:0.4139,FIN:0.1900,NFE:0.3582,OTH:0.4302,ASJ:0.2434	601685	.	.	.	.	.	.	.	.	.	.	.	6	1(upper_aerodigestive_tract)	0.3875
6	166862233	166862233	T	C	RPS6KA2	exonic	synonymous SNV	ENSG00000071242	rs2230730	ENSG00000071242:ENST00000265678:exon14:c.A1311G:p.T437T,ENSG00000071242:ENST00000405189:exon14:c.A1044G:p.T348T,ENSG00000071242:ENST00000481261:exon14:c.A1044G:p.T348T,ENSG00000071242:ENST00000503859:exon15:c.A1335G:p.T445T,ENSG00000071242:ENST00000510118:exon16:c.A1386G:p.T462T	RPS6KA2:NM_001318937:exon12:c.A1017G:p.T339T,RPS6KA2:NM_001318938:exon14:c.A1044G:p.T348T,RPS6KA2:NM_021135:exon14:c.A1311G:p.T437T,RPS6KA2:NM_001006932:exon15:c.A1335G:p.T445T,RPS6KA2:NM_001318936:exon16:c.A1386G:p.T462T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2778	0.2705	0.198882	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|4|170|0.0235294,COCA-CN|1|321|0.00311526,ESCA-CN|1|332|0.00301205	.	.	.	.	.	.	.	.	RPS6KA2:uc003qvb.1:exon14:c.A1311G:p.T437T,RPS6KA2:uc010kkl.1:exon14:c.A1044G:p.T348T,RPS6KA2:uc011ego.1:exon14:c.A1044G:p.T348T,RPS6KA2:uc003qvc.1:exon15:c.A1335G:p.T445T,RPS6KA2:uc003qvd.1:exon16:c.A1386G:p.T462T	.	AFR:0.2505,AMR:0.1997,EAS:0.3245,FIN:0.0713,NFE:0.2587,OTH:0.2933,ASJ:0.2907	601685	.	.	.	.	.	.	.	.	.	.	.	6	3(lung)	0.2561
6	166864693	166864693	G	A	RPS6KA2	exonic	synonymous SNV	ENSG00000071242	rs4710047	ENSG00000071242:ENST00000265678:exon13:c.C1104T:p.N368N,ENSG00000071242:ENST00000405189:exon13:c.C837T:p.N279N,ENSG00000071242:ENST00000481261:exon13:c.C837T:p.N279N,ENSG00000071242:ENST00000503859:exon14:c.C1128T:p.N376N,ENSG00000071242:ENST00000510118:exon15:c.C1179T:p.N393N	RPS6KA2:NM_001318937:exon11:c.C810T:p.N270N,RPS6KA2:NM_001318938:exon13:c.C837T:p.N279N,RPS6KA2:NM_021135:exon13:c.C1104T:p.N368N,RPS6KA2:NM_001006932:exon14:c.C1128T:p.N376N,RPS6KA2:NM_001318936:exon15:c.C1179T:p.N393N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0221	0.0149	0.0445288	MU800774	.	.	.	.	.	.	.	.	RPS6KA2:uc003qvb.1:exon13:c.C1104T:p.N368N,RPS6KA2:uc010kkl.1:exon13:c.C837T:p.N279N,RPS6KA2:uc011ego.1:exon13:c.C837T:p.N279N,RPS6KA2:uc003qvc.1:exon14:c.C1128T:p.N376N,RPS6KA2:uc003qvd.1:exon15:c.C1179T:p.N393N	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,BTCA-JP|1|239|0.0041841,AMR:0.0190,EAS:0.0453,FIN:0,NFE:0.1032,OTH:0,ASJ:0.0421	601685	.	.	.	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.0007
6	166873010	166873010	C	T	RPS6KA2	exonic	synonymous SNV	ENSG00000071242	rs2230729	ENSG00000071242:ENST00000265678:exon12:c.G1002A:p.P334P,ENSG00000071242:ENST00000405189:exon12:c.G735A:p.P245P,ENSG00000071242:ENST00000481261:exon12:c.G735A:p.P245P,ENSG00000071242:ENST00000503859:exon13:c.G1026A:p.P342P,ENSG00000071242:ENST00000510118:exon14:c.G1077A:p.P359P	RPS6KA2:NM_001318937:exon10:c.G708A:p.P236P,RPS6KA2:NM_001318938:exon12:c.G735A:p.P245P,RPS6KA2:NM_021135:exon12:c.G1002A:p.P334P,RPS6KA2:NM_001006932:exon13:c.G1026A:p.P342P,RPS6KA2:NM_001318936:exon14:c.G1077A:p.P359P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1610	0.1454	0.150759	LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	RPS6KA2:uc003qvb.1:exon12:c.G1002A:p.P334P,RPS6KA2:uc010kkl.1:exon12:c.G735A:p.P245P,RPS6KA2:uc011ego.1:exon12:c.G735A:p.P245P,RPS6KA2:uc003qvc.1:exon13:c.G1026A:p.P342P,RPS6KA2:uc003qvd.1:exon14:c.G1077A:p.P359P	.	AFR:0.1386,AMR:0.1245,EAS:0.2020,FIN:0.1900,NFE:0.1191,OTH:0.1392,ASJ:0.2290	601685	.	.	.	.	.	.	.	.	.	.	.	6	1(breast)	0.1449
6	166912062	166912062	C	T	RPS6KA2	exonic	synonymous SNV	ENSG00000071242	rs2230732	ENSG00000071242:ENST00000265678:exon8:c.G681A:p.A227A,ENSG00000071242:ENST00000366863:exon8:c.G219A:p.A73A,ENSG00000071242:ENST00000405189:exon8:c.G414A:p.A138A,ENSG00000071242:ENST00000481261:exon8:c.G414A:p.A138A,ENSG00000071242:ENST00000503859:exon9:c.G705A:p.A235A,ENSG00000071242:ENST00000510118:exon10:c.G756A:p.A252A	RPS6KA2:NM_001318937:exon6:c.G387A:p.A129A,RPS6KA2:NM_001318938:exon8:c.G414A:p.A138A,RPS6KA2:NM_021135:exon8:c.G681A:p.A227A,RPS6KA2:NM_001006932:exon9:c.G705A:p.A235A,RPS6KA2:NM_001318936:exon10:c.G756A:p.A252A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1263	0.2134	0.205471	LUSC-KR|1|170|0.00588235,GACA-JP|1|585|0.0017094	.	.	.	.	.	.	.	.	RPS6KA2:uc003qvb.1:exon8:c.G681A:p.A227A,RPS6KA2:uc010kkl.1:exon8:c.G414A:p.A138A,RPS6KA2:uc011ego.1:exon8:c.G414A:p.A138A,RPS6KA2:uc003qvc.1:exon9:c.G705A:p.A235A,RPS6KA2:uc003qvd.1:exon10:c.G756A:p.A252A	.	AFR:0.1994,AMR:0.4707,EAS:0.0567,FIN:0.0117,NFE:0.0733,OTH:0.1021,ASJ:0.1838	601685	.	.	.	.	.	.	.	.	.	.	.	6	1(lung)	0.0939
6	166912157	166912157	C	T	RPS6KA2	intronic	.	ENSG00000071242	rs6923965	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1230	0.2018	0.19369	0.1899	.	.	.	.	.	.	.	.	.	.	AFR:0.4390,AMR:0.1802,EAS:0.0105,FIN:0.0733,NFE:0.1015,OTH:0.0937,ASJ:0.0563	601685	.	.	.	.	.	.	.	.	.	.	.	6	MU113473373	het
6	166952264	166952264	G	A	RPS6KA2	exonic	synonymous SNV	ENSG00000071242	rs1003857	ENSG00000071242:ENST00000265678:exon2:c.C108T:p.G36G,ENSG00000071242:ENST00000507371:exon2:c.C60T:p.G20G,ENSG00000071242:ENST00000503859:exon3:c.C132T:p.G44G,ENSG00000071242:ENST00000510118:exon4:c.C183T:p.G61G,ENSG00000071242:ENST00000506565:exon5:c.C183T:p.G61G	RPS6KA2:NM_021135:exon2:c.C108T:p.G36G,RPS6KA2:NM_001006932:exon3:c.C132T:p.G44G,RPS6KA2:NM_001318936:exon4:c.C183T:p.G61G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7924	0.7214	0.787939	COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	RPS6KA2:uc003qvb.1:exon2:c.C108T:p.G36G,RPS6KA2:uc003qvc.1:exon3:c.C132T:p.G44G,RPS6KA2:uc003qvd.1:exon4:c.C183T:p.G61G	.	AFR:0.7292,AMR:0.6418,EAS:0.7649,FIN:0.9518,NFE:0.7648,OTH:0.7372,ASJ:0.8819	601685	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.7464
6	167271711	167271711	T	C	RPS6KA2	exonic	nonsynonymous SNV	ENSG00000071242;ENSG00000249141	rs943687	ENSG00000071242:ENST00000503859:exon2:c.A100G:p.T34A,ENSG00000071242:ENST00000510118:exon2:c.A100G:p.T34A,ENSG00000071242:ENST00000506565:exon3:c.A100G:p.T34A	RPS6KA2:NM_001006932:exon2:c.A100G:p.T34A,RPS6KA2:NM_001318936:exon2:c.A100G:p.T34A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9643	0.9407	0.922125	0.9515	-3.152	0.001	0.838	-9.48	0.000	.	.	.	RPS6KA2:uc003qvc.1:exon2:c.A100G:p.T34A,RPS6KA2:uc003qvd.1:exon2:c.A100G:p.T34A	-1.098	AFR:0.8527,AMR:0.9809,EAS:0.9604,FIN:0.9994,NFE:0.9933,OTH:0.9776,ASJ:0.9570	601685	.	.	.	.	.	.	.	0.0	-0.36	0.034	.	6	MU19401550	unknown
6	167271716	167271716	T	C	RPS6KA2	exonic	nonsynonymous SNV	ENSG00000071242;ENSG00000249141	rs9347162	ENSG00000071242:ENST00000503859:exon2:c.A95G:p.E32G,ENSG00000071242:ENST00000510118:exon2:c.A95G:p.E32G,ENSG00000071242:ENST00000506565:exon3:c.A95G:p.E32G	RPS6KA2:NM_001006932:exon2:c.A95G:p.E32G,RPS6KA2:NM_001318936:exon2:c.A95G:p.E32G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7054	0.5814	0.607628	0.6165	0.605	8.191	0.335	3.56	0.007	.	.	.	RPS6KA2:uc003qvc.1:exon2:c.A95G:p.E32G,RPS6KA2:uc003qvd.1:exon2:c.A95G:p.E32G	-1.027	AFR:0.2480,AMR:0.7912,EAS:0.8784,FIN:0.7153,NFE:0.7601,OTH:0.7357,ASJ:0.6854	601685	.	.	.	.	.	.	.	0.0	-0.5	0.024	.	6	MU19401625	unknown
6	167413539	167413539	T	C	FGFR1OP	intronic	.	ENSG00000272980	rs12212247	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3764	0.3620	0.26278	MU19411290	.	.	.	.	.	0.0001	0.024	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.3574,EAS:0.3198,FIN:0.4238,NFE:0.2574,OTH:0.4175,ASJ:0.1707	605392	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.4625
6	167424293	167424293	T	C	FGFR1OP	intronic	.	ENSG00000272980	rs1322077	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5258	0.3920	0.299321	0.3830	.	.	.	.	.	0.0002	0.058	.	.	.	AFR:0.2612,AMR:0.3246,EAS:0.2574,FIN:0.4182,NFE:0.4624,OTH:0.3817,ASJ:0.3874	605392	.	.	.	.	.	.	.	.	.	.	.	6	MU21296248	het
6	167453519	167453519	-	T	FGFR1OP	UTR3	.	ENSG00000272980	rs368396376	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5074	0.5145	0.520966	0.7698	.	.	.	.	.	.	.	.	.	.	AFR:0.5960,AMR:0.8240,EAS:0.8238,FIN:0.7609,NFE:0.8631,OTH:0.8096,ASJ:0.8346	605392	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
7	2257612	2257612	G	A	MAD1L1	exonic	synonymous SNV	ENSG00000002822	rs6951493	ENSG00000002822:ENST00000429625:exon4:c.C450T:p.H150H,ENSG00000002822:ENST00000445959:exon4:c.C294T:p.H98H,ENSG00000002822:ENST00000402746:exon5:c.C387T:p.H129H,ENSG00000002822:ENST00000265854:exon6:c.C663T:p.H221H,ENSG00000002822:ENST00000399654:exon7:c.C663T:p.H221H,ENSG00000002822:ENST00000406869:exon7:c.C663T:p.H221H	MAD1L1:NM_001304524:exon5:c.C387T:p.H129H,MAD1L1:NM_001304523:exon6:c.C663T:p.H221H,MAD1L1:NM_001013836:exon7:c.C663T:p.H221H,MAD1L1:NM_001013837:exon7:c.C663T:p.H221H,MAD1L1:NM_003550:exon7:c.C663T:p.H221H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3496	0.3347	0.365615	0.3322	.	.	.	.	.	.	.	.	MAD1L1:uc003sli.1:exon5:c.C387T:p.H129H,MAD1L1:uc010ksi.1:exon5:c.C522T:p.H174H,MAD1L1:uc010ksh.1:exon6:c.C663T:p.H221H,MAD1L1:uc003slf.1:exon7:c.C663T:p.H221H,MAD1L1:uc003slg.1:exon7:c.C663T:p.H221H,MAD1L1:uc003slh.1:exon7:c.C663T:p.H221H,MAD1L1:uc010ksj.3:exon7:c.C663T:p.H221H	.	AFR:0.2777,AMR:0.4041,EAS:0.5341,FIN:0.2723,NFE:0.3526,OTH:0.3388,ASJ:0.2815	602686	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	~ko04110 Cell cycle~ko04111 Cell cycle - yeast~ko04113 Meiosis - yeast~ko04114 Oocyte meiosis~ko04914 Progesterone-mediated oocyte maturation~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	7	MU109089	hom
7	2290314	2290314	C	T	NUDT1	exonic	synonymous SNV	ENSG00000106268	rs12699806	.	NUDT1:NM_001367555:exon4:c.C336T:p.L112L,NUDT1:NM_001367554:exon5:c.C336T:p.L112L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.610823	0.6427	.	.	.	.	.	.	.	.	.	.	AFR:0.4812,AMR:0.5955,EAS:0.7219,FIN:0.7434,NFE:0.7104,OTH:0.6798,ASJ:0.5714	600312	.	.	.	.	.	.	.	.	.	.	.	7	.	unknown
7	2290317	2290317	T	G	NUDT1	exonic	nonsynonymous SNV	ENSG00000106268	rs60298419	.	NUDT1:NM_001367555:exon4:c.T339G:p.D113E,NUDT1:NM_001367554:exon5:c.T339G:p.D113E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.611222	0.6413	.	.	.	.	.	.	.	.	.	.	AFR:0.4801,AMR:0.5952,EAS:0.7207,FIN:0.7404,NFE:0.7096,OTH:0.6806,ASJ:0.568	600312	.	.	.	.	.	.	.	.	.	.	.	7	.	unknown
7	2290320	2290320	C	-	NUDT1	exonic	frameshift deletion	ENSG00000106268	rs373496719	.	NUDT1:NM_001367555:exon4:c.342delC:p.L114fs,NUDT1:NM_001367554:exon5:c.342delC:p.L114fs	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.611022	0.6409	.	.	.	.	.	.	.	.	.	.	AFR:0.4799,AMR:0.5942,EAS:0.7204,FIN:0.7413,NFE:0.7086,OTH:0.6813,ASJ:0.5650	600312	.	.	.	.	.	.	.	.	.	.	.	7	.	unknown
7	2290328	2290328	C	T	NUDT1	exonic	nonsynonymous SNV	ENSG00000106268	rs10230814	.	NUDT1:NM_001367555:exon4:c.C350T:p.S117L,NUDT1:NM_001367554:exon5:c.C350T:p.S117L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.611422	0.6436	.	.	.	.	.	.	.	.	.	.	AFR:0.4818,AMR:0.5980,EAS:0.7212,FIN:0.7432,NFE:0.7114,OTH:0.6809,ASJ:0.5853	600312	.	.	.	.	.	.	.	.	.	.	.	7	MU14062065	unknown
7	2290336	2290336	T	G	NUDT1	UTR3	.	ENSG00000106268	rs10249180	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.311901	0.2812	.	.	.	.	.	.	.	.	.	.	AFR:0.1047,AMR:0.3793,EAS:0.5553,FIN:0.2879,NFE:0.3484,OTH:0.3185,ASJ:0.2810	600312	.	.	.	.	.	.	.	.	.	.	.	7	.	unknown
7	2946461	2946461	T	C	CARD11	exonic	synonymous SNV	ENSG00000198286	rs1124581	ENSG00000198286:ENST00000396946:exon25:c.A3276G:p.R1092R	CARD11:NM_032415:exon25:c.A3276G:p.R1092R,CARD11:NM_001324281:exon26:c.A3276G:p.R1092R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5163	0.5466	0.596446	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	CARD11:uc003smv.3:exon25:c.A3276G:p.R1092R	.	AFR:MU62210,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763,EAS:0.6721,FIN:0.4880,NFE:0.4040,OTH:0.6410,ASJ:0.5349	607210	615206;616452;	464336;357237;	464336|B-cell expansion with NF-kB and T-cell anergy disease|-|Autosomal dominant|-|616452 ~357237|SCID due to CARD11 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615206 ~	.	.	.	.	.	.	.	.	7	2(large_intestine)	0.4029
7	2962753	2962753	G	A	CARD11	intronic	.	ENSG00000198286	rs2527509	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6795	0.6346	0.505391	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.6370,AMR:0.3526,EAS:0.7550,FIN:0.3714,NFE:0.8256,OTH:0.7775,ASJ:0.6444	607210	615206;616452;	464336;357237;	464336|B-cell expansion with NF-kB and T-cell anergy disease|-|Autosomal dominant|-|616452 ~357237|SCID due to CARD11 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615206 ~	.	.	.	.	.	.	.	.	7	1(lung)	0.7383
7	2966445	2966445	T	G	CARD11	intronic	.	ENSG00000198286	rs1182136	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5711	.	0.560503	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.5294,AMR:0.3676,EAS:0.4967,FIN:0.2041,NFE:0.7129,OTH:0.6081,ASJ:0.5644	607210	615206;616452;	464336;357237;	464336|B-cell expansion with NF-kB and T-cell anergy disease|-|Autosomal dominant|-|616452 ~357237|SCID due to CARD11 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615206 ~	.	.	.	.	.	.	.	.	7	12(soft_tissue)	0.6276
7	6013049	6013049	C	G	PMS2	exonic	nonsynonymous SNV	ENSG00000122512	rs1802683	ENSG00000122512:ENST00000382321:exon11:c.G1367C:p.G456A,ENSG00000122512:ENST00000441476:exon12:c.G2252C:p.G751A,ENSG00000122512:ENST00000265849:exon15:c.G2570C:p.G857A	PMS2:NM_001322008:exon13:c.G2252C:p.G751A,PMS2:NM_001322010:exon13:c.G2009C:p.G670A,PMS2:NM_001322004:exon14:c.G2165C:p.G722A,PMS2:NM_001322006:exon14:c.G2414C:p.G805A,PMS2:NM_001322007:exon14:c.G2252C:p.G751A,PMS2:NM_001322013:exon14:c.G1997C:p.G666A,PMS2:NM_000535:exon15:c.G2570C:p.G857A,PMS2:NM_001322003:exon15:c.G2165C:p.G722A,PMS2:NM_001322005:exon15:c.G2165C:p.G722A,PMS2:NM_001322009:exon15:c.G2198C:p.G733A,PMS2:NM_001322011:exon15:c.G1637C:p.G546A,PMS2:NM_001322012:exon15:c.G1637C:p.G546A,PMS2:NM_001322014:exon15:c.G2603C:p.G868A,PMS2:NM_001322015:exon15:c.G2261C:p.G754A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3702	.	.	2(breast)	0.850	9.768	0.312	2.84	0.996	.	.	.	PMS2:uc010kte.3:exon11:c.G1367C:p.G456A,PMS2:uc003spj.3:exon12:c.G2252C:p.G751A,PMS2:uc011jwl.2:exon14:c.G2165C:p.G722A,PMS2:uc003spk.3:exon15:c.G2165C:p.G722A,PMS2:uc003spl.3:exon15:c.G2570C:p.G857A,PMS2:uc010ktg.3:exon15:c.G1637C:p.G546A	-1.103	AFR:MU4547754,AMR:SKCA-BR|1|100|0.01,COCA-CN|2|321|0.00623053,EAS:0.3920,FIN:0.3317,NFE:0.2590,OTH:0.4383,ASJ:0.3225	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	0.0	-1.86	0.000	-0.32	7	1(thyroid)	0.2642
7	6022626	6022626	C	T	PMS2	intronic	.	ENSG00000122512	rs1805326	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1548	.	0.16274	LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|2|321|0.00623053	.	.	.	.	.	0.0001	0.006	.	.	.	AFR:0.1281,AMR:0.0406,EAS:0.1523,FIN:0.3090,NFE:0.1205,OTH:0.1541,ASJ:0.2284	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	.	.	.	.	7	8(soft_tissue)	0.1404
7	6026775	6026775	T	C	PMS2	exonic	nonsynonymous SNV	ENSG00000122512	rs2228006	ENSG00000122512:ENST00000441476:exon8:c.A1303G:p.K435E,ENSG00000122512:ENST00000265849:exon11:c.A1621G:p.K541E,ENSG00000122512:ENST00000406569:exon11:c.A1621G:p.K541E	PMS2:NM_001322008:exon9:c.A1303G:p.K435E,PMS2:NM_001322010:exon9:c.A1060G:p.K354E,PMS2:NM_001322004:exon10:c.A1216G:p.K406E,PMS2:NM_001322006:exon10:c.A1465G:p.K489E,PMS2:NM_001322007:exon10:c.A1303G:p.K435E,PMS2:NM_001322013:exon10:c.A1048G:p.K350E,PMS2:NM_000535:exon11:c.A1621G:p.K541E,PMS2:NM_001322003:exon11:c.A1216G:p.K406E,PMS2:NM_001322005:exon11:c.A1216G:p.K406E,PMS2:NM_001322009:exon11:c.A1216G:p.K406E,PMS2:NM_001322011:exon11:c.A688G:p.K230E,PMS2:NM_001322012:exon11:c.A688G:p.K230E,PMS2:NM_001322014:exon11:c.A1621G:p.K541E,PMS2:NM_001322015:exon11:c.A1312G:p.K438E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8514	0.8704	0.883187	0.8722	-0.586	0.135	1.0	4.66	0.013	.	.	.	PMS2:uc003spj.3:exon8:c.A1303G:p.K435E,PMS2:uc011jwl.2:exon10:c.A1216G:p.K406E,PMS2:uc003spk.3:exon11:c.A1216G:p.K406E,PMS2:uc003spl.3:exon11:c.A1621G:p.K541E,PMS2:uc010ktf.2:exon11:c.A1621G:p.K541E,PMS2:uc010ktg.3:exon11:c.A688G:p.K230E	-0.949	AFR:0.9248,AMR:0.7213,EAS:0.9202,FIN:0.8447,NFE:0.8522,OTH:0.8507,ASJ:0.8974	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	0.0	1.0	0.000	-1.87	7	MU784023	hom
7	6026988	6026988	G	A	PMS2	exonic	nonsynonymous SNV	ENSG00000122512	rs1805321	ENSG00000122512:ENST00000441476:exon8:c.C1090T:p.P364S,ENSG00000122512:ENST00000265849:exon11:c.C1408T:p.P470S,ENSG00000122512:ENST00000406569:exon11:c.C1408T:p.P470S	PMS2:NM_001322008:exon9:c.C1090T:p.P364S,PMS2:NM_001322010:exon9:c.C847T:p.P283S,PMS2:NM_001322004:exon10:c.C1003T:p.P335S,PMS2:NM_001322006:exon10:c.C1252T:p.P418S,PMS2:NM_001322007:exon10:c.C1090T:p.P364S,PMS2:NM_001322013:exon10:c.C835T:p.P279S,PMS2:NM_000535:exon11:c.C1408T:p.P470S,PMS2:NM_001322003:exon11:c.C1003T:p.P335S,PMS2:NM_001322005:exon11:c.C1003T:p.P335S,PMS2:NM_001322009:exon11:c.C1003T:p.P335S,PMS2:NM_001322011:exon11:c.C475T:p.P159S,PMS2:NM_001322012:exon11:c.C475T:p.P159S,PMS2:NM_001322014:exon11:c.C1408T:p.P470S,PMS2:NM_001322015:exon11:c.C1099T:p.P367S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3854	0.3738	0.358227	1(large_intestine)	-0.661	0.089	0.844	0.572	0.000	.	.	.	PMS2:uc003spj.3:exon8:c.C1090T:p.P364S,PMS2:uc011jwl.2:exon10:c.C1003T:p.P335S,PMS2:uc003spk.3:exon11:c.C1003T:p.P335S,PMS2:uc003spl.3:exon11:c.C1408T:p.P470S,PMS2:uc010ktf.2:exon11:c.C1408T:p.P470S,PMS2:uc010ktg.3:exon11:c.C475T:p.P159S	-1.002	AFR:1(thyroid),AMR:MU4566009,EAS:0.3706,FIN:0.2827,NFE:0.4045,OTH:0.4040,ASJ:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	0.018	1.14	0.000	1.03	7	1(skin)	0.3890
7	6036980	6036980	G	C	PMS2	exonic	synonymous SNV	ENSG00000122512	rs1805319	ENSG00000122512:ENST00000441476:exon4:c.C462G:p.S154S,ENSG00000122512:ENST00000265849:exon7:c.C780G:p.S260S,ENSG00000122512:ENST00000382321:exon7:c.C780G:p.S260S,ENSG00000122512:ENST00000406569:exon7:c.C780G:p.S260S	PMS2:NM_001322008:exon5:c.C462G:p.S154S,PMS2:NM_001322004:exon6:c.C375G:p.S125S,PMS2:NM_001322007:exon6:c.C462G:p.S154S,PMS2:NM_001322010:exon6:c.C375G:p.S125S,PMS2:NM_001322013:exon6:c.C207G:p.S69S,PMS2:NM_000535:exon7:c.C780G:p.S260S,PMS2:NM_001322003:exon7:c.C375G:p.S125S,PMS2:NM_001322005:exon7:c.C375G:p.S125S,PMS2:NM_001322006:exon7:c.C780G:p.S260S,PMS2:NM_001322009:exon7:c.C375G:p.S125S,PMS2:NM_001322014:exon7:c.C780G:p.S260S,PMS2:NM_001322015:exon7:c.C471G:p.S157S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8109	0.8238	0.83127	0.8205	.	.	.	.	.	.	.	.	PMS2:uc003spj.3:exon4:c.C462G:p.S154S,PMS2:uc011jwl.2:exon6:c.C375G:p.S125S,PMS2:uc003spk.3:exon7:c.C375G:p.S125S,PMS2:uc003spl.3:exon7:c.C780G:p.S260S,PMS2:uc010kte.3:exon7:c.C780G:p.S260S,PMS2:uc010ktf.2:exon7:c.C780G:p.S260S	.	AFR:0.8433,AMR:0.7031,EAS:0.9180,FIN:0.7911,NFE:0.8107,OTH:0.8010,ASJ:0.8444	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	.	.	.	.	7	MU4565970	hom
7	6037058	6037058	A	-	PMS2	intronic	.	ENSG00000122512	rs60794673	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0] 	0.4422	.	0.453075	0.4480	.	.	.	.	.	.	.	.	.	.	AFR:0.3371,AMR:0.4701,EAS:0.7010,FIN:0.4676,NFE:0.4763,OTH:0.4749,ASJ:0.4958	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	.	.	.	.	7	.	het
7	6038722	6038722	T	C	PMS2	intronic	.	ENSG00000122512	rs62456182	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3678	0.3439	0.325679	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841	.	.	.	.	.	.	.	.	.	.	AFR:0.3392,AMR:0.1978,EAS:0.4007,FIN:0.3626,NFE:0.3525,OTH:0.4139,ASJ:0.3278	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	.	.	.	.	7	3(lung)	0.3617
7	6431690	6431690	C	T	RAC1	intronic	.	ENSG00000136238	rs836478	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5603	0.5425	0.691494	0.5664	.	.	.	.	.	.	.	.	.	.	AFR:0.7118,AMR:0.6439,EAS:0.9142,FIN:0.4745,NFE:0.4697,OTH:0.4949,ASJ:0.3874	602048	.	.	.	~ko04010 MAPK signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04071 Sphingolipid signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04310 Wnt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko04620 Toll-like receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04972 Pancreatic secretion~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05132 Salmonella infection~ko05135 Yersinia infection~ko05163 Human cytomegalovirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05231 Choline metabolism in cancer~ko05416 Viral myocarditis~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	7	MU18753436	het
7	13978809	13978809	T	C	ETV1	exonic	nonsynonymous SNV	ENSG00000006468	rs9639168	ENSG00000006468:ENST00000420159:exon2:c.A124G:p.S42G,ENSG00000006468:ENST00000438956:exon2:c.A124G:p.S42G,ENSG00000006468:ENST00000399357:exon3:c.A178G:p.S60G,ENSG00000006468:ENST00000403527:exon3:c.A178G:p.S60G,ENSG00000006468:ENST00000443608:exon3:c.A178G:p.S60G,ENSG00000006468:ENST00000403685:exon5:c.A244G:p.S82G,ENSG00000006468:ENST00000405358:exon5:c.A340G:p.S114G,ENSG00000006468:ENST00000242066:exon6:c.A244G:p.S82G,ENSG00000006468:ENST00000343495:exon6:c.A244G:p.S82G,ENSG00000006468:ENST00000405192:exon6:c.A298G:p.S100G,ENSG00000006468:ENST00000405218:exon6:c.A298G:p.S100G,ENSG00000006468:ENST00000421381:exon6:c.A298G:p.S100G,ENSG00000006468:ENST00000430479:exon7:c.A298G:p.S100G,ENSG00000006468:ENST00000443137:exon7:c.A298G:p.S100G	ETV1:NM_001163151:exon2:c.A124G:p.S42G,ETV1:NM_001163150:exon3:c.A178G:p.S60G,ETV1:NM_001163152:exon3:c.A178G:p.S60G,ETV1:NM_001163149:exon5:c.A244G:p.S82G,ETV1:NM_001370556:exon5:c.A250G:p.S84G,ETV1:NM_001163147:exon6:c.A298G:p.S100G,ETV1:NM_001163148:exon6:c.A244G:p.S82G,ETV1:NM_001370555:exon6:c.A298G:p.S100G,ETV1:NM_004956:exon7:c.A298G:p.S100G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3500	0.2929	0.319289	1(stomach)	1.292	12.23	0.494	4.57	0.990	.	.	PEA3-type ETS-domain transcription factor, N-terminal	ETV1:uc021zzv.1:exon2:c.A124G:p.S42G,ETV1:uc021zzy.1:exon2:c.A124G:p.S42G,ETV1:uc021zzt.1:exon3:c.A178G:p.S60G,ETV1:uc021zzu.1:exon3:c.A178G:p.S60G,ETV1:uc021zzw.1:exon3:c.A178G:p.S60G,ETV1:uc021zzx.1:exon3:c.A178G:p.S60G,ETV1:uc022aaa.1:exon4:c.A244G:p.S82G,ETV1:uc021zzz.1:exon5:c.A298G:p.S100G,ETV1:uc022aac.1:exon5:c.A244G:p.S82G,ETV1:uc003ssw.4:exon6:c.A298G:p.S100G,ETV1:uc022aad.1:exon6:c.A244G:p.S82G,ETV1:uc022aab.1:exon7:c.A298G:p.S100G	-0.907	AFR:1(breast),AMR:1(large_intestine),EAS:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,FIN:0.3134,NFE:0.1878,OTH:0.3361,ASJ:MU159382	600541	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.0	1.96	0.000	0.345	7	1(skin)	0.4040
7	14025727	14025727	C	T	ETV1	intronic	.	ENSG00000006468	rs3823704	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5455	0.5528	0.563698	0.5822	.	.	.	.	.	.	.	.	.	.	AFR:0.6356,AMR:0.6687,EAS:0.5887,FIN:0.6230,NFE:0.5440,OTH:0.5398,ASJ:0.33	600541	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	7	MU12866402	het
7	14025766	14025766	T	A	ETV1	exonic	synonymous SNV	ENSG00000006468	rs10215655	ENSG00000006468:ENST00000399357:exon1:c.A36T:p.P12P,ENSG00000006468:ENST00000403527:exon1:c.A36T:p.P12P,ENSG00000006468:ENST00000420159:exon1:c.A36T:p.P12P,ENSG00000006468:ENST00000438956:exon1:c.A36T:p.P12P,ENSG00000006468:ENST00000443608:exon1:c.A36T:p.P12P	ETV1:NM_001163150:exon1:c.A36T:p.P12P,ETV1:NM_001163151:exon1:c.A36T:p.P12P,ETV1:NM_001163152:exon1:c.A36T:p.P12P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5744	0.5544	0.564097	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ETV1:uc021zzt.1:exon1:c.A36T:p.P12P,ETV1:uc021zzu.1:exon1:c.A36T:p.P12P,ETV1:uc021zzv.1:exon1:c.A36T:p.P12P,ETV1:uc021zzw.1:exon1:c.A36T:p.P12P,ETV1:uc021zzx.1:exon1:c.A36T:p.P12P,ETV1:uc021zzy.1:exon1:c.A36T:p.P12P	.	AFR:MU159388,AMR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,EAS:0.6351,FIN:0.6675,NFE:0.3278,OTH:0.5915,ASJ:0.5821	600541	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	7	1(thyroid)	0.6233
7	24756951	24756951	C	T	GSDME	exonic	nonsynonymous SNV	ENSG00000105928	rs12540919	ENSG00000105928:ENST00000411476:exon3:c.G388A:p.V130M,ENSG00000105928:ENST00000409970:exon4:c.G127A:p.V43M,ENSG00000105928:ENST00000419307:exon4:c.G127A:p.V43M,ENSG00000105928:ENST00000342947:exon5:c.G619A:p.V207M,ENSG00000105928:ENST00000409775:exon5:c.G619A:p.V207M,ENSG00000105928:ENST00000545231:exon7:c.G127A:p.V43M	GSDME:NM_001127454:exon4:c.G127A:p.V43M,GSDME:NM_001127453:exon5:c.G619A:p.V207M,GSDME:NM_004403:exon5:c.G619A:p.V207M	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0943	0.0783	0.0898562	1(stomach)	6.515	31	0.032	4.82	0.485	.	.	.	DFNA5:uc010kut.1:exon4:c.G127A:p.V43M,DFNA5:uc003sxa.1:exon5:c.G619A:p.V207M,DFNA5:uc010kus.1:exon5:c.G619A:p.V207M	-1.064	AFR:MU3888724,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,EAS:0.0435,FIN:0.0811,NFE:0.0695,OTH:0.1078,ASJ:0.0774	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	0.994	1.85	0.001	2.93	7	1(breast)	0.0759
7	24758753	24758753	C	T	GSDME	exonic	synonymous SNV	ENSG00000105928	rs754555	ENSG00000105928:ENST00000411476:exon2:c.G258A:p.T86T,ENSG00000105928:ENST00000342947:exon4:c.G489A:p.T163T,ENSG00000105928:ENST00000409775:exon4:c.G489A:p.T163T	GSDME:NM_001127453:exon4:c.G489A:p.T163T,GSDME:NM_004403:exon4:c.G489A:p.T163T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2056	0.1657	0.259185	2(large_intestine)	.	.	.	.	.	.	.	.	DFNA5:uc003sxa.1:exon4:c.G489A:p.T163T,DFNA5:uc010kus.1:exon4:c.G489A:p.T163T	.	AFR:MU61299,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.2004,FIN:0.1551,NFE:0.1026,OTH:0.4702,ASJ:0.1827	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	7	1(urinary_tract)	0.1613
7	24758795	24758795	T	C	GSDME	exonic	synonymous SNV	ENSG00000105928	rs876305	ENSG00000105928:ENST00000411476:exon2:c.A216G:p.E72E,ENSG00000105928:ENST00000342947:exon4:c.A447G:p.E149E,ENSG00000105928:ENST00000409775:exon4:c.A447G:p.E149E	GSDME:NM_001127453:exon4:c.A447G:p.E149E,GSDME:NM_004403:exon4:c.A447G:p.E149E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5712	0.5374	0.73762	0.5719	.	.	.	.	.	.	.	.	DFNA5:uc003sxa.1:exon4:c.A447G:p.E149E,DFNA5:uc010kus.1:exon4:c.A447G:p.E149E	.	AFR:0.7803,AMR:0.6770,EAS:0.9926,FIN:0.4538,NFE:0.4361,OTH:0.4857,ASJ:0.3742	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	7	MU81828348	het
7	24758818	24758818	G	T	GSDME	exonic	nonsynonymous SNV	ENSG00000105928	rs754554	ENSG00000105928:ENST00000411476:exon2:c.C193A:p.P65T,ENSG00000105928:ENST00000342947:exon4:c.C424A:p.P142T,ENSG00000105928:ENST00000409775:exon4:c.C424A:p.P142T	GSDME:NM_001127453:exon4:c.C424A:p.P142T,GSDME:NM_004403:exon4:c.C424A:p.P142T	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2061	0.1657	0.259185	1(lung)	-1.558	0.002	0.926	0.252	0.000	.	.	.	DFNA5:uc003sxa.1:exon4:c.C424A:p.P142T,DFNA5:uc010kus.1:exon4:c.C424A:p.P142T	-0.927	AFR:MU815198,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.2005,FIN:0.1551,NFE:0.1026,OTH:0.4733,ASJ:0.1828	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	0.267	2.04	0.000	2.32	7	1(large_intestine)	0.1615
7	24758852	24758852	C	T	GSDME	intronic	.	ENSG00000105928	rs754553	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2054	0.1657	0.259784	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.1828,AMR:0.2007,EAS:0.1026,FIN:0.4746,NFE:0.1616,OTH:0.1497,ASJ:0.1551	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	7	1(breast)	0.1721
7	45703971	45703971	G	A	ADCY1	exonic	synonymous SNV	ENSG00000164742	rs1042009	ENSG00000164742:ENST00000432715:exon10:c.G1014A:p.T338T	ADCY1:NM_001281768:exon10:c.G1014A:p.T338T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6815	.	0.472644	MU5454033	.	.	.	.	.	.	.	.	ADCY1:uc003tnd.3:exon10:c.G1014A:p.T338T	.	AFR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.5516,EAS:0.6229,FIN:0.6490,NFE:0.2954,OTH:0.7317,ASJ:0.2343	103072	610154;	90636;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~	~ko00230 Purine metabolism~ko01100 Metabolic pathways~ko01522 Endocrine resistance~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04072 Phospholipase D signaling pathway~ko04114 Oocyte meiosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04713 Circadian entrainment~ko04714 Thermogenesis~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04727 GABAergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04913 Ovarian steroidogenesis~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04921 Oxytocin signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04976 Bile secretion~ko05032 Morphine addiction~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	7	2(breast)	0.7067
7	45957055	45957055	G	C	IGFBP3	intronic	.	ENSG00000146674	rs2471551	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1980	0.2001	0.181709	0.1777	.	.	.	.	.	.	.	.	.	.	AFR:0.2016,AMR:0.1623,EAS:0.0327,FIN:0.1329,NFE:0.1898,OTH:0.1823,ASJ:0.2185	146732	.	.	.	~ko04115 p53 signaling pathway~ko04218 Cellular senescence~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	7	MU587416	het
7	45960323	45960323	C	A	IGFBP3	exonic	synonymous SNV	ENSG00000146674	rs6950868	ENSG00000146674:ENST00000381083:exon1:c.G417T:p.A139A	IGFBP3:NM_001013398:exon1:c.G417T:p.A139A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5572	.	0.190096	0.1800	.	.	.	.	.	.	.	.	IGFBP3:uc003tnr.3:exon1:c.G417T:p.A139A	.	AFR:0.2239,AMR:0.1650,EAS:0.0327,FIN:0.1335,NFE:0.1814,OTH:0.1789,ASJ:0.2152	146732	.	.	.	~ko04115 p53 signaling pathway~ko04218 Cellular senescence~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	7	MU67378611	het
7	45960645	45960645	G	C	IGFBP3	exonic	nonsynonymous SNV	ENSG00000146674	rs2854746	ENSG00000146674:ENST00000275521:exon1:c.C95G:p.A32G,ENSG00000146674:ENST00000381083:exon1:c.C95G:p.A32G	IGFBP3:NM_000598:exon1:c.C95G:p.A32G,IGFBP3:NM_001013398:exon1:c.C95G:p.A32G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4761	.	0.42512	0.3803	-0.320	0.598	0.38	0.626	0.150	.	.	.	IGFBP3:uc003tnr.3:exon1:c.C95G:p.A32G,IGFBP3:uc003tns.3:exon1:c.C95G:p.A32G	-0.970	AFR:0.3151,AMR:0.3047,EAS:0.7596,FIN:0.3377,NFE:0.3864,OTH:0.3909,ASJ:0.4933	146732	.	.	.	~ko04115 p53 signaling pathway~ko04218 Cellular senescence~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.006	2.37	0.000	0.805	7	MU4548620	het
7	48004962	48004962	C	T	HUS1	exonic	synonymous SNV	ENSG00000136273	rs1056663	ENSG00000136273:ENST00000258774:exon8:c.G834A:p.A278A,ENSG00000136273:ENST00000432325:exon8:c.G771A:p.A257A,ENSG00000136273:ENST00000436444:exon8:c.G834A:p.A278A,ENSG00000136273:ENST00000458191:exon8:c.G771A:p.A257A	HUS1:NM_001363683:exon8:c.G771A:p.A257A,HUS1:NM_004507:exon8:c.G834A:p.A278A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4840	0.4439	0.423323	0.4797	.	.	.	.	.	.	.	.	HUS1:uc003tod.2:exon8:c.G834A:p.A278A	.	AFR:0.3069,AMR:0.4785,EAS:0.5627,FIN:0.5856,NFE:0.5456,OTH:0.5163,ASJ:0.4205	603760	.	.	.	.	.	.	.	.	.	.	.	7	MU59165	het
7	50435777	50435777	T	G	IKZF1	exonic	synonymous SNV	ENSG00000185811	rs12669559	ENSG00000185811:ENST00000413698:exon4:c.T234G:p.P78P	IKZF1:NM_001291845:exon4:c.T234G:p.P78P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.3607	.	0.292133	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	IKZF1:uc003tov.1:exon4:c.T234G:p.P78P	.	AFR:0.2991,AMR:0.2368,EAS:0.4404,FIN:0.1570,NFE:0.2557,OTH:0.3524,ASJ:0.3549	603023	616873;	317473;	317473|CID due to IKAROS deficiency<br>Combined immunodeficiency due to IKAROS deficiency|-|Autosomal dominant|-|616873 ~	.	,6183	.	.	.	.	.	.	7	1(thyroid)	0.3367
7	50436033	50436033	A	G	IKZF1	exonic	nonsynonymous SNV	ENSG00000185811	rs10899750	ENSG00000185811:ENST00000413698:exon4:c.A490G:p.R164G	IKZF1:NM_001291845:exon4:c.A490G:p.R164G	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6862	.	0.717652	LICA-CN|2|402|0.00497512,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	-0.360	0.481	0.0	-6.26	0.000	.	.	.	IKZF1:uc003tov.1:exon4:c.A490G:p.R164G	-0.968	AFR:0.7485,AMR:0.9139,EAS:0.7351,FIN:0.5297,NFE:0.7467,OTH:0.6808,ASJ:0.7225	603023	616873;	317473;	317473|CID due to IKAROS deficiency<br>Combined immunodeficiency due to IKAROS deficiency|-|Autosomal dominant|-|616873 ~	.	,6183	.	.	0.0	.	0.000	.	7	1(liver)	0.7061
7	55214348	55214348	C	T	EGFR	exonic	synonymous SNV	ENSG00000146648	rs2072454	ENSG00000146648:ENST00000275493:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000342916:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000344576:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000420316:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000442591:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000450046:exon4:c.C315T:p.N105N,ENSG00000146648:ENST00000454757:exon4:c.C315T:p.N105N	EGFR:NM_001346898:exon4:c.C474T:p.N158N,EGFR:NM_001346900:exon4:c.C315T:p.N105N,EGFR:NM_005228:exon4:c.C474T:p.N158N,EGFR:NM_201282:exon4:c.C474T:p.N158N,EGFR:NM_201283:exon4:c.C474T:p.N158N,EGFR:NM_201284:exon4:c.C474T:p.N158N	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5090	0.5151	0.475439	2(central_nervous_system)	.	.	.	.	.	.	.	.	EGFR:uc003tqh.3:exon4:c.C474T:p.N158N,EGFR:uc003tqi.3:exon4:c.C474T:p.N158N,EGFR:uc003tqj.3:exon4:c.C474T:p.N158N,EGFR:uc003tqk.3:exon4:c.C474T:p.N158N,EGFR:uc011kco.2:exon4:c.C315T:p.N105N,EGFR:uc022adm.1:exon4:c.C474T:p.N158N	.	AFR:18(soft_tissue),AMR:1(prostate),EAS:1(large_intestine),FIN:MU4807633,NFE:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,ESCA-CN|1|332|0.00301205,OTH:0.5053,ASJ:1(lung)	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,3228,3217,2510,3224,3236,3246,2508,3267,3225,3240,3220,3216,3247,3226,3262,3238,3253,3254,3251,3235,3244,3218,3252,3222,2506,3255,3264,3232,3239,3259,3221,3245,3230,3260,3214,2509,3227,3212,3211,3233,3269,3237,3223,3268,3219,3243,3231,3256,3257,3258,3265,3266,2507,3229,3242,3263,3234,3241,3248,3261,3213,3215	.	3249,,3250	.	.	.	.	7	3(haematopoietic_and_lymphoid_tissue)	0.5028
7	55229255	55229255	G	A	EGFR	exonic	nonsynonymous SNV	ENSG00000146648	rs2227983	ENSG00000146648:ENST00000455089:exon12:c.G1427A:p.R476K,ENSG00000146648:ENST00000275493:exon13:c.G1562A:p.R521K,ENSG00000146648:ENST00000342916:exon13:c.G1562A:p.R521K,ENSG00000146648:ENST00000344576:exon13:c.G1562A:p.R521K,ENSG00000146648:ENST00000442591:exon13:c.G1562A:p.R521K,ENSG00000146648:ENST00000454757:exon13:c.G1403A:p.R468K	EGFR:NM_001346941:exon7:c.G761A:p.R254K,EGFR:NM_001346897:exon12:c.G1427A:p.R476K,EGFR:NM_001346899:exon12:c.G1427A:p.R476K,EGFR:NM_001346898:exon13:c.G1562A:p.R521K,EGFR:NM_001346900:exon13:c.G1403A:p.R468K,EGFR:NM_005228:exon13:c.G1562A:p.R521K,EGFR:NM_201282:exon13:c.G1562A:p.R521K,EGFR:NM_201284:exon13:c.G1562A:p.R521K	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.2870	0.2027	0.292133	1(upper_aerodigestive_tract)	-0.782	0.047	0.927	-5.79	0.247	.	.	Growth factor receptor cysteine-rich domain|Growth factor receptor domain 4	EGFR:uc010kzg.2:exon12:c.G1427A:p.R476K,EGFR:uc022adn.1:exon12:c.G1427A:p.R476K,EGFR:uc003tqi.3:exon13:c.G1562A:p.R521K,EGFR:uc003tqj.3:exon13:c.G1562A:p.R521K,EGFR:uc003tqk.3:exon13:c.G1562A:p.R521K,EGFR:uc011kco.2:exon13:c.G1403A:p.R468K,EGFR:uc022adm.1:exon13:c.G1562A:p.R521K	-0.907	AFR:2(central_nervous_system),AMR:1(autonomic_ganglia),EAS:1(pleura),FIN:64(meninges),NFE:MU150493,OTH:LAML-KR|1|205|0.00487805,LUSC-KR|4|170|0.0235294,COCA-CN|4|321|0.0124611,ASJ:1(haematopoietic_and_lymphoid_tissue)	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,3228,3217,2510,3224,3236,3246,2508,3267,3225,3240,3220,3216,3247,3226,3262,3238,3253,3254,3251,3235,3244,3218,3252,3222,2506,3255,3264,3232,3239,3259,3221,3245,3230,3260,3214,2509,3227,3212,3211,3233,3269,3237,3223,3268,3219,3243,3231,3256,3257,3258,3265,3266,2507,3229,3242,3263,3234,3241,3248,3261,3213,3215	.	3249,,3250	0.0	1.63	0.000	0.23	7	1(thyroid)	0.2326
7	55238874	55238874	T	A	EGFR	exonic	synonymous SNV	ENSG00000146648	rs2227984	ENSG00000146648:ENST00000455089:exon15:c.T1752A:p.T584T,ENSG00000146648:ENST00000275493:exon16:c.T1887A:p.T629T,ENSG00000146648:ENST00000442591:exon16:c.T1887A:p.T629T,ENSG00000146648:ENST00000454757:exon16:c.T1728A:p.T576T	EGFR:NM_001346941:exon10:c.T1086A:p.T362T,EGFR:NM_001346897:exon15:c.T1752A:p.T584T,EGFR:NM_001346899:exon15:c.T1752A:p.T584T,EGFR:NM_001346898:exon16:c.T1887A:p.T629T,EGFR:NM_001346900:exon16:c.T1728A:p.T576T,EGFR:NM_005228:exon16:c.T1887A:p.T629T	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3740	0.3225	0.390375	3(lung)	.	.	.	.	.	.	.	.	EGFR:uc010kzg.2:exon15:c.T1752A:p.T584T,EGFR:uc022adn.1:exon15:c.T1752A:p.T584T,EGFR:uc003tqk.3:exon16:c.T1887A:p.T629T,EGFR:uc011kco.2:exon16:c.T1728A:p.T576T,EGFR:uc022adm.1:exon16:c.T1887A:p.T629T	.	AFR:MU150509,AMR:COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.2827,FIN:0.3890,NFE:0.4371,OTH:0.5266,ASJ:0.3338	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,3228,3217,2510,3224,3236,3246,2508,3267,3225,3240,3220,3216,3247,3226,3262,3238,3253,3254,3251,3235,3244,3218,3252,3222,2506,3255,3264,3232,3239,3259,3221,3245,3230,3260,3214,2509,3227,3212,3211,3233,3269,3237,3223,3268,3219,3243,3231,3256,3257,3258,3265,3266,2507,3229,3242,3263,3234,3241,3248,3261,3213,3215	.	3249,,3250	.	.	.	.	7	1(large_intestine)	0.3336
7	55266417	55266417	T	C	EGFR	exonic	synonymous SNV	ENSG00000146648	rs1140475	ENSG00000146648:ENST00000455089:exon22:c.T2574C:p.T858T,ENSG00000146648:ENST00000275493:exon23:c.T2709C:p.T903T,ENSG00000146648:ENST00000454757:exon23:c.T2550C:p.T850T	EGFR:NM_001346941:exon17:c.T1908C:p.T636T,EGFR:NM_001346897:exon22:c.T2574C:p.T858T,EGFR:NM_001346899:exon22:c.T2574C:p.T858T,EGFR:NM_001346898:exon23:c.T2709C:p.T903T,EGFR:NM_001346900:exon23:c.T2550C:p.T850T,EGFR:NM_005228:exon23:c.T2709C:p.T903T	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.8957	0.8891	0.916733	SKCA-BR|1|100|0.01,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	EGFR:uc010kzg.2:exon22:c.T2574C:p.T858T,EGFR:uc022adn.1:exon22:c.T2574C:p.T858T,EGFR:uc003tqk.3:exon23:c.T2709C:p.T903T,EGFR:uc011kco.2:exon23:c.T2550C:p.T850T,EGFR:uc022adm.1:exon23:c.T2709C:p.T903T	.	AFR:0.8922,AMR:0.9260,EAS:0.9139,FIN:0.9228,NFE:0.8832,OTH:0.8703,ASJ:0.9103	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,3228,3217,2510,3224,3236,3246,2508,3267,3225,3240,3220,3216,3247,3226,3262,3238,3253,3254,3251,3235,3244,3218,3252,3222,2506,3255,3264,3232,3239,3259,3221,3245,3230,3260,3214,2509,3227,3212,3211,3233,3269,3237,3223,3268,3219,3243,3231,3256,3257,3258,3265,3266,2507,3229,3242,3263,3234,3241,3248,3261,3213,3215	.	3249,,3250	.	.	.	.	7	3(lung)	0.8878
7	73467651	73467654	TGTG	-	ELN	intronic	.	ENSG00000049540	rs10579871	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.3935	.	.	0.5303	.	.	.	.	.	.	.	.	.	.	AFR:0.4804,AMR:0.5388,EAS:0.5781,FIN:0.4950,NFE:0.5601,OTH:0.5215,ASJ:0.6318	130160	123700;185500;	3193;90348;	3193|SVAS|1-5 / 10 000|Autosomal dominant|All ages|185500 ~90348|ADCL|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123700 614434 616603 ~	.	.	.	.	.	.	.	.	7	.	hom
7	73470782	73470782	C	T	ELN	intronic	.	ENSG00000049540	rs2856728	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7895	0.7932	0.756589	0.7980	.	.	.	.	.	.	.	.	.	.	AFR:0.7664,AMR:0.7739,EAS:0.6866,FIN:0.8373,NFE:0.8203,OTH:0.7898,ASJ:0.8377	130160	123700;185500;	3193;90348;	3193|SVAS|1-5 / 10 000|Autosomal dominant|All ages|185500 ~90348|ADCL|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123700 614434 616603 ~	.	.	.	.	.	.	.	.	7	MU81832477	het
7	75137097	75137097	A	G	PMS2P3	ncRNA_exonic	.	ENSG00000127957	rs62477735	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.44988	0.3287	.	.	.	.	.	.	.	.	.	.	AFR:0.0816,AMR:0.5565,EAS:0.8029,FIN:0.4723,NFE:0.3745,OTH:0.4344,ASJ:0.3586	.	.	.	.	.	.	.	.	.	.	.	.	7	.	hom
7	75145411	75145411	T	C	PMS2P3	ncRNA_intronic	.	ENSG00000127957	rs794378	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9744	.	0.975839	0.9805	.	.	.	.	.	.	.	.	.	.	AFR:0.9886,AMR:0.9592,EAS:0.9507,FIN:0.9616,NFE:0.9844,OTH:0.9774,ASJ:0.9966	.	.	.	.	.	.	.	.	.	.	.	.	7	.	hom
7	75145495	75145495	G	A	PMS2P3	ncRNA_exonic	.	ENSG00000127957	rs794377	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4386	0.2710	0.408147	0.3578	.	.	.	.	.	.	.	.	.	.	AFR:0.0864,AMR:0.5921,EAS:0.6756,FIN:0.5270,NFE:0.4207,OTH:0.4785,ASJ:0.4060	.	.	.	.	.	.	.	.	.	.	.	.	7	MU13048068	hom
7	75583325	75583325	A	G	POR	exonic	synonymous SNV	ENSG00000127948	rs10262966	ENSG00000127948:ENST00000412064:exon1:c.A15G:p.G5G,ENSG00000127948:ENST00000454934:exon1:c.A15G:p.G5G,ENSG00000127948:ENST00000394893:exon2:c.A15G:p.G5G,ENSG00000127948:ENST00000414186:exon2:c.A15G:p.G5G,ENSG00000127948:ENST00000421059:exon2:c.A15G:p.G5G,ENSG00000127948:ENST00000432753:exon2:c.A15G:p.G5G,ENSG00000127948:ENST00000439963:exon2:c.A15G:p.G5G,ENSG00000127948:ENST00000448410:exon2:c.A15G:p.G5G,ENSG00000127948:ENST00000449920:exon2:c.A15G:p.G5G,ENSG00000127948:ENST00000453773:exon2:c.A15G:p.G5G,ENSG00000127948:ENST00000461988:exon2:c.A15G:p.G5G,ENSG00000127948:ENST00000412521:exon3:c.A15G:p.G5G,ENSG00000127948:ENST00000418341:exon3:c.A15G:p.G5G	POR:NM_000941:exon2:c.A15G:p.G5G,POR:NM_001367562:exon3:c.A15G:p.G5G	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0745	0.0822	0.104633	0.0778	.	.	.	.	.	.	.	.	POR:uc003udy.3:exon2:c.A15G:p.G5G	.	AFR:0.2617,AMR:0.0274,EAS:0.0006,FIN:0.0080,NFE:0.0034,OTH:0.0214,ASJ:0.0166	124015	201750;613571;	418;95699;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~95699|Congenital adrenal hyperplasia due to cytochrome POR deficiency<br>POR deficiency<br>PORD|Unknown|Autosomal recessive|Infancy<br>Neonatal|613571 ~	.	.	.	.	.	.	.	.	7	.	het
7	75614082	75614082	C	G	POR	intronic	.	ENSG00000127948	rs4732516	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9091	0.8527	0.811901	0.8553	.	.	.	.	.	.	.	.	.	.	AFR:0.6054,AMR:0.8612,EAS:0.8585,FIN:0.9760,NFE:0.9643,OTH:0.9296,ASJ:0.9735	124015	201750;613571;	418;95699;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~95699|Congenital adrenal hyperplasia due to cytochrome POR deficiency<br>POR deficiency<br>PORD|Unknown|Autosomal recessive|Infancy<br>Neonatal|613571 ~	.	.	.	.	.	.	.	.	7	MU27551504	hom
7	75614953	75614953	T	C	POR	exonic	synonymous SNV	ENSG00000127948	rs2228104	ENSG00000127948:ENST00000439269:exon7:c.T669C:p.A223A,ENSG00000127948:ENST00000545601:exon8:c.T879C:p.A293A,ENSG00000127948:ENST00000450476:exon9:c.T1152C:p.A384A,ENSG00000127948:ENST00000394893:exon13:c.T1455C:p.A485A,ENSG00000127948:ENST00000419840:exon13:c.T897C:p.A299A,ENSG00000127948:ENST00000461988:exon13:c.T1455C:p.A485A	POR:NM_000941:exon13:c.T1455C:p.A485A,POR:NM_001367562:exon14:c.T1455C:p.A485A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9226	0.8729	0.835264	0.8763	.	.	.	.	.	.	.	.	POR:uc011kge.2:exon7:c.T669C:p.A223A,POR:uc011kgc.2:exon8:c.T879C:p.A293A,POR:uc003udy.3:exon13:c.T1455C:p.A485A	.	AFR:0.6665,AMR:0.8831,EAS:0.8631,FIN:0.9840,NFE:0.9676,OTH:0.9439,ASJ:0.9735	124015	201750;613571;	418;95699;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~95699|Congenital adrenal hyperplasia due to cytochrome POR deficiency<br>POR deficiency<br>PORD|Unknown|Autosomal recessive|Infancy<br>Neonatal|613571 ~	.	.	.	.	.	.	.	.	7	MU4554694	hom
7	75615006	75615006	C	T	POR	exonic	nonsynonymous SNV	ENSG00000127948	rs1057868	ENSG00000127948:ENST00000439269:exon7:c.C722T:p.A241V,ENSG00000127948:ENST00000545601:exon8:c.C932T:p.A311V,ENSG00000127948:ENST00000450476:exon9:c.C1205T:p.A402V,ENSG00000127948:ENST00000394893:exon13:c.C1508T:p.A503V,ENSG00000127948:ENST00000419840:exon13:c.C950T:p.A317V,ENSG00000127948:ENST00000461988:exon13:c.C1508T:p.A503V	POR:NM_000941:exon13:c.C1508T:p.A503V,POR:NM_001367562:exon14:c.C1508T:p.A503V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3639	0.2367	0.286142	1(oesophagus)	0.704	8.850	0.218	3.51	0.213	.	.	Ferredoxin reductase-type FAD-binding domain|Riboflavin synthase-like beta-barrel	POR:uc011kge.2:exon7:c.C722T:p.A241V,POR:uc011kgc.2:exon8:c.C932T:p.A311V,POR:uc003udy.3:exon13:c.C1508T:p.A503V	-1.038	AFR:1(large_intestine),AMR:MU132199,EAS:0.2805,FIN:0.1822,NFE:0.2632,OTH:0.2583,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,BTCA-JP|1|239|0.0041841,ESCA-CN|1|332|0.00301205	124015	201750;613571;	418;95699;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~95699|Congenital adrenal hyperplasia due to cytochrome POR deficiency<br>POR deficiency<br>PORD|Unknown|Autosomal recessive|Infancy<br>Neonatal|613571 ~	.	.	.	.	0.0	-1.64	0.000	1.195	7	1(prostate)	0.3778
7	77756580	77756580	T	C	MAGI2	exonic	synonymous SNV	ENSG00000187391	rs2074641	ENSG00000187391:ENST00000419488:exon18:c.A3315G:p.L1105L,ENSG00000187391:ENST00000354212:exon19:c.A3357G:p.L1119L,ENSG00000187391:ENST00000522391:exon19:c.A3357G:p.L1119L	MAGI2:NM_001301128:exon18:c.A3315G:p.L1105L,MAGI2:NM_012301:exon19:c.A3357G:p.L1119L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8248	0.8840	0.786542	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	MAGI2:uc010ldx.1:exon14:c.A2136G:p.L712L,MAGI2:uc003ugy.3:exon18:c.A3315G:p.L1105L,MAGI2:uc003ugx.3:exon19:c.A3357G:p.L1119L	.	AFR:0.8715,AMR:0.9082,EAS:0.8013,FIN:0.6043,NFE:0.8788,OTH:0.8868,ASJ:0.7362	606382	.	.	.	.	.	.	.	.	.	.	.	7	1(lung)	0.8615
7	77756724	77756724	C	T	MAGI2	exonic	synonymous SNV	ENSG00000187391	rs7812015	ENSG00000187391:ENST00000419488:exon18:c.G3171A:p.S1057S,ENSG00000187391:ENST00000354212:exon19:c.G3213A:p.S1071S,ENSG00000187391:ENST00000522391:exon19:c.G3213A:p.S1071S	MAGI2:NM_001301128:exon18:c.G3171A:p.S1057S,MAGI2:NM_012301:exon19:c.G3213A:p.S1071S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8244	0.8840	0.786342	MU116389	.	.	.	.	.	.	.	.	MAGI2:uc010ldx.1:exon14:c.G1992A:p.S664S,MAGI2:uc003ugy.3:exon18:c.G3171A:p.S1057S,MAGI2:uc003ugx.3:exon19:c.G3213A:p.S1071S	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.8715,EAS:0.7380,FIN:0.8013,NFE:0.6032,OTH:0.8789,ASJ:0.9082	606382	.	.	.	.	.	.	.	.	.	.	.	7	1(lung)	0.8869
7	78119109	78119109	C	T	MAGI2	exonic	synonymous SNV	ENSG00000187391	rs3735442	ENSG00000187391:ENST00000535697:exon5:c.G525A:p.K175K,ENSG00000187391:ENST00000354212:exon6:c.G1014A:p.K338K,ENSG00000187391:ENST00000419488:exon6:c.G1014A:p.K338K,ENSG00000187391:ENST00000522391:exon6:c.G1014A:p.K338K,ENSG00000187391:ENST00000536571:exon6:c.G510A:p.K170K	MAGI2:NM_001301128:exon6:c.G1014A:p.K338K,MAGI2:NM_012301:exon6:c.G1014A:p.K338K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2942	0.3455	0.323083	1(stomach)	.	.	.	.	.	.	.	.	MAGI2:uc011kgs.1:exon5:c.G525A:p.K175K,MAGI2:uc003ugx.3:exon6:c.G1014A:p.K338K,MAGI2:uc003ugy.3:exon6:c.G1014A:p.K338K,MAGI2:uc011kgr.1:exon6:c.G510A:p.K170K	.	AFR:1(breast),AMR:MU30304050,EAS:0.3279,FIN:0.4237,NFE:0.2208,OTH:0.3543,ASJ:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	606382	.	.	.	.	.	.	.	.	.	.	.	7	1(lung)	0.2443
7	78256514	78256514	C	G	MAGI2	exonic	nonsynonymous SNV	ENSG00000187391	.	ENSG00000187391:ENST00000354212:exon3:c.G460C:p.D154H,ENSG00000187391:ENST00000419488:exon3:c.G460C:p.D154H,ENSG00000187391:ENST00000522391:exon3:c.G460C:p.D154H	MAGI2:NM_001301128:exon3:c.G460C:p.D154H,MAGI2:NM_012301:exon3:c.G460C:p.D154H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	6.419	29.7	0.025	5.3	1.000	.	.	Guanylate kinase, conserved site|Guanylate kinase-like domain|Guanylate kinase/L-type calcium channel beta subunit|P-loop containing nucleoside triphosphate hydrolase;Guanylate kinase/L-type calcium channel beta subunit|P-loop containing nucleoside triphosphate hydrolase	MAGI2:uc003ugx.3:exon3:c.G460C:p.D154H,MAGI2:uc003ugy.3:exon3:c.G460C:p.D154H	-0.524	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606382	.	.	.	.	.	.	.	1.0	0.57	0.293	1.6	7	.	het
7	80290369	80290369	A	G	CD36	intronic	.	ENSG00000135218	rs3211892	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9649	0.9203	0.918331	0.9293	.	.	.	.	.	0	0	.	.	.	AFR:0.8000,AMR:0.9773,EAS:0.9994,FIN:0.9834,NFE:0.9777,OTH:0.9776,ASJ:0.9603	173510	608404;610938;611162;	673;	673|-|1-9 / 100 000|Not applicable|All ages|611162 ~	.	.	.	.	.	.	.	.	7	MU81833340	hom
7	81346685	81346685	T	C	HGF	intronic	.	ENSG00000019991	rs1800793	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8053	0.7530	0.798323	0.7671	.	.	.	.	.	0.0002	0.044	.	.	.	AFR:0.6746,AMR:0.8675,EAS:0.8335,FIN:0.7857,NFE:0.7983,OTH:0.8136,ASJ:0.8825	142409	608265;	90636;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05144 Malaria~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	7	MU26259331	hom
7	87032613	87032613	A	G	ABCB4	intronic	.	ENSG00000005471	rs31653	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8775	0.9234	0.879992	0.9026	.	.	.	.	.	.	.	.	.	.	AFR:0.9733,AMR:0.8361,EAS:0.7247,FIN:0.8706,NFE:0.8926,OTH:0.8878,ASJ:0.9139	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	MU20973608	hom
7	87053206	87053206	G	A	ABCB4	intronic	.	ENSG00000005471	rs31668	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8990	0.9260	0.873602	0.9132	.	.	.	.	.	.	.	.	.	.	AFR:0.9313,AMR:0.8840,EAS:0.7120,FIN:0.9407,NFE:0.9191,OTH:0.9224,ASJ:0.9139	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	MU20974205	hom
7	91632306	91632306	C	T	AKAP9	exonic	synonymous SNV	ENSG00000127914	rs1989779	ENSG00000127914:ENST00000356239:exon8:c.C3075T:p.T1025T,ENSG00000127914:ENST00000358100:exon9:c.C3111T:p.T1037T,ENSG00000127914:ENST00000359028:exon9:c.C3111T:p.T1037T	AKAP9:NM_005751:exon8:c.C3075T:p.T1025T,AKAP9:NM_147185:exon8:c.C3075T:p.T1025T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8924	0.9064	0.935903	0.8912	.	.	.	.	.	.	.	.	AKAP9:uc003uli.3:exon1:c.C1950T:p.T650T,AKAP9:uc003ulf.3:exon8:c.C3075T:p.T1025T,AKAP9:uc003ulg.3:exon8:c.C3075T:p.T1025T,AKAP9:uc003ule.2:exon9:c.C3111T:p.T1037T	.	AFR:0.9731,AMR:0.9284,EAS:0.9728,FIN:0.8373,NFE:0.8471,OTH:0.8678,ASJ:0.8676	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	MU81834056	het
7	91708898	91708898	A	G	AKAP9	exonic	nonsynonymous SNV	ENSG00000127914	rs35759833	ENSG00000127914:ENST00000394534:exon5:c.A989G:p.K330R,ENSG00000127914:ENST00000356239:exon31:c.A7451G:p.K2484R,ENSG00000127914:ENST00000358100:exon32:c.A7487G:p.K2496R,ENSG00000127914:ENST00000359028:exon32:c.A7487G:p.K2496R	AKAP9:NM_005751:exon31:c.A7451G:p.K2484R,AKAP9:NM_147185:exon31:c.A7427G:p.K2476R	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.1090	0.0945	0.0654952	0.1098	-1.816	0.002	0.552	-8.74	0.001	.	.	.	AKAP9:uc003ulj.3:exon5:c.A761G:p.K254R,AKAP9:uc003uli.3:exon24:c.A6320G:p.K2107R,AKAP9:uc003ulf.3:exon31:c.A7427G:p.K2476R,AKAP9:uc003ulg.3:exon31:c.A7451G:p.K2484R	-0.927	AFR:0.0299,AMR:0.0716,EAS:0.0260,FIN:0.1622,NFE:0.1533,OTH:0.1337,ASJ:0.1358	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	0.0	4.04	0.000	-0.455	7	.	het
7	91714911	91714911	C	T	AKAP9	exonic	nonsynonymous SNV	ENSG00000127914	rs1063242	ENSG00000127914:ENST00000394534:exon10:c.C2473T:p.P825S,ENSG00000127914:ENST00000358100:exon35:c.C8785T:p.P2929S,ENSG00000127914:ENST00000356239:exon36:c.C8935T:p.P2979S,ENSG00000127914:ENST00000359028:exon36:c.C8947T:p.P2983S	AKAP9:NM_005751:exon36:c.C8935T:p.P2979S,AKAP9:NM_147185:exon36:c.C8911T:p.P2971S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9962	0.9974	0.998802	0.9959	-0.130	1.518	1.0	2.47	0.977	.	.	.	AKAP9:uc003ulk.3:exon4:c.C760T:p.P254S,AKAP9:uc003ulj.3:exon10:c.C2245T:p.P749S,AKAP9:uc003uli.3:exon29:c.C7804T:p.P2602S,AKAP9:uc003ulf.3:exon36:c.C8911T:p.P2971S,AKAP9:uc003ulg.3:exon36:c.C8935T:p.P2979S	-1.027	AFR:0.9997,AMR:1,EAS:1,FIN:0.9920,NFE:0.9942,OTH:0.9908,ASJ:1	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	0.0	4.21	0.000	-2.075	7	MU81834100	hom
7	92300863	92300863	C	T	CDK6	intronic	.	ENSG00000105810	rs2301557	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0568	0.0198	0.0986422	ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,COCA-CN|7|321|0.0218069	.	.	.	.	.	.	.	.	.	.	AFR:0.0387,AMR:0.0176,EAS:0.0232,FIN:0.3313,NFE:0.0272,OTH:0.0211,ASJ:0.0716	603368	616080;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma ~	.	.	.	.	.	.	.	7	2(large_intestine)	0.0305
7	92764489	92764489	C	T	SAMD9L	exonic	nonsynonymous SNV	ENSG00000177409	rs10488532	ENSG00000177409:ENST00000318238:exon5:c.G796A:p.V266I,ENSG00000177409:ENST00000411955:exon6:c.G796A:p.V266I,ENSG00000177409:ENST00000437805:exon6:c.G796A:p.V266I	SAMD9L:NM_001303500:exon4:c.G796A:p.V266I,SAMD9L:NM_001350083:exon4:c.G796A:p.V266I,SAMD9L:NM_001303496:exon5:c.G796A:p.V266I,SAMD9L:NM_001303498:exon5:c.G796A:p.V266I,SAMD9L:NM_001350085:exon5:c.G796A:p.V266I,SAMD9L:NM_152703:exon5:c.G796A:p.V266I,SAMD9L:NM_001303497:exon6:c.G796A:p.V266I,SAMD9L:NM_001350082:exon6:c.G796A:p.V266I,SAMD9L:NM_001350084:exon6:c.G796A:p.V266I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1109	0.1014	0.0992412	0.0868	-3.095	0.001	0.394	-9.31	0.880	.	.	Tetratricopeptide-like helical domain	SAMD9L:uc022ahh.1:exon1:c.G796A:p.V266I,SAMD9L:uc010lfd.1:exon2:c.G796A:p.V266I,SAMD9L:uc010lfc.1:exon4:c.G796A:p.V266I,SAMD9L:uc003umh.1:exon5:c.G796A:p.V266I,SAMD9L:uc003umk.1:exon5:c.G796A:p.V266I,SAMD9L:uc010lfb.1:exon5:c.G796A:p.V266I,SAMD9L:uc003umi.1:exon6:c.G796A:p.V266I,SAMD9L:uc003umj.1:exon6:c.G796A:p.V266I	-1.046	AFR:0.0664,AMR:0.1062,EAS:0.0235,FIN:0.0748,NFE:0.1028,OTH:0.1092,ASJ:0.2384	611170	159550;	2585;	2585|Myelocerebellar disorder|-|Autosomal dominant|-|159550 ~	.	.	.	.	0.0	2.55	0.000	0.145	7	MU82262753	het
7	95800820	95800820	T	C	SLC25A13	exonic	synonymous SNV	ENSG00000004864	rs2301629	ENSG00000004864:ENST00000542654:exon11:c.A870G:p.L290L,ENSG00000004864:ENST00000265631:exon12:c.A1194G:p.L398L,ENSG00000004864:ENST00000416240:exon12:c.A1197G:p.L399L	SLC25A13:NM_001160210:exon12:c.A1197G:p.L399L,SLC25A13:NM_014251:exon12:c.A1194G:p.L398L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3958	0.3202	0.409145	0.3492	.	.	.	.	.	.	.	.	SLC25A13:uc011kik.2:exon11:c.A870G:p.L290L,SLC25A13:uc003uof.4:exon12:c.A1194G:p.L398L,SLC25A13:uc003uog.4:exon12:c.A1197G:p.L399L	.	AFR:0.2530,AMR:0.3612,EAS:0.5739,FIN:0.3732,NFE:0.3748,OTH:0.3806,ASJ:0.2450	603859	603471;605814;	247598;247585;	247598|NICCD<br>Neonatal intrahepatic cholestasis caused by citrin deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|605814 ~247585|Adult-onset citrin deficiency<br>Adult-onset type 2 citrullinemia<br>Adult-onset type II citrullinemia<br>CTLN2<br>Citrullinemia type 2|Unknown|Autosomal recessive|Adult|603471 ~	.	.	.	.	.	.	.	.	7	MU138872	het
7	95864108	95864108	T	C	SLC25A13	intronic	.	ENSG00000004864	rs6957975	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6179	0.6890	0.609824	0.6656	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.7499,AMR:0.6481,EAS:0.4595,FIN:0.6518,NFE:0.6430,OTH:0.6328,ASJ:0.7633	603859	603471;605814;	247598;247585;	247598|NICCD<br>Neonatal intrahepatic cholestasis caused by citrin deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|605814 ~247585|Adult-onset citrin deficiency<br>Adult-onset type 2 citrullinemia<br>Adult-onset type II citrullinemia<br>CTLN2<br>Citrullinemia type 2|Unknown|Autosomal recessive|Adult|603471 ~	.	.	.	.	.	.	.	.	7	MU13094841	het
7	98558880	98558880	G	C	TRRAP	intronic	.	ENSG00000196367	rs160384	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9007	0.9160	0.886981	0.9051	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.9094,AMR:0.8616,EAS:0.7432,FIN:0.9255,NFE:0.9166,OTH:0.9175,ASJ:0.9139	603015	.	.	.	.	.	.	.	.	.	.	.	7	MU18827407	hom
7	100411278	100411278	T	C	EPHB4	exonic	synonymous SNV	ENSG00000196411	rs314359	ENSG00000196411:ENST00000358173:exon10:c.A1752G:p.G584G,ENSG00000196411:ENST00000360620:exon10:c.A1752G:p.G584G	EPHB4:NM_004444:exon10:c.A1752G:p.G584G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6080	0.5660	0.575679	MU159236	.	.	.	.	.	.	.	.	EPHB4:uc003uwm.1:exon9:c.A1473G:p.G491G,EPHB4:uc003uwn.1:exon10:c.A1752G:p.G584G,EPHB4:uc010lhj.1:exon10:c.A1752G:p.G584G	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.5625,EAS:0.6890,FIN:0.57,NFE:0.6458,OTH:0.5679,ASJ:0.4802	600011	.	.	.	.	.	.	.	.	.	.	.	7	1(lung)	0.5900
7	100416139	100416139	T	C	EPHB4	intronic	.	ENSG00000196411	rs3857809	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1178	0.0585	0.242412	MU17117530	.	.	.	.	.	0.0013	0.052	.	.	.	AFR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.0903,EAS:0.2978,FIN:0.0066,NFE:0.5846,OTH:0.0135,ASJ:0.1630	600011	.	.	.	.	.	.	.	.	.	.	.	7	2(soft_tissue)	0.0048
7	100416250	100416250	A	G	EPHB4	exonic	synonymous SNV	ENSG00000196411	rs144173	ENSG00000196411:ENST00000358173:exon7:c.T1314C:p.S438S,ENSG00000196411:ENST00000360620:exon7:c.T1314C:p.S438S	EPHB4:NM_004444:exon7:c.T1314C:p.S438S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6059	0.5553	0.563698	0.5521	.	.	.	.	.	.	.	.	EPHB4:uc011kkh.1:exon7:c.T1232C:p.L411P	.	AFR:0.4464,AMR:0.6842,EAS:0.6435,FIN:0.5676,NFE:0.5890,OTH:0.6072,ASJ:0.5662	600011	.	.	.	.	.	.	.	.	.	.	.	7	MU654988	het
7	100424587	100424587	G	-	SLC12A9	UTR5	.	ENSG00000196411	rs35907339	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3477	.	.	0.2382	.	.	.	.	.	.	.	.	.	.	AFR:0.1606,AMR:0.1575,EAS:0.0019,FIN:0.3019,NFE:0.2944,OTH:0.3015,ASJ:0.3546	616861	.	.	.	.	.	.	.	.	.	.	.	7	MU29256393	het
7	100781084	100781084	T	C	SERPINE1	UTR3	.	ENSG00000106366	rs11178	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	.	.	0.430911	0.4457	.	.	.	.	.	.	.	.	.	.	AFR:0.4956,AMR:0.3246,EAS:0.4598,FIN:0.4218,NFE:0.4270,OTH:0.4327,ASJ:0.5132	173360	613329;	465;	465|Congenital PAI-1 deficiency|Unknown|Autosomal recessive|Infancy<br>Childhood<br>Adolescent<br>Adult|613329 ~	.	.	.	.	.	.	.	.	7	MU87763021	hom
7	103124207	103124207	T	C	RELN	exonic	synonymous SNV	ENSG00000189056	rs1062831	ENSG00000189056:ENST00000343529:exon62:c.A10074G:p.A3358A,ENSG00000189056:ENST00000424685:exon62:c.A10074G:p.A3358A,ENSG00000189056:ENST00000428762:exon62:c.A10074G:p.A3358A	RELN:NM_005045:exon62:c.A10074G:p.A3358A,RELN:NM_173054:exon62:c.A10074G:p.A3358A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1389	0.1748	0.231629	1(large_intestine)	.	.	.	.	.	.	.	.	RELN:uc010liz.3:exon62:c.A10074G:p.A3358A,RELN:uc022ajq.1:exon62:c.A10074G:p.A3358A,RELN:uc022ajr.1:exon62:c.A10074G:p.A3358A	.	AFR:MU12779279,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,EAS:0.3454,FIN:0.1181,NFE:0.0762,OTH:0.2562,ASJ:0.1708	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	1(stomach)	0.0575
7	103138517	103138517	C	G	LOC101927870	ncRNA_intronic	.	ENSG00000234715	rs2711885	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9870	0.9909	0.995607	0.9867	.	.	.	.	.	0	0	.	.	.	AFR:0.9976,AMR:0.9940,EAS:1,FIN:0.9717,NFE:0.9826,OTH:0.9796,ASJ:0.9834	.	.	.	.	.	.	.	.	.	.	.	.	7	MU81837834	hom
7	103155705	103155705	A	G	RELN	exonic	synonymous SNV	ENSG00000189056	rs2229864	ENSG00000189056:ENST00000343529:exon50:c.T8046C:p.H2682H,ENSG00000189056:ENST00000424685:exon50:c.T8046C:p.H2682H,ENSG00000189056:ENST00000428762:exon50:c.T8046C:p.H2682H	RELN:NM_005045:exon50:c.T8046C:p.H2682H,RELN:NM_173054:exon50:c.T8046C:p.H2682H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4722	0.4955	0.648363	0.5053	.	.	.	.	.	.	.	.	RELN:uc010liz.3:exon50:c.T8046C:p.H2682H,RELN:uc022ajq.1:exon50:c.T8046C:p.H2682H,RELN:uc022ajr.1:exon50:c.T8046C:p.H2682H	.	AFR:0.7569,AMR:0.4415,EAS:0.7974,FIN:0.3554,NFE:0.3733,OTH:0.4267,ASJ:0.3841	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	MU81837859	hom
7	103180872	103180872	A	G	RELN	exonic	synonymous SNV	ENSG00000189056	rs2075043	ENSG00000189056:ENST00000343529:exon44:c.T6702C:p.C2234C,ENSG00000189056:ENST00000424685:exon44:c.T6702C:p.C2234C,ENSG00000189056:ENST00000428762:exon44:c.T6702C:p.C2234C	RELN:NM_005045:exon44:c.T6702C:p.C2234C,RELN:NM_173054:exon44:c.T6702C:p.C2234C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0749	0.0467	0.109425	COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	RELN:uc010liz.3:exon44:c.T6702C:p.C2234C,RELN:uc022ajq.1:exon44:c.T6702C:p.C2234C,RELN:uc022ajr.1:exon44:c.T6702C:p.C2234C	.	AFR:0.0706,AMR:0.0477,EAS:0.0629,FIN:0.2634,NFE:0.1031,OTH:0.0532,ASJ:0.1062	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	1(breast)	0.0816
7	103202408	103202408	A	-	RELN	intronic	.	ENSG00000189056	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	.	unknown
7	103206001	103206001	-	A	RELN	intronic	.	ENSG00000189056	rs35268159	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.3149	0.2705	0.250799	0.2906	.	.	.	.	.	.	.	.	.	.	AFR:0.2923,AMR:0.2361,EAS:0.0761,FIN:0.3735,NFE:0.3034,OTH:0.3082,ASJ:0.2786	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	.	het
7	103389954	103389954	A	G	RELN	intronic	.	ENSG00000189056	rs607755	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4960	0.5108	0.465455	2(breast)	.	.	.	.	.	0	0	.	.	.	AFR:MU44519711,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.4444,FIN:0.4093,NFE:0.5265,OTH:0.3883,ASJ:0.4905	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	2(haematopoietic_and_lymphoid_tissue)	0.4585
7	103629803	103629803	-	GCCGCC	RELN	UTR5	.	ENSG00000189056	rs55656324	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0] 	0.0752	.	0.604233	0.5209	.	.	.	.	.	.	.	.	.	.	AFR:0.5162,AMR:0.5628,EAS:0.7892,FIN:0.4903,NFE:0.4968,OTH:0.5691,ASJ:0.4861	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	MU4408439	unknown
7	105177041	105177041	A	T	RINT1	exonic	nonsynonymous SNV	ENSG00000135249	rs11556986	ENSG00000135249:ENST00000257700:exon3:c.A118T:p.S40C,ENSG00000135249:ENST00000467392:exon3:c.A118T:p.S40C,ENSG00000135249:ENST00000497979:exon3:c.A118T:p.S40C	RINT1:NM_001346599:exon3:c.A21T:p.E7D,RINT1:NM_021930:exon3:c.A118T:p.S40C	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1891	0.2049	0.191494	0.2002	0.047	3.052	0.057	2.75	0.057	.	.	.	RINT1:uc003vda.1:exon3:c.A118T:p.S40C	-1.020	AFR:0.2515,AMR:0.2141,EAS:0.0278,FIN:0.2002,NFE:0.1870,OTH:0.2137,ASJ:0.2152	610089	.	.	.	.	.	.	.	0.0	1.8	0.000	0.895	7	MU152733	het
7	106508978	106508978	A	G	PIK3CG	exonic	synonymous SNV	ENSG00000105851	rs849389	ENSG00000105851:ENST00000359195:exon2:c.A972G:p.P324P,ENSG00000105851:ENST00000440650:exon2:c.A972G:p.P324P,ENSG00000105851:ENST00000496166:exon2:c.A972G:p.P324P	PIK3CG:NM_001282426:exon2:c.A972G:p.P324P,PIK3CG:NM_001282427:exon2:c.A972G:p.P324P,PIK3CG:NM_002649:exon2:c.A972G:p.P324P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9490	0.9174	0.939497	0.9283	.	.	.	.	.	.	.	.	PIK3CG:uc003vdu.3:exon2:c.A972G:p.P324P,PIK3CG:uc003vdv.4:exon2:c.A972G:p.P324P,PIK3CG:uc003vdw.3:exon2:c.A972G:p.P324P	.	AFR:0.8501,AMR:0.9664,EAS:0.9981,FIN:0.9607,NFE:0.9549,OTH:0.9389,ASJ:0.9636	601232	.	.	.	.	.	.	.	.	.	.	.	7	MU81838218	unknown
7	106508987	106508987	T	C	PIK3CG	exonic	synonymous SNV	ENSG00000105851	rs849390	ENSG00000105851:ENST00000359195:exon2:c.T981C:p.D327D,ENSG00000105851:ENST00000440650:exon2:c.T981C:p.D327D,ENSG00000105851:ENST00000496166:exon2:c.T981C:p.D327D	PIK3CG:NM_001282426:exon2:c.T981C:p.D327D,PIK3CG:NM_001282427:exon2:c.T981C:p.D327D,PIK3CG:NM_002649:exon2:c.T981C:p.D327D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9502	0.9187	0.940895	0.9295	.	.	.	.	.	.	.	.	PIK3CG:uc003vdu.3:exon2:c.T981C:p.D327D,PIK3CG:uc003vdv.4:exon2:c.T981C:p.D327D,PIK3CG:uc003vdw.3:exon2:c.T981C:p.D327D	.	AFR:0.8507,AMR:0.9665,EAS:0.9981,FIN:0.9613,NFE:0.9568,OTH:0.9420,ASJ:0.9636	601232	.	.	.	.	.	.	.	.	.	.	.	7	MU81838233	unknown
7	106509331	106509331	C	A	PIK3CG	exonic	nonsynonymous SNV	ENSG00000105851	rs17847825	ENSG00000105851:ENST00000359195:exon2:c.C1325A:p.S442Y,ENSG00000105851:ENST00000440650:exon2:c.C1325A:p.S442Y,ENSG00000105851:ENST00000496166:exon2:c.C1325A:p.S442Y	PIK3CG:NM_001282426:exon2:c.C1325A:p.S442Y,PIK3CG:NM_001282427:exon2:c.C1325A:p.S442Y,PIK3CG:NM_002649:exon2:c.C1325A:p.S442Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.1176	0.0797	0.116014	1(thyroid)	3.635	23.2	0.013	5.51	0.150	.	.	C2 domain|Phosphatidylinositol 3-kinase, C2 domain	PIK3CG:uc003vdu.3:exon2:c.C1325A:p.S442Y,PIK3CG:uc003vdv.4:exon2:c.C1325A:p.S442Y,PIK3CG:uc003vdw.3:exon2:c.C1325A:p.S442Y	-1.151	AFR:MU130656,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,EAS:0.0215,FIN:0.0549,NFE:0.1325,OTH:0.1706,ASJ:0.0853	601232	.	.	.	.	.	.	.	0.984	-1.12	0.001	1.935	7	1(large_intestine)	0.1151
7	106513011	106513011	C	T	PIK3CG	exonic	synonymous SNV	ENSG00000105851	rs1129293	ENSG00000105851:ENST00000359195:exon3:c.C2025T:p.S675S,ENSG00000105851:ENST00000440650:exon3:c.C2025T:p.S675S,ENSG00000105851:ENST00000496166:exon3:c.C2025T:p.S675S	PIK3CG:NM_001282426:exon3:c.C2025T:p.S675S,PIK3CG:NM_001282427:exon3:c.C2025T:p.S675S,PIK3CG:NM_002649:exon3:c.C2025T:p.S675S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3104	0.2389	0.253794	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	PIK3CG:uc003vdu.3:exon3:c.C2025T:p.S675S,PIK3CG:uc003vdv.4:exon3:c.C2025T:p.S675S,PIK3CG:uc003vdw.3:exon3:c.C2025T:p.S675S	.	AFR:MU44519853,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.1232,FIN:0.4689,NFE:0.2119,OTH:0.3381,ASJ:0.2618	601232	.	.	.	.	.	.	.	.	.	.	.	7	2(lung)	0.3164
7	106524689	106524689	C	T	PIK3CG	exonic	synonymous SNV	ENSG00000105851	rs2230460	ENSG00000105851:ENST00000359195:exon9:c.C2850T:p.D950D,ENSG00000105851:ENST00000440650:exon9:c.C2850T:p.D950D,ENSG00000105851:ENST00000496166:exon9:c.C2850T:p.D950D	PIK3CG:NM_001282426:exon9:c.C2850T:p.D950D,PIK3CG:NM_001282427:exon9:c.C2850T:p.D950D,PIK3CG:NM_002649:exon9:c.C2850T:p.D950D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1196	0.0824	0.11861	MU130671	.	.	.	.	.	.	.	.	PIK3CG:uc003vdu.3:exon9:c.C2850T:p.D950D,PIK3CG:uc003vdv.4:exon9:c.C2850T:p.D950D,PIK3CG:uc003vdw.3:exon9:c.C2850T:p.D950D	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.0886,EAS:0.0526,FIN:0.1325,NFE:0.1692,OTH:0.1234,ASJ:0.0267	601232	.	.	.	.	.	.	.	.	.	.	.	7	1(lung)	0.1063
7	107414419	107414419	A	G	SLC26A3	exonic	synonymous SNV	ENSG00000091138	rs41669	ENSG00000091138:ENST00000340010:exon17:c.T1953C:p.L651L	SLC26A3:NM_000111:exon17:c.T1953C:p.L651L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9936	0.9916	0.998003	0.9937	.	.	.	.	.	.	.	.	SLC26A3:uc003ver.2:exon17:c.T1953C:p.L651L	.	AFR:0.9974,AMR:0.9928,EAS:1,FIN:0.9977,NFE:0.9899,OTH:0.9939,ASJ:1	126650	214700;	53689;	53689|-|-|Autosomal recessive|-|214700 ~	.	.	.	.	.	.	.	.	7	MU81838359	hom
7	107545799	107545799	T	C	DLD	intronic	.	ENSG00000091140	rs10263341	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6182	0.6485	0.716054	0.6630	.	.	.	.	.	0.0308	0.07	.	.	.	AFR:0.7964,AMR:0.5635,EAS:0.8418,FIN:0.6017,NFE:0.5913,OTH:0.6053,ASJ:0.5728	238331	246900;	2394;765;	2394|DLD deficiency<br>Dihydrolipoamide dehydrogenase deficiency<br>E3-deficient maple syrup urine disease|<1 / 1 000 000|Autosomal recessive|Childhood|246900 ~765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~	.	.	.	.	.	.	.	.	7	MU713564	het
7	116339672	116339672	C	T	MET	exonic	synonymous SNV	ENSG00000105976	rs35775721	ENSG00000105976:ENST00000436117:exon1:c.C534T:p.S178S,ENSG00000105976:ENST00000318493:exon2:c.C534T:p.S178S,ENSG00000105976:ENST00000397752:exon2:c.C534T:p.S178S	MET:NM_000245:exon2:c.C534T:p.S178S,MET:NM_001127500:exon2:c.C534T:p.S178S,MET:NM_001324401:exon2:c.C534T:p.S178S	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0597	0.0697	0.0884585	16(meninges)	.	.	.	.	.	.	.	.	MET:uc011kmz.1:exon1:c.C534T:p.S178S,MET:uc011kna.1:exon1:c.C534T:p.S178S,MET:uc011knb.1:exon1:c.C534T:p.S178S,MET:uc011knc.1:exon1:c.C534T:p.S178S,MET:uc011knd.2:exon1:c.C534T:p.S178S,MET:uc011kne.2:exon1:c.C534T:p.S178S,MET:uc011knf.2:exon1:c.C534T:p.S178S,MET:uc011kng.1:exon1:c.C534T:p.S178S,MET:uc011knh.1:exon1:c.C534T:p.S178S,MET:uc011kni.2:exon1:c.C534T:p.S178S,MET:uc003vij.3:exon2:c.C534T:p.S178S,MET:uc010lkg.3:exon2:c.C534T:p.S178S,MET:uc010lkh.3:exon2:c.C534T:p.S178S,MET:uc022akk.1:exon2:c.C534T:p.S178S,MET:uc003vii.1:exon3:c.C591T:p.S197S	.	AFR:MU32361880,AMR:LAML-KR|1|205|0.00487805,EAS:0.1438,FIN:0.0334,NFE:0.0397,OTH:0.0719,ASJ:0.0734	164860	114550;605074;607278;616705;	90636;47044;449;88673;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~47044|HPRCC|-|Autosomal dominant|Adult|605074 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05144 Malaria~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,7502,7485,7492,7489,7490,7496,7501,7487,7495,7500,7499,7488,7493,7486,7503,7504,7498,7497,7491	.	.	.	.	.	.	7	31(prostate)	0.0538
7	116340262	116340262	A	G	MET	exonic	nonsynonymous SNV	ENSG00000105976	rs33917957	ENSG00000105976:ENST00000436117:exon1:c.A1124G:p.N375S,ENSG00000105976:ENST00000318493:exon2:c.A1124G:p.N375S,ENSG00000105976:ENST00000397752:exon2:c.A1124G:p.N375S	MET:NM_000245:exon2:c.A1124G:p.N375S,MET:NM_001127500:exon2:c.A1124G:p.N375S,MET:NM_001324401:exon2:c.A1124G:p.N375S	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.0283	0.0146	0.0329473	1(endometrium)	1.011	10.73	0.096	4.91	0.998	.	.	Sema domain|WD40/YVTN repeat-like-containing domain	MET:uc011kmz.1:exon1:c.A1124G:p.N375S,MET:uc011kna.1:exon1:c.A1124G:p.N375S,MET:uc011knb.1:exon1:c.A1124G:p.N375S,MET:uc011knc.1:exon1:c.A1124G:p.N375S,MET:uc011knd.2:exon1:c.A1124G:p.N375S,MET:uc011kne.2:exon1:c.A1124G:p.N375S,MET:uc011knf.2:exon1:c.A1124G:p.N375S,MET:uc011kng.1:exon1:c.A1124G:p.N375S,MET:uc011knh.1:exon1:c.A1124G:p.N375S,MET:uc011kni.2:exon1:c.A1124G:p.N375S,MET:uc003vij.3:exon2:c.A1124G:p.N375S,MET:uc010lkg.3:exon2:c.A1124G:p.N375S,MET:uc010lkh.3:exon2:c.A1124G:p.N375S,MET:uc022akk.1:exon2:c.A1124G:p.N375S,MET:uc003vii.1:exon3:c.A1181G:p.N394S	-0.974	AFR:1(ovary),AMR:1(vulva),EAS:1(bone),FIN:3(NS),NFE:2(central_nervous_system),OTH:4(lung),ASJ:1(pancreas)	164860	114550;605074;607278;616705;	90636;47044;449;88673;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~47044|HPRCC|-|Autosomal dominant|Adult|605074 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05144 Malaria~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,7502,7485,7492,7489,7490,7496,7501,7505,7487,7495,7500,7499,7507,7488,7493,7486,7503,7504,7498,7497,7491,7506	.	.	0.051	3.6	0.003	1.275	7	1(skin)	12(prostate)
7	116435768	116435768	C	T	MET	exonic	synonymous SNV	ENSG00000105976	rs41736	ENSG00000105976:ENST00000539704:exon6:c.C468T:p.D156D,ENSG00000105976:ENST00000318493:exon20:c.C3912T:p.D1304D,ENSG00000105976:ENST00000397752:exon20:c.C3858T:p.D1286D	MET:NM_001324402:exon19:c.C2568T:p.D856D,MET:NM_000245:exon20:c.C3858T:p.D1286D,MET:NM_001127500:exon20:c.C3912T:p.D1304D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4228	0.3235	0.352236	5(lung)	.	.	.	.	.	.	.	.	MET:uc003vij.3:exon20:c.C3858T:p.D1286D,MET:uc010lkh.3:exon20:c.C3912T:p.D1304D,MET:uc011knj.2:exon20:c.C2568T:p.D856D	.	AFR:2(stomach),AMR:2(urinary_tract),EAS:1(large_intestine),FIN:MU118149,NFE:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,OTH:0.3407,ASJ:1(breast)	164860	114550;605074;607278;616705;	90636;47044;449;88673;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~47044|HPRCC|-|Autosomal dominant|Adult|605074 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05144 Malaria~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,7502,7485,7492,7489,7490,7496,7501,7487,7495,7500,7499,7488,7493,7486,7503,7504,7498,7497,7491	.	.	.	.	.	.	7	12(meninges)	0.1006
7	116436022	116436022	G	A	MET	exonic	synonymous SNV	ENSG00000105976	rs2023748	ENSG00000105976:ENST00000539704:exon7:c.G627A:p.A209A,ENSG00000105976:ENST00000318493:exon21:c.G4071A:p.A1357A,ENSG00000105976:ENST00000397752:exon21:c.G4017A:p.A1339A	MET:NM_001324402:exon20:c.G2727A:p.A909A,MET:NM_000245:exon21:c.G4017A:p.A1339A,MET:NM_001127500:exon21:c.G4071A:p.A1357A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4245	0.3225	0.353834	3(lung)	.	.	.	.	.	.	.	.	MET:uc003vij.3:exon21:c.G4017A:p.A1339A,MET:uc010lkh.3:exon21:c.G4071A:p.A1357A,MET:uc011knj.2:exon21:c.G2727A:p.A909A	.	AFR:1(prostate),AMR:19(soft_tissue),EAS:1(breast),FIN:2(large_intestine),NFE:MU118166,OTH:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763,EOPC-DE|1|202|0.0049505,BRCA-KR|1|50|0.02,ASJ:2(stomach)	164860	114550;605074;607278;616705;	90636;47044;449;88673;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~47044|HPRCC|-|Autosomal dominant|Adult|605074 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05144 Malaria~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,7502,7485,7492,7489,7490,7496,7501,7487,7495,7500,7499,7488,7493,7486,7503,7504,7498,7497,7491	.	.	.	.	.	.	7	12(meninges)	0.3420
7	116436097	116436097	G	A	MET	exonic	synonymous SNV	ENSG00000105976	rs41737	ENSG00000105976:ENST00000539704:exon7:c.G702A:p.P234P,ENSG00000105976:ENST00000318493:exon21:c.G4146A:p.P1382P,ENSG00000105976:ENST00000397752:exon21:c.G4092A:p.P1364P	MET:NM_001324402:exon20:c.G2802A:p.P934P,MET:NM_000245:exon21:c.G4092A:p.P1364P,MET:NM_001127500:exon21:c.G4146A:p.P1382P	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4248	0.3210	0.354633	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	MET:uc003vij.3:exon21:c.G4092A:p.P1364P,MET:uc010lkh.3:exon21:c.G4146A:p.P1382P,MET:uc011knj.2:exon21:c.G2802A:p.P934P	.	AFR:12(meninges),AMR:2(large_intestine),EAS:MU118189,FIN:COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,NFE:0.3428,OTH:0.1030,ASJ:1(breast)	164860	114550;605074;607278;616705;	90636;47044;449;88673;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~47044|HPRCC|-|Autosomal dominant|Adult|605074 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05144 Malaria~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,7502,7485,7492,7489,7490,7496,7501,7487,7495,7500,7499,7488,7493,7486,7503,7504,7498,7497,7491	.	.	.	.	.	.	7	19(soft_tissue)	0.4761
7	117120141	117120141	G	C	CFTR	UTR5	.	ENSG00000001626	rs1800501	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0455	0.0406	0.0273562	0.0558	.	.	.	.	.	.	.	.	.	.	AFR:0.0114,AMR:0.0144,EAS:0.0691,FIN:0.0930,NFE:0.0730,OTH:0.0745,ASJ:0.0331	602421	167800;211400;219700;277180;	48;586;60033;676;	48|Congenital bilateral agenesis of vas deferens<br>Congenital bilateral aplasia of vas deferens|1-5 / 10 000|X-linked recessive<br>or&nbsp;Autosomal recessive|Adolescent<br>Adult|277180 300985 ~586|CF<br>Mucoviscidosis|1-9 / 100 000|Autosomal recessive|All ages|219700 ~60033|-|-|-|-|211400 613021 613071 ~676|-|1-9 / 1 000 000|Autosomal dominant|Childhood<br>Adolescent|167800 ~	.	.	.	.	.	.	.	.	7	MU12806055	het
7	117199533	117199533	G	A	CFTR	exonic	nonsynonymous SNV	ENSG00000001626	rs213950	ENSG00000001626:ENST00000426809:exon10:c.G1318A:p.V440M,ENSG00000001626:ENST00000454343:exon10:c.G1225A:p.V409M,ENSG00000001626:ENST00000003084:exon11:c.G1408A:p.V470M	CFTR:NM_000492:exon11:c.G1408A:p.V470M	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4829	0.5976	0.582069	1(large_intestine)	1.458	13.09	1.0	3.05	0.996	.	.	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	CFTR:uc003vjd.3:exon11:c.G1408A:p.V470M	-0.948	AFR:MU155975,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.8655,FIN:0.5431,NFE:0.2848,OTH:0.4282,ASJ:0.5815	602421	167800;211400;219700;277180;	48;586;60033;676;	48|Congenital bilateral agenesis of vas deferens<br>Congenital bilateral aplasia of vas deferens|1-5 / 10 000|X-linked recessive<br>or&nbsp;Autosomal recessive|Adolescent<br>Adult|277180 300985 ~586|CF<br>Mucoviscidosis|1-9 / 100 000|Autosomal recessive|All ages|219700 ~60033|-|-|-|-|211400 613021 613071 ~676|-|1-9 / 1 000 000|Autosomal dominant|Childhood<br>Adolescent|167800 ~	.	.	.	.	0.0	-3.39	0.000	0.14	7	4(lung)	0.5529
7	117235055	117235055	T	G	CFTR	exonic	synonymous SNV	ENSG00000001626	rs1042077	ENSG00000001626:ENST00000426809:exon14:c.T2472G:p.T824T,ENSG00000001626:ENST00000454343:exon14:c.T2379G:p.T793T,ENSG00000001626:ENST00000003084:exon15:c.T2562G:p.T854T	CFTR:NM_000492:exon15:c.T2562G:p.T854T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3889	0.4028	0.479233	MU4566070	.	.	.	.	.	.	.	.	CFTR:uc003vjd.3:exon15:c.T2562G:p.T854T,CFTR:uc011knq.2:exon15:c.T780G:p.T260T	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.4486,EAS:0.4510,FIN:0.1722,NFE:0.4297,OTH:0.4198,ASJ:0.6375	602421	167800;211400;219700;277180;	48;586;60033;676;	48|Congenital bilateral agenesis of vas deferens<br>Congenital bilateral aplasia of vas deferens|1-5 / 10 000|X-linked recessive<br>or&nbsp;Autosomal recessive|Adolescent<br>Adult|277180 300985 ~586|CF<br>Mucoviscidosis|1-9 / 100 000|Autosomal recessive|All ages|219700 ~60033|-|-|-|-|211400 613021 613071 ~676|-|1-9 / 1 000 000|Autosomal dominant|Childhood<br>Adolescent|167800 ~	.	.	.	.	.	.	.	.	7	2(haematopoietic_and_lymphoid_tissue)	0.3533
7	124481245	124481245	G	A	POT1	intronic	.	ENSG00000128513	rs3815221	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4114	0.3889	0.41893	0.4055	.	.	.	.	.	.	.	.	.	.	AFR:0.3634,AMR:0.4677,EAS:0.5031,FIN:0.4948,NFE:0.3932,OTH:0.4292,ASJ:0.4172	606478	615848;616568;	251627;251630;618;	251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~	.	.	.	.	.	.	.	.	7	MU655818	het
7	124486980	124486980	T	C	POT1	intronic	.	ENSG00000128513	rs7794637	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6950	0.7104	0.721845	0.7064	.	.	.	.	.	.	.	.	.	.	AFR:0.7353,AMR:0.6998,EAS:0.8092,FIN:0.7067,NFE:0.6792,OTH:0.6925,ASJ:0.7285	606478	615848;616568;	251627;251630;618;	251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~	.	.	.	.	.	.	.	.	7	MU25063529	het
7	124499002	124499002	A	C	POT1	intronic	.	ENSG00000128513	rs6977407	ENSG00000128513:ENST00000487564:exon2:c.T201G:p.Y67X	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5903	0.0976	0.582069	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	0.434	6.906	.	-7.16	0.210	.	.	.	.	.	AFR:0.5920,AMR:0.6336,EAS:0.5772,FIN:0.4887,NFE:0.5055,OTH:0.6043,ASJ:0.5310	606478	615848;616568;	251627;251630;618;	251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~	.	.	.	.	.	.	.	.	7	1(breast)	0.5710
7	124499003	124499003	T	A	POT1	intronic	.	ENSG00000128513	rs6959712	ENSG00000128513:ENST00000487564:exon2:c.A200T:p.Y67F	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5901	0.1507	0.582468	0.5920	0.678	8.682	.	1.56	0.325	0.0002	0.078	.	.	.	AFR:0.6339,AMR:0.5310,EAS:0.4893,FIN:0.5043,NFE:0.6043,OTH:0.5710,ASJ:0.5772	606478	615848;616568;	251627;251630;618;	251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~	.	.	.	.	.	.	.	.	7	MU787028	unknown
7	127251732	127251732	-	A	PAX4	splicing	.	ENSG00000106331	rs35434068	.	.	clinvar: Uncertain_significance 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0308	0.0409	.	0.0351	.	.	.	.	.	.	.	.	.	.	AFR:0.0809,AMR:0.0174,EAS:0.0013,FIN:0.0263,NFE:0.0139,OTH:0.0277,ASJ:0.0041	167413	125853;612225;612227;	552;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~	.	.	.	.	.	.	.	.	7	.	het
7	128843396	128843396	G	A	SMO	exonic	nonsynonymous SNV	ENSG00000128602	rs61746143	ENSG00000128602:ENST00000249373:exon2:c.G503A:p.R168H	SMO:NM_005631:exon2:c.G503A:p.R168H	clinvar: not_provided 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 1, 1, 1, 1] 	0.0095	0.0021	0.00958466	0.0014	6.748	32	0.007	4.43	0.998	.	.	Frizzled domain	SMO:uc003vor.3:exon2:c.G503A:p.R168H	-0.225	AFR:0.0005,AMR:0,EAS:0.0006,FIN:0,NFE:0.0021,OTH:0.0031,ASJ:0.0132	601500	601707;605462;	1553;	1553|Corpus callosum agenesis-polysyndactyly syndrome|<1 / 1 000 000|Not applicable|Neonatal|601707 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05217 Basal cell carcinoma ~	,9805,9820,9804,9806,9748	.	.	0.768	-1.34	0.322	1.64	7	.	het
7	128846328	128846328	G	C	SMO	exonic	synonymous SNV	ENSG00000128602	rs2228617	ENSG00000128602:ENST00000462420:exon3:c.G246C:p.G82G,ENSG00000128602:ENST00000249373:exon6:c.G1164C:p.G388G	SMO:NM_005631:exon6:c.G1164C:p.G388G	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7975	0.7896	0.75619	0.7929	.	.	.	.	.	.	.	.	SMO:uc003vos.3:exon2:c.G189C:p.G63G,SMO:uc003vor.3:exon6:c.G1164C:p.G388G	.	AFR:0.6895,AMR:0.7721,EAS:0.7674,FIN:0.8099,NFE:0.8520,OTH:0.7837,ASJ:0.8709	601500	601707;605462;	1553;	1553|Corpus callosum agenesis-polysyndactyly syndrome|<1 / 1 000 000|Not applicable|Neonatal|601707 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05217 Basal cell carcinoma ~	,9805,9804,9806,9748	.	.	.	.	.	.	7	MU802754	hom
7	137586080	137586080	C	T	CREB3L2	intronic	.	ENSG00000182158	rs56200577	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0364	0.1184	0.123602	0.1026	.	.	.	.	.	.	.	.	.	.	AFR:0.3513,AMR:0.0334,EAS:0.0173,FIN:0,NFE:0.0026,OTH:0.0183,ASJ:0.0099	608834	.	.	.	~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04668 TNF signaling pathway~ko04714 Thermogenesis~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04911 Insulin secretion~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04922 Glucagon signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04931 Insulin resistance~ko04934 Cushing syndrome~ko04962 Vasopressin-regulated water reabsorption~ko05016 Huntington disease~ko05030 Cocaine addiction~ko05031 Amphetamine addiction~ko05034 Alcoholism~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	7	MU18857448	het
7	137600690	137600690	C	T	CREB3L2	exonic	nonsynonymous SNV	ENSG00000182158	rs273957	ENSG00000182158:ENST00000330387:exon3:c.G388A:p.V130I,ENSG00000182158:ENST00000420629:exon3:c.G367A:p.V123I,ENSG00000182158:ENST00000452463:exon3:c.G388A:p.V130I,ENSG00000182158:ENST00000456390:exon3:c.G388A:p.V130I,ENSG00000182158:ENST00000458726:exon3:c.G199A:p.V67I	CREB3L2:NM_001253775:exon3:c.G388A:p.V130I,CREB3L2:NM_001318246:exon3:c.G199A:p.V67I,CREB3L2:NM_194071:exon3:c.G388A:p.V130I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6893	0.7151	0.804313	0.7149	-0.089	1.817	1.0	5.01	0.525	.	.	.	CREB3L2:uc003vtv.3:exon3:c.G199A:p.V67I,CREB3L2:uc003vtw.3:exon3:c.G388A:p.V130I,CREB3L2:uc003vtx.2:exon3:c.G388A:p.V130I,CREB3L2:uc003vty.4:exon3:c.G388A:p.V130I,CREB3L2:uc031szf.1:exon4:c.G199A:p.V67I	-0.976	AFR:0.9201,AMR:0.7662,EAS:0.9227,FIN:0.5615,NFE:0.6136,OTH:0.6268,ASJ:0.6093	608834	.	.	.	~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04668 TNF signaling pathway~ko04714 Thermogenesis~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04911 Insulin secretion~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04922 Glucagon signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04931 Insulin resistance~ko04934 Cushing syndrome~ko04962 Vasopressin-regulated water reabsorption~ko05016 Huntington disease~ko05030 Cocaine addiction~ko05031 Amphetamine addiction~ko05034 Alcoholism~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis~ko05215 Prostate cancer ~	.	.	.	0.0	0.42	0.000	-1.67	7	MU641291	het
7	137612914	137612916	TGG	-	CREB3L2	exonic	nonframeshift deletion	ENSG00000182158	rs3217268	ENSG00000182158:ENST00000420629:exon1:c.100_102del:p.34_34del,ENSG00000182158:ENST00000330387:exon2:c.299_301del:p.100_101del,ENSG00000182158:ENST00000452463:exon2:c.299_301del:p.100_101del,ENSG00000182158:ENST00000456390:exon2:c.299_301del:p.100_101del,ENSG00000182158:ENST00000458726:exon2:c.110_112del:p.37_38del	CREB3L2:NM_001253775:exon2:c.299_301del:p.100_101del,CREB3L2:NM_001318246:exon2:c.110_112del:p.37_38del,CREB3L2:NM_194071:exon2:c.299_301del:p.100_101del	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6918	0.6397	0.690695	0.6404	.	.	.	.	.	.	.	.	CREB3L2:uc003vtv.3:exon2:c.110_112del:p.37_38del,CREB3L2:uc003vtw.3:exon2:c.299_301del:p.100_101del,CREB3L2:uc003vtx.2:exon2:c.299_301del:p.100_101del,CREB3L2:uc003vty.4:exon2:c.299_301del:p.100_101del,CREB3L2:uc031szf.1:exon3:c.110_112del:p.37_38del	.	AFR:0.6728,AMR:0.7319,EAS:0.8470,FIN:0.6195,NFE:0.6021,OTH:0.6299,ASJ:0.52	608834	.	.	.	~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04668 TNF signaling pathway~ko04714 Thermogenesis~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04911 Insulin secretion~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04922 Glucagon signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04931 Insulin resistance~ko04934 Cushing syndrome~ko04962 Vasopressin-regulated water reabsorption~ko05016 Huntington disease~ko05030 Cocaine addiction~ko05031 Amphetamine addiction~ko05034 Alcoholism~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	7	MU28483034	het
7	138145778	138145778	C	T	TRIM24	intronic	.	ENSG00000122779	rs112619223	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.4196	.	0.243011	0.3171	.	.	.	.	.	.	.	.	.	.	AFR:0.4192,AMR:0.2027,EAS:0.0012,FIN:0.2593,NFE:0.3127,OTH:0.2676,ASJ:0.4636	603406	.	.	.	.	.	.	.	.	.	.	.	7	.	het
7	138200117	138200117	A	T	TRIM24	intronic	.	ENSG00000122779	rs3757381	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7660	0.8246	0.71905	0.7838	.	.	.	.	.	.	.	.	.	.	AFR:0.8205,AMR:0.7333,EAS:0.5149,FIN:0.7665,NFE:0.7985,OTH:0.7551,ASJ:0.8633	603406	.	.	.	.	.	.	.	.	.	.	.	7	MU12863507	het
7	140426257	140426257	A	G	BRAF	UTR3	.	ENSG00000157764	rs3829814	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3356	.	0.221645	0.3768	.	.	.	.	.	.	.	.	.	.	AFR:0.0974,AMR:0.3055,EAS:0.1479,FIN:0.5049,NFE:0.5340,OTH:0.4346,ASJ:0.4040	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04150 mTOR signaling pathway~ko04214 Apoptosis - fly~ko04270 Vascular smooth muscle contraction~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	7	MU12866811	het
7	141439003	141439003	C	T	SSBP1	intronic	.	ENSG00000106028	rs75358342	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1701	0.1677	0.102636	0.1622	.	.	.	.	.	.	.	.	.	.	AFR:0.0446,AMR:0.1885,EAS:0.0544,FIN:0.2106,NFE:0.2271,OTH:0.1965,ASJ:0.1733	600439	.	.	.	.	.	.	.	.	.	.	.	7	MU12868221	het
7	142457132	142457132	A	C	PRSS1	upstream	.	ENSG00000204983	rs4726576	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.409744	0.5722	.	.	.	.	.	.	.	.	.	.	AFR:0.5573,AMR:0.5593,EAS:0.2793,FIN:0.6039,NFE:0.5967,OTH:0.5862,ASJ:0.6014	276000	167800;614044;	676;	676|-|1-9 / 1 000 000|Autosomal dominant|Childhood<br>Adolescent|167800 ~	.	.	.	.	.	.	.	.	7	MU24384021	hom
7	142460313	142460313	T	C	PRSS1	exonic	synonymous SNV	ENSG00000204983	rs6666	ENSG00000204983:ENST00000492062:exon3:c.T336C:p.D112D,ENSG00000204983:ENST00000311737:exon4:c.T486C:p.D162D,ENSG00000204983:ENST00000486171:exon5:c.T528C:p.D176D	PRSS1:NM_002769:exon4:c.T486C:p.D162D	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3693	.	0.396565	0.4118	.	.	.	.	.	.	.	.	PRSS1:uc003wam.2:exon2:c.T306C:p.D102D,PRSS1:uc003wak.2:exon4:c.T486C:p.D162D	.	AFR:0.3514,AMR:0.3990,EAS:0.1832,FIN:0.4223,NFE:0.4676,OTH:0.4113,ASJ:0.5167	276000	167800;614044;	676;	676|-|1-9 / 1 000 000|Autosomal dominant|Childhood<br>Adolescent|167800 ~	.	.	.	.	.	.	.	.	7	MU4550788	hom
7	142460865	142460865	T	C	PRSS1	exonic	synonymous SNV	ENSG00000204983	rs6667	ENSG00000204983:ENST00000311737:exon5:c.T738C:p.N246N,ENSG00000204983:ENST00000486171:exon6:c.T780C:p.N260N	PRSS1:NM_002769:exon5:c.T738C:p.N246N	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5041	.	0.39377	0.5213	.	.	.	.	.	.	.	.	PRSS1:uc003wam.2:exon3:c.T558C:p.N186N,PRSS1:uc003wak.2:exon5:c.T738C:p.N246N	.	AFR:0.4502,AMR:0.5311,EAS:0.2094,FIN:0.5940,NFE:0.5740,OTH:0.5591,ASJ:0.5933	276000	167800;614044;	676;	676|-|1-9 / 1 000 000|Autosomal dominant|Childhood<br>Adolescent|167800 ~	.	.	.	.	.	.	.	.	7	MU24384057	hom
7	142563873	142563873	G	T	EPHB6	exonic	nonsynonymous SNV	ENSG00000106123	rs541552138	ENSG00000106123:ENST00000411471:exon4:c.G430T:p.G144W,ENSG00000106123:ENST00000392957:exon9:c.G1261T:p.G421W,ENSG00000106123:ENST00000442129:exon9:c.G1261T:p.G421W	EPHB6:NM_001280795:exon5:c.G385T:p.G129W,EPHB6:NM_001280794:exon8:c.G385T:p.G129W,EPHB6:NM_004445:exon9:c.G1261T:p.G421W	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0001	.	0.000199681	.	2.104	16.88	.	0.413	0.001	.	.	Fibronectin type III|Growth factor receptor cysteine-rich domain|Immunoglobulin-like fold	EPHB6:uc003wbu.3:exon5:c.G385T:p.G129W,EPHB6:uc003wbs.3:exon8:c.G385T:p.G129W,EPHB6:uc011kst.2:exon9:c.G1261T:p.G421W,EPHB6:uc011ksu.2:exon9:c.G1261T:p.G421W	0.326	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602757	.	.	.	.	.	.	.	0.946	.	0.879	2.2	7	.	het
7	146805228	146805228	-	G	CNTNAP2	intronic	.	ENSG00000174469	rs35167289	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.3982	.	0.377995	0.4293	.	.	.	.	.	.	.	.	.	.	AFR:0.4688,AMR:0.5694,EAS:0.3731,FIN:0.4132,NFE:0.4141,OTH:0.3901,ASJ:0.2649	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	.	het
7	147183143	147183143	A	G	CNTNAP2	intronic	.	ENSG00000174469	rs2286127	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2255	0.1897	0.274561	MU587631	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|4|205|0.0195122,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.2054,EAS:0.3289,FIN:0.1192,NFE:0.3758,OTH:0.1778,ASJ:0.2401	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	1(stomach)	0.1689
7	147926888	147926888	A	C	CNTNAP2	intronic	.	ENSG00000174469	rs3779032	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3755	0.4165	0.360224	ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.3922,AMR:0.4085,EAS:0.3133,FIN:0.3313,NFE:0.3903,OTH:0.3979,ASJ:0.2962	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	1(haematopoietic_and_lymphoid_tissue)	0.3724
7	148106475	148106475	-	TT	CNTNAP2	intronic	.	ENSG00000174469	rs397782655	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5027	.	0.547923	0.5785	.	.	.	.	.	.	.	.	.	.	AFR:0.6489,AMR:0.2978,EAS:0.3658,FIN:0.6574,NFE:0.5600,OTH:0.5898,ASJ:0.3924	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	MU114278353	unknown
7	148106477	148106477	-	TG	CNTNAP2	intronic	.	ENSG00000174469	rs374969707	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5143	.	0.547923	0.5865	.	.	.	.	.	.	.	.	.	.	AFR:0.6502,AMR:0.3034,EAS:0.3666,FIN:0.6578,NFE:0.5737,OTH:0.6,ASJ:0.4053	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	MU114270516	unknown
7	148106490	148106490	G	A	CNTNAP2	exonic	unknown	ENSG00000174469	rs9648691	ENSG00000174469:ENST00000538075:exon8:c.G900A:p.A300A,ENSG00000174469:ENST00000361727:exon23:c.G3723A:p.A1241A	UNKNOWN	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5407	0.5850	0.549121	0.5892	.	.	.	.	.	.	.	.	CNTNAP2:uc003wev.2:exon3:c.G54A:p.A18A,CNTNAP2:uc003weu.2:exon23:c.G3723A:p.A1241A	.	AFR:0.6502,AMR:0.3081,EAS:0.3694,FIN:0.6578,NFE:0.5783,OTH:0.6066,ASJ:0.4321	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	MU119103	unknown
7	148543694	148543694	A	-	EZH2	intronic	.	ENSG00000106462	rs3214332	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.7134	.	0.761182	0.7479	.	.	.	.	.	.	.	.	.	.	AFR:0.9272,AMR:0.7404,EAS:0.6804,FIN:0.6355,NFE:0.6781,OTH:0.6721,ASJ:0.6926	601573	277590;	3447;	3447|Camptodactyly-overgrowth-unusual facies syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|277590 ~	.	.	.	.	.	.	.	.	7	.	het
7	150644883	150644883	-	C	KCNH2	exonic	frameshift insertion	ENSG00000055118	rs794728455	ENSG00000055118:ENST00000330883:exon8:c.1755dupG:p.P586fs,ENSG00000055118:ENST00000392968:exon10:c.2487dupG:p.P830fs,ENSG00000055118:ENST00000262186:exon12:c.2775dupG:p.P926fs	KCNH2:NM_172057:exon8:c.1755dupG:p.P586fs,KCNH2:NM_000238:exon12:c.2775dupG:p.P926fs	clinvar: Pathogenic 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 1, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	KCNH2:uc003wib.3:exon8:c.1755dupG:p.P586fs,KCNH2:uc011kux.2:exon10:c.2487dupG:p.P830fs,KCNH2:uc003wic.3:exon12:c.2775dupG:p.P926fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	152427	609620;613688;	101016;768;51083;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~51083|SQTS|Unknown|Autosomal dominant|All ages|609620 609621 609622 ~	.	.	.	.	.	.	.	.	7	.	het
7	150648198	150648198	A	G	KCNH2	exonic	synonymous SNV	ENSG00000055118	rs1137617	ENSG00000055118:ENST00000330883:exon4:c.T936C:p.Y312Y,ENSG00000055118:ENST00000392968:exon6:c.T1668C:p.Y556Y,ENSG00000055118:ENST00000262186:exon8:c.T1956C:p.Y652Y,ENSG00000055118:ENST00000430723:exon8:c.T1956C:p.Y652Y	KCNH2:NM_001204798:exon4:c.T936C:p.Y312Y,KCNH2:NM_172057:exon4:c.T936C:p.Y312Y,KCNH2:NM_000238:exon8:c.T1956C:p.Y652Y,KCNH2:NM_172056:exon8:c.T1956C:p.Y652Y	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6658	0.6905	0.772165	0.7031	.	.	.	.	.	.	.	.	KCNH2:uc003wib.3:exon4:c.T936C:p.Y312Y,KCNH2:uc003wid.3:exon4:c.T936C:p.Y312Y,KCNH2:uc011kux.2:exon6:c.T1668C:p.Y556Y,KCNH2:uc003wic.3:exon8:c.T1956C:p.Y652Y,KCNH2:uc003wie.3:exon8:c.T1956C:p.Y652Y	.	AFR:0.8883,AMR:0.6766,EAS:0.9021,FIN:0.6263,NFE:0.6004,OTH:0.6222,ASJ:0.61	152427	609620;613688;	101016;768;51083;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~51083|SQTS|Unknown|Autosomal dominant|All ages|609620 609621 609622 ~	.	.	.	.	.	.	.	.	7	MU4567794	hom
7	150648789	150648789	T	C	KCNH2	exonic	synonymous SNV	ENSG00000055118	rs1805121	ENSG00000055118:ENST00000330883:exon3:c.A672G:p.L224L,ENSG00000055118:ENST00000392968:exon5:c.A1404G:p.L468L,ENSG00000055118:ENST00000262186:exon7:c.A1692G:p.L564L,ENSG00000055118:ENST00000430723:exon7:c.A1692G:p.L564L	KCNH2:NM_001204798:exon3:c.A672G:p.L224L,KCNH2:NM_172057:exon3:c.A672G:p.L224L,KCNH2:NM_000238:exon7:c.A1692G:p.L564L,KCNH2:NM_172056:exon7:c.A1692G:p.L564L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4786	0.4894	0.608427	0.5247	.	.	.	.	.	.	.	.	KCNH2:uc003wib.3:exon3:c.A672G:p.L224L,KCNH2:uc003wid.3:exon3:c.A672G:p.L224L,KCNH2:uc011kux.2:exon5:c.A1404G:p.L468L,KCNH2:uc003wic.3:exon7:c.A1692G:p.L564L,KCNH2:uc003wie.3:exon7:c.A1692G:p.L564L	.	AFR:0.7417,AMR:0.5263,EAS:0.8605,FIN:0.4644,NFE:0.3836,OTH:0.4491,ASJ:0.3808	152427	609620;613688;	101016;768;51083;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~51083|SQTS|Unknown|Autosomal dominant|All ages|609620 609621 609622 ~	.	.	.	.	.	.	.	.	7	MU4567796	hom
7	150649531	150649531	G	A	KCNH2	exonic	synonymous SNV	ENSG00000055118	rs1805120	ENSG00000055118:ENST00000330883:exon2:c.C519T:p.F173F,ENSG00000055118:ENST00000392968:exon4:c.C1251T:p.F417F,ENSG00000055118:ENST00000262186:exon6:c.C1539T:p.F513F,ENSG00000055118:ENST00000430723:exon6:c.C1539T:p.F513F	KCNH2:NM_001204798:exon2:c.C519T:p.F173F,KCNH2:NM_172057:exon2:c.C519T:p.F173F,KCNH2:NM_000238:exon6:c.C1539T:p.F513F,KCNH2:NM_172056:exon6:c.C1539T:p.F513F	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2935	0.2264	0.341653	0.2667	.	.	.	.	.	.	.	.	KCNH2:uc003wib.3:exon2:c.C519T:p.F173F,KCNH2:uc003wid.3:exon2:c.C519T:p.F173F,KCNH2:uc011kux.2:exon4:c.C1251T:p.F417F,KCNH2:uc003wic.3:exon6:c.C1539T:p.F513F,KCNH2:uc003wie.3:exon6:c.C1539T:p.F513F	.	AFR:0.2454,AMR:0.3756,EAS:0.6539,FIN:0.2964,NFE:0.2223,OTH:0.2838,ASJ:0.3113	152427	609620;613688;	101016;768;51083;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~51083|SQTS|Unknown|Autosomal dominant|All ages|609620 609621 609622 ~	.	.	.	.	.	.	.	.	7	MU736249	het
7	150649603	150649603	G	A	KCNH2	exonic	synonymous SNV	ENSG00000055118	rs740952	ENSG00000055118:ENST00000330883:exon2:c.C447T:p.I149I,ENSG00000055118:ENST00000392968:exon4:c.C1179T:p.I393I,ENSG00000055118:ENST00000262186:exon6:c.C1467T:p.I489I,ENSG00000055118:ENST00000430723:exon6:c.C1467T:p.I489I	KCNH2:NM_001204798:exon2:c.C447T:p.I149I,KCNH2:NM_172057:exon2:c.C447T:p.I149I,KCNH2:NM_000238:exon6:c.C1467T:p.I489I,KCNH2:NM_172056:exon6:c.C1467T:p.I489I	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2929	0.2302	0.342652	0.2687	.	.	.	.	.	.	.	.	KCNH2:uc003wib.3:exon2:c.C447T:p.I149I,KCNH2:uc003wid.3:exon2:c.C447T:p.I149I,KCNH2:uc011kux.2:exon4:c.C1179T:p.I393I,KCNH2:uc003wic.3:exon6:c.C1467T:p.I489I,KCNH2:uc003wie.3:exon6:c.C1467T:p.I489I	.	AFR:0.2551,AMR:0.3786,EAS:0.6472,FIN:0.2887,NFE:0.2231,OTH:0.2853,ASJ:0.3146	152427	609620;613688;	101016;768;51083;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~51083|SQTS|Unknown|Autosomal dominant|All ages|609620 609621 609622 ~	.	.	.	.	.	.	.	.	7	MU18877935	het
7	151859683	151859683	G	A	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs74483926	ENSG00000055609:ENST00000424877:exon1:c.C737T:p.S246L,ENSG00000055609:ENST00000262189:exon43:c.C10979T:p.S3660L,ENSG00000055609:ENST00000355193:exon43:c.C10979T:p.S3660L	KMT2C:NM_170606:exon43:c.C10979T:p.S3660L	clinvar: not_provided 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.0477	0.0284	0.0579073	2(liver)	0.598	8.146	0.365	1.72	0.000	.	.	.	KMT2C:uc003wky.3:exon6:c.C3506T:p.S1169L,KMT2C:uc003wkz.3:exon29:c.C8162T:p.S2721L,KMT2C:uc003wla.3:exon43:c.C10979T:p.S3660L	-0.997	AFR:1(large_intestine),AMR:MU18504708,EAS:0.0385,FIN:0.0092,NFE:0.0119,OTH:0.0265,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053	606833	.	.	.	.	.	.	,6806	0.002	-1.77	0.004	0.695	7	1(haematopoietic_and_lymphoid_tissue)	0.1790
7	151882623	151882624	AG	-	KMT2C	intronic	.	ENSG00000055609	rs112646605	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4647	.	.	0.0011	.	.	.	.	.	.	.	.	.	.	AFR:0.0006,AMR:0.0039,EAS:0.0006,FIN:0.0028,NFE:0.0009,OTH:0,ASJ:0	606833	.	.	.	.	.	.	.	.	.	.	.	7	MU74344210	het
7	151927021	151927021	C	A	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs28522267	ENSG00000055609:ENST00000262189:exon18:c.G2963T:p.C988F,ENSG00000055609:ENST00000355193:exon18:c.G2963T:p.C988F	KMT2C:NM_170606:exon18:c.G2963T:p.C988F	clinvar: Benign 	 CancerVar: 7#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, -1, 2, 2, 1, 1] 	0.1065	.	.	20(upper_aerodigestive_tract)	7.018	33	0.0	4.67	1.000	.	.	Zinc finger, FYVE/PHD-type|Zinc finger, PHD-finger|Zinc finger, PHD-type|Zinc finger, RING-type|Zinc finger, RING/FYVE/PHD-type	KMT2C:uc003wkz.3:exon4:c.G146T:p.C49F,KMT2C:uc003wla.3:exon18:c.G2963T:p.C988F	0.852	AFR:24(central_nervous_system),AMR:3(thyroid),EAS:MU587659,FIN:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,NFE:0.4338,OTH:0.4036,ASJ:2(bone)	606833	.	.	.	.	.	.	,6806	0.999	-8.15	0.996	2.495	7	22(soft_tissue)	0.3934
7	151927025	151927025	A	G	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs77735469	ENSG00000055609:ENST00000262189:exon18:c.T2959C:p.Y987H,ENSG00000055609:ENST00000355193:exon18:c.T2959C:p.Y987H	KMT2C:NM_170606:exon18:c.T2959C:p.Y987H	clinvar: UNK 	 CancerVar: 8#Tier_II_potential EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, 2, 1, 1] 	0.4728	.	.	19(central_nervous_system)	6.190	28.6	0.001	4.67	0.996	.	.	Zinc finger, FYVE/PHD-type|Zinc finger, PHD-finger|Zinc finger, PHD-type|Zinc finger, RING-type|Zinc finger, RING/FYVE/PHD-type	KMT2C:uc003wkz.3:exon4:c.T142C:p.Y48H,KMT2C:uc003wla.3:exon18:c.T2959C:p.Y987H	0.656	AFR:1(thyroid),AMR:1(large_intestine),EAS:COCA-CN|5|321|0.0155763,BLCA-CN|1|103|0.00970874,FIN:0.2021,NFE:0.3091,OTH:0.2654,ASJ:MU4563013	606833	.	.	.	.	.	.	,6806	1.0	-2.28	0.754	2.22	7	2(urinary_tract)	0.2062
7	151927026	151927026	T	C	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs28439884	ENSG00000055609:ENST00000262189:exon18:c.A2958G:p.P986P,ENSG00000055609:ENST00000355193:exon18:c.A2958G:p.P986P	KMT2C:NM_170606:exon18:c.A2958G:p.P986P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.1156	.	.	1(stomach)	.	.	.	.	.	.	.	.	KMT2C:uc003wkz.3:exon4:c.A141G:p.P47P,KMT2C:uc003wla.3:exon18:c.A2958G:p.P986P	.	AFR:1(upper_aerodigestive_tract),AMR:6(central_nervous_system),EAS:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,RECA-EU|1|422|0.00236967,FIN:0.4317,NFE:0.4026,OTH:0.3909,ASJ:MU587660	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	2(thyroid)	0.3976
7	151927127	151927127	A	G	KMT2C	intronic	.	ENSG00000055609	rs62481502	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4893	.	.	1(liver)	.	.	.	.	.	.	.	.	.	.	AFR:MU587661,AMR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,EAS:0.2777,FIN:0.3209,NFE:0.2929,OTH:0.4236,ASJ:0.3394	606833	.	.	.	.	.	.	.	.	.	.	.	7	1(stomach)	0.3022
7	151932897	151932897	C	A	KMT2C	intronic	.	ENSG00000055609	rs73728782	.	.	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1450	.	.	1(lung)	.	.	.	.	.	0.9999	0.978	.	.	.	AFR:MU44683266,AMR:PACA-CA|1|268|0.00373134,LICA-CN|4|402|0.00995025,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,EAS:0.0001,FIN:0,NFE:0,OTH:0,ASJ:0.0002	606833	.	.	.	.	.	.	.	.	.	.	.	7	3(biliary_tract)	0.0018
7	151932949	151932949	C	A	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs77173318	ENSG00000055609:ENST00000262189:exon16:c.G2722T:p.G908C,ENSG00000055609:ENST00000355193:exon16:c.G2722T:p.G908C	KMT2C:NM_170606:exon16:c.G2722T:p.G908C	clinvar: UNK 	 CancerVar: 8#Tier_II_potential EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, 2, 1, 1] 	0.0029	0.0039	.	.	7.306	34	0.001	5.0	1.000	.	.	.	KMT2C:uc003wla.3:exon16:c.G2722T:p.G908C	0.412	AFR:.,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	606833	.	.	.	.	.	.	,6806	1.0	-2.21	0.643	2.475	7	2(soft_tissue)	0
7	151945007	151945007	C	T	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs2479172	ENSG00000055609:ENST00000262189:exon14:c.G2512A:p.G838S,ENSG00000055609:ENST00000355193:exon14:c.G2512A:p.G838S	KMT2C:NM_170606:exon14:c.G2512A:p.G838S	clinvar: UNK 	 CancerVar: 8#Tier_II_potential EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, 2, 1, 1] 	0.4944	.	.	1(large_intestine)	6.636	32	0.003	5.67	1.000	.	.	.	KMT2C:uc003wla.3:exon14:c.G2512A:p.G838S	-0.835	AFR:3(bone),AMR:MU31381223,EAS:0.4950,FIN:0.4995,NFE:0.5,OTH:0.4927,ASJ:SKCA-BR|1|100|0.01,COCA-CN|6|321|0.0186916	606833	.	.	.	.	.	.	,6806	1.0	-2.3	0.230	2.075	7	3(prostate)	0.4981
7	151945071	151945071	-	T	KMT2C	exonic	stopgain	ENSG00000055609	rs150073007	ENSG00000055609:ENST00000262189:exon14:c.2447dupA:p.Y816_I817delinsX,ENSG00000055609:ENST00000355193:exon14:c.2447dupA:p.Y816_I817delinsX,ENSG00000055609:ENST00000558084:exon14:c.2447dupA:p.Y816_I817delinsX	KMT2C:NM_170606:exon14:c.2447dupA:p.Y816_I817delinsX	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4901	.	.	0.4828	.	.	.	.	.	.	.	.	KMT2C:uc003wla.3:exon14:c.2447dupA:p.Y816_I817delinsX	.	AFR:0.4719,AMR:0.4904,EAS:0.4977,FIN:0.4841,NFE:0.4847,OTH:0.4893,ASJ:0.4902	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	MU2245504	het
7	151945140	151945140	C	T	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs2537263	ENSG00000055609:ENST00000262189:exon14:c.G2379A:p.S793S,ENSG00000055609:ENST00000355193:exon14:c.G2379A:p.S793S,ENSG00000055609:ENST00000558084:exon14:c.G2379A:p.S793S	KMT2C:NM_170606:exon14:c.G2379A:p.S793S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4564	.	.	4(central_nervous_system)	.	.	.	.	.	.	.	.	KMT2C:uc003wla.3:exon14:c.G2379A:p.S793S	.	AFR:1(upper_aerodigestive_tract),AMR:1(stomach),EAS:1(haematopoietic_and_lymphoid_tissue),FIN:MU22082,NFE:MELA-AU|1|183|0.00546448,LAML-KR|1|205|0.00487805,COCA-CN|7|321|0.0218069,GACA-JP|1|585|0.0017094,OTH:0.4617,ASJ:1(skin)	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	1(thyroid)	0.4870
7	151945167	151945167	G	T	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs2537264	ENSG00000055609:ENST00000262189:exon14:c.C2352A:p.S784S,ENSG00000055609:ENST00000355193:exon14:c.C2352A:p.S784S,ENSG00000055609:ENST00000558084:exon14:c.C2352A:p.S784S	KMT2C:NM_170606:exon14:c.C2352A:p.S784S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4776	.	.	1(prostate)	.	.	.	.	.	.	.	.	KMT2C:uc003wla.3:exon14:c.C2352A:p.S784S	.	AFR:MU4548885,AMR:COCA-CN|7|321|0.0218069,PRAD-CA|1|306|0.00326797,EAS:0.4972,FIN:0.4852,NFE:0.4530,OTH:0.4924,ASJ:0.4815	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	2(large_intestine)	0.4671
7	151945204	151945204	G	A	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs4024453	ENSG00000055609:ENST00000262189:exon14:c.C2315T:p.S772L,ENSG00000055609:ENST00000355193:exon14:c.C2315T:p.S772L,ENSG00000055609:ENST00000558084:exon14:c.C2315T:p.S772L	KMT2C:NM_170606:exon14:c.C2315T:p.S772L	clinvar: UNK 	 CancerVar: 8#Tier_II_potential EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, 2, 1, 1] 	0.4861	.	.	1(bone)	1.271	12.12	0.004	5.68	0.008	.	.	.	KMT2C:uc003wla.3:exon14:c.C2315T:p.S772L	-0.137	AFR:.,AMR:.,EAS:0.4996,FIN:0.4802,NFE:0.4788,OTH:0.5,ASJ:0.4890	606833	.	.	.	.	.	.	,6806	0.546	-1.82	0.481	2.19	7	22(upper_aerodigestive_tract)	0.4257
7	151962309	151962309	G	A	KMT2C	intronic	.	ENSG00000055609	rs201948579	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0003	.	0.000399361	LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.0316,AMR:0.0274,EAS:0.0099,FIN:0.0502,NFE:0.0792,OTH:0.0210,ASJ:0.0714	606833	.	.	.	.	.	.	.	.	.	.	.	7	1(meninges)	0.0243
7	151970856	151970856	T	A	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs10454320	ENSG00000055609:ENST00000262189:exon7:c.A946T:p.T316S,ENSG00000055609:ENST00000355193:exon7:c.A946T:p.T316S,ENSG00000055609:ENST00000558084:exon7:c.A946T:p.T316S	KMT2C:NM_170606:exon7:c.A946T:p.T316S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.5276	.	.	1(bone)	3.363	22.9	0.415	3.71	0.842	.	.	Extended PHD (ePHD) domain|Zinc finger, PHD-type	KMT2C:uc003wla.3:exon7:c.A946T:p.T316S	-0.940	AFR:MU4218242,AMR:COCA-CN|5|321|0.0155763,EAS:0.4998,FIN:0.4988,NFE:0.4892,OTH:0.5006,ASJ:0.4945	606833	.	.	.	.	.	.	,6806	0.684	-0.5	0.162	1.15	7	2(kidney)	0.5
7	152346007	152346007	C	T	XRCC2	exonic	nonsynonymous SNV	ENSG00000196584	rs3218536	ENSG00000196584:ENST00000359321:exon3:c.G563A:p.R188H	XRCC2:NM_005431:exon3:c.G563A:p.R188H	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0655	0.0558	0.052516	0.0482	1.958	15.95	0.368	1.85	0.971	.	.	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|P-loop containing nucleoside triphosphate hydrolase	XRCC2:uc003wld.3:exon3:c.G563A:p.R188H	-1.098	AFR:0.0155,AMR:0.0418,EAS:0,FIN:0.0295,NFE:0.0761,OTH:0.0621,ASJ:0.0596	600375	.	.	.	.	.	.	.	0.047	-0.18	0.005	0.345	7	.	het
7	154738409	154738409	T	C	PAXIP1	exonic	nonsynonymous SNV	ENSG00000157212	rs3501	ENSG00000157212:ENST00000397192:exon18:c.A3037G:p.M1013V,ENSG00000157212:ENST00000404141:exon18:c.A3037G:p.M1013V	PAXIP1:NM_007349:exon18:c.A3037G:p.M1013V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2813	0.2137	0.235423	1(stomach)	1.033	10.85	0.328	0.184	0.980	.	.	BRCT domain	PAXIP1:uc022aqi.1:exon16:c.A2929G:p.M977V,PAXIP1:uc022aqf.1:exon18:c.A3037G:p.M1013V,PAXIP1:uc022aqg.1:exon18:c.A3037G:p.M1013V,PAXIP1:uc022aqh.1:exon19:c.A2935G:p.M979V	-0.929	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU587665,EAS:0.2242,FIN:0.1022,NFE:0.4211,OTH:0.2733,ASJ:LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	608254	.	.	.	.	.	.	.	0.0	0.99	0.000	1.7	7	1(thyroid)	0.1864
7	154760369	154760369	A	G	PAXIP1	exonic	synonymous SNV	ENSG00000157212	rs935037	ENSG00000157212:ENST00000397192:exon7:c.T1542C:p.L514L,ENSG00000157212:ENST00000404141:exon7:c.T1542C:p.L514L	PAXIP1:NM_007349:exon7:c.T1542C:p.L514L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5995	0.5959	0.615415	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	PAXIP1:uc003wlr.1:exon3:c.T1269C:p.L423L,PAXIP1:uc022aqi.1:exon5:c.T1434C:p.L478L,PAXIP1:uc022aqf.1:exon7:c.T1542C:p.L514L,PAXIP1:uc022aqg.1:exon7:c.T1542C:p.L514L,PAXIP1:uc022aqh.1:exon8:c.T1440C:p.L480L	.	AFR:0.5835,AMR:0.5346,EAS:0.6324,FIN:0.5944,NFE:0.6474,OTH:0.5861,ASJ:0.7356	608254	.	.	.	.	.	.	.	.	.	.	.	7	1(thyroid)	0.5869
7	154760666	154760666	C	T	PAXIP1	exonic	synonymous SNV	ENSG00000157212	rs61752011	ENSG00000157212:ENST00000397192:exon7:c.G1245A:p.P415P,ENSG00000157212:ENST00000404141:exon7:c.G1245A:p.P415P	PAXIP1:NM_007349:exon7:c.G1245A:p.P415P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2543	0.1762	0.221645	1(thyroid)	.	.	.	.	.	.	.	.	PAXIP1:uc003wlr.1:exon3:c.G972A:p.P324P,PAXIP1:uc022aqi.1:exon5:c.G1137A:p.P379P,PAXIP1:uc022aqf.1:exon7:c.G1245A:p.P415P,PAXIP1:uc022aqg.1:exon7:c.G1245A:p.P415P,PAXIP1:uc022aqh.1:exon8:c.G1143A:p.P381P	.	AFR:MU4568209,AMR:COCA-CN|2|321|0.00623053,EAS:0.0772,FIN:0.4057,NFE:0.2417,OTH:0.1897,ASJ:0.2109	608254	.	.	.	.	.	.	.	.	.	.	.	7	1(ovary)	0.3039
7	155596413	155596413	C	T	SHH	exonic	synonymous SNV	ENSG00000164690	rs9333633	ENSG00000164690:ENST00000297261:exon3:c.G570A:p.S190S	SHH:NM_000193:exon3:c.G570A:p.S190S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0058	0.0021	0.00479233	0.0027	.	.	.	.	.	.	.	.	SHH:uc003wmk.1:exon3:c.G570A:p.S190S,SHH:uc003wmj.1:exon4:c.G309A:p.S103S	.	AFR:0.0005,AMR:0.0036,EAS:0,FIN:0,NFE:0.0049,OTH:0.0031,ASJ:0	600725	142945;147250;269160;611638;	98938;799;2162;2286;280200;2162;	98938|MAC<br>Microphthalmia with colobomatous cyst<br>Microphthalmia-anophthalmia-coloboma syndrome|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|251505 300345 601186 605738 610092 611638 613703 614497 615145 616428 ~799|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|269160 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~2286|SMMCI<br>Single upper central incisor|Unknown|Multigenic/multifactorial|Childhood|147250 ~280200|Microform HPE|1-9 / 100 000|Multigenic/multifactorial|Infancy<br>Neonatal|147250 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05217 Basal cell carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	7	.	het
8	6272399	6272399	G	T	MCPH1	exonic	synonymous SNV	ENSG00000147316	rs2305022	ENSG00000147316:ENST00000344683:exon3:c.G228T:p.V76V,ENSG00000147316:ENST00000519480:exon3:c.G228T:p.V76V,ENSG00000147316:ENST00000522905:exon3:c.G228T:p.V76V	MCPH1:NM_001172574:exon3:c.G228T:p.V76V,MCPH1:NM_001172575:exon3:c.G228T:p.V76V,MCPH1:NM_001322042:exon3:c.G228T:p.V76V,MCPH1:NM_001322043:exon3:c.G222T:p.V74V,MCPH1:NM_001322045:exon3:c.G126T:p.V42V,MCPH1:NM_001363979:exon3:c.G228T:p.V76V,MCPH1:NM_001363980:exon3:c.G228T:p.V76V,MCPH1:NM_024596:exon3:c.G228T:p.V76V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7719	0.6980	0.678115	0.7172	.	.	.	.	.	.	.	.	MCPH1:uc003wqh.3:exon3:c.G228T:p.V76V,MCPH1:uc003wqi.3:exon3:c.G228T:p.V76V,MCPH1:uc011kwl.2:exon3:c.G228T:p.V76V	.	AFR:0.4414,AMR:0.8189,EAS:0.7833,FIN:0.8881,NFE:0.8188,OTH:0.8033,ASJ:0.6954	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	.	.	.	.	8	MU18893251	hom
8	6296550	6296550	G	T	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs2442513	ENSG00000147316:ENST00000344683:exon6:c.G513T:p.R171S,ENSG00000147316:ENST00000519480:exon6:c.G513T:p.R171S	MCPH1:NM_001172574:exon6:c.G513T:p.R171S,MCPH1:NM_001322042:exon6:c.G513T:p.R171S,MCPH1:NM_001322043:exon6:c.G507T:p.R169S,MCPH1:NM_001322045:exon6:c.G411T:p.R137S,MCPH1:NM_001363979:exon6:c.G513T:p.R171S,MCPH1:NM_001363980:exon6:c.G513T:p.R171S,MCPH1:NM_024596:exon6:c.G513T:p.R171S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9662	0.9251	0.916933	0.9276	-1.150	0.008	0.857	-4.59	0.012	.	.	BRCT domain	MCPH1:uc003wqh.3:exon6:c.G513T:p.R171S,MCPH1:uc003wqi.3:exon6:c.G513T:p.R171S	-1.032	AFR:0.7806,AMR:0.9797,EAS:0.9889,FIN:0.9865,NFE:0.9859,OTH:0.9695,ASJ:0.9768	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	0.0	3.78	0.000	-1.355	8	MU81846801	hom
8	6302183	6302183	G	C	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs930557	ENSG00000147316:ENST00000522905:exon7:c.G796C:p.D266H,ENSG00000147316:ENST00000344683:exon8:c.G940C:p.D314H,ENSG00000147316:ENST00000519480:exon8:c.G940C:p.D314H	MCPH1:NM_001172575:exon7:c.G796C:p.D266H,MCPH1:NM_001172574:exon8:c.G940C:p.D314H,MCPH1:NM_001322042:exon8:c.G940C:p.D314H,MCPH1:NM_001322043:exon8:c.G934C:p.D312H,MCPH1:NM_001322045:exon8:c.G838C:p.D280H,MCPH1:NM_001363979:exon8:c.G940C:p.D314H,MCPH1:NM_001363980:exon8:c.G940C:p.D314H,MCPH1:NM_024596:exon8:c.G940C:p.D314H	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.7714	0.6758	0.644768	0.6908	3.901	23.5	0.056	2.68	0.032	.	.	.	MCPH1:uc011kwl.2:exon7:c.G796C:p.D266H,MCPH1:uc003wqh.3:exon8:c.G940C:p.D314H,MCPH1:uc003wqi.3:exon8:c.G940C:p.D314H	-1.055	AFR:0.3336,AMR:0.8222,EAS:0.7984,FIN:0.8821,NFE:0.8270,OTH:0.8092,ASJ:0.6933	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	1.0	2.69	0.000	2.125	8	MU18893493	hom
8	6302218	6302218	G	A	MCPH1	exonic	synonymous SNV	ENSG00000147316	rs556632758	ENSG00000147316:ENST00000522905:exon7:c.G831A:p.T277T,ENSG00000147316:ENST00000344683:exon8:c.G975A:p.T325T,ENSG00000147316:ENST00000519480:exon8:c.G975A:p.T325T	MCPH1:NM_001172575:exon7:c.G831A:p.T277T,MCPH1:NM_001172574:exon8:c.G975A:p.T325T,MCPH1:NM_001322042:exon8:c.G975A:p.T325T,MCPH1:NM_001322043:exon8:c.G969A:p.T323T,MCPH1:NM_001322045:exon8:c.G873A:p.T291T,MCPH1:NM_001363979:exon8:c.G975A:p.T325T,MCPH1:NM_001363980:exon8:c.G975A:p.T325T,MCPH1:NM_024596:exon8:c.G975A:p.T325T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 0, 0, 0] 	0.0001	.	0.000399361	3.227e-05	.	.	.	.	.	.	.	.	MCPH1:uc011kwl.2:exon7:c.G831A:p.T277T,MCPH1:uc003wqh.3:exon8:c.G975A:p.T325T,MCPH1:uc003wqi.3:exon8:c.G975A:p.T325T	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.66e-05,OTH:0,ASJ:0	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	.	.	.	.	8	MU89273105	het
8	6302418	6302418	A	G	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs2515569	ENSG00000147316:ENST00000522905:exon7:c.A1031G:p.D344G,ENSG00000147316:ENST00000344683:exon8:c.A1175G:p.D392G,ENSG00000147316:ENST00000519480:exon8:c.A1175G:p.D392G	MCPH1:NM_001172575:exon7:c.A1031G:p.D344G,MCPH1:NM_001172574:exon8:c.A1175G:p.D392G,MCPH1:NM_001322042:exon8:c.A1175G:p.D392G,MCPH1:NM_001322043:exon8:c.A1169G:p.D390G,MCPH1:NM_001322045:exon8:c.A1073G:p.D358G,MCPH1:NM_001363979:exon8:c.A1175G:p.D392G,MCPH1:NM_001363980:exon8:c.A1175G:p.D392G,MCPH1:NM_024596:exon8:c.A1175G:p.D392G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9980	0.9927	0.994409	0.9918	-1.735	0.002	0.573	-11.5	0.000	.	.	.	MCPH1:uc011kwl.2:exon7:c.A1031G:p.D344G,MCPH1:uc003wqh.3:exon8:c.A1175G:p.D392G,MCPH1:uc003wqi.3:exon8:c.A1175G:p.D392G	-0.923	AFR:0.9711,AMR:1,EAS:1,FIN:1,NFE:1,OTH:0.9990,ASJ:1	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	0.0	2.99	0.000	-1.355	8	MU81846820	hom
8	6402992	6402992	A	G	ANGPT2;MCPH1	intronic	.	ENSG00000091879;ENSG00000147316	rs2442596	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.995807	0.9936	.	.	.	.	.	.	.	.	.	.	AFR:0.9777,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	.	.	.	.	.	.	.	.	.	.	.	.	8	.	hom
8	6403006	6403006	A	C	ANGPT2;MCPH1	intronic	.	ENSG00000091879;ENSG00000147316	rs2515488	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.524161	0.4971	.	.	.	.	.	.	.	.	.	.	AFR:0.5782,AMR:0.4519,EAS:0.5322,FIN:0.4447,NFE:0.4646,OTH:0.4653,ASJ:0.4233	.	.	.	.	.	.	.	.	.	.	.	.	8	MU13321322	hom
8	6483482	6483482	C	T	MCPH1-AS1	ncRNA_intronic	.	ENSG00000249898	rs2912057	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.507188	0.4638	.	.	.	.	.	.	.	.	.	.	AFR:0.5270,AMR:0.3768,EAS:0.6663,FIN:0.4378,NFE:0.4214,OTH:0.4242,ASJ:0.33	.	.	.	.	.	.	.	.	.	.	.	.	8	.	het
8	6495443	6495443	C	G	MCPH1	exonic	nonsynonymous SNV	ENSG00000249898	rs2454525	.	MCPH1:NM_001363979:exon14:c.C2474G:p.T825R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.152356	0.1428	.	.	.	.	.	.	.	.	.	.	AFR:0.2014,AMR:0.0957,EAS:0.1205,FIN:0.0914,NFE:0.1271,OTH:0.1155,ASJ:0.1689	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	.	.	.	.	8	.	het
8	6500544	6500544	C	T	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs1057091	ENSG00000147316:ENST00000344683:exon14:c.C2482T:p.P828S	MCPH1:NM_001363980:exon11:c.C2203T:p.P735S,MCPH1:NM_024596:exon14:c.C2482T:p.P828S,MCPH1:NM_001322042:exon15:c.C2624T:p.P875L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2917	0.2649	0.24361	0.2661	-0.618	0.113	0.407	-1.42	0.228	.	.	BRCT domain	MCPH1:uc003wqi.3:exon14:c.C2482T:p.P828S	-1.034	AFR:0.1867,AMR:0.1974,EAS:0.1900,FIN:0.2756,NFE:0.3180,OTH:0.3098,ASJ:0.3233	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	0.0	-2.55	0.000	-0.51	8	MU23365881	hom
8	11566223	11566223	T	A	GATA4	exonic	nonsynonymous SNV	ENSG00000136574	.	ENSG00000136574:ENST00000532059:exon1:c.T402A:p.S134R,ENSG00000136574:ENST00000335135:exon2:c.T402A:p.S134R	GATA4:NM_001308093:exon1:c.T402A:p.S134R,GATA4:NM_002052:exon2:c.T402A:p.S134R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	-0.166	1.287	0.555	-6.66	0.543	.	.	GATA-type transcription activator, N-terminal	GATA4:uc011kxc.1:exon1:c.T402A:p.S134R,GATA4:uc003wuc.2:exon2:c.T402A:p.S134R,GATA4:uc010lrz.1:exon3:c.T402A:p.S134R,GATA4:uc011kxb.1:exon3:c.T402A:p.S134R	0.453	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600576	187500;607941;614429;614430;615542;	98722;1480;1478;3303;	98722|AVSD<br>Atrioventricular septal defect|-|-|-|600309 606215 606217 614430 614474 615779 ~1480|Interventricular communication<br>VSD|-|-|-|614429 614431 614432 ~1478|ASD<br>Atrial septal defect<br>Interauricular communication|1-9 / 100 000|-|Childhood|108800 607941 611363 612794 613087 614089 614433 614475 ~3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~	.	.	.	.	0.534	-4.92	0.875	1.565	8	.	hom
8	11629119	11629119	T	C	NEIL2	intronic	.	ENSG00000154328	rs804269	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7141	0.6032	0.697883	0.6418	.	.	.	.	.	.	.	.	.	.	AFR:0.4632,AMR:0.8067,EAS:0.9690,FIN:0.7636,NFE:0.6712,OTH:0.6878,ASJ:0.5662	608933	.	.	.	.	.	.	.	.	.	.	.	8	MU81847463	hom
8	12948951	12948951	A	G	DLC1	intronic	.	ENSG00000164741	rs609020	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5562	0.6111	0.571486	MU587710	.	.	.	.	.	0.0002	0.034	.	.	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.5898,EAS:0.3735,FIN:0.6623,NFE:0.4107,OTH:0.5433,ASJ:0.7230	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	1(stomach)	0.5541
8	12950110	12950110	G	A	DLC1	intronic	.	ENSG00000164741	rs7829535	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4475	0.4115	0.336861	0.4052	.	.	.	.	.	.	.	.	.	.	AFR:0.2205,AMR:0.2990,EAS:0.3412,FIN:0.4662,NFE:0.5021,OTH:0.4908,ASJ:0.5762	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	MU32417843	het
8	12950315	12950315	G	T	DLC1	exonic	synonymous SNV	ENSG00000164741	rs568182	ENSG00000164741:ENST00000358919:exon9:c.C2235A:p.R745R,ENSG00000164741:ENST00000512044:exon9:c.C2337A:p.R779R,ENSG00000164741:ENST00000520226:exon9:c.C2013A:p.R671R,ENSG00000164741:ENST00000276297:exon13:c.C3546A:p.R1182R	DLC1:NM_001348084:exon8:c.C2013A:p.R671R,DLC1:NM_001164271:exon9:c.C2013A:p.R671R,DLC1:NM_001316668:exon9:c.C2337A:p.R779R,DLC1:NM_001348083:exon9:c.C2013A:p.R671R,DLC1:NM_006094:exon9:c.C2235A:p.R745R,DLC1:NM_001348082:exon12:c.C2013A:p.R671R,DLC1:NM_001348081:exon13:c.C3546A:p.R1182R,DLC1:NM_182643:exon13:c.C3546A:p.R1182R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0767	0.1127	0.113019	MU136399	.	.	.	.	.	.	.	.	DLC1:uc003wwk.1:exon9:c.C2235A:p.R745R,DLC1:uc003wwl.1:exon9:c.C2337A:p.R779R,DLC1:uc011kxx.1:exon9:c.C2013A:p.R671R,DLC1:uc003wwm.2:exon13:c.C3546A:p.R1182R	.	AFR:LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,BTCA-JP|1|239|0.0041841,AMR:0.1078,EAS:0.0502,FIN:0.0867,NFE:0.0210,OTH:0.0762,ASJ:0.2459	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	1(haematopoietic_and_lymphoid_tissue)	0.0510
8	12952293	12952293	C	T	DLC1	exonic	synonymous SNV	ENSG00000164741	rs658856	ENSG00000164741:ENST00000358919:exon8:c.G2190A:p.S730S,ENSG00000164741:ENST00000512044:exon8:c.G2292A:p.S764S,ENSG00000164741:ENST00000520226:exon8:c.G1968A:p.S656S,ENSG00000164741:ENST00000276297:exon12:c.G3501A:p.S1167S	DLC1:NM_001348084:exon7:c.G1968A:p.S656S,DLC1:NM_001164271:exon8:c.G1968A:p.S656S,DLC1:NM_001316668:exon8:c.G2292A:p.S764S,DLC1:NM_001348083:exon8:c.G1968A:p.S656S,DLC1:NM_006094:exon8:c.G2190A:p.S730S,DLC1:NM_001348082:exon11:c.G1968A:p.S656S,DLC1:NM_001348081:exon12:c.G3501A:p.S1167S,DLC1:NM_182643:exon12:c.G3501A:p.S1167S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0715	0.1127	0.112819	MU114305632	.	.	.	.	.	.	.	.	DLC1:uc003wwk.1:exon8:c.G2190A:p.S730S,DLC1:uc003wwl.1:exon8:c.G2292A:p.S764S,DLC1:uc011kxx.1:exon8:c.G1968A:p.S656S,DLC1:uc003wwm.2:exon12:c.G3501A:p.S1167S	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,AMR:0.1072,EAS:0.0525,FIN:0.0861,NFE:0.0198,OTH:0.0707,ASJ:0.2486	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	1(haematopoietic_and_lymphoid_tissue)	0.0500
8	12957475	12957475	C	T	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs532841	ENSG00000164741:ENST00000358919:exon5:c.G1060A:p.V354M,ENSG00000164741:ENST00000512044:exon5:c.G1162A:p.V388M,ENSG00000164741:ENST00000520226:exon5:c.G838A:p.V280M,ENSG00000164741:ENST00000276297:exon9:c.G2371A:p.V791M	DLC1:NM_001348084:exon4:c.G838A:p.V280M,DLC1:NM_001164271:exon5:c.G838A:p.V280M,DLC1:NM_001316668:exon5:c.G1162A:p.V388M,DLC1:NM_001348083:exon5:c.G838A:p.V280M,DLC1:NM_006094:exon5:c.G1060A:p.V354M,DLC1:NM_001348082:exon8:c.G838A:p.V280M,DLC1:NM_001348081:exon9:c.G2371A:p.V791M,DLC1:NM_182643:exon9:c.G2371A:p.V791M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4935	0.5252	0.496605	28(soft_tissue)	-0.212	1.034	0.322	-6.1	0.746	.	.	.	DLC1:uc003wwk.1:exon5:c.G1060A:p.V354M,DLC1:uc003wwl.1:exon5:c.G1162A:p.V388M,DLC1:uc011kxx.1:exon5:c.G838A:p.V280M,DLC1:uc003wwm.2:exon9:c.G2371A:p.V791M	-0.963	AFR:1(pancreas),AMR:1(thyroid),EAS:MU55000,FIN:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,NFE:0.5114,OTH:0.6111,ASJ:4(large_intestine)	604258	114500;	.	.	.	.	.	.	0.0	3.64	0.000	0.11	8	1(stomach)	0.3246
8	12960281	12960281	T	C	DLC1	intronic	.	ENSG00000164741	rs2280335	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4335	0.3683	0.304712	0.3718	.	.	.	.	.	.	.	.	.	.	AFR:0.1033,AMR:0.2888,EAS:0.3401,FIN:0.4785,NFE:0.4997,OTH:0.4867,ASJ:0.5762	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	MU13156967	het
8	12973078	12973078	T	C	DLC1	intronic	.	ENSG00000164741	rs34462909	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4850	0.4305	0.394569	0.4342	.	.	.	.	.	.	.	.	.	.	AFR:0.2706,AMR:0.4402,EAS:0.3775,FIN:0.5123,NFE:0.5076,OTH:0.5286,ASJ:0.5933	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	MU803582	het
8	13356621	13356621	T	G	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs34591797	ENSG00000164741:ENST00000276297:exon2:c.A960C:p.Q320H,ENSG00000164741:ENST00000316609:exon2:c.A960C:p.Q320H,ENSG00000164741:ENST00000511869:exon2:c.A960C:p.Q320H	DLC1:NM_001348081:exon2:c.A960C:p.Q320H,DLC1:NM_024767:exon2:c.A960C:p.Q320H,DLC1:NM_182643:exon2:c.A960C:p.Q320H	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0219	0.0434	0.0587061	0.0390	-1.766	0.002	1.0	1.12	0.267	.	.	.	DLC1:uc003wwm.2:exon2:c.A960C:p.Q320H,DLC1:uc003wwn.3:exon2:c.A960C:p.Q320H,DLC1:uc011kxy.2:exon2:c.A960C:p.Q320H	-0.964	AFR:0.1337,AMR:0.0131,EAS:0,FIN:0,NFE:0.0009,OTH:0.0173,ASJ:0	604258	114500;	.	.	.	.	.	.	0.0	3.85	0.000	-1.59	8	.	het
8	13356802	13356802	G	A	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs3816747	ENSG00000164741:ENST00000276297:exon2:c.C779T:p.T260I,ENSG00000164741:ENST00000316609:exon2:c.C779T:p.T260I,ENSG00000164741:ENST00000511869:exon2:c.C779T:p.T260I	DLC1:NM_001348081:exon2:c.C779T:p.T260I,DLC1:NM_024767:exon2:c.C779T:p.T260I,DLC1:NM_182643:exon2:c.C779T:p.T260I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8777	0.9101	0.815096	0.8937	-3.066	0.001	0.193	-9.96	0.001	.	.	.	DLC1:uc003wwm.2:exon2:c.C779T:p.T260I,DLC1:uc003wwn.3:exon2:c.C779T:p.T260I,DLC1:uc011kxy.2:exon2:c.C779T:p.T260I	-0.942	AFR:0.8611,AMR:0.7470,EAS:0.6101,FIN:0.9408,NFE:0.9387,OTH:0.9083,ASJ:0.9272	604258	114500;	.	.	.	.	.	.	0.0	3.65	0.000	-1.245	8	MU18918835	hom
8	13356818	13356818	T	C	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs11203494	ENSG00000164741:ENST00000276297:exon2:c.A763G:p.N255D,ENSG00000164741:ENST00000316609:exon2:c.A763G:p.N255D,ENSG00000164741:ENST00000511869:exon2:c.A763G:p.N255D	DLC1:NM_001348081:exon2:c.A763G:p.N255D,DLC1:NM_024767:exon2:c.A763G:p.N255D,DLC1:NM_182643:exon2:c.A763G:p.N255D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9673	0.9461	0.958067	0.9540	-2.148	0.001	1.0	1.93	0.003	.	.	.	DLC1:uc003wwm.2:exon2:c.A763G:p.N255D,DLC1:uc003wwn.3:exon2:c.A763G:p.N255D,DLC1:uc011kxy.2:exon2:c.A763G:p.N255D	-0.998	AFR:0.9099,AMR:0.9761,EAS:1,FIN:0.9785,NFE:0.9664,OTH:0.9715,ASJ:0.9636	604258	114500;	.	.	.	.	.	.	0.0	3.92	0.000	-0.955	8	MU81847893	hom
8	13356819	13356819	T	G	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs11203495	ENSG00000164741:ENST00000276297:exon2:c.A762C:p.Q254H,ENSG00000164741:ENST00000316609:exon2:c.A762C:p.Q254H,ENSG00000164741:ENST00000511869:exon2:c.A762C:p.Q254H	DLC1:NM_001348081:exon2:c.A762C:p.Q254H,DLC1:NM_024767:exon2:c.A762C:p.Q254H,DLC1:NM_182643:exon2:c.A762C:p.Q254H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8558	0.8644	0.758387	0.8541	-1.363	0.004	0.208	-5.59	0.000	.	.	.	DLC1:uc003wwm.2:exon2:c.A762C:p.Q254H,DLC1:uc003wwn.3:exon2:c.A762C:p.Q254H,DLC1:uc011kxy.2:exon2:c.A762C:p.Q254H	-1.018	AFR:0.7255,AMR:0.7345,EAS:0.6110,FIN:0.9408,NFE:0.9375,OTH:0.8910,ASJ:0.9272	604258	114500;	.	.	.	.	.	.	0.005	3.38	0.000	1.055	8	MU18918882	het
8	13357587	13357587	G	A	DLC1	UTR5	.	ENSG00000164741	rs1383942	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8562	0.8371	0.741613	0.8287	.	.	.	.	.	.	.	.	.	.	AFR:0.6355,AMR:0.7279,EAS:0.6098,FIN:0.9408,NFE:0.9376,OTH:0.8951,ASJ:0.9267	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	MU18918940	hom
8	15508200	15508200	T	C	TUSC3	intronic	.	ENSG00000104723	rs1035972	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3380	0.3072	0.293131	LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	0	0.01	.	.	.	AFR:0.3355,AMR:0.1799,EAS:0.3146,FIN:0.4431,NFE:0.4370,OTH:0.3872,ASJ:0.3481	601385	611093;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	.	.	.	.	8	1(haematopoietic_and_lymphoid_tissue)	0.3849
8	15978063	15978063	C	T	MSR1	exonic	synonymous SNV	ENSG00000038945	rs4338104	ENSG00000038945:ENST00000262101:exon9:c.G1086A:p.R362R,ENSG00000038945:ENST00000445506:exon9:c.G1140A:p.R380R	MSR1:NM_001363744:exon9:c.G1140A:p.R380R,MSR1:NM_138715:exon9:c.G1086A:p.R362R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9992	0.9975	0.997404	0.9982	.	.	.	.	.	.	.	.	MSR1:uc003wwz.3:exon9:c.G1086A:p.R362R,MSR1:uc010lsu.3:exon9:c.G1140A:p.R380R	.	AFR:0.9936,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	153622	176807;614266;	99976;1331;	99976|Esophageal adenocarcinoma|1-9 / 100 000|Not applicable|Adult|614266 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	8	MU81848037	hom
8	15978126	15978127	AA	-	MSR1	intronic	.	ENSG00000038945	rs770675030	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0092	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	153622	176807;614266;	99976;1331;	99976|Esophageal adenocarcinoma|1-9 / 100 000|Not applicable|Adult|614266 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	8	.	hom
8	16025964	16025964	T	C	MSR1	intronic	.	ENSG00000038945	rs13306550	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0093	0.0002	0.0245607	0.0066	.	.	.	.	.	0.1721	0.306	.	.	.	AFR:0.0008,AMR:0.0012,EAS:0.1187,FIN:0,NFE:0.0001,OTH:0.0020,ASJ:0	153622	176807;614266;	99976;1331;	99976|Esophageal adenocarcinoma|1-9 / 100 000|Not applicable|Adult|614266 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	8	MU23386460	het
8	16043667	16043667	C	T	MSR1	splicing	.	ENSG00000038945	rs435815	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2588	.	0.398163	MU5477370	-0.071	1.954	.	0.054	0.016	0	0.002	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.2426,EAS:0.4593,FIN:0.1556,NFE:0.5336,OTH:0.0656,ASJ:0.4661	153622	176807;614266;	99976;1331;	99976|Esophageal adenocarcinoma|1-9 / 100 000|Not applicable|Adult|614266 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	8	1(lung)	0.1171
8	17796382	17796382	A	G	PCM1	exonic	nonsynonymous SNV	ENSG00000078674	rs412750	ENSG00000078674:ENST00000523055:exon4:c.A476G:p.N159S,ENSG00000078674:ENST00000524226:exon4:c.A476G:p.N159S,ENSG00000078674:ENST00000325083:exon5:c.A476G:p.N159S,ENSG00000078674:ENST00000517730:exon5:c.A476G:p.N159S,ENSG00000078674:ENST00000518537:exon5:c.A476G:p.N159S,ENSG00000078674:ENST00000519253:exon5:c.A476G:p.N159S	PCM1:NM_001352647:exon4:c.A476G:p.N159S,PCM1:NM_001352651:exon4:c.A476G:p.N159S,PCM1:NM_001352652:exon4:c.A476G:p.N159S,PCM1:NM_001315507:exon5:c.A476G:p.N159S,PCM1:NM_001315508:exon5:c.A476G:p.N159S,PCM1:NM_001352632:exon5:c.A476G:p.N159S,PCM1:NM_001352634:exon5:c.A476G:p.N159S,PCM1:NM_001352636:exon5:c.A476G:p.N159S,PCM1:NM_001352637:exon5:c.A476G:p.N159S,PCM1:NM_001352639:exon5:c.A476G:p.N159S,PCM1:NM_001352640:exon5:c.A476G:p.N159S,PCM1:NM_001352641:exon5:c.A476G:p.N159S,PCM1:NM_001352643:exon5:c.A476G:p.N159S,PCM1:NM_001352644:exon5:c.A476G:p.N159S,PCM1:NM_001352646:exon5:c.A476G:p.N159S,PCM1:NM_001352649:exon5:c.A476G:p.N159S,PCM1:NM_001352654:exon5:c.A476G:p.N159S,PCM1:NM_001352658:exon5:c.A476G:p.N159S,PCM1:NM_001352659:exon5:c.A476G:p.N159S,PCM1:NM_006197:exon5:c.A476G:p.N159S,PCM1:NM_001352638:exon6:c.A476G:p.N159S,PCM1:NM_001352655:exon6:c.A476G:p.N159S,PCM1:NM_001352633:exon7:c.A476G:p.N159S,PCM1:NM_001352635:exon7:c.A476G:p.N159S,PCM1:NM_001352642:exon7:c.A476G:p.N159S,PCM1:NM_001352645:exon7:c.A476G:p.N159S,PCM1:NM_001352648:exon7:c.A476G:p.N159S,PCM1:NM_001352650:exon7:c.A476G:p.N159S,PCM1:NM_001352653:exon7:c.A476G:p.N159S,PCM1:NM_001352656:exon7:c.A476G:p.N159S,PCM1:NM_001352657:exon7:c.A476G:p.N159S,PCM1:NM_001352660:exon7:c.A476G:p.N159S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7324	0.8139	0.690495	0.7933	-1.468	0.003	1.0	4.85	0.007	.	.	.	PCM1:uc022asj.1:exon3:c.A476G:p.N159S,PCM1:uc003wyg.2:exon4:c.A476G:p.N159S,PCM1:uc003wyj.4:exon4:c.A476G:p.N159S,PCM1:uc003wyh.3:exon5:c.A476G:p.N159S,PCM1:uc003wyi.4:exon5:c.A476G:p.N159S,PCM1:uc010lta.1:exon5:c.A476G:p.N159S,PCM1:uc011kyh.2:exon5:c.A476G:p.N159S	-0.976	AFR:0.8326,AMR:0.5493,EAS:0.6044,FIN:0.8153,NFE:0.8004,OTH:0.7920,ASJ:0.7351	600299	.	.	.	.	.	.	.	0.0	3.99	0.000	.	8	MU18922720	unknown
8	17796383	17796383	C	T	PCM1	exonic	synonymous SNV	ENSG00000078674	rs454755	ENSG00000078674:ENST00000523055:exon4:c.C477T:p.N159N,ENSG00000078674:ENST00000524226:exon4:c.C477T:p.N159N,ENSG00000078674:ENST00000325083:exon5:c.C477T:p.N159N,ENSG00000078674:ENST00000517730:exon5:c.C477T:p.N159N,ENSG00000078674:ENST00000518537:exon5:c.C477T:p.N159N,ENSG00000078674:ENST00000519253:exon5:c.C477T:p.N159N	PCM1:NM_001352647:exon4:c.C477T:p.N159N,PCM1:NM_001352651:exon4:c.C477T:p.N159N,PCM1:NM_001352652:exon4:c.C477T:p.N159N,PCM1:NM_001315507:exon5:c.C477T:p.N159N,PCM1:NM_001315508:exon5:c.C477T:p.N159N,PCM1:NM_001352632:exon5:c.C477T:p.N159N,PCM1:NM_001352634:exon5:c.C477T:p.N159N,PCM1:NM_001352636:exon5:c.C477T:p.N159N,PCM1:NM_001352637:exon5:c.C477T:p.N159N,PCM1:NM_001352639:exon5:c.C477T:p.N159N,PCM1:NM_001352640:exon5:c.C477T:p.N159N,PCM1:NM_001352641:exon5:c.C477T:p.N159N,PCM1:NM_001352643:exon5:c.C477T:p.N159N,PCM1:NM_001352644:exon5:c.C477T:p.N159N,PCM1:NM_001352646:exon5:c.C477T:p.N159N,PCM1:NM_001352649:exon5:c.C477T:p.N159N,PCM1:NM_001352654:exon5:c.C477T:p.N159N,PCM1:NM_001352658:exon5:c.C477T:p.N159N,PCM1:NM_001352659:exon5:c.C477T:p.N159N,PCM1:NM_006197:exon5:c.C477T:p.N159N,PCM1:NM_001352638:exon6:c.C477T:p.N159N,PCM1:NM_001352655:exon6:c.C477T:p.N159N,PCM1:NM_001352633:exon7:c.C477T:p.N159N,PCM1:NM_001352635:exon7:c.C477T:p.N159N,PCM1:NM_001352642:exon7:c.C477T:p.N159N,PCM1:NM_001352645:exon7:c.C477T:p.N159N,PCM1:NM_001352648:exon7:c.C477T:p.N159N,PCM1:NM_001352650:exon7:c.C477T:p.N159N,PCM1:NM_001352653:exon7:c.C477T:p.N159N,PCM1:NM_001352656:exon7:c.C477T:p.N159N,PCM1:NM_001352657:exon7:c.C477T:p.N159N,PCM1:NM_001352660:exon7:c.C477T:p.N159N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7324	0.8139	0.690495	0.7932	.	.	.	.	.	.	.	.	PCM1:uc022asj.1:exon3:c.C477T:p.N159N,PCM1:uc003wyg.2:exon4:c.C477T:p.N159N,PCM1:uc003wyj.4:exon4:c.C477T:p.N159N,PCM1:uc003wyh.3:exon5:c.C477T:p.N159N,PCM1:uc003wyi.4:exon5:c.C477T:p.N159N,PCM1:uc010lta.1:exon5:c.C477T:p.N159N,PCM1:uc011kyh.2:exon5:c.C477T:p.N159N	.	AFR:0.8327,AMR:0.5478,EAS:0.6039,FIN:0.8148,NFE:0.8004,OTH:0.7920,ASJ:0.7351	600299	.	.	.	.	.	.	.	.	.	.	.	8	MU803684	unknown
8	17799172	17799172	T	G	PCM1	intronic	.	ENSG00000078674	rs2467076	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	1	1	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600299	.	.	.	.	.	.	.	.	.	.	.	8	.	hom
8	17799241	17799241	T	C	PCM1	intronic	.	ENSG00000078674	rs10108545	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.297125	0.4425	.	.	.	.	.	.	.	.	.	.	AFR:0.2216,AMR:0.2812,EAS:0.1253,FIN:0.5743,NFE:0.5776,OTH:0.5328,ASJ:0.4633	600299	.	.	.	.	.	.	.	.	.	.	.	8	.	het
8	17814915	17814915	A	G	PCM1	exonic	nonsynonymous SNV	ENSG00000078674	rs208753	ENSG00000078674:ENST00000524226:exon11:c.A1789G:p.M597V,ENSG00000078674:ENST00000325083:exon12:c.A1789G:p.M597V,ENSG00000078674:ENST00000519253:exon12:c.A1789G:p.M597V,ENSG00000078674:ENST00000517730:exon13:c.A1906G:p.M636V	PCM1:NM_001352647:exon11:c.A1789G:p.M597V,PCM1:NM_001352652:exon11:c.A1789G:p.M597V,PCM1:NM_001315507:exon12:c.A1789G:p.M597V,PCM1:NM_001315508:exon12:c.A1789G:p.M597V,PCM1:NM_001352634:exon12:c.A1789G:p.M597V,PCM1:NM_001352639:exon12:c.A1789G:p.M597V,PCM1:NM_001352640:exon12:c.A1789G:p.M597V,PCM1:NM_001352641:exon12:c.A1789G:p.M597V,PCM1:NM_001352644:exon12:c.A1789G:p.M597V,PCM1:NM_001352646:exon12:c.A1789G:p.M597V,PCM1:NM_001352649:exon12:c.A1789G:p.M597V,PCM1:NM_001352651:exon12:c.A1906G:p.M636V,PCM1:NM_001352654:exon12:c.A1789G:p.M597V,PCM1:NM_001352658:exon12:c.A1789G:p.M597V,PCM1:NM_006197:exon12:c.A1789G:p.M597V,PCM1:NM_001352632:exon13:c.A1906G:p.M636V,PCM1:NM_001352636:exon13:c.A1906G:p.M636V,PCM1:NM_001352637:exon13:c.A1906G:p.M636V,PCM1:NM_001352643:exon13:c.A1906G:p.M636V,PCM1:NM_001352655:exon13:c.A1789G:p.M597V,PCM1:NM_001352635:exon14:c.A1789G:p.M597V,PCM1:NM_001352638:exon14:c.A1906G:p.M636V,PCM1:NM_001352642:exon14:c.A1789G:p.M597V,PCM1:NM_001352645:exon14:c.A1789G:p.M597V,PCM1:NM_001352648:exon14:c.A1789G:p.M597V,PCM1:NM_001352653:exon14:c.A1789G:p.M597V,PCM1:NM_001352656:exon14:c.A1789G:p.M597V,PCM1:NM_001352657:exon14:c.A1789G:p.M597V,PCM1:NM_001352633:exon15:c.A1906G:p.M636V,PCM1:NM_001352650:exon15:c.A1906G:p.M636V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7362	0.8150	0.692891	0.7961	-1.590	0.002	0.302	-4.09	0.892	.	.	.	PCM1:uc003wyj.4:exon11:c.A1789G:p.M597V,PCM1:uc022asj.1:exon11:c.A1906G:p.M636V,PCM1:uc003wyi.4:exon12:c.A1789G:p.M597V,PCM1:uc011kyh.2:exon12:c.A1789G:p.M597V,PCM1:uc010lta.1:exon13:c.A1906G:p.M636V	-1.018	AFR:0.8299,AMR:0.5502,EAS:0.6344,FIN:0.8192,NFE:0.8036,OTH:0.7943,ASJ:0.7318	600299	.	.	.	.	.	.	.	0.0	1.59	0.000	1.15	8	MU13207274	het
8	17868895	17868895	-	CTAT	PCM1	intronic	.	ENSG00000078674	rs111996350	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1255	0.1757	0.176917	0.1676	.	.	.	.	.	.	.	.	.	.	AFR:0.3836,AMR:0.0704,EAS:0.0643,FIN:0.0690,NFE:0.0891,OTH:0.0878,ASJ:0.0927	600299	.	.	.	.	.	.	.	.	.	.	.	8	.	het
8	21964802	21964802	C	T	NUDT18	UTR3	.	ENSG00000173566	rs1552286	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9048	0.8733	0.920527	0.8847	.	.	.	.	.	.	.	.	.	.	AFR:0.8719,AMR:0.9305,EAS:0.9944,FIN:0.9147,NFE:0.8698,OTH:0.8953,ASJ:0.8940	615791	.	.	.	.	.	.	.	.	.	.	.	8	MU81848854	hom
8	21965113	21965113	T	C	NUDT18	exonic	nonsynonymous SNV	ENSG00000173566	rs3739435	ENSG00000173566:ENST00000522405:exon3:c.A439G:p.M147V,ENSG00000173566:ENST00000309188:exon5:c.A670G:p.M224V	NUDT18:NM_024815:exon5:c.A670G:p.M224V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5141	0.4747	0.554113	0.5037	-3.587	0.001	.	-2.23	0.553	.	.	.	NUDT18:uc003xaq.1:exon4:c.A670G:p.M224V	-0.939	AFR:0.5174,AMR:0.6938,EAS:0.6354,FIN:0.5838,NFE:0.4534,OTH:0.5154,ASJ:0.4033	615791	.	.	.	.	.	.	.	.	.	0.000	1.185	8	MU18563877	hom
8	23049292	23049292	C	T	TNFRSF10A	exonic	nonsynonymous SNV	ENSG00000104689	rs2230229	ENSG00000104689:ENST00000221132:exon10:c.G1322A:p.R441K	TNFRSF10A:NM_003844:exon10:c.G1322A:p.R441K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8782	0.8493	0.91254	0.8540	-1.070	0.011	1.0	-2.61	0.001	.	.	Death domain|Death-like domain|Tumour necrosis factor receptor 10A/B, death domain	TNFRSF10A:uc003xda.3:exon10:c.G1322A:p.R441K	-0.992	AFR:0.8633,AMR:0.9342,EAS:0.9808,FIN:0.8049,NFE:0.8418,OTH:0.8480,ASJ:0.8742	603611	.	.	.	.	.	.	.	0.0	-2.0	0.000	-1.345	8	MU81849571	hom
8	23059324	23059324	C	G	TNFRSF10A	exonic	nonsynonymous SNV	ENSG00000104689	rs20575	ENSG00000104689:ENST00000221132:exon4:c.G626C:p.R209T,ENSG00000104689:ENST00000524158:exon4:c.G20C:p.R7T	TNFRSF10A:NM_003844:exon4:c.G626C:p.R209T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5279	0.4103	0.579473	0.4435	-1.605	0.002	1.0	0.222	0.000	.	.	TNFR/NGFR cysteine-rich region;TNFR/NGFR cysteine-rich region|Tumor necrosis factor receptor 10, N-terminal	TNFRSF10A:uc003xda.3:exon4:c.G626C:p.R209T	-0.966	AFR:0.3146,AMR:0.6432,EAS:0.9735,FIN:0.4050,NFE:0.4544,OTH:0.4867,ASJ:0.4636	603611	.	.	.	.	.	.	.	0.0	-2.7	0.000	-1.105	8	MU64437	hom
8	23060256	23060256	T	C	TNFRSF10A	exonic	nonsynonymous SNV	ENSG00000104689	rs17620	ENSG00000104689:ENST00000221132:exon3:c.A422G:p.H141R	TNFRSF10A:NM_003844:exon3:c.A422G:p.H141R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5254	0.4000	0.571685	0.4325	-3.114	0.001	0.419	-6.96	0.000	.	.	Tumor necrosis factor receptor 10, N-terminal	TNFRSF10A:uc003xda.3:exon3:c.A422G:p.H141R	-0.910	AFR:0.2767,AMR:0.6435,EAS:0.9735,FIN:0.4044,NFE:0.4554,OTH:0.4847,ASJ:0.4636	603611	.	.	.	.	.	.	.	0.824	0.99	0.000	1.15	8	MU144012	hom
8	23540417	23540417	C	T	NKX3-1	UTR5	.	ENSG00000167034	rs11781886	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7480	0.8300	0.685903	0.7179	.	.	.	.	.	.	.	.	.	.	AFR:0.6950,AMR:0.6803,EAS:0.7186,FIN:0.6328,NFE:0.7556,OTH:0.6921,ASJ:0.6812	602041	.	.	.	~ko05200 Pathways in cancer~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	8	MU9652193	het
8	27634064	27634064	C	T	ESCO2	exonic	nonsynonymous SNV	ENSG00000171320	rs4732748	ENSG00000171320:ENST00000305188:exon3:c.C239T:p.A80V,ENSG00000171320:ENST00000519637:exon3:c.C239T:p.A80V,ENSG00000171320:ENST00000522378:exon3:c.C239T:p.A80V,ENSG00000171320:ENST00000523566:exon3:c.C239T:p.A80V	ESCO2:NM_001017420:exon3:c.C239T:p.A80V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1148	0.0987	0.139377	0.1033	-0.150	1.389	0.487	1.8	0.247	.	.	.	ESCO2:uc003xgh.3:exon2:c.C239T:p.A80V,ESCO2:uc003xgg.3:exon3:c.C239T:p.A80V	-1.060	AFR:0.0957,AMR:0.0998,EAS:0.2515,FIN:0.0862,NFE:0.0938,OTH:0.1141,ASJ:0.1755	609353	268300;269000;	3103;3103;	3103|Pseudothalidomide syndrome<br>Roberts-SC phocomelia syndrome<br>SC phocomelia<br>SC pseudothalidomide syndrome|Unknown|Autosomal recessive|Neonatal<br>Antenatal|268300 269000 ~3103|Pseudothalidomide syndrome<br>Roberts-SC phocomelia syndrome<br>SC phocomelia<br>SC pseudothalidomide syndrome|Unknown|Autosomal recessive|Neonatal<br>Antenatal|268300 269000 ~	.	.	.	.	0.023	0.71	0.000	1.995	8	MU151233	het
8	29197672	29197672	A	G	DUSP4	exonic	synonymous SNV	ENSG00000120875	rs583034	ENSG00000120875:ENST00000240100:exon2:c.T522C:p.S174S,ENSG00000120875:ENST00000240101:exon3:c.T249C:p.S83S	DUSP4:NM_001394:exon2:c.T522C:p.S174S,DUSP4:NM_057158:exon3:c.T249C:p.S83S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5589	0.5339	0.622404	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	DUSP4:uc003xhm.3:exon2:c.T522C:p.S174S,DUSP4:uc003xhl.3:exon3:c.T249C:p.S83S	.	AFR:0.5519,AMR:0.7727,EAS:0.55,FIN:0.6425,NFE:0.4768,OTH:0.4305,ASJ:0.6523	602747	.	.	.	.	.	.	.	.	.	.	.	8	1(haematopoietic_and_lymphoid_tissue)	0.4775
8	30469805	30469805	A	C	GTF2E2	intronic	.	ENSG00000197265	rs7815625	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4031	0.3503	0.333666	0.3542	.	.	.	.	.	.	.	.	.	.	AFR:0.1840,AMR:0.2757,EAS:0.2466,FIN:0.4787,NFE:0.4311,OTH:0.4348,ASJ:0.5530	189964	616943;	33364;	33364|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|234050 300953 601675 616390 616395 616943 ~	~ko03022 Basal transcription factors~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	8	MU717268	hom
8	30958354	30958354	T	-	WRN	intronic	.	ENSG00000165392	rs397723919	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.9943	0.9784	0.98123	0.9825	.	.	.	.	.	.	.	.	.	.	AFR:0.9388,AMR:0.9952,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:1	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	.	hom
8	30973957	30973957	G	T	WRN	exonic	synonymous SNV	ENSG00000165392	rs1800392	ENSG00000165392:ENST00000298139:exon20:c.G2361T:p.L787L	WRN:NM_000553:exon20:c.G2361T:p.L787L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4466	0.4482	0.471246	0.4285	.	.	.	.	.	.	.	.	WRN:uc010lvk.3:exon8:c.G762T:p.L254L,WRN:uc003xio.4:exon20:c.G2361T:p.L787L	.	AFR:0.4064,AMR:0.5598,EAS:0.6073,FIN:0.3639,NFE:0.4294,OTH:0.4255,ASJ:0.4570	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	MU131479	het
8	30999122	30999122	C	T	WRN	intronic	.	ENSG00000165392	rs3024239	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4704	0.3866	0.375	0.4182	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.1976,AMR:0.4031,EAS:0.3604,FIN:0.5664,NFE:0.5129,OTH:0.4908,ASJ:0.49	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	MU661076	het
8	30999123	30999123	G	A	WRN	intronic	.	ENSG00000165392	rs2737335	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4479	0.4660	0.494808	0.4445	.	.	.	.	.	0	0	.	.	.	AFR:0.4792,AMR:0.5514,EAS:0.6203,FIN:0.3598,NFE:0.4203,OTH:0.4235,ASJ:0.4533	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	MU18938553	het
8	30999280	30999280	G	T	WRN	exonic	nonsynonymous SNV	ENSG00000165392	rs1801195	ENSG00000165392:ENST00000298139:exon26:c.G3222T:p.L1074F	WRN:NM_000553:exon26:c.G3222T:p.L1074F	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4492	0.4669	0.496006	0.4457	-0.691	0.076	0.764	1.4	0.007	.	.	Winged helix-turn-helix DNA-binding domain	WRN:uc010lvk.3:exon14:c.G1623T:p.L541F,WRN:uc003xio.4:exon26:c.G3222T:p.L1074F	-0.938	AFR:0.4802,AMR:0.5504,EAS:0.6186,FIN:0.3607,NFE:0.4221,OTH:0.4262,ASJ:0.4536	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	0.0	1.48	0.000	-1.24	8	MU131494	het
8	31024654	31024654	T	C	WRN	exonic	nonsynonymous SNV	ENSG00000165392	rs1346044	ENSG00000165392:ENST00000298139:exon34:c.T4099C:p.C1367R	WRN:NM_000553:exon34:c.T4099C:p.C1367R	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.2416	0.2274	0.192692	0.2282	1.231	11.91	0.035	2.45	0.273	.	.	.	WRN:uc010lvk.3:exon22:c.T2500C:p.C834R,WRN:uc003xio.4:exon34:c.T4099C:p.C1367R	-1.067	AFR:0.1610,AMR:0.1659,EAS:0.1239,FIN:0.2821,NFE:0.2679,OTH:0.2664,ASJ:0.1788	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	0.744	0.93	0.000	1.87	8	MU804166	het
8	31497549	31497549	G	A	NRG1	exonic	nonsynonymous SNV	ENSG00000157168	.	ENSG00000157168:ENST00000520407:exon1:c.G49A:p.A17T	NRG1:NM_013962:exon1:c.G49A:p.A17T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 0] 	.	.	.	.	0.908	10.13	0.007	-4.73	0.004	.	.	Immunoglobulin-like fold	NRG1:uc003xip.3:exon1:c.G49A:p.A17T	-0.804	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	142445	603013;	.	.	.	.	.	.	0.061	-1.12	0.260	.	8	.	het
8	31497672	31497672	G	A	NRG1	exonic	nonsynonymous SNV	ENSG00000157168	rs113317778	ENSG00000157168:ENST00000520407:exon1:c.G172A:p.G58R	NRG1:NM_013962:exon1:c.G172A:p.G58R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4191	0.0955	0.127196	0.1286	3.969	23.6	0.0	1.36	1.000	.	.	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	NRG1:uc003xip.3:exon1:c.G172A:p.G58R	-1.033	AFR:0.1410,AMR:0.2188,EAS:0.0006,FIN:0.1351,NFE:0.1321,OTH:0.1347,ASJ:0.1140	142445	603013;	.	.	.	.	.	.	0.0	-1.39	0.003	.	8	MU118208383	hom
8	32453358	32453358	G	A	NRG1	exonic	nonsynonymous SNV	ENSG00000157168	rs3924999	ENSG00000157168:ENST00000287842:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000287845:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000338921:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000341377:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000356819:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000405005:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000518104:exon2:c.G50A:p.R17Q,ENSG00000157168:ENST00000519301:exon2:c.G50A:p.R17Q,ENSG00000157168:ENST00000520407:exon2:c.G758A:p.R253Q,ENSG00000157168:ENST00000521670:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000523079:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000523534:exon2:c.G317A:p.R106Q	NRG1:NM_001160002:exon2:c.G113A:p.R38Q,NRG1:NM_001160004:exon2:c.G113A:p.R38Q,NRG1:NM_001160005:exon2:c.G113A:p.R38Q,NRG1:NM_001160007:exon2:c.G113A:p.R38Q,NRG1:NM_001160008:exon2:c.G113A:p.R38Q,NRG1:NM_004495:exon2:c.G113A:p.R38Q,NRG1:NM_013956:exon2:c.G113A:p.R38Q,NRG1:NM_013957:exon2:c.G113A:p.R38Q,NRG1:NM_013958:exon2:c.G113A:p.R38Q,NRG1:NM_013960:exon2:c.G113A:p.R38Q,NRG1:NM_013962:exon2:c.G758A:p.R253Q,NRG1:NM_013964:exon2:c.G113A:p.R38Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3913	0.3068	0.385184	MELA-AU|1|183|0.00546448,ESAD-UK|1|409|0.00244499,COCA-CN|4|321|0.0124611	5.399	26.0	0.044	5.65	0.998	.	.	Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin-like fold;Neuregulin, C-terminal	NRG1:uc010lvp.2:exon1:c.G11A:p.R4Q,NRG1:uc003xip.3:exon2:c.G758A:p.R253Q,NRG1:uc003xir.3:exon2:c.G113A:p.R38Q,NRG1:uc003xis.3:exon2:c.G113A:p.R38Q,NRG1:uc003xit.2:exon2:c.G113A:p.R38Q,NRG1:uc003xiu.2:exon2:c.G113A:p.R38Q,NRG1:uc003xiv.2:exon2:c.G113A:p.R38Q,NRG1:uc003xiw.2:exon2:c.G113A:p.R38Q,NRG1:uc010lvl.3:exon2:c.G113A:p.R38Q,NRG1:uc010lvm.3:exon2:c.G113A:p.R38Q,NRG1:uc010lvn.3:exon2:c.G113A:p.R38Q,NRG1:uc010lvo.2:exon2:c.G113A:p.R38Q,NRG1:uc011lbf.1:exon2:c.G113A:p.R38Q,NRG1:uc022ats.1:exon2:c.G50A:p.R17Q	-1.014	AFR:0.3166,AMR:0.1107,EAS:0.3841,FIN:0.7711,NFE:0.3321,OTH:0.3739,ASJ:0.4234	142445	603013;	.	.	.	.	.	.	0.381	1.02	0.000	0.41	8	1(skin)	0.3554
8	37693302	37693302	T	C	ADGRA2	intronic	.	ENSG00000020181	rs10101560	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9539	0.9521	0.978834	0.9606	.	.	.	.	.	.	.	.	.	.	AFR:0.9885,AMR:0.9797,EAS:1,FIN:0.9613,NFE:0.9393,OTH:0.9488,ASJ:0.9768	606823	.	.	.	.	.	.	.	.	.	.	.	8	MU81850840	hom
8	37699195	37699195	C	G	ADGRA2	exonic	synonymous SNV	ENSG00000020181	rs4976898	ENSG00000020181:ENST00000315215:exon16:c.C2688G:p.G896G,ENSG00000020181:ENST00000412232:exon19:c.C3339G:p.G1113G	ADGRA2:NM_032777:exon19:c.C3339G:p.G1113G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7665	0.8037	0.798323	COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	GPR124:uc010lvy.3:exon16:c.C2688G:p.G896G,GPR124:uc003xkj.3:exon19:c.C3339G:p.G1113G	.	AFR:0.7670,AMR:0.8245,EAS:0.6324,FIN:0.8885,NFE:0.7815,OTH:0.7189,ASJ:0.8036	606823	.	.	.	.	.	.	.	.	.	.	.	8	9(large_intestine)	0.7490
8	37699516	37699516	C	T	ADGRA2	exonic	synonymous SNV	ENSG00000020181	rs7010546	ENSG00000020181:ENST00000315215:exon16:c.C3009T:p.G1003G,ENSG00000020181:ENST00000412232:exon19:c.C3660T:p.G1220G	ADGRA2:NM_032777:exon19:c.C3660T:p.G1220G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4587	0.2834	0.464058	MU116072	.	.	.	.	.	.	.	.	GPR124:uc010lvy.3:exon16:c.C3009T:p.G1003G,GPR124:uc003xkj.3:exon19:c.C3660T:p.G1220G	.	AFR:COCA-CN|5|321|0.0155763,LINC-JP|1|394|0.00253807,AMR:0.3968,EAS:0.5024,FIN:0.3557,NFE:0.6519,OTH:0.4630,ASJ:0.3011	606823	.	.	.	.	.	.	.	.	.	.	.	8	2(thyroid)	0.4024
8	41166638	41166640	GCT	-	SFRP1	exonic	nonframeshift deletion	ENSG00000104332	rs3055861	ENSG00000104332:ENST00000220772:exon1:c.39_41del:p.13_14del	SFRP1:NM_003012:exon1:c.39_41del:p.13_14del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4030	0.0002	0.311102	0.3212	.	.	.	.	.	.	.	.	SFRP1:uc003xnt.3:exon1:c.39_41del:p.13_14del	.	AFR:0.0883,AMR:0.4007,EAS:0.4029,FIN:0.4585,NFE:0.4046,OTH:0.4411,ASJ:0.3013	604156	.	.	.	.	.	.	.	.	.	.	.	8	MU618803	het
8	41519462	41519462	A	G	ANK1	intronic	.	ENSG00000253389	rs515071	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7805	0.7499	0.786342	0.7661	.	.	.	.	.	0	0.002	.	.	.	AFR:0.7498,AMR:0.7799,EAS:0.8492,FIN:0.7946,NFE:0.7620,OTH:0.7643,ASJ:0.6291	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	MU21380244	het
8	41525914	41525914	C	T	ANK1	exonic	synonymous SNV	ENSG00000029534	rs750625	ENSG00000029534:ENST00000289734:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000347528:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000352337:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000379758:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000396942:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000396945:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000265709:exon40:c.G5388A:p.V1796V	ANK1:NM_000037:exon39:c.G5265A:p.V1755V,ANK1:NM_020475:exon39:c.G5265A:p.V1755V,ANK1:NM_020476:exon39:c.G5265A:p.V1755V,ANK1:NM_020477:exon39:c.G4779A:p.V1593V,ANK1:NM_001142446:exon40:c.G5388A:p.V1796V	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2134	0.2312	0.194688	1(lung)	.	.	.	.	.	.	.	.	ANK1:uc003xoh.3:exon23:c.G2727A:p.V909V,ANK1:uc003xoi.3:exon39:c.G5265A:p.V1755V,ANK1:uc003xoj.3:exon39:c.G5265A:p.V1755V,ANK1:uc003xok.3:exon39:c.G5265A:p.V1755V,ANK1:uc003xol.3:exon39:c.G4779A:p.V1593V,ANK1:uc003xom.3:exon40:c.G5388A:p.V1796V	.	AFR:MU156389,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,EAS:0.1994,FIN:0.2148,NFE:0.3742,OTH:0.1194,ASJ:0.2180	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	1(large_intestine)	0.2054
8	41529856	41529856	A	G	ANK1	intronic	.	ENSG00000029534	rs508112	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9921	0.9723	0.977636	0.9781	.	.	.	.	.	.	.	.	.	.	AFR:0.9241,AMR:0.9940,EAS:1,FIN:1,NFE:0.9995,OTH:0.9959,ASJ:1	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	MU81851353	hom
8	41553928	41553928	C	G	ANK1	exonic	synonymous SNV	ENSG00000029534	rs504574	ENSG00000029534:ENST00000289734:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000347528:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000352337:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000379758:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000396942:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000396945:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000265709:exon27:c.G3036C:p.L1012L	ANK1:NM_000037:exon26:c.G2913C:p.L971L,ANK1:NM_020475:exon26:c.G2913C:p.L971L,ANK1:NM_020476:exon26:c.G2913C:p.L971L,ANK1:NM_020477:exon26:c.G2913C:p.L971L,ANK1:NM_001142446:exon27:c.G3036C:p.L1012L	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4767	0.3628	0.407149	1(large_intestine)	.	.	.	.	.	.	.	.	ANK1:uc003xoh.3:exon10:c.G861C:p.L287L,ANK1:uc003xoi.3:exon26:c.G2913C:p.L971L,ANK1:uc003xoj.3:exon26:c.G2913C:p.L971L,ANK1:uc003xok.3:exon26:c.G2913C:p.L971L,ANK1:uc003xol.3:exon26:c.G2913C:p.L971L,ANK1:uc003xom.3:exon27:c.G3036C:p.L1012L	.	AFR:MU98129,AMR:LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,EAS:0.1422,FIN:0.5685,NFE:0.4106,OTH:0.5025,ASJ:0.3998	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	1(stomach)	0.5598
8	41585438	41585438	G	A	ANK1	exonic	synonymous SNV	ENSG00000029534	rs2304871	ENSG00000029534:ENST00000265709:exon4:c.C414T:p.N138N,ENSG00000029534:ENST00000289734:exon4:c.C315T:p.N105N,ENSG00000029534:ENST00000347528:exon4:c.C315T:p.N105N,ENSG00000029534:ENST00000352337:exon4:c.C315T:p.N105N,ENSG00000029534:ENST00000379758:exon4:c.C315T:p.N105N,ENSG00000029534:ENST00000396942:exon4:c.C315T:p.N105N,ENSG00000029534:ENST00000396945:exon4:c.C315T:p.N105N	ANK1:NM_000037:exon4:c.C315T:p.N105N,ANK1:NM_001142446:exon4:c.C414T:p.N138N,ANK1:NM_020475:exon4:c.C315T:p.N105N,ANK1:NM_020476:exon4:c.C315T:p.N105N,ANK1:NM_020477:exon4:c.C315T:p.N105N	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2443	0.2497	0.228435	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	ANK1:uc003xoi.3:exon4:c.C315T:p.N105N,ANK1:uc003xoj.3:exon4:c.C315T:p.N105N,ANK1:uc003xok.3:exon4:c.C315T:p.N105N,ANK1:uc003xol.3:exon4:c.C315T:p.N105N,ANK1:uc003xom.3:exon4:c.C414T:p.N138N	.	AFR:0.2346,AMR:0.1844,EAS:0.3477,FIN:0.2208,NFE:0.2199,OTH:0.2695,ASJ:0.1615	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	1(large_intestine)	0.2490
8	48689526	48689526	G	A	PRKDC	exonic	unknown	ENSG00000253729	rs1048546800	ENSG00000253729:ENST00000338368:exon85:c.C11965T:p.L3989L,ENSG00000253729:ENST00000314191:exon86:c.C12058T:p.L4020L	UNKNOWN	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	PRKDC:uc003xqj.3:exon85:c.C11965T:p.L3989L,PRKDC:uc003xqi.3:exon86:c.C12058T:p.L4020L	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600899	615966;	317425;	317425|SCID due to DNA-PKcs deficiency|-|-|-|615966 ~	.	.	.	.	.	.	.	.	8	.	het
8	48710955	48710955	A	G	PRKDC	exonic	unknown	ENSG00000253729	rs7830743	ENSG00000253729:ENST00000314191:exon74:c.T10298C:p.I3433T,ENSG00000253729:ENST00000338368:exon74:c.T10298C:p.I3433T	UNKNOWN	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1374	0.1206	0.184505	12(prostate)	-1.089	0.010	.	-7.65	0.000	.	.	PIK-related kinase|PIK-related kinase, FAT|Tetratricopeptide-like helical domain	PRKDC:uc003xqi.3:exon74:c.T10298C:p.I3433T,PRKDC:uc003xqj.3:exon74:c.T10298C:p.I3433T	-1.066	AFR:MU13279569,AMR:LAML-KR|1|205|0.00487805,EAS:0.2733,FIN:0.2613,NFE:0.0927,OTH:0.0679,ASJ:0.1171	600899	615966;	317425;	317425|SCID due to DNA-PKcs deficiency|-|-|-|615966 ~	.	.	.	.	0.0	.	0.000	-0.4	8	2(lung)	0.0341
8	48732075	48732075	A	-	PRKDC	intronic	.	ENSG00000253729	rs11311765	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1835	.	.	0.1462	.	.	.	.	.	.	.	.	.	.	AFR:0.2992,AMR:0.1952,EAS:0.0707,FIN:0.0225,NFE:0.0647,OTH:0.1089,ASJ:0.1092	600899	615966;	317425;	317425|SCID due to DNA-PKcs deficiency|-|-|-|615966 ~	.	.	.	.	.	.	.	.	8	.	het
8	48739440	48739440	C	A	PRKDC	intronic	.	ENSG00000253729	rs4873728	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1502	0.0950	0.168131	0.1054	.	.	.	.	.	.	.	.	.	.	AFR:0.2340,AMR:0.2613,EAS:0.0623,FIN:0.0341,NFE:0.0450,OTH:0.0845,ASJ:0.0927	600899	615966;	317425;	317425|SCID due to DNA-PKcs deficiency|-|-|-|615966 ~	.	.	.	.	.	.	.	.	8	.	het
8	48846519	48846519	T	C	PRKDC	intronic	.	ENSG00000253729	rs1231202	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9598	0.9623	0.983626	0.9656	.	.	.	.	.	.	.	.	.	.	AFR:0.9926,AMR:0.9785,EAS:0.9994,FIN:0.9528,NFE:0.9498,OTH:0.9561,ASJ:0.9338	600899	615966;	317425;	317425|SCID due to DNA-PKcs deficiency|-|-|-|615966 ~	.	.	.	.	.	.	.	.	8	MU81851562	hom
8	48885436	48885436	T	A	MCM4	exonic	nonsynonymous SNV	ENSG00000104738	rs762679	ENSG00000104738:ENST00000262105:exon13:c.T1948A:p.L650M,ENSG00000104738:ENST00000523944:exon14:c.T1948A:p.L650M	MCM4:NM_005914:exon13:c.T1948A:p.L650M,MCM4:NM_182746:exon14:c.T1948A:p.L650M	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8669	0.8730	0.914137	0.8783	1.663	14.20	1.0	5.32	1.000	.	.	MCM domain|P-loop containing nucleoside triphosphate hydrolase	MCM4:uc003xql.2:exon13:c.T1948A:p.L650M,MCM4:uc003xqk.2:exon14:c.T1948A:p.L650M,MCM4:uc011ldi.2:exon15:c.T1909A:p.L637M	-0.942	AFR:0.9223,AMR:0.9308,EAS:0.9994,FIN:0.8306,NFE:0.8494,OTH:0.8635,ASJ:0.8444	602638	609981;	75391;	75391|Primary immunodeficiency due to MCM4 deficiency|<1 / 1 000 000|Autosomal recessive|Childhood|609981 ~	.	.	.	.	0.002	2.56	0.000	0.04	8	MU81851575	hom
8	56792159	56792159	T	C	LYN	upstream	.	ENSG00000254087	rs1450741	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.715655	0.6942	.	.	.	.	.	.	.	.	.	.	AFR:0.6917,AMR:0.7267,EAS:0.7954,FIN:0.6894,NFE:0.6821,OTH:0.6916,ASJ:0.7980	165120	.	.	.	~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04611 Platelet activation~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04730 Long-term depression~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	8	.	hom
8	56792586	56792586	G	A	LYN	UTR5	.	ENSG00000254087	rs1050855	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5321	.	0.527157	0.5125	.	.	.	.	.	.	.	.	.	.	AFR:0.4980,AMR:0.6148,EAS:0.6514,FIN:0.5526,NFE:0.4899,OTH:0.5340,ASJ:0.5604	165120	.	.	.	~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04611 Platelet activation~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04730 Long-term depression~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	8	MU19188446	het
8	57078933	57078933	G	T	PLAG1	exonic	nonsynonymous SNV	ENSG00000181690	rs35883156	ENSG00000181690:ENST00000423799:exon3:c.C1126A:p.P376T,ENSG00000181690:ENST00000429357:exon4:c.C1372A:p.P458T,ENSG00000181690:ENST00000316981:exon5:c.C1372A:p.P458T	PLAG1:NM_001114635:exon3:c.C1126A:p.P376T,PLAG1:NM_001114634:exon4:c.C1372A:p.P458T,PLAG1:NM_002655:exon5:c.C1372A:p.P458T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1503	0.1353	0.109824	0.1273	0.443	6.976	0.284	2.42	0.993	.	.	.	PLAG1:uc022aur.1:exon1:c.C1126A:p.P376T,PLAG1:uc003xsq.4:exon3:c.C1372A:p.P458T,PLAG1:uc010lyj.3:exon3:c.C1126A:p.P376T,PLAG1:uc010lyi.3:exon4:c.C1372A:p.P458T,PLAG1:uc003xsr.4:exon5:c.C1372A:p.P458T	-0.929	AFR:0.0308,AMR:0.1229,EAS:0.0733,FIN:0.1464,NFE:0.1795,OTH:0.1551,ASJ:0.3113	603026	181030;	276148;454821;	276148|-|-|Not applicable|-|181030 ~454821|-|-|Not applicable|All ages|181030 ~	.	.	.	.	0.063	2.78	0.000	1.59	8	MU4564774	het
8	95419698	95419698	A	G	RAD54B	exonic	synonymous SNV	ENSG00000197275	rs2291439	ENSG00000197275:ENST00000336148:exon5:c.T750C:p.N250N	RAD54B:NM_001205263:exon3:c.T198C:p.N66N,RAD54B:NM_012415:exon5:c.T750C:p.N250N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4125	0.3611	0.418131	1(stomach)	.	.	.	.	.	.	.	.	RAD54B:uc010may.2:exon3:c.T198C:p.N66N,RAD54B:uc003ygk.3:exon5:c.T750C:p.N250N	.	AFR:MU149839,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.3418,FIN:0.5562,NFE:0.3377,OTH:0.4634,ASJ:0.3844	604289	114500;605027;	547;	547|NHL|1-5 / 10 000|-|Adult|605027 ~	.	.	.	.	.	.	.	.	8	1(haematopoietic_and_lymphoid_tissue)	0.4116
8	102505691	102505691	C	G	GRHL2	intronic	.	ENSG00000083307	rs114871790	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.177716	0.1504	.	.	.	.	.	.	.	.	.	.	AFR:0.3256,AMR:0.1031,EAS:0.2657,FIN:0.0738,NFE:0.0541,OTH:0.0897,ASJ:0.0993	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	.	het
8	102678798	102678798	C	T	GRHL2	intronic	.	ENSG00000083307	rs10093032	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3972	0.3680	0.434704	LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.3675,AMR:0.4313,EAS:0.3742,FIN:0.3645,NFE:0.3236,OTH:0.3355,ASJ:0.4403	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	1(lung)	0.3859
8	103220351	103220351	A	G	RRM2B	UTR3	.	ENSG00000048392	rs1265117	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9999	0.9999	1	1.0000	.	.	.	.	.	.	.	.	.	.	AFR:0.9999,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	604712	612075;613077;	254892;254803;255235;298;	254892|adPEO|-|-|-|157640 609283 609286 610131 613077 ~254803|mtDNA depletion syndrome, encephalomyopathic form|-|Autosomal recessive|Infancy<br>Neonatal|612073 612075 ~255235|mtDNA depletion syndrome, encephalomyopathic form with renal tubulopathy|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|612075 ~298|MNGIE|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Childhood<br>Adult|603041 612075 613662 ~	.	.	.	.	.	.	.	.	8	MU81854103	hom
8	108970367	108970367	A	G	RSPO2	exonic	nonsynonymous SNV	ENSG00000147655	rs601558	ENSG00000147655:ENST00000378439:exon4:c.T365C:p.L122P,ENSG00000147655:ENST00000517781:exon4:c.T365C:p.L122P,ENSG00000147655:ENST00000517939:exon4:c.T356C:p.L119P,ENSG00000147655:ENST00000521502:exon4:c.T356C:p.L119P,ENSG00000147655:ENST00000276659:exon5:c.T557C:p.L186P	RSPO2:NM_001282863:exon4:c.T365C:p.L122P,RSPO2:NM_001317942:exon4:c.T356C:p.L119P,RSPO2:NM_178565:exon5:c.T557C:p.L186P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5784	0.4729	0.490216	COCA-CN|6|321|0.0186916	2.545	19.76	0.655	4.95	0.759	.	.	Growth factor receptor cysteine-rich domain	RSPO2:uc003ymq.3:exon4:c.T356C:p.L119P,RSPO2:uc003ymr.3:exon4:c.T365C:p.L122P,RSPO2:uc003yms.3:exon5:c.T557C:p.L186P	-0.958	AFR:0.4824,AMR:0.1523,EAS:0.5894,FIN:0.7177,NFE:0.5967,OTH:0.6087,ASJ:0.6145	610575	.	.	.	.	.	.	.	0.0	-0.89	0.000	-1.44	8	1(large_intestine)	0.5543
8	109001465	109001465	A	G	RSPO2	exonic	synonymous SNV	ENSG00000147655	rs559945268	ENSG00000147655:ENST00000520026:exon2:c.T18C:p.Y6Y,ENSG00000147655:ENST00000521956:exon2:c.T102C:p.Y34Y,ENSG00000147655:ENST00000276659:exon3:c.T102C:p.Y34Y,ENSG00000147655:ENST00000522333:exon3:c.T102C:p.Y34Y	RSPO2:NM_178565:exon3:c.T102C:p.Y34Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	2.517e-05	.	.	.	.	.	.	.	.	.	.	.	RSPO2:uc003yms.3:exon3:c.T102C:p.Y34Y	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	610575	.	.	.	.	.	.	.	.	.	.	.	8	.	het
8	109094747	109094747	C	T	RSPO2	intronic	.	ENSG00000147655	rs10955475	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2121	0.1575	0.195088	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BTCA-JP|1|239|0.0041841	.	.	.	.	.	.	.	.	.	.	AFR:0.1799,AMR:0.0557,EAS:0.1854,FIN:0.4333,NFE:0.2109,OTH:0.2170,ASJ:0.1563	610575	.	.	.	.	.	.	.	.	.	.	.	8	1(biliary_tract)	0.2098
8	117864217	117864217	A	G	RAD21	exonic	synonymous SNV	ENSG00000164754	rs1050838	ENSG00000164754:ENST00000518055:exon1:c.T75C:p.A25A,ENSG00000164754:ENST00000297338:exon11:c.T1440C:p.A480A	RAD21:NM_006265:exon11:c.T1440C:p.A480A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1728	0.1241	0.133187	1(large_intestine)	.	.	.	.	.	.	.	.	RAD21:uc003yod.3:exon11:c.T1440C:p.A480A	.	AFR:MU134726,AMR:LAML-KR|3|205|0.0146341,COCA-CN|4|321|0.0124611,EAS:0.0303,FIN:0.2363,NFE:0.2450,OTH:0.1735,ASJ:0.1372	606462	614701;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	,9365	.	.	.	.	.	.	8	8(soft_tissue)	0.1703
8	118819578	118819578	C	T	EXT1	exonic	synonymous SNV	ENSG00000182197	rs7837891	ENSG00000182197:ENST00000378204:exon9:c.G1761A:p.E587E	EXT1:NM_000127:exon9:c.G1761A:p.E587E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3974	0.3511	0.338458	0.3570	.	.	.	.	.	.	.	.	EXT1:uc003yok.1:exon9:c.G1761A:p.E587E	.	AFR:0.2065,AMR:0.5012,EAS:0.3953,FIN:0.4140,NFE:0.4146,OTH:0.4102,ASJ:0.4007	608177	133700;215300;	55880;321;	55880|-|1-9 / 100 000|Unknown<br>or&nbsp;Not applicable|Adult|215300 ~321|Bessel-Hagen disease<br>EXT1/EXT2-CDG<br>Multiple cartilaginous exostoses|1-9 / 100 000|Autosomal dominant|Childhood|133700 133701 600209 ~	.	.	.	.	.	.	.	.	8	MU805083	het
8	118832020	118832020	G	A	EXT1	exonic	synonymous SNV	ENSG00000182197	rs17439693	ENSG00000182197:ENST00000378204:exon6:c.C1431T:p.P477P	EXT1:NM_000127:exon6:c.C1431T:p.P477P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1746	0.1643	0.120208	0.1845	.	.	.	.	.	.	.	.	EXT1:uc003yok.1:exon6:c.C1431T:p.P477P	.	AFR:0.1025,AMR:0.1806,EAS:0.0345,FIN:0.2935,NFE:0.2208,OTH:0.2449,ASJ:0.1093	608177	133700;215300;	55880;321;	55880|-|1-9 / 100 000|Unknown<br>or&nbsp;Not applicable|Adult|215300 ~321|Bessel-Hagen disease<br>EXT1/EXT2-CDG<br>Multiple cartilaginous exostoses|1-9 / 100 000|Autosomal dominant|Childhood|133700 133701 600209 ~	.	.	.	.	.	.	.	.	8	MU805086	het
8	134260174	134260174	G	A	NDRG1	intronic	.	ENSG00000104419	rs2227262	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1368	0.1121	0.104233	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BTCA-JP|1|239|0.0041841	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.1144,AMR:0.0319,EAS:0.1722,FIN:0.0796,NFE:0.1444,OTH:0.1550,ASJ:0.1124	605262	601455;	99950;	99950|CMT4D<br>HMSN, Lom type<br>HMSN-Lom<br>Hereditary motor and sensory neuropathy, Lom type|Unknown|Autosomal recessive|Childhood<br>Adolescent|601455 ~	.	.	.	.	.	.	.	.	8	1(lung)	0.1653
8	134292516	134292516	A	G	NDRG1	intronic	.	ENSG00000104419	rs2272653	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5635	0.6678	0.613419	0.6519	.	.	.	.	.	0	0	.	.	.	AFR:0.8639,AMR:0.4952,EAS:0.4506,FIN:0.5755,NFE:0.5806,OTH:0.5906,ASJ:0.66	605262	601455;	99950;	99950|CMT4D<br>HMSN, Lom type<br>HMSN-Lom<br>Hereditary motor and sensory neuropathy, Lom type|Unknown|Autosomal recessive|Childhood<br>Adolescent|601455 ~	.	.	.	.	.	.	.	.	8	MU13169204	het
8	145004546	145004546	G	A	PLEC	intronic	.	ENSG00000178209	rs11780911	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7411	0.6988	0.571885	0.6622	.	.	.	.	.	0	0.004	.	.	.	AFR:0.3862,AMR:0.6411,EAS:0.6188,FIN:0.7603,NFE:0.7994,OTH:0.7162,ASJ:0.78	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	.	.	.	.	8	MU81858392	het
8	145737286	145737286	G	A	RECQL4	intronic	.	ENSG00000160957	rs756627	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4670	0.3500	0.400559	0.3818	-0.092	1.788	.	-1.53	0.005	0	0	.	.	.	AFR:0.1395,AMR:0.5561,EAS:0.4913,FIN:0.4966,NFE:0.4678,OTH:0.4795,ASJ:0.4040	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU684944	het
8	145737514	145737514	G	A	RECQL4	intronic	.	ENSG00000160957	rs4244610	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5063	0.3932	0.433307	0.4144	.	.	.	.	.	.	.	.	.	.	AFR:0.2530,AMR:0.5692,EAS:0.4672,FIN:0.4969,NFE:0.4705,OTH:0.4846,ASJ:0.4073	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU27648814	het
8	145737636	145737636	A	G	RECQL4	exonic	synonymous SNV	ENSG00000160957	rs4925828	ENSG00000160957:ENST00000428558:exon19:c.T3127C:p.L1043L	RECQL4:NM_004260:exon19:c.T3127C:p.L1043L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9728	0.9984	0.946086	0.9838	.	.	.	.	.	.	.	.	RECQL4:uc003zdj.3:exon19:c.T3127C:p.L1043L	.	AFR:0.9944,AMR:0.9224,EAS:0.7879,FIN:0.9960,NFE:0.9989,OTH:0.9878,ASJ:1	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU4561850	hom
8	145737816	145737816	C	T	RECQL4	exonic	nonsynonymous SNV	ENSG00000160957	rs4251691	ENSG00000160957:ENST00000428558:exon18:c.G3014A:p.R1005Q	RECQL4:NM_004260:exon18:c.G3014A:p.R1005Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4612	0.3419	0.384385	0.3717	2.434	19.04	.	0.281	0.015	.	.	.	RECQL4:uc003zdj.3:exon18:c.G3014A:p.R1005Q	.	AFR:0.1265,AMR:0.5502,EAS:0.4412,FIN:0.4940,NFE:0.4624,OTH:0.4703,ASJ:0.3642	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	0.035	.	.	0.815	8	MU73030	het
8	145738583	145738584	GG	-	RECQL4	intronic	.	ENSG00000265393	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	.	unknown
8	145738768	145738768	G	-	RECQL4	splicing	.	ENSG00000160957;ENSG00000160957	rs11342077	ENSG00000160957:ENST00000428558:exon15:c.2296delC:p.R766fs	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9999	.	1	0.9999	.	.	.	.	.	.	.	.	RECQL4:uc003zdj.3:exon15:c.2296delC:p.R766fs	.	AFR:1,AMR:1,EAS:1,FIN:0.9997,NFE:0.9999,OTH:1,ASJ:1	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	.	hom
8	145739924	145739924	G	A	RECQL4	intronic	.	ENSG00000160957	rs4244611	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4802	0.3505	0.394569	0.3814	.	.	.	.	.	.	.	.	.	.	AFR:0.1378,AMR:0.5549,EAS:0.4703,FIN:0.4991,NFE:0.4696,OTH:0.4784,ASJ:0.4073	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU654936	het
8	145741130	145741130	C	T	RECQL4	intronic	.	ENSG00000160957	rs4251689	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4716	0.3650	0.400958	0.3905	.	.	.	.	.	.	.	.	.	.	AFR:0.1768,AMR:0.5549,EAS:0.4689,FIN:0.4966,NFE:0.4669,OTH:0.4775,ASJ:0.4073	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU18988417	het
8	145741702	145741702	C	G	RECQL4	exonic	nonsynonymous SNV	ENSG00000160957	rs4244612	ENSG00000160957:ENST00000428558:exon5:c.G801C:p.E267D	RECQL4:NM_004260:exon5:c.G801C:p.E267D	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4377	0.3919	0.447684	0.4191	-0.697	0.073	.	-2.99	0.000	.	.	.	RECQL4:uc003zdj.3:exon5:c.G801C:p.E267D	.	AFR:0.4289,AMR:0.5119,EAS:0.4586,FIN:0.4195,NFE:0.4052,OTH:0.4097,ASJ:0.3775	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	0.002	.	.	.	8	MU69391	het
8	145741748	145741748	G	A	RECQL4	exonic	nonsynonymous SNV	ENSG00000160957	rs199773279	ENSG00000160957:ENST00000428558:exon5:c.C755T:p.P252L	RECQL4:NM_004260:exon5:c.C755T:p.P252L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0064	.	0.0115815	0.0002	-0.292	0.694	.	-0.014	0.005	.	.	.	RECQL4:uc003zdj.3:exon5:c.C755T:p.P252L	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.673e-05,OTH:0.0051,ASJ:0	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	0.011	.	.	.	8	.	hom
8	145742514	145742514	A	G	RECQL4	exonic	nonsynonymous SNV	ENSG00000160957	rs2721190	ENSG00000160957:ENST00000428558:exon4:c.T274C:p.S92P	RECQL4:NM_004260:exon4:c.T274C:p.S92P	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9733	0.9952	0.943291	0.9815	-1.106	0.010	.	1.99	0.000	.	.	.	RECQL4:uc003zdj.3:exon4:c.T274C:p.S92P	.	AFR:0.9837,AMR:0.9224,EAS:0.8006,FIN:0.9960,NFE:0.999,OTH:0.9857,ASJ:1	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU4561873	hom
8	145742879	145742879	T	C	RECQL4	exonic	synonymous SNV	ENSG00000160957	rs2306386	ENSG00000160957:ENST00000428558:exon3:c.A132G:p.E44E	RECQL4:NM_004260:exon3:c.A132G:p.E44E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5552	0.5507	0.57508	0.5372	.	.	.	.	.	.	.	.	RECQL4:uc003zdj.3:exon3:c.A132G:p.E44E	.	AFR:0.6164,AMR:0.6533,EAS:0.4931,FIN:0.5158,NFE:0.4973,OTH:0.5164,ASJ:0.4603	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU73049	het
9	271638	271638	C	T	DOCK8	exonic	nonsynonymous SNV	ENSG00000107099	rs506121	ENSG00000107099:ENST00000453981:exon2:c.C65T:p.A22V,ENSG00000107099:ENST00000469197:exon2:c.C65T:p.A22V	DOCK8:NM_203447:exon2:c.C65T:p.A22V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3245	0.3189	0.307708	ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579	4.843	24.8	.	4.05	0.971	.	.	.	DOCK8:uc003zgf.2:exon2:c.C65T:p.A22V,DOCK8:uc011lls.1:exon2:c.C65T:p.A22V	-0.952	AFR:0.3393,AMR:0.2787,EAS:0.2384,FIN:0.4333,NFE:0.4020,OTH:0.3550,ASJ:0.2703	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	0.001	.	0.000	2.325	9	2(haematopoietic_and_lymphoid_tissue)	0.35
9	286593	286593	C	A	DOCK8	exonic	nonsynonymous SNV	ENSG00000107099	rs529208	ENSG00000107099:ENST00000469391:exon2:c.C85A:p.P29T,ENSG00000107099:ENST00000483757:exon2:c.C85A:p.P29T,ENSG00000107099:ENST00000432829:exon3:c.C85A:p.P29T,ENSG00000107099:ENST00000453981:exon3:c.C289A:p.P97T,ENSG00000107099:ENST00000479404:exon3:c.C85A:p.P29T,ENSG00000107099:ENST00000487230:exon3:c.C85A:p.P29T	DOCK8:NM_001190458:exon2:c.C85A:p.P29T,DOCK8:NM_001193536:exon2:c.C85A:p.P29T,DOCK8:NM_203447:exon3:c.C289A:p.P97T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 1, 0, 0] 	0.5206	0.4642	0.529752	MU137609	4.030	23.6	0.052	4.57	0.984	.	.	Dedicator of cytokinesis C/D, N-terminal	DOCK8:uc003zgg.3:exon2:c.C85A:p.P29T,DOCK8:uc010mgt.3:exon2:c.C85A:p.P29T,DOCK8:uc010mgv.3:exon2:c.C85A:p.P29T,DOCK8:uc022bcu.1:exon2:c.C85A:p.P29T,DOCK8:uc003zgf.2:exon3:c.C289A:p.P97T,DOCK8:uc011lls.1:exon3:c.C289A:p.P97T	-0.961	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|6|321|0.0186916,AMR:0.4918,EAS:0.5336,FIN:0.4329,NFE:0.7621,OTH:0.5750,ASJ:0.3944	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	0.996	0.72	0.000	2.395	9	2(large_intestine)	0.4970
9	328006	328006	T	C	DOCK8	intronic	.	ENSG00000107099	rs2296828	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6886	0.6684	0.695887	LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.6703,AMR:0.6491,EAS:0.5331,FIN:0.7367,NFE:0.6710,OTH:0.6803,ASJ:0.6504	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	1(lung)	0.6531
9	399275	399275	-	C	DOCK8	intronic	.	ENSG00000107099	rs3831174	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2634	0.2666	.	0.3747	.	.	.	.	.	.	.	.	.	.	AFR:0.4678,AMR:0.3664,EAS:0.3310,FIN:0.3573,NFE:0.3246,OTH:0.3435,ASJ:0.1429	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	.	hom
9	421032	421032	C	G	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs2297079	ENSG00000107099:ENST00000382329:exon19:c.C2508G:p.L836L,ENSG00000107099:ENST00000469391:exon30:c.C3807G:p.L1269L,ENSG00000107099:ENST00000432829:exon32:c.C3903G:p.L1301L,ENSG00000107099:ENST00000453981:exon32:c.C4107G:p.L1369L	DOCK8:NM_001190458:exon30:c.C3807G:p.L1269L,DOCK8:NM_001193536:exon31:c.C3903G:p.L1301L,DOCK8:NM_203447:exon32:c.C4107G:p.L1369L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5094	0.4626	0.391773	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	DOCK8:uc003zgk.2:exon19:c.C2481G:p.L827L,DOCK8:uc010mgu.3:exon30:c.C2013G:p.L671L,DOCK8:uc010mgv.3:exon30:c.C3807G:p.L1269L,DOCK8:uc022bcu.1:exon31:c.C3903G:p.L1301L,DOCK8:uc003zgf.2:exon32:c.C4107G:p.L1369L	.	AFR:0.4491,AMR:0.1521,EAS:0.4801,FIN:0.5155,NFE:0.4814,OTH:0.6050,ASJ:0.4354	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	1(large_intestine)	0.4837
9	429719	429719	T	C	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs7854035	ENSG00000107099:ENST00000382329:exon23:c.T2892C:p.F964F,ENSG00000107099:ENST00000469391:exon34:c.T4191C:p.F1397F,ENSG00000107099:ENST00000432829:exon36:c.T4287C:p.F1429F,ENSG00000107099:ENST00000453981:exon36:c.T4491C:p.F1497F	DOCK8:NM_001190458:exon34:c.T4191C:p.F1397F,DOCK8:NM_001193536:exon35:c.T4287C:p.F1429F,DOCK8:NM_203447:exon36:c.T4491C:p.F1497F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9978	0.9968	0.999401	0.9979	.	.	.	.	.	.	.	.	DOCK8:uc003zgk.2:exon23:c.T2865C:p.F955F,DOCK8:uc010mgu.3:exon34:c.T2397C:p.F799F,DOCK8:uc010mgv.3:exon34:c.T4191C:p.F1397F,DOCK8:uc022bcu.1:exon35:c.T4287C:p.F1429F,DOCK8:uc003zgf.2:exon36:c.T4491C:p.F1497F	.	AFR:0.9993,AMR:0.9928,EAS:1,FIN:0.9997,NFE:0.9965,OTH:1,ASJ:1	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU81859376	hom
9	432330	432330	C	G	DOCK8	intronic	.	ENSG00000107099	rs7036567	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7577	0.6692	0.714257	0.7017	.	.	.	.	.	0.0001	0.042	.	.	.	AFR:0.4865,AMR:0.8305,EAS:0.9870,FIN:0.8003,NFE:0.7628,OTH:0.7351,ASJ:0.7417	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU81859387	het
9	433978	433978	A	G	DOCK8	intronic	.	ENSG00000107099	rs2360712	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7588	0.6749	0.721046	0.7071	.	.	.	.	.	0.0041	0.204	.	.	.	AFR:0.5078,AMR:0.8313,EAS:0.9871,FIN:0.7994,NFE:0.7610,OTH:0.7383,ASJ:0.7417	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU81859414	het
9	441952	441952	G	A	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs1887957	ENSG00000107099:ENST00000382329:exon29:c.G3834A:p.E1278E,ENSG00000107099:ENST00000469391:exon40:c.G5133A:p.E1711E,ENSG00000107099:ENST00000432829:exon42:c.G5229A:p.E1743E,ENSG00000107099:ENST00000453981:exon42:c.G5433A:p.E1811E	DOCK8:NM_001190458:exon40:c.G5133A:p.E1711E,DOCK8:NM_001193536:exon41:c.G5229A:p.E1743E,DOCK8:NM_203447:exon42:c.G5433A:p.E1811E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8201	0.7429	0.803914	0.7641	.	.	.	.	.	.	.	.	DOCK8:uc003zgk.2:exon29:c.G3807A:p.E1269E,DOCK8:uc010mgu.3:exon40:c.G3339A:p.E1113E,DOCK8:uc010mgv.3:exon40:c.G5133A:p.E1711E,DOCK8:uc022bcu.1:exon41:c.G5229A:p.E1743E,DOCK8:uc003zgf.2:exon42:c.G5433A:p.E1811E	.	AFR:0.5880,AMR:0.8795,EAS:0.9981,FIN:0.8293,NFE:0.8162,OTH:0.8020,ASJ:0.8013	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU4566310	het
9	446352	446352	G	C	DOCK8	intronic	.	ENSG00000107099	rs10814952	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6887	0.5583	0.632987	0.5990	.	.	.	.	.	.	.	.	.	.	AFR:0.2953,AMR:0.7852,EAS:0.9858,FIN:0.7018,NFE:0.6930,OTH:0.6837,ASJ:0.6457	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU32516518	het
9	712060	712060	G	C	KANK1	exonic	nonsynonymous SNV	ENSG00000107104	rs4465020	ENSG00000107104:ENST00000382293:exon2:c.G820C:p.E274Q,ENSG00000107104:ENST00000382297:exon3:c.G1294C:p.E432Q,ENSG00000107104:ENST00000382303:exon7:c.G1294C:p.E432Q	KANK1:NM_001354335:exon2:c.G820C:p.E274Q,KANK1:NM_001354336:exon2:c.G820C:p.E274Q,KANK1:NM_001354337:exon2:c.G820C:p.E274Q,KANK1:NM_001354338:exon2:c.G820C:p.E274Q,KANK1:NM_001354339:exon2:c.G820C:p.E274Q,KANK1:NM_001354340:exon2:c.G820C:p.E274Q,KANK1:NM_001354341:exon2:c.G820C:p.E274Q,KANK1:NM_001354342:exon2:c.G820C:p.E274Q,KANK1:NM_001354343:exon2:c.G820C:p.E274Q,KANK1:NM_001354344:exon2:c.G820C:p.E274Q,KANK1:NM_153186:exon2:c.G820C:p.E274Q,KANK1:NM_001354331:exon3:c.G1294C:p.E432Q,KANK1:NM_001354332:exon3:c.G1294C:p.E432Q,KANK1:NM_001354333:exon3:c.G820C:p.E274Q,KANK1:NM_015158:exon3:c.G1294C:p.E432Q,KANK1:NM_001256877:exon4:c.G1294C:p.E432Q,KANK1:NM_001354334:exon4:c.G1294C:p.E432Q,KANK1:NM_001256876:exon7:c.G1294C:p.E432Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3392	0.2880	0.235224	0.2889	-0.550	0.166	0.093	4.81	0.013	.	.	.	KANK1:uc003zgq.2:exon2:c.G820C:p.E274Q,KANK1:uc003zgr.1:exon2:c.G820C:p.E274Q,KANK1:uc003zgs.2:exon2:c.G820C:p.E274Q,KANK1:uc003zgm.4:exon3:c.G1294C:p.E432Q,KANK1:uc003zgn.2:exon3:c.G1294C:p.E432Q,KANK1:uc003zgo.1:exon3:c.G1294C:p.E432Q,KANK1:uc003zgp.1:exon4:c.G1294C:p.E432Q,KANK1:uc031tct.1:exon4:c.G1294C:p.E432Q,KANK1:uc003zgl.2:exon7:c.G1294C:p.E432Q	-0.942	AFR:0.0792,AMR:0.2081,EAS:0.1267,FIN:0.3625,NFE:0.4079,OTH:0.3845,ASJ:0.3841	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	0.36	0.85	0.000	2.3	9	MU10850812	hom
9	712599	712599	C	T	KANK1	exonic	synonymous SNV	ENSG00000107104	rs11789987	ENSG00000107104:ENST00000382293:exon2:c.C1359T:p.N453N,ENSG00000107104:ENST00000382297:exon3:c.C1833T:p.N611N,ENSG00000107104:ENST00000382303:exon7:c.C1833T:p.N611N	KANK1:NM_001354335:exon2:c.C1359T:p.N453N,KANK1:NM_001354336:exon2:c.C1359T:p.N453N,KANK1:NM_001354337:exon2:c.C1359T:p.N453N,KANK1:NM_001354338:exon2:c.C1359T:p.N453N,KANK1:NM_001354339:exon2:c.C1359T:p.N453N,KANK1:NM_001354340:exon2:c.C1359T:p.N453N,KANK1:NM_001354341:exon2:c.C1359T:p.N453N,KANK1:NM_001354342:exon2:c.C1359T:p.N453N,KANK1:NM_001354343:exon2:c.C1359T:p.N453N,KANK1:NM_001354344:exon2:c.C1359T:p.N453N,KANK1:NM_153186:exon2:c.C1359T:p.N453N,KANK1:NM_001354331:exon3:c.C1833T:p.N611N,KANK1:NM_001354332:exon3:c.C1833T:p.N611N,KANK1:NM_001354333:exon3:c.C1359T:p.N453N,KANK1:NM_015158:exon3:c.C1833T:p.N611N,KANK1:NM_001256877:exon4:c.C1833T:p.N611N,KANK1:NM_001354334:exon4:c.C1833T:p.N611N,KANK1:NM_001256876:exon7:c.C1833T:p.N611N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3486	0.3125	0.252995	0.3095	.	.	.	.	.	.	.	.	KANK1:uc003zgq.2:exon2:c.C1359T:p.N453N,KANK1:uc003zgr.1:exon2:c.C1359T:p.N453N,KANK1:uc003zgs.2:exon2:c.C1359T:p.N453N,KANK1:uc003zgm.4:exon3:c.C1833T:p.N611N,KANK1:uc003zgn.2:exon3:c.C1833T:p.N611N,KANK1:uc003zgo.1:exon3:c.C1833T:p.N611N,KANK1:uc003zgp.1:exon4:c.C1833T:p.N611N,KANK1:uc031tct.1:exon4:c.C1833T:p.N611N,KANK1:uc003zgl.2:exon7:c.C1833T:p.N611N	.	AFR:0.1373,AMR:0.2172,EAS:0.1270,FIN:0.3630,NFE:0.4153,OTH:0.3870,ASJ:0.3974	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	.	.	.	.	9	MU1788343	hom
9	732395	732395	G	C	KANK1	exonic	nonsynonymous SNV	ENSG00000107104	rs548754374	ENSG00000107104:ENST00000382293:exon5:c.G2549C:p.S850T,ENSG00000107104:ENST00000382297:exon6:c.G3023C:p.S1008T,ENSG00000107104:ENST00000382303:exon10:c.G3023C:p.S1008T	KANK1:NM_001354335:exon5:c.G2549C:p.S850T,KANK1:NM_001354337:exon5:c.G2549C:p.S850T,KANK1:NM_001354338:exon5:c.G2495C:p.S832T,KANK1:NM_001354340:exon5:c.G2495C:p.S832T,KANK1:NM_001354341:exon5:c.G2549C:p.S850T,KANK1:NM_001354344:exon5:c.G2495C:p.S832T,KANK1:NM_153186:exon5:c.G2549C:p.S850T,KANK1:NM_001354332:exon6:c.G2969C:p.S990T,KANK1:NM_001354333:exon6:c.G2549C:p.S850T,KANK1:NM_015158:exon6:c.G3023C:p.S1008T,KANK1:NM_001256877:exon7:c.G3023C:p.S1008T,KANK1:NM_001354334:exon7:c.G3023C:p.S1008T,KANK1:NM_001256876:exon10:c.G3023C:p.S1008T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0] 	1.653e-05	.	0.000399361	.	5.149	25.4	0.003	5.64	1.000	.	.	Ankyrin repeat-containing domain	KANK1:uc003zgs.2:exon5:c.G2549C:p.S850T,KANK1:uc003zgn.2:exon6:c.G3023C:p.S1008T,KANK1:uc031tct.1:exon7:c.G3023C:p.S1008T,KANK1:uc003zgl.2:exon10:c.G3023C:p.S1008T	-0.563	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	0.998	0.82	0.280	3.475	9	.	het
9	740770	740776	TTTTTTT	-	KANK1	intronic	.	ENSG00000107104	rs758575219	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0946	.	.	0.0820	.	.	.	.	.	.	.	.	.	.	AFR:0.1655,AMR:0.0493,EAS:0.0006,FIN:0.0675,NFE:0.0474,OTH:0.0533,ASJ:0.0444	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	.	.	.	.	9	MU112644276	het
9	740901	740901	C	T	KANK1	exonic	synonymous SNV	ENSG00000107104	rs2296049	ENSG00000107104:ENST00000382286:exon4:c.C420T:p.F140F,ENSG00000107104:ENST00000382289:exon5:c.C663T:p.F221F,ENSG00000107104:ENST00000382293:exon8:c.C3189T:p.F1063F,ENSG00000107104:ENST00000382297:exon9:c.C3663T:p.F1221F,ENSG00000107104:ENST00000382303:exon13:c.C3663T:p.F1221F	KANK1:NM_001354336:exon7:c.C2895T:p.F965F,KANK1:NM_001354339:exon7:c.C2949T:p.F983F,KANK1:NM_001354342:exon7:c.C2949T:p.F983F,KANK1:NM_001354343:exon7:c.C2949T:p.F983F,KANK1:NM_001354331:exon8:c.C3423T:p.F1141F,KANK1:NM_001354335:exon8:c.C3189T:p.F1063F,KANK1:NM_001354337:exon8:c.C3189T:p.F1063F,KANK1:NM_001354338:exon8:c.C3135T:p.F1045F,KANK1:NM_001354340:exon8:c.C3135T:p.F1045F,KANK1:NM_001354341:exon8:c.C3189T:p.F1063F,KANK1:NM_001354344:exon8:c.C3135T:p.F1045F,KANK1:NM_153186:exon8:c.C3189T:p.F1063F,KANK1:NM_001354332:exon9:c.C3609T:p.F1203F,KANK1:NM_001354333:exon9:c.C3189T:p.F1063F,KANK1:NM_015158:exon9:c.C3663T:p.F1221F,KANK1:NM_001256877:exon10:c.C3663T:p.F1221F,KANK1:NM_001354334:exon10:c.C3663T:p.F1221F,KANK1:NM_001256876:exon13:c.C3663T:p.F1221F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2418	0.2793	0.265974	0.2654	.	.	.	.	.	.	.	.	KANK1:uc003zgt.1:exon3:c.C399T:p.F133F,KANK1:uc010mgy.2:exon3:c.C399T:p.F133F,KANK1:uc010mgx.2:exon5:c.C597T:p.F199F,KANK1:uc003zgs.2:exon8:c.C3189T:p.F1063F,KANK1:uc003zgn.2:exon9:c.C3663T:p.F1221F,KANK1:uc031tct.1:exon10:c.C3663T:p.F1221F,KANK1:uc003zgl.2:exon13:c.C3663T:p.F1221F	.	AFR:0.3983,AMR:0.3732,EAS:0.2206,FIN:0.1804,NFE:0.2117,OTH:0.2086,ASJ:0.2020	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	.	.	.	.	9	MU587925	hom
9	742342	742342	A	G	KANK1	exonic	synonymous SNV	ENSG00000107104	rs10733535	ENSG00000107104:ENST00000382286:exon5:c.A591G:p.G197G,ENSG00000107104:ENST00000382289:exon6:c.A834G:p.G278G,ENSG00000107104:ENST00000382293:exon9:c.A3360G:p.G1120G,ENSG00000107104:ENST00000382297:exon10:c.A3834G:p.G1278G,ENSG00000107104:ENST00000382303:exon14:c.A3834G:p.G1278G	KANK1:NM_001354336:exon8:c.A3066G:p.G1022G,KANK1:NM_001354339:exon8:c.A3120G:p.G1040G,KANK1:NM_001354342:exon8:c.A3120G:p.G1040G,KANK1:NM_001354343:exon8:c.A3120G:p.G1040G,KANK1:NM_001354331:exon9:c.A3594G:p.G1198G,KANK1:NM_001354335:exon9:c.A3360G:p.G1120G,KANK1:NM_001354337:exon9:c.A3360G:p.G1120G,KANK1:NM_001354338:exon9:c.A3306G:p.G1102G,KANK1:NM_001354340:exon9:c.A3306G:p.G1102G,KANK1:NM_001354341:exon9:c.A3360G:p.G1120G,KANK1:NM_001354344:exon9:c.A3306G:p.G1102G,KANK1:NM_153186:exon9:c.A3360G:p.G1120G,KANK1:NM_001354332:exon10:c.A3780G:p.G1260G,KANK1:NM_001354333:exon10:c.A3360G:p.G1120G,KANK1:NM_015158:exon10:c.A3834G:p.G1278G,KANK1:NM_001256877:exon11:c.A3834G:p.G1278G,KANK1:NM_001354334:exon11:c.A3834G:p.G1278G,KANK1:NM_001256876:exon14:c.A3834G:p.G1278G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9953	0.9934	0.997604	0.9934	.	.	.	.	.	.	.	.	KANK1:uc003zgt.1:exon4:c.A570G:p.G190G,KANK1:uc010mgy.2:exon4:c.A570G:p.G190G,KANK1:uc010mgx.2:exon6:c.A768G:p.G256G,KANK1:uc003zgs.2:exon9:c.A3360G:p.G1120G,KANK1:uc003zgn.2:exon10:c.A3834G:p.G1278G,KANK1:uc031tct.1:exon11:c.A3834G:p.G1278G,KANK1:uc003zgl.2:exon14:c.A3834G:p.G1278G	.	AFR:0.9989,AMR:0.9916,EAS:1,FIN:0.9989,NFE:0.9887,OTH:0.9878,ASJ:1	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	.	.	.	.	9	MU93460	hom
9	5050706	5050706	C	T	JAK2	exonic	synonymous SNV	ENSG00000096968	rs2230722	ENSG00000096968:ENST00000544510:exon3:c.C42T:p.H14H,ENSG00000096968:ENST00000539801:exon5:c.C489T:p.H163H,ENSG00000096968:ENST00000381652:exon6:c.C489T:p.H163H	JAK2:NM_001322204:exon3:c.C42T:p.H14H,JAK2:NM_001322195:exon5:c.C489T:p.H163H,JAK2:NM_001322196:exon5:c.C489T:p.H163H,JAK2:NM_001322194:exon6:c.C489T:p.H163H,JAK2:NM_004972:exon6:c.C489T:p.H163H	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3257	0.3565	0.358227	0.3526	.	.	.	.	.	.	.	.	JAK2:uc010mhm.3:exon5:c.C489T:p.H163H,JAK2:uc003ziw.3:exon6:c.C489T:p.H163H	.	AFR:0.4528,AMR:0.3345,EAS:0.2631,FIN:0.3475,NFE:0.3065,OTH:0.3681,ASJ:0.2848	147796	133100;254450;263300;600800;601626;614521;	3318;71493;519;729;824;90042;	3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~729|Acquired primary erythrocytosis<br>Osler-Vaquez disease<br>PV<br>Polycythemia rubra vera<br>Vaquez disease|1-5 / 10 000|Not applicable|All ages|263300 ~824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~90042|Congenital erythrocytosis due to erythropoietin receptor mutation<br>Congenital polycythemia due to erythropoietin receptor mutation<br>Familial erythrocytosis<br>PFCP<br>Primary congenital erythrocytosis<br>Primary familial and congenital polycythemia|Unknown|Autosomal dominant|All ages|133100 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04725 Cholinergic synapse~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,6214	.	.	.	.	.	.	9	MU80615669	het
9	5081780	5081780	G	A	JAK2	exonic	synonymous SNV	ENSG00000096968	rs2230724	ENSG00000096968:ENST00000544510:exon16:c.G2043A:p.L681L,ENSG00000096968:ENST00000539801:exon18:c.G2490A:p.L830L,ENSG00000096968:ENST00000381652:exon19:c.G2490A:p.L830L	JAK2:NM_001322204:exon16:c.G2043A:p.L681L,JAK2:NM_001322195:exon18:c.G2490A:p.L830L,JAK2:NM_001322196:exon18:c.G2490A:p.L830L,JAK2:NM_001322194:exon19:c.G2490A:p.L830L,JAK2:NM_001322198:exon19:c.G1275A:p.L425L,JAK2:NM_001322199:exon19:c.G1275A:p.L425L,JAK2:NM_004972:exon19:c.G2490A:p.L830L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5328	0.6243	0.616813	14(meninges)	.	.	.	.	.	.	.	.	JAK2:uc010mhm.3:exon18:c.G2490A:p.L830L,JAK2:uc003ziw.3:exon19:c.G2490A:p.L830L	.	AFR:3(large_intestine),AMR:1(breast),EAS:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,FIN:0.6108,NFE:0.8679,OTH:0.5096,ASJ:MU99782	147796	133100;254450;263300;600800;601626;614521;	3318;71493;519;729;824;90042;	3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~729|Acquired primary erythrocytosis<br>Osler-Vaquez disease<br>PV<br>Polycythemia rubra vera<br>Vaquez disease|1-5 / 10 000|Not applicable|All ages|263300 ~824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~90042|Congenital erythrocytosis due to erythropoietin receptor mutation<br>Congenital polycythemia due to erythropoietin receptor mutation<br>Familial erythrocytosis<br>PFCP<br>Primary congenital erythrocytosis<br>Primary familial and congenital polycythemia|Unknown|Autosomal dominant|All ages|133100 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04725 Cholinergic synapse~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,6214	.	.	.	.	.	.	9	1(lung)	0.6159
9	5557672	5557672	T	C	PDCD1LG2	exonic	nonsynonymous SNV	ENSG00000197646	rs7854303	ENSG00000197646:ENST00000397745:exon4:c.T416C:p.F139S,ENSG00000197646:ENST00000397747:exon5:c.T686C:p.F229S	PDCD1LG2:NM_025239:exon5:c.T686C:p.F229S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9992	0.9988	0.997804	0.9989	-0.047	2.158	0.552	0.724	0.021	.	.	.	PDCD1LG2:uc010mho.1:exon3:c.T416C:p.F139S,PDCD1LG2:uc003zjg.4:exon5:c.T686C:p.F229S,PDCD1LG2:uc011lmc.2:exon5:c.T686C:p.F229S	-1.036	AFR:0.9975,AMR:0.9964,EAS:1,FIN:1,NFE:0.9995,OTH:0.9980,ASJ:1	605723	.	.	.	.	.	.	.	0.0	5.16	0.000	.	9	MU81859703	hom
9	8389364	8389364	C	G	PTPRD	exonic	synonymous SNV	ENSG00000153707	rs2279776	ENSG00000153707:ENST00000397606:exon20:c.G3033C:p.G1011G,ENSG00000153707:ENST00000397617:exon20:c.G3033C:p.G1011G,ENSG00000153707:ENST00000537002:exon20:c.G3024C:p.G1008G,ENSG00000153707:ENST00000397611:exon21:c.G3024C:p.G1008G,ENSG00000153707:ENST00000355233:exon22:c.G3036C:p.G1012G,ENSG00000153707:ENST00000358503:exon22:c.G4188C:p.G1396G,ENSG00000153707:ENST00000486161:exon22:c.G3033C:p.G1011G,ENSG00000153707:ENST00000360074:exon23:c.G4215C:p.G1405G,ENSG00000153707:ENST00000356435:exon26:c.G4254C:p.G1418G,ENSG00000153707:ENST00000540109:exon26:c.G4254C:p.G1418G,ENSG00000153707:ENST00000381196:exon34:c.G4254C:p.G1418G	PTPRD:NM_001171025:exon20:c.G3033C:p.G1011G,PTPRD:NM_130393:exon20:c.G3006C:p.G1002G,PTPRD:NM_001040712:exon21:c.G3024C:p.G1008G,PTPRD:NM_130391:exon22:c.G3033C:p.G1011G,PTPRD:NM_130392:exon22:c.G3036C:p.G1012G,PTPRD:NM_002839:exon37:c.G4254C:p.G1418G	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.4992	0.4847	0.55631	0.4920	.	.	.	.	.	.	.	.	PTPRD:uc003zkr.3:exon20:c.G3006C:p.G1002G,PTPRD:uc003zks.3:exon20:c.G3033C:p.G1011G,PTPRD:uc022bdj.1:exon21:c.G3024C:p.G1008G,PTPRD:uc003zkp.3:exon22:c.G3036C:p.G1012G,PTPRD:uc003zkq.3:exon22:c.G3033C:p.G1011G,PTPRD:uc003zkk.3:exon37:c.G4254C:p.G1418G	.	AFR:0.5735,AMR:0.5072,EAS:0.6897,FIN:0.4948,NFE:0.4231,OTH:0.4691,ASJ:0.5066	601598	.	.	.	.	,9360,9359	.	.	.	.	.	.	9	MU733175	het
9	8436703	8436703	C	G	PTPRD	intronic	.	ENSG00000153707	rs1359118	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6025	0.5886	0.622404	LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.6082,AMR:0.5829,EAS:0.5728,FIN:0.6301,NFE:0.6051,OTH:0.6252,ASJ:0.5504	601598	.	.	.	.	.	.	.	.	.	.	.	9	1(large_intestine)	0.6090
9	20413875	20413875	G	A	MLLT3	exonic	synonymous SNV	ENSG00000171843	rs549653424	ENSG00000171843:ENST00000380338:exon5:c.C969T:p.D323D,ENSG00000171843:ENST00000429426:exon5:c.C960T:p.D320D	MLLT3:NM_001286691:exon5:c.C960T:p.D320D,MLLT3:NM_004529:exon5:c.C969T:p.D323D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0001	.	0.000599042	.	.	.	.	.	.	.	.	.	MLLT3:uc003zof.3:exon3:c.C372T:p.D124D,MLLT3:uc011lne.1:exon4:c.C873T:p.D291D,MLLT3:uc003zoe.2:exon5:c.C969T:p.D323D,MLLT3:uc011lnf.1:exon5:c.C960T:p.D320D	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	159558	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	9	.	het
9	21854740	21854740	C	T	MTAP	exonic	synonymous SNV	ENSG00000099810	rs10965163	ENSG00000099810:ENST00000577563:exon1:c.C18T:p.R6R,ENSG00000099810:ENST00000380172:exon6:c.C561T:p.R187R,ENSG00000099810:ENST00000460874:exon6:c.C612T:p.R204R,ENSG00000099810:ENST00000580718:exon6:c.C561T:p.R187R,ENSG00000099810:ENST00000580900:exon6:c.C561T:p.R187R	MTAP:NM_002451:exon6:c.C561T:p.R187R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0628	0.0662	0.0407348	LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	MTAP:uc011lnl.2:exon3:c.C360T:p.R120R,MTAP:uc003zph.3:exon6:c.C561T:p.R187R,MTAP:uc011lnk.2:exon6:c.C612T:p.R204R,MTAP:uc031tcz.1:exon6:c.C561T:p.R187R,MTAP:uc031tda.1:exon6:c.C561T:p.R187R,MTAP:uc031tdb.1:exon6:c.C561T:p.R187R,MTAP:uc031tdc.1:exon6:c.C561T:p.R187R,MTAP:uc031tdd.1:exon6:c.C561T:p.R187R,MTAP:uc031tde.1:exon6:c.C561T:p.R187R	.	AFR:0.0515,AMR:0.0162,EAS:0.1225,FIN:0.0197,NFE:0.0312,OTH:0.0772,ASJ:0.0597	156540	112250;	85182;	85182|Bone dysplasia-medullary fibrosarcoma syndrome<br>Diaphyseal medullary stenosis-malignant fibrous histiocytoma syndrome<br>Hardcastle syndrome|-|Autosomal dominant|-|112250 ~	.	.	.	.	.	.	.	.	9	1(lung)	0.0694
9	27183463	27183463	A	C	TEK	exonic	nonsynonymous SNV	ENSG00000120156	rs682632	ENSG00000120156:ENST00000519080:exon5:c.A467C:p.Q156P,ENSG00000120156:ENST00000519097:exon6:c.A596C:p.Q199P,ENSG00000120156:ENST00000406359:exon7:c.A908C:p.Q303P,ENSG00000120156:ENST00000380036:exon8:c.A1037C:p.Q346P	TEK:NM_001290078:exon6:c.A596C:p.Q199P,TEK:NM_001290077:exon7:c.A908C:p.Q303P,TEK:NM_000459:exon8:c.A1037C:p.Q346P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9733	0.9727	0.989816	0.9758	1.658	14.17	0.411	5.52	0.985	.	.	Immunoglobulin-like fold	TEK:uc003zqj.1:exon6:c.A839C:p.Q280P,TEK:uc011lnp.2:exon6:c.A596C:p.Q199P,TEK:uc011lno.2:exon7:c.A908C:p.Q303P,TEK:uc003zqi.4:exon8:c.A1037C:p.Q346P	-0.934	AFR:0.9924,AMR:0.9905,EAS:1,FIN:0.9720,NFE:0.9639,OTH:0.9674,ASJ:0.9834	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	0.0	-0.81	0.000	-0.345	9	MU81860880	hom
9	27190655	27190655	G	A	TEK	exonic	nonsynonymous SNV	ENSG00000120156	rs1334811	ENSG00000120156:ENST00000519080:exon7:c.G886A:p.V296I,ENSG00000120156:ENST00000519097:exon8:c.G1015A:p.V339I,ENSG00000120156:ENST00000406359:exon9:c.G1327A:p.V443I,ENSG00000120156:ENST00000380036:exon10:c.G1456A:p.V486I	TEK:NM_001290078:exon8:c.G1015A:p.V339I,TEK:NM_001290077:exon9:c.G1327A:p.V443I,TEK:NM_000459:exon10:c.G1456A:p.V486I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0574	0.0750	0.0786741	0.0583	2.625	20.4	0.183	4.65	0.996	.	.	EGF-like domain|EGF-like, conserved site;Fibronectin type III|Immunoglobulin-like fold;Immunoglobulin-like domain|Immunoglobulin-like fold	TEK:uc003zqj.1:exon8:c.G1258A:p.V420I,TEK:uc011lnp.2:exon8:c.G1015A:p.V339I,TEK:uc011lno.2:exon9:c.G1327A:p.V443I,TEK:uc003zqi.4:exon10:c.G1456A:p.V486I	-1.179	AFR:0.1223,AMR:0.0394,EAS:0.0056,FIN:0.0238,NFE:0.0370,OTH:0.0499,ASJ:0.03	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	0.329	0.35	0.002	1.1	9	MU67603859	hom
9	27202870	27202870	A	G	TEK	exonic	synonymous SNV	ENSG00000120156	rs639225	ENSG00000120156:ENST00000519080:exon10:c.A1392G:p.S464S,ENSG00000120156:ENST00000519097:exon11:c.A1521G:p.S507S,ENSG00000120156:ENST00000406359:exon12:c.A1833G:p.S611S,ENSG00000120156:ENST00000380036:exon13:c.A1962G:p.S654S	TEK:NM_001290078:exon11:c.A1521G:p.S507S,TEK:NM_001290077:exon12:c.A1833G:p.S611S,TEK:NM_000459:exon13:c.A1962G:p.S654S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4649	0.4463	0.414337	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	TEK:uc003zqj.1:exon11:c.A1764G:p.S588S,TEK:uc011lnp.2:exon11:c.A1521G:p.S507S,TEK:uc011lno.2:exon12:c.A1833G:p.S611S,TEK:uc003zqi.4:exon13:c.A1962G:p.S654S	.	AFR:0.4777,AMR:0.3685,EAS:0.4033,FIN:0.4114,NFE:0.6298,OTH:0.5107,ASJ:0.5024	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	.	.	.	.	9	1(lung)	0.5132
9	27203134	27203134	A	G	TEK	intronic	.	ENSG00000120156	rs638203	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4657	0.4471	0.414936	LAML-KR|1|205|0.00487805,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.4779,AMR:0.3706,EAS:0.4007,FIN:0.4084,NFE:0.6302,OTH:0.5101,ASJ:0.5012	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	.	.	.	.	9	1(liver)	0.5133
9	27213580	27213580	T	C	TEK	exonic	synonymous SNV	ENSG00000120156	rs3737188	ENSG00000120156:ENST00000519097:exon16:c.T2532C:p.Y844Y,ENSG00000120156:ENST00000406359:exon17:c.T2847C:p.Y949Y,ENSG00000120156:ENST00000380036:exon18:c.T2976C:p.Y992Y	TEK:NM_001290078:exon16:c.T2532C:p.Y844Y,TEK:NM_001290077:exon17:c.T2847C:p.Y949Y,TEK:NM_000459:exon18:c.T2976C:p.Y992Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1937	0.1788	0.153754	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	TEK:uc011lnp.2:exon16:c.T2532C:p.Y844Y,TEK:uc011lno.2:exon17:c.T2847C:p.Y949Y,TEK:uc003zqi.4:exon18:c.T2976C:p.Y992Y	.	AFR:MU142762,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.1009,FIN:0.1647,NFE:0.1424,OTH:0.2154,ASJ:0.1851	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	.	.	.	.	9	2(breast)	0.2484
9	27220066	27220066	G	A	TEK	exonic	synonymous SNV	ENSG00000120156	rs2273719	ENSG00000120156:ENST00000519097:exon19:c.G2679A:p.G893G,ENSG00000120156:ENST00000406359:exon20:c.G2994A:p.G998G,ENSG00000120156:ENST00000380036:exon21:c.G3123A:p.G1041G	TEK:NM_001290078:exon19:c.G2679A:p.G893G,TEK:NM_001290077:exon20:c.G2994A:p.G998G,TEK:NM_000459:exon21:c.G3123A:p.G1041G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1800	0.2246	0.224241	LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	TEK:uc011lnp.2:exon19:c.G2679A:p.G893G,TEK:uc011lno.2:exon20:c.G2994A:p.G998G,TEK:uc003zqi.4:exon21:c.G3123A:p.G1041G	.	AFR:0.2107,AMR:0.3527,EAS:0.1192,FIN:0.1890,NFE:0.1657,OTH:0.1513,ASJ:0.1163	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	.	.	.	.	9	4(haematopoietic_and_lymphoid_tissue)	0.1640
9	32542204	32542204	A	G	TOPORS	exonic	synonymous SNV	ENSG00000197579	rs10971019	ENSG00000197579:ENST00000379858:exon2:c.T2124C:p.S708S,ENSG00000197579:ENST00000360538:exon3:c.T2319C:p.S773S	TOPORS:NM_001195622:exon2:c.T2124C:p.S708S,TOPORS:NM_005802:exon3:c.T2319C:p.S773S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2075	0.1794	0.179113	LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	TOPORS:uc003zrc.3:exon2:c.T2124C:p.S708S,TOPORS:uc003zrb.3:exon3:c.T2319C:p.S773S	.	AFR:0.1688,AMR:0.0925,EAS:0.27,FIN:0.0761,NFE:0.1603,OTH:0.2208,ASJ:0.1647	609507	609923;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	9	1(stomach)	0.2082
9	32635385	32635385	A	G	TAF1L	exonic	synonymous SNV	ENSG00000122728	rs533514923	ENSG00000122728:ENST00000242310:exon1:c.T193C:p.L65L	TAF1L:NM_153809:exon1:c.T193C:p.L65L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0002	.	0.00139776	.	.	.	.	.	.	.	.	.	TAF1L:uc003zrg.1:exon1:c.T193C:p.L65L	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607798	.	.	.	.	.	.	.	.	.	.	.	9	.	het
9	32926463	32926463	-	A	TMEM215;APTX	intergenic	.	ENSG00000223807	rs11396915	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	.	.	.	.	.	.	.	.	.	.	.	.	9	.	het
9	32974570	32974570	-	A	APTX	intronic	.	ENSG00000137074	rs34600530	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.6513	0.5835	0.688698	0.6408	.	.	.	.	.	.	.	.	.	.	AFR:0.5482,AMR:0.7017,EAS:0.8639,FIN:0.6968,NFE:0.6540,OTH:0.6840,ASJ:0.5567	606350	208920;	1168;	1168|AOA1|Unknown|Autosomal recessive|Childhood|208920 ~	.	.	.	.	.	.	.	.	9	.	het
9	32986031	32986031	A	-	APTX	intronic	.	ENSG00000137074	rs373304582	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1653	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606350	208920;	1168;	1168|AOA1|Unknown|Autosomal recessive|Childhood|208920 ~	.	.	.	.	.	.	.	.	9	MU117502	het
9	32986033	32986053	AAAAAAAACAAAAAAAAAAAC	-	APTX	intronic	.	ENSG00000137074	rs200922655	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.2897	.	0.972644	0.4015	.	.	.	.	.	.	.	.	.	.	AFR:0.3327,AMR:0.3850,EAS:0.2309,FIN:0.4089,NFE:0.4560,OTH:0.4133,ASJ:0.4956	606350	208920;	1168;	1168|AOA1|Unknown|Autosomal recessive|Childhood|208920 ~	.	.	.	.	.	.	.	.	9	.	het
9	32986034	32986053	AAAAAAACAAAAAAAAAAAC	-	APTX	intronic	.	ENSG00000137074	rs771925873	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0393	.	.	0.0046	.	.	.	.	.	.	.	.	.	.	AFR:0.0067,AMR:0.0077,EAS:0.0038,FIN:0.0108,NFE:0.0025,OTH:0.0028,ASJ:0.0114	606350	208920;	1168;	1168|AOA1|Unknown|Autosomal recessive|Childhood|208920 ~	.	.	.	.	.	.	.	.	9	.	het
9	35074917	35074917	T	C	FANCG	intronic	.	ENSG00000221829	rs587118	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3957	0.3621	0.220248	0.3611	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.0939,AMR:0.4952,EAS:0.0006,FIN:0.5063,NFE:0.5084,OTH:0.4481,ASJ:0.3808	602956	614082;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	9	MU10698616	hom
9	36840623	36840623	G	A	PAX5	exonic	nonsynonymous SNV	ENSG00000196092	rs3780135	ENSG00000196092:ENST00000520154:exon7:c.C791T:p.T264I,ENSG00000196092:ENST00000523241:exon8:c.C878T:p.T293I	PAX5:NM_001280550:exon7:c.C791T:p.T264I,PAX5:NM_001280549:exon8:c.C878T:p.T293I	clinvar: not_provided 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	0.8687	0.7631	0.742013	COCA-CN|5|321|0.0155763	-0.039	2.223	0.215	2.41	0.999	.	.	.	PAX5:uc010mls.1:exon7:c.C791T:p.T264I,PAX5:uc010mlr.1:exon8:c.C878T:p.T293I	-0.922	AFR:0.7818,AMR:0.3822,EAS:0.8974,FIN:0.8837,NFE:0.9527,OTH:0.9467,ASJ:0.8816	167414	615545;	99860;	99860|B-ALL<br>Precursor B-cell acute lymphoblastic leukemia/lymphoma<br>Precursor B-cell acute lymphocytic leukemia<br>Precursor B-cell acute lymphocytic leukemia/lymphoma|-|-|-|615545 ~	~ko05202 Transcriptional misregulation in cancer ~	,8446	.	.	0.0	-4.59	0.000	.	9	1(thyroid)	0.8949
9	71831398	71831398	T	C	TJP2	intronic	.	ENSG00000119139	rs2498417	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9209	0.9038	0.894169	0.9094	.	.	.	.	.	.	.	.	.	.	AFR:0.8609,AMR:0.9081,EAS:0.9333,FIN:0.9479,NFE:0.9244,OTH:0.9328,ASJ:0.9205	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	.	.	.	.	9	MU81862766	het
9	71843023	71843023	C	A	TJP2	exonic	nonsynonymous SNV	ENSG00000119139	rs2309428	ENSG00000119139:ENST00000265384:exon9:c.C1446A:p.D482E,ENSG00000119139:ENST00000348208:exon9:c.C1446A:p.D482E,ENSG00000119139:ENST00000377245:exon9:c.C1446A:p.D482E,ENSG00000119139:ENST00000535702:exon9:c.C1458A:p.D486E,ENSG00000119139:ENST00000539225:exon9:c.C1539A:p.D513E,ENSG00000119139:ENST00000453658:exon10:c.C1377A:p.D459E	TJP2:NM_001170415:exon9:c.C1458A:p.D486E,TJP2:NM_001170416:exon9:c.C1539A:p.D513E,TJP2:NM_001369872:exon9:c.C1446A:p.D482E,TJP2:NM_001369873:exon9:c.C1446A:p.D482E,TJP2:NM_001369874:exon9:c.C1458A:p.D486E,TJP2:NM_001369875:exon9:c.C1458A:p.D486E,TJP2:NM_004817:exon9:c.C1446A:p.D482E,TJP2:NM_201629:exon9:c.C1446A:p.D482E,TJP2:NM_001170414:exon10:c.C1377A:p.D459E,TJP2:NM_001369870:exon10:c.C1371A:p.D457E,TJP2:NM_001369871:exon11:c.C1377A:p.D459E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8115	0.7580	0.772165	0.7864	-0.778	0.048	1.0	-1.25	0.390	.	.	PDZ domain	TJP2:uc004ahd.3:exon9:c.C1446A:p.D482E,TJP2:uc004ahe.3:exon9:c.C1446A:p.D482E,TJP2:uc004ahf.3:exon9:c.C1446A:p.D482E,TJP2:uc011lru.2:exon9:c.C1458A:p.D486E,TJP2:uc011lrv.2:exon9:c.C1539A:p.D513E,TJP2:uc011lrs.2:exon10:c.C1377A:p.D459E,TJP2:uc011lrt.1:exon11:c.C1377A:p.D459E	-0.968	AFR:0.6611,AMR:0.8616,EAS:0.8906,FIN:0.8698,NFE:0.8210,OTH:0.8310,ASJ:0.7947	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	0.0	3.13	0.000	-0.485	9	MU10854686	hom
9	71862975	71862975	C	T	TJP2	exonic	synonymous SNV	ENSG00000119139	rs2282336	ENSG00000119139:ENST00000265384:exon19:c.C2715T:p.T905T,ENSG00000119139:ENST00000348208:exon19:c.C2715T:p.T905T,ENSG00000119139:ENST00000377245:exon19:c.C2715T:p.T905T,ENSG00000119139:ENST00000535702:exon19:c.C2727T:p.T909T,ENSG00000119139:ENST00000539225:exon19:c.C2808T:p.T936T,ENSG00000119139:ENST00000453658:exon20:c.C2646T:p.T882T	TJP2:NM_001170415:exon19:c.C2727T:p.T909T,TJP2:NM_001170416:exon19:c.C2808T:p.T936T,TJP2:NM_001369872:exon19:c.C2715T:p.T905T,TJP2:NM_001369874:exon19:c.C2727T:p.T909T,TJP2:NM_001369875:exon19:c.C2727T:p.T909T,TJP2:NM_004817:exon19:c.C2715T:p.T905T,TJP2:NM_201629:exon19:c.C2715T:p.T905T,TJP2:NM_001170414:exon20:c.C2646T:p.T882T,TJP2:NM_001369870:exon20:c.C2640T:p.T880T,TJP2:NM_001369871:exon21:c.C2646T:p.T882T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2614	0.1975	0.284145	MU10854788	.	.	.	.	.	.	.	.	TJP2:uc010mom.1:exon2:c.C195T:p.T65T,TJP2:uc004ahd.3:exon19:c.C2715T:p.T905T,TJP2:uc004ahe.3:exon19:c.C2715T:p.T905T,TJP2:uc004ahf.3:exon19:c.C2715T:p.T905T,TJP2:uc011lru.2:exon19:c.C2727T:p.T909T,TJP2:uc011lrv.2:exon19:c.C2808T:p.T936T,TJP2:uc011lrs.2:exon20:c.C2646T:p.T882T	.	AFR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.2233,EAS:0.4856,FIN:0.1523,NFE:0.4249,OTH:0.2242,ASJ:0.1776	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	.	.	.	.	9	2(haematopoietic_and_lymphoid_tissue)	0.2139
9	71862987	71862987	G	A	TJP2	exonic	synonymous SNV	ENSG00000119139	rs2095876	ENSG00000119139:ENST00000265384:exon19:c.G2727A:p.A909A,ENSG00000119139:ENST00000348208:exon19:c.G2727A:p.A909A,ENSG00000119139:ENST00000377245:exon19:c.G2727A:p.A909A,ENSG00000119139:ENST00000535702:exon19:c.G2739A:p.A913A,ENSG00000119139:ENST00000539225:exon19:c.G2820A:p.A940A,ENSG00000119139:ENST00000453658:exon20:c.G2658A:p.A886A	TJP2:NM_001170415:exon19:c.G2739A:p.A913A,TJP2:NM_001170416:exon19:c.G2820A:p.A940A,TJP2:NM_001369872:exon19:c.G2727A:p.A909A,TJP2:NM_001369874:exon19:c.G2739A:p.A913A,TJP2:NM_001369875:exon19:c.G2739A:p.A913A,TJP2:NM_004817:exon19:c.G2727A:p.A909A,TJP2:NM_201629:exon19:c.G2727A:p.A909A,TJP2:NM_001170414:exon20:c.G2658A:p.A886A,TJP2:NM_001369870:exon20:c.G2652A:p.A884A,TJP2:NM_001369871:exon21:c.G2658A:p.A886A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2606	0.1974	0.284145	ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	TJP2:uc010mom.1:exon2:c.G207A:p.A69A,TJP2:uc004ahd.3:exon19:c.G2727A:p.A909A,TJP2:uc004ahe.3:exon19:c.G2727A:p.A909A,TJP2:uc004ahf.3:exon19:c.G2727A:p.A909A,TJP2:uc011lru.2:exon19:c.G2739A:p.A913A,TJP2:uc011lrv.2:exon19:c.G2820A:p.A940A,TJP2:uc011lrs.2:exon20:c.G2658A:p.A886A	.	AFR:0.2231,AMR:0.1773,EAS:0.1533,FIN:0.4200,NFE:0.2241,OTH:0.2140,ASJ:0.4868	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	.	.	.	.	9	1(liver)	0.2367
9	71865932	71865932	G	A	TJP2	intronic	.	ENSG00000119139	rs2282335	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3704	0.4050	0.359824	MU44530448	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.4030,EAS:0.2333,FIN:0.4238,NFE:0.1483,OTH:0.4587,ASJ:0.4565	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	.	.	.	.	9	1(liver)	0.3941
9	72897434	72897434	G	A	SMC5	exonic	nonsynonymous SNV	ENSG00000198887	rs1180116	ENSG00000198887:ENST00000361138:exon7:c.G916A:p.V306I	SMC5:NM_015110:exon7:c.G916A:p.V306I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8824	0.8558	0.855032	0.8686	0.072	3.315	0.655	-1.31	0.909	.	.	RecF/RecN/SMC, N-terminal	SMC5:uc004ahr.2:exon7:c.G916A:p.V306I	-1.035	AFR:0.7743,AMR:0.8849,EAS:0.8476,FIN:0.9321,NFE:0.9100,OTH:0.8845,ASJ:0.8146	609386	.	.	.	.	.	.	.	0.0	2.34	0.000	0	9	MU25197989	unknown
9	72897440	72897440	T	C	SMC5	exonic	nonsynonymous SNV	ENSG00000198887	rs1180117	ENSG00000198887:ENST00000361138:exon7:c.T922C:p.C308R	SMC5:NM_015110:exon7:c.T922C:p.C308R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2104	0.2154	0.246006	0.2132	-0.634	0.103	1.0	2.61	0.833	.	.	RecF/RecN/SMC, N-terminal	SMC5:uc004ahr.2:exon7:c.T922C:p.C308R	-0.917	AFR:0.2456,AMR:0.1456,EAS:0.2481,FIN:0.2002,NFE:0.1994,OTH:0.1953,ASJ:0.1788	609386	.	.	.	.	.	.	.	0.0	2.38	0.000	-0.59	9	MU13487471	unknown
9	72901096	72901096	T	C	SMC5	intronic	.	ENSG00000198887	rs1180123	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9933	0.9749	0.978235	0.9800	.	.	.	.	.	.	.	.	.	.	AFR:0.9295,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9927,ASJ:1	609386	.	.	.	.	.	.	.	.	.	.	.	9	MU81862879	hom
9	72929769	72929769	C	T	SMC5	intronic	.	ENSG00000198887	rs11142363	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2222	0.2002	0.246406	0.2137	.	.	.	.	.	.	.	.	.	.	AFR:0.2463,AMR:0.1459,EAS:0.2509,FIN:0.2001,NFE:0.1993,OTH:0.1971,ASJ:0.1788	609386	.	.	.	.	.	.	.	.	.	.	.	9	MU20828691	het
9	72962509	72962509	-	T	SMC5	intronic	.	ENSG00000198887	rs539828240	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0033	.	0.00159744	0.0002	.	.	.	.	.	.	.	.	.	.	AFR:0.0001,AMR:0,EAS:0.0037,FIN:0,NFE:0,OTH:0,ASJ:0	609386	.	.	.	.	.	.	.	.	.	.	.	9	.	het
9	80343587	80343587	-	A	GNAQ	intronic	.	ENSG00000156052	rs397773021	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.4414	0.4315	0.372005	0.6019	.	.	.	.	.	.	.	.	.	.	AFR:0.4886,AMR:0.5915,EAS:0.4121,FIN:0.5959,NFE:0.6915,OTH:0.6529,ASJ:0.6763	600998	163000;185300;	3205;624;	3205|Encephalofacial angiomatosis<br>Encephalotrigeminal angiomatosis<br>SWS<br>Sturge-Weber-Dimitri syndrome<br>Sturge-Weber-Krabbe angiomatosis<br>Sturge-Weber-Krabbe syndrome|1-9 / 100 000|Not applicable|Infancy<br>Neonatal<br>Childhood<br>Adolescent|185300 ~624|Familial multiple port-wine stains|-|-|Neonatal|163000 ~	~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04071 Sphingolipid signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04713 Circadian entrainment~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04745 Phototransduction - fly~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	9	.	het
9	86617265	86617265	A	G	RMI1	exonic	nonsynonymous SNV	ENSG00000178966	rs1982151	ENSG00000178966:ENST00000325875:exon3:c.A1364G:p.N455S	RMI1:NM_001358291:exon3:c.A1364G:p.N455S,RMI1:NM_001358294:exon3:c.A1364G:p.N455S,RMI1:NM_024945:exon3:c.A1364G:p.N455S,RMI1:NM_001358292:exon4:c.A1364G:p.N455S,RMI1:NM_001358293:exon4:c.A1364G:p.N455S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7152	0.6857	0.671126	0.6902	-3.981	0.001	1.0	-2.97	0.162	.	.	.	RMI1:uc022bjb.1:exon1:c.A1364G:p.N455S,RMI1:uc004ans.4:exon2:c.A1364G:p.N455S,RMI1:uc004anp.4:exon3:c.A1364G:p.N455S,RMI1:uc004anq.4:exon3:c.A1364G:p.N455S,RMI1:uc004anr.4:exon4:c.A1364G:p.N455S	-0.986	AFR:0.5670,AMR:0.8381,EAS:0.7447,FIN:0.7441,NFE:0.7344,OTH:0.6944,ASJ:0.7119	610404	.	.	.	.	.	.	.	0.0	1.57	0.000	-1.15	9	MU14191257	het
9	90322023	90322023	G	A	DAPK1	exonic	nonsynonymous SNV	ENSG00000196730	rs1056719	ENSG00000196730:ENST00000491893:exon24:c.G3839A:p.S1280N,ENSG00000196730:ENST00000358077:exon26:c.G4037A:p.S1346N,ENSG00000196730:ENST00000408954:exon26:c.G4037A:p.S1346N,ENSG00000196730:ENST00000472284:exon26:c.G4037A:p.S1346N,ENSG00000196730:ENST00000469640:exon27:c.G4112A:p.S1371N	DAPK1:NM_001288729:exon26:c.G4037A:p.S1346N,DAPK1:NM_001288730:exon26:c.G4037A:p.S1346N,DAPK1:NM_001288731:exon26:c.G4037A:p.S1346N,DAPK1:NM_004938:exon26:c.G4037A:p.S1346N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6672	0.5858	0.65595	MU4558958	-2.158	0.001	0.528	-2.04	0.011	.	.	Death domain|Death-like domain	DAPK1:uc004apg.2:exon1:c.G968A:p.S323N,DAPK1:uc011ltg.2:exon24:c.G3839A:p.S1280N,DAPK1:uc011lth.2:exon24:c.G3248A:p.S1083N,DAPK1:uc004apc.3:exon26:c.G4037A:p.S1346N,DAPK1:uc004apd.3:exon26:c.G4037A:p.S1346N	-0.943	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763,AML-US|1|166|0.0060241,AMR:0.5999,EAS:0.7290,FIN:0.6424,NFE:0.8327,OTH:0.6407,ASJ:0.4523	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	0.0	-1.98	0.000	-0.14	9	71(lung)	0.6415
9	93606309	93606309	G	A	SYK	exonic	synonymous SNV	ENSG00000165025	rs35758162	ENSG00000165025:ENST00000375746:exon2:c.G129A:p.Q43Q,ENSG00000165025:ENST00000375747:exon2:c.G129A:p.Q43Q,ENSG00000165025:ENST00000375751:exon2:c.G129A:p.Q43Q,ENSG00000165025:ENST00000375754:exon2:c.G129A:p.Q43Q	SYK:NM_001135052:exon2:c.G129A:p.Q43Q,SYK:NM_001174167:exon2:c.G129A:p.Q43Q,SYK:NM_001174168:exon2:c.G129A:p.Q43Q,SYK:NM_003177:exon2:c.G129A:p.Q43Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1781	0.1787	0.111022	0.1537	.	.	.	.	.	.	.	.	SYK:uc004aqz.3:exon2:c.G129A:p.Q43Q,SYK:uc004ara.3:exon2:c.G129A:p.Q43Q,SYK:uc004arb.3:exon2:c.G129A:p.Q43Q,SYK:uc004arc.3:exon2:c.G129A:p.Q43Q	.	AFR:0.1133,AMR:0.0885,EAS:0.0105,FIN:0.1162,NFE:0.2026,OTH:0.1690,ASJ:0.2285	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	MU113484569	hom
9	93639849	93639849	G	A	SYK	intronic	.	ENSG00000165025	rs2290889	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0681	0.0507	0.0846645	0.0566	.	.	.	.	.	0	0.002	.	.	.	AFR:0.0454,AMR:0.0513,EAS:0.0568,FIN:0.0716,NFE:0.0596,OTH:0.0743,ASJ:0.0166	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	.	het
9	95947478	95947478	C	T	WNK2	exonic	synonymous SNV	ENSG00000165238	rs141292063	ENSG00000165238:ENST00000297954:exon1:c.C267T:p.A89A,ENSG00000165238:ENST00000395475:exon1:c.C225T:p.A75A,ENSG00000165238:ENST00000395477:exon1:c.C267T:p.A89A,ENSG00000165238:ENST00000448039:exon1:c.C267T:p.A89A	WNK2:NM_001282394:exon1:c.C267T:p.A89A,WNK2:NM_006648:exon1:c.C267T:p.A89A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3478	.	0.188099	0.1837	.	.	.	.	.	.	.	.	WNK2:uc004ati.1:exon1:c.C267T:p.A89A,WNK2:uc004atj.3:exon1:c.C267T:p.A89A,WNK2:uc010mrc.1:exon1:c.C267T:p.A89A,WNK2:uc011lud.1:exon1:c.C267T:p.A89A	.	AFR:0.2845,AMR:0.1137,EAS:0.0761,FIN:0.1573,NFE:0.1434,OTH:0.1667,ASJ:0.1777	606249	.	.	.	.	.	.	.	.	.	.	.	9	.	hom
9	95993326	95993326	T	C	WNK2	exonic	synonymous SNV	ENSG00000165238	rs11787888	ENSG00000165238:ENST00000297954:exon3:c.T1011C:p.S337S,ENSG00000165238:ENST00000395475:exon3:c.T969C:p.S323S,ENSG00000165238:ENST00000395477:exon3:c.T1011C:p.S337S,ENSG00000165238:ENST00000448039:exon3:c.T1011C:p.S337S	WNK2:NM_001282394:exon3:c.T1011C:p.S337S,WNK2:NM_006648:exon3:c.T1011C:p.S337S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1490	0.1267	0.148562	0.1281	.	.	.	.	.	.	.	.	WNK2:uc004ati.1:exon3:c.T1011C:p.S337S,WNK2:uc004atj.3:exon3:c.T1011C:p.S337S,WNK2:uc010mrc.1:exon3:c.T1011C:p.S337S,WNK2:uc011lud.1:exon3:c.T1011C:p.S337S	.	AFR:0.0991,AMR:0.0861,EAS:0.0742,FIN:0.1721,NFE:0.1403,OTH:0.1527,ASJ:0.1722	606249	.	.	.	.	.	.	.	.	.	.	.	9	.	het
9	96000622	96000622	C	T	WNK2	intronic	.	ENSG00000165238	rs1539670	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9482	0.9682	0.94349	0.9599	.	.	.	.	.	.	.	.	.	.	AFR:0.9757,AMR:0.9773,EAS:0.8938,FIN:0.9550,NFE:0.9595,OTH:0.95,ASJ:0.9205	606249	.	.	.	.	.	.	.	.	.	.	.	9	MU82109719	hom
9	96015256	96015256	C	T	WNK2	exonic	synonymous SNV	ENSG00000165238	rs4744201	ENSG00000165238:ENST00000297954:exon8:c.C1926T:p.D642D,ENSG00000165238:ENST00000349097:exon8:c.C762T:p.D254D,ENSG00000165238:ENST00000395475:exon8:c.C1884T:p.D628D,ENSG00000165238:ENST00000395477:exon8:c.C1926T:p.D642D,ENSG00000165238:ENST00000427277:exon8:c.C762T:p.D254D,ENSG00000165238:ENST00000448039:exon8:c.C1926T:p.D642D	WNK2:NM_001282394:exon8:c.C1926T:p.D642D,WNK2:NM_006648:exon8:c.C1926T:p.D642D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4840	0.3729	0.316094	0.3945	.	.	.	.	.	.	.	.	WNK2:uc004atk.3:exon5:c.C837T:p.D279D,WNK2:uc004ati.1:exon8:c.C1926T:p.D642D,WNK2:uc004atj.3:exon8:c.C1926T:p.D642D,WNK2:uc010mrc.1:exon8:c.C1926T:p.D642D,WNK2:uc011lud.1:exon8:c.C1926T:p.D642D	.	AFR:0.1299,AMR:0.6067,EAS:0.4387,FIN:0.4745,NFE:0.5109,OTH:0.4356,ASJ:0.3940	606249	.	.	.	.	.	.	.	.	.	.	.	9	MU684061	het
9	96015377	96015377	A	G	WNK2	intronic	.	ENSG00000165238	rs4744202	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9528	0.9707	0.948283	0.9646	.	.	.	.	.	.	.	.	.	.	AFR:0.9917,AMR:0.9785,EAS:0.8936,FIN:0.9548,NFE:0.9597,OTH:0.9499,ASJ:0.9238	606249	.	.	.	.	.	.	.	.	.	.	.	9	MU81864351	hom
9	96021312	96021312	G	A	WNK2	exonic	nonsynonymous SNV	ENSG00000165238	rs10761203	ENSG00000165238:ENST00000395475:exon10:c.G2284A:p.V762M,ENSG00000165238:ENST00000448039:exon10:c.G2326A:p.V776M,ENSG00000165238:ENST00000297954:exon11:c.G2482A:p.V828M,ENSG00000165238:ENST00000349097:exon11:c.G1318A:p.V440M,ENSG00000165238:ENST00000395477:exon11:c.G2482A:p.V828M,ENSG00000165238:ENST00000427277:exon11:c.G1318A:p.V440M	WNK2:NM_001282394:exon11:c.G2482A:p.V828M,WNK2:NM_006648:exon11:c.G2482A:p.V828M	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.4327	0.3680	0.313498	2(thyroid)	2.757	21.1	0.013	2.9	0.024	.	.	.	WNK2:uc004atk.3:exon8:c.G1393A:p.V465M,WNK2:uc010mrc.1:exon10:c.G2326A:p.V776M,WNK2:uc004ati.1:exon11:c.G2482A:p.V828M,WNK2:uc004atj.3:exon11:c.G2482A:p.V828M,WNK2:uc011lud.1:exon11:c.G2482A:p.V828M	-0.915	AFR:MU4551848,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,GACA-JP|1|585|0.0017094,EAS:0.1329,FIN:0.6014,NFE:0.3933,OTH:0.4368,ASJ:0.3837	606249	.	.	.	.	.	.	.	0.675	-0.72	0.000	2.35	9	52(lung)	0.4357
9	96051521	96051521	A	G	WNK2	exonic	synonymous SNV	ENSG00000165238	rs2169756	ENSG00000165238:ENST00000395477:exon19:c.A4485G:p.Q1495Q,ENSG00000165238:ENST00000427277:exon19:c.A3321G:p.Q1107Q,ENSG00000165238:ENST00000297954:exon20:c.A4596G:p.Q1532Q,ENSG00000165238:ENST00000349097:exon20:c.A3432G:p.Q1144Q	WNK2:NM_006648:exon19:c.A4485G:p.Q1495Q,WNK2:NM_001282394:exon20:c.A4596G:p.Q1532Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9500	0.9056	0.920527	0.9124	.	.	.	.	.	.	.	.	WNK2:uc004atl.1:exon1:c.A270G:p.Q90Q,WNK2:uc004atk.3:exon16:c.A3396G:p.Q1132Q,WNK2:uc004atj.3:exon19:c.A4485G:p.Q1495Q,WNK2:uc011lud.1:exon19:c.A4485G:p.Q1495Q,WNK2:uc004ati.1:exon20:c.A4596G:p.Q1532Q	.	AFR:0.7950,AMR:0.9749,EAS:1,FIN:0.9708,NFE:0.9491,OTH:0.9641,ASJ:0.9934	606249	.	.	.	.	.	.	.	.	.	.	.	9	MU67319	hom
9	96055063	96055063	C	T	WNK2	exonic	synonymous SNV	ENSG00000165238	rs41278286	ENSG00000165238:ENST00000356055:exon22:c.C408T:p.D136D,ENSG00000165238:ENST00000395477:exon22:c.C5316T:p.D1772D,ENSG00000165238:ENST00000427277:exon22:c.C4152T:p.D1384D,ENSG00000165238:ENST00000297954:exon23:c.C5427T:p.D1809D,ENSG00000165238:ENST00000349097:exon23:c.C4263T:p.D1421D	WNK2:NM_006648:exon22:c.C5316T:p.D1772D,WNK2:NM_001282394:exon23:c.C5427T:p.D1809D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4516	0.3056	0.392372	1(thyroid)	.	.	.	.	.	.	.	.	WNK2:uc004atl.1:exon4:c.C1098T:p.D366D,WNK2:uc004atk.3:exon19:c.C4227T:p.D1409D,WNK2:uc004atj.3:exon22:c.C5316T:p.D1772D,WNK2:uc011lud.1:exon22:c.C5316T:p.D1772D,WNK2:uc004ati.1:exon23:c.C5427T:p.D1809D	.	AFR:MU131383,AMR:COCA-CN|3|321|0.00934579,EAS:0.3474,FIN:0.2625,NFE:0.37,OTH:0.3994,ASJ:0.3147	606249	.	.	.	.	.	.	.	.	.	.	.	9	1(breast)	0.3024
9	98209594	98209594	G	A	PTCH1	exonic	nonsynonymous SNV	ENSG00000185920	rs357564	ENSG00000185920:ENST00000331920:exon23:c.C3944T:p.P1315L,ENSG00000185920:ENST00000375274:exon23:c.C3941T:p.P1314L,ENSG00000185920:ENST00000418258:exon23:c.C3491T:p.P1164L,ENSG00000185920:ENST00000421141:exon23:c.C3491T:p.P1164L,ENSG00000185920:ENST00000429896:exon23:c.C3491T:p.P1164L,ENSG00000185920:ENST00000430669:exon23:c.C3746T:p.P1249L,ENSG00000185920:ENST00000437951:exon23:c.C3746T:p.P1249L	PTCH1:NM_001354918:exon22:c.C3788T:p.P1263L,PTCH1:NM_000264:exon23:c.C3944T:p.P1315L,PTCH1:NM_001083602:exon23:c.C3746T:p.P1249L,PTCH1:NM_001083603:exon23:c.C3941T:p.P1314L,PTCH1:NM_001083604:exon23:c.C3491T:p.P1164L,PTCH1:NM_001083605:exon23:c.C3491T:p.P1164L,PTCH1:NM_001083606:exon23:c.C3491T:p.P1164L,PTCH1:NM_001083607:exon23:c.C3491T:p.P1164L	clinvar: Benign 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, 2, 1, 1] 	0.3855	0.2993	0.396765	1(biliary_tract)	6.218	28.8	0.025	4.83	0.995	.	.	.	PTCH1:uc010mrn.3:exon2:c.C320T:p.P107L,PTCH1:uc004avk.4:exon23:c.C3944T:p.P1315L,PTCH1:uc004avl.4:exon23:c.C3491T:p.P1164L,PTCH1:uc004avm.4:exon23:c.C3941T:p.P1314L,PTCH1:uc010mro.3:exon23:c.C3491T:p.P1164L,PTCH1:uc010mrp.3:exon23:c.C3491T:p.P1164L,PTCH1:uc010mrq.3:exon23:c.C3491T:p.P1164L,PTCH1:uc010mrr.3:exon23:c.C3746T:p.P1249L	-1.000	AFR:1(bone),AMR:2(pancreas),EAS:2(lung),FIN:11(soft_tissue),NFE:1(large_intestine),OTH:MU148935,ASJ:3(penis)	601309	109400;605462;610828;	2162;377;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04024 cAMP signaling pathway~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05217 Basal cell carcinoma ~	,9110,9113,9111,9112,9114	.	.	0.944	-2.76	0.000	2.295	9	3(haematopoietic_and_lymphoid_tissue)	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,BOCA-UK|1|130|0.00769231,BRCA-KR|1|50|0.02
9	110081018	110081018	A	G	RAD23B	intronic	.	ENSG00000119318	rs1805335	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5495	0.5537	0.579073	0.5503	.	.	.	.	.	.	.	.	.	.	AFR:0.5487,AMR:0.5383,EAS:0.7920,FIN:0.5692,NFE:0.5193,OTH:0.5463,ASJ:0.6567	600062	.	.	.	.	.	.	.	.	.	.	.	9	MU81865700	hom
9	111641825	111641825	G	A	ELP1	exonic	nonsynonymous SNV	ENSG00000070061	rs1538660	ENSG00000070061:ENST00000537196:exon26:c.C2426T:p.P809L,ENSG00000070061:ENST00000374647:exon33:c.C3473T:p.P1158L	ELP1:NM_001330749:exon31:c.C2426T:p.P809L,ELP1:NM_001318360:exon33:c.C3131T:p.P1044L,ELP1:NM_003640:exon33:c.C3473T:p.P1158L	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1988	0.2119	0.245008	MU91184	0.517	7.563	0.721	2.96	0.890	.	.	.	IKBKAP:uc004bdk.3:exon6:c.C485T:p.P162L,IKBKAP:uc004bdl.3:exon25:c.C2426T:p.P809L,IKBKAP:uc010mtq.3:exon26:c.C2426T:p.P809L,IKBKAP:uc004bdm.4:exon33:c.C3473T:p.P1158L,IKBKAP:uc011lwc.2:exon33:c.C3131T:p.P1044L	-0.951	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,AMR:0.2276,EAS:0.1663,FIN:0.1933,NFE:0.2882,OTH:0.1850,ASJ:0.3180	603722	223900;	1764;	1764|HSAN3<br>Hereditary sensory and autonomic neuropathy type 3<br>Riley-Day syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|223900 ~	.	.	.	.	0.002	2.05	0.000	1.74	9	1(thyroid)	0.1845
9	111651620	111651620	A	T	ELP1	exonic	nonsynonymous SNV	ENSG00000070061	rs3204145	ENSG00000070061:ENST00000537196:exon22:c.T2167A:p.C723S,ENSG00000070061:ENST00000374647:exon29:c.T3214A:p.C1072S	ELP1:NM_001330749:exon27:c.T2167A:p.C723S,ELP1:NM_001318360:exon29:c.T2872A:p.C958S,ELP1:NM_003640:exon29:c.T3214A:p.C1072S	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1984	0.2125	0.245807	MU91204	2.245	17.80	0.012	5.51	0.995	.	.	.	IKBKAP:uc004bdk.3:exon2:c.T226A:p.C76S,IKBKAP:uc004bdl.3:exon21:c.T2167A:p.C723S,IKBKAP:uc010mtq.3:exon22:c.T2167A:p.C723S,IKBKAP:uc004bdm.4:exon29:c.T3214A:p.C1072S,IKBKAP:uc011lwc.2:exon29:c.T2872A:p.C958S	-0.989	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,AMR:0.2278,EAS:0.1659,FIN:0.1987,NFE:0.2899,OTH:0.1853,ASJ:0.3190	603722	223900;	1764;	1764|HSAN3<br>Hereditary sensory and autonomic neuropathy type 3<br>Riley-Day syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|223900 ~	.	.	.	.	0.0	1.75	0.000	-0.345	9	2(lung)	0.1843
9	111688828	111688828	C	T	ELP1	exonic	synonymous SNV	ENSG00000070061	rs2230788	ENSG00000070061:ENST00000374647:exon5:c.G441A:p.Q147Q	ELP1:NM_001318360:exon5:c.G99A:p.Q33Q,ELP1:NM_003640:exon5:c.G441A:p.Q147Q	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0936	0.0733	0.0798722	MU4567391	.	.	.	.	.	.	.	.	IKBKAP:uc004bdm.4:exon5:c.G441A:p.Q147Q,IKBKAP:uc011lwc.2:exon5:c.G99A:p.Q33Q	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.0864,EAS:0.1205,FIN:0.1589,NFE:0.1171,OTH:0.1113,ASJ:0.0396	603722	223900;	1764;	1764|HSAN3<br>Hereditary sensory and autonomic neuropathy type 3<br>Riley-Day syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|223900 ~	.	.	.	.	.	.	.	.	9	1(stomach)	0.1001
9	120475302	120475302	A	G	TLR4	exonic	nonsynonymous SNV	ENSG00000136869	rs4986790	ENSG00000136869:ENST00000355622:exon3:c.A896G:p.D299G,ENSG00000136869:ENST00000394487:exon4:c.A776G:p.D259G	TLR4:NM_138557:exon2:c.A296G:p.D99G,TLR4:NM_138554:exon3:c.A896G:p.D299G,TLR4:NM_003266:exon4:c.A776G:p.D259G	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, -1, 1, 0] 	0.0599	0.0639	0.0599042	0.0661	0.388	6.513	0.093	4.64	0.002	.	.	Leucine-rich repeat domain, L domain-like	TLR4:uc004bkb.4:exon2:c.A296G:p.D99G,TLR4:uc004bjz.4:exon3:c.A896G:p.D299G,TLR4:uc004bka.4:exon4:c.A776G:p.D259G	-1.094	AFR:0.0753,AMR:0.0394,EAS:0.0006,FIN:0.0933,NFE:0.0624,OTH:0.0733,ASJ:0.0629	603030	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05132 Salmonella infection~ko05133 Pertussis~ko05134 Legionellosis~ko05135 Yersinia infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05144 Malaria~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05162 Measles~ko05164 Influenza A~ko05170 Human immunodeficiency virus 1 infection~ko05205 Proteoglycans in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD)~ko05323 Rheumatoid arthritis ~	.	.	.	0.026	2.03	0.004	2.415	9	.	het
9	120475602	120475602	C	T	TLR4	exonic	nonsynonymous SNV	ENSG00000136869	rs4986791	ENSG00000136869:ENST00000355622:exon3:c.C1196T:p.T399I,ENSG00000136869:ENST00000394487:exon4:c.C1076T:p.T359I	TLR4:NM_138557:exon2:c.C596T:p.T199I,TLR4:NM_138554:exon3:c.C1196T:p.T399I,TLR4:NM_003266:exon4:c.C1076T:p.T359I	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, -1, 1, 0] 	0.0552	0.0470	0.0407348	0.0503	1.414	12.86	0.024	0.434	0.005	.	.	Leucine-rich repeat domain, L domain-like	TLR4:uc004bkb.4:exon2:c.C596T:p.T199I,TLR4:uc004bjz.4:exon3:c.C1196T:p.T399I,TLR4:uc004bka.4:exon4:c.C1076T:p.T359I	-0.956	AFR:0.0155,AMR:0.0323,EAS:0.0012,FIN:0.0933,NFE:0.0653,OTH:0.0714,ASJ:0.0563	603030	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05132 Salmonella infection~ko05133 Pertussis~ko05134 Legionellosis~ko05135 Yersinia infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05144 Malaria~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05162 Measles~ko05164 Influenza A~ko05170 Human immunodeficiency virus 1 infection~ko05205 Proteoglycans in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD)~ko05323 Rheumatoid arthritis ~	.	.	.	0.177	5.4	0.001	1.305	9	.	het
9	131085373	131085373	G	C	COQ4	exonic	nonsynonymous SNV	ENSG00000167113	rs3003601	ENSG00000167113:ENST00000300452:exon2:c.G149C:p.G50A,ENSG00000167113:ENST00000372875:exon2:c.G149C:p.G50A,ENSG00000167113:ENST00000608951:exon2:c.G149C:p.G50A,ENSG00000167113:ENST00000609948:exon2:c.G149C:p.G50A	COQ4:NM_001305942:exon2:c.G149C:p.G50A,COQ4:NM_016035:exon2:c.G149C:p.G50A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9988	0.9970	0.998003	0.9967	-0.680	0.080	1.0	-2.65	0.956	.	.	.	COQ4:uc010mxy.3:exon1:c.G77C:p.G26A,COQ4:uc004bur.4:exon2:c.G149C:p.G50A,COQ4:uc011max.1:exon2:c.G149C:p.G50A	-1.009	AFR:0.9890,AMR:0.9988,EAS:1,FIN:1,NFE:0.9997,OTH:0.9980,ASJ:1	612898	616276;	457185;	457185|COQ4-related neonatal encephalomyopathy|<1 / 1 000 000|Autosomal recessive|Neonatal|616276 ~	.	.	.	.	0.001	1.13	0.000	-1.765	9	MU81869115	hom
9	131346218	131346218	A	C	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs10760566	ENSG00000197694:ENST00000358161:exon16:c.A2163C:p.A721A,ENSG00000197694:ENST00000372731:exon16:c.A2163C:p.A721A,ENSG00000197694:ENST00000372739:exon16:c.A2163C:p.A721A	SPTAN1:NM_001130438:exon16:c.A2163C:p.A721A,SPTAN1:NM_001195532:exon16:c.A2163C:p.A721A,SPTAN1:NM_001363759:exon16:c.A2163C:p.A721A,SPTAN1:NM_001363765:exon16:c.A2163C:p.A721A,SPTAN1:NM_003127:exon16:c.A2163C:p.A721A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9914	0.9701	0.969848	0.9713	.	.	.	.	.	.	.	.	SPTAN1:uc004bvl.4:exon16:c.A2163C:p.A721A,SPTAN1:uc004bvm.4:exon16:c.A2163C:p.A721A,SPTAN1:uc004bvn.4:exon16:c.A2163C:p.A721A,SPTAN1:uc011mbg.2:exon16:c.A2163C:p.A721A,SPTAN1:uc011mbh.2:exon17:c.A2199C:p.A733A	.	AFR:0.8996,AMR:0.9952,EAS:1,FIN:1,NFE:0.9998,OTH:0.9939,ASJ:1	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	MU81869219	hom
9	131360750	131360750	C	T	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs2227864	ENSG00000197694:ENST00000358161:exon25:c.C3486T:p.L1162L,ENSG00000197694:ENST00000372731:exon25:c.C3486T:p.L1162L,ENSG00000197694:ENST00000372739:exon25:c.C3486T:p.L1162L	SPTAN1:NM_001195532:exon24:c.C3426T:p.L1142L,SPTAN1:NM_001363765:exon24:c.C3426T:p.L1142L,SPTAN1:NM_001130438:exon25:c.C3486T:p.L1162L,SPTAN1:NM_001363759:exon25:c.C3486T:p.L1162L,SPTAN1:NM_003127:exon25:c.C3486T:p.L1162L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8064	0.7604	0.642772	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SPTAN1:uc004bvn.4:exon24:c.C3426T:p.L1142L,SPTAN1:uc011mbg.2:exon24:c.C3426T:p.L1142L,SPTAN1:uc004bvl.4:exon25:c.C3486T:p.L1162L,SPTAN1:uc004bvm.4:exon25:c.C3486T:p.L1162L,SPTAN1:uc011mbh.2:exon26:c.C3522T:p.L1174L	.	AFR:0.7491,AMR:0.4777,EAS:0.9172,FIN:0.5161,NFE:0.8242,OTH:0.9048,ASJ:0.7828	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	1(salivary_gland)	0.8160
9	131374144	131374144	G	A	MIR1268A	ncRNA_intronic	.	ENSG00000197694	rs200959763	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 2, 0, 0, 0] 	0.0024	7.7e-05	0.00279553	6.457e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.661e-05,OTH:0.0010,ASJ:0	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	MU16452711	het
9	131375701	131375701	A	G	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs1415568	ENSG00000197694:ENST00000372731:exon39:c.A5070G:p.L1690L,ENSG00000197694:ENST00000358161:exon40:c.A5085G:p.L1695L,ENSG00000197694:ENST00000372739:exon40:c.A5085G:p.L1695L	SPTAN1:NM_001195532:exon38:c.A5010G:p.L1670L,SPTAN1:NM_001363765:exon39:c.A5025G:p.L1675L,SPTAN1:NM_003127:exon39:c.A5070G:p.L1690L,SPTAN1:NM_001130438:exon40:c.A5085G:p.L1695L,SPTAN1:NM_001363759:exon40:c.A5085G:p.L1695L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9959	0.9854	0.984824	0.9846	.	.	.	.	.	.	.	.	SPTAN1:uc004bvn.4:exon38:c.A5010G:p.L1670L,SPTAN1:uc004bvl.4:exon39:c.A5070G:p.L1690L,SPTAN1:uc004bvm.4:exon40:c.A5085G:p.L1695L	.	AFR:0.9466,AMR:0.9952,EAS:1,FIN:1,NFE:0.9999,OTH:0.9939,ASJ:1	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	MU81869234	hom
9	131379967	131379967	C	T	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs2227862	ENSG00000197694:ENST00000372731:exon41:c.C5391T:p.T1797T,ENSG00000197694:ENST00000358161:exon42:c.C5406T:p.T1802T,ENSG00000197694:ENST00000372739:exon42:c.C5406T:p.T1802T	SPTAN1:NM_001195532:exon40:c.C5331T:p.T1777T,SPTAN1:NM_001363765:exon41:c.C5346T:p.T1782T,SPTAN1:NM_003127:exon41:c.C5391T:p.T1797T,SPTAN1:NM_001130438:exon42:c.C5406T:p.T1802T,SPTAN1:NM_001363759:exon42:c.C5406T:p.T1802T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7913	0.7328	0.617013	MU4566604	.	.	.	.	.	.	.	.	SPTAN1:uc004bvn.4:exon40:c.C5331T:p.T1777T,SPTAN1:uc004bvl.4:exon41:c.C5391T:p.T1797T,SPTAN1:uc004bvm.4:exon42:c.C5406T:p.T1802T	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.7233,EAS:0.7709,FIN:0.9133,NFE:0.5099,OTH:0.8235,ASJ:0.3892	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	1(thyroid)	0.9049
9	131454120	131454120	C	T	SET	intronic	.	ENSG00000119335	rs3750330	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9470	0.8618	0.846645	0.8696	.	.	.	.	.	.	.	.	.	.	AFR:0.5820,AMR:0.9570,EAS:0.9061,FIN:0.9716,NFE:0.9960,OTH:0.9593,ASJ:0.9801	600960	.	.	.	.	.	.	.	.	.	.	.	9	MU21478205	hom
9	131455903	131455903	C	T	SET	intronic	.	ENSG00000119335	rs4836618	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9465	0.8600	0.845248	0.8698	.	.	.	.	.	.	.	.	.	.	AFR:0.5824,AMR:0.9570,EAS:0.9068,FIN:0.9719,NFE:0.9959,OTH:0.9593,ASJ:0.9801	600960	.	.	.	.	.	.	.	.	.	.	.	9	MU21478277	hom
9	131456385	131456385	-	TATA	SET	intronic	.	ENSG00000119335	rs10637043	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	.	0.0237	.	.	.	.	.	.	.	.	.	.	AFR:0.0260,AMR:0.0362,EAS:0.0126,FIN:0.0185,NFE:0.0248,OTH:0.0165,ASJ:0.0035	600960	.	.	.	.	.	.	.	.	.	.	.	9	MU121303677	het
9	133710819	133710819	-	C	ABL1	UTR5	.	ENSG00000097007	rs11433463	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	189980	.	.	.	~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04110 Cell cycle~ko04360 Axon guidance~ko04722 Neurotrophin signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05220 Chronic myeloid leukemia~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	9	.	unknown
9	133761001	133761001	A	G	ABL1	exonic	synonymous SNV	ENSG00000097007	rs1056171	ENSG00000097007:ENST00000318560:exon11:c.A3324G:p.P1108P,ENSG00000097007:ENST00000372348:exon11:c.A3381G:p.P1127P	ABL1:NM_005157:exon11:c.A3324G:p.P1108P,ABL1:NM_007313:exon11:c.A3381G:p.P1127P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.5490	0.5849	0.654153	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ABL1:uc004bzv.3:exon11:c.A3381G:p.P1127P,ABL1:uc004bzw.3:exon11:c.A3324G:p.P1108P	.	AFR:16(soft_tissue),AMR:MU27188632,EAS:0.5911,FIN:0.8308,NFE:0.6969,OTH:0.5099,ASJ:LAML-KR|2|205|0.0097561,COCA-CN|6|321|0.0186916	189980	.	.	.	~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04110 Cell cycle~ko04360 Axon guidance~ko04722 Neurotrophin signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05220 Chronic myeloid leukemia~ko05416 Viral myocarditis ~	,155	.	.	.	.	.	.	9	1(large_intestine)	0.6222
9	134020092	134020092	C	T	NUP214	exonic	nonsynonymous SNV	ENSG00000126883	rs103612	ENSG00000126883:ENST00000359428:exon12:c.C1720T:p.P574S,ENSG00000126883:ENST00000411637:exon12:c.C1720T:p.P574S,ENSG00000126883:ENST00000451030:exon12:c.C1720T:p.P574S	NUP214:NM_001318324:exon12:c.C1720T:p.P574S,NUP214:NM_005085:exon12:c.C1720T:p.P574S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6641	0.6687	0.641973	0.6707	3.049	22.4	0.225	1.78	0.261	.	.	.	NUP214:uc004cai.3:exon1:c.C7T:p.P3S,NUP214:uc004caf.1:exon12:c.C1720T:p.P574S,NUP214:uc004cag.3:exon12:c.C1720T:p.P574S,NUP214:uc004cah.3:exon12:c.C1720T:p.P574S	-0.996	AFR:0.6539,AMR:0.7572,EAS:0.6210,FIN:0.6907,NFE:0.6767,OTH:0.6806,ASJ:0.6167	114350	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	0.002	1.51	0.000	1.92	9	MU82111232	het
9	134021630	134021630	A	G	NUP214	exonic	synonymous SNV	ENSG00000126883	rs2296710	ENSG00000126883:ENST00000359428:exon13:c.A1884G:p.T628T,ENSG00000126883:ENST00000411637:exon13:c.A1851G:p.T617T,ENSG00000126883:ENST00000451030:exon13:c.A1884G:p.T628T	NUP214:NM_001318324:exon13:c.A1851G:p.T617T,NUP214:NM_005085:exon13:c.A1884G:p.T628T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3309	0.3022	0.346446	0.3227	.	.	.	.	.	.	.	.	NUP214:uc004cai.3:exon2:c.A171G:p.T57T,NUP214:uc004caf.1:exon13:c.A1851G:p.T617T,NUP214:uc004cag.3:exon13:c.A1884G:p.T628T,NUP214:uc004cah.3:exon13:c.A1851G:p.T617T	.	AFR:0.2908,AMR:0.2416,EAS:0.4250,FIN:0.3437,NFE:0.3280,OTH:0.3299,ASJ:0.3833	114350	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	9	MU588209	het
9	134062770	134062770	-	T	NUP214	intronic	.	ENSG00000126883	rs762584920	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0535	.	.	0.1108	.	.	.	.	.	.	.	.	.	.	AFR:0.0708,AMR:0.1273,EAS:0.2088,FIN:0.0212,NFE:0.1283,OTH:0.0906,ASJ:0.1465	114350	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	9	.	het
9	135773000	135773000	-	A	TSC1	intronic	.	ENSG00000165699	rs5901000	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1686	.	.	0.0118	.	.	.	.	.	.	.	.	.	.	AFR:0.0258,AMR:0.0139,EAS:0.0072,FIN:0.0345,NFE:0.0050,OTH:0.0148,ASJ:0.0106	605284	191100;606690;	538;805;	538|LAM|1-9 / 1 000 000|Not applicable|Adult|606690 ~805|Bourneville syndrome<br>Tuberous sclerosis|1-5 / 10 000|Autosomal dominant|All ages|191100 613254 ~	~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04218 Cellular senescence~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	9	.	unknown
9	136637177	136637177	-	CACACGGCCCCGGCGGTCACTGCGTGAGGGC	VAV2	intronic	.	ENSG00000160293	rs367642598	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	0.3902	0.22524	0.3475	.	.	.	.	.	.	.	.	.	.	AFR:0.2947,AMR:0.2852,EAS:0.0377,FIN:0.3645,NFE:0.4099,OTH:0.3690,ASJ:0.3767	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	MU112597187	het
9	136648606	136648606	G	A	VAV2	intronic	.	ENSG00000160293	rs1468128	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7246	0.6048	0.690096	0.6390	.	.	.	.	.	.	.	.	.	.	AFR:0.4276,AMR:0.7222,EAS:0.9639,FIN:0.6866,NFE:0.7070,OTH:0.6936,ASJ:0.7207	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	MU81871689	hom
9	136648611	136648611	-	G	VAV2	intronic	.	ENSG00000160293	rs56145872	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.8287	0.7097	0.131789	0.7542	.	.	.	.	.	.	.	.	.	.	AFR:0.4406,AMR:0.8017,EAS:0.9682,FIN:0.8421,NFE:0.8711,OTH:0.8333,ASJ:0.8699	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	.	hom
9	136804211	136804211	G	A	VAV2	intronic	.	ENSG00000160293	rs2073886	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7450	0.7196	0.702676	0.7217	.	.	.	.	.	.	.	.	.	.	AFR:0.6228,AMR:0.7041,EAS:0.7892,FIN:0.7327,NFE:0.7658,OTH:0.7658,ASJ:0.8046	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	MU19104859	het
9	139391636	139391636	G	A	NOTCH1	exonic	synonymous SNV	ENSG00000148400	rs2229974	ENSG00000148400:ENST00000277541:exon34:c.C6555T:p.D2185D	NOTCH1:NM_017617:exon34:c.C6555T:p.D2185D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6187	0.5813	0.695088	1(breast)	.	.	.	.	.	.	.	.	NOTCH1:uc004chz.3:exon34:c.C6555T:p.D2185D	.	AFR:1(large_intestine),AMR:MU123836,EAS:0.5914,FIN:0.6176,NFE:0.6734,OTH:0.5232,ASJ:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7820,7822,7810,7823,7811,7818,7817,7815,7821,7812,7816	.	,7814,7813,7819	.	.	.	.	9	2(skin)	0.9635
9	139397707	139397707	G	A	NOTCH1	exonic	synonymous SNV	ENSG00000148400	rs10521	ENSG00000148400:ENST00000277541:exon27:c.C5094T:p.D1698D	NOTCH1:NM_017617:exon27:c.C5094T:p.D1698D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4443	0.4080	0.553514	13(soft_tissue)	.	.	.	.	.	.	.	.	NOTCH1:uc004cia.1:exon14:c.C2784T:p.D928D,NOTCH1:uc004chz.3:exon27:c.C5094T:p.D1698D	.	AFR:1(lung),AMR:12(haematopoietic_and_lymphoid_tissue),EAS:MU58034,FIN:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,NFE:0.4460,OTH:0.5089,ASJ:12(meninges)	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7820,7822,7810,7823,7811,7818,7817,7815,7821,7812,7816	.	,7814,7813,7819	.	.	.	.	9	1(liver)	0.5240
9	139410177	139410177	T	C	NOTCH1	intronic	.	ENSG00000148400	rs3124603	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4361	0.3961	0.58726	0.4866	.	.	.	.	.	0	0.006	.	.	.	AFR:0.6389,AMR:0.5383,EAS:0.8663,FIN:0.4845,NFE:0.3626,OTH:0.4294,ASJ:0.2781	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	9	MU32592860	het
9	139410424	139410424	A	G	NOTCH1	intronic	.	ENSG00000148400	rs3125006	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8704	0.8733	0.883986	0.8911	.	.	.	.	.	.	.	.	.	.	AFR:0.8972,AMR:0.9153,EAS:0.9463,FIN:0.9257,NFE:0.8743,OTH:0.8867,ASJ:0.7980	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	9	MU81872781	hom
9	139410535	139410535	G	A	NOTCH1	exonic	nonsynonymous SNV	ENSG00000148400	rs572103199	ENSG00000148400:ENST00000277541:exon10:c.C1567T:p.H523Y	NOTCH1:NM_017617:exon10:c.C1567T:p.H523Y	clinvar: Likely_benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 1, 1, 1, 1] 	0.0004	.	0.000599042	.	3.687	23.3	0.067	4.1	0.796	.	.	EGF-like calcium-binding domain|EGF-like domain|EGF-like, conserved site|Growth factor receptor cysteine-rich domain	NOTCH1:uc004chz.3:exon10:c.C1567T:p.H523Y	-0.091	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7820,7822,7810,7823,7811,7818,7817,7815,7821,7812,7816	.	,7814,7813,7819	0.495	-2.26	0.396	1.14	9	.	het
9	139411714	139411714	T	C	NOTCH1	intronic	.	ENSG00000148400	rs11145767	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5481	0.4280	0.605431	0.4993	.	.	.	.	.	.	.	.	.	.	AFR:0.7107,AMR:0.5180,EAS:0.8767,FIN:0.4902,NFE:0.3459,OTH:0.4308,ASJ:0.2450	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	9	MU26998549	het
9	139412197	139412197	G	A	NOTCH1	intronic	.	ENSG00000148400	rs9411208	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5768	0.5544	0.696286	COCA-CN|5|321|0.0155763	.	.	.	.	.	0.0010	0.052	.	.	.	AFR:0.5928,AMR:0.7293,EAS:0.4603,FIN:0.9273,NFE:0.5904,OTH:0.4803,ASJ:0.6280	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	9	13(meninges)	0.5612
9	139418260	139418260	A	G	NOTCH1	exonic	synonymous SNV	ENSG00000148400	rs4489420	ENSG00000148400:ENST00000277541:exon3:c.T312C:p.N104N	NOTCH1:NM_017617:exon3:c.T312C:p.N104N	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5970	0.6087	0.740016	1(salivary_gland)	.	.	.	.	.	.	.	.	NOTCH1:uc004chz.3:exon3:c.T312C:p.N104N	.	AFR:MU4624948,AMR:COCA-CN|4|321|0.0124611,BLCA-CN|1|103|0.00970874,EAS:0.8853,FIN:0.6388,NFE:0.46,OTH:0.8547,ASJ:0.6424	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7820,7822,7810,7823,7811,7818,7817,7815,7821,7812,7816	.	,7814,7813,7819	.	.	.	.	9	13(meninges)	0.6006
10	8100763	8100763	G	C	GATA3	exonic	nonsynonymous SNV	ENSG00000107485	rs548018172	ENSG00000107485:ENST00000346208:exon3:c.G737C:p.G246A,ENSG00000107485:ENST00000379328:exon3:c.G737C:p.G246A	GATA3:NM_001002295:exon3:c.G737C:p.G246A,GATA3:NM_002051:exon3:c.G737C:p.G246A	clinvar: not_provided 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 1] 	0.0009	.	0.00159744	6.48e-05	1.358	12.57	0.238	5.55	0.984	.	.	.	GATA3:uc001ijz.3:exon3:c.G737C:p.G246A,GATA3:uc001ika.3:exon3:c.G737C:p.G246A	0.316	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0020,ASJ:0	131320	146255;	2237;	2237|Barakat syndrome<br>HDR syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|146255 ~	.	,5845,5846	.	.	0.047	-4.03	0.753	1.125	10	.	het
10	14976414	14976414	G	A	DCLRE1C	exonic	synonymous SNV	ENSG00000152457	rs7076862	ENSG00000152457:ENST00000357717:exon6:c.C298T:p.L100L,ENSG00000152457:ENST00000378249:exon6:c.C298T:p.L100L,ENSG00000152457:ENST00000378246:exon7:c.C298T:p.L100L,ENSG00000152457:ENST00000378278:exon8:c.C643T:p.L215L,ENSG00000152457:ENST00000378289:exon8:c.C643T:p.L215L,ENSG00000152457:ENST00000453695:exon8:c.C283T:p.L95L,ENSG00000152457:ENST00000378254:exon9:c.C283T:p.L95L,ENSG00000152457:ENST00000378258:exon9:c.C283T:p.L95L,ENSG00000152457:ENST00000418843:exon9:c.C205T:p.L69L,ENSG00000152457:ENST00000378255:exon10:c.C283T:p.L95L,ENSG00000152457:ENST00000396817:exon10:c.C283T:p.L95L	DCLRE1C:NM_001289076:exon6:c.C298T:p.L100L,DCLRE1C:NM_001289078:exon6:c.C298T:p.L100L,DCLRE1C:NM_001350966:exon6:c.C298T:p.L100L,DCLRE1C:NM_022487:exon7:c.C298T:p.L100L,DCLRE1C:NM_001033855:exon8:c.C643T:p.L215L,DCLRE1C:NM_001350965:exon8:c.C643T:p.L215L,DCLRE1C:NM_001033857:exon9:c.C283T:p.L95L,DCLRE1C:NM_001289077:exon9:c.C283T:p.L95L,DCLRE1C:NM_001350967:exon9:c.C283T:p.L95L,DCLRE1C:NM_001033858:exon10:c.C283T:p.L95L,DCLRE1C:NM_001289079:exon10:c.C283T:p.L95L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4187	0.4497	0.5	0.4302	.	.	.	.	.	.	.	.	DCLRE1C:uc021pni.1:exon4:c.C298T:p.L100L,DCLRE1C:uc001inr.3:exon6:c.C298T:p.L100L,DCLRE1C:uc009xji.3:exon6:c.C298T:p.L100L,DCLRE1C:uc001ino.3:exon7:c.C298T:p.L100L,DCLRE1C:uc001inn.3:exon8:c.C643T:p.L215L,DCLRE1C:uc010qbx.2:exon8:c.C643T:p.L215L,DCLRE1C:uc001inl.3:exon9:c.C283T:p.L95L,DCLRE1C:uc001inp.3:exon9:c.C283T:p.L95L,DCLRE1C:uc001inm.3:exon10:c.C283T:p.L95L,DCLRE1C:uc001inq.3:exon10:c.C283T:p.L95L	.	AFR:0.6495,AMR:0.4796,EAS:0.4133,FIN:0.2474,NFE:0.3506,OTH:0.3276,ASJ:0.4503	605988	602450;603554;	39041;275;	39041|Combined immunodeficiency with hypereosinophilia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|603554 ~275|SCID due to ARTEMIS deficiency<br>SCID due to DCLRE1C deficiency<br>SCID, Athabascan type<br>SCID, Athabaskan type<br>Severe combined immunodeficiency due to ARTEMIS deficiency<br>Severe combined immunodeficiency, Athabascan type<br>Severe combined immunodeficiency, Athabaskan type|Unknown|Autosomal recessive|Infancy<br>Neonatal|602450 ~	.	.	.	.	.	.	.	.	10	MU19126674	het
10	21827796	21827796	G	A	MLLT10	exonic	synonymous SNV	ENSG00000078403	rs1802669	ENSG00000078403:ENST00000377059:exon2:c.G195A:p.P65P,ENSG00000078403:ENST00000307729:exon3:c.G195A:p.P65P,ENSG00000078403:ENST00000377072:exon3:c.G195A:p.P65P,ENSG00000078403:ENST00000377091:exon3:c.G195A:p.P65P,ENSG00000078403:ENST00000377100:exon3:c.G195A:p.P65P,ENSG00000078403:ENST00000446906:exon3:c.G195A:p.P65P	MLLT10:NM_001195626:exon3:c.G195A:p.P65P,MLLT10:NM_001195627:exon3:c.G195A:p.P65P,MLLT10:NM_001195628:exon3:c.G195A:p.P65P,MLLT10:NM_001195630:exon3:c.G195A:p.P65P,MLLT10:NM_001324296:exon3:c.G195A:p.P65P,MLLT10:NM_004641:exon3:c.G195A:p.P65P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3118	0.3664	0.277356	0.3427	.	.	.	.	.	.	.	.	MLLT10:uc001iqw.1:exon2:c.G195A:p.P65P,MLLT10:uc021pny.1:exon2:c.G195A:p.P65P,MLLT10:uc001iqq.2:exon3:c.G195A:p.P65P,MLLT10:uc001iqr.2:exon3:c.G195A:p.P65P,MLLT10:uc001iqs.3:exon3:c.G195A:p.P65P,MLLT10:uc001iqt.3:exon3:c.G195A:p.P65P,MLLT10:uc001iqu.2:exon3:c.G195A:p.P65P	.	AFR:0.4100,AMR:0.2883,EAS:0.0402,FIN:0.3237,NFE:0.3428,OTH:0.3357,ASJ:0.4073	602409	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	10	MU119020	het
10	27269516	27269516	C	G	FAM238C;ANKRD26	intergenic	.	ENSG00000236983;ENSG00000107890	rs3740229	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.0694888	0.0194	.	.	.	.	.	.	.	.	.	.	AFR:0.0009,AMR:0.0251,EAS:0.1502,FIN:0.0561,NFE:0.0061,OTH:0.0418,ASJ:0.0033	.	.	.	.	.	.	.	.	.	.	.	.	10	.	het
10	27271749	27271749	A	-	FAM238C;ANKRD26	intergenic	.	ENSG00000236983;ENSG00000107890	rs144481731	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.0770767	0.0252	.	.	.	.	.	.	.	.	.	.	AFR:0.0194,AMR:0.0252,EAS:0.1582,FIN:0.0572,NFE:0.0061,OTH:0.0420,ASJ:0.0066	.	.	.	.	.	.	.	.	.	.	.	.	10	.	het
10	27303605	27303605	A	T	ANKRD26	exonic	nonsynonymous SNV	ENSG00000107890	rs2274741	ENSG00000107890:ENST00000376070:exon16:c.T3213A:p.F1071L,ENSG00000107890:ENST00000376087:exon31:c.T4542A:p.F1514L,ENSG00000107890:ENST00000436985:exon31:c.T4590A:p.F1530L	ANKRD26:NM_001256053:exon31:c.T4539A:p.F1513L,ANKRD26:NM_014915:exon31:c.T4542A:p.F1514L	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2258	0.1717	0.317292	0.2050	0.365	6.303	1.0	1.33	0.834	.	.	.	ANKRD26:uc001itg.2:exon25:c.T3600A:p.F1200L,ANKRD26:uc001ith.2:exon31:c.T4539A:p.F1513L,ANKRD26:uc009xku.1:exon31:c.T4542A:p.F1514L	-0.964	AFR:0.2263,AMR:0.1675,EAS:0.5643,FIN:0.2329,NFE:0.1498,OTH:0.2147,ASJ:0.1623	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	0.0	1.91	0.000	-3.085	10	MU794304	hom
10	27317778	27317778	T	C	ANKRD26	intronic	.	ENSG00000107890	rs72807627	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1127	0.0795	0.142173	0.0912	.	.	.	.	.	0.0003	0.004	.	.	.	AFR:0.0624,AMR:0.1065,EAS:0.2971,FIN:0.1082,NFE:0.0808,OTH:0.0953,ASJ:0.0867	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	MU11641537	het
10	27317840	27317840	C	T	ANKRD26	exonic	nonsynonymous SNV	ENSG00000107890	rs10829163	ENSG00000107890:ENST00000376070:exon12:c.G2584A:p.V862I,ENSG00000107890:ENST00000376087:exon27:c.G3913A:p.V1305I,ENSG00000107890:ENST00000436985:exon27:c.G3961A:p.V1321I	ANKRD26:NM_001256053:exon27:c.G3910A:p.V1304I,ANKRD26:NM_014915:exon27:c.G3913A:p.V1305I	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2217	0.1723	0.317292	0.2051	-0.852	0.033	1.0	-4.39	0.007	.	.	.	ANKRD26:uc001itg.2:exon21:c.G2971A:p.V991I,ANKRD26:uc001ith.2:exon27:c.G3910A:p.V1304I,ANKRD26:uc009xku.1:exon27:c.G3913A:p.V1305I	-1.016	AFR:0.2260,AMR:0.1683,EAS:0.5649,FIN:0.2339,NFE:0.1498,OTH:0.2137,ASJ:0.1623	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	0.0	-0.9	0.000	-0.63	10	MU794298	hom
10	27319462	27319462	C	T	ANKRD26	intronic	.	ENSG00000107890	rs34795543	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.141773	0.0909	.	.	.	.	.	.	.	.	.	.	AFR:0.0604,AMR:0.1086,EAS:0.2981,FIN:0.1095,NFE:0.0807,OTH:0.0967,ASJ:0.0867	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	het
10	27319465	27319465	T	C	ANKRD26	intronic	.	ENSG00000107890	rs10829165	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.857628	0.8220	.	.	.	.	.	.	.	.	.	.	AFR:0.8599,AMR:0.7133,EAS:0.9932,FIN:0.8683,NFE:0.7763,OTH:0.8378,ASJ:0.7833	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	hom
10	27319546	27319546	T	C	ANKRD26	intronic	.	ENSG00000107890	rs34844053	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.317292	0.2052	.	.	.	.	.	.	.	.	.	.	AFR:0.2264,AMR:0.1671,EAS:0.5665,FIN:0.2332,NFE:0.1499,OTH:0.2143,ASJ:0.1623	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	hom
10	27322303	27322303	C	G	ANKRD26	exonic	nonsynonymous SNV	ENSG00000107890	rs12572862	ENSG00000107890:ENST00000376070:exon10:c.G2329C:p.V777L,ENSG00000107890:ENST00000376087:exon25:c.G3658C:p.V1220L,ENSG00000107890:ENST00000436985:exon25:c.G3706C:p.V1236L	ANKRD26:NM_001256053:exon25:c.G3655C:p.V1219L,ANKRD26:NM_014915:exon25:c.G3658C:p.V1220L	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0358	0.0016	0.0672923	0.0191	1.348	12.52	0.07	-3.7	0.752	.	.	.	ANKRD26:uc001itg.2:exon19:c.G2716C:p.V906L,ANKRD26:uc001ith.2:exon25:c.G3655C:p.V1219L,ANKRD26:uc009xku.1:exon25:c.G3658C:p.V1220L	-0.985	AFR:0.0009,AMR:0.0252,EAS:0.1459,FIN:0.0562,NFE:0.0061,OTH:0.0400,ASJ:0.0033	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	0.005	1.49	0.000	2.34	10	MU80621918	het
10	27326999	27326999	T	C	ANKRD26	intronic	.	ENSG00000107890	rs7096505	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8408	0.8289	0.865216	0.8452	.	.	.	.	.	.	.	.	.	.	AFR:0.8609,AMR:0.7321,EAS:0.9932,FIN:0.9057,NFE:0.8121,OTH:0.8612,ASJ:0.8067	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	MU19136977	hom
10	27333122	27333122	A	-	ANKRD26	intronic	.	ENSG00000107890	rs113123391	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.3891	.	0.302316	0.1593	.	.	.	.	.	.	.	.	.	.	AFR:0.2271,AMR:0.1067,EAS:0.2708,FIN:0.3163,NFE:0.0864,OTH:0.1824,ASJ:0.1111	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	het
10	27341090	27341090	C	T	ANKRD26	intronic	.	ENSG00000107890	rs12762165	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.129992	0.0794	.	.	.	.	.	.	.	.	.	.	AFR:0.0207,AMR:0.1041,EAS:0.2965,FIN:0.1097,NFE:0.0809,OTH:0.0920,ASJ:0.0861	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	het
10	27342286	27342288	TCT	-	ANKRD26	exonic	nonframeshift deletion	ENSG00000107890	rs138423863	ENSG00000107890:ENST00000376087:exon16:c.1596_1598del:p.532_533del,ENSG00000107890:ENST00000436985:exon16:c.1644_1646del:p.548_549del	ANKRD26:NM_001256053:exon16:c.1596_1598del:p.532_533del,ANKRD26:NM_014915:exon16:c.1596_1598del:p.532_533del	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0366	0.0032	0.0676917	0.0207	.	.	.	.	.	.	.	.	ANKRD26:uc001itg.2:exon10:c.654_656del:p.218_219del,ANKRD26:uc001ith.2:exon16:c.1596_1598del:p.532_533del,ANKRD26:uc009xku.1:exon16:c.1596_1598del:p.532_533del	.	AFR:0.0077,AMR:0.0239,EAS:0.1418,FIN:0.0564,NFE:0.0061,OTH:0.0400,ASJ:0.0033	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	het
10	27355404	27355405	CA	-	ANKRD26	intronic	.	ENSG00000107890	rs375101238	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0095	.	.	0.0214	.	.	.	.	.	.	.	.	.	.	AFR:0.0113,AMR:0.0240,EAS:0.1381,FIN:0.0569,NFE:0.0058,OTH:0.0389,ASJ:0	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	het
10	27355407	27355409	AGA	-	ANKRD26	intronic	.	ENSG00000107890	rs200015812	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0110	0.0028	.	0.0215	.	.	.	.	.	.	.	.	.	.	AFR:0.0113,AMR:0.0239,EAS:0.1382,FIN:0.0567,NFE:0.0058,OTH:0.0390,ASJ:0.0033	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	het
10	27381349	27381349	T	C	ANKRD26	exonic	synonymous SNV	ENSG00000107890	rs2297145	ENSG00000107890:ENST00000376087:exon4:c.A624G:p.V208V,ENSG00000107890:ENST00000436985:exon4:c.A624G:p.V208V	ANKRD26:NM_001256053:exon4:c.A624G:p.V208V,ANKRD26:NM_014915:exon4:c.A624G:p.V208V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2571	0.2101	0.346645	0.2429	.	.	.	.	.	.	.	.	ANKRD26:uc001ith.2:exon4:c.A624G:p.V208V,ANKRD26:uc009xku.1:exon4:c.A624G:p.V208V	.	AFR:0.3237,AMR:0.1830,EAS:0.5597,FIN:0.2497,NFE:0.1657,OTH:0.2352,ASJ:0.1722	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	MU16245236	hom
10	27389197	27389197	T	C	ANKRD26	exonic	nonsynonymous SNV	ENSG00000107890	rs7897309	ENSG00000107890:ENST00000376087:exon1:c.A59G:p.Q20R,ENSG00000107890:ENST00000436985:exon1:c.A59G:p.Q20R	ANKRD26:NM_001256053:exon1:c.A59G:p.Q20R,ANKRD26:NM_014915:exon1:c.A59G:p.Q20R	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8977	0.8935	0.944688	0.9039	-1.524	0.002	1.0	-1.08	0.003	.	.	.	ANKRD26:uc001ith.2:exon1:c.A59G:p.Q20R,ANKRD26:uc009xku.1:exon1:c.A59G:p.Q20R	-0.984	AFR:0.9727,AMR:0.9010,EAS:1,FIN:0.9275,NFE:0.8493,OTH:0.9043,ASJ:0.8477	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	0.0	1.63	0.000	-1.355	10	MU71687	hom
10	31803516	31803516	G	A	ZEB1	intronic	.	ENSG00000148516	rs220060	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9425	0.9154	0.921326	0.9197	.	.	.	.	.	.	.	.	.	.	AFR:0.8338,AMR:0.9725,EAS:1,FIN:0.9372,NFE:0.9520,OTH:0.9407,ASJ:0.9503	189909	609141;613270;	98974;98973;	98974|Endoepithelial corneal dystrophy<br>FECD<br>Late hereditary endothelial dystrophy|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|136800 610158 613267 613268 613269 613270 613271 615523 ~98973|PPCD<br>Posterior polymorphous dystrophy<br>Schlichting dystrophy|Unknown|Autosomal dominant|Childhood|122000 609140 609141 ~	~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	10	MU81878063	het
10	32311969	32311969	A	G	KIF5B	intronic	.	ENSG00000170759	rs176924	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9914	0.9677	0.967053	0.9753	.	.	.	.	.	0.0002	0.006	.	.	.	AFR:0.9135,AMR:0.9940,EAS:1,FIN:1,NFE:1,OTH:0.9939,ASJ:1	602809	.	.	.	.	.	.	.	.	.	.	.	10	MU81878086	hom
10	43606687	43606687	A	G	RET	exonic	synonymous SNV	ENSG00000165731	rs1800860	ENSG00000165731:ENST00000340058:exon7:c.A1296G:p.A432A,ENSG00000165731:ENST00000355710:exon7:c.A1296G:p.A432A	RET:NM_001355216:exon4:c.A534G:p.A178A,RET:NM_020630:exon7:c.A1296G:p.A432A,RET:NM_020975:exon7:c.A1296G:p.A432A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7061	0.7486	0.77516	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	RET:uc010qez.1:exon4:c.A534G:p.A178A,RET:uc001jak.1:exon7:c.A1296G:p.A432A,RET:uc001jal.3:exon7:c.A1296G:p.A432A	.	AFR:0.7388,AMR:0.8614,EAS:0.7351,FIN:0.7862,NFE:0.6981,OTH:0.6843,ASJ:0.5586	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	,9514,9512,9508,9509,9513,9511,9507,9510,9506	.	.	.	.	.	.	10	17(meninges)	0.7031
10	50667105	50667105	T	C	ERCC6	exonic	nonsynonymous SNV	ENSG00000225830	rs2228529	ENSG00000225830:ENST00000542458:exon15:c.A2348G:p.Q783R,ENSG00000225830:ENST00000355832:exon21:c.A4238G:p.Q1413R	ERCC6:NM_000124:exon21:c.A4238G:p.Q1413R,ERCC6:NM_001346440:exon21:c.A4238G:p.Q1413R	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 1] 	0.2178	0.1891	0.178914	MU4561288	-0.728	0.062	0.508	-4.93	0.011	.	.	.	ERCC6:uc009xod.4:exon11:c.A1718G:p.Q573R,ERCC6:uc001jhr.5:exon15:c.A2342G:p.Q781R,ERCC6:uc010qgr.3:exon15:c.A2348G:p.Q783R,ERCC6:uc001jhs.5:exon21:c.A4238G:p.Q1413R	-1.123	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,AMR:0.1952,EAS:0.1866,FIN:0.2467,NFE:0.0476,OTH:0.2679,ASJ:0.1259	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	,4781	.	.	0.128	-1.63	0.000	0.895	10	7(soft_tissue)	0.2302
10	50678369	50678369	T	C	ERCC6	exonic	nonsynonymous SNV	ENSG00000225830	rs2228527	ENSG00000225830:ENST00000542458:exon12:c.A1747G:p.R583G,ENSG00000225830:ENST00000355832:exon18:c.A3637G:p.R1213G	ERCC6:NM_000124:exon18:c.A3637G:p.R1213G,ERCC6:NM_001346440:exon18:c.A3637G:p.R1213G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 1] 	0.2203	0.1967	0.184704	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235	1.449	13.04	0.117	1.87	0.319	.	.	.	ERCC6:uc009xod.4:exon8:c.A1117G:p.R373G,ERCC6:uc001jhr.5:exon12:c.A1741G:p.R581G,ERCC6:uc010qgr.3:exon12:c.A1747G:p.R583G,ERCC6:uc001jhs.5:exon18:c.A3637G:p.R1213G	-1.146	AFR:0.2016,AMR:0.1470,EAS:0.2517,FIN:0.0475,NFE:0.2680,OTH:0.2306,ASJ:0.1885	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	,4781	.	.	0.651	-1.74	0.000	2.8	10	1(large_intestine)	0.2561
10	50678717	50678717	T	C	ERCC6	exonic	nonsynonymous SNV	ENSG00000225830	rs2228526	ENSG00000225830:ENST00000542458:exon12:c.A1399G:p.M467V,ENSG00000225830:ENST00000355832:exon18:c.A3289G:p.M1097V	ERCC6:NM_000124:exon18:c.A3289G:p.M1097V,ERCC6:NM_001346440:exon18:c.A3289G:p.M1097V	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 1] 	0.2186	0.1909	0.182508	1(lung)	-1.845	0.002	0.519	-6.21	0.001	.	.	.	ERCC6:uc009xod.4:exon8:c.A769G:p.M257V,ERCC6:uc001jhr.5:exon12:c.A1393G:p.M465V,ERCC6:uc010qgr.3:exon12:c.A1399G:p.M467V,ERCC6:uc001jhs.5:exon18:c.A3289G:p.M1097V	-1.116	AFR:7(soft_tissue),AMR:MU151139,EAS:0.1964,FIN:0.1306,NFE:0.1874,OTH:0.2483,ASJ:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	,4781	.	.	0.001	-1.55	0.000	-1.04	10	2(large_intestine)	0.0475
10	50681033	50681033	G	A	ERCC6	exonic	synonymous SNV	ENSG00000225830	rs2229760	ENSG00000225830:ENST00000542458:exon9:c.C861T:p.G287G,ENSG00000225830:ENST00000355832:exon15:c.C2751T:p.G917G	ERCC6:NM_000124:exon15:c.C2751T:p.G917G,ERCC6:NM_001346440:exon15:c.C2751T:p.G917G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.3370	0.3238	0.254193	1(stomach)	.	.	.	.	.	.	.	.	ERCC6:uc009xod.4:exon5:c.C231T:p.G77G,ERCC6:uc001jhr.5:exon9:c.C855T:p.G285G,ERCC6:uc010qgr.3:exon9:c.C861T:p.G287G,ERCC6:uc001jhs.5:exon15:c.C2751T:p.G917G	.	AFR:12(soft_tissue),AMR:1(lung),EAS:MU159322,FIN:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,PACA-AU|1|391|0.00255754,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,NFE:0.3151,OTH:0.1333,ASJ:1(haematopoietic_and_lymphoid_tissue)	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	,4781	.	.	.	.	.	.	10	1(pancreas)	0.3031
10	50701156	50701156	G	A	ERCC6	intronic	.	ENSG00000225830	rs4253132	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8887	0.8322	0.876997	0.8456	.	.	.	.	.	0.0003	0.004	.	.	.	AFR:0.7220,AMR:0.9269,EAS:0.9994,FIN:0.9026,NFE:0.8787,OTH:0.9057,ASJ:0.8642	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	.	.	.	.	.	.	.	10	MU81879491	hom
10	50723684	50723684	G	A	ERCC6;PGBD3	exonic	synonymous SNV	ENSG00000243251;ENSG00000258838	rs4253073	ENSG00000243251:ENST00000508005:exon1:c.C1477T:p.L493L,ENSG00000243251:ENST00000374127:exon2:c.C1477T:p.L493L,ENSG00000258838:ENST00000447839:exon6:c.C2881T:p.L961L,ENSG00000258838:ENST00000515869:exon6:c.C2881T:p.L961L,ENSG00000243251:ENST00000603152:exon6:c.C2881T:p.L961L	PGBD3:NM_170753:exon2:c.C1477T:p.L493L,ERCC6:NM_001277058:exon6:c.C2881T:p.L961L,ERCC6:NM_001277059:exon6:c.C2881T:p.L961L	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.9070	0.8491	0.893371	0.8616	.	.	.	.	.	.	.	.	PGBD3:uc021pqe.1:exon1:c.C1477T:p.L493L,ERCC6-PGBD3:uc001jhu.3:exon6:c.C2881T:p.L961L,ERCC6-PGBD3:uc009xoe.4:exon6:c.C2881T:p.L961L	.	AFR:0.7277,AMR:0.9368,EAS:0.9994,FIN:0.9319,NFE:0.8994,OTH:0.9196,ASJ:0.8974	.	.	.	.	.	,4781	.	.	.	.	.	.	10	MU81879509	hom
10	50724016	50724016	C	T	ERCC6;PGBD3	exonic	nonsynonymous SNV	ENSG00000243251;ENSG00000258838	rs4253072	ENSG00000243251:ENST00000508005:exon1:c.G1145A:p.R382K,ENSG00000243251:ENST00000374127:exon2:c.G1145A:p.R382K,ENSG00000258838:ENST00000447839:exon6:c.G2549A:p.R850K,ENSG00000258838:ENST00000515869:exon6:c.G2549A:p.R850K,ENSG00000243251:ENST00000603152:exon6:c.G2549A:p.R850K	PGBD3:NM_170753:exon2:c.G1145A:p.R382K,ERCC6:NM_001277058:exon6:c.G2549A:p.R850K,ERCC6:NM_001277059:exon6:c.G2549A:p.R850K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 1] 	0.9983	0.9939	0.996206	0.9951	0.120	3.819	1.0	0.699	0.923	.	.	PiggyBac transposable element-derived protein	PGBD3:uc021pqe.1:exon1:c.G1145A:p.R382K,ERCC6-PGBD3:uc001jhu.3:exon6:c.G2549A:p.R850K,ERCC6-PGBD3:uc009xoe.4:exon6:c.G2549A:p.R850K	-1.056	AFR:0.9835,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:0.9959,ASJ:1	.	.	.	.	.	,4781	.	.	0.0	2.35	0.000	-0.75	10	MU81879516	hom
10	50740876	50740876	G	C	ERCC6	exonic	synonymous SNV	ENSG00000225830;ENSG00000243251;ENSG00000258838	rs2228524	ENSG00000225830:ENST00000355832:exon2:c.C135G:p.L45L,ENSG00000258838:ENST00000447839:exon2:c.C135G:p.L45L,ENSG00000225830:ENST00000462247:exon2:c.C135G:p.L45L,ENSG00000258838:ENST00000515869:exon2:c.C135G:p.L45L,ENSG00000243251:ENST00000603152:exon2:c.C135G:p.L45L	ERCC6:NM_000124:exon2:c.C135G:p.L45L,ERCC6:NM_001277058:exon2:c.C135G:p.L45L,ERCC6:NM_001277059:exon2:c.C135G:p.L45L,ERCC6:NM_001346440:exon2:c.C135G:p.L45L	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.6946	0.6276	0.590855	0.6264	.	.	.	.	.	.	.	.	ERCC6:uc001jhs.5:exon2:c.C135G:p.L45L,ERCC6-PGBD3:uc001jhu.3:exon2:c.C135G:p.L45L,ERCC6-PGBD3:uc009xoe.4:exon2:c.C135G:p.L45L	.	AFR:0.3820,AMR:0.6595,EAS:0.5217,FIN:0.7570,NFE:0.7389,OTH:0.7286,ASJ:0.7219	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	,4781	.	.	.	.	.	.	10	MU786536	hom
10	51568378	51568378	T	G	NCOA4	exonic	nonsynonymous SNV	ENSG00000138293	rs10761581	ENSG00000138293:ENST00000438493:exon2:c.T22G:p.F8V,ENSG00000138293:ENST00000452682:exon2:c.T22G:p.F8V	NCOA4:NM_001145260:exon2:c.T22G:p.F8V,NCOA4:NM_001145261:exon2:c.T22G:p.F8V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5164	0.4135	0.459665	MU122440	.	.	.	0.858	0.001	.	.	.	NCOA4:uc009xon.3:exon2:c.T22G:p.F8V,NCOA4:uc010qhd.2:exon2:c.T22G:p.F8V	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,AMR:0.4109,EAS:0.2644,FIN:0.4272,NFE:0.5466,OTH:0.4610,ASJ:0.3500	601984	.	.	.	~ko04216 Ferroptosis~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	.	.	.	.	10	1(haematopoietic_and_lymphoid_tissue)	0.4255
10	54074757	54074757	A	G	DKK1	exonic	synonymous SNV	ENSG00000107984	rs2241529	ENSG00000107984:ENST00000373970:exon2:c.A318G:p.A106A	DKK1:NM_012242:exon2:c.A318G:p.A106A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5383	0.6050	0.525359	0.5553	.	.	.	.	.	.	.	.	DKK1:uc001jjr.3:exon2:c.A318G:p.A106A	.	AFR:0.6948,AMR:0.4472,EAS:0.2718,FIN:0.4788,NFE:0.5297,OTH:0.5114,ASJ:0.6490	605189	.	.	.	.	.	.	.	.	.	.	.	10	MU731054	het
10	61552692	61552692	G	T	CCDC6	exonic	nonsynonymous SNV	ENSG00000108091	rs1053266	ENSG00000108091:ENST00000263102:exon9:c.C1408A:p.P470T	CCDC6:NM_005436:exon9:c.C1408A:p.P470T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0] 	0.5020	0.4223	0.435304	1(stomach)	3.726	23.3	0.0	5.6	1.000	.	.	.	CCDC6:uc001jks.4:exon9:c.C1408A:p.P470T	-0.870	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:1(large_intestine),EAS:MU581841,FIN:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,NFE:0.4412,OTH:0.2718,ASJ:1(thyroid)	601985	.	.	.	~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	0.998	0.54	0.000	0.805	10	4(prostate)	0.6340
10	61552774	61552774	C	T	CCDC6	exonic	synonymous SNV	ENSG00000108091	rs1053265	ENSG00000108091:ENST00000263102:exon9:c.G1326A:p.P442P	CCDC6:NM_005436:exon9:c.G1326A:p.P442P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7276	0.6525	0.611621	LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	CCDC6:uc001jks.4:exon9:c.G1326A:p.P442P	.	AFR:0.6649,AMR:0.4247,EAS:0.7318,FIN:0.6781,NFE:0.7385,OTH:0.7733,ASJ:0.8094	601985	.	.	.	~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	.	.	.	.	10	1(thyroid)	0.7163
10	61823998	61823998	C	T	ANK3	exonic	nonsynonymous SNV	ENSG00000151150	rs780088040	ENSG00000151150:ENST00000373820:exon5:c.G305A:p.R102H,ENSG00000151150:ENST00000355288:exon15:c.G1931A:p.R644H,ENSG00000151150:ENST00000373827:exon38:c.G4511A:p.R1504H,ENSG00000151150:ENST00000503366:exon38:c.G4532A:p.R1511H,ENSG00000151150:ENST00000280772:exon39:c.G12368A:p.R4123H	ANK3:NM_001149:exon15:c.G1931A:p.R644H,ANK3:NM_001320874:exon37:c.G4529A:p.R1510H,ANK3:NM_001204403:exon38:c.G4511A:p.R1504H,ANK3:NM_001204404:exon38:c.G4532A:p.R1511H,ANK3:NM_020987:exon39:c.G12368A:p.R4123H	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 2, 1, 0] 	8.321e-06	.	.	3.23e-05	8.085	35	0.0	5.4	1.000	.	.	Ankyrin repeat-containing domain;Death domain|Death-like domain	ANK3:uc001jkv.3:exon5:c.G128A:p.R43H,ANK3:uc001jkw.3:exon15:c.G1931A:p.R644H,ANK3:uc009xpa.3:exon15:c.G1931A:p.R644H,ANK3:uc001jkx.3:exon17:c.G2063A:p.R688H,ANK3:uc001jkz.4:exon38:c.G4511A:p.R1504H,ANK3:uc010qih.2:exon38:c.G4532A:p.R1511H,ANK3:uc001jky.3:exon39:c.G12368A:p.R4123H	-0.342	AFR:0,AMR:0,EAS:0,FIN:0.0003,NFE:0,OTH:0,ASJ:0	600465	615493;	356996;	356996|-|<1 / 1 000 000|Autosomal recessive|Childhood|615493 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	0.999	-2.12	0.395	2.875	10	.	het
10	61831271	61831271	T	C	ANK3	exonic	nonsynonymous SNV	ENSG00000151150	rs10821668	ENSG00000151150:ENST00000280772:exon37:c.A9368G:p.K3123R	ANK3:NM_020987:exon37:c.A9368G:p.K3123R	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2019	0.1899	0.125799	LICA-CN|1|402|0.00248756	0.918	10.18	0.814	5.23	0.998	.	.	.	ANK3:uc001jky.3:exon37:c.A9368G:p.K3123R	-1.059	AFR:0.1876,AMR:0.0486,EAS:0.24,FIN:0.0333,NFE:0.2527,OTH:0.2660,ASJ:0.1814	600465	615493;	356996;	356996|-|<1 / 1 000 000|Autosomal recessive|Childhood|615493 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	0.001	-0.03	0.000	-0.11	10	1(urinary_tract)	0.2388
10	61831744	61831744	A	G	ANK3	exonic	synonymous SNV	ENSG00000151150	rs10740006	ENSG00000151150:ENST00000280772:exon37:c.T8895C:p.A2965A	ANK3:NM_020987:exon37:c.T8895C:p.A2965A	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2023	0.1905	0.125998	0.1878	.	.	.	.	.	.	.	.	ANK3:uc001jky.3:exon37:c.T8895C:p.A2965A	.	AFR:0.0487,AMR:0.1823,EAS:0.0333,FIN:0.2531,NFE:0.2663,OTH:0.2403,ASJ:0.2384	600465	615493;	356996;	356996|-|<1 / 1 000 000|Autosomal recessive|Childhood|615493 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	10	MU85090693	het
10	61868716	61868716	C	A	ANK3	exonic	synonymous SNV	ENSG00000151150	rs3750800	ENSG00000151150:ENST00000355288:exon5:c.G447T:p.T149T,ENSG00000151150:ENST00000373815:exon5:c.G420T:p.T140T,ENSG00000151150:ENST00000513049:exon5:c.G420T:p.T140T,ENSG00000151150:ENST00000280772:exon27:c.G3045T:p.T1015T,ENSG00000151150:ENST00000373827:exon28:c.G3027T:p.T1009T,ENSG00000151150:ENST00000503366:exon28:c.G3048T:p.T1016T	ANK3:NM_001149:exon5:c.G447T:p.T149T,ANK3:NM_001320874:exon27:c.G3045T:p.T1015T,ANK3:NM_020987:exon27:c.G3045T:p.T1015T,ANK3:NM_001204403:exon28:c.G3027T:p.T1009T,ANK3:NM_001204404:exon28:c.G3048T:p.T1016T	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2640	0.2396	0.179113	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	ANK3:uc001jla.1:exon3:c.G243T:p.T81T,ANK3:uc001jkw.3:exon5:c.G447T:p.T149T,ANK3:uc009xpa.3:exon5:c.G447T:p.T149T,ANK3:uc001jkx.3:exon7:c.G579T:p.T193T,ANK3:uc001jky.3:exon27:c.G3045T:p.T1015T,ANK3:uc001jkz.4:exon28:c.G3027T:p.T1009T,ANK3:uc001jlb.1:exon28:c.G1599T:p.T533T,ANK3:uc010qih.2:exon28:c.G3048T:p.T1016T	.	AFR:0.2304,AMR:0.0615,EAS:0.3389,FIN:0.0637,NFE:0.3413,OTH:0.3174,ASJ:0.1897	600465	615493;	356996;	356996|-|<1 / 1 000 000|Autosomal recessive|Childhood|615493 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	10	1(haematopoietic_and_lymphoid_tissue)	0.2873
10	61965625	61965625	A	G	ANK3	exonic	synonymous SNV	ENSG00000151150	rs2297979	ENSG00000151150:ENST00000280772:exon11:c.T1218C:p.I406I,ENSG00000151150:ENST00000503366:exon11:c.T1167C:p.I389I,ENSG00000151150:ENST00000373827:exon12:c.T1200C:p.I400I	ANK3:NM_001204404:exon11:c.T1167C:p.I389I,ANK3:NM_001320874:exon11:c.T1218C:p.I406I,ANK3:NM_020987:exon11:c.T1218C:p.I406I,ANK3:NM_001204403:exon12:c.T1200C:p.I400I	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1596	0.1818	0.151558	MU581843	.	.	.	.	.	.	.	.	ANK3:uc001jlc.1:exon2:c.T201C:p.I67I,ANK3:uc001jky.3:exon11:c.T1218C:p.I406I,ANK3:uc010qih.2:exon11:c.T1167C:p.I389I,ANK3:uc001jkz.4:exon12:c.T1200C:p.I400I	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.1649,EAS:0.1492,FIN:0.1788,NFE:0.0686,OTH:0.1477,ASJ:0.1887	600465	615493;	356996;	356996|-|<1 / 1 000 000|Autosomal recessive|Childhood|615493 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	10	2(lung)	0.1667
10	64573771	64573771	C	T	EGR2	exonic	synonymous SNV	ENSG00000122877	rs224083	ENSG00000122877:ENST00000242480:exon2:c.G627A:p.P209P,ENSG00000122877:ENST00000411732:exon3:c.G477A:p.P159P,ENSG00000122877:ENST00000439032:exon4:c.G627A:p.P209P	EGR2:NM_000399:exon2:c.G627A:p.P209P,EGR2:NM_001136177:exon3:c.G627A:p.P209P,EGR2:NM_001136179:exon3:c.G477A:p.P159P,EGR2:NM_001321037:exon3:c.G477A:p.P159P,EGR2:NM_001136178:exon4:c.G627A:p.P209P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9953	0.9822	0.986022	0.9847	.	.	.	.	.	.	.	.	EGR2:uc001jmi.3:exon2:c.G627A:p.P209P,EGR2:uc010qim.2:exon3:c.G627A:p.P209P,EGR2:uc010qin.2:exon3:c.G477A:p.P159P,EGR2:uc010qio.2:exon3:c.G666A:p.P222P,EGR2:uc009xph.3:exon4:c.G627A:p.P209P	.	AFR:0.9457,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	129010	145900;605253;607678;	101084;99951;64748;	101084|CMT1D|-|Autosomal dominant|Adolescent<br>Infancy<br>Childhood<br>Adult|607678 ~99951|Autosomal recessive congenital hypomyelinating neuropathy<br>CMT4E|-|Autosomal recessive|Infancy<br>Neonatal|605253 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	~ko04625 C-type lectin receptor signaling pathway~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	10	MU81880257	hom
10	70332580	70332580	A	G	TET1	exonic	nonsynonymous SNV	ENSG00000138336	rs10823229	ENSG00000138336:ENST00000373644:exon2:c.A485G:p.D162G	TET1:NM_030625:exon2:c.A485G:p.D162G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3291	0.2862	0.258586	1(kidney)	1.481	13.21	0.019	4.08	0.001	.	.	.	TET1:uc001jok.4:exon2:c.A485G:p.D162G	-0.915	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:MU142838,EAS:0.2734,FIN:0.0721,NFE:0.2625,OTH:0.5166,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	607790	.	.	.	.	.	.	.	0.295	3.08	0.000	1.67	10	1(large_intestine)	0.3792
10	70405855	70405855	A	G	TET1	exonic	nonsynonymous SNV	ENSG00000138336	rs3998860	ENSG00000138336:ENST00000373644:exon4:c.A3369G:p.I1123M	TET1:NM_030625:exon4:c.A3369G:p.I1123M	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7737	0.7212	0.693291	1(haematopoietic_and_lymphoid_tissue)	-1.096	0.010	0.157	-3.65	0.415	.	.	.	TET1:uc001jok.4:exon4:c.A3369G:p.I1123M	-0.998	AFR:MU4560467,AMR:LICA-CN|1|402|0.00248756,COCA-CN|6|321|0.0186916,EAS:0.4861,FIN:0.7351,NFE:0.8874,OTH:0.8407,ASJ:0.7067	607790	.	.	.	.	.	.	.	0.07	3.12	0.000	0.69	10	1(liver)	0.7855
10	70451064	70451064	G	A	TET1	exonic	synonymous SNV	ENSG00000138336	rs150437059	ENSG00000138336:ENST00000373644:exon12:c.G5904A:p.E1968E	TET1:NM_030625:exon12:c.G5904A:p.E1968E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0091	0.0069	0.00359425	LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	TET1:uc001jok.4:exon12:c.G5904A:p.E1968E	.	AFR:0.0069,AMR:0.0017,EAS:0.0099,FIN:0,NFE:0.0020,OTH:0.0115,ASJ:0.0155	607790	.	.	.	.	.	.	.	.	.	.	.	10	1(lung)	0.0041
10	72358577	72358577	G	A	PRF1	exonic	synonymous SNV	ENSG00000180644	rs885822	ENSG00000180644:ENST00000373209:exon3:c.C900T:p.H300H,ENSG00000180644:ENST00000441259:exon3:c.C900T:p.H300H	PRF1:NM_001083116:exon3:c.C900T:p.H300H,PRF1:NM_005041:exon3:c.C900T:p.H300H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6357	0.6624	0.695887	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	PRF1:uc001jrf.4:exon3:c.C900T:p.H300H,PRF1:uc009xqg.3:exon3:c.C900T:p.H300H	.	AFR:0.6730,AMR:0.8060,EAS:0.5705,FIN:0.7645,NFE:0.6571,OTH:0.5915,ASJ:0.6878	170280	603553;605027;609135;	88;547;540;	88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~547|NHL|1-5 / 10 000|-|Adult|605027 ~540|Familial HLH|Unknown|Autosomal recessive|Infancy<br>Adolescent|267700 603552 603553 608898 613101 ~	.	.	.	.	.	.	.	.	10	1(haematopoietic_and_lymphoid_tissue)	0.6619
10	72358655	72358655	G	A	PRF1	exonic	synonymous SNV	ENSG00000180644	rs885821	ENSG00000180644:ENST00000373209:exon3:c.C822T:p.A274A,ENSG00000180644:ENST00000441259:exon3:c.C822T:p.A274A	PRF1:NM_001083116:exon3:c.C822T:p.A274A,PRF1:NM_005041:exon3:c.C822T:p.A274A	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1582	0.1479	0.11262	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	PRF1:uc001jrf.4:exon3:c.C822T:p.A274A,PRF1:uc009xqg.3:exon3:c.C822T:p.A274A	.	AFR:MU4137796,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,EAS:0.0771,FIN:0.1563,NFE:0.2020,OTH:0.1154,ASJ:0.1636	170280	603553;605027;609135;	88;547;540;	88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~547|NHL|1-5 / 10 000|-|Adult|605027 ~540|Familial HLH|Unknown|Autosomal recessive|Infancy<br>Adolescent|267700 603552 603553 608898 613101 ~	.	.	.	.	.	.	.	.	10	8(soft_tissue)	0.2722
10	73082563	73082563	A	G	SLC29A3	exonic	nonsynonymous SNV	ENSG00000198246	rs2277257	ENSG00000198246:ENST00000373189:exon2:c.A52G:p.R18G	SLC29A3:NM_001174098:exon2:c.A52G:p.R18G,SLC29A3:NM_018344:exon2:c.A52G:p.R18G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4247	0.4874	0.469249	0.4753	0.245	5.151	0.114	1.21	0.017	.	.	.	SLC29A3:uc001jrr.4:exon2:c.A52G:p.R18G,SLC29A3:uc001jrs.4:exon2:c.A52G:p.R18G	-0.950	AFR:0.6475,AMR:0.3513,EAS:0.3461,FIN:0.4266,NFE:0.4106,OTH:0.4296,ASJ:0.4603	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	0.001	-0.32	0.000	1.43	10	MU4138358	het
10	73104056	73104056	A	G	SLC29A3	intronic	.	ENSG00000198246	rs2243540	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8674	0.8794	0.814297	0.8696	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.8539,AMR:0.8640,EAS:0.7043,FIN:0.8585,NFE:0.8980,OTH:0.8806,ASJ:0.91	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	.	.	.	.	10	MU14180483	het
10	73111408	73111408	C	T	SLC29A3	exonic	nonsynonymous SNV	ENSG00000198246	rs780668	ENSG00000198246:ENST00000373189:exon4:c.C473T:p.S158F	SLC29A3:NM_001174098:exon4:c.C473T:p.S158F,SLC29A3:NM_001363518:exon4:c.C239T:p.S80F,SLC29A3:NM_018344:exon4:c.C473T:p.S158F	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.6384	0.6183	0.479832	MU139025	6.297	29.1	0.062	4.62	0.992	.	.	.	SLC29A3:uc010qjq.2:exon3:c.C35T:p.S12F,SLC29A3:uc001jrr.4:exon4:c.C473T:p.S158F,SLC29A3:uc001jrs.4:exon4:c.C473T:p.S158F	-0.969	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.6241,EAS:0.5227,FIN:0.7417,NFE:0.4472,OTH:0.7288,ASJ:0.3520	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	0.656	0.33	0.000	3.085	10	1(liver)	0.7743
10	73115941	73115941	T	C	SLC29A3	exonic	synonymous SNV	ENSG00000198246	rs2252997	ENSG00000198246:ENST00000373189:exon5:c.T714C:p.T238T	SLC29A3:NM_001174098:exon5:c.T714C:p.T238T,SLC29A3:NM_001363518:exon5:c.T480C:p.T160T,SLC29A3:NM_018344:exon5:c.T714C:p.T238T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8294	0.8891	0.780751	0.8679	.	.	.	.	.	.	.	.	SLC29A3:uc001jrt.4:exon3:c.T96C:p.T32T,SLC29A3:uc010qjq.2:exon4:c.T276C:p.T92T,SLC29A3:uc001jrr.4:exon5:c.T714C:p.T238T,SLC29A3:uc001jrs.4:exon5:c.T714C:p.T238T	.	AFR:0.8897,AMR:0.6885,EAS:0.6926,FIN:0.8490,NFE:0.8879,OTH:0.8551,ASJ:0.93	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	.	.	.	.	10	MU14239655	unknown
10	73115942	73115942	G	A	SLC29A3	exonic	nonsynonymous SNV	ENSG00000198246	rs2252996	ENSG00000198246:ENST00000373189:exon5:c.G715A:p.V239I	SLC29A3:NM_001174098:exon5:c.G715A:p.V239I,SLC29A3:NM_001363518:exon5:c.G481A:p.V161I,SLC29A3:NM_018344:exon5:c.G715A:p.V239I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8217	0.8616	0.760184	0.8453	-0.811	0.040	0.508	-2.2	0.000	.	.	.	SLC29A3:uc001jrt.4:exon3:c.G97A:p.V33I,SLC29A3:uc010qjq.2:exon4:c.G277A:p.V93I,SLC29A3:uc001jrr.4:exon5:c.G715A:p.V239I,SLC29A3:uc001jrs.4:exon5:c.G715A:p.V239I	-0.980	AFR:0.8111,AMR:0.6850,EAS:0.6926,FIN:0.8490,NFE:0.8875,OTH:0.8520,ASJ:0.93	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	0.002	-0.28	0.000	1.37	10	MU14239707	unknown
10	73121913	73121913	A	G	SLC29A3	exonic	nonsynonymous SNV	ENSG00000198246	rs2487068	ENSG00000198246:ENST00000373189:exon6:c.A976G:p.I326V	SLC29A3:NM_001363518:exon6:c.A742G:p.I248V,SLC29A3:NM_018344:exon6:c.A976G:p.I326V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8246	0.8923	0.792732	0.8745	-2.319	0.001	1.0	-9.0	0.003	.	.	.	SLC29A3:uc001jrt.4:exon4:c.A358G:p.I120V,SLC29A3:uc010qjq.2:exon5:c.A538G:p.I180V,SLC29A3:uc001jrr.4:exon6:c.A976G:p.I326V	-0.954	AFR:0.9235,AMR:0.6771,EAS:0.7228,FIN:0.8389,NFE:0.8824,OTH:0.8599,ASJ:0.8874	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	0.002	0.05	0.000	-0.515	10	MU14239795	het
10	73121945	73121945	T	C	SLC29A3	exonic	synonymous SNV	ENSG00000198246	rs1084004	ENSG00000198246:ENST00000373189:exon6:c.T1008C:p.G336G	SLC29A3:NM_001363518:exon6:c.T774C:p.G258G,SLC29A3:NM_018344:exon6:c.T1008C:p.G336G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8302	0.8666	0.753794	0.8444	.	.	.	.	.	.	.	.	SLC29A3:uc001jrt.4:exon4:c.T390C:p.G130G,SLC29A3:uc010qjq.2:exon5:c.T570C:p.G190G,SLC29A3:uc001jrr.4:exon6:c.T1008C:p.G336G	.	AFR:0.7526,AMR:0.6758,EAS:0.7271,FIN:0.8288,NFE:0.9204,OTH:0.8643,ASJ:0.9338	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	.	.	.	.	10	MU14239860	het
10	75865065	75865065	G	A	VCL	exonic	synonymous SNV	ENSG00000035403	rs767809	ENSG00000035403:ENST00000436396:exon9:c.G1404A:p.P468P,ENSG00000035403:ENST00000211998:exon16:c.G2388A:p.P796P,ENSG00000035403:ENST00000372755:exon16:c.G2388A:p.P796P	VCL:NM_003373:exon16:c.G2388A:p.P796P,VCL:NM_014000:exon16:c.G2388A:p.P796P	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4761	0.4387	0.324681	3(lung)	.	.	.	.	.	.	.	.	VCL:uc010qky.1:exon15:c.G2109A:p.P703P,VCL:uc001jwd.3:exon16:c.G2388A:p.P796P,VCL:uc001jwe.3:exon16:c.G2388A:p.P796P,VCL:uc009xrr.3:exon18:c.G1635A:p.P545P	.	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:MU63916,EAS:0.4299,FIN:0.1369,NFE:0.4511,OTH:0.6967,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|4|170|0.0235294,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	193065	611407;613255;	154;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~	.	.	.	.	.	.	.	.	10	1(large_intestine)	0.2801
10	75871735	75871735	C	G	VCL	exonic	synonymous SNV	ENSG00000035403	rs2131956	ENSG00000035403:ENST00000436396:exon12:c.C1830G:p.G610G,ENSG00000035403:ENST00000211998:exon19:c.C2814G:p.G938G	VCL:NM_014000:exon19:c.C2814G:p.G938G	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6734	0.7624	0.623003	1(thyroid)	.	.	.	.	.	.	.	.	VCL:uc010qky.1:exon18:c.C2535G:p.G845G,VCL:uc001jwd.3:exon19:c.C2814G:p.G938G	.	AFR:MU4547934,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02,EAS:0.7918,FIN:0.6447,NFE:0.8676,OTH:0.3861,ASJ:0.7277	193065	611407;613255;	154;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~	.	.	.	.	.	.	.	.	10	1(haematopoietic_and_lymphoid_tissue)	0.6712
10	76781906	76781908	GAA	-	KAT6B	exonic	nonframeshift deletion	ENSG00000156650	rs71929101	ENSG00000156650:ENST00000372711:exon15:c.2740_2742del:p.914_914del,ENSG00000156650:ENST00000372714:exon15:c.2413_2415del:p.805_805del,ENSG00000156650:ENST00000372725:exon15:c.2413_2415del:p.805_805del,ENSG00000156650:ENST00000287239:exon16:c.3289_3291del:p.1097_1097del,ENSG00000156650:ENST00000372724:exon16:c.2413_2415del:p.805_805del	KAT6B:NM_001370135:exon8:c.946_948del:p.316_316del,KAT6B:NM_001370133:exon9:c.1600_1602del:p.534_534del,KAT6B:NM_001370134:exon10:c.1204_1206del:p.402_402del,KAT6B:NM_001370143:exon13:c.2224_2226del:p.742_742del,KAT6B:NM_001370144:exon14:c.2224_2226del:p.742_742del,KAT6B:NM_001370132:exon15:c.2251_2253del:p.751_751del,KAT6B:NM_001370141:exon15:c.2413_2415del:p.805_805del,KAT6B:NM_001370142:exon15:c.2413_2415del:p.805_805del,KAT6B:NM_001256468:exon16:c.2740_2742del:p.914_914del,KAT6B:NM_001256469:exon16:c.2413_2415del:p.805_805del,KAT6B:NM_001370136:exon16:c.3289_3291del:p.1097_1097del,KAT6B:NM_001370137:exon16:c.3289_3291del:p.1097_1097del,KAT6B:NM_001370138:exon16:c.2740_2742del:p.914_914del,KAT6B:NM_001370139:exon16:c.2413_2415del:p.805_805del,KAT6B:NM_001370140:exon16:c.2413_2415del:p.805_805del,KAT6B:NM_012330:exon16:c.3289_3291del:p.1097_1097del	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2507	.	0.458666	0.3003	.	.	.	.	.	.	.	.	KAT6B:uc001jwm.2:exon16:c.2413_2415del:p.805_805del,KAT6B:uc001jwn.2:exon16:c.3289_3291del:p.1097_1097del,KAT6B:uc031pvy.1:exon16:c.2740_2742del:p.914_914del	.	AFR:0.7455,AMR:0.2833,EAS:0.3266,FIN:0.0878,NFE:0.1064,OTH:0.1763,ASJ:0.1318	605880	603736;606170;	85201;3047;	85201|Absent patellae-scrotal hypoplasia-renal anomalies-facial dysmorphism-intellectual disability syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|606170 ~3047|Hypothyroidism-dysmorphism-postaxial polydactyly-intellectual disability syndrome<br>SBBYSS<br>Say-Barber-Biesecker-Young-Simpson syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|603736 ~	.	.	.	.	.	.	.	.	10	MU9689	het
10	88676886	88676886	T	C	BMPR1A	intronic	.	ENSG00000107779	rs200537780	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, 0, 1, 0] 	0.0026	.	0.00599042	6.456e-05	.	.	.	.	.	0.0003	0.008	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0020,ASJ:0	601299	174900;610069;	157794;2929;329971;	157794|HMPS|-|Autosomal dominant|Childhood|601228 610069 ~2929|JIP<br>JPS<br>Juvenile gastrointestinal polyposis<br>Juvenile intestinal polyposis|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|174900 175050 612242 ~329971|-|Unknown|Autosomal dominant|All ages|174900 ~	.	.	.	.	.	.	.	.	10	.	het
10	88930249	88930249	A	T	SHLD2	exonic	nonsynonymous SNV	ENSG00000122376	rs11202365	ENSG00000122376:ENST00000298784:exon5:c.A1648T:p.S550C,ENSG00000122376:ENST00000298786:exon5:c.A1648T:p.S550C	SHLD2:NM_001330112:exon5:c.A1648T:p.S550C,SHLD2:NM_019054:exon5:c.A1648T:p.S550C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.3463	0.3246	0.275359	1(lung)	4.059	23.7	0.017	2.92	0.150	.	.	.	FAM35A:uc001kei.4:exon5:c.A1648T:p.S550C	-0.930	AFR:MU4559196,AMR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.1987,FIN:0.2668,NFE:0.3543,OTH:0.1609,ASJ:0.3152	.	.	.	.	.	.	.	.	0.995	-0.13	0.000	2.3	10	2(thyroid)	0.3434
10	88939898	88939898	C	T	SHLD2	exonic	nonsynonymous SNV	ENSG00000122376	rs77534648	ENSG00000122376:ENST00000298784:exon7:c.C2030T:p.A677V,ENSG00000122376:ENST00000298786:exon8:c.C2237T:p.A746V	SHLD2:NM_019054:exon7:c.C2030T:p.A677V,SHLD2:NM_001330112:exon8:c.C2237T:p.A746V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0168	0.0003	0.0385383	MU80623628	1.019	10.77	0.784	-3.05	0.853	.	.	Protein FAM35A, C-terminal domain	FAM35A:uc001kej.4:exon5:c.C368T:p.A123V,FAM35A:uc001kei.4:exon7:c.C2030T:p.A677V	-1.069	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,GACA-JP|1|585|0.0017094,BRCA-KR|1|50|0.02,AMR:0.0028,EAS:0.0012,FIN:0,NFE:0.0451,OTH:0.0003,ASJ:0.0005	.	.	.	.	.	.	.	.	0.001	0.02	0.011	0.29	10	1(lung)	0.0003
10	88939962	88939962	T	C	SHLD2	exonic	synonymous SNV	ENSG00000122376	rs7081609	ENSG00000122376:ENST00000298784:exon7:c.T2094C:p.G698G,ENSG00000122376:ENST00000298786:exon8:c.T2301C:p.G767G	SHLD2:NM_019054:exon7:c.T2094C:p.G698G,SHLD2:NM_001330112:exon8:c.T2301C:p.G767G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8356	0.8848	0.793331	LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	FAM35A:uc001kej.4:exon5:c.T432C:p.G144G,FAM35A:uc001kei.4:exon7:c.T2094C:p.G698G	.	AFR:0.8588,AMR:0.9648,EAS:0.8758,FIN:0.3841,NFE:0.8222,OTH:0.8577,ASJ:0.8317	.	.	.	.	.	.	.	.	.	.	.	.	10	2(lung)	0.8632
10	89623861	89623861	T	-	PTEN	splicing	.	ENSG00000171862	rs71022512	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, 0, 1, 0] 	.	.	1	0.9975	.	.	.	.	.	.	.	.	.	.	AFR:0.9993,AMR:0.9963,EAS:0.9969,FIN:0.9897,NFE:0.9986,OTH:0.9947,ASJ:0.9933	601728	153480;155600;158350;176807;275355;276950;605309;607174;608089;613028;	182067;263662;210548;3412;67037;1331;201;2969;65285;404560;618;109;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~263662|-|Unknown|Autosomal dominant|All ages|607174 ~210548|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|605309 ~3412|Sujansky-Leonard syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|276950 314390 ~67037|HNSCC<br>Head and neck squamous cell carcinoma|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|275355 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~2969|Cohen-Hayden syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|158350 ~65285|Dysplastic gangliocytoma of the cerebellum<br>LDD|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|158350 ~404560|B-K mole syndrome<br>FAMM-PC syndrome<br>FAMMM syndrome<br>Familial Clark nevus syndrome<br>Familial atypical mole syndrome<br>Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome<br>Familial dysplastic nevus syndrome<br>Melanoma-pancreatic cancer syndrome|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|155600 606719 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~109|BRRS<br>Myhre-Riley-Smith syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|153480 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04212 Longevity regulating pathway - worm~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04931 Insulin resistance~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05222 Small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05230 Central carbon metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	89623901	89623901	G	C	PTEN	exonic	nonsynonymous SNV	ENSG00000171862	rs2943772	.	PTEN:NM_001304717:exon2:c.G194C:p.C65S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 1, 0, 0, 0, -1, 1, 0, 1, 1] 	.	.	1	0.9996	.	.	.	.	.	.	.	.	.	.	AFR:0.9998,AMR:0.9976,EAS:1,FIN:0.9983,NFE:0.9999,OTH:1,ASJ:1	601728	153480;155600;158350;176807;275355;276950;605309;607174;608089;613028;	182067;263662;210548;3412;67037;1331;201;2969;65285;404560;618;109;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~263662|-|Unknown|Autosomal dominant|All ages|607174 ~210548|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|605309 ~3412|Sujansky-Leonard syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|276950 314390 ~67037|HNSCC<br>Head and neck squamous cell carcinoma|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|275355 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~2969|Cohen-Hayden syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|158350 ~65285|Dysplastic gangliocytoma of the cerebellum<br>LDD|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|158350 ~404560|B-K mole syndrome<br>FAMM-PC syndrome<br>FAMMM syndrome<br>Familial Clark nevus syndrome<br>Familial atypical mole syndrome<br>Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome<br>Familial dysplastic nevus syndrome<br>Melanoma-pancreatic cancer syndrome|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|155600 606719 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~109|BRRS<br>Myhre-Riley-Smith syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|153480 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04212 Longevity regulating pathway - worm~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04931 Insulin resistance~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05222 Small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05230 Central carbon metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	9321,,9313,9269,9325,9293,9290,9292,9324,9327,9298,9315,9326,9291,9322,9317,9276,9299,9305,9275,9303,9300,9316,9301,9319,9311,9272,9306,9328,9297,9323,9295,9308,9296,9320,9330,9302,9304,9314,9273,9270,9329,9310,9267,9274,9268,9294,9307,9271,9309	,9312	.	.	.	.	.	10	.	hom
10	90750982	90750982	T	G	ACTA2	UTR5	.	ENSG00000107796	rs7079111	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.937899	0.9023	.	.	.	.	.	.	.	.	.	.	AFR:0.9738,AMR:0.8780,EAS:0.9957,FIN:0.8421,NFE:0.8684,OTH:0.8709,ASJ:0.8808	102620	611788;613834;614042;	2573;404463;91387;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~404463|-|<1 / 1 000 000|Unknown|Infancy|613834 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	10	.	het
10	90771829	90771829	T	C	FAS	exonic	synonymous SNV	ENSG00000026103	rs2234978	ENSG00000026103:ENST00000357339:exon6:c.T579C:p.T193T,ENSG00000026103:ENST00000352159:exon7:c.T642C:p.T214T,ENSG00000026103:ENST00000355279:exon7:c.T642C:p.T214T,ENSG00000026103:ENST00000355740:exon7:c.T642C:p.T214T	FAS:NM_152871:exon6:c.T579C:p.T193T,FAS:NM_000043:exon7:c.T642C:p.T214T,FAS:NM_152872:exon7:c.T642C:p.T214T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7561	0.6952	0.775359	0.7328	-0.976	0.018	.	-0.619	0.000	.	.	.	FAS:uc001kft.3:exon6:c.T579C:p.T193T,FAS:uc001kfr.3:exon7:c.T642C:p.T214T,FAS:uc001kfs.3:exon7:c.T642C:p.T214T	.	AFR:0.6849,AMR:0.8146,EAS:0.9840,FIN:0.7967,NFE:0.7117,OTH:0.7576,ASJ:0.7649	134637	601859;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04217 Necroptosis~ko04650 Natural killer cell mediated cytotoxicity~ko04668 TNF signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04940 Type I diabetes mellitus~ko05010 Alzheimer disease~ko05130 Pathogenic Escherichia coli infection~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05320 Autoimmune thyroid disease~ko05330 Allograft rejection~ko05332 Graft-versus-host disease ~	.	.	.	.	.	.	.	10	MU67395980	hom
10	95549836	95549836	-	TT	LGI1	intronic	.	ENSG00000108231	rs371933363	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4481	.	0.453075	0.8264	.	.	.	.	.	.	.	.	.	.	AFR:0.6826,AMR:0.9059,EAS:0.8932,FIN:0.7581,NFE:0.9027,OTH:0.8843,ASJ:0.8578	604619	600512;	101046;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~	.	.	.	.	.	.	.	.	10	.	unknown
10	95552653	95552653	T	C	LGI1	exonic	synonymous SNV	ENSG00000108231	rs1111820	ENSG00000108231:ENST00000542308:exon4:c.T513C:p.F171F,ENSG00000108231:ENST00000371413:exon6:c.T657C:p.F219F,ENSG00000108231:ENST00000371418:exon6:c.T657C:p.F219F	LGI1:NM_001308276:exon4:c.T513C:p.F171F,LGI1:NM_001308275:exon6:c.T657C:p.F219F,LGI1:NM_005097:exon6:c.T657C:p.F219F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9928	0.9769	0.977436	0.9798	.	.	.	.	.	.	.	.	LGI1:uc010qnv.2:exon4:c.T513C:p.F171F,LGI1:uc001kjc.4:exon6:c.T657C:p.F219F,LGI1:uc021pwk.1:exon6:c.T657C:p.F219F	.	AFR:0.9302,AMR:0.9964,EAS:1,FIN:0.9997,NFE:0.9995,OTH:0.9959,ASJ:1	604619	600512;	101046;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~	.	.	.	.	.	.	.	.	10	MU81883389	hom
10	95552925	95552925	T	C	LGI1	intronic	.	ENSG00000108231	rs1108877	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1180	0.2274	0.240615	0.2086	.	.	.	.	.	.	.	.	.	.	AFR:0.5665,AMR:0.0740,EAS:0.1840,FIN:0.0836,NFE:0.0507,OTH:0.0838,ASJ:0.0894	604619	600512;	101046;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~	.	.	.	.	.	.	.	.	10	MU26983058	het
10	95791613	95791613	T	C	PLCE1	exonic	synonymous SNV	ENSG00000138193	rs17109671	ENSG00000138193:ENST00000371380:exon1:c.T810C:p.C270C,ENSG00000138193:ENST00000260766:exon2:c.T810C:p.C270C	PLCE1:NM_001288989:exon2:c.T810C:p.C270C,PLCE1:NM_016341:exon2:c.T810C:p.C270C	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3197	0.3965	0.460463	0.4010	.	.	.	.	.	.	.	.	PLCE1:uc010qnx.2:exon1:c.T810C:p.C270C,PLCE1:uc001kjk.3:exon2:c.T810C:p.C270C	.	AFR:0.7076,AMR:0.2093,EAS:0.4593,FIN:0.2942,NFE:0.2599,OTH:0.3258,ASJ:0.2715	608414	610725;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05205 Proteoglycans in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	10	MU19200714	het
10	95791763	95791763	G	A	PLCE1	exonic	synonymous SNV	ENSG00000138193	rs17109674	ENSG00000138193:ENST00000371380:exon1:c.G960A:p.E320E,ENSG00000138193:ENST00000260766:exon2:c.G960A:p.E320E	PLCE1:NM_001288989:exon2:c.G960A:p.E320E,PLCE1:NM_016341:exon2:c.G960A:p.E320E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2860	0.3182	0.378195	0.3281	.	.	.	.	.	.	.	.	PLCE1:uc010qnx.2:exon1:c.G960A:p.E320E,PLCE1:uc001kjk.3:exon2:c.G960A:p.E320E	.	AFR:0.4769,AMR:0.1647,EAS:0.4226,FIN:0.2937,NFE:0.2519,OTH:0.3122,ASJ:0.2148	608414	610725;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05205 Proteoglycans in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	10	MU19200752	het
10	95931087	95931087	G	T	PLCE1	exonic	nonsynonymous SNV	ENSG00000138193	rs17417407	ENSG00000138193:ENST00000371375:exon3:c.G719T:p.R240L,ENSG00000138193:ENST00000371380:exon3:c.G1643T:p.R548L,ENSG00000138193:ENST00000371385:exon3:c.G719T:p.R240L,ENSG00000138193:ENST00000260766:exon4:c.G1643T:p.R548L	PLCE1:NM_001165979:exon3:c.G719T:p.R240L,PLCE1:NM_001288989:exon4:c.G1643T:p.R548L,PLCE1:NM_016341:exon4:c.G1643T:p.R548L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.1782	0.1717	0.201078	MU146233	6.231	28.8	0.049	4.91	0.908	.	.	Ras guanine nucleotide exchange factor domain|Ras guanine-nucleotide exchange factors catalytic domain	PLCE1:uc001kjm.3:exon3:c.G719T:p.R240L,PLCE1:uc010qnx.2:exon3:c.G1643T:p.R548L,PLCE1:uc001kjk.3:exon4:c.G1643T:p.R548L	-1.129	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.1553,EAS:0.0955,FIN:0.1987,NFE:0.1136,OTH:0.1260,ASJ:0.1897	608414	610725;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05205 Proteoglycans in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	0.997	1.41	0.000	1.59	10	1(lung)	0.1483
10	96025697	96025697	G	A	PLCE1	exonic	synonymous SNV	ENSG00000138193	rs41291134	ENSG00000138193:ENST00000371375:exon15:c.G3339A:p.S1113S,ENSG00000138193:ENST00000371380:exon15:c.G4263A:p.S1421S,ENSG00000138193:ENST00000371385:exon15:c.G3339A:p.S1113S,ENSG00000138193:ENST00000260766:exon16:c.G4263A:p.S1421S	PLCE1:NM_001165979:exon15:c.G3339A:p.S1113S,PLCE1:NM_001288989:exon16:c.G4215A:p.S1405S,PLCE1:NM_016341:exon16:c.G4263A:p.S1421S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0348	0.0507	0.0652955	0.0462	.	.	.	.	.	.	.	.	PLCE1:uc001kjm.3:exon15:c.G3339A:p.S1113S,PLCE1:uc010qnx.2:exon15:c.G4215A:p.S1405S,PLCE1:uc001kjk.3:exon16:c.G4263A:p.S1421S	.	AFR:0.1112,AMR:0.0298,EAS:0.0408,FIN:0.0072,NFE:0.0216,OTH:0.0143,ASJ:0.0232	608414	610725;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05205 Proteoglycans in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	10	.	het
10	96039597	96039597	G	C	PLCE1	exonic	nonsynonymous SNV	ENSG00000138193	rs2274224	ENSG00000138193:ENST00000371375:exon19:c.G3800C:p.R1267P,ENSG00000138193:ENST00000371380:exon19:c.G4724C:p.R1575P,ENSG00000138193:ENST00000371385:exon19:c.G3800C:p.R1267P,ENSG00000138193:ENST00000260766:exon20:c.G4724C:p.R1575P	PLCE1:NM_001165979:exon19:c.G3800C:p.R1267P,PLCE1:NM_001288989:exon20:c.G4676C:p.R1559P,PLCE1:NM_016341:exon20:c.G4724C:p.R1575P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4378	0.4759	0.486222	MU11784347	1.510	13.37	1.0	4.64	0.741	.	.	PLC-like phosphodiesterase, TIM beta/alpha-barrel domain	PLCE1:uc001kjm.3:exon19:c.G3800C:p.R1267P,PLCE1:uc010qnx.2:exon19:c.G4676C:p.R1559P,PLCE1:uc001kjk.3:exon20:c.G4724C:p.R1575P	-0.950	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.4707,EAS:0.3732,FIN:0.5033,NFE:0.5462,OTH:0.3449,ASJ:0.5530	608414	610725;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05205 Proteoglycans in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	0.0	1.92	0.000	-0.55	10	1(stomach)	0.4521
10	96058298	96058298	C	T	PLCE1	exonic	nonsynonymous SNV	ENSG00000138193	rs3765524	ENSG00000138193:ENST00000371375:exon23:c.C4406T:p.T1469I,ENSG00000138193:ENST00000371380:exon23:c.C5330T:p.T1777I,ENSG00000138193:ENST00000371385:exon23:c.C4406T:p.T1469I,ENSG00000138193:ENST00000260766:exon24:c.C5330T:p.T1777I	PLCE1:NM_001165979:exon23:c.C4406T:p.T1469I,PLCE1:NM_001288989:exon24:c.C5282T:p.T1761I,PLCE1:NM_016341:exon24:c.C5330T:p.T1777I	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2711	0.3210	0.307907	1(stomach)	1.616	13.94	1.0	5.6	1.000	.	.	PLC-like phosphodiesterase, TIM beta/alpha-barrel domain|Phosphatidylinositol-specific phospholipase C, X domain;PLC-like phosphodiesterase, TIM beta/alpha-barrel domain|Phospholipase C, phosphatidylinositol-specific, Y domain	PLCE1:uc001kjp.3:exon3:c.C404T:p.T135I,PLCE1:uc001kjm.3:exon23:c.C4406T:p.T1469I,PLCE1:uc010qnx.2:exon23:c.C5282T:p.T1761I,PLCE1:uc001kjk.3:exon24:c.C5330T:p.T1777I	-0.957	AFR:3(large_intestine),AMR:MU82115281,EAS:0.3104,FIN:0.4131,NFE:0.1874,OTH:0.4233,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	608414	610725;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05205 Proteoglycans in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	0.0	0.76	0.000	-1.49	10	9(soft_tissue)	0.2135
10	96066341	96066341	A	G	PLCE1	exonic	nonsynonymous SNV	ENSG00000138193	rs2274223	ENSG00000138193:ENST00000371375:exon25:c.A4856G:p.H1619R,ENSG00000138193:ENST00000371380:exon25:c.A5780G:p.H1927R,ENSG00000138193:ENST00000371385:exon25:c.A4856G:p.H1619R,ENSG00000138193:ENST00000260766:exon26:c.A5780G:p.H1927R	PLCE1:NM_001165979:exon25:c.A4856G:p.H1619R,PLCE1:NM_001288989:exon26:c.A5732G:p.H1911R,PLCE1:NM_016341:exon26:c.A5780G:p.H1927R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2846	0.3186	0.298522	4(large_intestine)	0.210	4.782	1.0	5.43	0.992	.	.	C2 domain;PLC-like phosphodiesterase, TIM beta/alpha-barrel domain	PLCE1:uc001kjp.3:exon5:c.A854G:p.H285R,PLCE1:uc001kjm.3:exon25:c.A4856G:p.H1619R,PLCE1:uc010qnx.2:exon25:c.A5732G:p.H1911R,PLCE1:uc001kjk.3:exon26:c.A5780G:p.H1927R	-1.071	AFR:MU82115293,AMR:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,EAS:0.3440,FIN:0.1926,NFE:0.4272,OTH:0.2126,ASJ:0.3086	608414	610725;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05205 Proteoglycans in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	0.0	-0.31	0.000	-0.955	10	10(soft_tissue)	0.2199
10	96522561	96522561	T	C	CYP2C19	exonic	synonymous SNV	ENSG00000165841	rs17885098	ENSG00000165841:ENST00000371321:exon1:c.T99C:p.P33P	CYP2C19:NM_000769:exon1:c.T99C:p.P33P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0789	0.0820	0.091853	0.0798	.	.	.	.	.	.	.	.	CYP2C19:uc010qnz.2:exon1:c.T99C:p.P33P	.	AFR:0.1179,AMR:0.0477,EAS:0.0785,FIN:0.0536,NFE:0.0665,OTH:0.0653,ASJ:0.0861	124020	609535;	240935;	240935|-|-|-|-|609535 ~	~ko00590 Arachidonic acid metabolism~ko00591 Linoleic acid metabolism~ko00982 Drug metabolism - cytochrome P450~ko01100 Metabolic pathways~ko04726 Serotonergic synapse~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	10	.	het
10	96602623	96602623	G	A	CYP2C19	exonic	nonsynonymous SNV	ENSG00000165841	rs3758581	ENSG00000165841:ENST00000371321:exon7:c.G991A:p.V331I	CYP2C19:NM_000769:exon7:c.G991A:p.V331I	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0624	0.0473	0.0485224	0.0457	.	.	.	.	.	.	.	.	CYP2C19:uc010qnz.2:exon7:c.G991A:p.V331I,CYP2C19:uc010qny.2:exon12:c.G925A:p.V309I	.	AFR:0.0134,AMR:0.0442,EAS:0.0284,FIN:0.0533,NFE:0.0633,OTH:0.0550,ASJ:0.0861	124020	609535;	240935;	240935|-|-|-|-|609535 ~	~ko00590 Arachidonic acid metabolism~ko00591 Linoleic acid metabolism~ko00982 Drug metabolism - cytochrome P450~ko01100 Metabolic pathways~ko04726 Serotonergic synapse~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	10	MU68172832	het
10	96827119	96827119	-	A	CYP2C8	intronic	.	ENSG00000138115	rs11572078	ENSG00000138115:ENST00000539050:exon2:c.68dupT:p.L23fs	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2679	0.3041	0.34984	0.2909	.	.	.	.	.	.	.	.	CYP2C8:uc010qob.2:exon2:c.68dupT:p.L23fs,CYP2C8:uc010qod.1:exon2:c.68dupT:p.L23fs	.	AFR:0.4530,AMR:0.1882,EAS:0.3807,FIN:0.2096,NFE:0.2130,OTH:0.2556,ASJ:0.3179	601129	.	.	.	~ko00590 Arachidonic acid metabolism~ko00591 Linoleic acid metabolism~ko00830 Retinol metabolism~ko00982 Drug metabolism - cytochrome P450~ko01100 Metabolic pathways~ko04726 Serotonergic synapse~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	10	.	het
10	99219885	99219885	G	A	MMS19	exonic	synonymous SNV	ENSG00000155229	rs2152092	ENSG00000155229:ENST00000327238:exon24:c.C2280T:p.A760A,ENSG00000155229:ENST00000355839:exon25:c.C2445T:p.A815A,ENSG00000155229:ENST00000438925:exon26:c.C2574T:p.A858A,ENSG00000155229:ENST00000370782:exon27:c.C2574T:p.A858A	MMS19:NM_001330128:exon24:c.C2280T:p.A760A,MMS19:NM_001289403:exon25:c.C2445T:p.A815A,MMS19:NM_001289404:exon25:c.C2097T:p.A699A,MMS19:NM_001351357:exon25:c.C2100T:p.A700A,MMS19:NM_001351358:exon25:c.C1482T:p.A494A,MMS19:NM_001351359:exon26:c.C1482T:p.A494A,MMS19:NM_022362:exon26:c.C2574T:p.A858A,MMS19:NM_001289405:exon27:c.C2574T:p.A858A,MMS19:NM_001351356:exon27:c.C2691T:p.A897A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5370	0.5026	0.52516	1(lung)	.	.	.	.	.	.	.	.	MMS19:uc001knq.3:exon4:c.C363T:p.A121A,MMS19:uc009xvs.3:exon13:c.C1329T:p.A443A,MMS19:uc009xvt.3:exon23:c.C1806T:p.A602A,MMS19:uc001knr.3:exon25:c.C2097T:p.A699A,MMS19:uc010qox.3:exon25:c.C2445T:p.A815A,MMS19:uc001kns.4:exon26:c.C2574T:p.A858A,MMS19:uc001knt.3:exon27:c.C2574T:p.A858A	.	AFR:MU730327,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,EAS:0.4120,FIN:0.4940,NFE:0.5861,OTH:0.5810,ASJ:0.5159	614777	.	.	.	.	.	.	.	.	.	.	.	10	1(urinary_tract)	0.5547
10	99220707	99220707	C	T	MMS19	exonic	nonsynonymous SNV	ENSG00000155229	rs3740526	ENSG00000155229:ENST00000327238:exon22:c.G2075A:p.G692D,ENSG00000155229:ENST00000355839:exon23:c.G2240A:p.G747D,ENSG00000155229:ENST00000438925:exon24:c.G2369A:p.G790D,ENSG00000155229:ENST00000370782:exon25:c.G2369A:p.G790D	MMS19:NM_001330128:exon22:c.G2075A:p.G692D,MMS19:NM_001289403:exon23:c.G2240A:p.G747D,MMS19:NM_001289404:exon23:c.G1892A:p.G631D,MMS19:NM_001351357:exon23:c.G1895A:p.G632D,MMS19:NM_001351358:exon23:c.G1277A:p.G426D,MMS19:NM_001351359:exon24:c.G1277A:p.G426D,MMS19:NM_022362:exon24:c.G2369A:p.G790D,MMS19:NM_001289405:exon25:c.G2369A:p.G790D,MMS19:NM_001351356:exon25:c.G2486A:p.G829D	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4288	0.3420	0.330072	1(pancreas)	1.394	12.76	0.406	3.64	0.256	.	.	Armadillo-like helical|Armadillo-type fold|MMS19, C-terminal;Armadillo-like helical|MMS19, C-terminal	MMS19:uc001knq.3:exon2:c.G158A:p.G53D,MMS19:uc009xvs.3:exon11:c.G1124A:p.G375D,MMS19:uc009xvt.3:exon21:c.G1601A:p.G534D,MMS19:uc001knr.3:exon23:c.G1892A:p.G631D,MMS19:uc010qox.3:exon23:c.G2240A:p.G747D,MMS19:uc001kns.4:exon24:c.G2369A:p.G790D,MMS19:uc001knt.3:exon25:c.G2369A:p.G790D	-0.937	AFR:MU581955,AMR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,EAS:0.2058,FIN:0.4701,NFE:0.3609,OTH:0.3984,ASJ:0.3559	614777	.	.	.	.	.	.	.	0.103	1.62	0.000	-0.805	10	1(prostate)	0.4042
10	99229489	99229489	G	A	MMS19	intronic	.	ENSG00000155229	rs11592973	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2197	0.2302	0.159744	0.2355	.	.	.	.	.	0.0003	0.054	.	.	.	AFR:0.1654,AMR:0.2069,EAS:0.0377,FIN:0.2920,NFE:0.2849,OTH:0.2694,ASJ:0.19	614777	.	.	.	.	.	.	.	.	.	.	.	10	MU85509719	het
10	99240048	99240048	C	T	MMS19	exonic	nonsynonymous SNV	ENSG00000155229	rs7897727	ENSG00000155229:ENST00000422685:exon4:c.G329A:p.R110Q	MMS19:NM_001351356:exon4:c.G329A:p.R110Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5807	.	0.507388	0.5076	0.685	8.726	0.028	0.046	0.001	.	.	Armadillo-like helical	.	-0.939	AFR:0.3955,AMR:0.4084,EAS:0.5564,FIN:0.5608,NFE:0.5547,OTH:0.5760,ASJ:0.59	614777	.	.	.	.	.	.	.	.	1.91	0.000	.	10	MU4558789	het
10	99240758	99240758	G	C	MMS19	exonic	nonsynonymous SNV	ENSG00000155229	rs2275586	ENSG00000155229:ENST00000327238:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000355839:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000422685:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000437002:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000438925:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000439048:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000448660:exon3:c.C197G:p.A66G,ENSG00000155229:ENST00000370782:exon4:c.C203G:p.A68G	MMS19:NM_001289403:exon3:c.C203G:p.A68G,MMS19:NM_001330128:exon3:c.C203G:p.A68G,MMS19:NM_001351356:exon3:c.C203G:p.A68G,MMS19:NM_022362:exon3:c.C203G:p.A68G,MMS19:NM_001289405:exon4:c.C203G:p.A68G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9649	0.9468	0.9375	0.9507	1.135	11.40	1.0	6.08	0.993	.	.	Armadillo-like helical;Armadillo-like helical|Armadillo-type fold	MMS19:uc001kns.4:exon3:c.C203G:p.A68G,MMS19:uc010qox.3:exon3:c.C203G:p.A68G,MMS19:uc001knt.3:exon4:c.C203G:p.A68G	-0.955	AFR:0.8826,AMR:0.9821,EAS:0.9796,FIN:0.9614,NFE:0.9804,OTH:0.9827,ASJ:0.9669	614777	.	.	.	.	.	.	.	0.0	-0.57	0.000	-0.515	10	MU81883983	hom
10	99531571	99531571	C	G	SFRP5	exonic	nonsynonymous SNV	ENSG00000120057	rs11815012	ENSG00000120057:ENST00000266066:exon1:c.G20C:p.G7A	SFRP5:NM_003015:exon1:c.G20C:p.G7A	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.8387	.	0.78155	0.8447	-1.393	0.003	1.0	.	0.001	.	.	.	SFRP5:uc001kor.4:exon1:c.G20C:p.G7A	-0.961	AFR:0.9526,AMR:0.6704,EAS:0.4913,FIN:0.8104,NFE:0.8344,OTH:0.8225,ASJ:0.7953	604158	.	.	.	.	.	.	.	.	-0.17	0.000	0	10	.	het
10	101544447	101544447	A	T	ABCC2	exonic	nonsynonymous SNV	ENSG00000023839	rs927344	ENSG00000023839:ENST00000370434:exon2:c.A116T:p.Y39F,ENSG00000023839:ENST00000370449:exon2:c.A116T:p.Y39F	ABCC2:NM_000392:exon2:c.A116T:p.Y39F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9980	0.9935	0.994609	0.9944	1.609	13.90	1.0	5.58	0.991	.	.	.	ABCC2:uc001kqf.2:exon2:c.A116T:p.Y39F	-0.937	AFR:0.9802,AMR:1,EAS:1,FIN:1,NFE:1,OTH:0.9980,ASJ:1	601107	237500;	234;	234|Dubin-Sprinz disease<br>Hyperbilirubinemia type 2<br>Sprinz-Nelson syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|237500 ~	.	.	.	.	0.0	0.5	0.000	-1.375	10	MU81884479	hom
10	101604207	101604207	C	T	ABCC2	exonic	synonymous SNV	ENSG00000023839	rs3740066	ENSG00000023839:ENST00000370449:exon28:c.C3972T:p.I1324I	ABCC2:NM_000392:exon28:c.C3972T:p.I1324I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3420	0.3335	0.288139	0.3248	.	.	.	.	.	.	.	.	ABCC2:uc001kqf.2:exon28:c.C3972T:p.I1324I	.	AFR:0.2637,AMR:0.3520,EAS:0.2136,FIN:0.3455,NFE:0.3656,OTH:0.3282,ASJ:0.3377	601107	237500;	234;	234|Dubin-Sprinz disease<br>Hyperbilirubinemia type 2<br>Sprinz-Nelson syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|237500 ~	.	.	.	.	.	.	.	.	10	MU157609	het
10	102506070	102506070	G	C	PAX2	intronic	.	ENSG00000075891	rs4472867	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8365	0.7750	0.846645	0.8077	.	.	.	.	.	.	.	.	.	.	AFR:0.7489,AMR:0.8086,EAS:1,FIN:0.8548,NFE:0.8090,OTH:0.8160,ASJ:0.8311	167409	120330;616002;	656;1475;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~1475|Coloboma of optic nerve with renal disease<br>Papillo-renal syndrome|Unknown|Autosomal dominant|Childhood|120330 ~	.	.	.	.	.	.	.	.	10	MU81884534	hom
10	104157727	104157727	C	T	NFKB2	intronic	.	ENSG00000077150	rs4919632	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9646	0.9222	0.922125	0.9335	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.8030,AMR:0.9678,EAS:1,FIN:0.9963,NFE:0.9820,OTH:0.9785,ASJ:0.9636	164012	615577;	1572;293978;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~293978|DAVID syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615577 ~	~ko04010 MAPK signaling pathway~ko04064 NF-kappa B signaling pathway~ko04380 Osteoclast differentiation~ko04625 C-type lectin receptor signaling pathway~ko05134 Legionellosis~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05224 Breast cancer ~	.	.	.	.	.	.	.	10	MU81884905	hom
10	104159196	104159196	A	G	NFKB2	exonic	synonymous SNV	ENSG00000077150	rs4919633	ENSG00000077150:ENST00000189444:exon13:c.A1269G:p.P423P,ENSG00000077150:ENST00000369966:exon13:c.A1269G:p.P423P,ENSG00000077150:ENST00000428099:exon13:c.A1269G:p.P423P	NFKB2:NM_001261403:exon12:c.A1269G:p.P423P,NFKB2:NM_001322935:exon12:c.A1143G:p.P381P,NFKB2:NM_001077494:exon13:c.A1269G:p.P423P,NFKB2:NM_001288724:exon13:c.A1269G:p.P423P,NFKB2:NM_001322934:exon13:c.A1269G:p.P423P,NFKB2:NM_002502:exon13:c.A1269G:p.P423P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9971	0.9919	0.986821	0.9893	.	.	.	.	.	.	.	.	NFKB2:uc009xxc.4:exon12:c.A1269G:p.P423P,NFKB2:uc001kva.4:exon13:c.A1269G:p.P423P,NFKB2:uc001kvb.4:exon13:c.A1269G:p.P423P,NFKB2:uc001kvd.4:exon13:c.A1269G:p.P423P	.	AFR:0.9632,AMR:0.9952,EAS:1,FIN:1,NFE:0.9998,OTH:0.9969,ASJ:1	164012	615577;	1572;293978;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~293978|DAVID syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615577 ~	~ko04010 MAPK signaling pathway~ko04064 NF-kappa B signaling pathway~ko04380 Osteoclast differentiation~ko04625 C-type lectin receptor signaling pathway~ko05134 Legionellosis~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05224 Breast cancer ~	.	.	.	.	.	.	.	10	MU68086	hom
10	104160434	104160434	A	G	NFKB2	exonic	synonymous SNV	ENSG00000077150	rs4919634	ENSG00000077150:ENST00000189444:exon17:c.A1821G:p.A607A,ENSG00000077150:ENST00000369966:exon17:c.A1821G:p.A607A,ENSG00000077150:ENST00000428099:exon17:c.A1821G:p.A607A	NFKB2:NM_001261403:exon16:c.A1821G:p.A607A,NFKB2:NM_001322935:exon16:c.A1695G:p.A565A,NFKB2:NM_001077494:exon17:c.A1821G:p.A607A,NFKB2:NM_001288724:exon17:c.A1821G:p.A607A,NFKB2:NM_001322934:exon17:c.A1821G:p.A607A,NFKB2:NM_002502:exon17:c.A1821G:p.A607A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9968	0.9895	0.986821	0.9894	.	.	.	.	.	.	.	.	NFKB2:uc009xxc.4:exon16:c.A1821G:p.A607A,NFKB2:uc001kva.4:exon17:c.A1821G:p.A607A,NFKB2:uc001kvb.4:exon17:c.A1821G:p.A607A,NFKB2:uc001kvd.4:exon17:c.A1821G:p.A607A	.	AFR:0.9636,AMR:0.9952,EAS:1,FIN:1,NFE:0.9998,OTH:0.9969,ASJ:1	164012	615577;	1572;293978;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~293978|DAVID syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615577 ~	~ko04010 MAPK signaling pathway~ko04064 NF-kappa B signaling pathway~ko04380 Osteoclast differentiation~ko04625 C-type lectin receptor signaling pathway~ko05134 Legionellosis~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05224 Breast cancer ~	.	.	.	.	.	.	.	10	MU4556917	hom
10	104386934	104386934	T	C	SUFU	exonic	synonymous SNV	ENSG00000107882	rs17114803	ENSG00000107882:ENST00000369902:exon11:c.T1299C:p.I433I	SUFU:NM_016169:exon11:c.T1299C:p.I433I	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1587	0.1285	0.246006	0.1487	.	.	.	.	.	.	.	.	SUFU:uc001kvy.2:exon11:c.T1299C:p.I433I	.	AFR:0.2265,AMR:0.2177,EAS:0.3999,FIN:0.0684,NFE:0.0944,OTH:0.1224,ASJ:0.0795	607035	109400;155255;607174;	263662;251858;251863;251867;616;377;	263662|-|Unknown|Autosomal dominant|All ages|607174 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	10	MU23889338	hom
10	104387019	104387019	T	C	SUFU	intronic	.	ENSG00000107882	rs12414407	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6628	0.6811	0.719649	0.6861	.	.	.	.	.	.	.	.	.	.	AFR:0.7605,AMR:0.5979,EAS:0.7627,FIN:0.6097,NFE:0.6594,OTH:0.6510,ASJ:0.6967	607035	109400;155255;607174;	263662;251858;251863;251867;616;377;	263662|-|Unknown|Autosomal dominant|All ages|607174 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	10	MU23889391	hom
10	104389932	104389932	T	G	SUFU	UTR3	.	ENSG00000107882	rs4917980	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9994	0.9978	0.997404	0.9983	.	.	.	.	.	.	.	.	.	.	AFR:0.9940,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	607035	109400;155255;607174;	263662;251858;251863;251867;616;377;	263662|-|Unknown|Autosomal dominant|All ages|607174 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	10	MU81885050	hom
10	104596981	104596981	G	A	CYP17A1	exonic	synonymous SNV	ENSG00000148795	rs6162	ENSG00000148795:ENST00000369887:exon1:c.C138T:p.H46H	CYP17A1:NM_000102:exon1:c.C138T:p.H46H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4248	0.3949	0.442492	0.4116	.	.	.	.	.	.	.	.	CYP17A1:uc001kwg.3:exon1:c.C138T:p.H46H	.	AFR:0.3683,AMR:0.4117,EAS:0.5963,FIN:0.3645,NFE:0.4254,OTH:0.4305,ASJ:0.4735	609300	202110;	418;90793;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~90793|CAH due to 17-alpha-hydroxylase deficiency<br>Combined 17-hydroxylase/17,20-lyase deficiency|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|202110 ~	.	.	.	.	.	.	.	.	10	MU135047	het
10	104849468	104849468	G	A	NT5C2	exonic	synonymous SNV	ENSG00000076685	rs3740387	ENSG00000076685:ENST00000404739:exon17:c.C1647T:p.D549D,ENSG00000076685:ENST00000423468:exon17:c.C1560T:p.D520D,ENSG00000076685:ENST00000343289:exon18:c.C1647T:p.D549D	NT5C2:NM_001351181:exon16:c.C1074T:p.D358D,NT5C2:NM_001351174:exon17:c.C1560T:p.D520D,NT5C2:NM_001351183:exon17:c.C1074T:p.D358D,NT5C2:NM_001351191:exon17:c.C1074T:p.D358D,NT5C2:NM_001134373:exon18:c.C1647T:p.D549D,NT5C2:NM_001351176:exon18:c.C1074T:p.D358D,NT5C2:NM_001351180:exon18:c.C1074T:p.D358D,NT5C2:NM_001351192:exon18:c.C1074T:p.D358D,NT5C2:NM_001351194:exon18:c.C933T:p.D311D,NT5C2:NM_001351169:exon19:c.C1647T:p.D549D,NT5C2:NM_001351170:exon19:c.C1671T:p.D557D,NT5C2:NM_001351173:exon19:c.C1671T:p.D557D,NT5C2:NM_001351177:exon19:c.C1074T:p.D358D,NT5C2:NM_001351184:exon19:c.C1074T:p.D358D,NT5C2:NM_001351185:exon19:c.C1074T:p.D358D,NT5C2:NM_001351188:exon19:c.C1074T:p.D358D,NT5C2:NM_001351189:exon19:c.C1074T:p.D358D,NT5C2:NM_001351190:exon19:c.C1074T:p.D358D,NT5C2:NM_001351193:exon19:c.C1074T:p.D358D,NT5C2:NM_012229:exon19:c.C1647T:p.D549D,NT5C2:NM_001351171:exon20:c.C1671T:p.D557D,NT5C2:NM_001351172:exon20:c.C1671T:p.D557D,NT5C2:NM_001351175:exon20:c.C1554T:p.D518D,NT5C2:NM_001351179:exon20:c.C1074T:p.D358D,NT5C2:NM_001351182:exon20:c.C1074T:p.D358D,NT5C2:NM_001351195:exon20:c.C933T:p.D311D,NT5C2:NM_001351197:exon20:c.C1074T:p.D358D,NT5C2:NM_001351178:exon21:c.C1074T:p.D358D,NT5C2:NM_001351186:exon21:c.C1074T:p.D358D,NT5C2:NM_001351196:exon21:c.C933T:p.D311D,NT5C2:NM_001351187:exon22:c.C1074T:p.D358D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4171	0.3968	0.422125	1(stomach)	.	.	.	.	.	.	.	.	NT5C2:uc010qqp.2:exon17:c.C1560T:p.D520D,NT5C2:uc001kwq.3:exon18:c.C1647T:p.D549D,NT5C2:uc001kwo.3:exon19:c.C1647T:p.D549D,NT5C2:uc001kwp.3:exon19:c.C1188T:p.D396D	.	AFR:1(urinary_tract),AMR:MU23889750,EAS:0.4122,FIN:0.3846,NFE:0.4067,OTH:0.4735,ASJ:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205	600417	613162;	320396;	320396|Autosomal recessive spastic paraplegia type 65<br>SPG45<br>SPG65|<1 / 1 000 000|-|Neonatal<br>Infancy|613162 ~	.	,8380	.	.	.	.	.	.	10	2(haematopoietic_and_lymphoid_tissue)	0.5211
10	104896078	104896078	T	A	NT5C2	exonic	stopgain	ENSG00000076685	rs34104646	.	NT5C2:NM_001351175:exon5:c.A10T:p.R4X	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	.	.	0.286741	0.3245	.	.	.	.	.	.	.	.	.	.	AFR:0.3276,AMR:0.2344,EAS:0.3171,FIN:0.2951,NFE:0.3353,OTH:0.2990,ASJ:0.4073	600417	613162;	320396;	320396|Autosomal recessive spastic paraplegia type 65<br>SPG45<br>SPG65|<1 / 1 000 000|-|Neonatal<br>Infancy|613162 ~	.	,8380	.	.	.	.	.	.	10	MU115986040	het
10	112361870	112361870	A	G	SMC3	exonic	synonymous SNV	ENSG00000108055	rs2419565	ENSG00000108055:ENST00000361804:exon25:c.A3039G:p.S1013S	SMC3:NM_005445:exon25:c.A3039G:p.S1013S	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.9963	0.9899	0.986821	0.9897	.	.	.	.	.	.	.	.	SMC3:uc001kze.3:exon25:c.A3039G:p.S1013S	.	AFR:0.9651,AMR:0.9976,EAS:1,FIN:1,NFE:0.9997,OTH:0.9990,ASJ:0.9834	606062	610759;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	,9741	.	.	.	.	.	.	10	MU81885879	hom
10	112724834	112724836	ATT	-	SHOC2	intronic	.	ENSG00000108061	rs370351651	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0035	.	0.00259585	0.0002	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.668e-05,OTH:0.0041,ASJ:0	602775	607721;	2701;	2701|NS/LAH<br>Tosti syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|607721 ~	.	.	.	.	.	.	.	.	10	.	het
10	115609915	115609915	C	G	DCLRE1A	exonic	nonsynonymous SNV	ENSG00000198924	rs3750898	ENSG00000198924:ENST00000361384:exon2:c.G949C:p.D317H,ENSG00000198924:ENST00000369305:exon3:c.G949C:p.D317H	DCLRE1A:NM_014881:exon2:c.G949C:p.D317H,DCLRE1A:NM_001271816:exon3:c.G949C:p.D317H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.7562	0.6379	0.657748	0.6768	5.545	26.4	0.007	4.13	0.506	.	.	.	DCLRE1A:uc001law.3:exon2:c.G949C:p.D317H,DCLRE1A:uc031pxf.1:exon3:c.G949C:p.D317H	-1.003	AFR:0.3802,AMR:0.8508,EAS:0.8776,FIN:0.7975,NFE:0.7802,OTH:0.7704,ASJ:0.8367	609682	.	.	.	.	.	.	.	0.993	-0.29	0.000	1.59	10	MU23502967	het
10	123298158	123298158	T	C	FGFR2	exonic	synonymous SNV	ENSG00000066468	rs1047100	ENSG00000066468:ENST00000356226:exon4:c.A351G:p.V117V,ENSG00000066468:ENST00000369059:exon4:c.A351G:p.V117V,ENSG00000066468:ENST00000604236:exon4:c.A351G:p.V117V,ENSG00000066468:ENST00000336553:exon5:c.A429G:p.V143V,ENSG00000066468:ENST00000346997:exon5:c.A696G:p.V232V,ENSG00000066468:ENST00000357555:exon5:c.A429G:p.V143V,ENSG00000066468:ENST00000360144:exon5:c.A429G:p.V143V,ENSG00000066468:ENST00000369056:exon5:c.A696G:p.V232V,ENSG00000066468:ENST00000369061:exon5:c.A696G:p.V232V,ENSG00000066468:ENST00000351936:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000358487:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000359354:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000369058:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000369060:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000457416:exon6:c.A696G:p.V232V	FGFR2:NM_001144916:exon3:c.A351G:p.V117V,FGFR2:NM_001144918:exon4:c.A351G:p.V117V,FGFR2:NM_023029:exon4:c.A429G:p.V143V,FGFR2:NM_001144913:exon5:c.A696G:p.V232V,FGFR2:NM_001144914:exon5:c.A696G:p.V232V,FGFR2:NM_001144915:exon5:c.A429G:p.V143V,FGFR2:NM_001144919:exon5:c.A429G:p.V143V,FGFR2:NM_000141:exon6:c.A696G:p.V232V,FGFR2:NM_001144917:exon6:c.A696G:p.V232V,FGFR2:NM_001320658:exon6:c.A696G:p.V232V,FGFR2:NM_022970:exon6:c.A696G:p.V232V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7797	0.7667	0.795327	0.7635	.	.	.	.	.	.	.	.	FGFR2:uc010qto.2:exon3:c.A408G:p.V136V,FGFR2:uc021pzw.1:exon3:c.A351G:p.V117V,FGFR2:uc010qtm.2:exon4:c.A351G:p.V117V,FGFR2:uc031pxk.1:exon4:c.A429G:p.V143V,FGFR2:uc010qtn.2:exon5:c.A753G:p.V251V,FGFR2:uc010qtp.2:exon5:c.A753G:p.V251V,FGFR2:uc010qtq.2:exon5:c.A753G:p.V251V,FGFR2:uc021pzv.1:exon5:c.A696G:p.V232V,FGFR2:uc021pzx.1:exon5:c.A429G:p.V143V,FGFR2:uc021qaa.1:exon5:c.A696G:p.V232V,FGFR2:uc021qab.1:exon5:c.A429G:p.V143V,FGFR2:uc021qac.1:exon5:c.A486G:p.V162V,FGFR2:uc001lfo.1:exon6:c.A753G:p.V251V,FGFR2:uc010qtl.2:exon6:c.A696G:p.V232V,FGFR2:uc021pzy.1:exon6:c.A696G:p.V232V,FGFR2:uc021pzz.1:exon6:c.A696G:p.V232V	.	AFR:0.7530,AMR:0.8126,EAS:0.9030,FIN:0.7590,NFE:0.7519,OTH:0.7459,ASJ:0.8676	176943	101200;101400;101600;123150;123500;123790;149730;207410;609579;613659;614592;	313855;168624;83;2363;1555;207;1540;710;794;87;	313855|Perinatal lethal bent bone dysplasia|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614592 ~168624|Scaphocephaly-macrocephaly-maxillary retrusion-intellectual disability syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|609579 ~83|-|<1 / 1 000 000|Autosomal recessive|Neonatal|207410 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~1555|Beare-Stevenson cutis gyrata syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|123790 ~207|Crouzon craniofacial dysostosis|1-9 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123500 ~1540|Craniosynostosis-midfacial hypoplasia-foot abnormalities syndrome<br>JWS|<1 / 1 000 000|Autosomal dominant|Neonatal|123150 ~710|ACS5<br>Acrocephalosyndactyly type 5|Unknown|Autosomal dominant|Antenatal<br>Neonatal|101600 ~794|ACS3<br>Acrocephalosyndactyly type 3<br>SCS|1-9 / 100 000|Autosomal dominant|Neonatal|101400 ~87|ACS1<br>Acrocephalosyndactyly type 1|1-9 / 100 000|Autosomal dominant|Antenatal<br>Neonatal|101200 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05215 Prostate cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	5280,,5294,5286,5283,5288,5282,5292,5289,5290,5287,5284,5293,5291,5295,5285,5323,5281,5219	.	.	.	.	.	.	10	MU81887223	het
10	124221270	124221270	C	T	HTRA1	exonic	synonymous SNV	ENSG00000166033	rs1049331	ENSG00000166033:ENST00000368984:exon1:c.C102T:p.A34A	HTRA1:NM_002775:exon1:c.C102T:p.A34A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4159	.	0.293131	0.2510	.	.	.	.	.	.	.	.	HTRA1:uc001lgj.2:exon1:c.C102T:p.A34A	.	AFR:0.2426,AMR:0.2943,EAS:0.4204,FIN:0.2546,NFE:0.2346,OTH:0.2579,ASJ:0.2366	602194	600142;610149;616779;	199354;	199354|Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy<br>Maeda syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|600142 ~	.	.	.	.	.	.	.	.	10	MU68023589	unknown
10	124221276	124221276	G	T	HTRA1	exonic	synonymous SNV	ENSG00000166033	rs2293870	ENSG00000166033:ENST00000368984:exon1:c.G108T:p.G36G	HTRA1:NM_002775:exon1:c.G108T:p.G36G	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4104	.	0.291334	0.2502	.	.	.	.	.	.	.	.	HTRA1:uc001lgj.2:exon1:c.G108T:p.G36G	.	AFR:0.2404,AMR:0.2949,EAS:0.4202,FIN:0.2552,NFE:0.2342,OTH:0.2594,ASJ:0.2366	602194	600142;610149;616779;	199354;	199354|Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy<br>Maeda syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|600142 ~	.	.	.	.	.	.	.	.	10	MU30116630	unknown
10	124271589	124271589	G	A	HTRA1	intronic	.	ENSG00000166033	rs2672586	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9998	0.9994	0.999401	0.9996	.	.	.	.	.	0.0001	0.076	.	.	.	AFR:0.9986,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	602194	600142;610149;616779;	199354;	199354|Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy<br>Maeda syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|600142 ~	.	.	.	.	.	.	.	.	10	MU81887516	unknown
10	124271595	124271595	G	A	HTRA1	intronic	.	ENSG00000166033	rs2272599	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6113	0.6506	0.627995	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,ESCA-CN|1|332|0.00301205	.	.	.	.	.	.	.	.	.	.	AFR:0.6342,AMR:0.7012,EAS:0.6391,FIN:0.6190,NFE:0.6070,OTH:0.6126,ASJ:0.4892	602194	600142;610149;616779;	199354;	199354|Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy<br>Maeda syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|600142 ~	.	.	.	.	.	.	.	.	10	2(lung)	0.6133
11	534242	534242	A	G	HRAS	exonic	synonymous SNV	ENSG00000174775	rs12628	ENSG00000174775:ENST00000397594:exon1:c.T81C:p.H27H,ENSG00000174775:ENST00000311189:exon2:c.T81C:p.H27H,ENSG00000174775:ENST00000397596:exon2:c.T81C:p.H27H,ENSG00000174775:ENST00000417302:exon2:c.T81C:p.H27H,ENSG00000174775:ENST00000451590:exon2:c.T81C:p.H27H,ENSG00000174775:ENST00000493230:exon2:c.T81C:p.H27H	HRAS:NM_001130442:exon2:c.T81C:p.H27H,HRAS:NM_005343:exon2:c.T81C:p.H27H,HRAS:NM_176795:exon2:c.T81C:p.H27H	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3135	0.3545	0.297125	1(thyroid)	.	.	.	.	.	.	.	.	HRAS:uc001lpv.3:exon2:c.T81C:p.H27H,HRAS:uc010qvw.2:exon2:c.T81C:p.H27H,HRAS:uc010qvx.2:exon2:c.T81C:p.H27H	.	AFR:26(urinary_tract),AMR:3(haematopoietic_and_lymphoid_tissue),EAS:11(meninges),FIN:1(liver),NFE:2(biliary_tract),OTH:MU107046,ASJ:1(skin)	190020	109800;137550;162900;163200;188470;218040;	3071;319487;2612;79414;626;	3071|FCS syndrome<br>Faciocutaneoskeletal syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|218040 ~319487|FNMTC<br>Familial pure nonmedullary thyroid carcinoma|-|-|-|188470 188550 603386 603744 606240 616534 616535 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~626|Congenital pigmented nevus<br>GMN<br>Giant congenital melanocytic nevus<br>Giant pigmented hairy nevus<br>LCMN|1-9 / 100 000|-|Infancy<br>Neonatal|137550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04144 Endocytosis~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,5962,5963,5969,5970,5974,5966,5967,5961,5973,5968,5975,5965,5964,5971,5972	.	.	.	.	.	.	11	1(large_intestine)	LAML-KR|2|205|0.0097561,LUSC-KR|4|170|0.0235294,COCA-CN|4|321|0.0124611
11	2016619	2016619	A	G	HOTS	exonic	nonsynonymous SNV	ENSG00000130600	rs3741219	.	HOTS:NM_001293171:exon1:c.A193G:p.T65A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4208	0.3961	0.298323	0.3805	.	.	.	.	.	.	.	.	.	.	AFR:0.1407,AMR:0.3628,EAS:0.3176,FIN:0.5362,NFE:0.4846,OTH:0.4448,ASJ:0.53	615509	.	.	.	.	.	.	.	.	.	.	.	11	MU641843	het
11	2016659	2016659	T	C	HOTS	exonic	nonsynonymous SNV	ENSG00000130600	rs2839704	.	HOTS:NM_001293171:exon1:c.T233C:p.V78A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3381	0.3088	0.26877	0.2926	.	.	.	.	.	.	.	.	.	.	AFR:0.1188,AMR:0.3294,EAS:0.3106,FIN:0.3657,NFE:0.3664,OTH:0.3488,ASJ:0.4470	615509	.	.	.	.	.	.	.	.	.	.	.	11	MU641826	unknown
11	2016662	2016662	T	C	HOTS	exonic	nonsynonymous SNV	ENSG00000130600	rs2839703	.	HOTS:NM_001293171:exon1:c.T236C:p.L79P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3378	0.3088	0.26897	0.2925	.	.	.	.	.	.	.	.	.	.	AFR:0.1188,AMR:0.3294,EAS:0.3110,FIN:0.3657,NFE:0.3662,OTH:0.3488,ASJ:0.4470	615509	.	.	.	.	.	.	.	.	.	.	.	11	MU641807	unknown
11	2016908	2016908	G	A	H19	ncRNA_exonic	.	ENSG00000130600	rs217727	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2000	0.1551	0.202077	0.1737	.	.	.	.	.	.	.	.	.	.	AFR:0.0944,AMR:0.2536,EAS:0.3391,FIN:0.1815,NFE:0.1946,OTH:0.2047,ASJ:0.1233	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU782426	unknown
11	2016924	2016924	A	G	H19	ncRNA_exonic	.	ENSG00000130600	rs10840159	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4183	0.3921	0.291334	0.3742	.	.	.	.	.	.	.	.	.	.	AFR:0.1167,AMR:0.3612,EAS:0.3168,FIN:0.5408,NFE:0.4849,OTH:0.4426,ASJ:0.5232	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU20292210	unknown
11	2017017	2017017	A	C	H19	ncRNA_exonic	.	ENSG00000130600	rs2839702	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4211	0.3907	0.290136	0.3742	.	.	.	.	.	.	.	.	.	.	AFR:0.1161,AMR:0.3624,EAS:0.3148,FIN:0.5420,NFE:0.4858,OTH:0.4434,ASJ:0.5232	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU751270	het
11	2017110	2017110	C	G	H19	ncRNA_exonic	.	ENSG00000130600	rs2839701	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4142	0.3888	0.290136	0.3693	.	.	.	.	.	.	.	.	.	.	AFR:0.1154,AMR:0.3585,EAS:0.3155,FIN:0.5247,NFE:0.4799,OTH:0.4356,ASJ:0.53	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU18733638	het
11	2017439	2017439	C	G	H19	ncRNA_intronic	.	ENSG00000130600	rs3024270	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5041	0.4241	0.365415	0.4171	.	.	.	.	.	.	.	.	.	.	AFR:0.1915,AMR:0.3831,EAS:0.4876,FIN:0.5588,NFE:0.5037,OTH:0.4639,ASJ:0.5667	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU698421	het
11	2018168	2018168	C	T	H19	ncRNA_exonic	.	ENSG00000130600	rs2067051	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3852	.	0.286342	0.3717	.	.	.	.	.	.	.	.	.	.	AFR:0.1176,AMR:0.3636,EAS:0.2918,FIN:0.5485,NFE:0.4806,OTH:0.4414,ASJ:0.5066	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU727189	het
11	2018336	2018336	A	T	H19	ncRNA_exonic	.	ENSG00000130600	rs2075745	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3831	.	0.292931	0.3762	.	.	.	.	.	.	.	.	.	.	AFR:0.1186,AMR:0.3678,EAS:0.3104,FIN:0.5527,NFE:0.4856,OTH:0.4452,ASJ:0.5133	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU18733733	het
11	2018449	2018449	A	G	H19	ncRNA_exonic	.	ENSG00000130600	rs2075744	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3626	.	0.29353	0.3779	.	.	.	.	.	.	.	.	.	.	AFR:0.1188,AMR:0.3696,EAS:0.3109,FIN:0.5534,NFE:0.4882,OTH:0.4462,ASJ:0.5233	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU18733797	het
11	2018853	2018853	G	A	H19	ncRNA_exonic	.	ENSG00000130600	rs2839698	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3592	.	0.292931	0.3757	.	.	.	.	.	.	.	.	.	.	AFR:0.1185,AMR:0.3675,EAS:0.3098,FIN:0.5523,NFE:0.4850,OTH:0.4433,ASJ:0.5132	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU29996451	het
11	2797237	2797237	G	A	KCNQ1	exonic	synonymous SNV	ENSG00000053918	rs1057128	ENSG00000053918:ENST00000155840:exon13:c.G1638A:p.S546S,ENSG00000053918:ENST00000335475:exon13:c.G1257A:p.S419S	KCNQ1:NM_000218:exon13:c.G1638A:p.S546S,KCNQ1:NM_181798:exon13:c.G1257A:p.S419S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2584	0.1435	0.180911	MU824185	.	.	.	.	.	.	.	.	KCNQ1:uc009ydp.2:exon11:c.G990A:p.S330S,KCNQ1:uc001lwn.3:exon13:c.G1638A:p.S546S,KCNQ1:uc001lwo.4:exon13:c.G1257A:p.S419S	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,LINC-JP|1|394|0.00253807,AMR:0.1654,EAS:0.3329,FIN:0.1490,NFE:0.2932,OTH:0.1970,ASJ:0.0459	607542	192500;220400;607554;609621;	51083;334;768;90647;101016;768;	51083|SQTS|Unknown|Autosomal dominant|All ages|609620 609621 609622 ~334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~90647|Long QT interval-deafness syndrome|1-9 / 1 000 000|Autosomal recessive|Childhood|220400 612347 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	1(lung)	0.2029
11	6629665	6629665	C	T	ILK	exonic	synonymous SNV	ENSG00000166333	rs1043388	ENSG00000166333:ENST00000396751:exon3:c.C297T:p.H99H,ENSG00000166333:ENST00000299421:exon4:c.C297T:p.H99H,ENSG00000166333:ENST00000420936:exon4:c.C297T:p.H99H,ENSG00000166333:ENST00000527327:exon4:c.C297T:p.H99H,ENSG00000166333:ENST00000527394:exon4:c.C297T:p.H99H,ENSG00000166333:ENST00000528995:exon4:c.C297T:p.H99H	ILK:NM_001014795:exon3:c.C297T:p.H99H,ILK:NM_001014794:exon4:c.C297T:p.H99H,ILK:NM_001278441:exon4:c.C297T:p.H99H,ILK:NM_004517:exon4:c.C297T:p.H99H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2677	0.2950	0.314696	0.2953	.	.	.	.	.	.	.	.	ILK:uc001meh.3:exon3:c.C297T:p.H99H,ILK:uc001mee.3:exon4:c.C297T:p.H99H,ILK:uc001mef.3:exon4:c.C297T:p.H99H,ILK:uc010raq.2:exon4:c.C297T:p.H99H	.	AFR:0.3774,AMR:0.2053,EAS:0.3455,FIN:0.2407,NFE:0.2609,OTH:0.2755,ASJ:0.3079	602366	.	.	.	.	.	.	.	.	.	.	.	11	MU108851	het
11	6630029	6630029	C	-	TAF10	UTR3	.	ENSG00000166333	rs11314683	ENSG00000166333:ENST00000527327:exon5:c.457delC:p.P153fs,ENSG00000166333:ENST00000527394:exon5:c.457delC:p.P153fs	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600475	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	6630833	6630833	G	A	ILK	exonic	synonymous SNV	ENSG00000166333	rs1043390	ENSG00000166333:ENST00000528995:exon7:c.G636A:p.P212P,ENSG00000166333:ENST00000396751:exon8:c.G819A:p.P273P,ENSG00000166333:ENST00000537806:exon8:c.G417A:p.P139P,ENSG00000166333:ENST00000299421:exon9:c.G819A:p.P273P,ENSG00000166333:ENST00000420936:exon9:c.G819A:p.P273P	ILK:NM_001278441:exon7:c.G636A:p.P212P,ILK:NM_001014795:exon8:c.G819A:p.P273P,ILK:NM_001278442:exon8:c.G417A:p.P139P,ILK:NM_001014794:exon9:c.G819A:p.P273P,ILK:NM_004517:exon9:c.G819A:p.P273P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2782	0.3269	0.347444	0.3227	.	.	.	.	.	.	.	.	ILK:uc010raq.2:exon7:c.G636A:p.P212P,ILK:uc001meh.3:exon8:c.G819A:p.P273P,ILK:uc010rap.2:exon8:c.G417A:p.P139P,ILK:uc001mee.3:exon9:c.G819A:p.P273P,ILK:uc001mef.3:exon9:c.G819A:p.P273P	.	AFR:0.4732,AMR:0.2076,EAS:0.3462,FIN:0.2414,NFE:0.2613,OTH:0.2787,ASJ:0.3079	602366	.	.	.	.	.	.	.	.	.	.	.	11	MU108871	het
11	8256125	8256125	C	G	LMO1	intronic	.	ENSG00000166407	rs204925	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.595847	0.6416	.	.	.	.	.	.	.	.	.	.	AFR:0.4044,AMR:0.6340,EAS:0.6163,FIN:0.7532,NFE:0.7485,OTH:0.7276,ASJ:0.7815	186921	.	.	.	.	.	.	.	.	.	.	.	11	MU87154591	het
11	8256255	8256255	A	C	LMO1	intronic	.	ENSG00000166407	rs204924	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.995807	0.9964	.	.	.	.	.	.	.	.	.	.	AFR:0.9877,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	186921	.	.	.	.	.	.	.	.	.	.	.	11	.	unknown
11	8717003	8717003	C	T	ST5	intronic	.	ENSG00000254665	rs2270956	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4271	0.3648	0.336462	ESAD-UK|2|409|0.00488998,LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	0.0002	0.026	.	.	.	AFR:0.3852,AMR:0.1700,EAS:0.4073,FIN:0.4328,NFE:0.5123,OTH:0.4711,ASJ:0.4163	140750	.	.	.	.	.	.	.	.	.	.	.	11	4(haematopoietic_and_lymphoid_tissue)	0.4192
11	8751889	8751889	C	G	ST5	exonic	nonsynonymous SNV	ENSG00000166444	rs3794153	ENSG00000166444:ENST00000313726:exon3:c.G948C:p.K316N,ENSG00000166444:ENST00000357665:exon4:c.G948C:p.K316N,ENSG00000166444:ENST00000534127:exon6:c.G948C:p.K316N	ST5:NM_213618:exon3:c.G948C:p.K316N,ST5:NM_005418:exon6:c.G948C:p.K316N	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 0, 0] 	0.4004	0.3210	0.280152	LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	4.058	23.7	0.001	6.17	1.000	.	.	.	ST5:uc001mgt.3:exon3:c.G948C:p.K316N,ST5:uc001mgv.3:exon6:c.G948C:p.K316N,ST5:uc001mgw.1:exon7:c.G948C:p.K316N	-0.938	AFR:0.3604,AMR:0.0891,EAS:0.3377,FIN:0.3635,NFE:0.5487,OTH:0.4659,ASJ:0.4652	140750	.	.	.	.	.	.	.	0.998	2.92	0.000	1.895	11	1(thyroid)	0.4090
11	8788168	8788168	A	T	ST5	intronic	.	ENSG00000166444	rs10743089	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5940	.	0.55631	0.5932	.	.	.	.	.	.	.	.	.	.	AFR:0.4117,AMR:0.6067,EAS:0.6747,FIN:0.6912,NFE:0.6648,OTH:0.6242,ASJ:0.5629	140750	.	.	.	.	.	.	.	.	.	.	.	11	MU81895107	hom
11	8788225	8788225	A	C	ST5	intronic	.	ENSG00000166444	rs10734637	ENSG00000166444:ENST00000527930:exon1:c.T24G:p.G8G,ENSG00000166444:ENST00000532734:exon1:c.T24G:p.G8G	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6366	.	0.616813	0.6461	.	.	.	.	.	.	.	.	.	.	AFR:0.5597,AMR:0.6280,EAS:0.6776,FIN:0.6955,NFE:0.6832,OTH:0.6459,ASJ:0.61	140750	.	.	.	.	.	.	.	.	.	.	.	11	MU4552287	hom
11	10786142	10786142	C	T	CTR9	exonic	synonymous SNV	ENSG00000198730	rs3736326	ENSG00000198730:ENST00000361367:exon12:c.C1461T:p.H487H	CTR9:NM_001346279:exon12:c.C1461T:p.H487H,CTR9:NM_014633:exon12:c.C1461T:p.H487H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6377	0.5111	0.611621	0.5535	.	.	.	.	.	.	.	.	CTR9:uc001mja.3:exon12:c.C1461T:p.H487H	.	AFR:0.3711,AMR:0.7184,EAS:0.8395,FIN:0.6282,NFE:0.5961,OTH:0.6255,ASJ:0.6192	609366	.	.	.	.	.	.	.	.	.	.	.	11	MU4555501	hom
11	11986061	11986061	T	C	DKK3	exonic	nonsynonymous SNV	ENSG00000050165	rs3206824	ENSG00000050165:ENST00000450094:exon6:c.A919G:p.R307G,ENSG00000050165:ENST00000326932:exon8:c.A1003G:p.R335G,ENSG00000050165:ENST00000396505:exon8:c.A1003G:p.R335G,ENSG00000050165:ENST00000525493:exon8:c.A1045G:p.R349G	DKK3:NM_001018057:exon7:c.A1003G:p.R335G,DKK3:NM_001330220:exon8:c.A1045G:p.R349G,DKK3:NM_013253:exon8:c.A1003G:p.R335G,DKK3:NM_015881:exon8:c.A1003G:p.R335G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7781	0.7718	0.812101	1(liver)	-0.421	0.344	0.693	-2.65	0.008	.	.	.	DKK3:uc010rcf.2:exon6:c.A919G:p.R307G,DKK3:uc001mju.3:exon7:c.A1003G:p.R335G,DKK3:uc001mjv.3:exon8:c.A1003G:p.R335G,DKK3:uc001mjw.3:exon8:c.A1003G:p.R335G,DKK3:uc010rcg.1:exon8:c.A1045G:p.R349G	-1.001	AFR:1(thyroid),AMR:MU751806,EAS:0.7566,FIN:0.8232,NFE:0.8711,OTH:0.8676,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	605416	.	.	.	.	.	.	.	0.0	2.29	0.000	-2.08	11	1(urinary_tract)	0.8019
11	11988197	11988197	G	A	DKK3	intronic	.	ENSG00000050165	rs7479970	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.365216	0.2832	.	.	.	.	.	.	.	.	.	.	AFR:0.5140,AMR:0.4387,EAS:0.2385,FIN:0.1328,NFE:0.1856,OTH:0.2285,ASJ:0.1987	605416	.	.	.	.	.	.	.	.	.	.	.	11	MU28472933	het
11	20623007	20623007	C	T	SLC6A5	exonic	synonymous SNV	ENSG00000165970	rs7109418	ENSG00000165970:ENST00000298923:exon2:c.C336T:p.S112S,ENSG00000165970:ENST00000525748:exon2:c.C336T:p.S112S	SLC6A5:NM_004211:exon2:c.C336T:p.S112S	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.2624	0.2661	0.190296	0.2524	.	.	.	.	.	.	.	.	SLC6A5:uc001mqd.3:exon2:c.C336T:p.S112S	.	AFR:0.2385,AMR:0.1420,EAS:0.0049,FIN:0.2951,NFE:0.2817,OTH:0.2848,ASJ:0.2384	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	.	.	.	.	11	.	unknown
11	20623023	20623023	C	T	SLC6A5	exonic	synonymous SNV	ENSG00000165970	rs2241941	ENSG00000165970:ENST00000298923:exon2:c.C352T:p.L118L,ENSG00000165970:ENST00000525748:exon2:c.C352T:p.L118L	SLC6A5:NM_004211:exon2:c.C352T:p.L118L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3503	0.3245	0.326877	0.3308	.	.	.	.	.	.	.	.	SLC6A5:uc001mqd.3:exon2:c.C352T:p.L118L	.	AFR:0.3058,AMR:0.3640,EAS:0.3300,FIN:0.3718,NFE:0.3325,OTH:0.3493,ASJ:0.3411	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	.	.	.	.	11	MU4554537	unknown
11	20623042	20623042	T	C	SLC6A5	exonic	nonsynonymous SNV	ENSG00000165970	rs1443548	ENSG00000165970:ENST00000298923:exon2:c.T371C:p.F124S,ENSG00000165970:ENST00000525748:exon2:c.T371C:p.F124S	SLC6A5:NM_004211:exon2:c.T371C:p.F124S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7789	0.7950	0.793131	0.791	0.592	8.102	0.44	2.8	0.440	.	.	.	SLC6A5:uc001mqd.3:exon2:c.T371C:p.F124S	-0.983	AFR:0.8759,AMR:0.7398,EAS:0.7438,FIN:0.7420,NFE:0.7632,OTH:0.7541,ASJ:0.8013	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	0.0	-0.48	0.000	0	11	MU81309978	unknown
11	20623156	20623156	C	G	SLC6A5	exonic	nonsynonymous SNV	ENSG00000165970	rs1443549	ENSG00000165970:ENST00000298923:exon2:c.C485G:p.A162G,ENSG00000165970:ENST00000525748:exon2:c.C485G:p.A162G	SLC6A5:NM_004211:exon2:c.C485G:p.A162G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9983	0.9932	0.99361	0.9951	1.483	13.22	1.0	5.59	0.995	.	.	.	SLC6A5:uc001mqd.3:exon2:c.C485G:p.A162G	-0.929	AFR:0.9829,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	0.0	-0.5	0.000	-1.845	11	MU81897454	hom
11	20639400	20639400	A	G	SLC6A5	exonic	synonymous SNV	ENSG00000165970	rs7925597	ENSG00000165970:ENST00000525748:exon7:c.A1230G:p.S410S	SLC6A5:NM_001318369:exon6:c.A528G:p.S176S,SLC6A5:NM_004211:exon7:c.A1230G:p.S410S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9989	0.9950	0.997404	0.9969	.	.	.	.	.	.	.	.	SLC6A5:uc009yic.3:exon6:c.A525G:p.S175S,SLC6A5:uc001mqd.3:exon7:c.A1230G:p.S410S	.	AFR:0.9891,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9990,ASJ:1	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	.	.	.	.	11	MU81897460	hom
11	20673867	20673867	G	A	SLC6A5	exonic	synonymous SNV	ENSG00000165970	rs2276433	ENSG00000165970:ENST00000525748:exon15:c.G2103A:p.E701E	SLC6A5:NM_001318369:exon14:c.G1401A:p.E467E,SLC6A5:NM_004211:exon15:c.G2103A:p.E701E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4506	0.3238	0.478235	0.3685	.	.	.	.	.	.	.	.	SLC6A5:uc009yic.3:exon14:c.G1398A:p.E466E,SLC6A5:uc001mqd.3:exon15:c.G2103A:p.E701E	.	AFR:0.1879,AMR:0.6103,EAS:0.8486,FIN:0.4015,NFE:0.3941,OTH:0.4296,ASJ:0.4934	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	.	.	.	.	11	MU159624	het
11	20676253	20676253	T	C	SLC6A5	intronic	.	ENSG00000165970	rs2276432	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1583	0.1807	0.159944	0.1767	.	.	.	.	.	0	0.016	.	.	.	AFR:0.1993,AMR:0.1122,EAS:0.0499,FIN:0.2115,NFE:0.1736,OTH:0.1874,ASJ:0.1067	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	.	.	.	.	11	MU82206230	het
11	31811461	31811462	TT	-	PAX6	exonic	frameshift deletion	ENSG00000007372	rs759391101	.	PAX6:NM_001368929:exon9:c.730_731del:p.K244fs,PAX6:NM_001368911:exon10:c.1183_1184del:p.K395fs,PAX6:NM_001368916:exon11:c.1138_1139del:p.K380fs,PAX6:NM_001368913:exon12:c.1180_1181del:p.K394fs,PAX6:NM_001368915:exon12:c.1138_1139del:p.K380fs,PAX6:NM_001368917:exon12:c.1138_1139del:p.K380fs,PAX6:NM_001368912:exon13:c.1180_1181del:p.K394fs,PAX6:NM_001368914:exon13:c.1180_1181del:p.K394fs,PAX6:NM_001368921:exon13:c.979_980del:p.K327fs	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0009	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607108	106210;120200;120430;136520;148190;165550;604229;	708;137902;2334;2253;35737;194;98942;98944;250923;	708|Peters congenital glaucoma|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|604229 ~137902|-|-|Autosomal dominant|-|165550 ~2334|Hereditary keratitis|Unknown|Autosomal dominant|Childhood|148190 ~2253|O'Donnell-Pappas syndrome|<1 / 1 000 000|Autosomal dominant|Adult|136520 ~35737|Ectasic coloboma<br>Volubilis syndrome|Unknown|Autosomal dominant|Childhood|120430 ~194|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|120200 216820 ~98942|-|-|-|-|120200 ~98944|-|-|-|-|120200 ~250923|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|106210 617141 617142 ~	.	.	.	.	.	.	.	.	11	.	het
11	31814879	31814879	G	A	PAX6	exonic	nonsynonymous SNV	ENSG00000007372	rs3026384	.	PAX6:NM_001310159:exon9:c.C1139T:p.S380L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3174	.	0.149361	LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	PAX6:uc021qfn.1:exon8:c.C1139T:p.S380L	.	AFR:0.2258,AMR:0.1294,EAS:0.3,FIN:0.0284,NFE:0.3104,OTH:0.2814,ASJ:0.2124	607108	106210;120200;120430;136520;148190;165550;604229;	708;137902;2334;2253;35737;194;98942;98944;250923;	708|Peters congenital glaucoma|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|604229 ~137902|-|-|Autosomal dominant|-|165550 ~2334|Hereditary keratitis|Unknown|Autosomal dominant|Childhood|148190 ~2253|O'Donnell-Pappas syndrome|<1 / 1 000 000|Autosomal dominant|Adult|136520 ~35737|Ectasic coloboma<br>Volubilis syndrome|Unknown|Autosomal dominant|Childhood|120430 ~194|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|120200 216820 ~98942|-|-|-|-|120200 ~98944|-|-|-|-|120200 ~250923|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|106210 617141 617142 ~	.	.	.	.	.	.	.	.	11	5(upper_aerodigestive_tract)	0.2475
11	31815362	31815362	G	A	PAX6	intronic	.	ENSG00000007372	rs667773	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0779	0.0459	0.0904553	0.0577	.	.	.	.	.	0	0	.	.	.	AFR:0.0405,AMR:0.1909,EAS:0.2200,FIN:0.0487,NFE:0.0453,OTH:0.0449,ASJ:0.0728	607108	106210;120200;120430;136520;148190;165550;604229;	708;137902;2334;2253;35737;194;98942;98944;250923;	708|Peters congenital glaucoma|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|604229 ~137902|-|-|Autosomal dominant|-|165550 ~2334|Hereditary keratitis|Unknown|Autosomal dominant|Childhood|148190 ~2253|O'Donnell-Pappas syndrome|<1 / 1 000 000|Autosomal dominant|Adult|136520 ~35737|Ectasic coloboma<br>Volubilis syndrome|Unknown|Autosomal dominant|Childhood|120430 ~194|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|120200 216820 ~98942|-|-|-|-|120200 ~98944|-|-|-|-|120200 ~250923|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|106210 617141 617142 ~	.	.	.	.	.	.	.	.	11	MU11899448	het
11	32417945	32417945	T	C	WT1	exonic	synonymous SNV	ENSG00000184937	rs16754	ENSG00000184937:ENST00000452863:exon6:c.A1056G:p.R352R,ENSG00000184937:ENST00000530998:exon6:c.A420G:p.R140R,ENSG00000184937:ENST00000332351:exon7:c.A1107G:p.R369R,ENSG00000184937:ENST00000379079:exon7:c.A471G:p.R157R,ENSG00000184937:ENST00000448076:exon7:c.A1107G:p.R369R,ENSG00000184937:ENST00000527775:exon7:c.A360G:p.R120R	WT1:NM_000378:exon6:c.A1071G:p.R357R,WT1:NM_001198552:exon6:c.A420G:p.R140R,WT1:NM_001198551:exon7:c.A471G:p.R157R,WT1:NM_024424:exon7:c.A1122G:p.R374R,WT1:NM_024426:exon7:c.A1122G:p.R374R	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2335	0.1303	0.33147	2(large_intestine)	.	.	.	.	.	.	.	.	WT1:uc001mtm.2:exon6:c.A420G:p.R140R,WT1:uc001mtq.2:exon6:c.A1056G:p.R352R,WT1:uc001mtl.2:exon7:c.A471G:p.R157R,WT1:uc001mtn.2:exon7:c.A1107G:p.R369R,WT1:uc001mto.2:exon7:c.A1107G:p.R369R	.	AFR:1(bone),AMR:MU117615,EAS:0.1757,FIN:0.1051,NFE:0.3270,OTH:0.1921,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|7|321|0.0218069	607102	136680;156240;194070;194080;256370;608978;	3097;656;220;654;50251;347;	3097|Meacham-Winn-Culler syndrome<br>Rhabdomyomatous dysplasia-cardiopathy-genital anomalies syndrome|<1 / 1 000 000|-|Infancy<br>Neonatal|608978 ~656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~220|Drash syndrome<br>Wilms tumor and pseudohermaphroditism|<1 / 1 000 000|-|Infancy<br>Neonatal|194080 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~50251|-|1-9 / 100 000|Not applicable|All ages|156240 ~347|-|<1 / 1 000 000|Autosomal dominant|Childhood|136680 ~	~ko05202 Transcriptional misregulation in cancer ~	,10422	.	.	.	.	.	.	11	94(prostate)	0.7135
11	32456562	32456562	G	A	WT1	exonic	synonymous SNV	ENSG00000184937	rs1799925	ENSG00000184937:ENST00000332351:exon1:c.C330T:p.P110P,ENSG00000184937:ENST00000379077:exon1:c.C330T:p.P110P,ENSG00000184937:ENST00000448076:exon1:c.C330T:p.P110P,ENSG00000184937:ENST00000452863:exon1:c.C330T:p.P110P	WT1:NM_000378:exon1:c.C345T:p.P115P,WT1:NM_024424:exon1:c.C345T:p.P115P,WT1:NM_024426:exon1:c.C345T:p.P115P	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3243	.	0.303914	0.1647	.	.	.	.	.	.	.	.	WT1:uc001mtn.2:exon1:c.C330T:p.P110P,WT1:uc001mto.2:exon1:c.C330T:p.P110P,WT1:uc001mtq.2:exon1:c.C330T:p.P110P	.	AFR:0.0700,AMR:0.3251,EAS:0.6864,FIN:0.1693,NFE:0.1518,OTH:0.1811,ASJ:0.1722	607102	136680;156240;194070;194080;256370;608978;	3097;656;220;654;50251;347;	3097|Meacham-Winn-Culler syndrome<br>Rhabdomyomatous dysplasia-cardiopathy-genital anomalies syndrome|<1 / 1 000 000|-|Infancy<br>Neonatal|608978 ~656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~220|Drash syndrome<br>Wilms tumor and pseudohermaphroditism|<1 / 1 000 000|-|Infancy<br>Neonatal|194080 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~50251|-|1-9 / 100 000|Not applicable|All ages|156240 ~347|-|<1 / 1 000 000|Autosomal dominant|Childhood|136680 ~	~ko05202 Transcriptional misregulation in cancer ~	,10422	.	.	.	.	.	.	11	MU81898088	hom
11	33880896	33880896	T	A	LMO2	UTR3	.	ENSG00000135363	rs3740616	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1956	0.1888	0.146166	0.1810	.	.	.	.	.	.	.	.	.	.	AFR:0.1024,AMR:0.1232,EAS:0.0809,FIN:0.2524,NFE:0.2232,OTH:0.1892,ASJ:0.2053	180385	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	11	MU646572	het
11	33886294	33886294	A	G	LMO2	exonic	synonymous SNV	ENSG00000135363	rs2038602	ENSG00000135363:ENST00000395833:exon2:c.T111C:p.I37I,ENSG00000135363:ENST00000257818:exon5:c.T318C:p.I106I	LMO2:NM_001142316:exon2:c.T111C:p.I37I,LMO2:NM_001142315:exon3:c.T111C:p.I37I,LMO2:NM_005574:exon5:c.T318C:p.I106I	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4118	0.4613	0.434305	MU91806	.	.	.	.	.	.	.	.	LMO2:uc001mvc.3:exon1:c.T90C:p.I30I,LMO2:uc001mvd.3:exon2:c.T90C:p.I30I,LMO2:uc001mve.3:exon2:c.T111C:p.I37I,LMO2:uc010rel.2:exon3:c.T111C:p.I37I,LMO2:uc010rem.2:exon5:c.T318C:p.I106I	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611,AMR:0.4557,EAS:0.2656,FIN:0.3067,NFE:0.3932,OTH:0.5218,ASJ:0.5523	180385	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	11	2(large_intestine)	0.4064
11	43911365	43911365	T	C	ALKBH3	exonic	synonymous SNV	ENSG00000166199	rs2434478	ENSG00000166199:ENST00000529366:exon5:c.T354C:p.T118T,ENSG00000166199:ENST00000302708:exon6:c.T357C:p.T119T,ENSG00000166199:ENST00000378840:exon6:c.T354C:p.T118T,ENSG00000166199:ENST00000530803:exon6:c.T354C:p.T118T,ENSG00000166199:ENST00000532962:exon6:c.T357C:p.T119T	ALKBH3:NM_139178:exon6:c.T357C:p.T119T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9990	0.9968	0.997604	0.9968	.	.	.	.	.	.	.	.	ALKBH3:uc001mxs.2:exon6:c.T357C:p.T119T	.	AFR:0.9888,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	610603	.	.	.	.	.	.	.	.	.	.	.	11	MU81898914	hom
11	43913604	43913604	G	A	ALKBH3	exonic	synonymous SNV	ENSG00000166199	rs16937692	ENSG00000166199:ENST00000529366:exon6:c.G381A:p.Q127Q,ENSG00000166199:ENST00000302708:exon7:c.G384A:p.Q128Q	ALKBH3:NM_139178:exon7:c.G384A:p.Q128Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0573	0.0314	0.0605032	0.0359	.	.	.	.	.	.	.	.	ALKBH3:uc001mxs.2:exon7:c.G384A:p.Q128Q	.	AFR:0.0413,AMR:0.2285,EAS:0.0309,FIN:0.0074,NFE:0.0275,OTH:0.0449,ASJ:0.0927	610603	.	.	.	.	.	.	.	.	.	.	.	11	MU113398918	hom
11	43940644	43940644	G	T	ALKBH3	exonic	synonymous SNV	ENSG00000166199	rs1048928	ENSG00000166199:ENST00000302708:exon9:c.G726T:p.G242G	ALKBH3:NM_139178:exon9:c.G726T:p.G242G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6514	0.5354	0.616214	0.5714	.	.	.	.	.	.	.	.	ALKBH3:uc001mxs.2:exon9:c.G726T:p.G242G	.	AFR:0.3515,AMR:0.7387,EAS:0.8282,FIN:0.6657,NFE:0.6325,OTH:0.6782,ASJ:0.6060	610603	.	.	.	.	.	.	.	.	.	.	.	11	MU728136	hom
11	44129290	44129290	C	A	EXT2	exonic	synonymous SNV	ENSG00000151348	rs4755228	ENSG00000151348:ENST00000343631:exon2:c.C28A:p.R10R,ENSG00000151348:ENST00000358681:exon2:c.C28A:p.R10R,ENSG00000151348:ENST00000395673:exon2:c.C127A:p.R43R,ENSG00000151348:ENST00000533608:exon2:c.C28A:p.R10R,ENSG00000151348:ENST00000527014:exon3:c.C28A:p.R10R,ENSG00000151348:ENST00000532479:exon4:c.C28A:p.R10R	EXT2:NM_000401:exon2:c.C127A:p.R43R,EXT2:NM_001178083:exon2:c.C28A:p.R10R,EXT2:NM_207122:exon2:c.C28A:p.R10R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0334	0.0058	0.0780751	0.0236	.	.	.	.	.	.	.	.	EXT2:uc001mxz.3:exon2:c.C28A:p.R10R,EXT2:uc001mya.3:exon2:c.C127A:p.R43R,EXT2:uc009ykt.3:exon2:c.C28A:p.R10R,EXT2:uc010rfo.2:exon2:c.C112A:p.R38R	.	AFR:0.0050,AMR:0.0299,EAS:0.3092,FIN:0.0157,NFE:0.0062,OTH:0.0143,ASJ:0.0033	608210	133701;616682;	321;	321|Bessel-Hagen disease<br>EXT1/EXT2-CDG<br>Multiple cartilaginous exostoses|1-9 / 100 000|Autosomal dominant|Childhood|133700 133701 600209 ~	.	.	.	.	.	.	.	.	11	MU82206464	het
11	44146490	44146490	C	G	EXT2	exonic	nonsynonymous SNV	ENSG00000151348	.	ENSG00000151348:ENST00000343631:exon5:c.C895G:p.R299G,ENSG00000151348:ENST00000358681:exon5:c.C895G:p.R299G,ENSG00000151348:ENST00000395673:exon5:c.C994G:p.R332G,ENSG00000151348:ENST00000533608:exon5:c.C895G:p.R299G	EXT2:NM_000401:exon5:c.C994G:p.R332G,EXT2:NM_001178083:exon5:c.C895G:p.R299G,EXT2:NM_207122:exon5:c.C895G:p.R299G	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 2, 1, 0] 	.	.	.	.	7.042	33	0.012	5.81	0.939	.	.	.	EXT2:uc001mxz.3:exon5:c.C895G:p.R299G,EXT2:uc001mya.3:exon5:c.C994G:p.R332G,EXT2:uc009ykt.3:exon5:c.C895G:p.R299G,EXT2:uc010rfo.2:exon5:c.C979G:p.R327G	1.079	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608210	133701;616682;	321;	321|Bessel-Hagen disease<br>EXT1/EXT2-CDG<br>Multiple cartilaginous exostoses|1-9 / 100 000|Autosomal dominant|Childhood|133700 133701 600209 ~	.	.	.	.	0.996	-4.42	0.951	3.265	11	.	het
11	47238522	47238522	T	C	DDB2	exonic	synonymous SNV	ENSG00000134574	rs326212	ENSG00000134574:ENST00000256996:exon3:c.T378C:p.T126T,ENSG00000134574:ENST00000378600:exon3:c.T378C:p.T126T,ENSG00000134574:ENST00000378601:exon3:c.T378C:p.T126T	DDB2:NM_000107:exon3:c.T378C:p.T126T,DDB2:NM_001300734:exon3:c.T378C:p.T126T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9987	0.9953	0.994209	0.9963	.	.	.	.	.	.	.	.	DDB2:uc001nef.2:exon2:c.T336C:p.T112T,DDB2:uc001neb.2:exon3:c.T378C:p.T126T,DDB2:uc001nee.2:exon3:c.T378C:p.T126T	.	AFR:0.9869,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600811	278740;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	~ko03420 Nucleotide excision repair~ko04115 p53 signaling pathway~ko04120 Ubiquitin mediated proteolysis~ko05161 Hepatitis B~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	MU81899467	hom
11	47371485	47371485	G	-	MYBPC3	intronic	.	ENSG00000134571	rs11570050	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.6879	0.6200	0.610823	0.6108	.	.	.	.	.	.	.	.	.	.	AFR:0.3940,AMR:0.6396,EAS:0.6646,FIN:0.6201,NFE:0.7226,OTH:0.6398,ASJ:0.7450	600958	115197;615396;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	11	.	hom
11	48145247	48145247	T	C	PTPRJ	exonic	synonymous SNV	ENSG00000149177	rs2270992	ENSG00000149177:ENST00000527952:exon4:c.T435C:p.T145T,ENSG00000149177:ENST00000418331:exon5:c.T699C:p.T233T,ENSG00000149177:ENST00000440289:exon5:c.T699C:p.T233T	PTPRJ:NM_001098503:exon5:c.T699C:p.T233T,PTPRJ:NM_002843:exon5:c.T699C:p.T233T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5721	0.4686	0.452276	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	PTPRJ:uc001ngo.4:exon5:c.T699C:p.T233T,PTPRJ:uc001ngp.4:exon5:c.T699C:p.T233T	.	AFR:0.4967,AMR:0.1920,EAS:0.5795,FIN:0.5149,NFE:0.6582,OTH:0.6178,ASJ:0.6770	600925	114500;	.	.	.	.	.	.	.	.	.	.	11	1(lung)	0.5736
11	48145375	48145375	A	C	PTPRJ	exonic	nonsynonymous SNV	ENSG00000149177	rs1566734	ENSG00000149177:ENST00000418331:exon5:c.A827C:p.Q276P,ENSG00000149177:ENST00000440289:exon5:c.A827C:p.Q276P	PTPRJ:NM_001098503:exon5:c.A827C:p.Q276P,PTPRJ:NM_002843:exon5:c.A827C:p.Q276P	clinvar: Pathogenic 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, -1, 0, 0] 	0.1694	0.1475	0.189896	1(prostate)	-0.709	0.069	0.237	1.54	0.002	.	.	Fibronectin type III|Immunoglobulin-like fold	PTPRJ:uc001ngo.4:exon5:c.A827C:p.Q276P,PTPRJ:uc001ngp.4:exon5:c.A827C:p.Q276P	-0.983	AFR:1(lung),AMR:1(pancreas),EAS:MU14713834,FIN:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,NFE:0.1398,OTH:0.1199,ASJ:1(large_intestine)	600925	114500;	.	.	.	.	.	.	0.001	2.56	0.000	0.895	11	2(haematopoietic_and_lymphoid_tissue)	0.1205
11	48146622	48146622	G	A	PTPRJ	exonic	nonsynonymous SNV	ENSG00000149177	rs1503185	ENSG00000149177:ENST00000418331:exon6:c.G977A:p.R326Q,ENSG00000149177:ENST00000440289:exon6:c.G977A:p.R326Q	PTPRJ:NM_001098503:exon6:c.G977A:p.R326Q,PTPRJ:NM_002843:exon6:c.G977A:p.R326Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1807	0.1922	0.242812	1(urinary_tract)	-2.199	0.001	0.491	-10.3	0.000	.	.	Fibronectin type III|Immunoglobulin-like fold	PTPRJ:uc001ngo.4:exon6:c.G977A:p.R326Q,PTPRJ:uc001ngp.4:exon6:c.G977A:p.R326Q	-0.987	AFR:1(stomach),AMR:MU149213,EAS:0.1762,FIN:0.2477,NFE:0.1256,OTH:0.2384,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	600925	114500;	.	.	.	.	.	.	0.0	3.64	0.000	0.315	11	1(large_intestine)	0.2921
11	48166267	48166267	G	C	PTPRJ	exonic	nonsynonymous SNV	ENSG00000149177	rs4752904	ENSG00000149177:ENST00000418331:exon13:c.G2616C:p.E872D	PTPRJ:NM_002843:exon13:c.G2616C:p.E872D	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5153	0.4313	0.367212	0.4539	-2.152	0.001	0.645	-10.9	0.852	.	.	Fibronectin type III|Immunoglobulin-like fold	PTPRJ:uc001ngp.4:exon13:c.G2616C:p.E872D	-0.911	AFR:0.1318,AMR:0.6217,EAS:0.4023,FIN:0.6186,NFE:0.5899,OTH:0.5367,ASJ:0.6167	600925	114500;	.	.	.	.	.	.	0.007	2.57	0.000	0.55	11	MU742433	het
11	57563991	57563991	C	T	CTNND1	exonic	synonymous SNV	ENSG00000198561	rs10896644	ENSG00000198561:ENST00000532245:exon3:c.C180T:p.D60D,ENSG00000198561:ENST00000534647:exon3:c.C249T:p.D83D,ENSG00000198561:ENST00000415361:exon4:c.C180T:p.D60D,ENSG00000198561:ENST00000426142:exon4:c.C180T:p.D60D,ENSG00000198561:ENST00000528232:exon4:c.C180T:p.D60D,ENSG00000198561:ENST00000529986:exon4:c.C180T:p.D60D,ENSG00000198561:ENST00000530094:exon4:c.C180T:p.D60D,ENSG00000198561:ENST00000532463:exon4:c.C180T:p.D60D,ENSG00000198561:ENST00000532787:exon4:c.C180T:p.D60D,ENSG00000198561:ENST00000428599:exon5:c.C483T:p.D161D,ENSG00000198561:ENST00000526357:exon5:c.C321T:p.D107D,ENSG00000198561:ENST00000526938:exon5:c.C483T:p.D161D,ENSG00000198561:ENST00000528621:exon5:c.C321T:p.D107D,ENSG00000198561:ENST00000529873:exon5:c.C321T:p.D107D,ENSG00000198561:ENST00000530068:exon5:c.C321T:p.D107D,ENSG00000198561:ENST00000530748:exon5:c.C321T:p.D107D,ENSG00000198561:ENST00000532844:exon5:c.C321T:p.D107D,ENSG00000198561:ENST00000358694:exon6:c.C483T:p.D161D,ENSG00000198561:ENST00000360682:exon6:c.C483T:p.D161D,ENSG00000198561:ENST00000361332:exon6:c.C483T:p.D161D,ENSG00000198561:ENST00000361391:exon6:c.C483T:p.D161D,ENSG00000198561:ENST00000361796:exon6:c.C483T:p.D161D,ENSG00000198561:ENST00000399039:exon6:c.C483T:p.D161D,ENSG00000198561:ENST00000399050:exon6:c.C483T:p.D161D,ENSG00000198561:ENST00000524630:exon6:c.C483T:p.D161D,ENSG00000198561:ENST00000529526:exon6:c.C321T:p.D107D,ENSG00000198561:ENST00000529919:exon6:c.C483T:p.D161D,ENSG00000198561:ENST00000532649:exon6:c.C321T:p.D107D,ENSG00000198561:ENST00000534579:exon6:c.C321T:p.D107D	CTNND1:NM_001085469:exon3:c.C180T:p.D60D,CTNND1:NM_001085463:exon4:c.C180T:p.D60D,CTNND1:NM_001085464:exon4:c.C180T:p.D60D,CTNND1:NM_001085465:exon4:c.C180T:p.D60D,CTNND1:NM_001085466:exon4:c.C180T:p.D60D,CTNND1:NM_001085467:exon4:c.C180T:p.D60D,CTNND1:NM_001085468:exon4:c.C180T:p.D60D,CTNND1:NM_001206890:exon4:c.C180T:p.D60D,CTNND1:NM_001085462:exon5:c.C483T:p.D161D,CTNND1:NM_001206883:exon5:c.C321T:p.D107D,CTNND1:NM_001206884:exon5:c.C321T:p.D107D,CTNND1:NM_001206886:exon5:c.C321T:p.D107D,CTNND1:NM_001206887:exon5:c.C321T:p.D107D,CTNND1:NM_001206888:exon5:c.C321T:p.D107D,CTNND1:NM_001085458:exon6:c.C483T:p.D161D,CTNND1:NM_001085459:exon6:c.C483T:p.D161D,CTNND1:NM_001085460:exon6:c.C483T:p.D161D,CTNND1:NM_001085461:exon6:c.C483T:p.D161D,CTNND1:NM_001206885:exon6:c.C483T:p.D161D,CTNND1:NM_001206889:exon6:c.C321T:p.D107D,CTNND1:NM_001206891:exon6:c.C321T:p.D107D,CTNND1:NM_001331:exon6:c.C483T:p.D161D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3559	0.3500	0.271366	0.3193	.	.	.	.	.	.	.	.	CTNND1:uc001nlw.4:exon3:c.C180T:p.D60D,CTNND1:uc001nlo.4:exon4:c.C180T:p.D60D,CTNND1:uc001nlq.4:exon4:c.C180T:p.D60D,CTNND1:uc001nls.4:exon4:c.C180T:p.D60D,CTNND1:uc001nlt.4:exon4:c.C180T:p.D60D,CTNND1:uc001nlu.4:exon4:c.C180T:p.D60D,CTNND1:uc001nlv.4:exon4:c.C180T:p.D60D,CTNND1:uc001nmi.4:exon4:c.C180T:p.D60D,CTNND1:uc001nlj.4:exon5:c.C321T:p.D107D,CTNND1:uc001nlk.4:exon5:c.C321T:p.D107D,CTNND1:uc001nln.4:exon5:c.C483T:p.D161D,CTNND1:uc001nlp.4:exon5:c.C321T:p.D107D,CTNND1:uc001nlr.4:exon5:c.C321T:p.D107D,CTNND1:uc001nmd.4:exon5:c.C321T:p.D107D,TMX2-CTNND1:uc001nlh.1:exon6:c.C483T:p.D161D,CTNND1:uc001nli.4:exon6:c.C483T:p.D161D,CTNND1:uc001nll.4:exon6:c.C321T:p.D107D,CTNND1:uc001nlm.4:exon6:c.C483T:p.D161D,CTNND1:uc001nmc.4:exon6:c.C483T:p.D161D,CTNND1:uc001nme.4:exon6:c.C483T:p.D161D,CTNND1:uc001nmf.4:exon6:c.C483T:p.D161D,CTNND1:uc001nmg.4:exon6:c.C321T:p.D107D,CTNND1:uc001nmh.4:exon6:c.C483T:p.D161D,CTNND1:uc021qjk.1:exon6:c.C483T:p.D161D,TMX2-CTNND1:uc001nlf.2:exon7:c.C483T:p.D161D	.	AFR:0.2106,AMR:0.3258,EAS:0.0853,FIN:0.3097,NFE:0.4079,OTH:0.3,ASJ:0.4768	601045	.	.	.	.	.	.	.	.	.	.	.	11	MU11953442	hom
11	57571232	57571232	C	T	CTNND1	exonic	synonymous SNV	ENSG00000198561	rs11229137	ENSG00000198561:ENST00000525902:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000526772:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000527467:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000531014:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000533667:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000532245:exon5:c.C1257T:p.H419H,ENSG00000198561:ENST00000415361:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000426142:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000528232:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000529986:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000530094:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000532463:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000532787:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000428599:exon7:c.C1560T:p.H520H,ENSG00000198561:ENST00000526357:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000526938:exon7:c.C1560T:p.H520H,ENSG00000198561:ENST00000528621:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000529873:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000530748:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000532844:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000358694:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000360682:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000361332:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000361391:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000361796:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000399039:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000399050:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000524630:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000529526:exon8:c.C1398T:p.H466H,ENSG00000198561:ENST00000529919:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000532649:exon8:c.C1398T:p.H466H,ENSG00000198561:ENST00000534579:exon8:c.C1398T:p.H466H	CTNND1:NM_001085469:exon5:c.C1257T:p.H419H,CTNND1:NM_001085463:exon6:c.C1257T:p.H419H,CTNND1:NM_001085464:exon6:c.C1257T:p.H419H,CTNND1:NM_001085465:exon6:c.C1257T:p.H419H,CTNND1:NM_001085466:exon6:c.C1257T:p.H419H,CTNND1:NM_001085467:exon6:c.C1257T:p.H419H,CTNND1:NM_001085468:exon6:c.C1257T:p.H419H,CTNND1:NM_001206890:exon6:c.C1257T:p.H419H,CTNND1:NM_001085462:exon7:c.C1560T:p.H520H,CTNND1:NM_001206883:exon7:c.C1398T:p.H466H,CTNND1:NM_001206884:exon7:c.C1398T:p.H466H,CTNND1:NM_001206886:exon7:c.C1398T:p.H466H,CTNND1:NM_001206887:exon7:c.C1398T:p.H466H,CTNND1:NM_001206888:exon7:c.C1398T:p.H466H,CTNND1:NM_001085458:exon8:c.C1560T:p.H520H,CTNND1:NM_001085459:exon8:c.C1560T:p.H520H,CTNND1:NM_001085460:exon8:c.C1560T:p.H520H,CTNND1:NM_001085461:exon8:c.C1560T:p.H520H,CTNND1:NM_001206885:exon8:c.C1560T:p.H520H,CTNND1:NM_001206889:exon8:c.C1398T:p.H466H,CTNND1:NM_001206891:exon8:c.C1398T:p.H466H,CTNND1:NM_001331:exon8:c.C1560T:p.H520H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9992	0.9979	0.996206	0.9972	.	.	.	.	.	.	.	.	CTNND1:uc001nlx.4:exon3:c.C591T:p.H197H,CTNND1:uc001nly.4:exon3:c.C591T:p.H197H,CTNND1:uc001nlz.4:exon3:c.C591T:p.H197H,CTNND1:uc001nma.4:exon3:c.C591T:p.H197H,CTNND1:uc001nmb.4:exon3:c.C591T:p.H197H,CTNND1:uc009ymn.3:exon3:c.C591T:p.H197H,CTNND1:uc001nlw.4:exon5:c.C1257T:p.H419H,CTNND1:uc001nlo.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlq.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nls.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlt.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlu.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlv.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nmi.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlj.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nlk.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nln.4:exon7:c.C1560T:p.H520H,CTNND1:uc001nlp.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nlr.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nmd.4:exon7:c.C1398T:p.H466H,TMX2-CTNND1:uc001nlh.1:exon8:c.C1560T:p.H520H,CTNND1:uc001nli.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nll.4:exon8:c.C1398T:p.H466H,CTNND1:uc001nlm.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nmc.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nme.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nmf.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nmg.4:exon8:c.C1398T:p.H466H,CTNND1:uc001nmh.4:exon8:c.C1560T:p.H520H,CTNND1:uc021qjk.1:exon8:c.C1560T:p.H520H,TMX2-CTNND1:uc001nlf.2:exon9:c.C1560T:p.H520H	.	AFR:0.9899,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	601045	.	.	.	.	.	.	.	.	.	.	.	11	MU81901822	hom
11	60666116	60666116	G	T	PRPF19	intronic	.	ENSG00000110107	rs3763841	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3711	0.3298	0.309904	0.3285	.	.	.	.	.	.	.	.	.	.	AFR:0.1902,AMR:0.4427,EAS:0.2856,FIN:0.3985,NFE:0.3850,OTH:0.3778,ASJ:0.4570	608330	.	.	.	.	.	.	.	.	.	.	.	11	MU30007000	het
11	60666341	60666341	G	A	PRPF19	exonic	synonymous SNV	ENSG00000110107	rs3763840	ENSG00000110107:ENST00000535326:exon1:c.C63T:p.S21S,ENSG00000110107:ENST00000227524:exon12:c.C1047T:p.S349S	PRPF19:NM_014502:exon12:c.C1047T:p.S349S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4315	0.3265	0.308506	LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	PRPF19:uc001nqf.3:exon12:c.C1047T:p.S349S	.	AFR:0.3279,AMR:0.1864,EAS:0.4570,FIN:0.2853,NFE:0.4,OTH:0.3860,ASJ:0.4400	608330	.	.	.	.	.	.	.	.	.	.	.	11	1(stomach)	0.3765
11	60673868	60673868	T	C	PRPF19	UTR5	.	ENSG00000110107	rs17155470	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4474	0.3585	0.357428	COCA-CN|3|321|0.00934579,BLCA-CN|1|103|0.00970874	.	.	.	.	.	.	.	.	.	.	AFR:0.3669,AMR:0.3223,EAS:0.4636,FIN:0.2886,NFE:0.3991,OTH:0.3859,ASJ:0.4487	608330	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.3875
11	62292882	62292882	G	T	AHNAK	exonic	nonsynonymous SNV	ENSG00000124942	rs566144	ENSG00000124942:ENST00000378024:exon5:c.C9007A:p.Q3003K	AHNAK:NM_001346445:exon5:c.C9007A:p.Q3003K,AHNAK:NM_001346446:exon5:c.C9007A:p.Q3003K,AHNAK:NM_001620:exon5:c.C9007A:p.Q3003K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	1	.	1	0.9999	-0.671	0.084	1.0	3.97	0.067	.	.	.	AHNAK:uc001ntl.3:exon5:c.C9007A:p.Q3003K	-1.013	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	103390	.	.	.	.	.	.	.	0.0	2.88	0.000	-2.045	11	MU81903251	hom
11	62293948	62293948	G	A	AHNAK	exonic	synonymous SNV	ENSG00000124942	rs486903	ENSG00000124942:ENST00000378024:exon5:c.C7941T:p.S2647S	AHNAK:NM_001346445:exon5:c.C7941T:p.S2647S,AHNAK:NM_001346446:exon5:c.C7941T:p.S2647S,AHNAK:NM_001620:exon5:c.C7941T:p.S2647S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6638	0.5583	0.473043	1(large_intestine)	.	.	.	.	.	.	.	.	AHNAK:uc001ntl.3:exon5:c.C7941T:p.S2647S	.	AFR:MU150832,AMR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.1716,FIN:0.6845,NFE:0.6093,OTH:0.2963,ASJ:0.5748	103390	.	.	.	.	.	.	.	.	.	.	.	11	1(lung)	0.8322
11	64572018	64572018	T	C	MEN1	exonic	nonsynonymous SNV	ENSG00000133895	rs2959656	ENSG00000133895:ENST00000377316:exon8:c.A1456G:p.T486A,ENSG00000133895:ENST00000377313:exon9:c.A1636G:p.T546A,ENSG00000133895:ENST00000377326:exon9:c.A1621G:p.T541A,ENSG00000133895:ENST00000312049:exon10:c.A1621G:p.T541A,ENSG00000133895:ENST00000315422:exon10:c.A1621G:p.T541A,ENSG00000133895:ENST00000337652:exon10:c.A1636G:p.T546A,ENSG00000133895:ENST00000377321:exon10:c.A1516G:p.T506A,ENSG00000133895:ENST00000394374:exon10:c.A1636G:p.T546A,ENSG00000133895:ENST00000443283:exon10:c.A1636G:p.T546A,ENSG00000133895:ENST00000394376:exon11:c.A1636G:p.T546A	MEN1:NM_000244:exon10:c.A1636G:p.T546A,MEN1:NM_001370259:exon10:c.A1621G:p.T541A,MEN1:NM_001370260:exon10:c.A1621G:p.T541A,MEN1:NM_001370261:exon10:c.A1621G:p.T541A,MEN1:NM_001370262:exon10:c.A1516G:p.T506A,MEN1:NM_001370263:exon10:c.A1516G:p.T506A,MEN1:NM_130799:exon10:c.A1621G:p.T541A,MEN1:NM_130800:exon10:c.A1636G:p.T546A,MEN1:NM_130801:exon10:c.A1636G:p.T546A,MEN1:NM_130802:exon10:c.A1636G:p.T546A,MEN1:NM_130803:exon10:c.A1636G:p.T546A,MEN1:NM_001370251:exon11:c.A1747G:p.T583A,MEN1:NM_130804:exon11:c.A1636G:p.T546A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9378	0.9084	0.834465	MU17436755	-0.869	0.030	0.866	3.35	0.004	.	.	.	MEN1:uc001obj.3:exon10:c.A1636G:p.T546A,MEN1:uc001obk.3:exon10:c.A1636G:p.T546A,MEN1:uc001obl.3:exon10:c.A1516G:p.T506A,MEN1:uc001obm.3:exon10:c.A1621G:p.T541A,MEN1:uc001obn.3:exon10:c.A1636G:p.T546A,MEN1:uc001obo.3:exon10:c.A1636G:p.T546A,MEN1:uc001obr.3:exon10:c.A1636G:p.T546A,MEN1:uc001obq.3:exon11:c.A1636G:p.T546A	-0.936	AFR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.8934,EAS:0.8986,FIN:0.9967,NFE:0.6936,OTH:0.9814,ASJ:0.7058	613733	131100;	652;	652|MEN1<br>Wermer syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|131100 ~	~ko04934 Cushing syndrome~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.0	-5.71	0.000	-0.69	11	22(soft_tissue)	0.9959
11	64572557	64572557	A	G	MEN1	exonic	synonymous SNV	ENSG00000133895	rs540012	ENSG00000133895:ENST00000377313:exon8:c.T1314C:p.H438H,ENSG00000133895:ENST00000377326:exon8:c.T1299C:p.H433H,ENSG00000133895:ENST00000312049:exon9:c.T1299C:p.H433H,ENSG00000133895:ENST00000315422:exon9:c.T1299C:p.H433H,ENSG00000133895:ENST00000337652:exon9:c.T1314C:p.H438H,ENSG00000133895:ENST00000377321:exon9:c.T1194C:p.H398H,ENSG00000133895:ENST00000394374:exon9:c.T1314C:p.H438H,ENSG00000133895:ENST00000443283:exon9:c.T1314C:p.H438H,ENSG00000133895:ENST00000394376:exon10:c.T1314C:p.H438H	MEN1:NM_000244:exon9:c.T1314C:p.H438H,MEN1:NM_001370259:exon9:c.T1299C:p.H433H,MEN1:NM_001370260:exon9:c.T1299C:p.H433H,MEN1:NM_001370261:exon9:c.T1299C:p.H433H,MEN1:NM_001370262:exon9:c.T1194C:p.H398H,MEN1:NM_001370263:exon9:c.T1194C:p.H398H,MEN1:NM_130799:exon9:c.T1299C:p.H433H,MEN1:NM_130800:exon9:c.T1314C:p.H438H,MEN1:NM_130801:exon9:c.T1314C:p.H438H,MEN1:NM_130802:exon9:c.T1314C:p.H438H,MEN1:NM_130803:exon9:c.T1314C:p.H438H,MEN1:NM_001370251:exon10:c.T1425C:p.H475H,MEN1:NM_130804:exon10:c.T1314C:p.H438H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9927	0.9761	0.976038	0.9768	.	.	.	.	.	.	.	.	MEN1:uc001obj.3:exon9:c.T1314C:p.H438H,MEN1:uc001obk.3:exon9:c.T1314C:p.H438H,MEN1:uc001obl.3:exon9:c.T1194C:p.H398H,MEN1:uc001obm.3:exon9:c.T1299C:p.H433H,MEN1:uc001obn.3:exon9:c.T1314C:p.H438H,MEN1:uc001obo.3:exon9:c.T1314C:p.H438H,MEN1:uc001obr.3:exon9:c.T1314C:p.H438H,MEN1:uc001obq.3:exon10:c.T1314C:p.H438H	.	AFR:0.9185,AMR:0.9976,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	613733	131100;	652;	652|MEN1<br>Wermer syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|131100 ~	~ko04934 Cushing syndrome~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	11	MU81904595	hom
11	64572602	64572602	G	A	MEN1	exonic	synonymous SNV	ENSG00000133895	rs2071313	ENSG00000133895:ENST00000377313:exon8:c.C1269T:p.D423D,ENSG00000133895:ENST00000377326:exon8:c.C1254T:p.D418D,ENSG00000133895:ENST00000312049:exon9:c.C1254T:p.D418D,ENSG00000133895:ENST00000315422:exon9:c.C1254T:p.D418D,ENSG00000133895:ENST00000337652:exon9:c.C1269T:p.D423D,ENSG00000133895:ENST00000377321:exon9:c.C1149T:p.D383D,ENSG00000133895:ENST00000394374:exon9:c.C1269T:p.D423D,ENSG00000133895:ENST00000443283:exon9:c.C1269T:p.D423D,ENSG00000133895:ENST00000394376:exon10:c.C1269T:p.D423D	MEN1:NM_000244:exon9:c.C1269T:p.D423D,MEN1:NM_001370259:exon9:c.C1254T:p.D418D,MEN1:NM_001370260:exon9:c.C1254T:p.D418D,MEN1:NM_001370261:exon9:c.C1254T:p.D418D,MEN1:NM_001370262:exon9:c.C1149T:p.D383D,MEN1:NM_001370263:exon9:c.C1149T:p.D383D,MEN1:NM_130799:exon9:c.C1254T:p.D418D,MEN1:NM_130800:exon9:c.C1269T:p.D423D,MEN1:NM_130801:exon9:c.C1269T:p.D423D,MEN1:NM_130802:exon9:c.C1269T:p.D423D,MEN1:NM_130803:exon9:c.C1269T:p.D423D,MEN1:NM_001370251:exon10:c.C1380T:p.D460D,MEN1:NM_130804:exon10:c.C1269T:p.D423D	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3934	0.3040	0.307907	1(liver)	.	.	.	.	.	.	.	.	MEN1:uc001obj.3:exon9:c.C1269T:p.D423D,MEN1:uc001obk.3:exon9:c.C1269T:p.D423D,MEN1:uc001obl.3:exon9:c.C1149T:p.D383D,MEN1:uc001obm.3:exon9:c.C1254T:p.D418D,MEN1:uc001obn.3:exon9:c.C1269T:p.D423D,MEN1:uc001obo.3:exon9:c.C1269T:p.D423D,MEN1:uc001obr.3:exon9:c.C1269T:p.D423D,MEN1:uc001obq.3:exon10:c.C1269T:p.D423D	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:1(breast),EAS:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,FIN:0.3262,NFE:0.0877,OTH:0.3285,ASJ:MU90806	613733	131100;	652;	652|MEN1<br>Wermer syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|131100 ~	~ko04934 Cushing syndrome~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	11	3(lung)	0.3576
11	65664346	65664346	T	C	FOSL1	exonic	synonymous SNV	ENSG00000175592	rs637571	ENSG00000175592:ENST00000312562:exon2:c.A231G:p.Q77Q,ENSG00000175592:ENST00000531493:exon2:c.A231G:p.Q77Q,ENSG00000175592:ENST00000532401:exon2:c.A231G:p.Q77Q	FOSL1:NM_001300844:exon2:c.A231G:p.Q77Q,FOSL1:NM_001300855:exon2:c.A231G:p.Q77Q,FOSL1:NM_005438:exon2:c.A231G:p.Q77Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5077	0.4840	0.56849	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FOSL1:uc001ogg.1:exon2:c.A231G:p.Q77Q	.	AFR:0.4865,AMR:0.5561,EAS:0.4570,FIN:0.7665,NFE:0.3964,OTH:0.4281,ASJ:0.6679	136515	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.4743
11	65667796	65667796	G	A	FOSL1	exonic	synonymous SNV	ENSG00000175592	rs1058068	ENSG00000175592:ENST00000312562:exon1:c.C15T:p.F5F,ENSG00000175592:ENST00000448083:exon1:c.C15T:p.F5F,ENSG00000175592:ENST00000531493:exon1:c.C15T:p.F5F,ENSG00000175592:ENST00000532401:exon1:c.C15T:p.F5F	FOSL1:NM_001300844:exon1:c.C15T:p.F5F,FOSL1:NM_001300855:exon1:c.C15T:p.F5F,FOSL1:NM_001300856:exon1:c.C15T:p.F5F,FOSL1:NM_001300857:exon1:c.C15T:p.F5F,FOSL1:NM_005438:exon1:c.C15T:p.F5F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5503	0.2131	0.361821	ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FOSL1:uc001ogg.1:exon1:c.C15T:p.F5F,FOSL1:uc010ros.1:exon1:c.C15T:p.F5F	.	AFR:0.3391,AMR:0.1016,EAS:0.4305,FIN:0.4703,NFE:0.3971,OTH:0.4258,ASJ:0.6178	136515	.	.	.	.	.	.	.	.	.	.	.	11	2(large_intestine)	0.4443
11	67257823	67257823	C	A	AIP	exonic	nonsynonymous SNV	ENSG00000110711	rs641081	ENSG00000110711:ENST00000525341:exon3:c.C334A:p.Q112K,ENSG00000110711:ENST00000528641:exon4:c.C493A:p.Q165K,ENSG00000110711:ENST00000279146:exon5:c.C682A:p.Q228K	AIP:NM_001302959:exon5:c.C505A:p.Q169K,AIP:NM_001302960:exon5:c.C682A:p.Q228K,AIP:NM_003977:exon5:c.C682A:p.Q228K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9550	0.8343	0.845447	0.8508	-1.180	0.007	1.0	1.08	0.068	.	.	Tetratricopeptide-like helical domain	AIP:uc001olv.3:exon5:c.C682A:p.Q228K	-0.952	AFR:0.4803,AMR:0.9582,EAS:0.9994,FIN:1,NFE:0.9977,OTH:0.9755,ASJ:1	605555	102200;219090;600634;	314777;96253;314777;96256;963;99725;	314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96253|Corticotroph pituitary adenoma<br>Pituitary corticotroph micro-adenoma<br>Pituitary-dependent Cushing syndrome|1-9 / 100 000|Not applicable|Adult|219090 ~314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96256|Somatotropinoma|-|-|-|102200 ~963|-|1-9 / 100 000|Not applicable|Adult|102200 300943 ~99725|Hypophyseal gigantism<br>Infantile and juvenile forms of acromegaly|-|-|-|102200 ~	.	.	.	.	0.0	-0.72	0.000	0.42	11	MU4550249	hom
11	67258391	67258391	A	G	AIP	exonic	nonsynonymous SNV	ENSG00000110711	rs4930199	ENSG00000110711:ENST00000279146:exon6:c.A920G:p.Q307R	AIP:NM_001302959:exon6:c.A743G:p.Q248R,AIP:NM_003977:exon6:c.A920G:p.Q307R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9999	0.9998	0.999401	0.9998	.	.	.	.	.	.	.	.	AIP:uc001olv.3:exon6:c.A920G:p.Q307R	.	AFR:0.9995,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	605555	102200;219090;600634;	314777;96253;314777;96256;963;99725;	314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96253|Corticotroph pituitary adenoma<br>Pituitary corticotroph micro-adenoma<br>Pituitary-dependent Cushing syndrome|1-9 / 100 000|Not applicable|Adult|219090 ~314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96256|Somatotropinoma|-|-|-|102200 ~963|-|1-9 / 100 000|Not applicable|Adult|102200 300943 ~99725|Hypophyseal gigantism<br>Infantile and juvenile forms of acromegaly|-|-|-|102200 ~	.	.	.	.	.	.	.	.	11	MU4550266	hom
11	67351585	67351585	C	G	GSTP1	intronic	.	ENSG00000084207	rs4147581	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4913	0.3879	0.424321	0.4018	.	.	.	.	.	.	.	.	.	.	AFR:0.1433,AMR:0.3816,EAS:0.7071,FIN:0.5032,NFE:0.4885,OTH:0.4815,ASJ:0.5933	134660	.	.	.	~ko00480 Glutathione metabolism~ko00980 Metabolism of xenobiotics by cytochrome P450~ko00982 Drug metabolism - cytochrome P450~ko00983 Drug metabolism - other enzymes~ko01100 Metabolic pathways~ko01524 Platinum drug resistance~ko04212 Longevity regulating pathway - worm~ko05200 Pathways in cancer~ko05204 Chemical carcinogenesis~ko05225 Hepatocellular carcinoma~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	11	MU796812	het
11	67352256	67352256	C	A	GSTP1	intronic	.	ENSG00000084207	rs762803	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3512	0.4102	0.311901	MU11965238	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|1|205|0.00487805,BRCA-KR|1|50|0.02,AMR:0.3776,EAS:0.2230,FIN:0.2881,NFE:0.1512,OTH:0.3270,ASJ:0.3888	134660	.	.	.	~ko00480 Glutathione metabolism~ko00980 Metabolism of xenobiotics by cytochrome P450~ko00982 Drug metabolism - cytochrome P450~ko00983 Drug metabolism - other enzymes~ko01100 Metabolic pathways~ko01524 Platinum drug resistance~ko04212 Longevity regulating pathway - worm~ko05200 Pathways in cancer~ko05204 Chemical carcinogenesis~ko05225 Hepatocellular carcinoma~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	11	5(haematopoietic_and_lymphoid_tissue)	0.4177
11	68125304	68125304	C	T	LRP5	exonic	synonymous SNV	ENSG00000162337	rs138207107	ENSG00000162337:ENST00000294304:exon3:c.C675T:p.D225D,ENSG00000162337:ENST00000529993:exon3:c.C675T:p.D225D	LRP5:NM_002335:exon3:c.C675T:p.D225D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0030	0.0004	0.00419329	0.0003	.	.	.	.	.	.	.	.	LRP5:uc001ont.3:exon3:c.C675T:p.D225D	.	AFR:0.0003,AMR:0,EAS:0,FIN:0,NFE:6.668e-05,OTH:0.0041,ASJ:0	603506	144750;166710;259770;601813;601884;607634;607636;	3416;2783;891;2788;2790;	3416|Van Buchem disease|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent|239100 607636 ~2783|-|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Childhood|607634 ~891|Criswick-Schepens syndrome<br>FEVR|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|133780 305390 601813 605750 613310 616468 ~2788|OPPG<br>Ocular form of osteogenesis imperfecta|<1 / 1 000 000|Autosomal recessive|Childhood|259770 ~2790|Endosteal hyperostosis, Worth type<br>Worth syndrome|-|Autosomal dominant|-|144750 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	.	het
11	68171013	68171013	T	C	LRP5	exonic	synonymous SNV	ENSG00000162337	rs545382	ENSG00000162337:ENST00000294304:exon8:c.T1647C:p.F549F	LRP5:NM_002335:exon8:c.T1647C:p.F549F	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9001	0.8154	0.841454	0.8459	.	.	.	.	.	.	.	.	LRP5:uc001ont.3:exon8:c.T1647C:p.F549F	.	AFR:0.6314,AMR:0.9320,EAS:0.9883,FIN:0.9645,NFE:0.9169,OTH:0.9153,ASJ:0.9073	603506	144750;166710;259770;601813;601884;607634;607636;	3416;2783;891;2788;2790;	3416|Van Buchem disease|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent|239100 607636 ~2783|-|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Childhood|607634 ~891|Criswick-Schepens syndrome<br>FEVR|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|133780 305390 601813 605750 613310 616468 ~2788|OPPG<br>Ocular form of osteogenesis imperfecta|<1 / 1 000 000|Autosomal recessive|Childhood|259770 ~2790|Endosteal hyperostosis, Worth type<br>Worth syndrome|-|Autosomal dominant|-|144750 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	MU4557319	hom
11	68192690	68192690	G	A	LRP5	exonic	synonymous SNV	ENSG00000162337	rs556442	ENSG00000162337:ENST00000294304:exon15:c.G3357A:p.V1119V	LRP5:NM_001291902:exon15:c.G1614A:p.V538V,LRP5:NM_002335:exon15:c.G3357A:p.V1119V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6755	0.5265	0.579273	2(large_intestine)	.	.	.	.	.	.	.	.	LRP5:uc001ont.3:exon15:c.G3357A:p.V1119V	.	AFR:MU64296,AMR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,EAS:0.2359,FIN:0.6675,NFE:0.6258,OTH:0.7689,ASJ:0.5925	603506	144750;166710;259770;601813;601884;607634;607636;	3416;2783;891;2788;2790;	3416|Van Buchem disease|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent|239100 607636 ~2783|-|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Childhood|607634 ~891|Criswick-Schepens syndrome<br>FEVR|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|133780 305390 601813 605750 613310 616468 ~2788|OPPG<br>Ocular form of osteogenesis imperfecta|<1 / 1 000 000|Autosomal recessive|Childhood|259770 ~2790|Endosteal hyperostosis, Worth type<br>Worth syndrome|-|Autosomal dominant|-|144750 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	1(skin)	0.8595
11	68822739	68822739	T	C	TPCN2	exonic	synonymous SNV	ENSG00000162341	rs1470892	ENSG00000162341:ENST00000294309:exon4:c.T348C:p.A116A,ENSG00000162341:ENST00000542467:exon4:c.T348C:p.A116A	TPCN2:NM_139075:exon4:c.T348C:p.A116A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9994	0.9975	0.998802	0.9977	.	.	.	.	.	.	.	.	TPCN2:uc001oos.2:exon4:c.T348C:p.A116A,TPCN2:uc010rqg.1:exon4:c.T348C:p.A116A	.	AFR:0.9921,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	MU81906316	hom
11	68822831	68822831	C	T	TPCN2	intronic	.	ENSG00000162341	rs72917389	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1758	0.1293	0.0978435	0.1539	.	.	.	.	.	.	.	.	.	.	AFR:0.0313,AMR:0.0778,EAS:0.0019,FIN:0.3009,NFE:0.2075,OTH:0.2071,ASJ:0.1867	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	MU113407972	het
11	68825037	68825037	A	C	TPCN2	intronic	.	ENSG00000162341	rs3750973	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8786	0.9005	0.747804	0.8742	.	.	.	.	.	0.0001	0.028	.	.	.	AFR:0.7215,AMR:0.6026,EAS:0.5278,FIN:0.9797,NFE:0.9844,OTH:0.9399,ASJ:0.9768	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	MU726998	hom
11	68834968	68834968	T	C	TPCN2	intronic	.	ENSG00000162341	rs6591368	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9577	0.9435	0.898363	0.9415	.	.	.	.	.	0.0001	0.02	.	.	.	AFR:0.8347,AMR:0.9296,EAS:0.8609,FIN:0.9926,NFE:0.9974,OTH:0.9827,ASJ:0.9901	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	MU23558361	hom
11	68840160	68840160	A	G	TPCN2	exonic	nonsynonymous SNV	ENSG00000162341	rs3750965	ENSG00000162341:ENST00000294309:exon12:c.A1127G:p.K376R,ENSG00000162341:ENST00000542467:exon12:c.A1127G:p.K376R	TPCN2:NM_139075:exon12:c.A1127G:p.K376R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.2934	0.2917	0.290735	MU23558422	-0.014	2.458	0.5	2.61	0.618	.	.	.	TPCN2:uc001oor.2:exon10:c.A872G:p.K291R,TPCN2:uc001oos.2:exon12:c.A1127G:p.K376R,TPCN2:uc010rqg.1:exon12:c.A1127G:p.K376R	-1.154	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.2626,EAS:0.1719,FIN:0.2833,NFE:0.2160,OTH:0.2224,ASJ:0.2376	612163	612267;	.	.	.	.	.	.	0.287	-4.16	0.000	1.95	11	1(upper_aerodigestive_tract)	0.2962
11	68846399	68846399	A	T	TPCN2	exonic	nonsynonymous SNV	ENSG00000162341	rs35264875	ENSG00000162341:ENST00000294309:exon16:c.A1450T:p.M484L,ENSG00000162341:ENST00000542467:exon16:c.A1450T:p.M484L	TPCN2:NM_139075:exon16:c.A1450T:p.M484L	clinvar: association 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1634	0.1286	0.0996406	MU4550608	-1.220	0.006	1.0	-3.89	0.986	.	.	Ion transport domain	TPCN2:uc001oor.2:exon14:c.A1195T:p.M399L,TPCN2:uc001oos.2:exon16:c.A1450T:p.M484L,TPCN2:uc010rqg.1:exon16:c.A1450T:p.M484L	-0.996	AFR:LUSC-KR|2|170|0.0117647,AMR:0.1562,EAS:0.0779,FIN:0.1887,NFE:0.0018,OTH:0.3143,ASJ:0.0320	612163	612267;	.	.	.	.	.	.	0.007	-4.35	0.000	1.265	11	3(soft_tissue)	0.2086
11	68851414	68851414	T	C	TPCN2	exonic	nonsynonymous SNV	ENSG00000162341	rs2376558	ENSG00000162341:ENST00000294309:exon19:c.T1691C:p.L564P	TPCN2:NM_139075:exon19:c.T1691C:p.L564P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8797	0.9113	0.752995	LICA-CN|3|402|0.00746269,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763	1.001	10.67	0.245	2.65	0.031	0.0001	0.01	Ion transport domain	TPCN2:uc001oos.2:exon19:c.T1691C:p.L564P	-0.952	AFR:0.8821,AMR:0.7519,EAS:0.9768,FIN:0.5155,NFE:0.9797,OTH:0.9843,ASJ:0.6014	612163	612267;	.	.	.	.	.	.	0.001	-4.93	0.000	.	11	1(haematopoietic_and_lymphoid_tissue)	0.9409
11	68854012	68854012	A	G	TPCN2	exonic	synonymous SNV	ENSG00000162341	rs35337391	ENSG00000162341:ENST00000294309:exon23:c.A2025G:p.V675V	TPCN2:NM_139075:exon23:c.A2025G:p.V675V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1661	0.1349	0.103235	LUSC-KR|5|170|0.0294118	.	.	.	.	.	.	.	.	TPCN2:uc001oos.2:exon23:c.A2025G:p.V675V	.	AFR:0.1633,AMR:0.0463,EAS:0.1921,FIN:0.0019,NFE:0.3226,OTH:0.2125,ASJ:0.0779	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	1(thyroid)	0.2141
11	69462910	69462910	G	A	CCND1	exonic	synonymous SNV	ENSG00000110092	rs9344	ENSG00000110092:ENST00000227507:exon4:c.G723A:p.P241P	CCND1:NM_053056:exon4:c.G723A:p.P241P	clinvar: risk_factor 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4551	0.3867	0.413538	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	0.4188	0.388	.	CCND1:uc001opa.3:exon4:c.G723A:p.P241P	.	AFR:12(meninges),AMR:1(thyroid),EAS:MU4550663,FIN:LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611,NFE:0.3966,OTH:0.2158,ASJ:1(salivary_gland)	168461	114500;193300;254500;	29073;314701;85443;892;	29073|Kahler's disease<br>Medullary plasmacytoma<br>Myelomatosis<br>Plasma cell myeloma|1-5 / 10 000|-|Adult|254500 ~314701|Systemic AL amyloidosis|-|Not applicable|-|254500 ~85443|Light-chain amyloidosis<br>Primary amyloidosis|1-5 / 10 000|Not applicable|Adult|254500 ~892|Familial cerebelloretinal angiomatosis<br>Lindau disease<br>VHL<br>Von Hippel-Lindau syndrome|1-9 / 100 000|Autosomal dominant|Adult|193300 ~	~ko01522 Endocrine resistance~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04218 Cellular senescence~ko04310 Wnt signaling pathway~ko04340 Hedgehog signaling pathway~ko04371 Apelin signaling pathway~ko04390 Hippo signaling pathway~ko04510 Focal adhesion~ko04530 Tight junction~ko04630 JAK-STAT signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	11	1(prostate)	0.4125
11	74329615	74329615	T	C	POLD3	exonic	synonymous SNV	ENSG00000077514	rs4944052	ENSG00000077514:ENST00000531615:exon4:c.T309C:p.P103P,ENSG00000077514:ENST00000532497:exon5:c.T108C:p.P36P,ENSG00000077514:ENST00000263681:exon6:c.T426C:p.P142P,ENSG00000077514:ENST00000527458:exon6:c.T309C:p.P103P,ENSG00000077514:ENST00000528481:exon6:c.T309C:p.P103P,ENSG00000077514:ENST00000530511:exon6:c.T309C:p.P103P	POLD3:NM_001363597:exon6:c.T309C:p.P103P,POLD3:NM_006591:exon6:c.T426C:p.P142P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3710	0.4061	0.449081	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	POLD3:uc009yua.2:exon5:c.T108C:p.P36P,POLD3:uc001ovf.2:exon6:c.T426C:p.P142P,POLD3:uc031qcr.1:exon6:c.T309C:p.P103P	.	AFR:MU132016,AMR:SKCA-BR|1|100|0.01,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,EAS:0.5660,FIN:0.4200,NFE:0.2616,OTH:0.3259,ASJ:0.3766	611415	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.2702
11	74379809	74379809	-	T	POLD3;CHRDL2	intergenic	.	ENSG00000077514	rs397716648	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2404	.	0.208466	0.1921	.	.	.	.	.	.	.	.	.	.	AFR:0.2631,AMR:0.1146,EAS:0.0943,FIN:0.1125,NFE:0.1880,OTH:0.1509,ASJ:0.1367	611415	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	76227182	76227182	G	A	EMSY	intronic	.	ENSG00000158636	rs2508740	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6438	0.5499	0.636182	0.5850	.	.	.	.	.	0	0	.	.	.	AFR:0.4349,AMR:0.7339,EAS:0.8422,FIN:0.6299,NFE:0.6216,OTH:0.6612,ASJ:0.53	608574	.	.	.	.	.	.	.	.	.	.	.	11	MU81907639	hom
11	85968623	85968623	C	T	EED	exonic	synonymous SNV	ENSG00000074266	rs974144	ENSG00000074266:ENST00000263360:exon6:c.C619T:p.L207L,ENSG00000074266:ENST00000327320:exon6:c.C619T:p.L207L,ENSG00000074266:ENST00000351625:exon6:c.C619T:p.L207L,ENSG00000074266:ENST00000528180:exon6:c.C619T:p.L207L	EED:NM_001308007:exon6:c.C619T:p.L207L,EED:NM_001330334:exon6:c.C619T:p.L207L,EED:NM_003797:exon6:c.C619T:p.L207L	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.3724	0.3244	0.294728	MU17479045	.	.	.	.	.	.	.	.	EED:uc001pbp.3:exon6:c.C619T:p.L207L,EED:uc001pbq.3:exon6:c.C619T:p.L207L,EED:uc001pbr.3:exon6:c.C619T:p.L207L,EED:uc010rtm.2:exon6:c.C619T:p.L207L	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841,AMR:0.3452,EAS:0.2590,FIN:0.3046,NFE:0.3387,OTH:0.4218,ASJ:0.1770	605984	.	.	.	.	,2256	.	.	.	.	.	.	11	16(soft_tissue)	0.4264
11	85977117	85977117	G	A	EED	intronic	.	ENSG00000074266	rs10898460	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7872	0.8184	0.764976	0.8069	.	.	.	.	.	0	0.032	.	.	.	AFR:0.8129,AMR:0.6504,EAS:0.7118,FIN:0.7643,NFE:0.8347,OTH:0.8200,ASJ:0.65	605984	.	.	.	.	.	.	.	.	.	.	.	11	MU17479112	hom
11	92227198	92227200	TTT	-	FAT3	intronic	.	ENSG00000165323	rs201710620	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	.	0.4738	.	.	.	.	.	.	.	.	.	.	AFR:0.4523,AMR:0.5763,EAS:0.5728,FIN:0.4808,NFE:0.4673,OTH:0.4742,ASJ:0.5752	612483	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	92531356	92531356	A	G	FAT3	exonic	nonsynonymous SNV	ENSG00000165323	rs7949157	ENSG00000165323:ENST00000298047:exon9:c.A5177G:p.Q1726R,ENSG00000165323:ENST00000409404:exon9:c.A5177G:p.Q1726R,ENSG00000165323:ENST00000525166:exon9:c.A4727G:p.Q1576R	FAT3:NM_001008781:exon9:c.A5177G:p.Q1726R,FAT3:NM_001367949:exon10:c.A5177G:p.Q1726R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8230	0.7982	0.769768	0.8011	-0.294	0.685	0.348	0.257	0.132	.	.	Cadherin|Cadherin-like	FAT3:uc001pdj.4:exon9:c.A5177G:p.Q1726R	-1.004	AFR:0.6949,AMR:0.8589,EAS:0.7438,FIN:0.8701,NFE:0.8467,OTH:0.8371,ASJ:0.8212	612483	.	.	.	.	.	.	.	0.0	0.75	0.000	0.215	11	MU17485846	hom
11	92532677	92532677	T	C	FAT3	exonic	synonymous SNV	ENSG00000165323	rs12362722	ENSG00000165323:ENST00000298047:exon9:c.T6498C:p.P2166P,ENSG00000165323:ENST00000409404:exon9:c.T6498C:p.P2166P,ENSG00000165323:ENST00000525166:exon9:c.T6048C:p.P2016P	FAT3:NM_001008781:exon9:c.T6498C:p.P2166P,FAT3:NM_001367949:exon10:c.T6498C:p.P2166P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8272	0.8269	0.799321	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FAT3:uc001pdj.4:exon9:c.T6498C:p.P2166P	.	AFR:0.8210,AMR:0.7962,EAS:0.8179,FIN:0.7469,NFE:0.8353,OTH:0.8374,ASJ:0.8652	612483	.	.	.	.	.	.	.	.	.	.	.	11	1(upper_aerodigestive_tract)	0.8238
11	92534442	92534442	A	G	FAT3	exonic	nonsynonymous SNV	ENSG00000165323	rs3847531	ENSG00000165323:ENST00000298047:exon9:c.A8263G:p.I2755V,ENSG00000165323:ENST00000409404:exon9:c.A8263G:p.I2755V,ENSG00000165323:ENST00000525166:exon9:c.A7813G:p.I2605V	FAT3:NM_001008781:exon9:c.A8263G:p.I2755V,FAT3:NM_001367949:exon10:c.A8263G:p.I2755V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8637	0.8229	0.85643	0.8408	-0.756	0.054	1.0	4.8	0.559	.	.	Cadherin|Cadherin-like	FAT3:uc001pdj.4:exon9:c.A8263G:p.I2755V	-0.957	AFR:0.7577,AMR:0.8699,EAS:0.9543,FIN:0.9124,NFE:0.8554,OTH:0.8735,ASJ:0.8907	612483	.	.	.	.	.	.	.	0.0	0.18	0.000	-0.49	11	MU23948427	hom
11	92570812	92570812	T	A	FAT3	intronic	.	ENSG00000165323	rs11020075	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4042	0.3166	0.385383	MU12019188	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.3892,EAS:0.4414,FIN:0.4967,NFE:0.4631,OTH:0.4487,ASJ:0.3152	612483	.	.	.	.	.	.	.	.	.	.	.	11	1(haematopoietic_and_lymphoid_tissue)	0.4020
11	92570813	92570813	C	A	FAT3	intronic	.	ENSG00000165323	rs11020076	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4041	0.3148	0.385383	1(lung)	.	.	.	.	.	.	.	.	.	.	AFR:MU12019194,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.3154,FIN:0.4414,NFE:0.4967,OTH:0.4625,ASJ:0.3894	612483	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.4489
11	92573911	92573911	G	T	FAT3	exonic	nonsynonymous SNV	ENSG00000165323	rs10765565	ENSG00000165323:ENST00000298047:exon17:c.G10552T:p.V3518L,ENSG00000165323:ENST00000409404:exon17:c.G10552T:p.V3518L,ENSG00000165323:ENST00000525166:exon17:c.G10102T:p.V3368L	FAT3:NM_001008781:exon17:c.G10552T:p.V3518L,FAT3:NM_001367949:exon18:c.G10552T:p.V3518L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3740	0.3404	0.323482	MU160112	0.718	8.947	1.0	0.41	0.873	.	.	Cadherin|Cadherin-like	FAT3:uc001pdj.4:exon17:c.G10552T:p.V3518L	-0.955	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.3264,EAS:0.3657,FIN:0.3675,NFE:0.2007,OTH:0.3317,ASJ:0.2266	612483	.	.	.	.	.	.	.	0.001	0.62	0.000	-0.09	11	1(thyroid)	0.3924
11	92590448	92590448	A	G	FAT3	exonic	nonsynonymous SNV	ENSG00000165323	rs4753069	ENSG00000165323:ENST00000533797:exon2:c.A439G:p.S147G,ENSG00000165323:ENST00000298047:exon19:c.A11434G:p.S3812G,ENSG00000165323:ENST00000409404:exon19:c.A11434G:p.S3812G,ENSG00000165323:ENST00000525166:exon19:c.A10984G:p.S3662G	FAT3:NM_001008781:exon19:c.A11434G:p.S3812G,FAT3:NM_001367949:exon20:c.A11434G:p.S3812G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8175	0.8418	0.828474	0.8266	1.015	10.75	0.872	4.1	0.893	.	.	EGF-like domain	FAT3:uc001pdi.4:exon3:c.A754G:p.S252G,FAT3:uc001pdj.4:exon19:c.A11434G:p.S3812G	-1.008	AFR:0.9099,AMR:0.8278,EAS:0.6755,FIN:0.7872,NFE:0.8031,OTH:0.8200,ASJ:0.8676	612483	.	.	.	.	.	.	.	0.0	1.64	0.000	-1.04	11	MU737516	hom
11	93517874	93517874	C	G	MED17	exonic	synonymous SNV	ENSG00000042429	rs7116967	ENSG00000042429:ENST00000251871:exon1:c.C195G:p.G65G,ENSG00000042429:ENST00000530819:exon1:c.C195G:p.G65G,ENSG00000042429:ENST00000533133:exon1:c.C195G:p.G65G,ENSG00000042429:ENST00000533359:exon1:c.C195G:p.G65G	MED17:NM_004268:exon1:c.C195G:p.G65G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6174	0.5453	0.565695	0.5575	.	.	.	.	.	.	.	.	MED17:uc001pel.2:exon1:c.C195G:p.G65G,MED17:uc001pem.4:exon1:c.C195G:p.G65G	.	AFR:0.3368,AMR:0.7902,EAS:0.7509,FIN:0.6596,NFE:0.6234,OTH:0.6386,ASJ:0.54	603810	613668;	402364;	402364|-|<1 / 1 000 000|Autosomal recessive|Infancy|613668 ~	.	.	.	.	.	.	.	.	11	MU90907	unknown
11	93517882	93517882	A	C	MED17	exonic	nonsynonymous SNV	ENSG00000042429	rs200317687	ENSG00000042429:ENST00000251871:exon1:c.A203C:p.Q68P,ENSG00000042429:ENST00000530819:exon1:c.A203C:p.Q68P,ENSG00000042429:ENST00000533133:exon1:c.A203C:p.Q68P,ENSG00000042429:ENST00000533359:exon1:c.A203C:p.Q68P	MED17:NM_004268:exon1:c.A203C:p.Q68P	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0003	.	0.00299521	0.0004	0.751	9.160	0.173	3.41	0.301	.	.	.	MED17:uc001pel.2:exon1:c.A203C:p.Q68P,MED17:uc001pem.4:exon1:c.A203C:p.Q68P	-1.054	AFR:0.0002,AMR:0,EAS:0.0049,FIN:0,NFE:0,OTH:0.0010,ASJ:0	603810	613668;	402364;	402364|-|<1 / 1 000 000|Autosomal recessive|Infancy|613668 ~	.	.	.	.	0.011	0.5	0.066	1.1	11	.	unknown
11	93517886	93517886	G	C	MED17	exonic	nonsynonymous SNV	ENSG00000042429	rs2848477	ENSG00000042429:ENST00000251871:exon1:c.G207C:p.E69D,ENSG00000042429:ENST00000530819:exon1:c.G207C:p.E69D,ENSG00000042429:ENST00000533133:exon1:c.G207C:p.E69D,ENSG00000042429:ENST00000533359:exon1:c.G207C:p.E69D	MED17:NM_004268:exon1:c.G207C:p.E69D	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6183	0.5506	0.565695	0.5573	0.495	7.396	0.867	1.67	0.309	.	.	.	MED17:uc001pel.2:exon1:c.G207C:p.E69D,MED17:uc001pem.4:exon1:c.G207C:p.E69D	-0.952	AFR:0.3363,AMR:0.7902,EAS:0.7491,FIN:0.6591,NFE:0.6237,OTH:0.6380,ASJ:0.54	603810	613668;	402364;	402364|-|<1 / 1 000 000|Autosomal recessive|Infancy|613668 ~	.	.	.	.	0.0	0.51	0.000	1.445	11	MU90893	unknown
11	93527219	93527219	T	C	MED17	intronic	.	ENSG00000042429	rs657177	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9826	0.9399	0.933107	0.9455	.	.	.	.	.	.	.	.	.	.	AFR:0.8101,AMR:0.9856,EAS:1,FIN:0.9994,NFE:0.9992,OTH:0.9949,ASJ:1	603810	613668;	402364;	402364|-|<1 / 1 000 000|Autosomal recessive|Infancy|613668 ~	.	.	.	.	.	.	.	.	11	MU81909259	hom
11	93534990	93534990	G	A	MED17	intronic	.	ENSG00000042429	rs655699	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6075	0.4893	0.527556	0.5235	.	.	.	.	.	0.0008	0.006	.	.	.	AFR:0.2167,AMR:0.7709,EAS:0.7481,FIN:0.6594,NFE:0.6247,OTH:0.6260,ASJ:0.5397	603810	613668;	402364;	402364|-|<1 / 1 000 000|Autosomal recessive|Infancy|613668 ~	.	.	.	.	.	.	.	.	11	MU19347293	hom
11	108121410	108121410	-	T	ATM	intronic	.	ENSG00000149311	rs34325032	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.3717	0.3252	0.40595	0.5019	.	.	.	.	.	.	.	.	.	.	AFR:0.4265,AMR:0.5668,EAS:0.4125,FIN:0.4710,NFE:0.5539,OTH:0.5839,ASJ:0.5875	607585	114480;208900;	100;227535;	100|Louis-Bar syndrome|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|208900 208910 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko03440 Homologous recombination~ko04064 NF-kappa B signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	11	.	het
11	108151707	108151707	-	A	ATM	intronic	.	ENSG00000149311	rs3218681	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.5675	0.5562	0.542133	0.5369	.	.	.	.	.	.	.	.	.	.	AFR:0.4641,AMR:0.6383,EAS:0.3782,FIN:0.6205,NFE:0.5659,OTH:0.6052,ASJ:0.6324	607585	114480;208900;	100;227535;	100|Louis-Bar syndrome|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|208900 208910 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko03440 Homologous recombination~ko04064 NF-kappa B signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	11	.	het
11	108183167	108183167	A	G	ATM	exonic	nonsynonymous SNV	ENSG00000149311	rs659243	ENSG00000149311:ENST00000278616:exon40:c.A5948G:p.N1983S,ENSG00000149311:ENST00000452508:exon41:c.A5948G:p.N1983S	ATM:NM_000051:exon40:c.A5948G:p.N1983S,ATM:NM_001351834:exon41:c.A5948G:p.N1983S	clinvar: Benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	1	.	1	MU81910525	.	.	.	.	.	.	.	.	ATM:uc009yxt.1:exon3:c.A290G:p.N97S,ATM:uc001pkg.1:exon8:c.A1019G:p.N340S,ATM:uc001pke.2:exon14:c.A1904G:p.N635S,ATM:uc001pkb.1:exon40:c.A5948G:p.N1983S,ATM:uc009yxr.1:exon41:c.A5948G:p.N1983S	.	AFR:COCA-CN|5|321|0.0155763,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	607585	114480;208900;	100;227535;	100|Louis-Bar syndrome|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|208900 208910 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko03440 Homologous recombination~ko04064 NF-kappa B signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	904,,910,902,906,911,908,901,899,898,903,907,909,893,877,900,895,894,912	.	,896,897	.	.	.	.	11	85(lung)	1
11	111227170	111227170	T	C	POU2AF1	intronic	.	ENSG00000110777	rs4387383	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.429912	0.5191	.	.	.	.	.	.	.	.	.	.	AFR:0.3196,AMR:0.6802,EAS:0.3004,FIN:0.5802,NFE:0.6319,OTH:0.5755,ASJ:0.5	601206	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	111248514	111248514	C	G	POU2AF1	intronic	.	ENSG00000110777	rs4622303	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.561102	0.6695	.	.	.	.	.	.	.	.	.	.	AFR:0.5779,AMR:0.8177,EAS:0.3790,FIN:0.6764,NFE:0.7414,OTH:0.6893,ASJ:0.7433	601206	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	111963860	111963860	A	G	SDHD	exonic	nonsynonymous SNV	ENSG00000204370	rs592626	ENSG00000204370:ENST00000526592:exon4:c.A371G:p.Q124R	SDHD:NM_001276506:exon4:c.A371G:p.Q124R	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9967	.	0.945487	0.9510	-0.354	0.498	0.269	-0.298	0.000	.	.	.	SDHD:uc031qee.1:exon4:c.A371G:p.Q124R	-0.867	AFR:0.8286,AMR:0.9866,EAS:0.9988,FIN:1,NFE:0.9995,OTH:0.9907,ASJ:1	602690	114900;168000;171300;252011;606864;615106;	201;97286;3208;29072;29072;100093;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~97286|Carney dyad<br>Carney-Stratakis dyad<br>GIST-paraganglioma dyad<br>Paraganglioma and gastric stromal sarcoma|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|606864 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~100093|-|-|-|-|114900 ~	.	.	.	.	.	-2.93	0.000	.	11	MU81910959	hom
11	118377297	118377297	C	T	KMT2A	exonic	nonsynonymous SNV	ENSG00000118058	rs555310772	ENSG00000118058:ENST00000354520:exon26:c.C10567T:p.R3523W,ENSG00000118058:ENST00000389506:exon27:c.C10681T:p.R3561W,ENSG00000118058:ENST00000534358:exon27:c.C10690T:p.R3564W	KMT2A:NM_001197104:exon27:c.C10690T:p.R3564W,KMT2A:NM_005933:exon27:c.C10681T:p.R3561W	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, -1, 1, -1, 1, 0] 	0.0012	.	0.00379393	9.686e-05	3.734	23.3	0.324	2.89	1.000	.	.	.	KMT2A:uc001pta.3:exon27:c.C10681T:p.R3561W,KMT2A:uc001ptb.3:exon27:c.C10690T:p.R3564W	-0.815	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0001,OTH:0.0010,ASJ:0	159555	605130;	319182;	319182|Hypertrichosis-short stature-facial dysmorphism-developmental delay syndrome|-|X-linked recessive<br>or&nbsp;Unknown|-|605130 ~	~ko00310 Lysine degradation~ko04934 Cushing syndrome~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.001	-1.56	0.232	0.205	11	.	het
11	118625609	118625609	C	T	DDX6	intronic	.	ENSG00000110367	rs580079	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8909	.	0.88758	0.8687	.	.	.	.	.	.	.	.	.	.	AFR:0.7968,AMR:0.9141,EAS:0.9994,FIN:0.9066,NFE:0.8832,OTH:0.8941,ASJ:0.8742	600326	.	.	.	.	.	.	.	.	.	.	.	11	MU81912502	hom
11	119148573	119148573	G	T	CBL	intronic	.	ENSG00000110395	rs2510152	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6011	0.6246	0.728634	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:1(bone),AMR:MU21722970,EAS:0.6228,FIN:0.8009,NFE:0.4055,OTH:0.6523,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	165360	607785;613563;	363972;86834;	363972|CBL syndrome<br>Noonan syndrome-like disorder with JMML|-|Autosomal dominant|-|613563 ~86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	~ko04012 ErbB signaling pathway~ko04120 Ubiquitin mediated proteolysis~ko04144 Endocytosis~ko04910 Insulin signaling pathway~ko05100 Bacterial invasion of epithelial cells~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	11	1(lung)	0.8846
11	120292570	120292570	T	A	ARHGEF12	intronic	.	ENSG00000196914	rs532006	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9964	0.9865	0.985024	0.9891	.	.	.	.	.	.	.	.	.	.	AFR:0.9618,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	604763	.	.	.	~ko04270 Vascular smooth muscle contraction~ko04360 Axon guidance~ko04361 Axon regeneration~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05130 Pathogenic Escherichia coli infection~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	MU81913066	hom
11	120300559	120300559	G	A	ARHGEF12	intronic	.	ENSG00000196914	rs74596881	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0263	0.0017	0.0513179	COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.0051,AMR:0.0008,EAS:0.0132,FIN:0.0420,NFE:0.0126,OTH:0.0014,ASJ:0	604763	.	.	.	~ko04270 Vascular smooth muscle contraction~ko04360 Axon guidance~ko04361 Axon regeneration~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05130 Pathogenic Escherichia coli infection~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	1(haematopoietic_and_lymphoid_tissue)	0.0133
11	120302629	120302629	T	C	ARHGEF12	intronic	.	ENSG00000196914	rs74387821	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0295	0.0065	0.0617013	COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.0106,AMR:0.0159,EAS:0.0132,FIN:0.0611,NFE:0.0129,OTH:0.0018,ASJ:0	604763	.	.	.	~ko04270 Vascular smooth muscle contraction~ko04360 Axon guidance~ko04361 Axon regeneration~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05130 Pathogenic Escherichia coli infection~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	1(haematopoietic_and_lymphoid_tissue)	0.0143
11	120319064	120319064	A	C	ARHGEF12	intronic	.	ENSG00000196914	rs2305008	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4203	0.4354	0.427716	MU11826432	.	.	.	.	.	0.0001	0	.	ARHGEF12:uc021qrm.1:exon19:c.A1687C:p.M563L	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.4342,EAS:0.3457,FIN:0.4467,NFE:0.2976,OTH:0.4504,ASJ:0.5346	604763	.	.	.	~ko04270 Vascular smooth muscle contraction~ko04360 Axon guidance~ko04361 Axon regeneration~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05130 Pathogenic Escherichia coli infection~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	3(haematopoietic_and_lymphoid_tissue)	0.3905
11	120330019	120330019	T	G	ARHGEF12	exonic	synonymous SNV	ENSG00000196914;ENSG00000269601	rs2305009	ENSG00000269601:ENST00000595283:exon1:c.A29C:p.E10A	ARHGEF12:NM_001198665:exon25:c.T2460G:p.L820L,ARHGEF12:NM_001301084:exon26:c.T2208G:p.L736L,ARHGEF12:NM_015313:exon26:c.T2517G:p.L839L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0273	0.0018	0.0551118	COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	ARHGEF12:uc009zat.3:exon25:c.T2460G:p.L820L,ARHGEF12:uc001pxl.2:exon26:c.T2517G:p.L839L,ARHGEF12:uc009zau.1:exon26:c.T2208G:p.L736L,ARHGEF12:uc010rzn.1:exon26:c.T2208G:p.L736L	.	AFR:0.0061,AMR:0.0010,EAS:0.0132,FIN:0.0593,NFE:0.0126,OTH:0.0015,ASJ:0	604763	.	.	.	~ko04270 Vascular smooth muscle contraction~ko04360 Axon guidance~ko04361 Axon regeneration~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05130 Pathogenic Escherichia coli infection~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	1(haematopoietic_and_lymphoid_tissue)	0.0133
11	120347940	120347940	A	G	ARHGEF12	exonic	synonymous SNV	ENSG00000196914	rs74518328	ENSG00000196914:ENST00000356641:exon34:c.A3321G:p.L1107L,ENSG00000196914:ENST00000397843:exon35:c.A3378G:p.L1126L,ENSG00000196914:ENST00000532993:exon35:c.A3069G:p.L1023L	ARHGEF12:NM_001198665:exon34:c.A3321G:p.L1107L,ARHGEF12:NM_001301084:exon35:c.A3069G:p.L1023L,ARHGEF12:NM_015313:exon35:c.A3378G:p.L1126L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0267	0.0017	0.0515176	COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	ARHGEF12:uc009zat.3:exon34:c.A3321G:p.L1107L,ARHGEF12:uc001pxl.2:exon35:c.A3378G:p.L1126L,ARHGEF12:uc009zau.1:exon35:c.A3069G:p.L1023L,ARHGEF12:uc010rzn.1:exon35:c.A3069G:p.L1023L	.	AFR:0.0054,AMR:0.0013,EAS:0.0133,FIN:0.0457,NFE:0.0126,OTH:0.0014,ASJ:0	604763	.	.	.	~ko04270 Vascular smooth muscle contraction~ko04360 Axon guidance~ko04361 Axon regeneration~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05130 Pathogenic Escherichia coli infection~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	1(meninges)	0.0132
11	120355230	120355230	A	G	ARHGEF12	intronic	.	ENSG00000196914	rs503473	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4158	0.3649	0.344848	0.3830	.	.	.	.	.	.	.	.	.	.	AFR:0.1563,AMR:0.2661,EAS:0.6576,FIN:0.4627,NFE:0.4709,OTH:0.4143,ASJ:0.4073	604763	.	.	.	~ko04270 Vascular smooth muscle contraction~ko04360 Axon guidance~ko04361 Axon regeneration~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05130 Pathogenic Escherichia coli infection~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	MU11826461	het
11	125495737	125495737	T	C	CHEK1	exonic	nonsynonymous SNV	ENSG00000149554	rs112362212	ENSG00000149554:ENST00000427383:exon1:c.T82C:p.S28P	CHEK1:NM_001330427:exon1:c.T82C:p.S28P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0112	.	0.00519169	0.0130	0.001	2.595	0.0	-2.56	0.000	.	.	Protein kinase domain	CHEK1:uc010sbh.2:exon1:c.T82C:p.S28P	-1.065	AFR:0.0027,AMR:0.0060,EAS:0,FIN:0.0180,NFE:0.0194,OTH:0.0143,ASJ:0.0166	603078	.	.	.	~ko04110 Cell cycle~ko04111 Cell cycle - yeast~ko04113 Meiosis - yeast~ko04115 p53 signaling pathway~ko04218 Cellular senescence~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	0.191	-0.46	0.077	.	11	.	het
11	125525195	125525195	A	G	CHEK1	exonic	nonsynonymous SNV	ENSG00000149554	rs506504	ENSG00000149554:ENST00000278916:exon11:c.A1279G:p.I427V,ENSG00000149554:ENST00000427383:exon12:c.A1459G:p.I487V,ENSG00000149554:ENST00000524737:exon12:c.A1411G:p.I471V,ENSG00000149554:ENST00000544373:exon12:c.A1309G:p.I437V,ENSG00000149554:ENST00000428830:exon13:c.A1411G:p.I471V,ENSG00000149554:ENST00000438015:exon13:c.A1411G:p.I471V,ENSG00000149554:ENST00000534070:exon13:c.A1411G:p.I471V	CHEK1:NM_001244846:exon12:c.A1309G:p.I437V,CHEK1:NM_001330427:exon12:c.A1459G:p.I487V,CHEK1:NM_001330428:exon12:c.A1129G:p.I377V,CHEK1:NM_001114121:exon13:c.A1411G:p.I471V,CHEK1:NM_001114122:exon13:c.A1411G:p.I471V,CHEK1:NM_001274:exon13:c.A1411G:p.I471V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9726	0.9738	0.985823	0.9774	-0.257	0.830	1.0	1.8	0.993	.	.	.	CHEK1:uc010sbh.2:exon12:c.A1459G:p.I487V,CHEK1:uc010sbi.2:exon12:c.A1309G:p.I437V,CHEK1:uc001qcf.4:exon13:c.A1411G:p.I471V,CHEK1:uc001qcg.4:exon13:c.A1411G:p.I471V,CHEK1:uc009zbo.3:exon13:c.A1411G:p.I471V,CHEK1:uc009zbp.3:exon13:c.A1411G:p.I471V	-0.951	AFR:0.9928,AMR:0.9761,EAS:1,FIN:0.9694,NFE:0.9683,OTH:0.9776,ASJ:0.9603	603078	.	.	.	~ko04110 Cell cycle~ko04111 Cell cycle - yeast~ko04113 Meiosis - yeast~ko04115 p53 signaling pathway~ko04218 Cellular senescence~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	0.0	-0.5	0.000	-1.155	11	MU81914120	hom
11	125830970	125830970	A	T	CDON	exonic	nonsynonymous SNV	ENSG00000064309	rs684535	ENSG00000064309:ENST00000531738:exon11:c.T1793A:p.I598N,ENSG00000064309:ENST00000263577:exon20:c.T3662A:p.I1221N,ENSG00000064309:ENST00000392693:exon20:c.T3731A:p.I1244N	CDON:NM_001243597:exon20:c.T3731A:p.I1244N,CDON:NM_016952:exon20:c.T3662A:p.I1221N	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7310	0.73	.	COCA-CN|5|321|0.0155763	-0.119	1.592	1.0	4.34	0.018	.	.	.	CDON:uc001qdb.4:exon11:c.T1793A:p.I598N,CDON:uc001qdc.4:exon20:c.T3662A:p.I1221N,CDON:uc009zbw.3:exon20:c.T3731A:p.I1244N	-0.950	AFR:0.7411,AMR:0.8439,EAS:0.7318,FIN:0.9321,NFE:0.6754,OTH:0.6769,ASJ:0.7792	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	0.0	-0.03	0.000	-2.05	11	1(salivary_gland)	0.6939
11	125831701	125831701	G	A	CDON	exonic	synonymous SNV	ENSG00000064309	rs2276061	ENSG00000064309:ENST00000531738:exon10:c.C1680T:p.V560V,ENSG00000064309:ENST00000263577:exon19:c.C3549T:p.V1183V,ENSG00000064309:ENST00000392693:exon19:c.C3549T:p.V1183V	CDON:NM_001243597:exon19:c.C3549T:p.V1183V,CDON:NM_016952:exon19:c.C3549T:p.V1183V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2906	0.2531	0.242212	LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	CDON:uc001qdb.4:exon10:c.C1680T:p.V560V,CDON:uc001qdc.4:exon19:c.C3549T:p.V1183V,CDON:uc009zbw.3:exon19:c.C3549T:p.V1183V	.	AFR:0.2547,AMR:0.1235,EAS:0.2980,FIN:0.2954,NFE:0.3078,OTH:0.3128,ASJ:0.2554	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	.	.	.	.	11	1(lung)	0.2627
11	125848261	125848261	C	T	CDON	exonic	synonymous SNV	ENSG00000064309	rs3740904	ENSG00000064309:ENST00000531738:exon9:c.G1425A:p.T475T,ENSG00000064309:ENST00000263577:exon18:c.G3294A:p.T1098T,ENSG00000064309:ENST00000392693:exon18:c.G3294A:p.T1098T	CDON:NM_001243597:exon18:c.G3294A:p.T1098T,CDON:NM_016952:exon18:c.G3294A:p.T1098T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4143	0.3565	0.399561	1(large_intestine)	.	.	.	.	.	.	.	.	CDON:uc001qdb.4:exon9:c.G1425A:p.T475T,CDON:uc001qdc.4:exon18:c.G3294A:p.T1098T,CDON:uc009zbw.3:exon18:c.G3294A:p.T1098T	.	AFR:MU77425,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,BRCA-KR|1|50|0.02,EAS:0.3498,FIN:0.4415,NFE:0.3467,OTH:0.3958,ASJ:0.3650	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	.	.	.	.	11	1(lung)	0.4055
11	125871735	125871735	C	T	CDON	exonic	synonymous SNV	ENSG00000064309	rs516664	ENSG00000064309:ENST00000531738:exon2:c.G168A:p.A56A,ENSG00000064309:ENST00000263577:exon11:c.G2037A:p.A679A,ENSG00000064309:ENST00000392693:exon11:c.G2037A:p.A679A	CDON:NM_001243597:exon11:c.G2037A:p.A679A,CDON:NM_016952:exon11:c.G2037A:p.A679A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3127	0.3454	0.302516	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	CDON:uc001qdb.4:exon2:c.G168A:p.A56A,CDON:uc001qdc.4:exon11:c.G2037A:p.A679A,CDON:uc009zbw.3:exon11:c.G2037A:p.A679A	.	AFR:0.3286,AMR:0.3686,EAS:0.3675,FIN:0.1795,NFE:0.3486,OTH:0.3148,ASJ:0.3469	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	.	.	.	.	11	1(stomach)	0.3292
11	125891269	125891269	C	T	CDON	exonic	nonsynonymous SNV	ENSG00000064309	rs3740912	ENSG00000064309:ENST00000263577:exon3:c.G223A:p.V75I,ENSG00000064309:ENST00000392693:exon3:c.G223A:p.V75I,ENSG00000064309:ENST00000527967:exon3:c.G223A:p.V75I,ENSG00000064309:ENST00000531586:exon3:c.G223A:p.V75I,ENSG00000064309:ENST00000534818:exon3:c.G223A:p.V75I	CDON:NM_001243597:exon3:c.G223A:p.V75I,CDON:NM_016952:exon3:c.G223A:p.V75I	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5573	0.6452	0.572284	0.6357	-0.550	0.165	0.792	1.84	0.002	.	.	Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	CDON:uc001qdc.4:exon3:c.G223A:p.V75I,CDON:uc009zbw.3:exon3:c.G223A:p.V75I,CDON:uc009zbx.3:exon3:c.G223A:p.V75I	-0.960	AFR:0.8210,AMR:0.5538,EAS:0.3190,FIN:0.6323,NFE:0.5715,OTH:0.5784,ASJ:0.6093	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	0.0	1.08	0.000	0.645	11	MU582469	het
11	128333503	128333503	T	C	ETS1	exonic	synonymous SNV	ENSG00000134954	rs2230004	ENSG00000134954:ENST00000535549:exon3:c.A363G:p.L121L,ENSG00000134954:ENST00000345075:exon6:c.A750G:p.L250L,ENSG00000134954:ENST00000526145:exon6:c.A750G:p.L250L,ENSG00000134954:ENST00000319397:exon7:c.A1011G:p.L337L,ENSG00000134954:ENST00000392668:exon9:c.A1143G:p.L381L	ETS1:NM_001162422:exon3:c.A363G:p.L121L,ETS1:NM_001330451:exon6:c.A750G:p.L250L,ETS1:NM_005238:exon7:c.A1011G:p.L337L,ETS1:NM_001143820:exon9:c.A1143G:p.L381L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4668	0.4712	0.479633	0.4959	.	.	.	.	.	.	.	.	ETS1:uc009zch.2:exon3:c.A363G:p.L121L,ETS1:uc010sbs.1:exon7:c.A1011G:p.L337L,ETS1:uc001qej.2:exon9:c.A1143G:p.L381L	.	AFR:0.4745,AMR:0.3385,EAS:0.5700,FIN:0.5507,NFE:0.4991,OTH:0.4898,ASJ:0.38	164720	.	.	.	~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04218 Cellular senescence~ko04320 Dorso-ventral axis formation~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	11	MU20946672	het
11	128355977	128355977	C	T	ETS1	exonic	synonymous SNV	ENSG00000134954	rs149636924	ENSG00000134954:ENST00000319397:exon4:c.G468A:p.S156S,ENSG00000134954:ENST00000345075:exon4:c.G468A:p.S156S,ENSG00000134954:ENST00000526145:exon4:c.G468A:p.S156S,ENSG00000134954:ENST00000531611:exon4:c.G468A:p.S156S,ENSG00000134954:ENST00000392668:exon6:c.G600A:p.S200S	ETS1:NM_001330451:exon4:c.G468A:p.S156S,ETS1:NM_005238:exon4:c.G468A:p.S156S,ETS1:NM_001143820:exon6:c.G600A:p.S200S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0051	0.0005	0.0061901	0.0005	.	.	.	.	.	.	.	.	ETS1:uc009zcg.2:exon4:c.G468A:p.S156S,ETS1:uc010sbs.1:exon4:c.G468A:p.S156S,ETS1:uc001qej.2:exon6:c.G600A:p.S200S	.	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0.0007,OTH:0.0010,ASJ:0.0132	164720	.	.	.	~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04218 Cellular senescence~ko04320 Dorso-ventral axis formation~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	11	.	het
11	128781339	128781339	T	C	KCNJ5	exonic	synonymous SNV	ENSG00000120457	rs6590357	ENSG00000120457:ENST00000533599:exon1:c.T171C:p.S57S,ENSG00000120457:ENST00000529694:exon2:c.T171C:p.S57S,ENSG00000120457:ENST00000338350:exon3:c.T171C:p.S57S	KCNJ5:NM_000890:exon2:c.T171C:p.S57S,KCNJ5:NM_001354169:exon3:c.T171C:p.S57S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8436	0.8483	0.869808	0.8476	.	.	.	.	.	.	.	.	KCNJ5:uc001qew.3:exon1:c.T171C:p.S57S,KCNJ5:uc001qet.3:exon2:c.T171C:p.S57S,KCNJ5:uc009zck.3:exon3:c.T171C:p.S57S	.	AFR:0.9048,AMR:0.8162,EAS:0.8915,FIN:0.7991,NFE:0.8249,OTH:0.8218,ASJ:0.8179	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	MU19381753	hom
11	128781978	128781978	T	G	KCNJ5	exonic	synonymous SNV	ENSG00000120457	rs7118824	ENSG00000120457:ENST00000533599:exon1:c.T810G:p.L270L,ENSG00000120457:ENST00000529694:exon2:c.T810G:p.L270L,ENSG00000120457:ENST00000338350:exon3:c.T810G:p.L270L	KCNJ5:NM_000890:exon2:c.T810G:p.L270L,KCNJ5:NM_001354169:exon3:c.T810G:p.L270L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8414	0.8427	0.866214	0.8424	.	.	.	.	.	.	.	.	KCNJ5:uc001qew.3:exon1:c.T810G:p.L270L,KCNJ5:uc001qet.3:exon2:c.T810G:p.L270L,KCNJ5:uc009zck.3:exon3:c.T810G:p.L270L	.	AFR:0.8930,AMR:0.8150,EAS:0.8912,FIN:0.7990,NFE:0.8212,OTH:0.8203,ASJ:0.8167	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	MU19381815	unknown
11	128782002	128782002	T	C	KCNJ5	exonic	synonymous SNV	ENSG00000120457	rs7118833	ENSG00000120457:ENST00000533599:exon1:c.T834C:p.H278H,ENSG00000120457:ENST00000529694:exon2:c.T834C:p.H278H,ENSG00000120457:ENST00000338350:exon3:c.T834C:p.H278H	KCNJ5:NM_000890:exon2:c.T834C:p.H278H,KCNJ5:NM_001354169:exon3:c.T834C:p.H278H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8416	0.8440	0.867013	0.8435	.	.	.	.	.	.	.	.	KCNJ5:uc001qew.3:exon1:c.T834C:p.H278H,KCNJ5:uc001qet.3:exon2:c.T834C:p.H278H,KCNJ5:uc009zck.3:exon3:c.T834C:p.H278H	.	AFR:0.8970,AMR:0.8182,EAS:0.8912,FIN:0.7991,NFE:0.8211,OTH:0.8193,ASJ:0.8167	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	MU16066762	unknown
11	128782012	128782012	C	G	KCNJ5	exonic	nonsynonymous SNV	ENSG00000120457	rs7102584	ENSG00000120457:ENST00000533599:exon1:c.C844G:p.Q282E,ENSG00000120457:ENST00000529694:exon2:c.C844G:p.Q282E,ENSG00000120457:ENST00000338350:exon3:c.C844G:p.Q282E	KCNJ5:NM_000890:exon2:c.C844G:p.Q282E,KCNJ5:NM_001354169:exon3:c.C844G:p.Q282E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9865	0.9871	0.995008	0.9849	0.157	4.219	1.0	5.46	0.990	.	.	Immunoglobulin E-set|Potassium channel, inwardly rectifying, Kir, cytoplasmic	KCNJ5:uc001qew.3:exon1:c.C844G:p.Q282E,KCNJ5:uc001qet.3:exon2:c.C844G:p.Q282E,KCNJ5:uc009zck.3:exon3:c.C844G:p.Q282E	-0.907	AFR:0.9984,AMR:0.9940,EAS:1,FIN:0.9728,NFE:0.9776,OTH:0.9805,ASJ:1	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	0.0	-2.58	0.000	-1.455	11	MU194151	unknown
11	128786294	128786294	G	A	KCNJ5	intronic	.	ENSG00000120457	rs4937391	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7346	0.7478	0.735823	0.7394	.	.	.	.	.	0	0.002	.	.	.	AFR:0.7966,AMR:0.7022,EAS:0.6720,FIN:0.6878,NFE:0.7287,OTH:0.7274,ASJ:0.7219	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	MU17126561	hom
12	406292	406292	G	A	KDM5A	exonic	synonymous SNV	ENSG00000073614	rs2229351	ENSG00000073614:ENST00000382815:exon25:c.C4149T:p.S1383S,ENSG00000073614:ENST00000399788:exon25:c.C4149T:p.S1383S	KDM5A:NM_001042603:exon25:c.C4149T:p.S1383S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3104	0.2732	0.352636	0.3029	.	.	.	.	.	.	.	.	KDM5A:uc001qif.1:exon25:c.C4149T:p.S1383S	.	AFR:0.3108,AMR:0.3413,EAS:0.5175,FIN:0.3369,NFE:0.2666,OTH:0.2918,ASJ:0.2715	180202	.	.	.	.	.	.	.	.	.	.	.	12	MU19386993	het
12	419036	419036	T	C	KDM5A	exonic	nonsynonymous SNV	ENSG00000073614	rs201344078	ENSG00000073614:ENST00000382815:exon22:c.A3311G:p.D1104G,ENSG00000073614:ENST00000399788:exon22:c.A3311G:p.D1104G	KDM5A:NM_001042603:exon22:c.A3311G:p.D1104G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0017	0.0002	0.00259585	0.0001	2.577	19.96	0.192	5.92	0.995	.	.	.	KDM5A:uc010sdn.1:exon21:c.A3188G:p.D1063G,KDM5A:uc001qif.1:exon22:c.A3311G:p.D1104G	-0.378	AFR:0,AMR:0.0012,EAS:0,FIN:0,NFE:0.0002,OTH:0,ASJ:0	180202	.	.	.	.	.	.	.	0.0	-1.92	0.444	0.255	12	.	het
12	427575	427575	A	G	KDM5A	exonic	nonsynonymous SNV	ENSG00000073614	rs11062385	ENSG00000073614:ENST00000544760:exon10:c.T1451C:p.M484T,ENSG00000073614:ENST00000382815:exon19:c.T2594C:p.M865T,ENSG00000073614:ENST00000399788:exon19:c.T2594C:p.M865T	KDM5A:NM_001042603:exon19:c.T2594C:p.M865T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3102	0.2734	0.353035	0.3030	1.007	10.70	0.496	3.99	1.000	.	.	Lysine-specific demethylase-like domain	KDM5A:uc010sdn.1:exon18:c.T2471C:p.M824T,KDM5A:uc001qif.1:exon19:c.T2594C:p.M865T	-0.915	AFR:0.3112,AMR:0.3413,EAS:0.5167,FIN:0.3379,NFE:0.2661,OTH:0.2930,ASJ:0.2748	180202	.	.	.	.	.	.	.	0.0	1.05	0.000	0.695	12	MU19387110	het
12	498269	498269	G	-	KDM5A	UTR5	.	ENSG00000073614	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	180202	.	.	.	.	.	.	.	.	.	.	.	12	.	unknown
12	862989	862989	T	C	WNK1	exonic	synonymous SNV	ENSG00000060237	rs3168640	ENSG00000060237:ENST00000315939:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000447667:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000530271:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000535572:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000537687:exon1:c.T258C:p.C86C	WNK1:NM_001184985:exon1:c.T258C:p.C86C,WNK1:NM_014823:exon1:c.T258C:p.C86C,WNK1:NM_018979:exon1:c.T258C:p.C86C,WNK1:NM_213655:exon1:c.T258C:p.C86C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9924	0.9724	0.975639	0.9784	.	.	.	.	.	.	.	.	WNK1:uc001qin.3:exon1:c.T258C:p.C86C,WNK1:uc001qio.4:exon1:c.T258C:p.C86C,WNK1:uc001qip.4:exon1:c.T258C:p.C86C,WNK1:uc021qss.1:exon1:c.T258C:p.C86C,WNK1:uc021qst.1:exon1:c.T258C:p.C86C,WNK1:uc031qfk.1:exon1:c.T258C:p.C86C	.	AFR:0.9240,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:0.9949,ASJ:1	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	MU81915326	hom
12	863505	863505	A	C	WNK1	intronic	.	ENSG00000060237	rs11064518	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0383	.	0.0539137	0.0496	.	.	.	.	.	.	.	.	.	.	AFR:0.1169,AMR:0.1316,EAS:0,FIN:0.0180,NFE:0.0193,OTH:0.0419,ASJ:0.0364	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	.	het
12	939302	939302	A	G	WNK1	exonic	synonymous SNV	ENSG00000060237	rs10774466	ENSG00000060237:ENST00000315939:exon4:c.A1287G:p.A429A,ENSG00000060237:ENST00000530271:exon4:c.A1287G:p.A429A,ENSG00000060237:ENST00000535572:exon4:c.A1287G:p.A429A,ENSG00000060237:ENST00000537687:exon4:c.A1287G:p.A429A	WNK1:NM_001184985:exon4:c.A1287G:p.A429A,WNK1:NM_014823:exon4:c.A1287G:p.A429A,WNK1:NM_018979:exon4:c.A1287G:p.A429A,WNK1:NM_213655:exon4:c.A1287G:p.A429A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7451	0.6855	0.69349	0.7201	.	.	.	.	.	.	.	.	WNK1:uc001qio.4:exon4:c.A1287G:p.A429A,WNK1:uc001qip.4:exon4:c.A1287G:p.A429A,WNK1:uc021qss.1:exon4:c.A1287G:p.A429A,WNK1:uc021qst.1:exon4:c.A1287G:p.A429A,WNK1:uc031qfk.1:exon4:c.A1287G:p.A429A	.	AFR:0.5713,AMR:0.7757,EAS:0.8843,FIN:0.8041,NFE:0.7632,OTH:0.7796,ASJ:0.6689	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	MU147437	hom
12	974308	974308	-	C	WNK1	exonic	frameshift insertion	ENSG00000060237	rs141823469	ENSG00000060237:ENST00000530271:exon9:c.2173dupC:p.V724fs	WNK1:NM_213655:exon9:c.2173dupC:p.V724fs	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3039	.	.	0.2503	.	.	.	.	.	.	.	.	WNK1:uc021qst.1:exon9:c.2173dupC:p.V724fs	.	AFR:0.2256,AMR:0.1802,EAS:0.0967,FIN:0.2499,NFE:0.2823,OTH:0.2531,ASJ:0.3907	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	.	het
12	974404	974404	T	C	WNK1	exonic	synonymous SNV	ENSG00000060237	rs7300829	ENSG00000060237:ENST00000530271:exon9:c.T2268C:p.P756P	WNK1:NM_213655:exon9:c.T2268C:p.P756P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6031	.	0.653954	LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	WNK1:uc021qst.1:exon9:c.T2268C:p.P756P	.	AFR:0.6457,AMR:0.7034,EAS:0.5596,FIN:0.5876,NFE:0.6814,OTH:0.6158,ASJ:0.5871	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	3(haematopoietic_and_lymphoid_tissue)	0.6350
12	987482	987482	G	A	WNK1	exonic	synonymous SNV	ENSG00000060237	rs1012729	ENSG00000060237:ENST00000535698:exon2:c.G138A:p.Q46Q,ENSG00000060237:ENST00000340908:exon7:c.G1107A:p.Q369Q,ENSG00000060237:ENST00000315939:exon10:c.G2328A:p.Q776Q,ENSG00000060237:ENST00000535572:exon10:c.G2325A:p.Q775Q,ENSG00000060237:ENST00000537687:exon11:c.G3567A:p.Q1189Q,ENSG00000060237:ENST00000530271:exon12:c.G3822A:p.Q1274Q	WNK1:NM_014823:exon10:c.G2325A:p.Q775Q,WNK1:NM_018979:exon10:c.G2328A:p.Q776Q,WNK1:NM_001184985:exon11:c.G3567A:p.Q1189Q,WNK1:NM_213655:exon12:c.G3822A:p.Q1274Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7340	0.6795	0.679513	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	WNK1:uc001qir.4:exon3:c.G585A:p.Q195Q,WNK1:uc001qio.4:exon10:c.G2328A:p.Q776Q,WNK1:uc001qip.4:exon10:c.G2325A:p.Q775Q,WNK1:uc021qss.1:exon11:c.G3567A:p.Q1189Q,WNK1:uc031qfk.1:exon11:c.G3567A:p.Q1189Q,WNK1:uc021qst.1:exon12:c.G3822A:p.Q1274Q	.	AFR:0.7141,AMR:0.5771,EAS:0.6433,FIN:0.8181,NFE:0.8038,OTH:0.7559,ASJ:0.7715	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	1(large_intestine)	0.7740
12	987533	987533	-	T	WNK1	intronic	.	ENSG00000060237	rs398116010	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.4607	.	0.442093	0.6757	.	.	.	.	.	.	.	.	.	.	AFR:0.5438,AMR:0.6859,EAS:0.8054,FIN:0.6491,NFE:0.7405,OTH:0.7359,ASJ:0.6194	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	.	het
12	988894	988894	G	A	WNK1	exonic	synonymous SNV	ENSG00000060237	rs9804992	ENSG00000060237:ENST00000535698:exon3:c.G339A:p.Q113Q,ENSG00000060237:ENST00000340908:exon8:c.G1308A:p.Q436Q,ENSG00000060237:ENST00000315939:exon11:c.G2529A:p.Q843Q,ENSG00000060237:ENST00000530271:exon13:c.G4023A:p.Q1341Q	WNK1:NM_018979:exon11:c.G2529A:p.Q843Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1542	0.1478	0.145767	1(large_intestine)	.	.	.	.	.	.	.	.	WNK1:uc001qio.4:exon11:c.G2529A:p.Q843Q,WNK1:uc031qfk.1:exon12:c.G3768A:p.Q1256Q	.	AFR:MU100931,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,EAS:0.1256,FIN:0.2117,NFE:0.1333,OTH:0.0776,ASJ:0.1407	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	2(haematopoietic_and_lymphoid_tissue)	0.1065
12	990912	990912	A	C	WNK1	exonic	nonsynonymous SNV	ENSG00000060237	rs956868	ENSG00000060237:ENST00000340908:exon10:c.A1945C:p.T649P,ENSG00000060237:ENST00000535572:exon11:c.A2425C:p.T809P,ENSG00000060237:ENST00000315939:exon13:c.A3166C:p.T1056P,ENSG00000060237:ENST00000537687:exon13:c.A3946C:p.T1316P,ENSG00000060237:ENST00000530271:exon15:c.A4660C:p.T1554P	WNK1:NM_014823:exon11:c.A2425C:p.T809P,WNK1:NM_001184985:exon13:c.A3946C:p.T1316P,WNK1:NM_018979:exon13:c.A3166C:p.T1056P,WNK1:NM_213655:exon13:c.A3922C:p.T1308P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8314	0.8526	0.852835	0.8317	-0.728	0.062	1.0	0.635	0.064	.	.	.	WNK1:uc001qir.4:exon4:c.A685C:p.T229P,WNK1:uc001qip.4:exon11:c.A2425C:p.T809P,WNK1:uc001qio.4:exon13:c.A3166C:p.T1056P,WNK1:uc021qss.1:exon13:c.A3946C:p.T1316P,WNK1:uc021qst.1:exon13:c.A3922C:p.T1308P,WNK1:uc031qfk.1:exon14:c.A4405C:p.T1469P	-1.004	AFR:0.8503,AMR:0.8783,EAS:0.8021,FIN:0.7460,NFE:0.8424,OTH:0.8194,ASJ:0.8212	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	0.0	2.86	0.000	-1.445	12	MU777778	hom
12	994487	994487	G	C	WNK1	exonic	nonsynonymous SNV	ENSG00000060237	rs7955371	ENSG00000060237:ENST00000340908:exon16:c.G3296C:p.C1099S,ENSG00000060237:ENST00000535572:exon17:c.G3776C:p.C1259S,ENSG00000060237:ENST00000315939:exon19:c.G4517C:p.C1506S,ENSG00000060237:ENST00000537687:exon19:c.G5297C:p.C1766S,ENSG00000060237:ENST00000530271:exon21:c.G6011C:p.C2004S	WNK1:NM_014823:exon17:c.G3776C:p.C1259S,WNK1:NM_001184985:exon19:c.G5297C:p.C1766S,WNK1:NM_018979:exon19:c.G4517C:p.C1506S,WNK1:NM_213655:exon19:c.G5273C:p.C1758S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9963	0.9861	0.986821	0.9877	-1.695	0.002	1.0	5.3	0.235	.	.	.	WNK1:uc001qir.4:exon10:c.G2036C:p.C679S,WNK1:uc001qip.4:exon17:c.G3776C:p.C1259S,WNK1:uc001qio.4:exon19:c.G4517C:p.C1506S,WNK1:uc021qss.1:exon19:c.G5297C:p.C1766S,WNK1:uc021qst.1:exon19:c.G5273C:p.C1758S,WNK1:uc031qfk.1:exon20:c.G5756C:p.C1919S	-0.954	AFR:0.9570,AMR:0.9964,EAS:1,FIN:1,NFE:0.9998,OTH:0.9990,ASJ:1	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	0.0	-0.2	0.000	-1.79	12	MU81915388	hom
12	998365	998365	G	T	WNK1	exonic	nonsynonymous SNV	ENSG00000060237	rs12828016	ENSG00000060237:ENST00000340908:exon18:c.G4203T:p.M1401I,ENSG00000060237:ENST00000535572:exon19:c.G4683T:p.M1561I,ENSG00000060237:ENST00000315939:exon21:c.G5424T:p.M1808I,ENSG00000060237:ENST00000537687:exon21:c.G6204T:p.M2068I,ENSG00000060237:ENST00000530271:exon23:c.G6918T:p.M2306I	WNK1:NM_014823:exon19:c.G4683T:p.M1561I,WNK1:NM_001184985:exon21:c.G6204T:p.M2068I,WNK1:NM_018979:exon21:c.G5424T:p.M1808I,WNK1:NM_213655:exon21:c.G6180T:p.M2060I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3766	0.4314	0.417532	1(large_intestine)	1.329	12.42	0.207	2.16	0.311	.	.	.	WNK1:uc001qir.4:exon12:c.G2943T:p.M981I,WNK1:uc001qip.4:exon19:c.G4683T:p.M1561I,WNK1:uc001qio.4:exon21:c.G5424T:p.M1808I,WNK1:uc021qss.1:exon21:c.G6204T:p.M2068I,WNK1:uc021qst.1:exon21:c.G6180T:p.M2060I,WNK1:uc031qfk.1:exon22:c.G6663T:p.M2221I	-0.925	AFR:MU131371,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.4944,FIN:0.2978,NFE:0.3967,OTH:0.2581,ASJ:0.3909	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	0.0	1.71	0.000	-0.69	12	59(lung)	0.2836
12	1017197	1017197	C	T	WNK1	exonic	synonymous SNV	ENSG00000060237	rs4766334	ENSG00000060237:ENST00000340908:exon24:c.C5607T:p.Y1869Y,ENSG00000060237:ENST00000535572:exon25:c.C6084T:p.Y2028Y,ENSG00000060237:ENST00000315939:exon27:c.C6828T:p.Y2276Y,ENSG00000060237:ENST00000537687:exon27:c.C7608T:p.Y2536Y,ENSG00000060237:ENST00000530271:exon29:c.C8322T:p.Y2774Y	WNK1:NM_014823:exon25:c.C6084T:p.Y2028Y,WNK1:NM_001184985:exon27:c.C7608T:p.Y2536Y,WNK1:NM_018979:exon27:c.C6828T:p.Y2276Y,WNK1:NM_213655:exon27:c.C7584T:p.Y2528Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9964	0.9862	0.987021	0.9884	.	.	.	.	.	.	.	.	WNK1:uc001qir.4:exon18:c.C4347T:p.Y1449Y,WNK1:uc001qip.4:exon25:c.C6084T:p.Y2028Y,WNK1:uc001qio.4:exon27:c.C6828T:p.Y2276Y,WNK1:uc021qss.1:exon27:c.C7608T:p.Y2536Y,WNK1:uc021qst.1:exon27:c.C7584T:p.Y2528Y,WNK1:uc031qfk.1:exon30:c.C8181T:p.Y2727Y	.	AFR:0.9597,AMR:0.9952,EAS:1,FIN:1,NFE:0.9998,OTH:0.9990,ASJ:1	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	MU4552882	hom
12	1022569	1022569	A	C	RAD52	exonic	stopgain	ENSG00000002016	rs4987208	ENSG00000002016:ENST00000539046:exon10:c.T1014G:p.Y338X,ENSG00000002016:ENST00000358495:exon12:c.T1245G:p.Y415X,ENSG00000002016:ENST00000430095:exon12:c.T1245G:p.Y415X	RAD52:NM_001297421:exon10:c.T1014G:p.Y338X,RAD52:NM_001297419:exon12:c.T1245G:p.Y415X,RAD52:NM_134424:exon12:c.T1245G:p.Y415X	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0294	0.0148	0.0221645	0.0172	7.812	35	.	1.8	0.843	.	.	.	RAD52:uc010sdt.1:exon10:c.T1014G:p.Y338X,RAD52:uc031qfl.1:exon11:c.T612G:p.Y204X,RAD52:uc001qis.1:exon12:c.T1245G:p.Y415X,RAD52:uc001qiu.1:exon12:c.T1245G:p.Y415X,RAD52:uc001qit.2:exon14:c.T612G:p.Y204X	.	AFR:0.0032,AMR:0.1289,EAS:0,FIN:0.0180,NFE:0.0187,OTH:0.0356,ASJ:0.0596	600392	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	1035947	1035947	C	A	RAD52	intronic	.	ENSG00000002016	rs6489763	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9969	0.9937	0.992812	0.9935	.	.	.	.	.	.	.	.	.	.	AFR:0.9773,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	600392	.	.	.	.	.	.	.	.	.	.	.	12	MU81915469	hom
12	1040373	1040373	T	C	RAD52	intronic	.	ENSG00000002016	rs7303748	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5490	0.5512	0.544928	LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.5323,AMR:0.5221,EAS:0.6126,FIN:0.4588,NFE:0.5437,OTH:0.5467,ASJ:0.4185	600392	.	.	.	.	.	.	.	.	.	.	.	12	1(haematopoietic_and_lymphoid_tissue)	0.5575
12	4553332	4553332	A	G	FGF6	exonic	synonymous SNV	ENSG00000111241	rs2241280	ENSG00000111241:ENST00000543077:exon1:c.T54C:p.V18V,ENSG00000111241:ENST00000228837:exon2:c.T417C:p.V139V	FGF6:NM_020996:exon2:c.T417C:p.V139V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4245	0.4533	0.472244	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|4|205|0.0195122,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	FGF6:uc001qmr.1:exon2:c.T417C:p.V139V	.	AFR:0.4362,AMR:0.5645,EAS:0.2967,FIN:0.4356,NFE:0.4028,OTH:0.3793,ASJ:0.3489	134921	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	12	2(haematopoietic_and_lymphoid_tissue)	0.4012
12	4553383	4553383	A	G	FGF6	exonic	synonymous SNV	ENSG00000111241	rs2241279	ENSG00000111241:ENST00000543077:exon1:c.T3C:p.T1T,ENSG00000111241:ENST00000228837:exon2:c.T366C:p.T122T	FGF6:NM_020996:exon2:c.T366C:p.T122T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4265	0.4612	0.479633	1(lung)	.	.	.	.	.	.	.	.	FGF6:uc001qmr.1:exon2:c.T366C:p.T122T	.	AFR:MU153822,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02,EAS:0.5890,FIN:0.3505,NFE:0.3013,OTH:0.4338,ASJ:0.4430	134921	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	12	1(large_intestine)	0.4028
12	4554548	4554548	G	C	FGF6	exonic	synonymous SNV	ENSG00000111241	rs7358740	ENSG00000111241:ENST00000228837:exon1:c.C189G:p.A63A	FGF6:NM_020996:exon1:c.C189G:p.A63A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9721	0.9056	0.903155	0.9177	.	.	.	.	.	.	.	.	FGF6:uc001qmr.1:exon1:c.C189G:p.A63A	.	AFR:0.7134,AMR:0.9821,EAS:1,FIN:1,NFE:0.9993,OTH:0.9764,ASJ:0.9967	134921	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	12	MU4555769	hom
12	6711147	6711147	C	A	CHD4	exonic	nonsynonymous SNV	ENSG00000111642	rs1639122	ENSG00000111642:ENST00000309577:exon4:c.G417T:p.E139D,ENSG00000111642:ENST00000357008:exon4:c.G417T:p.E139D,ENSG00000111642:ENST00000544040:exon4:c.G396T:p.E132D,ENSG00000111642:ENST00000544484:exon4:c.G408T:p.E136D,ENSG00000111642:ENST00000545942:exon4:c.G417T:p.E139D	CHD4:NM_001297553:exon3:c.G396T:p.E132D,CHD4:NM_001273:exon4:c.G417T:p.E139D,CHD4:NM_001363606:exon4:c.G417T:p.E139D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4118	0.5487	0.553115	4(haematopoietic_and_lymphoid_tissue)	-2.517	0.001	1.0	-8.15	0.143	.	.	.	CHD4:uc001qpn.3:exon3:c.G396T:p.E132D,CHD4:uc001qpo.3:exon4:c.G417T:p.E139D,CHD4:uc001qpp.3:exon4:c.G408T:p.E136D	-0.910	AFR:1(skin),AMR:3(large_intestine),EAS:MU79283,FIN:LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,GACA-JP|1|585|0.0017094,NFE:0.5568,OTH:0.8376,ASJ:1(pancreas)	603277	.	.	.	~ko05165 Human papillomavirus infection~ko05203 Viral carcinogenesis ~	.	.	.	0.0	-2.64	0.000	-0.37	12	2(prostate)	0.4015
12	7065576	7065576	G	A	PTPN6	intronic	.	ENSG00000111679	rs2110071	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9141	0.7978	0.816094	0.8137	.	.	.	.	.	0	0.042	.	.	.	AFR:0.4921,AMR:0.9296,EAS:0.9994,FIN:0.9304,NFE:0.9366,OTH:0.9184,ASJ:0.9735	176883	.	.	.	~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05140 Leishmaniasis~ko05205 Proteoglycans in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	12	MU81917016	hom
12	7065635	7065635	T	C	PTPN6	exonic	synonymous SNV	ENSG00000111679	rs2110072	ENSG00000111679:ENST00000447931:exon8:c.T861C:p.G287G,ENSG00000111679:ENST00000318974:exon9:c.T978C:p.G326G,ENSG00000111679:ENST00000399448:exon9:c.T984C:p.G328G,ENSG00000111679:ENST00000456013:exon9:c.T978C:p.G326G	PTPN6:NM_002831:exon9:c.T978C:p.G326G,PTPN6:NM_080548:exon9:c.T984C:p.G328G,PTPN6:NM_080549:exon9:c.T978C:p.G326G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9499	0.9216	0.948682	0.9221	.	.	.	.	.	.	.	.	PTPN6:uc010sfr.1:exon8:c.T861C:p.G287G,PTPN6:uc010sfs.1:exon8:c.T942C:p.G314G,PTPN6:uc001qsa.1:exon9:c.T984C:p.G328G,PTPN6:uc001qsb.2:exon9:c.T978C:p.G326G,PTPN6:uc009zfl.1:exon9:c.T978C:p.G326G	.	AFR:0.8686,AMR:0.9606,EAS:1,FIN:0.9306,NFE:0.9383,OTH:0.9409,ASJ:0.9768	176883	.	.	.	~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05140 Leishmaniasis~ko05205 Proteoglycans in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	12	MU81917038	hom
12	11992168	11992168	G	A	ETV6	exonic	synonymous SNV	ENSG00000139083	rs11611479	ENSG00000139083:ENST00000545027:exon2:c.G174A:p.T58T,ENSG00000139083:ENST00000396373:exon3:c.G258A:p.T86T	ETV6:NM_001987:exon3:c.G258A:p.T86T	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.1519	0.1309	0.212859	MU151360	.	.	.	.	.	.	.	.	ETV6:uc001qzz.3:exon3:c.G258A:p.T86T	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,AMR:0.1394,EAS:0.1026,FIN:0.1291,NFE:0.25,OTH:0.0976,ASJ:0.1938	600618	601626;616216;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko04013 MAPK signaling pathway - fly~ko04320 Dorso-ventral axis formation~ko05202 Transcriptional misregulation in cancer ~	4828,	.	,4830,4829	.	.	.	.	12	1(haematopoietic_and_lymphoid_tissue)	0.1085
12	12301898	12301898	C	T	LRP6	exonic	nonsynonymous SNV	ENSG00000070018	rs2302685	ENSG00000070018:ENST00000261349:exon14:c.G3184A:p.V1062I,ENSG00000070018:ENST00000543091:exon14:c.G3184A:p.V1062I	LRP6:NM_002336:exon14:c.G3184A:p.V1062I	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8474	0.8400	0.885583	0.8348	2.258	17.89	1.0	5.45	1.000	.	.	Six-bladed beta-propeller, TolB-like	LRP6:uc001rah.4:exon14:c.G3184A:p.V1062I,LRP6:uc010shl.1:exon14:c.G3184A:p.V1062I	-0.936	AFR:0.8707,AMR:0.9113,EAS:0.9376,FIN:0.8148,NFE:0.8037,OTH:0.8227,ASJ:0.85	603507	610947;616724;	99798;	99798|Selective tooth agenesis|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|106600 150400 313500 604625 610926 616724 617073 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	0.0	-2.67	0.000	-2.195	12	MU25428801	hom
12	15656832	15656832	T	A	PTPRO	intronic	.	ENSG00000151490	rs4764199	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8496	0.8513	0.786342	0.8396	.	.	.	.	.	0.1606	0.498	.	.	.	AFR:0.7807,AMR:0.8198,EAS:0.6214,FIN:0.8987,NFE:0.8816,OTH:0.8668,ASJ:0.9007	600579	614196;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	12	MU12093012	hom
12	15710425	15710425	C	T	PTPRO	exonic	synonymous SNV	ENSG00000151490	rs569333096	ENSG00000151490:ENST00000442921:exon4:c.C162T:p.S54S,ENSG00000151490:ENST00000445537:exon4:c.C162T:p.S54S,ENSG00000151490:ENST00000542557:exon4:c.C162T:p.S54S,ENSG00000151490:ENST00000544244:exon4:c.C162T:p.S54S,ENSG00000151490:ENST00000281171:exon16:c.C2595T:p.S865S,ENSG00000151490:ENST00000348962:exon16:c.C2595T:p.S865S	PTPRO:NM_030668:exon4:c.C162T:p.S54S,PTPRO:NM_030669:exon4:c.C162T:p.S54S,PTPRO:NM_030670:exon4:c.C162T:p.S54S,PTPRO:NM_030671:exon4:c.C162T:p.S54S,PTPRO:NM_002848:exon16:c.C2595T:p.S865S,PTPRO:NM_030667:exon16:c.C2595T:p.S865S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	9.893e-05	.	0.000399361	.	.	.	.	.	.	.	.	.	PTPRO:uc001rcx.2:exon4:c.C162T:p.S54S,PTPRO:uc001rcy.2:exon4:c.C162T:p.S54S,PTPRO:uc001rcz.2:exon4:c.C162T:p.S54S,PTPRO:uc001rda.2:exon4:c.C162T:p.S54S,PTPRO:uc001rcv.2:exon16:c.C2595T:p.S865S,PTPRO:uc001rcw.2:exon16:c.C2595T:p.S865S	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600579	614196;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	12	.	het
12	15733669	15733669	G	A	PTPRO	exonic	synonymous SNV	ENSG00000151490	rs3748299	ENSG00000151490:ENST00000542557:exon9:c.G519A:p.G173G,ENSG00000151490:ENST00000544244:exon9:c.G519A:p.G173G,ENSG00000151490:ENST00000442921:exon10:c.G603A:p.G201G,ENSG00000151490:ENST00000445537:exon10:c.G603A:p.G201G,ENSG00000151490:ENST00000348962:exon21:c.G2952A:p.G984G,ENSG00000151490:ENST00000281171:exon22:c.G3036A:p.G1012G	PTPRO:NM_030668:exon9:c.G519A:p.G173G,PTPRO:NM_030670:exon9:c.G519A:p.G173G,PTPRO:NM_030669:exon10:c.G603A:p.G201G,PTPRO:NM_030671:exon10:c.G603A:p.G201G,PTPRO:NM_002848:exon21:c.G2952A:p.G984G,PTPRO:NM_030667:exon22:c.G3036A:p.G1012G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0988	0.0810	0.132588	0.0858	.	.	.	.	.	.	.	.	PTPRO:uc001rcz.2:exon9:c.G519A:p.G173G,PTPRO:uc001rda.2:exon9:c.G519A:p.G173G,PTPRO:uc001rcx.2:exon10:c.G603A:p.G201G,PTPRO:uc001rcy.2:exon10:c.G603A:p.G201G,PTPRO:uc001rcw.2:exon21:c.G2952A:p.G984G,PTPRO:uc001rcv.2:exon22:c.G3036A:p.G1012G	.	AFR:0.0694,AMR:0.0621,EAS:0.3139,FIN:0.0386,NFE:0.0841,OTH:0.0767,ASJ:0.0728	600579	614196;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	12	MU12093552	het
12	18435399	18435401	CCC	-	PIK3C2G	exonic	nonframeshift deletion	ENSG00000139144	rs35277916	ENSG00000139144:ENST00000266497:exon1:c.384_386del:p.128_129del,ENSG00000139144:ENST00000538779:exon1:c.384_386del:p.128_129del,ENSG00000139144:ENST00000546003:exon1:c.384_386del:p.128_129del,ENSG00000139144:ENST00000433979:exon2:c.384_386del:p.128_129del,ENSG00000139144:ENST00000535651:exon2:c.384_386del:p.128_129del	PIK3C2G:NM_001288772:exon2:c.384_386del:p.128_129del,PIK3C2G:NM_004570:exon2:c.384_386del:p.128_129del	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3732	0.3424	0.308307	0.3505	.	.	.	.	.	.	.	.	PIK3C2G:uc010sib.2:exon1:c.384_386del:p.128_129del,PIK3C2G:uc001rdt.3:exon2:c.384_386del:p.128_129del	.	AFR:0.2142,AMR:0.3759,EAS:0.2612,FIN:0.4338,NFE:0.4158,OTH:0.3887,ASJ:0.3758	609001	.	.	.	.	.	.	.	.	.	.	.	12	.	hom
12	18435452	18435452	C	T	PIK3C2G	exonic	nonsynonymous SNV	ENSG00000139144	rs11044004	ENSG00000139144:ENST00000266497:exon1:c.C437T:p.P146L,ENSG00000139144:ENST00000538779:exon1:c.C437T:p.P146L,ENSG00000139144:ENST00000546003:exon1:c.C437T:p.P146L,ENSG00000139144:ENST00000433979:exon2:c.C437T:p.P146L,ENSG00000139144:ENST00000535651:exon2:c.C437T:p.P146L	PIK3C2G:NM_001288772:exon2:c.C437T:p.P146L,PIK3C2G:NM_004570:exon2:c.C437T:p.P146L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3865	0.3859	0.353235	2(haematopoietic_and_lymphoid_tissue)	0.582	8.028	0.047	3.9	0.050	.	.	.	PIK3C2G:uc010sib.2:exon1:c.C437T:p.P146L,PIK3C2G:uc001rdt.3:exon2:c.C437T:p.P146L	-1.054	AFR:18(lung),AMR:MU718438,EAS:0.3920,FIN:0.3533,NFE:0.3858,OTH:0.3841,ASJ:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841	609001	.	.	.	.	.	.	.	0.003	1.22	0.000	1.5	12	1(large_intestine)	0.2627
12	18499777	18499777	C	G	PIK3C2G	intronic	.	ENSG00000139144	rs10770357	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	0.0002	0.032	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	609001	.	.	.	.	.	.	.	.	.	.	.	12	MU81920074	hom
12	18649057	18649057	C	T	PIK3C2G	exonic	nonsynonymous SNV	ENSG00000139144	rs12312266	ENSG00000139144:ENST00000266497:exon19:c.C2732T:p.P911L,ENSG00000139144:ENST00000433979:exon20:c.C2732T:p.P911L,ENSG00000139144:ENST00000538779:exon20:c.C2855T:p.P952L	PIK3C2G:NM_004570:exon20:c.C2732T:p.P911L,PIK3C2G:NM_001288772:exon21:c.C2855T:p.P952L,PIK3C2G:NM_001288774:exon21:c.C2189T:p.P730L	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0] 	0.3560	0.2933	0.374401	1(haematopoietic_and_lymphoid_tissue)	7.430	34	0.017	4.37	1.000	.	.	Protein kinase-like domain	PIK3C2G:uc001rdt.3:exon20:c.C2732T:p.P911L,PIK3C2G:uc010sib.2:exon20:c.C2855T:p.P952L,PIK3C2G:uc010sic.2:exon20:c.C2189T:p.P730L	-1.157	AFR:6(meninges),AMR:9(lung),EAS:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,THCA-SA|1|243|0.00411523,FIN:0.2980,NFE:0.4763,OTH:0.3210,ASJ:MU130618	609001	.	.	.	.	.	.	.	1.0	-1.55	0.000	3.08	12	1(large_intestine)	0.2384
12	18868668	18868668	G	C	PLCZ1	intronic	.	ENSG00000255648	rs11044266	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.264577	0.1957	.	.	.	.	.	.	.	.	.	.	AFR:0.1969,AMR:0.2852,EAS:0.3985,FIN:0.1641,NFE:0.1732,OTH:0.1878,ASJ:0.3278	608075	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	21011480	21011480	T	G	SLCO1B3;SLCO1B3-SLCO1B7	exonic	nonsynonymous SNV	ENSG00000111700;ENSG00000205754;ENSG00000257046	rs4149117	ENSG00000257046:ENST00000381541:exon3:c.T334G:p.S112A,ENSG00000257046:ENST00000540229:exon3:c.T334G:p.S112A,ENSG00000111700:ENST00000553473:exon3:c.T334G:p.S112A,ENSG00000205754:ENST00000554957:exon3:c.T334G:p.S112A,ENSG00000111700:ENST00000261196:exon4:c.T334G:p.S112A,ENSG00000111700:ENST00000540853:exon4:c.T334G:p.S112A,ENSG00000111700:ENST00000381545:exon5:c.T334G:p.S112A	SLCO1B3:NM_001349920:exon3:c.T250G:p.S84A,SLCO1B3-SLCO1B7:NM_001371097:exon3:c.T334G:p.S112A,SLCO1B3:NM_019844:exon5:c.T334G:p.S112A	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8045	0.7229	0.702476	COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	0.800	9.463	1.0	3.99	0.885	.	.	Major facilitator superfamily domain	SLCO1B3:uc010sil.2:exon3:c.T334G:p.S112A,SLCO1B7:uc010sim.2:exon3:c.T334G:p.S112A,SLCO1B3:uc031qgp.1:exon4:c.T334G:p.S112A,SLCO1B3:uc001rel.4:exon5:c.T334G:p.S112A	-0.938	AFR:0.7021,AMR:0.4330,EAS:0.8841,FIN:0.7351,NFE:0.7477,OTH:0.8294,ASJ:0.8007	.	.	.	.	.	.	.	.	0.0	0.68	0.000	-1.73	12	1(haematopoietic_and_lymphoid_tissue)	0.7924
12	21013948	21013948	C	T	SLCO1B3;SLCO1B3-SLCO1B7	intronic	.	ENSG00000111700;ENSG00000205754;ENSG00000257046	rs3764009	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8066	0.7222	0.702276	0.7025	.	.	.	.	.	0.0003	0.02	.	.	.	AFR:0.4334,AMR:0.7998,EAS:0.7364,FIN:0.7469,NFE:0.8296,OTH:0.7929,ASJ:0.8841	.	.	.	.	.	.	.	.	.	.	.	.	12	MU12102388	hom
12	21015760	21015760	G	A	SLCO1B3;SLCO1B3-SLCO1B7	exonic	nonsynonymous SNV	ENSG00000111700;ENSG00000257046	rs7311358	ENSG00000111700:ENST00000544370:exon2:c.G171A:p.M57I,ENSG00000257046:ENST00000540229:exon6:c.G699A:p.M233I,ENSG00000111700:ENST00000553473:exon6:c.G699A:p.M233I,ENSG00000111700:ENST00000261196:exon7:c.G699A:p.M233I,ENSG00000111700:ENST00000540853:exon7:c.G699A:p.M233I,ENSG00000111700:ENST00000381545:exon8:c.G699A:p.M233I	SLCO1B3:NM_001349920:exon6:c.G615A:p.M205I,SLCO1B3-SLCO1B7:NM_001371097:exon6:c.G699A:p.M233I,SLCO1B3:NM_019844:exon8:c.G699A:p.M233I	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8044	0.7228	0.702476	COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	0.775	9.308	0.447	-2.0	0.910	.	.	Major facilitator superfamily domain	SLCO1B3:uc010sil.2:exon6:c.G699A:p.M233I,SLCO1B3:uc031qgp.1:exon7:c.G699A:p.M233I,SLCO1B3:uc001rel.4:exon8:c.G699A:p.M233I	-1.046	AFR:0.7024,AMR:0.4328,EAS:0.8833,FIN:0.7379,NFE:0.7470,OTH:0.8296,ASJ:0.8002	.	.	.	.	.	.	.	.	0.092	1.31	0.000	0.33	12	1(haematopoietic_and_lymphoid_tissue)	0.7933
12	21036411	21036411	A	G	SLCO1B3;SLCO1B3-SLCO1B7	exonic	synonymous SNV	ENSG00000111700;ENSG00000257046	rs2053098	ENSG00000111700:ENST00000544370:exon7:c.A1029G:p.A343A,ENSG00000257046:ENST00000540229:exon11:c.A1557G:p.A519A,ENSG00000111700:ENST00000553473:exon11:c.A1557G:p.A519A,ENSG00000111700:ENST00000261196:exon12:c.A1557G:p.A519A,ENSG00000111700:ENST00000381545:exon13:c.A1557G:p.A519A	SLCO1B3:NM_001349920:exon11:c.A1473G:p.A491A,SLCO1B3-SLCO1B7:NM_001371097:exon11:c.A1557G:p.A519A,SLCO1B3:NM_019844:exon13:c.A1557G:p.A519A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8047	0.7231	0.702875	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	SLCO1B3:uc010sil.2:exon11:c.A1557G:p.A519A,SLCO1B3:uc001rel.4:exon13:c.A1557G:p.A519A	.	AFR:0.7023,AMR:0.4326,EAS:0.8841,FIN:0.7348,NFE:0.7468,OTH:0.8298,ASJ:0.8002	.	.	.	.	.	.	.	.	.	.	.	.	12	1(lung)	0.7904
12	21054369	21054369	G	A	SLCO1B3;SLCO1B3-SLCO1B7	exonic	synonymous SNV	ENSG00000111700;ENSG00000257046	rs3764006	ENSG00000111700:ENST00000544370:exon9:c.G1305A:p.G435G,ENSG00000257046:ENST00000540229:exon13:c.G1833A:p.G611G,ENSG00000111700:ENST00000553473:exon13:c.G1833A:p.G611G,ENSG00000111700:ENST00000261196:exon14:c.G1833A:p.G611G,ENSG00000111700:ENST00000381545:exon15:c.G1833A:p.G611G	SLCO1B3:NM_001349920:exon13:c.G1749A:p.G583G,SLCO1B3-SLCO1B7:NM_001371097:exon13:c.G1833A:p.G611G,SLCO1B3:NM_019844:exon15:c.G1833A:p.G611G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8182	0.7124	0.678714	COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	SLCO1B3:uc010sil.2:exon13:c.G1833A:p.G611G,SLCO1B3:uc001rel.4:exon15:c.G1833A:p.G611G	.	AFR:0.7044,AMR:0.3483,EAS:0.9172,FIN:0.7531,NFE:0.7802,OTH:0.8721,ASJ:0.7769	.	.	.	.	.	.	.	.	.	.	.	.	12	1(stomach)	0.8173
12	21327652	21327652	-	A	SLCO1B1	intronic	.	ENSG00000134538;ENSG00000257062	rs34728625	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0] 	0.4002	0.3504	0.370607	0.4005	.	.	.	.	.	.	.	.	.	.	AFR:0.2754,AMR:0.4601,EAS:0.4438,FIN:0.4279,NFE:0.4551,OTH:0.5057,ASJ:0.5296	604843	237450;	3111;	3111|Hyperbilirubinemia, Rotor type|<1 / 1 000 000|Autosomal recessive|All ages|237450 ~	.	.	.	.	.	.	.	.	12	.	hom
12	21329738	21329738	A	G	SLCO1B1	exonic	nonsynonymous SNV	ENSG00000134538	rs2306283	ENSG00000134538:ENST00000256958:exon5:c.A388G:p.N130D	SLCO1B1:NM_006446:exon5:c.A388G:p.N130D	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 1, 2, -1, 0, 1] 	0.4795	0.5263	0.622404	0.5307	-1.733	0.002	0.45	-2.63	0.000	.	.	Major facilitator superfamily domain	SLCO1B1:uc001req.4:exon5:c.A388G:p.N130D	-0.983	AFR:0.7688,AMR:0.4412,EAS:0.7571,FIN:0.4593,NFE:0.3971,OTH:0.4414,ASJ:0.4262	604843	237450;	3111;	3111|Hyperbilirubinemia, Rotor type|<1 / 1 000 000|Autosomal recessive|All ages|237450 ~	.	,9700	.	.	0.0	1.12	0.000	0.6	12	MU4554337	het
12	21331599	21331599	T	C	SLCO1B1	exonic	synonymous SNV	ENSG00000134538	rs4149057	ENSG00000134538:ENST00000256958:exon6:c.T571C:p.L191L	SLCO1B1:NM_006446:exon6:c.T571C:p.L191L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5260	0.4881	0.367412	0.4538	.	.	.	.	.	.	.	.	SLCO1B1:uc001req.4:exon6:c.T571C:p.L191L	.	AFR:0.2051,AMR:0.5287,EAS:0.2478,FIN:0.5014,NFE:0.5976,OTH:0.5194,ASJ:0.6424	604843	237450;	3111;	3111|Hyperbilirubinemia, Rotor type|<1 / 1 000 000|Autosomal recessive|All ages|237450 ~	.	.	.	.	.	.	.	.	12	MU139556	het
12	21623122	21623122	T	G	PYROXD1;RECQL	UTR3	.	ENSG00000004700;ENSG00000121350	rs13035	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4280	0.3396	0.369409	0.3718	.	.	.	.	.	.	.	.	.	.	AFR:0.1470,AMR:0.4029,EAS:0.4245,FIN:0.5281,NFE:0.4527,OTH:0.4534,ASJ:0.5	.	.	.	.	.	.	.	.	.	.	.	.	12	MU12104130	het
12	21623179	21623179	T	C	RECQL	exonic	synonymous SNV	ENSG00000004700	rs17849408	ENSG00000004700:ENST00000444129:exon15:c.A1899G:p.Q633Q,ENSG00000004700:ENST00000421138:exon16:c.A1899G:p.Q633Q	RECQL:NM_002907:exon15:c.A1899G:p.Q633Q,RECQL:NM_032941:exon16:c.A1899G:p.Q633Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1116	0.0746	0.150759	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	RECQL:uc001rey.3:exon15:c.A1899G:p.Q633Q,RECQL:uc001rex.3:exon16:c.A1899G:p.Q633Q	.	AFR:0.1137,AMR:0.1254,EAS:0.1014,FIN:0.3388,NFE:0.0983,OTH:0.0868,ASJ:0.1220	600537	.	.	.	.	.	.	.	.	.	.	.	12	1(large_intestine)	0.1048
12	21623284	21623284	-	AA	PYROXD1	UTR3	.	ENSG00000121350	rs368017481	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0995	.	.	0.0321	.	.	.	.	.	.	.	.	.	.	AFR:0.0584,AMR:0.0161,EAS:0,FIN:0.0182,NFE:0.0223,OTH:0.0187,ASJ:0.0287	.	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	21623969	21623969	A	G	RECQL	exonic	synonymous SNV	ENSG00000004700	rs6500	ENSG00000004700:ENST00000444129:exon14:c.T1731C:p.N577N,ENSG00000004700:ENST00000421138:exon15:c.T1731C:p.N577N	RECQL:NM_002907:exon14:c.T1731C:p.N577N,RECQL:NM_032941:exon15:c.T1731C:p.N577N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1120	0.0990	0.151358	MU135242	.	.	.	.	.	.	.	.	RECQL:uc001rey.3:exon14:c.T1731C:p.N577N,RECQL:uc001rex.3:exon15:c.T1731C:p.N577N	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,AMR:0.1148,EAS:0.1220,FIN:0.1026,NFE:0.3414,OTH:0.1020,ASJ:0.1265	600537	.	.	.	.	.	.	.	.	.	.	.	12	2(haematopoietic_and_lymphoid_tissue)	0.0872
12	21639529	21639529	A	-	RECQL	intronic	.	ENSG00000004700	rs10712738	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4521	.	0.378395	0.4745	.	.	.	.	.	.	.	.	.	.	AFR:0.3694,AMR:0.4942,EAS:0.6075,FIN:0.5817,NFE:0.4950,OTH:0.5243,ASJ:0.4133	600537	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	21644667	21644667	G	A	RECQL	intronic	.	ENSG00000004700	rs10841834	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4692	0.3667	0.373203	1(large_intestine)	.	.	.	.	.	.	.	.	.	.	AFR:1(liver),AMR:MU582602,EAS:0.3902,FIN:0.1789,NFE:0.4353,OTH:0.5232,ASJ:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763	600537	.	.	.	.	.	.	.	.	.	.	.	12	1(prostate)	0.4446
12	25362777	25362777	A	G	KRAS	exonic	synonymous SNV	ENSG00000133703	rs1137282	ENSG00000133703:ENST00000557334:exon3:c.T180C:p.D60D,ENSG00000133703:ENST00000311936:exon5:c.T519C:p.D173D	KRAS:NM_001369787:exon5:c.T519C:p.D173D,KRAS:NM_004985:exon5:c.T519C:p.D173D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1969	0.2008	0.175519	MU112831	.	.	.	.	.	.	.	.	KRAS:uc001rgq.1:exon5:c.T519C:p.D173D	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,AMR:0.1879,EAS:0.1993,FIN:0.1821,NFE:0.0871,OTH:0.1601,ASJ:0.1742	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04137 Mitophagy - animal~ko04138 Autophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko04320 Dorso-ventral axis formation~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,7062,6998,7007,7006,7009,7013,7050,7030,6839,7005,7043,6844,7056,7019,7052,7064,6840,7017,6835,7021,7022,6837,6997,7057,7038,7045,7040,6836,7058,7012,7042,7015,7049,7032,7003,7048,7029,6838,6999,7046,6842,7018,6845,7008,7044,7002,7036,7031,7028,7063,7000,7059,7041,7024,7025,7054,7016,7001,7060,7061,7039,7034,7014,7051,7023,7035,7053,7027,7010,6841,7055,7037,7004,7033,7047,6843	.	7011,,7020,7026	.	.	.	.	12	1(thyroid)	0.2119
12	25368462	25368462	C	T	KRAS	exonic	synonymous SNV	ENSG00000133703	rs4362222	ENSG00000133703:ENST00000256078:exon5:c.G483A:p.R161R	KRAS:NM_001369786:exon5:c.G483A:p.R161R,KRAS:NM_033360:exon5:c.G483A:p.R161R	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9995	0.9985	0.997604	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	KRAS:uc001rgp.1:exon5:c.G483A:p.R161R	.	AFR:0.9985,AMR:0.9948,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04137 Mitophagy - animal~ko04138 Autophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko04320 Dorso-ventral axis formation~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,7062,6998,7007,7006,7009,7013,7050,7030,6839,7005,7043,6844,7056,7019,7052,7064,6840,7017,6835,7021,7022,6837,6997,7057,7038,7045,7040,6836,7058,7012,7042,7015,7049,7032,7003,7048,7029,6838,6999,7046,6842,7018,6845,7008,7044,7002,7036,7031,7028,7063,7000,7059,7041,7024,7025,7054,7016,7001,7060,7061,7039,7034,7014,7051,7023,7035,7053,7027,7010,6841,7055,7037,7004,7033,7047,6843	.	7011,,7020,7026	.	.	.	.	12	4(meninges)	1
12	32949029	32949029	-	G	PKP2	intronic	.	ENSG00000057294	rs149968852	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.2108	0.1903	0.318291	0.2044	.	.	.	.	.	.	.	.	.	.	AFR:0.2708,AMR:0.1706,EAS:0.5513,FIN:0.1713,NFE:0.1401,OTH:0.1892,ASJ:0.1733	602861	609040;	217656;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	12	.	hom
12	32949252	32949253	AC	-	PKP2	intronic	.	ENSG00000057294	rs200266270	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0376	0.0247	.	0.0060	.	.	.	.	.	.	.	.	.	.	AFR:0.0014,AMR:0.0111,EAS:0.0044,FIN:0.0048,NFE:0.0084,OTH:0.0105,ASJ:0.0132	602861	609040;	217656;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	12	MU111856772	het
12	32955330	32955330	G	A	PKP2	intronic	.	ENSG00000057294	rs74072938	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0324	0.0723	0.0716853	0.0590	.	.	.	.	.	0	0.006	.	.	.	AFR:0.1851,AMR:0.0251,EAS:0.0025,FIN:0.0063,NFE:0.0099,OTH:0.0163,ASJ:0.0132	602861	609040;	217656;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	12	.	het
12	40619082	40619082	G	A	LRRK2	exonic	nonsynonymous SNV	ENSG00000188906	rs2256408	ENSG00000188906:ENST00000298910:exon1:c.G149A:p.R50H,ENSG00000188906:ENST00000343742:exon1:c.G149A:p.R50H	LRRK2:NM_198578:exon1:c.G149A:p.R50H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9911	0.9655	0.969249	0.9708	1.601	13.86	1.0	-1.31	0.559	0	0	Armadillo-like helical|Armadillo-type fold;Armadillo-type fold	LRRK2:uc001rmg.4:exon1:c.G149A:p.R50H	-0.974	AFR:0.8981,AMR:0.9916,EAS:1,FIN:1,NFE:0.9999,OTH:0.9939,ASJ:1	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	0.0	0.7	0.000	-0.255	12	MU81922046	hom
12	40671989	40671989	A	G	LRRK2	exonic	nonsynonymous SNV	ENSG00000188906	rs10878307	ENSG00000188906:ENST00000416796:exon14:c.A1411G:p.I471V,ENSG00000188906:ENST00000298910:exon18:c.A2167G:p.I723V,ENSG00000188906:ENST00000343742:exon18:c.A2167G:p.I723V	LRRK2:NM_198578:exon18:c.A2167G:p.I723V	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0592	0.0518	0.0403355	0.0414	0.279	5.489	0.68	-0.905	0.999	.	.	Ankyrin repeat-containing domain	LRRK2:uc001rmh.1:exon9:c.A1033G:p.I345V,LRRK2:uc001rmg.4:exon18:c.A2167G:p.I723V	-1.025	AFR:0.0111,AMR:0.0383,EAS:0.0031,FIN:0.0272,NFE:0.0632,OTH:0.0480,ASJ:0.1887	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	0.001	0.6	0.004	0.49	12	.	het
12	40693068	40693068	T	G	LRRK2	intronic	.	ENSG00000188906	rs560559629	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0004	.	0.000798722	3.231e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0.0006,FIN:0,NFE:0,OTH:0,ASJ:0	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	.	het
12	40713834	40713834	C	A	LRRK2	exonic	synonymous SNV	ENSG00000188906	rs1427263	ENSG00000188906:ENST00000298910:exon34:c.C4872A:p.G1624G	LRRK2:NM_198578:exon34:c.C4872A:p.G1624G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6781	0.6859	0.682907	0.7114	.	.	.	.	.	.	.	.	LRRK2:uc001rmi.3:exon9:c.C1371A:p.G457G,LRRK2:uc009zjw.3:exon13:c.C1386A:p.G462G,LRRK2:uc001rmg.4:exon34:c.C4872A:p.G1624G	.	AFR:0.7787,AMR:0.7344,EAS:0.5075,FIN:0.7790,NFE:0.6787,OTH:0.7243,ASJ:0.5894	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU108484	het
12	40713873	40713873	A	G	LRRK2	exonic	synonymous SNV	ENSG00000188906	rs11176013	ENSG00000188906:ENST00000298910:exon34:c.A4911G:p.K1637K	LRRK2:NM_198578:exon34:c.A4911G:p.K1637K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5734	0.5517	0.585663	0.5647	.	.	.	.	.	.	.	.	LRRK2:uc001rmi.3:exon9:c.A1410G:p.K470K,LRRK2:uc009zjw.3:exon13:c.A1425G:p.K475K,LRRK2:uc001rmg.4:exon34:c.A4911G:p.K1637K	.	AFR:0.5966,AMR:0.6514,EAS:0.4805,FIN:0.5359,NFE:0.5579,OTH:0.5584,ASJ:0.5367	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU108500	het
12	40716260	40716260	T	C	LRRK2	exonic	synonymous SNV	ENSG00000188906	rs10878371	ENSG00000188906:ENST00000298910:exon37:c.T5457C:p.G1819G	LRRK2:NM_198578:exon37:c.T5457C:p.G1819G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5733	0.5534	0.585264	0.5631	.	.	.	.	.	.	.	.	LRRK2:uc001rmi.3:exon12:c.T1956C:p.G652G,LRRK2:uc009zjw.3:exon16:c.T1971C:p.G657G,LRRK2:uc001rmg.4:exon37:c.T5457C:p.G1819G	.	AFR:0.5938,AMR:0.6506,EAS:0.4783,FIN:0.5362,NFE:0.5567,OTH:0.5603,ASJ:0.5331	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU12139841	het
12	40753044	40753044	-	T	LRRK2	intronic	.	ENSG00000188906	rs111612315	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6216	0.6696	0.592252	0.7410	.	.	.	.	.	.	.	.	.	.	AFR:0.5599,AMR:0.6227,EAS:0.6724,FIN:0.7778,NFE:0.8499,OTH:0.8063,ASJ:0.8111	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU41962212	hom
12	42854205	42854205	A	G	PRICKLE1	exonic	synonymous SNV	ENSG00000139174	rs3747562	ENSG00000139174:ENST00000345127:exon8:c.T1902C:p.S634S,ENSG00000139174:ENST00000445766:exon8:c.T1902C:p.S634S,ENSG00000139174:ENST00000455697:exon8:c.T1902C:p.S634S,ENSG00000139174:ENST00000548696:exon8:c.T1902C:p.S634S,ENSG00000139174:ENST00000552240:exon8:c.T1902C:p.S634S	PRICKLE1:NM_001144881:exon8:c.T1902C:p.S634S,PRICKLE1:NM_001144882:exon8:c.T1902C:p.S634S,PRICKLE1:NM_001144883:exon8:c.T1902C:p.S634S,PRICKLE1:NM_153026:exon8:c.T1902C:p.S634S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4385	0.4353	0.429313	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PRICKLE1:uc001rnl.3:exon8:c.T1902C:p.S634S,PRICKLE1:uc001rnm.3:exon8:c.T1902C:p.S634S,PRICKLE1:uc010skv.2:exon8:c.T1902C:p.S634S,PRICKLE1:uc010skw.2:exon8:c.T1902C:p.S634S	.	AFR:0.4552,AMR:0.4609,EAS:0.4073,FIN:0.4338,NFE:0.4291,OTH:0.4633,ASJ:0.4689	608500	612437;	308;	308|PME type 1<br>Progressive myoclonic epilepsy type 1<br>Progressive myoclonus epilepsy type 1<br>ULD|1-9 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent|254800 310370 612437 ~	.	.	.	.	.	.	.	.	12	1(lung)	0.4110
12	42854208	42854208	A	G	PRICKLE1	exonic	synonymous SNV	ENSG00000139174	rs3747563	ENSG00000139174:ENST00000345127:exon8:c.T1899C:p.F633F,ENSG00000139174:ENST00000445766:exon8:c.T1899C:p.F633F,ENSG00000139174:ENST00000455697:exon8:c.T1899C:p.F633F,ENSG00000139174:ENST00000548696:exon8:c.T1899C:p.F633F,ENSG00000139174:ENST00000552240:exon8:c.T1899C:p.F633F	PRICKLE1:NM_001144881:exon8:c.T1899C:p.F633F,PRICKLE1:NM_001144882:exon8:c.T1899C:p.F633F,PRICKLE1:NM_001144883:exon8:c.T1899C:p.F633F,PRICKLE1:NM_153026:exon8:c.T1899C:p.F633F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3459	0.2999	0.270567	5(lung)	.	.	.	.	.	.	.	.	PRICKLE1:uc001rnl.3:exon8:c.T1899C:p.F633F,PRICKLE1:uc001rnm.3:exon8:c.T1899C:p.F633F,PRICKLE1:uc010skv.2:exon8:c.T1899C:p.F633F,PRICKLE1:uc010skw.2:exon8:c.T1899C:p.F633F	.	AFR:MU12145019,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|6|170|0.0352941,COCA-CN|3|321|0.00934579,EAS:0.2048,FIN:0.3720,NFE:0.3113,OTH:0.2640,ASJ:0.3308	608500	612437;	308;	308|PME type 1<br>Progressive myoclonic epilepsy type 1<br>Progressive myoclonus epilepsy type 1<br>ULD|1-9 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent|254800 310370 612437 ~	.	.	.	.	.	.	.	.	12	1(breast)	0.3948
12	46123719	46123719	C	G	ARID2	intronic	.	ENSG00000189079	rs572055564	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0003	.	0.000199681	.	.	.	.	.	.	0.0007	0.012	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	609539	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	48375568	48375568	A	G	COL2A1	exonic	synonymous SNV	ENSG00000139219	rs1635553	ENSG00000139219:ENST00000337299:exon35:c.T2193C:p.N731N,ENSG00000139219:ENST00000380518:exon36:c.T2400C:p.N800N	COL2A1:NM_033150:exon35:c.T2193C:p.N731N,COL2A1:NM_001844:exon36:c.T2400C:p.N800N	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4896	0.4528	0.482827	LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763,LINC-JP|2|394|0.00507614	.	.	.	.	.	.	.	.	COL2A1:uc001rqv.3:exon35:c.T2193C:p.N731N,COL2A1:uc001rqu.3:exon36:c.T2400C:p.N800N	.	AFR:0.4612,AMR:0.4612,EAS:0.4338,FIN:0.6179,NFE:0.3937,OTH:0.4698,ASJ:0.3230	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	.	.	.	.	12	1(thyroid)	0.4395
12	48376291	48376291	G	A	COL2A1	exonic	synonymous SNV	ENSG00000139219	rs2276454	ENSG00000139219:ENST00000337299:exon33:c.C2088T:p.G696G,ENSG00000139219:ENST00000380518:exon34:c.C2295T:p.G765G	COL2A1:NM_033150:exon33:c.C2088T:p.G696G,COL2A1:NM_001844:exon34:c.C2295T:p.G765G	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3958	0.3868	0.429712	0.3773	.	.	.	.	.	.	.	.	COL2A1:uc001rqv.3:exon33:c.C2088T:p.G696G,COL2A1:uc001rqu.3:exon34:c.C2295T:p.G765G	.	AFR:0.3455,AMR:0.3007,EAS:0.6190,FIN:0.3174,NFE:0.3877,OTH:0.3668,ASJ:0.4272	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	.	.	.	.	12	MU17231064	hom
12	48398002	48398002	G	C	COL2A1	intronic	.	ENSG00000139219	rs3803184	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7712	0.7842	0.685903	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,LINC-JP|3|394|0.00761421	.	.	.	.	.	.	.	.	.	.	AFR:0.7536,AMR:0.6662,EAS:0.7947,FIN:0.6135,NFE:0.7450,OTH:0.8263,ASJ:0.6199	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	.	.	.	.	12	1(lung)	0.7848
12	48398080	48398080	T	A	COL2A1	exonic	nonsynonymous SNV	ENSG00000139219	rs3803183	ENSG00000139219:ENST00000337299:exon1:c.A25T:p.T9S,ENSG00000139219:ENST00000380518:exon1:c.A25T:p.T9S	COL2A1:NM_001844:exon1:c.A25T:p.T9S,COL2A1:NM_033150:exon1:c.A25T:p.T9S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7726	0.7891	0.685304	COCA-CN|5|321|0.0155763	2.078	16.71	0.645	2.88	0.995	.	.	.	COL2A1:uc001rqu.3:exon1:c.A25T:p.T9S,COL2A1:uc001rqv.3:exon1:c.A25T:p.T9S	-0.948	AFR:0.7543,AMR:0.6675,EAS:0.7947,FIN:0.6134,NFE:0.7461,OTH:0.8267,ASJ:0.6193	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	0.0	-2.49	0.000	-0.345	12	1(thyroid)	0.7869
12	48399403	48399403	T	C	COL2A1;SENP1	intergenic	.	ENSG00000258203	rs1859444	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.702077	0.7673	.	.	.	.	.	.	.	.	.	.	AFR:0.7114,AMR:0.6196,EAS:0.6157,FIN:0.7464,NFE:0.8272,OTH:0.7883,ASJ:0.8	.	.	.	.	.	.	.	.	.	.	.	.	12	.	hom
12	49416047	49416047	C	-	KMT2D	intronic	.	ENSG00000167548	rs34546217	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3221	0.2555	0.274561	0.2772	.	.	.	.	.	.	.	.	.	.	AFR:0.0802,AMR:0.2434,EAS:0.4504,FIN:0.3604,NFE:0.3514,OTH:0.3541,ASJ:0.2483	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU114556438	het
12	49425978	49425978	T	C	KMT2D	exonic	synonymous SNV	ENSG00000167548	rs3741622	ENSG00000167548:ENST00000301067:exon39:c.A12510G:p.P4170P	KMT2D:NM_003482:exon39:c.A12510G:p.P4170P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3192	0.2507	0.275359	0.2777	.	.	.	.	.	.	.	.	KMT2D:uc001rta.4:exon39:c.A12510G:p.P4170P	.	AFR:0.0801,AMR:0.2464,EAS:0.4498,FIN:0.3607,NFE:0.3524,OTH:0.3525,ASJ:0.2483	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU582657	het
12	49427652	49427652	C	T	KMT2D	exonic	synonymous SNV	ENSG00000167548	rs3782357	ENSG00000167548:ENST00000301067:exon39:c.G10836A:p.Q3612Q	KMT2D:NM_003482:exon39:c.G10836A:p.Q3612Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4616	0.4217	0.44349	0.4374	.	.	.	.	.	.	.	.	KMT2D:uc001rta.4:exon39:c.G10836A:p.Q3612Q	.	AFR:0.5324,AMR:0.3067,EAS:0.4504,FIN:0.4064,NFE:0.3999,OTH:0.4199,ASJ:0.2682	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU118941	het
12	49434074	49434074	C	A	KMT2D	exonic	synonymous SNV	ENSG00000167548	rs10747559	ENSG00000167548:ENST00000301067:exon31:c.G7479T:p.G2493G	KMT2D:NM_003482:exon31:c.G7479T:p.G2493G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4197	0.4165	0.435503	0.4423	.	.	.	.	.	.	.	.	KMT2D:uc001rta.4:exon31:c.G7479T:p.G2493G	.	AFR:0.4714,AMR:0.3377,EAS:0.4647,FIN:0.4266,NFE:0.4355,OTH:0.4448,ASJ:0.2914	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU118954	het
12	49444545	49444545	G	A	KMT2D	exonic	synonymous SNV	ENSG00000167548	rs2241726	ENSG00000167548:ENST00000301067:exon11:c.C2826T:p.I942I	KMT2D:NM_003482:exon11:c.C2826T:p.I942I	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3796	0.3854	0.403554	0.4069	.	.	.	.	.	.	.	.	KMT2D:uc001rta.4:exon11:c.C2826T:p.I942I	.	AFR:0.4267,AMR:0.3010,EAS:0.4382,FIN:0.4082,NFE:0.3998,OTH:0.4177,ASJ:0.2682	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU118972	het
12	49579696	49579696	C	G	TUBA1A	exonic	synonymous SNV	ENSG00000167552	rs697624	ENSG00000167552:ENST00000546918:exon3:c.G605C:p.R202P	TUBA1A:NM_001270399:exon4:c.G453C:p.S151S,TUBA1A:NM_001270400:exon4:c.G348C:p.S116S,TUBA1A:NM_006009:exon4:c.G453C:p.S151S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4203	0.4351	0.547724	0.4685	0.695	8.793	0.004	0.167	0.997	.	.	.	TUBA1A:uc001rtp.4:exon4:c.G453C:p.S151S,TUBA1A:uc009zlf.4:exon4:c.G453C:p.S151S,TUBA1A:uc031qhc.1:exon4:c.G348C:p.S116S	-0.950	AFR:0.6547,AMR:0.3840,EAS:0.7585,FIN:0.4167,NFE:0.3527,OTH:0.4273,ASJ:0.2867	602529	611603;	171680;	171680|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|-|611603 ~	.	.	.	.	.	0.02	0.000	.	12	MU16146878	hom
12	49580180	49580180	T	C	TUBA1A	exonic	synonymous SNV	ENSG00000167552	rs1056875	ENSG00000167552:ENST00000546918:exon2:c.A440G:p.K147R	TUBA1A:NM_001270399:exon3:c.A288G:p.K96K,TUBA1A:NM_001270400:exon3:c.A183G:p.K61K,TUBA1A:NM_006009:exon3:c.A288G:p.K96K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4258	0.4420	0.55631	0.4736	-1.209	0.006	0.0	3.41	0.999	.	.	Tubulin/FtsZ, GTPase domain	TUBA1A:uc001rtp.4:exon3:c.A288G:p.K96K,TUBA1A:uc009zlf.4:exon3:c.A288G:p.K96K,TUBA1A:uc031qhc.1:exon3:c.A183G:p.K61K	-0.921	AFR:0.6684,AMR:0.3855,EAS:0.7587,FIN:0.4208,NFE:0.3531,OTH:0.4268,ASJ:0.29	602529	611603;	171680;	171680|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|-|611603 ~	.	.	.	.	.	0.02	0.000	.	12	MU17233097	hom
12	52369300	52369300	C	T	ACVR1B	intronic	.	ENSG00000135503	rs2242106	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2887	0.2314	0.29353	1(liver)	.	.	.	.	.	.	.	.	.	.	AFR:MU673284,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841,EAS:0.2294,FIN:0.5251,NFE:0.2053,OTH:0.2754,ASJ:0.2431	601300	.	.	.	.	.	.	.	.	.	.	.	12	1(lung)	0.2225
12	56079084	56079084	C	G	ITGA7	intronic	.	ENSG00000135424	rs3852533	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5841	0.4394	0.594649	0.5018	.	.	.	.	.	0.0001	0.038	.	.	.	AFR:0.2954,AMR:0.6400,EAS:0.9442,FIN:0.6297,NFE:0.5333,OTH:0.5684,ASJ:0.4536	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	MU81926243	hom
12	56088773	56088773	C	T	ITGA7	intronic	.	ENSG00000135424	rs2293410	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5900	0.4380	0.589257	0.5015	.	.	.	.	.	.	.	.	.	.	AFR:0.2915,AMR:0.6379,EAS:0.9442,FIN:0.6311,NFE:0.5346,OTH:0.5647,ASJ:0.4463	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	MU81926272	hom
12	56089357	56089357	C	T	ITGA7	exonic	nonsynonymous SNV	ENSG00000135424	rs1800974	ENSG00000135424:ENST00000257879:exon14:c.G1952A:p.R651H,ENSG00000135424:ENST00000347027:exon14:c.G1934A:p.R645H,ENSG00000135424:ENST00000394229:exon14:c.G1952A:p.R651H,ENSG00000135424:ENST00000394230:exon14:c.G1964A:p.R655H,ENSG00000135424:ENST00000452168:exon14:c.G1673A:p.R558H,ENSG00000135424:ENST00000553804:exon14:c.G1964A:p.R655H,ENSG00000135424:ENST00000257880:exon15:c.G2084A:p.R695H,ENSG00000135424:ENST00000555728:exon15:c.G2084A:p.R695H	ITGA7:NM_001367994:exon13:c.G608A:p.R203H,ITGA7:NM_001144996:exon14:c.G1964A:p.R655H,ITGA7:NM_001144997:exon14:c.G1673A:p.R558H,ITGA7:NM_002206:exon14:c.G1952A:p.R651H,ITGA7:NM_001367993:exon15:c.G1625A:p.R542H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5854	0.4513	0.599441	0.5134	2.355	18.52	0.281	-0.706	0.124	.	.	Integrin alpha-2|Integrin domain	ITGA7:uc009znx.3:exon12:c.G1595A:p.R532H,ITGA7:uc001shg.3:exon14:c.G1952A:p.R651H,ITGA7:uc001shh.3:exon14:c.G1964A:p.R655H,ITGA7:uc010sps.2:exon14:c.G1673A:p.R558H	-1.002	AFR:0.3328,AMR:0.6423,EAS:0.9455,FIN:0.6320,NFE:0.5344,OTH:0.5661,ASJ:0.45	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	0.0	0.84	0.000	0.345	12	MU4556768	hom
12	56091617	56091617	A	G	ITGA7	intronic	.	ENSG00000135424	rs2293412	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6206	0.5648	0.702676	0.6065	.	.	.	.	.	0.0041	0	.	.	.	AFR:0.6506,AMR:0.6790,EAS:0.9524,FIN:0.6341,NFE:0.5370,OTH:0.5792,ASJ:0.4765	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	MU4326330	hom
12	56096816	56096816	T	C	ITGA7	intronic	.	ENSG00000135424	rs2293413	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5902	0.4637	0.612021	0.5229	.	.	.	.	.	.	.	.	.	.	AFR:0.3660,AMR:0.6456,EAS:0.9431,FIN:0.6318,NFE:0.5344,OTH:0.5676,ASJ:0.48	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	MU81926323	hom
12	56477694	56477694	A	T	ERBB3	intronic	.	ENSG00000065361	rs2271194	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6173	0.4955	0.592252	0.5370	.	.	.	.	.	0	0	.	.	.	AFR:0.3344,AMR:0.7279,EAS:0.7841,FIN:0.5922,NFE:0.6002,OTH:0.6074,ASJ:0.5199	190151	607598;	137776;	137776|LCCS2<br>Multiple contracture syndrome, Israeli-Bedouin type|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|607598 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04151 PI3K-Akt signaling pathway~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	12	MU28644046	hom
12	57859431	57859431	G	A	GLI1	exonic	synonymous SNV	ENSG00000111087	rs2228225	ENSG00000111087:ENST00000528467:exon4:c.G453A:p.E151E,ENSG00000111087:ENST00000532291:exon4:c.G192A:p.E64E,ENSG00000111087:ENST00000543426:exon4:c.G192A:p.E64E,ENSG00000111087:ENST00000546141:exon5:c.G453A:p.E151E,ENSG00000111087:ENST00000228682:exon6:c.G576A:p.E192E	GLI1:NM_001160045:exon4:c.G192A:p.E64E,GLI1:NM_001167609:exon5:c.G453A:p.E151E,GLI1:NM_005269:exon6:c.G576A:p.E192E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4999	0.4976	0.363019	1(breast)	.	.	.	.	.	.	.	.	GLI1:uc009zpq.3:exon4:c.G192A:p.E64E,GLI1:uc021qzi.1:exon5:c.G453A:p.E151E,GLI1:uc001snx.3:exon6:c.G576A:p.E192E	.	AFR:MU12167256,AMR:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,EAS:0.2446,FIN:0.4041,NFE:0.5695,OTH:0.2787,ASJ:0.4690	165220	.	.	.	~ko04024 cAMP signaling pathway~ko04340 Hedgehog signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	12	3(haematopoietic_and_lymphoid_tissue)	0.5198
12	57865321	57865321	G	A	GLI1	exonic	nonsynonymous SNV	ENSG00000111087	rs2228224	ENSG00000111087:ENST00000528467:exon10:c.G2675A:p.G892D,ENSG00000111087:ENST00000543426:exon10:c.G2414A:p.G805D,ENSG00000111087:ENST00000546141:exon11:c.G2675A:p.G892D,ENSG00000111087:ENST00000228682:exon12:c.G2798A:p.G933D	GLI1:NM_001160045:exon10:c.G2414A:p.G805D,GLI1:NM_001167609:exon11:c.G2675A:p.G892D,GLI1:NM_005269:exon12:c.G2798A:p.G933D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5027	0.4982	0.364018	MU12167285	-0.011	2.485	0.028	0.557	1.000	.	.	.	GLI1:uc009zpq.3:exon10:c.G2414A:p.G805D,GLI1:uc021qzi.1:exon11:c.G2675A:p.G892D,GLI1:uc001snx.3:exon12:c.G2798A:p.G933D	-1.002	AFR:LICA-CN|3|402|0.00746269,LAML-KR|3|205|0.0146341,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.4704,EAS:0.4043,FIN:0.5973,NFE:0.2786,OTH:0.5201,ASJ:0.2492	165220	.	.	.	~ko04024 cAMP signaling pathway~ko04340 Hedgehog signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	0.1	2.65	0.000	0.55	12	1(breast)	0.6059
12	57865821	57865821	G	C	GLI1	exonic	nonsynonymous SNV	ENSG00000111087	rs2228226	ENSG00000111087:ENST00000528467:exon10:c.G3175C:p.E1059Q,ENSG00000111087:ENST00000543426:exon10:c.G2914C:p.E972Q,ENSG00000111087:ENST00000546141:exon11:c.G3175C:p.E1059Q,ENSG00000111087:ENST00000228682:exon12:c.G3298C:p.E1100Q	GLI1:NM_001160045:exon10:c.G2914C:p.E972Q,GLI1:NM_001167609:exon11:c.G3175C:p.E1059Q,GLI1:NM_005269:exon12:c.G3298C:p.E1100Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6061	0.7118	0.586262	0.6558	0.353	6.190	1.0	4.69	1.000	.	.	.	GLI1:uc009zpq.3:exon10:c.G2914C:p.E972Q,GLI1:uc021qzi.1:exon11:c.G3175C:p.E1059Q,GLI1:uc001snx.3:exon12:c.G3298C:p.E1100Q	-1.052	AFR:0.7710,AMR:0.4737,EAS:0.3429,FIN:0.5720,NFE:0.6562,OTH:0.5871,ASJ:0.6788	165220	.	.	.	~ko04024 cAMP signaling pathway~ko04340 Hedgehog signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	0.0	2.99	0.000	-1.245	12	MU723291	het
12	65514266	65514266	T	C	WIF1	exonic	synonymous SNV	ENSG00000156076	rs7301320	ENSG00000156076:ENST00000546001:exon1:c.A33G:p.A11A,ENSG00000156076:ENST00000286574:exon2:c.A219G:p.A73A	WIF1:NM_007191:exon2:c.A219G:p.A73A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7765	0.7476	0.824081	0.7638	.	.	.	.	.	.	.	.	WIF1:uc001ssk.3:exon2:c.A219G:p.A73A	.	AFR:0.7632,AMR:0.7005,EAS:0.9981,FIN:0.7507,NFE:0.7451,OTH:0.7612,ASJ:0.7881	605186	.	.	.	.	.	.	.	.	.	.	.	12	MU81927819	het
12	66308644	66308644	A	G	HMGA2	exonic	nonsynonymous SNV	ENSG00000149948	rs10878345	ENSG00000149948:ENST00000536545:exon4:c.A394G:p.R132G	HMGA2:NM_001300919:exon4:c.A394G:p.R132G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4869	.	0.417732	COCA-CN|2|321|0.00623053	-0.460	0.275	1.0	-0.47	0.003	.	.	.	HMGA2:uc001ssu.1:exon4:c.A394G:p.R132G	-0.904	AFR:0.3533,AMR:0.6060,EAS:0.2881,FIN:0.2729,NFE:0.2328,OTH:0.2503,ASJ:0.3122	600698	150699;	.	.	~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	0.003	1.2	0.000	.	12	8(upper_aerodigestive_tract)	0.3027
12	66346121	66346121	A	G	HMGA2	intronic	.	ENSG00000149948	rs1480469	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2840	.	0.31889	0.1919	.	.	.	.	.	.	.	.	.	.	AFR:0.0861,AMR:0.3918,EAS:0.7758,FIN:0.1460,NFE:0.1892,OTH:0.1861,ASJ:0.2583	600698	150699;	.	.	~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	12	MU81927840	het
12	69967862	69967862	G	A	FRS2	exonic	synonymous SNV	ENSG00000166225	rs547497	ENSG00000166225:ENST00000550389:exon7:c.G654A:p.A218A,ENSG00000166225:ENST00000397997:exon8:c.G654A:p.A218A,ENSG00000166225:ENST00000549921:exon9:c.G654A:p.A218A,ENSG00000166225:ENST00000299293:exon10:c.G654A:p.A218A	FRS2:NM_001278357:exon7:c.G654A:p.A218A,FRS2:NM_001278356:exon9:c.G654A:p.A218A,FRS2:NM_001042555:exon10:c.G654A:p.A218A,FRS2:NM_001278354:exon10:c.G654A:p.A218A,FRS2:NM_001278355:exon10:c.G654A:p.A218A,FRS2:NM_006654:exon10:c.G654A:p.A218A,FRS2:NM_001278351:exon11:c.G654A:p.A218A,FRS2:NM_001278353:exon11:c.G654A:p.A218A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4810	0.4845	0.463059	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	FRS2:uc009zrk.3:exon7:c.G654A:p.A218A,FRS2:uc009zrj.3:exon9:c.G654A:p.A218A,FRS2:uc001suy.3:exon10:c.G654A:p.A218A,FRS2:uc001suz.3:exon10:c.G654A:p.A218A	.	AFR:1(lung),AMR:1(stomach),EAS:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,FIN:0.4660,NFE:0.5010,OTH:0.5442,ASJ:MU81689	607743	.	.	.	~ko04714 Thermogenesis~ko04722 Neurotrophin signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	12	2(thyroid)	0.5795
12	88454594	88454594	-	A	CEP290	intronic	.	ENSG00000198707	rs11405846	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.8612	0.7616	0.761581	0.7892	.	.	.	.	.	.	.	.	.	.	AFR:0.4244,AMR:0.9159,EAS:0.9685,FIN:0.9578,NFE:0.9262,OTH:0.9165,ASJ:0.8885	610142	610188;610189;611134;611755;615991;	110;65;564;3156;2318;	110|BBS|1-9 / 1 000 000|Oligogenic<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|209900 600151 605231 615981 615982 615983 615984 615985 615986 615987 615988 615989 615990 615991 615992 615993 615994 615995 615996 617119 ~65|Amaurosis congenita of Leber|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|179900 204000 204100 604232 604393 604537 608553 610612 611755 612712 613341 613826 613829 613835 613837 613843 614186 615360 ~564|Meckel-Gruber syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal|249000 603194 607361 611134 611561 612284 613885 614175 614209 615397 ~3156|Nephronophthisis with retinal dystrophy<br>Renal dysplasia-retinal aplasia syndrome<br>SLSN|<1 / 1 000 000|Autosomal recessive|Childhood|266900 606995 606996 609254 610189 613615 614845 616307 616629 ~2318|Arima syndrome<br>CORS<br>Cerebello-oculo-renal syndrome<br>Dekaban-Arima syndrome<br>JS type B<br>JS-OR<br>Joubert syndrome with Senior-Loken syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243910 608091 610188 612285 614424 614465 614844 ~	.	.	.	.	.	.	.	.	12	.	hom
12	88483273	88483273	A	-	CEP290	intronic	.	ENSG00000198707	rs10717563	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.9161	0.8720	0.873602	0.8910	.	.	.	.	.	.	.	.	.	.	AFR:0.7273,AMR:0.9426,EAS:0.9852,FIN:0.9845,NFE:0.9472,OTH:0.9499,ASJ:0.8907	610142	610188;610189;611134;611755;615991;	110;65;564;3156;2318;	110|BBS|1-9 / 1 000 000|Oligogenic<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|209900 600151 605231 615981 615982 615983 615984 615985 615986 615987 615988 615989 615990 615991 615992 615993 615994 615995 615996 617119 ~65|Amaurosis congenita of Leber|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|179900 204000 204100 604232 604393 604537 608553 610612 611755 612712 613341 613826 613829 613835 613837 613843 614186 615360 ~564|Meckel-Gruber syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal|249000 603194 607361 611134 611561 612284 613885 614175 614209 615397 ~3156|Nephronophthisis with retinal dystrophy<br>Renal dysplasia-retinal aplasia syndrome<br>SLSN|<1 / 1 000 000|Autosomal recessive|Childhood|266900 606995 606996 609254 610189 613615 614845 616307 616629 ~2318|Arima syndrome<br>CORS<br>Cerebello-oculo-renal syndrome<br>Dekaban-Arima syndrome<br>JS type B<br>JS-OR<br>Joubert syndrome with Senior-Loken syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243910 608091 610188 612285 614424 614465 614844 ~	.	.	.	.	.	.	.	.	12	.	hom
12	88505078	88505078	T	C	CEP290	exonic	synonymous SNV	ENSG00000198707	rs2468255	ENSG00000198707:ENST00000604024:exon14:c.A1527G:p.S509S,ENSG00000198707:ENST00000309041:exon22:c.A2274G:p.S758S,ENSG00000198707:ENST00000552810:exon22:c.A2268G:p.S756S	CEP290:NM_025114:exon22:c.A2268G:p.S756S	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8888	0.7713	0.764577	0.7923	.	.	.	.	.	.	.	.	CEP290:uc001tat.3:exon14:c.A1647G:p.S549S,CEP290:uc001tar.3:exon22:c.A2268G:p.S756S	.	AFR:0.4264,AMR:0.9199,EAS:0.9746,FIN:0.9595,NFE:0.9282,OTH:0.9194,ASJ:0.8907	610142	610188;610189;611134;611755;615991;	110;65;564;3156;2318;	110|BBS|1-9 / 1 000 000|Oligogenic<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|209900 600151 605231 615981 615982 615983 615984 615985 615986 615987 615988 615989 615990 615991 615992 615993 615994 615995 615996 617119 ~65|Amaurosis congenita of Leber|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|179900 204000 204100 604232 604393 604537 608553 610612 611755 612712 613341 613826 613829 613835 613837 613843 614186 615360 ~564|Meckel-Gruber syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal|249000 603194 607361 611134 611561 612284 613885 614175 614209 615397 ~3156|Nephronophthisis with retinal dystrophy<br>Renal dysplasia-retinal aplasia syndrome<br>SLSN|<1 / 1 000 000|Autosomal recessive|Childhood|266900 606995 606996 609254 610189 613615 614845 616307 616629 ~2318|Arima syndrome<br>CORS<br>Cerebello-oculo-renal syndrome<br>Dekaban-Arima syndrome<br>JS type B<br>JS-OR<br>Joubert syndrome with Senior-Loken syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243910 608091 610188 612285 614424 614465 614844 ~	.	.	.	.	.	.	.	.	12	MU81929253	hom
12	88522823	88522823	-	C	CEP290	intronic	.	ENSG00000198707	rs71082425	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.9284	0.8705	0.873602	0.8899	.	.	.	.	.	.	.	.	.	.	AFR:0.7247,AMR:0.9415,EAS:0.9856,FIN:0.9846,NFE:0.9472,OTH:0.9489,ASJ:0.8907	610142	610188;610189;611134;611755;615991;	110;65;564;3156;2318;	110|BBS|1-9 / 1 000 000|Oligogenic<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|209900 600151 605231 615981 615982 615983 615984 615985 615986 615987 615988 615989 615990 615991 615992 615993 615994 615995 615996 617119 ~65|Amaurosis congenita of Leber|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|179900 204000 204100 604232 604393 604537 608553 610612 611755 612712 613341 613826 613829 613835 613837 613843 614186 615360 ~564|Meckel-Gruber syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal|249000 603194 607361 611134 611561 612284 613885 614175 614209 615397 ~3156|Nephronophthisis with retinal dystrophy<br>Renal dysplasia-retinal aplasia syndrome<br>SLSN|<1 / 1 000 000|Autosomal recessive|Childhood|266900 606995 606996 609254 610189 613615 614845 616307 616629 ~2318|Arima syndrome<br>CORS<br>Cerebello-oculo-renal syndrome<br>Dekaban-Arima syndrome<br>JS type B<br>JS-OR<br>Joubert syndrome with Senior-Loken syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243910 608091 610188 612285 614424 614465 614844 ~	.	.	.	.	.	.	.	.	12	.	hom
12	89743223	89743223	G	A	DUSP6	exonic	synonymous SNV	ENSG00000139318	rs704075	ENSG00000139318:ENST00000308385:exon2:c.C516T:p.D172D,ENSG00000139318:ENST00000547291:exon2:c.C579T:p.D193D,ENSG00000139318:ENST00000279488:exon3:c.C954T:p.D318D	DUSP6:NM_022652:exon2:c.C516T:p.D172D,DUSP6:NM_001946:exon3:c.C954T:p.D318D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9965	0.9882	0.985024	0.9884	.	.	.	.	.	.	.	.	DUSP6:uc001taz.3:exon2:c.C516T:p.D172D,DUSP6:uc001tay.3:exon3:c.C954T:p.D318D	.	AFR:0.9594,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:0.9969,ASJ:1	602748	615269;	432;478;	432|Gonadotropic deficiency<br>Isolated congenital gonadotropin deficiency<br>Normosmic idiopathic hypogonadotropic hypogonadism<br>nIHH|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|146110 147950 244200 308700 610628 612370 612702 614837 614838 614839 614840 614841 614842 614858 614880 615266 615269 615270 ~478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	~ko04010 MAPK signaling pathway~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	.	.	.	.	12	MU81929270	hom
12	102517753	102517753	T	C	PARPBP	exonic	synonymous SNV	ENSG00000185480	rs2036772	ENSG00000185480:ENST00000358383:exon2:c.T87C:p.T29T,ENSG00000185480:ENST00000378128:exon2:c.T87C:p.T29T,ENSG00000185480:ENST00000392909:exon2:c.T87C:p.T29T,ENSG00000185480:ENST00000537257:exon2:c.T87C:p.T29T,ENSG00000185480:ENST00000541394:exon2:c.T87C:p.T29T,ENSG00000185480:ENST00000543784:exon2:c.T87C:p.T29T	PARPBP:NM_001319988:exon2:c.T87C:p.T29T,PARPBP:NM_001319996:exon2:c.T87C:p.T29T,PARPBP:NM_017915:exon2:c.T87C:p.T29T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2321	.	0.16234	1(upper_aerodigestive_tract)	.	.	.	.	.	.	.	.	PARPBP:uc001tjk.3:exon1:c.T87C:p.T29T,PARPBP:uc009zud.3:exon1:c.T87C:p.T29T,PARPBP:uc001tjd.3:exon2:c.T87C:p.T29T,PARPBP:uc001tjf.3:exon2:c.T87C:p.T29T,PARPBP:uc001tji.3:exon2:c.T99C:p.T33T,PARPBP:uc010swa.2:exon2:c.T87C:p.T29T,PARPBP:uc010swb.2:exon2:c.T87C:p.T29T	.	AFR:MU4940903,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.0365,FIN:0.1367,NFE:0.2351,OTH:0.2574,ASJ:0.1583	613687	.	.	.	.	.	.	.	.	.	.	.	12	1(large_intestine)	0.1606
12	102875569	102875569	A	G	IGF1;LINC00485	intergenic	.	ENSG00000017427;ENSG00000257254	rs35767	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.696286	0.7437	.	.	.	.	.	.	.	.	.	.	AFR:0.5698,AMR:0.7513,EAS:0.6484,FIN:0.8014,NFE:0.8411,OTH:0.7927,ASJ:0.7886	.	.	.	.	.	.	.	.	.	.	.	.	12	MU19938323	hom
12	104373600	104373600	G	A	TDG	intronic	.	ENSG00000139372	rs3751209	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2883	0.2516	0.337061	0.2805	.	.	.	.	.	0.0002	0.012	.	.	.	AFR:0.3070,AMR:0.2264,EAS:0.5355,FIN:0.2728,NFE:0.2427,OTH:0.2796,ASJ:0.2781	601423	.	.	.	.	.	.	.	.	.	.	.	12	MU582822	het
12	104373728	104373728	-	A	TDG	exonic	frameshift insertion	ENSG00000139372	rs151041931	ENSG00000139372:ENST00000392872:exon3:c.287dupA:p.E96fs,ENSG00000139372:ENST00000537100:exon3:c.287dupA:p.E96fs,ENSG00000139372:ENST00000266775:exon4:c.275dupA:p.E92fs,ENSG00000139372:ENST00000436021:exon4:c.212dupA:p.E71fs	TDG:NM_003211:exon3:c.287dupA:p.E96fs	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4489	0.4450	0.472244	0.4495	.	.	.	.	.	.	.	.	TDG:uc001tkg.3:exon3:c.287dupA:p.E96fs,TDG:uc010swh.1:exon3:c.287dupA:p.E96fs,TDG:uc009zuk.3:exon4:c.275dupA:p.E92fs	.	AFR:0.4909,AMR:0.4854,EAS:0.4795,FIN:0.4457,NFE:0.4199,OTH:0.4259,ASJ:0.4409	601423	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	109540752	109540752	-	TT	UNG	intronic	.	ENSG00000076248	rs386377711	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0198	.	.	0.1499	.	.	.	.	.	.	.	.	.	.	AFR:0.1439,AMR:0.125,EAS:0.3089,FIN:0.0556,NFE:0.1426,OTH:0.1536,ASJ:0.1968	191525	608106;	101092;183666;	101092|HIGM5<br>Hyper-IgM syndrome due to UNG deficiency<br>Hyper-IgM syndrome due to uracil N-glycosylase|-|-|-|608106 ~183666|HIGM without susceptibility to opportunistic infections|-|-|-|605258 608106 608184 ~	.	.	.	.	.	.	.	.	12	.	het
12	109605730	109605730	C	T	ACACB	exonic	synonymous SNV	ENSG00000076555	rs4766516	ENSG00000076555:ENST00000377848:exon3:c.C816T:p.A272A,ENSG00000076555:ENST00000377854:exon3:c.C816T:p.A272A,ENSG00000076555:ENST00000544726:exon3:c.C210T:p.A70A,ENSG00000076555:ENST00000338432:exon4:c.C816T:p.A272A	ACACB:NM_001093:exon4:c.C816T:p.A272A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2280	0.1571	0.231629	MU668362	.	.	.	.	.	.	.	.	ACACB:uc001toc.3:exon3:c.C816T:p.A272A,ACACB:uc001tob.3:exon4:c.C816T:p.A272A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.1855,EAS:0.2506,FIN:0.2550,NFE:0.5685,OTH:0.2227,ASJ:0.0723	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(large_intestine)	0.1947
12	109617865	109617865	T	C	ACACB	exonic	synonymous SNV	ENSG00000076555	rs11065772	ENSG00000076555:ENST00000377848:exon10:c.T1791C:p.D597D,ENSG00000076555:ENST00000377854:exon10:c.T1791C:p.D597D,ENSG00000076555:ENST00000338432:exon11:c.T1791C:p.D597D	ACACB:NM_001093:exon11:c.T1791C:p.D597D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7715	0.7400	0.677316	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	ACACB:uc001toc.3:exon10:c.T1791C:p.D597D,ACACB:uc001tob.3:exon11:c.T1791C:p.D597D	.	AFR:0.7444,AMR:0.5579,EAS:0.9067,FIN:0.7333,NFE:0.8340,OTH:0.8309,ASJ:0.6587	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(thyroid)	0.7996
12	109623516	109623516	G	A	ACACB	exonic	nonsynonymous SNV	ENSG00000076555	rs2300455	ENSG00000076555:ENST00000377848:exon11:c.G1951A:p.A651T,ENSG00000076555:ENST00000377854:exon11:c.G1951A:p.A651T,ENSG00000076555:ENST00000338432:exon12:c.G1951A:p.A651T	ACACB:NM_001093:exon12:c.G1951A:p.A651T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.1889	0.1462	0.159545	MU724553	4.805	24.8	0.052	4.44	0.968	.	.	Biotin carboxylase, C-terminal|Biotin carboxylation domain|Rudiment single hybrid motif	ACACB:uc001toc.3:exon11:c.G1951A:p.A651T,ACACB:uc001tob.3:exon12:c.G1951A:p.A651T	-1.256	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|2|321|0.00623053,AMR:0.1528,EAS:0.1706,FIN:0.2384,NFE:0.2976,OTH:0.1759,ASJ:0.0404	601557	.	.	.	.	.	.	.	1.0	-1.67	0.000	2.06	12	3(large_intestine)	0.1927
12	109625977	109625984	TCCTTCCT	-	ACACB	intronic	.	ENSG00000076555	rs1060499836	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0364	.	0.294529	0.3129	.	.	.	.	.	.	.	.	.	.	AFR:0.1771,AMR:0.2373,EAS:0.3029,FIN:0.3975,NFE:0.3699,OTH:0.3552,ASJ:0.2816	601557	.	.	.	.	.	.	.	.	.	.	.	12	MU74317174	unknown
12	109629457	109629457	C	T	ACACB	exonic	synonymous SNV	ENSG00000076555	rs7135947	ENSG00000076555:ENST00000377848:exon13:c.C2184T:p.G728G,ENSG00000076555:ENST00000377854:exon13:c.C2184T:p.G728G,ENSG00000076555:ENST00000338432:exon14:c.C2184T:p.G728G	ACACB:NM_001093:exon14:c.C2184T:p.G728G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4891	0.4450	0.38139	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ACACB:uc001toc.3:exon13:c.C2184T:p.G728G,ACACB:uc001tob.3:exon14:c.C2184T:p.G728G	.	AFR:MU4553399,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.2543,FIN:0.5361,NFE:0.5397,OTH:0.2611,ASJ:0.4447	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(thyroid)	0.5198
12	109637188	109637188	G	C	ACACB	intronic	.	ENSG00000076555	rs7299171	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5686	0.6176	0.571086	0.5994	.	.	.	.	.	.	.	.	.	.	AFR:0.7023,AMR:0.5863,EAS:0.2957,FIN:0.5544,NFE:0.5851,OTH:0.5767,ASJ:0.5927	601557	.	.	.	.	.	.	.	.	.	.	.	12	MU12049097	het
12	109670468	109670468	T	C	ACACB	intronic	.	ENSG00000076555	rs3742027	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8819	0.9263	0.866414	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	0	0.022	.	.	.	AFR:0.9149,AMR:0.9797,EAS:0.9040,FIN:0.7463,NFE:0.8896,OTH:0.9024,ASJ:0.9308	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(lung)	0.8857
12	109675029	109675029	T	C	ACACB	exonic	synonymous SNV	ENSG00000076555	rs2241220	ENSG00000076555:ENST00000543201:exon6:c.T504C:p.L168L,ENSG00000076555:ENST00000377854:exon32:c.T4296C:p.L1432L,ENSG00000076555:ENST00000377848:exon33:c.T4506C:p.L1502L,ENSG00000076555:ENST00000338432:exon34:c.T4506C:p.L1502L	ACACB:NM_001093:exon34:c.T4506C:p.L1502L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8239	0.8030	0.779153	0.8114	.	.	.	.	.	.	.	.	ACACB:uc010sxm.2:exon7:c.T504C:p.L168L,ACACB:uc001toc.3:exon33:c.T4506C:p.L1502L,ACACB:uc001tob.3:exon34:c.T4506C:p.L1502L	.	AFR:0.7388,AMR:0.8914,EAS:0.7469,FIN:0.8231,NFE:0.8507,OTH:0.8340,ASJ:0.8642	601557	.	.	.	.	.	.	.	.	.	.	.	12	MU16253196	hom
12	109696838	109696838	G	A	ACACB	exonic	nonsynonymous SNV	ENSG00000076555	rs2075260	ENSG00000076555:ENST00000543201:exon19:c.G2419A:p.V807I,ENSG00000076555:ENST00000377854:exon45:c.G6211A:p.V2071I,ENSG00000076555:ENST00000377848:exon46:c.G6421A:p.V2141I,ENSG00000076555:ENST00000338432:exon47:c.G6421A:p.V2141I	ACACB:NM_001093:exon47:c.G6421A:p.V2141I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7891	0.7810	0.738818	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	2.067	16.64	1.0	5.07	0.992	.	.	Acetyl-CoA carboxylase|Acetyl-coenzyme A carboxyltransferase, C-terminal|ClpP/crotonase-like domain	ACACB:uc010sxm.2:exon20:c.G2419A:p.V807I,ACACB:uc001toc.3:exon46:c.G6421A:p.V2141I,ACACB:uc001tob.3:exon47:c.G6421A:p.V2141I	-0.903	AFR:0.7894,AMR:0.7096,EAS:0.8642,FIN:0.7373,NFE:0.8456,OTH:0.8210,ASJ:0.8711	601557	.	.	.	.	.	.	.	0.002	-4.36	0.000	-3.51	12	1(lung)	0.8084
12	109698427	109698427	G	A	ACACB	exonic	synonymous SNV	ENSG00000076555	rs61753862	ENSG00000076555:ENST00000377854:exon46:c.G6429A:p.P2143P,ENSG00000076555:ENST00000377848:exon47:c.G6639A:p.P2213P,ENSG00000076555:ENST00000338432:exon48:c.G6639A:p.P2213P	ACACB:NM_001093:exon48:c.G6639A:p.P2213P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0004	.	0.000599042	.	.	.	.	.	.	.	.	.	ACACB:uc010sxm.2:exon21:c.G2637A:p.P879P,ACACB:uc001toc.3:exon47:c.G6639A:p.P2213P,ACACB:uc001tob.3:exon48:c.G6639A:p.P2213P	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601557	.	.	.	.	.	.	.	.	.	.	.	12	MU121113350	het
12	110019338	110019338	C	T	MVK	exonic	synonymous SNV	ENSG00000110921	rs2287218	ENSG00000110921:ENST00000228510:exon5:c.C510T:p.D170D,ENSG00000110921:ENST00000539335:exon5:c.C510T:p.D170D,ENSG00000110921:ENST00000546277:exon5:c.C510T:p.D170D	MVK:NM_000431:exon5:c.C510T:p.D170D,MVK:NM_001114185:exon5:c.C510T:p.D170D	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1618	0.1776	0.163339	0.1668	.	.	.	.	.	.	.	.	MVK:uc021rdo.1:exon4:c.C510T:p.D170D,MVK:uc001toy.4:exon5:c.C510T:p.D170D,MVK:uc009zvk.3:exon5:c.C510T:p.D170D	.	AFR:0.1924,AMR:0.1527,EAS:0.1493,FIN:0.1060,NFE:0.1711,OTH:0.1339,ASJ:0.1623	251170	175900;260920;610377;	29;343;735;79152;	29|Complete mevalonate kinase deficiency<br>MVA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|610377 ~343|HIDS<br>Hyper-IgD syndrome<br>Hyperimmunoglobinemia D with recurrent fever<br>Hyperimmunoglobulinemia D syndrome<br>Partial mevalonate kinase deficiency|Unknown|Autosomal recessive|Infancy|260920 ~735|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|175800 175900 ~79152|-|Unknown|Autosomal dominant|Adult|175900 607728 612293 612353 614714 616063 616631 ~	.	.	.	.	.	.	.	.	12	MU663414	het
12	110024541	110024541	A	G	MVK	intronic	.	ENSG00000110921	rs2270375	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2339	0.2720	0.228634	0.2532	.	.	.	.	.	.	.	.	.	.	AFR:0.3150,AMR:0.2088,EAS:0.1681,FIN:0.1790,NFE:0.2505,OTH:0.2026,ASJ:0.2119	251170	175900;260920;610377;	29;343;735;79152;	29|Complete mevalonate kinase deficiency<br>MVA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|610377 ~343|HIDS<br>Hyper-IgD syndrome<br>Hyperimmunoglobinemia D with recurrent fever<br>Hyperimmunoglobulinemia D syndrome<br>Partial mevalonate kinase deficiency|Unknown|Autosomal recessive|Infancy|260920 ~735|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|175800 175900 ~79152|-|Unknown|Autosomal dominant|Adult|175900 607728 612293 612353 614714 616063 616631 ~	.	.	.	.	.	.	.	.	12	MU21446883	het
12	110029186	110029186	G	A	MVK	intronic	.	ENSG00000110921	rs2270374	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1490	0.1289	0.111422	MU28687517	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|2|409|0.00488998,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,AMR:0.1214,EAS:0.1384,FIN:0.1623,NFE:0.1506,OTH:0.1062,ASJ:0.0331	251170	175900;260920;610377;	29;343;735;79152;	29|Complete mevalonate kinase deficiency<br>MVA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|610377 ~343|HIDS<br>Hyper-IgD syndrome<br>Hyperimmunoglobinemia D with recurrent fever<br>Hyperimmunoglobulinemia D syndrome<br>Partial mevalonate kinase deficiency|Unknown|Autosomal recessive|Infancy|260920 ~735|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|175800 175900 ~79152|-|Unknown|Autosomal dominant|Adult|175900 607728 612293 612353 614714 616063 616631 ~	.	.	.	.	.	.	.	.	12	1(haematopoietic_and_lymphoid_tissue)	0.1711
12	112036754	112036756	GCT	-	ATXN2	exonic	nonframeshift deletion	ENSG00000204842	rs10560189	ENSG00000204842:ENST00000377617:exon1:c.563_565del:p.188_189del,ENSG00000204842:ENST00000550104:exon1:c.563_565del:p.188_189del,ENSG00000204842:ENST00000608853:exon1:c.83_85del:p.28_29del	ATXN2:NM_002973:exon1:c.83_85del:p.28_29del	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.5912	0.9081	0.951078	0.8379	.	.	.	.	.	.	.	.	ATXN2:uc001tsj.3:exon1:c.563_565del:p.188_189del	.	AFR:0.6558,AMR:0.8634,EAS:0.9291,FIN:0.9112,NFE:0.9045,OTH:0.8974,ASJ:0.9148	601517	168600;183090;	98756;	98756|SCA2|1-9 / 100 000|Autosomal dominant|All ages|183090 ~	.	.	.	.	.	.	.	.	12	.	het
12	112036797	112036797	C	T	ATXN2	exonic	synonymous SNV	ENSG00000204842	rs4098854	ENSG00000204842:ENST00000377617:exon1:c.G522A:p.Q174Q,ENSG00000204842:ENST00000550104:exon1:c.G522A:p.Q174Q,ENSG00000204842:ENST00000608853:exon1:c.G42A:p.Q14Q	ATXN2:NM_002973:exon1:c.G42A:p.Q14Q	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6209	.	0.656749	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	ATXN2:uc001tsj.3:exon1:c.G522A:p.Q174Q	.	AFR:0.7523,AMR:0.7127,EAS:0.8596,FIN:0.6469,NFE:0.7924,OTH:0.7792,ASJ:0.7054	601517	168600;183090;	98756;	98756|SCA2|1-9 / 100 000|Autosomal dominant|All ages|183090 ~	.	.	.	.	.	.	.	.	12	1(large_intestine)	0.7306
12	121416622	121416622	C	G	HNF1A	exonic	synonymous SNV	ENSG00000135100	rs1169289	ENSG00000135100:ENST00000257555:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000400024:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000402929:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000538626:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000538646:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000540108:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000541395:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000541924:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000544413:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000544574:exon1:c.C51G:p.L17L	HNF1A:NM_000545:exon1:c.C51G:p.L17L,HNF1A:NM_001306179:exon1:c.C51G:p.L17L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4722	0.4175	0.428514	MU94809	.	.	.	.	.	.	.	.	HNF1A:uc001tze.2:exon1:c.C51G:p.L17L,HNF1A:uc001tzf.3:exon1:c.C51G:p.L17L,HNF1A:uc001tzg.3:exon1:c.C51G:p.L17L,HNF1A:uc010szn.2:exon1:c.C51G:p.L17L,HNF1A:uc021rez.1:exon1:c.C51G:p.L17L,HNF1A:uc021rfa.1:exon1:c.C51G:p.L17L	.	AFR:LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579,AMR:0.4253,EAS:0.4713,FIN:0.5533,NFE:0.3823,OTH:0.4897,ASJ:0.3333	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	.	.	.	.	12	15(liver)	0.4598
12	121416650	121416650	A	C	HNF1A	exonic	nonsynonymous SNV	ENSG00000135100	rs1169288	ENSG00000135100:ENST00000257555:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000400024:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000402929:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000538646:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000540108:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000541395:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000541924:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000544413:exon1:c.A79C:p.I27L	HNF1A:NM_000545:exon1:c.A79C:p.I27L,HNF1A:NM_001306179:exon1:c.A79C:p.I27L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.3533	0.2625	0.298522	4(prostate)	5.234	25.6	0.082	4.45	0.999	.	.	Hepatocyte nuclear factor 1, N-terminal|Hepatocyte nuclear factor 1, dimerisation domain	HNF1A:uc001tze.2:exon1:c.A79C:p.I27L,HNF1A:uc001tzf.3:exon1:c.A79C:p.I27L,HNF1A:uc001tzg.3:exon1:c.A79C:p.I27L,HNF1A:uc010szn.2:exon1:c.A79C:p.I27L,HNF1A:uc021rfa.1:exon1:c.A79C:p.I27L	-1.199	AFR:10(soft_tissue),AMR:1(urinary_tract),EAS:COCA-CN|4|321|0.0124611,FIN:0.2924,NFE:0.1228,OTH:0.3648,ASJ:MU94794	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.02	-4.99	0.000	2.125	12	1(large_intestine)	0.43
12	121435342	121435342	C	T	HNF1A	exonic	synonymous SNV	ENSG00000135100	rs2259820	ENSG00000135100:ENST00000535955:exon2:c.C91T:p.L31L,ENSG00000135100:ENST00000538626:exon2:c.C121T:p.L41L,ENSG00000135100:ENST00000257555:exon7:c.C1375T:p.L459L,ENSG00000135100:ENST00000400024:exon7:c.C1375T:p.L459L,ENSG00000135100:ENST00000541395:exon7:c.C1375T:p.L459L,ENSG00000135100:ENST00000544413:exon7:c.C1375T:p.L459L	HNF1A:NM_000545:exon7:c.C1375T:p.L459L,HNF1A:NM_001306179:exon7:c.C1375T:p.L459L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3368	0.2464	0.316693	1(large_intestine)	.	.	.	.	.	.	.	.	HNF1A:uc021rey.1:exon2:c.C22T:p.L8L,HNF1A:uc021rez.1:exon2:c.C121T:p.L41L,HNF1A:uc021rex.1:exon3:c.C163T:p.L55L,HNF1A:uc021rfb.1:exon6:c.C991T:p.L331L,HNF1A:uc001tzf.3:exon7:c.C1375T:p.L459L,HNF1A:uc001tzg.3:exon7:c.C1375T:p.L459L,HNF1A:uc010szn.2:exon7:c.C1375T:p.L459L,HNF1A:uc021rfa.1:exon7:c.C1375T:p.L459L	.	AFR:MU4605555,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BLCA-CN|1|103|0.00970874,EAS:0.1214,FIN:0.3624,NFE:0.4533,OTH:0.4839,ASJ:0.2679	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	.	.	.	.	12	1(urinary_tract)	0.3200
12	121435427	121435427	G	A	HNF1A	exonic	nonsynonymous SNV	ENSG00000135100	rs2464196	ENSG00000135100:ENST00000535955:exon2:c.G176A:p.S59N,ENSG00000135100:ENST00000538626:exon2:c.G206A:p.S69N,ENSG00000135100:ENST00000257555:exon7:c.G1460A:p.S487N,ENSG00000135100:ENST00000400024:exon7:c.G1460A:p.S487N,ENSG00000135100:ENST00000541395:exon7:c.G1460A:p.S487N,ENSG00000135100:ENST00000544413:exon7:c.G1460A:p.S487N	HNF1A:NM_000545:exon7:c.G1460A:p.S487N,HNF1A:NM_001306179:exon7:c.G1460A:p.S487N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3465	0.2473	0.317692	1(thymus)	1.856	15.32	0.111	3.53	0.998	.	.	Hepatocyte nuclear factor 1, beta isoform, C-terminal	HNF1A:uc021rey.1:exon2:c.G107A:p.S36N,HNF1A:uc021rez.1:exon2:c.G206A:p.S69N,HNF1A:uc021rex.1:exon3:c.G248A:p.S83N,HNF1A:uc021rfb.1:exon6:c.G1076A:p.S359N,HNF1A:uc001tzf.3:exon7:c.G1460A:p.S487N,HNF1A:uc001tzg.3:exon7:c.G1460A:p.S487N,HNF1A:uc010szn.2:exon7:c.G1460A:p.S487N,HNF1A:uc021rfa.1:exon7:c.G1460A:p.S487N	-1.097	AFR:1(large_intestine),AMR:MU30045786,EAS:0.2682,FIN:0.1233,NFE:0.3628,OTH:0.4536,ASJ:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.0	-4.39	0.000	1.1	12	11(soft_tissue)	0.4839
12	121435475	121435475	G	A	HNF1A	intronic	.	ENSG00000135100	rs2464195	ENSG00000135100:ENST00000535955:exon2:c.G224A:p.R75H,ENSG00000135100:ENST00000538626:exon2:c.G254A:p.R85H,ENSG00000135100:ENST00000400024:exon7:c.G1508A:p.R503H	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4347	0.2901	0.359625	0.3080	-0.684	0.078	.	-8.98	0.005	0	0.002	.	HNF1A:uc021rey.1:exon2:c.G155A:p.R52H,HNF1A:uc021rez.1:exon2:c.G254A:p.R85H,HNF1A:uc021rex.1:exon3:c.G296A:p.R99H,HNF1A:uc001tzf.3:exon7:c.G1508A:p.R503H	-1.027	AFR:0.1407,AMR:0.4069,EAS:0.4851,FIN:0.3794,NFE:0.3552,OTH:0.3867,ASJ:0.5	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.0	.	0.000	.	12	MU30045803	hom
12	121437221	121437221	T	C	HNF1A	intronic	.	ENSG00000135100	rs1169304	ENSG00000135100:ENST00000541395:exon8:c.T1652C:p.L551S	.	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8145	0.7439	0.776957	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	-0.395	0.398	0.046	-10.8	0.000	.	.	.	HNF1A:uc021rfa.1:exon8:c.T1652C:p.L551S	-0.976	AFR:0.7423,AMR:0.5893,EAS:0.8808,FIN:0.8666,NFE:0.8200,OTH:0.7835,ASJ:0.8986	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	.	-5.3	0.000	.	12	18(meninges)	0.8170
12	121437382	121437382	A	G	HNF1A	exonic	nonsynonymous SNV	ENSG00000135100	rs1169305	ENSG00000135100:ENST00000541395:exon8:c.A1813G:p.S605G,ENSG00000135100:ENST00000257555:exon9:c.A1720G:p.S574G,ENSG00000135100:ENST00000544413:exon9:c.A1741G:p.S581G	HNF1A:NM_000545:exon9:c.A1720G:p.S574G,HNF1A:NM_001306179:exon9:c.A1741G:p.S581G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9958	0.9869	0.985224	0.9870	0.272	5.414	0.779	2.58	0.047	.	.	Hepatocyte nuclear factor 1, alpha isoform C-terminal	HNF1A:uc021rfa.1:exon8:c.A1813G:p.S605G,HNF1A:uc021rfb.1:exon8:c.A1336G:p.S446G,HNF1A:uc001tzg.3:exon9:c.A1720G:p.S574G,HNF1A:uc010szn.2:exon9:c.A1741G:p.S581G	-0.950	AFR:0.9548,AMR:0.9940,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:1	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.0	-2.86	0.000	.	12	MU81933200	hom
12	122807369	122807369	A	C	CLIP1	intronic	.	ENSG00000256304	rs868181	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.436901	0.5076	.	.	.	.	.	.	.	.	.	.	AFR:0.1974,AMR:0.5286,EAS:0.3930,FIN:0.7046,NFE:0.6419,OTH:0.6367,ASJ:0.6490	179838	.	.	.	.	.	.	.	.	.	.	.	12	.	hom
12	122807572	122807572	C	T	CLIP1	intronic	.	ENSG00000256304	rs11057522	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.436502	0.5075	.	.	.	.	.	.	.	.	.	.	AFR:0.1971,AMR:0.5288,EAS:0.3904,FIN:0.7040,NFE:0.6422,OTH:0.6378,ASJ:0.6490	179838	.	.	.	.	.	.	.	.	.	.	.	12	MU27354982	hom
12	122812503	122812503	G	C	CLIP1	exonic	nonsynonymous SNV	ENSG00000130779	rs1129167	ENSG00000130779:ENST00000545889:exon12:c.C1965G:p.D655E,ENSG00000130779:ENST00000302528:exon15:c.C3207G:p.D1069E,ENSG00000130779:ENST00000361654:exon15:c.C2874G:p.D958E,ENSG00000130779:ENST00000537178:exon15:c.C3102G:p.D1034E,ENSG00000130779:ENST00000358808:exon16:c.C3207G:p.D1069E,ENSG00000130779:ENST00000540338:exon16:c.C3240G:p.D1080E	CLIP1:NM_198240:exon15:c.C3102G:p.D1034E,CLIP1:NM_002956:exon16:c.C3207G:p.D1069E,CLIP1:NM_001247997:exon17:c.C3240G:p.D1080E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5625	0.4683	0.40655	MU12068476	-0.563	0.154	0.428	0.728	0.376	.	.	.	CLIP1:uc001ucj.1:exon12:c.C1965G:p.D655E,CLIP1:uc001uci.1:exon15:c.C3102G:p.D1034E,CLIP1:uc001uch.1:exon16:c.C3207G:p.D1069E,CLIP1:uc001ucg.2:exon17:c.C3240G:p.D1080E	-0.930	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|4|170|0.0235294,COCA-CN|4|321|0.0124611,AMR:0.4857,EAS:0.5191,FIN:0.6324,NFE:0.3775,OTH:0.7017,ASJ:0.1444	179838	.	.	.	.	.	.	.	0.0	1.26	0.000	0.145	12	4(lung)	0.6316
12	133201947	133201947	T	C	POLE	intronic	.	ENSG00000177084	rs4883544	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6446	0.6455	0.716254	0.6670	.	.	.	.	.	.	.	.	.	.	AFR:0.8092,AMR:0.7721,EAS:0.8098,FIN:0.5787,NFE:0.5909,OTH:0.6014,ASJ:0.5099	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	12	MU10345598	het
12	133202004	133202004	C	T	POLE	intronic	.	ENSG00000177084	rs4883543	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4917	0.4674	0.566494	0.4949	.	.	.	.	.	.	.	.	.	.	AFR:0.5844,AMR:0.5825,EAS:0.7052,FIN:0.4396,NFE:0.4328,OTH:0.4601,ASJ:0.3775	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	12	MU19385780	het
12	133202215	133202215	G	A	POLE	intronic	.	ENSG00000177084	rs5745075	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3703	0.3203	0.423323	0.3590	.	.	.	.	.	.	.	.	.	.	AFR:0.3566,AMR:0.4726,EAS:0.6983,FIN:0.4014,NFE:0.3111,OTH:0.3561,ASJ:0.19	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	12	MU12087933	het
12	133208886	133208886	C	T	POLE	intronic	.	ENSG00000177084	rs5745023	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4941	0.4803	0.565096	0.4931	.	.	.	.	.	.	.	.	.	.	AFR:0.5854,AMR:0.5813,EAS:0.7048,FIN:0.4327,NFE:0.4301,OTH:0.4611,ASJ:0.3775	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	12	MU731565	het
12	133208979	133208979	T	C	POLE	exonic	synonymous SNV	ENSG00000177084	rs5745022	ENSG00000177084:ENST00000535270:exon44:c.A6171G:p.S2057S,ENSG00000177084:ENST00000320574:exon45:c.A6252G:p.S2084S	POLE:NM_006231:exon45:c.A6252G:p.S2084S	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6381	0.6427	0.699081	0.6546	.	.	.	.	.	.	.	.	POLE:uc001ukq.1:exon7:c.A882G:p.S294S,POLE:uc001ukr.1:exon19:c.A2664G:p.S888S,POLE:uc001uks.1:exon45:c.A6252G:p.S2084S	.	AFR:0.7676,AMR:0.7685,EAS:0.8075,FIN:0.5790,NFE:0.5901,OTH:0.5992,ASJ:0.5099	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	,9090,9089,9091	.	.	.	.	.	.	12	MU20983838	het
12	133219831	133219831	T	C	POLE	exonic	synonymous SNV	ENSG00000177084	rs5744944	ENSG00000177084:ENST00000535270:exon34:c.A4449G:p.A1483A,ENSG00000177084:ENST00000320574:exon35:c.A4530G:p.A1510A	POLE:NM_006231:exon35:c.A4530G:p.A1510A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5032	0.5224	0.605232	0.5291	.	.	.	.	.	.	.	.	POLE:uc001ukr.1:exon9:c.A942G:p.A314A,POLE:uc009zyu.1:exon34:c.A4449G:p.A1483A,POLE:uc001uks.1:exon35:c.A4530G:p.A1510A	.	AFR:0.7113,AMR:0.5897,EAS:0.7043,FIN:0.4335,NFE:0.4301,OTH:0.4684,ASJ:0.3733	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	,9090,9089,9091	.	.	.	.	.	.	12	MU4555145	het
12	133233705	133233705	T	C	POLE	intronic	.	ENSG00000177084	rs5744889	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9712	0.9729	0.983826	0.9764	.	.	.	.	.	.	.	.	.	.	AFR:0.9929,AMR:0.9749,EAS:1,FIN:0.9625,NFE:0.9678,OTH:0.9694,ASJ:0.9868	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	12	MU81935649	hom
12	133236000	133236000	C	T	POLE	exonic	synonymous SNV	ENSG00000177084	rs5744857	ENSG00000177084:ENST00000536445:exon1:c.G87A:p.T29T,ENSG00000177084:ENST00000539006:exon20:c.G2496A:p.T832T,ENSG00000177084:ENST00000535270:exon25:c.G3075A:p.T1025T,ENSG00000177084:ENST00000320574:exon26:c.G3156A:p.T1052T	POLE:NM_006231:exon26:c.G3156A:p.T1052T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5029	0.5225	0.605431	0.5300	.	.	.	.	.	.	.	.	POLE:uc009zyu.1:exon25:c.G3075A:p.T1025T,POLE:uc001uks.1:exon26:c.G3156A:p.T1052T	.	AFR:0.7123,AMR:0.5935,EAS:0.7048,FIN:0.4338,NFE:0.4309,OTH:0.4682,ASJ:0.3885	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	,9090,9089,9091	.	.	.	.	.	.	12	MU19389260	het
12	133252796	133252796	C	G	POLE	intronic	.	ENSG00000177084	rs4077170	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6307	0.6821	0.571685	0.6435	.	.	.	.	.	0.0001	0.018	.	.	.	AFR:0.6422,AMR:0.5251,EAS:0.3015,FIN:0.6059,NFE:0.6933,OTH:0.6436,ASJ:0.8133	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	12	MU13664180	het
12	133263825	133263825	G	A	POLE	intronic	.	ENSG00000177084	rs2075784	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4901	.	0.378794	0.4355	.	.	.	.	.	.	.	.	.	.	AFR:0.2512,AMR:0.3955,EAS:0.2926,FIN:0.5271,NFE:0.5325,OTH:0.5011,ASJ:0.61	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	12	MU81935707	het
13	20763341	20763341	C	T	GJB2	exonic	nonsynonymous SNV	ENSG00000165474	rs111033196	ENSG00000165474:ENST00000382844:exon1:c.G380A:p.R127H,ENSG00000165474:ENST00000382848:exon2:c.G380A:p.R127H	GJB2:NM_004004:exon2:c.G380A:p.R127H	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 1, 1, -1, 0, 0] 	0.0154	0.0023	0.0269569	0.0015	3.543	23.1	0.207	5.47	0.997	.	.	Connexin, N-terminal	GJB2:uc021rha.1:exon1:c.G380A:p.R127H,GJB2:uc001umy.3:exon2:c.G380A:p.R127H	0.322	AFR:0.0005,AMR:0.0012,EAS:0.0006,FIN:0,NFE:0.0021,OTH:0.0092,ASJ:0	121011	124500;148210;148350;149200;220290;601544;602540;	477;90635;90636;2698;2202;477;494;	477|KID/HID syndrome<br>Keratitis-ichthyosis-deafness/Hystrix-like ichthyosis-deafness syndrome<br>Senter syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal|148210 242150 602540 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~2698|Bart-Pumphrey syndrome<br>Knuckle pads-leukonychia-sensorineural deafness-palmoplantar keratoderma syndrome|<1 / 1 000 000|-|Childhood|149200 ~2202|PPK-deafness syndrome<br>Palmoplantar hyperkeratosis-deafness syndrome<br>Palmoplantar hyperkeratosis-hearing loss syndrome<br>Palmoplantar keratoderma-hearing loss syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Mitochondrial inheritance|Childhood|148350 ~477|KID/HID syndrome<br>Keratitis-ichthyosis-deafness/Hystrix-like ichthyosis-deafness syndrome<br>Senter syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal|148210 242150 602540 ~494|Mutilating keratoderma of Vohwinkel<br>Mutilating keratoderma plus deafness<br>PPK mutilans and deafness<br>Vohwinkel syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|124500 ~	.	.	.	.	0.001	-4.51	0.757	1.325	13	.	het
13	21562482	21562482	-	GGGGCG	LATS2	exonic	nonframeshift insertion	ENSG00000150457	rs550642106	ENSG00000150457:ENST00000382592:exon4:c.1436_1437insCGCCCC:p.P479delinsPAP,ENSG00000150457:ENST00000542899:exon4:c.1436_1437insCGCCCC:p.P479delinsPAP	LATS2:NM_014572:exon4:c.1436_1437insCGCCCC:p.P479delinsPAP	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0072	0.1606	0.254393	0.4392	.	.	.	.	.	.	.	.	LATS2:uc001unr.4:exon4:c.1436_1437insCGCCCC:p.P479delinsPAP,LATS2:uc009zzs.3:exon4:c.1436_1437insCGCCCC:p.P479delinsPAP	.	AFR:0.2789,AMR:0.4558,EAS:0.3763,FIN:0.4664,NFE:0.5314,OTH:0.4918,ASJ:0.5584	604861	.	.	.	.	.	.	.	.	.	.	.	13	MU3892220	hom
13	21562832	21562832	C	T	LATS2	exonic	nonsynonymous SNV	ENSG00000150457	rs2770928	ENSG00000150457:ENST00000382592:exon4:c.G1087A:p.G363S,ENSG00000150457:ENST00000542899:exon4:c.G1087A:p.G363S	LATS2:NM_014572:exon4:c.G1087A:p.G363S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8729	0.8326	0.85024	MU64421	-0.186	1.173	0.472	-1.07	0.002	.	.	.	LATS2:uc001unr.4:exon4:c.G1087A:p.G363S,LATS2:uc009zzs.3:exon4:c.G1087A:p.G363S	-0.913	AFR:COCA-CN|5|321|0.0155763,AMR:0.8239,EAS:0.9270,FIN:0.9503,NFE:0.9981,OTH:0.8210,ASJ:0.7116	604861	.	.	.	.	.	.	.	0.002	0.4	0.000	0.38	13	1(thyroid)	0.8614
13	21562948	21562948	G	A	LATS2	exonic	nonsynonymous SNV	ENSG00000150457	rs558614	ENSG00000150457:ENST00000382592:exon4:c.C971T:p.A324V,ENSG00000150457:ENST00000542899:exon4:c.C971T:p.A324V	LATS2:NM_014572:exon4:c.C971T:p.A324V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7345	0.7346	0.629593	1(peritoneum)	1.454	13.07	0.194	2.72	0.215	.	.	.	LATS2:uc001unr.4:exon4:c.C971T:p.A324V,LATS2:uc009zzs.3:exon4:c.C971T:p.A324V	-0.968	AFR:MU60225,AMR:COCA-CN|3|321|0.00934579,EAS:0.5518,FIN:0.6842,NFE:0.8733,OTH:0.5211,ASJ:0.6984	604861	.	.	.	.	.	.	.	0.216	0.29	0.000	0.345	13	1(thyroid)	0.7110
13	21569227	21569227	T	C	LATS2	intronic	.	ENSG00000150457	rs12323117	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.0810703	0.1126	.	.	.	.	.	.	.	.	.	.	AFR:0.0700,AMR:0.0562,EAS:0.0019,FIN:0.1790,NFE:0.1365,OTH:0.1434,ASJ:0.0372	604861	.	.	.	.	.	.	.	.	.	.	.	13	.	het
13	21620085	21620085	T	C	LATS2	exonic	synonymous SNV	ENSG00000150457	rs7317471	ENSG00000150457:ENST00000382592:exon2:c.A81G:p.K27K,ENSG00000150457:ENST00000542899:exon2:c.A81G:p.K27K	LATS2:NM_014572:exon2:c.A81G:p.K27K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8496	0.7806	0.807508	0.8142	.	.	.	.	.	.	.	.	LATS2:uc001unr.4:exon2:c.A81G:p.K27K,LATS2:uc009zzs.3:exon2:c.A81G:p.K27K	.	AFR:0.6717,AMR:0.8969,EAS:0.9047,FIN:0.8845,NFE:0.8646,OTH:0.8661,ASJ:0.7185	604861	.	.	.	.	.	.	.	.	.	.	.	13	MU114292	hom
13	22249144	22249144	C	G	FGF9	intronic	.	ENSG00000102678	rs12430456	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.834864	0.8289	.	.	.	.	.	.	.	.	.	.	AFR:0.7127,AMR:0.8990,EAS:1,FIN:0.8364,NFE:0.8634,OTH:0.8610,ASJ:0.8214	600921	612961;	3237;	3237|Deafness-Hermann type symphalangism syndrome<br>Facio-audio-symphalangism<br>Symphalangism-brachydactyly syndrome<br>WL syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|186500 610017 612961 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	.	hom
13	22275394	22275394	A	G	FGF9	exonic	synonymous SNV	ENSG00000102678	rs9509841	ENSG00000102678:ENST00000382353:exon3:c.A447G:p.S149S	FGF9:NM_002010:exon3:c.A447G:p.S149S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8398	0.7740	0.832468	0.7863	.	.	.	.	.	.	.	.	FGF9:uc001uog.2:exon3:c.A447G:p.S149S	.	AFR:0.6565,AMR:0.9067,EAS:0.9561,FIN:0.7947,NFE:0.8312,OTH:0.8259,ASJ:0.8278	600921	612961;	3237;	3237|Deafness-Hermann type symphalangism syndrome<br>Facio-audio-symphalangism<br>Symphalangism-brachydactyly syndrome<br>WL syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|186500 610017 612961 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	MU28813827	hom
13	22275583	22275583	G	A	FGF9	UTR3	.	ENSG00000102678	rs9509842	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9948	0.9805	0.981829	0.9831	.	.	.	.	.	.	.	.	.	.	AFR:0.9409,AMR:0.9952,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:0.9967	600921	612961;	3237;	3237|Deafness-Hermann type symphalangism syndrome<br>Facio-audio-symphalangism<br>Symphalangism-brachydactyly syndrome<br>WL syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|186500 610017 612961 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	MU81936344	hom
13	26125490	26125490	G	A	ATP8A2	exonic	synonymous SNV	ENSG00000132932	rs9581388	ENSG00000132932:ENST00000255283:exon10:c.G786A:p.A262A,ENSG00000132932:ENST00000281620:exon10:c.G426A:p.A142A,ENSG00000132932:ENST00000381655:exon11:c.G906A:p.A302A	ATP8A2:NM_001313741:exon11:c.G786A:p.A262A,ATP8A2:NM_016529:exon11:c.G906A:p.A302A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0584	0.0602	0.0846645	0.0566	.	.	.	.	.	.	.	.	ATP8A2:uc001uql.1:exon10:c.G786A:p.A262A,ATP8A2:uc001uqk.3:exon11:c.G906A:p.A302A,ATP8A2:uc010tdi.2:exon11:c.G786A:p.A262A	.	AFR:0.1154,AMR:0.0692,EAS:0.0006,FIN:0.0530,NFE:0.0286,OTH:0.0573,ASJ:0.06	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	MU80632170	het
13	26148966	26148966	C	T	ATP8A2	exonic	synonymous SNV	ENSG00000132932	rs6491066	ENSG00000132932:ENST00000255283:exon18:c.C1563T:p.F521F,ENSG00000132932:ENST00000281620:exon18:c.C1203T:p.F401F,ENSG00000132932:ENST00000381655:exon19:c.C1683T:p.F561F	ATP8A2:NM_001313741:exon19:c.C1563T:p.F521F,ATP8A2:NM_016529:exon19:c.C1683T:p.F561F	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6287	0.7083	0.536342	MU12280117	.	.	.	.	.	.	.	.	ATP8A2:uc010aaj.1:exon4:c.C213T:p.F71F,ATP8A2:uc001uqk.3:exon19:c.C1683T:p.F561F,ATP8A2:uc010tdi.2:exon19:c.C1563T:p.F521F	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.6729,EAS:0.5805,FIN:0.72,NFE:0.1,OTH:0.6735,ASJ:0.6978	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	1(large_intestine)	0.7251
13	26155953	26155953	G	C	ATP8A2	intronic	.	ENSG00000132932	rs7335339	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5764	0.6578	0.43111	LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	0	0	.	.	.	AFR:0.6009,AMR:0.5279,EAS:0.6733,FIN:0.0105,NFE:0.6420,OTH:0.7033,ASJ:0.4450	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	1(large_intestine)	0.6260
13	26273385	26273385	G	C	ATP8A2	exonic	synonymous SNV	ENSG00000132932	rs6491088	ENSG00000132932:ENST00000255283:exon24:c.G2166C:p.L722L,ENSG00000132932:ENST00000281620:exon24:c.G1806C:p.L602L,ENSG00000132932:ENST00000381655:exon25:c.G2286C:p.L762L	ATP8A2:NM_001313741:exon25:c.G2166C:p.L722L,ATP8A2:NM_016529:exon25:c.G2286C:p.L762L	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9973	0.9898	0.98742	0.9919	.	.	.	.	.	.	.	.	ATP8A2:uc010aaj.1:exon11:c.G936C:p.L312L,ATP8A2:uc001uqk.3:exon25:c.G2286C:p.L762L,ATP8A2:uc010tdi.2:exon25:c.G2166C:p.L722L	.	AFR:0.9715,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:0.9990,ASJ:1	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	MU81937382	hom
13	26436641	26436641	C	T	ATP8A2	intronic	.	ENSG00000132932	rs2249800	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.503195	0.5360	.	.	.	.	.	.	.	.	.	.	AFR:0.4786,AMR:0.3864,EAS:0.6225,FIN:0.6073,NFE:0.5490,OTH:0.5898,ASJ:0.5	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	MU12280346	het
13	28608459	28608459	T	C	FLT3	exonic	synonymous SNV	ENSG00000122025	rs34374211	ENSG00000122025:ENST00000241453:exon13:c.A1683G:p.L561L,ENSG00000122025:ENST00000380982:exon13:c.A1683G:p.L561L,ENSG00000122025:ENST00000380987:exon13:c.A1683G:p.L561L,ENSG00000122025:ENST00000537084:exon13:c.A1683G:p.L561L	FLT3:NM_004119:exon13:c.A1683G:p.L561L	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.0823	0.0960	0.139776	1(small_intestine)	.	.	.	.	.	.	.	.	FLT3:uc001urw.3:exon13:c.A1683G:p.L561L,FLT3:uc010tdn.2:exon13:c.A1683G:p.L561L	.	AFR:MU21541441,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,EAS:0.2274,FIN:0.0489,NFE:0.0728,OTH:0.1068,ASJ:0.1007	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05230 Central carbon metabolism in cancer ~	,5779,5791,5787,5789,5780,5782,5784,5788,5790,5783,5781,5786,5795,5785	.	.	.	.	.	.	13	1(soft_tissue)	0.0372
13	28624294	28624294	G	A	FLT3	exonic	nonsynonymous SNV	ENSG00000122025	rs1933437	ENSG00000122025:ENST00000241453:exon6:c.C680T:p.T227M,ENSG00000122025:ENST00000380982:exon6:c.C680T:p.T227M,ENSG00000122025:ENST00000380987:exon6:c.C680T:p.T227M,ENSG00000122025:ENST00000537084:exon6:c.C680T:p.T227M	FLT3:NM_004119:exon6:c.C680T:p.T227M	clinvar: not_provided 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.5988	0.5229	0.558706	11(meninges)	4.144	23.8	0.042	3.85	0.613	.	.	.	FLT3:uc001urw.3:exon6:c.C680T:p.T227M,FLT3:uc010tdn.2:exon6:c.C680T:p.T227M	-0.903	AFR:MU24013025,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|6|321|0.0186916,EAS:0.3404,FIN:0.6154,NFE:0.5861,OTH:0.7751,ASJ:0.5435	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05230 Central carbon metabolism in cancer ~	,5779,5791,5787,5789,5780,5782,5784,5800,5788,5790,5783,5781,5786,5795,5785	.	.	0.999	-1.23	0.000	0.895	13	18(soft_tissue)	0.6133
13	28636084	28636084	G	A	FLT3	exonic	synonymous SNV	ENSG00000122025	rs7338903	ENSG00000122025:ENST00000241453:exon3:c.C288T:p.D96D,ENSG00000122025:ENST00000380982:exon3:c.C288T:p.D96D,ENSG00000122025:ENST00000380987:exon3:c.C288T:p.D96D,ENSG00000122025:ENST00000537084:exon3:c.C288T:p.D96D	FLT3:NM_004119:exon3:c.C288T:p.D96D	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9827	0.9599	0.958067	0.9662	.	.	.	.	.	.	.	.	FLT3:uc001urw.3:exon3:c.C288T:p.D96D,FLT3:uc010tdn.2:exon3:c.C288T:p.D96D	.	AFR:0.9027,AMR:0.9869,EAS:0.9994,FIN:0.9957,NFE:0.9893,OTH:0.9898,ASJ:0.9967	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05230 Central carbon metabolism in cancer ~	,5779,5791,5787,5789,5780,5782,5784,5788,5790,5783,5781,5786,5795,5785	.	.	.	.	.	.	13	MU81937601	hom
13	28674628	28674628	T	C	FLT3	exonic	nonsynonymous SNV	ENSG00000122025	rs12872889	ENSG00000122025:ENST00000241453:exon1:c.A20G:p.D7G,ENSG00000122025:ENST00000380982:exon1:c.A20G:p.D7G,ENSG00000122025:ENST00000380987:exon1:c.A20G:p.D7G,ENSG00000122025:ENST00000537084:exon1:c.A20G:p.D7G	FLT3:NM_004119:exon1:c.A20G:p.D7G	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 1, 0, 2, -1, 1, 1] 	0	.	0.373602	.	2.005	16.24	0.797	2.1	0.961	.	.	.	FLT3:uc001urw.3:exon1:c.A20G:p.D7G,FLT3:uc010tdn.2:exon1:c.A20G:p.D7G	-0.943	AFR:.,AMR:0.3645,EAS:0.1619,FIN:0.1747,NFE:0.3531,OTH:0.2879,ASJ:0.6005	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05230 Central carbon metabolism in cancer ~	,5779,5791,5787,5789,5780,5782,5784,5788,5790,5783,5781,5786,5795,5785	.	.	0.0	-1.07	0.000	0	13	7(meninges)	0.2633
13	28883061	28883061	G	A	FLT1	exonic	synonymous SNV	ENSG00000102755	rs7993418	ENSG00000102755:ENST00000543394:exon8:c.C708T:p.Y236Y,ENSG00000102755:ENST00000540678:exon15:c.C1293T:p.Y431Y,ENSG00000102755:ENST00000282397:exon28:c.C3639T:p.Y1213Y	FLT1:NM_002019:exon28:c.C3639T:p.Y1213Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7921	0.6465	0.730831	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FLT1:uc010aap.2:exon7:c.C654T:p.Y218Y,FLT1:uc010aaq.2:exon10:c.C1014T:p.Y338Y,FLT1:uc001usa.3:exon15:c.C1293T:p.Y431Y,FLT1:uc001usb.3:exon28:c.C3639T:p.Y1213Y	.	AFR:0.6798,AMR:0.3548,EAS:0.8477,FIN:0.9969,NFE:0.7871,OTH:0.7888,ASJ:0.8433	165070	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05202 Transcriptional misregulation in cancer~ko05323 Rheumatoid arthritis ~	.	.	.	.	.	.	.	13	1(lung)	0.7990
13	28886113	28886113	A	G	FLT1	intronic	.	ENSG00000102755	rs7328692	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9929	0.9751	0.974042	0.9748	.	.	.	.	.	.	.	.	.	.	AFR:0.9122,AMR:0.9952,EAS:1,FIN:1,NFE:0.9999,OTH:0.9969,ASJ:0.9967	165070	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05202 Transcriptional misregulation in cancer~ko05323 Rheumatoid arthritis ~	.	.	.	.	.	.	.	13	MU81937639	hom
13	28893642	28893642	A	G	FLT1	exonic	synonymous SNV	ENSG00000102755	rs2296189	ENSG00000102755:ENST00000543394:exon4:c.T273C:p.P91P,ENSG00000102755:ENST00000540678:exon11:c.T858C:p.P286P,ENSG00000102755:ENST00000282397:exon24:c.T3204C:p.P1068P	FLT1:NM_002019:exon24:c.T3204C:p.P1068P	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2188	0.2141	0.243011	MU10475303	.	.	.	.	.	.	.	.	FLT1:uc010aap.2:exon3:c.T219C:p.P73P,FLT1:uc010aaq.2:exon6:c.T579C:p.P193P,FLT1:uc001usa.3:exon11:c.T858C:p.P286P,FLT1:uc001usb.3:exon24:c.T3204C:p.P1068P	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,AMR:0.1991,EAS:0.1086,FIN:0.2433,NFE:0.1788,OTH:0.1274,ASJ:0.2770	165070	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05202 Transcriptional misregulation in cancer~ko05323 Rheumatoid arthritis ~	.	.	.	.	.	.	.	13	2(lung)	0.1782
13	32906729	32906729	A	C	BRCA2	exonic	nonsynonymous SNV	ENSG00000139618	rs144848	ENSG00000139618:ENST00000380152:exon10:c.A1114C:p.N372H,ENSG00000139618:ENST00000530893:exon10:c.A745C:p.N249H,ENSG00000139618:ENST00000544455:exon10:c.A1114C:p.N372H	BRCA2:NM_000059:exon10:c.A1114C:p.N372H	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.2779	0.2332	0.249401	0.2218	-1.126	0.009	0.139	0.396	0.202	.	.	.	BRCA2:uc001uua.1:exon10:c.A745C:p.N249H,BRCA2:uc001uub.1:exon10:c.A1114C:p.N372H	-0.951	AFR:0.1201,AMR:0.2637,EAS:0.2679,FIN:0.2272,NFE:0.2670,OTH:0.2668,ASJ:0.3510	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1819,1842,1839,1833,1845,1825,1827,1830,1826,1836,1820,1838,1844,1840,1834,1824,1841,1828,1829,1831,1832,1843,1835,1823,1837	.	,1822,1821	.	5.79	0.000	.	13	MU154185	het
13	32912299	32912299	T	C	BRCA2	exonic	synonymous SNV	ENSG00000139618	rs543304	ENSG00000139618:ENST00000380152:exon11:c.T3807C:p.V1269V,ENSG00000139618:ENST00000544455:exon11:c.T3807C:p.V1269V	BRCA2:NM_000059:exon11:c.T3807C:p.V1269V	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1898	0.1911	0.168131	0.1816	.	.	.	.	.	.	.	.	BRCA2:uc001uub.1:exon11:c.T3807C:p.V1269V	.	AFR:0.1911,AMR:0.1998,EAS:0.1648,FIN:0.1869,NFE:0.1770,OTH:0.1684,ASJ:0.1523	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1819,1842,1839,1833,1845,1825,1827,1830,1826,1836,1820,1838,1844,1840,1834,1824,1841,1828,1829,1831,1832,1843,1835,1823,1837	.	,1822,1821	.	.	.	.	13	MU12290336	het
13	32913055	32913055	A	G	BRCA2	exonic	synonymous SNV	ENSG00000139618	rs206075	ENSG00000139618:ENST00000380152:exon11:c.A4563G:p.L1521L,ENSG00000139618:ENST00000544455:exon11:c.A4563G:p.L1521L	BRCA2:NM_000059:exon11:c.A4563G:p.L1521L	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9931	0.9758	0.974042	0.9799	.	.	.	.	.	.	.	.	BRCA2:uc001uub.1:exon11:c.A4563G:p.L1521L	.	AFR:0.9301,AMR:0.9976,EAS:0.9994,FIN:1,NFE:0.9997,OTH:0.9959,ASJ:1	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1819,1842,1839,1833,1845,1825,1827,1830,1826,1836,1820,1838,1844,1840,1834,1824,1841,1828,1829,1831,1832,1843,1835,1823,1837	.	,1822,1821	.	.	.	.	13	MU81938056	hom
13	32915005	32915005	G	C	BRCA2	exonic	synonymous SNV	ENSG00000139618	rs206076	ENSG00000139618:ENST00000380152:exon11:c.G6513C:p.V2171V,ENSG00000139618:ENST00000544455:exon11:c.G6513C:p.V2171V	BRCA2:NM_000059:exon11:c.G6513C:p.V2171V	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9930	0.9755	0.973642	0.9798	.	.	.	.	.	.	.	.	BRCA2:uc001uub.1:exon11:c.G6513C:p.V2171V	.	AFR:0.9299,AMR:0.9976,EAS:0.9994,FIN:1,NFE:0.9997,OTH:0.9959,ASJ:1	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1819,1842,1839,1833,1845,1825,1827,1830,1826,1836,1820,1838,1844,1840,1834,1824,1841,1828,1829,1831,1832,1843,1835,1823,1837	.	,1822,1821	.	.	.	.	13	MU4551142	hom
13	32929387	32929387	T	C	BRCA2	exonic	nonsynonymous SNV	ENSG00000139618	rs169547	ENSG00000139618:ENST00000380152:exon14:c.T7397C:p.V2466A,ENSG00000139618:ENST00000544455:exon14:c.T7397C:p.V2466A	BRCA2:NM_000059:exon14:c.T7397C:p.V2466A	clinvar: Benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9937	0.9777	0.975839	0.9819	-0.407	0.372	1.0	5.07	0.005	.	.	.	BRCA2:uc031qky.1:exon1:c.T221C:p.V74A,BRCA2:uc001uub.1:exon14:c.T7397C:p.V2466A	-0.930	AFR:0.9369,AMR:0.9976,EAS:0.9994,FIN:1,NFE:0.9997,OTH:0.9980,ASJ:1	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1819,1842,1839,1833,1845,1825,1827,1830,1826,1836,1820,1838,1844,1840,1834,1824,1841,1828,1829,1831,1832,1843,1835,1823,1837	.	,1822,1821	.	5.95	0.000	.	13	MU81938081	hom
13	33232435	33232435	A	G	PDS5B	exonic	synonymous SNV	ENSG00000083642	rs2301393	ENSG00000083642:ENST00000315596:exon4:c.A372G:p.Q124Q,ENSG00000083642:ENST00000450460:exon4:c.A372G:p.Q124Q	PDS5B:NM_015032:exon4:c.A372G:p.Q124Q	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.3724	0.3797	0.271366	0.3782	.	.	.	.	.	.	.	.	PDS5B:uc001uuo.3:exon4:c.A372G:p.Q124Q,PDS5B:uc010abf.3:exon4:c.A372G:p.Q124Q	.	AFR:0.2715,AMR:0.3789,EAS:0.1648,FIN:0.4355,NFE:0.4491,OTH:0.3961,ASJ:0.37	605333	.	.	.	.	,8616	.	.	.	.	.	.	13	MU129748	het
13	33270971	33270971	T	-	PDS5B	intronic	.	ENSG00000083642	rs367730081	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0176	0.0183	0.0173722	0.0099	.	.	.	.	.	.	.	.	.	.	AFR:0.0141,AMR:0.0156,EAS:0.0025,FIN:0.0020,NFE:0.0092,OTH:0.0153,ASJ:0.0166	605333	.	.	.	.	.	.	.	.	.	.	.	13	.	het
13	33315206	33315206	G	A	PDS5B	intronic	.	ENSG00000083642	rs733487	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3649	0.3840	0.274561	0.3918	.	.	.	.	.	0	0	.	.	.	AFR:0.2883,AMR:0.3865,EAS:0.1770,FIN:0.4473,NFE:0.4653,OTH:0.4099,ASJ:0.4051	605333	.	.	.	.	.	.	.	.	.	.	.	13	MU28569403	het
13	33344242	33344242	T	-	PDS5B	intronic	.	ENSG00000083642	rs112309957	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4256	0.4040	0.288938	0.3943	.	.	.	.	.	.	.	.	.	.	AFR:0.3134,AMR:0.3886,EAS:0.1642,FIN:0.4492,NFE:0.4540,OTH:0.4056,ASJ:0.3878	605333	.	.	.	.	.	.	.	.	.	.	.	13	MU41099207	het
13	33590851	33590851	T	C	KL	exonic	synonymous SNV	ENSG00000133116	rs2772364	ENSG00000133116:ENST00000380099:exon1:c.T273C:p.D91D	KL:NM_004795:exon1:c.T273C:p.D91D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9865	0.9475	0.944089	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	KL:uc001uus.3:exon1:c.T273C:p.D91D	.	AFR:0.9500,AMR:0.8254,EAS:1,FIN:1,NFE:1,OTH:0.9993,ASJ:0.9892	604824	211900;	306661;53715;	306661|Hypercalcemic tumoral calcinosis|-|Autosomal recessive|-|211900 ~53715|-|Unknown|Autosomal recessive|Childhood|211900 610455 ~	.	.	.	.	.	.	.	.	13	2(thyroid)	0.9927
13	33635463	33635463	T	C	KL	exonic	synonymous SNV	ENSG00000133116	rs648202	ENSG00000133116:ENST00000380099:exon4:c.T2247C:p.A749A	KL:NM_004795:exon4:c.T2247C:p.A749A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8036	0.7690	0.710863	0.7635	.	.	.	.	.	.	.	.	KL:uc001uus.3:exon4:c.T2247C:p.A749A	.	AFR:0.5728,AMR:0.7955,EAS:0.6103,FIN:0.8794,NFE:0.8528,OTH:0.8514,ASJ:0.9205	604824	211900;	306661;53715;	306661|Hypercalcemic tumoral calcinosis|-|Autosomal recessive|-|211900 ~53715|-|Unknown|Autosomal recessive|Childhood|211900 610455 ~	.	.	.	.	.	.	.	.	13	MU13667379	het
13	33635835	33635835	T	C	KL	exonic	synonymous SNV	ENSG00000133116	rs649964	ENSG00000133116:ENST00000380099:exon4:c.T2619C:p.N873N	KL:NM_004795:exon4:c.T2619C:p.N873N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9919	0.9683	0.976238	0.9760	.	.	.	.	.	.	.	.	KL:uc001uus.3:exon4:c.T2619C:p.N873N	.	AFR:0.9164,AMR:0.9893,EAS:0.9994,FIN:1,NFE:0.9997,OTH:1,ASJ:1	604824	211900;	306661;53715;	306661|Hypercalcemic tumoral calcinosis|-|Autosomal recessive|-|211900 ~53715|-|Unknown|Autosomal recessive|Childhood|211900 610455 ~	.	.	.	.	.	.	.	.	13	MU81938143	hom
13	34404912	34404912	A	G	RFC3	exonic	synonymous SNV	ENSG00000133119	rs1805376	ENSG00000133119:ENST00000380071:exon6:c.A630G:p.Q210Q,ENSG00000133119:ENST00000434425:exon6:c.A630G:p.Q210Q	RFC3:NM_002915:exon6:c.A630G:p.Q210Q,RFC3:NM_181558:exon6:c.A630G:p.Q210Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0225	0.0292	0.0413339	0.0289	.	.	.	.	.	.	.	.	RFC3:uc001uuz.3:exon6:c.A630G:p.Q210Q,RFC3:uc001uva.3:exon6:c.A630G:p.Q210Q,RFC3:uc010ted.1:exon6:c.A630G:p.Q210Q	.	AFR:0.0691,AMR:0.0274,EAS:0.0538,FIN:0.0109,NFE:0.0083,OTH:0.0204,ASJ:0.0033	600405	.	.	.	.	.	.	.	.	.	.	.	13	MU85103695	het
13	48914792	48914792	A	G	RB1	intronic	.	ENSG00000139687	rs198636	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.914137	0.9411	.	.	.	.	.	.	.	.	.	.	AFR:0.8226,AMR:0.9461,EAS:0.9957,FIN:0.9991,NFE:0.9882,OTH:0.9845,ASJ:0.9404	614041	109800;180200;182280;259500;	668;70573;790;	668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~70573|SCLC|1-5 / 10 000|Not applicable|Adult|182280 ~790|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Childhood<br>Antenatal|180200 ~	~ko01522 Endocrine resistance~ko04110 Cell cycle~ko04218 Cellular senescence~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	.	het
13	52520507	52520507	C	T	ATP7B	exonic	synonymous SNV	ENSG00000123191	rs1801246	ENSG00000123191:ENST00000400370:exon5:c.G1683A:p.T561T,ENSG00000123191:ENST00000417240:exon7:c.G789A:p.T263T,ENSG00000123191:ENST00000344297:exon9:c.G2352A:p.T784T,ENSG00000123191:ENST00000448424:exon12:c.G2739A:p.T913T,ENSG00000123191:ENST00000242839:exon13:c.G2973A:p.T991T,ENSG00000123191:ENST00000400366:exon14:c.G2640A:p.T880T	ATP7B:NM_001005918:exon9:c.G2352A:p.T784T,ATP7B:NM_001330579:exon11:c.G2721A:p.T907T,ATP7B:NM_001330578:exon12:c.G2739A:p.T913T,ATP7B:NM_000053:exon13:c.G2973A:p.T991T,ATP7B:NM_001243182:exon14:c.G2640A:p.T880T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0580	0.0529	0.0249601	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	ATP7B:uc010adv.2:exon5:c.G1683A:p.T561T,ATP7B:uc001vfv.2:exon6:c.G789A:p.T263T,ATP7B:uc010tgs.1:exon7:c.G789A:p.T263T,ATP7B:uc001vfx.2:exon9:c.G2352A:p.T784T,ATP7B:uc010tgv.1:exon12:c.G2739A:p.T913T,ATP7B:uc001vfw.2:exon13:c.G2973A:p.T991T,ATP7B:uc010tgu.1:exon13:c.G2829A:p.T943T,ATP7B:uc001vfy.2:exon14:c.G2640A:p.T880T	.	AFR:0.0508,AMR:0.0128,EAS:0.0795,FIN:0,NFE:0.0464,OTH:0.0806,ASJ:0.0251	606882	277900;	905;	905|Hepatolenticular degeneration|1-9 / 100 000|Autosomal recessive|Childhood|277900 ~	.	.	.	.	.	.	.	.	13	1(large_intestine)	0.0468
13	73334662	73334662	C	A	DIS3	intronic	.	ENSG00000083520	rs182271579	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0015	0.0005	0.00199681	0.0002	.	.	.	.	.	0.9997	0.822	.	.	.	AFR:0,AMR:0,EAS:0.0012,FIN:0,NFE:0.0002,OTH:0,ASJ:0.0066	607533	.	.	.	.	.	.	.	.	.	.	.	13	.	het
13	73343039	73343039	C	T	DIS3	exonic	synonymous SNV	ENSG00000083520	rs2196979	ENSG00000083520:ENST00000377767:exon14:c.G1767A:p.T589T,ENSG00000083520:ENST00000377780:exon14:c.G1677A:p.T559T,ENSG00000083520:ENST00000545453:exon15:c.G1281A:p.T427T	DIS3:NM_001322348:exon13:c.G1398A:p.T466T,DIS3:NM_001128226:exon14:c.G1677A:p.T559T,DIS3:NM_014953:exon14:c.G1767A:p.T589T,DIS3:NM_001322349:exon15:c.G1281A:p.T427T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7373	0.7476	0.770168	0.7393	.	.	.	.	.	.	.	.	DIS3:uc001vix.4:exon14:c.G1767A:p.T589T,DIS3:uc001viy.4:exon14:c.G1677A:p.T559T	.	AFR:0.8187,AMR:0.8098,EAS:0.7503,FIN:0.6790,NFE:0.7044,OTH:0.7026,ASJ:0.7384	607533	.	.	.	.	.	.	.	.	.	.	.	13	MU20994899	het
13	73350079	73350079	T	C	DIS3	exonic	nonsynonymous SNV	ENSG00000083520	rs4883918	ENSG00000083520:ENST00000377767:exon5:c.A806G:p.N269S,ENSG00000083520:ENST00000377780:exon5:c.A716G:p.N239S,ENSG00000083520:ENST00000490646:exon5:c.A806G:p.N269S,ENSG00000083520:ENST00000545453:exon6:c.A320G:p.N107S	DIS3:NM_001322348:exon4:c.A437G:p.N146S,DIS3:NM_001128226:exon5:c.A716G:p.N239S,DIS3:NM_014953:exon5:c.A806G:p.N269S,DIS3:NM_001322349:exon6:c.A320G:p.N107S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3363	0.2346	0.327077	0.2589	-1.853	0.002	0.464	-8.07	0.645	.	.	Nucleic acid-binding, OB-fold|Rrp44-like cold shock domain	DIS3:uc001vix.4:exon5:c.A806G:p.N269S,DIS3:uc001viy.4:exon5:c.A716G:p.N239S	-0.938	AFR:0.1060,AMR:0.5084,EAS:0.4807,FIN:0.3083,NFE:0.2964,OTH:0.3108,ASJ:0.2152	607533	.	.	.	.	.	.	.	0.0	2.09	0.000	-0.59	13	MU742526	het
13	101795422	101795422	A	G	NALCN	intronic	.	ENSG00000102452	rs661585	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4910	0.5050	0.521765	0.5118	.	.	.	.	.	.	.	.	NALCN:uc001voy.3:exon17:c.T1272C:p.S424S	.	AFR:0.6003,AMR:0.3998,EAS:0.5087,FIN:0.5146,NFE:0.4689,OTH:0.4836,ASJ:0.4768	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	MU13671660	het
13	101881777	101881777	G	A	NALCN	exonic	synonymous SNV	ENSG00000102452	rs3916906	ENSG00000102452:ENST00000251127:exon13:c.C1593T:p.V531V,ENSG00000102452:ENST00000376196:exon13:c.C1593T:p.V531V	NALCN:NM_001350750:exon12:c.C1506T:p.V502V,NALCN:NM_001350751:exon12:c.C1506T:p.V502V,NALCN:NM_001350748:exon13:c.C1593T:p.V531V,NALCN:NM_001350749:exon13:c.C1593T:p.V531V,NALCN:NM_052867:exon13:c.C1593T:p.V531V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2858	0.2829	0.192292	MU122072	.	.	.	.	.	.	.	.	NALCN:uc001vox.1:exon13:c.C1593T:p.V531V,NALCN:uc001voy.3:exon13:c.C738T:p.V246V,NALCN:uc001voz.2:exon13:c.C1593T:p.V531V,NALCN:uc001vpa.2:exon13:c.C1593T:p.V531V	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,AMR:0.2724,EAS:0.1945,FIN:0.2815,NFE:0.0309,OTH:0.3593,ASJ:0.1311	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	1(urinary_tract)	0.3613
13	101999939	101999939	A	G	NALCN	intronic	.	ENSG00000102452	rs9582475	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.388778	0.3415	.	.	.	.	.	.	.	.	.	.	AFR:0.3471,AMR:0.4820,EAS:0.3717,FIN:0.2897,NFE:0.3368,OTH:0.3569,ASJ:0.4172	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	.	het
13	103504517	103504517	T	C	BIVM-ERCC5;ERCC5	exonic	synonymous SNV	ENSG00000134899;ENSG00000270181	rs1047768	ENSG00000134899:ENST00000355739:exon2:c.T138C:p.H46H,ENSG00000134899:ENST00000535557:exon2:c.T138C:p.H46H	ERCC5:NM_000123:exon2:c.T138C:p.H46H,BIVM-ERCC5:NM_001204425:exon10:c.T1500C:p.H500H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5291	0.6118	0.493011	ESAD-UK|1|409|0.00244499,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	ERCC5:uc001vpw.3:exon2:c.T138C:p.H46H,ERCC5:uc010tjb.2:exon2:c.T138C:p.H46H,BIVM-ERCC5:uc001vpu.2:exon10:c.T1500C:p.H500H	.	AFR:0.5913,AMR:0.6566,EAS:0.5795,FIN:0.2574,NFE:0.6019,OTH:0.6009,ASJ:0.3732	.	.	.	.	.	.	.	.	.	.	.	.	13	2(large_intestine)	0.5682
13	103515085	103515085	G	C	BIVM-ERCC5;ERCC5	exonic	nonsynonymous SNV	ENSG00000134899;ENSG00000270181	rs2227869	ENSG00000134899:ENST00000355739:exon8:c.G1586C:p.C529S	ERCC5:NM_000123:exon8:c.G1586C:p.C529S,BIVM-ERCC5:NM_001204425:exon16:c.G2948C:p.C983S	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0441	0.0432	0.0423323	2(skin)	-1.704	0.002	0.884	1.94	0.000	.	.	PIN domain-like	ERCC5:uc010tjd.1:exon6:c.G1082C:p.C361S,ERCC5:uc001vpw.3:exon8:c.G1586C:p.C529S,ERCC5:uc010tjb.2:exon8:c.G1586C:p.C529S,BIVM-ERCC5:uc001vpu.2:exon16:c.G2948C:p.C983S	-0.935	AFR:MU153100,AMR:LAML-KR|1|205|0.00487805,EAS:0.0409,FIN:0.0203,NFE:0.0298,OTH:0.0419,ASJ:0.0495	.	.	.	.	.	.	.	.	0.0	3.83	0.000	-1.845	13	23(prostate)	0.0650
13	103524762	103524762	C	T	BIVM-ERCC5;ERCC5	intronic	.	ENSG00000134899	rs4150360	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4513	0.4345	0.317093	0.4289	.	.	.	.	.	.	.	.	.	.	AFR:0.2296,AMR:0.3258,EAS:0.1947,FIN:0.5338,NFE:0.5461,OTH:0.4765,ASJ:0.5331	133530	278780;616570;	1466;191;1466;191;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	13	MU29059313	het
13	103527849	103527849	G	C	BIVM-ERCC5;ERCC5	exonic	nonsynonymous SNV	ENSG00000134899	rs9514066	ENSG00000134899:ENST00000375954:exon6:c.G856C:p.G286R,ENSG00000134899:ENST00000355739:exon15:c.G3157C:p.G1053R	ERCC5:NM_000123:exon15:c.G3157C:p.G1053R,BIVM-ERCC5:NM_001204425:exon23:c.G4519C:p.G1507R	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.9994	0.9975	0.998203	0.9981	3.453	23.0	0.039	4.28	0.996	.	.	.	ERCC5:uc001vpw.3:exon15:c.G3157C:p.G1053R,BIVM-ERCC5:uc001vpu.2:exon23:c.G4519C:p.G1507R	-0.856	AFR:0.9934,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	133530	278780;616570;	1466;191;1466;191;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	0.926	3.59	0.000	2.14	13	MU81941476	hom
13	103527930	103527930	G	C	BIVM-ERCC5;ERCC5	exonic	nonsynonymous SNV	ENSG00000134899	rs9514067	ENSG00000134899:ENST00000375954:exon6:c.G937C:p.G313R,ENSG00000134899:ENST00000355739:exon15:c.G3238C:p.G1080R	ERCC5:NM_000123:exon15:c.G3238C:p.G1080R,BIVM-ERCC5:NM_001204425:exon23:c.G4600C:p.G1534R	clinvar: not_provided 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9993	0.9975	0.997204	0.9981	-0.838	0.035	0.588	0.141	0.016	.	.	.	ERCC5:uc001vpw.3:exon15:c.G3238C:p.G1080R,BIVM-ERCC5:uc001vpu.2:exon23:c.G4600C:p.G1534R	-1.004	AFR:0.9934,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	133530	278780;616570;	1466;191;1466;191;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	0.0	3.65	0.000	-0.205	13	MU81941490	hom
13	103528002	103528002	G	C	BIVM-ERCC5;ERCC5	exonic	nonsynonymous SNV	ENSG00000134899	rs17655	ENSG00000134899:ENST00000375954:exon6:c.G1009C:p.D337H,ENSG00000134899:ENST00000355739:exon15:c.G3310C:p.D1104H	ERCC5:NM_000123:exon15:c.G3310C:p.D1104H,BIVM-ERCC5:NM_001204425:exon23:c.G4672C:p.D1558H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 1, 0, 0] 	0.2777	0.3058	0.361422	1(liver)	4.613	24.4	0.004	4.11	0.001	.	.	PIN domain-like	ERCC5:uc001vpw.3:exon15:c.G3310C:p.D1104H,BIVM-ERCC5:uc001vpu.2:exon23:c.G4672C:p.D1558H	-0.903	AFR:2(large_intestine),AMR:MU62519,EAS:0.3035,FIN:0.4516,NFE:0.3031,OTH:0.3013,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205	133530	278780;616570;	1466;191;1466;191;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	0.995	3.27	0.000	1.975	13	5(soft_tissue)	0.4969
13	110435231	110435231	C	T	IRS2	exonic	nonsynonymous SNV	ENSG00000185950	rs1805097	ENSG00000185950:ENST00000375856:exon1:c.G3170A:p.G1057D	IRS2:NM_003749:exon1:c.G3170A:p.G1057D	clinvar: risk_factor 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3821	0.2326	0.283347	0.2955	-0.829	0.037	0.221	2.11	0.002	.	.	.	IRS2:uc001vqv.3:exon1:c.G3170A:p.G1057D	-0.960	AFR:0.1275,AMR:0.4589,EAS:0.3943,FIN:0.3603,NFE:0.3552,OTH:0.3190,ASJ:0.3926	600797	125853;	.	.	.	.	.	.	0.089	0.81	0.000	1.61	13	MU99277	hom
13	110435953	110435953	A	G	IRS2	exonic	synonymous SNV	ENSG00000185950	rs4773092	ENSG00000185950:ENST00000375856:exon1:c.T2448C:p.C816C	IRS2:NM_003749:exon1:c.T2448C:p.C816C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5871	0.6018	0.563898	0.6108	.	.	.	.	.	.	.	.	IRS2:uc001vqv.3:exon1:c.T2448C:p.C816C	.	AFR:0.6150,AMR:0.6885,EAS:0.4623,FIN:0.6269,NFE:0.6172,OTH:0.6031,ASJ:0.5960	600797	125853;	.	.	.	.	.	.	.	.	.	.	13	MU119589	hom
13	110436232	110436232	G	A	IRS2	exonic	synonymous SNV	ENSG00000185950	rs3742210	ENSG00000185950:ENST00000375856:exon1:c.C2169T:p.S723S	IRS2:NM_003749:exon1:c.C2169T:p.S723S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5537	0.6395	0.559505	0.6035	.	.	.	.	.	.	.	.	IRS2:uc001vqv.3:exon1:c.C2169T:p.S723S	.	AFR:0.5998,AMR:0.6901,EAS:0.4602,FIN:0.6204,NFE:0.6130,OTH:0.5973,ASJ:0.5933	600797	125853;	.	.	.	.	.	.	.	.	.	.	13	MU66862	hom
13	110436922	110436922	G	A	IRS2	exonic	synonymous SNV	ENSG00000185950	rs572999394	ENSG00000185950:ENST00000375856:exon1:c.C1479T:p.S493S	IRS2:NM_003749:exon1:c.C1479T:p.S493S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0026	.	0.00219649	.	.	.	.	.	.	.	.	.	IRS2:uc001vqv.3:exon1:c.C1479T:p.S493S	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600797	125853;	.	.	.	.	.	.	.	.	.	.	13	.	het
13	113888201	113888201	T	C	CUL4A	intronic	.	ENSG00000139842	rs2146408	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9753	0.9108	0.911941	0.9240	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.7357,AMR:0.9809,EAS:1,FIN:1,NFE:0.9987,OTH:0.9878,ASJ:0.9901	603137	.	.	.	.	.	.	.	.	.	.	.	13	MU81942591	hom
13	113889474	113889474	C	T	CUL4A	intronic	.	ENSG00000139842	rs2287250	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6738	0.7040	0.573283	MU732829	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.6723,EAS:0.5767,FIN:0.8344,NFE:0.4093,OTH:0.7117,ASJ:0.5802	603137	.	.	.	.	.	.	.	.	.	.	.	13	1(haematopoietic_and_lymphoid_tissue)	0.7467
13	113960780	113960780	G	A	LAMP1	intronic	.	ENSG00000185896	rs572146184	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0001	.	0.000798722	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	153330	.	.	.	.	.	.	.	.	.	.	.	13	.	het
13	113965176	113965176	C	A	LAMP1	exonic	synonymous SNV	ENSG00000185896	rs9577503	ENSG00000185896:ENST00000332556:exon4:c.C556A:p.R186R	LAMP1:NM_005561:exon4:c.C556A:p.R186R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9916	0.9809	0.979233	0.9753	.	.	.	.	.	.	.	.	LAMP1:uc001vtm.1:exon4:c.C556A:p.R186R	.	AFR:0.9157,AMR:0.9905,EAS:1,FIN:1,NFE:0.9989,OTH:0.9928,ASJ:1	153330	.	.	.	.	.	.	.	.	.	.	.	13	MU81942635	hom
14	20813289	20813289	G	A	PARP2	intronic	.	ENSG00000254846	rs2297616	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2459	0.1972	0.205471	0.2123	.	.	.	.	.	0.0002	0.08	.	.	.	AFR:0.0834,AMR:0.2494,EAS:0.1900,FIN:0.2943,NFE:0.2654,OTH:0.2597,ASJ:0.2152	607725	.	.	.	.	.	.	.	.	.	.	.	14	MU638667	hom
14	20815013	20815013	C	T	PARP2	intronic	.	ENSG00000254846	rs1713430	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4150	0.4595	0.516573	MU12429369	.	.	.	.	.	0	0	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|5|170|0.0294118,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.4596,EAS:0.4387,FIN:0.3389,NFE:0.3596,OTH:0.3623,ASJ:0.7040	607725	.	.	.	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.3599
14	20825321	20825321	-	TTCAC	PARP2	intronic	.	ENSG00000129484	rs10625811	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2710	0.2235	.	.	.	.	.	.	.	.	.	.	PARP2:uc010tle.2:exon7:c.730_731insTTCAC:p.Y244fs	.	AFR:0.2449,AMR:0.1465,EAS:0.2252,FIN:0.2691,NFE:0.2970,OTH:0.2848,ASJ:0.2644	607725	.	.	.	.	.	.	.	.	.	.	.	14	11(upper_aerodigestive_tract)	0.2746
14	20825323	20825323	T	G	PARP2	intronic	.	ENSG00000129484	rs200223594	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2712	.	0.249201	1(liver)	.	.	.	.	.	.	.	.	PARP2:uc010tle.2:exon7:c.T732G:p.Y244X	.	AFR:MU12429430,AMR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.1462,FIN:0.2644,NFE:0.2252,OTH:0.2687,ASJ:0.2446	607725	.	.	.	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.2970
14	20825965	20825965	A	C	PARP2	UTR3	.	ENSG00000129484	rs2700	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2799	0.2325	0.23722	LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,ESCA-CN|1|332|0.00301205	.	.	.	.	.	.	.	.	.	.	AFR:0.2396,AMR:0.0988,EAS:0.2517,FIN:0.2741,NFE:0.3115,OTH:0.2969,ASJ:0.2697	607725	.	.	.	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.2770
14	20916249	20916249	T	C	OSGEP	intronic	.	ENSG00000092094	rs2275008	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2581	0.3075	0.244808	MU652858	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,RECA-EU|1|422|0.00236967,BRCA-KR|1|50|0.02,AMR:0.2995,EAS:0.2745,FIN:0.2384,NFE:0.0723,OTH:0.3184,ASJ:0.3443	610107	.	.	.	.	.	.	.	.	.	.	.	14	1(breast)	0.2970
14	20917442	20917442	A	T	OSGEP	intronic	.	ENSG00000092094	rs938881	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5757	0.6050	0.546126	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.5894,AMR:0.6048,EAS:0.6821,FIN:0.3966,NFE:0.6667,OTH:0.5876,ASJ:0.4415	610107	.	.	.	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.6191
14	20920250	20920250	T	C	OSGEP	exonic	synonymous SNV	ENSG00000092094	rs2275007	ENSG00000092094:ENST00000206542:exon3:c.A294G:p.Q98Q,ENSG00000092094:ENST00000488532:exon3:c.A294G:p.Q98Q,ENSG00000092094:ENST00000553640:exon3:c.A294G:p.Q98Q	OSGEP:NM_017807:exon3:c.A294G:p.Q98Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5802	0.6050	0.553115	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	OSGEP:uc001vxf.3:exon3:c.A294G:p.Q98Q	.	AFR:0.5896,AMR:0.6022,EAS:0.6867,FIN:0.3973,NFE:0.6661,OTH:0.5878,ASJ:0.4689	610107	.	.	.	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.6207
14	21871653	21871653	C	T	CHD8	exonic	synonymous SNV	ENSG00000100888	rs8022395	ENSG00000100888:ENST00000399982:exon16:c.G3477A:p.V1159V,ENSG00000100888:ENST00000430710:exon17:c.G2640A:p.V880V,ENSG00000100888:ENST00000557364:exon17:c.G3477A:p.V1159V	CHD8:NM_001170629:exon17:c.G3477A:p.V1159V,CHD8:NM_020920:exon17:c.G2640A:p.V880V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9093	0.9410	0.907348	0.9174	.	.	.	.	.	.	.	.	CHD8:uc001wav.1:exon7:c.G966A:p.V322V,CHD8:uc001war.2:exon16:c.G3477A:p.V1159V,CHD8:uc001was.2:exon17:c.G2640A:p.V880V	.	AFR:0.9449,AMR:0.7943,EAS:0.8552,FIN:0.8938,NFE:0.9202,OTH:0.9121,ASJ:0.9536	610528	615032;	.	.	.	.	.	.	.	.	.	.	14	MU14351469	hom
14	21899631	21899631	C	T	CHD8	exonic	nonsynonymous SNV	ENSG00000100888	rs10467770	ENSG00000100888:ENST00000399982:exon1:c.G172A:p.V58M,ENSG00000100888:ENST00000557364:exon2:c.G172A:p.V58M,ENSG00000100888:ENST00000553622:exon4:c.G97A:p.V33M	CHD8:NM_001170629:exon2:c.G172A:p.V58M	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2516	0.2462	0.252796	MU4553303	0.062	3.209	0.002	0.251	0.973	.	.	.	CHD8:uc001war.2:exon1:c.G172A:p.V58M	-1.066	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,AMR:0.2585,EAS:0.1770,FIN:0.1821,NFE:0.3288,OTH:0.2514,ASJ:0.2396	610528	615032;	.	.	.	.	.	.	.	-2.77	0.000	0	14	1(large_intestine)	0.2691
14	23777374	23777374	A	G	BCL2L2;BCL2L2-PABPN1	exonic	nonsynonymous SNV	ENSG00000129473;ENSG00000258643	rs910332	ENSG00000258643:ENST00000557008:exon2:c.A398G:p.Q133R,ENSG00000129473:ENST00000250405:exon3:c.A398G:p.Q133R,ENSG00000258643:ENST00000553781:exon3:c.A398G:p.Q133R,ENSG00000258643:ENST00000556100:exon3:c.A398G:p.Q133R,ENSG00000129473:ENST00000557236:exon3:c.A398G:p.Q133R,ENSG00000129473:ENST00000557579:exon3:c.A398G:p.Q133R	BCL2L2:NM_001199839:exon3:c.A398G:p.Q133R,BCL2L2-PABPN1:NM_001199864:exon3:c.A398G:p.Q133R,BCL2L2:NM_004050:exon3:c.A398G:p.Q133R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9979	0.9977	0.999401	0.9983	-0.797	0.043	0.187	1.43	0.992	.	.	.	BCL2L2:uc001wji.4:exon2:c.A398G:p.Q133R,BCL2L2:uc001wjg.4:exon3:c.A398G:p.Q133R,BCL2L2-PABPN1:uc001wjh.4:exon3:c.A398G:p.Q133R,BCL2L2:uc021rqx.1:exon3:c.A398G:p.Q133R	-1.011	AFR:0.9993,AMR:0.9988,EAS:1,FIN:1,NFE:0.9970,OTH:0.9990,ASJ:1	.	.	.	.	.	.	.	.	0.0	1.1	0.000	0.11	14	MU4559093	hom
14	23889445	23889445	-	G	MYH7	splicing	.	ENSG00000092054	rs45504498	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0023	.	0.0403355	0.0596	.	.	.	.	.	.	.	.	.	.	AFR:0.0297,AMR:0.0550,EAS:0.0637,FIN:0.0826,NFE:0.0704,OTH:0.0643,ASJ:0.1047	160760	160500;181430;192600;255160;608358;613426;	154;54260;53698;53698;437572;59135;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~437572|MYH7-related late-onset SPMD<br>MYH7-related late-onset scapuloperoneal syndrome|<1 / 1 000 000|Autosomal dominant|Adult|181430 ~59135|Distal myopathy type 1<br>Gowers disease<br>MPD1|Unknown|Autosomal dominant|Childhood|160500 ~	.	.	.	.	.	.	.	.	14	.	hom
14	23892888	23892888	A	G	MYH7	exonic	synonymous SNV	ENSG00000092054	rs7157716	ENSG00000092054:ENST00000355349:exon24:c.T2967C:p.I989I	MYH7:NM_000257:exon24:c.T2967C:p.I989I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3212	0.4547	0.376398	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	MYH7:uc001wjx.3:exon24:c.T2967C:p.I989I	.	AFR:1(breast),AMR:MU583161,EAS:0.4165,FIN:0.7157,NFE:0.2428,OTH:0.44,ASJ:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	160760	160500;181430;192600;255160;608358;613426;	154;54260;53698;53698;437572;59135;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~437572|MYH7-related late-onset SPMD<br>MYH7-related late-onset scapuloperoneal syndrome|<1 / 1 000 000|Autosomal dominant|Adult|181430 ~59135|Distal myopathy type 1<br>Gowers disease<br>MPD1|Unknown|Autosomal dominant|Childhood|160500 ~	.	.	.	.	.	.	.	.	14	2(urinary_tract)	0.1389
14	23899060	23899060	G	A	MYH7	exonic	synonymous SNV	ENSG00000092054	rs735712	ENSG00000092054:ENST00000355349:exon12:c.C1062T:p.G354G	MYH7:NM_000257:exon12:c.C1062T:p.G354G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0704	0.0626	0.0638978	0.0587	.	.	.	.	.	.	.	.	MYH7:uc001wjx.3:exon12:c.C1062T:p.G354G	.	AFR:0.0293,AMR:0.0585,EAS:0.0630,FIN:0.0607,NFE:0.0738,OTH:0.0594,ASJ:0.1167	160760	160500;181430;192600;255160;608358;613426;	154;54260;53698;53698;437572;59135;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~437572|MYH7-related late-onset SPMD<br>MYH7-related late-onset scapuloperoneal syndrome|<1 / 1 000 000|Autosomal dominant|Adult|181430 ~59135|Distal myopathy type 1<br>Gowers disease<br>MPD1|Unknown|Autosomal dominant|Childhood|160500 ~	.	.	.	.	.	.	.	.	14	MU67329272	hom
14	23900794	23900794	G	A	MYH7	exonic	synonymous SNV	ENSG00000092054	rs2069542	ENSG00000092054:ENST00000355349:exon8:c.C732T:p.F244F	MYH7:NM_000257:exon8:c.C732T:p.F244F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1836	0.2889	0.263778	LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053,GACA-JP|1|585|0.0017094	.	.	.	.	.	0.0008	0.104	.	MYH7:uc001wjx.3:exon8:c.C732T:p.F244F	.	AFR:0.2555,AMR:0.5406,EAS:0.2152,FIN:0.0679,NFE:0.1215,OTH:0.1547,ASJ:0.1435	160760	160500;181430;192600;255160;608358;613426;	154;54260;53698;53698;437572;59135;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~437572|MYH7-related late-onset SPMD<br>MYH7-related late-onset scapuloperoneal syndrome|<1 / 1 000 000|Autosomal dominant|Adult|181430 ~59135|Distal myopathy type 1<br>Gowers disease<br>MPD1|Unknown|Autosomal dominant|Childhood|160500 ~	.	.	.	.	.	.	.	.	14	1(stomach)	0.1575
14	23902753	23902753	G	A	MYH7	exonic	synonymous SNV	ENSG00000092054	rs2069540	ENSG00000092054:ENST00000355349:exon3:c.C189T:p.T63T	MYH7:NM_000257:exon3:c.C189T:p.T63T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4888	0.5275	0.520367	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MYH7:uc001wjx.3:exon3:c.C189T:p.T63T	.	AFR:0.5085,AMR:0.6281,EAS:0.4603,FIN:0.3933,NFE:0.4186,OTH:0.4778,ASJ:0.4510	160760	160500;181430;192600;255160;608358;613426;	154;54260;53698;53698;437572;59135;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~437572|MYH7-related late-onset SPMD<br>MYH7-related late-onset scapuloperoneal syndrome|<1 / 1 000 000|Autosomal dominant|Adult|181430 ~59135|Distal myopathy type 1<br>Gowers disease<br>MPD1|Unknown|Autosomal dominant|Childhood|160500 ~	.	.	.	.	.	.	.	.	14	1(large_intestine)	0.4898
14	30047580	30047580	C	T	PRKD1	intronic	.	ENSG00000184304	rs2273815	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6894	0.7311	0.626398	LAML-KR|4|205|0.0195122,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.7117,AMR:0.7253,EAS:0.6623,FIN:0.5692,NFE:0.6564,OTH:0.7390,ASJ:0.6366	605435	.	.	.	.	.	.	.	.	.	.	.	14	2(lung)	0.6743
14	30066929	30066929	A	G	PRKD1	exonic	synonymous SNV	ENSG00000184304	rs2230505	ENSG00000184304:ENST00000331968:exon16:c.T2202C:p.I734I,ENSG00000184304:ENST00000415220:exon17:c.T2226C:p.I742I	PRKD1:NM_002742:exon16:c.T2202C:p.I734I,PRKD1:NM_001330069:exon17:c.T2226C:p.I742I,PRKD1:NM_001348390:exon17:c.T1938C:p.I646I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4350	0.5095	0.511781	MU133037	.	.	.	.	.	.	.	.	PRKD1:uc001wqh.3:exon16:c.T2202C:p.I734I	.	AFR:LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,AMR:0.4944,EAS:0.4590,FIN:0.3311,NFE:0.2010,OTH:0.4068,ASJ:0.7796	605435	.	.	.	.	.	.	.	.	.	.	.	14	3(haematopoietic_and_lymphoid_tissue)	0.3912
14	30066976	30066976	A	T	PRKD1	intronic	.	ENSG00000184304	rs3783299	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4170	0.4305	0.430711	0.4260	.	.	.	.	.	0.2090	0.472	.	.	.	AFR:0.5418,AMR:0.4356,EAS:0.2017,FIN:0.4064,NFE:0.3902,OTH:0.4031,ASJ:0.3333	605435	.	.	.	.	.	.	.	.	.	.	.	14	MU12450159	het
14	35242828	35242828	G	A	BAZ1A	exonic	synonymous SNV	ENSG00000198604	rs2275145	ENSG00000198604:ENST00000358716:exon19:c.C3006T:p.D1002D,ENSG00000198604:ENST00000382422:exon19:c.C3102T:p.D1034D,ENSG00000198604:ENST00000360310:exon20:c.C3102T:p.D1034D	BAZ1A:NM_182648:exon19:c.C3006T:p.D1002D,BAZ1A:NM_013448:exon20:c.C3102T:p.D1034D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5180	0.4943	0.515375	0.5217	.	.	.	.	.	.	.	.	BAZ1A:uc001wsl.3:exon19:c.C3006T:p.D1002D,BAZ1A:uc001wsk.3:exon20:c.C3102T:p.D1034D	.	AFR:0.4800,AMR:0.5744,EAS:0.4715,FIN:0.5963,NFE:0.5292,OTH:0.5609,ASJ:0.5	605680	.	.	.	.	.	.	.	.	.	.	.	14	MU643123	hom
14	35263983	35263983	T	C	BAZ1A	exonic	synonymous SNV	ENSG00000198604	rs17102745	ENSG00000198604:ENST00000382422:exon10:c.A1335G:p.Q445Q,ENSG00000198604:ENST00000358716:exon11:c.A1335G:p.Q445Q,ENSG00000198604:ENST00000360310:exon11:c.A1335G:p.Q445Q	BAZ1A:NM_013448:exon11:c.A1335G:p.Q445Q,BAZ1A:NM_182648:exon11:c.A1335G:p.Q445Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1032	0.1008	0.115815	.	.	.	.	.	.	.	.	.	BAZ1A:uc001wsk.3:exon11:c.A1335G:p.Q445Q,BAZ1A:uc001wsl.3:exon11:c.A1335G:p.Q445Q	.	AFR:0.1011,AMR:0.1161,EAS:0.1457,FIN:0.0290,NFE:0.0865,OTH:0.1032,ASJ:0.0847	605680	.	.	.	.	.	.	.	.	.	.	.	14	1(breast)	0.1061
14	35871217	35871217	G	A	NFKBIA	UTR3	.	ENSG00000100906	rs8904	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4011	0.4449	0.447883	MU4606592	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BLCA-CN|1|103|0.00970874,AMR:0.4551,EAS:0.3246,FIN:0.41,NFE:0.4278,OTH:0.4064,ASJ:0.6007	164008	612132;	238468;98813;	238468|Anhidrotic ectodermal dysplasia<br>HED|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|129490 224900 300291 305100 612132 614940 614941 ~98813|Anhidrotic ectodermal dysplasia with immunodeficiency<br>EDA-ID<br>HED-ID|Unknown|Autosomal dominant<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300291 612132 ~	~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04210 Apoptosis~ko04380 Osteoclast differentiation~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04623 Cytosolic DNA-sensing pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04926 Relaxin signaling pathway~ko04931 Insulin resistance~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05134 Legionellosis~ko05135 Yersinia infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	14	1(urinary_tract)	0.3957
14	39650234	39650234	A	T	PNN	exonic	nonsynonymous SNV	ENSG00000100941	rs2180792	ENSG00000100941:ENST00000216832:exon9:c.A1321T:p.T441S	PNN:NM_002687:exon9:c.A1321T:p.T441S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9155	0.9383	0.902955	0.9305	-1.118	0.009	0.642	3.5	0.998	.	.	.	PNN:uc001wuw.4:exon9:c.A1321T:p.T441S	-0.938	AFR:0.9297,AMR:0.8473,EAS:0.95,FIN:0.9210,NFE:0.9360,OTH:0.9277,ASJ:0.9238	603154	.	.	.	.	.	.	.	.	0.95	0.000	.	14	MU81947250	het
14	45606287	45606287	C	T	FANCM	exonic	nonsynonymous SNV	ENSG00000187790	rs10138997	ENSG00000187790:ENST00000267430:exon2:c.C524T:p.S175F,ENSG00000187790:ENST00000542564:exon2:c.C524T:p.S175F,ENSG00000187790:ENST00000556036:exon2:c.C524T:p.S175F	FANCM:NM_001308133:exon2:c.C524T:p.S175F,FANCM:NM_001308134:exon2:c.C524T:p.S175F,FANCM:NM_020937:exon2:c.C524T:p.S175F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1093	0.1704	0.205871	LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	0.518	7.570	0.055	4.21	0.980	.	.	Helicase superfamily 1/2, ATP-binding domain|Helicase/UvrB, N-terminal|P-loop containing nucleoside triphosphate hydrolase	FANCM:uc001wwc.2:exon2:c.C524T:p.S175F,FANCM:uc001wwd.4:exon2:c.C524T:p.S175F,FANCM:uc010anf.3:exon2:c.C524T:p.S175F	-0.917	AFR:0.1648,AMR:0.4002,EAS:0.0662,FIN:0.1116,NFE:0.0876,OTH:0.0621,ASJ:0.0871	609644	.	.	.	.	.	.	.	0.0	2.39	0.000	1.94	14	1(large_intestine)	0.1031
14	45628284	45628285	TA	-	FANCM	intronic	.	ENSG00000187790	rs112326758	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.2866	0.1649	0.118211	0.0920	.	.	.	.	.	.	.	.	.	.	AFR:0.0395,AMR:0.1379,EAS:0.1094,FIN:0.1215,NFE:0.1082,OTH:0.1366,ASJ:0.1336	609644	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	45644589	45644589	G	T	FANCM	exonic	nonsynonymous SNV	ENSG00000187790	rs1367580	ENSG00000187790:ENST00000556250:exon7:c.G1180T:p.V394L,ENSG00000187790:ENST00000542564:exon13:c.G2554T:p.V852L,ENSG00000187790:ENST00000267430:exon14:c.G2632T:p.V878L	FANCM:NM_001308133:exon13:c.G2554T:p.V852L,FANCM:NM_020937:exon14:c.G2632T:p.V878L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1568	0.1913	0.232228	MU152383	-1.480	0.003	1.0	4.08	0.028	.	.	.	FANCM:uc010ang.3:exon1:c.G274T:p.V92L,FANCM:uc001wwe.4:exon7:c.G1240T:p.V414L,FANCM:uc010anf.3:exon13:c.G2554T:p.V852L,FANCM:uc001wwd.4:exon14:c.G2632T:p.V878L	-0.903	AFR:LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,AMR:0.1891,EAS:0.1599,FIN:0.1325,NFE:0.1253,OTH:0.1158,ASJ:0.3546	609644	.	.	.	.	.	.	.	0.0	2.94	0.000	-2.015	14	1(thyroid)	0.1211
14	45650900	45650900	A	G	FANCM	exonic	nonsynonymous SNV	ENSG00000187790	rs78211950	ENSG00000187790:ENST00000556250:exon9:c.A2926G:p.I976V,ENSG00000187790:ENST00000542564:exon15:c.A4300G:p.I1434V,ENSG00000187790:ENST00000267430:exon16:c.A4378G:p.I1460V	FANCM:NM_001308133:exon15:c.A4300G:p.I1434V,FANCM:NM_020937:exon16:c.A4378G:p.I1460V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1200	0.0760	0.101438	LICA-CN|1|402|0.00248756,COCA-CN|1|321|0.00311526	-0.170	1.267	0.98	-1.19	0.556	.	.	.	FANCM:uc010ang.3:exon3:c.A2020G:p.I674V,FANCM:uc001wwe.4:exon9:c.A2986G:p.I996V,FANCM:uc010anf.3:exon15:c.A4300G:p.I1434V,FANCM:uc001wwd.4:exon16:c.A4378G:p.I1460V	-1.016	AFR:0.0856,AMR:0.0231,EAS:0.1291,FIN:0.1108,NFE:0.1145,OTH:0.1076,ASJ:0.1026	609644	.	.	.	.	.	.	.	0.039	3.07	0.000	0	14	1(large_intestine)	0.1334
14	45654411	45654414	CTTA	-	FANCM	intronic	.	ENSG00000187790	rs796584585	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1977	0.2264	0.271166	0.2157	.	.	.	.	.	.	.	.	.	.	AFR:0.4472,AMR:0.1671,EAS:0.1235,FIN:0.1213,NFE:0.1213,OTH:0.1660,ASJ:0.1358	609644	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	45665468	45665468	C	G	FANCM	exonic	nonsynonymous SNV	ENSG00000187790	rs3736772	ENSG00000187790:ENST00000557110:exon1:c.C94G:p.P32A,ENSG00000187790:ENST00000556250:exon14:c.C3982G:p.P1328A,ENSG00000187790:ENST00000542564:exon20:c.C5356G:p.P1786A,ENSG00000187790:ENST00000267430:exon21:c.C5434G:p.P1812A	FANCM:NM_001308133:exon20:c.C5356G:p.P1786A,FANCM:NM_020937:exon21:c.C5434G:p.P1812A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1158	0.0779	0.10623	0.0870	0.405	6.657	0.178	3.29	0.357	.	.	.	FANCM:uc010ang.3:exon9:c.C3181G:p.P1061A,FANCM:uc001wwe.4:exon14:c.C4042G:p.P1348A,FANCM:uc010anf.3:exon20:c.C5356G:p.P1786A,FANCM:uc001wwd.4:exon21:c.C5434G:p.P1812A	-1.051	AFR:0.0234,AMR:0.1029,EAS:0.1106,FIN:0.1193,NFE:0.1088,OTH:0.1375,ASJ:0.1325	609644	.	.	.	.	.	.	.	0.003	2.56	0.002	2.015	14	MU160245	hom
14	50585574	50585574	-	A	SOS2	intronic	.	ENSG00000100485	rs10658395	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.5487	0.5416	0.503195	0.5770	.	.	.	.	.	.	.	.	.	.	AFR:0.4899,AMR:0.6117,EAS:0.4665,FIN:0.5593,NFE:0.6352,OTH:0.5907,ASJ:0.7143	601247	616559;	648;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04926 Relaxin signaling pathway~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	14	.	hom
14	50600834	50600834	G	A	SOS2	intronic	.	ENSG00000100485	rs144391749	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0087	0.0083	0.00499201	0.0072	.	.	.	.	.	0.0001	0.008	.	.	.	AFR:0.0021,AMR:0.0107,EAS:0,FIN:0.0083,NFE:0.0107,OTH:0.0020,ASJ:0.0099	601247	616559;	648;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04926 Relaxin signaling pathway~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	14	MU123400664	het
14	50616878	50616878	G	A	SOS2	exonic	synonymous SNV	ENSG00000100485	rs2229869	ENSG00000100485:ENST00000543680:exon13:c.C2133T:p.N711N,ENSG00000100485:ENST00000216373:exon14:c.C2232T:p.N744N	SOS2:NM_006939:exon14:c.C2232T:p.N744N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6215	0.6080	0.518371	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	SOS2:uc010tql.2:exon13:c.C2133T:p.N711N,SOS2:uc001wxs.4:exon14:c.C2232T:p.N744N	.	AFR:0.5881,AMR:0.4507,EAS:0.7318,FIN:0.4173,NFE:0.5965,OTH:0.6749,ASJ:0.6555	601247	616559;	648;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04926 Relaxin signaling pathway~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	14	1(lung)	0.6306
14	51204996	51204996	C	T	NIN	exonic	synonymous SNV	ENSG00000100503	rs11376	ENSG00000100503:ENST00000485005:exon2:c.G90A:p.Q30Q,ENSG00000100503:ENST00000382043:exon25:c.G3498A:p.Q1166Q,ENSG00000100503:ENST00000530997:exon25:c.G5637A:p.Q1879Q,ENSG00000100503:ENST00000389868:exon26:c.G3498A:p.Q1166Q,ENSG00000100503:ENST00000245441:exon27:c.G5637A:p.Q1879Q,ENSG00000100503:ENST00000324330:exon27:c.G5637A:p.Q1879Q,ENSG00000100503:ENST00000382041:exon27:c.G5637A:p.Q1879Q,ENSG00000100503:ENST00000453196:exon27:c.G5637A:p.Q1879Q,ENSG00000100503:ENST00000476352:exon27:c.G5637A:p.Q1879Q	NIN:NM_016350:exon26:c.G3498A:p.Q1166Q,NIN:NM_020921:exon27:c.G5637A:p.Q1879Q,NIN:NM_182944:exon27:c.G5637A:p.Q1879Q,NIN:NM_182946:exon27:c.G5637A:p.Q1879Q	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5044	0.5779	0.508786	0.5656	.	.	.	.	.	.	.	.	NIN:uc001wyk.3:exon26:c.G3498A:p.Q1166Q,NIN:uc001wyi.3:exon27:c.G5637A:p.Q1879Q,NIN:uc001wym.2:exon27:c.G5637A:p.Q1879Q,NIN:uc001wyo.3:exon27:c.G5637A:p.Q1879Q	.	AFR:0.6990,AMR:0.4125,EAS:0.3525,FIN:0.5467,NFE:0.5282,OTH:0.5092,ASJ:0.5533	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	MU23624074	het
14	51206021	51206021	A	G	NIN	intronic	.	ENSG00000100503	rs3015485	.	.	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9976	0.9913	0.992612	0.9927	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.9748,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:0.9969,ASJ:1	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	MU81947943	hom
14	51223789	51223789	C	T	NIN	exonic	nonsynonymous SNV	ENSG00000100503	rs2073347	ENSG00000100503:ENST00000530997:exon16:c.G3959A:p.G1320E,ENSG00000100503:ENST00000245441:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000324330:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000382041:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000453196:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000476352:exon18:c.G3959A:p.G1320E	NIN:NM_020921:exon18:c.G3959A:p.G1320E,NIN:NM_182944:exon18:c.G3959A:p.G1320E,NIN:NM_182946:exon18:c.G3959A:p.G1320E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7454	0.7922	0.764377	MU28671496	1.353	12.54	1.0	6.06	0.945	.	.	.	NIN:uc001wyi.3:exon18:c.G3959A:p.G1320E,NIN:uc001wym.2:exon18:c.G3959A:p.G1320E,NIN:uc001wyo.3:exon18:c.G3959A:p.G1320E	-0.997	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,AMR:0.7599,EAS:0.8353,FIN:0.8245,NFE:0.6617,OTH:0.6770,ASJ:0.8613	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	0.0	3.8	0.000	-2.085	14	2(lung)	0.7277
14	51224374	51224374	T	G	NIN	exonic	nonsynonymous SNV	ENSG00000100503	rs12882191	ENSG00000100503:ENST00000530997:exon16:c.A3374C:p.Q1125P,ENSG00000100503:ENST00000245441:exon18:c.A3374C:p.Q1125P,ENSG00000100503:ENST00000324330:exon18:c.A3374C:p.Q1125P,ENSG00000100503:ENST00000382041:exon18:c.A3374C:p.Q1125P,ENSG00000100503:ENST00000453196:exon18:c.A3374C:p.Q1125P,ENSG00000100503:ENST00000476352:exon18:c.A3374C:p.Q1125P	NIN:NM_020921:exon18:c.A3374C:p.Q1125P,NIN:NM_182944:exon18:c.A3374C:p.Q1125P,NIN:NM_182946:exon18:c.A3374C:p.Q1125P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7533	0.8076	0.784944	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	-2.411	0.001	1.0	4.07	0.000	.	.	.	NIN:uc001wyi.3:exon18:c.A3374C:p.Q1125P,NIN:uc001wym.2:exon18:c.A3374C:p.Q1125P,NIN:uc001wyo.3:exon18:c.A3374C:p.Q1125P	-1.024	AFR:0.7732,AMR:0.9003,EAS:0.8245,FIN:0.6792,NFE:0.6768,OTH:0.7299,ASJ:0.8421	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	0.0	3.58	0.000	-2.125	14	1(liver)	0.7281
14	51224658	51224658	T	A	NIN	exonic	synonymous SNV	ENSG00000100503	rs2073348	ENSG00000100503:ENST00000530997:exon16:c.A3090T:p.S1030S,ENSG00000100503:ENST00000245441:exon18:c.A3090T:p.S1030S,ENSG00000100503:ENST00000324330:exon18:c.A3090T:p.S1030S,ENSG00000100503:ENST00000382041:exon18:c.A3090T:p.S1030S,ENSG00000100503:ENST00000453196:exon18:c.A3090T:p.S1030S,ENSG00000100503:ENST00000476352:exon18:c.A3090T:p.S1030S	NIN:NM_020921:exon18:c.A3090T:p.S1030S,NIN:NM_182944:exon18:c.A3090T:p.S1030S,NIN:NM_182946:exon18:c.A3090T:p.S1030S	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3248	0.2751	0.320887	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon18:c.A3090T:p.S1030S,NIN:uc001wym.2:exon18:c.A3090T:p.S1030S,NIN:uc001wyo.3:exon18:c.A3090T:p.S1030S	.	AFR:MU12492660,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02,EAS:0.1963,FIN:0.4511,NFE:0.3245,OTH:0.5180,ASJ:0.2960	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	1(liver)	0.3312
14	51225132	51225132	G	T	NIN	exonic	synonymous SNV	ENSG00000100503	rs2073349	ENSG00000100503:ENST00000530997:exon16:c.C2616A:p.A872A,ENSG00000100503:ENST00000245441:exon18:c.C2616A:p.A872A,ENSG00000100503:ENST00000324330:exon18:c.C2616A:p.A872A,ENSG00000100503:ENST00000382041:exon18:c.C2616A:p.A872A,ENSG00000100503:ENST00000453196:exon18:c.C2616A:p.A872A,ENSG00000100503:ENST00000476352:exon18:c.C2616A:p.A872A	NIN:NM_020921:exon18:c.C2616A:p.A872A,NIN:NM_182944:exon18:c.C2616A:p.A872A,NIN:NM_182946:exon18:c.C2616A:p.A872A	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3775	0.3411	0.38758	MU718965	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon18:c.C2616A:p.A872A,NIN:uc001wym.2:exon18:c.C2616A:p.A872A,NIN:uc001wyo.3:exon18:c.C2616A:p.A872A	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.3583,EAS:0.4964,FIN:0.3974,NFE:0.5248,OTH:0.3697,ASJ:0.2917	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	1(lung)	0.3667
14	51237701	51237701	A	G	NIN	exonic	synonymous SNV	ENSG00000100503	rs17793018	ENSG00000100503:ENST00000530997:exon9:c.T1128C:p.V376V,ENSG00000100503:ENST00000382043:exon10:c.T1128C:p.V376V,ENSG00000100503:ENST00000245441:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000324330:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000382041:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000389868:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000453196:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000453401:exon11:c.T1014C:p.V338V,ENSG00000100503:ENST00000476352:exon11:c.T1128C:p.V376V	NIN:NM_016350:exon11:c.T1128C:p.V376V,NIN:NM_020921:exon11:c.T1128C:p.V376V,NIN:NM_182944:exon11:c.T1128C:p.V376V,NIN:NM_182946:exon11:c.T1128C:p.V376V	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6207	0.5033	0.577276	0.5651	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon11:c.T1128C:p.V376V,NIN:uc001wyk.3:exon11:c.T1128C:p.V376V,NIN:uc001wym.2:exon11:c.T1128C:p.V376V,NIN:uc001wyo.3:exon11:c.T1128C:p.V376V,NIN:uc001wyp.1:exon11:c.T1014C:p.V338V	.	AFR:0.2872,AMR:0.6611,EAS:0.8744,FIN:0.6938,NFE:0.6522,OTH:0.6663,ASJ:0.5232	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	MU123123	hom
14	51239067	51239067	C	G	NIN	exonic	synonymous SNV	ENSG00000100503	rs8020503	ENSG00000100503:ENST00000530997:exon7:c.G933C:p.L311L,ENSG00000100503:ENST00000382043:exon8:c.G933C:p.L311L,ENSG00000100503:ENST00000245441:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000324330:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000382041:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000389868:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000453196:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000453401:exon9:c.G819C:p.L273L,ENSG00000100503:ENST00000476352:exon9:c.G933C:p.L311L	NIN:NM_016350:exon9:c.G933C:p.L311L,NIN:NM_020921:exon9:c.G933C:p.L311L,NIN:NM_182944:exon9:c.G933C:p.L311L,NIN:NM_182946:exon9:c.G933C:p.L311L	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9973	0.9907	0.992412	0.9924	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon9:c.G933C:p.L311L,NIN:uc001wyk.3:exon9:c.G933C:p.L311L,NIN:uc001wym.2:exon9:c.G933C:p.L311L,NIN:uc001wyo.3:exon9:c.G933C:p.L311L,NIN:uc001wyp.1:exon9:c.G819C:p.L273L	.	AFR:0.9735,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:1	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	MU81947976	hom
14	51372099	51372099	A	-	PYGL	UTR3	.	ENSG00000100504	rs3216001	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3614	0.3356	0.458866	0.3574	.	.	.	.	.	.	.	.	.	.	AFR:0.4598,AMR:0.5871,EAS:0.5943,FIN:0.2935,NFE:0.2785,OTH:0.3323,ASJ:0.2550	613741	232700;	369;	369|GSD due to liver glycogen phosphorylase deficiency<br>GSD type 6<br>GSD type VI<br>Glycogen storage disease type 6<br>Glycogen storage disease type VI<br>Glycogenosis due to liver glycogen phosphorylase deficiency<br>Glycogenosis type 6<br>Glycogenosis type VI<br>Hepatic glycogen phosphorylase deficiency<br>Hepatic phosphorylase deficiency<br>Hers disease<br>Liver glycogen phosphorylase deficiency|Unknown|Autosomal recessive|Childhood|232700 ~	.	.	.	.	.	.	.	.	14	MU116276890	unknown
14	51372103	51372103	C	G	PYGL	UTR3	.	ENSG00000100504	rs1042266	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2357	0.1501	0.250998	0.1783	.	.	.	.	.	.	.	.	.	.	AFR:0.0687,AMR:0.4606,EAS:0.4414,FIN:0.2011,NFE:0.1895,OTH:0.2285,ASJ:0.1788	613741	232700;	369;	369|GSD due to liver glycogen phosphorylase deficiency<br>GSD type 6<br>GSD type VI<br>Glycogen storage disease type 6<br>Glycogen storage disease type VI<br>Glycogenosis due to liver glycogen phosphorylase deficiency<br>Glycogenosis type 6<br>Glycogenosis type VI<br>Hepatic glycogen phosphorylase deficiency<br>Hepatic phosphorylase deficiency<br>Hers disease<br>Liver glycogen phosphorylase deficiency|Unknown|Autosomal recessive|Childhood|232700 ~	.	.	.	.	.	.	.	.	14	MU30067353	unknown
14	51376774	51376774	G	A	PYGL	exonic	synonymous SNV	ENSG00000100504	rs15669	ENSG00000100504:ENST00000544180:exon16:c.C1914T:p.T638T,ENSG00000100504:ENST00000216392:exon17:c.C2016T:p.T672T,ENSG00000100504:ENST00000532462:exon17:c.C2016T:p.T672T	PYGL:NM_001163940:exon16:c.C1914T:p.T638T,PYGL:NM_002863:exon17:c.C2016T:p.T672T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1604	0.2189	0.222644	MU648114	.	.	.	.	.	.	.	.	PYGL:uc010tqq.2:exon16:c.C1914T:p.T638T,PYGL:uc001wyu.3:exon17:c.C2016T:p.T672T	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,AMR:0.2070,EAS:0.0859,FIN:0.1722,NFE:0.0981,OTH:0.1206,ASJ:0.4111	613741	232700;	369;	369|GSD due to liver glycogen phosphorylase deficiency<br>GSD type 6<br>GSD type VI<br>Glycogen storage disease type 6<br>Glycogen storage disease type VI<br>Glycogenosis due to liver glycogen phosphorylase deficiency<br>Glycogenosis type 6<br>Glycogenosis type VI<br>Hepatic glycogen phosphorylase deficiency<br>Hepatic phosphorylase deficiency<br>Hers disease<br>Liver glycogen phosphorylase deficiency|Unknown|Autosomal recessive|Childhood|232700 ~	.	.	.	.	.	.	.	.	14	2(lung)	0.1327
14	51378591	51378591	T	-	PYGL	splicing	.	ENSG00000100504	rs11356035	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4379	0.4435	0.551917	0.4559	.	.	.	.	.	.	.	.	.	.	AFR:0.6589,AMR:0.6253,EAS:0.6043,FIN:0.3460,NFE:0.3433,OTH:0.4031,ASJ:0.3576	613741	232700;	369;	369|GSD due to liver glycogen phosphorylase deficiency<br>GSD type 6<br>GSD type VI<br>Glycogen storage disease type 6<br>Glycogen storage disease type VI<br>Glycogenosis due to liver glycogen phosphorylase deficiency<br>Glycogenosis type 6<br>Glycogenosis type VI<br>Hepatic glycogen phosphorylase deficiency<br>Hepatic phosphorylase deficiency<br>Hers disease<br>Liver glycogen phosphorylase deficiency|Unknown|Autosomal recessive|Childhood|232700 ~	.	.	.	.	.	.	.	.	14	MU149537	hom
14	51383432	51383432	G	A	PYGL	exonic	synonymous SNV	ENSG00000100504	rs2075643	ENSG00000100504:ENST00000544180:exon8:c.C918T:p.D306D,ENSG00000100504:ENST00000216392:exon9:c.C1020T:p.D340D,ENSG00000100504:ENST00000532462:exon9:c.C1020T:p.D340D	PYGL:NM_001163940:exon8:c.C918T:p.D306D,PYGL:NM_002863:exon9:c.C1020T:p.D340D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2253	0.1382	0.235423	LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	PYGL:uc010anz.1:exon5:c.C429T:p.D143D,PYGL:uc010tqq.2:exon8:c.C918T:p.D306D,PYGL:uc001wyu.3:exon9:c.C1020T:p.D340D	.	AFR:0.1684,AMR:0.0619,EAS:0.1556,FIN:0.4379,NFE:0.1943,OTH:0.1782,ASJ:0.4258	613741	232700;	369;	369|GSD due to liver glycogen phosphorylase deficiency<br>GSD type 6<br>GSD type VI<br>Glycogen storage disease type 6<br>Glycogen storage disease type VI<br>Glycogenosis due to liver glycogen phosphorylase deficiency<br>Glycogenosis type 6<br>Glycogenosis type VI<br>Hepatic glycogen phosphorylase deficiency<br>Hepatic phosphorylase deficiency<br>Hers disease<br>Liver glycogen phosphorylase deficiency|Unknown|Autosomal recessive|Childhood|232700 ~	.	.	.	.	.	.	.	.	14	1(urinary_tract)	0.2173
14	51410969	51410969	G	A	PYGL	exonic	synonymous SNV	ENSG00000100504	rs77316189	ENSG00000100504:ENST00000216392:exon1:c.C153T:p.D51D,ENSG00000100504:ENST00000532462:exon1:c.C153T:p.D51D,ENSG00000100504:ENST00000544180:exon1:c.C153T:p.D51D	PYGL:NM_001163940:exon1:c.C153T:p.D51D,PYGL:NM_002863:exon1:c.C153T:p.D51D	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0469	0.0759	0.0579073	0.0714	.	.	.	.	.	.	.	.	PYGL:uc001wyu.3:exon1:c.C153T:p.D51D,PYGL:uc001wyw.4:exon1:c.C153T:p.D51D,PYGL:uc010tqq.2:exon1:c.C153T:p.D51D	.	AFR:0.1489,AMR:0.0215,EAS:0.0006,FIN:0.0490,NFE:0.0442,OTH:0.0450,ASJ:0.0497	613741	232700;	369;	369|GSD due to liver glycogen phosphorylase deficiency<br>GSD type 6<br>GSD type VI<br>Glycogen storage disease type 6<br>Glycogen storage disease type VI<br>Glycogenosis due to liver glycogen phosphorylase deficiency<br>Glycogenosis type 6<br>Glycogenosis type VI<br>Hepatic glycogen phosphorylase deficiency<br>Hepatic phosphorylase deficiency<br>Hers disease<br>Liver glycogen phosphorylase deficiency|Unknown|Autosomal recessive|Childhood|232700 ~	.	.	.	.	.	.	.	.	14	.	het
14	58838668	58838668	A	G	ARID4A	exonic	synonymous SNV	ENSG00000032219	rs1051860	ENSG00000032219:ENST00000431317:exon22:c.A3528G:p.S1176S,ENSG00000032219:ENST00000348476:exon23:c.A3528G:p.S1176S,ENSG00000032219:ENST00000355431:exon24:c.A3735G:p.S1245S,ENSG00000032219:ENST00000395168:exon24:c.A3573G:p.S1191S	ARID4A:NM_023001:exon23:c.A3528G:p.S1176S,ARID4A:NM_002892:exon24:c.A3735G:p.S1245S,ARID4A:NM_023000:exon24:c.A3573G:p.S1191S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5777	0.5303	0.539137	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ARID4A:uc001xdq.3:exon23:c.A3528G:p.S1176S,ARID4A:uc001xdo.3:exon24:c.A3573G:p.S1191S,ARID4A:uc001xdp.3:exon24:c.A3735G:p.S1245S	.	AFR:1(oesophagus),AMR:MU791666,EAS:0.5370,FIN:0.4099,NFE:0.6571,OTH:0.5767,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02	180201	.	.	.	.	.	.	.	.	.	.	.	14	1(lung)	0.5118
14	58838701	58838701	C	T	ARID4A	exonic	synonymous SNV	ENSG00000032219	rs1051861	ENSG00000032219:ENST00000431317:exon22:c.C3561T:p.C1187C,ENSG00000032219:ENST00000348476:exon23:c.C3561T:p.C1187C,ENSG00000032219:ENST00000355431:exon24:c.C3768T:p.C1256C,ENSG00000032219:ENST00000395168:exon24:c.C3606T:p.C1202C	ARID4A:NM_023001:exon23:c.C3561T:p.C1187C,ARID4A:NM_002892:exon24:c.C3768T:p.C1256C,ARID4A:NM_023000:exon24:c.C3606T:p.C1202C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5737	0.5220	0.531949	1(breast)	.	.	.	.	.	.	.	.	ARID4A:uc001xdq.3:exon23:c.C3561T:p.C1187C,ARID4A:uc001xdo.3:exon24:c.C3606T:p.C1202C,ARID4A:uc001xdp.3:exon24:c.C3768T:p.C1256C	.	AFR:1(oesophagus),AMR:MU791663,EAS:0.5304,FIN:0.3867,NFE:0.6567,OTH:0.5767,ASJ:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02	180201	.	.	.	.	.	.	.	.	.	.	.	14	1(stomach)	0.5137
14	61445967	61445967	A	G	TRMT5	exonic	nonsynonymous SNV	ENSG00000126814	rs7142228	ENSG00000126814:ENST00000261249:exon2:c.T649C:p.S217P	TRMT5:NM_001350253:exon2:c.T733C:p.S245P,TRMT5:NM_001350254:exon2:c.T730C:p.S244P,TRMT5:NM_020810:exon2:c.T649C:p.S217P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	TRMT5:uc001xff.4:exon2:c.T649C:p.S217P	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	611023	616539;	.	.	.	.	.	.	.	.	.	.	14	MU81949241	hom
14	62207359	62207362	TTTG	-	HIF1A-AS3	ncRNA_intronic	.	ENSG00000258667;ENSG00000258964	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	.	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	64694749	64694749	T	G	ESR2	exonic	nonsynonymous SNV	ENSG00000140009	rs17225885	ENSG00000140009:ENST00000553796:exon8:c.A1421C:p.K474T	ESR2:NM_001271876:exon8:c.A1421C:p.K474T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1222	.	0.101637	COCA-CN|2|321|0.00623053	0.303	5.724	0.0	0.918	0.002	.	.	Nuclear hormone receptor, ligand-binding domain	ESR2:uc031qoy.1:exon8:c.A1421C:p.K474T	-0.859	AFR:0.0692,AMR:0.1121,EAS:0.0762,FIN:0.1094,NFE:0.0212,OTH:0.0520,ASJ:0.0550	601663	.	.	.	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04929 GnRH secretion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	-2.66	0.013	.	14	1(soft_tissue)	0.0652
14	65544367	65544367	C	A	MAX	intronic	.	ENSG00000125952	rs762810	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3400	.	0.20627	0.2819	.	.	.	.	.	0.0001	0.038	.	.	.	AFR:0.1605,AMR:0.1998,EAS:0.1184,FIN:0.4232,NFE:0.3408,OTH:0.3279,ASJ:0.1867	154950	171300;	29072;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~	~ko04010 MAPK signaling pathway~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	14	MU81949947	hom
14	67147816	67147816	T	C	GPHN	intronic	.	ENSG00000171723	rs3759753	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2661	0.3141	0.45028	MU583252	.	.	.	.	.	0.0001	0.024	.	.	.	AFR:COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.3165,EAS:0.4017,FIN:0.2483,NFE:0.4813,OTH:0.1581,ASJ:0.6641	603930	615501;	308400;833;99732;	308400|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase type C<br>MOCOD type C|-|-|-|615501 ~833|-|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|252150 252160 272300 615501 ~99732|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase<br>MOCOD|-|-|-|252150 252160 615501 ~	.	.	.	.	.	.	.	.	14	2(haematopoietic_and_lymphoid_tissue)	0.1373
14	67291186	67291186	T	C	GPHN	intronic	.	ENSG00000171723	rs3784075	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1856	0.2184	0.38119	MU645105	.	.	.	.	.	0.0001	0.012	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.2249,EAS:0.3301,FIN:0.0695,NFE:0.4763,OTH:0.0866,ASJ:0.5662	603930	615501;	308400;833;99732;	308400|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase type C<br>MOCOD type C|-|-|-|615501 ~833|-|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|252150 252160 272300 615501 ~99732|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase<br>MOCOD|-|-|-|252150 252160 615501 ~	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.0364
14	69006913	69006913	A	G	RAD51B	intronic	.	ENSG00000182185	rs2525523	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.196086	0.2003	.	.	.	.	.	.	.	.	.	.	AFR:0.0592,AMR:0.2537,EAS:0.1887,FIN:0.3658,NFE:0.2531,OTH:0.2859,ASJ:0.2127	602948	.	.	.	.	.	.	.	.	.	.	.	14	MU38988821	unknown
14	69006922	69006922	A	G	RAD51B	exonic	nonsynonymous SNV	ENSG00000182185	rs2525524	.	RAD51B:NM_001321812:exon10:c.A1042G:p.R348G,RAD51B:NM_001321814:exon11:c.A1042G:p.R348G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.196086	0.2036	.	.	.	.	.	.	.	.	.	.	AFR:0.0567,AMR:0.2687,EAS:0.1913,FIN:0.3689,NFE:0.2544,OTH:0.2956,ASJ:0.2071	602948	.	.	.	.	.	.	.	.	.	.	.	14	MU38988825	unknown
14	69259662	69259662	C	A	ZFP36L1	exonic	synonymous SNV	ENSG00000185650	rs1051533	ENSG00000185650:ENST00000553375:exon2:c.G201T:p.T67T	ZFP36L1:NM_001244701:exon2:c.G201T:p.T67T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2037	0.2690	0.203474	0.2397	.	.	.	.	.	.	.	.	ZFP36L1:uc021rve.1:exon2:c.G201T:p.T67T	.	AFR:0.3499,AMR:0.1495,EAS:0.0049,FIN:0.1742,NFE:0.2229,OTH:0.2150,ASJ:0.2417	601064	.	.	.	.	.	.	.	.	.	.	.	14	MU113401527	het
14	75513828	75513828	G	A	MLH3	exonic	nonsynonymous SNV	ENSG00000119684	rs175080	ENSG00000119684:ENST00000556740:exon1:c.C2531T:p.P844L,ENSG00000119684:ENST00000238662:exon2:c.C2531T:p.P844L,ENSG00000119684:ENST00000355774:exon2:c.C2531T:p.P844L,ENSG00000119684:ENST00000556257:exon2:c.C2531T:p.P844L	MLH3:NM_001040108:exon2:c.C2531T:p.P844L,MLH3:NM_014381:exon2:c.C2531T:p.P844L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4126	0.4426	0.363818	MU112082	0.239	5.081	0.286	4.12	0.920	.	.	.	MLH3:uc001xrd.1:exon2:c.C2531T:p.P844L,MLH3:uc001xre.1:exon2:c.C2531T:p.P844L	-0.979	AFR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,AMR:0.4205,EAS:0.2788,FIN:0.5397,NFE:0.1481,OTH:0.4607,ASJ:0.3988	604395	114500;608089;614385;	144;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	.	.	.	.	0.01	-1.43	0.000	1.15	14	2(lung)	0.4575
14	75513883	75513883	T	C	MLH3	exonic	nonsynonymous SNV	ENSG00000119684	rs175081	ENSG00000119684:ENST00000556740:exon1:c.A2476G:p.N826D,ENSG00000119684:ENST00000238662:exon2:c.A2476G:p.N826D,ENSG00000119684:ENST00000355774:exon2:c.A2476G:p.N826D,ENSG00000119684:ENST00000556257:exon2:c.A2476G:p.N826D	MLH3:NM_001040108:exon2:c.A2476G:p.N826D,MLH3:NM_014381:exon2:c.A2476G:p.N826D	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9968	0.9888	0.990415	0.9902	-0.981	0.017	0.848	1.33	0.019	.	.	.	MLH3:uc001xrd.1:exon2:c.A2476G:p.N826D,MLH3:uc001xre.1:exon2:c.A2476G:p.N826D	-0.969	AFR:0.9660,AMR:0.9988,EAS:0.9994,FIN:1,NFE:0.9999,OTH:0.9969,ASJ:1	604395	114500;608089;614385;	144;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	.	.	.	.	0.001	-1.3	0.000	0	14	MU81951479	hom
14	81558965	81558965	A	G	TSHR	intronic	.	ENSG00000165409	rs2241119	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1887	0.2688	0.29972	0.2612	.	.	.	.	.	.	.	.	.	.	AFR:0.5320,AMR:0.1050,EAS:0.3348,FIN:0.1544,NFE:0.1398,OTH:0.1531,ASJ:0.1225	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	.	.	.	.	14	MU13685464	het
14	81562998	81562998	T	C	TSHR	exonic	synonymous SNV	ENSG00000165409	rs2075179	ENSG00000165409:ENST00000298171:exon7:c.T561C:p.N187N,ENSG00000165409:ENST00000342443:exon7:c.T561C:p.N187N,ENSG00000165409:ENST00000554263:exon7:c.T561C:p.N187N,ENSG00000165409:ENST00000554435:exon7:c.T561C:p.N187N,ENSG00000165409:ENST00000541158:exon8:c.T561C:p.N187N	TSHR:NM_000369:exon7:c.T561C:p.N187N,TSHR:NM_001018036:exon7:c.T561C:p.N187N,TSHR:NM_001142626:exon7:c.T561C:p.N187N	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1913	0.2697	0.30012	1(thyroid)	.	.	.	.	.	.	.	.	TSHR:uc001xvb.1:exon7:c.T561C:p.N187N,TSHR:uc001xvc.3:exon7:c.T561C:p.N187N,TSHR:uc001xvd.1:exon7:c.T561C:p.N187N,TSHR:uc010tvs.2:exon7:c.T561C:p.N187N	.	AFR:2(large_intestine),AMR:MU145337,EAS:0.2662,FIN:0.5338,NFE:0.1050,OTH:0.1225,ASJ:LICA-CN|2|402|0.00497512,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	.	.	.	.	14	3(soft_tissue)	0.3342
14	81574959	81574959	A	G	TSHR	exonic	synonymous SNV	ENSG00000165409	rs3783942	ENSG00000165409:ENST00000342443:exon9:c.A696G:p.L232L,ENSG00000165409:ENST00000554435:exon9:c.A759G:p.L253L	TSHR:NM_001018036:exon9:c.A696G:p.L232L,TSHR:NM_001142626:exon9:c.A759G:p.L253L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6468	0.6438	0.611222	0.6259	.	.	.	.	.	.	.	.	TSHR:uc001xvc.3:exon9:c.A696G:p.L232L,TSHR:uc010tvs.2:exon9:c.A759G:p.L253L	.	AFR:0.6285,AMR:0.6635,EAS:0.3247,FIN:0.6673,NFE:0.6404,OTH:0.6612,ASJ:0.7583	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	.	.	.	.	14	MU16499962	het
14	81575005	81575005	C	A	TSHR	exonic	nonsynonymous SNV	ENSG00000165409	rs3783941	ENSG00000165409:ENST00000342443:exon9:c.C742A:p.R248S,ENSG00000165409:ENST00000554435:exon9:c.C805A:p.R269S	TSHR:NM_001018036:exon9:c.C742A:p.R248S,TSHR:NM_001142626:exon9:c.C805A:p.R269S	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6465	0.6425	0.610224	0.6233	0.085	3.453	1.0	-8.59	0.000	.	.	Leucine-rich repeat domain, L domain-like	TSHR:uc001xvc.3:exon9:c.C742A:p.R248S,TSHR:uc010tvs.2:exon9:c.C805A:p.R269S	-1.021	AFR:0.6213,AMR:0.6623,EAS:0.3224,FIN:0.6665,NFE:0.6397,OTH:0.6608,ASJ:0.7583	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	0.0	-1.17	0.000	.	14	MU16500020	het
14	81610583	81610583	G	C	TSHR	exonic	nonsynonymous SNV	ENSG00000165409	rs1991517	ENSG00000165409:ENST00000298171:exon10:c.G2181C:p.E727D,ENSG00000165409:ENST00000541158:exon11:c.G2181C:p.E727D	TSHR:NM_000369:exon10:c.G2181C:p.E727D	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9004	0.9233	0.896765	0.8977	-1.490	0.003	1.0	2.08	0.751	.	.	.	TSHR:uc001xvd.1:exon10:c.G2181C:p.E727D	-0.975	AFR:0.9392,AMR:0.8675,EAS:0.8100,FIN:0.8495,NFE:0.8968,OTH:0.8798,ASJ:0.9106	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	0.0	-0.92	0.000	.	14	MU19600230	het
14	92441066	92441066	C	T	TRIP11	exonic	nonsynonymous SNV	ENSG00000100815	rs1051340	ENSG00000100815:ENST00000267622:exon19:c.G5479A:p.G1827S	TRIP11:NM_001321851:exon19:c.G5476A:p.G1826S,TRIP11:NM_004239:exon19:c.G5479A:p.G1827S	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.3155	0.2933	0.271366	0.2923	3.315	22.9	0.045	3.9	0.123	.	.	.	TRIP11:uc010auf.2:exon13:c.G4687A:p.G1563S,TRIP11:uc001xzy.3:exon19:c.G5479A:p.G1827S	-0.973	AFR:0.2330,AMR:0.2012,EAS:0.3263,FIN:0.3179,NFE:0.3196,OTH:0.3033,ASJ:0.3940	604505	200600;	932;93299;	932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93299|Achondrogenesis, Houston-Harris type|Unknown|Autosomal recessive|Antenatal<br>Neonatal|200600 ~	.	.	.	.	0.973	3.52	0.000	1.805	14	MU126413	het
14	92505915	92505915	T	A	TRIP11	exonic	nonsynonymous SNV	ENSG00000100815	rs17127898	ENSG00000100815:ENST00000267622:exon1:c.A115T:p.M39L	TRIP11:NM_001321851:exon1:c.A115T:p.M39L,TRIP11:NM_004239:exon1:c.A115T:p.M39L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 1, 0] 	0.0661	0.0640	0.0333466	0.0646	-0.664	0.088	1.0	-11.4	0.989	.	.	.	TRIP11:uc001xzy.3:exon1:c.A115T:p.M39L	-1.032	AFR:0.0147,AMR:0.0383,EAS:0.0006,FIN:0.1057,NFE:0.0916,OTH:0.0866,ASJ:0.0430	604505	200600;	932;93299;	932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93299|Achondrogenesis, Houston-Harris type|Unknown|Autosomal recessive|Antenatal<br>Neonatal|200600 ~	.	.	.	.	0.0	0.09	0.002	-0.59	14	.	het
14	93276654	93276654	T	C	GOLGA5	exonic	nonsynonymous SNV	ENSG00000066455	rs1040835	ENSG00000066455:ENST00000163416:exon5:c.T1048C:p.F350L,ENSG00000066455:ENST00000355976:exon5:c.T1048C:p.F350L	GOLGA5:NM_005113:exon5:c.T1048C:p.F350L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7999	0.7962	0.859625	MU103194	1.303	12.28	1.0	4.75	0.990	.	.	.	GOLGA5:uc001yaz.1:exon5:c.T1048C:p.F350L	-0.989	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.8175,EAS:0.8484,FIN:0.7252,NFE:0.8802,OTH:0.8143,ASJ:0.9357	606918	.	.	.	.	.	.	.	0.0	2.73	0.000	-1.975	14	1(thyroid)	0.7439
14	94844843	94844843	T	G	SERPINA1	exonic	nonsynonymous SNV	ENSG00000197249	rs1303	ENSG00000197249:ENST00000355814:exon5:c.A1200C:p.E400D,ENSG00000197249:ENST00000393087:exon5:c.A1200C:p.E400D,ENSG00000197249:ENST00000440909:exon5:c.A1200C:p.E400D,ENSG00000197249:ENST00000404814:exon6:c.A1200C:p.E400D,ENSG00000197249:ENST00000437397:exon6:c.A1200C:p.E400D,ENSG00000197249:ENST00000449399:exon6:c.A1200C:p.E400D,ENSG00000197249:ENST00000393088:exon7:c.A1200C:p.E400D,ENSG00000197249:ENST00000448921:exon7:c.A1200C:p.E400D	SERPINA1:NM_000295:exon5:c.A1200C:p.E400D,SERPINA1:NM_001002235:exon5:c.A1200C:p.E400D,SERPINA1:NM_001127700:exon5:c.A1200C:p.E400D,SERPINA1:NM_001127702:exon6:c.A1200C:p.E400D,SERPINA1:NM_001127706:exon6:c.A1200C:p.E400D,SERPINA1:NM_001127707:exon6:c.A1200C:p.E400D,SERPINA1:NM_001002236:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127701:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127703:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127704:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127705:exon7:c.A1200C:p.E400D	clinvar: Benign/Likely_benign,_other 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2747	0.2071	0.280351	3(stomach)	-2.890	0.001	1.0	-9.02	0.000	.	.	Serpin domain	SERPINA1:uc001ycx.4:exon5:c.A1200C:p.E400D,SERPINA1:uc001ycz.4:exon5:c.A1200C:p.E400D,SERPINA1:uc010aux.3:exon5:c.A1200C:p.E400D,SERPINA1:uc001ydc.4:exon6:c.A1200C:p.E400D,SERPINA1:uc010auz.3:exon6:c.A1200C:p.E400D,SERPINA1:uc010avb.3:exon6:c.A1200C:p.E400D,SERPINA1:uc001ycy.4:exon7:c.A1200C:p.E400D,SERPINA1:uc001ydb.4:exon7:c.A1200C:p.E400D,SERPINA1:uc010auw.3:exon7:c.A1200C:p.E400D,SERPINA1:uc010auy.3:exon7:c.A1200C:p.E400D,SERPINA1:uc010ava.3:exon7:c.A1200C:p.E400D	-0.918	AFR:4(haematopoietic_and_lymphoid_tissue),AMR:1(large_intestine),EAS:MU158468,FIN:LAML-KR|2|205|0.0097561,GACA-CN|1|123|0.00813008,COCA-CN|3|321|0.00934579,NFE:0.2132,OTH:0.1141,ASJ:1(biliary_tract)	107400	606963;613490;	60;	60|Deficiency in Alpa-1-proteinase inhibitor|1-5 / 10 000|Autosomal recessive|All ages|613490 ~	.	.	.	.	0.0	-2.13	0.000	-0.585	14	1(prostate)	0.3441
14	94849201	94849201	C	T	SERPINA1	exonic	nonsynonymous SNV	ENSG00000197249	rs709932	ENSG00000197249:ENST00000489769:exon1:c.G374A:p.R125H,ENSG00000197249:ENST00000355814:exon2:c.G374A:p.R125H,ENSG00000197249:ENST00000393087:exon2:c.G374A:p.R125H,ENSG00000197249:ENST00000402629:exon2:c.G374A:p.R125H,ENSG00000197249:ENST00000440909:exon2:c.G374A:p.R125H,ENSG00000197249:ENST00000554720:exon2:c.G116A:p.R39H,ENSG00000197249:ENST00000556091:exon2:c.G374A:p.R125H,ENSG00000197249:ENST00000404814:exon3:c.G374A:p.R125H,ENSG00000197249:ENST00000437397:exon3:c.G374A:p.R125H,ENSG00000197249:ENST00000449399:exon3:c.G374A:p.R125H,ENSG00000197249:ENST00000393088:exon4:c.G374A:p.R125H,ENSG00000197249:ENST00000448921:exon4:c.G374A:p.R125H,ENSG00000197249:ENST00000557492:exon4:c.G374A:p.R125H	SERPINA1:NM_000295:exon2:c.G374A:p.R125H,SERPINA1:NM_001002235:exon2:c.G374A:p.R125H,SERPINA1:NM_001127700:exon2:c.G374A:p.R125H,SERPINA1:NM_001127702:exon3:c.G374A:p.R125H,SERPINA1:NM_001127706:exon3:c.G374A:p.R125H,SERPINA1:NM_001127707:exon3:c.G374A:p.R125H,SERPINA1:NM_001002236:exon4:c.G374A:p.R125H,SERPINA1:NM_001127701:exon4:c.G374A:p.R125H,SERPINA1:NM_001127703:exon4:c.G374A:p.R125H,SERPINA1:NM_001127704:exon4:c.G374A:p.R125H,SERPINA1:NM_001127705:exon4:c.G374A:p.R125H	clinvar: Benign/Likely_benign,_other 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1631	0.1216	0.160543	6(haematopoietic_and_lymphoid_tissue)	-0.526	0.190	1.0	-2.82	0.000	.	.	Serpin domain	SERPINA1:uc001ycx.4:exon2:c.G374A:p.R125H,SERPINA1:uc001ycz.4:exon2:c.G374A:p.R125H,SERPINA1:uc001yda.1:exon2:c.G374A:p.R125H,SERPINA1:uc010aux.3:exon2:c.G374A:p.R125H,SERPINA1:uc001ydc.4:exon3:c.G374A:p.R125H,SERPINA1:uc010auz.3:exon3:c.G374A:p.R125H,SERPINA1:uc010avb.3:exon3:c.G374A:p.R125H,SERPINA1:uc001ycy.4:exon4:c.G374A:p.R125H,SERPINA1:uc001ydb.4:exon4:c.G374A:p.R125H,SERPINA1:uc010auw.3:exon4:c.G374A:p.R125H,SERPINA1:uc010auy.3:exon4:c.G374A:p.R125H,SERPINA1:uc010ava.3:exon4:c.G374A:p.R125H	-1.077	AFR:2(large_intestine),AMR:MU12568955,EAS:0.1219,FIN:0.0372,NFE:0.1388,OTH:0.1589,ASJ:LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763	107400	606963;613490;	60;	60|Deficiency in Alpa-1-proteinase inhibitor|1-5 / 10 000|Autosomal recessive|All ages|613490 ~	.	.	.	.	0.0	-1.77	0.000	-1.17	14	3(soft_tissue)	0.2074
14	95566104	95566104	C	-	DICER1	intronic	.	ENSG00000100697	rs35300142	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2971	.	.	0.4139	.	.	.	.	.	.	.	.	.	.	AFR:0.2451,AMR:0.4189,EAS:0.4108,FIN:0.4285,NFE:0.5062,OTH:0.4602,ASJ:0.4394	606241	138800;180295;601200;	284343;64742;276399;	284343|DICER1 syndrome<br>PPB familial tumor susceptibility syndrome<br>PPBFTDS<br>Pleuro-pulmonary blastoma familial tumor susceptibility syndrome|-|Autosomal dominant|Adolescent<br>Childhood<br>Adult|601200 ~64742|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|601200 ~276399|FMNG<br>Familial MNG|Unknown|Autosomal dominant|Adolescent|138800 ~	.	.	.	.	.	.	.	.	14	MU114385099	hom
14	95566106	95566108	CAC	-	DICER1	intronic	.	ENSG00000100697	rs367764979	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.3077	.	.	0.4123	.	.	.	.	.	.	.	.	.	.	AFR:0.2442,AMR:0.4092,EAS:0.4085,FIN:0.4213,NFE:0.5058,OTH:0.4658,ASJ:0.4351	606241	138800;180295;601200;	284343;64742;276399;	284343|DICER1 syndrome<br>PPB familial tumor susceptibility syndrome<br>PPBFTDS<br>Pleuro-pulmonary blastoma familial tumor susceptibility syndrome|-|Autosomal dominant|Adolescent<br>Childhood<br>Adult|601200 ~64742|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|601200 ~276399|FMNG<br>Familial MNG|Unknown|Autosomal dominant|Adolescent|138800 ~	.	.	.	.	.	.	.	.	14	.	het
14	97299853	97299853	A	G	VRK1	exonic	synonymous SNV	ENSG00000100749	rs2145635	ENSG00000100749:ENST00000216639:exon2:c.A45G:p.A15A	VRK1:NM_003384:exon2:c.A45G:p.A15A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3565	0.3309	0.289537	MU130355	.	.	.	.	.	.	.	.	VRK1:uc001yft.3:exon2:c.A45G:p.A15A	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.3264,EAS:0.3520,FIN:0.2933,NFE:0.1040,OTH:0.3974,ASJ:0.2168	602168	607596;	2254;	2254|Norman disease<br>PCH1|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607596 614678 616081 ~	.	.	.	.	.	.	.	.	14	1(lung)	0.3943
14	101295830	101295830	G	C	MEG3	ncRNA_exonic	.	ENSG00000214548	rs941575	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.955671	0.9330	.	.	.	.	.	.	.	.	.	.	AFR:0.9362,AMR:0.9594,EAS:0.9790,FIN:0.9390,NFE:0.9228,OTH:0.9338,ASJ:0.9570	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	101301012	101301012	T	C	MEG3	ncRNA_exonic	.	ENSG00000214548	rs10132552	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.23742	0.2605	.	.	.	.	.	.	.	.	.	.	AFR:0.2148,AMR:0.3305,EAS:0.2633,FIN:0.3544,NFE:0.2604,OTH:0.2802,ASJ:0.2185	605636	.	.	.	.	.	.	.	.	.	.	.	14	MU85249504	het
14	101302086	101302086	C	T	MEG3	ncRNA_exonic	.	ENSG00000214548	rs4906022	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.21266	0.2411	.	.	.	.	.	.	.	.	.	.	AFR:0.1487,AMR:0.3261,EAS:0.2643,FIN:0.3542,NFE:0.2594,OTH:0.2777,ASJ:0.2167	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101302211	101302211	G	T	MEG3	ncRNA_exonic	.	ENSG00000214548	rs11859	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.351038	0.2551	.	.	.	.	.	.	.	.	.	.	AFR:0.3916,AMR:0.1770,EAS:0.4522,FIN:0.1464,NFE:0.1890,OTH:0.1861,ASJ:0.2367	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101314863	101314863	C	T	MEG3	ncRNA_exonic	.	ENSG00000214548	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101316947	101316947	-	AAA	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	.	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	.	0.0037	.	.	.	.	.	.	.	.	.	.	AFR:0.0014,AMR:0.0019,EAS:0,FIN:0.0008,NFE:0.0048,OTH:0.0049,ASJ:0.0292	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101318311	101318311	C	G	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs2295389	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.274161	0.2980	.	.	.	.	.	.	.	.	.	.	AFR:0.1104,AMR:0.3389,EAS:0.3288,FIN:0.4107,NFE:0.3694,OTH:0.3865,ASJ:0.3079	605636	.	.	.	.	.	.	.	.	.	.	.	14	MU113782627	het
14	101320034	101320034	A	G	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs1998053	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.936901	0.9265	.	.	.	.	.	.	.	.	.	.	AFR:0.9848,AMR:0.9582,EAS:0.8832,FIN:0.8650,NFE:0.9116,OTH:0.8921,ASJ:0.9536	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	103338324	103338324	T	A	TRAF3	intronic	.	ENSG00000131323	rs2295402	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2673	0.3552	0.39976	1(breast)	.	.	.	.	.	.	.	.	.	.	AFR:1(large_intestine),AMR:MU23643680,EAS:0.3526,FIN:0.6786,NFE:0.3385,OTH:0.2583,ASJ:MALY-DE|1|241|0.00414938,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02	601896	614849;	1930;	1930|HSV encephalitis<br>Herpes simplex meningo-encephalitis<br>Herpes simplex neuroinvasion<br>Herpetic encephalitis|Unknown|Not applicable<br>or&nbsp;Multigenic/multifactorial|All ages|610551 613002 614849 614850 616532 ~	~ko04064 NF-kappa B signaling pathway~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04668 TNF signaling pathway~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	14	2(haematopoietic_and_lymphoid_tissue)	0.4125
14	103342049	103342049	T	C	TRAF3	exonic	nonsynonymous SNV	ENSG00000131323	rs1131877	ENSG00000131323:ENST00000559734:exon1:c.T26C:p.M9T,ENSG00000131323:ENST00000558700:exon2:c.T131C:p.M44T,ENSG00000131323:ENST00000351691:exon4:c.T386C:p.M129T,ENSG00000131323:ENST00000539721:exon4:c.T386C:p.M129T,ENSG00000131323:ENST00000560371:exon4:c.T386C:p.M129T,ENSG00000131323:ENST00000347662:exon5:c.T386C:p.M129T,ENSG00000131323:ENST00000392745:exon5:c.T386C:p.M129T	TRAF3:NM_001199427:exon4:c.T386C:p.M129T,TRAF3:NM_003300:exon4:c.T386C:p.M129T,TRAF3:NM_145725:exon5:c.T386C:p.M129T,TRAF3:NM_145726:exon5:c.T386C:p.M129T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3155	0.4308	0.469848	1(large_intestine)	-0.918	0.024	0.847	3.64	0.170	.	.	TRAF-like|Zinc finger, RING/FYVE/PHD-type	TRAF3:uc001ymd.2:exon4:c.T386C:p.M129T,TRAF3:uc010txy.2:exon4:c.T386C:p.M129T,TRAF3:uc001ymc.2:exon5:c.T386C:p.M129T,TRAF3:uc001yme.2:exon5:c.T386C:p.M129T	-1.024	AFR:1(lung),AMR:MU23643733,EAS:0.4289,FIN:0.8337,NFE:0.4390,OTH:0.2767,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	601896	614849;	1930;	1930|HSV encephalitis<br>Herpes simplex meningo-encephalitis<br>Herpes simplex neuroinvasion<br>Herpetic encephalitis|Unknown|Not applicable<br>or&nbsp;Multigenic/multifactorial|All ages|610551 613002 614849 614850 616532 ~	~ko04064 NF-kappa B signaling pathway~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04668 TNF signaling pathway~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05222 Small cell lung cancer ~	.	.	.	0.0	1.88	0.000	-1.78	14	1(breast)	0.4163
14	104165125	104165125	C	T	XRCC3	UTR3	.	ENSG00000126215	rs768944628	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0	.	.	3.241e-05	.	.	.	.	.	.	.	.	.	.	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	600675	114480;613972;	618;227535;	618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	14	.	het
14	105239894	105239894	C	T	AKT1	exonic	synonymous SNV	ENSG00000142208	rs1130233	ENSG00000142208:ENST00000544168:exon7:c.G540A:p.E180E,ENSG00000142208:ENST00000554581:exon8:c.G726A:p.E242E,ENSG00000142208:ENST00000402615:exon9:c.G726A:p.E242E,ENSG00000142208:ENST00000407796:exon9:c.G726A:p.E242E,ENSG00000142208:ENST00000554848:exon9:c.G726A:p.E242E,ENSG00000142208:ENST00000555528:exon9:c.G726A:p.E242E,ENSG00000142208:ENST00000349310:exon10:c.G726A:p.E242E	AKT1:NM_001014431:exon9:c.G726A:p.E242E,AKT1:NM_005163:exon9:c.G726A:p.E242E,AKT1:NM_001014432:exon10:c.G726A:p.E242E	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3141	0.2016	0.322484	54(meninges)	.	.	.	.	.	.	.	.	AKT1:uc010tyk.2:exon7:c.G540A:p.E180E,AKT1:uc001ypl.3:exon8:c.G726A:p.E242E,AKT1:uc001ypk.3:exon9:c.G726A:p.E242E,AKT1:uc001ypn.3:exon9:c.G726A:p.E242E,AKT1:uc010axa.3:exon9:c.G726A:p.E242E,AKT1:uc001ypm.3:exon10:c.G726A:p.E242E	.	AFR:1(oesophagus),AMR:1(urinary_tract),EAS:3(lung),FIN:MU4606458,NFE:LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611,BTCA-JP|1|239|0.0041841,ESCA-CN|1|332|0.00301205,BLCA-CN|1|103|0.00970874,OTH:0.2264,ASJ:1(stomach)	164730	114480;114500;167000;176920;181500;615109;	201;744;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~744|Partial gigantism-nevi-hemihypertrophy-macrocephaly syndrome|<1 / 1 000 000|Not applicable|Infancy|176920 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04261 Adrenergic signaling in cardiomyocytes~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04973 Carbohydrate digestion and absorption~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	,395,390,392,394,391,396,393	.	.	.	.	.	.	14	1(breast)	0.1037
14	105246407	105246407	G	A	AKT1	intronic	.	ENSG00000142208	rs3730358	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1589	0.1726	0.174121	COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.1555,AMR:0.2023,EAS:0.1788,FIN:0.0469,NFE:0.1193,OTH:0.1451,ASJ:0.2351	164730	114480;114500;167000;176920;181500;615109;	201;744;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~744|Partial gigantism-nevi-hemihypertrophy-macrocephaly syndrome|<1 / 1 000 000|Not applicable|Infancy|176920 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04261 Adrenergic signaling in cardiomyocytes~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04973 Carbohydrate digestion and absorption~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	14	3(soft_tissue)	0.1327
14	105722726	105722726	T	C	BRF1	exonic	synonymous SNV	ENSG00000185024	rs1008628	ENSG00000185024:ENST00000548421:exon4:c.A600G:p.P200P	BRF1:NM_001242790:exon4:c.A600G:p.P200P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3709	.	0.222644	MU4558705	.	.	.	.	.	.	.	.	BRF1:uc001yqr.3:exon4:c.A600G:p.P200P	.	AFR:LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526,AMR:0.2567,EAS:0.2285,FIN:0.2119,NFE:0.1269,OTH:0.3364,ASJ:0.2338	604902	616202;	444072;	444072|Cerebellofaciodental syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal<br>Neonatal|616202 ~	.	.	.	.	.	.	.	.	14	2(lung)	0.2663
15	28359744	28359744	G	A	HERC2	intronic	.	ENSG00000128731	rs7495441	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9275	0.8259	0.790935	0.8527	.	.	.	.	.	.	.	.	.	.	AFR:0.4982,AMR:0.9618,EAS:0.9759,FIN:0.9997,NFE:0.9947,OTH:0.9633,ASJ:0.9633	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU81958444	het
15	28419746	28419746	G	A	HERC2	exonic	synonymous SNV	ENSG00000128731	rs139335991	ENSG00000128731:ENST00000261609:exon65:c.C9852T:p.N3284N	HERC2:NM_004667:exon65:c.C9852T:p.N3284N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1384	.	.	0.0830	.	.	.	.	.	.	.	.	HERC2:uc001zbj.4:exon65:c.C9852T:p.N3284N	.	AFR:0.0881,AMR:0.2342,EAS:0.4082,FIN:0.0822,NFE:0.0406,OTH:0.0630,ASJ:0.0398	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU17131536	het
15	28419774	28419774	C	T	HERC2	intronic	.	ENSG00000128731	rs774428903	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0015	.	.	0.0016	.	.	.	.	.	0	0.016	.	.	.	AFR:0.0012,AMR:0.0041,EAS:0,FIN:0.0006,NFE:0.0020,OTH:0.0022,ASJ:0.0038	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	.	unknown
15	28419779	28419779	A	G	HERC2	intronic	.	ENSG00000128731	rs750466901	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0005	.	.	0.0004	.	.	.	.	.	.	.	.	.	.	AFR:0.0002,AMR:0.0026,EAS:0,FIN:0.0003,NFE:0.0004,OTH:0.0011,ASJ:0.0036	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU14110449	unknown
15	28419786	28419786	A	T	HERC2	intronic	.	ENSG00000128731	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 0, 0, 0] 	2.816e-05	.	.	6.617e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0.0012,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU63779834	unknown
15	28517546	28517546	G	T	HERC2	intronic	.	ENSG00000128731	rs79819039	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0007	.	0.00319489	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	.	het
15	31197564	31197564	G	A	FAN1	exonic	nonsynonymous SNV	ENSG00000198690	rs4779794	ENSG00000198690:ENST00000362065:exon2:c.G698A:p.G233E,ENSG00000198690:ENST00000561594:exon2:c.G698A:p.G233E,ENSG00000198690:ENST00000561607:exon2:c.G698A:p.G233E,ENSG00000198690:ENST00000565280:exon2:c.G698A:p.G233E,ENSG00000198690:ENST00000565466:exon2:c.G698A:p.G233E	FAN1:NM_001146094:exon2:c.G698A:p.G233E,FAN1:NM_001146095:exon2:c.G698A:p.G233E,FAN1:NM_001146096:exon2:c.G698A:p.G233E,FAN1:NM_014967:exon2:c.G698A:p.G233E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4594	0.3195	0.422524	MU4560159	-1.462	0.003	0.791	-2.16	0.002	.	.	.	FAN1:uc001zfc.3:exon2:c.G698A:p.G233E,FAN1:uc001zfd.3:exon2:c.G698A:p.G233E,FAN1:uc001zff.3:exon2:c.G698A:p.G233E,FAN1:uc010azw.2:exon2:c.G698A:p.G233E	-0.903	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,THCA-SA|1|243|0.00411523,AMR:0.3667,EAS:0.5456,FIN:0.54,NFE:0.8103,OTH:0.4811,ASJ:0.1055	613534	614817;	401996;	401996|KIN<br>Systemic karyomegaly|<1 / 1 000 000|Autosomal recessive|Adult|614817 ~	.	.	.	.	0.146	1.01	0.000	2.045	15	2(pancreas)	0.4257
15	31229420	31229420	T	C	FAN1	exonic	synonymous SNV	ENSG00000198690	rs2955795	ENSG00000198690:ENST00000362065:exon14:c.T3015C:p.H1005H	FAN1:NM_014967:exon14:c.T3015C:p.H1005H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4755	0.3482	0.457069	MU20615899	.	.	.	.	.	.	.	.	FAN1:uc001zff.3:exon14:c.T3015C:p.H1005H,FAN1:uc001zfe.3:exon15:c.T1830C:p.H610H	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.3958,EAS:0.5585,FIN:0.5563,NFE:0.8583,OTH:0.4911,ASJ:0.1658	613534	614817;	401996;	401996|KIN<br>Systemic karyomegaly|<1 / 1 000 000|Autosomal recessive|Adult|614817 ~	.	.	.	.	.	.	.	.	15	1(urinary_tract)	0.4408
15	35083509	35083512	CACA	-	LOC101928174	ncRNA_intronic	.	ENSG00000250007	rs572654192	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0] 	.	.	0.244808	0.1347	.	.	.	.	.	.	.	.	.	.	AFR:0.1241,AMR:0.1085,EAS:0.0185,FIN:0.2255,NFE:0.1298,OTH:0.1729,ASJ:0.1624	.	.	.	.	.	.	.	.	.	.	.	.	15	.	unknown
15	38614525	38614525	G	A	SPRED1	exonic	synonymous SNV	ENSG00000166068	rs7182445	ENSG00000166068:ENST00000299084:exon3:c.G291A:p.K97K,ENSG00000166068:ENST00000561317:exon4:c.G228A:p.K76K	SPRED1:NM_152594:exon3:c.G291A:p.K97K	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8637	0.8258	0.80012	LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SPRED1:uc001zka.4:exon3:c.G291A:p.K97K	.	AFR:0.8318,AMR:0.6692,EAS:0.8709,FIN:0.7922,NFE:0.9345,OTH:0.9005,ASJ:0.8517	609291	611431;	137605;	137605|NF1-like syndrome<br>Neurofibromatosis 1-like syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|611431 ~	.	.	.	.	.	.	.	.	15	1(thyroid)	0.8939
15	38631930	38631930	C	A	SPRED1	intronic	.	ENSG00000166068	rs7180446	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8637	0.8255	0.799321	0.8318	.	.	.	.	.	0.0051	0.082	.	.	.	AFR:0.6692,AMR:0.8520,EAS:0.7932,FIN:0.9352,NFE:0.9005,OTH:0.8939,ASJ:0.8709	609291	611431;	137605;	137605|NF1-like syndrome<br>Neurofibromatosis 1-like syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|611431 ~	.	.	.	.	.	.	.	.	15	MU666813	hom
15	38643574	38643574	T	C	SPRED1	exonic	synonymous SNV	ENSG00000166068	rs3751526	ENSG00000166068:ENST00000299084:exon7:c.T1044C:p.V348V	SPRED1:NM_152594:exon7:c.T1044C:p.V348V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8637	0.8254	0.799521	LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SPRED1:uc001zka.4:exon7:c.T1044C:p.V348V	.	AFR:0.8315,AMR:0.6681,EAS:0.8709,FIN:0.7924,NFE:0.9345,OTH:0.9005,ASJ:0.8508	609291	611431;	137605;	137605|NF1-like syndrome<br>Neurofibromatosis 1-like syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|611431 ~	.	.	.	.	.	.	.	.	15	4(haematopoietic_and_lymphoid_tissue)	0.8941
15	40477831	40477831	G	A	BUB1B	exonic	nonsynonymous SNV	ENSG00000156970	rs1801376	ENSG00000156970:ENST00000287598:exon8:c.G1046A:p.R349Q,ENSG00000156970:ENST00000412359:exon8:c.G1088A:p.R363Q	BUB1B:NM_001211:exon8:c.G1046A:p.R349Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6566	0.7360	0.628195	72(lung)	2.297	18.15	1.0	4.72	0.977	.	.	.	BUB1B:uc010ucl.1:exon4:c.G635A:p.R212Q,BUB1B:uc001zkx.4:exon8:c.G1046A:p.R349Q	-0.980	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU20627954,EAS:0.7235,FIN:0.8293,NFE:0.6325,OTH:0.6159,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	602860	114500;176430;257300;	1052;	1052|Warburton-Anyane-Yeboa syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|257300 614114 ~	.	.	.	.	0.0	2.74	0.000	-2.255	15	1(large_intestine)	0.3188
15	40500986	40500986	C	T	BUB1B	intronic	.	ENSG00000156970	rs11630664	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4916	0.4667	0.396965	0.4666	.	.	.	.	.	.	.	.	.	.	AFR:0.3045,AMR:0.5072,EAS:0.2349,FIN:0.5516,NFE:0.5612,OTH:0.5327,ASJ:0.3874	602860	114500;176430;257300;	1052;	1052|Warburton-Anyane-Yeboa syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|257300 614114 ~	.	.	.	.	.	.	.	.	15	MU20628209	hom
15	40898643	40898643	G	C	KNL1	exonic	nonsynonymous SNV	ENSG00000137812	rs7177192	ENSG00000137812:ENST00000346991:exon4:c.G128C:p.R43T,ENSG00000137812:ENST00000399668:exon4:c.G128C:p.R43T,ENSG00000137812:ENST00000527044:exon4:c.G128C:p.R43T	KNL1:NM_144508:exon4:c.G128C:p.R43T,KNL1:NM_170589:exon4:c.G128C:p.R43T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7456	0.8222	0.653754	1(haematopoietic_and_lymphoid_tissue)	-1.469	0.003	0.53	-4.84	0.891	.	.	.	CASC5:uc001zme.3:exon4:c.G128C:p.R43T,CASC5:uc010bbs.1:exon4:c.G128C:p.R43T,CASC5:uc010bbt.1:exon4:c.G128C:p.R43T	-0.968	AFR:1(large_intestine),AMR:MU583520,EAS:0.7939,FIN:0.7709,NFE:0.5634,OTH:0.8046,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.0	1.93	0.000	-1.61	15	2(prostate)	0.2983
15	40913840	40913840	G	T	KNL1	exonic	nonsynonymous SNV	ENSG00000137812	rs2412541	ENSG00000137812:ENST00000399668:exon10:c.G1378T:p.A460S,ENSG00000137812:ENST00000346991:exon11:c.G1456T:p.A486S	KNL1:NM_144508:exon10:c.G1378T:p.A460S,KNL1:NM_170589:exon11:c.G1456T:p.A486S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7455	0.8217	0.653954	0.7942	-1.118	0.009	1.0	1.67	0.975	.	.	.	CASC5:uc010ucq.1:exon9:c.G928T:p.A310S,CASC5:uc001zme.3:exon10:c.G1378T:p.A460S,CASC5:uc010bbt.1:exon10:c.G1378T:p.A460S,CASC5:uc010bbs.1:exon11:c.G1456T:p.A486S	-1.032	AFR:0.7706,AMR:0.5621,EAS:0.3,FIN:0.8417,NFE:0.8617,OTH:0.8008,ASJ:0.8046	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.0	3.69	0.000	-0.46	15	MU25432617	het
15	40914177	40914177	T	C	KNL1	exonic	nonsynonymous SNV	ENSG00000137812	rs11858113	ENSG00000137812:ENST00000399668:exon10:c.T1715C:p.M572T,ENSG00000137812:ENST00000346991:exon11:c.T1793C:p.M598T	KNL1:NM_144508:exon10:c.T1715C:p.M572T,KNL1:NM_170589:exon11:c.T1793C:p.M598T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3924	0.3915	0.351438	1(haematopoietic_and_lymphoid_tissue)	-0.133	1.498	0.196	0.769	0.987	.	.	.	CASC5:uc010ucq.1:exon9:c.T1265C:p.M422T,CASC5:uc001zme.3:exon10:c.T1715C:p.M572T,CASC5:uc010bbt.1:exon10:c.T1715C:p.M572T,CASC5:uc010bbs.1:exon11:c.T1793C:p.M598T	-0.938	AFR:MU154932,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.3778,FIN:0.2883,NFE:0.3841,OTH:0.2184,ASJ:0.4074	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.001	2.16	0.000	1.795	15	1(bone)	0.4624
15	40914772	40914772	C	T	KNL1	exonic	synonymous SNV	ENSG00000137812	rs11855334	ENSG00000137812:ENST00000399668:exon10:c.C2310T:p.V770V,ENSG00000137812:ENST00000346991:exon11:c.C2388T:p.V796V	KNL1:NM_144508:exon10:c.C2310T:p.V770V,KNL1:NM_170589:exon11:c.C2388T:p.V796V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3928	0.3899	0.350839	1(lung)	.	.	.	.	.	.	.	.	CASC5:uc010ucq.1:exon9:c.C1860T:p.V620V,CASC5:uc001zme.3:exon10:c.C2310T:p.V770V,CASC5:uc010bbt.1:exon10:c.C2310T:p.V770V,CASC5:uc010bbs.1:exon11:c.C2388T:p.V796V	.	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:MU154937,EAS:0.4067,FIN:0.3741,NFE:0.2883,OTH:0.3867,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	15	1(stomach)	0.2191
15	40915045	40915045	T	G	KNL1	exonic	synonymous SNV	ENSG00000137812	rs8041534	ENSG00000137812:ENST00000399668:exon10:c.T2583G:p.T861T,ENSG00000137812:ENST00000346991:exon11:c.T2661G:p.T887T	KNL1:NM_144508:exon10:c.T2583G:p.T861T,KNL1:NM_170589:exon11:c.T2661G:p.T887T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3923	0.3932	0.351238	MU154943	.	.	.	.	.	.	.	.	CASC5:uc010ucq.1:exon9:c.T2133G:p.T711T,CASC5:uc001zme.3:exon10:c.T2583G:p.T861T,CASC5:uc010bbt.1:exon10:c.T2583G:p.T861T,CASC5:uc010bbs.1:exon11:c.T2661G:p.T887T	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|1|321|0.00311526,AMR:0.4067,EAS:0.2859,FIN:0.38,NFE:0.2184,OTH:0.4628,ASJ:0.3755	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	15	2(haematopoietic_and_lymphoid_tissue)	0.4373
15	40915190	40915190	A	G	KNL1	exonic	nonsynonymous SNV	ENSG00000137812	rs8040502	ENSG00000137812:ENST00000399668:exon10:c.A2728G:p.R910G,ENSG00000137812:ENST00000346991:exon11:c.A2806G:p.R936G	KNL1:NM_144508:exon10:c.A2728G:p.R910G,KNL1:NM_170589:exon11:c.A2806G:p.R936G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7589	0.8695	0.705671	1(prostate)	0.453	7.062	1.0	3.03	0.884	.	.	.	CASC5:uc010ucq.1:exon9:c.A2278G:p.R760G,CASC5:uc001zme.3:exon10:c.A2728G:p.R910G,CASC5:uc010bbt.1:exon10:c.A2728G:p.R910G,CASC5:uc010bbs.1:exon11:c.A2806G:p.R936G	-1.015	AFR:1(stomach),AMR:2(haematopoietic_and_lymphoid_tissue),EAS:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,FIN:0.8352,NFE:0.9146,OTH:0.5680,ASJ:MU583521	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.0	2.57	0.000	-1.59	15	1(lung)	0.8046
15	40915894	40915894	T	C	KNL1	exonic	synonymous SNV	ENSG00000137812	rs11070285	ENSG00000137812:ENST00000399668:exon10:c.T3432C:p.N1144N,ENSG00000137812:ENST00000346991:exon11:c.T3510C:p.N1170N	KNL1:NM_144508:exon10:c.T3432C:p.N1144N,KNL1:NM_170589:exon11:c.T3510C:p.N1170N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3935	0.3928	0.351837	0.4079	.	.	.	.	.	.	.	.	CASC5:uc010ucq.1:exon9:c.T2982C:p.N994N,CASC5:uc001zme.3:exon10:c.T3432C:p.N1144N,CASC5:uc010bbt.1:exon10:c.T3432C:p.N1144N,CASC5:uc010bbs.1:exon11:c.T3510C:p.N1170N	.	AFR:0.3764,AMR:0.2871,EAS:0.2208,FIN:0.4624,NFE:0.4385,OTH:0.4398,ASJ:0.3974	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	15	MU154948	het
15	41798142	41798142	C	T	LTK	exonic	nonsynonymous SNV	ENSG00000062524	rs35932273	ENSG00000062524:ENST00000561619:exon6:c.G697A:p.D233N,ENSG00000062524:ENST00000355166:exon11:c.G1420A:p.D474N,ENSG00000062524:ENST00000263800:exon12:c.G1603A:p.D535N	LTK:NM_206961:exon11:c.G1420A:p.D474N,LTK:NM_002344:exon12:c.G1603A:p.D535N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.0229	0.0221	0.0177716	.	4.034	23.7	0.002	0.835	0.930	.	.	Protein kinase domain|Protein kinase, ATP binding site|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase, catalytic domain|Tyrosine-protein kinase, catalytic domain	LTK:uc010bcg.2:exon6:c.G697A:p.D233N,LTK:uc001zob.3:exon11:c.G1420A:p.D474N,LTK:uc001zoa.3:exon12:c.G1603A:p.D535N	-0.568	AFR:.,AMR:0.0180,EAS:0.0144,FIN:0.0331,NFE:0.0049,OTH:0.0155,ASJ:0.0057	151520	.	.	.	.	.	.	.	0.829	-1.64	0.218	0.865	15	1(soft_tissue)	0.0266
15	41803914	41803914	A	G	LTK	intronic	.	ENSG00000062524	rs2254078	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.379992	0.4025	.	.	.	.	.	.	.	.	.	.	AFR:0.2809,AMR:0.4771,EAS:0.3181,FIN:0.4378,NFE:0.4672,OTH:0.4380,ASJ:0.4333	151520	.	.	.	.	.	.	.	.	.	.	.	15	.	hom
15	41857303	41857303	T	C	TYRO3	exonic	synonymous SNV	ENSG00000092445	rs2277536	ENSG00000092445:ENST00000263798:exon6:c.T747C:p.A249A,ENSG00000092445:ENST00000559066:exon6:c.T612C:p.A204A	TYRO3:NM_001330264:exon6:c.T612C:p.A204A,TYRO3:NM_006293:exon6:c.T747C:p.A249A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2746	0.2572	0.267173	MU30087667	.	.	.	.	.	.	.	.	TYRO3:uc001zof.2:exon6:c.T747C:p.A249A	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.2660,EAS:0.3592,FIN:0.3013,NFE:0.1681,OTH:0.3025,ASJ:0.2084	600341	.	.	.	.	.	.	.	.	.	.	.	15	1(stomach)	0.2957
15	41860411	41860411	G	A	TYRO3	intronic	.	ENSG00000092445	rs7171675	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3679	0.4417	0.332668	0.4087	.	.	.	.	.	0	0	.	.	.	AFR:0.4962,AMR:0.3113,EAS:0.0193,FIN:0.4139,NFE:0.4032,OTH:0.4227,ASJ:0.4167	600341	.	.	.	.	.	.	.	.	.	.	.	15	MU25623926	het
15	41862354	41862436	GGTAAGGGGATGGGGATGTGGAGGGAGAGGCAGGTAATGATGAAAGACCTTGGAGCTGACCCCAAATCCTGGGTTTTCCTTTA	-	TYRO3	exonic	frameshift deletion	ENSG00000092445	.	ENSG00000092445:ENST00000263798:exon10:c.1382delG:p.G461fs,ENSG00000092445:ENST00000559066:exon10:c.1247delG:p.G416fs	TYRO3:NM_001330264:exon10:c.1247delG:p.G416fs,TYRO3:NM_006293:exon10:c.1382delG:p.G461fs	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0770	.	.	0.0041	.	.	.	.	.	.	.	.	TYRO3:uc001zof.2:exon10:c.1382delG:p.G461fs	.	AFR:0.0018,AMR:0.0025,EAS:0,FIN:0.0041,NFE:0.0062,OTH:0.0033,ASJ:0.0037	600341	.	.	.	.	.	.	.	.	.	.	.	15	.	het
15	41862801	41862801	G	T	TYRO3	splicing	.	ENSG00000092445	rs200684350	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 0, 0, 0] 	9.762e-05	.	.	2(urinary_tract)	5.406	26.0	.	4.99	0.939	1.0000	0.932	.	.	.	AFR:MU27360,AMR:PRAD-CA|2|306|0.00653595,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600341	.	.	.	.	.	.	.	.	.	.	.	15	1(kidney)	.
15	41865488	41865488	C	T	TYRO3	intronic	.	ENSG00000092445	rs2246444	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4163	0.3897	0.446685	0.4406	.	.	.	.	.	.	.	.	.	.	AFR:0.4291,AMR:0.4339,EAS:0.7968,FIN:0.3794,NFE:0.4245,OTH:0.4156,ASJ:0.3442	600341	.	.	.	.	.	.	.	.	.	.	.	15	MU4328220	het
15	43724646	43724646	T	G	TP53BP1	exonic	nonsynonymous SNV	ENSG00000067369	rs2602141	ENSG00000067369:ENST00000263801:exon17:c.A3406C:p.K1136Q,ENSG00000067369:ENST00000382039:exon17:c.A3421C:p.K1141Q,ENSG00000067369:ENST00000382044:exon17:c.A3421C:p.K1141Q,ENSG00000067369:ENST00000450115:exon17:c.A3421C:p.K1141Q	TP53BP1:NM_001141979:exon17:c.A3421C:p.K1141Q,TP53BP1:NM_001141980:exon17:c.A3421C:p.K1141Q,TP53BP1:NM_005657:exon17:c.A3406C:p.K1136Q,TP53BP1:NM_001355001:exon18:c.A541C:p.K181Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3750	0.4836	0.526358	4(haematopoietic_and_lymphoid_tissue)	1.331	12.43	1.0	4.45	0.961	.	.	.	TP53BP1:uc010udp.2:exon16:c.A3406C:p.K1136Q,TP53BP1:uc001zrq.4:exon17:c.A3421C:p.K1141Q,TP53BP1:uc001zrr.4:exon17:c.A3421C:p.K1141Q,TP53BP1:uc001zrs.3:exon17:c.A3406C:p.K1136Q,TP53BP1:uc010udq.1:exon17:c.A3421C:p.K1141Q	-1.000	AFR:MU125397,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.8481,FIN:0.3353,NFE:0.3907,OTH:0.3995,ASJ:0.4422	605230	.	.	.	.	.	.	.	0.0	3.86	0.000	-2.28	15	1(pancreas)	0.2126
15	48720526	48720526	G	C	FBN1	intronic	.	ENSG00000166147	rs363832	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7404	0.6784	0.65595	0.6718	.	.	.	.	.	.	.	.	.	.	AFR:0.4800,AMR:0.7847,EAS:0.6314,FIN:0.7437,NFE:0.7594,OTH:0.7219,ASJ:0.7616	134797	102370;129600;154700;184900;604308;608328;614185;616914;	300382;2623;2084;3449;2833;284963;558;1885;969;	300382|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616914 ~2623|Geleophysic dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|231050 614185 ~2084|GEMSS syndrome|<1 / 1 000 000|Autosomal dominant|All ages|608328 ~3449|Spherophakia-brachymorphia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|277600 608328 614819 ~2833|-|-|-|-|184900 228020 ~284963|MFS1|-|Autosomal dominant|All ages|154700 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~1885|Ectopia lentis syndrome<br>Familial ectopia lentis|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|129600 225100 225200 ~969|-|<1 / 1 000 000|Autosomal dominant|Neonatal|102370 ~	.	.	.	.	.	.	.	.	15	MU12633444	hom
15	48764778	48764778	C	T	FBN1	exonic	nonsynonymous SNV	ENSG00000166147	rs377338217	ENSG00000166147:ENST00000316623:exon35:c.G4306A:p.V1436M	FBN1:NM_000138:exon35:c.G4306A:p.V1436M	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 1, 1, 1, 0, 0] 	0.0007	.	0.00159744	3.23e-05	5.283	25.7	0.465	5.81	0.997	.	.	EGF-like calcium-binding domain|EGF-like domain|EGF-like, conserved site|Growth factor receptor cysteine-rich domain	FBN1:uc001zwx.2:exon35:c.G4306A:p.V1436M	-0.049	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.666e-05,OTH:0,ASJ:0	134797	102370;129600;154700;184900;604308;608328;614185;616914;	300382;2623;2084;3449;2833;284963;558;1885;969;	300382|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616914 ~2623|Geleophysic dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|231050 614185 ~2084|GEMSS syndrome|<1 / 1 000 000|Autosomal dominant|All ages|608328 ~3449|Spherophakia-brachymorphia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|277600 608328 614819 ~2833|-|-|-|-|184900 228020 ~284963|MFS1|-|Autosomal dominant|All ages|154700 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~1885|Ectopia lentis syndrome<br>Familial ectopia lentis|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|129600 225100 225200 ~969|-|<1 / 1 000 000|Autosomal dominant|Neonatal|102370 ~	.	.	.	.	0.943	-3.13	0.512	0.18	15	.	het
15	48807637	48807637	C	T	FBN1	exonic	nonsynonymous SNV	ENSG00000166147	rs4775765	ENSG00000166147:ENST00000316623:exon12:c.G1415A:p.C472Y	FBN1:NM_000138:exon12:c.G1415A:p.C472Y	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	1	.	1	1	.	.	.	.	.	.	.	.	FBN1:uc001zwx.2:exon12:c.G1415A:p.C472Y	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	134797	102370;129600;154700;184900;604308;608328;614185;616914;	300382;2623;2084;3449;2833;284963;558;1885;969;	300382|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616914 ~2623|Geleophysic dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|231050 614185 ~2084|GEMSS syndrome|<1 / 1 000 000|Autosomal dominant|All ages|608328 ~3449|Spherophakia-brachymorphia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|277600 608328 614819 ~2833|-|-|-|-|184900 228020 ~284963|MFS1|-|Autosomal dominant|All ages|154700 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~1885|Ectopia lentis syndrome<br>Familial ectopia lentis|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|129600 225100 225200 ~969|-|<1 / 1 000 000|Autosomal dominant|Neonatal|102370 ~	.	.	.	.	.	.	.	.	15	MU81961571	hom
15	51502986	51502986	G	A	MIR4713HG	ncRNA_intronic	.	ENSG00000259240	rs10046	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4492	0.4329	0.362819	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.4477,AMR:0.2428,EAS:0.5331,FIN:0.5267,NFE:0.5272,OTH:0.5416,ASJ:0.3305	.	.	.	.	.	.	.	.	.	.	.	.	15	1(haematopoietic_and_lymphoid_tissue)	0.4949
15	51507968	51507968	G	A	CYP19A1	exonic	nonsynonymous SNV	ENSG00000137869	rs700519	ENSG00000137869:ENST00000559878:exon6:c.C790T:p.R264C,ENSG00000137869:ENST00000561075:exon6:c.C613T:p.R205C,ENSG00000137869:ENST00000260433:exon7:c.C790T:p.R264C,ENSG00000137869:ENST00000396402:exon7:c.C790T:p.R264C,ENSG00000137869:ENST00000557934:exon7:c.C790T:p.R264C,ENSG00000137869:ENST00000558328:exon7:c.C790T:p.R264C,ENSG00000137869:ENST00000396404:exon8:c.C790T:p.R264C,ENSG00000137869:ENST00000439712:exon8:c.C790T:p.R264C	CYP19A1:NM_001347256:exon6:c.C790T:p.R264C,CYP19A1:NM_000103:exon7:c.C790T:p.R264C,CYP19A1:NM_001347248:exon7:c.C790T:p.R264C,CYP19A1:NM_001347249:exon7:c.C790T:p.R264C,CYP19A1:NM_001347250:exon7:c.C790T:p.R264C,CYP19A1:NM_001347251:exon7:c.C790T:p.R264C,CYP19A1:NM_001347252:exon7:c.C790T:p.R264C,CYP19A1:NM_001347253:exon7:c.C790T:p.R264C,CYP19A1:NM_001347254:exon7:c.C790T:p.R264C,CYP19A1:NM_001347255:exon7:c.C790T:p.R264C,CYP19A1:NM_031226:exon8:c.C790T:p.R264C	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0796	0.0774	0.139976	MU29353498	4.625	24.5	0.044	4.4	0.988	.	.	.	CYP19A1:uc001zza.4:exon7:c.C790T:p.R264C,CYP19A1:uc001zyz.4:exon8:c.C790T:p.R264C,CYP19A1:uc001zzb.2:exon8:c.C790T:p.R264C	-1.069	AFR:LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053,AMR:0.0814,EAS:0.0455,FIN:0.0497,NFE:0.1390,OTH:0.0424,ASJ:0.1668	107910	139300;613546;	91;178345;	91|Congenital estrogen deficiency|<1 / 1 000 000|Autosomal recessive|All ages|613546 ~178345|AEXS<br>Familial hyperestrogenism<br>Hereditary prepubertal gynecomastia|-|Autosomal dominant|-|139300 ~	.	.	.	.	0.011	-0.44	0.001	1.73	15	1(stomach)	0.0382
15	51510868	51510868	A	C	MIR4713HG	ncRNA_intronic	.	ENSG00000259240	rs4324076	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4867	0.3976	0.367212	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:MU23684803,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,EAS:0.2364,FIN:0.3301,NFE:0.5298,OTH:0.5249,ASJ:0.4418	.	.	.	.	.	.	.	.	.	.	.	.	15	1(lung)	0.5011
15	66729250	66729250	C	T	MAP2K1	intronic	.	ENSG00000169032	rs16949939	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0272	0.0169	0.0191693	.	.	.	.	.	.	.	.	.	.	.	AFR:0.0135,AMR:0.0038,EAS:0.0132,FIN:0.0068,NFE:0.0138,OTH:0.0203,ASJ:0.0095	176872	615279;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04114 Oocyte meiosis~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04218 Cellular senescence~ko04270 Vascular smooth muscle contraction~ko04320 Dorso-ventral axis formation~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04620 Toll-like receptor signaling pathway~ko04626 Plant-pathogen interaction~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05020 Prion diseases~ko05034 Alcoholism~ko05135 Yersinia infection~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	15	25(prostate)	0.0082
15	66745890	66745890	G	A	MAP2K1	intronic	.	ENSG00000169032	rs7169326	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9989	.	0.983227	0.9869	.	.	.	.	.	.	.	.	.	.	AFR:0.9543,AMR:0.9976,EAS:1,FIN:1,NFE:0.9998,OTH:0.9969,ASJ:1	176872	615279;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04114 Oocyte meiosis~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04218 Cellular senescence~ko04270 Vascular smooth muscle contraction~ko04320 Dorso-ventral axis formation~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04620 Toll-like receptor signaling pathway~ko04626 Plant-pathogen interaction~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05020 Prion diseases~ko05034 Alcoholism~ko05135 Yersinia infection~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	15	.	hom
15	66782048	66782048	C	T	MAP2K1	intronic	.	ENSG00000169032	rs41306345	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0843	0.0918	0.0892572	ESAD-UK|1|409|0.00244499,COCA-CN|1|321|0.00311526	.	.	.	.	.	0.0003	0.008	.	.	.	AFR:0.0938,AMR:0.1058,EAS:0.0828,FIN:0.0451,NFE:0.1154,OTH:0.0887,ASJ:0.0561	176872	615279;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04114 Oocyte meiosis~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04218 Cellular senescence~ko04270 Vascular smooth muscle contraction~ko04320 Dorso-ventral axis formation~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04620 Toll-like receptor signaling pathway~ko04626 Plant-pathogen interaction~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05020 Prion diseases~ko05034 Alcoholism~ko05135 Yersinia infection~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	15	1(haematopoietic_and_lymphoid_tissue)	0.1041
15	67358478	67358478	G	A	SMAD3	UTR5	.	ENSG00000166949	rs1061427	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3770	0.2130	0.223642	0.2348	.	.	.	.	.	.	.	.	.	.	AFR:0.1926,AMR:0.1365,EAS:0.2435,FIN:0.2684,NFE:0.2557,OTH:0.2322,ASJ:0.2718	603109	613795;	284984;	284984|-|<1 / 1 000 000|Autosomal dominant|All ages|613795 ~	~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04371 Apelin signaling pathway~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04659 Th17 cell differentiation~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	15	MU15510574	het
15	67457335	67457335	A	G	SMAD3	exonic	synonymous SNV	ENSG00000166949	rs1065080	ENSG00000166949:ENST00000559092:exon2:c.A254G:p.Y85C	SMAD3:NM_001145103:exon2:c.A177G:p.L59L,SMAD3:NM_005902:exon2:c.A309G:p.L103L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8635	0.88	0.834065	0.8640	0.949	10.37	.	2.36	0.993	.	.	.	SMAD3:uc002aqj.3:exon2:c.A309G:p.L103L,SMAD3:uc010ujs.2:exon2:c.A177G:p.L59L	.	AFR:0.8614,AMR:0.9177,EAS:0.7472,FIN:0.8660,NFE:0.8754,OTH:0.8582,ASJ:0.8477	603109	613795;	284984;	284984|-|<1 / 1 000 000|Autosomal dominant|All ages|613795 ~	~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04371 Apelin signaling pathway~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04659 Th17 cell differentiation~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	15	MU675295	hom
15	74328116	74328116	A	G	PML	exonic	nonsynonymous SNV	ENSG00000140464	rs743580	ENSG00000140464:ENST00000354026:exon7:c.A2170G:p.S724G,ENSG00000140464:ENST00000268059:exon8:c.A2314G:p.S772G	PML:NM_033250:exon7:c.A2170G:p.S724G,PML:NM_033239:exon8:c.A2314G:p.S772G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.5226	0.4991	0.551917	MU131868	0.090	3.499	1.0	0.623	0.000	.	.	.	PML:uc002awy.3:exon3:c.A601G:p.S201G,PML:uc002awo.3:exon7:c.A2170G:p.S724G,PML:uc002awk.3:exon8:c.A2314G:p.S772G	-0.930	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763,PBCA-DE|1|499|0.00200401,AMR:0.5295,EAS:0.5203,FIN:0.4702,NFE:0.6387,OTH:0.5699,ASJ:0.5075	102578	.	.	.	~ko04120 Ubiquitin mediated proteolysis~ko04144 Endocytosis~ko05164 Influenza A~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	0.0	.	0.000	.	15	1(large_intestine)	0.5204
15	74328141	74328141	G	T	PML	exonic	nonsynonymous SNV	ENSG00000140464	rs743581	ENSG00000140464:ENST00000354026:exon7:c.G2195T:p.G732V,ENSG00000140464:ENST00000268059:exon8:c.G2339T:p.G780V	PML:NM_033250:exon7:c.G2195T:p.G732V,PML:NM_033239:exon8:c.G2339T:p.G780V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3599	0.3464	0.351238	1(liver)	-0.295	0.683	0.22	-2.39	0.002	.	.	.	PML:uc002awy.3:exon3:c.G626T:p.G209V,PML:uc002awo.3:exon7:c.G2195T:p.G732V,PML:uc002awk.3:exon8:c.G2339T:p.G780V	-0.910	AFR:1(large_intestine),AMR:MU627388,EAS:0.3743,FIN:0.3175,NFE:0.4294,OTH:0.22,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|6|321|0.0186916,BLCA-CN|1|103|0.00970874	102578	.	.	.	~ko04120 Ubiquitin mediated proteolysis~ko04144 Endocytosis~ko05164 Influenza A~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	0.077	.	0.000	.	15	1(urinary_tract)	0.4156
15	75640569	75640569	A	G	NEIL1	intronic	.	ENSG00000140398	rs8030014	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.466054	0.4325	.	.	.	.	.	.	.	.	.	.	AFR:0.2957,AMR:0.6235,EAS:0.5410,FIN:0.4885,NFE:0.4757,OTH:0.4504,ASJ:0.42	608844	.	.	.	.	.	.	.	.	.	.	.	15	.	hom
15	75664570	75664570	A	T	SIN3A	intronic	.	ENSG00000169375	rs4886696	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6939	0.4284	0.58726	0.6572	.	.	.	.	.	.	.	.	.	.	AFR:0.4607,AMR:0.7392,EAS:0.5546,FIN:0.7828,NFE:0.7481,OTH:0.6780,ASJ:0.6093	607776	613406;	94065;	94065|Del(15)(q24)<br>Monosomy 15q24|<1 / 1 000 000|Not applicable<br>or&nbsp;Unknown|Childhood|613406 ~	~ko04139 Mitophagy - yeast~ko04919 Thyroid hormone signaling pathway~ko05016 Huntington disease~ko05169 Epstein-Barr virus infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	15	MU677604	unknown
15	80450389	80450389	G	A	FAH	intronic	.	ENSG00000103876	rs1370275	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5141	0.4463	0.506789	0.4629	.	.	.	.	.	.	.	.	.	.	AFR:0.3137,AMR:0.4233,EAS:0.7553,FIN:0.4593,NFE:0.5188,OTH:0.4794,ASJ:0.5265	613871	276700;	882;	882|FAH deficiency<br>Fumarylacetoacetase deficiency<br>Fumarylacetoacetate hydrolase deficiency<br>Hepatorenal tyrosinemia<br>Tyrosinemia type I|Unknown|Autosomal recessive|All ages|276700 ~	.	.	.	.	.	.	.	.	15	MU20682033	het
15	85188994	85188994	T	C	WDR73	exonic	synonymous SNV	ENSG00000177082	rs2271432	ENSG00000177082:ENST00000434634:exon7:c.A591G:p.S197S	WDR73:NM_032856:exon7:c.A591G:p.S197S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8550	0.8788	0.895367	0.8747	.	.	.	.	.	.	.	.	AL357213:uc002bky.1:exon1:c.T486C:p.P162P,WDR73:uc002bkw.2:exon7:c.A591G:p.S197S	.	AFR:0.9672,AMR:0.9117,EAS:0.9407,FIN:0.7903,NFE:0.8342,OTH:0.8259,ASJ:0.8874	616144	251300;	2065;	2065|Galloway syndrome<br>Microcephaly-hiatus hernia-nephrotic syndrome<br>Nephrosis-neuronal dysmigration syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|251300 ~	.	.	.	.	.	.	.	.	15	MU4561231	hom
15	85189464	85189464	T	G	WDR73	exonic	synonymous SNV	ENSG00000177082	rs2271431	ENSG00000177082:ENST00000434634:exon6:c.A468C:p.R156R	WDR73:NM_032856:exon6:c.A468C:p.R156R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2294	0.2045	0.147165	MU131122	.	.	.	.	.	.	.	.	WDR73:uc002bkw.2:exon6:c.A468C:p.R156R,WDR73:uc010upa.1:exon6:c.A468C:p.R156R	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.1911,EAS:0.2242,FIN:0.2219,NFE:0.1255,OTH:0.2244,ASJ:0.0585	616144	251300;	2065;	2065|Galloway syndrome<br>Microcephaly-hiatus hernia-nephrotic syndrome<br>Nephrosis-neuronal dysmigration syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|251300 ~	.	.	.	.	.	.	.	.	15	1(lung)	0.2608
15	88451765	88451765	A	G	NTRK3	intronic	.	ENSG00000140538	rs3784441	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.713259	0.7411	.	.	.	.	.	.	.	.	.	.	AFR:0.7618,AMR:0.6794,EAS:0.6981,FIN:0.7182,NFE:0.7455,OTH:0.7020,ASJ:0.7185	191316	.	.	.	~ko04722 Neurotrophin signaling pathway~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	15	.	hom
15	88576185	88576185	G	C	NTRK3	exonic	synonymous SNV	ENSG00000140538	rs2229910	ENSG00000140538:ENST00000557856:exon11:c.C1464G:p.A488A,ENSG00000140538:ENST00000558676:exon11:c.C1464G:p.A488A,ENSG00000140538:ENST00000357724:exon12:c.C1464G:p.A488A,ENSG00000140538:ENST00000540489:exon12:c.C1488G:p.A496A,ENSG00000140538:ENST00000542733:exon12:c.C1194G:p.A398A,ENSG00000140538:ENST00000317501:exon13:c.C1488G:p.A496A,ENSG00000140538:ENST00000355254:exon13:c.C1488G:p.A496A,ENSG00000140538:ENST00000360948:exon13:c.C1488G:p.A496A,ENSG00000140538:ENST00000394480:exon14:c.C1488G:p.A496A	NTRK3:NM_001320134:exon12:c.C1488G:p.A496A,NTRK3:NM_001320135:exon12:c.C1194G:p.A398A,NTRK3:NM_001243101:exon13:c.C1464G:p.A488A,NTRK3:NM_001007156:exon14:c.C1488G:p.A496A,NTRK3:NM_001012338:exon14:c.C1488G:p.A496A,NTRK3:NM_002530:exon14:c.C1488G:p.A496A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3610	0.3719	0.35004	13(soft_tissue)	.	.	.	.	.	.	.	.	NTRK3:uc002bmh.2:exon11:c.C1464G:p.A488A,NTRK3:uc010bnh.1:exon11:c.C1464G:p.A488A,NTRK3:uc010upl.1:exon12:c.C1194G:p.A398A,NTRK3:uc021sua.1:exon13:c.C1464G:p.A488A,NTRK3:uc002bme.2:exon14:c.C1488G:p.A496A,NTRK3:uc002bmf.2:exon14:c.C1488G:p.A496A,NTRK3:uc002bmg.3:exon14:c.C1488G:p.A496A	.	AFR:MU583670,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.4131,FIN:0.3598,NFE:0.4324,OTH:0.2279,ASJ:0.3598	191316	.	.	.	~ko04722 Neurotrophin signaling pathway~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	15	1(stomach)	0.2966
15	88679785	88679785	G	A	NTRK3	exonic	synonymous SNV	ENSG00000140538	rs1863480	ENSG00000140538:ENST00000540489:exon6:c.C678T:p.N226N,ENSG00000140538:ENST00000542733:exon6:c.C384T:p.N128N,ENSG00000140538:ENST00000557856:exon6:c.C678T:p.N226N,ENSG00000140538:ENST00000558676:exon6:c.C678T:p.N226N,ENSG00000140538:ENST00000317501:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000355254:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000357724:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000360948:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000394480:exon8:c.C678T:p.N226N	NTRK3:NM_001320134:exon6:c.C678T:p.N226N,NTRK3:NM_001320135:exon6:c.C384T:p.N128N,NTRK3:NM_001007156:exon8:c.C678T:p.N226N,NTRK3:NM_001012338:exon8:c.C678T:p.N226N,NTRK3:NM_001243101:exon8:c.C678T:p.N226N,NTRK3:NM_002530:exon8:c.C678T:p.N226N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9967	0.9958	0.998203	0.9971	.	.	.	.	.	.	.	.	NTRK3:uc002bmh.2:exon6:c.C678T:p.N226N,NTRK3:uc010bnh.1:exon6:c.C678T:p.N226N,NTRK3:uc010upl.1:exon6:c.C384T:p.N128N,NTRK3:uc002bme.2:exon8:c.C678T:p.N226N,NTRK3:uc002bmf.2:exon8:c.C678T:p.N226N,NTRK3:uc002bmg.3:exon8:c.C678T:p.N226N,NTRK3:uc021sua.1:exon8:c.C678T:p.N226N	.	AFR:0.9995,AMR:0.9988,EAS:1,FIN:0.9977,NFE:0.9951,OTH:0.9969,ASJ:0.9967	191316	.	.	.	~ko04722 Neurotrophin signaling pathway~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	15	MU4561260	hom
15	89838236	89838236	G	A	FANCI	exonic	synonymous SNV	ENSG00000140525	rs7183618	ENSG00000140525:ENST00000310775:exon24:c.G2547A:p.K849K	FANCI:NM_001113378:exon24:c.G2547A:p.K849K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9593	0.9601	0.980831	0.9538	.	.	.	.	.	.	.	.	FANCI:uc002bnq.1:exon10:c.G786A:p.K262K,FANCI:uc010bnp.1:exon24:c.G2547A:p.K849K	.	AFR:0.9905,AMR:0.9821,EAS:1,FIN:0.8758,NFE:0.9457,OTH:0.9274,ASJ:0.9636	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	15	MU81967158	het
15	91428290	91428290	C	T	FES	exonic	synonymous SNV	ENSG00000182511	rs11539637	ENSG00000182511:ENST00000394300:exon1:c.C15T:p.S5S,ENSG00000182511:ENST00000444422:exon1:c.C15T:p.S5S,ENSG00000182511:ENST00000450438:exon1:c.C15T:p.S5S,ENSG00000182511:ENST00000328850:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000394302:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000414248:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000416779:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000443697:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000452243:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000464684:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000470152:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000559355:exon2:c.C15T:p.S5S	FES:NM_001143783:exon1:c.C15T:p.S5S,FES:NM_001143784:exon1:c.C15T:p.S5S,FES:NM_001143785:exon2:c.C15T:p.S5S,FES:NM_002005:exon2:c.C15T:p.S5S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5849	0.4937	0.58746	1(cervix)	.	.	.	.	.	.	.	.	FES:uc002bpx.3:exon1:c.C15T:p.S5S,FES:uc002bpy.3:exon1:c.C15T:p.S5S,FES:uc010bny.3:exon1:c.C15T:p.S5S,FES:uc002bpv.3:exon2:c.C15T:p.S5S,FES:uc010uqj.2:exon2:c.C15T:p.S5S,FES:uc010uqk.2:exon2:c.C15T:p.S5S	.	AFR:MU4326664,AMR:COCA-CN|5|321|0.0155763,EAS:0.4141,FIN:0.7416,NFE:0.5033,OTH:0.8063,ASJ:0.5301	190030	.	.	.	.	.	.	.	.	.	.	.	15	1(urinary_tract)	0.6337
15	91428636	91428636	G	A	FES	intronic	.	ENSG00000182511	rs7177338	ENSG00000182511:ENST00000470152:exon2:c.G361A:p.V121I	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5809	0.5079	0.587859	17(soft_tissue)	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:MU10889595,AMR:COCA-CN|5|321|0.0155763,EAS:0.4676,FIN:0.6687,NFE:0.5,OTH:0.8016,ASJ:0.5425	190030	.	.	.	.	.	.	.	.	.	.	.	15	20(lung)	0.6343
15	91430436	91430436	T	C	FES	exonic	synonymous SNV	ENSG00000182511	rs2071383	ENSG00000182511:ENST00000394300:exon3:c.T330C:p.A110A,ENSG00000182511:ENST00000450438:exon3:c.T330C:p.A110A,ENSG00000182511:ENST00000394302:exon4:c.T330C:p.A110A,ENSG00000182511:ENST00000414248:exon4:c.T330C:p.A110A,ENSG00000182511:ENST00000444422:exon4:c.T504C:p.A168A,ENSG00000182511:ENST00000328850:exon5:c.T504C:p.A168A,ENSG00000182511:ENST00000464684:exon5:c.T504C:p.A168A,ENSG00000182511:ENST00000559355:exon5:c.T504C:p.A168A	FES:NM_001143783:exon3:c.T330C:p.A110A,FES:NM_001143784:exon4:c.T504C:p.A168A,FES:NM_001143785:exon4:c.T330C:p.A110A,FES:NM_002005:exon5:c.T504C:p.A168A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9608	0.9552	0.9377	0.9534	.	.	.	.	.	.	.	.	FES:uc002bpy.3:exon3:c.T330C:p.A110A,FES:uc010bny.3:exon3:c.T330C:p.A110A,FES:uc002bpx.3:exon4:c.T504C:p.A168A,FES:uc010uqj.2:exon4:c.T330C:p.A110A,FES:uc002bpv.3:exon5:c.T504C:p.A168A,FES:uc010uqk.2:exon5:c.T450C:p.A150A	.	AFR:0.9307,AMR:0.9821,EAS:0.8909,FIN:0.9533,NFE:0.9708,OTH:0.9664,ASJ:0.9603	190030	.	.	.	.	.	.	.	.	.	.	.	15	MU82136926	hom
15	91430617	91430617	G	A	FES	intronic	.	ENSG00000182511	rs2071384	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4634	0.2910	0.453674	0.3484	.	.	.	.	.	.	.	.	.	.	AFR:0.1717,AMR:0.6193,EAS:0.7797,FIN:0.4327,NFE:0.3646,OTH:0.4287,ASJ:0.3467	190030	.	.	.	.	.	.	.	.	.	.	.	15	MU29420728	het
15	93510603	93510603	A	G	CHD2	exonic	synonymous SNV	ENSG00000173575	rs4777755	ENSG00000173575:ENST00000394196:exon17:c.A2049G:p.E683E,ENSG00000173575:ENST00000557381:exon17:c.A2049G:p.E683E	CHD2:NM_001271:exon17:c.A2049G:p.E683E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8419	0.7656	0.826478	0.7708	.	.	.	.	.	.	.	.	CHD2:uc002bso.1:exon17:c.A2049G:p.E683E,CHD2:uc002bsp.3:exon17:c.A2049G:p.E683E	.	AFR:0.6178,AMR:0.9105,EAS:0.9981,FIN:0.7596,NFE:0.8233,OTH:0.8219,ASJ:0.9305	602119	615369;	1942;2382;	1942|Doose syndrome<br>EMAS<br>Epilepsy with myoclonic-astatic seizures<br>Epilepsy with myoclonic-atonic seizures<br>MAE<br>Myoclonic atonic epilepsy<br>Myoclonic-astatic epilepsy in early childhood|Unknown|Unknown|Childhood|615369 616421 ~2382|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Childhood|615369 616346 617113 ~	.	.	.	.	.	.	.	.	15	MU81967798	het
15	93521604	93521604	A	G	CHD2	exonic	synonymous SNV	ENSG00000173575	rs11074121	ENSG00000173575:ENST00000557116:exon3:c.A258G:p.Q86Q,ENSG00000173575:ENST00000394196:exon21:c.A2718G:p.Q906Q,ENSG00000173575:ENST00000557381:exon21:c.A2718G:p.Q906Q	CHD2:NM_001271:exon21:c.A2718G:p.Q906Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8353	0.7477	0.809105	0.7534	.	.	.	.	.	.	.	.	CHD2:uc010bog.1:exon4:c.A539G:p.K180R	.	AFR:0.5632,AMR:0.9069,EAS:0.9981,FIN:0.7585,NFE:0.8202,OTH:0.8112,ASJ:0.9272	602119	615369;	1942;2382;	1942|Doose syndrome<br>EMAS<br>Epilepsy with myoclonic-astatic seizures<br>Epilepsy with myoclonic-atonic seizures<br>MAE<br>Myoclonic atonic epilepsy<br>Myoclonic-astatic epilepsy in early childhood|Unknown|Unknown|Childhood|615369 616421 ~2382|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Childhood|615369 616346 617113 ~	.	.	.	.	.	.	.	.	15	MU81967815	het
15	99251356	99251356	C	T	IGF1R	intronic	.	ENSG00000140443	rs7174918	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2907	0.2642	0.233427	COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.2568,AMR:0.1319,EAS:0.3974,FIN:0.2311,NFE:0.2657,OTH:0.3260,ASJ:0.2356	147370	270450;	73273;	73273|Resistance to IGF-1|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|270450 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04114 Oocyte meiosis~ko04140 Autophagy - animal~ko04144 Endocytosis~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04510 Focal adhesion~ko04520 Adherens junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04730 Long-term depression~ko04913 Ovarian steroidogenesis~ko04914 Progesterone-mediated oocyte maturation~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma ~	.	.	.	.	.	.	.	15	9(soft_tissue)	0.2957
15	99478225	99478225	G	A	IGF1R	exonic	synonymous SNV	ENSG00000140443	rs2229765	ENSG00000140443:ENST00000268035:exon16:c.G3129A:p.E1043E,ENSG00000140443:ENST00000558762:exon16:c.G3126A:p.E1042E	IGF1R:NM_000875:exon16:c.G3129A:p.E1043E,IGF1R:NM_001291858:exon16:c.G3126A:p.E1042E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3972	0.4027	0.335663	1(large_intestine)	.	.	.	.	.	.	.	.	IGF1R:uc002bul.3:exon16:c.G3129A:p.E1043E,IGF1R:uc010bon.3:exon16:c.G3126A:p.E1042E	.	AFR:2(lung),AMR:MU732251,EAS:0.3945,FIN:0.2935,NFE:0.3357,OTH:0.4073,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|5|321|0.0155763	147370	270450;	73273;	73273|Resistance to IGF-1|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|270450 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04114 Oocyte meiosis~ko04140 Autophagy - animal~ko04144 Endocytosis~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04510 Focal adhesion~ko04520 Adherens junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04730 Long-term depression~ko04913 Ovarian steroidogenesis~ko04914 Progesterone-mediated oocyte maturation~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma ~	.	.	.	.	.	.	.	15	1(haematopoietic_and_lymphoid_tissue)	0.3371
15	100215596	100215596	G	A	MEF2A	intronic	.	ENSG00000068305	rs530865200	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0014	.	0.00399361	3.228e-05	.	.	.	.	.	0.0003	0.026	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.66e-05,OTH:0,ASJ:0	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	.	het
15	100218867	100218867	A	G	MEF2A	exonic	nonsynonymous SNV	ENSG00000068305	rs2581470	.	MEF2A:NM_001365210:exon8:c.A691G:p.K231E,MEF2A:NM_001365211:exon8:c.A685G:p.K229E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.630791	0.6681	.	.	.	.	.	.	.	.	.	.	AFR:0.3552,AMR:0.7045,EAS:0.7109,FIN:0.8311,NFE:0.7923,OTH:0.8143,ASJ:0.8510	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	MU12577973	hom
15	100246936	100246936	T	C	MEF2A	exonic	synonymous SNV	ENSG00000068305	rs325408	ENSG00000068305:ENST00000449277:exon7:c.T657C:p.N219N,ENSG00000068305:ENST00000453228:exon8:c.T861C:p.N287N,ENSG00000068305:ENST00000558812:exon8:c.T681C:p.N227N,ENSG00000068305:ENST00000354410:exon9:c.T867C:p.N289N,ENSG00000068305:ENST00000557785:exon9:c.T861C:p.N287N,ENSG00000068305:ENST00000338042:exon10:c.T888C:p.N296N,ENSG00000068305:ENST00000557942:exon10:c.T885C:p.N295N	MEF2A:NM_001130928:exon6:c.T657C:p.N219N,MEF2A:NM_001130926:exon8:c.T861C:p.N287N,MEF2A:NM_001130927:exon8:c.T681C:p.N227N,MEF2A:NM_001365206:exon8:c.T879C:p.N293N,MEF2A:NM_001365207:exon8:c.T867C:p.N289N,MEF2A:NM_001352616:exon9:c.T885C:p.N295N,MEF2A:NM_001352617:exon9:c.T867C:p.N289N,MEF2A:NM_001352618:exon9:c.T879C:p.N293N,MEF2A:NM_001365202:exon9:c.T903C:p.N301N,MEF2A:NM_001365204:exon9:c.T891C:p.N297N,MEF2A:NM_001365205:exon9:c.T885C:p.N295N,MEF2A:NM_001365208:exon9:c.T861C:p.N287N,MEF2A:NM_001365209:exon9:c.T681C:p.N227N,MEF2A:NM_005587:exon9:c.T867C:p.N289N,MEF2A:NM_001171894:exon10:c.T861C:p.N287N,MEF2A:NM_001319206:exon10:c.T885C:p.N295N,MEF2A:NM_001352614:exon10:c.T861C:p.N287N,MEF2A:NM_001365201:exon10:c.T903C:p.N301N,MEF2A:NM_001365203:exon10:c.T891C:p.N297N,MEF2A:NM_001352615:exon11:c.T861C:p.N287N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7471	0.6406	0.61242	0.6476	.	.	.	.	.	.	.	.	MEF2A:uc010bot.3:exon6:c.T657C:p.N219N,MEF2A:uc002bvi.3:exon8:c.T861C:p.N287N,MEF2A:uc010bos.3:exon8:c.T861C:p.N287N,MEF2A:uc010urv.2:exon8:c.T681C:p.N227N,MEF2A:uc002bvf.3:exon9:c.T867C:p.N289N,MEF2A:uc010urw.2:exon9:c.T891C:p.N297N,MEF2A:uc002bve.3:exon10:c.T885C:p.N295N,MEF2A:uc002bvg.3:exon10:c.T861C:p.N287N	.	AFR:0.2872,AMR:0.6974,EAS:0.7153,FIN:0.8232,NFE:0.7910,OTH:0.8086,ASJ:0.8477	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	MU700988	unknown
15	100246942	100246942	G	A	MEF2A	exonic	synonymous SNV	ENSG00000068305	rs325407	ENSG00000068305:ENST00000449277:exon7:c.G663A:p.Q221Q,ENSG00000068305:ENST00000453228:exon8:c.G867A:p.Q289Q,ENSG00000068305:ENST00000558812:exon8:c.G687A:p.Q229Q,ENSG00000068305:ENST00000354410:exon9:c.G873A:p.Q291Q,ENSG00000068305:ENST00000557785:exon9:c.G867A:p.Q289Q,ENSG00000068305:ENST00000338042:exon10:c.G894A:p.Q298Q,ENSG00000068305:ENST00000557942:exon10:c.G891A:p.Q297Q	MEF2A:NM_001130928:exon6:c.G663A:p.Q221Q,MEF2A:NM_001130926:exon8:c.G867A:p.Q289Q,MEF2A:NM_001130927:exon8:c.G687A:p.Q229Q,MEF2A:NM_001365206:exon8:c.G885A:p.Q295Q,MEF2A:NM_001365207:exon8:c.G873A:p.Q291Q,MEF2A:NM_001352616:exon9:c.G891A:p.Q297Q,MEF2A:NM_001352617:exon9:c.G873A:p.Q291Q,MEF2A:NM_001352618:exon9:c.G885A:p.Q295Q,MEF2A:NM_001365202:exon9:c.G909A:p.Q303Q,MEF2A:NM_001365204:exon9:c.G897A:p.Q299Q,MEF2A:NM_001365205:exon9:c.G891A:p.Q297Q,MEF2A:NM_001365208:exon9:c.G867A:p.Q289Q,MEF2A:NM_001365209:exon9:c.G687A:p.Q229Q,MEF2A:NM_005587:exon9:c.G873A:p.Q291Q,MEF2A:NM_001171894:exon10:c.G867A:p.Q289Q,MEF2A:NM_001319206:exon10:c.G891A:p.Q297Q,MEF2A:NM_001352614:exon10:c.G867A:p.Q289Q,MEF2A:NM_001365201:exon10:c.G909A:p.Q303Q,MEF2A:NM_001365203:exon10:c.G897A:p.Q299Q,MEF2A:NM_001352615:exon11:c.G867A:p.Q289Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9669	0.8850	0.886781	0.8929	.	.	.	.	.	.	.	.	MEF2A:uc010bot.3:exon6:c.G663A:p.Q221Q,MEF2A:uc002bvi.3:exon8:c.G867A:p.Q289Q,MEF2A:uc010bos.3:exon8:c.G867A:p.Q289Q,MEF2A:uc010urv.2:exon8:c.G687A:p.Q229Q,MEF2A:uc002bvf.3:exon9:c.G873A:p.Q291Q,MEF2A:uc010urw.2:exon9:c.G897A:p.Q299Q,MEF2A:uc002bve.3:exon10:c.G891A:p.Q297Q,MEF2A:uc002bvg.3:exon10:c.G867A:p.Q289Q	.	AFR:0.6237,AMR:0.9821,EAS:1,FIN:1,NFE:0.9985,OTH:0.9868,ASJ:1	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	MU81968211	unknown
15	100252710	100252715	CAGCAG	-	MEF2A	exonic	nonframeshift deletion	ENSG00000068305	rs3138597	ENSG00000068305:ENST00000449277:exon9:c.1024_1029del:p.342_343del,ENSG00000068305:ENST00000453228:exon10:c.1228_1233del:p.410_411del,ENSG00000068305:ENST00000558812:exon10:c.1048_1053del:p.350_351del,ENSG00000068305:ENST00000354410:exon11:c.1234_1239del:p.412_413del,ENSG00000068305:ENST00000557785:exon11:c.1228_1233del:p.410_411del,ENSG00000068305:ENST00000338042:exon12:c.1255_1260del:p.419_420del,ENSG00000068305:ENST00000557942:exon12:c.1252_1257del:p.418_419del	MEF2A:NM_001130928:exon8:c.1024_1029del:p.342_343del,MEF2A:NM_001130926:exon10:c.1228_1233del:p.410_411del,MEF2A:NM_001130927:exon10:c.1048_1053del:p.350_351del,MEF2A:NM_001365206:exon10:c.1246_1251del:p.416_417del,MEF2A:NM_001365207:exon10:c.1234_1239del:p.412_413del,MEF2A:NM_001352616:exon11:c.1252_1257del:p.418_419del,MEF2A:NM_001352617:exon11:c.1234_1239del:p.412_413del,MEF2A:NM_001352618:exon11:c.1246_1251del:p.416_417del,MEF2A:NM_001365202:exon11:c.1270_1275del:p.424_425del,MEF2A:NM_001365204:exon11:c.1258_1263del:p.420_421del,MEF2A:NM_001365205:exon11:c.1252_1257del:p.418_419del,MEF2A:NM_001365208:exon11:c.1228_1233del:p.410_411del,MEF2A:NM_001365209:exon11:c.1048_1053del:p.350_351del,MEF2A:NM_005587:exon11:c.1234_1239del:p.412_413del,MEF2A:NM_001171894:exon12:c.1228_1233del:p.410_411del,MEF2A:NM_001319206:exon12:c.1252_1257del:p.418_419del,MEF2A:NM_001352614:exon12:c.1228_1233del:p.410_411del,MEF2A:NM_001365201:exon12:c.1270_1275del:p.424_425del,MEF2A:NM_001365203:exon12:c.1258_1263del:p.420_421del,MEF2A:NM_001352615:exon13:c.1228_1233del:p.410_411del	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.2791	0.1623	.	0.2751	.	.	.	.	.	.	.	.	MEF2A:uc010bot.3:exon8:c.1024_1029del:p.342_343del,MEF2A:uc002bvi.3:exon10:c.1228_1233del:p.410_411del,MEF2A:uc010bos.3:exon10:c.1228_1233del:p.410_411del,MEF2A:uc010urv.2:exon10:c.1048_1053del:p.350_351del,MEF2A:uc002bvf.3:exon11:c.1234_1239del:p.412_413del,MEF2A:uc010urw.2:exon11:c.1258_1263del:p.420_421del,MEF2A:uc002bve.3:exon12:c.1252_1257del:p.418_419del,MEF2A:uc002bvg.3:exon12:c.1228_1233del:p.410_411del	.	AFR:0.0642,AMR:0.2845,EAS:0.3553,FIN:0.3896,NFE:0.3560,OTH:0.3650,ASJ:0.3221	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	.	het
15	100252805	100252805	G	T	MEF2A	exonic	synonymous SNV	ENSG00000068305	rs325400	ENSG00000068305:ENST00000449277:exon9:c.G1119T:p.G373G,ENSG00000068305:ENST00000453228:exon10:c.G1323T:p.G441G,ENSG00000068305:ENST00000558812:exon10:c.G1143T:p.G381G,ENSG00000068305:ENST00000354410:exon11:c.G1329T:p.G443G,ENSG00000068305:ENST00000557785:exon11:c.G1323T:p.G441G,ENSG00000068305:ENST00000338042:exon12:c.G1350T:p.G450G,ENSG00000068305:ENST00000557942:exon12:c.G1347T:p.G449G	MEF2A:NM_001130928:exon8:c.G1119T:p.G373G,MEF2A:NM_001130926:exon10:c.G1323T:p.G441G,MEF2A:NM_001130927:exon10:c.G1143T:p.G381G,MEF2A:NM_001365206:exon10:c.G1341T:p.G447G,MEF2A:NM_001365207:exon10:c.G1329T:p.G443G,MEF2A:NM_001352616:exon11:c.G1347T:p.G449G,MEF2A:NM_001352617:exon11:c.G1329T:p.G443G,MEF2A:NM_001352618:exon11:c.G1341T:p.G447G,MEF2A:NM_001365202:exon11:c.G1365T:p.G455G,MEF2A:NM_001365204:exon11:c.G1353T:p.G451G,MEF2A:NM_001365205:exon11:c.G1347T:p.G449G,MEF2A:NM_001365208:exon11:c.G1323T:p.G441G,MEF2A:NM_001365209:exon11:c.G1143T:p.G381G,MEF2A:NM_005587:exon11:c.G1329T:p.G443G,MEF2A:NM_001171894:exon12:c.G1323T:p.G441G,MEF2A:NM_001319206:exon12:c.G1347T:p.G449G,MEF2A:NM_001352614:exon12:c.G1323T:p.G441G,MEF2A:NM_001365201:exon12:c.G1365T:p.G455G,MEF2A:NM_001365203:exon12:c.G1353T:p.G451G,MEF2A:NM_001352615:exon13:c.G1323T:p.G441G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4953	0.3889	0.349241	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	MEF2A:uc010bot.3:exon8:c.G1119T:p.G373G,MEF2A:uc002bvi.3:exon10:c.G1323T:p.G441G,MEF2A:uc010bos.3:exon10:c.G1323T:p.G441G,MEF2A:uc010urv.2:exon10:c.G1143T:p.G381G,MEF2A:uc002bvf.3:exon11:c.G1329T:p.G443G,MEF2A:uc010urw.2:exon11:c.G1353T:p.G451G,MEF2A:uc002bve.3:exon12:c.G1347T:p.G449G,MEF2A:uc002bvg.3:exon12:c.G1323T:p.G441G	.	AFR:0.4154,AMR:0.1778,EAS:0.5403,FIN:0.3194,NFE:0.5307,OTH:0.5236,ASJ:0.4916	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	1(lung)	0.5144
16	359953	359953	A	G	AXIN1	intronic	.	ENSG00000103126	rs2301522	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6387	0.7276	0.649161	0.6909	.	.	.	.	.	.	.	.	.	.	AFR:0.8845,AMR:0.5647,EAS:0.3653,FIN:0.6372,NFE:0.6400,OTH:0.6235,ASJ:0.5430	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU27447663	het
16	396264	396264	A	G	AXIN1	exonic	synonymous SNV	ENSG00000103126	rs1805105	ENSG00000103126:ENST00000262320:exon2:c.T762C:p.D254D,ENSG00000103126:ENST00000354866:exon2:c.T762C:p.D254D	AXIN1:NM_003502:exon2:c.T762C:p.D254D,AXIN1:NM_181050:exon2:c.T762C:p.D254D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6218	0.7141	0.638978	0.6766	.	.	.	.	.	.	.	.	AXIN1:uc002cgp.2:exon2:c.T762C:p.D254D,AXIN1:uc002cgq.2:exon2:c.T762C:p.D254D	.	AFR:0.8682,AMR:0.4940,EAS:0.3050,FIN:0.6045,NFE:0.6388,OTH:0.6109,ASJ:0.5497	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU152642	het
16	1823444	1823444	C	G	EME2	exonic	synonymous SNV	ENSG00000197774	rs761065	ENSG00000197774:ENST00000307394:exon1:c.C216G:p.V72V,ENSG00000197774:ENST00000568449:exon1:c.C216G:p.V72V	EME2:NM_001257370:exon1:c.C216G:p.V72V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5569	0.4177	0.336062	MU78075	.	.	.	.	.	.	.	.	EME2:uc002cmq.1:exon1:c.C216G:p.V72V,EME2:uc010brw.1:exon1:c.C216G:p.V72V	.	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|4|321|0.0124611,LINC-JP|1|394|0.00253807,AMR:0.4234,EAS:0.5467,FIN:0.5795,NFE:0.3053,OTH:0.4753,ASJ:0.1388	610886	.	.	.	.	.	.	.	.	.	.	.	16	2(large_intestine)	0.5734
16	2144182	2144182	G	A	PKD1	exonic	nonsynonymous SNV	ENSG00000008710	rs45478794	ENSG00000008710:ENST00000262304:exon35:c.C10529T:p.T3510M,ENSG00000008710:ENST00000423118:exon35:c.C10526T:p.T3509M	PKD1:NM_000296:exon35:c.C10526T:p.T3509M,PKD1:NM_001009944:exon35:c.C10529T:p.T3510M	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0287	0.0052	0.0383387	COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02	0.357	6.235	0.047	0.474	0.000	.	.	.	PKD1:uc002cos.1:exon35:c.C10529T:p.T3510M,PKD1:uc002cot.1:exon35:c.C10526T:p.T3509M	-1.074	AFR:0.0116,AMR:0.0014,EAS:0.0033,FIN:0.0629,NFE:0.0063,OTH:0.0134,ASJ:0.0024	601313	173900;	.	.	.	.	.	.	0.857	1.19	0.005	0.665	16	1(large_intestine)	0.0204
16	2158314	2158314	T	C	PKD1	exonic	nonsynonymous SNV	ENSG00000008710	rs532992498	ENSG00000008710:ENST00000487932:exon1:c.A1541G:p.N514S,ENSG00000008710:ENST00000262304:exon15:c.A6854G:p.N2285S,ENSG00000008710:ENST00000423118:exon15:c.A6854G:p.N2285S	PKD1:NM_000296:exon15:c.A6854G:p.N2285S,PKD1:NM_001009944:exon15:c.A6854G:p.N2285S	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	2.609e-05	.	0.000399361	3.234e-05	4.344	24.1	0.01	5.35	0.576	.	.	PKD/REJ-like domain|Polycystin cation channel|REJ domain	PKD1:uc002cos.1:exon15:c.A6854G:p.N2285S,PKD1:uc002cot.1:exon15:c.A6854G:p.N2285S	0.125	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	601313	173900;	.	.	.	.	.	.	1.0	-0.54	0.529	2.65	16	.	het
16	2162979	2162979	G	A	PKD1	intronic	.	ENSG00000261240	rs2855349	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0539	0.0172	0.101637	0.0286	.	.	.	.	.	.	.	.	.	.	AFR:0.0230,AMR:0.0442,EAS:0.2413,FIN:0.0080,NFE:0.0128,OTH:0.0356,ASJ:0.0132	601313	173900;	.	.	.	.	.	.	.	.	.	.	16	MU25578792	het
16	2164808	2164808	C	T	PKD1	exonic	nonsynonymous SNV	ENSG00000008710	rs40433	ENSG00000008710:ENST00000262304:exon11:c.G2216A:p.R739Q,ENSG00000008710:ENST00000423118:exon11:c.G2216A:p.R739Q	PKD1:NM_000296:exon11:c.G2216A:p.R739Q,PKD1:NM_001009944:exon11:c.G2216A:p.R739Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9586	.	0.979233	.	-0.560	0.156	0.719	-2.55	0.000	.	.	Polycystin cation channel	PKD1:uc002cos.1:exon11:c.G2216A:p.R739Q,PKD1:uc002cot.1:exon11:c.G2216A:p.R739Q	-0.965	AFR:0.9693,AMR:0.9926,EAS:0.9133,FIN:0.9994,NFE:0.9653,OTH:0.9545,ASJ:0.9758	601313	173900;	.	.	.	.	.	.	0.005	1.27	0.000	-0.625	16	22(upper_aerodigestive_tract)	0.9629
16	2167874	2167874	G	A	PKD1	exonic	synonymous SNV	ENSG00000008710	rs35842	ENSG00000008710:ENST00000568591:exon1:c.C87T:p.L29L,ENSG00000008710:ENST00000262304:exon5:c.C1119T:p.L373L,ENSG00000008710:ENST00000423118:exon5:c.C1119T:p.L373L	PKD1:NM_000296:exon5:c.C1119T:p.L373L,PKD1:NM_001009944:exon5:c.C1119T:p.L373L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9051	.	0.944289	.	.	.	.	.	.	.	.	.	PKD1:uc002cos.1:exon5:c.C1119T:p.L373L,PKD1:uc002cot.1:exon5:c.C1119T:p.L373L	.	AFR:0.8356,AMR:0.9129,EAS:0.7743,FIN:0.9515,NFE:0.8171,OTH:0.7820,ASJ:0.8883	601313	173900;	.	.	.	.	.	.	.	.	.	.	16	1(upper_aerodigestive_tract)	0.8191
16	3639139	3639139	A	G	SLX4	exonic	synonymous SNV	ENSG00000188827	rs3810812	ENSG00000188827:ENST00000294008:exon12:c.T4500C:p.N1500N	SLX4:NM_032444:exon12:c.T4500C:p.N1500N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6116	0.6266	0.739617	0.6327	.	.	.	.	.	.	.	.	SLX4:uc002cvp.2:exon12:c.T4500C:p.N1500N	.	AFR:0.8818,AMR:0.6244,EAS:0.7336,FIN:0.5011,NFE:0.5156,OTH:0.5608,ASJ:0.47	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	MU25678123	het
16	5122072	5122072	-	GTCT	ALG1	intronic	.	ENSG00000033011	rs112683515	ENSG00000033011:ENST00000591822:exon1:c.222_223insGTCT:p.R74fs	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.6041	0.5126	0.583466	0.5624	.	.	.	.	.	.	.	.	.	.	AFR:0.5416,AMR:0.4556,EAS:0.6941,FIN:0.5931,NFE:0.5623,OTH:0.5484,ASJ:0.4536	605907	608540;	79327;	79327|CDG syndrome type Ik<br>CDG-Ik<br>CDG1K<br>Carbohydrate deficient glycoprotein syndrome type Ik<br>Congenital disorder of glycosylation type 1k<br>Congenital disorder of glycosylation type Ik<br>Mannosyltransferase 1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|608540 ~	.	.	.	.	.	.	.	.	16	.	het
16	5128001	5128001	C	T	ALG1	exonic	synonymous SNV	ENSG00000033011	rs7195893	ENSG00000033011:ENST00000262374:exon6:c.C723T:p.H241H,ENSG00000033011:ENST00000544428:exon6:c.C390T:p.H130H,ENSG00000033011:ENST00000591783:exon6:c.C390T:p.H130H,ENSG00000033011:ENST00000588623:exon7:c.C390T:p.H130H	ALG1:NM_001330504:exon6:c.C390T:p.H130H,ALG1:NM_019109:exon6:c.C723T:p.H241H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0695	0.0647	0.0924521	.	.	.	.	.	.	.	.	.	ALG1:uc002cym.3:exon6:c.C723T:p.H241H,ALG1:uc010bue.3:exon6:c.C390T:p.H130H,ALG1:uc002cyj.3:exon7:c.C390T:p.H130H	.	AFR:0.0657,AMR:0.0969,EAS:0.0728,FIN:0.0358,NFE:0.0478,OTH:0.0506,ASJ:0.1408	605907	608540;	79327;	79327|CDG syndrome type Ik<br>CDG-Ik<br>CDG1K<br>Carbohydrate deficient glycoprotein syndrome type Ik<br>Congenital disorder of glycosylation type 1k<br>Congenital disorder of glycosylation type Ik<br>Mannosyltransferase 1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|608540 ~	.	.	.	.	.	.	.	.	16	1(large_intestine)	0.0665
16	5132636	5132636	C	T	ALG1	exonic	synonymous SNV	ENSG00000033011	rs1047732	ENSG00000033011:ENST00000262374:exon11:c.C1149T:p.F383F,ENSG00000033011:ENST00000544428:exon11:c.C816T:p.F272F,ENSG00000033011:ENST00000588623:exon12:c.C816T:p.F272F	ALG1:NM_001330504:exon11:c.C816T:p.F272F,ALG1:NM_019109:exon11:c.C1149T:p.F383F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5243	0.4694	0.519768	0.5046	.	.	.	.	.	.	.	.	ALG1:uc002cym.3:exon11:c.C1149T:p.F383F,ALG1:uc010bue.3:exon11:c.C816T:p.F272F,ALG1:uc002cyj.3:exon12:c.C816T:p.F272F	.	AFR:0.4030,AMR:0.4400,EAS:0.6658,FIN:0.5702,NFE:0.5350,OTH:0.5204,ASJ:0.4404	605907	608540;	79327;	79327|CDG syndrome type Ik<br>CDG-Ik<br>CDG1K<br>Carbohydrate deficient glycoprotein syndrome type Ik<br>Congenital disorder of glycosylation type 1k<br>Congenital disorder of glycosylation type Ik<br>Mannosyltransferase 1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|608540 ~	.	.	.	.	.	.	.	.	16	MU62996	het
16	5134774	5134774	T	A	ALG1	exonic	nonsynonymous SNV	ENSG00000033011	rs9745522	ENSG00000033011:ENST00000262374:exon13:c.T1287A:p.D429E,ENSG00000033011:ENST00000544428:exon13:c.T954A:p.D318E,ENSG00000033011:ENST00000588623:exon14:c.T954A:p.D318E	ALG1:NM_001330504:exon13:c.T954A:p.D318E,ALG1:NM_019109:exon13:c.T1287A:p.D429E	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.1174	0.1136	0.126997	0.1174	0.413	6.728	0.313	0.753	0.794	.	.	Glycosyl transferase, family 1	ALG1:uc002cym.3:exon13:c.T1287A:p.D429E,ALG1:uc010bue.3:exon13:c.T954A:p.D318E,ALG1:uc002cyj.3:exon14:c.T954A:p.D318E	-1.072	AFR:0.1452,AMR:0.1706,EAS:0.0364,FIN:0.1266,NFE:0.1044,OTH:0.1245,ASJ:0.1126	605907	608540;	79327;	79327|CDG syndrome type Ik<br>CDG-Ik<br>CDG1K<br>Carbohydrate deficient glycoprotein syndrome type Ik<br>Congenital disorder of glycosylation type 1k<br>Congenital disorder of glycosylation type Ik<br>Mannosyltransferase 1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|608540 ~	.	.	.	.	0.048	-0.95	0.001	1.85	16	.	het
16	9934671	9934671	A	-	GRIN2A	intronic	.	ENSG00000183454	rs745951746	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0219	.	.	0.0181	.	.	.	.	.	.	.	.	.	.	AFR:0.0112,AMR:0.0294,EAS:0.0023,FIN:0.0377,NFE:0.0251,OTH:0.0181,ASJ:0	138253	245570;	163721;1945;725;98818;	163721|-|-|Autosomal dominant<br>or&nbsp;X-linked dominant|-|245570 300643 ~1945|BECRS<br>BECTS<br>BRE<br>Benign epilepsy of childhood with centrotemporal spikes<br>Benign familial epilepsy of childhood with rolandic spikes<br>Benign rolandic epilepsy<br>Centrotemporal epilepsy|Unknown|Autosomal dominant|Childhood|117100 245570 ~725|CSWS<br>CSWSS syndrome<br>Continuous spikes and waves during slow-wave sleep<br>Epileptic encephalopathy with continuous spike-and-wave during slow sleep|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|245570 ~98818|Acquired epileptic aphasia<br>LKS|-|Autosomal dominant|Childhood|245570 ~	.	.	.	.	.	.	.	.	16	.	het
16	10989374	10989374	C	T	CIITA	intronic	.	ENSG00000179583	rs11074937	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.949681	0.9548	.	.	.	.	.	.	.	.	.	.	AFR:0.8423,AMR:0.9893,EAS:0.9994,FIN:1,NFE:0.9994,OTH:0.9980,ASJ:0.9901	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	.	hom
16	10995933	10995933	A	G	CIITA	exonic	nonsynonymous SNV	ENSG00000179583	rs8046121	ENSG00000179583:ENST00000324288:exon7:c.A520G:p.R174G,ENSG00000179583:ENST00000576601:exon7:c.A448G:p.R150G	CIITA:NM_000246:exon7:c.A520G:p.R174G,CIITA:NM_001286402:exon7:c.A523G:p.R175G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9959	0.9831	0.98722	0.9861	.	.	.	.	.	.	.	.	CIITA:uc002dag.2:exon7:c.A520G:p.R174G,CIITA:uc002dai.4:exon7:c.A520G:p.R174G,CIITA:uc002daj.4:exon7:c.A523G:p.R175G,CIITA:uc010bup.1:exon7:c.A520G:p.R174G	.	AFR:0.9511,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9990,ASJ:1	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	MU4561336	hom
16	11001743	11001743	G	A	CIITA	exonic	synonymous SNV	ENSG00000179583	rs2229320	ENSG00000179583:ENST00000324288:exon11:c.G2394A:p.P798P	CIITA:NM_000246:exon11:c.G2394A:p.P798P,CIITA:NM_001286402:exon11:c.G2397A:p.P799P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2122	0.1512	0.189297	MU90735	.	.	.	.	.	.	.	.	CIITA:uc002dah.2:exon10:c.G2250A:p.P750P,CIITA:uc002dag.2:exon11:c.G2394A:p.P798P,CIITA:uc002dai.4:exon11:c.G2394A:p.P798P,CIITA:uc002daj.4:exon11:c.G2397A:p.P799P	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,AMR:0.1683,EAS:0.1396,FIN:0.1954,NFE:0.3030,OTH:0.2417,ASJ:0.0527	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	6(soft_tissue)	0.2022
16	11002904	11002904	G	A	CIITA	exonic	synonymous SNV	ENSG00000179583	rs2228238	ENSG00000179583:ENST00000381835:exon10:c.G924A:p.T308T,ENSG00000179583:ENST00000324288:exon12:c.G2676A:p.T892T	CIITA:NM_001286403:exon10:c.G924A:p.T308T,CIITA:NM_000246:exon12:c.G2676A:p.T892T,CIITA:NM_001286402:exon12:c.G2679A:p.T893T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6840	0.6347	0.663139	0.6606	.	.	.	.	.	.	.	.	CIITA:uc002dak.4:exon10:c.G924A:p.T308T,CIITA:uc002dai.4:exon12:c.G2676A:p.T892T,CIITA:uc002daj.4:exon12:c.G2679A:p.T893T	.	AFR:0.5082,AMR:0.5490,EAS:0.8681,FIN:0.7666,NFE:0.7023,OTH:0.7336,ASJ:0.7267	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	MU27455469	unknown
16	11002927	11002927	A	G	CIITA	exonic	nonsynonymous SNV	ENSG00000179583	rs7197779	ENSG00000179583:ENST00000381835:exon10:c.A947G:p.Q316R,ENSG00000179583:ENST00000324288:exon12:c.A2699G:p.Q900R	CIITA:NM_001286403:exon10:c.A947G:p.Q316R,CIITA:NM_000246:exon12:c.A2699G:p.Q900R,CIITA:NM_001286402:exon12:c.A2702G:p.Q901R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9787	0.9199	0.928714	0.9325	-0.355	0.495	0.518	-0.248	0.010	.	.	.	CIITA:uc002dak.4:exon10:c.A947G:p.Q316R,CIITA:uc002dai.4:exon12:c.A2699G:p.Q900R,CIITA:uc002daj.4:exon12:c.A2702G:p.Q901R	-0.980	AFR:0.7626,AMR:0.9928,EAS:1,FIN:1,NFE:0.9994,OTH:0.9949,ASJ:1	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	0.001	-0.68	0.000	1.3	16	MU81973165	unknown
16	11012734	11012734	T	C	CIITA	intronic	.	ENSG00000179583	rs8062961	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.978435	0.9790	.	.	.	.	.	.	.	.	.	.	AFR:0.9259,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	.	hom
16	12060163	12060163	A	G	TNFRSF17	exonic	nonsynonymous SNV	ENSG00000048462	rs373496	ENSG00000048462:ENST00000053243:exon2:c.A242G:p.N81S	TNFRSF17:NM_001192:exon2:c.A242G:p.N81S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9792	0.9581	0.961262	0.9635	-2.420	0.001	1.0	-3.14	0.038	.	.	.	TNFRSF17:uc002dbv.3:exon2:c.A242G:p.N81S,TNFRSF17:uc010buy.3:exon2:c.A242G:p.N81S	-0.975	AFR:0.9007,AMR:0.9881,EAS:1,FIN:0.9917,NFE:0.9861,OTH:0.9868,ASJ:0.9901	109545	.	.	.	.	.	.	.	0.0	2.97	0.000	-0.345	16	MU81973453	hom
16	14014240	14014240	G	A	ERCC4	intronic	.	ENSG00000175595	rs762521	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3330	0.2314	0.220248	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.2310,AMR:0.1747,EAS:0.2980,FIN:0.2609,NFE:0.2174,OTH:0.2639,ASJ:0.1643	133520	278760;610965;615272;	84;220295;910;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	16	1(lung)	0.2648
16	14026007	14026007	G	A	ERCC4	intronic	.	ENSG00000262732	rs254942	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9661	0.9846	0.946486	0.9716	.	.	.	.	.	0.0002	0.002	.	.	.	AFR:0.9954,AMR:0.9857,EAS:0.7519,FIN:0.9754,NFE:0.9797,OTH:0.9745,ASJ:0.9669	133520	278760;610965;615272;	84;220295;910;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	16	MU25355495	hom
16	14041958	14041958	T	C	ERCC4	exonic	synonymous SNV	ENSG00000175595	rs1799801	ENSG00000175595:ENST00000311895:exon11:c.T2505C:p.S835S	ERCC4:NM_005236:exon11:c.T2505C:p.S835S	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2723	0.2532	0.241214	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	ERCC4:uc010uyz.1:exon6:c.T1155C:p.S385S,ERCC4:uc002dce.2:exon11:c.T2505C:p.S835S	.	AFR:0.2433,AMR:0.1744,EAS:0.3245,FIN:0.2429,NFE:0.2291,OTH:0.2802,ASJ:0.2661	133520	278760;610965;615272;	84;220295;910;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	,4780	.	.	.	.	.	.	16	1(haematopoietic_and_lymphoid_tissue)	0.2984
16	15758608	15758608	G	A	NDE1	UTR5	.	ENSG00000072864	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	609449	605013;614019;	1083;443162;	1083|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|614019 616212 ~443162|MHAC|<1 / 1 000 000|Autosomal recessive|Antenatal<br>Neonatal|605013 ~	.	.	.	.	.	.	.	.	16	.	het
16	15811023	15811023	C	T	MYH11	exonic	synonymous SNV	ENSG00000133392	rs1050163	ENSG00000133392:ENST00000300036:exon38:c.G5478A:p.L1826L,ENSG00000133392:ENST00000576790:exon38:c.G5478A:p.L1826L,ENSG00000133392:ENST00000396324:exon39:c.G5499A:p.L1833L,ENSG00000133392:ENST00000452625:exon39:c.G5499A:p.L1833L	MYH11:NM_002474:exon38:c.G5478A:p.L1826L,MYH11:NM_022844:exon38:c.G5478A:p.L1826L,MYH11:NM_001040113:exon39:c.G5499A:p.L1833L,MYH11:NM_001040114:exon39:c.G5499A:p.L1833L	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4818	0.4390	0.396166	1(biliary_tract)	.	.	.	.	.	.	.	.	MYH11:uc010bvh.3:exon10:c.G1596A:p.L532L,MYH11:uc002ddw.3:exon38:c.G5478A:p.L1826L,MYH11:uc002ddy.3:exon38:c.G5478A:p.L1826L,MYH11:uc002ddv.3:exon39:c.G5499A:p.L1833L,MYH11:uc002ddx.3:exon39:c.G5499A:p.L1833L,MYH11:uc010bvg.3:exon39:c.G4974A:p.L1658L	.	AFR:1(bone),AMR:MU690795,EAS:0.4419,FIN:0.3028,NFE:0.5680,OTH:0.5265,ASJ:LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205	160745	132900;	91387;	91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	16	1(haematopoietic_and_lymphoid_tissue)	0.3077
16	15811062	15811062	C	T	MYH11	exonic	synonymous SNV	ENSG00000133392	rs1050162	ENSG00000133392:ENST00000300036:exon38:c.G5439A:p.K1813K,ENSG00000133392:ENST00000576790:exon38:c.G5439A:p.K1813K,ENSG00000133392:ENST00000396324:exon39:c.G5460A:p.K1820K,ENSG00000133392:ENST00000452625:exon39:c.G5460A:p.K1820K	MYH11:NM_002474:exon38:c.G5439A:p.K1813K,MYH11:NM_022844:exon38:c.G5439A:p.K1813K,MYH11:NM_001040113:exon39:c.G5460A:p.K1820K,MYH11:NM_001040114:exon39:c.G5460A:p.K1820K	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4823	0.4394	0.396765	MU15806097	.	.	.	.	.	.	.	.	MYH11:uc010bvh.3:exon10:c.G1557A:p.K519K,MYH11:uc002ddw.3:exon38:c.G5439A:p.K1813K,MYH11:uc002ddy.3:exon38:c.G5439A:p.K1813K,MYH11:uc002ddv.3:exon39:c.G5460A:p.K1820K,MYH11:uc002ddx.3:exon39:c.G5460A:p.K1820K,MYH11:uc010bvg.3:exon39:c.G4935A:p.K1645K	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,AMR:0.4421,EAS:0.5683,FIN:0.5265,NFE:0.3091,OTH:0.5241,ASJ:0.3018	160745	132900;	91387;	91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	16	1(oesophagus)	0.5062
16	15818141	15818141	A	C	MYH11	exonic	synonymous SNV	ENSG00000133392	rs2075511	ENSG00000133392:ENST00000300036:exon31:c.T4242G:p.A1414A,ENSG00000133392:ENST00000576790:exon31:c.T4242G:p.A1414A,ENSG00000133392:ENST00000396324:exon32:c.T4263G:p.A1421A,ENSG00000133392:ENST00000452625:exon32:c.T4263G:p.A1421A	MYH11:NM_002474:exon31:c.T4242G:p.A1414A,MYH11:NM_022844:exon31:c.T4242G:p.A1414A,MYH11:NM_001040113:exon32:c.T4263G:p.A1421A,MYH11:NM_001040114:exon32:c.T4263G:p.A1421A	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5009	0.4590	0.410144	MU15806372	.	.	.	.	.	.	.	.	MYH11:uc010bvh.3:exon3:c.T360G:p.A120A,MYH11:uc002ddw.3:exon31:c.T4242G:p.A1414A,MYH11:uc002ddy.3:exon31:c.T4242G:p.A1414A,MYH11:uc002ddv.3:exon32:c.T4263G:p.A1421A,MYH11:uc002ddx.3:exon32:c.T4263G:p.A1421A,MYH11:uc010bvg.3:exon32:c.T3738G:p.A1246A	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,AMR:0.4487,EAS:0.5800,FIN:0.6358,NFE:0.2938,OTH:0.5189,ASJ:0.3073	160745	132900;	91387;	91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	16	1(oesophagus)	0.5164
16	28617485	28617485	C	T	SULT1A1	exonic	nonsynonymous SNV	ENSG00000196502	rs1801030	ENSG00000196502:ENST00000350842:exon5:c.G433A:p.V145M,ENSG00000196502:ENST00000569554:exon6:c.G667A:p.V223M,ENSG00000196502:ENST00000314752:exon7:c.G667A:p.V223M,ENSG00000196502:ENST00000395607:exon7:c.G667A:p.V223M,ENSG00000196502:ENST00000566189:exon7:c.G667A:p.V223M,ENSG00000196502:ENST00000395609:exon9:c.G667A:p.V223M	SULT1A1:NM_177536:exon5:c.G433A:p.V145M,SULT1A1:NM_177534:exon6:c.G667A:p.V223M,SULT1A1:NM_001055:exon7:c.G667A:p.V223M,SULT1A1:NM_177529:exon7:c.G667A:p.V223M,SULT1A1:NM_177530:exon7:c.G667A:p.V223M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9714	0.8729	.	0.9256	2.497	19.45	0.093	2.18	0.007	.	.	P-loop containing nucleoside triphosphate hydrolase|Sulfotransferase domain	SULT1A1:uc002dqm.3:exon5:c.G433A:p.V145M,SULT1A1:uc002dqi.3:exon6:c.G667A:p.V223M,SULT1A1:uc002dqj.3:exon7:c.G667A:p.V223M,SULT1A1:uc002dqk.3:exon7:c.G667A:p.V223M,SULT1A1:uc002dql.3:exon7:c.G667A:p.V223M,SULT1A1:uc002dqp.3:exon9:c.G667A:p.V223M,SULT1A1:uc002dqn.3:exon10:c.G940A:p.V314M	-1.034	AFR:0.7421,AMR:0.9808,EAS:1,FIN:1,NFE:0.9987,OTH:0.9907,ASJ:0.9901	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	0.036	4.53	0.000	2.515	16	MU81975347	hom
16	28621311	28621311	T	C	SULT1A1	UTR5	.	ENSG00000196502;ENSG00000196502	rs2077412	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6819	.	0.676518	MU25371586	.	.	.	.	.	.	.	.	SULT1A1:uc002dqn.3:exon3:c.A137G:p.N46S	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.7180,EAS:0.7653,FIN:0.7682,NFE:0.5227,OTH:0.7194,ASJ:0.7639	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	16	22(upper_aerodigestive_tract)	0.7106
16	31193942	31193942	C	A	FUS	exonic	synonymous SNV	ENSG00000089280	rs741810	ENSG00000089280:ENST00000254108:exon3:c.C147A:p.G49G,ENSG00000089280:ENST00000380244:exon3:c.C147A:p.G49G,ENSG00000089280:ENST00000566605:exon3:c.C147A:p.G49G,ENSG00000089280:ENST00000568685:exon3:c.C147A:p.G49G	FUS:NM_001170634:exon3:c.C147A:p.G49G,FUS:NM_001170937:exon3:c.C147A:p.G49G,FUS:NM_004960:exon3:c.C147A:p.G49G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3221	0.2167	0.278954	MU71012	.	.	.	.	.	.	.	.	FUS:uc002ebe.2:exon3:c.C147A:p.G49G,FUS:uc002ebf.3:exon3:c.C147A:p.G49G,FUS:uc002ebh.3:exon3:c.C147A:p.G49G,FUS:uc010vfi.2:exon3:c.C147A:p.G49G	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,AMR:0.2545,EAS:0.3389,FIN:0.2053,NFE:0.2522,OTH:0.3872,ASJ:0.0677	137070	608030;614782;	275872;803;	275872|FTD-ALS<br>FTD-MND<br>Frontotemporal dementia with amyotrophic lateral sclerosis|Unknown|Autosomal dominant|Adult|105550 608030 612069 613954 615911 616437 616439 ~803|ALS<br>Charcot disease<br>Lou Gehrig disease|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Adult|105400 205250 300857 606070 606640 608030 608031 608627 611895 612069 612577 613435 613954 614696 614808 615426 615515 616208 616437 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	16	2(lung)	0.3223
16	50827518	50827518	C	T	CYLD	exonic	synonymous SNV	ENSG00000083799	rs2066852	ENSG00000083799:ENST00000568704:exon12:c.C1857T:p.D619D,ENSG00000083799:ENST00000564326:exon15:c.C2403T:p.D801D,ENSG00000083799:ENST00000398568:exon16:c.C2403T:p.D801D,ENSG00000083799:ENST00000427738:exon16:c.C2412T:p.D804D,ENSG00000083799:ENST00000566206:exon16:c.C2403T:p.D801D,ENSG00000083799:ENST00000569418:exon16:c.C2403T:p.D801D,ENSG00000083799:ENST00000540145:exon17:c.C2412T:p.D804D,ENSG00000083799:ENST00000311559:exon18:c.C2412T:p.D804D	CYLD:NM_001042355:exon16:c.C2403T:p.D801D,CYLD:NM_001042412:exon16:c.C2403T:p.D801D,CYLD:NM_015247:exon18:c.C2412T:p.D804D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0855	0.0630	0.0790735	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	CYLD:uc021tib.1:exon15:c.C2412T:p.D804D,CYLD:uc002egq.1:exon16:c.C2403T:p.D801D,CYLD:uc002egr.1:exon16:c.C2403T:p.D801D,CYLD:uc010cbs.1:exon16:c.C2403T:p.D801D,CYLD:uc002egp.1:exon17:c.C2403T:p.D801D	.	AFR:0.0519,AMR:0.0282,EAS:0.1325,FIN:0.0309,NFE:0.0458,OTH:0.0679,ASJ:0.0358	605018	132700;601606;605041;	79493;79493;867;211;79493;	79493|CYLD cutaneous syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|132700 601606 605041 612099 ~79493|CYLD cutaneous syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|132700 601606 605041 612099 ~867|-|Unknown|Autosomal dominant|Childhood|601606 612099 ~211|Turban tumor syndrome|-|Autosomal dominant|-|132700 ~79493|CYLD cutaneous syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|132700 601606 605041 612099 ~	.	.	.	.	.	.	.	.	16	1(lung)	0.0643
16	55519535	55519535	G	C	MMP2	exonic	synonymous SNV	ENSG00000087245	rs1132896	ENSG00000087245:ENST00000219070:exon5:c.G678C:p.G226G,ENSG00000087245:ENST00000437642:exon5:c.G528C:p.G176G,ENSG00000087245:ENST00000543485:exon5:c.G450C:p.G150G,ENSG00000087245:ENST00000564864:exon5:c.G450C:p.G150G,ENSG00000087245:ENST00000570308:exon6:c.G450C:p.G150G	MMP2:NM_001127891:exon5:c.G528C:p.G176G,MMP2:NM_001302508:exon5:c.G450C:p.G150G,MMP2:NM_001302509:exon5:c.G450C:p.G150G,MMP2:NM_001302510:exon5:c.G450C:p.G150G,MMP2:NM_004530:exon5:c.G678C:p.G226G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3013	0.2568	0.20008	1(lung)	.	.	.	.	.	.	.	.	MMP2:uc002ehz.4:exon5:c.G678C:p.G226G,MMP2:uc010ccc.3:exon5:c.G528C:p.G176G,MMP2:uc010vhd.2:exon5:c.G450C:p.G150G	.	AFR:4(haematopoietic_and_lymphoid_tissue),AMR:MU12795193,EAS:0.2634,FIN:0.0731,NFE:0.3747,OTH:0.29,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02	120360	259600;	3460;371428;85196;	3460|Winchester syndrome|<1 / 1 000 000|-|Childhood|259600 277950 ~371428|MONA spectrum|Unknown|Autosomal recessive|Infancy<br>Childhood|259600 277950 ~85196|Multicentric osteolysis-nodulosis-arthropathy syndrome<br>NAO syndrome|-|-|-|259600 277950 ~	~ko01522 Endocrine resistance~ko04670 Leukocyte transendothelial migration~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05219 Bladder cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	16	1(breast)	0.1553
16	55523705	55523705	T	C	MMP2	exonic	synonymous SNV	ENSG00000087245	rs243849	ENSG00000087245:ENST00000219070:exon7:c.T1149C:p.D383D,ENSG00000087245:ENST00000437642:exon7:c.T999C:p.D333D,ENSG00000087245:ENST00000543485:exon7:c.T921C:p.D307D,ENSG00000087245:ENST00000570308:exon8:c.T921C:p.D307D	MMP2:NM_001127891:exon7:c.T999C:p.D333D,MMP2:NM_001302508:exon7:c.T921C:p.D307D,MMP2:NM_001302509:exon7:c.T921C:p.D307D,MMP2:NM_001302510:exon7:c.T921C:p.D307D,MMP2:NM_004530:exon7:c.T1149C:p.D383D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8378	0.7993	0.79992	0.8073	.	.	.	.	.	.	.	.	MMP2:uc002ehz.4:exon7:c.T1149C:p.D383D,MMP2:uc010ccc.3:exon7:c.T999C:p.D333D,MMP2:uc010vhd.2:exon7:c.T921C:p.D307D	.	AFR:0.7081,AMR:0.7955,EAS:0.7652,FIN:0.8688,NFE:0.8527,OTH:0.8476,ASJ:0.8278	120360	259600;	3460;371428;85196;	3460|Winchester syndrome|<1 / 1 000 000|-|Childhood|259600 277950 ~371428|MONA spectrum|Unknown|Autosomal recessive|Infancy<br>Childhood|259600 277950 ~85196|Multicentric osteolysis-nodulosis-arthropathy syndrome<br>NAO syndrome|-|-|-|259600 277950 ~	~ko01522 Endocrine resistance~ko04670 Leukocyte transendothelial migration~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05219 Bladder cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	16	MU4562717	hom
16	55527113	55527113	G	A	MMP2	exonic	synonymous SNV	ENSG00000087245	rs2287074	ENSG00000087245:ENST00000570283:exon3:c.G255A:p.T85T,ENSG00000087245:ENST00000219070:exon9:c.G1380A:p.T460T,ENSG00000087245:ENST00000437642:exon9:c.G1230A:p.T410T,ENSG00000087245:ENST00000543485:exon9:c.G1152A:p.T384T,ENSG00000087245:ENST00000570308:exon10:c.G1152A:p.T384T	MMP2:NM_001127891:exon9:c.G1230A:p.T410T,MMP2:NM_001302508:exon9:c.G1152A:p.T384T,MMP2:NM_001302509:exon9:c.G1152A:p.T384T,MMP2:NM_001302510:exon9:c.G1152A:p.T384T,MMP2:NM_004530:exon9:c.G1380A:p.T460T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3927	0.3592	0.32488	LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	MMP2:uc002ehz.4:exon9:c.G1380A:p.T460T,MMP2:uc010ccc.3:exon9:c.G1230A:p.T410T,MMP2:uc010vhd.2:exon9:c.G1152A:p.T384T	.	AFR:0.3610,AMR:0.2135,EAS:0.3411,FIN:0.2732,NFE:0.3788,OTH:0.4464,ASJ:0.4149	120360	259600;	3460;371428;85196;	3460|Winchester syndrome|<1 / 1 000 000|-|Childhood|259600 277950 ~371428|MONA spectrum|Unknown|Autosomal recessive|Infancy<br>Childhood|259600 277950 ~85196|Multicentric osteolysis-nodulosis-arthropathy syndrome<br>NAO syndrome|-|-|-|259600 277950 ~	~ko01522 Endocrine resistance~ko04670 Leukocyte transendothelial migration~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05219 Bladder cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	16	1(large_intestine)	0.4115
16	55536727	55536727	C	T	MMP2	exonic	synonymous SNV	ENSG00000087245	rs14070	ENSG00000087245:ENST00000570283:exon6:c.C681T:p.F227F,ENSG00000087245:ENST00000219070:exon12:c.C1806T:p.F602F,ENSG00000087245:ENST00000437642:exon12:c.C1656T:p.F552F,ENSG00000087245:ENST00000543485:exon12:c.C1578T:p.F526F,ENSG00000087245:ENST00000570308:exon13:c.C1578T:p.F526F	MMP2:NM_001127891:exon12:c.C1656T:p.F552F,MMP2:NM_001302508:exon12:c.C1578T:p.F526F,MMP2:NM_001302509:exon12:c.C1578T:p.F526F,MMP2:NM_001302510:exon12:c.C1578T:p.F526F,MMP2:NM_004530:exon12:c.C1806T:p.F602F	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3950	0.3664	0.303914	1(breast)	.	.	.	.	.	.	.	.	MMP2:uc002ehz.4:exon12:c.C1806T:p.F602F,MMP2:uc010ccc.3:exon12:c.C1656T:p.F552F,MMP2:uc010vhd.2:exon12:c.C1578T:p.F526F	.	AFR:MU12795244,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02,EAS:0.1865,FIN:0.4499,NFE:0.4503,OTH:0.2472,ASJ:0.3634	120360	259600;	3460;371428;85196;	3460|Winchester syndrome|<1 / 1 000 000|-|Childhood|259600 277950 ~371428|MONA spectrum|Unknown|Autosomal recessive|Infancy<br>Childhood|259600 277950 ~85196|Multicentric osteolysis-nodulosis-arthropathy syndrome<br>NAO syndrome|-|-|-|259600 277950 ~	~ko01522 Endocrine resistance~ko04670 Leukocyte transendothelial migration~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05219 Bladder cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	16	2(haematopoietic_and_lymphoid_tissue)	0.3998
16	55730124	55730124	A	C	SLC6A2	intronic	.	ENSG00000103546	rs5568	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3156	0.2670	0.252396	LAML-KR|2|205|0.0097561,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.2719,AMR:0.1007,EAS:0.4139,FIN:0.2726,NFE:0.3620,OTH:0.3406,ASJ:0.3305	163970	604715;	443236;	443236|Familial orthostatic tachycardia due to norepinephrine transporter deficiency<br>Postural tachycardia syndrome due to NET deficiency|<1 / 1 000 000|Autosomal dominant|Adult|604715 ~	.	.	.	.	.	.	.	.	16	2(haematopoietic_and_lymphoid_tissue)	0.3282
16	56855496	56855496	C	G	NUP93	exonic	synonymous SNV	ENSG00000102900	rs2118017	ENSG00000102900:ENST00000563858:exon3:c.C24G:p.L8L,ENSG00000102900:ENST00000542526:exon5:c.C276G:p.L92L,ENSG00000102900:ENST00000564887:exon5:c.C276G:p.L92L,ENSG00000102900:ENST00000567641:exon5:c.C276G:p.L92L,ENSG00000102900:ENST00000569863:exon6:c.C276G:p.L92L,ENSG00000102900:ENST00000308159:exon7:c.C645G:p.L215L,ENSG00000102900:ENST00000569842:exon7:c.C645G:p.L215L	NUP93:NM_001242795:exon5:c.C276G:p.L92L,NUP93:NM_001242796:exon5:c.C276G:p.L92L,NUP93:NM_014669:exon7:c.C645G:p.L215L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8299	0.8329	0.875799	0.8261	.	.	.	.	.	.	.	.	NUP93:uc002ekb.3:exon5:c.C276G:p.L92L,NUP93:uc010vhi.2:exon5:c.C276G:p.L92L,NUP93:uc002eka.3:exon7:c.C645G:p.L215L	.	AFR:0.8848,AMR:0.8568,EAS:0.9137,FIN:0.7923,NFE:0.7896,OTH:0.8035,ASJ:0.8467	614351	616892;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	16	MU116544	hom
16	56868700	56868700	A	G	NUP93	intronic	.	ENSG00000102900	rs1347591	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4775	0.4722	0.541733	ESAD-UK|1|409|0.00244499,PACA-CA|1|268|0.00373134,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.4610,AMR:0.5376,EAS:0.3974,FIN:0.7051,NFE:0.3354,OTH:0.4230,ASJ:0.4472	614351	616892;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	16	1(haematopoietic_and_lymphoid_tissue)	0.4375
16	56873495	56873495	C	T	NUP93	exonic	synonymous SNV	ENSG00000102900	rs1138295	ENSG00000102900:ENST00000569322:exon2:c.C123T:p.A41A,ENSG00000102900:ENST00000542526:exon18:c.C1830T:p.A610A,ENSG00000102900:ENST00000564887:exon18:c.C1830T:p.A610A,ENSG00000102900:ENST00000308159:exon20:c.C2199T:p.A733A,ENSG00000102900:ENST00000569842:exon20:c.C2199T:p.A733A	NUP93:NM_001242795:exon18:c.C1830T:p.A610A,NUP93:NM_001242796:exon18:c.C1830T:p.A610A,NUP93:NM_014669:exon20:c.C2199T:p.A733A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1797	0.1668	0.210663	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	NUP93:uc002ekb.3:exon18:c.C1830T:p.A610A,NUP93:uc010vhi.2:exon18:c.C1830T:p.A610A,NUP93:uc002eka.3:exon20:c.C2199T:p.A733A	.	AFR:MU12798719,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,THCA-SA|1|243|0.00411523,EAS:0.1995,FIN:0.2041,NFE:0.1424,OTH:0.3412,ASJ:0.1735	614351	616892;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	16	1(breast)	0.1264
16	65005462	65005462	G	A	CDH11	intronic	.	ENSG00000140937	rs12597529	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5274	0.4151	0.547324	0.4590	.	.	.	.	.	.	.	.	.	.	AFR:0.3247,AMR:0.6110,EAS:0.7916,FIN:0.5542,NFE:0.4681,OTH:0.5061,ASJ:0.4305	600023	.	.	.	.	.	.	.	.	.	.	.	16	MU21091308	het
16	65016087	65016087	A	C	CDH11	exonic	nonsynonymous SNV	ENSG00000140937	rs35213	ENSG00000140937:ENST00000566827:exon7:c.T739G:p.S247A,ENSG00000140937:ENST00000268603:exon8:c.T1117G:p.S373A,ENSG00000140937:ENST00000394156:exon8:c.T1117G:p.S373A	CDH11:NM_001330576:exon7:c.T739G:p.S247A,CDH11:NM_001308392:exon8:c.T1117G:p.S373A,CDH11:NM_001797:exon8:c.T1117G:p.S373A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8043	0.6928	0.745407	0.7215	-0.605	0.122	0.716	1.34	0.089	.	.	Cadherin|Cadherin-like	CDH11:uc010vin.2:exon7:c.T739G:p.S247A,CDH11:uc002eoi.3:exon8:c.T1117G:p.S373A,CDH11:uc002eoj.3:exon8:c.T1117G:p.S373A	-0.969	AFR:0.4484,AMR:0.8213,EAS:0.9981,FIN:0.7975,NFE:0.8188,OTH:0.8184,ASJ:0.8046	600023	.	.	.	.	.	.	.	0.001	4.7	0.000	1.52	16	MU81978235	hom
16	65022114	65022114	C	T	CDH11	exonic	synonymous SNV	ENSG00000140937	rs28216	ENSG00000140937:ENST00000566827:exon6:c.G567A:p.S189S,ENSG00000140937:ENST00000268603:exon7:c.G945A:p.S315S,ENSG00000140937:ENST00000394156:exon7:c.G945A:p.S315S	CDH11:NM_001330576:exon6:c.G567A:p.S189S,CDH11:NM_001308392:exon7:c.G945A:p.S315S,CDH11:NM_001797:exon7:c.G945A:p.S315S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3306	0.3222	0.223642	1(breast)	.	.	.	.	.	.	.	.	CDH11:uc010vin.2:exon6:c.G567A:p.S189S,CDH11:uc002eoi.3:exon7:c.G945A:p.S315S,CDH11:uc002eoj.3:exon7:c.G945A:p.S315S	.	AFR:MU155560,AMR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,EAS:0.1220,FIN:0.2380,NFE:0.4463,OTH:0.2072,ASJ:0.3088	600023	.	.	.	.	.	.	.	.	.	.	.	16	3(haematopoietic_and_lymphoid_tissue)	0.3332
16	65022234	65022234	C	T	CDH11	exonic	nonsynonymous SNV	ENSG00000140937	rs1130821	ENSG00000140937:ENST00000566827:exon6:c.G447A:p.M149I,ENSG00000140937:ENST00000268603:exon7:c.G825A:p.M275I,ENSG00000140937:ENST00000394156:exon7:c.G825A:p.M275I	CDH11:NM_001330576:exon6:c.G447A:p.M149I,CDH11:NM_001308392:exon7:c.G825A:p.M275I,CDH11:NM_001797:exon7:c.G825A:p.M275I	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0] 	0.1824	0.1153	0.217252	4(stomach)	6.014	27.9	0.039	5.75	1.000	.	.	Cadherin|Cadherin-like	CDH11:uc010vin.2:exon6:c.G447A:p.M149I,CDH11:uc002eoi.3:exon7:c.G825A:p.M275I,CDH11:uc002eoj.3:exon7:c.G825A:p.M275I	-0.566	AFR:1(lung),AMR:MU155566,EAS:0.1546,FIN:0.0987,NFE:0.3565,OTH:0.0894,ASJ:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|7|321|0.0218069	600023	.	.	.	.	.	.	.	0.94	4.71	0.000	0.21	16	1(oesophagus)	0.4493
16	65025658	65025658	T	C	CDH11	intronic	.	ENSG00000140937	rs35196	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9150	0.9021	0.926917	0.9068	.	.	.	.	.	.	.	.	.	.	AFR:0.8999,AMR:0.8998,EAS:1,FIN:0.8955,NFE:0.9033,OTH:0.9124,ASJ:0.9106	600023	.	.	.	.	.	.	.	.	.	.	.	16	MU81978243	hom
16	65025718	65025718	G	A	CDH11	exonic	nonsynonymous SNV	ENSG00000140937	rs35195	ENSG00000140937:ENST00000566827:exon5:c.C386T:p.T129M,ENSG00000140937:ENST00000268603:exon6:c.C764T:p.T255M,ENSG00000140937:ENST00000394156:exon6:c.C764T:p.T255M	CDH11:NM_001330576:exon5:c.C386T:p.T129M,CDH11:NM_001308392:exon6:c.C764T:p.T255M,CDH11:NM_001797:exon6:c.C764T:p.T255M	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0] 	0.2728	0.2601	0.18151	MU4562873	6.096	28.2	0.016	4.59	0.996	.	.	Cadherin|Cadherin-like	CDH11:uc010vin.2:exon5:c.C386T:p.T129M,CDH11:uc002eoi.3:exon6:c.C764T:p.T255M,CDH11:uc002eoj.3:exon6:c.C764T:p.T255M	-0.899	AFR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.2473,EAS:0.2076,FIN:0.3742,NFE:0.2060,OTH:0.2440,ASJ:0.0691	600023	.	.	.	.	.	.	.	0.986	3.92	0.000	2.295	16	1(lung)	0.3518
16	65025849	65025849	A	G	CDH11	intronic	.	ENSG00000140937	rs35194	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9144	0.8999	0.925919	0.9052	.	.	.	.	.	0.0008	0.006	.	.	.	AFR:0.8951,AMR:0.8995,EAS:1,FIN:0.8955,NFE:0.9029,OTH:0.9121,ASJ:0.9106	600023	.	.	.	.	.	.	.	.	.	.	.	16	MU81978256	hom
16	68771372	68771372	C	T	CDH1	intronic	.	ENSG00000039068	rs3743674	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8111	0.8603	0.763379	16(meninges)	.	.	.	.	.	0	0.032	.	.	.	AFR:1(lung),AMR:MU51154082,EAS:0.7976,FIN:0.6539,NFE:0.7548,OTH:0.9367,ASJ:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	192090	114480;137215;167000;176807;608089;	1331;26106;227535;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko04015 Rap1 signaling pathway~ko04371 Apelin signaling pathway~ko04390 Hippo signaling pathway~ko04514 Cell adhesion molecules (CAMs)~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05200 Pathways in cancer~ko05213 Endometrial cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	1(breast)	0.7605
16	70287177	70287177	A	G	AARS	exonic	synonymous SNV	ENSG00000090861	rs4081753	ENSG00000090861:ENST00000261772:exon20:c.T2715C:p.V905V	AARS:NM_001605:exon20:c.T2715C:p.V905V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8241	0.8492	0.88119	0.8640	.	.	.	.	.	.	.	.	AARS:uc010vlu.1:exon16:c.T2253C:p.V751V,AARS:uc002eyn.1:exon20:c.T2715C:p.V905V	.	AFR:0.9664,AMR:0.8549,EAS:0.9697,FIN:0.8542,NFE:0.8008,OTH:0.8153,ASJ:0.7616	601065	613287;616339;	442835;228174;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~228174|CMT2N|<1 / 1 000 000|Autosomal dominant|All ages|613287 ~	.	.	.	.	.	.	.	.	16	MU4563135	hom
16	72827758	72827758	T	C	ZFHX3	exonic	synonymous SNV	ENSG00000140836	rs699444	ENSG00000140836:ENST00000397992:exon8:c.A6081G:p.G2027G,ENSG00000140836:ENST00000268489:exon9:c.A8823G:p.G2941G	ZFHX3:NM_001164766:exon8:c.A6081G:p.G2027G,ZFHX3:NM_006885:exon9:c.A8823G:p.G2941G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8771	0.8816	0.920727	0.8969	.	.	.	.	.	.	.	.	ZFHX3:uc002fcl.3:exon8:c.A6081G:p.G2027G,ZFHX3:uc002fck.3:exon9:c.A8823G:p.G2941G	.	AFR:0.9704,AMR:0.8950,EAS:0.9981,FIN:0.9041,NFE:0.8456,OTH:0.8676,ASJ:0.7914	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	MU81979263	het
16	72830248	72830248	C	T	ZFHX3	exonic	synonymous SNV	ENSG00000140836	rs142316393	ENSG00000140836:ENST00000397992:exon8:c.G3591A:p.P1197P,ENSG00000140836:ENST00000268489:exon9:c.G6333A:p.P2111P	ZFHX3:NM_001164766:exon8:c.G3591A:p.P1197P,ZFHX3:NM_006885:exon9:c.G6333A:p.P2111P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0142	0.0141	0.0121805	0.0103	.	.	.	.	.	.	.	.	ZFHX3:uc002fcl.3:exon8:c.G3591A:p.P1197P,ZFHX3:uc002fck.3:exon9:c.G6333A:p.P2111P	.	AFR:0.0042,AMR:0.0119,EAS:0,FIN:0.0077,NFE:0.0149,OTH:0.0173,ASJ:0.0099	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	MU128815386	het
16	72832135	72832135	T	A	ZFHX3	exonic	synonymous SNV	ENSG00000140836	rs740178	ENSG00000140836:ENST00000397992:exon8:c.A1704T:p.A568A,ENSG00000140836:ENST00000268489:exon9:c.A4446T:p.A1482A	ZFHX3:NM_001164766:exon8:c.A1704T:p.A568A,ZFHX3:NM_006885:exon9:c.A4446T:p.A1482A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8362	0.8548	0.886182	0.8673	.	.	.	.	.	.	.	.	ZFHX3:uc002fcl.3:exon8:c.A1704T:p.A568A,ZFHX3:uc002fck.3:exon9:c.A4446T:p.A1482A	.	AFR:0.9647,AMR:0.8373,EAS:0.9710,FIN:0.8709,NFE:0.8043,OTH:0.8350,ASJ:0.7649	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	MU81979273	het
16	72991660	72991660	C	G	ZFHX3	exonic	synonymous SNV	ENSG00000140836	rs10852515	ENSG00000140836:ENST00000268489:exon2:c.G2385C:p.P795P	ZFHX3:NM_006885:exon2:c.G2385C:p.P795P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8359	0.8359	0.770966	MU4555792	.	.	.	.	.	.	.	.	ZFHX3:uc002fck.3:exon2:c.G2385C:p.P795P	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,AMR:0.8398,EAS:0.9153,FIN:0.8278,NFE:0.6621,OTH:0.9107,ASJ:0.7901	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	2(haematopoietic_and_lymphoid_tissue)	0.8661
16	72991715	72991715	A	G	ZFHX3	exonic	nonsynonymous SNV	ENSG00000140836	rs4788682	ENSG00000140836:ENST00000268489:exon2:c.T2330C:p.V777A	ZFHX3:NM_006885:exon2:c.T2330C:p.V777A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7713	0.8221	0.765575	MU15108548	-0.599	0.126	0.771	4.54	0.002	.	.	.	ZFHX3:uc002fck.3:exon2:c.T2330C:p.V777A	-0.974	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.8262,EAS:0.8898,FIN:0.8167,NFE:0.6629,OTH:0.8708,ASJ:0.7827	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	0.002	-0.67	0.000	-0.69	16	1(prostate)	0.8546
16	72992221	72992221	G	A	ZFHX3	exonic	synonymous SNV	ENSG00000140836	rs61735550	ENSG00000140836:ENST00000268489:exon2:c.C1824T:p.S608S	ZFHX3:NM_006885:exon2:c.C1824T:p.S608S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1803	0.1807	0.0830671	0.1833	.	.	.	.	.	.	.	.	ZFHX3:uc002fck.3:exon2:c.C1824T:p.S608S	.	AFR:0.0448,AMR:0.1026,EAS:0,FIN:0.2596,NFE:0.2681,OTH:0.2200,ASJ:0.2020	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	.	het
16	72992443	72992443	G	A	ZFHX3	exonic	synonymous SNV	ENSG00000140836	rs62640008	ENSG00000140836:ENST00000268489:exon2:c.C1602T:p.P534P	ZFHX3:NM_006885:exon2:c.C1602T:p.P534P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0319	0.0462	0.0451278	0.0380	.	.	.	.	.	.	.	.	ZFHX3:uc002fck.3:exon2:c.C1602T:p.P534P	.	AFR:0.0842,AMR:0.0300,EAS:0.0290,FIN:0.0046,NFE:0.0221,OTH:0.0143,ASJ:0.0232	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	MU113901293	het
16	72993831	72993831	A	C	ZFHX3	exonic	nonsynonymous SNV	ENSG00000140836	rs7193297	ENSG00000140836:ENST00000268489:exon2:c.T214G:p.S72A	ZFHX3:NM_006885:exon2:c.T214G:p.S72A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4014	0.4739	0.470447	1(lung)	0.001	2.598	1.0	5.11	0.788	.	.	.	ZFHX3:uc002fck.3:exon2:c.T214G:p.S72A	-0.963	AFR:MU71249,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,EAS:0.7036,FIN:0.2542,NFE:0.4503,OTH:0.2667,ASJ:0.4903	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	0.006	-0.66	0.000	0.345	16	1(thyroid)	0.4885
16	78198192	78198192	T	C	WWOX	intronic	.	ENSG00000186153	rs2303191	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7482	0.7435	0.789137	0.7460	.	.	.	.	.	0.0002	0.046	.	.	.	AFR:0.8026,AMR:0.8158,EAS:0.8854,FIN:0.6865,NFE:0.7112,OTH:0.7261,ASJ:0.6556	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	.	.	.	.	16	MU772162	hom
16	78312497	78312497	C	A	WWOX	intronic	.	ENSG00000186153	rs8050128	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4595	0.4620	0.472244	0.4589	.	.	.	.	.	0	0	.	.	.	AFR:0.5141,AMR:0.4284,EAS:0.5,FIN:0.4225,NFE:0.4315,OTH:0.4541,ASJ:0.5364	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	.	.	.	.	16	MU25384686	het
16	78458750	78458750	G	A	WWOX	intronic	.	ENSG00000186153	rs4130513	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1447	0.2301	0.292332	MU709669	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.2341,EAS:0.1193,FIN:0.1291,NFE:0.1887,OTH:0.0953,ASJ:0.6014	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	.	.	.	.	16	1(liver)	0.0737
16	78458915	78458915	C	G	WWOX	exonic	nonsynonymous SNV	ENSG00000186153	rs75559202	ENSG00000186153:ENST00000408984:exon7:c.C754G:p.P252A,ENSG00000186153:ENST00000566780:exon7:c.C754G:p.P252A	WWOX:NM_001291997:exon6:c.C415G:p.P139A,WWOX:NM_016373:exon7:c.C754G:p.P252A	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0232	0.0006	0.0461262	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579	3.069	22.4	0.333	5.66	0.926	.	.	NAD(P)-binding domain	WWOX:uc010vnk.2:exon6:c.C415G:p.P139A,WWOX:uc002ffk.3:exon7:c.C754G:p.P252A	-0.523	AFR:0.0065,AMR:0.0011,EAS:0.0033,FIN:0.0762,NFE:0.0031,OTH:0.0007,ASJ:0.0430	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	0.788	-2.16	0.069	0.46	16	2(haematopoietic_and_lymphoid_tissue)	0.0102
16	78466437	78466437	C	G	WWOX	exonic	nonsynonymous SNV	ENSG00000186153	rs3764340	ENSG00000186153:ENST00000408984:exon8:c.C844G:p.P282A,ENSG00000186153:ENST00000566780:exon8:c.C844G:p.P282A	WWOX:NM_001291997:exon7:c.C505G:p.P169A,WWOX:NM_016373:exon8:c.C844G:p.P282A	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0743	0.0680	0.0916534	0.0736	1.496	13.29	0.066	5.93	0.286	.	.	NAD(P)-binding domain	WWOX:uc010vnk.2:exon7:c.C505G:p.P169A,WWOX:uc002ffk.3:exon8:c.C844G:p.P282A	-0.620	AFR:0.0969,AMR:0.0680,EAS:0.0784,FIN:0.0585,NFE:0.0630,OTH:0.0757,ASJ:0.0828	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	0.994	-2.05	0.067	1.17	16	MU12847069	het
16	79245687	79245687	C	T	WWOX	exonic	synonymous SNV	ENSG00000186153	rs199576434	ENSG00000186153:ENST00000402655:exon5:c.C592T:p.R198W	WWOX:NM_001291997:exon8:c.C900T:p.S300S,WWOX:NM_016373:exon9:c.C1239T:p.S413S	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0063	0.0052	0.00319489	0.0051	1.849	15.28	0.0	2.65	0.003	.	.	NAD(P)-binding domain	WWOX:uc010che.3:exon5:c.C592T:p.R198W	-1.056	AFR:0.0015,AMR:0.0060,EAS:0,FIN:0.0146,NFE:0.0055,OTH:0.0061,ASJ:0.0033	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	0.055	1.04	0.065	.	16	.	het
16	79619835	79619835	G	A	WWOX;MAF	intergenic	.	ENSG00000178573	rs60533944	ENSG00000178573:ENST00000569649:exon2:c.C1122T:p.Y374Y	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2483	.	0.268371	0.2042	.	.	.	.	.	.	.	.	.	.	AFR:0.1312,AMR:0.3612,EAS:0.4196,FIN:0.1787,NFE:0.2196,OTH:0.2035,ASJ:0.2583	177075	601088;610202;	91492;	91492|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|115650 115660 115665 115700 115800 115900 116100 116200 116300 116400 116600 116700 116800 212500 302200 600881 601202 601547 601885 604219 604307 605387 605728 605749 607304 609376 609741 610019 610202 610425 610623 611391 611544 611597 612968 613763 614422 614691 615188 615274 615277 616279 616509 616851 ~	.	.	.	.	.	.	.	.	16	MU4563391	het
16	79633806	79633808	GCC	-	MAF	UTR5	.	ENSG00000178573	rs5818251	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.7107	.	0.808706	0.7762	.	.	.	.	.	.	.	.	.	.	AFR:0.7969,AMR:0.7631,EAS:0.9253,FIN:0.8126,NFE:0.7421,OTH:0.7653,ASJ:0.7138	177075	601088;610202;	91492;	91492|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|115650 115660 115665 115700 115800 115900 116100 116200 116300 116400 116600 116700 116800 212500 302200 600881 601202 601547 601885 604219 604307 605387 605728 605749 607304 609376 609741 610019 610202 610425 610623 611391 611544 611597 612968 613763 614422 614691 615188 615274 615277 616279 616509 616851 ~	~ko04658 Th1 and Th2 cell differentiation~ko05202 Transcriptional misregulation in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	16	.	hom
16	81819768	81819768	T	C	PLCG2	exonic	synonymous SNV	ENSG00000197943	rs1143685	ENSG00000197943:ENST00000359376:exon2:c.T174C:p.A58A,ENSG00000197943:ENST00000565054:exon3:c.T174C:p.A58A	PLCG2:NM_002661:exon2:c.T174C:p.A58A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7248	0.6680	0.733227	0.6846	.	.	.	.	.	.	.	.	PLCG2:uc010chg.1:exon1:c.T174C:p.A58A,PLCG2:uc002fgt.3:exon2:c.T174C:p.A58A	.	AFR:0.6496,AMR:0.7566,EAS:0.8813,FIN:0.7388,NFE:0.6671,OTH:0.6898,ASJ:0.6589	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	,9076	.	.	.	.	16	MU21476980	het
16	81888152	81888152	A	G	PLCG2	exonic	synonymous SNV	ENSG00000197943	rs1143686	ENSG00000197943:ENST00000359376:exon3:c.A297G:p.L99L,ENSG00000197943:ENST00000565054:exon4:c.A297G:p.L99L	PLCG2:NM_002661:exon3:c.A297G:p.L99L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2752	0.2557	0.212061	0.2652	.	.	.	.	.	.	.	.	PLCG2:uc010chg.1:exon2:c.A297G:p.L99L,PLCG2:uc002fgt.3:exon3:c.A297G:p.L99L	.	AFR:0.1688,AMR:0.2859,EAS:0.0760,FIN:0.3166,NFE:0.3263,OTH:0.2847,ASJ:0.3179	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	,9076	.	.	.	.	16	MU12857569	het
16	81929488	81929488	C	T	PLCG2	exonic	synonymous SNV	ENSG00000197943	rs1143688	ENSG00000197943:ENST00000359376:exon13:c.C1149T:p.D383D	PLCG2:NM_002661:exon13:c.C1149T:p.D383D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4158	0.2885	0.40655	0.3500	.	.	.	.	.	.	.	.	PLCG2:uc010chg.1:exon12:c.C1149T:p.D383D,PLCG2:uc002fgt.3:exon13:c.C1149T:p.D383D	.	AFR:0.1426,AMR:0.6005,EAS:0.7348,FIN:0.4361,NFE:0.3913,OTH:0.4090,ASJ:0.3543	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	,9076	.	.	.	.	16	MU19853194	het
16	81941319	81941319	C	T	PLCG2	exonic	synonymous SNV	ENSG00000197943	rs1143689	ENSG00000197943:ENST00000359376:exon16:c.C1497T:p.A499A	PLCG2:NM_002661:exon16:c.C1497T:p.A499A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7837	0.7225	0.77496	0.7313	.	.	.	.	.	.	.	.	PLCG2:uc010chg.1:exon15:c.C1497T:p.A499A,PLCG2:uc002fgt.3:exon16:c.C1497T:p.A499A	.	AFR:0.6046,AMR:0.8708,EAS:0.9765,FIN:0.7461,NFE:0.7639,OTH:0.7699,ASJ:0.7748	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	,9076	.	.	.	.	16	MU22636505	hom
16	81953081	81953081	T	C	PLCG2	intronic	.	ENSG00000197943	rs12448130	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9969	0.9884	0.988618	0.9912	.	.	.	.	.	0	0	.	.	.	AFR:0.9698,AMR:0.9952,EAS:1,FIN:1,NFE:0.9997,OTH:1,ASJ:1	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	16	MU17469065	hom
16	81971403	81971403	T	C	PLCG2	exonic	synonymous SNV	ENSG00000197943	rs1071644	ENSG00000197943:ENST00000359376:exon28:c.T3093C:p.N1031N	PLCG2:NM_002661:exon28:c.T3093C:p.N1031N	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4487	0.4056	0.313898	0.4023	.	.	.	.	.	.	.	.	PLCG2:uc002fgt.3:exon28:c.T3093C:p.N1031N	.	AFR:0.1394,AMR:0.3002,EAS:0.3775,FIN:0.5126,NFE:0.5296,OTH:0.4867,ASJ:0.5497	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	,9076	.	.	.	.	16	MU760686	het
16	85945231	85945231	C	T	IRF8	exonic	synonymous SNV	ENSG00000140968	rs8052064	ENSG00000140968:ENST00000268638:exon4:c.C414T:p.C138C,ENSG00000140968:ENST00000564617:exon4:c.C414T:p.C138C,ENSG00000140968:ENST00000564803:exon4:c.C414T:p.C138C	IRF8:NM_001363907:exon4:c.C444T:p.C148C,IRF8:NM_002163:exon4:c.C414T:p.C138C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1236	0.1370	0.0874601	0.1461	.	.	.	.	.	.	.	.	IRF8:uc002fjh.3:exon4:c.C414T:p.C138C	.	AFR:0.1360,AMR:0.1158,EAS:0.0019,FIN:0.1959,NFE:0.1571,OTH:0.1673,ASJ:0.1093	601565	614893;614894;	319600;	319600|MSMD due to partial IRF8 deficiency<br>MSMD due to partial interferon regulatory factor 8 deficiency<br>Mendelian susceptibility to mycobacterial diseases due to partial interferon regulatory factor 8 deficiency|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614893 ~	.	.	.	.	.	.	.	.	16	MU113818449	het
16	85953846	85953847	TT	-	IRF8	intronic	.	ENSG00000140968	rs779733168	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0010	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601565	614893;614894;	319600;	319600|MSMD due to partial IRF8 deficiency<br>MSMD due to partial interferon regulatory factor 8 deficiency<br>Mendelian susceptibility to mycobacterial diseases due to partial interferon regulatory factor 8 deficiency|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614893 ~	.	.	.	.	.	.	.	.	16	.	het
16	88872145	88872145	T	C	CDT1	exonic	nonsynonymous SNV	ENSG00000167513	rs507329	ENSG00000167513:ENST00000301019:exon5:c.T700C:p.C234R	CDT1:NM_030928:exon5:c.T700C:p.C234R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9993	0.9995	0.9998	0.9996	-0.295	0.681	1.0	3.83	0.188	.	.	CDT1 Geminin-binding domain-like|Winged helix-turn-helix DNA-binding domain	CDT1:uc002flu.3:exon5:c.T700C:p.C234R	-0.972	AFR:0.9998,AMR:1,EAS:1,FIN:0.9997,NFE:0.9995,OTH:0.9990,ASJ:1	605525	613804;	2554;	2554|Meier-Gorlin syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Antenatal<br>Neonatal|224690 613800 613803 613804 613805 616835 617063 ~	.	.	.	.	0.001	1.7	0.000	-2.455	16	MU81982302	hom
16	88872511	88872511	T	C	CDT1	exonic	synonymous SNV	ENSG00000167513	rs510862	ENSG00000167513:ENST00000301019:exon6:c.T915C:p.H305H	CDT1:NM_030928:exon6:c.T915C:p.H305H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8183	0.8476	0.870208	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	CDT1:uc002flu.3:exon6:c.T915C:p.H305H	.	AFR:0.8308,AMR:0.9556,EAS:0.8510,FIN:0.9142,NFE:0.7572,OTH:0.7749,ASJ:0.7146	605525	613804;	2554;	2554|Meier-Gorlin syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Antenatal<br>Neonatal|224690 613800 613803 613804 613805 616835 617063 ~	.	.	.	.	.	.	.	.	16	1(thyroid)	0.7912
16	88964557	88964557	C	G	CBFA2T3	exonic	nonsynonymous SNV	ENSG00000129993	rs61734177	ENSG00000129993:ENST00000268679:exon3:c.G308C:p.R103P,ENSG00000129993:ENST00000562719:exon3:c.G125C:p.R42P,ENSG00000129993:ENST00000564416:exon3:c.G125C:p.R42P,ENSG00000129993:ENST00000569464:exon3:c.G125C:p.R42P	CBFA2T3:NM_005187:exon3:c.G308C:p.R103P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0648	0.0673	0.0289537	0.0676	3.077	22.5	0.197	3.32	0.369	.	.	.	CBFA2T3:uc002fmm.2:exon3:c.G308C:p.R103P,CBFA2T3:uc010cif.1:exon3:c.G125C:p.R42P	-1.125	AFR:0.0160,AMR:0.0274,EAS:0,FIN:0.0920,NFE:0.0996,OTH:0.0644,ASJ:0.1755	603870	.	.	.	.	.	.	.	0.811	0.89	0.003	1.355	16	.	het
16	89346444	89346444	C	T	ANKRD11	exonic	nonsynonymous SNV	ENSG00000167522	rs573380956	ENSG00000167522:ENST00000301030:exon9:c.G6506A:p.G2169E,ENSG00000167522:ENST00000378330:exon10:c.G6506A:p.G2169E	ANKRD11:NM_001256183:exon9:c.G6506A:p.G2169E,ANKRD11:NM_013275:exon9:c.G6506A:p.G2169E,ANKRD11:NM_001256182:exon10:c.G6506A:p.G2169E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	7.064e-05	.	0.000599042	.	3.661	23.2	0.051	4.47	0.007	.	.	.	ANKRD11:uc002fnb.1:exon6:c.G6377A:p.G2126E,ANKRD11:uc002fmx.2:exon9:c.G6506A:p.G2169E,ANKRD11:uc002fnc.2:exon9:c.G6506A:p.G2169E,ANKRD11:uc002fmy.2:exon10:c.G6506A:p.G2169E	-1.038	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	611192	148050;	2332;	2332|Short stature-facial and skeletal anomalies-intellectual disability-macrodontia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|148050 ~	.	.	.	.	0.02	1.19	0.101	1.905	16	.	het
16	89346774	89346774	G	T	ANKRD11	exonic	nonsynonymous SNV	ENSG00000167522	rs117997391	ENSG00000167522:ENST00000301030:exon9:c.C6176A:p.P2059H,ENSG00000167522:ENST00000378330:exon10:c.C6176A:p.P2059H	ANKRD11:NM_001256183:exon9:c.C6176A:p.P2059H,ANKRD11:NM_013275:exon9:c.C6176A:p.P2059H,ANKRD11:NM_001256182:exon10:c.C6176A:p.P2059H	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0547	0.0023	0.0910543	0.0256	4.131	23.8	0.0	5.29	0.041	.	.	.	ANKRD11:uc002fnb.1:exon6:c.C6047A:p.P2016H,ANKRD11:uc002fmx.2:exon9:c.C6176A:p.P2059H,ANKRD11:uc002fnc.2:exon9:c.C6176A:p.P2059H,ANKRD11:uc002fmy.2:exon10:c.C6176A:p.P2059H	-1.113	AFR:0.0033,AMR:0.0716,EAS:0.2621,FIN:0.0367,NFE:0.0077,OTH:0.0357,ASJ:0.0033	611192	148050;	2332;	2332|Short stature-facial and skeletal anomalies-intellectual disability-macrodontia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|148050 ~	.	.	.	.	0.988	0.79	0.000	2.455	16	MU80655048	hom
16	89348038	89348038	G	C	ANKRD11	exonic	nonsynonymous SNV	ENSG00000167522	rs113527563	ENSG00000167522:ENST00000301030:exon9:c.C4912G:p.P1638A,ENSG00000167522:ENST00000378330:exon10:c.C4912G:p.P1638A	ANKRD11:NM_001256183:exon9:c.C4912G:p.P1638A,ANKRD11:NM_013275:exon9:c.C4912G:p.P1638A,ANKRD11:NM_001256182:exon10:c.C4912G:p.P1638A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0569	0.0126	0.105232	0.0410	-2.030	0.001	0.079	1.89	0.001	.	.	.	ANKRD11:uc002fnb.1:exon6:c.C4783G:p.P1595A,ANKRD11:uc002fmx.2:exon9:c.C4912G:p.P1638A,ANKRD11:uc002fnc.2:exon9:c.C4912G:p.P1638A,ANKRD11:uc002fmy.2:exon10:c.C4912G:p.P1638A	-1.016	AFR:0.0429,AMR:0.0752,EAS:0.2766,FIN:0.0533,NFE:0.0099,OTH:0.0510,ASJ:0.0033	611192	148050;	2332;	2332|Short stature-facial and skeletal anomalies-intellectual disability-macrodontia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|148050 ~	.	.	.	.	0.001	1.29	0.000	1.59	16	MU583981	het
16	89805977	89805977	G	A	ZNF276	UTR3	.	ENSG00000158805	rs1061646	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4098	0.3475	0.538139	0.4091	.	.	.	.	.	.	.	.	.	.	AFR:0.5340,AMR:0.5680,EAS:0.7338,FIN:0.3808,NFE:0.3033,OTH:0.4002,ASJ:0.2367	608460	.	.	.	.	.	.	.	.	.	.	.	16	MU67342665	het
16	89831493	89831493	C	G	FANCA	intronic	.	ENSG00000187741	rs17233225	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0040	.	0.00878594	0.0001	.	.	.	.	.	.	.	.	.	.	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0031,ASJ:0	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	.	het
16	89836323	89836323	C	T	FANCA	exonic	nonsynonymous SNV	ENSG00000187741	rs7195066	ENSG00000187741:ENST00000567205:exon1:c.G110A:p.G37D,ENSG00000187741:ENST00000389301:exon26:c.G2426A:p.G809D,ENSG00000187741:ENST00000568369:exon26:c.G2426A:p.G809D	FANCA:NM_000135:exon26:c.G2426A:p.G809D,FANCA:NM_001286167:exon26:c.G2426A:p.G809D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.4690	0.4307	0.666733	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	0.068	3.273	0.528	-0.167	0.000	.	.	.	FANCA:uc002fou.1:exon26:c.G2426A:p.G809D,FANCA:uc010vpn.1:exon26:c.G2426A:p.G809D	-1.008	AFR:0.4758,AMR:0.6626,EAS:0.2583,FIN:0.9796,NFE:0.3961,OTH:0.3317,ASJ:0.5800	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	,4918	.	.	0.0	-1.85	0.000	-0.345	16	10(soft_tissue)	0.4488
16	89838078	89838078	A	G	FANCA	intronic	.	ENSG00000187741	rs1800340	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4315	0.3743	0.559904	0.4106	.	.	.	.	.	0	0	.	.	.	AFR:0.5094,AMR:0.5692,EAS:0.7345,FIN:0.3960,NFE:0.3151,OTH:0.4264,ASJ:0.2567	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	MU80655261	het
16	89845194	89845194	A	G	FANCA	intronic	.	ENSG00000187741	rs1800337	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5115	0.4882	0.682508	0.5225	.	.	.	.	.	.	.	.	.	.	AFR:0.6752,AMR:0.6005,EAS:0.9790,FIN:0.4579,NFE:0.4010,OTH:0.4959,ASJ:0.3079	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	MU81983268	het
16	89849480	89849480	C	T	FANCA	exonic	nonsynonymous SNV	ENSG00000187741	rs2239359	ENSG00000187741:ENST00000389301:exon16:c.G1501A:p.G501S,ENSG00000187741:ENST00000568369:exon16:c.G1501A:p.G501S	FANCA:NM_000135:exon16:c.G1501A:p.G501S,FANCA:NM_001286167:exon16:c.G1501A:p.G501S	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.4995	0.4823	0.624002	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	-0.709	0.069	1.0	-4.64	0.012	.	.	Fanconi anaemia group A protein, N-terminal domain	FANCA:uc002fou.1:exon16:c.G1501A:p.G501S,FANCA:uc010vpn.1:exon16:c.G1501A:p.G501S	-0.957	AFR:0.5222,AMR:0.6818,EAS:0.35,FIN:0.8375,NFE:0.5413,OTH:0.3945,ASJ:0.5742	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	,4918	.	.	0.0	-1.65	0.000	-1.245	16	1(kidney)	0.4764
16	89857964	89857964	T	C	FANCA	intronic	.	ENSG00000187741	rs1800330	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4370	0.3907	0.571885	0.4208	.	.	.	.	.	.	.	.	.	.	AFR:0.5416,AMR:0.5728,EAS:0.7447,FIN:0.3912,NFE:0.3170,OTH:0.4236,ASJ:0.2467	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	MU81983299	het
16	89866043	89866043	T	C	FANCA	exonic	nonsynonymous SNV	ENSG00000187741	rs7190823	ENSG00000187741:ENST00000565582:exon7:c.A626G:p.H209R,ENSG00000187741:ENST00000543736:exon8:c.A700G:p.T234A,ENSG00000187741:ENST00000389301:exon9:c.A796G:p.T266A,ENSG00000187741:ENST00000389302:exon9:c.A796G:p.T266A,ENSG00000187741:ENST00000534992:exon9:c.A796G:p.T266A,ENSG00000187741:ENST00000563673:exon9:c.A796G:p.T266A,ENSG00000187741:ENST00000568369:exon9:c.A796G:p.T266A	FANCA:NM_001351830:exon8:c.A700G:p.T234A,FANCA:NM_000135:exon9:c.A796G:p.T266A,FANCA:NM_001018112:exon9:c.A796G:p.T266A,FANCA:NM_001286167:exon9:c.A796G:p.T266A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.5166	0.5060	0.690495	0.5344	-1.498	0.003	1.0	1.85	0.024	.	.	Fanconi anaemia group A protein, N-terminal domain	FANCA:uc010ciu.1:exon8:c.A700G:p.T234A,FANCA:uc002fou.1:exon9:c.A796G:p.T266A,FANCA:uc002fow.1:exon9:c.A796G:p.T266A,FANCA:uc002fox.1:exon9:c.A796G:p.T266A,FANCA:uc010vpn.1:exon9:c.A796G:p.T266A	-1.001	AFR:0.7087,AMR:0.6062,EAS:0.9802,FIN:0.4539,NFE:0.4064,OTH:0.5020,ASJ:0.3079	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	,4918	.	.	0.0	1.19	0.000	-2.125	16	MU81983326	het
16	89869761	89869761	T	C	FANCA	intronic	.	ENSG00000187741	rs1800286	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7013	0.6958	0.842851	0.7226	.	.	.	.	.	0.0002	0.04	.	.	.	AFR:0.9146,AMR:0.7404,EAS:0.9852,FIN:0.6640,NFE:0.6020,OTH:0.6759,ASJ:0.5132	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	MU81983327	hom
16	90001525	90001525	C	T	TUBB3	exonic	synonymous SNV	ENSG00000198211;ENSG00000258947	rs61743676	ENSG00000258947:ENST00000304984:exon3:c.C450T:p.Y150Y,ENSG00000258947:ENST00000315491:exon4:c.C666T:p.Y222Y,ENSG00000258947:ENST00000554444:exon4:c.C450T:p.Y150Y,ENSG00000258947:ENST00000555810:exon4:c.C450T:p.Y150Y,ENSG00000198211:ENST00000556922:exon5:c.C1707T:p.Y569Y	TUBB3:NM_001197181:exon4:c.C450T:p.Y150Y,TUBB3:NM_006086:exon4:c.C666T:p.Y222Y	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0048	0.0002	0.0091853	PACA-CA|1|268|0.00373134,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	TUBB3:uc002fpk.1:exon2:c.C228T:p.Y76Y,TUBB3:uc002fpj.1:exon3:c.C450T:p.Y150Y,TUBB3:uc002fph.2:exon4:c.C666T:p.Y222Y,TUBB3:uc010ciz.1:exon4:c.C450T:p.Y150Y,TUBB3:uc002fpf.2:exon5:c.C1707T:p.Y569Y	.	AFR:0.0001,AMR:0.0002,EAS:0,FIN:0,NFE:0,OTH:6.68e-05,ASJ:0.0012	602661	600638;614039;	300570;45358;	300570|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614039 ~45358|FEOM|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Neonatal|135700 600638 602078 609384 609428 609612 ~	.	.	.	.	.	.	.	.	16	1(lung)	0
17	465775	465775	G	A	VPS53	exonic	synonymous SNV	ENSG00000141252	rs2075443	ENSG00000141252:ENST00000401468:exon7:c.C693T:p.Y231Y,ENSG00000141252:ENST00000291074:exon13:c.C1437T:p.Y479Y,ENSG00000141252:ENST00000389040:exon13:c.C1380T:p.Y460Y,ENSG00000141252:ENST00000437048:exon14:c.C1524T:p.Y508Y,ENSG00000141252:ENST00000571805:exon14:c.C1524T:p.Y508Y,ENSG00000141252:ENST00000446250:exon15:c.C930T:p.Y310Y	VPS53:NM_018289:exon13:c.C1437T:p.Y479Y,VPS53:NM_001128159:exon14:c.C1524T:p.Y508Y,VPS53:NM_001366253:exon14:c.C1524T:p.Y508Y,VPS53:NM_001366254:exon15:c.C930T:p.Y310Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2784	0.3342	0.348642	LUSC-KR|4|170|0.0235294,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	VPS53:uc010cjp.1:exon7:c.C693T:p.Y231Y,VPS53:uc002frk.3:exon9:c.C81T:p.Y27Y,VPS53:uc002frm.2:exon13:c.C1437T:p.Y479Y,VPS53:uc002frn.2:exon14:c.C1524T:p.Y508Y,VPS53:uc010cjo.2:exon14:c.C1524T:p.Y508Y,VPS53:uc002fro.2:exon15:c.C930T:p.Y310Y	.	AFR:0.3181,AMR:0.5503,EAS:0.1854,FIN:0.1925,NFE:0.1881,OTH:0.2281,ASJ:0.3947	615850	615851;	247198;	247198|PCCA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615851 ~	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.2741
17	600735	600735	A	G	VPS53	intronic	.	ENSG00000141252	rs4968100	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1863	0.1881	0.221046	0.1878	.	.	.	.	.	0.0540	0.334	.	.	.	AFR:0.2585,AMR:0.2410,EAS:0.1897,FIN:0.1490,NFE:0.1537,OTH:0.1914,ASJ:0.1159	615850	615851;	247198;	247198|PCCA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615851 ~	.	.	.	.	.	.	.	.	17	MU22359478	het
17	1782957	1782957	C	T	RPA1	exonic	synonymous SNV	ENSG00000132383	rs2230930	ENSG00000132383:ENST00000574049:exon3:c.C324T:p.S108S,ENSG00000132383:ENST00000254719:exon11:c.C1056T:p.S352S	RPA1:NM_001355120:exon11:c.C1017T:p.S339S,RPA1:NM_001355121:exon11:c.C1056T:p.S352S,RPA1:NM_002945:exon11:c.C1056T:p.S352S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2223	0.1628	0.270966	0.1960	.	.	.	.	.	.	.	.	RPA1:uc002fto.2:exon11:c.C1056T:p.S352S	.	AFR:0.1810,AMR:0.2990,EAS:0.4270,FIN:0.2394,NFE:0.1610,OTH:0.2337,ASJ:0.2152	179835	.	.	.	.	.	.	.	.	.	.	.	17	MU18319768	het
17	1795180	1795180	T	C	RPA1	exonic	synonymous SNV	ENSG00000132383	rs2230931	ENSG00000132383:ENST00000574049:exon6:c.T696C:p.S232S,ENSG00000132383:ENST00000254719:exon15:c.T1605C:p.S535S	RPA1:NM_001355121:exon14:c.T1428C:p.S476S,RPA1:NM_001355120:exon15:c.T1566C:p.S522S,RPA1:NM_002945:exon15:c.T1605C:p.S535S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2344	0.2384	0.29393	0.2507	.	.	.	.	.	.	.	.	RPA1:uc002fto.2:exon15:c.T1605C:p.S535S	.	AFR:0.3731,AMR:0.2955,EAS:0.2522,FIN:0.2208,NFE:0.1864,OTH:0.2240,ASJ:0.2185	179835	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	4455162	4455162	G	A	MYBBP1A	intronic	.	ENSG00000132382	rs76953250	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0304	0.0177	0.0321486	0.0287	.	.	.	.	.	.	.	.	.	.	AFR:0.0200,AMR:0.0239,EAS:0.0673,FIN:0.0524,NFE:0.0242,OTH:0.0255,ASJ:0.0430	604885	.	.	.	.	.	.	.	.	.	.	.	17	MU85520882	het
17	4455500	4455500	T	C	MYBBP1A	exonic	synonymous SNV	ENSG00000132382	rs7206974	ENSG00000132382:ENST00000254718:exon7:c.A825G:p.A275A,ENSG00000132382:ENST00000381556:exon7:c.A825G:p.A275A	MYBBP1A:NM_001105538:exon7:c.A825G:p.A275A,MYBBP1A:NM_014520:exon7:c.A825G:p.A275A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9977	0.9906	0.992812	0.9914	.	.	.	.	.	.	.	.	MYBBP1A:uc002fxz.4:exon7:c.A825G:p.A275A,MYBBP1A:uc002fyb.4:exon7:c.A825G:p.A275A	.	AFR:0.9704,AMR:1,EAS:1,FIN:1,NFE:0.9997,OTH:0.9969,ASJ:1	604885	.	.	.	.	.	.	.	.	.	.	.	17	MU4564618	hom
17	4457580	4457580	G	A	MYBBP1A	intronic	.	ENSG00000132382	rs2306270	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1425	0.0978	0.20028	1(stomach)	.	.	.	.	.	0.0001	0.044	.	.	.	AFR:MU584003,AMR:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,EAS:0.1205,FIN:0.1217,NFE:0.0960,OTH:0.4436,ASJ:0.1249	604885	.	.	.	.	.	.	.	.	.	.	.	17	3(haematopoietic_and_lymphoid_tissue)	0.1236
17	4458598	4458598	G	C	MYBBP1A	exonic	nonsynonymous SNV	ENSG00000132382	rs3809849	ENSG00000132382:ENST00000254718:exon1:c.C22G:p.Q8E,ENSG00000132382:ENST00000381556:exon1:c.C22G:p.Q8E	MYBBP1A:NM_001105538:exon1:c.C22G:p.Q8E,MYBBP1A:NM_014520:exon1:c.C22G:p.Q8E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2632	0.2147	0.211861	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053	-1.067	0.012	1.0	4.08	0.000	.	.	.	MYBBP1A:uc002fxz.4:exon1:c.C22G:p.Q8E,MYBBP1A:uc002fyb.4:exon1:c.C22G:p.Q8E	-0.970	AFR:0.2158,AMR:0.2383,EAS:0.1623,FIN:0.1512,NFE:0.2080,OTH:0.2163,ASJ:0.1730	604885	.	.	.	.	.	.	.	0.0	2.4	0.000	-1.495	17	1(haematopoietic_and_lymphoid_tissue)	0.1945
17	5033880	5033880	C	A	USP6	intronic	.	ENSG00000129204	rs376011303	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0040	.	0.00658946	0.0001	.	.	.	.	.	.	.	.	.	.	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0031,ASJ:0	604334	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	5042894	5042894	T	C	USP6	exonic	nonsynonymous SNV	ENSG00000129204	rs8073787	ENSG00000129204:ENST00000250066:exon14:c.T1423C:p.W475R,ENSG00000129204:ENST00000572949:exon14:c.T1423C:p.W475R,ENSG00000129204:ENST00000304328:exon15:c.T472C:p.W158R,ENSG00000129204:ENST00000332776:exon22:c.T1423C:p.W475R,ENSG00000129204:ENST00000574788:exon22:c.T1423C:p.W475R	USP6:NM_004505:exon14:c.T1423C:p.W475R,USP6:NM_001304284:exon22:c.T1423C:p.W475R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6492	0.6377	0.77496	MU9249277	-0.312	0.625	0.067	-0.532	0.000	.	.	.	USP6:uc002gav.1:exon14:c.T1423C:p.W475R,USP6:uc010ckz.1:exon15:c.T472C:p.W158R,USP6:uc002gau.1:exon22:c.T1423C:p.W475R	-1.065	AFR:COCA-CN|5|321|0.0155763,AMR:0.6723,EAS:0.5791,FIN:0.5662,NFE:0.8974,OTH:0.6812,ASJ:0.8215	604334	.	.	.	.	.	.	.	0.003	3.11	0.000	0.69	17	1(salivary_gland)	0.5679
17	5047985	5047985	C	T	USP6	exonic	nonsynonymous SNV	ENSG00000129204	rs567810284	ENSG00000129204:ENST00000250066:exon18:c.C1819T:p.R607W,ENSG00000129204:ENST00000572949:exon18:c.C1819T:p.R607W,ENSG00000129204:ENST00000304328:exon19:c.C868T:p.R290W,ENSG00000129204:ENST00000332776:exon26:c.C1819T:p.R607W,ENSG00000129204:ENST00000574788:exon26:c.C1819T:p.R607W	USP6:NM_004505:exon18:c.C1819T:p.R607W,USP6:NM_001304284:exon26:c.C1819T:p.R607W	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0001	.	0.000199681	.	1.880	15.47	0.538	1.22	0.984	0	0.078	Peptidase C19, ubiquitin carboxyl-terminal hydrolase|Ubiquitin specific protease domain	USP6:uc002gav.1:exon18:c.C1819T:p.R607W,USP6:uc010ckz.1:exon19:c.C868T:p.R290W,USP6:uc002gau.1:exon26:c.C1819T:p.R607W	-1.023	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	604334	.	.	.	.	.	.	.	0.004	1.46	0.028	-0.885	17	.	het
17	5487164	5487164	C	G	NLRP1	exonic	synonymous SNV	ENSG00000091592	rs884367	ENSG00000091592:ENST00000262467:exon1:c.G114C:p.S38S,ENSG00000091592:ENST00000345221:exon1:c.G114C:p.S38S,ENSG00000091592:ENST00000354411:exon1:c.G114C:p.S38S,ENSG00000091592:ENST00000544378:exon1:c.G114C:p.S38S,ENSG00000091592:ENST00000571451:exon1:c.G114C:p.S38S,ENSG00000091592:ENST00000572272:exon1:c.G114C:p.S38S,ENSG00000091592:ENST00000577119:exon1:c.G114C:p.S38S,ENSG00000091592:ENST00000269280:exon2:c.G114C:p.S38S	NLRP1:NM_001033053:exon1:c.G114C:p.S38S,NLRP1:NM_014922:exon1:c.G114C:p.S38S,NLRP1:NM_033004:exon1:c.G114C:p.S38S,NLRP1:NM_033006:exon1:c.G114C:p.S38S,NLRP1:NM_033007:exon1:c.G114C:p.S38S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3234	0.1299	0.283147	MU123380	.	.	.	.	.	.	.	.	NLRP1:uc002gcg.1:exon1:c.G114C:p.S38S,NLRP1:uc002gci.3:exon1:c.G114C:p.S38S,NLRP1:uc002gcj.3:exon1:c.G114C:p.S38S,NLRP1:uc002gck.3:exon1:c.G114C:p.S38S,NLRP1:uc002gcl.3:exon1:c.G114C:p.S38S,NLRP1:uc002gch.4:exon2:c.G114C:p.S38S,NLRP1:uc010clh.3:exon2:c.G114C:p.S38S	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.1752,EAS:0.2146,FIN:0.2583,NFE:0.6922,OTH:0.2467,ASJ:0.0423	606636	606579;615225;	352662;247871;	352662|-|<1 / 1 000 000|Autosomal dominant|All ages|615225 ~247871|-|-|-|Childhood<br>Adolescent<br>Adult|193200 606579 607836 608391 608392 609400 ~	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.1725
17	7154534	7154534	G	A	CTDNEP1	exonic	synonymous SNV	ENSG00000175826	rs414206	ENSG00000175826:ENST00000570380:exon1:c.C82T:p.L28L,ENSG00000175826:ENST00000574205:exon1:c.C82T:p.L28L,ENSG00000175826:ENST00000574322:exon1:c.C82T:p.L28L,ENSG00000175826:ENST00000318988:exon2:c.C82T:p.L28L,ENSG00000175826:ENST00000571409:exon2:c.C82T:p.L28L,ENSG00000175826:ENST00000573600:exon2:c.C82T:p.L28L,ENSG00000175826:ENST00000575783:exon2:c.C82T:p.L28L	CTDNEP1:NM_001143775:exon1:c.C82T:p.L28L,CTDNEP1:NM_015343:exon2:c.C82T:p.L28L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6607	0.6938	0.701078	0.6985	.	.	.	.	.	.	.	.	CTDNEP1:uc002gfd.2:exon1:c.C82T:p.L28L,CTDNEP1:uc002gfe.2:exon2:c.C82T:p.L28L	.	AFR:0.8422,AMR:0.6017,EAS:0.6611,FIN:0.6675,NFE:0.6355,OTH:0.6478,ASJ:0.6589	610684	.	.	.	.	.	.	.	.	.	.	.	17	MU18201074	het
17	7154582	7154582	T	C	CTDNEP1	exonic	nonsynonymous SNV	ENSG00000175826	rs3744399	ENSG00000175826:ENST00000570380:exon1:c.A34G:p.T12A,ENSG00000175826:ENST00000574205:exon1:c.A34G:p.T12A,ENSG00000175826:ENST00000574322:exon1:c.A34G:p.T12A,ENSG00000175826:ENST00000318988:exon2:c.A34G:p.T12A,ENSG00000175826:ENST00000571409:exon2:c.A34G:p.T12A,ENSG00000175826:ENST00000573600:exon2:c.A34G:p.T12A,ENSG00000175826:ENST00000575783:exon2:c.A34G:p.T12A	CTDNEP1:NM_001143775:exon1:c.A34G:p.T12A,CTDNEP1:NM_015343:exon2:c.A34G:p.T12A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1558	0.1084	0.109425	0.1040	0.345	6.120	1.0	4.88	1.000	.	.	.	CTDNEP1:uc002gfd.2:exon1:c.A34G:p.T12A,CTDNEP1:uc002gfe.2:exon2:c.A34G:p.T12A	-0.985	AFR:0.0293,AMR:0.2458,EAS:0.0833,FIN:0.0900,NFE:0.1422,OTH:0.1439,ASJ:0.1093	610684	.	.	.	.	.	.	.	0.0	2.63	0.000	0.35	17	MU36793	het
17	7579472	7579472	G	C	TP53	exonic	nonsynonymous SNV	ENSG00000141510	rs1042522	ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R	TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R	clinvar: drug_response 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.6600	0.6300	0.542931	2(thyroid)	-0.415	0.355	0.262	1.87	0.001	.	.	.	TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R	-0.929	AFR:38(large_intestine),AMR:5(penis),EAS:15(bone),FIN:1(small_intestine),NFE:18(meninges),OTH:10(skin),ASJ:3(pancreas)	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04071 Sphingolipid signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04137 Mitophagy - animal~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04216 Ferroptosis~ko04218 Cellular senescence~ko04310 Wnt signaling pathway~ko04722 Neurotrophin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05016 Huntington disease~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05418 Fluid shear stress and atherosclerosis ~	,10127,10039,10092,10138,10114,10036,10131,10038,10035,10106,10154,10042,10094,10128,10103,10180,10109,10139,10177,10175,10104,10107,10183,10096,10097,10108,10190,10193,10133,10144,10122,10123,10181,10182,10149,10166,10120,10134,10136,10119,10178,10142,10101,10176,10126,10152,10150,10172,10095,10112,10032,10124,10174,10087,10100,10089,10102,10091,10145,10125,10137,10043,10041,10140,10044,10088,10153,10189,10098,10143,10151,10099,10037,10179,10135,10040,10188,10132,10169,10115,10191,10192,10110,10105,10118,10141,10116,10117,10130,10162,10173,10121,10148,10164,10194,10093,10113	.	,10146,10168,10161,10160,10033,10167,10156,10155,10111,10157,10170,10147,10171,10165,10090,10158,10163,10129,10159	0.0	-5.23	0.000	1.355	17	1(pleura)	1(endometrium)
17	7788409	7788409	C	G	CHD3;NAA38	intronic	.	ENSG00000170004;ENSG00000183011	rs201772788	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	1	.	.	0.9997	.	.	.	.	.	0.0002	0.004	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9996,OTH:0.9984,ASJ:1	.	.	.	.	.	.	.	.	.	.	.	.	17	.	unknown
17	7811998	7811998	T	C	CHD3	intronic	.	ENSG00000170004	rs4239111	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8852	0.8802	0.944888	0.9012	.	.	.	.	.	.	.	.	.	.	AFR:0.9727,AMR:0.9105,EAS:0.9988,FIN:0.8931,NFE:0.8527,OTH:0.8918,ASJ:0.8212	602120	.	.	.	.	.	.	.	.	.	.	.	17	MU81987243	hom
17	8046772	8046772	C	G	PER1	exonic	nonsynonymous SNV	ENSG00000179094	rs2585405	ENSG00000179094:ENST00000581082:exon18:c.G2815C:p.A939P,ENSG00000179094:ENST00000317276:exon19:c.G2884C:p.A962P	PER1:NM_002616:exon19:c.G2884C:p.A962P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8544	0.8592	0.771765	MU650358	0.259	5.289	0.581	3.22	0.001	.	.	.	PER1:uc002gkd.3:exon19:c.G2884C:p.A962P	-1.042	AFR:COCA-CN|4|321|0.0124611,AMR:0.8581,EAS:0.8091,FIN:0.7848,NFE:0.5131,OTH:0.9364,ASJ:0.8049	602260	.	.	.	.	.	.	.	0.0	2.59	0.000	-1.665	17	1(bone)	0.9092
17	8048169	8048169	T	C	PER1	exonic	synonymous SNV	ENSG00000179094	rs2253820	ENSG00000179094:ENST00000583559:exon2:c.A210G:p.T70T,ENSG00000179094:ENST00000581082:exon17:c.A2301G:p.T767T,ENSG00000179094:ENST00000317276:exon18:c.A2361G:p.T787T,ENSG00000179094:ENST00000354903:exon18:c.A2313G:p.T771T,ENSG00000179094:ENST00000582719:exon18:c.A2361G:p.T787T	PER1:NM_002616:exon18:c.A2361G:p.T787T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7486	0.7404	0.570288	MU4550577	.	.	.	.	.	.	.	.	PER1:uc002gkd.3:exon18:c.A2361G:p.T787T,PER1:uc010vur.1:exon18:c.A2313G:p.T771T	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,AMR:0.7271,EAS:0.4582,FIN:0.6433,NFE:0.2971,OTH:0.8701,ASJ:0.5607	602260	.	.	.	.	.	.	.	.	.	.	.	17	2(lung)	0.8475
17	8048283	8048283	G	A	PER1	exonic	synonymous SNV	ENSG00000179094	rs2735611	ENSG00000179094:ENST00000583559:exon2:c.C96T:p.G32G,ENSG00000179094:ENST00000581082:exon17:c.C2187T:p.G729G,ENSG00000179094:ENST00000317276:exon18:c.C2247T:p.G749G,ENSG00000179094:ENST00000354903:exon18:c.C2199T:p.G733G,ENSG00000179094:ENST00000582719:exon18:c.C2247T:p.G749G	PER1:NM_002616:exon18:c.C2247T:p.G749G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7253	0.7423	0.570487	MU657495	.	.	.	.	.	.	.	.	PER1:uc002gkd.3:exon18:c.C2247T:p.G749G,PER1:uc010vur.1:exon18:c.C2199T:p.G733G	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,AMR:0.7275,EAS:0.4582,FIN:0.6467,NFE:0.2966,OTH:0.8698,ASJ:0.5619	602260	.	.	.	.	.	.	.	.	.	.	.	17	2(thyroid)	0.8477
17	8108331	8108331	A	G	AURKB	exonic	nonsynonymous SNV	ENSG00000178999	rs1059476	ENSG00000178999:ENST00000534871:exon8:c.T770C:p.M257T,ENSG00000178999:ENST00000578549:exon8:c.T797C:p.M266T,ENSG00000178999:ENST00000316199:exon9:c.T896C:p.M299T,ENSG00000178999:ENST00000585124:exon9:c.T893C:p.M298T	AURKB:NM_001313955:exon7:c.T389C:p.M130T,AURKB:NM_001256834:exon8:c.T770C:p.M257T,AURKB:NM_001313952:exon8:c.T773C:p.M258T,AURKB:NM_001284526:exon9:c.T896C:p.M299T,AURKB:NM_001313950:exon9:c.T893C:p.M298T,AURKB:NM_001313951:exon9:c.T770C:p.M257T,AURKB:NM_001313953:exon9:c.T797C:p.M266T,AURKB:NM_001313954:exon9:c.T437C:p.M146T,AURKB:NM_004217:exon9:c.T893C:p.M298T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8306	0.8219	0.736022	MU656579	-1.014	0.015	0.39	-1.93	0.312	.	.	Protein kinase domain|Protein kinase-like domain	AURKB:uc010cnu.3:exon7:c.T353C:p.M118T,AURKB:uc010vuu.3:exon8:c.T770C:p.M257T,AURKB:uc021tpy.1:exon8:c.T797C:p.M266T,AURKB:uc002gkm.4:exon9:c.T893C:p.M298T,AURKB:uc002gkn.4:exon9:c.T896C:p.M299T	-0.992	AFR:LAML-KR|4|205|0.0195122,COCA-CN|4|321|0.0124611,AMR:0.8160,EAS:0.7728,FIN:0.76,NFE:0.5252,OTH:0.9068,ASJ:0.6942	604970	.	.	.	.	.	.	.	0.0	-0.07	0.000	-0.44	17	33(lung)	0.8955
17	8108339	8108339	G	A	AURKB	exonic	synonymous SNV	ENSG00000178999	rs2241909	ENSG00000178999:ENST00000534871:exon8:c.C762T:p.S254S,ENSG00000178999:ENST00000578549:exon8:c.C789T:p.S263S,ENSG00000178999:ENST00000316199:exon9:c.C888T:p.S296S,ENSG00000178999:ENST00000585124:exon9:c.C885T:p.S295S	AURKB:NM_001313955:exon7:c.C381T:p.S127S,AURKB:NM_001256834:exon8:c.C762T:p.S254S,AURKB:NM_001313952:exon8:c.C765T:p.S255S,AURKB:NM_001284526:exon9:c.C888T:p.S296S,AURKB:NM_001313950:exon9:c.C885T:p.S295S,AURKB:NM_001313951:exon9:c.C762T:p.S254S,AURKB:NM_001313953:exon9:c.C789T:p.S263S,AURKB:NM_001313954:exon9:c.C429T:p.S143S,AURKB:NM_004217:exon9:c.C885T:p.S295S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6547	0.6183	0.620807	2(thyroid)	.	.	.	.	.	.	.	.	AURKB:uc010cnu.3:exon7:c.C345T:p.S115S,AURKB:uc010vuu.3:exon8:c.C762T:p.S254S,AURKB:uc021tpy.1:exon8:c.C789T:p.S263S,AURKB:uc002gkm.4:exon9:c.C885T:p.S295S,AURKB:uc002gkn.4:exon9:c.C888T:p.S296S	.	AFR:MU773382,AMR:LAML-KR|4|205|0.0195122,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.5578,FIN:0.6719,NFE:0.5403,OTH:0.4729,ASJ:0.6398	604970	.	.	.	.	.	.	.	.	.	.	.	17	1(breast)	0.7446
17	8387438	8387438	-	ATGA	MYH10	intronic	.	ENSG00000133026;ENSG00000166579	rs113838551	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9900	0.9616	0.971246	0.9685	.	.	.	.	.	.	.	.	.	.	AFR:0.8902,AMR:0.9940,EAS:1,FIN:1,NFE:0.9996,OTH:0.9918,ASJ:1	160776	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	8390733	8390733	A	G	MYH10	intronic	.	ENSG00000133026;ENSG00000166579	rs3826463	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5619	0.5012	0.496605	MU81987538	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.5070,EAS:0.6017,FIN:0.6887,NFE:0.5841,OTH:0.5613,ASJ:0.3239	160776	.	.	.	.	.	.	.	.	.	.	.	17	1(bone)	0.5782
17	8416901	8416901	C	T	MYH10	exonic	synonymous SNV	ENSG00000133026	rs11374	ENSG00000133026:ENST00000269243:exon21:c.G2607A:p.T869T,ENSG00000133026:ENST00000379980:exon22:c.G2655A:p.T885T,ENSG00000133026:ENST00000396239:exon22:c.G2670A:p.T890T,ENSG00000133026:ENST00000360416:exon23:c.G2700A:p.T900T	MYH10:NM_005964:exon21:c.G2607A:p.T869T,MYH10:NM_001256095:exon22:c.G2634A:p.T878T,MYH10:NM_001256012:exon23:c.G2700A:p.T900T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4031	0.3832	0.423323	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	MYH10:uc002gll.4:exon21:c.G2607A:p.T869T,MYH10:uc010cnx.4:exon22:c.G2634A:p.T878T,MYH10:uc002glm.4:exon23:c.G2700A:p.T900T	.	AFR:MU12983113,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,EAS:0.3787,FIN:0.3612,NFE:0.2933,OTH:0.4969,ASJ:0.4027	160776	.	.	.	.	.	.	.	.	.	.	.	17	1(prostate)	0.4441
17	8417007	8417007	T	-	MYH10	intronic	.	ENSG00000133026	rs66631876	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3986	.	.	0.4548	.	.	.	.	.	.	.	.	.	.	AFR:0.5514,AMR:0.4113,EAS:0.4899,FIN:0.4603,NFE:0.3992,OTH:0.4135,ASJ:0.3346	160776	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	8424270	8424270	G	A	MYH10	exonic	synonymous SNV	ENSG00000133026	rs8067456	ENSG00000133026:ENST00000269243:exon17:c.C2106T:p.N702N,ENSG00000133026:ENST00000379980:exon18:c.C2154T:p.N718N,ENSG00000133026:ENST00000396239:exon18:c.C2169T:p.N723N,ENSG00000133026:ENST00000360416:exon19:c.C2199T:p.N733N	MYH10:NM_005964:exon17:c.C2106T:p.N702N,MYH10:NM_001256095:exon18:c.C2133T:p.N711N,MYH10:NM_001256012:exon19:c.C2199T:p.N733N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9923	0.9700	0.979433	0.9765	.	.	.	.	.	.	.	.	MYH10:uc002gll.4:exon17:c.C2106T:p.N702N,MYH10:uc010cnx.4:exon18:c.C2133T:p.N711N,MYH10:uc002glm.4:exon19:c.C2199T:p.N733N	.	AFR:0.9179,AMR:0.9964,EAS:1,FIN:1,NFE:0.9997,OTH:0.9969,ASJ:1	160776	.	.	.	.	.	.	.	.	.	.	.	17	MU81987554	hom
17	8451745	8451745	A	-	MYH10	intronic	.	ENSG00000133026	rs398030289	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9907	.	0.97484	0.9711	.	.	.	.	.	.	.	.	.	.	AFR:0.8999,AMR:0.9952,EAS:1,FIN:0.9997,NFE:0.9994,OTH:0.9949,ASJ:1	160776	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	10415713	10415713	T	A	MYHAS	ncRNA_intronic	.	ENSG00000272736;ENSG00000272975	rs781014318	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0001	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	.	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	10415840	10415840	A	G	MYH1	exonic	synonymous SNV	ENSG00000109061	rs2007027	ENSG00000109061:ENST00000226207:exon12:c.T1032C:p.F344F	MYH1:NM_005963:exon12:c.T1032C:p.F344F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9288	0.8759	0.88139	0.8945	.	.	.	.	.	.	.	.	MYH1:uc002gmo.3:exon12:c.T1032C:p.F344F	.	AFR:0.7410,AMR:0.9436,EAS:0.9988,FIN:0.9805,NFE:0.9471,OTH:0.9318,ASJ:0.9040	160730	.	.	.	.	.	.	.	.	.	.	.	17	MU81988040	het
17	17122327	17122327	G	A	FLCN	intronic	.	ENSG00000154803;ENSG00000264187	rs8065832	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5023	0.4491	0.502995	0.4924	.	.	.	.	.	0	0.002	.	.	.	AFR:0.3692,AMR:0.5525,EAS:0.6512,FIN:0.6579,NFE:0.5025,OTH:0.5305,ASJ:0.4834	607273	114500;135150;144700;173600;	2903;422526;122;	2903|-|-|Autosomal dominant|-|173600 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~122|Fibrofolliculomas with trichodiscomas and acrochordons|1-9 / 1 000 000|Autosomal dominant|Adult|135150 ~	.	.	.	.	.	.	.	.	17	MU19893918	het
17	17948475	17948475	G	A	GID4	exonic	synonymous SNV	ENSG00000141034	rs2955355	ENSG00000141034:ENST00000268719:exon2:c.G453A:p.G151G,ENSG00000141034:ENST00000376345:exon2:c.G453A:p.G151G	GID4:NM_024052:exon2:c.G453A:p.G151G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5233	0.5973	0.366014	1(thyroid)	.	.	.	.	.	.	.	.	GID4:uc002gsg.1:exon2:c.G453A:p.G151G	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:1(lung),EAS:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,FIN:0.5574,NFE:0.4664,OTH:0.4199,ASJ:MU4563810	.	.	.	.	.	.	.	.	.	.	.	.	17	1(salivary_gland)	0.5728
17	18194242	18194242	C	T	TOP3A	exonic	nonsynonymous SNV	ENSG00000177302	rs61753153	ENSG00000177302:ENST00000542570:exon11:c.G1096A:p.A366T,ENSG00000177302:ENST00000321105:exon12:c.G1381A:p.A461T,ENSG00000177302:ENST00000580095:exon12:c.G1306A:p.A436T	TOP3A:NM_001320759:exon11:c.G1096A:p.A366T,TOP3A:NM_004618:exon12:c.G1381A:p.A461T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0] 	0.0047	0.0069	0.0119808	0.0067	6.431	29.8	0.025	3.71	0.798	.	.	DNA topoisomerase, type IA, DNA-binding domain|DNA topoisomerase, type IA, central|DNA topoisomerase, type IA, central region, subdomain 2|DNA topoisomerase, type IA, core domain	TOP3A:uc010vxs.1:exon11:c.G1075A:p.A359T,TOP3A:uc002gsx.1:exon12:c.G1381A:p.A461T	-0.864	AFR:0.0201,AMR:0.0072,EAS:0.0012,FIN:0,NFE:0.0012,OTH:0.0020,ASJ:0.0099	601243	.	.	.	.	.	.	.	0.987	1.92	0.087	3.05	17	.	unknown
17	18194248	18194248	C	T	TOP3A	exonic	nonsynonymous SNV	ENSG00000177302	rs28671051	ENSG00000177302:ENST00000542570:exon11:c.G1090A:p.D364N,ENSG00000177302:ENST00000321105:exon12:c.G1375A:p.D459N,ENSG00000177302:ENST00000580095:exon12:c.G1300A:p.D434N	TOP3A:NM_001320759:exon11:c.G1090A:p.D364N,TOP3A:NM_004618:exon12:c.G1375A:p.D459N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0219	0.0623	0.0642971	0.0522	3.925	23.5	0.068	3.71	0.882	.	.	DNA topoisomerase, type IA, DNA-binding domain|DNA topoisomerase, type IA, central|DNA topoisomerase, type IA, central region, subdomain 2|DNA topoisomerase, type IA, core domain	TOP3A:uc010vxs.1:exon11:c.G1069A:p.D357N,TOP3A:uc002gsx.1:exon12:c.G1375A:p.D459N	-1.065	AFR:0.1764,AMR:0.0179,EAS:0.0012,FIN:0,NFE:0.0030,OTH:0.0071,ASJ:0.0265	601243	.	.	.	.	.	.	.	0.154	1.94	0.000	2.495	17	MU67344441	unknown
17	18208544	18208544	G	A	TOP3A	intronic	.	ENSG00000177302	rs7207123	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3080	0.4114	0.320487	1(lung)	.	.	.	.	.	0	0	.	.	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU584069,EAS:0.3906,FIN:0.5994,NFE:0.2410,OTH:0.3841,ASJ:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BTCA-JP|1|239|0.0041841	601243	.	.	.	.	.	.	.	.	.	.	.	17	1(liver)	0.0760
17	20000131	20000131	G	T	SPECC1	intronic	.	ENSG00000128487	rs4925085	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4945	0.5249	0.413938	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.4808,AMR:0.4341,EAS:0.5828,FIN:0.1912,NFE:0.4702,OTH:0.5386,ASJ:0.4952	608793	.	.	.	.	.	.	.	.	.	.	.	17	1(lung)	0.4847
17	20107773	20107773	T	C	SPECC1	exonic	synonymous SNV	ENSG00000128487	rs2703805	ENSG00000128487:ENST00000395522:exon2:c.T168C:p.S56S,ENSG00000128487:ENST00000395525:exon2:c.T168C:p.S56S,ENSG00000128487:ENST00000395530:exon2:c.T168C:p.S56S,ENSG00000128487:ENST00000261503:exon4:c.T411C:p.S137S,ENSG00000128487:ENST00000395527:exon4:c.T411C:p.S137S,ENSG00000128487:ENST00000395529:exon4:c.T411C:p.S137S	SPECC1:NM_001033554:exon2:c.T168C:p.S56S,SPECC1:NM_001033555:exon2:c.T168C:p.S56S,SPECC1:NM_001243438:exon2:c.T168C:p.S56S,SPECC1:NM_001033553:exon4:c.T411C:p.S137S,SPECC1:NM_001243439:exon4:c.T411C:p.S137S,SPECC1:NM_152904:exon4:c.T411C:p.S137S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4782	0.3982	0.539936	LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	SPECC1:uc002gwt.3:exon2:c.T168C:p.S56S,SPECC1:uc002gwu.3:exon2:c.T168C:p.S56S,SPECC1:uc002gwv.3:exon2:c.T168C:p.S56S,SPECC1:uc002gwq.3:exon4:c.T411C:p.S137S,SPECC1:uc002gwr.3:exon4:c.T411C:p.S137S,SPECC1:uc002gws.3:exon4:c.T411C:p.S137S,SPECC1:uc010cqx.3:exon4:c.T411C:p.S137S	.	AFR:0.4545,AMR:0.4073,EAS:0.4305,FIN:0.8220,NFE:0.5049,OTH:0.4264,ASJ:0.4964	608793	.	.	.	.	.	.	.	.	.	.	.	17	2(urinary_tract)	0.4867
17	20108239	20108239	A	T	SPECC1	exonic	nonsynonymous SNV	ENSG00000128487	rs2703806	ENSG00000128487:ENST00000395522:exon2:c.A634T:p.M212L,ENSG00000128487:ENST00000395525:exon2:c.A634T:p.M212L,ENSG00000128487:ENST00000395530:exon2:c.A634T:p.M212L,ENSG00000128487:ENST00000261503:exon4:c.A877T:p.M293L,ENSG00000128487:ENST00000395527:exon4:c.A877T:p.M293L,ENSG00000128487:ENST00000395529:exon4:c.A877T:p.M293L	SPECC1:NM_001033554:exon2:c.A634T:p.M212L,SPECC1:NM_001033555:exon2:c.A634T:p.M212L,SPECC1:NM_001243438:exon2:c.A634T:p.M212L,SPECC1:NM_001033553:exon4:c.A877T:p.M293L,SPECC1:NM_001243439:exon4:c.A877T:p.M293L,SPECC1:NM_152904:exon4:c.A877T:p.M293L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6741	0.6898	0.819289	0.7198	-3.117	0.001	1.0	-10.8	0.053	.	.	.	SPECC1:uc002gwt.3:exon2:c.A634T:p.M212L,SPECC1:uc002gwu.3:exon2:c.A634T:p.M212L,SPECC1:uc002gwv.3:exon2:c.A634T:p.M212L,SPECC1:uc002gwq.3:exon4:c.A877T:p.M293L,SPECC1:uc002gwr.3:exon4:c.A877T:p.M293L,SPECC1:uc002gws.3:exon4:c.A877T:p.M293L,SPECC1:uc010cqx.3:exon4:c.A877T:p.M293L	-0.902	AFR:0.9190,AMR:0.6722,EAS:0.9914,FIN:0.6289,NFE:0.6068,OTH:0.6516,ASJ:0.5166	608793	.	.	.	.	.	.	.	0.0	0.16	0.000	-2.28	17	MU81989794	het
17	20109189	20109189	C	T	SPECC1	exonic	synonymous SNV	ENSG00000128487	rs2703807	ENSG00000128487:ENST00000584527:exon1:c.C81T:p.N27N,ENSG00000128487:ENST00000395522:exon2:c.C1584T:p.N528N,ENSG00000128487:ENST00000395525:exon2:c.C1584T:p.N528N,ENSG00000128487:ENST00000395530:exon2:c.C1584T:p.N528N,ENSG00000128487:ENST00000261503:exon4:c.C1827T:p.N609N,ENSG00000128487:ENST00000395527:exon4:c.C1827T:p.N609N,ENSG00000128487:ENST00000395529:exon4:c.C1827T:p.N609N	SPECC1:NM_001033554:exon2:c.C1584T:p.N528N,SPECC1:NM_001033555:exon2:c.C1584T:p.N528N,SPECC1:NM_001243438:exon2:c.C1584T:p.N528N,SPECC1:NM_001033553:exon4:c.C1827T:p.N609N,SPECC1:NM_001243439:exon4:c.C1827T:p.N609N,SPECC1:NM_152904:exon4:c.C1827T:p.N609N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4747	0.3805	0.522764	PACA-CA|1|268|0.00373134,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	SPECC1:uc002gwt.3:exon2:c.C1584T:p.N528N,SPECC1:uc002gwu.3:exon2:c.C1584T:p.N528N,SPECC1:uc002gwv.3:exon2:c.C1584T:p.N528N,SPECC1:uc002gwq.3:exon4:c.C1827T:p.N609N,SPECC1:uc002gwr.3:exon4:c.C1827T:p.N609N,SPECC1:uc002gws.3:exon4:c.C1827T:p.N609N,SPECC1:uc010cqx.3:exon4:c.C1827T:p.N609N	.	AFR:0.4403,AMR:0.3638,EAS:0.4305,FIN:0.8201,NFE:0.5006,OTH:0.4247,ASJ:0.4905	608793	.	.	.	.	.	.	.	.	.	.	.	17	2(haematopoietic_and_lymphoid_tissue)	0.4786
17	20163529	20163529	A	G	SPECC1	exonic	synonymous SNV	ENSG00000128487	rs2703791	ENSG00000128487:ENST00000536879:exon9:c.A882G:p.A294A,ENSG00000128487:ENST00000395530:exon10:c.A2619G:p.A873A,ENSG00000128487:ENST00000261503:exon12:c.A2862G:p.A954A,ENSG00000128487:ENST00000395527:exon12:c.A2862G:p.A954A	SPECC1:NM_001033555:exon10:c.A2619G:p.A873A,SPECC1:NM_001033553:exon12:c.A2862G:p.A954A,SPECC1:NM_001243439:exon12:c.A2862G:p.A954A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6741	0.6896	0.819289	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SPECC1:uc010vzf.2:exon9:c.A882G:p.A294A,SPECC1:uc002gwv.3:exon10:c.A2619G:p.A873A,SPECC1:uc002gwq.3:exon12:c.A2862G:p.A954A,SPECC1:uc002gws.3:exon12:c.A2862G:p.A954A	.	AFR:0.7198,AMR:0.9185,EAS:0.5166,FIN:0.9914,NFE:0.6289,OTH:0.6070,ASJ:0.6718	608793	.	.	.	.	.	.	.	.	.	.	.	17	1(breast)	0.6517
17	20216095	20216095	T	C	SPECC1	intronic	.	ENSG00000263494	rs11870147	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.819289	0.7198	.	.	.	.	.	.	.	.	.	.	AFR:0.9192,AMR:0.6706,EAS:0.9914,FIN:0.6285,NFE:0.6069,OTH:0.6496,ASJ:0.5166	608793	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	29508775	29508775	G	A	NF1	exonic	synonymous SNV	ENSG00000196712	rs1801052	ENSG00000196712:ENST00000356175:exon7:c.G702A:p.L234L,ENSG00000196712:ENST00000358273:exon7:c.G702A:p.L234L,ENSG00000196712:ENST00000431387:exon7:c.G702A:p.L234L,ENSG00000196712:ENST00000579081:exon7:c.G804A:p.L268L	NF1:NM_000267:exon7:c.G702A:p.L234L,NF1:NM_001042492:exon7:c.G702A:p.L234L,NF1:NM_001128147:exon7:c.G702A:p.L234L	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6228	0.5744	0.511781	3(large_intestine)	.	.	.	.	.	.	.	.	NF1:uc010csn.2:exon5:c.G282A:p.L94L,NF1:uc002hge.2:exon7:c.G702A:p.L234L,NF1:uc002hgf.2:exon7:c.G702A:p.L234L,NF1:uc002hgg.3:exon7:c.G702A:p.L234L,NF1:uc002hgh.3:exon7:c.G702A:p.L234L	.	AFR:MU120056,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,EAS:0.3000,FIN:0.5365,NFE:0.7285,OTH:0.5877,ASJ:0.5603	613113	162200;162210;193520;601321;607785;	86834;638;636;363700;636;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~638|NFNS<br>Neurofibromatosis type 1-Noonan syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|601321 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~363700|Von Recklinghausen disease due to NF1 mutation or intragenic deletion|-|-|-|162200 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~	.	,7733,7725,7711,7715,7735,7718,7737,7712,7713,7724,7714,7720,7732,7707,7734,7728,7721,7717,7709,7723,7710,7704,7706,7708,7736,7730,7731,7719,7716,7729,7727,7726,7705,7722	.	.	.	.	.	.	17	2(haematopoietic_and_lymphoid_tissue)	0.6524
17	29508819	29508819	-	T	NF1	intronic	.	ENSG00000196712	rs373999174	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3108	.	.	0.4967	.	.	.	.	.	.	.	.	.	.	AFR:0.1881,AMR:0.5038,EAS:0.5859,FIN:0.5072,NFE:0.6616,OTH:0.6062,ASJ:0.7246	613113	162200;162210;193520;601321;607785;	86834;638;636;363700;636;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~638|NFNS<br>Neurofibromatosis type 1-Noonan syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|601321 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~363700|Von Recklinghausen disease due to NF1 mutation or intragenic deletion|-|-|-|162200 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~	.	.	.	.	.	.	.	.	17	.	hom
17	29654876	29654876	T	A	NF1	intronic	.	ENSG00000196712	rs2285894	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5364	0.5162	0.431909	8(meninges)	.	.	.	.	.	.	.	.	.	.	AFR:1(lung),AMR:MU695061,EAS:0.4925,FIN:0.2920,NFE:0.4221,OTH:0.6788,ASJ:ESAD-UK|1|409|0.00244499,PACA-CA|1|268|0.00373134,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916	613113	162200;162210;193520;601321;607785;	86834;638;636;363700;636;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~638|NFNS<br>Neurofibromatosis type 1-Noonan syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|601321 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~363700|Von Recklinghausen disease due to NF1 mutation or intragenic deletion|-|-|-|162200 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~	.	.	.	.	.	.	.	.	17	1(pancreas)	0.3480
17	33307586	33307586	G	A	LIG3	UTR5	.	ENSG00000005156	rs12945428	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3654	.	0.306709	0.3954	.	.	.	.	.	.	.	.	.	.	AFR:0.1524,AMR:0.4349,EAS:0.2829,FIN:0.5753,NFE:0.4994,OTH:0.5,ASJ:0.32	600940	.	.	.	.	.	.	.	.	.	.	.	17	MU113836440	het
17	33433487	33433487	C	T	RAD51D	exonic	nonsynonymous SNV	ENSG00000185379;ENSG00000267618	rs4796033	ENSG00000267618:ENST00000593039:exon2:c.G17A:p.R6Q,ENSG00000185379:ENST00000335858:exon3:c.G158A:p.R53Q,ENSG00000185379:ENST00000587405:exon4:c.G137A:p.R46Q,ENSG00000185379:ENST00000588372:exon4:c.G137A:p.R46Q,ENSG00000185379:ENST00000360276:exon5:c.G359A:p.R120Q,ENSG00000185379:ENST00000460118:exon5:c.G137A:p.R46Q,ENSG00000267618:ENST00000592181:exon5:c.G137A:p.R46Q,ENSG00000185379:ENST00000345365:exon6:c.G494A:p.R165Q,ENSG00000185379:ENST00000590016:exon6:c.G554A:p.R185Q,ENSG00000185379:ENST00000592577:exon6:c.G500A:p.R167Q,ENSG00000185379:ENST00000394589:exon7:c.G494A:p.R165Q	RAD51D:NM_133629:exon3:c.G158A:p.R53Q,RAD51D:NM_001142571:exon6:c.G554A:p.R185Q,RAD51D:NM_002878:exon6:c.G494A:p.R165Q	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.1593	0.1068	0.0950479	0.1192	2.110	16.92	1.0	0.253	0.997	.	.	AAA+ ATPase domain|DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|P-loop containing nucleoside triphosphate hydrolase|Rad51/DMC1/RadA;DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|P-loop containing nucleoside triphosphate hydrolase	RAD51L3-RFFL:uc002hiq.2:exon2:c.G17A:p.R6Q,RAD51D:uc002his.2:exon3:c.G158A:p.R53Q,RAD51D:uc002hit.2:exon5:c.G137A:p.R46Q,RAD51D:uc010ctk.2:exon5:c.G137A:p.R46Q,RAD51D:uc002hir.2:exon6:c.G494A:p.R165Q,RAD51D:uc010wcd.1:exon6:c.G554A:p.R185Q,RAD51D:uc010wce.1:exon6:c.G137A:p.R46Q	-1.032	AFR:0.0296,AMR:0.2883,EAS:0.0420,FIN:0.1652,NFE:0.1548,OTH:0.1554,ASJ:0.2351	602954	614291;	145;	145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~	.	.	.	.	0.016	-0.18	0.000	-1.43	17	.	het
17	36861983	36861983	T	C	MLLT6	exonic	nonsynonymous SNV	ENSG00000108292	rs17855918	ENSG00000108292:ENST00000325718:exon1:c.T98C:p.V33A,ENSG00000108292:ENST00000378137:exon1:c.T98C:p.V33A	MLLT6:NM_005937:exon1:c.T98C:p.V33A	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	1	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MLLT6:uc002hqi.4:exon1:c.T98C:p.V33A,MLLT6:uc010cvm.1:exon1:c.T98C:p.V33A,MLLT6:uc010wdr.2:exon1:c.T98C:p.V33A	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600328	.	.	.	.	.	.	.	.	.	.	.	17	1(thyroid)	1
17	37868715	37868715	C	T	ERBB2	intronic	.	ENSG00000141736	rs4252627	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6058	0.5123	0.444489	3(lung)	.	.	.	.	.	.	.	.	.	.	AFR:20(soft_tissue),AMR:MU584146,EAS:0.5113,FIN:0.2147,NFE:0.5573,OTH:0.6358,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LUSC-KR|4|170|0.0235294,COCA-CN|5|321|0.0155763	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	17	1(liver)	0.3486
17	37884037	37884037	C	G	ERBB2	exonic	nonsynonymous SNV	ENSG00000141736	rs1058808	ENSG00000141736:ENST00000445658:exon21:c.C2680G:p.P894A,ENSG00000141736:ENST00000269571:exon27:c.C3508G:p.P1170A,ENSG00000141736:ENST00000540147:exon27:c.C3418G:p.P1140A,ENSG00000141736:ENST00000541774:exon27:c.C3463G:p.P1155A,ENSG00000141736:ENST00000406381:exon29:c.C3418G:p.P1140A,ENSG00000141736:ENST00000584601:exon31:c.C3418G:p.P1140A	ERBB2:NM_004448:exon27:c.C3508G:p.P1170A,ERBB2:NM_001005862:exon30:c.C3418G:p.P1140A,ERBB2:NM_001289936:exon31:c.C3463G:p.P1155A	clinvar: not_provided 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.6070	0.5135	0.452077	2(oesophagus)	4.041	23.7	0.03	5.04	0.999	.	.	.	ERBB2:uc010wek.2:exon21:c.C2680G:p.P894A,ERBB2:uc002hso.3:exon27:c.C3508G:p.P1170A,ERBB2:uc002hsp.3:exon27:c.C2917G:p.P973A,ERBB2:uc002hsm.3:exon30:c.C3418G:p.P1140A,ERBB2:uc010cwa.3:exon31:c.C3463G:p.P1155A	-0.881	AFR:MU774596,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BTCA-JP|1|239|0.0041841,ESCA-CN|2|332|0.0060241,EAS:0.2211,FIN:0.5589,NFE:0.6358,OTH:0.3504,ASJ:0.5139	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	4459,,4495,4407,4413,4494,4490,4424,4489,4414,4469,4509,4404,4433,4422,4445,4487,4408,4441,4510,4378,4471,4455,4460,4382,4500,4443,4419,4462,4394,4451,4493,4402,4415,4403,4501,4438,4463,4416,4420,4396,4481,4452,4432,4392,4479,4504,4503,4453,4389,4461,4393,4467,4499,4411,4477,4476,4478,4385,4388,4387,4444,4480,4464,4435,4454,4512,4439,4400,4434,4418,4431,4417,4436,4401,4380,4485,4406,4473,4492,4470,4458,4399,4384,4483,4421,4513,4446,4472,4442,4474,4502,4405,4423,4428,4383,4484,4486,4475,4386,4426,4482,4381,4457,4397,4437,4468,4410,4430,4409,4466,4440,4429,4448,4496,4412,4425,4395,4398,4447,4450,4511,4391,4456,4488,4497,4427,4390,4491,4449,4465,4377,4498,4379	.	.	0.941	-0.81	0.000	0.695	17	1(biliary_tract)	0.6785
17	38556770	38556770	T	C	TOP2A	intronic	.	ENSG00000131747	rs471692	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7958	0.8615	0.812899	0.8623	.	.	.	.	.	.	.	.	.	.	AFR:0.9581,AMR:0.6770,EAS:0.7426,FIN:0.8749,NFE:0.8294,OTH:0.8330,ASJ:0.8344	126430	.	.	.	.	.	.	.	.	.	.	.	17	MU19923769	hom
17	39912095	39912095	C	T	JUP	exonic	synonymous SNV	ENSG00000173801	rs782165431	ENSG00000173801:ENST00000310706:exon14:c.G2139A:p.P713P,ENSG00000173801:ENST00000393930:exon14:c.G2139A:p.P713P,ENSG00000173801:ENST00000393931:exon14:c.G2139A:p.P713P	JUP:NM_001352773:exon14:c.G2139A:p.P713P,JUP:NM_001352774:exon14:c.G2139A:p.P713P,JUP:NM_001352775:exon14:c.G2139A:p.P713P,JUP:NM_001352777:exon14:c.G2139A:p.P713P,JUP:NM_002230:exon14:c.G2139A:p.P713P,JUP:NM_021991:exon14:c.G2139A:p.P713P,JUP:NM_001352776:exon15:c.G2139A:p.P713P	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, 0, 1, 0] 	4.177e-05	.	.	3.234e-05	.	.	.	.	.	.	.	.	JUP:uc002hxq.2:exon14:c.G2139A:p.P713P,JUP:uc002hxr.2:exon14:c.G2139A:p.P713P,JUP:uc002hxs.2:exon14:c.G2139A:p.P713P	.	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	173325	601214;611528;	217656;34217;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~34217|KWWH type I<br>Keratoderma with woolly hair type I<br>Keratosis palmoplantaris with arrythmogenic cardiomyopathy<br>Palmoplantar hyperkeratosis with arrythmogenic cardiomyopathy<br>Palmoplantar keratoderma with arrythmogenic cardiomyopathy|-|Autosomal recessive|Infancy<br>Neonatal|601214 ~	~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	.	.	.	.	17	.	het
17	39912145	39912145	T	A	JUP	exonic	nonsynonymous SNV	ENSG00000173801	rs1126821	ENSG00000173801:ENST00000310706:exon14:c.A2089T:p.M697L,ENSG00000173801:ENST00000393930:exon14:c.A2089T:p.M697L,ENSG00000173801:ENST00000393931:exon14:c.A2089T:p.M697L	JUP:NM_001352773:exon14:c.A2089T:p.M697L,JUP:NM_001352774:exon14:c.A2089T:p.M697L,JUP:NM_001352775:exon14:c.A2089T:p.M697L,JUP:NM_001352777:exon14:c.A2089T:p.M697L,JUP:NM_002230:exon14:c.A2089T:p.M697L,JUP:NM_021991:exon14:c.A2089T:p.M697L,JUP:NM_001352776:exon15:c.A2089T:p.M697L	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6592	0.6970	0.58726	LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579	1.242	11.97	0.706	1.12	0.998	.	.	.	JUP:uc002hxq.2:exon14:c.A2089T:p.M697L,JUP:uc002hxr.2:exon14:c.A2089T:p.M697L,JUP:uc002hxs.2:exon14:c.A2089T:p.M697L	-0.959	AFR:0.6634,AMR:0.6017,EAS:0.6821,FIN:0.3202,NFE:0.6645,OTH:0.7421,ASJ:0.4880	173325	601214;611528;	217656;34217;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~34217|KWWH type I<br>Keratoderma with woolly hair type I<br>Keratosis palmoplantaris with arrythmogenic cardiomyopathy<br>Palmoplantar hyperkeratosis with arrythmogenic cardiomyopathy<br>Palmoplantar keratoderma with arrythmogenic cardiomyopathy|-|Autosomal recessive|Infancy<br>Neonatal|601214 ~	~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	0.0	0.31	0.000	-0.625	17	4(lung)	0.7119
17	39923614	39923614	A	G	JUP	intronic	.	ENSG00000173801	rs12942034	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7638	0.8343	0.744209	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.8105,AMR:0.8903,EAS:0.8033,FIN:0.4975,NFE:0.7995,OTH:0.8146,ASJ:0.5704	173325	601214;611528;	217656;34217;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~34217|KWWH type I<br>Keratoderma with woolly hair type I<br>Keratosis palmoplantaris with arrythmogenic cardiomyopathy<br>Palmoplantar hyperkeratosis with arrythmogenic cardiomyopathy<br>Palmoplantar keratoderma with arrythmogenic cardiomyopathy|-|Autosomal recessive|Infancy<br>Neonatal|601214 ~	~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	.	.	.	.	17	1(lung)	0.7980
17	39925925	39925925	A	G	JUP	exonic	synonymous SNV	ENSG00000173801	rs7405731	ENSG00000173801:ENST00000540235:exon2:c.T213C:p.D71D,ENSG00000173801:ENST00000310706:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000393930:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000393931:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000420370:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000437187:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000449889:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000591690:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000424457:exon4:c.T213C:p.D71D,ENSG00000173801:ENST00000437369:exon4:c.T213C:p.D71D	JUP:NM_001352773:exon3:c.T213C:p.D71D,JUP:NM_001352774:exon3:c.T213C:p.D71D,JUP:NM_001352775:exon3:c.T213C:p.D71D,JUP:NM_001352777:exon3:c.T213C:p.D71D,JUP:NM_002230:exon3:c.T213C:p.D71D,JUP:NM_021991:exon3:c.T213C:p.D71D,JUP:NM_001352776:exon4:c.T213C:p.D71D	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7364	0.7956	0.715655	1(breast)	.	.	.	.	.	.	.	.	JUP:uc010wfs.2:exon2:c.T213C:p.D71D,JUP:uc002hxq.2:exon3:c.T213C:p.D71D,JUP:uc002hxr.2:exon3:c.T213C:p.D71D,JUP:uc002hxs.2:exon3:c.T213C:p.D71D	.	AFR:MU23590898,AMR:LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,EAS:0.8828,FIN:0.5632,NFE:0.8278,OTH:0.5056,ASJ:0.7654	173325	601214;611528;	217656;34217;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~34217|KWWH type I<br>Keratoderma with woolly hair type I<br>Keratosis palmoplantaris with arrythmogenic cardiomyopathy<br>Palmoplantar hyperkeratosis with arrythmogenic cardiomyopathy<br>Palmoplantar keratoderma with arrythmogenic cardiomyopathy|-|Autosomal recessive|Infancy<br>Neonatal|601214 ~	~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	.	.	.	.	17	2(lung)	0.6822
17	40475650	40475650	-	A	STAT3	intronic	.	ENSG00000168610	rs3830585	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.2617	0.3545	0.401957	0.3398	.	.	.	.	.	.	.	.	.	.	AFR:0.6827,AMR:0.1504,EAS:0.3482,FIN:0.1925,NFE:0.1918,OTH:0.2439,ASJ:0.2649	102582	147060;615952;	438159;2314;	438159|-|-|Autosomal dominant|-|615952 ~2314|AD-HIES<br>Autosomal dominant HIES<br>Autosomal dominant hyperimmunoglobulin E syndrome<br>Buckley syndrome<br>Hyperimmunoglobulin E syndrome type 1<br>Hyperimmunoglobulin E-recurrent infection syndrome<br>Job syndrome<br>STAT3 deficiency|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|147060 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04931 Insulin resistance~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05145 Toxoplasmosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	17	.	het
17	40481529	40481529	G	C	STAT3	intronic	.	ENSG00000168610	rs2293152	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6025	0.6879	0.653754	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.6533,AMR:0.8458,EAS:0.5596,FIN:0.5218,NFE:0.5835,OTH:0.5875,ASJ:0.4462	102582	147060;615952;	438159;2314;	438159|-|-|Autosomal dominant|-|615952 ~2314|AD-HIES<br>Autosomal dominant HIES<br>Autosomal dominant hyperimmunoglobulin E syndrome<br>Buckley syndrome<br>Hyperimmunoglobulin E syndrome type 1<br>Hyperimmunoglobulin E-recurrent infection syndrome<br>Job syndrome<br>STAT3 deficiency|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|147060 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04931 Insulin resistance~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05145 Toxoplasmosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	17	1(breast)	0.6166
17	40835819	40835819	-	T	CNTNAP1	intronic	.	ENSG00000267765	rs36108420	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5941	0.5652	0.547324	0.5643	.	.	.	.	.	.	.	.	.	.	AFR:0.5075,AMR:0.5144,EAS:0.4491,FIN:0.6350,NFE:0.5958,OTH:0.6160,ASJ:0.4172	602346	616286;	2680;	2680|Boylan-Dew syndrome|-|-|-|616286 616287 ~	.	.	.	.	.	.	.	.	17	MU113836025	het
17	40835922	40835922	A	C	CNTNAP1	exonic	synonymous SNV	ENSG00000108797	rs2271029	ENSG00000108797:ENST00000264638:exon2:c.A151C:p.R51R,ENSG00000108797:ENST00000591662:exon2:c.A151C:p.R51R	CNTNAP1:NM_003632:exon2:c.A151C:p.R51R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5981	0.5985	0.578275	1(large_intestine)	.	.	.	.	.	.	.	.	CNTNAP1:uc002iay.3:exon2:c.A151C:p.R51R	.	AFR:MU78204,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,EAS:0.5912,FIN:0.5180,NFE:0.4305,OTH:0.4522,ASJ:0.5899	602346	616286;	2680;	2680|Boylan-Dew syndrome|-|-|-|616286 616287 ~	.	.	.	.	.	.	.	.	17	1(liver)	0.6354
17	41223094	41223094	T	C	BRCA1	exonic	nonsynonymous SNV	ENSG00000012048	rs1799966	ENSG00000012048:ENST00000591534:exon3:c.A310G:p.S104G,ENSG00000012048:ENST00000484087:exon9:c.A1150G:p.S384G,ENSG00000012048:ENST00000351666:exon11:c.A1288G:p.S430G,ENSG00000012048:ENST00000309486:exon14:c.A3949G:p.S1317G,ENSG00000012048:ENST00000352993:exon14:c.A1411G:p.S471G,ENSG00000012048:ENST00000493795:exon14:c.A4696G:p.S1566G,ENSG00000012048:ENST00000493919:exon14:c.A1387G:p.S463G,ENSG00000012048:ENST00000357654:exon15:c.A4837G:p.S1613G,ENSG00000012048:ENST00000468300:exon15:c.A1525G:p.S509G,ENSG00000012048:ENST00000478531:exon15:c.A1525G:p.S509G,ENSG00000012048:ENST00000491747:exon15:c.A1525G:p.S509G,ENSG00000012048:ENST00000471181:exon16:c.A4900G:p.S1634G	BRCA1:NM_007297:exon14:c.A4696G:p.S1566G,BRCA1:NM_007298:exon14:c.A1525G:p.S509G,BRCA1:NM_007294:exon15:c.A4837G:p.S1613G,BRCA1:NM_007299:exon15:c.A1525G:p.S509G,BRCA1:NM_007300:exon16:c.A4900G:p.S1634G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.3496	0.2982	0.355831	1(urinary_tract)	-0.337	0.547	0.032	1.5	0.030	.	.	BRCA1, serine-rich domain;BRCT domain	BRCA1:uc010whn.2:exon3:c.A310G:p.S104G,BRCA1:uc010whq.1:exon9:c.A1024G:p.S342G,BRCA1:uc010cyx.3:exon14:c.A4696G:p.S1566G,BRCA1:uc010whl.2:exon14:c.A1525G:p.S509G,BRCA1:uc010whp.2:exon14:c.A1384G:p.S462G,BRCA1:uc010whr.1:exon14:c.A1387G:p.S463G,BRCA1:uc002icp.4:exon15:c.A4624G:p.S1542G,BRCA1:uc002icq.3:exon15:c.A4837G:p.S1613G,BRCA1:uc002icu.3:exon15:c.A1525G:p.S509G,BRCA1:uc002idc.1:exon15:c.A1525G:p.S509G,BRCA1:uc002ict.3:exon16:c.A4900G:p.S1634G	-1.080	AFR:3(haematopoietic_and_lymphoid_tissue),AMR:1(breast),EAS:9(meninges),FIN:MU153243,NFE:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,PRAD-CN|1|65|0.0153846,OTH:0.3179,ASJ:1(thymus)	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1781,1786,1773,1791,1792,1776,1785,1779,1778,1789,1788,1772,1797,1796,1798,1799,1780,1787,1790,1782,1793,1784,1783,1795,1777,1794	.	,1774,1775	0.002	-1.93	0.000	1.845	17	2(large_intestine)	0.2330
17	41234470	41234470	A	G	BRCA1	exonic	synonymous SNV	ENSG00000012048	rs1060915	ENSG00000012048:ENST00000484087:exon6:c.T621C:p.S207S,ENSG00000012048:ENST00000487825:exon6:c.T624C:p.S208S,ENSG00000012048:ENST00000351666:exon8:c.T759C:p.S253S,ENSG00000012048:ENST00000309486:exon11:c.T3420C:p.S1140S,ENSG00000012048:ENST00000352993:exon11:c.T882C:p.S294S,ENSG00000012048:ENST00000493795:exon11:c.T4167C:p.S1389S,ENSG00000012048:ENST00000493919:exon11:c.T858C:p.S286S,ENSG00000012048:ENST00000346315:exon12:c.T4308C:p.S1436S,ENSG00000012048:ENST00000354071:exon12:c.T4308C:p.S1436S,ENSG00000012048:ENST00000357654:exon12:c.T4308C:p.S1436S,ENSG00000012048:ENST00000468300:exon12:c.T999C:p.S333S,ENSG00000012048:ENST00000471181:exon12:c.T4308C:p.S1436S,ENSG00000012048:ENST00000478531:exon12:c.T996C:p.S332S,ENSG00000012048:ENST00000491747:exon12:c.T999C:p.S333S	BRCA1:NM_007297:exon11:c.T4167C:p.S1389S,BRCA1:NM_007298:exon11:c.T999C:p.S333S,BRCA1:NM_007294:exon12:c.T4308C:p.S1436S,BRCA1:NM_007299:exon12:c.T999C:p.S333S,BRCA1:NM_007300:exon12:c.T4308C:p.S1436S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3431	0.2796	0.336262	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	BRCA1:uc010whq.1:exon6:c.T495C:p.S165S,BRCA1:uc010cyx.3:exon11:c.T4167C:p.S1389S,BRCA1:uc010whl.2:exon11:c.T999C:p.S333S,BRCA1:uc010whp.2:exon11:c.T858C:p.S286S,BRCA1:uc010whr.1:exon11:c.T858C:p.S286S,BRCA1:uc002icp.4:exon12:c.T4095C:p.S1365S,BRCA1:uc002icq.3:exon12:c.T4308C:p.S1436S,BRCA1:uc002ict.3:exon12:c.T4308C:p.S1436S,BRCA1:uc002icu.3:exon12:c.T999C:p.S333S,BRCA1:uc002idc.1:exon12:c.T996C:p.S332S	.	AFR:9(meninges),AMR:MU12924798,EAS:0.3011,FIN:0.1748,NFE:0.3210,OTH:0.3179,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1781,1786,1773,1791,1792,1776,1785,1779,1778,1789,1788,1772,1797,1796,1798,1799,1780,1787,1790,1782,1793,1784,1783,1795,1777,1794	.	,1774,1775	.	.	.	.	17	1(liver)	0.3675
17	41244000	41244000	T	C	BRCA1	exonic	nonsynonymous SNV	ENSG00000012048	rs16942	ENSG00000012048:ENST00000309486:exon9:c.A2660G:p.K887R,ENSG00000012048:ENST00000493795:exon9:c.A3407G:p.K1136R,ENSG00000012048:ENST00000346315:exon10:c.A3548G:p.K1183R,ENSG00000012048:ENST00000354071:exon10:c.A3548G:p.K1183R,ENSG00000012048:ENST00000357654:exon10:c.A3548G:p.K1183R,ENSG00000012048:ENST00000471181:exon10:c.A3548G:p.K1183R	BRCA1:NM_007297:exon9:c.A3407G:p.K1136R,BRCA1:NM_007294:exon10:c.A3548G:p.K1183R,BRCA1:NM_007300:exon10:c.A3548G:p.K1183R	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.3490	0.2952	0.352636	1(ovary)	-2.334	0.001	1.0	-2.35	0.005	.	.	.	BRCA1:uc010wht.1:exon2:c.A2660G:p.K887R,BRCA1:uc002ide.1:exon4:c.A3041G:p.K1014R,BRCA1:uc002idd.3:exon9:c.A3548G:p.K1183R,BRCA1:uc010cyx.3:exon9:c.A3407G:p.K1136R,BRCA1:uc010cza.2:exon9:c.A3470G:p.K1157R,BRCA1:uc002icp.4:exon10:c.A3335G:p.K1112R,BRCA1:uc002icq.3:exon10:c.A3548G:p.K1183R,BRCA1:uc002ict.3:exon10:c.A3548G:p.K1183R,BRCA1:uc010cyy.1:exon10:c.A3548G:p.K1183R,BRCA1:uc010whs.1:exon10:c.A3548G:p.K1183R,BRCA1:uc010cyz.2:exon11:c.A3407G:p.K1136R	-1.024	AFR:1(stomach),AMR:2(prostate),EAS:14(soft_tissue),FIN:40(lung),NFE:1(thyroid),OTH:MU153252,ASJ:4(large_intestine)	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1781,1786,1773,1791,1792,1776,1785,1779,1778,1789,1788,1772,1797,1796,1798,1799,1780,1787,1790,1782,1793,1784,1783,1795,1777,1794	.	,1774,1775	0.0	-0.35	0.000	-0.485	17	1(breast)	LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579
17	41244435	41244435	T	C	BRCA1	exonic	nonsynonymous SNV	ENSG00000012048	rs16941	ENSG00000012048:ENST00000309486:exon9:c.A2225G:p.E742G,ENSG00000012048:ENST00000493795:exon9:c.A2972G:p.E991G,ENSG00000012048:ENST00000346315:exon10:c.A3113G:p.E1038G,ENSG00000012048:ENST00000354071:exon10:c.A3113G:p.E1038G,ENSG00000012048:ENST00000357654:exon10:c.A3113G:p.E1038G,ENSG00000012048:ENST00000471181:exon10:c.A3113G:p.E1038G	BRCA1:NM_007297:exon9:c.A2972G:p.E991G,BRCA1:NM_007294:exon10:c.A3113G:p.E1038G,BRCA1:NM_007300:exon10:c.A3113G:p.E1038G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.3429	0.2790	0.335663	3(haematopoietic_and_lymphoid_tissue)	2.989	22.2	0.028	-0.974	0.952	.	.	.	BRCA1:uc010wht.1:exon2:c.A2225G:p.E742G,BRCA1:uc002ide.1:exon4:c.A2606G:p.E869G,BRCA1:uc002idd.3:exon9:c.A3113G:p.E1038G,BRCA1:uc010cyx.3:exon9:c.A2972G:p.E991G,BRCA1:uc010cza.2:exon9:c.A3035G:p.E1012G,BRCA1:uc002icp.4:exon10:c.A2900G:p.E967G,BRCA1:uc002icq.3:exon10:c.A3113G:p.E1038G,BRCA1:uc002ict.3:exon10:c.A3113G:p.E1038G,BRCA1:uc010cyy.1:exon10:c.A3113G:p.E1038G,BRCA1:uc010whs.1:exon10:c.A3113G:p.E1038G,BRCA1:uc010cyz.2:exon11:c.A2972G:p.E991G	-1.094	AFR:1(thymus),AMR:1(breast),EAS:MU153259,FIN:LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,NFE:0.3004,OTH:0.1749,ASJ:9(meninges)	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1781,1786,1773,1791,1792,1776,1785,1779,1778,1789,1788,1772,1797,1796,1798,1799,1780,1787,1790,1782,1793,1784,1783,1795,1777,1794	.	,1774,1775	0.012	-1.24	0.000	2.275	17	35(lung)	0.3182
17	41244936	41244936	G	A	BRCA1	exonic	nonsynonymous SNV	ENSG00000012048	rs799917	ENSG00000012048:ENST00000309486:exon9:c.C1724T:p.P575L,ENSG00000012048:ENST00000493795:exon9:c.C2471T:p.P824L,ENSG00000012048:ENST00000346315:exon10:c.C2612T:p.P871L,ENSG00000012048:ENST00000354071:exon10:c.C2612T:p.P871L,ENSG00000012048:ENST00000357654:exon10:c.C2612T:p.P871L,ENSG00000012048:ENST00000471181:exon10:c.C2612T:p.P871L	BRCA1:NM_007297:exon9:c.C2471T:p.P824L,BRCA1:NM_007294:exon10:c.C2612T:p.P871L,BRCA1:NM_007300:exon10:c.C2612T:p.P871L	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.4100	0.4932	0.54393	1(stomach)	1.633	14.03	1.0	5.04	0.979	.	.	.	BRCA1:uc010wht.1:exon2:c.C1724T:p.P575L,BRCA1:uc002ide.1:exon4:c.C2105T:p.P702L,BRCA1:uc002idd.3:exon9:c.C2612T:p.P871L,BRCA1:uc010cyx.3:exon9:c.C2471T:p.P824L,BRCA1:uc010cza.2:exon9:c.C2534T:p.P845L,BRCA1:uc002icp.4:exon10:c.C2399T:p.P800L,BRCA1:uc002icq.3:exon10:c.C2612T:p.P871L,BRCA1:uc002ict.3:exon10:c.C2612T:p.P871L,BRCA1:uc010cyy.1:exon10:c.C2612T:p.P871L,BRCA1:uc010whs.1:exon10:c.C2612T:p.P871L,BRCA1:uc010cyz.2:exon11:c.C2471T:p.P824L	-0.937	AFR:3(haematopoietic_and_lymphoid_tissue),AMR:9(meninges),EAS:4(large_intestine),FIN:1(peritoneum),NFE:1(breast),OTH:MU153268,ASJ:1(skin)	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1781,1786,1773,1791,1792,1776,1785,1779,1778,1789,1788,1772,1797,1796,1798,1799,1780,1787,1790,1782,1793,1784,1783,1795,1777,1794	.	,1774,1775	0.0	-0.05	0.000	-3.445	17	14(soft_tissue)	LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579
17	41245237	41245237	A	G	BRCA1	exonic	synonymous SNV	ENSG00000012048	rs16940	ENSG00000012048:ENST00000309486:exon9:c.T1423C:p.L475L,ENSG00000012048:ENST00000493795:exon9:c.T2170C:p.L724L,ENSG00000012048:ENST00000346315:exon10:c.T2311C:p.L771L,ENSG00000012048:ENST00000354071:exon10:c.T2311C:p.L771L,ENSG00000012048:ENST00000357654:exon10:c.T2311C:p.L771L,ENSG00000012048:ENST00000471181:exon10:c.T2311C:p.L771L	BRCA1:NM_007297:exon9:c.T2170C:p.L724L,BRCA1:NM_007294:exon10:c.T2311C:p.L771L,BRCA1:NM_007300:exon10:c.T2311C:p.L771L	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3420	0.2776	0.335264	9(meninges)	.	.	.	.	.	.	.	.	BRCA1:uc010wht.1:exon2:c.T1423C:p.L475L,BRCA1:uc002ide.1:exon4:c.T1804C:p.L602L,BRCA1:uc002idd.3:exon9:c.T2311C:p.L771L,BRCA1:uc010cyx.3:exon9:c.T2170C:p.L724L,BRCA1:uc010cza.2:exon9:c.T2233C:p.L745L,BRCA1:uc002icp.4:exon10:c.T2098C:p.L700L,BRCA1:uc002icq.3:exon10:c.T2311C:p.L771L,BRCA1:uc002ict.3:exon10:c.T2311C:p.L771L,BRCA1:uc010cyy.1:exon10:c.T2311C:p.L771L,BRCA1:uc010whs.1:exon10:c.T2311C:p.L771L,BRCA1:uc010cyz.2:exon11:c.T2170C:p.L724L	.	AFR:1(lung),AMR:MU153274,EAS:0.2998,FIN:0.1749,NFE:0.3206,OTH:0.3179,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1781,1786,1773,1791,1792,1776,1785,1779,1778,1789,1788,1772,1797,1796,1798,1799,1780,1787,1790,1782,1793,1784,1783,1795,1777,1794	.	,1774,1775	.	.	.	.	17	2(large_intestine)	0.3657
17	41245466	41245466	G	A	BRCA1	exonic	synonymous SNV	ENSG00000012048	rs1799949	ENSG00000012048:ENST00000309486:exon9:c.C1194T:p.S398S,ENSG00000012048:ENST00000493795:exon9:c.C1941T:p.S647S,ENSG00000012048:ENST00000346315:exon10:c.C2082T:p.S694S,ENSG00000012048:ENST00000354071:exon10:c.C2082T:p.S694S,ENSG00000012048:ENST00000357654:exon10:c.C2082T:p.S694S,ENSG00000012048:ENST00000471181:exon10:c.C2082T:p.S694S	BRCA1:NM_007297:exon9:c.C1941T:p.S647S,BRCA1:NM_007294:exon10:c.C2082T:p.S694S,BRCA1:NM_007300:exon10:c.C2082T:p.S694S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3483	0.2957	0.336462	13(soft_tissue)	.	.	.	.	.	.	.	.	BRCA1:uc010wht.1:exon2:c.C1194T:p.S398S,BRCA1:uc002ide.1:exon4:c.C1575T:p.S525S,BRCA1:uc002idd.3:exon9:c.C2082T:p.S694S,BRCA1:uc010cyx.3:exon9:c.C1941T:p.S647S,BRCA1:uc010cza.2:exon9:c.C2004T:p.S668S,BRCA1:uc002icp.4:exon10:c.C1869T:p.S623S,BRCA1:uc002icq.3:exon10:c.C2082T:p.S694S,BRCA1:uc002ict.3:exon10:c.C2082T:p.S694S,BRCA1:uc010cyy.1:exon10:c.C2082T:p.S694S,BRCA1:uc010whs.1:exon10:c.C2082T:p.S694S,BRCA1:uc010cyz.2:exon11:c.C1941T:p.S647S	.	AFR:3(lung),AMR:1(breast),EAS:MU153282,FIN:LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,NFE:0.3160,OTH:0.2290,ASJ:2(large_intestine)	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1781,1786,1773,1791,1792,1776,1785,1779,1778,1789,1788,1772,1797,1796,1798,1799,1780,1787,1790,1782,1793,1784,1783,1795,1777,1794	.	,1774,1775	.	.	.	.	17	3(haematopoietic_and_lymphoid_tissue)	0.3234
17	42949808	42949808	G	A	EFTUD2	intronic	.	ENSG00000108883	rs11654183	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2673	0.2648	0.242612	0.2780	.	.	.	.	.	0	0.036	.	.	.	AFR:0.2317,AMR:0.2363,EAS:0.2615,FIN:0.3267,NFE:0.2989,OTH:0.2710,ASJ:0.24	603892	610536;	79113;	79113|Growth delay-intellectual disability-mandibulofacial dysostosis-microcephaly-cleft palate syndrome<br>MFDM syndrome<br>Mandibulofacial dysostosis, Guion-Almeida type|<1 / 1 000 000|Autosomal dominant|Neonatal|610536 ~	.	.	.	.	.	.	.	.	17	MU12926828	het
17	42961009	42961009	C	T	EFTUD2	intronic	.	ENSG00000108883	rs2289677	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5693	0.6431	0.560503	0.6292	.	.	.	.	.	0.0001	0.012	.	.	.	AFR:0.7327,AMR:0.4654,EAS:0.4950,FIN:0.5642,NFE:0.6115,OTH:0.5622,ASJ:0.6523	603892	610536;	79113;	79113|Growth delay-intellectual disability-mandibulofacial dysostosis-microcephaly-cleft palate syndrome<br>MFDM syndrome<br>Mandibulofacial dysostosis, Guion-Almeida type|<1 / 1 000 000|Autosomal dominant|Neonatal|610536 ~	.	.	.	.	.	.	.	.	17	MU12926862	het
17	43342141	43342141	G	C	MAP3K14	exonic	unknown	ENSG00000006062	rs1047833	.	UNKNOWN	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7173	0.7471	0.718251	0.7495	.	.	.	.	.	.	.	.	MAP3K14:uc002iiu.1:exon8:c.C1296G:p.V432V,MAP3K14:uc002iiv.1:exon15:c.C1458G:p.V486V,MAP3K14:uc002iiw.1:exon17:c.C2703G:p.V901V	.	AFR:0.7872,AMR:0.7560,EAS:0.7321,FIN:0.7081,NFE:0.7416,OTH:0.7224,ASJ:0.6987	604655	.	.	.	.	.	.	.	.	.	.	.	17	MU14991608	hom
17	45331221	45331221	G	C	ITGB3	UTR5	.	ENSG00000259207	rs117052258	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2222	.	0.0728834	0.0327	.	.	.	.	.	.	.	.	.	.	AFR:0.0069,AMR:0.0237,EAS:0.2522,FIN:0.0284,NFE:0.0249,OTH:0.0389,ASJ:0.0238	173470	187800;273800;608446;	849;140957;	849|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|273800 ~140957|-|<1 / 1 000 000|Autosomal dominant|-|187800 613112 615193 ~	~ko04015 Rap1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	17	MU82145543	het
17	45364540	45364540	T	C	ITGB3	exonic	synonymous SNV	ENSG00000259207;ENSG00000259753	rs5919	ENSG00000259207:ENST00000435993:exon6:c.T741C:p.P247P,ENSG00000259207:ENST00000559488:exon6:c.T882C:p.P294P,ENSG00000259207:ENST00000571680:exon6:c.T882C:p.P294P	ITGB3:NM_000212:exon6:c.T882C:p.P294P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1029	0.0982	0.14397	0.1006	.	.	.	.	.	.	.	.	ITGB3:uc002ili.1:exon6:c.T882C:p.P294P,ITGB3:uc002ilj.3:exon6:c.T882C:p.P294P	.	AFR:0.1626,AMR:0.0632,EAS:0.2608,FIN:0.0384,NFE:0.0648,OTH:0.0754,ASJ:0.1358	173470	187800;273800;608446;	849;140957;	849|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|273800 ~140957|-|<1 / 1 000 000|Autosomal dominant|-|187800 613112 615193 ~	~ko04015 Rap1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	17	MU12929114	het
17	45368337	45368337	A	C	ITGB3	exonic	synonymous SNV	ENSG00000259207;ENSG00000259753	rs15908	ENSG00000259207:ENST00000435993:exon9:c.A1002C:p.V334V,ENSG00000259207:ENST00000559488:exon9:c.A1143C:p.V381V,ENSG00000259207:ENST00000571680:exon9:c.A1143C:p.V381V	ITGB3:NM_000212:exon9:c.A1143C:p.V381V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3902	0.3851	0.43111	0.3933	.	.	.	.	.	.	.	.	ITGB3:uc002ili.1:exon9:c.A1143C:p.V381V,ITGB3:uc002ilj.3:exon9:c.A1143C:p.V381V	.	AFR:0.4354,AMR:0.3222,EAS:0.6072,FIN:0.3199,NFE:0.3673,OTH:0.3834,ASJ:0.4033	173470	187800;273800;608446;	849;140957;	849|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|273800 ~140957|-|<1 / 1 000 000|Autosomal dominant|-|187800 613112 615193 ~	~ko04015 Rap1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	17	MU13755074	hom
17	45369777	45369777	A	G	ITGB3	exonic	synonymous SNV	ENSG00000259207;ENSG00000259753	rs4642	ENSG00000259207:ENST00000435993:exon10:c.A1392G:p.E464E,ENSG00000259207:ENST00000559488:exon10:c.A1533G:p.E511E	ITGB3:NM_000212:exon10:c.A1533G:p.E511E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2871	0.2839	0.28734	0.2891	.	.	.	.	.	.	.	.	ITGB3:uc002ilj.3:exon10:c.A1533G:p.E511E	.	AFR:0.2635,AMR:0.2566,EAS:0.3493,FIN:0.2818,NFE:0.3007,OTH:0.3027,ASJ:0.2649	173470	187800;273800;608446;	849;140957;	849|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|273800 ~140957|-|<1 / 1 000 000|Autosomal dominant|-|187800 613112 615193 ~	~ko04015 Rap1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	17	MU775201	unknown
17	45369789	45369789	G	A	ITGB3	exonic	synonymous SNV	ENSG00000259207;ENSG00000259753	rs4634	ENSG00000259207:ENST00000435993:exon10:c.G1404A:p.R468R,ENSG00000259207:ENST00000559488:exon10:c.G1545A:p.R515R	ITGB3:NM_000212:exon10:c.G1545A:p.R515R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2873	0.2839	0.28734	0.2890	.	.	.	.	.	.	.	.	ITGB3:uc002ilj.3:exon10:c.G1545A:p.R515R	.	AFR:0.2638,AMR:0.2560,EAS:0.3502,FIN:0.2815,NFE:0.3001,OTH:0.3041,ASJ:0.2649	173470	187800;273800;608446;	849;140957;	849|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|273800 ~140957|-|<1 / 1 000 000|Autosomal dominant|-|187800 613112 615193 ~	~ko04015 Rap1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	17	MU775204	unknown
17	45377825	45377825	T	C	ITGB3	intronic	.	ENSG00000259207;ENSG00000259753	rs11870252	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0906	0.0830	0.120407	0.0800	.	.	.	.	.	.	.	.	.	.	AFR:0.1007,AMR:0.0621,EAS:0.1943,FIN:0.0389,NFE:0.0657,OTH:0.0686,ASJ:0.1391	173470	187800;273800;608446;	849;140957;	849|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|273800 ~140957|-|<1 / 1 000 000|Autosomal dominant|-|187800 613112 615193 ~	~ko04015 Rap1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	17	MU584185	het
17	48263021	48263021	C	T	COL1A1	intronic	.	ENSG00000108821	rs2249492	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5828	0.5103	0.485024	0.5145	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.2833,AMR:0.6835,EAS:0.5075,FIN:0.6341,NFE:0.6035,OTH:0.5969,ASJ:0.6722	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	MU797249	het
17	48263208	48263208	G	A	COL1A1	exonic	synonymous SNV	ENSG00000108821	rs1800219	ENSG00000108821:ENST00000225964:exon50:c.C4179T:p.S1393S	COL1A1:NM_000088:exon50:c.C4179T:p.S1393S	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0] 	0.0032	0.0036	0.00419329	0.0026	.	.	.	.	.	.	.	.	COL1A1:uc002iqm.3:exon50:c.C4179T:p.S1393S	.	AFR:0.0080,AMR:0.0012,EAS:0,FIN:0,NFE:0.0005,OTH:0.0010,ASJ:0.0066	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	.	het
17	48264448	48264448	A	G	COL1A1	exonic	synonymous SNV	ENSG00000108821	rs1800218	ENSG00000108821:ENST00000225964:exon47:c.T3459C:p.D1153D	COL1A1:NM_000088:exon47:c.T3459C:p.D1153D	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0193	0.0511	0.0467252	0.0415	.	.	.	.	.	.	.	.	COL1A1:uc002iqm.3:exon47:c.T3459C:p.D1153D	.	AFR:0.1429,AMR:0.0131,EAS:0,FIN:0,NFE:0.0011,OTH:0.0092,ASJ:0.0066	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	.	het
17	48265495	48265495	T	C	COL1A1	exonic	nonsynonymous SNV	ENSG00000108821	rs1800215	ENSG00000108821:ENST00000225964:exon44:c.A3223G:p.T1075A	COL1A1:NM_000088:exon44:c.A3223G:p.T1075A	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9848	0.9710	0.978834	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	COL1A1:uc002iqm.3:exon44:c.A3223G:p.T1075A	.	AFR:0.9727,AMR:0.9433,EAS:0.9967,FIN:1,NFE:0.9794,OTH:0.9834,ASJ:0.9869	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	1(thyroid)	0.9836
17	48267291	48267291	G	C	COL1A1	intronic	.	ENSG00000108821	rs2075559	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5261	0.5249	0.541334	0.5101	.	.	.	.	.	.	.	.	.	.	AFR:0.5630,AMR:0.6492,EAS:0.5143,FIN:0.4616,NFE:0.4831,OTH:0.4969,ASJ:0.51	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	MU699787	het
17	48268223	48268223	A	G	COL1A1	exonic	synonymous SNV	ENSG00000108821	rs2734272	ENSG00000108821:ENST00000225964:exon33:c.T2298C:p.T766T	COL1A1:NM_000088:exon33:c.T2298C:p.T766T	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9998	0.9998	0.9998	0.9996	.	.	.	.	.	.	.	.	COL1A1:uc002iqm.3:exon33:c.T2298C:p.T766T	.	AFR:0.9991,AMR:0.9988,EAS:1,FIN:1,NFE:0.9998,OTH:1,ASJ:1	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	MU4564816	hom
17	48276971	48276971	G	C	COL1A1	intronic	.	ENSG00000108821	rs2256835	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6187	0.5531	0.518171	0.5630	.	.	.	.	.	.	.	.	.	.	AFR:0.2800,AMR:0.6160,EAS:0.6118,FIN:0.7435,NFE:0.6685,OTH:0.6794,ASJ:0.6225	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	MU762212	het
17	48433958	48433958	T	C	XYLT2	exonic	synonymous SNV	ENSG00000015532	rs4794136	ENSG00000015532:ENST00000511654:exon2:c.T165C:p.Y55Y,ENSG00000015532:ENST00000017003:exon8:c.T1569C:p.Y523Y,ENSG00000015532:ENST00000376550:exon8:c.T1569C:p.Y523Y,ENSG00000015532:ENST00000507602:exon8:c.T1569C:p.Y523Y	XYLT2:NM_022167:exon8:c.T1569C:p.Y523Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4363	0.4846	0.382588	MU147644	.	.	.	.	.	.	.	.	XYLT2:uc002iqo.3:exon8:c.T1569C:p.Y523Y	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.4428,EAS:0.5598,FIN:0.4437,NFE:0.1038,OTH:0.3997,ASJ:0.5081	608125	264800;605822;	85194;758;	85194|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|605822 ~758|Gronblad-Strandberg-Touraine syndrome<br>PXE|1-9 / 100 000|Autosomal recessive|All ages|177850 264800 ~	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.4459
17	48452776	48452776	A	C	EME1	exonic	nonsynonymous SNV	ENSG00000154920	rs3760413	ENSG00000154920:ENST00000511648:exon1:c.A207C:p.E69D,ENSG00000154920:ENST00000338165:exon2:c.A207C:p.E69D,ENSG00000154920:ENST00000393271:exon2:c.A207C:p.E69D,ENSG00000154920:ENST00000511519:exon2:c.A207C:p.E69D,ENSG00000154920:ENST00000511711:exon2:c.A207C:p.E69D	EME1:NM_001166131:exon2:c.A207C:p.E69D,EME1:NM_152463:exon2:c.A207C:p.E69D	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8180	0.9213	0.745407	0.8630	-3.075	0.001	1.0	-6.36	0.000	.	.	.	EME1:uc002iqs.2:exon2:c.A207C:p.E69D,EME1:uc010dbp.2:exon2:c.A207C:p.E69D	-0.955	AFR:0.9767,AMR:0.8819,EAS:0.2217,FIN:0.8308,NFE:0.8721,OTH:0.8480,ASJ:0.9106	610885	.	.	.	.	.	.	.	0.0	2.87	0.000	-1.04	17	MU25489170	het
17	48452978	48452978	-	AGC	EME1	exonic	nonframeshift insertion	ENSG00000154920	rs3060668	ENSG00000154920:ENST00000511648:exon1:c.409_410insAGC:p.K137delinsKQ,ENSG00000154920:ENST00000338165:exon2:c.409_410insAGC:p.K137delinsKQ,ENSG00000154920:ENST00000393271:exon2:c.409_410insAGC:p.K137delinsKQ	EME1:NM_001166131:exon2:c.409_410insAGC:p.K137delinsKQ,EME1:NM_152463:exon2:c.409_410insAGC:p.K137delinsKQ	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4524	0.5434	0.445887	0.4936	.	.	.	.	.	.	.	.	EME1:uc002iqs.2:exon2:c.409_410insAGC:p.K137delinsKQ,EME1:uc010dbp.2:exon2:c.409_410insAGC:p.K137delinsKQ	.	AFR:0.6910,AMR:0.5789,EAS:0.1033,FIN:0.3989,NFE:0.4433,OTH:0.4429,ASJ:0.44	610885	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	59760996	59760996	A	G	BRIP1	exonic	synonymous SNV	ENSG00000136492	rs4986763	ENSG00000136492:ENST00000259008:exon20:c.T3411C:p.Y1137Y	BRIP1:NM_032043:exon20:c.T3411C:p.Y1137Y	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5941	0.6060	0.620807	0.5824	.	.	.	.	.	.	.	.	BRIP1:uc002izk.2:exon20:c.T3411C:p.Y1137Y	.	AFR:0.6486,AMR:0.7584,EAS:0.7076,FIN:0.4205,NFE:0.5619,OTH:0.5133,ASJ:0.6291	605882	114480;609054;	84;227535;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	17	MU67347164	het
17	59763347	59763347	A	G	BRIP1	exonic	nonsynonymous SNV	ENSG00000136492	rs4986764	ENSG00000136492:ENST00000577598:exon18:c.T2755C:p.S919P,ENSG00000136492:ENST00000259008:exon19:c.T2755C:p.S919P	BRIP1:NM_032043:exon19:c.T2755C:p.S919P	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.5972	0.6134	0.627796	LICA-CN|1|402|0.00248756,COCA-CN|6|321|0.0186916	-0.521	0.195	0.154	0.71	0.000	.	.	.	BRIP1:uc002izl.1:exon8:c.T898C:p.S300P,BRIP1:uc002izk.2:exon19:c.T2755C:p.S919P	-0.937	AFR:0.5893,AMR:0.6691,EAS:0.6490,FIN:0.7063,NFE:0.4212,OTH:0.5632,ASJ:0.7655	605882	114480;609054;	84;227535;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.0	-0.86	0.000	.	17	1(stomach)	0.5173
17	59763465	59763465	T	C	BRIP1	exonic	synonymous SNV	ENSG00000136492	rs4986765	ENSG00000136492:ENST00000577598:exon18:c.A2637G:p.E879E,ENSG00000136492:ENST00000259008:exon19:c.A2637G:p.E879E	BRIP1:NM_032043:exon19:c.A2637G:p.E879E	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7188	0.7343	0.815096	0.7178	.	.	.	.	.	.	.	.	BRIP1:uc002izl.1:exon8:c.A780G:p.E260E,BRIP1:uc002izk.2:exon19:c.A2637G:p.E879E	.	AFR:0.9073,AMR:0.8473,EAS:0.8812,FIN:0.5120,NFE:0.6355,OTH:0.6307,ASJ:0.7483	605882	114480;609054;	84;227535;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	17	MU13758307	het
17	59856129	59856129	G	A	BRIP1	intronic	.	ENSG00000136492	rs4968449	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.989816	0.9893	.	.	.	.	.	.	.	.	.	.	AFR:0.9623,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9990,ASJ:1	605882	114480;609054;	84;227535;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	17	.	hom
17	59861633	59861633	G	A	BRIP1	exonic	synonymous SNV	ENSG00000136492	rs373709958	ENSG00000136492:ENST00000577598:exon10:c.C1626T:p.S542S,ENSG00000136492:ENST00000259008:exon11:c.C1626T:p.S542S	BRIP1:NM_032043:exon11:c.C1626T:p.S542S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, 0, 1, 0] 	0.0004	7.7e-05	0.000399361	3.229e-05	.	.	.	.	.	0.0348	0.214	.	BRIP1:uc002izk.2:exon11:c.C1626T:p.S542S	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.666e-05,OTH:0,ASJ:0	605882	114480;609054;	84;227535;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	17	.	het
17	60033217	60033217	A	-	MED13	intronic	.	ENSG00000108510	rs557700319	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0048	.	0.0483227	0.0653	.	.	.	.	.	.	.	.	.	.	AFR:0.0756,AMR:0.0517,EAS:0.0258,FIN:0,NFE:0.0650,OTH:0.1042,ASJ:0	603808	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	60040329	60040329	C	T	MED13	exonic	synonymous SNV	ENSG00000108510	rs2278812	ENSG00000108510:ENST00000397786:exon21:c.G4848A:p.T1616T	MED13:NM_005121:exon21:c.G4848A:p.T1616T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1854	0.1845	0.284944	0.2226	.	.	.	.	.	.	.	.	MED13:uc002izo.3:exon21:c.G4848A:p.T1616T	.	AFR:0.3449,AMR:0.1930,EAS:0.5099,FIN:0.2245,NFE:0.1283,OTH:0.1530,ASJ:0.1267	603808	.	.	.	.	.	.	.	.	.	.	.	17	MU81075	het
17	60043884	60043884	G	A	MED13	exonic	synonymous SNV	ENSG00000108510	rs671347	ENSG00000108510:ENST00000397786:exon19:c.C4320T:p.D1440D	MED13:NM_005121:exon19:c.C4320T:p.D1440D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9983	0.9931	0.996206	0.9943	.	.	.	.	.	.	.	.	MED13:uc002izo.3:exon19:c.C4320T:p.D1440D	.	AFR:0.9796,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	603808	.	.	.	.	.	.	.	.	.	.	.	17	MU81997073	hom
17	63533768	63533768	G	A	AXIN2	exonic	synonymous SNV	ENSG00000168646	rs1133683	ENSG00000168646:ENST00000375702:exon5:c.C1386T:p.P462P,ENSG00000168646:ENST00000307078:exon6:c.C1386T:p.P462P	AXIN2:NM_001363813:exon6:c.C1386T:p.P462P,AXIN2:NM_004655:exon6:c.C1386T:p.P462P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6236	0.5401	0.446086	0.5189	.	.	.	.	.	.	.	.	AXIN2:uc002jfh.3:exon5:c.C1386T:p.P462P,AXIN2:uc002jfi.3:exon6:c.C1386T:p.P462P	.	AFR:0.2818,AMR:0.5925,EAS:0.3547,FIN:0.6018,NFE:0.6402,OTH:0.6304,ASJ:0.7020	604025	114500;608615;	300576;	300576|Autosomal dominant ectodermal dysplasia-cancer predisposition syndrome|<1 / 1 000 000|Autosomal dominant|-|608615 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	17	MU68939	unknown
17	63533789	63533789	T	C	AXIN2	exonic	synonymous SNV	ENSG00000168646	rs9915936	ENSG00000168646:ENST00000375702:exon5:c.A1365G:p.P455P,ENSG00000168646:ENST00000307078:exon6:c.A1365G:p.P455P	AXIN2:NM_001363813:exon6:c.A1365G:p.P455P,AXIN2:NM_004655:exon6:c.A1365G:p.P455P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9144	0.9109	0.909744	0.8961	.	.	.	.	.	.	.	.	AXIN2:uc002jfh.3:exon5:c.A1365G:p.P455P,AXIN2:uc002jfi.3:exon6:c.A1365G:p.P455P	.	AFR:0.9306,AMR:0.8971,EAS:0.8079,FIN:0.9022,NFE:0.8823,OTH:0.9061,ASJ:0.9536	604025	114500;608615;	300576;	300576|Autosomal dominant ectodermal dysplasia-cancer predisposition syndrome|<1 / 1 000 000|Autosomal dominant|-|608615 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	17	MU94566	unknown
17	63554591	63554591	G	A	AXIN2	exonic	nonsynonymous SNV	ENSG00000168646	rs2240308	ENSG00000168646:ENST00000375702:exon1:c.C148T:p.P50S,ENSG00000168646:ENST00000307078:exon2:c.C148T:p.P50S,ENSG00000168646:ENST00000544103:exon2:c.C148T:p.P50S,ENSG00000168646:ENST00000577278:exon2:c.C148T:p.P50S,ENSG00000168646:ENST00000580513:exon2:c.C148T:p.P50S,ENSG00000168646:ENST00000585045:exon2:c.C148T:p.P50S	AXIN2:NM_001363813:exon2:c.C148T:p.P50S,AXIN2:NM_004655:exon2:c.C148T:p.P50S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4737	0.3948	0.33766	0.4049	-0.922	0.023	0.366	2.75	0.062	.	.	Axin-1/2, tankyrase-binding domain	AXIN2:uc002jfh.3:exon1:c.C148T:p.P50S,AXIN2:uc002jfi.3:exon2:c.C148T:p.P50S,AXIN2:uc002jfj.1:exon2:c.C148T:p.P50S,AXIN2:uc010den.1:exon4:c.C148T:p.P50S	-0.975	AFR:0.1314,AMR:0.5468,EAS:0.3360,FIN:0.5069,NFE:0.5315,OTH:0.5103,ASJ:0.4934	604025	114500;608615;	300576;	300576|Autosomal dominant ectodermal dysplasia-cancer predisposition syndrome|<1 / 1 000 000|Autosomal dominant|-|608615 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	0.0	-0.05	0.000	.	17	MU790515	hom
17	66519857	66519857	-	T	PRKAR1A	intronic	.	ENSG00000108946	rs3841514	ENSG00000108946:ENST00000585608:exon4:c.352dupT:p.F117fs	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.2224	0.2268	0.22524	0.2330	.	.	.	.	.	.	.	.	.	.	AFR:0.2381,AMR:0.1850,EAS:0.1321,FIN:0.2615,NFE:0.2362,OTH:0.2561,ASJ:0.2020	188830	101800;160980;255960;610489;	189439;615;1359;280651;950;	189439|PPNAD|<1 / 1 000 000|Autosomal dominant|All ages|610475 610489 614190 615830 ~615|-|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|255960 ~1359|Carney syndrome<br>Myxoma-spotty pigmentation-endocrine overactivity syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|160980 605244 ~280651|-|<1 / 1 000 000|Autosomal dominant|Childhood|101800 614613 ~950|Acrodysplasia<br>Arkless-Graham syndrome<br>Maroteaux-Malamut syndrome|Unknown|Autosomal dominant|Neonatal<br>Antenatal|101800 614613 ~	.	.	.	.	.	.	.	.	17	.	het
17	72862705	72862705	G	A	FDXR	intronic	.	ENSG00000161513	rs2070918	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5912	0.5738	0.449481	0.5852	.	.	.	.	.	.	.	.	.	.	AFR:0.3835,AMR:0.6005,EAS:0.2417,FIN:0.7467,NFE:0.6982,OTH:0.6646,ASJ:0.4834	103270	.	.	.	.	.	.	.	.	.	.	.	17	MU18446144	het
17	73625430	73625430	G	A	RECQL5	exonic	synonymous SNV	ENSG00000108469	rs4788902	ENSG00000108469:ENST00000582548:exon1:c.C93T:p.H31H,ENSG00000108469:ENST00000580707:exon9:c.C540T:p.H180H,ENSG00000108469:ENST00000317905:exon16:c.C2073T:p.H691H,ENSG00000108469:ENST00000423245:exon16:c.C1992T:p.H664H	RECQL5:NM_004259:exon16:c.C2073T:p.H691H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6127	0.4752	0.525958	0.5025	.	.	.	.	.	.	.	.	RECQL5:uc010dgk.3:exon15:c.C1992T:p.H664H,RECQL5:uc010dgl.3:exon16:c.C2073T:p.H691H	.	AFR:0.2075,AMR:0.6507,EAS:0.8189,FIN:0.6151,NFE:0.6010,OTH:0.5789,ASJ:0.4834	603781	.	.	.	.	.	.	.	.	.	.	.	17	MU75672	hom
17	73625478	73625478	T	C	RECQL5	exonic	synonymous SNV	ENSG00000108469	rs820191	ENSG00000108469:ENST00000582548:exon1:c.A45G:p.T15T,ENSG00000108469:ENST00000580707:exon9:c.A492G:p.T164T,ENSG00000108469:ENST00000317905:exon16:c.A2025G:p.T675T,ENSG00000108469:ENST00000423245:exon16:c.A1944G:p.T648T	RECQL5:NM_004259:exon16:c.A2025G:p.T675T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9968	0.9896	0.989217	0.9894	.	.	.	.	.	.	.	.	RECQL5:uc010dgk.3:exon15:c.A1944G:p.T648T,RECQL5:uc010dgl.3:exon16:c.A2025G:p.T675T	.	AFR:0.9629,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	603781	.	.	.	.	.	.	.	.	.	.	.	17	MU4565309	hom
17	73626922	73626922	-	T	RECQL5	intronic	.	ENSG00000108469	.	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4182	.	0.539936	0.5894	.	.	.	.	.	.	.	.	.	.	AFR:0.5300,AMR:0.5507,EAS:0.5989,FIN:0.6203,NFE:0.6076,OTH:0.5986,ASJ:0.5488	603781	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	73626923	73626923	-	T	RECQL5	intronic	.	ENSG00000108469	rs55982817	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1247	.	0.539936	0.4526	.	.	.	.	.	.	.	.	.	.	AFR:0.2492,AMR:0.4331,EAS:0.5013,FIN:0.5298,NFE:0.5315,OTH:0.4974,ASJ:0.3761	603781	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	73627565	73627565	A	G	RECQL5	exonic	synonymous SNV	ENSG00000108469	rs820197	ENSG00000108469:ENST00000578201:exon8:c.T1413C:p.Y471Y,ENSG00000108469:ENST00000317905:exon9:c.T1413C:p.Y471Y,ENSG00000108469:ENST00000423245:exon9:c.T1332C:p.Y444Y	RECQL5:NM_004259:exon9:c.T1413C:p.Y471Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9968	0.9896	0.988618	0.9890	.	.	.	.	.	.	.	.	RECQL5:uc010dgk.3:exon8:c.T1332C:p.Y444Y,RECQL5:uc010dgl.3:exon9:c.T1413C:p.Y471Y	.	AFR:0.9615,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	603781	.	.	.	.	.	.	.	.	.	.	.	17	MU4565311	hom
17	74475024	74475024	G	A	RHBDF2	exonic	nonsynonymous SNV	ENSG00000129667	rs3744045	ENSG00000129667:ENST00000313080:exon6:c.C623T:p.P208L,ENSG00000129667:ENST00000389760:exon6:c.C536T:p.P179L,ENSG00000129667:ENST00000591885:exon6:c.C536T:p.P179L	RHBDF2:NM_001005498:exon5:c.C536T:p.P179L,RHBDF2:NM_024599:exon6:c.C623T:p.P208L	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8787	0.7952	0.765176	0.8090	2.245	17.80	0.078	4.57	0.047	.	.	.	RHBDF2:uc002jrr.1:exon3:c.C179T:p.P60L,RHBDF2:uc002jrs.1:exon3:c.C608T:p.P203L,RHBDF2:uc010wtf.1:exon5:c.C536T:p.P179L,RHBDF2:uc021udh.1:exon5:c.C536T:p.P179L,RHBDF2:uc002jrq.2:exon6:c.C623T:p.P208L	-1.042	AFR:0.5027,AMR:0.8804,EAS:0.9523,FIN:0.9178,NFE:0.9344,OTH:0.8891,ASJ:0.9272	614404	148500;	2198;	2198|Bennion-Patterson syndrome<br>Howell-Evans syndrome<br>Keratosis palmoplantaris-esophageal carcinoma syndrome<br>Palmoplantar hyperkeratosis-esophageal carcinoma syndrome<br>Tylosis-oesophageal carcinoma syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|148500 ~	.	.	.	.	0.247	-0.18	0.000	1.81	17	MU4552271	hom
17	74475975	74475975	C	A	RHBDF2	exonic	nonsynonymous SNV	ENSG00000129667	rs3809694	ENSG00000129667:ENST00000313080:exon4:c.G199T:p.A67S,ENSG00000129667:ENST00000592123:exon5:c.G199T:p.A67S	RHBDF2:NM_024599:exon4:c.G199T:p.A67S	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5083	0.4041	0.45627	0.4367	-1.691	0.002	0.649	-2.03	0.000	.	.	.	RHBDF2:uc002jrq.2:exon4:c.G199T:p.A67S	-0.948	AFR:0.2943,AMR:0.6126,EAS:0.6429,FIN:0.5038,NFE:0.4696,OTH:0.4757,ASJ:0.4324	614404	148500;	2198;	2198|Bennion-Patterson syndrome<br>Howell-Evans syndrome<br>Keratosis palmoplantaris-esophageal carcinoma syndrome<br>Palmoplantar hyperkeratosis-esophageal carcinoma syndrome<br>Tylosis-oesophageal carcinoma syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|148500 ~	.	.	.	.	0.001	0.56	0.000	0	17	MU135545	het
17	74477620	74477620	C	T	RHBDF2	UTR5	.	ENSG00000129667	rs12943385	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1525	0.1244	0.14976	0.1329	.	.	.	.	.	.	.	.	.	.	AFR:0.0996,AMR:0.0835,EAS:0.2151,FIN:0.1781,NFE:0.1339,OTH:0.1558,ASJ:0.1457	614404	148500;	2198;	2198|Bennion-Patterson syndrome<br>Howell-Evans syndrome<br>Keratosis palmoplantaris-esophageal carcinoma syndrome<br>Palmoplantar hyperkeratosis-esophageal carcinoma syndrome<br>Tylosis-oesophageal carcinoma syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|148500 ~	.	.	.	.	.	.	.	.	17	MU82000103	het
17	74732507	74732507	A	G	SRSF2	exonic	synonymous SNV	ENSG00000161547	rs237058	ENSG00000161547:ENST00000358156:exon2:c.T381C:p.S127S,ENSG00000161547:ENST00000359995:exon2:c.T402C:p.S134S,ENSG00000161547:ENST00000392485:exon2:c.T402C:p.S134S,ENSG00000161547:ENST00000452355:exon2:c.T402C:p.S134S,ENSG00000161547:ENST00000508921:exon2:c.T366C:p.S122S,ENSG00000161547:ENST00000583836:exon2:c.T345C:p.S115S,ENSG00000161547:ENST00000585202:exon2:c.T402C:p.S134S	SRSF2:NM_001195427:exon2:c.T402C:p.S134S,SRSF2:NM_003016:exon2:c.T402C:p.S134S	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9973	0.9911	0.990615	0.9916	.	.	.	.	.	.	.	.	SRSF2:uc002jsv.3:exon2:c.T402C:p.S134S,SRSF2:uc002jsy.4:exon2:c.T402C:p.S134S,SRSF2:uc010wtg.2:exon2:c.T366C:p.S122S	.	AFR:0.9703,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600813	.	.	.	.	,9882,9888,9886,9889,9887	.	,9885,9883,9884	.	.	.	.	17	MU4554584	hom
17	74733099	74733099	G	A	SRSF2	exonic	synonymous SNV	ENSG00000161547	rs237057	ENSG00000161547:ENST00000358156:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000359995:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000392485:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000452355:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000508921:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000583836:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000585202:exon1:c.C144T:p.D48D	SRSF2:NM_001195427:exon1:c.C144T:p.D48D,SRSF2:NM_003016:exon1:c.C144T:p.D48D	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.8886	0.7970	0.785543	0.8039	.	.	.	.	.	.	.	.	SRSF2:uc002jsv.3:exon1:c.C144T:p.D48D,SRSF2:uc002jsy.4:exon1:c.C144T:p.D48D,SRSF2:uc010wtg.2:exon1:c.C144T:p.D48D	.	AFR:0.4961,AMR:0.9033,EAS:0.9210,FIN:0.8920,NFE:0.9347,OTH:0.8901,ASJ:0.9669	600813	.	.	.	.	,9882,9888,9886,9889,9887	.	,9885,9883,9884	.	.	.	.	17	MU82000212	hom
17	75303298	75303298	T	C	SEPTIN9	intronic	.	ENSG00000184640	rs4789439	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8853	0.8623	0.91873	0.8897	.	.	.	.	.	.	.	.	.	.	AFR:0.9079,AMR:0.9129,EAS:0.9889,FIN:0.9123,NFE:0.8646,OTH:0.8837,ASJ:0.7682	604061	162100;	2901;	2901|Acute brachial plexus neuritis<br>Brachial plexus neuritis<br>Immune brachial plexus neuropathy<br>Mononeuritis multiplex with brachial predilection<br>Neuralgic shoulder amyotrophy<br>Winged scapula|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|162100 ~	.	.	.	.	.	.	.	.	17	MU82000309	hom
17	75494705	75494705	A	G	SEPTIN9	exonic	nonsynonymous SNV	ENSG00000184640	rs2627223	ENSG00000184640:ENST00000427180:exon10:c.A1390G:p.M464V,ENSG00000184640:ENST00000541152:exon10:c.A973G:p.M325V,ENSG00000184640:ENST00000585930:exon10:c.A1054G:p.M352V,ENSG00000184640:ENST00000591088:exon10:c.A973G:p.M325V,ENSG00000184640:ENST00000592951:exon10:c.A973G:p.M325V,ENSG00000184640:ENST00000329047:exon11:c.A1672G:p.M558V,ENSG00000184640:ENST00000423034:exon11:c.A1705G:p.M569V,ENSG00000184640:ENST00000427674:exon11:c.A1234G:p.M412V,ENSG00000184640:ENST00000588690:exon11:c.A1234G:p.M412V,ENSG00000184640:ENST00000590294:exon11:c.A1672G:p.M558V,ENSG00000184640:ENST00000591198:exon11:c.A1669G:p.M557V,ENSG00000184640:ENST00000427177:exon12:c.A1726G:p.M576V,ENSG00000184640:ENST00000431235:exon12:c.A1234G:p.M412V,ENSG00000184640:ENST00000449803:exon12:c.A1234G:p.M412V	SEPTIN9:NM_001113495:exon10:c.A1390G:p.M464V,SEPTIN9:NM_001113496:exon10:c.A973G:p.M325V,SEPTIN9:NM_001293696:exon10:c.A1054G:p.M352V,SEPTIN9:NM_001293697:exon10:c.A973G:p.M325V,SEPTIN9:NM_001293698:exon10:c.A973G:p.M325V,SEPTIN9:NM_001113493:exon11:c.A1705G:p.M569V,SEPTIN9:NM_001113494:exon11:c.A1234G:p.M412V,SEPTIN9:NM_001293695:exon11:c.A1669G:p.M557V,SEPTIN9:NM_006640:exon11:c.A1672G:p.M558V,SEPTIN9:NM_001113491:exon12:c.A1726G:p.M576V,SEPTIN9:NM_001113492:exon12:c.A1234G:p.M412V	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9371	0.8923	0.90655	0.8893	-0.847	0.034	1.0	2.77	0.063	.	.	P-loop containing nucleoside triphosphate hydrolase|Septin-type guanine nucleotide-binding (G) domain;Septin-type guanine nucleotide-binding (G) domain	SEPT9:uc002jty.4:exon10:c.A973G:p.M325V,SEPT9:uc010dhd.3:exon10:c.A1390G:p.M464V,SEPT9:uc010wtl.2:exon10:c.A1054G:p.M352V,SEPT9:uc010wtm.2:exon10:c.A973G:p.M325V,SEPT9:uc010wtn.2:exon10:c.A973G:p.M325V,SEPT9:uc002jtu.4:exon11:c.A1672G:p.M558V,SEPT9:uc002jtv.3:exon11:c.A1705G:p.M569V,SEPT9:uc002jtw.3:exon11:c.A1234G:p.M412V,SEPT9:uc010wtk.2:exon11:c.A1669G:p.M557V,SEPT9:uc002jts.4:exon12:c.A1726G:p.M576V,SEPT9:uc002jtt.4:exon12:c.A1234G:p.M412V	-0.966	AFR:0.7668,AMR:0.9614,EAS:1,FIN:0.9147,NFE:0.9343,OTH:0.9255,ASJ:0.9503	604061	162100;	2901;	2901|Acute brachial plexus neuritis<br>Brachial plexus neuritis<br>Immune brachial plexus neuropathy<br>Mononeuritis multiplex with brachial predilection<br>Neuralgic shoulder amyotrophy<br>Winged scapula|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|162100 ~	.	.	.	.	0.0	1.55	0.000	-2.36	17	MU4565432	hom
17	75494746	75494746	A	G	SEPTIN9	UTR3	.	ENSG00000184640	rs1059485	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5267	0.3937	0.561701	0.4535	.	.	.	.	.	.	.	.	.	.	AFR:0.337,AMR:0.6783,EAS:0.9082,FIN:0.5047,NFE:0.4478,OTH:0.4405,ASJ:0.4333	604061	162100;	2901;	2901|Acute brachial plexus neuritis<br>Brachial plexus neuritis<br>Immune brachial plexus neuropathy<br>Mononeuritis multiplex with brachial predilection<br>Neuralgic shoulder amyotrophy<br>Winged scapula|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|162100 ~	.	.	.	.	.	.	.	.	17	MU17423690	het
17	76989782	76989782	G	A	CANT1	exonic	synonymous SNV	ENSG00000171302	rs3803781	ENSG00000171302:ENST00000302345:exon4:c.C1056T:p.N352N,ENSG00000171302:ENST00000392446:exon5:c.C1056T:p.N352N,ENSG00000171302:ENST00000591773:exon6:c.C1056T:p.N352N	CANT1:NM_138793:exon4:c.C1056T:p.N352N,CANT1:NM_001159773:exon5:c.C1056T:p.N352N,CANT1:NM_001159772:exon6:c.C1056T:p.N352N	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0411	0.0340	0.0710863	0.0382	.	.	.	.	.	.	.	.	CANT1:uc002jwj.3:exon4:c.C1056T:p.N352N,CANT1:uc002jwk.3:exon5:c.C1056T:p.N352N,CANT1:uc002jwn.3:exon6:c.C1056T:p.N352N	.	AFR:0.0526,AMR:0.0084,EAS:0.1689,FIN:0.0301,NFE:0.0204,OTH:0.0327,ASJ:0.0066	613165	251450;	1425;	1425|Desbuquois dysplasia|<1 / 1 000 000|Autosomal recessive|Antenatal<br>Neonatal|251450 300881 615777 ~	.	.	.	.	.	.	.	.	17	MU720065	het
17	76993546	76993546	A	G	CANT1	exonic	synonymous SNV	ENSG00000171302	rs8077024	ENSG00000171302:ENST00000302345:exon2:c.T159C:p.A53A,ENSG00000171302:ENST00000592228:exon2:c.T159C:p.A53A,ENSG00000171302:ENST00000392446:exon3:c.T159C:p.A53A,ENSG00000171302:ENST00000588075:exon3:c.T159C:p.A53A,ENSG00000171302:ENST00000590370:exon4:c.T159C:p.A53A,ENSG00000171302:ENST00000591773:exon4:c.T159C:p.A53A,ENSG00000171302:ENST00000586916:exon5:c.T159C:p.A53A	CANT1:NM_138793:exon2:c.T159C:p.A53A,CANT1:NM_001159773:exon3:c.T159C:p.A53A,CANT1:NM_001159772:exon4:c.T159C:p.A53A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3791	0.3210	0.44349	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	CANT1:uc002jwj.3:exon2:c.T159C:p.A53A,CANT1:uc002jwk.3:exon3:c.T159C:p.A53A,CANT1:uc002jwn.3:exon4:c.T159C:p.A53A	.	AFR:0.3461,AMR:0.4217,EAS:0.2384,FIN:0.6803,NFE:0.2368,OTH:0.2886,ASJ:0.4462	613165	251450;	1425;	1425|Desbuquois dysplasia|<1 / 1 000 000|Autosomal recessive|Antenatal<br>Neonatal|251450 300881 615777 ~	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.3384
17	78263514	78263514	G	A	RNF213	exonic	synonymous SNV	ENSG00000173821	rs17853713	ENSG00000173821:ENST00000319921:exon6:c.G990A:p.K330K,ENSG00000173821:ENST00000456466:exon6:c.G990A:p.K330K,ENSG00000173821:ENST00000582970:exon6:c.G990A:p.K330K,ENSG00000173821:ENST00000508628:exon7:c.G1137A:p.K379K	RNF213:NM_001256071:exon6:c.G990A:p.K330K,RNF213:NM_020954:exon6:c.G990A:p.K330K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1800	0.2585	0.220248	LAML-KR|1|205|0.00487805	.	.	.	.	.	.	.	.	RNF213:uc002jyg.1:exon3:c.G183A:p.K61K,RNF213:uc002jyf.4:exon6:c.G990A:p.K330K,RNF213:uc021uen.2:exon6:c.G990A:p.K330K	.	AFR:0.2384,AMR:0.4061,EAS:0.1391,FIN:0.0642,NFE:0.1422,OTH:0.1963,ASJ:0.1050	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	1(stomach)	0.1670
17	78269340	78269340	T	A	RNF213	intronic	.	ENSG00000173821	rs374072954	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	0.0005	7.7e-05	0.00139776	9.693e-05	.	.	.	.	.	.	.	.	.	.	AFR:0.0003,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	.	het
17	78272294	78272294	C	T	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs72849841	ENSG00000173821:ENST00000319921:exon11:c.C2186T:p.P729L,ENSG00000173821:ENST00000456466:exon11:c.C2186T:p.P729L,ENSG00000173821:ENST00000582970:exon11:c.C2186T:p.P729L,ENSG00000173821:ENST00000508628:exon12:c.C2333T:p.P778L	RNF213:NM_001256071:exon11:c.C2186T:p.P729L,RNF213:NM_020954:exon11:c.C2186T:p.P729L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1240	0.1452	0.113818	MU152932	0.953	10.39	0.093	2.14	0.097	.	.	.	RNF213:uc002jyg.1:exon8:c.C1379T:p.P460L,RNF213:uc002jyf.4:exon11:c.C2186T:p.P729L,RNF213:uc021uen.2:exon11:c.C2186T:p.P729L	-0.944	AFR:LAML-KR|1|205|0.00487805,AMR:0.1394,EAS:0.0823,FIN:0.1523,NFE:0.0111,OTH:0.1808,ASJ:0.1643	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	0.045	2.53	0.000	0.345	17	1(soft_tissue)	0.1326
17	78298938	78298938	A	G	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs6565674	ENSG00000173821:ENST00000456466:exon18:c.A3133G:p.N1045D,ENSG00000173821:ENST00000582970:exon18:c.A3133G:p.N1045D,ENSG00000173821:ENST00000508628:exon19:c.A3280G:p.N1094D	RNF213:NM_001256071:exon18:c.A3133G:p.N1045D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9999	.	0.999401	0.9999	.	.	.	.	.	.	.	.	RNF213:uc002jyg.1:exon15:c.A2326G:p.N776D,RNF213:uc021uen.2:exon18:c.A3133G:p.N1045D	.	AFR:1,AMR:1,EAS:0.9981,FIN:1,NFE:1,OTH:1,ASJ:1	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	MU82001690	hom
17	78302157	78302157	C	A	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs8082521	ENSG00000173821:ENST00000456466:exon20:c.C3397A:p.Q1133K,ENSG00000173821:ENST00000582970:exon20:c.C3397A:p.Q1133K,ENSG00000173821:ENST00000508628:exon21:c.C3544A:p.Q1182K	RNF213:NM_001256071:exon20:c.C3397A:p.Q1133K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6362	0.7008	0.558307	1(lung)	-2.287	0.001	0.998	-10.6	0.000	.	.	.	RNF213:uc002jyg.1:exon17:c.C2590A:p.Q864K,RNF213:uc021uen.2:exon20:c.C3397A:p.Q1133K	-1.007	AFR:1(stomach),AMR:2(large_intestine),EAS:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,FIN:0.6569,NFE:0.7177,OTH:0.4475,ASJ:MU584308	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	2.1	0.000	-0.63	17	17(soft_tissue)	0.6788
17	78305871	78305871	G	A	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs10782008	ENSG00000173821:ENST00000456466:exon21:c.G3583A:p.V1195M,ENSG00000173821:ENST00000582970:exon21:c.G3583A:p.V1195M,ENSG00000173821:ENST00000508628:exon22:c.G3730A:p.V1244M	RNF213:NM_001256071:exon21:c.G3583A:p.V1195M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5764	0.5907	0.488818	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	0.340	6.078	0.203	1.26	0.018	.	.	.	RNF213:uc002jyg.1:exon18:c.G2776A:p.V926M,RNF213:uc021uen.2:exon21:c.G3583A:p.V1195M	-0.996	AFR:0.5731,AMR:0.4597,EAS:0.6233,FIN:0.4054,NFE:0.6884,OTH:0.6364,ASJ:0.3947	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	1.88	0.000	0.99	17	2(lung)	0.6150
17	78306102	78306102	G	C	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs9913636	ENSG00000173821:ENST00000456466:exon21:c.G3814C:p.E1272Q,ENSG00000173821:ENST00000582970:exon21:c.G3814C:p.E1272Q,ENSG00000173821:ENST00000508628:exon22:c.G3961C:p.E1321Q	RNF213:NM_001256071:exon21:c.G3814C:p.E1272Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4389	0.3866	0.343251	1(lung)	-0.469	0.263	0.481	-2.58	0.000	.	.	.	RNF213:uc002jyg.1:exon18:c.G3007C:p.E1003Q,RNF213:uc021uen.2:exon21:c.G3814C:p.E1272Q	-0.918	AFR:MU12980178,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.2291,FIN:0.2745,NFE:0.4735,OTH:0.3888,ASJ:0.4053	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	1.86	0.000	2.045	17	1(haematopoietic_and_lymphoid_tissue)	0.5682
17	78306280	78306280	A	G	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs8074015	ENSG00000173821:ENST00000456466:exon21:c.A3992G:p.D1331G,ENSG00000173821:ENST00000582970:exon21:c.A3992G:p.D1331G,ENSG00000173821:ENST00000508628:exon22:c.A4139G:p.D1380G	RNF213:NM_001256071:exon21:c.A3992G:p.D1331G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6440	0.7032	0.596645	MU12980184	-0.774	0.049	0.198	-2.19	0.000	.	.	.	RNF213:uc002jyg.1:exon18:c.A3185G:p.D1062G,RNF213:uc021uen.2:exon21:c.A3992G:p.D1331G	-1.081	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579,AMR:0.6691,EAS:0.4522,FIN:0.6788,NFE:0.4024,OTH:0.7059,ASJ:0.7250	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	3.93	0.000	2.14	17	1(haematopoietic_and_lymphoid_tissue)	0.6691
17	78306308	78306308	C	G	RNF213	exonic	synonymous SNV	ENSG00000173821	rs9908287	ENSG00000173821:ENST00000456466:exon21:c.C4020G:p.V1340V,ENSG00000173821:ENST00000582970:exon21:c.C4020G:p.V1340V,ENSG00000173821:ENST00000508628:exon22:c.C4167G:p.V1389V	RNF213:NM_001256071:exon21:c.C4020G:p.V1340V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5725	0.5907	0.48742	MU14558322	.	.	.	.	.	.	.	.	RNF213:uc002jyg.1:exon18:c.C3213G:p.V1071V,RNF213:uc021uen.2:exon21:c.C4020G:p.V1340V	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,AMR:0.5724,EAS:0.3938,FIN:0.6258,NFE:0.3937,OTH:0.6883,ASJ:0.4601	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	2(large_intestine)	0.6360
17	78311508	78311508	G	A	RNF213	exonic	synonymous SNV	ENSG00000173821	rs4890009	ENSG00000173821:ENST00000582970:exon24:c.G4650A:p.A1550A,ENSG00000173821:ENST00000508628:exon25:c.G4797A:p.A1599A	RNF213:NM_001256071:exon24:c.G4650A:p.A1550A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6463	0.7081	0.598043	0.6720	.	.	.	.	.	.	.	.	RNF213:uc021uen.2:exon24:c.G4650A:p.A1550A	.	AFR:0.7383,AMR:0.4532,EAS:0.3756,FIN:0.7053,NFE:0.6702,OTH:0.6602,ASJ:0.6867	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	MU4565558	hom
17	78319136	78319136	G	A	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs9674961	ENSG00000173821:ENST00000336301:exon4:c.G1220A:p.S407N,ENSG00000173821:ENST00000582970:exon29:c.G7001A:p.S2334N,ENSG00000173821:ENST00000508628:exon30:c.G7148A:p.S2383N	RNF213:NM_001256071:exon29:c.G7001A:p.S2334N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6081	0.6605	0.558506	2(prostate)	-1.677	0.002	1.0	0.943	0.001	.	.	.	RNF213:uc021uen.2:exon29:c.G7001A:p.S2334N	-0.981	AFR:1(stomach),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,FIN:0.6355,NFE:0.6383,OTH:0.4318,ASJ:MU584311	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	0.0	1.99	0.000	-0.74	17	2(lung)	0.6490
17	78319380	78319380	G	C	RNF213	exonic	synonymous SNV	ENSG00000173821	rs4890012	ENSG00000173821:ENST00000336301:exon4:c.G1464C:p.P488P,ENSG00000173821:ENST00000582970:exon29:c.G7245C:p.P2415P,ENSG00000173821:ENST00000508628:exon30:c.G7392C:p.P2464P	RNF213:NM_001256071:exon29:c.G7245C:p.P2415P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5673	0.5725	0.473243	LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	RNF213:uc021uen.2:exon29:c.G7245C:p.P2415P	.	AFR:0.5618,AMR:0.4197,EAS:0.6324,FIN:0.3897,NFE:0.6884,OTH:0.6375,ASJ:0.3969	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	3(large_intestine)	0.6181
17	78321157	78321157	T	C	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs61600413	ENSG00000173821:ENST00000336301:exon4:c.T3241C:p.C1081R,ENSG00000173821:ENST00000582970:exon29:c.T9022C:p.C3008R,ENSG00000173821:ENST00000508628:exon30:c.T9169C:p.C3057R	RNF213:NM_001256071:exon29:c.T9022C:p.C3008R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0550	0.1134	0.103834	0.0938	-1.434	0.003	0.343	-0.606	0.003	.	.	.	RNF213:uc021uen.2:exon29:c.T9022C:p.C3008R	-0.943	AFR:0.2572,AMR:0.0561,EAS:0.0006,FIN:0.0178,NFE:0.0331,OTH:0.0438,ASJ:0.0497	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	0.002	2.05	0.000	2.015	17	.	het
17	78327358	78327358	G	A	RNF213	exonic	synonymous SNV	ENSG00000173821	rs7216493	ENSG00000173821:ENST00000336301:exon9:c.G4689A:p.E1563E,ENSG00000173821:ENST00000582970:exon34:c.G10470A:p.E3490E,ENSG00000173821:ENST00000508628:exon35:c.G10617A:p.E3539E	RNF213:NM_001256071:exon34:c.G10470A:p.E3490E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6657	0.7094	0.628994	1(stomach)	.	.	.	.	.	.	.	.	RNF213:uc021uen.2:exon34:c.G10470A:p.E3490E	.	AFR:MU584313,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,EAS:0.6880,FIN:0.4797,NFE:0.7152,OTH:0.5329,ASJ:0.6846	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.7239
17	78334206	78334206	G	A	RNF213-AS1	ncRNA_intronic	.	ENSG00000263069	rs8078251	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.45008	0.5860	.	.	.	.	.	.	.	.	.	.	AFR:0.3870,AMR:0.4189,EAS:0.3572,FIN:0.7182,NFE:0.6973,OTH:0.6609,ASJ:0.7053	.	.	.	.	.	.	.	.	.	.	.	.	17	MU14558984	het
17	78337058	78337058	G	C	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs35332090	ENSG00000173821:ENST00000336301:exon15:c.G5731C:p.V1911L,ENSG00000173821:ENST00000582970:exon40:c.G11512C:p.V3838L,ENSG00000173821:ENST00000508628:exon41:c.G11659C:p.V3887L	RNF213:NM_001256071:exon40:c.G11512C:p.V3838L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1089	0.1547	0.146166	MU152954	-0.359	0.484	0.254	-3.89	0.000	.	.	.	RNF213:uc021uen.2:exon40:c.G11512C:p.V3838L	-1.016	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,AMR:0.1295,EAS:0.0885,FIN:0.1192,NFE:0.0198,OTH:0.0636,ASJ:0.2520	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	0.319	1.82	0.000	2.14	17	1(urinary_tract)	0.0908
17	78337584	78337584	A	G	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs61740658	ENSG00000173821:ENST00000336301:exon16:c.A5963G:p.E1988G,ENSG00000173821:ENST00000582970:exon41:c.A11744G:p.E3915G,ENSG00000173821:ENST00000508628:exon42:c.A11891G:p.E3964G	RNF213:NM_001256071:exon41:c.A11744G:p.E3915G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.0848	0.0858	0.0810703	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235	1.333	12.44	0.025	2.81	0.130	.	.	Zinc finger, RING/FYVE/PHD-type	RNF213:uc021uen.2:exon41:c.A11744G:p.E3915G	-1.079	AFR:0.0737,AMR:0.0894,EAS:0.1126,FIN:0.0185,NFE:0.0601,OTH:0.0740,ASJ:0.0609	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	0.023	1.78	0.001	1.9	17	1(lung)	0.0685
17	78354661	78354661	C	T	RNF213	exonic	synonymous SNV	ENSG00000173821	rs4889848	ENSG00000173821:ENST00000336301:exon31:c.C7890T:p.H2630H,ENSG00000173821:ENST00000582970:exon56:c.C13671T:p.H4557H,ENSG00000173821:ENST00000508628:exon57:c.C13818T:p.H4606H	RNF213:NM_001256071:exon56:c.C13671T:p.H4557H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7762	0.8817	0.759385	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	RNF213:uc021uen.2:exon56:c.C13671T:p.H4557H	.	AFR:0.8452,AMR:0.9568,EAS:0.8808,FIN:0.5702,NFE:0.8092,OTH:0.8334,ASJ:0.5979	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.8106
17	78355412	78355412	G	A	RNF213	exonic	synonymous SNV	ENSG00000173821	rs200327542	ENSG00000173821:ENST00000336301:exon32:c.G8082A:p.L2694L,ENSG00000173821:ENST00000582970:exon57:c.G13863A:p.L4621L,ENSG00000173821:ENST00000508628:exon58:c.G14010A:p.L4670L	RNF213:NM_001256071:exon57:c.G13863A:p.L4621L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	0.0033	.	0.00698882	3.229e-05	.	.	.	.	.	.	.	.	RNF213:uc021uen.2:exon57:c.G13863A:p.L4621L	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	.	het
17	78363847	78363847	G	A	RNF213	exonic	synonymous SNV	ENSG00000173821	rs3185057	ENSG00000173821:ENST00000336301:exon42:c.G9540A:p.A3180A,ENSG00000173821:ENST00000582970:exon67:c.G15321A:p.A5107A,ENSG00000173821:ENST00000508628:exon68:c.G15468A:p.A5156A	RNF213:NM_001256071:exon67:c.G15321A:p.A5107A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0790	0.0851	0.0770767	0.0723	.	.	.	.	.	.	.	.	RNF213:uc010dhx.3:exon5:c.G372A:p.A124A,RNF213:uc021uen.2:exon67:c.G15321A:p.A5107A	.	AFR:0.0850,AMR:0.0597,EAS:0.0179,FIN:0.0598,NFE:0.0740,OTH:0.0672,ASJ:0.1093	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	MU152979	het
17	78401588	78401588	G	T	ENDOV	intronic	.	ENSG00000173818	rs8065290	ENSG00000173818:ENST00000519331:exon2:c.G238T:p.G80C	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7144	.	0.763379	0.8478	-0.437	0.314	0.288	-2.2	0.002	.	.	.	.	-1.014	AFR:0.9585,AMR:0.6184,EAS:0.6346,FIN:0.8140,NFE:0.8284,OTH:0.8160,ASJ:0.8775	.	.	.	.	.	.	.	.	.	0.53	0.000	.	17	MU82228311	het
17	78820329	78820329	C	T	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs3751945	ENSG00000141564:ENST00000537330:exon10:c.C714T:p.G238G,ENSG00000141564:ENST00000306801:exon11:c.C1269T:p.G423G,ENSG00000141564:ENST00000544334:exon11:c.C1269T:p.G423G	RPTOR:NM_001163034:exon11:c.C1269T:p.G423G,RPTOR:NM_020761:exon11:c.C1269T:p.G423G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5777	0.4962	0.436701	1(thyroid)	.	.	.	.	.	.	.	.	RPTOR:uc010wuf.1:exon10:c.C714T:p.G238G,RPTOR:uc002jyt.1:exon11:c.C1269T:p.G423G,RPTOR:uc010wug.1:exon11:c.C1269T:p.G423G	.	AFR:1(large_intestine),AMR:MU153336,EAS:0.5072,FIN:0.2247,NFE:0.6065,OTH:0.4901,ASJ:SKCA-BR|1|100|0.01,LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,BLCA-CN|1|103|0.00970874	607130	.	.	.	.	.	.	.	.	.	.	.	17	2(lung)	0.4466
17	78865546	78865546	T	C	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs2289764	ENSG00000141564:ENST00000544334:exon14:c.T1536C:p.L512L,ENSG00000141564:ENST00000306801:exon18:c.T2010C:p.L670L	RPTOR:NM_001163034:exon14:c.T1536C:p.L512L,RPTOR:NM_020761:exon18:c.T2010C:p.L670L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2833	0.3718	0.38139	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	RPTOR:uc010wug.1:exon14:c.T1536C:p.L512L,RPTOR:uc002jyt.1:exon18:c.T2010C:p.L670L	.	AFR:0.3610,AMR:0.6402,EAS:0.2067,FIN:0.2373,NFE:0.2707,OTH:0.2477,ASJ:0.2392	607130	.	.	.	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.2912
17	78865630	78865630	A	G	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs2289765	ENSG00000141564:ENST00000544334:exon14:c.A1620G:p.A540A,ENSG00000141564:ENST00000306801:exon18:c.A2094G:p.A698A	RPTOR:NM_001163034:exon14:c.A1620G:p.A540A,RPTOR:NM_020761:exon18:c.A2094G:p.A698A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1701	0.1825	0.230032	MU21134816	.	.	.	.	.	.	.	.	RPTOR:uc010wug.1:exon14:c.A1620G:p.A540A,RPTOR:uc002jyt.1:exon18:c.A2094G:p.A698A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.1822,EAS:0.1647,FIN:0.1192,NFE:0.2336,OTH:0.1319,ASJ:0.3017	607130	.	.	.	.	.	.	.	.	.	.	.	17	1(lung)	0.1227
17	78919558	78919558	C	T	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs1567962	ENSG00000141564:ENST00000544334:exon22:c.C2643T:p.A881A,ENSG00000141564:ENST00000306801:exon26:c.C3117T:p.A1039A	RPTOR:NM_001163034:exon22:c.C2643T:p.A881A,RPTOR:NM_020761:exon26:c.C3117T:p.A1039A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3595	0.3622	0.374601	1(stomach)	.	.	.	.	.	.	.	.	RPTOR:uc010wug.1:exon22:c.C2643T:p.A881A,RPTOR:uc002jyt.1:exon26:c.C3117T:p.A1039A	.	AFR:MU730207,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.3922,FIN:0.3321,NFE:0.3767,OTH:0.4504,ASJ:0.3587	607130	.	.	.	.	.	.	.	.	.	.	.	17	2(haematopoietic_and_lymphoid_tissue)	0.2964
17	78935197	78935197	C	T	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs9899178	ENSG00000141564:ENST00000544334:exon27:c.C3135T:p.R1045R,ENSG00000141564:ENST00000306801:exon31:c.C3609T:p.R1203R	RPTOR:NM_001163034:exon27:c.C3135T:p.R1045R,RPTOR:NM_020761:exon31:c.C3609T:p.R1203R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3298	0.2502	0.309505	0.2998	.	.	.	.	.	.	.	.	RPTOR:uc002jyu.1:exon4:c.C288T:p.R96R,RPTOR:uc010wug.1:exon27:c.C3135T:p.R1045R,RPTOR:uc002jyt.1:exon31:c.C3609T:p.R1203R	.	AFR:0.1310,AMR:0.3678,EAS:0.5547,FIN:0.3723,NFE:0.3449,OTH:0.3535,ASJ:0.3874	607130	.	.	.	.	.	.	.	.	.	.	.	17	MU4552093	het
17	79508400	79508400	T	C	FAAP100	exonic	nonsynonymous SNV	ENSG00000185504	rs14422	ENSG00000185504:ENST00000425898:exon4:c.A1396G:p.T466A,ENSG00000185504:ENST00000327787:exon8:c.A2449G:p.T817A,ENSG00000185504:ENST00000537152:exon8:c.A1996G:p.T666A	FAAP100:NM_025161:exon8:c.A2449G:p.T817A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9258	0.9239	0.946486	0.9253	-0.334	0.554	1.0	2.88	0.014	.	.	.	C17orf70:uc002kao.1:exon4:c.A1396G:p.T466A,C17orf70:uc002kap.3:exon8:c.A1996G:p.T666A,C17orf70:uc002kaq.3:exon8:c.A2449G:p.T817A	-1.002	AFR:0.9493,AMR:0.9451,EAS:1,FIN:0.8901,NFE:0.9112,OTH:0.9276,ASJ:0.8709	611301	.	.	.	.	.	.	.	0.0	1.82	0.000	-2.595	17	MU4565620	hom
17	79511135	79511135	A	G	FAAP100	exonic	synonymous SNV	ENSG00000185504	rs8077430	ENSG00000185504:ENST00000425898:exon3:c.T1269C:p.T423T,ENSG00000185504:ENST00000327787:exon7:c.T2322C:p.T774T,ENSG00000185504:ENST00000537152:exon7:c.T1869C:p.T623T	FAAP100:NM_025161:exon7:c.T2322C:p.T774T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7571	0.6971	0.704473	MU9296095	.	.	.	.	.	.	.	.	C17orf70:uc002kao.1:exon3:c.T1269C:p.T423T,C17orf70:uc002kap.3:exon7:c.T1869C:p.T623T,C17orf70:uc002kaq.3:exon7:c.T2322C:p.T774T	.	AFR:COCA-CN|5|321|0.0155763,BTCA-JP|1|239|0.0041841,AMR:0.7152,EAS:0.8261,FIN:0.69,NFE:0.7673,OTH:0.7745,ASJ:0.5533	611301	.	.	.	.	.	.	.	.	.	.	.	17	1(biliary_tract)	0.7801
17	79514129	79514129	G	A	FAAP100	exonic	nonsynonymous SNV	ENSG00000185504	rs11552304	ENSG00000185504:ENST00000425898:exon1:c.C926T:p.P309L,ENSG00000185504:ENST00000545865:exon1:c.C101T:p.P34L,ENSG00000185504:ENST00000327787:exon5:c.C1979T:p.P660L,ENSG00000185504:ENST00000537152:exon5:c.C1526T:p.P509L	FAAP100:NM_025161:exon5:c.C1979T:p.P660L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6217	0.5780	0.55631	1(thyroid)	0.156	4.215	0.358	0.069	0.001	.	.	.	C17orf70:uc002kao.1:exon1:c.C926T:p.P309L,C17orf70:uc002kap.3:exon5:c.C1526T:p.P509L,C17orf70:uc002kaq.3:exon5:c.C1979T:p.P660L	-0.955	AFR:1(urinary_tract),AMR:MU109692,EAS:0.5992,FIN:0.4122,NFE:0.4880,OTH:0.5728,ASJ:COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	611301	.	.	.	.	.	.	.	0.394	1.53	0.000	1.5	17	1(breast)	0.6735
17	79517286	79517286	T	C	FAAP100	exonic	nonsynonymous SNV	ENSG00000185504	rs151231414	ENSG00000185504:ENST00000541246:exon2:c.A781G:p.R261G,ENSG00000185504:ENST00000327787:exon3:c.A1234G:p.R412G,ENSG00000185504:ENST00000537152:exon3:c.A781G:p.R261G	FAAP100:NM_025161:exon3:c.A1234G:p.R412G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0056	0.0016	0.00479233	.	-0.205	1.071	0.574	-0.45	0.001	.	.	WD40/YVTN repeat-like-containing domain	C17orf70:uc002kap.3:exon3:c.A781G:p.R261G,C17orf70:uc002kaq.3:exon3:c.A1234G:p.R412G	-1.001	AFR:0.0017,AMR:0.0002,EAS:0.0232,FIN:0,NFE:0.0029,OTH:0.0020,ASJ:0.0024	611301	.	.	.	.	.	.	.	0.002	1.48	0.046	1.01	17	1(lung)	0.0031
17	79954544	79954544	T	A	ASPSCR1	exonic	nonsynonymous SNV	ENSG00000169696	rs8074498	ENSG00000169696:ENST00000582355:exon3:c.T242A:p.L81Q,ENSG00000169696:ENST00000580534:exon6:c.T524A:p.L175Q,ENSG00000169696:ENST00000306729:exon7:c.T755A:p.L252Q,ENSG00000169696:ENST00000306739:exon7:c.T755A:p.L252Q,ENSG00000169696:ENST00000581484:exon7:c.T746A:p.L249Q,ENSG00000169696:ENST00000584454:exon7:c.T524A:p.L175Q	ASPSCR1:NM_001330528:exon6:c.T524A:p.L175Q,ASPSCR1:NM_001251888:exon7:c.T755A:p.L252Q,ASPSCR1:NM_024083:exon7:c.T755A:p.L252Q	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 1, 0] 	0.4969	0.4969	0.382788	1(stomach)	4.005	23.6	0.055	4.93	0.876	.	.	.	ASPSCR1:uc002kda.3:exon6:c.T524A:p.L175Q,ASPSCR1:uc021ufj.1:exon6:c.T524A:p.L175Q,ASPSCR1:uc002kcx.3:exon7:c.T755A:p.L252Q,ASPSCR1:uc002kcy.3:exon7:c.T755A:p.L252Q,ASPSCR1:uc002kdb.1:exon7:c.T524A:p.L175Q	-0.867	AFR:1(upper_aerodigestive_tract),AMR:MU789868,EAS:0.4995,FIN:0.3309,NFE:0.4234,OTH:0.5894,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	606236	606243;	163699;	163699|ASPS<br>Alveolar soft-part sarcoma|-|-|All ages|606243 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	1.0	1.19	0.000	3.145	17	2(breast)	0.1886
17	79967461	79967461	-	GGGGCGACTGAGGCACAGCTCTGACGGGGCCCCCCTGAGGTCTACGGATGGGACGTA	ASPSCR1	intronic	.	ENSG00000169696	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0719	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606236	606243;	163699;	163699|ASPS<br>Alveolar soft-part sarcoma|-|-|All ages|606243 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	17	.	het
17	79974731	79974731	T	C	ASPSCR1	exonic	synonymous SNV	ENSG00000169696	rs13087	ENSG00000169696:ENST00000584454:exon15:c.T1351C:p.C451R	ASPSCR1:NM_001330528:exon13:c.T1305C:p.D435D,ASPSCR1:NM_024083:exon14:c.T1461C:p.D487D,ASPSCR1:NM_001251888:exon15:c.T1743C:p.D581D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5906	0.6464	0.580272	1(urinary_tract)	.	.	.	.	.	.	.	.	ASPSCR1:uc002kda.3:exon13:c.T1305C:p.D435D,ASPSCR1:uc021ufj.1:exon13:c.T1230C:p.D410D,ASPSCR1:uc002kcx.3:exon14:c.T1461C:p.D487D,ASPSCR1:uc002kcy.3:exon15:c.T1743C:p.D581D	.	AFR:1(stomach),AMR:2(lung),EAS:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,FIN:0.6414,NFE:0.7619,OTH:0.5167,ASJ:MU796615	606236	606243;	163699;	163699|ASPS<br>Alveolar soft-part sarcoma|-|-|All ages|606243 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	17	1(thyroid)	0.6093
17	80039028	80039028	A	G	FASN	intronic	.	ENSG00000169710	rs4246445	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6901	0.7545	0.664337	0.7443	.	.	.	.	.	.	.	.	.	.	AFR:0.8027,AMR:0.7464,EAS:0.4422,FIN:0.7504,NFE:0.7442,OTH:0.7362,ASJ:0.6258	600212	.	.	.	.	.	.	.	.	.	.	.	17	MU16099716	het
17	80039481	80039481	G	A	FASN	exonic	synonymous SNV	ENSG00000169710	rs1140616	ENSG00000169710:ENST00000306749:exon37:c.C6402T:p.I2134I	FASN:NM_004104:exon37:c.C6402T:p.I2134I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4254	0.4224	0.303914	MU816391	.	.	.	.	.	.	.	.	FASN:uc002kdu.3:exon37:c.C6402T:p.I2134I	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.4258,EAS:0.2840,FIN:0.3609,NFE:0.3325,OTH:0.5198,ASJ:0.2187	600212	.	.	.	.	.	.	.	.	.	.	.	17	1(salivary_gland)	0.5391
17	80043349	80043349	C	T	FASN	intronic	.	ENSG00000169710	rs17848939	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5105	0.5704	0.422125	0.5185	.	.	.	.	.	.	.	.	.	.	AFR:0.5097,AMR:0.2926,EAS:0.3548,FIN:0.5418,NFE:0.5509,OTH:0.5339,ASJ:0.35	600212	.	.	.	.	.	.	.	.	.	.	.	17	MU20220915	het
17	80048961	80048961	C	T	FASN	intronic	.	ENSG00000169710	rs17848927	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0214	0.0214	0.0493211	0.0210	.	.	.	.	.	.	.	.	.	.	AFR:0.0648,AMR:0.0119,EAS:0.0111,FIN:0,NFE:0.0023,OTH:0.0204,ASJ:0.0033	600212	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	80050555	80050556	GG	-	FASN	intronic	.	ENSG00000169710	rs10591316	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.8259	.	.	0.9578	.	.	.	.	.	.	.	.	.	.	AFR:0.9723,AMR:0.9644,EAS:0.9889,FIN:0.9440,NFE:0.9507,OTH:0.9350,ASJ:0.9195	600212	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
18	724612	724612	A	G	YES1	exonic	synonymous SNV	ENSG00000176105	rs537141	ENSG00000176105:ENST00000314574:exon12:c.T1444C:p.L482L,ENSG00000176105:ENST00000577961:exon12:c.T1459C:p.L487L,ENSG00000176105:ENST00000584307:exon12:c.T1444C:p.L482L	YES1:NM_005433:exon12:c.T1444C:p.L482L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9973	0.9913	0.989816	0.9924	.	.	.	.	.	.	.	.	YES1:uc002kky.3:exon12:c.T1444C:p.L482L,YES1:uc002kkz.3:exon12:c.T1444C:p.L482L	.	AFR:0.9731,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	164880	.	.	.	.	.	.	.	.	.	.	.	18	MU82003345	hom
18	3457606	3457606	C	T	TGIF1	exonic	nonsynonymous SNV	ENSG00000177426	rs4468717	ENSG00000177426:ENST00000472042:exon2:c.C427T:p.P143S,ENSG00000177426:ENST00000330513:exon3:c.C874T:p.P292S,ENSG00000177426:ENST00000343820:exon3:c.C487T:p.P163S,ENSG00000177426:ENST00000345133:exon3:c.C427T:p.P143S,ENSG00000177426:ENST00000400167:exon3:c.C427T:p.P143S,ENSG00000177426:ENST00000405385:exon3:c.C427T:p.P143S,ENSG00000177426:ENST00000548489:exon3:c.C529T:p.P177S,ENSG00000177426:ENST00000549546:exon3:c.C427T:p.P143S,ENSG00000177426:ENST00000549780:exon3:c.C427T:p.P143S,ENSG00000177426:ENST00000551541:exon3:c.C427T:p.P143S,ENSG00000177426:ENST00000401449:exon4:c.C427T:p.P143S,ENSG00000177426:ENST00000407501:exon4:c.C487T:p.P163S,ENSG00000177426:ENST00000552383:exon4:c.C427T:p.P143S	TGIF1:NM_001278682:exon3:c.C496T:p.P166S,TGIF1:NM_003244:exon3:c.C487T:p.P163S,TGIF1:NM_170695:exon3:c.C874T:p.P292S,TGIF1:NM_173207:exon3:c.C529T:p.P177S,TGIF1:NM_173209:exon3:c.C427T:p.P143S,TGIF1:NM_173210:exon3:c.C427T:p.P143S,TGIF1:NM_173211:exon3:c.C427T:p.P143S,TGIF1:NM_001278684:exon4:c.C487T:p.P163S,TGIF1:NM_001278686:exon4:c.C427T:p.P143S,TGIF1:NM_173208:exon4:c.C487T:p.P163S,TGIF1:NM_174886:exon4:c.C427T:p.P143S	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0602	0.0570	0.0313498	0.0611	1.301	12.27	0.017	5.26	0.014	.	.	Homeobox domain;Homeobox domain|Homeobox domain-like	TGIF1:uc002kmc.3:exon2:c.C427T:p.P143S,TGIF1:uc002klv.3:exon3:c.C529T:p.P177S,TGIF1:uc002klx.3:exon3:c.C427T:p.P143S,TGIF1:uc002kly.3:exon3:c.C487T:p.P163S,TGIF1:uc002klz.3:exon3:c.C874T:p.P292S,TGIF1:uc002kma.3:exon3:c.C427T:p.P143S,TGIF1:uc002kmb.3:exon3:c.C427T:p.P143S,TGIF1:uc002klu.3:exon4:c.C427T:p.P143S,TGIF1:uc002klw.3:exon4:c.C487T:p.P163S	-1.046	AFR:0.0145,AMR:0.0477,EAS:0,FIN:0.1442,NFE:0.0743,OTH:0.0774,ASJ:0.0960	602630	142946;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	0.726	-0.1	0.012	1.78	18	MU87231640	het
18	22642718	22642722	AAAAA	-	ZNF521	intronic	.	ENSG00000198795	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	610974	.	.	.	.	.	.	.	.	.	.	.	18	.	unknown
18	28673565	28673565	T	C	DSC2	exonic	synonymous SNV	ENSG00000134755	rs12954874	ENSG00000134755:ENST00000251081:exon2:c.A111G:p.L37L,ENSG00000134755:ENST00000280904:exon2:c.A111G:p.L37L	DSC2:NM_004949:exon2:c.A111G:p.L37L,DSC2:NM_024422:exon2:c.A111G:p.L37L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1127	0.1071	0.123602	ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	DSC2:uc002kwk.4:exon2:c.A111G:p.L37L,DSC2:uc002kwl.4:exon2:c.A111G:p.L37L,DSC2:uc010xbo.1:exon2:c.A111G:p.L37L	.	AFR:0.0998,AMR:0.0819,EAS:0.1424,FIN:0.1166,NFE:0.0370,OTH:0.1185,ASJ:0.1541	125645	610476;	217656;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	18	1(breast)	0.1063
18	42529996	42529996	G	C	SETBP1	exonic	nonsynonymous SNV	ENSG00000152217	rs11082414	ENSG00000152217:ENST00000282030:exon4:c.G691C:p.V231L	SETBP1:NM_015559:exon4:c.G691C:p.V231L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 1, -1, 1, 1] 	0.1934	0.1853	0.156749	0.1822	-1.244	0.006	0.029	-5.47	0.557	.	.	.	SETBP1:uc010dni.3:exon4:c.G691C:p.V231L	-1.011	AFR:0.1540,AMR:0.1885,EAS:0.0123,FIN:0.2212,NFE:0.2064,OTH:0.2076,ASJ:0.1567	611060	269150;616078;	436151;798;	436151|Intellectual disability-loss of expressive language-facial dysmorphism syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616078 616083 ~798|SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal<br>Infancy|269150 ~	.	,9643	.	,9646,9647	0.006	1.33	0.000	0	18	.	hom
18	42533130	42533130	A	G	SETBP1	exonic	synonymous SNV	ENSG00000152217	rs8096662	ENSG00000152217:ENST00000282030:exon4:c.A3825G:p.S1275S	SETBP1:NM_015559:exon4:c.A3825G:p.S1275S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8775	0.8996	0.906949	0.9062	.	.	.	.	.	.	.	.	SETBP1:uc010dni.3:exon4:c.A3825G:p.S1275S	.	AFR:0.9722,AMR:0.9427,EAS:0.9560,FIN:0.8886,NFE:0.8676,OTH:0.8663,ASJ:0.8775	611060	269150;616078;	436151;798;	436151|Intellectual disability-loss of expressive language-facial dysmorphism syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616078 616083 ~798|SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal<br>Infancy|269150 ~	.	,9643	.	,9646,9647	.	.	.	.	18	MU21144927	hom
18	49867224	49867224	T	C	DCC	exonic	nonsynonymous SNV	ENSG00000187323	rs9951523	ENSG00000187323:ENST00000442544:exon1:c.T67C:p.F23L	DCC:NM_005215:exon1:c.T67C:p.F23L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9862	0.9892	0.995807	0.9833	1.932	15.79	1.0	4.83	0.995	.	.	Immunoglobulin-like domain	DCC:uc002lfe.2:exon1:c.T67C:p.F23L	-0.966	AFR:0.9979,AMR:0.9904,EAS:1,FIN:0.9399,NFE:0.9834,OTH:0.9735,ASJ:0.9801	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	0.0	0.84	0.000	0	18	MU82007106	hom
18	50432602	50432602	C	G	DCC	exonic	nonsynonymous SNV	ENSG00000187323	rs2229080	ENSG00000187323:ENST00000412726:exon3:c.C145G:p.R49G,ENSG00000187323:ENST00000442544:exon3:c.C601G:p.R201G	DCC:NM_005215:exon3:c.C601G:p.R201G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4447	0.3594	0.477436	MU788932	2.708	20.9	0.114	-0.494	0.993	.	.	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	DCC:uc002lfe.2:exon3:c.C601G:p.R201G,DCC:uc010xdr.1:exon3:c.C145G:p.R49G	-0.913	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.3620,EAS:0.5769,FIN:0.4867,NFE:0.5330,OTH:0.3907,ASJ:0.3290	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	0.083	1.11	0.000	0.405	18	1(haematopoietic_and_lymphoid_tissue)	0.3401
18	50832102	50832102	A	G	DCC	intronic	.	ENSG00000187323	rs1431196	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3183	0.3201	0.161741	0.3176	.	.	.	.	.	.	.	.	.	.	AFR:0.1015,AMR:0.2064,EAS:0.0364,FIN:0.3975,NFE:0.4558,OTH:0.3931,ASJ:0.3543	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	18	MU124308961	het
18	50936994	50936994	T	C	DCC	exonic	synonymous SNV	ENSG00000187323	rs2229082	ENSG00000187323:ENST00000581580:exon17:c.T2013C:p.P671P,ENSG00000187323:ENST00000412726:exon20:c.T2592C:p.P864P,ENSG00000187323:ENST00000442544:exon20:c.T3108C:p.P1036P	DCC:NM_005215:exon20:c.T3108C:p.P1036P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4517	0.4359	0.310304	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	DCC:uc010dpf.2:exon17:c.T2013C:p.P671P,DCC:uc002lfe.2:exon20:c.T3108C:p.P1036P,DCC:uc010xdr.1:exon20:c.T2592C:p.P864P	.	AFR:3(lung),AMR:MU13066566,EAS:0.4582,FIN:0.2317,NFE:0.2924,OTH:0.4570,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	18	3(large_intestine)	0.2382
18	50937026	50937026	A	G	DCC	intronic	.	ENSG00000187323	rs11873515	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4537	0.4358	0.309904	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.4583,AMR:0.2323,EAS:0.46,FIN:0.2392,NFE:0.6188,OTH:0.5789,ASJ:0.2924	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	18	1(haematopoietic_and_lymphoid_tissue)	0.5594
18	51056915	51056915	G	T	DCC	intronic	.	ENSG00000264263	rs2270953	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1585	0.1243	0.182109	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:MU584431,AMR:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.1456,FIN:0.3282,NFE:0.0927,OTH:0.2166,ASJ:0.1343	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	18	1(stomach)	0.1246
18	51795958	51795960	CGA	-	POLI	exonic	nonframeshift deletion	ENSG00000101751	rs10584411	ENSG00000101751:ENST00000406285:exon1:c.42_44del:p.14_15del,ENSG00000101751:ENST00000579534:exon1:c.42_44del:p.14_15del	POLI:NM_001351610:exon1:c.42_44del:p.14_15del,POLI:NM_001351613:exon1:c.42_44del:p.14_15del,POLI:NM_001351616:exon1:c.42_44del:p.14_15del,POLI:NM_001351621:exon1:c.42_44del:p.14_15del,POLI:NM_007195:exon1:c.42_44del:p.14_15del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7635	0.7612	0.783946	0.7640	.	.	.	.	.	.	.	.	POLI:uc002lfj.4:exon1:c.42_44del:p.14_15del,POLI:uc010xds.2:exon1:c.42_44del:p.14_15del	.	AFR:0.9280,AMR:0.6019,EAS:0.7032,FIN:0.7334,NFE:0.6922,OTH:0.7330,ASJ:0.8079	605252	.	.	.	.	.	.	.	.	.	.	.	18	MU99873	het
18	51820805	51820805	G	A	POLI	exonic	nonsynonymous SNV	ENSG00000101751	rs8305	ENSG00000101751:ENST00000217800:exon9:c.G1813A:p.A605T,ENSG00000101751:ENST00000406285:exon9:c.G1954A:p.A652T,ENSG00000101751:ENST00000579434:exon9:c.G1882A:p.A628T,ENSG00000101751:ENST00000579534:exon10:c.G2191A:p.A731T	POLI:NM_001351616:exon8:c.G1828A:p.A610T,POLI:NM_001351610:exon9:c.G2065A:p.A689T,POLI:NM_001351613:exon9:c.G1954A:p.A652T,POLI:NM_001351614:exon9:c.G1882A:p.A628T,POLI:NM_001351615:exon9:c.G1882A:p.A628T,POLI:NM_001351617:exon9:c.G1648A:p.A550T,POLI:NM_001351620:exon9:c.G1411A:p.A471T,POLI:NM_001351611:exon10:c.G1987A:p.A663T,POLI:NM_001351612:exon10:c.G1987A:p.A663T,POLI:NM_001351618:exon10:c.G1648A:p.A550T,POLI:NM_001351619:exon10:c.G1648A:p.A550T,POLI:NM_001351632:exon10:c.G2116A:p.A706T,POLI:NM_007195:exon10:c.G2191A:p.A731T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7282	0.7780	0.789137	LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,WT-US|1|102|0.00980392	-0.572	0.146	0.892	-5.15	0.278	.	.	.	POLI:uc010dpg.3:exon6:c.G979A:p.A327T,POLI:uc002lfk.4:exon9:c.G1882A:p.A628T,POLI:uc010xds.2:exon9:c.G1954A:p.A652T,POLI:uc002lfj.4:exon10:c.G2191A:p.A731T	-0.992	AFR:0.7686,AMR:0.9401,EAS:0.8079,FIN:0.7055,NFE:0.7325,OTH:0.6945,ASJ:0.6041	605252	.	.	.	.	.	.	.	0.001	1.12	0.000	-0.345	18	2(lung)	0.7311
18	52895531	52895531	T	C	TCF4	exonic	synonymous SNV	ENSG00000196628	rs8766	ENSG00000196628:ENST00000457482:exon12:c.A1461G:p.S487S,ENSG00000196628:ENST00000561831:exon12:c.A1449G:p.S483S,ENSG00000196628:ENST00000570287:exon12:c.A1449G:p.S483S,ENSG00000196628:ENST00000537856:exon14:c.A1539G:p.S513S,ENSG00000196628:ENST00000570177:exon14:c.A1539G:p.S513S,ENSG00000196628:ENST00000544241:exon15:c.A1728G:p.S576S,ENSG00000196628:ENST00000561992:exon15:c.A1539G:p.S513S,ENSG00000196628:ENST00000564228:exon15:c.A1716G:p.S572S,ENSG00000196628:ENST00000567880:exon16:c.A1749G:p.S583S,ENSG00000196628:ENST00000543082:exon17:c.A1803G:p.S601S,ENSG00000196628:ENST00000566279:exon17:c.A1761G:p.S587S,ENSG00000196628:ENST00000537578:exon18:c.A1869G:p.S623S,ENSG00000196628:ENST00000540999:exon18:c.A1857G:p.S619S,ENSG00000196628:ENST00000566286:exon18:c.A1920G:p.S640S,ENSG00000196628:ENST00000568673:exon18:c.A1869G:p.S623S,ENSG00000196628:ENST00000568740:exon18:c.A1854G:p.S618S,ENSG00000196628:ENST00000354452:exon19:c.A1941G:p.S647S,ENSG00000196628:ENST00000356073:exon19:c.A1929G:p.S643S,ENSG00000196628:ENST00000564403:exon19:c.A1959G:p.S653S,ENSG00000196628:ENST00000564999:exon19:c.A1929G:p.S643S,ENSG00000196628:ENST00000565018:exon19:c.A1941G:p.S647S,ENSG00000196628:ENST00000398339:exon20:c.A2247G:p.S749S	TCF4:NM_001243234:exon12:c.A1461G:p.S487S,TCF4:NM_001243235:exon12:c.A1449G:p.S483S,TCF4:NM_001243236:exon12:c.A1449G:p.S483S,TCF4:NM_001348214:exon12:c.A1446G:p.S482S,TCF4:NM_001348215:exon12:c.A1293G:p.S431S,TCF4:NM_001348216:exon12:c.A1461G:p.S487S,TCF4:NM_001330605:exon14:c.A1551G:p.S517S,TCF4:NM_001243232:exon15:c.A1728G:p.S576S,TCF4:NM_001243233:exon15:c.A1539G:p.S513S,TCF4:NM_001306208:exon15:c.A1716G:p.S572S,TCF4:NM_001348212:exon15:c.A1539G:p.S513S,TCF4:NM_001348213:exon15:c.A1551G:p.S517S,TCF4:NM_001243231:exon17:c.A1803G:p.S601S,TCF4:NM_001348211:exon17:c.A1815G:p.S605S,TCF4:NM_001243227:exon18:c.A1869G:p.S623S,TCF4:NM_001243230:exon18:c.A1920G:p.S640S,TCF4:NM_001306207:exon18:c.A1857G:p.S619S,TCF4:NM_001348217:exon18:c.A1869G:p.S623S,TCF4:NM_001348218:exon18:c.A1869G:p.S623S,TCF4:NM_001348219:exon18:c.A1857G:p.S619S,TCF4:NM_001348220:exon18:c.A1854G:p.S618S,TCF4:NM_001369575:exon18:c.A1869G:p.S623S,TCF4:NM_001369576:exon18:c.A1866G:p.S622S,TCF4:NM_001369577:exon18:c.A1866G:p.S622S,TCF4:NM_001369578:exon18:c.A1866G:p.S622S,TCF4:NM_001369579:exon18:c.A1866G:p.S622S,TCF4:NM_001369580:exon18:c.A1866G:p.S622S,TCF4:NM_001369581:exon18:c.A1866G:p.S622S,TCF4:NM_001369582:exon18:c.A1857G:p.S619S,TCF4:NM_001369583:exon18:c.A1857G:p.S619S,TCF4:NM_001369584:exon18:c.A1854G:p.S618S,TCF4:NM_001369585:exon18:c.A1854G:p.S618S,TCF4:NM_001369586:exon18:c.A1872G:p.S624S,TCF4:NM_001083962:exon19:c.A1941G:p.S647S,TCF4:NM_001243228:exon19:c.A1959G:p.S653S,TCF4:NM_001330604:exon19:c.A1938G:p.S646S,TCF4:NM_001369567:exon19:c.A1941G:p.S647S,TCF4:NM_001369568:exon19:c.A1941G:p.S647S,TCF4:NM_001369569:exon19:c.A1938G:p.S646S,TCF4:NM_001369570:exon19:c.A1938G:p.S646S,TCF4:NM_001369571:exon19:c.A1929G:p.S643S,TCF4:NM_001369572:exon19:c.A1929G:p.S643S,TCF4:NM_001369573:exon19:c.A1926G:p.S642S,TCF4:NM_001369574:exon19:c.A1926G:p.S642S,TCF4:NM_003199:exon19:c.A1929G:p.S643S,TCF4:NM_001243226:exon20:c.A2247G:p.S749S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3714	0.3647	0.342452	MU19123238	.	.	.	.	.	.	.	.	TCF4:uc002lfw.4:exon12:c.A1461G:p.S487S,TCF4:uc021ukg.1:exon12:c.A1449G:p.S483S,TCF4:uc021ukh.1:exon12:c.A1449G:p.S483S,TCF4:uc010xdu.1:exon14:c.A1539G:p.S513S,TCF4:uc010xdv.1:exon14:c.A1539G:p.S513S,TCF4:uc002lfx.2:exon15:c.A1728G:p.S576S,TCF4:uc010xdw.1:exon15:c.A1539G:p.S513S,TCF4:uc021uki.1:exon15:c.A1716G:p.S572S,TCF4:uc021ukj.1:exon16:c.A1749G:p.S583S,TCF4:uc021ukk.1:exon16:c.A1761G:p.S587S,TCF4:uc002lfy.2:exon17:c.A1803G:p.S601S,TCF4:uc010xdx.1:exon18:c.A1857G:p.S619S,TCF4:uc010xdy.1:exon18:c.A1869G:p.S623S,TCF4:uc021ukl.1:exon18:c.A1920G:p.S640S,TCF4:uc002lfz.2:exon19:c.A1929G:p.S643S,TCF4:uc010dph.1:exon19:c.A1941G:p.S647S,TCF4:uc010dpi.3:exon19:c.A1959G:p.S653S,TCF4:uc002lga.3:exon20:c.A2247G:p.S749S	.	AFR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.3747,EAS:0.3565,FIN:0.3874,NFE:0.4709,OTH:0.3934,ASJ:0.3184	602272	610954;613267;	98974;2896;	98974|Endoepithelial corneal dystrophy<br>FECD<br>Late hereditary endothelial dystrophy|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|136800 610158 613267 613268 613269 613270 613271 615523 ~2896|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|610954 ~	.	.	.	.	.	.	.	.	18	1(lung)	0.3953
18	53303101	53303101	C	G	TCF4	exonic	nonsynonymous SNV	ENSG00000196628	rs611326	ENSG00000196628:ENST00000398339:exon1:c.G28C:p.A10P,ENSG00000196628:ENST00000565124:exon1:c.G28C:p.A10P	TCF4:NM_001243226:exon1:c.G28C:p.A10P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9994	0.9988	0.996805	0.9987	.	.	.	.	.	.	.	.	TCF4:uc002lga.3:exon1:c.G28C:p.A10P,TCF4:uc021ukp.1:exon1:c.G28C:p.A10P	.	AFR:0.9953,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	602272	610954;613267;	98974;2896;	98974|Endoepithelial corneal dystrophy<br>FECD<br>Late hereditary endothelial dystrophy|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|136800 610158 613267 613268 613269 613270 613271 615523 ~2896|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|610954 ~	.	.	.	.	.	.	.	.	18	MU82007295	hom
18	60970036	60970036	C	A	BCL2	intronic	.	ENSG00000171791	rs4941195	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.583067	0.5089	.	.	.	.	.	.	.	.	.	.	AFR:0.6602,AMR:0.4544,EAS:0.7348,FIN:0.4121,NFE:0.4239,OTH:0.4561,ASJ:0.6026	151430	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04141 Protein processing in endoplasmic reticulum~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04261 Adrenergic signaling in cardiomyocytes~ko04340 Hedgehog signaling pathway~ko04510 Focal adhesion~ko04621 NOD-like receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04915 Estrogen signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05162 Measles~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05215 Prostate cancer~ko05222 Small cell lung cancer~ko05226 Gastric cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	18	MU13088314	het
18	60985879	60985879	T	C	BCL2	exonic	synonymous SNV	ENSG00000171791	rs1801018	ENSG00000171791:ENST00000398117:exon1:c.A21G:p.T7T,ENSG00000171791:ENST00000589955:exon1:c.A21G:p.T7T,ENSG00000171791:ENST00000333681:exon2:c.A21G:p.T7T,ENSG00000171791:ENST00000444484:exon2:c.A21G:p.T7T	BCL2:NM_000633:exon2:c.A21G:p.T7T,BCL2:NM_000657:exon2:c.A21G:p.T7T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.3688	0.3104	0.243211	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	BCL2:uc002liu.1:exon1:c.A21G:p.T7T,BCL2:uc021ulf.1:exon1:c.A21G:p.T7T,BCL2:uc002lit.1:exon2:c.A21G:p.T7T,BCL2:uc002liv.1:exon2:c.A21G:p.T7T	.	AFR:MU13088333,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,EAS:0.0841,FIN:0.4055,NFE:0.3113,OTH:0.0953,ASJ:0.3240	151430	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04141 Protein processing in endoplasmic reticulum~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04261 Adrenergic signaling in cardiomyocytes~ko04340 Hedgehog signaling pathway~ko04510 Focal adhesion~ko04621 NOD-like receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04915 Estrogen signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05162 Measles~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05215 Prostate cancer~ko05222 Small cell lung cancer~ko05226 Gastric cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	966,	.	.	.	.	18	2(lung)	0.4679
18	67718688	67718688	A	G	RTTN	exonic	nonsynonymous SNV	ENSG00000176225	rs4891392	ENSG00000176225:ENST00000255674:exon39:c.T5282C:p.F1761S	RTTN:NM_001318520:exon38:c.T2546C:p.F849S,RTTN:NM_173630:exon39:c.T5282C:p.F1761S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9184	0.8027	0.790735	0.8082	-0.332	0.561	0.978	-1.23	0.000	.	.	Armadillo-like helical	RTTN:uc010dqp.2:exon5:c.T38C:p.F13S,RTTN:uc010xfb.1:exon38:c.T2546C:p.F849S,RTTN:uc002lkp.2:exon39:c.T5282C:p.F1761S	-1.032	AFR:0.4213,AMR:0.9391,EAS:1,FIN:0.9619,NFE:0.9574,OTH:0.9439,ASJ:0.9404	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	0.0	0.93	0.000	-0.65	18	MU82008699	hom
18	67753931	67753945	AAAAAAAAAAAAAAA	-	RTTN	intronic	.	ENSG00000176225	rs768452992	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0147	.	.	0.3739	.	.	.	.	.	.	.	.	.	.	AFR:0.3004,AMR:0.3427,EAS:0.6305,FIN:0.05,NFE:0.3849,OTH:0.3669,ASJ:0.2662	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	.	.	.	.	18	.	hom
18	67863850	67863850	-	CTC	RTTN	exonic	nonframeshift insertion	ENSG00000176225	rs58913700	ENSG00000176225:ENST00000583043:exon2:c.97_98insGAG:p.D33delinsGD,ENSG00000176225:ENST00000255674:exon7:c.727_728insGAG:p.D243delinsGD,ENSG00000176225:ENST00000437017:exon7:c.727_728insGAG:p.D243delinsGD,ENSG00000176225:ENST00000454359:exon7:c.727_728insGAG:p.D243delinsGD,ENSG00000176225:ENST00000581161:exon7:c.727_728insGAG:p.D243delinsGD	RTTN:NM_173630:exon7:c.727_728insGAG:p.D243delinsGD	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.9870	0.9540	0.952676	0.9584	.	.	.	.	.	.	.	.	RTTN:uc002lkp.2:exon7:c.727_728insGAG:p.D243delinsGD,RTTN:uc002lkq.1:exon7:c.727_728insGAG:p.D243delinsGD	.	AFR:0.8541,AMR:0.9892,EAS:1,FIN:1,NFE:0.9994,OTH:0.9969,ASJ:1	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	.	.	.	.	18	.	hom
18	67871343	67871343	A	C	RTTN	exonic	nonsynonymous SNV	ENSG00000176225	rs3911730	ENSG00000176225:ENST00000255674:exon3:c.T376G:p.S126A,ENSG00000176225:ENST00000437017:exon3:c.T376G:p.S126A,ENSG00000176225:ENST00000454359:exon3:c.T376G:p.S126A,ENSG00000176225:ENST00000581161:exon3:c.T376G:p.S126A	RTTN:NM_173630:exon3:c.T376G:p.S126A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8654	0.7273	0.71226	0.7339	-0.692	0.075	0.698	-1.54	0.175	.	.	Armadillo-like helical	RTTN:uc002lkp.2:exon3:c.T376G:p.S126A,RTTN:uc002lkq.1:exon3:c.T376G:p.S126A	-0.920	AFR:0.2612,AMR:0.8747,EAS:0.9994,FIN:0.9160,NFE:0.9166,OTH:0.8798,ASJ:0.8940	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	0.0	0.58	0.000	1.43	18	MU82008748	hom
18	72343008	72343008	T	C	ZNF407	exonic	synonymous SNV	ENSG00000215421	rs7243081	ENSG00000215421:ENST00000299687:exon1:c.T33C:p.D11D,ENSG00000215421:ENST00000309902:exon1:c.T33C:p.D11D,ENSG00000215421:ENST00000577538:exon1:c.T33C:p.D11D,ENSG00000215421:ENST00000582337:exon2:c.T33C:p.D11D	ZNF407:NM_001146189:exon1:c.T33C:p.D11D,ZNF407:NM_001146190:exon1:c.T33C:p.D11D,ZNF407:NM_017757:exon1:c.T33C:p.D11D	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9898	0.9987	0.99361	0.9969	.	.	.	.	.	.	.	.	ZNF407:uc002llw.2:exon1:c.T33C:p.D11D,ZNF407:uc010dqu.2:exon1:c.T33C:p.D11D,ZNF407:uc010xfc.2:exon1:c.T33C:p.D11D,ZNF407:uc002llu.2:exon2:c.T30C:p.D10D	.	AFR:0.9984,AMR:0.9093,EAS:1,FIN:1,NFE:0.9999,OTH:0.9939,ASJ:1	615894	.	.	.	.	.	.	.	.	.	.	.	18	MU82009013	hom
18	72343181	72343181	A	G	ZNF407	exonic	nonsynonymous SNV	ENSG00000215421	rs3794942	ENSG00000215421:ENST00000299687:exon1:c.A206G:p.N69S,ENSG00000215421:ENST00000309902:exon1:c.A206G:p.N69S,ENSG00000215421:ENST00000577538:exon1:c.A206G:p.N69S,ENSG00000215421:ENST00000582337:exon2:c.A206G:p.N69S	ZNF407:NM_001146189:exon1:c.A206G:p.N69S,ZNF407:NM_001146190:exon1:c.A206G:p.N69S,ZNF407:NM_017757:exon1:c.A206G:p.N69S	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0627	0.0775	0.0806709	0.0658	-1.533	0.002	0.324	0.117	0.004	.	.	.	ZNF407:uc002llw.2:exon1:c.A206G:p.N69S,ZNF407:uc010dqu.2:exon1:c.A206G:p.N69S,ZNF407:uc010xfc.2:exon1:c.A206G:p.N69S,ZNF407:uc002llu.2:exon2:c.A203G:p.N68S	-0.922	AFR:0.1124,AMR:0.0310,EAS:0.0432,FIN:0.0418,NFE:0.0498,OTH:0.0509,ASJ:0.0596	615894	.	.	.	.	.	.	.	0.004	3.33	0.000	1.7	18	MU82009022	het
18	72344223	72344223	T	C	ZNF407	exonic	synonymous SNV	ENSG00000215421	rs3794941	ENSG00000215421:ENST00000299687:exon1:c.T1248C:p.P416P,ENSG00000215421:ENST00000309902:exon1:c.T1248C:p.P416P,ENSG00000215421:ENST00000577538:exon1:c.T1248C:p.P416P,ENSG00000215421:ENST00000582337:exon2:c.T1248C:p.P416P	ZNF407:NM_001146189:exon1:c.T1248C:p.P416P,ZNF407:NM_001146190:exon1:c.T1248C:p.P416P,ZNF407:NM_017757:exon1:c.T1248C:p.P416P	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1581	0.1933	0.210064	0.1837	.	.	.	.	.	.	.	.	ZNF407:uc002llw.2:exon1:c.T1248C:p.P416P,ZNF407:uc010dqu.2:exon1:c.T1248C:p.P416P,ZNF407:uc010xfc.2:exon1:c.T1248C:p.P416P,ZNF407:uc002llu.2:exon2:c.T1245C:p.P415P	.	AFR:0.3439,AMR:0.1420,EAS:0.1667,FIN:0.1062,NFE:0.1164,OTH:0.1439,ASJ:0.1424	615894	.	.	.	.	.	.	.	.	.	.	.	18	MU44611863	het
18	72345890	72345890	A	C	ZNF407	exonic	nonsynonymous SNV	ENSG00000215421	rs948615	ENSG00000215421:ENST00000299687:exon1:c.A2915C:p.N972T,ENSG00000215421:ENST00000309902:exon1:c.A2915C:p.N972T,ENSG00000215421:ENST00000577538:exon1:c.A2915C:p.N972T,ENSG00000215421:ENST00000582337:exon2:c.A2915C:p.N972T	ZNF407:NM_001146189:exon1:c.A2915C:p.N972T,ZNF407:NM_001146190:exon1:c.A2915C:p.N972T,ZNF407:NM_017757:exon1:c.A2915C:p.N972T	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1584	0.1964	0.211062	1(biliary_tract)	-1.827	0.002	0.11	-9.3	0.670	.	.	.	ZNF407:uc002llw.2:exon1:c.A2915C:p.N972T,ZNF407:uc010dqu.2:exon1:c.A2915C:p.N972T,ZNF407:uc010xfc.2:exon1:c.A2915C:p.N972T,ZNF407:uc002llu.2:exon2:c.A2912C:p.N971T	-0.862	AFR:MU148620,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.3476,FIN:0.1447,NFE:0.1424,OTH:0.1677,ASJ:0.1847	615894	.	.	.	.	.	.	.	0.063	3.32	0.000	2.25	18	2(haematopoietic_and_lymphoid_tissue)	0.1062
18	72347482	72347482	T	C	ZNF407	exonic	synonymous SNV	ENSG00000215421	rs12327359	ENSG00000215421:ENST00000299687:exon1:c.T4507C:p.L1503L,ENSG00000215421:ENST00000309902:exon1:c.T4507C:p.L1503L,ENSG00000215421:ENST00000577538:exon1:c.T4507C:p.L1503L,ENSG00000215421:ENST00000582337:exon2:c.T4507C:p.L1503L	ZNF407:NM_001146189:exon1:c.T4507C:p.L1503L,ZNF407:NM_001146190:exon1:c.T4507C:p.L1503L,ZNF407:NM_017757:exon1:c.T4507C:p.L1503L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4198	0.5108	0.423922	1(large_intestine)	.	.	.	.	.	.	.	.	ZNF407:uc002llw.2:exon1:c.T4507C:p.L1503L,ZNF407:uc010dqu.2:exon1:c.T4507C:p.L1503L,ZNF407:uc010xfc.2:exon1:c.T4507C:p.L1503L,ZNF407:uc002llu.2:exon2:c.T4504C:p.L1502L	.	AFR:MU148628,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,EAS:0.6882,FIN:0.2804,NFE:0.4338,OTH:0.1917,ASJ:0.4802	615894	.	.	.	.	.	.	.	.	.	.	.	18	2(lung)	0.3587
18	72776121	72776121	G	A	ZNF407	exonic	synonymous SNV	ENSG00000215421	rs3744913	ENSG00000215421:ENST00000299687:exon8:c.G6444A:p.T2148T	ZNF407:NM_017757:exon8:c.G6444A:p.T2148T	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8322	0.7615	0.760383	0.7835	.	.	.	.	.	.	.	.	ZNF407:uc002llw.2:exon8:c.G6444A:p.T2148T	.	AFR:0.5472,AMR:0.8022,EAS:0.9116,FIN:0.9124,NFE:0.8690,OTH:0.8637,ASJ:0.8477	615894	.	.	.	.	.	.	.	.	.	.	.	18	MU4566146	het
18	74980809	74980809	G	A	GALR1	exonic	nonsynonymous SNV	ENSG00000166573	rs5376	ENSG00000166573:ENST00000299727:exon3:c.G1001A:p.S334N	GALR1:NM_001480:exon3:c.G1001A:p.S334N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9731	0.8956	0.90615	0.9156	-0.581	0.139	0.882	1.01	0.007	.	.	.	GALR1:uc002lms.4:exon3:c.G1001A:p.S334N	-0.988	AFR:0.7061,AMR:0.9749,EAS:1,FIN:1,NFE:0.9992,OTH:0.9807,ASJ:1	600377	.	.	.	.	.	.	.	0.0	-0.49	0.000	-0.845	18	MU82009144	hom
19	680378	680378	C	T	FSTL3	exonic	synonymous SNV	ENSG00000070404	rs7246311	ENSG00000070404:ENST00000588773:exon2:c.C128T:p.A43V	FSTL3:NM_005860:exon3:c.C394T:p.L132L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5719	.	0.348842	0.3951	.	.	.	.	.	.	.	.	FSTL3:uc002lpk.1:exon3:c.C394T:p.L132L	.	AFR:0.2872,AMR:0.3487,EAS:0.2271,FIN:0.4825,NFE:0.4570,OTH:0.4435,ASJ:0.3412	605343	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	929753	929753	A	G	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs1799595	ENSG00000116017:ENST00000263620:exon2:c.A225G:p.P75P	ARID3A:NM_005224:exon2:c.A225G:p.P75P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8572	0.8751	0.884185	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon2:c.A225G:p.P75P	.	AFR:0.8675,AMR:0.9034,EAS:0.8344,FIN:0.9994,NFE:0.8457,OTH:0.8432,ASJ:0.8077	603265	.	.	.	.	.	.	.	.	.	.	.	19	1(large_intestine)	0.8415
19	965043	965043	T	C	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs12608658	ENSG00000116017:ENST00000587532:exon4:c.T702C:p.N234N,ENSG00000116017:ENST00000263620:exon6:c.T1161C:p.N387N	ARID3A:NM_005224:exon6:c.T1161C:p.N387N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9575	0.9483	0.938898	0.9532	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon6:c.T1161C:p.N387N	.	AFR:0.8858,AMR:0.8699,EAS:1,FIN:0.9951,NFE:0.9802,OTH:0.9735,ASJ:0.9868	603265	.	.	.	.	.	.	.	.	.	.	.	19	MU82010062	hom
19	966693	966693	C	T	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs6510986	ENSG00000116017:ENST00000263620:exon7:c.C1320T:p.A440A	ARID3A:NM_005224:exon7:c.C1320T:p.A440A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7977	0.8170	0.714856	MU70212	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon7:c.C1320T:p.A440A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,AMR:0.7864,EAS:0.6304,FIN:0.9007,NFE:0.5902,OTH:0.7896,ASJ:0.7121	603265	.	.	.	.	.	.	.	.	.	.	.	19	1(liver)	0.8559
19	971933	971933	A	G	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs1051504	ENSG00000116017:ENST00000263620:exon9:c.A1650G:p.G550G	ARID3A:NM_005224:exon9:c.A1650G:p.G550G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6590	0.7290	0.594848	2(lung)	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon9:c.A1650G:p.G550G	.	AFR:MU1781969,AMR:LICA-CN|3|402|0.00746269,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.6337,FIN:0.5725,NFE:0.8033,OTH:0.4660,ASJ:0.6893	603265	.	.	.	.	.	.	.	.	.	.	.	19	1(large_intestine)	0.6883
19	971949	971949	G	A	ARID3A	exonic	nonsynonymous SNV	ENSG00000116017	rs1051505	ENSG00000116017:ENST00000263620:exon9:c.G1666A:p.G556S	ARID3A:NM_005224:exon9:c.G1666A:p.G556S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7812	0.8295	0.71865	1(lung)	-0.025	2.348	0.369	-7.15	0.000	.	.	.	ARID3A:uc002lql.3:exon9:c.G1666A:p.G556S	-0.998	AFR:MU98751,AMR:LIRI-JP|1|258|0.00387597,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.7094,FIN:0.6337,NFE:0.8974,OTH:0.5896,ASJ:0.7803	603265	.	.	.	.	.	.	.	0.0	1.17	0.000	-0.405	19	1(thyroid)	0.7743
19	1619093	1619093	C	G	TCF3	intronic	.	ENSG00000071564	rs540385028	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	3.351e-05	.	0.000199681	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	147141	616941;	229717;33110;	229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~	~ko04550 Signaling pathways regulating pluripotency of stem cells~ko05166 Human T-cell leukemia virus 1 infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	19	.	het
19	1619339	1619339	T	C	TCF3	exonic	synonymous SNV	ENSG00000071564	rs8140	ENSG00000071564:ENST00000453954:exon11:c.A1050G:p.S350S,ENSG00000071564:ENST00000395423:exon12:c.A1149G:p.S383S,ENSG00000071564:ENST00000588136:exon14:c.A1302G:p.S434S,ENSG00000071564:ENST00000262965:exon15:c.A1302G:p.S434S,ENSG00000071564:ENST00000344749:exon15:c.A1302G:p.S434S	TCF3:NM_001136139:exon15:c.A1302G:p.S434S,TCF3:NM_001351778:exon15:c.A1299G:p.S433S,TCF3:NM_001351779:exon15:c.A1302G:p.S434S,TCF3:NM_003200:exon15:c.A1302G:p.S434S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4963	0.4902	0.623802	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	TCF3:uc002lto.3:exon6:c.A585G:p.S195S,TCF3:uc002lts.1:exon11:c.A1050G:p.S350S,TCF3:uc002ltq.3:exon12:c.A1149G:p.S383S,TCF3:uc002ltt.4:exon14:c.A1302G:p.S434S,TCF3:uc002ltr.3:exon15:c.A1302G:p.S434S	.	AFR:0.5347,AMR:0.7222,EAS:0.4533,FIN:0.8829,NFE:0.4464,OTH:0.4131,ASJ:0.5300	147141	616941;	229717;33110;	229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~	~ko04550 Signaling pathways regulating pluripotency of stem cells~ko05166 Human T-cell leukemia virus 1 infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	19	1(lung)	0.4897
19	1624007	1624007	A	G	TCF3	intronic	.	ENSG00000071564	rs55677929	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2663	0.2472	0.366813	0.2731	.	.	.	.	.	0	0	.	.	.	AFR:0.2959,AMR:0.2518,EAS:0.6677,FIN:0.2319,NFE:0.2289,OTH:0.2602,ASJ:0.2815	147141	616941;	229717;33110;	229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~	~ko04550 Signaling pathways regulating pluripotency of stem cells~ko05166 Human T-cell leukemia virus 1 infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	19	MU27524588	het
19	3110349	3110349	T	G	GNA11	intronic	.	ENSG00000088256	rs11085000	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4198	0.3661	0.344249	MU727156	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,AMR:0.3824,EAS:0.4341,FIN:0.34,NFE:0.4108,OTH:0.3693,ASJ:0.2228	139313	145981;615361;	2238;428;101049;405;	2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~101049|FHH type 2|-|Autosomal dominant|-|145981 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~	~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04270 Vascular smooth muscle contraction~ko04540 Gap junction~ko04725 Cholinergic synapse~ko04730 Long-term depression~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	19	9(meninges)	0.4702
19	3119184	3119184	T	G	GNA11	intronic	.	ENSG00000267139	rs308046	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8340	0.8159	0.773562	0.8281	.	.	.	.	.	.	.	.	.	.	AFR:0.7489,AMR:0.8914,EAS:0.7451,FIN:0.8723,NFE:0.8656,OTH:0.8801,ASJ:0.8411	139313	145981;615361;	2238;428;101049;405;	2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~101049|FHH type 2|-|Autosomal dominant|-|145981 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~	~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04270 Vascular smooth muscle contraction~ko04540 Gap junction~ko04725 Cholinergic synapse~ko04730 Long-term depression~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	19	MU21352930	het
19	3119239	3119239	C	T	GNA11	exonic	synonymous SNV	ENSG00000088256	rs4900	ENSG00000088256:ENST00000078429:exon6:c.C771T:p.T257T	GNA11:NM_002067:exon6:c.C771T:p.T257T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4263	0.3822	0.348842	10(meninges)	.	.	.	.	.	.	.	.	GNA11:uc002lxd.3:exon6:c.C771T:p.T257T	.	AFR:1(lung),AMR:MU58843,EAS:0.3830,FIN:0.2226,NFE:0.4448,OTH:0.3775,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	139313	145981;615361;	2238;428;101049;405;	2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~101049|FHH type 2|-|Autosomal dominant|-|145981 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~	~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04270 Vascular smooth muscle contraction~ko04540 Gap junction~ko04725 Cholinergic synapse~ko04730 Long-term depression~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer ~	,5855,5851,5858,5856,5850,5859,5857,5854,5849,5852,5853	.	.	.	.	.	.	19	1(large_intestine)	0.4158
19	3526303	3526303	C	T	FZR1	exonic	synonymous SNV	ENSG00000105325	rs367591096	ENSG00000105325:ENST00000313639:exon4:c.C306T:p.A102A,ENSG00000105325:ENST00000395095:exon4:c.C306T:p.A102A,ENSG00000105325:ENST00000591290:exon4:c.C306T:p.A102A,ENSG00000105325:ENST00000441788:exon5:c.C306T:p.A102A	FZR1:NM_001136197:exon4:c.C306T:p.A102A,FZR1:NM_001136198:exon4:c.C306T:p.A102A,FZR1:NM_016263:exon5:c.C306T:p.A102A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	6.326e-05	.	0.000199681	9.702e-05	.	.	.	.	.	.	.	.	FZR1:uc002lxv.2:exon4:c.C306T:p.A102A,FZR1:uc010dtk.2:exon4:c.C306T:p.A102A,FZR1:uc002lxt.2:exon5:c.C306T:p.A102A	.	AFR:0.0002,AMR:0,EAS:0,FIN:0,NFE:6.674e-05,OTH:0,ASJ:0	603619	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	3533274	3533274	G	A	FZR1	intronic	.	ENSG00000105325	rs740681	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3405	0.2002	0.353435	0.2694	.	.	.	.	.	.	.	.	.	.	AFR:0.0594,AMR:0.5227,EAS:0.8459,FIN:0.3465,NFE:0.2934,OTH:0.3190,ASJ:0.2867	603619	.	.	.	.	.	.	.	.	.	.	.	19	MU82012116	het
19	3534842	3534842	G	A	FZR1	UTR3	.	ENSG00000105325	rs10155	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3344	0.2001	0.348043	0.2691	.	.	.	.	.	.	.	.	.	.	AFR:0.0592,AMR:0.5203,EAS:0.8396,FIN:0.3474,NFE:0.2943,OTH:0.3143,ASJ:0.2881	603619	.	.	.	.	.	.	.	.	.	.	.	19	MU736221	het
19	4099187	4099187	T	C	MAP2K2	intronic	.	ENSG00000126934	rs350911	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7718	0.7441	0.773562	0.7575	.	.	.	.	.	.	.	.	.	.	AFR:0.7408,AMR:0.8493,EAS:0.9270,FIN:0.7614,NFE:0.7420,OTH:0.7788,ASJ:0.7252	601263	615280;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04218 Cellular senescence~ko04270 Vascular smooth muscle contraction~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04620 Toll-like receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05020 Prion diseases~ko05135 Yersinia infection~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	19	MU50776075	hom
19	4362691	4362691	G	C	SH3GL1	exonic	synonymous SNV	ENSG00000141985	rs243261	ENSG00000141985:ENST00000417295:exon7:c.C627G:p.P209P,ENSG00000141985:ENST00000269886:exon8:c.C771G:p.P257P,ENSG00000141985:ENST00000598564:exon8:c.C579G:p.P193P	SH3GL1:NM_001199943:exon7:c.C627G:p.P209P,SH3GL1:NM_001199944:exon8:c.C579G:p.P193P,SH3GL1:NM_003025:exon8:c.C771G:p.P257P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3346	0.3021	0.391573	0.3198	.	.	.	.	.	.	.	.	SH3GL1:uc010xig.2:exon7:c.C627G:p.P209P,SH3GL1:uc002maj.3:exon8:c.C771G:p.P257P,SH3GL1:uc002mak.3:exon8:c.C579G:p.P193P	.	AFR:0.3323,AMR:0.4484,EAS:0.5743,FIN:0.3356,NFE:0.2734,OTH:0.3340,ASJ:0.3133	601768	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	19	MU4612009	hom
19	5595354	5595354	T	C	SAFB2	intronic	.	ENSG00000130254	rs10413286	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7299	0.7219	0.809305	0.7275	.	.	.	.	.	.	.	.	.	.	AFR:0.8615,AMR:0.7780,EAS:0.8908,FIN:0.6507,NFE:0.6490,OTH:0.6837,ASJ:0.77	608066	.	.	.	.	.	.	.	.	.	.	.	19	MU19175690	hom
19	5696245	5696245	A	G	LONP1	intronic	.	ENSG00000196365	rs4073993	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6030	0.6852	0.540735	MU734612	.	.	.	.	.	.	.	.	.	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.6411,EAS:0.5156,FIN:0.6358,NFE:0.2515,OTH:0.5842,ASJ:0.6682	605490	600373;	1458;	1458|Cerebro-oculo-dento-auriculo-skeletal syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|600373 ~	.	.	.	.	.	.	.	.	19	1(liver)	0.6880
19	6586268	6586268	G	A	CD70	exonic	synonymous SNV	ENSG00000125726	rs1862511	ENSG00000125726:ENST00000245903:exon3:c.C345T:p.C115C,ENSG00000125726:ENST00000423145:exon3:c.C345T:p.C115C	CD70:NM_001252:exon3:c.C345T:p.C115C,CD70:NM_001330332:exon3:c.C345T:p.C115C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3201	0.2632	0.350639	0.2883	.	.	.	.	.	.	.	.	CD70:uc002mfi.3:exon3:c.C345T:p.C115C,CD70:uc010xjf.1:exon3:c.C345T:p.C115C	.	AFR:0.1934,AMR:0.2279,EAS:0.6958,FIN:0.3762,NFE:0.2822,OTH:0.2971,ASJ:0.2616	602840	.	.	.	.	.	.	.	.	.	.	.	19	MU4574437	het
19	7125297	7125297	G	A	INSR	exonic	synonymous SNV	ENSG00000171105	rs1799817	ENSG00000171105:ENST00000341500:exon16:c.C3219T:p.H1073H,ENSG00000171105:ENST00000302850:exon17:c.C3255T:p.H1085H	INSR:NM_001079817:exon16:c.C3219T:p.H1073H,INSR:NM_000208:exon17:c.C3255T:p.H1085H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2273	0.1908	0.292532	LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	INSR:uc002mge.1:exon16:c.C3219T:p.H1073H,INSR:uc002mgd.1:exon17:c.C3255T:p.H1085H	.	AFR:0.2071,AMR:0.2331,EAS:0.1854,FIN:0.4174,NFE:0.1818,OTH:0.1740,ASJ:0.2410	147670	246200;262190;609968;610549;	2297;263458;769;508;	2297|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610549 ~263458|Hyperinsulinemic hypoglycemia due to INSR deficiency<br>Hyperinsulinemic hypoglycemia due to insulin receptor deficiency|<1 / 1 000 000|Autosomal dominant|All ages|609968 ~769|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|262190 ~508|Donohue syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|246200 ~	.	.	.	.	.	.	.	.	19	2(haematopoietic_and_lymphoid_tissue)	0.2061
19	7163140	7163140	T	G	INSR	exonic	synonymous SNV	ENSG00000171105	rs2245655	ENSG00000171105:ENST00000600492:exon3:c.A333C:p.P111P,ENSG00000171105:ENST00000302850:exon9:c.A1932C:p.P644P,ENSG00000171105:ENST00000341500:exon9:c.A1932C:p.P644P	INSR:NM_000208:exon9:c.A1932C:p.P644P,INSR:NM_001079817:exon9:c.A1932C:p.P644P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1056	0.1249	0.160743	LAML-KR|2|205|0.0097561	.	.	.	.	.	.	.	.	INSR:uc002mgd.1:exon9:c.A1932C:p.P644P,INSR:uc002mge.1:exon9:c.A1932C:p.P644P,INSR:uc002mgf.3:exon9:c.A1932C:p.P644P	.	AFR:0.1204,AMR:0.2483,EAS:0.0430,FIN:0.0235,NFE:0.0493,OTH:0.0801,ASJ:0.0597	147670	246200;262190;609968;610549;	2297;263458;769;508;	2297|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610549 ~263458|Hyperinsulinemic hypoglycemia due to INSR deficiency<br>Hyperinsulinemic hypoglycemia due to insulin receptor deficiency|<1 / 1 000 000|Autosomal dominant|All ages|609968 ~769|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|262190 ~508|Donohue syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|246200 ~	.	.	.	.	.	.	.	.	19	4(soft_tissue)	0.0900
19	7163154	7163154	G	A	INSR	exonic	synonymous SNV	ENSG00000171105	rs2963	ENSG00000171105:ENST00000600492:exon3:c.C319T:p.L107L,ENSG00000171105:ENST00000302850:exon9:c.C1918T:p.L640L,ENSG00000171105:ENST00000341500:exon9:c.C1918T:p.L640L	INSR:NM_000208:exon9:c.C1918T:p.L640L,INSR:NM_001079817:exon9:c.C1918T:p.L640L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1056	0.1319	0.159744	LAML-KR|2|205|0.0097561	.	.	.	.	.	.	.	.	INSR:uc002mgd.1:exon9:c.C1918T:p.L640L,INSR:uc002mge.1:exon9:c.C1918T:p.L640L,INSR:uc002mgf.3:exon9:c.C1918T:p.L640L	.	AFR:0.1201,AMR:0.2475,EAS:0.0430,FIN:0.0235,NFE:0.0493,OTH:0.0800,ASJ:0.0597	147670	246200;262190;609968;610549;	2297;263458;769;508;	2297|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610549 ~263458|Hyperinsulinemic hypoglycemia due to INSR deficiency<br>Hyperinsulinemic hypoglycemia due to insulin receptor deficiency|<1 / 1 000 000|Autosomal dominant|All ages|609968 ~769|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|262190 ~508|Donohue syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|246200 ~	.	.	.	.	.	.	.	.	19	2(haematopoietic_and_lymphoid_tissue)	0.0898
19	7163214	7163214	T	C	INSR	intronic	.	ENSG00000171105	rs2245649	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1055	0.1317	0.159145	LAML-KR|2|205|0.0097561	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.1202,AMR:0.2479,EAS:0.0430,FIN:0.0230,NFE:0.0490,OTH:0.0799,ASJ:0.0597	147670	246200;262190;609968;610549;	2297;263458;769;508;	2297|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610549 ~263458|Hyperinsulinemic hypoglycemia due to INSR deficiency<br>Hyperinsulinemic hypoglycemia due to insulin receptor deficiency|<1 / 1 000 000|Autosomal dominant|All ages|609968 ~769|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|262190 ~508|Donohue syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|246200 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.0896
19	7163230	7163230	T	C	INSR	intronic	.	ENSG00000171105	rs2245648	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2339	0.2883	0.271565	MU13233351	.	.	.	.	.	.	.	.	.	.	AFR:MELA-AU|1|183|0.00546448,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,AMR:0.2544,EAS:0.1360,FIN:0.1192,NFE:0.0454,OTH:0.1226,ASJ:0.3977	147670	246200;262190;609968;610549;	2297;263458;769;508;	2297|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610549 ~263458|Hyperinsulinemic hypoglycemia due to INSR deficiency<br>Hyperinsulinemic hypoglycemia due to insulin receptor deficiency|<1 / 1 000 000|Autosomal dominant|All ages|609968 ~769|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|262190 ~508|Donohue syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|246200 ~	.	.	.	.	.	.	.	.	19	1(lung)	0.2367
19	7166388	7166388	G	A	INSR	exonic	synonymous SNV	ENSG00000171105	rs2229429	ENSG00000171105:ENST00000600492:exon2:c.C39T:p.D13D,ENSG00000171105:ENST00000302850:exon8:c.C1638T:p.D546D,ENSG00000171105:ENST00000341500:exon8:c.C1638T:p.D546D	INSR:NM_000208:exon8:c.C1638T:p.D546D,INSR:NM_001079817:exon8:c.C1638T:p.D546D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2075	0.2776	0.256589	MU727999	.	.	.	.	.	.	.	.	INSR:uc002mgd.1:exon8:c.C1638T:p.D546D,INSR:uc002mge.1:exon8:c.C1638T:p.D546D,INSR:uc002mgf.3:exon8:c.C1638T:p.D546D	.	AFR:ESAD-UK|2|409|0.00488998,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,AMR:0.2495,EAS:0.1607,FIN:0.2053,NFE:0.0551,OTH:0.1377,ASJ:0.4311	147670	246200;262190;609968;610549;	2297;263458;769;508;	2297|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610549 ~263458|Hyperinsulinemic hypoglycemia due to INSR deficiency<br>Hyperinsulinemic hypoglycemia due to insulin receptor deficiency|<1 / 1 000 000|Autosomal dominant|All ages|609968 ~769|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|262190 ~508|Donohue syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|246200 ~	.	.	.	.	.	.	.	.	19	2(lung)	0.2008
19	7184518	7184518	G	A	INSR	exonic	synonymous SNV	ENSG00000171105	rs891087	ENSG00000171105:ENST00000302850:exon3:c.C783T:p.D261D,ENSG00000171105:ENST00000341500:exon3:c.C783T:p.D261D	INSR:NM_000208:exon3:c.C783T:p.D261D,INSR:NM_001079817:exon3:c.C783T:p.D261D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1029	0.1255	0.138578	LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647	.	.	.	.	.	.	.	.	INSR:uc002mgd.1:exon3:c.C783T:p.D261D,INSR:uc002mge.1:exon3:c.C783T:p.D261D,INSR:uc002mgf.3:exon3:c.C783T:p.D261D	.	AFR:0.1165,AMR:0.2039,EAS:0.0563,FIN:0.0316,NFE:0.0803,OTH:0.0895,ASJ:0.0549	147670	246200;262190;609968;610549;	2297;263458;769;508;	2297|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610549 ~263458|Hyperinsulinemic hypoglycemia due to INSR deficiency<br>Hyperinsulinemic hypoglycemia due to insulin receptor deficiency|<1 / 1 000 000|Autosomal dominant|All ages|609968 ~769|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|262190 ~508|Donohue syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|246200 ~	.	.	.	.	.	.	.	.	19	4(soft_tissue)	0.0949
19	7293898	7293898	G	C	INSR	exonic	nonsynonymous SNV	ENSG00000171105	rs7508518	ENSG00000171105:ENST00000302850:exon1:c.C5G:p.A2G,ENSG00000171105:ENST00000341500:exon1:c.C5G:p.A2G	INSR:NM_000208:exon1:c.C5G:p.A2G,INSR:NM_001079817:exon1:c.C5G:p.A2G	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	1	.	1	0.9999	-0.354	0.499	1.0	2.59	0.002	.	.	.	INSR:uc002mgd.1:exon1:c.C5G:p.A2G,INSR:uc002mge.1:exon1:c.C5G:p.A2G,INSR:uc002mgf.3:exon1:c.C5G:p.A2G	-0.961	AFR:1,AMR:1,EAS:0.9981,FIN:1,NFE:1,OTH:1,ASJ:1	147670	246200;262190;609968;610549;	2297;263458;769;508;	2297|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610549 ~263458|Hyperinsulinemic hypoglycemia due to INSR deficiency<br>Hyperinsulinemic hypoglycemia due to insulin receptor deficiency|<1 / 1 000 000|Autosomal dominant|All ages|609968 ~769|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|262190 ~508|Donohue syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|246200 ~	.	.	.	.	0.0	-0.93	0.000	-1.355	19	.	hom
19	7688039	7688039	C	T	XAB2	intronic	.	ENSG00000076924	rs4134846	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1059	0.1241	0.0758786	0.1154	.	.	.	.	.	.	.	.	.	.	AFR:0.0857,AMR:0.1077,EAS:0.0012,FIN:0.1425,NFE:0.1393,OTH:0.1227,ASJ:0.0867	610850	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	7688614	7688614	T	C	XAB2	intronic	.	ENSG00000076924	rs2335521	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1437	0.1473	0.123602	0.1501	.	.	.	.	.	0.1988	0.222	.	.	.	AFR:0.1544,AMR:0.2578,EAS:0.0451,FIN:0.1847,NFE:0.1457,OTH:0.1520,ASJ:0.1060	610850	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	7694393	7694393	G	A	XAB2	exonic	synonymous SNV	ENSG00000076924	rs4134809	ENSG00000076924:ENST00000358368:exon1:c.C21T:p.L7L,ENSG00000076924:ENST00000534844:exon1:c.C12T:p.L4L	XAB2:NM_020196:exon1:c.C21T:p.L7L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3691	0.3139	0.263578	3(lung)	.	.	.	.	.	.	.	.	XAB2:uc002mgx.3:exon1:c.C21T:p.L7L	.	AFR:MU147529,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,EAS:0.2061,FIN:0.2416,NFE:0.2848,OTH:0.1990,ASJ:0.3124	610850	.	.	.	.	.	.	.	.	.	.	.	19	1(salivary_gland)	0.4126
19	10265248	10265248	T	C	DNMT1	intronic	.	ENSG00000130816	rs2114724	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5180	0.4882	0.533347	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.5121,AMR:0.4941,EAS:0.5267,FIN:0.7122,NFE:0.5213,OTH:0.4972,ASJ:0.5168	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.5276
19	10265312	10265312	T	C	DNMT1	exonic	synonymous SNV	ENSG00000130816	rs721186	ENSG00000130816:ENST00000340748:exon20:c.A1734G:p.T578T,ENSG00000130816:ENST00000540357:exon20:c.A1734G:p.T578T,ENSG00000130816:ENST00000359526:exon21:c.A1782G:p.T594T	DNMT1:NM_001318730:exon20:c.A1734G:p.T578T,DNMT1:NM_001379:exon20:c.A1734G:p.T578T,DNMT1:NM_001130823:exon21:c.A1782G:p.T594T,DNMT1:NM_001318731:exon21:c.A1419G:p.T473T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9910	0.9897	0.995807	0.9905	.	.	.	.	.	.	.	.	DNMT1:uc002mng.3:exon20:c.A1734G:p.T578T,DNMT1:uc010xld.2:exon20:c.A1734G:p.T578T,DNMT1:uc002mnh.3:exon21:c.A1419G:p.T473T,DNMT1:uc010xlc.2:exon21:c.A1782G:p.T594T	.	AFR:0.9961,AMR:0.9916,EAS:1,FIN:0.9888,NFE:0.9862,OTH:0.9969,ASJ:0.9901	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	MU82016881	hom
19	10267077	10267077	T	C	DNMT1	exonic	synonymous SNV	ENSG00000130816	rs2228611	ENSG00000130816:ENST00000340748:exon17:c.A1341G:p.P447P,ENSG00000130816:ENST00000540357:exon17:c.A1341G:p.P447P,ENSG00000130816:ENST00000359526:exon18:c.A1389G:p.P463P	DNMT1:NM_001318730:exon17:c.A1341G:p.P447P,DNMT1:NM_001379:exon17:c.A1341G:p.P447P,DNMT1:NM_001130823:exon18:c.A1389G:p.P463P,DNMT1:NM_001318731:exon18:c.A1026G:p.P342P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5188	0.4912	0.533946	MU13784738	.	.	.	.	.	.	.	.	DNMT1:uc002mng.3:exon17:c.A1341G:p.P447P,DNMT1:uc010xld.2:exon17:c.A1341G:p.P447P,DNMT1:uc002mnh.3:exon18:c.A1026G:p.P342P,DNMT1:uc010xlc.2:exon18:c.A1389G:p.P463P	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,AMR:0.5138,EAS:0.5169,FIN:0.5298,NFE:0.7114,OTH:0.5205,ASJ:0.5008	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	2(urinary_tract)	0.4972
19	10270748	10270748	A	-	DNMT1	intronic	.	ENSG00000130816	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	.	unknown
19	10273372	10273372	T	C	DNMT1	exonic	nonsynonymous SNV	ENSG00000130816	rs2228612	ENSG00000130816:ENST00000340748:exon12:c.A931G:p.I311V,ENSG00000130816:ENST00000540357:exon12:c.A931G:p.I311V,ENSG00000130816:ENST00000359526:exon13:c.A979G:p.I327V	DNMT1:NM_001318730:exon12:c.A931G:p.I311V,DNMT1:NM_001379:exon12:c.A931G:p.I311V,DNMT1:NM_001130823:exon13:c.A979G:p.I327V,DNMT1:NM_001318731:exon13:c.A616G:p.I206V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1320	0.0863	0.198283	MU13145431	-1.756	0.002	1.0	-4.65	0.001	.	.	.	DNMT1:uc002mng.3:exon12:c.A931G:p.I311V,DNMT1:uc010xld.2:exon12:c.A931G:p.I311V,DNMT1:uc002mnh.3:exon13:c.A616G:p.I206V,DNMT1:uc010xlc.2:exon13:c.A979G:p.I327V	-1.092	AFR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02,AMR:0.1059,EAS:0.2222,FIN:0.0946,NFE:0.4440,OTH:0.0918,ASJ:0.1236	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	0.0	-1.29	0.000	-0.345	19	1(oesophagus)	0.0562
19	10600442	10600442	G	C	KEAP1	exonic	synonymous SNV	ENSG00000079999	rs1048290	ENSG00000079999:ENST00000171111:exon4:c.C1413G:p.L471L,ENSG00000079999:ENST00000393623:exon4:c.C1413G:p.L471L	KEAP1:NM_012289:exon4:c.C1413G:p.L471L,KEAP1:NM_203500:exon4:c.C1413G:p.L471L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4203	0.4780	0.508187	1(urinary_tract)	.	.	.	.	.	.	.	.	KEAP1:uc002mop.1:exon2:c.C567G:p.L189L,KEAP1:uc002moq.1:exon4:c.C1413G:p.L471L,KEAP1:uc002mor.1:exon4:c.C1413G:p.L471L	.	AFR:3(lung),AMR:17(soft_tissue),EAS:MU111229,FIN:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,NFE:0.4760,OTH:0.6959,ASJ:1(haematopoietic_and_lymphoid_tissue)	606016	.	.	.	~ko04120 Ubiquitin mediated proteolysis~ko05200 Pathways in cancer~ko05225 Hepatocellular carcinoma~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	19	2(breast)	0.3230
19	11221454	11221454	T	C	LDLR	intronic	.	ENSG00000130164	rs2738442	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0] 	0.9999	.	1	0.9999	.	.	.	.	.	0	0.006	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:1,ASJ:1	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	MU82017144	unknown
19	11221457	11221457	G	C	LDLR	intronic	.	ENSG00000130164	rs12710260	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3849	0.3377	0.276957	0.3290	.	.	.	.	.	.	.	.	.	.	AFR:0.0849,AMR:0.4021,EAS:0.1947,FIN:0.4894,NFE:0.4385,OTH:0.3929,ASJ:0.4139	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	MU82287187	unknown
19	11224265	11224265	A	G	LDLR	exonic	synonymous SNV	ENSG00000130164	rs5930	ENSG00000130164:ENST00000455727:exon8:c.A909G:p.R303R,ENSG00000130164:ENST00000535915:exon9:c.A1290G:p.R430R,ENSG00000130164:ENST00000545707:exon9:c.A1032G:p.R344R,ENSG00000130164:ENST00000557933:exon10:c.A1413G:p.R471R,ENSG00000130164:ENST00000558013:exon10:c.A1413G:p.R471R,ENSG00000130164:ENST00000558518:exon10:c.A1413G:p.R471R	LDLR:NM_001195800:exon8:c.A909G:p.R303R,LDLR:NM_001195799:exon9:c.A1290G:p.R430R,LDLR:NM_001195803:exon9:c.A1032G:p.R344R,LDLR:NM_000527:exon10:c.A1413G:p.R471R,LDLR:NM_001195798:exon10:c.A1413G:p.R471R	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6266	0.6566	0.654952	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	LDLR:uc010xlo.2:exon8:c.A909G:p.R303R,LDLR:uc010xll.2:exon9:c.A1290G:p.R430R,LDLR:uc010xlm.2:exon9:c.A972G:p.R324R,LDLR:uc010xln.2:exon9:c.A1032G:p.R344R,LDLR:uc021upc.1:exon9:c.A1050G:p.R350R,LDLR:uc002mqk.4:exon10:c.A1413G:p.R471R,LDLR:uc010xlk.2:exon10:c.A1413G:p.R471R,LDLR:uc021upd.1:exon10:c.A624G:p.R208R	.	AFR:0.6454,AMR:0.7415,EAS:0.5762,FIN:0.6163,NFE:0.6376,OTH:0.5965,ASJ:0.6933	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.5900
19	11227602	11227602	C	T	LDLR	exonic	synonymous SNV	ENSG00000130164	rs688	ENSG00000130164:ENST00000455727:exon10:c.C1269T:p.N423N,ENSG00000130164:ENST00000535915:exon11:c.C1650T:p.N550N,ENSG00000130164:ENST00000545707:exon11:c.C1392T:p.N464N,ENSG00000130164:ENST00000557933:exon12:c.C1773T:p.N591N,ENSG00000130164:ENST00000558013:exon12:c.C1773T:p.N591N,ENSG00000130164:ENST00000558518:exon12:c.C1773T:p.N591N	LDLR:NM_001195800:exon10:c.C1269T:p.N423N,LDLR:NM_001195799:exon11:c.C1650T:p.N550N,LDLR:NM_001195803:exon11:c.C1392T:p.N464N,LDLR:NM_000527:exon12:c.C1773T:p.N591N,LDLR:NM_001195798:exon12:c.C1773T:p.N591N	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3781	0.3352	0.275759	0.3273	.	.	.	.	.	.	.	.	LDLR:uc010xlo.2:exon10:c.C1269T:p.N423N,LDLR:uc010xll.2:exon11:c.C1650T:p.N550N,LDLR:uc010xlm.2:exon11:c.C1332T:p.N444N,LDLR:uc010xln.2:exon11:c.C1392T:p.N464N,LDLR:uc021upc.1:exon11:c.C1410T:p.N470N,LDLR:uc002mqk.4:exon12:c.C1773T:p.N591N,LDLR:uc010xlk.2:exon12:c.C1773T:p.N591N,LDLR:uc021upd.1:exon12:c.C984T:p.N328N	.	AFR:0.1001,AMR:0.3995,EAS:0.1960,FIN:0.4782,NFE:0.4299,OTH:0.3842,ASJ:0.3808	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	MU82017159	het
19	11230881	11230881	T	C	LDLR	exonic	synonymous SNV	ENSG00000130164	rs5925	ENSG00000130164:ENST00000455727:exon11:c.T1455C:p.V485V,ENSG00000130164:ENST00000535915:exon12:c.T1836C:p.V612V,ENSG00000130164:ENST00000545707:exon12:c.T1578C:p.V526V,ENSG00000130164:ENST00000557933:exon13:c.T1959C:p.V653V,ENSG00000130164:ENST00000558013:exon13:c.T1959C:p.V653V,ENSG00000130164:ENST00000558518:exon13:c.T1959C:p.V653V	LDLR:NM_001195800:exon11:c.T1455C:p.V485V,LDLR:NM_001195799:exon12:c.T1836C:p.V612V,LDLR:NM_001195803:exon12:c.T1578C:p.V526V,LDLR:NM_000527:exon13:c.T1959C:p.V653V,LDLR:NM_001195798:exon13:c.T1959C:p.V653V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4092	0.3662	0.335863	0.3620	.	.	.	.	.	.	.	.	LDLR:uc010xlo.2:exon11:c.T1455C:p.V485V,LDLR:uc010xll.2:exon12:c.T1836C:p.V612V,LDLR:uc010xlm.2:exon12:c.T1518C:p.V506V,LDLR:uc010xln.2:exon12:c.T1578C:p.V526V,LDLR:uc021upc.1:exon12:c.T1596C:p.V532V,LDLR:uc002mqk.4:exon13:c.T1959C:p.V653V,LDLR:uc010xlk.2:exon13:c.T1959C:p.V653V,LDLR:uc021upd.1:exon13:c.T1170C:p.V390V	.	AFR:0.1938,AMR:0.5036,EAS:0.2416,FIN:0.4828,NFE:0.4338,OTH:0.4010,ASJ:0.3833	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	MU27837937	het
19	11233941	11233941	A	G	LDLR	exonic	synonymous SNV	ENSG00000130164	rs5927	ENSG00000130164:ENST00000455727:exon13:c.A1728G:p.R576R,ENSG00000130164:ENST00000545707:exon13:c.A1698G:p.R566R,ENSG00000130164:ENST00000535915:exon14:c.A2109G:p.R703R,ENSG00000130164:ENST00000557933:exon15:c.A2232G:p.R744R,ENSG00000130164:ENST00000558013:exon15:c.A2232G:p.R744R,ENSG00000130164:ENST00000558518:exon15:c.A2232G:p.R744R	LDLR:NM_001195800:exon13:c.A1728G:p.R576R,LDLR:NM_001195803:exon13:c.A1698G:p.R566R,LDLR:NM_001195799:exon14:c.A2109G:p.R703R,LDLR:NM_000527:exon15:c.A2232G:p.R744R,LDLR:NM_001195798:exon15:c.A2232G:p.R744R	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7762	0.7387	0.780152	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LDLR:uc010xln.2:exon13:c.A1698G:p.R566R,LDLR:uc010xlo.2:exon13:c.A1728G:p.R576R,LDLR:uc010xll.2:exon14:c.A2109G:p.R703R,LDLR:uc010xlm.2:exon14:c.A1791G:p.R597R,LDLR:uc021upc.1:exon14:c.A1869G:p.R623R,LDLR:uc002mqk.4:exon15:c.A2232G:p.R744R,LDLR:uc010xlk.2:exon15:c.A2232G:p.R744R,LDLR:uc021upd.1:exon15:c.A1443G:p.R481R	.	AFR:0.7480,AMR:0.6849,EAS:0.7053,FIN:0.9491,NFE:0.7702,OTH:0.7530,ASJ:0.8484	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.75
19	13318673	13318690	CTGCTGCTGCTGCTGCTG	-	CACNA1A	exonic	nonframeshift deletion	ENSG00000141837	rs765169827	ENSG00000141837:ENST00000587525:exon19:c.2383_2400del:p.795_800del,ENSG00000141837:ENST00000585802:exon23:c.2980_2997del:p.994_999del,ENSG00000141837:ENST00000360228:exon47:c.6958_6975del:p.2320_2325del	CACNA1A:NM_001127222:exon47:c.6958_6975del:p.2320_2325del	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0300	.	.	0.0997	.	.	.	.	.	.	.	.	CACNA1A:uc002mwv.3:exon19:c.2473_2490del:p.825_830del,CACNA1A:uc002mwx.3:exon23:c.3040_3057del:p.1014_1019del,CACNA1A:uc010dzc.2:exon38:c.5536_5553del:p.1846_1851del,CACNA1A:uc002mwy.3:exon47:c.6958_6975del:p.2320_2325del,CACNA1A:uc010xne.2:exon47:c.6967_6984del:p.2323_2328del	.	AFR:0.0560,AMR:0.0693,EAS:0.0783,FIN:0.1930,NFE:0.1071,OTH:0.1373,ASJ:0.1053	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	.	het
19	13319693	13319693	A	G	CACNA1A	exonic	synonymous SNV	ENSG00000141837	rs16051	ENSG00000141837:ENST00000587525:exon18:c.T2082C:p.H694H,ENSG00000141837:ENST00000585802:exon22:c.T2679C:p.H893H,ENSG00000141837:ENST00000360228:exon46:c.T6657C:p.H2219H,ENSG00000141837:ENST00000573710:exon46:c.T6660C:p.H2220H	CACNA1A:NM_001127221:exon46:c.T6660C:p.H2220H,CACNA1A:NM_001127222:exon46:c.T6657C:p.H2219H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6160	0.6088	0.686901	COCA-CN|8|321|0.0249221	.	.	.	.	.	.	.	.	CACNA1A:uc002mwv.3:exon18:c.T2172C:p.H724H,CACNA1A:uc002mwx.3:exon22:c.T2739C:p.H913H,CACNA1A:uc010dzc.2:exon37:c.T5235C:p.H1745H,CACNA1A:uc002mwy.3:exon46:c.T6657C:p.H2219H,CACNA1A:uc010dze.2:exon46:c.T6657C:p.H2219H,CACNA1A:uc010xnd.2:exon46:c.T6666C:p.H2222H,CACNA1A:uc010xne.2:exon46:c.T6666C:p.H2222H,CACNA1A:uc021ups.1:exon46:c.T6657C:p.H2219H,CACNA1A:uc021upt.1:exon46:c.T6660C:p.H2220H	.	AFR:0.6902,AMR:0.7687,EAS:0.5352,FIN:0.7786,NFE:0.7115,OTH:0.6401,ASJ:0.6079	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	4(large_intestine)	0.6366
19	13397560	13397560	C	T	CACNA1A	exonic	nonsynonymous SNV	ENSG00000141837	rs16027	ENSG00000141837:ENST00000360228:exon20:c.G3310A:p.G1104S,ENSG00000141837:ENST00000573710:exon20:c.G3313A:p.G1105S	CACNA1A:NM_001127221:exon20:c.G3313A:p.G1105S,CACNA1A:NM_001127222:exon20:c.G3310A:p.G1104S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1127	0.0739	0.100439	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	2.876	21.7	0.193	-0.306	0.175	.	.	.	CACNA1A:uc010dzc.2:exon11:c.G1888A:p.G630S,CACNA1A:uc002mwy.3:exon20:c.G3310A:p.G1104S,CACNA1A:uc010dze.2:exon20:c.G3310A:p.G1104S,CACNA1A:uc010xnd.2:exon20:c.G3319A:p.G1107S,CACNA1A:uc010xne.2:exon20:c.G3319A:p.G1107S,CACNA1A:uc021ups.1:exon20:c.G3310A:p.G1104S,CACNA1A:uc021upt.1:exon20:c.G3313A:p.G1105S	-0.501	AFR:0.0736,AMR:0.0332,EAS:0.0894,FIN:0.0885,NFE:0.0815,OTH:0.0901,ASJ:0.0969	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	0.001	-3.75	0.078	1.1	19	1(lung)	0.1053
19	13411482	13411482	G	A	CACNA1A	intronic	.	ENSG00000141837	rs16018	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7491	0.6452	0.739217	0.6801	.	.	.	.	.	0	0.006	.	.	.	AFR:0.5061,AMR:0.7955,EAS:0.9981,FIN:0.7861,NFE:0.7122,OTH:0.7209,ASJ:0.7219	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	MU82017954	het
19	13445208	13445208	C	T	CACNA1A	exonic	synonymous SNV	ENSG00000141837	rs2248069	ENSG00000141837:ENST00000360228:exon8:c.G1182A:p.E394E,ENSG00000141837:ENST00000573710:exon8:c.G1182A:p.E394E	CACNA1A:NM_001127221:exon8:c.G1182A:p.E394E,CACNA1A:NM_001127222:exon8:c.G1182A:p.E394E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6857	0.6437	0.641174	0.6399	.	.	.	.	.	.	.	.	CACNA1A:uc002mwy.3:exon8:c.G1182A:p.E394E,CACNA1A:uc010dze.2:exon8:c.G1182A:p.E394E,CACNA1A:uc010xnd.2:exon8:c.G1182A:p.E394E,CACNA1A:uc010xne.2:exon8:c.G1182A:p.E394E,CACNA1A:uc021ups.1:exon8:c.G1182A:p.E394E,CACNA1A:uc021upt.1:exon8:c.G1182A:p.E394E	.	AFR:0.5194,AMR:0.7596,EAS:0.6225,FIN:0.6723,NFE:0.6930,OTH:0.7108,ASJ:0.6391	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	MU20064845	hom
19	15271771	15271771	G	A	NOTCH3	exonic	nonsynonymous SNV	ENSG00000074181	rs1044009	ENSG00000074181:ENST00000263388:exon33:c.C6668T:p.A2223V	NOTCH3:NM_000435:exon33:c.C6668T:p.A2223V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7591	0.7349	0.629393	0.7049	0.823	9.604	0.175	0.427	0.005	.	.	Domain of unknown function DUF3454, notch	NOTCH3:uc002nan.3:exon33:c.C6668T:p.A2223V	-0.953	AFR:0.5350,AMR:0.5943,EAS:0.5856,FIN:0.8099,NFE:0.7920,OTH:0.7813,ASJ:0.7682	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	0.001	-1.47	0.000	0.895	19	MU75620	hom
19	15273381	15273381	A	G	NOTCH3	intronic	.	ENSG00000074181	rs4809030	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8745	0.9233	0.86901	0.9108	.	.	.	.	.	0	0	.	.	.	AFR:0.9753,AMR:0.7578,EAS:0.8047,FIN:0.8885,NFE:0.9008,OTH:0.8801,ASJ:0.8974	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU23789083	hom
19	15276919	15276919	G	A	NOTCH3	intronic	.	ENSG00000074181	rs2074619	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8717	0.9222	0.866613	0.9094	.	.	.	.	.	.	.	.	.	.	AFR:0.9718,AMR:0.7578,EAS:0.8025,FIN:0.8884,NFE:0.9003,OTH:0.8788,ASJ:0.8974	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU649788	unknown
19	15278057	15278057	A	G	NOTCH3	intronic	.	ENSG00000074181	rs1548555	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8741	0.9237	0.870008	0.9112	.	.	.	.	.	0.0001	0.034	.	.	.	AFR:0.9764,AMR:0.7566,EAS:0.8049,FIN:0.8884,NFE:0.9009,OTH:0.8786,ASJ:0.8974	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU19223798	hom
19	15285052	15285052	T	C	NOTCH3	exonic	synonymous SNV	ENSG00000074181	rs1044006	ENSG00000074181:ENST00000263388:exon25:c.A4563G:p.P1521P	NOTCH3:NM_000435:exon25:c.A4563G:p.P1521P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8812	0.9261	0.871805	0.9112	.	.	.	.	.	.	.	.	NOTCH3:uc002nan.3:exon25:c.A4563G:p.P1521P	.	AFR:0.9774,AMR:0.7560,EAS:0.8045,FIN:0.8885,NFE:0.9005,OTH:0.8798,ASJ:0.8974	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU72607	hom
19	15292437	15292437	T	C	NOTCH3	exonic	synonymous SNV	ENSG00000074181	rs1043997	ENSG00000074181:ENST00000601011:exon16:c.A2583G:p.P861P,ENSG00000074181:ENST00000263388:exon17:c.A2742G:p.P914P	NOTCH3:NM_000435:exon17:c.A2742G:p.P914P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8019	0.7905	0.739018	0.7822	.	.	.	.	.	.	.	.	NOTCH3:uc002nao.1:exon16:c.A2586G:p.P862P,NOTCH3:uc002nan.3:exon17:c.A2742G:p.P914P	.	AFR:0.6053,AMR:0.7076,EAS:0.8340,FIN:0.8445,NFE:0.8651,OTH:0.8187,ASJ:0.8709	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU4550901	hom
19	15295134	15295134	G	A	NOTCH3	exonic	synonymous SNV	ENSG00000074181	rs1043996	ENSG00000074181:ENST00000263388:exon16:c.C2538T:p.C846C	NOTCH3:NM_000435:exon16:c.C2538T:p.C846C	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6427	0.5664	0.519968	0.5867	.	.	.	.	.	.	.	.	NOTCH3:uc002nan.3:exon16:c.C2538T:p.C846C	.	AFR:0.2616,AMR:0.5395,EAS:0.6050,FIN:0.7516,NFE:0.7284,OTH:0.6988,ASJ:0.6887	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU786918	hom
19	15300069	15300069	T	C	NOTCH3	intronic	.	ENSG00000074181	rs10423702	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8572	0.8891	0.854233	0.8807	.	.	.	.	.	.	.	.	.	.	AFR:0.9086,AMR:0.7434,EAS:0.8798,FIN:0.8635,NFE:0.8780,OTH:0.8449,ASJ:0.9040	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU19224492	hom
19	15302844	15302844	T	C	NOTCH3	exonic	synonymous SNV	ENSG00000074181	rs1043994	ENSG00000074181:ENST00000263388:exon4:c.A606G:p.A202A,ENSG00000074181:ENST00000601011:exon4:c.A603G:p.A201A	NOTCH3:NM_000435:exon4:c.A606G:p.A202A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8581	0.8893	0.855831	0.8808	.	.	.	.	.	.	.	.	NOTCH3:uc002nan.3:exon4:c.A606G:p.A202A,NOTCH3:uc002nao.1:exon4:c.A606G:p.A202A	.	AFR:0.9088,AMR:0.7452,EAS:0.8795,FIN:0.8643,NFE:0.8779,OTH:0.8469,ASJ:0.9073	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU763505	hom
19	15350594	15350594	G	A	BRD4	exonic	synonymous SNV	ENSG00000141867	rs11669901	ENSG00000141867:ENST00000263377:exon16:c.C3321T:p.L1107L	BRD4:NM_058243:exon16:c.C3321T:p.L1107L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1629	0.1613	0.131989	0.1617	.	.	.	.	.	.	.	.	BRD4:uc002nar.3:exon16:c.C3321T:p.L1107L	.	AFR:0.1351,AMR:0.1134,EAS:0.0587,FIN:0.1999,NFE:0.1823,OTH:0.1616,ASJ:0.1589	608749	.	.	.	.	.	.	.	.	.	.	.	19	MU68367	het
19	17392894	17392894	G	A	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs8100241	ENSG00000160117:ENST00000394458:exon2:c.G91A:p.A31T,ENSG00000160117:ENST00000404085:exon2:c.G157A:p.A53T,ENSG00000160117:ENST00000404261:exon2:c.G91A:p.A31T,ENSG00000160117:ENST00000433424:exon2:c.G253A:p.A85T,ENSG00000160117:ENST00000594072:exon2:c.G58A:p.A20T,ENSG00000160117:ENST00000598347:exon2:c.G91A:p.A31T	ANKLE1:NM_001278443:exon2:c.G58A:p.A20T,ANKLE1:NM_001278444:exon2:c.G91A:p.A31T,ANKLE1:NM_001278445:exon2:c.G49A:p.A17T,ANKLE1:NM_152363:exon2:c.G91A:p.A31T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4908	0.4351	0.427316	LICA-CN|2|402|0.00497512,COCA-CN|3|321|0.00934579	4.739	24.7	.	1.65	0.145	.	.	Ankyrin repeat-containing domain	ANKLE1:uc002nfy.2:exon2:c.G58A:p.A20T,ANKLE1:uc002nga.2:exon2:c.G91A:p.A31T,ANKLE1:uc010eao.1:exon2:c.G157A:p.A53T,ANKLE1:uc010xpn.1:exon2:c.G253A:p.A85T	-0.912	AFR:0.4815,AMR:0.4017,EAS:0.4934,FIN:0.3410,NFE:0.5655,OTH:0.5252,ASJ:0.4159	.	.	.	.	.	.	.	.	0.634	-0.13	0.000	2.555	19	9(large_intestine)	0.5082
19	17393015	17393015	C	T	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs1864116	ENSG00000160117:ENST00000394458:exon2:c.C212T:p.A71V,ENSG00000160117:ENST00000404085:exon2:c.C278T:p.A93V,ENSG00000160117:ENST00000404261:exon2:c.C212T:p.A71V,ENSG00000160117:ENST00000433424:exon2:c.C374T:p.A125V,ENSG00000160117:ENST00000594072:exon2:c.C179T:p.A60V,ENSG00000160117:ENST00000598347:exon2:c.C212T:p.A71V	ANKLE1:NM_001278443:exon2:c.C179T:p.A60V,ANKLE1:NM_001278444:exon2:c.C212T:p.A71V,ANKLE1:NM_001278445:exon2:c.C170T:p.A57V,ANKLE1:NM_152363:exon2:c.C212T:p.A71V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7176	0.8695	0.635383	COCA-CN|3|321|0.00934579	2.020	16.34	.	0.796	0.923	.	.	Ankyrin repeat-containing domain	ANKLE1:uc002nfy.2:exon2:c.C179T:p.A60V,ANKLE1:uc002nga.2:exon2:c.C212T:p.A71V,ANKLE1:uc010eao.1:exon2:c.C278T:p.A93V,ANKLE1:uc010xpn.1:exon2:c.C374T:p.A125V	-1.007	AFR:0.7910,AMR:0.7959,EAS:0.8245,FIN:0.3402,NFE:0.8764,OTH:0.8288,ASJ:0.5694	.	.	.	.	.	.	.	.	0.005	1.6	0.000	1.29	19	5(large_intestine)	0.7853
19	17393504	17393504	G	C	ANKLE1	exonic	synonymous SNV	ENSG00000160117	rs1864113	ENSG00000160117:ENST00000394458:exon3:c.G255C:p.A85A,ENSG00000160117:ENST00000404085:exon3:c.G321C:p.A107A,ENSG00000160117:ENST00000404261:exon3:c.G255C:p.A85A,ENSG00000160117:ENST00000433424:exon3:c.G417C:p.A139A,ENSG00000160117:ENST00000594072:exon3:c.G222C:p.A74A,ENSG00000160117:ENST00000598347:exon3:c.G255C:p.A85A	ANKLE1:NM_001278443:exon3:c.G222C:p.A74A,ANKLE1:NM_001278444:exon3:c.G255C:p.A85A,ANKLE1:NM_001278445:exon3:c.G213C:p.A71A,ANKLE1:NM_152363:exon3:c.G255C:p.A85A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7006	0.8398	0.635383	3(lung)	.	.	.	.	.	.	.	.	ANKLE1:uc002nfy.2:exon3:c.G222C:p.A74A,ANKLE1:uc002nga.2:exon3:c.G255C:p.A85A,ANKLE1:uc010eao.1:exon3:c.G321C:p.A107A,ANKLE1:uc010xpn.1:exon3:c.G417C:p.A139A	.	AFR:MU112067,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,EAS:0.7954,FIN:0.5680,NFE:0.8245,OTH:0.3397,ASJ:0.7911	.	.	.	.	.	.	.	.	.	.	.	.	19	5(large_intestine)	0.8759
19	17393530	17393530	T	A	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs8108174	ENSG00000160117:ENST00000394458:exon3:c.T281A:p.L94Q,ENSG00000160117:ENST00000404085:exon3:c.T347A:p.L116Q,ENSG00000160117:ENST00000404261:exon3:c.T281A:p.L94Q,ENSG00000160117:ENST00000433424:exon3:c.T443A:p.L148Q,ENSG00000160117:ENST00000594072:exon3:c.T248A:p.L83Q,ENSG00000160117:ENST00000598347:exon3:c.T281A:p.L94Q	ANKLE1:NM_001278443:exon3:c.T248A:p.L83Q,ANKLE1:NM_001278444:exon3:c.T281A:p.L94Q,ANKLE1:NM_001278445:exon3:c.T239A:p.L80Q,ANKLE1:NM_152363:exon3:c.T281A:p.L94Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.5191	0.5679	0.460663	1(lung)	5.385	26.0	.	4.27	0.033	.	.	Ankyrin repeat-containing domain	ANKLE1:uc002nfy.2:exon3:c.T248A:p.L83Q,ANKLE1:uc002nga.2:exon3:c.T281A:p.L94Q,ANKLE1:uc010eao.1:exon3:c.T347A:p.L116Q,ANKLE1:uc010xpn.1:exon3:c.T443A:p.L148Q	-0.867	AFR:MU67496,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.4994,FIN:0.4248,NFE:0.4967,OTH:0.3399,ASJ:0.5102	.	.	.	.	.	.	.	.	0.793	.	0.000	2.605	19	12(large_intestine)	0.5665
19	17394124	17394124	T	G	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs2363956	ENSG00000160117:ENST00000394458:exon5:c.T551G:p.L184W,ENSG00000160117:ENST00000404085:exon5:c.T617G:p.L206W,ENSG00000160117:ENST00000404261:exon5:c.T551G:p.L184W,ENSG00000160117:ENST00000433424:exon5:c.T713G:p.L238W,ENSG00000160117:ENST00000594072:exon5:c.T518G:p.L173W,ENSG00000160117:ENST00000598347:exon5:c.T551G:p.L184W	ANKLE1:NM_001278443:exon5:c.T518G:p.L173W,ANKLE1:NM_001278444:exon5:c.T551G:p.L184W,ANKLE1:NM_001278445:exon5:c.T509G:p.L170W,ANKLE1:NM_152363:exon5:c.T551G:p.L184W	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4869	0.5125	0.460663	3(lung)	3.307	22.9	.	2.26	0.002	.	.	.	ANKLE1:uc002nfy.2:exon5:c.T518G:p.L173W,ANKLE1:uc002nga.2:exon5:c.T551G:p.L184W,ANKLE1:uc010eao.1:exon5:c.T617G:p.L206W,ANKLE1:uc010xpn.1:exon5:c.T713G:p.L238W	-0.933	AFR:MU151415,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,PEME-CA|1|112|0.00892857,EAS:0.5,FIN:0.4269,NFE:0.4934,OTH:0.3395,ASJ:0.5096	.	.	.	.	.	.	.	.	0.246	.	0.000	1.65	19	1(thyroid)	0.5662
19	17394504	17394504	A	C	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs891017	ENSG00000160117:ENST00000394458:exon5:c.A931C:p.T311P,ENSG00000160117:ENST00000404085:exon5:c.A997C:p.T333P,ENSG00000160117:ENST00000404261:exon5:c.A931C:p.T311P,ENSG00000160117:ENST00000433424:exon5:c.A1093C:p.T365P,ENSG00000160117:ENST00000594072:exon5:c.A898C:p.T300P,ENSG00000160117:ENST00000598347:exon5:c.A931C:p.T311P	ANKLE1:NM_001278443:exon5:c.A898C:p.T300P,ANKLE1:NM_001278444:exon5:c.A931C:p.T311P,ANKLE1:NM_001278445:exon5:c.A889C:p.T297P,ANKLE1:NM_152363:exon5:c.A931C:p.T311P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7211	0.8005	0.635383	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	-0.449	0.293	.	0.314	0.003	.	.	LEM domain|LEM/LEM-like domain	ANKLE1:uc002nfz.2:exon4:c.A49C:p.T17P,ANKLE1:uc002nfy.2:exon5:c.A898C:p.T300P,ANKLE1:uc002nga.2:exon5:c.A931C:p.T311P,ANKLE1:uc010eao.1:exon5:c.A997C:p.T333P,ANKLE1:uc010xpn.1:exon5:c.A1093C:p.T365P	-0.972	AFR:0.7912,AMR:0.7954,EAS:0.8245,FIN:0.3402,NFE:0.8756,OTH:0.8296,ASJ:0.5680	.	.	.	.	.	.	.	.	0.0	.	0.000	-1.15	19	1(haematopoietic_and_lymphoid_tissue)	0.7848
19	17395003	17395003	A	G	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs11086065	ENSG00000160117:ENST00000394458:exon6:c.A1304G:p.Q435R,ENSG00000160117:ENST00000404085:exon6:c.A1292G:p.Q431R,ENSG00000160117:ENST00000594072:exon6:c.A1193G:p.Q398R,ENSG00000160117:ENST00000598347:exon6:c.A1226G:p.Q409R	ANKLE1:NM_001278443:exon6:c.A1193G:p.Q398R,ANKLE1:NM_001278444:exon6:c.A1226G:p.Q409R,ANKLE1:NM_001278445:exon6:c.A1184G:p.Q395R,ANKLE1:NM_152363:exon6:c.A1304G:p.Q435R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7206	0.8009	0.635184	1(haematopoietic_and_lymphoid_tissue)	-2.006	0.001	.	-7.51	0.017	.	.	GIY-YIG nuclease superfamily	ANKLE1:uc002nfz.2:exon5:c.A422G:p.Q141R,ANKLE1:uc002nfy.2:exon6:c.A1193G:p.Q398R,ANKLE1:uc002nga.2:exon6:c.A1304G:p.Q435R,ANKLE1:uc010eao.1:exon6:c.A1292G:p.Q431R,ANKLE1:uc010xpn.1:exon6:c.A1388G:p.Q463R	-0.963	AFR:MU4566639,AMR:LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,EAS:0.7954,FIN:0.5680,NFE:0.8233,OTH:0.3398,ASJ:0.7908	.	.	.	.	.	.	.	.	0.0	.	0.000	0.475	19	1(breast)	0.8756
19	17395055	17395055	C	G	ANKLE1	exonic	synonymous SNV	ENSG00000160117	rs11882562	ENSG00000160117:ENST00000394458:exon6:c.C1356G:p.T452T,ENSG00000160117:ENST00000404085:exon6:c.C1344G:p.T448T,ENSG00000160117:ENST00000594072:exon6:c.C1245G:p.T415T,ENSG00000160117:ENST00000598347:exon6:c.C1278G:p.T426T	ANKLE1:NM_001278443:exon6:c.C1245G:p.T415T,ANKLE1:NM_001278444:exon6:c.C1278G:p.T426T,ANKLE1:NM_001278445:exon6:c.C1236G:p.T412T,ANKLE1:NM_152363:exon6:c.C1356G:p.T452T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7208	0.8008	0.635383	LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	ANKLE1:uc002nfz.2:exon5:c.C474G:p.T158T,ANKLE1:uc002nfy.2:exon6:c.C1245G:p.T415T,ANKLE1:uc002nga.2:exon6:c.C1356G:p.T452T,ANKLE1:uc010eao.1:exon6:c.C1344G:p.T448T,ANKLE1:uc010xpn.1:exon6:c.C1440G:p.T480T	.	AFR:0.7910,AMR:0.7954,EAS:0.8221,FIN:0.3418,NFE:0.8756,OTH:0.8289,ASJ:0.5680	.	.	.	.	.	.	.	.	.	.	.	.	19	3(lung)	0.7867
19	17396549	17396549	T	C	ANKLE1	exonic	synonymous SNV	ENSG00000160117	rs751599	ENSG00000160117:ENST00000394458:exon8:c.T1596C:p.G532G,ENSG00000160117:ENST00000404085:exon8:c.T1584C:p.G528G,ENSG00000160117:ENST00000594072:exon8:c.T1485C:p.G495G	ANKLE1:NM_001278443:exon8:c.T1485C:p.G495G,ANKLE1:NM_001278445:exon8:c.T1476C:p.G492G,ANKLE1:NM_152363:exon8:c.T1596C:p.G532G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7214	0.8006	0.635383	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	ANKLE1:uc002nfz.2:exon7:c.T714C:p.G238G,ANKLE1:uc002nfy.2:exon8:c.T1485C:p.G495G,ANKLE1:uc002nga.2:exon8:c.T1596C:p.G532G,ANKLE1:uc010eao.1:exon8:c.T1584C:p.G528G	.	AFR:0.7914,AMR:0.7960,EAS:0.8245,FIN:0.3420,NFE:0.8757,OTH:0.8300,ASJ:0.5680	.	.	.	.	.	.	.	.	.	.	.	.	19	1(lung)	0.7857
19	17397501	17397501	T	G	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs1465582	ENSG00000160117:ENST00000598347:exon8:c.T1771G:p.L591V	ANKLE1:NM_001278444:exon8:c.T1771G:p.L591V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.315895	2(lung)	.	.	.	.	.	.	.	.	ANKLE1:uc010xpn.1:exon8:c.T1933G:p.L645V	.	AFR:1(cervix),AMR:MU4559301,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,THCA-CN|1|50|0.02,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	.	.	19	1(large_intestine)	.
19	17941294	17941294	T	C	JAK3	intronic	.	ENSG00000105639	rs2302603	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4096	0.3479	0.434305	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.3627,AMR:0.4001,EAS:0.2533,FIN:0.4688,NFE:0.3369,OTH:0.3299,ASJ:0.4759	600173	600802;	35078;	35078|T-B+ SCID due to JAK3 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|600802 ~	~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05161 Hepatitis B~ko05162 Measles~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05223 Non-small cell lung cancer~ko05340 Primary immunodeficiency ~	.	.	.	.	.	.	.	19	12(soft_tissue)	0.3835
19	17942478	17942478	C	T	JAK3	intronic	.	ENSG00000105639	rs200731018	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0008	.	0.00179712	.	.	.	.	.	.	1.0000	0.986	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600173	600802;	35078;	35078|T-B+ SCID due to JAK3 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|600802 ~	~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05161 Hepatitis B~ko05162 Measles~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05223 Non-small cell lung cancer~ko05340 Primary immunodeficiency ~	.	.	.	.	.	.	.	19	.	het
19	17958777	17958777	T	C	JAK3	UTR5	.	ENSG00000105639	rs7254346	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	.	.	0.28155	0.2145	.	.	.	.	.	.	.	.	.	.	AFR:0.5543,AMR:0.1065,EAS:0.2164,FIN:0.0341,NFE:0.0747,OTH:0.0990,ASJ:0.0993	600173	600802;	35078;	35078|T-B+ SCID due to JAK3 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|600802 ~	~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05161 Hepatitis B~ko05162 Measles~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05223 Non-small cell lung cancer~ko05340 Primary immunodeficiency ~	.	.	.	.	.	.	.	19	MU30174704	het
19	18273047	18273047	T	C	PIK3R2	exonic	nonsynonymous SNV	ENSG00000105647;ENSG00000268173	rs1011320	ENSG00000105647:ENST00000426902:exon7:c.T937C:p.S313P,ENSG00000105647:ENST00000222254:exon8:c.T937C:p.S313P,ENSG00000268173:ENST00000593731:exon8:c.T937C:p.S313P	PIK3R2:NM_005027:exon8:c.T937C:p.S313P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9501	0.9552	0.953474	0.9570	-1.239	0.006	0.722	-1.99	0.006	.	.	.	PIK3R2:uc002nia.2:exon8:c.T937C:p.S313P	-1.020	AFR:0.9703,AMR:0.9737,EAS:0.9635,FIN:0.9587,NFE:0.9480,OTH:0.9418,ASJ:0.9667	603157	603387;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	0.0	0.88	0.000	-1.04	19	MU82021073	hom
19	18279638	18279638	T	C	PIK3R2	exonic	synonymous SNV	ENSG00000105647;ENSG00000268173	rs273269	ENSG00000105647:ENST00000222254:exon15:c.T1911C:p.S637S,ENSG00000268173:ENST00000593731:exon15:c.T1911C:p.S637S	PIK3R2:NM_005027:exon15:c.T1911C:p.S637S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8800	0.8511	0.86242	0.8614	.	.	.	.	.	.	.	.	PIK3R2:uc002nia.2:exon15:c.T1911C:p.S637S	.	AFR:0.7798,AMR:0.9021,EAS:0.9227,FIN:0.9186,NFE:0.8861,OTH:0.8666,ASJ:0.8709	603157	603387;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	19	MU4566745	het
19	18280080	18280080	C	T	PIK3R2	exonic	synonymous SNV	ENSG00000105647;ENSG00000268173	rs147625988	ENSG00000105647:ENST00000222254:exon16:c.C2163T:p.P721P,ENSG00000268173:ENST00000593731:exon16:c.C2163T:p.P721P	PIK3R2:NM_005027:exon16:c.C2163T:p.P721P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0298	0.0002	0.0297524	0.0058	.	.	.	.	.	.	.	.	PIK3R2:uc002nia.2:exon16:c.C2163T:p.P721P	.	AFR:0.0015,AMR:0.0462,EAS:0.0636,FIN:0,NFE:0.0007,OTH:0.0136,ASJ:0	603157	603387;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	19	MU82153296	het
19	18857939	18857939	-	C	CRTC1	intronic	.	ENSG00000105662	rs56040769	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0949	0.1257	.	0.2415	.	.	.	.	.	.	.	.	.	.	AFR:0.1758,AMR:0.2623,EAS:0.2141,FIN:0.3460,NFE:0.2525,OTH:0.2926,ASJ:0.2826	607536	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	18876309	18876309	A	G	CRTC1	exonic	nonsynonymous SNV	ENSG00000105662	rs3746266	ENSG00000105662:ENST00000601916:exon8:c.A757G:p.T253A,ENSG00000105662:ENST00000321949:exon9:c.A982G:p.T328A,ENSG00000105662:ENST00000594658:exon9:c.A859G:p.T287A,ENSG00000105662:ENST00000338797:exon10:c.A1030G:p.T344A	CRTC1:NM_015321:exon9:c.A982G:p.T328A,CRTC1:NM_001098482:exon10:c.A1030G:p.T344A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0] 	0.1452	0.1307	0.126797	LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526	2.664	20.6	0.052	3.31	0.998	.	.	.	CRTC1:uc010ebw.3:exon6:c.A577G:p.T193A,CRTC1:uc002nkb.4:exon9:c.A982G:p.T328A,CRTC1:uc010ebv.3:exon10:c.A1030G:p.T344A	-1.061	AFR:0.1253,AMR:0.0700,EAS:0.2450,FIN:0.2043,NFE:0.1201,OTH:0.1484,ASJ:0.1086	607536	.	.	.	.	.	.	.	0.979	2.64	0.000	2.24	19	5(soft_tissue)	0.1296
19	18886431	18886431	T	C	CRTC1	intronic	.	ENSG00000105662	rs12609934	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2262	0.2186	0.221645	1(liver)	.	.	.	.	.	.	.	.	.	.	AFR:MU28604669,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,EAS:0.3493,FIN:0.1265,NFE:0.2567,OTH:0.2038,ASJ:0.2009	607536	.	.	.	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.1069
19	30314666	30314666	C	T	CCNE1	exonic	synonymous SNV	ENSG00000105173	rs7257694	ENSG00000105173:ENST00000576532:exon7:c.C834T:p.S278S,ENSG00000105173:ENST00000444983:exon10:c.C1170T:p.S390S,ENSG00000105173:ENST00000357943:exon11:c.C1086T:p.S362S,ENSG00000105173:ENST00000262643:exon12:c.C1215T:p.S405S	CCNE1:NM_001322259:exon11:c.C1080T:p.S360S,CCNE1:NM_001322261:exon11:c.C1068T:p.S356S,CCNE1:NM_001322262:exon11:c.C1170T:p.S390S,CCNE1:NM_001238:exon12:c.C1215T:p.S405S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3140	0.2954	0.192891	0.3080	.	.	.	.	.	.	.	.	CCNE1:uc002nso.3:exon10:c.C1170T:p.S390S,CCNE1:uc002nsn.3:exon12:c.C1215T:p.S405S	.	AFR:0.1120,AMR:0.2578,EAS:0.1210,FIN:0.4420,NFE:0.4085,OTH:0.3704,ASJ:0.3775	123837	.	.	.	~ko04110 Cell cycle~ko04114 Oocyte meiosis~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04391 Hippo signaling pathway - fly~ko04934 Cushing syndrome~ko05161 Hepatitis B~ko05162 Measles~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05215 Prostate cancer~ko05222 Small cell lung cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	19	MU30176389	het
19	31769763	31769763	G	A	TSHZ3	exonic	synonymous SNV	ENSG00000121297	rs12461253	ENSG00000121297:ENST00000240587:exon2:c.C936T:p.V312V	TSHZ3:NM_020856:exon2:c.C936T:p.V312V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3156	0.2691	0.35004	MU145347	.	.	.	.	.	.	.	.	TSHZ3:uc002nsy.4:exon2:c.C936T:p.V312V	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.2985,EAS:0.2828,FIN:0.3079,NFE:0.5668,OTH:0.3321,ASJ:0.2317	614119	.	.	.	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.2999
19	33467515	33467515	T	C	FAAP24	exonic	nonsynonymous SNV	ENSG00000131944	rs3816032	ENSG00000131944:ENST00000590179:exon3:c.T290C:p.I97T,ENSG00000131944:ENST00000589646:exon4:c.T290C:p.I97T,ENSG00000131944:ENST00000588258:exon5:c.T575C:p.I192T,ENSG00000131944:ENST00000590281:exon5:c.T575C:p.I192T	FAAP24:NM_001300978:exon3:c.T290C:p.I97T,FAAP24:NM_152266:exon5:c.T575C:p.I192T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1583	0.1070	0.189696	LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	-0.030	2.308	.	3.21	0.047	.	.	RuvA domain 2-like	C19orf40:uc002nud.4:exon5:c.T575C:p.I192T	-1.003	AFR:0.1155,AMR:0.0885,EAS:0.1821,FIN:0.3079,NFE:0.0868,OTH:0.1118,ASJ:0.1722	610884	.	.	.	.	.	.	.	0.002	2.02	0.000	1.585	19	1(lung)	0.1296
19	36213461	36213461	C	T	KMT2B	intronic	.	ENSG00000105663	rs11084828	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1745	0.1435	0.17492	0.1488	.	.	.	.	.	0	0.072	.	.	.	AFR:0.1727,AMR:0.0692,EAS:0.1815,FIN:0.1601,NFE:0.1321,OTH:0.1415,ASJ:0.2185	606834	.	.	.	.	.	.	.	.	.	.	.	19	MU638112	het
19	36218478	36218478	C	T	KMT2B	exonic	synonymous SNV	ENSG00000272333	rs11670414	ENSG00000272333:ENST00000222270:exon16:c.C4257T:p.G1419G,ENSG00000272333:ENST00000420124:exon16:c.C4257T:p.G1419G	KMT2B:NM_014727:exon16:c.C4257T:p.G1419G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1583	0.1430	0.178115	1(lung)	.	.	.	.	.	.	.	.	KMT2B:uc021usv.1:exon16:c.C4257T:p.G1419G	.	AFR:1(stomach),AMR:MU67695,EAS:0.1488,FIN:0.1731,NFE:0.0694,OTH:0.2185,ASJ:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	606834	.	.	.	.	.	.	.	.	.	.	.	19	3(large_intestine)	0.1828
19	36224705	36224705	A	G	KMT2B	exonic	nonsynonymous SNV	ENSG00000272333	rs231591	ENSG00000272333:ENST00000222270:exon30:c.A7091G:p.D2364G,ENSG00000272333:ENST00000420124:exon30:c.A7091G:p.D2364G	KMT2B:NM_014727:exon30:c.A7091G:p.D2364G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5331	0.5792	0.620407	1(pleura)	-0.588	0.134	1.0	1.66	0.103	.	.	.	KMT2B:uc021usv.1:exon30:c.A7091G:p.D2364G	-0.961	AFR:1(lung),AMR:1(stomach),EAS:MU112187,FIN:LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,NFE:0.5734,OTH:0.7952,ASJ:1(haematopoietic_and_lymphoid_tissue)	606834	.	.	.	.	.	.	.	0.0	-1.64	0.000	-0.69	19	1(large_intestine)	0.4209
19	38935280	38935280	A	G	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2229139	ENSG00000196218:ENST00000355481:exon7:c.A594G:p.L198L,ENSG00000196218:ENST00000359596:exon7:c.A594G:p.L198L,ENSG00000196218:ENST00000360985:exon7:c.A594G:p.L198L	RYR1:NM_000540:exon7:c.A594G:p.L198L,RYR1:NM_001042723:exon7:c.A594G:p.L198L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6074	0.6030	0.543331	MU17314527	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon7:c.A594G:p.L198L,RYR1:uc002oiu.3:exon7:c.A594G:p.L198L	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,AMR:0.6056,EAS:0.6882,FIN:0.6192,NFE:0.6322,OTH:0.6549,ASJ:0.5109	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	2(lung)	0.6400
19	38939408	38939408	T	C	RYR1	exonic	synonymous SNV	ENSG00000196218	rs10406027	ENSG00000196218:ENST00000355481:exon11:c.T1077C:p.A359A,ENSG00000196218:ENST00000359596:exon11:c.T1077C:p.A359A,ENSG00000196218:ENST00000360985:exon11:c.T1077C:p.A359A	RYR1:NM_000540:exon11:c.T1077C:p.A359A,RYR1:NM_001042723:exon11:c.T1077C:p.A359A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8844	0.8952	0.903954	0.9058	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon11:c.T1077C:p.A359A,RYR1:uc002oiu.3:exon11:c.T1077C:p.A359A	.	AFR:0.9348,AMR:0.9165,EAS:0.9938,FIN:0.9272,NFE:0.8741,OTH:0.8937,ASJ:0.9272	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	MU4567228	hom
19	38946182	38946182	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2288888	ENSG00000196218:ENST00000355481:exon15:c.G1668A:p.S556S,ENSG00000196218:ENST00000359596:exon15:c.G1668A:p.S556S,ENSG00000196218:ENST00000360985:exon15:c.G1668A:p.S556S	RYR1:NM_000540:exon15:c.G1668A:p.S556S,RYR1:NM_001042723:exon15:c.G1668A:p.S556S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6366	0.6321	0.571286	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon15:c.G1668A:p.S556S,RYR1:uc002oiu.3:exon15:c.G1668A:p.S556S	.	AFR:0.6389,AMR:0.5420,EAS:0.6954,FIN:0.6088,NFE:0.7077,OTH:0.6745,ASJ:0.7100	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	3(lung)	0.6838
19	38949904	38949904	C	T	RYR1	exonic	synonymous SNV	ENSG00000196218	rs3745847	ENSG00000196218:ENST00000355481:exon19:c.C2286T:p.P762P,ENSG00000196218:ENST00000359596:exon19:c.C2286T:p.P762P,ENSG00000196218:ENST00000360985:exon19:c.C2286T:p.P762P	RYR1:NM_000540:exon19:c.C2286T:p.P762P,RYR1:NM_001042723:exon19:c.C2286T:p.P762P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6211	0.6170	0.554113	MU4567230	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon19:c.C2286T:p.P762P,RYR1:uc002oiu.3:exon19:c.C2286T:p.P762P	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.6271,EAS:0.7005,FIN:0.6623,NFE:0.5893,OTH:0.6999,ASJ:0.5264	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	3(lung)	0.6645
19	38956803	38956803	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2228069	ENSG00000196218:ENST00000355481:exon24:c.G2943A:p.T981T,ENSG00000196218:ENST00000359596:exon24:c.G2943A:p.T981T,ENSG00000196218:ENST00000360985:exon24:c.G2943A:p.T981T	RYR1:NM_000540:exon24:c.G2943A:p.T981T,RYR1:NM_001042723:exon24:c.G2943A:p.T981T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5962	0.5971	0.545527	1(liver)	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon24:c.G2943A:p.T981T,RYR1:uc002oiu.3:exon24:c.G2943A:p.T981T	.	AFR:MU153475,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,EAS:0.5620,FIN:0.6993,NFE:0.6556,OTH:0.5235,ASJ:0.5968	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.5798
19	38968499	38968499	C	T	RYR1	exonic	synonymous SNV	ENSG00000196218	rs141317474	ENSG00000196218:ENST00000355481:exon30:c.C4443T:p.N1481N,ENSG00000196218:ENST00000359596:exon30:c.C4443T:p.N1481N,ENSG00000196218:ENST00000360985:exon30:c.C4443T:p.N1481N	RYR1:NM_000540:exon30:c.C4443T:p.N1481N,RYR1:NM_001042723:exon30:c.C4443T:p.N1481N	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0041	0.0017	0.00579073	0.0031	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon30:c.C4443T:p.N1481N,RYR1:uc002oiu.3:exon30:c.C4443T:p.N1481N	.	AFR:0.0010,AMR:0.0024,EAS:0,FIN:0.0069,NFE:0.0036,OTH:0.0041,ASJ:0.0066	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	.	het
19	38991516	38991516	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2228072	ENSG00000196218:ENST00000355481:exon47:c.G7500A:p.A2500A,ENSG00000196218:ENST00000359596:exon47:c.G7500A:p.A2500A,ENSG00000196218:ENST00000360985:exon47:c.G7500A:p.A2500A	RYR1:NM_000540:exon47:c.G7500A:p.A2500A,RYR1:NM_001042723:exon47:c.G7500A:p.A2500A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1140	0.0976	0.150759	MU30180040	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon47:c.G7500A:p.A2500A,RYR1:uc002oiu.3:exon47:c.G7500A:p.A2500A	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.0902,EAS:0.0764,FIN:0.0762,NFE:0.1722,OTH:0.0481,ASJ:0.1135	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(lung)	0.0800
19	38991543	38991543	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2071088	ENSG00000196218:ENST00000355481:exon47:c.G7527A:p.V2509V,ENSG00000196218:ENST00000359596:exon47:c.G7527A:p.V2509V,ENSG00000196218:ENST00000360985:exon47:c.G7527A:p.V2509V	RYR1:NM_000540:exon47:c.G7527A:p.V2509V,RYR1:NM_001042723:exon47:c.G7527A:p.V2509V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1116	0.0882	0.135982	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon47:c.G7527A:p.V2509V,RYR1:uc002oiu.3:exon47:c.G7527A:p.V2509V	.	AFR:0.0810,AMR:0.0812,EAS:0.0767,FIN:0.1702,NFE:0.0482,OTH:0.0801,ASJ:0.0764	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(large_intestine)	0.0686
19	38993372	38993372	A	G	RYR1	intronic	.	ENSG00000196218	rs1469695	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3366	0.3140	0.421925	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579	.	.	.	.	.	0	0.002	.	.	.	AFR:0.3469,AMR:0.4794,EAS:0.2598,FIN:0.3839,NFE:0.3440,OTH:0.2664,ASJ:0.4137	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.3201
19	38993547	38993547	C	T	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2229142	ENSG00000196218:ENST00000355481:exon49:c.C7863T:p.H2621H,ENSG00000196218:ENST00000359596:exon49:c.C7863T:p.H2621H,ENSG00000196218:ENST00000360985:exon49:c.C7863T:p.H2621H	RYR1:NM_000540:exon49:c.C7863T:p.H2621H,RYR1:NM_001042723:exon49:c.C7863T:p.H2621H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1821	0.1579	0.237819	1(breast)	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon49:c.C7863T:p.H2621H,RYR1:uc002oiu.3:exon49:c.C7863T:p.H2621H	.	AFR:1(large_intestine),AMR:MU153489,EAS:0.1636,FIN:0.1830,NFE:0.1289,OTH:0.1722,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	2(lung)	0.3225
19	38994910	38994910	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2229144	ENSG00000196218:ENST00000355481:exon50:c.G7977A:p.T2659T,ENSG00000196218:ENST00000359596:exon50:c.G7977A:p.T2659T,ENSG00000196218:ENST00000360985:exon50:c.G7977A:p.T2659T	RYR1:NM_000540:exon50:c.G7977A:p.T2659T,RYR1:NM_001042723:exon50:c.G7977A:p.T2659T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3261	0.3195	0.41234	MU584624	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon50:c.G7977A:p.T2659T,RYR1:uc002oiu.3:exon50:c.G7977A:p.T2659T	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.3252,EAS:0.3493,FIN:0.2550,NFE:0.3786,OTH:0.2901,ASJ:0.4657	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(stomach)	0.2477
19	38995438	38995438	T	C	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2960340	ENSG00000196218:ENST00000355481:exon51:c.T8118C:p.I2706I,ENSG00000196218:ENST00000359596:exon51:c.T8118C:p.I2706I,ENSG00000196218:ENST00000360985:exon51:c.T8118C:p.I2706I	RYR1:NM_000540:exon51:c.T8118C:p.I2706I,RYR1:NM_001042723:exon51:c.T8118C:p.I2706I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3264	0.3198	0.415136	1(large_intestine)	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon51:c.T8118C:p.I2706I,RYR1:uc002oiu.3:exon51:c.T8118C:p.I2706I	.	AFR:MU153496,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,EAS:0.4660,FIN:0.3505,NFE:0.2533,OTH:0.3778,ASJ:0.3253	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(oesophagus)	0.2904
19	38995510	38995510	T	C	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2915951	ENSG00000196218:ENST00000355481:exon51:c.T8190C:p.D2730D,ENSG00000196218:ENST00000359596:exon51:c.T8190C:p.D2730D,ENSG00000196218:ENST00000360985:exon51:c.T8190C:p.D2730D	RYR1:NM_000540:exon51:c.T8190C:p.D2730D,RYR1:NM_001042723:exon51:c.T8190C:p.D2730D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3294	0.3236	0.417133	MU584625	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon51:c.T8190C:p.D2730D,RYR1:uc002oiu.3:exon51:c.T8190C:p.D2730D	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579,AMR:0.3285,EAS:0.3505,FIN:0.2583,NFE:0.3755,OTH:0.2993,ASJ:0.4675	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(stomach)	0.2510
19	38995975	38995975	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2915952	ENSG00000196218:ENST00000355481:exon53:c.G8337A:p.E2779E,ENSG00000196218:ENST00000359596:exon53:c.G8337A:p.E2779E,ENSG00000196218:ENST00000360985:exon53:c.G8337A:p.E2779E	RYR1:NM_000540:exon53:c.G8337A:p.E2779E,RYR1:NM_001042723:exon53:c.G8337A:p.E2779E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3294	0.3082	0.40595	MU153503	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon53:c.G8337A:p.E2779E,RYR1:uc002oiu.3:exon53:c.G8337A:p.E2779E	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.3169,EAS:0.3496,FIN:0.2384,NFE:0.3776,OTH:0.2898,ASJ:0.4375	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	2(lung)	0.2472
19	38996990	38996990	T	C	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2229146	ENSG00000196218:ENST00000355481:exon55:c.T8589C:p.S2863S,ENSG00000196218:ENST00000359596:exon55:c.T8589C:p.S2863S,ENSG00000196218:ENST00000360985:exon55:c.T8589C:p.S2863S	RYR1:NM_000540:exon55:c.T8589C:p.S2863S,RYR1:NM_001042723:exon55:c.T8589C:p.S2863S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3265	0.3136	0.408147	1(large_intestine)	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon55:c.T8589C:p.S2863S,RYR1:uc002oiu.3:exon55:c.T8589C:p.S2863S	.	AFR:MU153510,AMR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.4390,FIN:0.3498,NFE:0.2417,OTH:0.3758,ASJ:0.3204	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	2(lung)	0.3
19	38997459	38997459	G	C	RYR1	intronic	.	ENSG00000196218	rs2915958	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3243	0.3086	0.40615	0.3169	.	.	.	.	.	0.0095	0.052	.	.	.	AFR:0.4380,AMR:0.3501,EAS:0.3784,FIN:0.2899,NFE:0.2469,OTH:0.3008,ASJ:0.2384	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	MU25908965	het
19	38997609	38997609	T	A	RYR1	intronic	.	ENSG00000196218	rs2915959	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3219	0.3072	0.404952	MU25909011	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.3169,EAS:0.3493,FIN:0.2384,NFE:0.3756,OTH:0.2899,ASJ:0.4385	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(large_intestine)	0.2470
19	39002725	39002725	A	G	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2071089	ENSG00000196218:ENST00000355481:exon62:c.A9186G:p.P3062P,ENSG00000196218:ENST00000359596:exon62:c.A9186G:p.P3062P,ENSG00000196218:ENST00000360985:exon62:c.A9186G:p.P3062P	RYR1:NM_000540:exon62:c.A9186G:p.P3062P,RYR1:NM_001042723:exon62:c.A9186G:p.P3062P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3251	0.3109	0.406949	3(lung)	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon62:c.A9186G:p.P3062P,RYR1:uc002oiu.3:exon62:c.A9186G:p.P3062P	.	AFR:MU153517,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.4374,FIN:0.3508,NFE:0.2384,OTH:0.3770,ASJ:0.3203	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(thyroid)	0.3012
19	39010053	39010053	C	T	RYR1	exonic	synonymous SNV	ENSG00000196218	rs41274330	ENSG00000196218:ENST00000355481:exon67:c.C10218T:p.Y3406Y,ENSG00000196218:ENST00000359596:exon67:c.C10218T:p.Y3406Y,ENSG00000196218:ENST00000360985:exon67:c.C10218T:p.Y3406Y	RYR1:NM_000540:exon67:c.C10218T:p.Y3406Y,RYR1:NM_001042723:exon67:c.C10218T:p.Y3406Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1055	0.0344	0.102236	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	RYR1:uc010xuf.1:exon6:c.C978T:p.Y326Y,RYR1:uc002oit.3:exon67:c.C10218T:p.Y3406Y,RYR1:uc002oiu.3:exon67:c.C10218T:p.Y3406Y	.	AFR:0.0395,AMR:0.0127,EAS:0.0563,FIN:0.1846,NFE:0.0195,OTH:0.0419,ASJ:0.0621	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	3(large_intestine)	0.0468
19	39018277	39018277	C	T	RYR1	intronic	.	ENSG00000269445	rs77592501	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0817	0.0409	0.10643	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	0.0001	0.006	.	.	.	AFR:0.0460,AMR:0.0261,EAS:0.0563,FIN:0.1842,NFE:0.0309,OTH:0.0447,ASJ:0.0668	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.0489
19	39406264	39406264	-	CCAGGCAGC	SARS2	exonic	nonframeshift insertion	ENSG00000104835;ENSG00000269547	rs551671819	ENSG00000104835:ENST00000598831:exon5:c.482_483insGCTGCCTGG:p.G161delinsGLPG,ENSG00000104835:ENST00000221431:exon16:c.1538_1539insGCTGCCTGG:p.G513delinsGLPG,ENSG00000104835:ENST00000430193:exon16:c.1538_1539insGCTGCCTGG:p.G513delinsGLPG,ENSG00000104835:ENST00000594171:exon16:c.968_969insGCTGCCTGG:p.G323delinsGLPG,ENSG00000104835:ENST00000600042:exon17:c.1544_1545insGCTGCCTGG:p.G515delinsGLPG,ENSG00000104835:ENST00000448145:exon20:c.1538_1539insGCTGCCTGG:p.G513delinsGLPG	SARS2:NM_017827:exon16:c.1538_1539insGCTGCCTGG:p.G513delinsGLPG,SARS2:NM_001145901:exon17:c.1544_1545insGCTGCCTGG:p.G515delinsGLPG	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0023	0.0011	0.00259585	0.0013	.	.	.	.	.	.	.	.	SARS2:uc002ojz.2:exon16:c.968_969insGCTGCCTGG:p.G323delinsGLPG,SARS2:uc002oka.2:exon16:c.1538_1539insGCTGCCTGG:p.G513delinsGLPG,SARS2:uc010xup.1:exon17:c.1544_1545insGCTGCCTGG:p.G515delinsGLPG,SARS2:uc010xuq.1:exon20:c.1538_1539insGCTGCCTGG:p.G513delinsGLPG	.	AFR:0.0003,AMR:0,EAS:0,FIN:0.0014,NFE:0.0021,OTH:0.0010,ASJ:0	612804	613845;	363694;	363694|HUPRA syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613845 ~	.	.	.	.	.	.	.	.	19	MU124508654	het
19	39408360	39408360	A	G	SARS2	intronic	.	ENSG00000104835;ENSG00000269547	rs7508411	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7066	0.7052	0.834665	0.7254	.	.	.	.	.	0	0.074	.	.	.	AFR:0.8753,AMR:0.7803,EAS:0.9659,FIN:0.6919,NFE:0.6179,OTH:0.6801,ASJ:0.7416	612804	613845;	363694;	363694|HUPRA syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613845 ~	.	.	.	.	.	.	.	.	19	MU9418845	het
19	39416887	39416887	C	T	SARS2	exonic	synonymous SNV	ENSG00000104835;ENSG00000269547	rs11544093	ENSG00000104835:ENST00000221431:exon2:c.G321A:p.E107E,ENSG00000104835:ENST00000430193:exon2:c.G321A:p.E107E,ENSG00000104835:ENST00000455102:exon2:c.G321A:p.E107E,ENSG00000104835:ENST00000598343:exon2:c.G321A:p.E107E,ENSG00000104835:ENST00000600042:exon2:c.G321A:p.E107E,ENSG00000104835:ENST00000448145:exon6:c.G321A:p.E107E	SARS2:NM_001145901:exon2:c.G321A:p.E107E,SARS2:NM_017827:exon2:c.G321A:p.E107E	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1773	0.1374	0.189896	MU13194184	.	.	.	.	.	.	.	.	SARS2:uc002oka.2:exon2:c.G321A:p.E107E,SARS2:uc010xup.1:exon2:c.G321A:p.E107E,SARS2:uc010xus.1:exon2:c.G321A:p.E107E,SARS2:uc010xuq.1:exon6:c.G321A:p.E107E	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.1629,EAS:0.1301,FIN:0.1523,NFE:0.3085,OTH:0.2298,ASJ:0.0977	612804	613845;	363694;	363694|HUPRA syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613845 ~	.	.	.	.	.	.	.	.	19	1(urinary_tract)	0.1703
19	39421388	39421388	A	G	MRPS12;SARS2	UTR5	.	ENSG00000104835;ENSG00000128626	rs730078	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7121	0.7138	0.842053	0.7293	.	.	.	.	.	.	.	.	.	.	AFR:0.8959,AMR:0.7769,EAS:0.9605,FIN:0.6932,NFE:0.6155,OTH:0.6820,ASJ:0.76	.	.	.	.	.	.	.	.	.	.	.	.	19	MU82024794	het
19	39905903	39905903	A	G	PLEKHG2	intronic	.	ENSG00000090924	rs3859551	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2609	0.1958	0.179712	0.2033	.	.	.	.	.	0.0111	0.144	.	.	.	AFR:0.2454,AMR:0.2291,EAS:0.0241,FIN:0.2090,NFE:0.1977,OTH:0.1694,ASJ:0.1987	611893	616763;	.	.	.	.	.	.	.	.	.	.	19	MU87255653	het
19	39906985	39906985	T	C	PLEKHG2	intronic	.	ENSG00000090924	rs10401595	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1888	0.1934	0.176318	0.1990	.	.	.	.	.	0.0014	0.006	.	.	.	AFR:0.2329,AMR:0.2267,EAS:0.0235,FIN:0.2082,NFE:0.1967,OTH:0.1667,ASJ:0.2	611893	616763;	.	.	.	.	.	.	.	.	.	.	19	.	het
19	39907036	39907036	C	T	PLEKHG2	exonic	synonymous SNV	ENSG00000090924	rs2277743	ENSG00000090924:ENST00000451354:exon4:c.C531T:p.A177A,ENSG00000090924:ENST00000378550:exon5:c.C528T:p.A176A,ENSG00000090924:ENST00000409794:exon5:c.C528T:p.A176A,ENSG00000090924:ENST00000409797:exon5:c.C528T:p.A176A,ENSG00000090924:ENST00000425673:exon5:c.C528T:p.A176A,ENSG00000090924:ENST00000458508:exon5:c.C351T:p.A117A	PLEKHG2:NM_001351693:exon5:c.C351T:p.A117A,PLEKHG2:NM_001351694:exon5:c.C528T:p.A176A,PLEKHG2:NM_022835:exon5:c.C528T:p.A176A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1884	0.1930	0.176318	LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	PLEKHG2:uc002olj.3:exon5:c.C528T:p.A176A,PLEKHG2:uc010xuy.2:exon5:c.C351T:p.A117A,PLEKHG2:uc010xuz.2:exon5:c.C528T:p.A176A	.	AFR:0.1974,AMR:0.2318,EAS:0.1987,FIN:0.0242,NFE:0.2081,OTH:0.1942,ASJ:0.2267	611893	616763;	.	.	.	.	.	.	.	.	.	.	19	3(urinary_tract)	0.1677
19	39913634	39913634	G	A	PLEKHG2	exonic	nonsynonymous SNV	ENSG00000090924	rs10407035	ENSG00000090924:ENST00000425673:exon16:c.G1853A:p.R618H,ENSG00000090924:ENST00000409794:exon18:c.G1940A:p.R647H,ENSG00000090924:ENST00000458508:exon18:c.G1763A:p.R588H	PLEKHG2:NM_001351693:exon18:c.G1763A:p.R588H,PLEKHG2:NM_022835:exon18:c.G1940A:p.R647H	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1735	0.1454	0.245008	1(liver)	0.008	2.660	0.133	-2.84	0.002	.	.	.	PLEKHG2:uc010xva.2:exon14:c.G1274A:p.R425H,PLEKHG2:uc010xuy.2:exon18:c.G1763A:p.R588H,PLEKHG2:uc010xuz.2:exon18:c.G1940A:p.R647H	-1.033	AFR:1(breast),AMR:MU13194408,EAS:0.1542,FIN:0.2010,NFE:0.1770,OTH:0.2219,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	611893	616763;	.	.	.	.	.	.	0.955	-0.33	0.000	0	19	1(stomach)	0.3789
19	39914308	39914308	C	T	PLEKHG2	intronic	.	ENSG00000090924	rs31725	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5017	0.5200	0.579073	0.5340	.	.	.	.	.	.	.	.	.	.	AFR:0.6675,AMR:0.5012,EAS:0.5318,FIN:0.5330,NFE:0.4606,OTH:0.5092,ASJ:0.5232	611893	616763;	.	.	.	.	.	.	.	.	.	.	19	MU635556	hom
19	39914748	39914748	G	A	PLEKHG2	exonic	nonsynonymous SNV	ENSG00000090924	rs31726	ENSG00000090924:ENST00000425673:exon17:c.G2888A:p.R963K,ENSG00000090924:ENST00000409794:exon19:c.G2975A:p.R992K,ENSG00000090924:ENST00000458508:exon19:c.G2798A:p.R933K	PLEKHG2:NM_001351693:exon19:c.G2798A:p.R933K,PLEKHG2:NM_022835:exon19:c.G2975A:p.R992K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5083	0.5226	0.575879	2(large_intestine)	0.257	5.263	0.101	0.404	0.001	.	.	.	PLEKHG2:uc010xva.2:exon15:c.G2309A:p.R770K,PLEKHG2:uc010xuy.2:exon19:c.G2798A:p.R933K,PLEKHG2:uc010xuz.2:exon19:c.G2975A:p.R992K	-0.924	AFR:MU146422,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.6473,FIN:0.5119,NFE:0.5232,OTH:0.5702,ASJ:0.5393	611893	616763;	.	.	.	.	.	.	0.004	-0.57	0.000	1.835	19	1(biliary_tract)	0.5350
19	39915637	39915637	G	A	PLEKHG2	exonic	synonymous SNV	ENSG00000090924	rs31727	ENSG00000090924:ENST00000425673:exon17:c.G3777A:p.Q1259Q,ENSG00000090924:ENST00000409794:exon19:c.G3864A:p.Q1288Q	PLEKHG2:NM_022835:exon19:c.G3864A:p.Q1288Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5511	0.5581	0.596845	MU146433	.	.	.	.	.	.	.	.	PLEKHG2:uc010xva.2:exon15:c.G3198A:p.Q1066Q,PLEKHG2:uc010xuz.2:exon19:c.G3864A:p.Q1288Q	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.5804,EAS:0.5346,FIN:0.55,NFE:0.5713,OTH:0.6101,ASJ:0.6601	611893	616763;	.	.	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.5333
19	39915758	39915758	C	G	PLEKHG2	exonic	nonsynonymous SNV	ENSG00000090924	rs31728	ENSG00000090924:ENST00000425673:exon17:c.C3898G:p.P1300A,ENSG00000090924:ENST00000409794:exon19:c.C3985G:p.P1329A	PLEKHG2:NM_022835:exon19:c.C3985G:p.P1329A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5527	0.5783	0.592252	MU74687	4.517	24.3	.	3.03	0.954	.	.	.	PLEKHG2:uc010xva.2:exon15:c.C3319G:p.P1107A,PLEKHG2:uc010xuz.2:exon19:c.C3985G:p.P1329A	-0.846	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BLCA-CN|1|103|0.00970874,AMR:0.5787,EAS:0.5288,FIN:0.5364,NFE:0.5760,OTH:0.6131,ASJ:0.6577	611893	616763;	.	.	.	.	.	.	0.582	.	0.000	1.04	19	3(large_intestine)	0.5309
19	40900865	40900865	C	T	PRX	exonic	nonsynonymous SNV	ENSG00000105227	rs268674	ENSG00000105227:ENST00000324001:exon7:c.G3394A:p.G1132R	PRX:NM_181882:exon7:c.G3394A:p.G1132R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9469	0.9538	0.965455	0.9599	0.019	2.769	0.129	3.64	0.017	.	.	.	PRX:uc002onq.3:exon3:c.G2977A:p.G993R,PRX:uc002onr.3:exon7:c.G3394A:p.G1132R	-1.009	AFR:0.9899,AMR:0.9678,EAS:0.9691,FIN:0.9472,NFE:0.9444,OTH:0.9561,ASJ:0.9437	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	0.0	4.2	0.000	-0.625	19	MU69136	hom
19	40901011	40901011	G	C	PRX	exonic	nonsynonymous SNV	ENSG00000105227	rs3745202	ENSG00000105227:ENST00000324001:exon7:c.C3248G:p.P1083R	PRX:NM_181882:exon7:c.C3248G:p.P1083R	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.1411	0.1332	0.0992412	0.1238	1.545	13.56	0.106	1.34	0.024	.	.	.	PRX:uc002onq.3:exon3:c.C2831G:p.P944R,PRX:uc002onr.3:exon7:c.C3248G:p.P1083R	-0.996	AFR:0.0436,AMR:0.0871,EAS:0.0290,FIN:0.1390,NFE:0.1771,OTH:0.1544,ASJ:0.1291	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	1.0	4.3	0.000	2.64	19	.	het
19	40901496	40901496	T	C	PRX	exonic	nonsynonymous SNV	ENSG00000105227	rs268673	ENSG00000105227:ENST00000324001:exon7:c.A2763G:p.I921M	PRX:NM_181882:exon7:c.A2763G:p.I921M	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3504	0.3663	0.296725	0.3517	-1.801	0.002	0.315	-5.36	0.878	.	.	.	PRX:uc002onq.3:exon3:c.A2346G:p.I782M,PRX:uc002onr.3:exon7:c.A2763G:p.I921M	-0.919	AFR:0.3290,AMR:0.4391,EAS:0.1300,FIN:0.3443,NFE:0.3845,OTH:0.3652,ASJ:0.3576	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	0.0	4.05	0.000	-1.79	19	MU133393	het
19	40901604	40901604	A	G	PRX	exonic	synonymous SNV	ENSG00000105227	rs268672	ENSG00000105227:ENST00000324001:exon7:c.T2655C:p.P885P	PRX:NM_181882:exon7:c.T2655C:p.P885P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5070	0.6091	0.531949	0.5686	.	.	.	.	.	.	.	.	PRX:uc002onq.3:exon3:c.T2238C:p.P746P,PRX:uc002onr.3:exon7:c.T2655C:p.P885P	.	AFR:0.8020,AMR:0.5337,EAS:0.1805,FIN:0.4487,NFE:0.5106,OTH:0.4949,ASJ:0.4901	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	.	.	.	.	19	MU4560643	unknown
19	40901614	40901614	A	G	PRX	exonic	nonsynonymous SNV	ENSG00000105227	rs268671	ENSG00000105227:ENST00000324001:exon7:c.T2645C:p.V882A	PRX:NM_181882:exon7:c.T2645C:p.V882A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5069	0.6097	0.531949	0.5680	-2.006	0.001	0.381	2.7	0.001	.	.	.	PRX:uc002onq.3:exon3:c.T2228C:p.V743A,PRX:uc002onr.3:exon7:c.T2645C:p.V882A	-1.137	AFR:0.8017,AMR:0.5337,EAS:0.1818,FIN:0.4487,NFE:0.5097,OTH:0.4980,ASJ:0.4867	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	0.0	5.32	0.000	-1.95	19	MU707749	unknown
19	40904602	40904602	G	A	PRX	exonic	synonymous SNV	ENSG00000105227	rs744389	ENSG00000105227:ENST00000291825:exon6:c.C306T:p.T102T,ENSG00000105227:ENST00000324001:exon6:c.C306T:p.T102T	PRX:NM_020956:exon6:c.C306T:p.T102T,PRX:NM_181882:exon6:c.C306T:p.T102T	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1455	0.1346	0.102236	0.125	.	.	.	.	.	.	.	.	PRX:uc002onr.3:exon6:c.C306T:p.T102T,PRX:uc002ons.3:exon6:c.C306T:p.T102T	.	AFR:0.0439,AMR:0.0919,EAS:0.0296,FIN:0.1387,NFE:0.1790,OTH:0.1558,ASJ:0.1291	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	.	.	.	.	19	.	het
19	41512792	41512792	C	T	CYP2B6	intronic	.	ENSG00000197408	rs4803419	.	.	clinvar: drug_response 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3353	0.2394	0.289137	0.2824	.	.	.	.	.	.	.	.	.	.	AFR:0.1143,AMR:0.4617,EAS:0.4512,FIN:0.3721,NFE:0.3277,OTH:0.3224,ASJ:0.3013	123930	614546;	240869;	240869|-|-|-|-|614546 ~	.	.	.	.	.	.	.	.	19	MU30125766	het
19	41743861	41743861	A	G	AXL	exonic	nonsynonymous SNV	ENSG00000167601	rs7249222	ENSG00000167601:ENST00000301178:exon7:c.A796G:p.N266D,ENSG00000167601:ENST00000359092:exon7:c.A796G:p.N266D	AXL:NM_001699:exon7:c.A796G:p.N266D,AXL:NM_021913:exon7:c.A796G:p.N266D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	AXL:uc010ehi.1:exon7:c.A796G:p.N266D,AXL:uc010ehj.3:exon7:c.A796G:p.N266D,AXL:uc010ehk.3:exon7:c.A796G:p.N266D	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	109135	.	.	.	.	.	.	.	.	.	.	.	19	23(upper_aerodigestive_tract)	1
19	41745214	41745214	G	A	AXL	exonic	nonsynonymous SNV	ENSG00000167601	rs750029623	ENSG00000167601:ENST00000593513:exon6:c.G476A:p.R159H,ENSG00000167601:ENST00000301178:exon9:c.G1280A:p.R427H,ENSG00000167601:ENST00000359092:exon9:c.G1280A:p.R427H	AXL:NM_001278599:exon6:c.G476A:p.R159H,AXL:NM_001699:exon9:c.G1280A:p.R427H,AXL:NM_021913:exon9:c.G1280A:p.R427H	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	1.784e-05	.	.	6.51e-05	2.631	20.4	0.274	2.39	0.990	.	.	Fibronectin type III|Immunoglobulin-like fold	AXL:uc010ehi.1:exon9:c.G1280A:p.R427H,AXL:uc010ehj.3:exon9:c.G1280A:p.R427H,AXL:uc010ehk.3:exon9:c.G1280A:p.R427H	-0.882	AFR:0.0002,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	109135	.	.	.	.	.	.	.	0.006	-0.91	0.224	0.92	19	.	het
19	41759632	41759634	CCC	-	AXL	intronic	.	ENSG00000167601	rs68001077	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4859	.	0.403754	0.3009	.	.	.	.	.	.	.	.	.	.	AFR:0.2114,AMR:0.2111,EAS:0.3807,FIN:0.3604,NFE:0.3327,OTH:0.3581,ASJ:0.3211	109135	.	.	.	.	.	.	.	.	.	.	.	19	.	unknown
19	41762525	41762525	A	G	AXL	intronic	.	ENSG00000167601	rs2304232	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1418	0.1400	0.150958	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.1425,AMR:0.1045,EAS:0.1987,FIN:0.3061,NFE:0.1334,OTH:0.1494,ASJ:0.1089	109135	.	.	.	.	.	.	.	.	.	.	.	19	1(liver)	0.1497
19	41858921	41858921	G	A	TGFB1	exonic	nonsynonymous SNV	ENSG00000105329	rs1800470	ENSG00000105329:ENST00000221930:exon1:c.C29T:p.P10L	TGFB1:NM_000660:exon1:c.C29T:p.P10L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.5623	.	0.545327	1(pancreas)	2.279	18.03	0.83	1.45	1.000	.	.	.	TGFB1:uc002oqh.2:exon1:c.C29T:p.P10L	-0.945	AFR:MU68390,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,EAS:0.5855,FIN:0.4856,NFE:0.5066,OTH:0.4199,ASJ:0.5998	190180	131300;219700;	586;1328;	586|CF<br>Mucoviscidosis|1-9 / 100 000|Autosomal recessive|All ages|219700 ~1328|Progressive diaphyseal dysplasia|Unknown|Autosomal dominant|All ages|131300 ~	~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04380 Osteoclast differentiation~ko04390 Hippo signaling pathway~ko04659 Th17 cell differentiation~ko04672 Intestinal immune network for IgA production~ko04926 Relaxin signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05144 Malaria~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05321 Inflammatory bowel disease (IBD)~ko05323 Rheumatoid arthritis~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	1.73	0.000	.	19	1(thyroid)	0.7066
19	42753034	42753034	A	G	ERF	exonic	synonymous SNV	ENSG00000105722	rs35493131	ENSG00000105722:ENST00000222329:exon4:c.T1230C:p.A410A,ENSG00000105722:ENST00000440177:exon4:c.T1005C:p.A335A	ERF:NM_001301035:exon4:c.T1005C:p.A335A,ERF:NM_001308402:exon4:c.T1005C:p.A335A,ERF:NM_001312656:exon4:c.T1005C:p.A335A,ERF:NM_006494:exon4:c.T1230C:p.A410A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0979	0.0813	0.101637	1(large_intestine)	.	.	.	.	.	.	.	.	ERF:uc002otd.4:exon2:c.T423C:p.A141A,ERF:uc002ote.4:exon4:c.T1230C:p.A410A	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU118964,EAS:0.0798,FIN:0.1159,NFE:0.1502,OTH:0.1141,ASJ:COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02	611888	600775;	2343;3267;35093;	2343|-|Unknown|Not applicable|Neonatal|148800 600775 ~3267|-|-|-|-|600775 ~35093|Isolated dolichocephaly<br>Non-syndromic sagittal synostosis|-|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|123100 600775 615529 ~	.	.	.	.	.	.	.	.	19	1(salivary_gland)	0.0573
19	42753283	42753283	G	A	ERF	exonic	synonymous SNV	ENSG00000105722	rs61735151	ENSG00000105722:ENST00000222329:exon4:c.C981T:p.S327S,ENSG00000105722:ENST00000440177:exon4:c.C756T:p.S252S	ERF:NM_001301035:exon4:c.C756T:p.S252S,ERF:NM_001308402:exon4:c.C756T:p.S252S,ERF:NM_001312656:exon4:c.C756T:p.S252S,ERF:NM_006494:exon4:c.C981T:p.S327S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0878	0.0506	0.0778754	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ERF:uc002otd.4:exon2:c.C174T:p.S58S,ERF:uc002ote.4:exon4:c.C981T:p.S327S	.	AFR:MU151156,AMR:LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.0131,FIN:0.1307,NFE:0.1126,OTH:0.0698,ASJ:0.0491	611888	600775;	2343;3267;35093;	2343|-|Unknown|Not applicable|Neonatal|148800 600775 ~3267|-|-|-|-|600775 ~35093|Isolated dolichocephaly<br>Non-syndromic sagittal synostosis|-|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|123100 600775 615529 ~	.	.	.	.	.	.	.	.	19	1(salivary_gland)	0.0378
19	42753649	42753649	G	C	ERF	exonic	synonymous SNV	ENSG00000105722	rs11557114	ENSG00000105722:ENST00000222329:exon4:c.C615G:p.R205R,ENSG00000105722:ENST00000440177:exon4:c.C390G:p.R130R	ERF:NM_001301035:exon4:c.C390G:p.R130R,ERF:NM_001308402:exon4:c.C390G:p.R130R,ERF:NM_001312656:exon4:c.C390G:p.R130R,ERF:NM_006494:exon4:c.C615G:p.R205R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0959	0.0626	0.0854633	MU151163	.	.	.	.	.	.	.	.	ERF:uc002ote.4:exon4:c.C615G:p.R205R	.	AFR:COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.0624,EAS:0.1337,FIN:0.1126,NFE:0.0569,OTH:0.0378,ASJ:0.0507	611888	600775;	2343;3267;35093;	2343|-|Unknown|Not applicable|Neonatal|148800 600775 ~3267|-|-|-|-|600775 ~35093|Isolated dolichocephaly<br>Non-syndromic sagittal synostosis|-|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|123100 600775 615529 ~	.	.	.	.	.	.	.	.	19	1(large_intestine)	0.0703
19	42776574	42776574	T	C	CIC	exonic	synonymous SNV	ENSG00000079432	rs10426306	ENSG00000079432:ENST00000572681:exon2:c.T639C:p.D213D	CIC:NM_001304815:exon2:c.T639C:p.D213D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1	.	0.0986422	0.0731	.	.	.	.	.	.	.	.	.	.	AFR:0.1076,AMR:0.1432,EAS:0.0606,FIN:0.0427,NFE:0.0579,OTH:0.0643,ASJ:0.0906	612082	.	.	.	.	.	.	.	.	.	.	.	19	.	unknown
19	42776580	42776580	T	C	CIC	exonic	synonymous SNV	ENSG00000079432	rs10426310	ENSG00000079432:ENST00000572681:exon2:c.T645C:p.L215L	CIC:NM_001304815:exon2:c.T645C:p.L215L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1	.	0.0996406	0.0743	.	.	.	.	.	.	.	.	.	.	AFR:0.1120,AMR:0.1435,EAS:0.0599,FIN:0.0427,NFE:0.0576,OTH:0.0663,ASJ:0.09	612082	.	.	.	.	.	.	.	.	.	.	.	19	.	unknown
19	42791994	42791994	T	C	CIC	exonic	synonymous SNV	ENSG00000079432	rs73033426	ENSG00000079432:ENST00000160740:exon6:c.T798C:p.D266D,ENSG00000079432:ENST00000575354:exon6:c.T798C:p.D266D,ENSG00000079432:ENST00000572681:exon7:c.T3525C:p.D1175D	CIC:NM_015125:exon6:c.T798C:p.D266D,CIC:NM_001304815:exon7:c.T3525C:p.D1175D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0134	0.0116	0.00419329	.	.	.	.	.	.	.	.	.	CIC:uc002otf.1:exon6:c.T798C:p.D266D	.	AFR:0.0103,AMR:0.0019,EAS:0.0397,FIN:0,NFE:0.0203,OTH:0.0142,ASJ:0.0036	612082	.	.	.	.	.	.	.	.	.	.	.	19	1(soft_tissue)	0.0051
19	42795554	42795554	T	C	CIC	exonic	synonymous SNV	ENSG00000079432	rs10410185	ENSG00000079432:ENST00000160740:exon10:c.T2634C:p.A878A,ENSG00000079432:ENST00000575354:exon10:c.T2634C:p.A878A,ENSG00000079432:ENST00000572681:exon11:c.T5361C:p.A1787A	CIC:NM_015125:exon10:c.T2634C:p.A878A,CIC:NM_001304815:exon11:c.T5361C:p.A1787A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0801	0.0597	0.086861	2(soft_tissue)	.	.	.	.	.	.	.	.	CIC:uc002otf.1:exon10:c.T2634C:p.A878A	.	AFR:1(large_intestine),AMR:1(thyroid),EAS:MU116849,FIN:COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,NFE:0.0607,OTH:0.0752,ASJ:1(urinary_tract)	612082	.	.	.	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.1372
19	44047550	44047550	T	C	XRCC1	exonic	synonymous SNV	ENSG00000073050	rs3547	ENSG00000073050:ENST00000543982:exon16:c.A1803G:p.Q601Q,ENSG00000073050:ENST00000262887:exon17:c.A1896G:p.Q632Q	XRCC1:NM_006297:exon17:c.A1896G:p.Q632Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6365	0.6075	0.710663	0.6135	.	.	.	.	.	.	.	.	XRCC1:uc010xwp.1:exon16:c.A1803G:p.Q601Q,XRCC1:uc002owt.2:exon17:c.A1896G:p.Q632Q	.	AFR:0.6640,AMR:0.7849,EAS:0.8777,FIN:0.5536,NFE:0.5609,OTH:0.5935,ASJ:0.6556	194360	.	.	.	.	.	.	.	.	.	.	.	19	MU168901	hom
19	44047826	44047826	T	A	XRCC1	exonic	nonsynonymous SNV	ENSG00000073050	rs2682557	ENSG00000073050:ENST00000543982:exon15:c.A1633T:p.N545Y,ENSG00000073050:ENST00000262887:exon16:c.A1726T:p.N576Y	XRCC1:NM_006297:exon16:c.A1726T:p.N576Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	0.9999	1	1	.	.	.	.	.	.	.	.	XRCC1:uc010xwp.1:exon15:c.A1633T:p.N545Y,XRCC1:uc002owt.2:exon16:c.A1726T:p.N576Y	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	194360	.	.	.	.	.	.	.	.	.	.	.	19	MU82026153	hom
19	45854919	45854919	T	G	ERCC2	exonic	nonsynonymous SNV	ENSG00000104884	rs13181	ENSG00000104884:ENST00000391944:exon21:c.A2017C:p.K673Q,ENSG00000104884:ENST00000391945:exon23:c.A2251C:p.K751Q	ERCC2:NM_000400:exon23:c.A2251C:p.K751Q	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.3308	0.3260	0.236621	MU4549012	0.982	10.56	0.582	4.29	0.068	.	.	.	ERCC2:uc002pbh.2:exon10:c.A940C:p.K314Q,ERCC2:uc002pbi.2:exon12:c.A1330C:p.K444Q,ERCC2:uc010ejz.2:exon21:c.A2017C:p.K673Q,ERCC2:uc002pbj.2:exon23:c.A2251C:p.K751Q	-1.087	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|1|321|0.00311526,AMR:0.3203,EAS:0.2273,FIN:0.4172,NFE:0.0749,OTH:0.4037,ASJ:0.2284	126340	278730;601675;610756;	1466;191;33364;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~33364|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|234050 300953 601675 616390 616395 616943 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	,4779,4777,4778,4776	.	.	0.0	-1.42	0.000	-0.165	19	14(soft_tissue)	0.3817
19	45855524	45855524	G	A	ERCC2	exonic	synonymous SNV	ENSG00000104884	rs1052555	ENSG00000104884:ENST00000391944:exon20:c.C1899T:p.D633D,ENSG00000104884:ENST00000391941:exon21:c.C2061T:p.D687D,ENSG00000104884:ENST00000391945:exon22:c.C2133T:p.D711D	ERCC2:NM_000400:exon22:c.C2133T:p.D711D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2859	0.2587	0.182308	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	ERCC2:uc002pbh.2:exon9:c.C822T:p.D274D,ERCC2:uc002pbi.2:exon11:c.C1212T:p.D404D,ERCC2:uc010ejz.2:exon20:c.C1899T:p.D633D,ERCC2:uc002pbk.2:exon21:c.C2061T:p.D687D,ERCC2:uc002pbj.2:exon22:c.C2133T:p.D711D	.	AFR:0.2615,AMR:0.1083,EAS:0.3709,FIN:0.0630,NFE:0.3814,OTH:0.3434,ASJ:0.1794	126340	278730;601675;610756;	1466;191;33364;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~33364|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|234050 300953 601675 616390 616395 616943 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	4779,,4778	.	.	.	.	.	.	19	13(soft_tissue)	0.3088
19	45867259	45867259	C	T	ERCC2	exonic	nonsynonymous SNV	ENSG00000104884	rs1799793	ENSG00000104884:ENST00000391944:exon8:c.G700A:p.D234N,ENSG00000104884:ENST00000391941:exon9:c.G862A:p.D288N,ENSG00000104884:ENST00000485403:exon9:c.G862A:p.D288N,ENSG00000104884:ENST00000391940:exon10:c.G862A:p.D288N,ENSG00000104884:ENST00000391945:exon10:c.G934A:p.D312N,ENSG00000104884:ENST00000586131:exon10:c.G862A:p.D288N	ERCC2:NM_001130867:exon9:c.G862A:p.D288N,ERCC2:NM_000400:exon10:c.G934A:p.D312N	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.3788	0.2438	0.194489	MU68959	4.308	24.0	0.174	5.15	0.880	.	.	Helical and beta-bridge domain	ERCC2:uc010ejz.2:exon8:c.G700A:p.D234N,ERCC2:uc002pbk.2:exon9:c.G862A:p.D288N,ERCC2:uc002pbl.4:exon9:c.G862A:p.D288N,ERCC2:uc002pbj.2:exon10:c.G934A:p.D312N	-1.005	AFR:ESAD-UK|1|409|0.00244499,AMR:0.2648,EAS:0.2103,FIN:0.3709,NFE:0.0438,OTH:0.3671,ASJ:0.1080	126340	278730;601675;610756;	1466;191;33364;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~33364|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|234050 300953 601675 616390 616395 616943 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	4779,,4778	.	.	0.065	-0.1	0.000	1.825	19	1(thyroid)	0.3541
19	45868309	45868309	T	G	ERCC2	exonic	synonymous SNV	ENSG00000104884	rs238406	ENSG00000104884:ENST00000586856:exon4:c.A318C:p.R106R,ENSG00000104884:ENST00000391941:exon5:c.A396C:p.R132R,ENSG00000104884:ENST00000485403:exon5:c.A396C:p.R132R,ENSG00000104884:ENST00000391940:exon6:c.A396C:p.R132R,ENSG00000104884:ENST00000391945:exon6:c.A468C:p.R156R,ENSG00000104884:ENST00000586131:exon6:c.A396C:p.R132R	ERCC2:NM_001130867:exon5:c.A396C:p.R132R,ERCC2:NM_000400:exon6:c.A468C:p.R156R	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5898	0.6625	0.636182	0.6449	.	.	.	.	.	.	.	.	ERCC2:uc002pbk.2:exon5:c.A396C:p.R132R,ERCC2:uc002pbl.4:exon5:c.A396C:p.R132R,ERCC2:uc002pbj.2:exon6:c.A468C:p.R156R	.	AFR:0.8673,AMR:0.5143,EAS:0.5068,FIN:0.5899,NFE:0.5556,OTH:0.5717,ASJ:0.6060	126340	278730;601675;610756;	1466;191;33364;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~33364|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|234050 300953 601675 616390 616395 616943 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	4779,,4778	.	.	.	.	.	.	19	MU21174602	het
19	47425424	47425424	G	T	ARHGAP35	exonic	synonymous SNV	ENSG00000160007	rs147079247	ENSG00000160007:ENST00000404338:exon1:c.G3492T:p.R1164R	ARHGAP35:NM_004491:exon2:c.G3492T:p.R1164R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0072	0.0062	0.00419329	0.0069	.	.	.	.	.	.	.	.	ARHGAP35:uc010ekv.3:exon1:c.G3492T:p.R1164R	.	AFR:0.0015,AMR:0.0072,EAS:0,FIN:0.0031,NFE:0.0115,OTH:0.0132,ASJ:0	605277	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	48621036	48621036	C	G	LIG1	exonic	synonymous SNV	ENSG00000105486	rs13436	ENSG00000105486:ENST00000536218:exon24:c.G2238C:p.A746A,ENSG00000105486:ENST00000427526:exon25:c.G2349C:p.A783A,ENSG00000105486:ENST00000263274:exon26:c.G2442C:p.A814A	LIG1:NM_001289064:exon24:c.G2238C:p.A746A,LIG1:NM_001289063:exon25:c.G2349C:p.A783A,LIG1:NM_001320971:exon25:c.G2352C:p.A784A,LIG1:NM_000234:exon26:c.G2442C:p.A814A,LIG1:NM_001320970:exon26:c.G2439C:p.A813A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4747	0.4595	0.544529	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LIG1:uc010xze.1:exon21:c.G1521C:p.A507A,LIG1:uc010xzf.1:exon24:c.G2238C:p.A746A,LIG1:uc010xzg.1:exon25:c.G2349C:p.A783A,LIG1:uc002pia.1:exon26:c.G2442C:p.A814A	.	AFR:0.4895,AMR:0.5486,EAS:0.3974,FIN:0.7577,NFE:0.4928,OTH:0.4324,ASJ:0.3974	126391	.	.	.	.	.	.	.	.	.	.	.	19	1(salivary_gland)	0.4888
19	48622427	48622427	A	G	LIG1	exonic	synonymous SNV	ENSG00000105486	rs20581	ENSG00000105486:ENST00000536218:exon23:c.T2202C:p.D734D,ENSG00000105486:ENST00000427526:exon24:c.T2313C:p.D771D,ENSG00000105486:ENST00000263274:exon25:c.T2406C:p.D802D	LIG1:NM_001289064:exon23:c.T2202C:p.D734D,LIG1:NM_001289063:exon24:c.T2313C:p.D771D,LIG1:NM_001320971:exon24:c.T2316C:p.D772D,LIG1:NM_000234:exon25:c.T2406C:p.D802D,LIG1:NM_001320970:exon25:c.T2403C:p.D801D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6228	0.6380	0.718051	1(pancreas)	.	.	.	.	.	.	.	.	LIG1:uc010xze.1:exon20:c.T1485C:p.D495D,LIG1:uc010xzf.1:exon23:c.T2202C:p.D734D,LIG1:uc010xzg.1:exon24:c.T2313C:p.D771D,LIG1:uc002pia.1:exon25:c.T2406C:p.D802D	.	AFR:1(thyroid),AMR:MU27558186,EAS:0.6542,FIN:0.8492,NFE:0.5251,OTH:0.4868,ASJ:COCA-CN|5|321|0.0155763,THCA-SA|1|243|0.00411523	126391	.	.	.	.	.	.	.	.	.	.	.	19	1(prostate)	0.8826
19	48634319	48634319	T	A	LIG1	intronic	.	ENSG00000105486	rs392891	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4684	0.4646	0.549121	0.4918	.	.	.	.	.	.	.	.	.	.	AFR:0.5584,AMR:0.3962,EAS:0.7550,FIN:0.4926,NFE:0.4322,OTH:0.4857,ASJ:0.3974	126391	.	.	.	.	.	.	.	.	.	.	.	19	MU23821406	het
19	48654553	48654553	G	T	LIG1	exonic	synonymous SNV	ENSG00000105486	rs20580	ENSG00000105486:ENST00000427526:exon6:c.C417A:p.A139A,ENSG00000105486:ENST00000542460:exon6:c.C414A:p.A138A,ENSG00000105486:ENST00000263274:exon7:c.C510A:p.A170A,ENSG00000105486:ENST00000594759:exon7:c.C507A:p.A169A,ENSG00000105486:ENST00000601091:exon7:c.C510A:p.A170A	LIG1:NM_001289063:exon6:c.C417A:p.A139A,LIG1:NM_001320971:exon6:c.C420A:p.A140A,LIG1:NM_000234:exon7:c.C510A:p.A170A,LIG1:NM_001320970:exon7:c.C507A:p.A169A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4875	0.5066	0.532947	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LIG1:uc010xzg.1:exon6:c.C417A:p.A139A,LIG1:uc002pia.1:exon7:c.C510A:p.A170A	.	AFR:0.5190,AMR:0.5483,EAS:0.4067,FIN:0.6944,NFE:0.5161,OTH:0.4918,ASJ:0.4329	126391	.	.	.	.	.	.	.	.	.	.	.	19	1(salivary_gland)	0.5031
19	48660244	48660251	AAGGGGCA	-	LIG1	intronic	.	ENSG00000105486	rs3730867	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4760	0.4378	0.510383	0.4796	.	.	.	.	.	.	.	.	.	.	AFR:0.4413,AMR:0.4279,EAS:0.6863,FIN:0.5038,NFE:0.4788,OTH:0.4764,ASJ:0.3897	126391	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	48668795	48668795	G	A	LIG1	intronic	.	ENSG00000105486	rs3730849	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3548	0.2846	0.317292	0.3193	.	.	.	.	.	.	.	.	.	.	AFR:0.1153,AMR:0.2931,EAS:0.5666,FIN:0.4274,NFE:0.3833,OTH:0.4029,ASJ:0.3079	126391	.	.	.	.	.	.	.	.	.	.	.	19	MU23821673	het
19	50140068	50140068	C	T	RRAS	intronic	.	ENSG00000126458	rs1368464	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7034	0.6968	0.738219	0.7241	.	.	.	.	.	.	.	.	.	.	AFR:0.7666,AMR:0.8341,EAS:0.8300,FIN:0.6882,NFE:0.6942,OTH:0.6814,ASJ:0.6577	165090	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04218 Cellular senescence~ko04360 Axon guidance~ko04371 Apelin signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	19	MU21511377	het
19	50140092	50140092	G	A	RRAS	exonic	synonymous SNV	ENSG00000126458	rs1865077	ENSG00000126458:ENST00000246792:exon3:c.C333T:p.N111N	RRAS:NM_006270:exon3:c.C333T:p.N111N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7034	0.6968	0.738219	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	RRAS:uc002pop.1:exon3:c.C333T:p.N111N	.	AFR:0.7243,AMR:0.7670,EAS:0.6577,FIN:0.8284,NFE:0.6881,OTH:0.6947,ASJ:0.8329	165090	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04218 Cellular senescence~ko04360 Axon guidance~ko04371 Apelin signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	19	1(large_intestine)	0.6814
19	50726570	50726570	G	A	MYH14	exonic	synonymous SNV	ENSG00000105357	rs4801822	ENSG00000105357:ENST00000262269:exon4:c.G657A:p.A219A,ENSG00000105357:ENST00000596571:exon4:c.G657A:p.A219A,ENSG00000105357:ENST00000376970:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000425460:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000440075:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000598205:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000599920:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000601313:exon5:c.G657A:p.A219A	MYH14:NM_001077186:exon5:c.G657A:p.A219A,MYH14:NM_001145809:exon5:c.G657A:p.A219A,MYH14:NM_024729:exon5:c.G657A:p.A219A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6057	0.4933	0.472843	1(large_intestine)	.	.	.	.	.	.	.	.	MYH14:uc002prq.1:exon5:c.G657A:p.A219A,MYH14:uc002prr.1:exon5:c.G657A:p.A219A,MYH14:uc010enu.1:exon5:c.G657A:p.A219A	.	AFR:MU115546,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763,EAS:0.2085,FIN:0.4233,NFE:0.5099,OTH:0.5513,ASJ:0.4990	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	1(prostate)	0.6498
19	50735340	50735340	C	T	MYH14	intronic	.	ENSG00000105357	rs11666328	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3588	0.3246	0.321486	0.3170	.	.	.	.	.	.	.	.	.	.	AFR:0.2318,AMR:0.3505,EAS:0.3714,FIN:0.3305,NFE:0.3531,OTH:0.3371,ASJ:0.3859	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU30144974	het
19	50753045	50753045	G	A	MYH14	exonic	nonsynonymous SNV	ENSG00000105357	rs942541070	ENSG00000105357:ENST00000596571:exon12:c.G1597A:p.D533N,ENSG00000105357:ENST00000262269:exon13:c.G1621A:p.D541N,ENSG00000105357:ENST00000376970:exon13:c.G1597A:p.D533N,ENSG00000105357:ENST00000425460:exon14:c.G1621A:p.D541N,ENSG00000105357:ENST00000440075:exon14:c.G1621A:p.D541N,ENSG00000105357:ENST00000598205:exon14:c.G1621A:p.D541N,ENSG00000105357:ENST00000599920:exon14:c.G1621A:p.D541N,ENSG00000105357:ENST00000601313:exon14:c.G1621A:p.D541N	MYH14:NM_024729:exon13:c.G1597A:p.D533N,MYH14:NM_001077186:exon14:c.G1621A:p.D541N,MYH14:NM_001145809:exon14:c.G1621A:p.D541N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 2, -1, 0, 0] 	.	.	.	.	3.895	23.5	0.052	4.37	0.662	.	.	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	MYH14:uc002prr.1:exon13:c.G1597A:p.D533N,MYH14:uc002prq.1:exon14:c.G1621A:p.D541N,MYH14:uc010enu.1:exon14:c.G1621A:p.D541N	0.006	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	0.987	-1.03	0.474	1.515	19	MU1695843	het
19	50760716	50760716	C	G	MYH14	exonic	synonymous SNV	ENSG00000105357	rs378811	ENSG00000105357:ENST00000596571:exon15:c.C2082G:p.R694R,ENSG00000105357:ENST00000262269:exon17:c.C2205G:p.R735R,ENSG00000105357:ENST00000376970:exon17:c.C2181G:p.R727R,ENSG00000105357:ENST00000425460:exon17:c.C2106G:p.R702R,ENSG00000105357:ENST00000598205:exon17:c.C2106G:p.R702R,ENSG00000105357:ENST00000599920:exon17:c.C2106G:p.R702R,ENSG00000105357:ENST00000440075:exon18:c.C2205G:p.R735R,ENSG00000105357:ENST00000601313:exon18:c.C2205G:p.R735R	MYH14:NM_024729:exon16:c.C2082G:p.R694R,MYH14:NM_001077186:exon17:c.C2106G:p.R702R,MYH14:NM_001145809:exon18:c.C2205G:p.R735R	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4141	0.3862	0.357827	MU120935	.	.	.	.	.	.	.	.	MYH14:uc002prr.1:exon16:c.C2082G:p.R694R,MYH14:uc002prq.1:exon17:c.C2106G:p.R702R,MYH14:uc010enu.1:exon18:c.C2205G:p.R735R	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.3751,EAS:0.2601,FIN:0.5298,NFE:0.3846,OTH:0.3720,ASJ:0.3040	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.4192
19	50762418	50762418	A	G	MYH14	exonic	synonymous SNV	ENSG00000105357	rs1651553	ENSG00000105357:ENST00000596571:exon16:c.A2127G:p.P709P,ENSG00000105357:ENST00000262269:exon18:c.A2250G:p.P750P,ENSG00000105357:ENST00000376970:exon18:c.A2226G:p.P742P,ENSG00000105357:ENST00000425460:exon18:c.A2151G:p.P717P,ENSG00000105357:ENST00000598205:exon18:c.A2151G:p.P717P,ENSG00000105357:ENST00000599920:exon18:c.A2151G:p.P717P,ENSG00000105357:ENST00000440075:exon19:c.A2250G:p.P750P,ENSG00000105357:ENST00000601313:exon19:c.A2250G:p.P750P	MYH14:NM_024729:exon17:c.A2127G:p.P709P,MYH14:NM_001077186:exon18:c.A2151G:p.P717P,MYH14:NM_001145809:exon19:c.A2250G:p.P750P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7719	0.7375	0.761182	0.7616	.	.	.	.	.	.	.	.	MYH14:uc002prr.1:exon17:c.A2127G:p.P709P,MYH14:uc002prq.1:exon18:c.A2151G:p.P717P,MYH14:uc010enu.1:exon19:c.A2250G:p.P750P	.	AFR:0.7206,AMR:0.8365,EAS:0.8255,FIN:0.8212,NFE:0.7614,OTH:0.7939,ASJ:0.6126	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU17693652	hom
19	50763886	50763886	C	T	MYH14	intronic	.	ENSG00000105357	rs28482851	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3167	0.2314	0.284545	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.2529,AMR:0.1230,EAS:0.35,FIN:0.5155,NFE:0.2731,OTH:0.2954,ASJ:0.1675	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	1(lung)	0.2963
19	50771409	50771409	A	C	MYH14	intronic	.	ENSG00000105357	rs3745503	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1999	0.1246	0.204273	0.1514	.	.	.	.	.	0	0.012	.	.	.	AFR:0.2375,AMR:0.0776,EAS:0.2244,FIN:0.0794,NFE:0.1145,OTH:0.1291,ASJ:0.2053	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU18258176	het
19	50771635	50771635	T	C	MYH14	intronic	.	ENSG00000105357	rs930086	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8757	0.8753	0.864617	0.8758	.	.	.	.	.	.	.	.	.	.	AFR:0.8629,AMR:0.9177,EAS:0.8422,FIN:0.8987,NFE:0.8784,OTH:0.8988,ASJ:0.8411	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU17694162	hom
19	50796905	50796905	G	A	MYH14	exonic	synonymous SNV	ENSG00000105357	rs3745509	ENSG00000105357:ENST00000596571:exon36:c.G5307A:p.S1769S,ENSG00000105357:ENST00000262269:exon38:c.G5430A:p.S1810S,ENSG00000105357:ENST00000376970:exon38:c.G5406A:p.S1802S,ENSG00000105357:ENST00000425460:exon38:c.G5331A:p.S1777S,ENSG00000105357:ENST00000598205:exon38:c.G5331A:p.S1777S,ENSG00000105357:ENST00000440075:exon39:c.G5430A:p.S1810S,ENSG00000105357:ENST00000601313:exon39:c.G5430A:p.S1810S	MYH14:NM_024729:exon37:c.G5307A:p.S1769S,MYH14:NM_001077186:exon38:c.G5331A:p.S1777S,MYH14:NM_001145809:exon39:c.G5430A:p.S1810S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7480	0.6146	0.682109	0.6579	.	.	.	.	.	.	.	.	MYH14:uc002prs.1:exon6:c.G360A:p.S120S,MYH14:uc010ycb.2:exon8:c.G360A:p.S120S,MYH14:uc002prr.1:exon37:c.G5307A:p.S1769S,MYH14:uc002prq.1:exon38:c.G5331A:p.S1777S,MYH14:uc010enu.1:exon39:c.G5430A:p.S1810S	.	AFR:0.3589,AMR:0.8313,EAS:0.9247,FIN:0.7665,NFE:0.7606,OTH:0.7546,ASJ:0.6921	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU82029104	hom
19	50796960	50796960	C	T	MYH14	intronic	.	ENSG00000105357	rs3745510	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7496	0.6257	0.694489	0.6671	.	.	.	.	.	.	.	.	.	.	AFR:0.3895,AMR:0.8349,EAS:0.9258,FIN:0.7672,NFE:0.7611,OTH:0.7622,ASJ:0.6954	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU26334128	hom
19	50805138	50805138	C	T	MYH14	intronic	.	ENSG00000105357	rs3826772	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8300	0.7947	0.750799	0.7877	.	.	.	.	.	.	.	.	.	.	AFR:0.6329,AMR:0.8577,EAS:0.8077,FIN:0.8333,NFE:0.8556,OTH:0.8429,ASJ:0.87	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU82029120	het
19	50905042	50905042	G	A	POLD1	exonic	synonymous SNV	ENSG00000062822	rs20582	ENSG00000062822:ENST00000595904:exon3:c.G324A:p.A108A,ENSG00000062822:ENST00000440232:exon4:c.G324A:p.A108A,ENSG00000062822:ENST00000599857:exon4:c.G324A:p.A108A,ENSG00000062822:ENST00000600859:exon4:c.G324A:p.A108A,ENSG00000062822:ENST00000601098:exon5:c.G324A:p.A108A	POLD1:NM_001308632:exon3:c.G324A:p.A108A,POLD1:NM_001256849:exon4:c.G324A:p.A108A,POLD1:NM_002691:exon4:c.G324A:p.A108A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1150	0.1444	0.188898	MU147125	.	.	.	.	.	.	.	.	POLD1:uc010eny.4:exon3:c.G324A:p.A108A,POLD1:uc002psb.5:exon4:c.G324A:p.A108A,POLD1:uc002psc.5:exon4:c.G324A:p.A108A	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.1281,EAS:0.0967,FIN:0.1192,NFE:0.1562,OTH:0.0305,ASJ:0.2921	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.0564
19	50905074	50905074	G	A	POLD1	exonic	nonsynonymous SNV	ENSG00000062822	rs1726801	ENSG00000062822:ENST00000595904:exon3:c.G356A:p.R119H,ENSG00000062822:ENST00000440232:exon4:c.G356A:p.R119H,ENSG00000062822:ENST00000599857:exon4:c.G356A:p.R119H,ENSG00000062822:ENST00000600859:exon4:c.G356A:p.R119H,ENSG00000062822:ENST00000601098:exon5:c.G356A:p.R119H	POLD1:NM_001308632:exon3:c.G356A:p.R119H,POLD1:NM_001256849:exon4:c.G356A:p.R119H,POLD1:NM_002691:exon4:c.G356A:p.R119H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.1154	0.148	0.188299	3(large_intestine)	-0.858	0.032	0.331	-8.08	0.000	.	.	Ribonuclease H-like domain	POLD1:uc010eny.4:exon3:c.G356A:p.R119H,POLD1:uc002psb.5:exon4:c.G356A:p.R119H,POLD1:uc002psc.5:exon4:c.G356A:p.R119H	-0.952	AFR:MU147134,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,THCA-SA|1|243|0.00411523,EAS:0.2914,FIN:0.0967,NFE:0.1192,OTH:0.1564,ASJ:0.1279	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	0.001	1.94	0.000	0.975	19	3(lung)	0.0307
19	50905189	50905189	G	T	POLD1	intronic	.	ENSG00000062822	rs1726802	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1145	0.1487	0.186901	LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	.	.	.	.	.	0	0	.	.	.	AFR:0.1286,AMR:0.2942,EAS:0.1192,FIN:0.1566,NFE:0.0306,OTH:0.0562,ASJ:0.0967	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.0975
19	50905762	50905762	T	C	POLD1	exonic	synonymous SNV	ENSG00000062822	rs1143666	ENSG00000062822:ENST00000595904:exon6:c.T810C:p.A270A,ENSG00000062822:ENST00000440232:exon7:c.T810C:p.A270A,ENSG00000062822:ENST00000599857:exon7:c.T810C:p.A270A,ENSG00000062822:ENST00000600859:exon7:c.T810C:p.A270A	POLD1:NM_001308632:exon6:c.T810C:p.A270A,POLD1:NM_001256849:exon7:c.T810C:p.A270A,POLD1:NM_002691:exon7:c.T810C:p.A270A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0532	0.1262	0.138379	0.1103	.	.	.	.	.	.	.	.	POLD1:uc010eny.4:exon6:c.T810C:p.A270A,POLD1:uc002psb.5:exon7:c.T810C:p.A270A,POLD1:uc002psc.5:exon7:c.T810C:p.A270A	.	AFR:0.3822,AMR:0.0310,EAS:0.0031,FIN:0,NFE:0.0016,OTH:0.0214,ASJ:0.0199	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	19	.	het
19	50916772	50916772	T	C	POLD1	exonic	synonymous SNV	ENSG00000062822	rs1274607	ENSG00000062822:ENST00000595904:exon17:c.T2322C:p.S774S,ENSG00000062822:ENST00000440232:exon18:c.T2244C:p.S748S,ENSG00000062822:ENST00000599857:exon18:c.T2244C:p.S748S,ENSG00000062822:ENST00000600859:exon18:c.T2244C:p.S748S	POLD1:NM_001308632:exon17:c.T2322C:p.S774S,POLD1:NM_001256849:exon18:c.T2244C:p.S748S,POLD1:NM_002691:exon18:c.T2244C:p.S748S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0450	0.1093	0.118411	0.0969	.	.	.	.	.	.	.	.	POLD1:uc010eny.4:exon17:c.T2322C:p.S774S,POLD1:uc002psb.5:exon18:c.T2244C:p.S748S,POLD1:uc002psc.5:exon18:c.T2244C:p.S748S	.	AFR:0.3357,AMR:0.0298,EAS:0.0012,FIN:0,NFE:0.0014,OTH:0.0195,ASJ:0.0167	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	19	.	het
19	50918969	50918969	A	G	POLD1	intronic	.	ENSG00000062822	rs3219433	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2659	0.2094	0.282149	0.4502	.	.	.	.	.	0	0.004	.	.	.	AFR:0.6608,AMR:0.3268,EAS:0.3840,FIN:0.1611,NFE:0.2007,OTH:0.3065,ASJ:0.2756	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	19	MU18465562	hom
19	50920410	50920410	C	T	POLD1	intronic	.	ENSG00000062822;ENSG00000142539	rs3212330	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0764	0.0935	0.108427	0.0839	.	.	.	.	.	.	.	.	.	.	AFR:0.2884,AMR:0.0286,EAS:0.0012,FIN:0,NFE:0.0025,OTH:0.0194,ASJ:0.0166	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	19	.	het
19	50920536	50920536	A	G	POLD1	intronic	.	ENSG00000062822;ENSG00000142539	rs2463239	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0569	0.1151	0.128594	0.1022	.	.	.	.	.	.	.	.	.	.	AFR:0.3524,AMR:0.0334,EAS:0.0031,FIN:0,NFE:0.0026,OTH:0.0214,ASJ:0.0199	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	19	.	het
19	55665584	55665584	A	C	TNNI3	intronic	.	ENSG00000129991	rs7252610	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	0.0052	0.15	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	191044	115210;611880;613286;613690;	154;154;75249;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~75249|Familial or idiopathic restrictive cardiomyopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|115210 609578 612422 615248 617047 ~	.	.	.	.	.	.	.	.	19	MU82031742	hom
20	2633936	2633936	T	C	NOP56	exonic	synonymous SNV	ENSG00000101361	rs2073194	ENSG00000101361:ENST00000329276:exon3:c.T105C:p.S35S,ENSG00000101361:ENST00000445139:exon3:c.T105C:p.S35S	NOP56:NM_006392:exon3:c.T105C:p.S35S	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8285	0.8343	0.861222	0.8402	.	.	.	.	.	.	.	.	NOP56:uc002wgh.3:exon3:c.T105C:p.S35S	.	AFR:0.8992,AMR:0.9234,EAS:0.8636,FIN:0.8038,NFE:0.8076,OTH:0.8350,ASJ:0.8344	614154	614153;	276198;	276198|Asidan<br>SCA36|<1 / 1 000 000|Autosomal dominant|Adult|614153 ~	.	.	.	.	.	.	.	.	20	MU745225	het
20	2635212	2635212	A	G	NOP56	exonic	nonsynonymous SNV	ENSG00000101361	rs2273137	ENSG00000101361:ENST00000329276:exon4:c.A361G:p.I121V,ENSG00000101361:ENST00000445139:exon4:c.A361G:p.I121V	NOP56:NM_006392:exon4:c.A361G:p.I121V	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1037	0.0700	0.118411	0.0794	1.346	12.51	0.203	4.69	1.000	.	.	.	NOP56:uc002wgh.3:exon4:c.A361G:p.I121V	-1.074	AFR:0.0491,AMR:0.1611,EAS:0.2188,FIN:0.0747,NFE:0.0792,OTH:0.0827,ASJ:0.0367	614154	614153;	276198;	276198|Asidan<br>SCA36|<1 / 1 000 000|Autosomal dominant|Adult|614153 ~	.	.	.	.	0.089	0.31	0.000	0.8	20	MU133787	het
20	2637071	2637071	T	C	NOP56	exonic	synonymous SNV	ENSG00000101361	rs8958	ENSG00000101361:ENST00000329276:exon9:c.T1035C:p.T345T	NOP56:NM_006392:exon9:c.T1035C:p.T345T	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6336	0.6509	0.673722	0.6509	.	.	.	.	.	.	.	.	NOP56:uc002wgi.3:exon8:c.T537C:p.T179T,NOP56:uc002wgh.3:exon9:c.T1035C:p.T345T	.	AFR:0.7235,AMR:0.7351,EAS:0.6194,FIN:0.5441,NFE:0.6347,OTH:0.6426,ASJ:0.5563	614154	614153;	276198;	276198|Asidan<br>SCA36|<1 / 1 000 000|Autosomal dominant|Adult|614153 ~	.	.	.	.	.	.	.	.	20	MU4554470	hom
20	2637880	2637880	G	A	NOP56	intronic	.	ENSG00000101361	rs373198884	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0007	0.0002	0.00179712	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	614154	614153;	276198;	276198|Asidan<br>SCA36|<1 / 1 000 000|Autosomal dominant|Adult|614153 ~	.	.	.	.	.	.	.	.	20	MU128860514	het
20	2638579	2638579	T	C	NOP56	exonic	nonsynonymous SNV	ENSG00000101361	rs6753	ENSG00000101361:ENST00000329276:exon12:c.T1424C:p.M475T	NOP56:NM_006392:exon12:c.T1424C:p.M475T	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3098	0.3584	0.376997	0.3530	-1.917	0.001	1.0	-3.07	0.004	.	.	.	NOP56:uc002wgi.3:exon11:c.T926C:p.M309T,NOP56:uc002wgh.3:exon12:c.T1424C:p.M475T	-0.964	AFR:0.5534,AMR:0.3981,EAS:0.2677,FIN:0.2348,NFE:0.2762,OTH:0.2965,ASJ:0.2483	614154	614153;	276198;	276198|Asidan<br>SCA36|<1 / 1 000 000|Autosomal dominant|Adult|614153 ~	.	.	.	.	0.0	1.05	0.000	-1.6	20	MU20182269	hom
20	2638728	2638728	A	G	NOP56	exonic	nonsynonymous SNV	ENSG00000101361	rs552059889	ENSG00000101361:ENST00000329276:exon12:c.A1573G:p.T525A	NOP56:NM_006392:exon12:c.A1573G:p.T525A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0006	.	0.00159744	.	-0.696	0.074	0.131	1.1	0.007	.	.	.	NOP56:uc002wgi.3:exon11:c.A1075G:p.T359A,NOP56:uc002wgh.3:exon12:c.A1573G:p.T525A	-1.031	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	614154	614153;	276198;	276198|Asidan<br>SCA36|<1 / 1 000 000|Autosomal dominant|Adult|614153 ~	.	.	.	.	0.0	0.99	0.051	1.175	20	.	het
20	2638882	2638882	T	C	NOP56	exonic	nonsynonymous SNV	ENSG00000101361	rs5856	ENSG00000101361:ENST00000329276:exon12:c.T1727C:p.V576A	NOP56:NM_006392:exon12:c.T1727C:p.V576A	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2931	0.3389	0.377396	0.3550	-1.703	0.002	1.0	1.17	0.001	.	.	.	NOP56:uc002wgi.3:exon11:c.T1229C:p.V410A,NOP56:uc002wgh.3:exon12:c.T1727C:p.V576A	-0.923	AFR:0.5534,AMR:0.3971,EAS:0.2671,FIN:0.2448,NFE:0.2782,OTH:0.2992,ASJ:0.25	614154	614153;	276198;	276198|Asidan<br>SCA36|<1 / 1 000 000|Autosomal dominant|Adult|614153 ~	.	.	.	.	0.0	0.46	0.000	-0.695	20	MU745243	hom
20	3193978	3193978	G	A	ITPA	exonic	synonymous SNV	ENSG00000125877	rs8362	ENSG00000125877:ENST00000380113:exon3:c.G138A:p.Q46Q,ENSG00000125877:ENST00000455664:exon3:c.G87A:p.Q29Q	ITPA:NM_001324240:exon3:c.G138A:p.Q46Q,ITPA:NM_033453:exon3:c.G138A:p.Q46Q,ITPA:NM_181493:exon3:c.G87A:p.Q29Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3520	0.3399	0.470447	MU99581	.	.	.	.	.	.	.	.	ITPA:uc002wid.4:exon3:c.G138A:p.Q46Q,ITPA:uc002wie.4:exon3:c.G87A:p.Q29Q	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.3449,EAS:0.2950,FIN:0.3411,NFE:0.5827,OTH:0.1970,ASJ:0.4528	147520	613850;616647;	457375;	457375|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616647 ~	.	.	.	.	.	.	.	.	20	1(urinary_tract)	0.2981
20	3202069	3202069	C	T	ITPA	intronic	.	ENSG00000125877	rs6139034	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.309704	0.2150	.	.	.	.	.	.	.	.	.	.	AFR:0.0912,AMR:0.2578,EAS:0.4727,FIN:0.1921,NFE:0.2589,OTH:0.2428,ASJ:0.2947	147520	613850;616647;	457375;	457375|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616647 ~	.	.	.	.	.	.	.	.	20	MU88198053	hom
20	3202129	3202129	T	C	ITPA	intronic	.	ENSG00000125877	rs6139035	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.332668	0.2501	.	.	.	.	.	.	.	.	.	.	AFR:0.1039,AMR:0.2794,EAS:0.4702,FIN:0.2160,NFE:0.3144,OTH:0.2721,ASJ:0.3543	147520	613850;616647;	457375;	457375|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616647 ~	.	.	.	.	.	.	.	.	20	MU114150678	hom
20	3204084	3204084	G	A	ITPA	exonic	nonsynonymous SNV	ENSG00000125877	rs9101	ENSG00000125877:ENST00000399838:exon6:c.G438A:p.E146E,ENSG00000125877:ENST00000380113:exon8:c.G561A:p.E187E,ENSG00000125877:ENST00000455664:exon8:c.G510A:p.E170E	ITPA:NM_001324236:exon7:c.G224A:p.S75N,ITPA:NM_001324238:exon7:c.G224A:p.S75N,ITPA:NM_001351739:exon7:c.G224A:p.S75N,ITPA:NM_001324237:exon8:c.G224A:p.S75N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3257	0.2270	0.340455	0.2473	.	.	.	.	.	.	.	.	ITPA:uc031rsg.1:exon6:c.G438A:p.E146E,ITPA:uc002wid.4:exon8:c.G561A:p.E187E,ITPA:uc002wie.4:exon8:c.G510A:p.E170E	.	AFR:0.1036,AMR:0.2691,EAS:0.4938,FIN:0.2136,NFE:0.3077,OTH:0.2695,ASJ:0.3533	147520	613850;616647;	457375;	457375|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616647 ~	.	.	.	.	.	.	.	.	20	MU21200389	hom
20	5933108	5933108	C	A	MCM8	exonic	nonsynonymous SNV	ENSG00000125885	rs236110	ENSG00000125885:ENST00000265187:exon3:c.C187A:p.Q63K,ENSG00000125885:ENST00000378883:exon3:c.C187A:p.Q63K,ENSG00000125885:ENST00000378886:exon3:c.C187A:p.Q63K,ENSG00000125885:ENST00000378896:exon3:c.C187A:p.Q63K	MCM8:NM_001281520:exon3:c.C187A:p.Q63K,MCM8:NM_001281521:exon3:c.C187A:p.Q63K,MCM8:NM_001281522:exon3:c.C187A:p.Q63K,MCM8:NM_032485:exon3:c.C187A:p.Q63K,MCM8:NM_182802:exon3:c.C187A:p.Q63K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1747	0.2283	0.261382	MU110512	0.114	3.753	0.199	0.235	0.426	.	.	.	MCM8:uc002wmi.3:exon3:c.C187A:p.Q63K,MCM8:uc002wmj.3:exon3:c.C187A:p.Q63K,MCM8:uc002wmk.3:exon3:c.C187A:p.Q63K,MCM8:uc002wml.3:exon3:c.C187A:p.Q63K,MCM8:uc010gbp.3:exon3:c.C187A:p.Q63K	-0.933	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.2203,EAS:0.1615,FIN:0.1225,NFE:0.2073,OTH:0.1586,ASJ:0.4355	608187	612885;	.	.	.	.	.	.	0.038	1.62	0.000	0.55	20	2(haematopoietic_and_lymphoid_tissue)	0.1198
20	5933130	5933130	A	G	MCM8	exonic	nonsynonymous SNV	ENSG00000125885	rs145498575	ENSG00000125885:ENST00000265187:exon3:c.A209G:p.D70G,ENSG00000125885:ENST00000378883:exon3:c.A209G:p.D70G,ENSG00000125885:ENST00000378886:exon3:c.A209G:p.D70G,ENSG00000125885:ENST00000378896:exon3:c.A209G:p.D70G	MCM8:NM_001281520:exon3:c.A209G:p.D70G,MCM8:NM_001281521:exon3:c.A209G:p.D70G,MCM8:NM_001281522:exon3:c.A209G:p.D70G,MCM8:NM_032485:exon3:c.A209G:p.D70G,MCM8:NM_182802:exon3:c.A209G:p.D70G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	0.0016	7.7e-05	0.00439297	3.229e-05	4.082	23.7	0.118	6.07	0.797	.	.	.	MCM8:uc002wmi.3:exon3:c.A209G:p.D70G,MCM8:uc002wmj.3:exon3:c.A209G:p.D70G,MCM8:uc002wmk.3:exon3:c.A209G:p.D70G,MCM8:uc002wml.3:exon3:c.A209G:p.D70G,MCM8:uc010gbp.3:exon3:c.A209G:p.D70G	-1.090	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	608187	612885;	.	.	.	.	.	.	0.012	1.48	0.089	2.425	20	.	unknown
20	5939214	5939214	A	C	MCM8	exonic	synonymous SNV	ENSG00000125885	rs3761873	ENSG00000125885:ENST00000265187:exon7:c.A631C:p.R211R,ENSG00000125885:ENST00000378883:exon7:c.A631C:p.R211R,ENSG00000125885:ENST00000378886:exon7:c.A631C:p.R211R,ENSG00000125885:ENST00000378896:exon7:c.A631C:p.R211R	MCM8:NM_001281520:exon7:c.A631C:p.R211R,MCM8:NM_001281521:exon7:c.A631C:p.R211R,MCM8:NM_001281522:exon7:c.A631C:p.R211R,MCM8:NM_032485:exon7:c.A631C:p.R211R,MCM8:NM_182802:exon7:c.A631C:p.R211R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0760	0.0702	0.120008	LICA-CN|1|402|0.00248756,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	MCM8:uc002wmi.3:exon7:c.A631C:p.R211R,MCM8:uc002wmj.3:exon7:c.A631C:p.R211R,MCM8:uc002wmk.3:exon7:c.A631C:p.R211R,MCM8:uc002wml.3:exon7:c.A631C:p.R211R,MCM8:uc010gbp.3:exon7:c.A631C:p.R211R	.	AFR:0.0779,AMR:0.1054,EAS:0.0861,FIN:0.2454,NFE:0.0495,OTH:0.0530,ASJ:0.0489	608187	612885;	.	.	.	.	.	.	.	.	.	.	20	1(haematopoietic_and_lymphoid_tissue)	0.0622
20	5953752	5953752	C	T	MCM8	exonic	synonymous SNV	ENSG00000125885	rs141574549	ENSG00000125885:ENST00000265187:exon12:c.C1257T:p.Y419Y,ENSG00000125885:ENST00000378886:exon12:c.C1425T:p.Y475Y,ENSG00000125885:ENST00000378896:exon12:c.C1305T:p.Y435Y	MCM8:NM_001281520:exon12:c.C1305T:p.Y435Y,MCM8:NM_001281521:exon12:c.C1425T:p.Y475Y,MCM8:NM_032485:exon12:c.C1305T:p.Y435Y,MCM8:NM_182802:exon12:c.C1257T:p.Y419Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0023	7.7e-05	0.00599042	6.456e-05	.	.	.	.	.	.	.	.	MCM8:uc002wmi.3:exon12:c.C1305T:p.Y435Y,MCM8:uc002wmj.3:exon12:c.C1257T:p.Y419Y,MCM8:uc002wmk.3:exon12:c.C1425T:p.Y475Y,MCM8:uc002wml.3:exon12:c.C1305T:p.Y435Y	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0020,ASJ:0	608187	612885;	.	.	.	.	.	.	.	.	.	.	20	.	het
20	5953833	5953833	A	G	MCM8	exonic	synonymous SNV	ENSG00000125885	rs16991617	ENSG00000125885:ENST00000265187:exon12:c.A1338G:p.Q446Q,ENSG00000125885:ENST00000378886:exon12:c.A1506G:p.Q502Q,ENSG00000125885:ENST00000378896:exon12:c.A1386G:p.Q462Q	MCM8:NM_001281520:exon12:c.A1386G:p.Q462Q,MCM8:NM_001281521:exon12:c.A1506G:p.Q502Q,MCM8:NM_032485:exon12:c.A1386G:p.Q462Q,MCM8:NM_182802:exon12:c.A1338G:p.Q446Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0752	0.0675	0.117812	LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	MCM8:uc002wmi.3:exon12:c.A1386G:p.Q462Q,MCM8:uc002wmj.3:exon12:c.A1338G:p.Q446Q,MCM8:uc002wmk.3:exon12:c.A1506G:p.Q502Q,MCM8:uc002wml.3:exon12:c.A1386G:p.Q462Q	.	AFR:0.0759,AMR:0.0983,EAS:0.0861,FIN:0.2460,NFE:0.0493,OTH:0.0530,ASJ:0.0490	608187	612885;	.	.	.	.	.	.	.	.	.	.	20	1(haematopoietic_and_lymphoid_tissue)	0.0622
20	6096695	6096695	C	T	FERMT1	intronic	.	ENSG00000101311	rs2295435	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4489	0.4070	0.419329	0.3801	.	.	.	.	.	0.0002	0.006	.	.	.	AFR:0.3611,AMR:0.4291,EAS:0.2906,FIN:0.3177,NFE:0.4083,OTH:0.3953,ASJ:0.5464	607900	173650;	306539;	306539|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|173650 ~	.	.	.	.	.	.	.	.	20	MU655370	het
20	6100088	6100088	A	G	FERMT1	exonic	synonymous SNV	ENSG00000101311	rs10373	ENSG00000101311:ENST00000217289:exon2:c.T114C:p.H38H,ENSG00000101311:ENST00000378844:exon2:c.T114C:p.H38H	FERMT1:NM_017671:exon2:c.T114C:p.H38H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5243	0.5324	0.524561	ESAD-UK|1|409|0.00244499,SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	FERMT1:uc002wmr.3:exon2:c.T114C:p.H38H,FERMT1:uc002wms.3:exon2:c.T114C:p.H38H	.	AFR:0.5005,AMR:0.5294,EAS:0.6225,FIN:0.3752,NFE:0.4129,OTH:0.5169,ASJ:0.4845	607900	173650;	306539;	306539|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|173650 ~	.	.	.	.	.	.	.	.	20	1(haematopoietic_and_lymphoid_tissue)	0.4878
20	8678446	8678446	G	A	PLCB1	intronic	.	ENSG00000182621	rs2295179	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6253	0.5757	0.532947	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.5856,AMR:0.3693,EAS:0.7483,FIN:0.5991,NFE:0.6776,OTH:0.6851,ASJ:0.4832	607120	613722;	293181;3451;	293181|MMPEI<br>MMPSI<br>MPEI<br>MPSI<br>Malignant migrating partial epilepsy of infancy<br>Migrating partial epilepsy of infancy<br>Migrating partial seizures of infancy|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|613722 614959 615338 616645 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04062 Chemokine signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04713 Circadian entrainment~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04745 Phototransduction - fly~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04973 Carbohydrate digestion and absorption~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	20	1(haematopoietic_and_lymphoid_tissue)	0.6731
20	8717713	8717713	G	A	PLCB1	exonic	synonymous SNV	ENSG00000182621	rs3761170	ENSG00000182621:ENST00000439627:exon1:c.G39A:p.G13G,ENSG00000182621:ENST00000338037:exon20:c.G2082A:p.G694G,ENSG00000182621:ENST00000378637:exon20:c.G2082A:p.G694G,ENSG00000182621:ENST00000378641:exon20:c.G2082A:p.G694G	PLCB1:NM_015192:exon20:c.G2082A:p.G694G,PLCB1:NM_182734:exon20:c.G2082A:p.G694G	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0796	0.0574	0.0992412	0.0568	.	.	.	.	.	.	.	.	PLCB1:uc002wnd.1:exon8:c.G813A:p.G271G,PLCB1:uc002wnc.1:exon18:c.G1779A:p.G593G,PLCB1:uc002wna.4:exon20:c.G2082A:p.G694G,PLCB1:uc002wnb.4:exon20:c.G2082A:p.G694G,PLCB1:uc010zrb.1:exon20:c.G1779A:p.G593G	.	AFR:0.0325,AMR:0.0919,EAS:0.1228,FIN:0.0393,NFE:0.0646,OTH:0.0662,ASJ:0.0960	607120	613722;	293181;3451;	293181|MMPEI<br>MMPSI<br>MPEI<br>MPSI<br>Malignant migrating partial epilepsy of infancy<br>Migrating partial epilepsy of infancy<br>Migrating partial seizures of infancy|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|613722 614959 615338 616645 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04062 Chemokine signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04713 Circadian entrainment~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04745 Phototransduction - fly~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04973 Carbohydrate digestion and absorption~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	20	MU82035671	het
20	8755243	8755243	T	C	PLCB1	exonic	synonymous SNV	ENSG00000182621	rs2235613	ENSG00000182621:ENST00000338037:exon27:c.T2988C:p.A996A,ENSG00000182621:ENST00000378637:exon27:c.T2988C:p.A996A,ENSG00000182621:ENST00000378641:exon27:c.T2988C:p.A996A	PLCB1:NM_015192:exon27:c.T2988C:p.A996A,PLCB1:NM_182734:exon27:c.T2988C:p.A996A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6155	0.6402	0.613219	MU146166	.	.	.	.	.	.	.	.	PLCB1:uc002wnd.1:exon15:c.T1719C:p.A573A,PLCB1:uc002wnc.1:exon25:c.T2685C:p.A895A,PLCB1:uc002wna.4:exon27:c.T2988C:p.A996A,PLCB1:uc002wnb.4:exon27:c.T2988C:p.A996A,PLCB1:uc010zrb.1:exon27:c.T2685C:p.A895A	.	AFR:LICA-CN|3|402|0.00746269,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.6163,EAS:0.5096,FIN:0.7119,NFE:0.5167,OTH:0.5516,ASJ:0.6384	607120	613722;	293181;3451;	293181|MMPEI<br>MMPSI<br>MPEI<br>MPSI<br>Malignant migrating partial epilepsy of infancy<br>Migrating partial epilepsy of infancy<br>Migrating partial seizures of infancy|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|613722 614959 615338 616645 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04062 Chemokine signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04713 Circadian entrainment~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04745 Phototransduction - fly~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04973 Carbohydrate digestion and absorption~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	20	1(prostate)	0.6330
20	8769180	8769180	C	T	PLCB1	intronic	.	ENSG00000182621	rs2327089	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9408	0.8914	0.896965	0.9039	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.7424,AMR:0.9630,EAS:0.9988,FIN:0.9820,NFE:0.9625,OTH:0.9481,ASJ:0.9371	607120	613722;	293181;3451;	293181|MMPEI<br>MMPSI<br>MPEI<br>MPSI<br>Malignant migrating partial epilepsy of infancy<br>Migrating partial epilepsy of infancy<br>Migrating partial seizures of infancy|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|613722 614959 615338 616645 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04062 Chemokine signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04713 Circadian entrainment~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04745 Phototransduction - fly~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04973 Carbohydrate digestion and absorption~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	20	MU82035692	hom
20	10620386	10620386	A	G	JAG1	exonic	synonymous SNV	ENSG00000101384	rs1051419	ENSG00000101384:ENST00000423891:exon24:c.T2940C:p.Y980Y,ENSG00000101384:ENST00000254958:exon26:c.T3417C:p.Y1139Y	JAG1:NM_000214:exon26:c.T3417C:p.Y1139Y	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6592	0.7272	0.71266	3(lung)	.	.	.	.	.	.	.	.	JAG1:uc002wnw.2:exon26:c.T3417C:p.Y1139Y	.	AFR:1(large_intestine),AMR:MU110199,EAS:0.6923,FIN:0.9037,NFE:0.6146,OTH:0.5828,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	601920	118450;187500;	3303;261600;261619;52;	3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~261600|Alagille syndrome due to del(20)(p12)<br>Alagille syndrome due to monosomy 20p12<br>Alagille-Watson syndrome due to monosomy 20p12<br>Arteriohepatic dysplasia due to monosomy 20p12<br>Syndromic bile duct paucity due to monosomy 20p12|Unknown|-|-|118450 ~261619|Alagille-Watson syndrome due to a JAG1 point mutation<br>Arteriohepatic dysplasia due to a JAG1 point mutation<br>Syndromic bile duct paucity due to a JAG1 point mutation|-|-|-|118450 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~	~ko01522 Endocrine resistance~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04668 TNF signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	1(urinary_tract)	0.4141
20	10622501	10622501	G	C	JAG1	exonic	nonsynonymous SNV	ENSG00000101384	rs35761929	ENSG00000101384:ENST00000423891:exon20:c.C2135G:p.P712R,ENSG00000101384:ENST00000254958:exon22:c.C2612G:p.P871R	JAG1:NM_000214:exon22:c.C2612G:p.P871R	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.0662	0.0481	0.0529153	0.0531	3.798	23.4	0.011	3.89	0.994	.	.	VWFC domain	JAG1:uc010gcd.1:exon14:c.C1286G:p.P429R,JAG1:uc002wnw.2:exon22:c.C2612G:p.P871R	-0.574	AFR:0.0143,AMR:0.0346,EAS:0.0352,FIN:0.0873,NFE:0.0704,OTH:0.0692,ASJ:0.0166	601920	118450;187500;	3303;261600;261619;52;	3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~261600|Alagille syndrome due to del(20)(p12)<br>Alagille syndrome due to monosomy 20p12<br>Alagille-Watson syndrome due to monosomy 20p12<br>Arteriohepatic dysplasia due to monosomy 20p12<br>Syndromic bile duct paucity due to monosomy 20p12|Unknown|-|-|118450 ~261619|Alagille-Watson syndrome due to a JAG1 point mutation<br>Arteriohepatic dysplasia due to a JAG1 point mutation<br>Syndromic bile duct paucity due to a JAG1 point mutation|-|-|-|118450 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~	~ko01522 Endocrine resistance~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04668 TNF signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	0.988	-0.11	0.095	1.715	20	MU82331549	het
20	10625804	10625804	T	G	JAG1	exonic	synonymous SNV	ENSG00000101384	rs1801140	ENSG00000101384:ENST00000423891:exon15:c.A1737C:p.T579T,ENSG00000101384:ENST00000254958:exon17:c.A2214C:p.T738T	JAG1:NM_000214:exon17:c.A2214C:p.T738T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1095	0.0755	0.100839	0.0813	.	.	.	.	.	.	.	.	JAG1:uc010gcd.1:exon9:c.A888C:p.T296T,JAG1:uc002wnw.2:exon17:c.A2214C:p.T738T	.	AFR:0.0357,AMR:0.1483,EAS:0.0370,FIN:0.1228,NFE:0.0979,OTH:0.1063,ASJ:0.0695	601920	118450;187500;	3303;261600;261619;52;	3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~261600|Alagille syndrome due to del(20)(p12)<br>Alagille syndrome due to monosomy 20p12<br>Alagille-Watson syndrome due to monosomy 20p12<br>Arteriohepatic dysplasia due to monosomy 20p12<br>Syndromic bile duct paucity due to monosomy 20p12|Unknown|-|-|118450 ~261619|Alagille-Watson syndrome due to a JAG1 point mutation<br>Arteriohepatic dysplasia due to a JAG1 point mutation<br>Syndromic bile duct paucity due to a JAG1 point mutation|-|-|-|118450 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~	~ko01522 Endocrine resistance~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04668 TNF signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	MU82290190	het
20	23860178	23860178	A	G	CST5	exonic	nonsynonymous SNV	ENSG00000170367	rs1799841	ENSG00000170367:ENST00000304710:exon1:c.T136C:p.C46R	CST5:NM_001900:exon1:c.T136C:p.C46R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4830	0.5414	0.565096	0.5442	-2.295	0.001	1.0	-0.399	0.001	.	.	Cystatin domain	CST5:uc002wtr.1:exon1:c.T136C:p.C46R	-0.970	AFR:0.7542,AMR:0.5347,EAS:0.4795,FIN:0.5451,NFE:0.4390,OTH:0.4579,ASJ:0.3467	123858	.	.	.	.	.	.	.	0.0	1.84	0.000	-1.845	20	MU585490	het
20	31022959	31022959	T	C	ASXL1	exonic	nonsynonymous SNV	ENSG00000171456	rs6058694	ENSG00000171456:ENST00000306058:exon12:c.T2429C:p.L810P,ENSG00000171456:ENST00000375687:exon13:c.T2444C:p.L815P	ASXL1:NM_001363734:exon11:c.T2261C:p.L754P,ASXL1:NM_015338:exon12:c.T2444C:p.L815P	clinvar: not_provided 	 CancerVar: 8#Tier_II_potential EVS=[1, 1, 1, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	1.0000	0.9999	1	1	.	.	.	.	.	.	.	.	ASXL1:uc010geb.3:exon9:c.T2117C:p.L706P,ASXL1:uc002wxs.3:exon12:c.T2441C:p.L814P,ASXL1:uc021wbw.1:exon13:c.T2444C:p.L815P	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	612990	605039;614286;	52688;97297;	52688|-|1-9 / 100 000|-|All ages|614286 ~97297|BOS syndrome<br>Bohring syndrome<br>C-like syndrome<br>Oberklaid-Danks syndrome<br>Opitz trigonocephaly-like syndrome|<1 / 1 000 000|-|-|605039 ~	.	,844,842,839	,853	845,,843,848,846,854,847,852,851,849,850	.	.	.	.	20	MU82037741	hom
20	32264675	32264675	C	T	E2F1	exonic	nonsynonymous SNV	ENSG00000101412	rs3213176	ENSG00000101412:ENST00000343380:exon7:c.G1177A:p.G393S	E2F1:NM_005225:exon7:c.G1177A:p.G393S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0300	0.0223	0.0117812	0.0172	0.338	6.052	0.7	-2.53	0.945	.	.	.	E2F1:uc002wzu.4:exon7:c.G1177A:p.G393S	-1.004	AFR:0.0041,AMR:0.0131,EAS:0,FIN:0.0117,NFE:0.0277,OTH:0.0174,ASJ:0.0364	189971	.	.	.	~ko01522 Endocrine resistance~ko04110 Cell cycle~ko04137 Mitophagy - animal~ko04218 Cellular senescence~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	0.022	1.29	0.007	0.225	20	.	het
20	36030939	36030939	G	C	SRC	exonic	synonymous SNV	ENSG00000197122	rs1885257	ENSG00000197122:ENST00000358208:exon10:c.G1218C:p.A406A,ENSG00000197122:ENST00000373558:exon10:c.G1236C:p.A412A,ENSG00000197122:ENST00000373567:exon10:c.G1218C:p.A406A,ENSG00000197122:ENST00000360723:exon11:c.G1236C:p.A412A,ENSG00000197122:ENST00000445403:exon11:c.G1218C:p.A406A,ENSG00000197122:ENST00000373578:exon12:c.G1218C:p.A406A	SRC:NM_005417:exon12:c.G1218C:p.A406A,SRC:NM_198291:exon12:c.G1218C:p.A406A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	1	.	1	1	.	.	.	.	.	.	.	.	SRC:uc002xgx.3:exon12:c.G1218C:p.A406A,SRC:uc002xgy.3:exon12:c.G1218C:p.A406A	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	190090	114500;616937;	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04015 Rap1 signaling pathway~ko04062 Chemokine signaling pathway~ko04137 Mitophagy - animal~ko04144 Endocytosis~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko04540 Gap junction~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04727 GABAergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05131 Shigellosis~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05219 Bladder cancer~ko05418 Fluid shear stress and atherosclerosis ~	,9876,9871,9880,9873,9878,9874,9875,9877,9870,9872,9879,9869	.	.	.	.	.	.	20	MU82038480	hom
20	40714479	40714479	G	A	PTPRT	exonic	synonymous SNV	ENSG00000196090	rs2016647	ENSG00000196090:ENST00000373201:exon27:c.C3831T:p.Y1277Y,ENSG00000196090:ENST00000356100:exon28:c.C3888T:p.Y1296Y,ENSG00000196090:ENST00000373184:exon28:c.C3891T:p.Y1297Y,ENSG00000196090:ENST00000373187:exon28:c.C3861T:p.Y1287Y,ENSG00000196090:ENST00000373190:exon28:c.C3858T:p.Y1286Y,ENSG00000196090:ENST00000373193:exon28:c.C3870T:p.Y1290Y,ENSG00000196090:ENST00000373198:exon29:c.C3918T:p.Y1306Y	PTPRT:NM_007050:exon28:c.C3861T:p.Y1287Y,PTPRT:NM_133170:exon29:c.C3918T:p.Y1306Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1951	0.2120	0.14397	0.1922	.	.	.	.	.	.	.	.	PTPRT:uc010ggi.3:exon13:c.C1470T:p.Y490Y,PTPRT:uc002xkg.3:exon28:c.C3861T:p.Y1287Y,PTPRT:uc010ggj.3:exon29:c.C3918T:p.Y1306Y	.	AFR:0.1386,AMR:0.1396,EAS:0.0660,FIN:0.1934,NFE:0.2372,OTH:0.2004,ASJ:0.2980	608712	.	.	.	.	.	.	.	.	.	.	.	20	MU149297	het
20	40743829	40743829	A	G	PTPRT	intronic	.	ENSG00000196090	rs2076248	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5308	0.5650	0.55651	0.5599	.	.	.	.	.	.	.	.	.	.	AFR:0.6257,AMR:0.5144,EAS:0.5632,FIN:0.5309,NFE:0.5305,OTH:0.5431,ASJ:0.6225	608712	.	.	.	.	.	.	.	.	.	.	.	20	MU23851333	hom
20	41306488	41306488	-	AA	PTPRT	intronic	.	ENSG00000196090	rs111229158	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.4277	.	0.477236	0.5209	.	.	.	.	.	.	.	.	.	.	AFR:0.5062,AMR:0.5315,EAS:0.5224,FIN:0.4946,NFE:0.5329,OTH:0.5231,ASJ:0.5906	608712	.	.	.	.	.	.	.	.	.	.	.	20	.	hom
20	41818289	41818289	C	G	PTPRT	exonic	nonsynonymous SNV	ENSG00000196090	rs2867655	ENSG00000196090:ENST00000356100:exon1:c.G85C:p.A29P,ENSG00000196090:ENST00000373184:exon1:c.G85C:p.A29P,ENSG00000196090:ENST00000373187:exon1:c.G85C:p.A29P,ENSG00000196090:ENST00000373190:exon1:c.G85C:p.A29P,ENSG00000196090:ENST00000373193:exon1:c.G85C:p.A29P,ENSG00000196090:ENST00000373198:exon1:c.G85C:p.A29P,ENSG00000196090:ENST00000373201:exon1:c.G85C:p.A29P	PTPRT:NM_007050:exon1:c.G85C:p.A29P,PTPRT:NM_133170:exon1:c.G85C:p.A29P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9211	.	0.711062	0.7053	3.530	23.1	0.027	2.81	1.000	.	.	MAM domain	PTPRT:uc002xkg.3:exon1:c.G85C:p.A29P,PTPRT:uc010ggj.3:exon1:c.G85C:p.A29P	-1.032	AFR:0.3404,AMR:0.8817,EAS:0.8323,FIN:0.8609,NFE:0.8464,OTH:0.8521,ASJ:0.8377	608712	.	.	.	.	.	.	.	0.014	1.3	0.000	0	20	MU82038896	hom
20	42310509	42310509	T	C	MYBL2	intronic	.	ENSG00000101057	rs442143	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8496	0.8537	0.825679	0.8648	.	.	.	.	.	.	.	.	.	.	AFR:0.8206,AMR:0.7225,EAS:0.8247,FIN:0.9226,NFE:0.8886,OTH:0.8829,ASJ:0.8411	601415	.	.	.	.	.	.	.	.	.	.	.	20	MU82039042	het
20	42320881	42320881	C	T	MYBL2	exonic	synonymous SNV	ENSG00000101057	rs2229036	ENSG00000101057:ENST00000396863:exon5:c.C513T:p.D171D,ENSG00000101057:ENST00000217026:exon6:c.C585T:p.D195D	MYBL2:NM_001278610:exon5:c.C513T:p.D171D,MYBL2:NM_002466:exon6:c.C585T:p.D195D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0472	0.0405	0.0505192	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	MYBL2:uc010zwj.1:exon5:c.C513T:p.D171D,MYBL2:uc002xlb.1:exon6:c.C585T:p.D195D	.	AFR:0.0385,AMR:0.0259,EAS:0.0596,FIN:0.0760,NFE:0.0309,OTH:0.0434,ASJ:0.0346	601415	.	.	.	.	.	.	.	.	.	.	.	20	2(haematopoietic_and_lymphoid_tissue)	0.0388
20	42328639	42328639	T	C	MYBL2	exonic	synonymous SNV	ENSG00000101057	rs285162	ENSG00000101057:ENST00000396863:exon6:c.T834C:p.P278P,ENSG00000101057:ENST00000217026:exon7:c.T906C:p.P302P	MYBL2:NM_001278610:exon6:c.T834C:p.P278P,MYBL2:NM_002466:exon7:c.T906C:p.P302P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9141	0.9372	0.932109	0.9385	.	.	.	.	.	.	.	.	MYBL2:uc010zwj.1:exon6:c.T834C:p.P278P,MYBL2:uc002xlb.1:exon7:c.T906C:p.P302P	.	AFR:0.9724,AMR:0.7602,EAS:0.9082,FIN:0.9505,NFE:0.9297,OTH:0.9235,ASJ:0.9570	601415	.	.	.	.	.	.	.	.	.	.	.	20	MU25976801	hom
20	42331457	42331457	A	G	MYBL2	exonic	nonsynonymous SNV	ENSG00000101057	rs2070235	ENSG00000101057:ENST00000396863:exon7:c.A1207G:p.S403G,ENSG00000101057:ENST00000217026:exon8:c.A1279G:p.S427G	MYBL2:NM_001278610:exon7:c.A1207G:p.S403G,MYBL2:NM_002466:exon8:c.A1279G:p.S427G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1080	0.1525	0.15655	1(breast)	1.102	11.22	0.55	2.73	0.923	.	.	.	MYBL2:uc010zwj.1:exon7:c.A1207G:p.S403G,MYBL2:uc002xlb.1:exon8:c.A1279G:p.S427G	-0.903	AFR:MU4557321,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.2664,FIN:0.0694,NFE:0.1159,OTH:0.0883,ASJ:0.1377	601415	.	.	.	.	.	.	.	0.002	2.52	0.000	0.805	20	1(haematopoietic_and_lymphoid_tissue)	0.0922
20	43964407	43964407	G	C	SDC4	intronic	.	ENSG00000124145	rs2072791	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7710	0.7280	0.769369	0.7446	.	.	.	.	.	.	.	.	.	.	AFR:0.6624,AMR:0.7912,EAS:0.9618,FIN:0.7983,NFE:0.7548,OTH:0.7377,ASJ:0.7067	600017	.	.	.	~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko05205 Proteoglycans in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	20	MU71379439	het
20	43976991	43976991	A	G	SDC4	exonic	nonsynonymous SNV	ENSG00000124145	rs2228384	ENSG00000124145:ENST00000372733:exon1:c.T34C:p.F12L	SDC4:NM_002999:exon1:c.T34C:p.F12L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4449	0.2800	0.3123	0.3122	1.585	13.77	1.0	1.9	0.796	.	.	.	SDC4:uc002xnu.3:exon1:c.T34C:p.F12L	-0.934	AFR:0.1663,AMR:0.3687,EAS:0.4062,FIN:0.3779,NFE:0.3641,OTH:0.3548,ASJ:0.39	600017	.	.	.	~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko05205 Proteoglycans in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	0.0	1.72	0.000	-1.905	20	MU69597	het
20	46267950	46267950	C	T	NCOA3	intronic	.	ENSG00000124151	rs4810648	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9411	0.9406	0.978435	0.9373	.	.	.	.	.	0.0002	0.034	.	.	.	AFR:0.9842,AMR:0.9533,EAS:1,FIN:0.9273,NFE:0.9051,OTH:0.9257,ASJ:0.9570	601937	.	.	.	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	MU82039696	hom
20	46279837	46279839	CAG	-	NCOA3	exonic	nonframeshift deletion	ENSG00000124151	rs147879509	ENSG00000124151:ENST00000341724:exon19:c.3541_3543del:p.1181_1181del,ENSG00000124151:ENST00000371997:exon20:c.3736_3738del:p.1246_1246del,ENSG00000124151:ENST00000371998:exon20:c.3763_3765del:p.1255_1255del,ENSG00000124151:ENST00000372004:exon20:c.3751_3753del:p.1251_1251del	NCOA3:NM_001174087:exon20:c.3760_3762del:p.1254_1254del,NCOA3:NM_001174088:exon20:c.3736_3738del:p.1246_1246del,NCOA3:NM_006534:exon20:c.3751_3753del:p.1251_1251del,NCOA3:NM_181659:exon20:c.3763_3765del:p.1255_1255del	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2798	0.3553	.	0.2872	.	.	.	.	.	.	.	.	NCOA3:uc010zyc.2:exon15:c.3148_3150del:p.1050_1050del,NCOA3:uc002xtk.3:exon20:c.3763_3765del:p.1255_1255del,NCOA3:uc002xtl.3:exon20:c.3751_3753del:p.1251_1251del,NCOA3:uc002xtm.3:exon20:c.3748_3750del:p.1250_1250del,NCOA3:uc002xtn.3:exon20:c.3760_3762del:p.1254_1254del,NCOA3:uc010ght.2:exon20:c.3736_3738del:p.1246_1246del	.	AFR:0.1825,AMR:0.2327,EAS:0.2542,FIN:0.2613,NFE:0.3590,OTH:0.2916,ASJ:0.4310	601937	.	.	.	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	MU4803	het
20	47604825	47604825	G	A	ARFGEF2	intronic	.	ENSG00000124198	rs4810905	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3062	0.2178	0.290735	0.2368	.	.	.	.	.	.	.	.	.	.	AFR:0.1178,AMR:0.4045,EAS:0.4770,FIN:0.2652,NFE:0.2597,OTH:0.3057,ASJ:0.2233	605371	608097;	2149;98892;	2149|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|All ages|300049 608097 608098 612881 615544 ~98892|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|-|300049 608097 608098 612881 615544 ~	.	.	.	.	.	.	.	.	20	MU585566	hom
20	47630449	47630449	C	T	ARFGEF2	exonic	synonymous SNV	ENSG00000124198	rs2281582	ENSG00000124198:ENST00000371917:exon30:c.C4131T:p.I1377I	ARFGEF2:NM_006420:exon30:c.C4131T:p.I1377I	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1899	0.1130	0.208466	0.1365	.	.	.	.	.	.	.	.	ARFGEF2:uc010zyf.2:exon16:c.C2010T:p.I670I,ARFGEF2:uc002xtx.4:exon30:c.C4131T:p.I1377I	.	AFR:0.0616,AMR:0.3270,EAS:0.3700,FIN:0.1584,NFE:0.1389,OTH:0.1680,ASJ:0.0563	605371	608097;	2149;98892;	2149|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|All ages|300049 608097 608098 612881 615544 ~98892|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|-|300049 608097 608098 612881 615544 ~	.	.	.	.	.	.	.	.	20	MU585569	hom
20	50405502	50405502	C	G	SALL4	exonic	synonymous SNV	ENSG00000101115	rs17802735	ENSG00000101115:ENST00000371539:exon2:c.G309C:p.S103S,ENSG00000101115:ENST00000217086:exon3:c.G2640C:p.S880S,ENSG00000101115:ENST00000395997:exon3:c.G1329C:p.S443S	SALL4:NM_001318031:exon3:c.G1329C:p.S443S,SALL4:NM_020436:exon3:c.G2640C:p.S880S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0897	0.0976	0.0497204	0.0903	.	.	.	.	.	.	.	.	SALL4:uc002xwi.4:exon2:c.G309C:p.S103S,SALL4:uc002xwh.4:exon3:c.G2640C:p.S880S,SALL4:uc010gii.3:exon3:c.G1329C:p.S443S	.	AFR:0.0217,AMR:0.0680,EAS:0.0012,FIN:0.1139,NFE:0.1359,OTH:0.0949,ASJ:0.0662	607343	147750;607323;	93293;959;2307;	93293|Duane-radial ray syndrome|-|Autosomal dominant|-|607323 ~959|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Antenatal|607323 ~2307|Oculo-oto-radial syndrome<br>Radial ray defects, hearing impairment, external ophthalmoplegia, and thrombocytopenia|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|147750 ~	.	.	.	.	.	.	.	.	20	.	het
20	50407162	50407162	T	C	SALL4	exonic	synonymous SNV	ENSG00000101115	rs6021437	ENSG00000101115:ENST00000217086:exon2:c.A1860G:p.T620T	SALL4:NM_020436:exon2:c.A1860G:p.T620T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3578	0.3021	0.381989	1(thyroid)	.	.	.	.	.	.	.	.	SALL4:uc002xwh.4:exon2:c.A1860G:p.T620T	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU157870,EAS:0.3093,FIN:0.2079,NFE:0.3062,OTH:0.4238,ASJ:LIRI-JP|1|258|0.00387597,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	607343	147750;607323;	93293;959;2307;	93293|Duane-radial ray syndrome|-|Autosomal dominant|-|607323 ~959|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Antenatal|607323 ~2307|Oculo-oto-radial syndrome<br>Radial ray defects, hearing impairment, external ophthalmoplegia, and thrombocytopenia|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|147750 ~	.	.	.	.	.	.	.	.	20	1(liver)	0.6112
20	50407502	50407502	A	C	SALL4	exonic	nonsynonymous SNV	ENSG00000101115	rs6126344	ENSG00000101115:ENST00000217086:exon2:c.T1520G:p.L507R	SALL4:NM_020436:exon2:c.T1520G:p.L507R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3506	0.2781	0.358826	1(breast)	1.722	14.53	0.59	1.9	0.841	.	.	.	SALL4:uc002xwh.4:exon2:c.T1520G:p.L507R	-0.966	AFR:MU157882,AMR:LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.1413,FIN:0.2962,NFE:0.4267,OTH:0.6060,ASJ:0.2892	607343	147750;607323;	93293;959;2307;	93293|Duane-radial ray syndrome|-|Autosomal dominant|-|607323 ~959|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Antenatal|607323 ~2307|Oculo-oto-radial syndrome<br>Radial ray defects, hearing impairment, external ophthalmoplegia, and thrombocytopenia|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|147750 ~	.	.	.	.	0.024	2.88	0.000	2.075	20	1(pancreas)	0.3183
20	50407966	50407966	C	T	SALL4	exonic	synonymous SNV	ENSG00000101115	rs13038893	ENSG00000101115:ENST00000217086:exon2:c.G1056A:p.A352A,ENSG00000101115:ENST00000395997:exon2:c.G1056A:p.A352A	SALL4:NM_001318031:exon2:c.G1056A:p.A352A,SALL4:NM_020436:exon2:c.G1056A:p.A352A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2522	0.3352	0.209265	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	SALL4:uc002xwh.4:exon2:c.G1056A:p.A352A,SALL4:uc010gii.3:exon2:c.G1056A:p.A352A	.	AFR:0.2936,AMR:0.3236,EAS:0.2086,FIN:0.0303,NFE:0.2483,OTH:0.3245,ASJ:0.1802	607343	147750;607323;	93293;959;2307;	93293|Duane-radial ray syndrome|-|Autosomal dominant|-|607323 ~959|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Antenatal|607323 ~2307|Oculo-oto-radial syndrome<br>Radial ray defects, hearing impairment, external ophthalmoplegia, and thrombocytopenia|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|147750 ~	.	.	.	.	.	.	.	.	20	1(large_intestine)	0.2770
20	50408482	50408482	A	G	SALL4	exonic	synonymous SNV	ENSG00000101115	rs6013281	ENSG00000101115:ENST00000217086:exon2:c.T540C:p.N180N,ENSG00000101115:ENST00000395997:exon2:c.T540C:p.N180N	SALL4:NM_001318031:exon2:c.T540C:p.N180N,SALL4:NM_020436:exon2:c.T540C:p.N180N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9965	0.9956	0.997404	0.9967	.	.	.	.	.	.	.	.	SALL4:uc002xwh.4:exon2:c.T540C:p.N180N,SALL4:uc010gii.3:exon2:c.T540C:p.N180N	.	AFR:0.9976,AMR:0.9988,EAS:1,FIN:0.9991,NFE:0.9953,OTH:0.9980,ASJ:0.9901	607343	147750;607323;	93293;959;2307;	93293|Duane-radial ray syndrome|-|Autosomal dominant|-|607323 ~959|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Antenatal|607323 ~2307|Oculo-oto-radial syndrome<br>Radial ray defects, hearing impairment, external ophthalmoplegia, and thrombocytopenia|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|147750 ~	.	.	.	.	.	.	.	.	20	MU82040420	hom
20	52185814	52185814	C	A	LOC101927770	ncRNA_intronic	.	ENSG00000197670	rs4602270	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7256	.	0.779153	0.7405	.	.	.	.	.	0	0	.	.	.	AFR:0.8270,AMR:0.7626,EAS:0.8209,FIN:0.7318,NFE:0.6834,OTH:0.7301,ASJ:0.7152	.	.	.	.	.	.	.	.	.	.	.	.	20	MU14541605	het
20	52192957	52192957	C	G	ZNF217	exonic	synonymous SNV	ENSG00000171940	rs41274708	ENSG00000171940:ENST00000302342:exon3:c.G2346C:p.A782A,ENSG00000171940:ENST00000371471:exon4:c.G2346C:p.A782A	ZNF217:NM_006526:exon3:c.G2346C:p.A782A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0066	0.0046	0.00379393	0.0040	.	.	.	.	.	.	.	.	ZNF217:uc002xwq.4:exon3:c.G2346C:p.A782A,ZNF217:uc010gij.1:exon4:c.G2322C:p.A774A	.	AFR:0.0009,AMR:0.0012,EAS:0,FIN:0.0029,NFE:0.0068,OTH:0.0020,ASJ:0	602967	.	.	.	.	.	.	.	.	.	.	.	20	.	het
20	52198340	52198340	T	A	ZNF217	exonic	synonymous SNV	ENSG00000171940	rs16998248	ENSG00000171940:ENST00000302342:exon1:c.A1026T:p.A342A,ENSG00000171940:ENST00000371471:exon2:c.A1026T:p.A342A	ZNF217:NM_006526:exon1:c.A1026T:p.A342A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1103	0.0662	0.175919	MU14541714	.	.	.	.	.	.	.	.	ZNF217:uc002xwq.4:exon1:c.A1026T:p.A342A,ZNF217:uc010gij.1:exon2:c.A1002T:p.A334A	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.0871,EAS:0.2220,FIN:0.0728,NFE:0.2996,OTH:0.0813,ASJ:0.1179	602967	.	.	.	.	.	.	.	.	.	.	.	20	1(urinary_tract)	0.0405
20	52198967	52198967	A	G	ZNF217	exonic	synonymous SNV	ENSG00000171940	rs1326862	ENSG00000171940:ENST00000302342:exon1:c.T399C:p.C133C,ENSG00000171940:ENST00000371471:exon2:c.T399C:p.C133C	ZNF217:NM_006526:exon1:c.T399C:p.C133C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0619	0.0599	0.110823	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ZNF217:uc002xwq.4:exon1:c.T399C:p.C133C,ZNF217:uc010gij.1:exon2:c.T375C:p.C125C	.	AFR:MU148294,AMR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,EAS:0.1203,FIN:0.1002,NFE:0.0166,OTH:0.1442,ASJ:0.0642	602967	.	.	.	.	.	.	.	.	.	.	.	20	1(urinary_tract)	0.0415
20	54961463	54961463	T	C	AURKA	exonic	nonsynonymous SNV	ENSG00000087586	rs1047972	ENSG00000087586:ENST00000347343:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000395907:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000395913:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000395915:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000312783:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000371356:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000395911:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000395914:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000422322:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000441357:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000395909:exon5:c.A169G:p.I57V,ENSG00000087586:ENST00000420474:exon5:c.A169G:p.I57V,ENSG00000087586:ENST00000451915:exon5:c.A169G:p.I57V,ENSG00000087586:ENST00000456249:exon5:c.A169G:p.I57V	AURKA:NM_003600:exon3:c.A169G:p.I57V,AURKA:NM_198435:exon3:c.A169G:p.I57V,AURKA:NM_198437:exon3:c.A169G:p.I57V,AURKA:NM_001323303:exon4:c.A169G:p.I57V,AURKA:NM_001323304:exon4:c.A169G:p.I57V,AURKA:NM_198434:exon4:c.A169G:p.I57V,AURKA:NM_198436:exon4:c.A169G:p.I57V,AURKA:NM_001323305:exon5:c.A169G:p.I57V,AURKA:NM_198433:exon5:c.A169G:p.I57V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8482	0.8378	0.84984	COCA-CN|5|321|0.0155763	-2.027	0.001	1.0	1.97	0.069	.	.	.	AURKA:uc002xxg.1:exon3:c.A169G:p.I57V,AURKA:uc002xxh.1:exon3:c.A169G:p.I57V,AURKA:uc002xxi.1:exon3:c.A169G:p.I57V,AURKA:uc002xxe.1:exon4:c.A169G:p.I57V,AURKA:uc002xxf.1:exon4:c.A169G:p.I57V,AURKA:uc002xxj.1:exon4:c.A169G:p.I57V,AURKA:uc002xxd.1:exon5:c.A169G:p.I57V	-0.937	AFR:0.8413,AMR:0.8405,EAS:0.8676,FIN:0.8881,NFE:0.8129,OTH:0.8406,ASJ:0.8986	603072	114500;	.	.	.	.	.	.	0.0	-0.1	0.000	.	20	1(stomach)	0.8262
20	54961541	54961541	A	T	AURKA	exonic	nonsynonymous SNV	ENSG00000087586	rs2273535	ENSG00000087586:ENST00000347343:exon3:c.T91A:p.F31I,ENSG00000087586:ENST00000395907:exon3:c.T91A:p.F31I,ENSG00000087586:ENST00000395913:exon3:c.T91A:p.F31I,ENSG00000087586:ENST00000395915:exon3:c.T91A:p.F31I,ENSG00000087586:ENST00000312783:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000371356:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000395911:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000395914:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000422322:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000441357:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000395909:exon5:c.T91A:p.F31I,ENSG00000087586:ENST00000420474:exon5:c.T91A:p.F31I,ENSG00000087586:ENST00000451915:exon5:c.T91A:p.F31I,ENSG00000087586:ENST00000456249:exon5:c.T91A:p.F31I	AURKA:NM_003600:exon3:c.T91A:p.F31I,AURKA:NM_198435:exon3:c.T91A:p.F31I,AURKA:NM_198437:exon3:c.T91A:p.F31I,AURKA:NM_001323303:exon4:c.T91A:p.F31I,AURKA:NM_001323304:exon4:c.T91A:p.F31I,AURKA:NM_198434:exon4:c.T91A:p.F31I,AURKA:NM_198436:exon4:c.T91A:p.F31I,AURKA:NM_001323305:exon5:c.T91A:p.F31I,AURKA:NM_198433:exon5:c.T91A:p.F31I	clinvar: risk_factor 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2735	0.1882	0.309704	1(skin)	-1.212	0.006	0.497	-7.55	0.093	.	.	.	AURKA:uc002xxg.1:exon3:c.T91A:p.F31I,AURKA:uc002xxh.1:exon3:c.T91A:p.F31I,AURKA:uc002xxi.1:exon3:c.T91A:p.F31I,AURKA:uc002xxe.1:exon4:c.T91A:p.F31I,AURKA:uc002xxf.1:exon4:c.T91A:p.F31I,AURKA:uc002xxj.1:exon4:c.T91A:p.F31I,AURKA:uc002xxd.1:exon5:c.T91A:p.F31I	-0.990	AFR:MU714003,AMR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,EAS:0.1428,FIN:0.3341,NFE:0.1689,OTH:0.6750,ASJ:0.2338	603072	114500;	.	.	.	.	.	.	0.0	-0.1	0.000	0.69	20	8(soft_tissue)	0.2761
20	57478807	57478807	C	T	GNAS	exonic	synonymous SNV	ENSG00000087460	rs7121	ENSG00000087460:ENST00000265620:exon4:c.C348T:p.I116I,ENSG00000087460:ENST00000371095:exon4:c.C351T:p.I117I,ENSG00000087460:ENST00000371102:exon4:c.C2280T:p.I760I,ENSG00000087460:ENST00000306090:exon5:c.C351T:p.I117I,ENSG00000087460:ENST00000349036:exon5:c.C444T:p.I148I,ENSG00000087460:ENST00000354359:exon5:c.C396T:p.I132I,ENSG00000087460:ENST00000371085:exon5:c.C393T:p.I131I,ENSG00000087460:ENST00000371100:exon5:c.C2322T:p.I774I,ENSG00000087460:ENST00000603546:exon5:c.C216T:p.I72I,ENSG00000087460:ENST00000604005:exon5:c.C216T:p.I72I	GNAS:NM_001077489:exon4:c.C348T:p.I116I,GNAS:NM_080426:exon4:c.C351T:p.I117I,GNAS:NM_000516:exon5:c.C393T:p.I131I,GNAS:NM_001077488:exon5:c.C396T:p.I132I,GNAS:NM_001309840:exon5:c.C216T:p.I72I,GNAS:NM_001309861:exon5:c.C216T:p.I72I,GNAS:NM_080425:exon5:c.C2322T:p.I774I	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5473	0.5794	0.644369	15(meninges)	.	.	.	.	.	.	.	.	GNAS:uc002yae.3:exon2:c.C168T:p.I56I,GNAS:uc002yad.3:exon3:c.C66T:p.I22I,GNAS:uc002yaa.3:exon4:c.C348T:p.I116I,GNAS:uc021wfp.1:exon4:c.C351T:p.I117I,GNAS:uc002xzt.3:exon5:c.C297T:p.I99I,GNAS:uc002xzw.3:exon5:c.C2322T:p.I774I,GNAS:uc002xzx.3:exon5:c.C216T:p.I72I,GNAS:uc010gjq.3:exon5:c.C216T:p.I72I,GNAS:uc021wfn.1:exon5:c.C393T:p.I131I,GNAS:uc021wfo.1:exon5:c.C396T:p.I132I	.	AFR:1(eye),AMR:MU84578,EAS:0.5563,FIN:0.7561,NFE:0.6235,OTH:0.64,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	139320	102200;103580;166350;174800;219080;603233;612462;612463;	79445;79444;94089;189427;562;2762;79443;314777;96256;963;99725;	79445|AHO-PPHP syndrome<br>Albright hereditary osteodystrophy-PPHP syndrome|Unknown|Autosomal dominant|All ages|612463 ~79444|-|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|612462 ~94089|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Infancy<br>Childhood<br>Adolescent|603233 ~189427|Primary bilateral macronodular adrenal hyperplasia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|219080 615954 ~562|Gonadotropin-independent female-limited sexual precocity|1-9 / 1 000 000|Not applicable|Childhood|174800 ~2762|Familial ectopic ossification<br>POH|-|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|166350 ~79443|AHO-PHP syndrome Ia<br>Albright hereditary osteodystrophy-PHP syndrome Ia|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|103580 ~314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96256|Somatotropinoma|-|-|-|102200 ~963|-|1-9 / 100 000|Not applicable|Adult|102200 300943 ~99725|Hypophyseal gigantism<br>Infantile and juvenile forms of acromegaly|-|-|-|102200 ~	~ko01522 Endocrine resistance~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04361 Axon regeneration~ko04540 Gap junction~ko04611 Platelet activation~ko04713 Circadian entrainment~ko04714 Thermogenesis~ko04724 Glutamatergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04913 Ovarian steroidogenesis~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04962 Vasopressin-regulated water reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04976 Bile secretion~ko05030 Cocaine addiction~ko05031 Amphetamine addiction~ko05032 Morphine addiction~ko05034 Alcoholism~ko05110 Vibrio cholerae infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05414 Dilated cardiomyopathy (DCM) ~	,5905,5904	.	.	.	.	.	.	20	1(urinary_tract)	0.6584
20	62333521	62333521	C	T	ARFRP1	exonic	nonsynonymous SNV	ENSG00000101246	rs35892492	ENSG00000101246:ENST00000359715:exon4:c.G313A:p.E105K,ENSG00000101246:ENST00000607873:exon4:c.G172A:p.E58K,ENSG00000101246:ENST00000324228:exon5:c.G313A:p.E105K,ENSG00000101246:ENST00000440854:exon5:c.G313A:p.E105K,ENSG00000101246:ENST00000609142:exon5:c.G313A:p.E105K,ENSG00000101246:ENST00000610136:exon5:c.G313A:p.E105K	ARFRP1:NM_001267546:exon4:c.G172A:p.E58K,ARFRP1:NM_001134758:exon5:c.G313A:p.E105K,ARFRP1:NM_001267544:exon5:c.G313A:p.E105K,ARFRP1:NM_001267545:exon5:c.G313A:p.E105K,ARFRP1:NM_001267547:exon5:c.G313A:p.E105K,ARFRP1:NM_001267548:exon5:c.G313A:p.E105K,ARFRP1:NM_001267549:exon5:c.G313A:p.E105K,ARFRP1:NM_003224:exon5:c.G313A:p.E105K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0004	0.0016	0.00119808	0.0011	3.591	23.2	.	5.38	0.131	.	.	P-loop containing nucleoside triphosphate hydrolase|Small GTP-binding protein domain	ARFRP1:uc002yga.3:exon4:c.G313A:p.E105K,ARFRP1:uc031ruq.1:exon4:c.G172A:p.E58K,ARFRP1:uc002ygc.4:exon5:c.G313A:p.E105K,ARFRP1:uc002ygf.4:exon5:c.G313A:p.E105K,ARFRP1:uc002ygh.5:exon5:c.G313A:p.E105K,ARFRP1:uc011abf.3:exon5:c.G313A:p.E105K,ARFRP1:uc011abg.3:exon5:c.G313A:p.E105K,ARFRP1:uc031rup.1:exon5:c.G313A:p.E105K,ARFRP1:uc031rur.1:exon5:c.G313A:p.E105K	-0.650	AFR:0.0037,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	604699	.	.	.	.	.	.	.	0.028	.	0.292	-0.865	20	.	het
21	34399401	34399401	A	G	OLIG2	exonic	synonymous SNV	ENSG00000205927	rs762178	ENSG00000205927:ENST00000333337:exon1:c.A231G:p.S77S,ENSG00000205927:ENST00000382357:exon2:c.A231G:p.S77S	OLIG2:NM_005806:exon2:c.A231G:p.S77S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5212	0.5559	0.439696	2(lung)	.	.	.	.	.	.	.	.	OLIG2:uc021wil.1:exon1:c.A231G:p.S77S,OLIG2:uc002yqx.2:exon2:c.A231G:p.S77S	.	AFR:MU9764520,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,EAS:0.5249,FIN:0.4928,NFE:0.6324,OTH:0.1719,ASJ:0.5263	606386	.	.	.	.	.	.	.	.	.	.	.	21	1(breast)	0.5195
21	36259324	36259324	A	G	RUNX1	exonic	nonsynonymous SNV	ENSG00000159216	rs111527738	ENSG00000159216:ENST00000344691:exon1:c.T86C:p.L29S,ENSG00000159216:ENST00000358356:exon1:c.T86C:p.L29S,ENSG00000159216:ENST00000399240:exon1:c.T86C:p.L29S,ENSG00000159216:ENST00000325074:exon2:c.T131C:p.L44S,ENSG00000159216:ENST00000399237:exon2:c.T131C:p.L44S,ENSG00000159216:ENST00000300305:exon3:c.T167C:p.L56S,ENSG00000159216:ENST00000455571:exon3:c.T128C:p.L43S,ENSG00000159216:ENST00000437180:exon4:c.T167C:p.L56S,ENSG00000159216:ENST00000486278:exon4:c.T95C:p.L32S	RUNX1:NM_001001890:exon1:c.T86C:p.L29S,RUNX1:NM_001122607:exon1:c.T86C:p.L29S,RUNX1:NM_001754:exon4:c.T167C:p.L56S	clinvar: Benign/Likely_benign 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, 1, 1, 1] 	0.0163	0.0106	0.0103834	.	3.370	22.9	0.513	5.04	0.999	.	.	Runt domain|p53-like transcription factor, DNA-binding|p53/RUNT-type transcription factor, DNA-binding domain	RUNX1:uc002yuh.3:exon1:c.T86C:p.L29S,RUNX1:uc002yuo.1:exon1:c.T86C:p.L29S,RUNX1:uc002yuk.4:exon3:c.T167C:p.L56S,RUNX1:uc010gmu.3:exon4:c.T167C:p.L56S,RUNX1:uc010gmv.3:exon4:c.T167C:p.L56S,RUNX1:uc010gmw.1:exon4:c.T167C:p.L56S	0.797	AFR:0.0120,AMR:0.0034,EAS:0,FIN:0,NFE:0.0138,OTH:0.0182,ASJ:0.0060	151385	601399;601626;	519;71290;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~71290|FPD/AML syndrome<br>FPS/AML syndrome<br>Familial platelet disorder with associated myeloid malignancy<br>Familial platelet syndrome|<1 / 1 000 000|Autosomal dominant|No data available|601399 ~	~ko04530 Tight junction~ko04659 Th17 cell differentiation~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia ~	,9624,9630	.	9631,,9627,9625,9628,9629,9633,9626,9632	0.985	-4.07	0.895	0.93	21	1(cervix)	0.0143
21	40191431	40191431	T	G	ETS2	exonic	synonymous SNV	ENSG00000157557	rs457705	ENSG00000157557:ENST00000360938:exon8:c.T816G:p.T272T,ENSG00000157557:ENST00000360214:exon9:c.T816G:p.T272T	ETS2:NM_005239:exon8:c.T816G:p.T272T,ETS2:NM_001256295:exon9:c.T1236G:p.T412T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7220	0.7713	0.58107	MU748847	.	.	.	.	.	.	.	.	ETS2:uc002yxg.4:exon8:c.T816G:p.T272T,ETS2:uc002yxf.3:exon9:c.T1236G:p.T412T	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.7428,EAS:0.5943,FIN:0.8543,NFE:0.4708,OTH:0.7596,ASJ:0.6169	164740	.	.	.	.	.	.	.	.	.	.	.	21	1(liver)	0.8457
21	40191638	40191638	A	G	ETS2	exonic	synonymous SNV	ENSG00000157557	rs461155	ENSG00000157557:ENST00000360938:exon8:c.A1023G:p.P341P,ENSG00000157557:ENST00000360214:exon9:c.A1023G:p.P341P	ETS2:NM_005239:exon8:c.A1023G:p.P341P,ETS2:NM_001256295:exon9:c.A1443G:p.P481P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7228	0.7706	0.580671	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	ETS2:uc002yxg.4:exon8:c.A1023G:p.P341P,ETS2:uc002yxf.3:exon9:c.A1443G:p.P481P	.	AFR:0.7422,AMR:0.6138,EAS:0.8543,FIN:0.4721,NFE:0.7594,OTH:0.8462,ASJ:0.5943	164740	.	.	.	.	.	.	.	.	.	.	.	21	2(lung)	0.7658
21	41434841	41434841	T	C	DSCAM	intronic	.	ENSG00000171587	rs2837409	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2931	0.2556	0.347244	LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.2650,AMR:0.2980,EAS:0.3079,FIN:0.5417,NFE:0.1758,OTH:0.2282,ASJ:0.4415	602523	.	.	.	.	.	.	.	.	.	.	.	21	1(haematopoietic_and_lymphoid_tissue)	0.2357
21	41684090	41684090	C	T	DSCAM	exonic	synonymous SNV	ENSG00000171587	rs34336407	ENSG00000171587:ENST00000404019:exon5:c.G1236A:p.S412S,ENSG00000171587:ENST00000400454:exon9:c.G1980A:p.S660S	DSCAM:NM_001271534:exon9:c.G1980A:p.S660S,DSCAM:NM_001389:exon9:c.G1980A:p.S660S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0759	0.0702	0.0798722	0.0705	.	.	.	.	.	.	.	.	DSCAM:uc002yyq.1:exon9:c.G1980A:p.S660S,DSCAM:uc031rvr.1:exon9:c.G1980A:p.S660S	.	AFR:0.0495,AMR:0.0646,EAS:0.1179,FIN:0.0755,NFE:0.0766,OTH:0.0725,ASJ:0.0728	602523	.	.	.	.	.	.	.	.	.	.	.	21	.	het
21	44837551	44837551	G	A	SIK1;SIK1B	exonic	synonymous SNV	ENSG00000142178	rs430552	ENSG00000142178:ENST00000270162:exon13:c.C1848T:p.P616P	SIK1B:NM_001320643:exon13:c.C1848T:p.P616P,SIK1:NM_173354:exon13:c.C1848T:p.P616P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8000	0.7241	0.725439	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SIK1:uc002zdf.2:exon13:c.C1848T:p.P616P	.	AFR:0.7315,AMR:0.5034,EAS:0.7162,FIN:0.8904,NFE:0.8819,OTH:0.7974,ASJ:0.8702	605705	616341;	1934;1935;3451;	1934|EIEE<br>Early infantile epileptic encephalopathy with suppression-bursts<br>Ohtahara syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|300672 308350 609304 612164 613402 613721 615473 616341 ~1935|Early myoclonic encephalopathy with suppression-bursts|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|609304 616341 617105 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	21	2(large_intestine)	0.8364
21	44837555	44837555	G	A	SIK1;SIK1B	exonic	nonsynonymous SNV	ENSG00000142178	rs430554	ENSG00000142178:ENST00000270162:exon13:c.C1844T:p.A615V	SIK1B:NM_001320643:exon13:c.C1844T:p.A615V,SIK1:NM_173354:exon13:c.C1844T:p.A615V	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8900	0.8455	0.830671	3(lung)	1.313	12.34	0.005	2.25	0.200	.	.	.	SIK1:uc002zdf.2:exon13:c.C1844T:p.A615V	-1.004	AFR:MU9773887,AMR:COCA-CN|5|321|0.0155763,EAS:0.7171,FIN:0.9173,NFE:0.8221,OTH:0.9047,ASJ:0.8533	605705	616341;	1934;1935;3451;	1934|EIEE<br>Early infantile epileptic encephalopathy with suppression-bursts<br>Ohtahara syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|300672 308350 609304 612164 613402 613721 615473 616341 ~1935|Early myoclonic encephalopathy with suppression-bursts|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|609304 616341 617105 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	0.281	-0.59	0.000	1.04	21	1(liver)	0.9561
21	46875564	46875564	T	C	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs914230	ENSG00000182871:ENST00000355480:exon1:c.T120C:p.H40H,ENSG00000182871:ENST00000359759:exon1:c.T120C:p.H40H	COL18A1:NM_030582:exon1:c.T120C:p.H40H,COL18A1:NM_130444:exon1:c.T120C:p.H40H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9705	0.9693	0.988419	0.9678	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon1:c.T120C:p.H40H	.	AFR:0.9925,AMR:0.9785,EAS:1,FIN:0.9631,NFE:0.9510,OTH:0.9551,ASJ:0.9801	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	MU82046823	hom
21	46908355	46908355	T	C	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs11702425	ENSG00000182871:ENST00000355480:exon17:c.T2460C:p.L820L,ENSG00000182871:ENST00000359759:exon17:c.T3165C:p.L1055L,ENSG00000182871:ENST00000400337:exon18:c.T1920C:p.L640L	COL18A1:NM_030582:exon17:c.T2460C:p.L820L,COL18A1:NM_130444:exon17:c.T3165C:p.L1055L,COL18A1:NM_130445:exon18:c.T1920C:p.L640L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3052	0.3129	0.319888	2(breast)	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon17:c.T2460C:p.L820L,COL18A1:uc002zhg.3:exon18:c.T1920C:p.L640L	.	AFR:MU156625,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02,EAS:0.3687,FIN:0.2613,NFE:0.3233,OTH:0.2420,ASJ:0.3220	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(thyroid)	0.3456
21	46909426	46909426	G	A	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs61731167	ENSG00000182871:ENST00000355480:exon18:c.G2490A:p.P830P,ENSG00000182871:ENST00000359759:exon18:c.G3195A:p.P1065P,ENSG00000182871:ENST00000400337:exon19:c.G1950A:p.P650P	COL18A1:NM_030582:exon18:c.G2490A:p.P830P,COL18A1:NM_130444:exon18:c.G3195A:p.P1065P,COL18A1:NM_130445:exon19:c.G1950A:p.P650P	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0942	0.0453	0.0459265	0.0651	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon18:c.G2490A:p.P830P,COL18A1:uc002zhg.3:exon19:c.G1950A:p.P650P	.	AFR:0.0287,AMR:0.0323,EAS:0.0099,FIN:0.1469,NFE:0.0738,OTH:0.0777,ASJ:0.0762	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	MU117063561	het
21	46910210	46910210	G	A	COL18A1	exonic	nonsynonymous SNV	ENSG00000182871	rs62000962	ENSG00000182871:ENST00000342220:exon1:c.G22A:p.V8I,ENSG00000182871:ENST00000355480:exon19:c.G2521A:p.V841I,ENSG00000182871:ENST00000359759:exon19:c.G3226A:p.V1076I,ENSG00000182871:ENST00000400337:exon20:c.G1981A:p.V661I	COL18A1:NM_030582:exon19:c.G2521A:p.V841I,COL18A1:NM_130444:exon19:c.G3226A:p.V1076I,COL18A1:NM_130445:exon20:c.G1981A:p.V661I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2169	0.1234	0.115615	SKCA-BR|1|100|0.01	-0.436	0.315	0.424	-2.52	0.008	.	.	.	COL18A1:uc002zhi.3:exon19:c.G2521A:p.V841I,COL18A1:uc002zhg.3:exon20:c.G1981A:p.V661I	-0.859	AFR:0.1330,AMR:0.1533,EAS:0.1358,FIN:0.0144,NFE:0.1644,OTH:0.1285,ASJ:0.0974	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	0.048	-3.2	0.004	0.05	21	1(liver)	0.1360
21	46910740	46910740	G	A	COL18A1	intronic	.	ENSG00000182871	rs368213286	.	.	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0107	0.0001	0.00499201	9.699e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0031,ASJ:0	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	.	het
21	46911188	46911188	C	G	COL18A1	exonic	nonsynonymous SNV	ENSG00000182871	rs79980197	ENSG00000182871:ENST00000342220:exon3:c.C158G:p.P53R,ENSG00000182871:ENST00000355480:exon21:c.C2657G:p.P886R,ENSG00000182871:ENST00000359759:exon21:c.C3362G:p.P1121R,ENSG00000182871:ENST00000400337:exon22:c.C2117G:p.P706R	COL18A1:NM_030582:exon21:c.C2657G:p.P886R,COL18A1:NM_130444:exon21:c.C3362G:p.P1121R,COL18A1:NM_130445:exon22:c.C2117G:p.P706R	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0877	0.0598	0.0688898	0.0785	5.006	25.1	0.094	3.85	0.004	.	.	.	COL18A1:uc002zhi.3:exon21:c.C2657G:p.P886R,COL18A1:uc002zhg.3:exon22:c.C2117G:p.P706R	-0.339	AFR:0.0342,AMR:0.0370,EAS:0.0729,FIN:0.1571,NFE:0.0883,OTH:0.0835,ASJ:0.0894	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	1.0	-3.09	0.242	2.3	21	MU4555974	het
21	46924426	46924434	GGCCCCCCA	-	COL18A1	exonic	frameshift deletion	ENSG00000182871	rs149296338	ENSG00000182871:ENST00000342220:exon15:c.865_873del:p.289_291del,ENSG00000182871:ENST00000355480:exon33:c.3364_3372del:p.1122_1124del,ENSG00000182871:ENST00000359759:exon33:c.4069_4077del:p.1357_1359del,ENSG00000182871:ENST00000400337:exon34:c.2824_2832del:p.942_944del	COL18A1:NM_030582:exon33:c.3364delG:p.G1122fs,COL18A1:NM_130444:exon33:c.4069delG:p.G1357fs,COL18A1:NM_130445:exon34:c.2824delG:p.G942fs	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9693	0.8055	.	0.9637	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon33:c.3364_3372del:p.1122_1124del,COL18A1:uc002zhg.3:exon34:c.2824_2832del:p.942_944del	.	AFR:0.9550,AMR:0.9737,EAS:0.9994,FIN:0.9728,NFE:0.9608,OTH:0.9762,ASJ:0.9868	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	MU56575	hom
21	46929467	46929467	G	A	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs1050351	ENSG00000182871:ENST00000342220:exon20:c.G1491A:p.A497A,ENSG00000182871:ENST00000355480:exon38:c.G3987A:p.A1329A,ENSG00000182871:ENST00000359759:exon38:c.G4692A:p.A1564A,ENSG00000182871:ENST00000400337:exon39:c.G3447A:p.A1149A	COL18A1:NM_030582:exon39:c.G3978A:p.A1326A,COL18A1:NM_130444:exon39:c.G4683A:p.A1561A,COL18A1:NM_130445:exon40:c.G3438A:p.A1146A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5110	0.3778	0.503594	MU77662	.	.	.	.	.	.	.	.	COL18A1:uc002zhj.3:exon6:c.G381A:p.A127A,COL18A1:uc002zhi.3:exon38:c.G3987A:p.A1329A,COL18A1:uc002zhg.3:exon39:c.G3447A:p.A1149A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841,AMR:0.4346,EAS:0.5613,FIN:0.3675,NFE:0.5509,OTH:0.4365,ASJ:0.4536	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(thyroid)	0.4068
21	46929523	46929523	C	-	COL18A1	intronic	.	ENSG00000173638;ENSG00000182871	rs3835286	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4859	0.4999	0.554912	0.4949	.	.	.	.	.	.	.	.	.	.	AFR:0.6141,AMR:0.4606,EAS:0.5893,FIN:0.4610,NFE:0.4306,OTH:0.4486,ASJ:0.3841	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	MU117081558	het
21	46932328	46932328	G	A	COL18A1	UTR3	.	ENSG00000182871	rs7499	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4461	0.4030	0.467252	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841	.	.	.	.	.	.	.	.	.	.	AFR:0.4212,AMR:0.4371,EAS:0.3576,FIN:0.5584,NFE:0.4191,OTH:0.4000,ASJ:0.4330	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(biliary_tract)	0.3959
22	18900669	18900669	A	G	LOC102724788;PRODH	UTR3	.	ENSG00000100033;ENSG00000183628	rs383964	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9212	0.9154	0.907548	0.9076	.	.	.	.	.	.	.	.	.	.	AFR:0.8428,AMR:0.9582,EAS:0.9540,FIN:0.9162,NFE:0.9332,OTH:0.9284,ASJ:0.9470	.	.	.	.	.	.	.	.	.	.	.	.	22	MU82047850	hom
22	18900750	18900750	G	A	LOC102724788;PRODH	exonic	synonymous SNV	ENSG00000100033	rs372055	ENSG00000100033:ENST00000334029:exon14:c.C1417T:p.L473L,ENSG00000100033:ENST00000357068:exon14:c.C1741T:p.L581L,ENSG00000100033:ENST00000420436:exon14:c.C1417T:p.L473L	PRODH:NM_001195226:exon14:c.C1417T:p.L473L,LOC102724788:NM_001368250:exon14:c.C1417T:p.L473L,LOC102724788:NM_001368249:exon15:c.C1741T:p.L581L,PRODH:NM_016335:exon15:c.C1741T:p.L581L	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7890	0.7588	0.763379	0.7524	.	.	.	.	.	.	.	.	PRODH:uc002zoj.5:exon14:c.C1417T:p.L473L,PRODH:uc002zol.4:exon14:c.C1417T:p.L473L,PRODH:uc002zok.4:exon15:c.C1741T:p.L581L	.	AFR:0.6254,AMR:0.7757,EAS:0.8455,FIN:0.7544,NFE:0.8110,OTH:0.7900,ASJ:0.7914	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	MU4559149	hom
22	18901004	18901004	C	T	LOC102724788;PRODH	exonic	nonsynonymous SNV	ENSG00000100033	rs450046	ENSG00000100033:ENST00000334029:exon13:c.G1238A:p.R413Q,ENSG00000100033:ENST00000357068:exon13:c.G1562A:p.R521Q,ENSG00000100033:ENST00000420436:exon13:c.G1238A:p.R413Q	PRODH:NM_001195226:exon13:c.G1238A:p.R413Q,LOC102724788:NM_001368250:exon13:c.G1238A:p.R413Q,LOC102724788:NM_001368249:exon14:c.G1562A:p.R521Q,PRODH:NM_016335:exon14:c.G1562A:p.R521Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9171	0.9042	0.905551	0.9057	3.411	23.0	0.455	4.67	0.202	.	.	FAD-linked oxidoreductase-like|Proline dehydrogenase domain	PRODH:uc002zoj.5:exon13:c.G1238A:p.R413Q,PRODH:uc002zol.4:exon13:c.G1238A:p.R413Q,PRODH:uc002zok.4:exon14:c.G1562A:p.R521Q	-0.985	AFR:0.8372,AMR:0.9570,EAS:0.9530,FIN:0.9155,NFE:0.9328,OTH:0.9283,ASJ:0.9470	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	0.0	1.63	0.000	.	22	MU4615939	hom
22	18904414	18904414	A	G	LOC102724788;PRODH	exonic	synonymous SNV	ENSG00000100033	rs455072	ENSG00000100033:ENST00000334029:exon12:c.T1191C:p.F397F,ENSG00000100033:ENST00000357068:exon12:c.T1515C:p.F505F,ENSG00000100033:ENST00000420436:exon12:c.T1191C:p.F397F	PRODH:NM_001195226:exon12:c.T1191C:p.F397F,LOC102724788:NM_001368250:exon12:c.T1191C:p.F397F,LOC102724788:NM_001368249:exon13:c.T1515C:p.F505F,PRODH:NM_016335:exon13:c.T1515C:p.F505F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9034	.	0.83746	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PRODH:uc002zoj.5:exon12:c.T1191C:p.F397F,PRODH:uc002zol.4:exon12:c.T1191C:p.F397F,PRODH:uc002zok.4:exon13:c.T1515C:p.F505F	.	AFR:0.8495,AMR:0.6583,EAS:0.9404,FIN:0.9016,NFE:0.9156,OTH:0.9287,ASJ:0.9474	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	1(thyroid)	0.9084
22	18907124	18907124	G	A	LOC102724788;PRODH	intronic	.	ENSG00000100033	rs1076466	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4689	0.4110	0.525958	0.4203	.	.	.	.	.	.	.	.	.	.	AFR:0.4126,AMR:0.4053,EAS:0.7574,FIN:0.3869,NFE:0.3974,OTH:0.4018,ASJ:0.4533	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	MU26626450	hom
22	18908875	18908875	A	G	LOC102724788;PRODH	exonic	synonymous SNV	ENSG00000100033	rs1808320	ENSG00000100033:ENST00000334029:exon8:c.T667C:p.L223L,ENSG00000100033:ENST00000357068:exon8:c.T991C:p.L331L,ENSG00000100033:ENST00000420436:exon8:c.T667C:p.L223L	PRODH:NM_001195226:exon8:c.T667C:p.L223L,LOC102724788:NM_001368250:exon8:c.T667C:p.L223L,LOC102724788:NM_001368249:exon9:c.T991C:p.L331L,PRODH:NM_016335:exon9:c.T991C:p.L331L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6781	0.6645	0.73143	0.6492	.	.	.	.	.	.	.	.	PRODH:uc002zoj.5:exon8:c.T667C:p.L223L,PRODH:uc002zol.4:exon8:c.T667C:p.L223L,PRODH:uc002zok.4:exon9:c.T991C:p.L331L	.	AFR:0.8364,AMR:0.5692,EAS:0.8062,FIN:0.5492,NFE:0.5560,OTH:0.5749,ASJ:0.6424	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	MU82163080	hom
22	18910355	18910355	G	T	LOC102724788;PRODH	exonic	nonsynonymous SNV	ENSG00000100033	rs5747933	ENSG00000100033:ENST00000334029:exon6:c.C500A:p.T167N,ENSG00000100033:ENST00000357068:exon6:c.C824A:p.T275N,ENSG00000100033:ENST00000420436:exon6:c.C500A:p.T167N,ENSG00000100033:ENST00000450579:exon6:c.C347A:p.T116N	PRODH:NM_001195226:exon6:c.C500A:p.T167N,LOC102724788:NM_001368250:exon6:c.C500A:p.T167N,LOC102724788:NM_001368249:exon7:c.C824A:p.T275N,PRODH:NM_016335:exon7:c.C824A:p.T275N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0579	0.0333	0.0720847	MU750197	0.353	6.194	0.604	0.756	0.085	.	.	FAD-linked oxidoreductase-like|Proline dehydrogenase domain;Proline dehydrogenase domain	PRODH:uc002zoj.5:exon6:c.C500A:p.T167N,PRODH:uc002zol.4:exon6:c.C500A:p.T167N,PRODH:uc002zok.4:exon7:c.C824A:p.T275N	-1.014	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.0376,EAS:0.1468,FIN:0.0894,NFE:0.1807,OTH:0.0077,ASJ:0.0126	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	0.355	1.43	0.000	1.67	22	1(lung)	0.0362
22	18910451	18910451	A	-	LOC102724788;PRODH	intronic	.	ENSG00000100033	rs3216765	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2381	0.3126	0.28734	0.2780	.	.	.	.	.	.	.	.	.	.	AFR:0.4684,AMR:0.3089,EAS:0.2092,FIN:0.1748,NFE:0.2007,OTH:0.2209,ASJ:0.3046	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	MU114637233	het
22	18912678	18912678	A	G	LOC102724788;PRODH	exonic	nonsynonymous SNV	ENSG00000100033	rs386819653	ENSG00000100033:ENST00000334029:exon4:c.T229C:p.W77R,ENSG00000100033:ENST00000357068:exon4:c.T553C:p.W185R,ENSG00000100033:ENST00000420436:exon4:c.T229C:p.W77R,ENSG00000100033:ENST00000450579:exon4:c.T76C:p.W26R	PRODH:NM_001195226:exon4:c.T229C:p.W77R,LOC102724788:NM_001368250:exon4:c.T229C:p.W77R,LOC102724788:NM_001368249:exon5:c.T553C:p.W185R,PRODH:NM_016335:exon5:c.T553C:p.W185R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6417	0.6739	0.78095	0.6509	-0.442	0.306	0.503	2.88	0.105	.	.	FAD-linked oxidoreductase-like	PRODH:uc002zoj.5:exon4:c.T229C:p.W77R,PRODH:uc002zol.4:exon4:c.T229C:p.W77R,PRODH:uc002zok.4:exon5:c.T553C:p.W185R	-0.991	AFR:0.8626,AMR:0.6583,EAS:0.9617,FIN:0.4811,NFE:0.5384,OTH:0.5685,ASJ:0.6424	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	0.0	-0.92	0.000	.	22	MU82047927	hom
22	18923745	18923745	G	T	LOC102724788;PRODH	exonic	nonsynonymous SNV	ENSG00000100033	rs2008720	ENSG00000100033:ENST00000357068:exon1:c.C56A:p.P19Q	LOC102724788:NM_001368249:exon2:c.C56A:p.P19Q,PRODH:NM_016335:exon2:c.C56A:p.P19Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6653	.	0.553315	0.4404	0.360	6.258	0.369	-0.024	0.000	.	.	.	PRODH:uc002zok.4:exon2:c.C56A:p.P19Q	-1.088	AFR:0.3919,AMR:0.5025,EAS:0.8088,FIN:0.3811,NFE:0.4376,OTH:0.4397,ASJ:0.4767	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	2.31	0.000	.	22	MU4585894	hom
22	19789541	19789541	A	C	GNB1L	exonic	nonsynonymous SNV	ENSG00000185838	rs2073770	ENSG00000185838:ENST00000403325:exon6:c.T715G:p.W239G,ENSG00000185838:ENST00000329517:exon7:c.T715G:p.W239G	GNB1L:NM_053004:exon7:c.T715G:p.W239G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2697	0.0877	0.20607	0.1128	1.065	11.03	0.544	4.78	0.598	.	.	WD40-repeat-containing domain	GNB1L:uc002zqf.1:exon7:c.T715G:p.W239G	-0.944	AFR:0.0381,AMR:0.2990,EAS:0.4759,FIN:0.0647,NFE:0.1176,OTH:0.0980,ASJ:0.1788	610778	.	.	.	.	.	.	.	0.0	2.33	0.000	-1.36	22	MU131611	het
22	21337325	21337325	G	A	LZTR1	exonic	synonymous SNV	ENSG00000099949	rs13054014	ENSG00000099949:ENST00000443265:exon2:c.G215A:p.S72N	LZTR1:NM_006767:exon2:c.G210A:p.K70K	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2850	0.2623	0.285144	MU116325	.	.	.	.	.	.	.	.	LZTR1:uc002zto.3:exon2:c.G210A:p.K70K,LZTR1:uc011ahy.2:exon2:c.G210A:p.K70K,LZTR1:uc002ztn.3:exon3:c.G87A:p.K29K	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.2716,EAS:0.4153,FIN:0.2219,NFE:0.2177,OTH:0.2582,ASJ:0.2520	600574	615670;616564;	648;93921;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~93921|NF3<br>Neurilemmomatosis<br>Schwannomatosis|Unknown|Autosomal dominant|Adult<br>Elderly|162091 162260 615670 ~	.	.	.	.	.	.	.	.	22	37(meninges)	0.2845
22	21343983	21344019	GGGGAGCCAGGGCGCAGGTAGAGGAGGTGAGGGGCAC	-	LZTR1	intronic	.	ENSG00000099949	rs138025454	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5810	0.8134	.	0.6272	.	.	.	.	.	.	.	.	.	.	AFR:0.6289,AMR:0.5974,EAS:0.7554,FIN:0.6237,NFE:0.6136,OTH:0.6087,ASJ:0.5329	600574	615670;616564;	648;93921;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~93921|NF3<br>Neurilemmomatosis<br>Schwannomatosis|Unknown|Autosomal dominant|Adult<br>Elderly|162091 162260 615670 ~	.	.	.	.	.	.	.	.	22	.	hom
22	23627369	23627369	A	G	BCR	exonic	nonsynonymous SNV	ENSG00000186716	rs140504	ENSG00000186716:ENST00000305877:exon10:c.A2387G:p.N796S,ENSG00000186716:ENST00000359540:exon10:c.A2387G:p.N796S	BCR:NM_004327:exon10:c.A2387G:p.N796S,BCR:NM_021574:exon10:c.A2387G:p.N796S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8186	0.8774	0.79373	1(large_intestine)	0.337	6.042	1.0	1.63	0.908	.	.	PH domain-like|Pleckstrin homology domain	BCR:uc002zwy.2:exon2:c.A245G:p.N82S,BCR:uc010gtx.1:exon8:c.A788G:p.N263S,BCR:uc002zww.3:exon10:c.A2387G:p.N796S,BCR:uc002zwx.3:exon10:c.A2387G:p.N796S,BCR:uc011aiy.2:exon10:c.A1154G:p.N385S	-0.964	AFR:MU152970,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,THCA-CN|1|50|0.02,EAS:0.9315,FIN:0.8496,NFE:0.8974,OTH:0.5118,ASJ:0.8471	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	0.002	1.85	0.000	-0.975	22	1(lung)	0.8400
22	23631801	23631801	T	C	BCR	exonic	synonymous SNV	ENSG00000186716	rs2227939	ENSG00000186716:ENST00000305877:exon13:c.T2700C:p.N900N,ENSG00000186716:ENST00000359540:exon13:c.T2700C:p.N900N	BCR:NM_004327:exon13:c.T2700C:p.N900N,BCR:NM_021574:exon13:c.T2700C:p.N900N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2964	0.3688	0.322684	MU152980	-0.021	2.391	.	2.7	0.992	.	.	.	BCR:uc002zwy.2:exon5:c.T558C:p.N186N,BCR:uc002zww.3:exon13:c.T2700C:p.N900N,BCR:uc002zwx.3:exon13:c.T2700C:p.N900N,BCR:uc011aiy.2:exon13:c.T1467C:p.N489N	.	AFR:LUSC-KR|1|170|0.00588235,AMR:0.3254,EAS:0.2990,FIN:0.3642,NFE:0.0580,OTH:0.1924,ASJ:0.5199	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	1(large_intestine)	0.2766
22	23631813	23631813	-	C	BCR	intronic	.	ENSG00000186716	rs113087899	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2965	0.3638	0.31849	0.3199	.	.	.	.	.	.	.	.	BCR:uc002zwy.2:exon5:c.571dupC:p.G190fs	.	AFR:0.5050,AMR:0.2990,EAS:0.0580,FIN:0.1924,NFE:0.2745,OTH:0.2684,ASJ:0.3609	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	.	unknown
22	23631823	23631823	T	C	BCR	intronic	.	ENSG00000186716	rs62219796	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3055	0.3661	0.322684	MU9796380	.	.	.	.	.	.	.	.	BCR:uc002zwy.2:exon5:c.T580C:p.F194L	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.3231,EAS:0.2990,FIN:0.3609,NFE:0.0580,OTH:0.1923,ASJ:0.5165	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	4(large_intestine)	0.2745
22	23632513	23632513	A	G	BCR	intronic	.	ENSG00000186716	rs16802	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2901	0.3696	0.311302	MU11366556	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,AMR:0.3275,EAS:0.3031,FIN:0.3642,NFE:0.0575,OTH:0.1949,ASJ:0.5207	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	1(lung)	0.2798
22	23637200	23637200	T	C	BCR	intronic	.	ENSG00000186716	rs2239666	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3210	0.3528	0.341454	0.3275	.	.	.	.	.	0	0.018	.	.	.	AFR:0.4510,AMR:0.3473,EAS:0.1829,FIN:0.2331,NFE:0.2946,OTH:0.2929,ASJ:0.3146	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	MU718621	het
22	23653975	23653975	-	CCGG	BCR	exonic	frameshift insertion	ENSG00000186716	rs372013175	ENSG00000186716:ENST00000359540:exon18:c.3142_3143insCCGG:p.S1048fs,ENSG00000186716:ENST00000305877:exon19:c.3274_3275insCCGG:p.S1092fs	BCR:NM_021574:exon18:c.3142_3143insCCGG:p.S1048fs,BCR:NM_004327:exon19:c.3274_3275insCCGG:p.S1092fs	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	.	0.0311	.	.	.	.	.	.	.	.	BCR:uc002zwx.3:exon18:c.3142_3143insCCGG:p.S1048fs,BCR:uc002zww.3:exon19:c.3274_3275insCCGG:p.S1092fs,BCR:uc011aiy.2:exon19:c.2041_2042insCCGG:p.S681fs	.	AFR:0.0219,AMR:0.0222,EAS:0.0894,FIN:0.0211,NFE:0.0353,OTH:0.0176,ASJ:0.0474	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	MU112765516	het
22	24175846	24175846	C	T	SMARCB1	exonic	synonymous SNV	ENSG00000099956	.	ENSG00000099956:ENST00000407082:exon7:c.C936T:p.D312D,ENSG00000099956:ENST00000263121:exon8:c.C1074T:p.D358D,ENSG00000099956:ENST00000344921:exon8:c.C1101T:p.D367D,ENSG00000099956:ENST00000407422:exon8:c.C1047T:p.D349D	SMARCB1:NM_001007468:exon8:c.C1047T:p.D349D,SMARCB1:NM_001317946:exon8:c.C1101T:p.D367D,SMARCB1:NM_001362877:exon8:c.C1128T:p.D376D,SMARCB1:NM_003073:exon8:c.C1074T:p.D358D	clinvar: Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 1, -1, 1, 0, 1, 1] 	.	.	.	.	.	.	.	.	.	.	.	.	SMARCB1:uc002zyb.3:exon8:c.C1074T:p.D358D,SMARCB1:uc002zyc.3:exon8:c.C1047T:p.D349D,SMARCB1:uc002zyd.3:exon8:c.C1101T:p.D367D	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601607	162091;609322;614608;	1465;231108;69077;99966;93921;	1465|CSS|<1 / 1 000 000|Autosomal dominant|Neonatal|135900 614607 614608 614609 615866 616938 ~231108|RTPS<br>Rhabdoid tumor predisposition syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|609322 613325 ~69077|Malignant rhabdoid tumor|Unknown|-|Antenatal<br>Neonatal<br>Infancy<br>Childhood|609322 613325 ~99966|ATRT|Unknown|-|Antenatal<br>Neonatal<br>Infancy<br>Childhood|609322 ~93921|NF3<br>Neurilemmomatosis<br>Schwannomatosis|Unknown|Autosomal dominant|Adult<br>Elderly|162091 162260 615670 ~	.	,9737,9739,9738	.	.	.	.	.	.	22	.	het
22	26159289	26159289	G	A	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs133885	ENSG00000133454:ENST00000539302:exon2:c.G131A:p.G44E,ENSG00000133454:ENST00000335473:exon3:c.G131A:p.G44E,ENSG00000133454:ENST00000407587:exon3:c.G131A:p.G44E,ENSG00000133454:ENST00000536101:exon3:c.G131A:p.G44E	MYO18B:NM_001318245:exon3:c.G131A:p.G44E,MYO18B:NM_032608:exon3:c.G131A:p.G44E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5433	0.5709	0.701677	COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	1.100	11.22	1.0	5.09	0.991	.	.	.	MYO18B:uc003abz.1:exon3:c.G131A:p.G44E	-0.942	AFR:0.5802,AMR:0.8419,EAS:0.5367,FIN:0.8333,NFE:0.4200,OTH:0.4408,ASJ:0.6623	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-1.38	0.000	-2.125	22	1(breast)	0.4744
22	26164079	26164079	C	T	MYO18B	intronic	.	ENSG00000133454	rs133902	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5407	0.5710	0.697883	0.5739	.	.	.	.	.	0.0002	0.002	.	.	.	AFR:0.84,AMR:0.6567,EAS:0.8377,FIN:0.4192,NFE:0.4300,OTH:0.4694,ASJ:0.5232	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	MU27577034	hom
22	26164413	26164413	C	T	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs13058434	ENSG00000133454:ENST00000539302:exon3:c.C530T:p.P177L,ENSG00000133454:ENST00000335473:exon4:c.C530T:p.P177L,ENSG00000133454:ENST00000407587:exon4:c.C530T:p.P177L,ENSG00000133454:ENST00000536101:exon4:c.C530T:p.P177L	MYO18B:NM_001318245:exon4:c.C530T:p.P177L,MYO18B:NM_032608:exon4:c.C530T:p.P177L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1405	0.0610	0.170927	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	0.670	8.631	0.144	3.08	0.000	.	.	.	MYO18B:uc003aca.1:exon2:c.C173T:p.P58L,MYO18B:uc010guy.1:exon2:c.C173T:p.P58L,MYO18B:uc010guz.1:exon2:c.C173T:p.P58L,MYO18B:uc003abz.1:exon4:c.C530T:p.P177L	-1.099	AFR:0.0902,AMR:0.0327,EAS:0.0567,FIN:0.3187,NFE:0.1262,OTH:0.0864,ASJ:0.1595	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.005	-2.04	0.000	0.55	22	1(haematopoietic_and_lymphoid_tissue)	0.1137
22	26166900	26166900	G	C	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs3859866	ENSG00000133454:ENST00000539302:exon5:c.G1641C:p.W547C,ENSG00000133454:ENST00000335473:exon6:c.G1641C:p.W547C,ENSG00000133454:ENST00000407587:exon6:c.G1641C:p.W547C,ENSG00000133454:ENST00000536101:exon6:c.G1641C:p.W547C	MYO18B:NM_001318245:exon6:c.G1641C:p.W547C,MYO18B:NM_032608:exon6:c.G1641C:p.W547C	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9579	0.9776	0.938498	0.9730	1.276	12.14	0.049	3.72	0.972	.	.	P-loop containing nucleoside triphosphate hydrolase	MYO18B:uc011akb.1:exon2:c.G180C:p.W60C,MYO18B:uc003aca.1:exon4:c.G1284C:p.W428C,MYO18B:uc010guy.1:exon4:c.G1284C:p.W428C,MYO18B:uc010guz.1:exon4:c.G1284C:p.W428C,MYO18B:uc003abz.1:exon6:c.G1641C:p.W547C	-0.952	AFR:0.9534,AMR:0.9857,EAS:0.8844,FIN:0.9914,NFE:0.9891,OTH:0.9715,ASJ:0.9768	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-0.56	0.000	-1.245	22	MU28574395	het
22	26173661	26173661	T	C	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs5761170	ENSG00000133454:ENST00000539302:exon7:c.T1981C:p.W661R,ENSG00000133454:ENST00000335473:exon8:c.T1981C:p.W661R,ENSG00000133454:ENST00000407587:exon8:c.T1981C:p.W661R,ENSG00000133454:ENST00000536101:exon8:c.T1981C:p.W661R	MYO18B:NM_001318245:exon8:c.T1981C:p.W661R,MYO18B:NM_032608:exon8:c.T1981C:p.W661R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9647	0.9714	0.932508	0.9680	-1.452	0.003	1.0	-0.033	0.975	.	.	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	MYO18B:uc011akb.1:exon4:c.T520C:p.W174R,MYO18B:uc003aca.1:exon6:c.T1624C:p.W542R,MYO18B:uc010guy.1:exon6:c.T1624C:p.W542R,MYO18B:uc010guz.1:exon6:c.T1624C:p.W542R,MYO18B:uc003abz.1:exon8:c.T1981C:p.W661R	-0.944	AFR:0.9366,AMR:0.9857,EAS:0.8820,FIN:0.9914,NFE:0.9888,OTH:0.9684,ASJ:0.9768	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-2.18	0.000	.	22	MU635506	het
22	26176063	26176063	C	T	MYO18B	exonic	synonymous SNV	ENSG00000133454	rs370428853	ENSG00000133454:ENST00000539302:exon8:c.C2109T:p.F703F,ENSG00000133454:ENST00000335473:exon9:c.C2109T:p.F703F,ENSG00000133454:ENST00000407587:exon9:c.C2109T:p.F703F,ENSG00000133454:ENST00000536101:exon9:c.C2109T:p.F703F	MYO18B:NM_001318245:exon9:c.C2109T:p.F703F,MYO18B:NM_032608:exon9:c.C2109T:p.F703F	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0101	8e-05	0.00838658	0.0002	.	.	.	.	.	.	.	.	MYO18B:uc011akb.1:exon5:c.C648T:p.F216F,MYO18B:uc003aca.1:exon7:c.C1752T:p.F584F,MYO18B:uc010guy.1:exon7:c.C1752T:p.F584F,MYO18B:uc010guz.1:exon7:c.C1752T:p.F584F,MYO18B:uc003abz.1:exon9:c.C2109T:p.F703F	.	AFR:0.0003,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0020,ASJ:0	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	.	het
22	26193982	26193982	C	G	MYO18B	exonic	synonymous SNV	ENSG00000133454	rs738642	ENSG00000133454:ENST00000335473:exon12:c.C2439G:p.L813L,ENSG00000133454:ENST00000407587:exon12:c.C2439G:p.L813L,ENSG00000133454:ENST00000536101:exon12:c.C2439G:p.L813L	MYO18B:NM_001318245:exon12:c.C2439G:p.L813L,MYO18B:NM_032608:exon12:c.C2439G:p.L813L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7296	0.6482	0.684305	0.6554	.	.	.	.	.	.	.	.	MYO18B:uc011akb.1:exon8:c.C978G:p.L326L,MYO18B:uc003aca.1:exon10:c.C2082G:p.L694L,MYO18B:uc010guy.1:exon10:c.C2082G:p.L694L,MYO18B:uc010guz.1:exon10:c.C2082G:p.L694L,MYO18B:uc003abz.1:exon12:c.C2439G:p.L813L	.	AFR:0.4509,AMR:0.7931,EAS:0.8969,FIN:0.6795,NFE:0.7307,OTH:0.7383,ASJ:0.5833	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	MU20292388	hom
22	26194045	26194045	T	C	MYO18B	exonic	synonymous SNV	ENSG00000133454	rs738643	ENSG00000133454:ENST00000335473:exon12:c.T2502C:p.G834G,ENSG00000133454:ENST00000407587:exon12:c.T2502C:p.G834G,ENSG00000133454:ENST00000536101:exon12:c.T2502C:p.G834G	MYO18B:NM_001318245:exon12:c.T2502C:p.G834G,MYO18B:NM_032608:exon12:c.T2502C:p.G834G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6636	0.5936	0.56889	0.5952	.	.	.	.	.	.	.	.	MYO18B:uc011akb.1:exon8:c.T1041C:p.G347G,MYO18B:uc003aca.1:exon10:c.T2145C:p.G715G,MYO18B:uc010guy.1:exon10:c.T2145C:p.G715G,MYO18B:uc010guz.1:exon10:c.T2145C:p.G715G,MYO18B:uc003abz.1:exon12:c.T2502C:p.G834G	.	AFR:0.3391,AMR:0.6806,EAS:0.6966,FIN:0.6597,NFE:0.7093,OTH:0.6834,ASJ:0.5232	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	MU13839222	hom
22	26239850	26239850	C	A	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs5761268	ENSG00000133454:ENST00000335473:exon18:c.C3357A:p.H1119Q,ENSG00000133454:ENST00000407587:exon18:c.C3360A:p.H1120Q,ENSG00000133454:ENST00000536101:exon18:c.C3357A:p.H1119Q	MYO18B:NM_001318245:exon18:c.C3360A:p.H1120Q,MYO18B:NM_032608:exon18:c.C3357A:p.H1119Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7340	0.6421	0.723442	0.6653	-0.536	0.179	1.0	-3.23	0.984	.	.	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	MYO18B:uc011akb.1:exon14:c.C1896A:p.H632Q,MYO18B:uc011aka.1:exon15:c.C819A:p.H273Q,MYO18B:uc003aca.1:exon16:c.C3000A:p.H1000Q,MYO18B:uc010guy.1:exon16:c.C3003A:p.H1001Q,MYO18B:uc010guz.1:exon16:c.C3000A:p.H1000Q,MYO18B:uc003abz.1:exon18:c.C3357A:p.H1119Q	-0.932	AFR:0.4657,AMR:0.7721,EAS:0.9975,FIN:0.7676,NFE:0.7124,OTH:0.7352,ASJ:0.5927	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-2.06	0.000	-2.535	22	MU4555172	hom
22	26343805	26343805	A	G	MYO18B	intronic	.	ENSG00000133454	rs2072007	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8055	0.8749	0.711861	MU585744	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|3|205|0.0146341,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.8292,EAS:0.6124,FIN:0.9603,NFE:0.4714,OTH:0.7786,ASJ:0.8210	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	3(haematopoietic_and_lymphoid_tissue)	0.8942
22	29108229	29108229	A	G	CHEK2	intronic	.	ENSG00000183765	rs5752776	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.682308	0.6598	.	.	.	.	.	.	.	.	.	.	AFR:0.4911,AMR:0.6575,EAS:0.8455,FIN:0.7517,NFE:0.7095,OTH:0.7255,ASJ:0.8013	604373	114480;176807;259500;609265;	524;668;1331;227535;	524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	22	MU117008065	hom
22	33253280	33253280	T	C	TIMP3	exonic	synonymous SNV	ENSG00000100234	rs9862	ENSG00000100234:ENST00000266085:exon3:c.T249C:p.H83H	TIMP3:NM_000362:exon3:c.T249C:p.H83H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5518	0.6127	0.650958	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	TIMP3:uc003anb.3:exon3:c.T249C:p.H83H	.	AFR:0.5980,AMR:0.8374,EAS:0.5629,FIN:0.5945,NFE:0.4422,OTH:0.4965,ASJ:0.6993	188826	136900;	59181;	59181|-|Unknown|Autosomal dominant|Adult|136900 264420 ~	~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	22	1(haematopoietic_and_lymphoid_tissue)	0.5051
22	36684354	36684354	T	C	MYH9	exonic	nonsynonymous SNV	ENSG00000100345	rs2269529	ENSG00000100345:ENST00000216181:exon34:c.A4876G:p.I1626V	MYH9:NM_002473:exon34:c.A4876G:p.I1626V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2584	0.1555	0.294129	0.1759	0.134	3.970	0.332	4.47	0.359	.	.	Myosin tail	MYH9:uc003apg.3:exon34:c.A4876G:p.I1626V	-0.911	AFR:0.0724,AMR:0.2440,EAS:0.6067,FIN:0.1758,NFE:0.1814,OTH:0.2137,ASJ:0.3179	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	0.042	-1.05	0.000	0.805	22	MU14584538	unknown
22	36684358	36684358	C	A	MYH9	exonic	synonymous SNV	ENSG00000100345	rs2269530	ENSG00000100345:ENST00000216181:exon34:c.G4872T:p.A1624A	MYH9:NM_002473:exon34:c.G4872T:p.A1624A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2582	0.1552	0.29373	0.1754	.	.	.	.	.	.	.	.	MYH9:uc003apg.3:exon34:c.G4872T:p.A1624A	.	AFR:0.0712,AMR:0.2440,EAS:0.6068,FIN:0.1755,NFE:0.1813,OTH:0.2137,ASJ:0.3179	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU14584585	unknown
22	36691607	36691607	A	C	MYH9	exonic	synonymous SNV	ENSG00000100345	rs710181	ENSG00000100345:ENST00000216181:exon26:c.T3429G:p.A1143A	MYH9:NM_002473:exon26:c.T3429G:p.A1143A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9766	0.9712	0.982628	0.9725	.	.	.	.	.	.	.	.	MYH9:uc003apg.3:exon26:c.T3429G:p.A1143A	.	AFR:0.9718,AMR:0.9773,EAS:0.9994,FIN:0.9673,NFE:0.9719,OTH:0.9693,ASJ:0.9404	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU82051855	hom
22	36708084	36708084	C	T	MYH9	intronic	.	ENSG00000100345	rs2413396	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8714	0.7555	0.760783	0.7779	.	.	.	.	.	.	.	.	.	.	AFR:0.4512,AMR:0.9021,EAS:0.9030,FIN:0.8967,NFE:0.9108,OTH:0.8755,ASJ:0.8874	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU14584855	hom
22	36710183	36710183	T	C	MYH9	intronic	.	ENSG00000100345	rs3752462	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5614	0.5347	0.39357	0.5361	.	.	.	.	.	0	0	.	.	.	AFR:0.2688,AMR:0.6367,EAS:0.2249,FIN:0.6641,NFE:0.6840,OTH:0.6176,ASJ:0.5533	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU82240671	het
22	38905446	38905446	G	A	DDX17;DMC1	intergenic	.	ENSG00000100201;ENSG00000100206	rs138462	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.934904	0.9569	.	.	.	.	.	.	.	.	.	.	AFR:0.9021,AMR:0.9821,EAS:0.8983,FIN:0.9954,NFE:0.9827,OTH:0.9806,ASJ:0.9801	.	.	.	.	.	.	.	.	.	.	.	.	22	.	hom
22	39357581	39357581	C	T	APOBEC3A;APOBEC3A_B	exonic	synonymous SNV	ENSG00000128383	rs35994173	ENSG00000128383:ENST00000249116:exon3:c.C364T:p.L122L,ENSG00000128383:ENST00000402255:exon4:c.C364T:p.L122L	APOBEC3A_B:NM_001193289:exon3:c.C364T:p.L122L,APOBEC3A:NM_001270406:exon3:c.C310T:p.L104L,APOBEC3A:NM_145699:exon3:c.C364T:p.L122L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2039	0.2064	0.245807	0.1331	.	.	.	.	.	.	.	.	APOBEC3A:uc003awn.2:exon3:c.C364T:p.L122L,APOBEC3A:uc011aob.1:exon3:c.C310T:p.L104L,APOBEC3A_B:uc011aoc.2:exon3:c.C364T:p.L122L	.	AFR:0.1947,AMR:0.0863,EAS:0.1918,FIN:0.0887,NFE:0.1086,OTH:0.1307,ASJ:0.1131	607109	.	.	.	.	.	.	.	.	.	.	.	22	.	hom
22	39357634	39357634	A	G	APOBEC3A;APOBEC3A_B	exonic	synonymous SNV	ENSG00000128383	rs2294363	ENSG00000128383:ENST00000249116:exon3:c.A417G:p.A139A,ENSG00000128383:ENST00000402255:exon4:c.A417G:p.A139A	APOBEC3A_B:NM_001193289:exon3:c.A417G:p.A139A,APOBEC3A:NM_001270406:exon3:c.A363G:p.A121A,APOBEC3A:NM_145699:exon3:c.A417G:p.A139A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0070	.	.	SKCA-BR|1|100|0.01,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	APOBEC3A:uc003awn.2:exon3:c.A417G:p.A139A,APOBEC3A:uc011aob.1:exon3:c.A363G:p.A121A,APOBEC3A_B:uc011aoc.2:exon3:c.A417G:p.A139A	.	AFR:0.4060,AMR:0.6103,EAS:0.3346,FIN:0.4211,NFE:0.2963,OTH:0.3346,ASJ:0.2877	607109	.	.	.	.	.	.	.	.	.	.	.	22	1(skin)	0.3591
22	39381826	39381826	A	G	APOBEC3B	exonic	nonsynonymous SNV	ENSG00000179750	rs2076109	ENSG00000179750:ENST00000333467:exon3:c.A184G:p.K62E,ENSG00000179750:ENST00000335760:exon3:c.A184G:p.K62E,ENSG00000179750:ENST00000402182:exon3:c.A184G:p.K62E,ENSG00000179750:ENST00000407298:exon3:c.A184G:p.K62E	APOBEC3B:NM_001270411:exon3:c.A184G:p.K62E,APOBEC3B:NM_004900:exon3:c.A184G:p.K62E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6016	0.6057	0.641174	0.6012	-1.879	0.002	0.72	-1.15	0.000	.	.	APOBEC-like, N-terminal|Cytidine and deoxycytidylate deaminase domain|Cytidine deaminase-like	APOBEC3B:uc003awo.2:exon3:c.A184G:p.K62E,APOBEC3B:uc003awp.2:exon3:c.A184G:p.K62E	-0.903	AFR:0.6745,AMR:0.5195,EAS:0.6416,FIN:0.6176,NFE:0.5592,OTH:0.5826,ASJ:0.4796	607110	.	.	.	.	.	.	.	0.032	-0.14	0.000	0.185	22	MU151842	het
22	39381999	39381999	T	C	APOBEC3B	exonic	synonymous SNV	ENSG00000179750	rs2076111	ENSG00000179750:ENST00000333467:exon3:c.T357C:p.S119S,ENSG00000179750:ENST00000335760:exon3:c.T357C:p.S119S,ENSG00000179750:ENST00000402182:exon3:c.T357C:p.S119S,ENSG00000179750:ENST00000407298:exon3:c.T357C:p.S119S	APOBEC3B:NM_001270411:exon3:c.T357C:p.S119S,APOBEC3B:NM_004900:exon3:c.T357C:p.S119S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5857	.	.	0.5927	.	.	.	.	.	.	.	.	APOBEC3B:uc003awo.2:exon3:c.T357C:p.S119S,APOBEC3B:uc003awp.2:exon3:c.T357C:p.S119S	.	AFR:0.6495,AMR:0.5225,EAS:0.6783,FIN:0.6151,NFE:0.5550,OTH:0.5689,ASJ:0.4755	607110	.	.	.	.	.	.	.	.	.	.	.	22	MU4559442	het
22	39382079	39382079	C	A	APOBEC3B	exonic	nonsynonymous SNV	ENSG00000179750	rs5995649	ENSG00000179750:ENST00000333467:exon3:c.C437A:p.T146K,ENSG00000179750:ENST00000335760:exon3:c.C437A:p.T146K,ENSG00000179750:ENST00000402182:exon3:c.C437A:p.T146K,ENSG00000179750:ENST00000407298:exon3:c.C437A:p.T146K	APOBEC3B:NM_001270411:exon3:c.C437A:p.T146K,APOBEC3B:NM_004900:exon3:c.C437A:p.T146K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9492	0.9511	0.949681	0.9538	-0.635	0.103	1.0	-4.25	0.000	.	.	APOBEC-like, N-terminal|Cytidine deaminase-like	APOBEC3B:uc003awo.2:exon3:c.C437A:p.T146K,APOBEC3B:uc003awp.2:exon3:c.C437A:p.T146K	-0.995	AFR:0.9398,AMR:0.9526,EAS:0.9757,FIN:0.9672,NFE:0.9586,OTH:0.9557,ASJ:0.87	607110	.	.	.	.	.	.	.	0.0	-0.02	0.000	-1.695	22	MU82052701	hom
22	39387558	39387558	C	T	APOBEC3B	exonic	synonymous SNV	ENSG00000179750	rs1065184	ENSG00000179750:ENST00000333467:exon6:c.C945T:p.Y315Y,ENSG00000179750:ENST00000402182:exon6:c.C945T:p.Y315Y,ENSG00000179750:ENST00000407298:exon6:c.C870T:p.Y290Y	APOBEC3B:NM_001270411:exon6:c.C870T:p.Y290Y,APOBEC3B:NM_004900:exon6:c.C945T:p.Y315Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4729	0.4836	.	0.4854	.	.	.	.	.	.	.	.	APOBEC3B:uc003awo.2:exon6:c.C945T:p.Y315Y,APOBEC3B:uc003awp.2:exon6:c.C870T:p.Y290Y	.	AFR:0.5375,AMR:0.4413,EAS:0.5290,FIN:0.4868,NFE:0.4591,OTH:0.4378,ASJ:0.4034	607110	.	.	.	.	.	.	.	.	.	.	.	22	MU151851	hom
22	39477123	39477123	T	C	APOBEC3G	exonic	synonymous SNV	ENSG00000239713	rs5757465	ENSG00000239713:ENST00000407997:exon3:c.T357C:p.F119F,ENSG00000239713:ENST00000452957:exon3:c.T357C:p.F119F	APOBEC3G:NM_001349437:exon2:c.T156C:p.F52F,APOBEC3G:NM_001349436:exon3:c.T324C:p.F108F,APOBEC3G:NM_001349438:exon3:c.T357C:p.F119F,APOBEC3G:NM_021822:exon3:c.T357C:p.F119F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3717	0.3175	0.284545	0.2919	.	.	.	.	.	.	.	.	APOBEC3G:uc003awy.3:exon1:c.T156C:p.F52F,APOBEC3G:uc003awx.3:exon3:c.T357C:p.F119F,APOBEC3G:uc021wpr.1:exon3:c.T357C:p.F119F	.	AFR:0.0804,AMR:0.3923,EAS:0.2228,FIN:0.2858,NFE:0.4120,OTH:0.3498,ASJ:0.4233	607113	.	.	.	.	.	.	.	.	.	.	.	22	MU151858	het
22	39497509	39497509	A	G	APOBEC3H	splicing	.	ENSG00000100298	rs139300	ENSG00000100298:ENST00000348946:exon3:c.A418G:p.K140E,ENSG00000100298:ENST00000401756:exon3:c.A418G:p.K140E,ENSG00000100298:ENST00000421988:exon3:c.A418G:p.N140D,ENSG00000100298:ENST00000442487:exon3:c.A418G:p.K140E	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	0	0.006	.	APOBEC3H:uc021wps.1:exon3:c.A418G:p.N140D,APOBEC3H:uc021wpt.1:exon3:c.A418G:p.K140E,APOBEC3H:uc021wpu.1:exon3:c.A418G:p.K140E,APOBEC3H:uc021wpv.1:exon3:c.A418G:p.K140E	.	AFR:0.9998,AMR:0.9998,EAS:1,FIN:1,NFE:1,OTH:0.9998,ASJ:1	610976	.	.	.	.	.	.	.	.	.	.	.	22	1(thyroid)	1
22	41537234	41537234	G	T	EP300	intronic	.	ENSG00000100393	rs6002267	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9892	.	0.961661	0.9661	.	.	.	.	.	0	0	.	.	.	AFR:0.8811,AMR:0.9988,EAS:1,FIN:1,NFE:0.9998,OTH:0.9919,ASJ:1	602700	114500;613684;	353284;783;	353284|-|-|-|-|613684 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	22	MU82053044	hom
22	41548008	41548008	A	G	EP300	exonic	nonsynonymous SNV	ENSG00000100393	rs20551	ENSG00000100393:ENST00000263253:exon15:c.A2989G:p.I997V	EP300:NM_001362843:exon14:c.A2911G:p.I971V,EP300:NM_001429:exon15:c.A2989G:p.I997V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.2959	0.2058	0.223442	0.2146	0.064	3.227	0.307	3.62	0.258	.	.	.	EP300:uc003azl.4:exon15:c.A2989G:p.I997V	-0.944	AFR:0.0580,AMR:0.5453,EAS:0.0723,FIN:0.3272,NFE:0.2692,OTH:0.2695,ASJ:0.3874	602700	114500;613684;	353284;783;	353284|-|-|-|-|613684 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	3901,	.	.	0.0	-1.56	0.000	0	22	MU30222105	het
22	41551039	41551039	T	A	EP300	exonic	synonymous SNV	ENSG00000100393	rs20552	ENSG00000100393:ENST00000263253:exon17:c.T3183A:p.T1061T	EP300:NM_001362843:exon16:c.T3105A:p.T1035T,EP300:NM_001429:exon17:c.T3183A:p.T1061T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6572	0.5831	0.673922	0.5925	.	.	.	.	.	.	.	.	EP300:uc003azl.4:exon17:c.T3183A:p.T1061T	.	AFR:0.5116,AMR:0.8122,EAS:0.8058,FIN:0.6084,NFE:0.5985,OTH:0.6133,ASJ:0.6225	602700	114500;613684;	353284;783;	353284|-|-|-|-|613684 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	3901,	.	.	.	.	.	.	22	MU13931129	hom
22	41566595	41566595	C	T	EP300	intronic	.	ENSG00000232754	rs6002271	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3011	0.2281	0.248403	0.2342	.	.	.	.	.	.	.	.	.	.	AFR:0.1266,AMR:0.5506,EAS:0.0699,FIN:0.3301,NFE:0.2694,OTH:0.2743,ASJ:0.3841	602700	114500;613684;	353284;783;	353284|-|-|-|-|613684 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	22	MU30222143	het
22	41569609	41569609	C	T	EP300	intronic	.	ENSG00000232754	rs2076578	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3085	0.2582	0.264177	0.2586	.	.	.	.	.	.	.	.	.	.	AFR:0.0917,AMR:0.2320,EAS:0.4607,FIN:0.2785,NFE:0.3278,OTH:0.3131,ASJ:0.2351	602700	114500;613684;	353284;783;	353284|-|-|-|-|613684 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	22	MU13931522	het
22	41574970	41574972	GTA	-	EP300	UTR3	.	ENSG00000231993;ENSG00000232754	rs35508493	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.3008	0.2214	0.247604	0.2281	.	.	.	.	.	.	.	.	.	.	AFR:0.1231,AMR:0.5541,EAS:0.0712,FIN:0.3205,NFE:0.2609,OTH:0.2699,ASJ:0.3733	602700	114500;613684;	353284;783;	353284|-|-|-|-|613684 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	22	.	het
22	41903813	41903813	A	C	ACO2	exonic	synonymous SNV	ENSG00000100412	rs137831	ENSG00000100412:ENST00000216254:exon3:c.A192C:p.T64T,ENSG00000100412:ENST00000396512:exon3:c.A192C:p.T64T	ACO2:NM_001098:exon3:c.A192C:p.T64T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3211	0.2580	0.418331	0.2820	.	.	.	.	.	.	.	.	ACO2:uc003bac.3:exon3:c.A192C:p.T64T	.	AFR:0.3553,AMR:0.5800,EAS:0.5795,FIN:0.2552,NFE:0.1987,OTH:0.2520,ASJ:0.2947	100850	614559;616289;	313850;	313850|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614559 ~	.	.	.	.	.	.	.	.	22	MU24294420	hom
22	41914593	41914593	C	T	ACO2	intronic	.	ENSG00000100412	rs203319	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3371	0.3239	0.484425	0.3372	.	.	.	.	.	.	.	.	.	.	AFR:0.5479,AMR:0.5931,EAS:0.5769,FIN:0.2543,NFE:0.1991,OTH:0.2643,ASJ:0.31	100850	614559;616289;	313850;	313850|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614559 ~	.	.	.	.	.	.	.	.	22	MU14588993	hom
22	41922473	41922473	T	C	POLR3H	UTR3	.	ENSG00000100413	rs542512553	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, 0, 0, 0] 	0.0004	.	0.00159744	6.464e-05	.	.	.	.	.	.	.	.	.	.	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	.	.	.	.	.	.	.	.	.	.	.	.	22	.	het
22	42032103	42032103	-	T	XRCC6	intronic	.	ENSG00000196419	rs199615942	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0353	0.0403	0.0597045	0.0357	.	.	.	.	.	.	.	.	.	.	AFR:0.0896,AMR:0.0698,EAS:0.0244,FIN:0.0156,NFE:0.0095,OTH:0.0240,ASJ:0.0069	152690	.	.	.	.	.	.	.	.	.	.	.	22	.	het
22	42523943	42523943	A	G	CYP2D6	exonic	nonsynonymous SNV	ENSG00000100197	rs16947	ENSG00000100197:ENST00000359033:exon5:c.T733C:p.C245R,ENSG00000100197:ENST00000360608:exon6:c.T886C:p.C296R,ENSG00000100197:ENST00000389970:exon7:c.T886C:p.C296R	CYP2D6:NM_001025161:exon5:c.T733C:p.C245R,CYP2D6:NM_000106:exon6:c.T886C:p.C296R	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6567	0.5996	0.640775	MU157540	.	.	.	.	.	.	.	.	CYP2D6:uc003bcf.3:exon5:c.T733C:p.C245R,CYP2D6:uc003bce.3:exon6:c.T886C:p.C296R	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.6150,EAS:0.7,FIN:0.65,NFE:0.8514,OTH:0.6486,ASJ:0.4759	124030	608902;	.	.	.	.	.	.	.	.	.	.	22	19(soft_tissue)	0.6542
22	42525756	42525756	G	A	CYP2D6	exonic	synonymous SNV	ENSG00000100197	rs1081003	ENSG00000100197:ENST00000360124:exon1:c.C156T:p.F52F,ENSG00000100197:ENST00000359033:exon2:c.C336T:p.F112F,ENSG00000100197:ENST00000360608:exon2:c.C336T:p.F112F,ENSG00000100197:ENST00000389970:exon2:c.C336T:p.F112F	CYP2D6:NM_000106:exon2:c.C336T:p.F112F,CYP2D6:NM_001025161:exon2:c.C336T:p.F112F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0777	0.0428	0.166933	3(large_intestine)	.	.	.	.	.	.	.	.	CYP2D6:uc003bce.3:exon2:c.C336T:p.F112F,CYP2D6:uc003bcf.3:exon2:c.C336T:p.F112F	.	AFR:MU687657,AMR:MELA-AU|1|183|0.00546448,PACA-CA|1|268|0.00373134,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763,EAS:0.0843,FIN:0.0564,NFE:0.0695,OTH:0.5752,ASJ:0.0702	124030	608902;	.	.	.	.	.	.	.	.	.	.	22	1(haematopoietic_and_lymphoid_tissue)	0.0164
22	42526694	42526694	G	A	CYP2D6	exonic	nonsynonymous SNV	ENSG00000100197	rs1065852	ENSG00000100197:ENST00000359033:exon1:c.C100T:p.P34S,ENSG00000100197:ENST00000360608:exon1:c.C100T:p.P34S,ENSG00000100197:ENST00000389970:exon1:c.C100T:p.P34S	CYP2D6:NM_000106:exon1:c.C100T:p.P34S,CYP2D6:NM_001025161:exon1:c.C100T:p.P34S	clinvar: Likely_benign,_drug_response,_other 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 2, 0, 0] 	0.2467	0.1885	0.238019	1(kidney)	4.875	24.9	0.023	3.46	0.255	.	.	.	CYP2D6:uc003bce.3:exon1:c.C100T:p.P34S,CYP2D6:uc003bcf.3:exon1:c.C100T:p.P34S	-1.130	AFR:1(biliary_tract),AMR:MU813852,EAS:0.1921,FIN:0.1214,NFE:0.1343,OTH:0.2667,ASJ:LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763	124030	608902;	.	.	.	.	.	.	1.0	-1.77	0.000	4.08	22	1(haematopoietic_and_lymphoid_tissue)	0.5812
22	50657010	50657010	C	G	TUBGCP6	exonic	nonsynonymous SNV	ENSG00000128159	rs4838864	ENSG00000128159:ENST00000425018:exon7:c.G919C:p.V307L,ENSG00000128159:ENST00000248846:exon22:c.G4861C:p.V1621L	TUBGCP6:NM_020461:exon22:c.G4861C:p.V1621L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9956	0.9947	0.998802	0.9955	1.233	11.92	1.0	1.61	0.999	.	.	.	TUBGCP6:uc003bka.1:exon7:c.G2122C:p.V708L,TUBGCP6:uc003bkb.1:exon22:c.G4861C:p.V1621L,TUBGCP6:uc010har.1:exon22:c.G4837C:p.V1613L	-1.016	AFR:0.9985,AMR:0.9976,EAS:1,FIN:0.9994,NFE:0.9922,OTH:0.9949,ASJ:1	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	0.003	3.43	0.000	-2.67	22	MU82055240	hom
22	50658053	50658053	A	G	TUBGCP6	intronic	.	ENSG00000128159	rs6537642	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9660	0.9595	0.982428	0.9677	.	.	.	.	.	.	.	.	.	.	AFR:0.9885,AMR:0.9665,EAS:1,FIN:0.9891,NFE:0.9481,OTH:0.9663,ASJ:0.9272	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	.	.	.	.	22	MU82055281	hom
22	50658424	50658424	T	C	TUBGCP6	exonic	nonsynonymous SNV	ENSG00000128159	rs11703226	ENSG00000128159:ENST00000425018:exon2:c.A187G:p.T63A,ENSG00000128159:ENST00000248846:exon17:c.A4129G:p.T1377A	TUBGCP6:NM_020461:exon17:c.A4129G:p.T1377A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4319	0.4577	0.427117	1(haematopoietic_and_lymphoid_tissue)	-1.682	0.002	0.787	-1.43	0.000	.	.	.	TUBGCP6:uc003bka.1:exon2:c.A1390G:p.T464A,TUBGCP6:uc003bkb.1:exon17:c.A4129G:p.T1377A,TUBGCP6:uc010har.1:exon17:c.A4105G:p.T1369A	-0.921	AFR:MU4553506,AMR:LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,EAS:0.4854,FIN:0.4010,NFE:0.4272,OTH:0.4042,ASJ:0.4489	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	0.005	3.14	0.000	0.83	22	1(thyroid)	0.4332
22	50658698	50658698	T	A	TUBGCP6	exonic	nonsynonymous SNV	ENSG00000128159	rs5771107	ENSG00000128159:ENST00000425018:exon1:c.A148T:p.S50C,ENSG00000128159:ENST00000248846:exon16:c.A4090T:p.S1364C,ENSG00000128159:ENST00000439308:exon16:c.A4090T:p.S1364C	TUBGCP6:NM_020461:exon16:c.A4090T:p.S1364C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1444	0.1272	0.161542	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053	2.196	17.48	0.12	-10.2	0.000	.	.	.	TUBGCP6:uc003bka.1:exon1:c.A1351T:p.S451C,TUBGCP6:uc003bkb.1:exon16:c.A4090T:p.S1364C,TUBGCP6:uc010har.1:exon16:c.A4066T:p.S1356C	-0.968	AFR:0.1169,AMR:0.0907,EAS:0.1987,FIN:0.2234,NFE:0.0934,OTH:0.1235,ASJ:0.1289	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	0.993	3.04	0.000	1.61	22	1(liver)	0.1232
22	50664612	50664612	A	G	TUBGCP6	exonic	nonsynonymous SNV	ENSG00000128159	rs4838865	ENSG00000128159:ENST00000248846:exon9:c.T1700C:p.L567S,ENSG00000128159:ENST00000439308:exon9:c.T1700C:p.L567S	TUBGCP6:NM_020461:exon9:c.T1700C:p.L567S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7912	0.8244	0.858826	0.8162	-1.386	0.003	0.692	-5.69	0.055	.	.	.	TUBGCP6:uc003bkb.1:exon9:c.T1700C:p.L567S,TUBGCP6:uc010har.1:exon9:c.T1700C:p.L567S	-1.069	AFR:0.9504,AMR:0.6563,EAS:0.8241,FIN:0.7956,NFE:0.7544,OTH:0.7888,ASJ:0.7318	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	0.005	3.31	0.000	-0.51	22	MU67370157	hom
22	50682865	50682865	G	A	TUBGCP6	exonic	synonymous SNV	ENSG00000128159	rs5771270	ENSG00000128159:ENST00000248846:exon1:c.C24T:p.F8F,ENSG00000128159:ENST00000439308:exon1:c.C24T:p.F8F	TUBGCP6:NM_020461:exon1:c.C24T:p.F8F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3600	0.3046	0.28155	0.3137	.	.	.	.	.	.	.	.	TUBGCP6:uc003bkb.1:exon1:c.C24T:p.F8F,TUBGCP6:uc010har.1:exon1:c.C24T:p.F8F,TUBGCP6:uc010hau.1:exon1:c.C24T:p.F8F	.	AFR:0.1362,AMR:0.2560,EAS:0.3710,FIN:0.3747,NFE:0.3943,OTH:0.3717,ASJ:0.3974	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	.	.	.	.	22	MU670488	het
22	50964236	50964236	G	A	TYMP	exonic	nonsynonymous SNV	ENSG00000025708	rs11479	ENSG00000025708:ENST00000425169:exon9:c.C1313T:p.S438L,ENSG00000025708:ENST00000252029:exon10:c.C1412T:p.S471L,ENSG00000025708:ENST00000395678:exon10:c.C1412T:p.S471L,ENSG00000025708:ENST00000395680:exon10:c.C1412T:p.S471L,ENSG00000025708:ENST00000395681:exon10:c.C1427T:p.S476L	TYMP:NM_001113756:exon9:c.C1412T:p.S471L,TYMP:NM_001113755:exon10:c.C1412T:p.S471L,TYMP:NM_001257988:exon10:c.C1412T:p.S471L,TYMP:NM_001257989:exon10:c.C1427T:p.S476L,TYMP:NM_001953:exon10:c.C1412T:p.S471L	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.1393	0.0684	0.142772	MU26811700	4.372	24.1	0.398	2.19	0.047	.	.	Pyrimidine nucleoside phosphorylase, C-terminal	TYMP:uc003bmb.5:exon9:c.C1412T:p.S471L,TYMP:uc003bmc.5:exon10:c.C1412T:p.S471L,TYMP:uc003bmd.5:exon10:c.C1412T:p.S471L,TYMP:uc003bme.5:exon10:c.C1427T:p.S476L,TYMP:uc010hbd.4:exon10:c.C1412T:p.S471L	-0.663	AFR:LAML-KR|1|205|0.00487805,THCA-CN|1|50|0.02,AMR:0.0932,EAS:0.1918,FIN:0.0927,NFE:0.2414,OTH:0.0967,ASJ:0.0498	131222	603041;	298;	298|MNGIE|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Childhood<br>Adult|603041 612075 613662 ~	.	.	.	.	0.986	-1.57	0.000	1.725	22	2(thyroid)	0.0946
X	14815021	14815021	C	T	GLRA2;FANCB	intergenic	.	ENSG00000221278;ENSG00000231066	rs7053178	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.0492715	0.0416	.	.	.	.	.	.	.	.	.	.	AFR:0.1437,AMR:0.0153,EAS:0.0069,FIN:0,NFE:0.0033,OTH:0.0099,ASJ:0	.	.	.	.	.	.	.	.	.	.	.	.	X	.	het
X	19364644	19364644	C	T	PDHA1	exonic	nonsynonymous SNV	ENSG00000131828	rs7883320	ENSG00000131828:ENST00000379806:exon2:c.C74T:p.T25M,ENSG00000131828:ENST00000423505:exon2:c.C74T:p.T25M	PDHA1:NM_001173454:exon2:c.C74T:p.T25M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 1, 0] 	0.1375	.	0.247947	0.2065	-0.327	0.577	0.336	-0.854	0.001	.	.	.	PDHA1:uc004czh.4:exon2:c.C74T:p.T25M	-0.933	AFR:0.6692,AMR:0.0891,EAS:0.0068,FIN:0.0292,NFE:0.0324,OTH:0.0834,ASJ:0.1444	300502	312170;	765;79243;	765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~79243|PDHAD<br>Pyruvate decarboxylase deficiency<br>Pyruvate dehydrogenase complex E1 component subunit alpha deficiency|Unknown|X-linked dominant|Infancy<br>Neonatal|312170 ~	~ko00010 Glycolysis / Gluconeogenesis~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04066 HIF-1 signaling pathway~ko04922 Glucagon signaling pathway~ko05230 Central carbon metabolism in cancer~~M00307 Pyruvate oxidation, pyruvate => acetyl-CoA ~	.	.	.	0.0	-4.72	0.000	.	X	.	het
X	19373452	19373452	C	T	PDHA1	intronic	.	ENSG00000131828	rs13440874	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0416	0.0416	.	0.0333	.	.	.	.	.	.	.	.	.	.	AFR:0.0623,AMR:0.0275,EAS:0.0066,FIN:0.0219,NFE:0.0201,OTH:0.0510,ASJ:0.1164	300502	312170;	765;79243;	765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~79243|PDHAD<br>Pyruvate decarboxylase deficiency<br>Pyruvate dehydrogenase complex E1 component subunit alpha deficiency|Unknown|X-linked dominant|Infancy<br>Neonatal|312170 ~	~ko00010 Glycolysis / Gluconeogenesis~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04066 HIF-1 signaling pathway~ko04922 Glucagon signaling pathway~ko05230 Central carbon metabolism in cancer~~M00307 Pyruvate oxidation, pyruvate => acetyl-CoA ~	.	.	.	.	.	.	.	X	.	het
X	19373789	19373789	C	A	PDHA1	intronic	.	ENSG00000131828	rs7058209	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1155	0.2614	0.247947	0.2065	.	.	.	.	.	.	.	.	.	.	AFR:0.6648,AMR:0.0884,EAS:0.0068,FIN:0.0293,NFE:0.0323,OTH:0.0764,ASJ:0.1568	300502	312170;	765;79243;	765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~79243|PDHAD<br>Pyruvate decarboxylase deficiency<br>Pyruvate dehydrogenase complex E1 component subunit alpha deficiency|Unknown|X-linked dominant|Infancy<br>Neonatal|312170 ~	~ko00010 Glycolysis / Gluconeogenesis~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04066 HIF-1 signaling pathway~ko04922 Glucagon signaling pathway~ko05230 Central carbon metabolism in cancer~~M00307 Pyruvate oxidation, pyruvate => acetyl-CoA ~	.	.	.	.	.	.	.	X	.	het
X	19373839	19373839	A	G	PDHA1	exonic	synonymous SNV	ENSG00000131828	rs1126565	ENSG00000131828:ENST00000540249:exon7:c.A702G:p.A234A,ENSG00000131828:ENST00000422285:exon8:c.A795G:p.A265A,ENSG00000131828:ENST00000545074:exon8:c.A816G:p.A272A,ENSG00000131828:ENST00000379806:exon9:c.A909G:p.A303A	PDHA1:NM_001173456:exon7:c.A702G:p.A234A,PDHA1:NM_000284:exon8:c.A795G:p.A265A,PDHA1:NM_001173455:exon8:c.A816G:p.A272A,PDHA1:NM_001173454:exon9:c.A909G:p.A303A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1339	0.3246	0.304636	0.2591	.	.	.	.	.	.	.	.	PDHA1:uc010nfl.3:exon2:c.A168G:p.A56A,PDHA1:uc011mjd.2:exon7:c.A702G:p.A234A,PDHA1:uc004czg.4:exon8:c.A795G:p.A265A,PDHA1:uc011mjc.2:exon8:c.A816G:p.A272A,PDHA1:uc004czh.4:exon9:c.A909G:p.A303A	.	AFR:0.8521,AMR:0.1077,EAS:0.0067,FIN:0.0292,NFE:0.0330,OTH:0.0882,ASJ:0.1444	300502	312170;	765;79243;	765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~79243|PDHAD<br>Pyruvate decarboxylase deficiency<br>Pyruvate dehydrogenase complex E1 component subunit alpha deficiency|Unknown|X-linked dominant|Infancy<br>Neonatal|312170 ~	~ko00010 Glycolysis / Gluconeogenesis~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04066 HIF-1 signaling pathway~ko04922 Glucagon signaling pathway~ko05230 Central carbon metabolism in cancer~~M00307 Pyruvate oxidation, pyruvate => acetyl-CoA ~	.	.	.	.	.	.	.	X	.	het
X	30326983	30326983	C	T	NR0B1	exonic	synonymous SNV	ENSG00000169297	rs2269345	ENSG00000169297:ENST00000378970:exon1:c.G498A:p.R166R,ENSG00000169297:ENST00000453287:exon1:c.G498A:p.R166R	NR0B1:NM_000475:exon1:c.G498A:p.R166R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3984	0.2828	0.476556	1(stomach)	.	.	.	.	.	.	.	.	NR0B1:uc004dcf.4:exon1:c.G498A:p.R166R	.	AFR:MU124109,AMR:LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,EAS:0.4177,FIN:0.4086,NFE:0.2222,OTH:0.7192,ASJ:0.2768	300473	300018;300200;	95702;242;	95702|X-linked congenital adrenal hypoplasia|-|X-linked recessive|-|202155 300200 ~242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	X	1(thyroid)	0.1727
X	30327367	30327367	G	A	NR0B1	exonic	synonymous SNV	ENSG00000169297	rs6150	ENSG00000169297:ENST00000378970:exon1:c.C114T:p.C38C,ENSG00000169297:ENST00000453287:exon1:c.C114T:p.C38C	NR0B1:NM_000475:exon1:c.C114T:p.C38C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1638	0.1425	0.0956291	0.1562	.	.	.	.	.	.	.	.	NR0B1:uc004dcf.4:exon1:c.C114T:p.C38C	.	AFR:0.0408,AMR:0.0656,EAS:0.1307,FIN:0.2637,NFE:0.2005,OTH:0.1761,ASJ:0.2162	300473	300018;300200;	95702;242;	95702|X-linked congenital adrenal hypoplasia|-|X-linked recessive|-|202155 300200 ~242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	X	MU2246332	het
X	31213723	31213723	C	T	DMD	intronic	.	ENSG00000198947	rs5972332	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.94649	0.9636	.	.	.	.	.	.	.	.	.	.	AFR:0.9022,AMR:0.9900,EAS:0.9700,FIN:0.9954,NFE:0.9868,OTH:0.9747,ASJ:0.9622	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	.	hom
X	31224684	31224684	A	G	DMD	intronic	.	ENSG00000198947	rs2293668	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8836	0.8265	0.803974	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.8406,AMR:0.7370,EAS:0.8723,FIN:0.7939,NFE:0.8858,OTH:0.8864,ASJ:0.9152	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	1(haematopoietic_and_lymphoid_tissue)	0.8396
X	31496350	31496350	C	T	DMD	exonic	nonsynonymous SNV	ENSG00000198947	rs1800280	ENSG00000198947:ENST00000358062:exon12:c.G1898A:p.R633Q,ENSG00000198947:ENST00000343523:exon16:c.G1430A:p.R477Q,ENSG00000198947:ENST00000359836:exon16:c.G1430A:p.R477Q,ENSG00000198947:ENST00000378707:exon16:c.G1430A:p.R477Q,ENSG00000198947:ENST00000474231:exon16:c.G1430A:p.R477Q,ENSG00000198947:ENST00000541735:exon16:c.G1430A:p.R477Q,ENSG00000198947:ENST00000357033:exon59:c.G8810A:p.R2937Q,ENSG00000198947:ENST00000378677:exon59:c.G8798A:p.R2933Q	DMD:NM_004014:exon5:c.G623A:p.R208Q,DMD:NM_004013:exon16:c.G1430A:p.R477Q,DMD:NM_004020:exon16:c.G1430A:p.R477Q,DMD:NM_004021:exon16:c.G1430A:p.R477Q,DMD:NM_004022:exon16:c.G1430A:p.R477Q,DMD:NM_004023:exon16:c.G1430A:p.R477Q,DMD:NM_004011:exon31:c.G4787A:p.R1596Q,DMD:NM_004012:exon31:c.G4778A:p.R1593Q,DMD:NM_000109:exon59:c.G8786A:p.R2929Q,DMD:NM_004006:exon59:c.G8810A:p.R2937Q,DMD:NM_004009:exon59:c.G8798A:p.R2933Q,DMD:NM_004010:exon59:c.G8441A:p.R2814Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9045	0.9568	0.881854	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	2.138	17.10	0.624	4.23	0.995	.	.	.	DMD:uc004dcq.1:exon5:c.G623A:p.R208Q,DMD:uc004dcr.1:exon16:c.G1430A:p.R477Q,DMD:uc004dcs.1:exon16:c.G1430A:p.R477Q,DMD:uc004dct.1:exon16:c.G1430A:p.R477Q,DMD:uc004dcu.1:exon16:c.G1430A:p.R477Q,DMD:uc004dcv.1:exon16:c.G1430A:p.R477Q,DMD:uc004dcw.2:exon31:c.G4778A:p.R1593Q,DMD:uc004dcx.2:exon31:c.G4787A:p.R1596Q,DMD:uc004dcy.1:exon59:c.G8798A:p.R2933Q,DMD:uc004dcz.2:exon59:c.G8441A:p.R2814Q,DMD:uc004dda.1:exon59:c.G8810A:p.R2937Q,DMD:uc004ddb.1:exon59:c.G8786A:p.R2929Q	-0.945	AFR:0.9524,AMR:0.9879,EAS:0.9565,FIN:0.9268,NFE:0.9410,OTH:0.9457,ASJ:0.8336	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	0.0	1.01	0.000	.	X	1(lung)	0.9392
X	32380996	32380996	C	T	DMD	exonic	nonsynonymous SNV	ENSG00000198947	rs1801187	ENSG00000198947:ENST00000357033:exon37:c.G5234A:p.R1745H,ENSG00000198947:ENST00000378677:exon37:c.G5222A:p.R1741H	DMD:NM_004011:exon9:c.G1211A:p.R404H,DMD:NM_004012:exon9:c.G1202A:p.R401H,DMD:NM_000109:exon37:c.G5210A:p.R1737H,DMD:NM_004006:exon37:c.G5234A:p.R1745H,DMD:NM_004009:exon37:c.G5222A:p.R1741H,DMD:NM_004010:exon37:c.G4865A:p.R1622H	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.5142	0.3331	0.465166	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	6.788	32	0.006	5.24	0.940	.	.	.	DMD:uc004dcw.2:exon9:c.G1202A:p.R401H,DMD:uc004dcx.2:exon9:c.G1211A:p.R404H,DMD:uc004dcy.1:exon37:c.G5222A:p.R1741H,DMD:uc004dcz.2:exon37:c.G4865A:p.R1622H,DMD:uc004dda.1:exon37:c.G5234A:p.R1745H,DMD:uc004ddb.1:exon37:c.G5210A:p.R1737H	-0.904	AFR:0.3913,AMR:0.0789,EAS:0.4293,FIN:0.7234,NFE:0.5224,OTH:0.4730,ASJ:0.6987	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	0.999	0.74	0.000	2.64	X	1(lung)	0.5245
X	32472763	32472763	-	T	DMD	intronic	.	ENSG00000198947	rs5902031	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.4978	0.3803	0.464106	0.5453	.	.	.	.	.	.	.	.	.	.	AFR:0.2239,AMR:0.7074,EAS:0.7851,FIN:0.6083,NFE:0.6948,OTH:0.7,ASJ:0.6408	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	.	het
X	32503194	32503194	T	C	DMD	exonic	nonsynonymous SNV	ENSG00000198947	rs228406	ENSG00000198947:ENST00000357033:exon21:c.A2645G:p.D882G,ENSG00000198947:ENST00000378677:exon21:c.A2633G:p.D878G	DMD:NM_000109:exon21:c.A2621G:p.D874G,DMD:NM_004006:exon21:c.A2645G:p.D882G,DMD:NM_004009:exon21:c.A2633G:p.D878G,DMD:NM_004010:exon21:c.A2276G:p.D759G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7211	0.6502	0.748344	0.6958	0.631	8.366	0.523	3.07	0.978	.	.	.	DMD:uc004dcy.1:exon21:c.A2633G:p.D878G,DMD:uc004dcz.2:exon21:c.A2276G:p.D759G,DMD:uc004dda.1:exon21:c.A2645G:p.D882G,DMD:uc004ddb.1:exon21:c.A2621G:p.D874G	-0.978	AFR:0.6291,AMR:0.8068,EAS:0.8869,FIN:0.8215,NFE:0.6750,OTH:0.7336,ASJ:0.6243	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	0.0	0.73	0.000	0	X	MU4584954	het
X	39911657	39911657	C	A	BCOR	intronic	.	ENSG00000183337	rs5963725	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1576	0.1907	0.136689	.	.	.	.	.	.	0	0	.	.	.	AFR:0.1585,AMR:0.1663,EAS:0.1803,FIN:0,NFE:0.1070,OTH:0.1856,ASJ:0.0909	300485	300166;	2712;568;	2712|Cataract-microphthalmia-radiculomegaly-cardiac septal defect syndrome<br>OFCD syndrome|Unknown|X-linked dominant|Infancy<br>Neonatal|300166 ~568|Lenz microphthalmia|Unknown|X-linked recessive|Neonatal|300166 309800 ~	.	.	.	.	.	.	.	.	X	5(meninges)	0.1657
X	39932808	39932808	G	A	BCOR	exonic	synonymous SNV	ENSG00000183337	rs144606152	ENSG00000183337:ENST00000342274:exon4:c.C1791T:p.H597H,ENSG00000183337:ENST00000378444:exon4:c.C1791T:p.H597H,ENSG00000183337:ENST00000378455:exon4:c.C1791T:p.H597H,ENSG00000183337:ENST00000397354:exon4:c.C1791T:p.H597H,ENSG00000183337:ENST00000406200:exon4:c.C1791T:p.H597H	BCOR:NM_001123383:exon4:c.C1791T:p.H597H,BCOR:NM_001123384:exon4:c.C1791T:p.H597H,BCOR:NM_001123385:exon4:c.C1791T:p.H597H,BCOR:NM_017745:exon4:c.C1791T:p.H597H	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0345	0.0373	0.0166887	.	.	.	.	.	.	.	.	.	BCOR:uc004dem.4:exon4:c.C1791T:p.H597H,BCOR:uc004den.4:exon4:c.C1791T:p.H597H,BCOR:uc004deo.4:exon4:c.C1791T:p.H597H,BCOR:uc004dep.4:exon4:c.C1791T:p.H597H,BCOR:uc004deq.4:exon4:c.C1791T:p.H597H	.	AFR:.,AMR:0.0317,EAS:0.0081,FIN:0.0576,NFE:0,OTH:0.0384,ASJ:0.0079	300485	300166;	2712;568;	2712|Cataract-microphthalmia-radiculomegaly-cardiac septal defect syndrome<br>OFCD syndrome|Unknown|X-linked dominant|Infancy<br>Neonatal|300166 ~568|Lenz microphthalmia|Unknown|X-linked recessive|Neonatal|300166 309800 ~	.	,972,969	.	,970,971	.	.	.	.	X	2(meninges)	0.0472
X	39932907	39932907	T	C	BCOR	exonic	synonymous SNV	ENSG00000183337	rs6520618	ENSG00000183337:ENST00000342274:exon4:c.A1692G:p.A564A,ENSG00000183337:ENST00000378444:exon4:c.A1692G:p.A564A,ENSG00000183337:ENST00000378455:exon4:c.A1692G:p.A564A,ENSG00000183337:ENST00000397354:exon4:c.A1692G:p.A564A,ENSG00000183337:ENST00000406200:exon4:c.A1692G:p.A564A	BCOR:NM_001123383:exon4:c.A1692G:p.A564A,BCOR:NM_001123384:exon4:c.A1692G:p.A564A,BCOR:NM_001123385:exon4:c.A1692G:p.A564A,BCOR:NM_017745:exon4:c.A1692G:p.A564A	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2671	0.3615	0.523974	MU14602427	.	.	.	.	.	.	.	.	BCOR:uc004dem.4:exon4:c.A1692G:p.A564A,BCOR:uc004den.4:exon4:c.A1692G:p.A564A,BCOR:uc004deo.4:exon4:c.A1692G:p.A564A,BCOR:uc004dep.4:exon4:c.A1692G:p.A564A,BCOR:uc004deq.4:exon4:c.A1692G:p.A564A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.3308,EAS:0.1980,FIN:0.1323,NFE:0.7143,OTH:0.1283,ASJ:0.8037	300485	300166;	2712;568;	2712|Cataract-microphthalmia-radiculomegaly-cardiac septal defect syndrome<br>OFCD syndrome|Unknown|X-linked dominant|Infancy<br>Neonatal|300166 ~568|Lenz microphthalmia|Unknown|X-linked recessive|Neonatal|300166 309800 ~	.	,972,969	.	,970,971	.	.	.	.	X	8(soft_tissue)	0.0976
X	39933339	39933339	A	G	BCOR	exonic	synonymous SNV	ENSG00000183337	rs5917933	ENSG00000183337:ENST00000342274:exon4:c.T1260C:p.D420D,ENSG00000183337:ENST00000378444:exon4:c.T1260C:p.D420D,ENSG00000183337:ENST00000378455:exon4:c.T1260C:p.D420D,ENSG00000183337:ENST00000397354:exon4:c.T1260C:p.D420D,ENSG00000183337:ENST00000406200:exon4:c.T1260C:p.D420D	BCOR:NM_001123383:exon4:c.T1260C:p.D420D,BCOR:NM_001123384:exon4:c.T1260C:p.D420D,BCOR:NM_001123385:exon4:c.T1260C:p.D420D,BCOR:NM_017745:exon4:c.T1260C:p.D420D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8952	0.8957	0.903046	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	BCOR:uc004dem.4:exon4:c.T1260C:p.D420D,BCOR:uc004den.4:exon4:c.T1260C:p.D420D,BCOR:uc004deo.4:exon4:c.T1260C:p.D420D,BCOR:uc004dep.4:exon4:c.T1260C:p.D420D,BCOR:uc004deq.4:exon4:c.T1260C:p.D420D	.	AFR:0.9153,AMR:0.9232,EAS:0.8771,FIN:0.9756,NFE:0.9487,OTH:0.8959,ASJ:0.9469	300485	300166;	2712;568;	2712|Cataract-microphthalmia-radiculomegaly-cardiac septal defect syndrome<br>OFCD syndrome|Unknown|X-linked dominant|Infancy<br>Neonatal|300166 ~568|Lenz microphthalmia|Unknown|X-linked recessive|Neonatal|300166 309800 ~	.	,972,969	.	,970,971	.	.	.	.	X	1(thyroid)	0.9042
X	41043944	41043944	T	C	USP9X	intronic	.	ENSG00000124486	rs5918130	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3395	0.2995	0.181457	0.2800	.	.	.	.	.	.	.	.	.	.	AFR:0.0932,AMR:0.1790,EAS:0.1133,FIN:0.3857,NFE:0.3775,OTH:0.2975,ASJ:0.4497	300072	300919;300968;	777;	777|X-linked non-specific intellectual disability|Unknown|X-linked recessive|Childhood|300046 300047 300062 300114 300115 300143 300210 300271 300324 300355 300372 300387 300419 300428 300433 300436 300454 300498 300504 300505 300518 300558 300705 300716 300802 300803 300844 300848 300849 300850 300851 300852 300919 300928 300978 300983 300984 309530 309549 ~	.	.	.	.	.	.	.	.	X	MU13579566	het
X	41047232	41047232	C	T	USP9X	intronic	.	ENSG00000124486	rs749324609	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0002	.	.	0.0002	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0.0049,FIN:0,NFE:0,OTH:0,ASJ:0	300072	300919;300968;	777;	777|X-linked non-specific intellectual disability|Unknown|X-linked recessive|Childhood|300046 300047 300062 300114 300115 300143 300210 300271 300324 300355 300372 300387 300419 300428 300433 300436 300454 300498 300504 300505 300518 300558 300705 300716 300802 300803 300844 300848 300849 300850 300851 300852 300919 300928 300978 300983 300984 309530 309549 ~	.	.	.	.	.	.	.	.	X	.	het
X	44929077	44929077	C	A	KDM6A	exonic	nonsynonymous SNV	ENSG00000147050	rs2230018	ENSG00000147050:ENST00000543216:exon15:c.C1940A:p.T647K,ENSG00000147050:ENST00000536777:exon16:c.C2042A:p.T681K,ENSG00000147050:ENST00000377967:exon17:c.C2177A:p.T726K,ENSG00000147050:ENST00000382899:exon17:c.C2198A:p.T733K	KDM6A:NM_001291418:exon15:c.C1940A:p.T647K,KDM6A:NM_001291421:exon15:c.C1289A:p.T430K,KDM6A:NM_001291417:exon16:c.C2042A:p.T681K,KDM6A:NM_001291416:exon17:c.C2198A:p.T733K,KDM6A:NM_021140:exon17:c.C2177A:p.T726K,KDM6A:NM_001291415:exon18:c.C2333A:p.T778K	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.1376	0.0928	0.155497	4(lung)	1.424	12.91	0.056	-2.48	0.912	.	.	.	KDM6A:uc011mld.2:exon6:c.C1094A:p.T365K,KDM6A:uc022bvi.1:exon14:c.C1187A:p.T396K,KDM6A:uc011mlc.2:exon15:c.C1289A:p.T430K,KDM6A:uc022bvj.1:exon15:c.C1940A:p.T647K,KDM6A:uc010nhk.2:exon16:c.C2075A:p.T692K,KDM6A:uc011mla.2:exon16:c.C2042A:p.T681K,KDM6A:uc004dge.4:exon17:c.C2177A:p.T726K,KDM6A:uc011mlb.2:exon17:c.C2198A:p.T733K,KDM6A:uc011mkz.2:exon18:c.C2333A:p.T778K	-1.010	AFR:3(soft_tissue),AMR:1(stomach),EAS:MU111211,FIN:LAML-KR|2|205|0.0097561,LUSC-KR|4|170|0.0235294,COCA-CN|1|321|0.00311526,NFE:0.1177,OTH:0.0424,ASJ:1(large_intestine)	300128	300867;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	~ko05202 Transcriptional misregulation in cancer ~	,6286	.	.	0.0	0.89	0.000	0.345	X	29(meninges)	0.0532
X	44935925	44935926	TT	-	KDM6A	intronic	.	ENSG00000147050	rs571223110	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.3341	.	0.276556	0.1431	.	.	.	.	.	.	.	.	.	.	AFR:0.0783,AMR:0.0777,EAS:0.3571,FIN:0.2504,NFE:0.1469,OTH:0.1845,ASJ:0.1935	300128	300867;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	X	.	unknown
X	44938563	44938563	G	A	KDM6A	exonic	synonymous SNV	ENSG00000147050	rs20539	ENSG00000147050:ENST00000543216:exon18:c.G2874A:p.Q958Q,ENSG00000147050:ENST00000536777:exon19:c.G2976A:p.Q992Q,ENSG00000147050:ENST00000377967:exon20:c.G3111A:p.Q1037Q,ENSG00000147050:ENST00000382899:exon20:c.G3132A:p.Q1044Q	KDM6A:NM_001291418:exon18:c.G2874A:p.Q958Q,KDM6A:NM_001291421:exon18:c.G2223A:p.Q741Q,KDM6A:NM_001291417:exon19:c.G2976A:p.Q992Q,KDM6A:NM_001291416:exon20:c.G3132A:p.Q1044Q,KDM6A:NM_021140:exon20:c.G3111A:p.Q1037Q,KDM6A:NM_001291415:exon21:c.G3267A:p.Q1089Q	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2384	0.1320	0.221722	47(meninges)	.	.	.	.	.	.	.	.	KDM6A:uc011mld.2:exon9:c.G2028A:p.Q676Q,KDM6A:uc011mlc.2:exon18:c.G2223A:p.Q741Q,KDM6A:uc022bvj.1:exon18:c.G2874A:p.Q958Q,KDM6A:uc010nhk.2:exon19:c.G3009A:p.Q1003Q,KDM6A:uc011mla.2:exon19:c.G2976A:p.Q992Q,KDM6A:uc004dge.4:exon20:c.G3111A:p.Q1037Q,KDM6A:uc011mlb.2:exon20:c.G3132A:p.Q1044Q,KDM6A:uc011mkz.2:exon21:c.G3267A:p.Q1089Q	.	AFR:MU768289,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|5|170|0.0294118,COCA-CN|3|321|0.00934579,EAS:0.0313,FIN:0.4365,NFE:0.2350,OTH:0.3330,ASJ:0.1641	300128	300867;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	~ko05202 Transcriptional misregulation in cancer ~	,6286	.	.	.	.	.	.	X	1(prostate)	0.2260
X	47424648	47424648	A	G	ARAF	exonic	synonymous SNV	ENSG00000078061	rs550399272	.	ARAF:NM_001256196:exon6:c.A465G:p.S155S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 1] 	0.0027	.	0.00662252	4.679e-05	.	.	.	.	.	0.5601	0.37	.	ARAF:uc004dic.2:exon6:c.A465G:p.S155S	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0014,ASJ:0	311010	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04068 FoxO signaling pathway~ko04270 Vascular smooth muscle contraction~ko04650 Natural killer cell mediated cytotoxicity~ko04720 Long-term potentiation~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04928 Parathyroid hormone synthesis, secretion and action~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,763,764,765,766	.	.	.	.	.	.	X	.	het
X	47426757	47426757	C	T	ARAF	exonic	synonymous SNV	ENSG00000078061	rs56322617	ENSG00000078061:ENST00000377045:exon10:c.C1002T:p.A334A	ARAF:NM_001256196:exon10:c.C1011T:p.A337A,ARAF:NM_001654:exon10:c.C1002T:p.A334A	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1] 	0.0050	0.0046	0.0013245	0.0033	.	.	.	.	.	.	.	.	ARAF:uc004dic.2:exon10:c.C1011T:p.A337A,ARAF:uc011mlo.3:exon10:c.C600T:p.A200A,ARAF:uc011mlp.3:exon10:c.C1002T:p.A334A	.	AFR:0.0017,AMR:0,EAS:0,FIN:0.0027,NFE:0.0048,OTH:0.0042,ASJ:0.0054	311010	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04068 FoxO signaling pathway~ko04270 Vascular smooth muscle contraction~ko04650 Natural killer cell mediated cytotoxicity~ko04720 Long-term potentiation~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04928 Parathyroid hormone synthesis, secretion and action~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,763,764,765,766	.	.	.	.	.	.	X	.	het
X	48125798	48125798	T	C	SSX1	exonic	synonymous SNV	ENSG00000126752	rs5952493	ENSG00000126752:ENST00000376919:exon7:c.T543C:p.S181S	SSX1:NM_005635:exon7:c.T543C:p.S181S,SSX1:NM_001278691:exon8:c.T543C:p.S181S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5025	0.4724	0.486093	0.4912	.	.	.	.	.	.	.	.	SSX1:uc004djb.1:exon7:c.T543C:p.S181S	.	AFR:0.4634,AMR:0.5637,EAS:0.6101,FIN:0.5306,NFE:0.4816,OTH:0.4979,ASJ:0.4420	312820	300813;	3273;	3273|Synovialosarcoma|Unknown|Not applicable|All ages|300813 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	X	MU729878	het
X	48888074	48888074	T	C	TFE3	exonic	synonymous SNV	ENSG00000068323	rs3027472	ENSG00000068323:ENST00000315869:exon10:c.A1323G:p.V441V	TFE3:NM_001282142:exon10:c.A1008G:p.V336V,TFE3:NM_006521:exon10:c.A1323G:p.V441V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3921	0.3650	0.231258	LUSC-KR|4|170|0.0235294,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	TFE3:uc004dmb.3:exon10:c.A1323G:p.V441V,TFE3:uc004dmc.3:exon10:c.A1008G:p.V336V	.	AFR:0.3553,AMR:0.0703,EAS:0.5824,FIN:0.0832,NFE:0.4753,OTH:0.5083,ASJ:0.3203	314310	300854;	319308;	319308|Carcinoma associated with MITF/TFE translocation<br>Translocation carcinoma|-|-|-|300854 ~	~ko04137 Mitophagy - animal~ko05202 Transcriptional misregulation in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	X	1(breast)	0.4226
X	49113312	49113312	G	A	FOXP3	exonic	synonymous SNV	ENSG00000049768	rs2232367	ENSG00000049768:ENST00000518685:exon4:c.C438T:p.S146S,ENSG00000049768:ENST00000557224:exon4:c.C438T:p.S146S,ENSG00000049768:ENST00000376197:exon5:c.C393T:p.S131S,ENSG00000049768:ENST00000376199:exon5:c.C438T:p.S146S,ENSG00000049768:ENST00000455775:exon5:c.C543T:p.S181S,ENSG00000049768:ENST00000376207:exon6:c.C543T:p.S181S	FOXP3:NM_001114377:exon5:c.C438T:p.S146S,FOXP3:NM_014009:exon6:c.C543T:p.S181S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0313	0.0297	0.0148344	.	.	.	.	.	.	0.0363	0.636	.	FOXP3:uc011mnb.2:exon4:c.C612T:p.S204S,FOXP3:uc004dne.4:exon5:c.C438T:p.S146S,FOXP3:uc011mnc.2:exon5:c.C543T:p.S181S,FOXP3:uc022bwa.1:exon5:c.C393T:p.S131S,FOXP3:uc004dnf.4:exon6:c.C543T:p.S181S	.	AFR:0.0305,AMR:0.0064,EAS:0.0757,FIN:0,NFE:0.0563,OTH:0.0397,ASJ:0.0177	300292	222100;304790;	37042;	37042|Autoimmune enteropathy type 1<br>IPEX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|304790 ~	.	.	.	.	.	.	.	.	X	4(lung)	0.0441
X	53228148	53228148	C	A	KDM5C	intronic	.	ENSG00000126012	rs1977364	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8920	0.7829	0.730331	0.8161	.	.	.	.	.	.	.	.	.	.	AFR:0.4295,AMR:0.8821,EAS:0.7619,FIN:0.9883,NFE:0.9786,OTH:0.9393,ASJ:0.9227	314690	300534;	85279;	85279|-|<1 / 1 000 000|X-linked recessive|Childhood|300534 ~	.	.	.	.	.	.	.	.	X	MU14608707	hom
X	53449568	53449568	G	A	SMC1A	UTR5	.	ENSG00000072501	rs1264011	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5163	0.4060	0.398411	LICA-CN|2|402|0.00497512,LUSC-KR|5|170|0.0294118,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.4571,AMR:0.0840,EAS:0.5430,FIN:0.5238,NFE:0.6082,OTH:0.6118,ASJ:0.5494	300040	300590;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	.	.	.	.	.	.	.	X	1(haematopoietic_and_lymphoid_tissue)	0.5676
X	53563589	53563589	A	G	HUWE1	exonic	synonymous SNV	ENSG00000086758	rs426298	ENSG00000086758:ENST00000342160:exon78:c.T12177C:p.G4059G,ENSG00000086758:ENST00000262854:exon79:c.T12177C:p.G4059G	HUWE1:NM_031407:exon79:c.T12177C:p.G4059G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9973	0.9920	0.994967	0.9942	.	.	.	.	.	.	.	.	HUWE1:uc004dsn.4:exon48:c.T8601C:p.G2867G,HUWE1:uc004dsp.4:exon79:c.T12177C:p.G4059G	.	AFR:0.9787,AMR:0.9984,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	300697	300706;	85328;	85328|-|<1 / 1 000 000|X-linked dominant|-|300706 ~	.	.	.	.	.	.	.	.	X	MU82057962	hom
X	53619388	53619388	T	C	HUWE1	exonic	synonymous SNV	ENSG00000086758	.	ENSG00000086758:ENST00000342160:exon32:c.A3942G:p.E1314E,ENSG00000086758:ENST00000218328:exon33:c.A3942G:p.E1314E,ENSG00000086758:ENST00000262854:exon33:c.A3942G:p.E1314E	HUWE1:NM_031407:exon33:c.A3942G:p.E1314E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	HUWE1:uc004dsn.4:exon2:c.A417G:p.E139E,HUWE1:uc004dsp.4:exon33:c.A3942G:p.E1314E	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300697	300706;	85328;	85328|-|<1 / 1 000 000|X-linked dominant|-|300706 ~	.	.	.	.	.	.	.	.	X	.	het
X	53641647	53641647	T	C	HUWE1	exonic	synonymous SNV	ENSG00000086758	rs6638360	ENSG00000086758:ENST00000342160:exon22:c.A2109G:p.S703S,ENSG00000086758:ENST00000218328:exon23:c.A2109G:p.S703S,ENSG00000086758:ENST00000262854:exon23:c.A2109G:p.S703S	HUWE1:NM_031407:exon23:c.A2109G:p.S703S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4895	0.3779	0.389669	LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	HUWE1:uc004dsp.4:exon23:c.A2109G:p.S703S	.	AFR:0.4342,AMR:0.0918,EAS:0.5222,FIN:0.5035,NFE:0.5784,OTH:0.5694,ASJ:0.5237	300697	300706;	85328;	85328|-|<1 / 1 000 000|X-linked dominant|-|300706 ~	.	.	.	.	.	.	.	.	X	2(haematopoietic_and_lymphoid_tissue)	0.5319
X	66765159	66765173	GCAGCAGCAGCAGCA	-	AR	exonic	nonframeshift deletion	ENSG00000169083	rs745982326	ENSG00000169083:ENST00000374690:exon1:c.171_185del:p.57_62del,ENSG00000169083:ENST00000396044:exon1:c.171_185del:p.57_62del,ENSG00000169083:ENST00000504326:exon1:c.171_185del:p.57_62del,ENSG00000169083:ENST00000514029:exon1:c.171_185del:p.57_62del	AR:NM_000044:exon1:c.171_185del:p.57_62del,AR:NM_001348061:exon1:c.171_185del:p.57_62del,AR:NM_001348063:exon1:c.171_185del:p.57_62del,AR:NM_001348064:exon1:c.171_185del:p.57_62del	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0065	.	.	.	.	.	.	.	.	.	.	.	AR:uc004dwu.2:exon1:c.171_185del:p.57_62del,AR:uc011mpd.2:exon1:c.171_185del:p.57_62del,AR:uc011mpf.1:exon1:c.171_185del:p.57_62del,AR:uc022byk.1:exon1:c.171_185del:p.57_62del	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	313700	176807;300068;300633;312300;313200;	481;90797;440;99429;1331;	481|SBMA<br>SMAX1-related spinobulbar muscular atrophy<br>X-linked BSMA<br>X-linked bulbospinal amyotrophy<br>X-linked bulbospinal muscular atrophy<br>X-linked spinal and bulbar muscular atrophy|1-9 / 100 000|X-linked recessive|Adult|313200 ~90797|PAIS<br>Partial androgen resistance syndrome|Unknown|X-linked recessive|All ages|312300 ~440|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|146450 300633 300758 300856 ~99429|CAIS<br>Complete androgen resistance syndrome|1-9 / 1 000 000|X-linked recessive|All ages|300068 300274 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	~ko04114 Oocyte meiosis~ko05200 Pathways in cancer~ko05215 Prostate cancer ~	,830,823	.	.	.	.	.	.	X	MU32438491	unknown
X	66765627	66765627	G	A	AR	exonic	synonymous SNV	ENSG00000169083	rs6152	ENSG00000169083:ENST00000374690:exon1:c.G639A:p.E213E,ENSG00000169083:ENST00000396044:exon1:c.G639A:p.E213E,ENSG00000169083:ENST00000504326:exon1:c.G639A:p.E213E,ENSG00000169083:ENST00000514029:exon1:c.G639A:p.E213E	AR:NM_000044:exon1:c.G639A:p.E213E,AR:NM_001348061:exon1:c.G639A:p.E213E,AR:NM_001348063:exon1:c.G639A:p.E213E,AR:NM_001348064:exon1:c.G639A:p.E213E	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1747	0.3189	0.238675	.	.	.	.	.	.	.	.	.	AR:uc004dwu.2:exon1:c.G639A:p.E213E,AR:uc011mpd.2:exon1:c.G639A:p.E213E,AR:uc011mpf.1:exon1:c.G639A:p.E213E,AR:uc022byk.1:exon1:c.G639A:p.E213E	.	AFR:0.2663,AMR:0.6150,EAS:0.1022,FIN:0.0019,NFE:0.1263,OTH:0.1559,ASJ:0.0878	313700	176807;300068;300633;312300;313200;	481;90797;440;99429;1331;	481|SBMA<br>SMAX1-related spinobulbar muscular atrophy<br>X-linked BSMA<br>X-linked bulbospinal amyotrophy<br>X-linked bulbospinal muscular atrophy<br>X-linked spinal and bulbar muscular atrophy|1-9 / 100 000|X-linked recessive|Adult|313200 ~90797|PAIS<br>Partial androgen resistance syndrome|Unknown|X-linked recessive|All ages|312300 ~440|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|146450 300633 300758 300856 ~99429|CAIS<br>Complete androgen resistance syndrome|1-9 / 1 000 000|X-linked recessive|All ages|300068 300274 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	~ko04114 Oocyte meiosis~ko05200 Pathways in cancer~ko05215 Prostate cancer ~	,830,823	.	.	.	.	.	.	X	68(prostate)	0.1295
X	66766145	66766145	G	A	AR	exonic	nonsynonymous SNV	ENSG00000169083	rs555361360	ENSG00000169083:ENST00000374690:exon1:c.G1157A:p.R386H,ENSG00000169083:ENST00000396044:exon1:c.G1157A:p.R386H,ENSG00000169083:ENST00000504326:exon1:c.G1157A:p.R386H,ENSG00000169083:ENST00000514029:exon1:c.G1157A:p.R386H	AR:NM_000044:exon1:c.G1157A:p.R386H,AR:NM_001348061:exon1:c.G1157A:p.R386H,AR:NM_001348063:exon1:c.G1157A:p.R386H,AR:NM_001348064:exon1:c.G1157A:p.R386H	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 1, 2, 1, 1] 	0.0005	.	0.0010596	.	6.814	32	0.0	5.06	0.116	.	.	Armadillo-like helical;WD40/YVTN repeat-like-containing domain	AR:uc004dwu.2:exon1:c.G1157A:p.R386H,AR:uc011mpd.2:exon1:c.G1157A:p.R386H,AR:uc011mpf.1:exon1:c.G1157A:p.R386H,AR:uc022byk.1:exon1:c.G1157A:p.R386H	1.075	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	313700	176807;300068;300633;312300;313200;	481;90797;440;99429;1331;	481|SBMA<br>SMAX1-related spinobulbar muscular atrophy<br>X-linked BSMA<br>X-linked bulbospinal amyotrophy<br>X-linked bulbospinal muscular atrophy<br>X-linked spinal and bulbar muscular atrophy|1-9 / 100 000|X-linked recessive|Adult|313200 ~90797|PAIS<br>Partial androgen resistance syndrome|Unknown|X-linked recessive|All ages|312300 ~440|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|146450 300633 300758 300856 ~99429|CAIS<br>Complete androgen resistance syndrome|1-9 / 1 000 000|X-linked recessive|All ages|300068 300274 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	~ko04114 Oocyte meiosis~ko05200 Pathways in cancer~ko05215 Prostate cancer ~	,830,823	.	.	1.0	-3.83	0.937	2.47	X	.	het
X	66766357	66766368	GGCGGCGGCGGC	-	AR	exonic	nonframeshift deletion	ENSG00000169083	rs746853821	ENSG00000169083:ENST00000374690:exon1:c.1369_1380del:p.457_460del,ENSG00000169083:ENST00000396044:exon1:c.1369_1380del:p.457_460del,ENSG00000169083:ENST00000504326:exon1:c.1369_1380del:p.457_460del,ENSG00000169083:ENST00000514029:exon1:c.1369_1380del:p.457_460del	AR:NM_000044:exon1:c.1369_1380del:p.457_460del,AR:NM_001348061:exon1:c.1369_1380del:p.457_460del,AR:NM_001348063:exon1:c.1369_1380del:p.457_460del,AR:NM_001348064:exon1:c.1369_1380del:p.457_460del	clinvar: Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.0149	.	.	0.0573	.	.	.	.	.	.	.	.	AR:uc004dwu.2:exon1:c.1369_1380del:p.457_460del,AR:uc011mpd.2:exon1:c.1369_1380del:p.457_460del,AR:uc011mpf.1:exon1:c.1369_1380del:p.457_460del,AR:uc022byk.1:exon1:c.1369_1380del:p.457_460del	.	AFR:0.0196,AMR:0.0615,EAS:0.0444,FIN:0.2353,NFE:0.0553,OTH:0.0590,ASJ:0.0690	313700	176807;300068;300633;312300;313200;	481;90797;440;99429;1331;	481|SBMA<br>SMAX1-related spinobulbar muscular atrophy<br>X-linked BSMA<br>X-linked bulbospinal amyotrophy<br>X-linked bulbospinal muscular atrophy<br>X-linked spinal and bulbar muscular atrophy|1-9 / 100 000|X-linked recessive|Adult|313200 ~90797|PAIS<br>Partial androgen resistance syndrome|Unknown|X-linked recessive|All ages|312300 ~440|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|146450 300633 300758 300856 ~99429|CAIS<br>Complete androgen resistance syndrome|1-9 / 1 000 000|X-linked recessive|All ages|300068 300274 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	~ko04114 Oocyte meiosis~ko05200 Pathways in cancer~ko05215 Prostate cancer ~	,830,823	.	.	.	.	.	.	X	.	unknown
X	76937963	76937963	G	C	ATRX	exonic	nonsynonymous SNV	ENSG00000085224	rs3088074	ENSG00000085224:ENST00000395603:exon8:c.C2671G:p.Q891E,ENSG00000085224:ENST00000373344:exon9:c.C2785G:p.Q929E	ATRX:NM_138270:exon8:c.C2671G:p.Q891E,ATRX:NM_000489:exon9:c.C2785G:p.Q929E	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 1, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3924	0.5083	0.552318	78(meninges)	.	.	.	.	.	.	.	.	ATRX:uc004ecq.4:exon8:c.C2671G:p.Q891E,ATRX:uc010nly.1:exon8:c.C2620G:p.Q874E,ATRX:uc004ecp.4:exon9:c.C2785G:p.Q929E,ATRX:uc004ecr.2:exon9:c.C2581G:p.Q861E,ATRX:uc004eco.4:exon10:c.C2140G:p.Q714E,ATRX:uc010nlx.1:exon10:c.C2698G:p.Q900E	.	AFR:2(urinary_tract),AMR:MU152592,EAS:0.4765,FIN:0.8691,NFE:0.2512,OTH:0.3161,ASJ:COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	300504	.	.	.	.	.	,933	.	.	.	.	.	X	1(large_intestine)	0.4430
X	96139406	96139406	G	A	RPA4	exonic	nonsynonymous SNV	ENSG00000204086	rs2642219	ENSG00000204086:ENST00000373040:exon1:c.G97A:p.A33T	RPA4:NM_013347:exon1:c.G97A:p.A33T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3297	0.4205	0.401854	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	-0.340	0.538	0.222	1.31	0.000	.	.	.	RPA4:uc004efv.4:exon1:c.G97A:p.A33T	-1.004	AFR:0.3766,AMR:0.6483,EAS:0.2414,FIN:0.3333,NFE:0.2502,OTH:0.2741,ASJ:0.4013	300767	.	.	.	.	.	.	.	0.18	2.21	0.000	0.695	X	1(lung)	0.2553
X	96139459	96139459	T	C	RPA4	exonic	synonymous SNV	ENSG00000204086	rs2642218	ENSG00000204086:ENST00000373040:exon1:c.T150C:p.N50N	RPA4:NM_013347:exon1:c.T150C:p.N50N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3313	0.4232	0.406093	LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	RPA4:uc004efv.4:exon1:c.T150C:p.N50N	.	AFR:0.3798,AMR:0.6565,EAS:0.2363,FIN:0.3277,NFE:0.2487,OTH:0.2743,ASJ:0.4142	300767	.	.	.	.	.	.	.	.	.	.	.	X	1(stomach)	0.2566
X	129147079	129147079	T	C	BCORL1	exonic	nonsynonymous SNV	ENSG00000085185	rs4830173	ENSG00000085185:ENST00000540052:exon3:c.T331C:p.F111L,ENSG00000085185:ENST00000218147:exon4:c.T331C:p.F111L,ENSG00000085185:ENST00000303743:exon4:c.T331C:p.F111L,ENSG00000085185:ENST00000359304:exon4:c.T331C:p.F111L	BCORL1:NM_001184772:exon3:c.T331C:p.F111L,BCORL1:NM_021946:exon3:c.T331C:p.F111L	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	BCORL1:uc010nrd.1:exon1:c.T37C:p.F13L,BCORL1:uc022cdu.1:exon3:c.T331C:p.F111L	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	300688	.	.	.	.	,968	.	.	.	.	.	.	X	MU82059516	hom
X	129283520	129283520	A	G	AIFM1	exonic	synonymous SNV	ENSG00000156709	rs1139851	ENSG00000156709:ENST00000527892:exon2:c.T130C:p.X44R	AIFM1:NM_001130847:exon3:c.T273C:p.D91D,AIFM1:NM_004208:exon3:c.T273C:p.D91D,AIFM1:NM_145812:exon3:c.T261C:p.D87D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4329	0.5098	0.491126	2(lung)	.	.	.	.	.	.	.	.	AIFM1:uc004evg.3:exon3:c.T273C:p.D91D,AIFM1:uc004evh.3:exon3:c.T261C:p.D87D,AIFM1:uc011mus.2:exon3:c.T273C:p.D91D	.	AFR:MU71557,AMR:LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.7096,FIN:0.4158,NFE:0.5246,OTH:0.1918,ASJ:0.4864	300169	300614;300816;310490;	101078;238329;139583;	101078|CMT4X<br>CMTX4<br>Cowchock syndrome|<1 / 1 000 000|X-linked recessive|Childhood|310490 ~238329|Mitochondrial encephalomyopathy due to COXPD6<br>Mitochondrial encephalomyopathy due to combined oxidative phosphorylation deficiency 6|<1 / 1 000 000|X-linked recessive|Infancy|300816 ~139583|X-linked HSAN with deafness<br>X-linked auditory neuropathy with peripheral sensory neuropathy type 1|<1 / 1 000 000|X-linked recessive|Childhood|300614 ~	.	.	.	.	.	.	.	.	X	1(large_intestine)	0.4586
X	140967121	140967121	A	T	MAGEC3	exonic	nonsynonymous SNV	ENSG00000165509	rs12852593	ENSG00000165509:ENST00000298296:exon3:c.A419T:p.D140V	MAGEC3:NM_138702:exon3:c.A419T:p.D140V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0902	0.0429	0.0831788	0.0452	2.715	20.9	0.001	-0.286	0.001	.	.	.	MAGEC3:uc011mwp.2:exon3:c.A419T:p.D140V	-0.994	AFR:0.0817,AMR:0.2144,EAS:0.0297,FIN:0.0336,NFE:0.0206,OTH:0.0350,ASJ:0.0053	300469	.	.	.	.	.	.	.	0.969	3.0	0.001	0	X	MU85288574	hom
X	140967165	140967165	T	C	MAGEC3	exonic	nonsynonymous SNV	ENSG00000165509	rs11095909	ENSG00000165509:ENST00000298296:exon3:c.T463C:p.S155P	MAGEC3:NM_138702:exon3:c.T463C:p.S155P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3294	0.2664	0.439205	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053	-2.705	0.001	1.0	-1.44	0.000	.	.	.	MAGEC3:uc011mwp.2:exon3:c.T463C:p.S155P	-0.984	AFR:0.2448,AMR:0.5102,EAS:0.0437,FIN:0.4561,NFE:0.1739,OTH:0.0899,ASJ:0.4851	300469	.	.	.	.	.	.	.	0.0	3.29	0.000	0	X	3(lung)	0.1784
X	140967195	140967195	T	A	MAGEC3	exonic	nonsynonymous SNV	ENSG00000165509	rs11095910	ENSG00000165509:ENST00000298296:exon3:c.T493A:p.L165M	MAGEC3:NM_138702:exon3:c.T493A:p.L165M	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3177	0.2054	0.369536	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|4|170|0.0235294,COCA-CN|2|321|0.00623053	-3.271	0.001	1.0	-0.451	0.000	.	.	.	MAGEC3:uc011mwp.2:exon3:c.T493A:p.L165M	-0.904	AFR:0.2242,AMR:0.4256,EAS:0.0398,FIN:0.4646,NFE:0.1739,OTH:0.0923,ASJ:0.4708	300469	.	.	.	.	.	.	.	0.0	3.15	0.000	0	X	4(lung)	0.1858
X	140993745	140993745	T	A	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs74333625	ENSG00000155495:ENST00000285879:exon4:c.T555A:p.S185R	MAGEC1:NM_005462:exon4:c.T555A:p.S185R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0093	.	.	18(upper_aerodigestive_tract)	-0.402	0.382	0.194	.	0.001	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T555A:p.S185R	-0.944	AFR:1(oesophagus),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,FIN:0.0197,NFE:0.0206,OTH:0.0171,ASJ:MU4557601	300223	.	.	.	.	.	.	.	0.347	4.12	0.004	0.255	X	3(large_intestine)	0
X	140993751	140993751	A	G	MAGEC1	exonic	synonymous SNV	ENSG00000155495	rs77851571	ENSG00000155495:ENST00000285879:exon4:c.A561G:p.Q187Q	MAGEC1:NM_005462:exon4:c.A561G:p.Q187Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0039	.	0.00291391	3(thyroid)	.	.	.	.	.	.	.	.	MAGEC1:uc004fbt.3:exon4:c.A561G:p.Q187Q	.	AFR:1(stomach),AMR:MU588340,EAS:0.0167,FIN:0.0392,NFE:0.0060,OTH:0,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|3|402|0.00746269,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	300223	.	.	.	.	.	.	.	.	.	.	.	X	1(biliary_tract)	0
X	140993755	140993755	C	A	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs74748246	ENSG00000155495:ENST00000285879:exon4:c.C565A:p.P189T	MAGEC1:NM_005462:exon4:c.C565A:p.P189T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0036	.	.	1(biliary_tract)	-0.981	0.017	0.984	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C565A:p.P189T	-0.918	AFR:18(upper_aerodigestive_tract),AMR:3(large_intestine),EAS:MU4562795,FIN:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,NFE:0.0119,OTH:0.0269,ASJ:4(thyroid)	300223	.	.	.	.	.	.	.	0.012	4.44	0.004	0.255	X	1(haematopoietic_and_lymphoid_tissue)	0.0109
X	140993852	140993852	C	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176038	ENSG00000155495:ENST00000285879:exon4:c.C662G:p.T221S	MAGEC1:NM_005462:exon4:c.C662G:p.T221S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3109	.	.	5(biliary_tract)	-1.617	0.002	0.612	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C662G:p.T221S	-0.928	AFR:18(upper_aerodigestive_tract),AMR:1(skin),EAS:MU24313706,FIN:SKCA-BR|1|100|0.01,LICA-CN|5|402|0.0124378,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,THCA-CN|2|50|0.04,NFE:0.4042,OTH:0.4465,ASJ:1(haematopoietic_and_lymphoid_tissue)	300223	.	.	.	.	.	.	.	0.002	3.86	0.005	1.1	X	4(thyroid)	0.4260
X	140993859	140993859	T	A	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs6634333	ENSG00000155495:ENST00000285879:exon4:c.T669A:p.S223R	MAGEC1:NM_005462:exon4:c.T669A:p.S223R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3075	.	0.410861	1(skin)	1.014	10.74	0.352	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T669A:p.S223R	-0.927	AFR:MU29513613,AMR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,THCA-CN|1|50|0.02,EAS:0.4339,FIN:0.3969,NFE:0.3649,OTH:0.3150,ASJ:0.4004	300223	.	.	.	.	.	.	.	0.162	4.26	0.004	1.65	X	1(bone)	0.3734
X	140993864	140993864	T	C	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs34836042	ENSG00000155495:ENST00000285879:exon4:c.T674C:p.F225S	MAGEC1:NM_005462:exon4:c.T674C:p.F225S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3129	.	.	2(thyroid)	-1.227	0.006	0.41	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T674C:p.F225S	-0.927	AFR:1(pancreas),AMR:1(kidney),EAS:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,THCA-CN|1|50|0.02,FIN:0.4010,NFE:0.4345,OTH:0.3969,ASJ:MU633586	300223	.	.	.	.	.	.	.	0.002	4.41	0.003	1.1	X	1(haematopoietic_and_lymphoid_tissue)	0.3649
X	140993877	140993877	C	A	MAGEC1	exonic	synonymous SNV	ENSG00000155495	rs176039	ENSG00000155495:ENST00000285879:exon4:c.C687A:p.A229A	MAGEC1:NM_005462:exon4:c.C687A:p.A229A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3381	.	.	1(upper_aerodigestive_tract)	.	.	.	.	.	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C687A:p.A229A	.	AFR:1(skin),AMR:MU624431,EAS:0.3915,FIN:0.4299,NFE:0.4207,OTH:0.3662,ASJ:SKCA-BR|1|100|0.01,LICA-CN|3|402|0.00746269,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	300223	.	.	.	.	.	.	.	.	.	.	.	X	2(large_intestine)	0.3098
X	140993905	140993905	C	T	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176040	ENSG00000155495:ENST00000285879:exon4:c.C715T:p.P239S	MAGEC1:NM_005462:exon4:c.C715T:p.P239S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4364	.	0.329272	2(large_intestine)	-1.155	0.008	0.465	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C715T:p.P239S	-0.926	AFR:MU578592,AMR:LICA-CN|3|402|0.00746269,LUSC-KR|2|170|0.0117647,EAS:0.4115,FIN:0.4096,NFE:0.3731,OTH:0.2952,ASJ:0.4009	300223	.	.	.	.	.	.	.	0.002	4.35	0.000	0	X	2(stomach)	0.3991
X	140993913	140993913	C	G	MAGEC1	exonic	synonymous SNV	ENSG00000155495	rs176041	ENSG00000155495:ENST00000285879:exon4:c.C723G:p.S241S	MAGEC1:NM_005462:exon4:c.C723G:p.S241S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4509	.	.	MU578589	.	.	.	.	.	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C723G:p.S241S	.	AFR:LICA-CN|3|402|0.00746269,LUSC-KR|3|170|0.0176471,AMR:0.3260,EAS:0.3477,FIN:0.3594,NFE:0.2277,OTH:0.3174,ASJ:0.3468	300223	.	.	.	.	.	.	.	.	.	.	.	X	1(stomach)	0.3273
X	140993945	140993945	T	C	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs145765891	ENSG00000155495:ENST00000285879:exon4:c.T755C:p.F252S	MAGEC1:NM_005462:exon4:c.T755C:p.F252S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1945	0.3136	0.488212	LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526	-1.133	0.009	0.623	.	0.002	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T755C:p.F252S	-0.914	AFR:0.3061,AMR:0.3252,EAS:0.2281,FIN:0.1908,NFE:0.3180,OTH:0.3054,ASJ:0.3102	300223	.	.	.	.	.	.	.	0.034	4.38	0.000	-0.83	X	1(lung)	0.3284
X	140993947	140993947	T	C	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs148942485	ENSG00000155495:ENST00000285879:exon4:c.T757C:p.S253P	MAGEC1:NM_005462:exon4:c.T757C:p.S253P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1733	0.3126	0.489272	MU4551709	-1.923	0.001	1.0	.	0.004	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T757C:p.S253P	-1.014	AFR:LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,AMR:0.2855,EAS:0.2780,FIN:0.2241,NFE:0.1754,OTH:0.2958,ASJ:0.3084	300223	.	.	.	.	.	.	.	0.898	4.22	0.000	-0.975	X	1(thyroid)	0.2822
X	140993964	140993964	T	A	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs145720656	ENSG00000155495:ENST00000285879:exon4:c.T774A:p.S258R	MAGEC1:NM_005462:exon4:c.T774A:p.S258R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0002	.	.	.	1.360	12.58	0.0	.	0.001	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T774A:p.S258R	-1.002	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300223	.	.	.	.	.	.	.	0.077	4.6	0.003	1.65	X	MU18621545	het
X	140993980	140993980	G	C	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176042	ENSG00000155495:ENST00000285879:exon4:c.G790C:p.A264P	MAGEC1:NM_005462:exon4:c.G790C:p.A264P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0489	0.0882	0.196026	LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647	-0.831	0.037	1.0	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.G790C:p.A264P	-0.998	AFR:0.0433,AMR:0.0374,EAS:0.0270,FIN:0.0155,NFE:0.0814,OTH:0.0407,ASJ:0.0345	300223	.	.	.	.	.	.	.	0.0	4.28	0.000	-0.66	X	1(peritoneum)	0.0451
X	140994171	140994171	C	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176047	ENSG00000155495:ENST00000285879:exon4:c.C981G:p.H327Q	MAGEC1:NM_005462:exon4:c.C981G:p.H327Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7166	0.6707	0.702517	2(pancreas)	-1.999	0.001	1.0	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C981G:p.H327Q	-0.955	AFR:2(lung),AMR:MU13865040,EAS:0.6995,FIN:0.6181,NFE:0.7429,OTH:0.6620,ASJ:LICA-CN|3|402|0.00746269,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	300223	.	.	.	.	.	.	.	0.001	4.46	0.000	-0.345	X	1(large_intestine)	0.7494
X	140994280	140994280	A	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs4824884	ENSG00000155495:ENST00000285879:exon4:c.A1090G:p.T364A	MAGEC1:NM_005462:exon4:c.A1090G:p.T364A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2552	0.1684	0.26596	0.1846	0.721	8.961	0.0	.	0.000	.	.	.	MAGEC1:uc022cfi.1:exon1:c.A67G:p.T23A,MAGEC1:uc004fbt.3:exon4:c.A1090G:p.T364A	-0.891	AFR:0.0674,AMR:0.3041,EAS:0.4577,FIN:0.2378,NFE:0.2024,OTH:0.2164,ASJ:0.2109	300223	.	.	.	.	.	.	.	0.414	3.88	0.000	0	X	MU14623882	hom
X	141290865	141290865	C	T	MAGEC2	exonic	synonymous SNV	ENSG00000046774	rs3765272	ENSG00000046774:ENST00000247452:exon3:c.G909A:p.P303P	MAGEC2:NM_016249:exon3:c.G909A:p.P303P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7018	0.6634	0.713377	0.6605	.	.	.	.	.	.	.	.	MAGEC2:uc022cfj.1:exon1:c.G909A:p.P303P,MAGEC2:uc004fbu.2:exon3:c.G909A:p.P303P	.	AFR:0.6071,AMR:0.7406,EAS:0.8593,FIN:0.6454,NFE:0.6685,OTH:0.6695,ASJ:0.7111	300468	.	.	.	.	.	.	.	.	.	.	.	X	MU4558141	hom
X	147010320	147010320	G	A	FMR1	exonic	synonymous SNV	ENSG00000102081	rs25707	ENSG00000102081:ENST00000218200:exon5:c.G414A:p.R138R,ENSG00000102081:ENST00000334557:exon5:c.G414A:p.R138R,ENSG00000102081:ENST00000370470:exon5:c.G414A:p.R138R,ENSG00000102081:ENST00000370471:exon5:c.G414A:p.R138R,ENSG00000102081:ENST00000370475:exon5:c.G414A:p.R138R,ENSG00000102081:ENST00000370477:exon5:c.G414A:p.R138R,ENSG00000102081:ENST00000439526:exon5:c.G414A:p.R138R	FMR1:NM_001185075:exon5:c.G414A:p.R138R,FMR1:NM_001185076:exon5:c.G414A:p.R138R,FMR1:NM_001185081:exon5:c.G414A:p.R138R,FMR1:NM_001185082:exon5:c.G414A:p.R138R,FMR1:NM_002024:exon5:c.G414A:p.R138R	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0868	0.1116	0.0996026	0.1010	.	.	.	.	.	.	.	.	FMR1:uc004fcj.3:exon5:c.G414A:p.R138R,FMR1:uc004fck.4:exon5:c.G414A:p.R138R,FMR1:uc010nst.3:exon5:c.G414A:p.R138R,FMR1:uc011mwz.2:exon5:c.G414A:p.R138R,FMR1:uc022cgc.1:exon5:c.G414A:p.R138R,FMR1:uc022cge.1:exon5:c.G414A:p.R138R,FMR1:uc022cgf.1:exon5:c.G414A:p.R138R	.	AFR:0.1659,AMR:0.0562,EAS:0.0010,FIN:0.0871,NFE:0.0823,OTH:0.0962,ASJ:0.0430	309550	300623;300624;311360;	449291;908;93256;	449291|-|Unknown|X-linked dominant|Neonatal<br>Infancy<br>Childhood|300624 ~908|FRAXA syndrome<br>FXS<br>FraX syndrome<br>Martin-Bell syndrome|1-5 / 10 000|X-linked dominant|Neonatal<br>Infancy<br>Childhood|300624 ~93256|FXTAS syndrome|1-9 / 100 000|X-linked dominant|Adult|300623 ~	.	.	.	.	.	.	.	.	X	.	het
X	153215839	153215839	G	A	HCFC1	exonic	synonymous SNV	ENSG00000172534	rs3027875	ENSG00000172534:ENST00000310441:exon24:c.C5859T:p.C1953C,ENSG00000172534:ENST00000369984:exon24:c.C5994T:p.C1998C,ENSG00000172534:ENST00000354233:exon25:c.C5652T:p.C1884C	HCFC1:NM_005334:exon24:c.C5859T:p.C1953C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4320	0.4393	0.191258	1(thyroid)	.	.	.	.	.	.	.	.	HCFC1:uc004fjp.3:exon24:c.C5859T:p.C1953C	.	AFR:MU125153,AMR:LUSC-KR|1|170|0.00588235,EAS:0.0921,FIN:0.2626,NFE:0.5459,OTH:0.0049,ASJ:0.4317	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	1(urinary_tract)	0.5878
X	153218365	153218365	C	A	HCFC1	exonic	synonymous SNV	ENSG00000172534	rs3027878	ENSG00000172534:ENST00000310441:exon19:c.G4542T:p.L1514L,ENSG00000172534:ENST00000369984:exon19:c.G4674T:p.L1558L,ENSG00000172534:ENST00000354233:exon20:c.G4335T:p.L1445L	HCFC1:NM_005334:exon19:c.G4542T:p.L1514L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4065	0.1192	0.383841	MU27601772	.	.	.	.	.	.	.	.	HCFC1:uc004fjp.3:exon19:c.G4542T:p.L1514L	.	AFR:LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,AMR:0.1675,EAS:0.4943,FIN:0.2663,NFE:0.7549,OTH:0.1337,ASJ:0.0704	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	1(stomach)	0.1494
X	153219665	153219665	C	T	HCFC1	exonic	synonymous SNV	ENSG00000172534	rs2071133	ENSG00000172534:ENST00000310441:exon17:c.G4185A:p.A1395A,ENSG00000172534:ENST00000369984:exon17:c.G4185A:p.A1395A,ENSG00000172534:ENST00000354233:exon18:c.G3978A:p.A1326A	HCFC1:NM_005334:exon17:c.G4185A:p.A1395A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3173	0.1513	0.403179	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	HCFC1:uc004fjp.3:exon17:c.G4185A:p.A1395A	.	AFR:0.2003,AMR:0.1108,EAS:0.2762,FIN:0.7653,NFE:0.1721,OTH:0.1801,ASJ:0.5083	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	1(stomach)	0.2348
X	153220360	153220360	A	G	HCFC1	exonic	nonsynonymous SNV	ENSG00000172534	rs1051152	ENSG00000172534:ENST00000310441:exon17:c.T3490C:p.S1164P,ENSG00000172534:ENST00000369984:exon17:c.T3490C:p.S1164P,ENSG00000172534:ENST00000354233:exon18:c.T3283C:p.S1095P	HCFC1:NM_005334:exon17:c.T3490C:p.S1164P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5008	0.3424	0.58596	1(large_intestine)	-0.925	0.023	1.0	-0.339	0.731	.	.	Immunoglobulin-like fold	HCFC1:uc004fjp.3:exon17:c.T3490C:p.S1164P	-1.026	AFR:1(pancreas),AMR:MU1777482,EAS:0.3640,FIN:0.6809,NFE:0.5435,OTH:0.2841,ASJ:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	0.0	4.25	0.000	-2.125	X	1(lung)	0.7737
X	153221657	153221657	T	C	HCFC1	exonic	synonymous SNV	ENSG00000172534	rs730106	ENSG00000172534:ENST00000310441:exon16:c.A2841G:p.P947P,ENSG00000172534:ENST00000369984:exon16:c.A2841G:p.P947P,ENSG00000172534:ENST00000354233:exon17:c.A2634G:p.P878P	HCFC1:NM_005334:exon16:c.A2841G:p.P947P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3737	0.3636	0.585166	0.3632	.	.	.	.	.	.	.	.	HCFC1:uc004fjp.3:exon16:c.A2841G:p.P947P	.	AFR:0.6821,AMR:0.5468,EAS:0.7704,FIN:0.1785,NFE:0.1877,OTH:0.2744,ASJ:0.3011	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	MU21067151	het
X	153222835	153222835	G	C	HCFC1	exonic	synonymous SNV	ENSG00000172534	rs2071134	ENSG00000172534:ENST00000310441:exon13:c.C2283G:p.T761T,ENSG00000172534:ENST00000369984:exon13:c.C2283G:p.T761T,ENSG00000172534:ENST00000354233:exon14:c.C2076G:p.T692T	HCFC1:NM_005334:exon13:c.C2283G:p.T761T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2882	0.1158	0.384106	LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	HCFC1:uc004fjp.3:exon13:c.C2283G:p.T761T	.	AFR:0.1662,AMR:0.0685,EAS:0.2637,FIN:0.7525,NFE:0.1326,OTH:0.1498,ASJ:0.4894	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	1(stomach)	0.2090
X	153227770	153227770	G	A	HCFC1	intronic	.	ENSG00000172534	rs59607260	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3419	0.1494	0.404503	0.2011	.	.	.	.	.	.	.	.	.	.	AFR:0.1162,AMR:0.5,EAS:0.7677,FIN:0.1725,NFE:0.1815,OTH:0.2293,ASJ:0.2826	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	MU27601829	het
X	153577719	153577719	G	A	FLNA	intronic	.	ENSG00000196924	rs7063300	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3221	0.3318	0.14702	0.3079	.	.	.	.	.	.	.	.	.	.	AFR:0.0655,AMR:0.1932,EAS:0.0019,FIN:0.3940,NFE:0.4560,OTH:0.3986,ASJ:0.4703	300017	300048;300049;300244;300321;304120;305620;309350;311300;314400;	1864;669;90650;2484;1826;669;90652;88630;2149;98892;2301;2978;	1864|-|Unknown|Not applicable|Childhood|314400 ~669|Taybi syndrome|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|304120 311300 ~90650|OPD I syndrome<br>OPD syndrome 1<br>Taybi syndrome|-|X-linked dominant|-|311300 ~2484|Melnick-Needles osteodysplasty|<1 / 1 000 000|X-linked dominant|Childhood|309350 ~1826|-|<1 / 1 000 000|X-linked dominant<br>or&nbsp;Autosomal dominant|Neonatal|305620 617137 ~669|Taybi syndrome|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|304120 311300 ~90652|OPD II syndrome<br>OPD syndrome 2|<1 / 1 000 000|X-linked dominant|Neonatal|304120 ~88630|-|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|300244 ~2149|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|All ages|300049 608097 608098 612881 615544 ~98892|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|-|300049 608097 608098 612881 615544 ~2301|-|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|300048 615237 ~2978|CIPO|Unknown|-|All ages|243180 300048 601223 609629 ~	~ko04010 MAPK signaling pathway~ko04510 Focal adhesion~ko05132 Salmonella infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	X	MU113482310	het
X	153994596	153994596	G	T	DKC1	exonic	synonymous SNV	ENSG00000130826	rs2728532	ENSG00000130826:ENST00000452771:exon4:c.G327T:p.T109T,ENSG00000130826:ENST00000369550:exon5:c.G369T:p.T123T,ENSG00000130826:ENST00000413910:exon5:c.G369T:p.T123T	DKC1:NM_001142463:exon5:c.G369T:p.T123T,DKC1:NM_001288747:exon5:c.G369T:p.T123T,DKC1:NM_001363:exon5:c.G369T:p.T123T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9974	0.9919	0.992583	0.9937	.	.	.	.	.	.	.	.	DKC1:uc004fmm.3:exon5:c.G369T:p.T123T,DKC1:uc010nvf.3:exon5:c.G369T:p.T123T	.	AFR:0.9777,AMR:0.9935,EAS:1,FIN:1,NFE:1,OTH:0.9986,ASJ:1	300126	305000;	1775;3322;	1775|DC<br>DKC<br>Zinsser-Engman-Cole syndrome|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|127550 224230 305000 613987 613988 613989 613990 615190 616353 ~3322|Progressive pancytopenia-immunodeficiency-cerebellar hypoplasia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|305000 613989 613990 615190 616353 616553 ~	.	.	.	.	.	.	.	.	X	MU82060809	hom
X	154020114	154020114	C	A	MPP1	exonic	synonymous SNV	ENSG00000130830	rs1126762	ENSG00000130830:ENST00000369531:exon3:c.G204T:p.T68T,ENSG00000130830:ENST00000369534:exon3:c.G255T:p.T85T,ENSG00000130830:ENST00000393529:exon3:c.G117T:p.T39T,ENSG00000130830:ENST00000393531:exon3:c.G255T:p.T85T,ENSG00000130830:ENST00000413259:exon4:c.G165T:p.T55T	MPP1:NM_001166460:exon3:c.G204T:p.T68T,MPP1:NM_001166461:exon3:c.G255T:p.T85T,MPP1:NM_002436:exon3:c.G255T:p.T85T,MPP1:NM_001166462:exon4:c.G165T:p.T55T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6400	0.5528	0.544106	0.5864	.	.	.	.	.	.	.	.	MPP1:uc004fmp.2:exon3:c.G255T:p.T85T,MPP1:uc010nvg.2:exon3:c.G255T:p.T85T,MPP1:uc011mzw.2:exon3:c.G204T:p.T68T,MPP1:uc011mzv.2:exon4:c.G165T:p.T55T	.	AFR:0.2496,AMR:0.5728,EAS:0.7547,FIN:0.7600,NFE:0.7057,OTH:0.7155,ASJ:0.6441	305360	.	.	.	.	.	.	.	.	.	.	.	X	MU13868845	hom
